PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Webb, DJ				Webb, David J.			Value-based medicine pricing: NICE work?	LANCET			English	Editorial Material									Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Webb, DJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland.	cpu@ed.ac.uk						*2020HEALTH ORG, 2009, IMPR PAT OUTC CAN VA; BOSELEY S, 2010, NICE LOSE POWERS DEC; Collier J, 2007, BRIT MED J, V334, P435, DOI 10.1136/bmj.39136.464421.BE; *DEP BUS INN SKILL, 2009, PHARM PRIC REG SCHEM; Hutton J, 2007, INT J TECHNOL ASSESS, V23, P425, DOI 10.1017/S0266462307070651; Martin S., 2007, LINK HEALTHCARE SPEN; Taylor D, 2009, HEALTH ECON POLICY L, V4, P515, DOI 10.1017/S1744133109990247; Webb DJ, 2007, LANCET, V369, P1415, DOI 10.1016/S0140-6736(07)60648-5; 2007, PHARM PRICE REGULATI	9	13	14	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1552	1553		10.1016/S0140-6736(10)62137-X	http://dx.doi.org/10.1016/S0140-6736(10)62137-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21093902				2022-12-01	WOS:000290549700008
J	Selyunin, AS; Sutton, SE; Weigele, BA; Reddick, LE; Orchard, RC; Bresson, SM; Tomchick, DR; Alto, NM				Selyunin, Andrey S.; Sutton, Sarah E.; Weigele, Bethany A.; Reddick, L. Evan; Orchard, Robert C.; Bresson, Stefan M.; Tomchick, Diana R.; Alto, Neal M.			The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold	NATURE			English	Article							STRUCTURAL BASIS; PROTEIN; ACTIVATION; SHIGELLA; MODEL; ARF; SECRETION; COATOMER; SOFTWARE; REVEALS	The fidelity and specificity of information flow within a cell is controlled by scaffolding proteins that assemble and link enzymes into signalling circuits(1,2). These circuits can be inhibited by bacterial effector proteins that post-translationally modify individual pathway components(3-6). However, there is emerging evidence that pathogens directly organize higher-order signalling networks through enzyme scaffolding(7,8), and the identity of the effectors and their mechanisms of action are poorly understood. Here we identify the enterohaemorrhagic Escherichia coli O157:H7 type III effector EspG as a regulator of endomembrane trafficking using a functional screen, and report ADP-ribosylation factor (ARF) GTPases and p21-activated kinases (PAKs) as its relevant host substrates. The 2.5 angstrom crystal structure of EspG in complex with ARF6 shows how EspG blocks GTPase-activating-protein-assisted GTP hydrolysis, revealing a potent mechanism of GTPase signalling inhibition at organelle membranes. In addition, the 2.8 angstrom crystal structure of EspG in complex with the autoinhibitory I alpha 3-helix of PAK2 defines a previously unknown catalytic site in EspG and provides an allosteric mechanism of kinase activation by a bacterial effector. Unexpectedly, ARF and PAKs are organized on adjacent surfaces of EspG, indicating its role as a 'catalytic scaffold' that effectively reprograms cellular events through the functional assembly of GTPase-kinase signalling complex.	[Selyunin, Andrey S.; Sutton, Sarah E.; Weigele, Bethany A.; Reddick, L. Evan; Orchard, Robert C.; Bresson, Stefan M.; Alto, Neal M.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Tomchick, Diana R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Alto, NM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	neal.alto@utsouthwestern.edu		Bresson, Stefan/0000-0002-0329-2243; Tomchick, Diana/0000-0002-7529-4643; Selyunin, Andrey/0000-0002-8980-0009	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NIH [5T32AI007520-12]; Welch Foundation [I-1704]; NIH (NIAID) [1RO1AI083359-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007520, R01AI083359] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank our colleagues, specifically K. Orth, M. Rosen, M. Cobb, J. Seeman, C. Brautigam and T. Fox, for helpful discussions in preparation of this manuscript, and we are particularly indebted to members of the Structural Biology Lab and mass spectrometry facilities for their efforts on this project. We would also like to thank J. Goldberg and G. Bokoch for providing valuable reagents. We would particularly like to thank J. Cherfils for providing preliminary insights into this work and for key reagents. The structure shown in this report is derived from work performed on beamlines 19-BM and 19-ID at the Structural Biology Center, Advanced Photon Source, Argonne National Laboratory. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. R.C.O. was supported by a NIH Molecular Microbiology training grant (5T32AI007520-12). This work was supported by the Welch Foundation (#I-1704) and a grant from the NIH (NIAID; 1RO1AI083359-01) to N.M.A.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, pG30, DOI 10.1152/ajpgi.00302.2005; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis J, 2008, PROTEIN SCI, V17, P2167, DOI 10.1110/ps.037978.108; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Germane KL, 2008, BIOCHEMISTRY-US, V47, P10241, DOI 10.1021/bi801533k; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Guttman JA, 2007, CELL MICROBIOL, V9, P131, DOI 10.1111/j.1462-5822.2006.00773.x; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Isabet T, 2009, EMBO J, V28, P2835, DOI 10.1038/emboj.2009.209; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn RA, 2009, FEBS LETT, V583, P3872, DOI 10.1016/j.febslet.2009.10.066; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shaw RK, 2005, INFECT IMMUN, V73, P4385, DOI 10.1128/IAI.73.7.4385-4390.2005; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Tomson FL, 2005, MOL MICROBIOL, V56, P447, DOI 10.1111/j.1365-2958.2005.04571.x; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Winnen B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002178; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	39	83	86	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					107	U127		10.1038/nature09593	http://dx.doi.org/10.1038/nature09593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21170023	Green Accepted			2022-12-01	WOS:000285921600041
J	Mawuenyega, KG; Sigurdson, W; Ovod, V; Munsell, L; Kasten, T; Morris, JC; Yarasheski, KE; Bateman, RJ				Mawuenyega, Kwasi G.; Sigurdson, Wendy; Ovod, Vitaliy; Munsell, Ling; Kasten, Tom; Morris, John C.; Yarasheski, Kevin E.; Bateman, Randall J.			Decreased Clearance of CNS beta-Amyloid in Alzheimer's Disease	SCIENCE			English	Article							IN-VIVO		[Mawuenyega, Kwasi G.; Sigurdson, Wendy; Ovod, Vitaliy; Munsell, Ling; Kasten, Tom; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Sigurdson, Wendy; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Morris, John C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Yarasheski, Kevin E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Bateman, Randall J.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bateman, RJ (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	batemanr@wustl.edu	Yarasheski, Kevin E/A-3025-2008; Morris, John C/A-1686-2012; Yarasheski, Kevin/AAC-7450-2021	Yarasheski, Kevin/0000-0001-5436-2451; Bateman, Randall/0000-0002-7729-1702	NIH [K08 AG027091, K23 AG030946, R01 NS065667, P50 AG05681, P01 AG03991, UL1 RR024992, P41 RR000954, P60 DK020579, P30 DK056341]; Eli Lilly research; Knight Initiative for Alzheimer's Research; James and Elizabeth McDonnell Fund for Alzheimer's Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG030946, K08AG027091, P50AG005681, P01AG003991] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly research; Knight Initiative for Alzheimer's Research; James and Elizabeth McDonnell Fund for Alzheimer's Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to the participants for their time and effort. The authors thank J. X. Wang for gas chromatography-mass spectrometry (MS) analysis and R. Connors and R. Potter for immunoprecipitation-MS analysis. Special thanks to D. M. Holtzman for mentoring, support, and review of the manuscript. This work was supported by grants from NIH (nos. K08 AG027091, K23 AG030946, R01 NS065667, P50 AG05681, P01 AG03991, UL1 RR024992, P41 RR000954, P60 DK020579, and P30 DK056341), an anonymous foundation, Eli Lilly research, the Knight Initiative for Alzheimer's Research, and the James and Elizabeth McDonnell Fund for Alzheimer's Research. R.J.B. and D. M. Holtzman are cofounders of a company (C2N Diagnostics) that has licensed a pending Washington University patent on the technology described in this article.	Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864	7	1411	1491	6	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1774	1774		10.1126/science.1197623	http://dx.doi.org/10.1126/science.1197623			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21148344	Green Accepted			2022-12-01	WOS:000285603700030
J	Long, EF; Brandeau, ML; Owens, DK				Long, Elisa F.; Brandeau, Margaret L.; Owens, Douglas K.			The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; QUALITY-OF-LIFE; HETEROSEXUAL TRANSMISSION; SEXUAL-BEHAVIOR; MALE CIRCUMCISION; CHILDBEARING AGE; RISK-REDUCTION; SAN-FRANCISCO; VIRAL LOAD	Background: Although recent guidelines call for expanded routine screening for HIV, resources for antiretroviral therapy (ART) are limited, and all eligible persons are not currently receiving treatment. Objective: To evaluate the effects on the U.S. HIV epidemic of expanded ART, HIV screening, or interventions to reduce risk behavior. Design: Dynamic mathematical model of HIV transmission and disease progression and cost-effectiveness analysis. Data Sources: Published literature. Target Population: High-risk (injection drug users and men who have sex with men) and low-risk persons aged 15 to 64 years in the United States. Time Horizon: Twenty years and lifetime (costs and quality-adjusted life-years [QALYs]). Perspective: Societal. Intervention: Expanded HIV screening and counseling, treatment with ART, or both. Outcome Measures: New HIV infections, discounted costs and QALYs, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: One-time HIV screening of low-risk persons coupled with annual screening of high-risk persons could prevent 6.7% of a projected 1.23 million new infections and cost $22 382 per QALY gained, assuming a 20% reduction in sexual activity after screening. Expanding ART utilization to 75% of eligible persons prevents 10.3% of infections and costs $20 300 per QALY gained. A combination strategy prevents 17.3% of infections and costs $21 580 per QALY gained. Results of Sensitivity Analysis: With no reduction in sexual activity, expanded screening prevents 3.7% of infections. Earlier ART initiation when a CD4 count is greater than 0.350 x 10(9) cells/L prevents 20% to 28% of infections. Additional efforts to halve high-risk behavior could reduce infections by 65%. Limitation: The model of disease progression and treatment was simplified, and acute HIV screening was excluded. Conclusion: Expanding HIV screening and treatment simultaneously offers the greatest health benefit and is cost-effective. However, even substantial expansion of HIV screening and treatment programs is not sufficient to markedly reduce the U.S. HIV epidemic without substantial reductions in risk behavior.	[Long, Elisa F.] Yale Univ, Sch Management, New Haven, CT 06520 USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Yale University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Long, EF (corresponding author), Yale Univ, Sch Management, 135 Prospect St, New Haven, CT 06520 USA.	elisa.long@yale.edu	Long, Elisa/AFQ-5915-2022		Department of Veterans Affairs; National Institutes of Health [R-01-DA-15612]; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse, National Institutes of Health, and Department of Veterans Affairs.; By the National Institute on Drug Abuse, National Institutes of Health (R-01-DA-15612), and Department of Veterans Affairs.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; [Anonymous], P 13 C RETR OPP INF; [Anonymous], 2008, SCHWEIZ ARZTEZTG; [Anonymous], CDCS HIV PREV PROGR; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bacon O, 2006, SEX TRANSM DIS, V33, P228, DOI 10.1097/01.olq.0000204914.91923.ad; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Bendavid E, 2009, JAIDS-J ACQ IMM DEF, V52, P106, DOI 10.1097/QAI.0b013e3181a4f9c4; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; BRANDEAU ML, 1993, MANAGE SCI, V39, P72, DOI 10.1287/mnsc.39.1.72; BRANDEAU ML, 1992, ARCH INTERN MED, V152, P2229, DOI 10.1001/archinte.152.11.2229; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brisson M, 1999, SEX TRANSM INFECT, V75, P296, DOI 10.1136/sti.75.5.296; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; *CDCP, 2010, HIV AIDS US; *CDCP, CAS HIV INF AIDS US, V18; *CDCP, HIV AIDS GAY BISEX M; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; *CENSUSSCOPE, 2000, US AGE DISTR; Centers for Disease Control and Prevention, 2008, EST NEW HIV INF US; Centers for Medicare and Medicaid Services, MED FEE SCHED; CLEARY PD, 1991, AM J PUBLIC HEALTH, V81, P1586, DOI 10.2105/AJPH.81.12.1586; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; DAVIS JO, GENERAL SOCIAL GENER; Desai K, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-19; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Fryar Cheryl D, 2007, Adv Data, P1; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gold MR., 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harawa NT, 2004, JAIDS-J ACQ IMM DEF, V35, P526, DOI 10.1097/00126334-200404150-00011; Harris ZK, 2006, HEALTH ECON, V15, P147, DOI 10.1002/hec.1021; HIGGINS DL, 1991, JAMA-J AM MED ASSOC, V266, P2419, DOI 10.1001/jama.266.17.2419; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Hutchinson AB, 2006, JAIDS-J ACQ IMM DEF, V43, P451, DOI 10.1097/01.qai.0000243090.32866.4e; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Joyce VR, 2009, JAIDS-J ACQ IMM DEF, V50, P27, DOI 10.1097/QAI.0b013e31818ce6f3; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; KAPLAN EH, 1990, J ACQ IMMUN DEF SYND, V3, P55; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; Kelly JA, 2009, AIDS BEHAV, V13, P1068, DOI 10.1007/s10461-009-9579-1; Kerndt PR, 2009, AIDS BEHAV, V13, P1037, DOI 10.1007/s10461-009-9580-8; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2009, VACCINE, V27, P5402, DOI 10.1016/j.vaccine.2009.06.063; MacKellar DA, 2006, AIDS, V20, P1637, DOI 10.1097/01.aids.0000238410.67700.d1; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Owens DK, 1996, ARCH INTERN MED, V156, P394, DOI 10.1001/archinte.156.4.394; Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P353, DOI 10.1097/00007435-199808000-00006; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Sanders GD, 2010, J GEN INTERN MED, V25, P556, DOI 10.1007/s11606-010-1265-5; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Taylor A, 2005, EPIDEMIOL INFECT, V133, P193, DOI 10.1017/S0950268804003504; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; TESHALE EH, 2005, P 12 C RETR OPP INF; Tyndall MW, 2002, SEX TRANSM INFECT, V78, pI170, DOI 10.1136/sti.78.suppl_1.i170; [U. S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents], 2009, GUID US ANT AG HIV 1; UNAIDS, 2008 REP GLOB AIDS E; Vernazza P, 2008, LANCET, V372, P1806, DOI 10.1016/S0140-6736(08)61753-5; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; WALL SD, 1991, AM J ROENTGENOL, V157, P911, DOI 10.2214/ajr.157.5.1927808; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; World Health Organization, GLOB HLTH OBS; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; [No title captured]	104	133	136	1	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					778	+		10.7326/0003-4819-153-12-201012210-00004	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173412	Green Accepted			2022-12-01	WOS:000285453700027
J	Axelsson, J; Sundelin, T; Ingre, M; Van Someren, EJW; Olsson, A; Lekander, M				Axelsson, John; Sundelin, Tina; Ingre, Michael; Van Someren, Eus J. W.; Olsson, Andreas; Lekander, Mats			CHRISTMAS 2010: RESEARCH Beauty sleep: experimental study on the perceived health and attractiveness of sleep deprived people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEPRIVATION; DURATION; SYSTEM; IMPACT; BRAIN; HEART; FACE	Objective To investigate whether sleep deprived people are perceived as less healthy, less attractive, and more tired than after a normal night's sleep. Design Experimental study. Setting Sleep laboratory in Stockholm, Sweden. Participants 23 healthy, sleep deprived adults (age 1831) who were photographed and 65 untrained observers (age 18-61) who rated the photographs. Intervention Participants were photographed after a normal night's sleep (eight hours) and after sleep deprivation (31 hours of wakefulness after a night of reduced sleep). The photographs were presented in a randomised order and rated by untrained observers. Main outcome measure Difference in observer ratings of perceived health, attractiveness, and tiredness between sleep deprived and well rested participants using a visual analogue scale (100 mm). Results Sleep deprived people were rated as less healthy (visual analogue scale scores, mean 63 (SE 2) v 68 (SE 2), P<0.001), more tired (53 (SE 3) v 44 (SE 3), P<0.001), and less attractive (38 (SE 2) v 40 (SE 2), P<0.001) than after a normal night's sleep. The decrease in rated health was associated with ratings of increased tiredness and decreased attractiveness. Conclusion Our findings show that sleep deprived people appear less healthy, less attractive, and more tired compared with when they are well rested. This suggests that humans are sensitive to sleep related facial cues, with potential implications for social and clinical judgments and behaviour. Studies are warranted for understanding how these effects may affect clinical decision making and can add knowledge with direct implications in a medical context.	[Axelsson, John; Lekander, Mats] Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, S-17177 Stockholm, Sweden; [Axelsson, John; Sundelin, Tina; Olsson, Andreas] Karolinska Inst, Dept Clin Neurosci, Div Psychol, S-17177 Stockholm, Sweden; [Ingre, Michael; Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Van Someren, Eus J. W.] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Van Someren, Eus J. W.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Karolinska Institutet; Karolinska Institutet; Stockholm University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Axelsson, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, S-17177 Stockholm, Sweden.	john.axelsson@ki.se	Van Someren, Eus/AAA-6789-2020; Axelsson, John/AAH-5998-2019	Axelsson, John/0000-0003-3932-7310; Ingre, Michael/0000-0003-0678-4494; Sundelin, Tina/0000-0002-7590-0826	Swedish Society for Medical Research; Rut and Arvid Wolff's Memory Fund; Osher Center for Integrative Medicine	Swedish Society for Medical Research; Rut and Arvid Wolff's Memory Fund; Osher Center for Integrative Medicine	This study was funded by the Swedish Society for Medical Research, Rut and Arvid Wolff's Memory Fund, and the Osher Center for Integrative Medicine.	Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Cirelli C, 2006, SLEEP MED REV, V10, P307, DOI 10.1016/j.smrv.2006.04.001; Deten A, 2005, CARDIOVASC RES, V65, P52, DOI 10.1016/j.cardiores.2004.11.009; Doyle AC, 1993, CASE BOOK S HOLMES S; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Horne J., 1989, WHY WE SLEEP; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Krull JL, 2001, MULTIVAR BEHAV RES, V36, P249, DOI 10.1207/S15327906MBR3602_06; Lieberman MD, 2002, ADV EXP SOC PSYCHOL, V34, P199, DOI 10.1016/S0065-2601(02)80006-5; Olson LG, 2006, BRIT J HOSP MED, V67, P118, DOI 10.12968/hmed.2006.67.3.20610; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Ranjbaran Z, 2007, INFLAMM RES, V56, P51, DOI 10.1007/s00011-006-6067-1; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; WIERWILLE WW, 1994, ACCIDENT ANAL PREV, V26, P571, DOI 10.1016/0001-4575(94)90019-1; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	23	65	65	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6614	10.1136/bmj.c6614	http://dx.doi.org/10.1136/bmj.c6614			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156746	Green Published, hybrid			2022-12-01	WOS:000285552200004
J	Ratje, AH; Loerke, J; Mikolajka, A; Brunner, M; Hildebrand, PW; Starosta, AL; Donhofer, A; Connell, SR; Fucini, P; Mielke, T; Whitford, PC; Onuchic, JN; Yu, YN; Sanbonmatsu, KY; Hartmann, RK; Penczek, PA; Wilson, DN; Spahn, CMT				Ratje, Andreas H.; Loerke, Justus; Mikolajka, Aleksandra; Bruenner, Matthias; Hildebrand, Peter W.; Starosta, Agata L.; Doenhoefer, Alexandra; Connell, Sean R.; Fucini, Paola; Mielke, Thorsten; Whitford, Paul C.; Onuchic, Jose N.; Yu, Yanan; Sanbonmatsu, Karissa Y.; Hartmann, Roland K.; Penczek, Pawel A.; Wilson, Daniel N.; Spahn, Christian M. T.			Head swivel on the ribosome facilitates translocation by means of intra-subunit tRNA hybrid sites	NATURE			English	Article							ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGES; INTERMEDIATE STATES; MESSENGER-RNA; 70S RIBOSOME; TRANSLATION; MECHANISM; MOVEMENT; GTP	The elongation cycle of protein synthesis involves the delivery of aminoacyl-transfer RNAs to the aminoacyl-tRNA-binding site (A site) of the ribosome, followed by peptide-bond formation and translocation of the tRNAs through the ribosome to reopen the A site(1,2). The translocation reaction is catalysed by elongation factor G (EF-G) in a GTP-dependent manner(3). Despite the availability of structures of various EF-G-ribosome complexes, the precise mechanism by which tRNAs move through the ribosome still remains unclear. Here we use multiparticle cryoelectron microscopy analysis to resolve two previously unseen subpopulations within Thermus thermophilus EF-G-ribosome complexes at subnanometre resolution, one of them with a partly translocated tRNA. Comparison of these substates reveals that translocation of tRNA on the 30S subunit parallels the swivelling of the 30S head and is coupled to unratcheting of the 30S body. Because the tRNA maintains contact with the peptidyl-tRNA-binding site (P site) on the 30S head and simultaneously establishes interaction with the exit site (E site) on the 30S platform, a novel intra-subunit 'pe/E' hybrid state is formed. This state is stabilized by domain IV of EF-G, which interacts with the swivelled 30S-head conformation. These findings provide direct structural and mechanistic insight into the 'missing link' in terms of tRNA intermediates involved in the universally conserved translocation process.	[Ratje, Andreas H.; Loerke, Justus; Bruenner, Matthias; Hildebrand, Peter W.; Mielke, Thorsten; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Ratje, Andreas H.; Hartmann, Roland K.] Univ Marburg, Inst Pharmazeut Chem, D-35037 Marburg, Germany; [Mikolajka, Aleksandra; Starosta, Agata L.; Doenhoefer, Alexandra; Wilson, Daniel N.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Mikolajka, Aleksandra; Starosta, Agata L.; Doenhoefer, Alexandra; Wilson, Daniel N.] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Mikolajka, Aleksandra; Wilson, Daniel N.] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Connell, Sean R.; Fucini, Paola] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Whitford, Paul C.; Sanbonmatsu, Karissa Y.] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Onuchic, Jose N.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Onuchic, Jose N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Yu, Yanan] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA; [Penczek, Pawel A.] Univ Texas Houston, Sch Med, Houston, TX 77030 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; University of Munich; University of Munich; University of Munich; Goethe University Frankfurt; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California San Diego; University of California System; University of California San Diego; State University System of Florida; Florida State University; University of Texas System; University of Texas Health Science Center Houston	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, Ziegelstr 5-9, D-10117 Berlin, Germany.	wilson@lmb.uni-muenchen.de; christian.spahn@charite.de	connell, sean/B-2305-2012; Yu, Yan/GYV-4514-2022; Connell, Sean R/K-6725-2013; Fucini, Paola/M-1118-2014; Connell, Sean/ABF-6090-2021; Starosta, Agata/D-9535-2017; Wilson, Daniel/AAE-8504-2019	connell, sean/0000-0001-7807-7049; Connell, Sean R/0000-0001-7807-7049; Fucini, Paola/0000-0003-1724-8507; Connell, Sean/0000-0001-7807-7049; Starosta, Agata/0000-0003-3915-5723; Wilson, Daniel/0000-0003-3816-3828; Loerke, Justus/0000-0002-3424-8536	Deutsche Forschungsgemeinschaft (DFG) [SFB 740 TP A3, TP Z1, SP 1130/2-1, FU579 1-3, HA 1672/7-5, WI3285/1-1]; European Union 3D-EM Network of Excellence; European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); US National Institutes of Health (NIH) [GM 60635]; Goethe University Frankfurt (DFG) [EXC 115]; Human Frontiers of Science Program [HFSP67/07]; LANL; National Science Foundation (NSF) [PHY-0822283]; NIH [R01-GM072686]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072686, R01GM060635] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union 3D-EM Network of Excellence(European Commission); European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goethe University Frankfurt (DFG)(German Research Foundation (DFG)); Human Frontiers of Science Program(Human Frontier Science Program); LANL(United States Department of Energy (DOE)Los Alamos National Laboratory); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The present work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; SFB 740 TP A3 and TP Z1, SP 1130/2-1 to C.M.T.S., FU579 1-3 to P.F., HA 1672/7-5 to R.K.H. and WI3285/1-1 to D.N.W.), the European Union 3D-EM Network of Excellence (to C.M.T.S.), the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum) and US National Institutes of Health (NIH; grant GM 60635 to P.A.P.), the Cluster of Excellence 'Macromolecular complexes' at the Goethe University Frankfurt (DFG Project EXC 115 to P.F. and S.C.), and the Human Frontiers of Science Program Young Investigators Award HFSP67/07 (to P.F.). We thank the New Mexico Computing Application Center for generous time on the Encanto Supercomputer. P.C.W. is currently funded by a LANL Director's Fellowship. This work was also supported by the Center for Theoretical Biological Physics sponsored by the National Science Foundation (NSF; grant PHY-0822283) with additional support from NSF-MCB-0543906, the LANL LDRD program and NIH grant R01-GM072686.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, REP PROG PHYS, V69, P1383, DOI 10.1088/0034-4885/69/5/R03; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Matassova NB, 2001, RNA, V7, P1879; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Orzechowski M, 2008, BIOPHYS J, V95, P5692, DOI 10.1529/biophysj.108.139451; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Shoji S, 2009, ACS CHEM BIOL, V4, P93, DOI 10.1021/cb8002946; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spirin AS, 2009, J BIOL CHEM, V284, P21103, DOI 10.1074/jbc.X109.001552; Ticu C, 2009, EMBO J, V28, P2053, DOI 10.1038/emboj.2009.169; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Whitford PC, 2009, BIOPHYS J, V96, pL7, DOI 10.1016/j.bpj.2008.10.033; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	42	268	269	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					713	U143		10.1038/nature09547	http://dx.doi.org/10.1038/nature09547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124459	Green Accepted			2022-12-01	WOS:000284836700045
J	Zuccotti, G; Pogliani, L; Pariani, E; Amendola, A; Zanetti, A				Zuccotti, GianVincenzo; Pogliani, Laura; Pariani, Elena; Amendola, Antonella; Zanetti, Alessandro			Transplacental Antibody Transfer Following Maternal Immunization With a Pandemic 2009 Influenza A(H1N1) MF59-Adjuvanted Vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MOTHERS		[Zuccotti, GianVincenzo; Pogliani, Laura] Univ Milan, Dept Pediat, Milan, Italy; [Pariani, Elena; Amendola, Antonella; Zanetti, Alessandro] Univ Milan, Dept Publ Hlth Microbiol & Virol, Milan, Italy	University of Milan; University of Milan	Zuccotti, G (corresponding author), Univ Milan, Dept Pediat, Milan, Italy.	gianvincenzo.zuccotti@unimi.it	Amendola, Antonella/M-8980-2016; Pariani, Elena/M-3491-2016; Zuccotti, Gianvincenzo/H-8572-2017	Amendola, Antonella/0000-0002-0499-8977; Pariani, Elena/0000-0001-5681-3455; Zuccotti, Gianvincenzo/0000-0002-2795-9874				Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	6	53	54	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2360	2361		10.1001/jama.2010.1729	http://dx.doi.org/10.1001/jama.2010.1729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119083				2022-12-01	WOS:000284763900016
J	Junttila, MR; Karnezis, AN; Garcia, D; Madriles, F; Kortlever, RM; Rostker, F; Swigart, LB; Pham, DM; Seo, Y; Evan, GI; Martins, CP				Junttila, Melissa R.; Karnezis, Anthony N.; Garcia, Daniel; Madriles, Francesc; Kortlever, Roderik M.; Rostker, Fanya; Swigart, Lamorna Brown; Pham, David M.; Seo, Youngho; Evan, Gerard I.; Martins, Carla P.			Selective activation of p53-mediated tumour suppression in high-grade tumours	NATURE			English	Article							P53 RESTORATION; MOUSE MODELS; LUNG-CANCER; IN-VIVO; K-RAS; SENESCENCE; EXPRESSION; ONCOGENE; KRAS2	Non-small cell lung carcinoma (NSCLC) is the leading cause of cancer-related death worldwide, with an overall 5-year survival rate of only 10-15%(1). Deregulation of the Ras pathway is a frequent hallmark of NSCLC, often through mutations that directly activate Kras(2). p53 is also frequently inactivated in NSCLC and, because oncogenic Ras can be a potent trigger of p53 (ref. 3), it seems likely that oncogenic Ras signalling has a major and persistent role in driving the selection against p53. Hence, pharmacological restoration of p53 is an appealing therapeutic strategy for treating this disease(4). Here we model the probable therapeutic impact of p53 restoration in a spontaneously evolving mouse model of NSCLC initiated by sporadic oncogenic activation of endogenous Kras(5). Surprisingly, p53 restoration failed to induce significant regression of established tumours, although it did result in a significant decrease in the relative proportion of high-grade tumours. This is due to selective activation of p53 only in the more aggressive tumour cells within each tumour. Such selective activation of p53 correlates with marked upregulation in Ras signal intensity and induction of the oncogenic signalling sensor p19(ARF) (ref. 6). Our data indicate that p53-mediated tumour suppression is triggered only when oncogenic Ras signal flux exceeds a critical threshold. Importantly, the failure of low-level oncogenic Kras to engage p53 reveals inherent limits in the capacity of p53 to restrain early tumour evolution and in the efficacy of therapeutic p53 restoration to eradicate cancers.	[Junttila, Melissa R.; Karnezis, Anthony N.; Garcia, Daniel; Kortlever, Roderik M.; Rostker, Fanya; Swigart, Lamorna Brown; Evan, Gerard I.; Martins, Carla P.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Junttila, Melissa R.; Karnezis, Anthony N.; Garcia, Daniel; Kortlever, Roderik M.; Rostker, Fanya; Swigart, Lamorna Brown; Pham, David M.; Seo, Youngho; Evan, Gerard I.; Martins, Carla P.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Madriles, Francesc] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Pham, David M.; Seo, Youngho] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Research UK; CRUK Cambridge Institute; University of California System; University of California San Francisco	Evan, GI (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	gie20@cam.ac.uk	Kortlever, Roderik/AAY-9220-2020; Seo, Youngho/D-5705-2013	Seo, Youngho/0000-0001-5908-6636; Kortlever, Roderik/0000-0001-5558-2851	NCI [CA98018, CA100193]; AICR [09-0649]; Ellison Medical Foundation; Samuel R. Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA100193, R01CA098018] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AICR; Ellison Medical Foundation(Lawrence Ellison Foundation); Samuel R. Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to T. Jacks for the KR mice, C. Sherr and M. Roussel for the p19<SUP>ARF</SUP> antibody, M. Dail and A.-T. Maia for advice on Kras copy number analysis and V. Weinberg for guidance on statistical analysis. We also thank D. Tuveson and all the members of the Evan laboratory for their comments. This work was supported by grants NCI CA98018, NCI CA100193, AICR 09-0649, the Ellison Medical Foundation and from the Samuel R. Waxman Cancer Research Foundation (all to G.I.E.). M.R.J. is the Enrique Cepero, PhD Fellow of the Damon Runyon Cancer Research Foundation.	Bertwistle D, 2004, HYBRIDOMA HYBRIDOM, V23, P293, DOI 10.1089/hyb.2004.23.293; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1994, CANCER RES, V54, P1169; FELDSER D, 1953, NATURE IN PRESS, DOI DOI 10.1038/NATURE09535; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Wagner PL, 2009, AM J CLIN PATHOL, V132, P500, DOI 10.1309/AJCPF10ZUNSOLIFG; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	30	191	193	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					567	U244		10.1038/nature09526	http://dx.doi.org/10.1038/nature09526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107427	Green Accepted, Green Submitted			2022-12-01	WOS:000284584200043
J	Doitsh, G; Cavrois, M; Lassen, KG; Zepeda, O; Yang, ZY; Santiago, ML; Hebbeler, AM; Greene, WC				Doitsh, Gilad; Cavrois, Marielle; Lassen, Kara G.; Zepeda, Orlando; Yang, Zhiyuan; Santiago, Mario L.; Hebbeler, Andrew M.; Greene, Warner C.			Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION; BYSTANDER APOPTOSIS; LYMPHOCYTES; FUSION; ACTIVATION; MECHANISM; THERAPY; ENTRY; DEATH	The mechanism by which CD4 T cells are depleted in HIV-infected hosts remains poorly understood. In ex vivo cultures of human tonsil tissue, CD4 T cells undergo a pronounced cytopathic response following HIV infection. Strikingly, >95% of these dying cells are not productively infected but instead correspond to bystander cells. We now show that the death of these "bystander'' cells involves abortive HIV infection. Inhibitors blocking HIV entry or early steps of reverse transcription prevent CD4 T cell death while inhibition of later events in the viral life cycle does not. We demonstrate that the nonpermissive state exhibited by the majority of resting CD4 tonsil T cells leads to accumulation of incomplete reverse transcripts. These cytoplasmic nucleic acids activate a host defense program that elicits a coordinated proapoptotic and proinflammatory response involving caspase-3 and caspase-1 activation. While this response likely evolved to protect the host, it centrally contributes to the immunopathogenic effects of HIV.	[Doitsh, Gilad; Cavrois, Marielle; Lassen, Kara G.; Zepeda, Orlando; Yang, Zhiyuan; Santiago, Mario L.; Hebbeler, Andrew M.; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu	Yang, Zhiyuan/C-9543-2012	Yang, Zhiyuan/0000-0002-1175-4188; Santiago, Mario L./0000-0001-7792-2706	Universitywide AIDS Research Program [F04-GIVI-210]; UCSF-GIVI Center for AIDS Research, NIH/NIAID [P30 AI027763]; Francis Goelet Fellowship; UCSF, NIH/NIGMS [T32 GM007618-32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA036502] Funding Source: NIH RePORTER	Universitywide AIDS Research Program; UCSF-GIVI Center for AIDS Research, NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Francis Goelet Fellowship; UCSF, NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank David N. Levy for the NLENG1 plasmid; David Fenard for the NL4-3 variant plasmids SIM, GIA, GIA-SKY, and SKY; George M. Shaw for the WEAU 16-8 env clone; and Suraj J. Patel, Kevin R. King, and Martin L. Yarmush for the H35 ISRE-GFP reporter cell line. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: AMD3100, T-20, Saquinavir, Amprenavir, Indinavir, Nevirapine, Efavirenz, and AZT-resistant HIV-1 clones #629 and #964. Special thanks to Dr. Eva Herker for assistance with fluorescence microscopy; to Dr. Stefanie Sowinski for help with assessing inflammatory responses in primary immune cells; and to Jason Neidleman for stimulating discussions and technical advice. We also thank Marty Bigos for assistance with the flow cytometry; Stephen Ordway and Gary Howard for editorial assistance; John C.W. Carroll and Alisha Wilson for graphics; and Robin Givens and Sue Cammack for administrative assistance. Funding for this project was provided by the Universitywide AIDS Research Program, F04-GIVI-210 (G.D.); the UCSF-GIVI Center for AIDS Research, NIH/NIAID P30 AI027763 (M.C.); the Francis Goelet Fellowship (K.G.L.); and the UCSF Medical Scientist Training Program, NIH/NIGMS T32 GM007618-32 (O.Z.).	ARTS EJ, 1994, ANTIMICROB AGENTS CH, V38, P1008, DOI 10.1128/AAC.38.5.1008; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Grivel JC, 2003, AIDS RES HUM RETROV, V19, P211, DOI 10.1089/088922203763315713; Hayden MS, 2003, AIDS, V17, P629, DOI 10.1097/00002030-200303070-00021; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Holm GH, 2005, J VIROL, V79, P6299, DOI 10.1128/JVI.79.10.6299-6311.2005; Holm GH, 2004, J VIROL, V78, P4541, DOI 10.1128/JVI.78.9.4541-4551.2004; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Labonte JA, 2000, J VIROL, V74, P10690, DOI 10.1128/JVI.74.22.10690-10698.2000; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; MARGOLIS LB, 1995, AIDS RES HUM RETROV, V11, P697, DOI 10.1089/aid.1995.11.697; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; SCHRODER K, 2010, NAT CELL BIOL, V9, P310; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Swiggard WJ, 2004, AIDS RES HUM RETROV, V20, P285, DOI 10.1089/088922204322996527; Thomas C, 2009, NAT MED, V15, P855, DOI 10.1038/nm0809-855; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Vlahakis SR, 2001, J CLIN INVEST, V107, P207, DOI 10.1172/JCI11109; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	41	309	317	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					789	801		10.1016/j.cell.2010.11.001	http://dx.doi.org/10.1016/j.cell.2010.11.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111238	Green Accepted, Bronze			2022-12-01	WOS:000284583500020
J	Shibata, Y; Shemesh, T; Prinz, WA; Palazzo, AF; Kozlov, MM; Rapoport, TA				Shibata, Yoko; Shemesh, Tom; Prinz, William A.; Palazzo, Alexander F.; Kozlov, Michael M.; Rapoport, Tom A.			Mechanisms Determining the Morphology of the Peripheral ER	CELL			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; RIBOSOME RECEPTOR; ROUGH; BINDING; IDENTIFICATION; BIOSYNTHESIS; MICROTUBULES; ORGANIZATION; GTPASES	The endoplasmic reticulum (ER) consists of the nuclear envelope and a peripheral network of tubules and membrane sheets. The tubules are shaped by the curvature-stabilizing proteins reticulons and DP1/Yop1p, but how the sheets are formed is unclear. Here, we identify several sheet-enriched membrane proteins in the mammalian ER, including proteins that translocate and modify newly synthesized polypeptides, as well as coiled-coil membrane proteins that are highly upregulated in cells with proliferated ER sheets, all of which are localized by membrane-bound polysomes. These results indicate that sheets and tubules correspond to rough and smooth ER, respectively. One of the coiled-coil proteins, Climp63, serves as a "luminal ER spacer'' and forms sheets when overexpressed. More universally, however, sheet formation appears to involve the reticulons and DP1/Yop1p, which localize to sheet edges and whose abundance determines the ratio of sheets to tubules. These proteins may generate sheets by stabilizing the high curvature of edges.	[Shemesh, Tom; Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Shibata, Yoko; Palazzo, Alexander F.; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Shibata, Yoko] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Prinz, William A.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Palazzo, Alexander F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Toronto	Kozlov, MM (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	michk@post.tau.ac.il; tom_rapoport@hms.harvard.edu	Palazzo, Alexander/B-1270-2013; Shemesh, Tom/J-5060-2013	Palazzo, Alexander/0000-0002-9700-1995; 	American Heart Association; National Institute of Diabetes and Digestive and Kidney Diseases; Israel Science Foundation (ISF); Marie Curie network "Virus Entry"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060105] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Israel Science Foundation (ISF)(Israel Science Foundation); Marie Curie network "Virus Entry"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Denison, J. Minsteris, and S. Gygi for mass spectrometry analysis; J. Baughman for microarray analysis; A. Condon and A. Boye-Doe for technical assistance; J. Iwasa for help with illustrations; G. Kreibich, K. Ogawa-Goto, L. Lu, and R. Yan for materials; the Nikon Imaging Center and the Electron Microscopy facility at HMS for microscopy assistance; and R. Klemm and A. Osborne for critical reading of the manuscript. Y.S. was supported by the American Heart Association and is a Howard Hughes Medical Institute postdoctoral fellow. W.A.P. is supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. T.A.R. is a Howard Hughes Medical Institute Investigator. M.M.K. is supported by the Israel Science Foundation (ISF) and the Marie Curie network "Virus Entry.''	AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Benyamini P, 2009, MOL BIOL CELL, V20, P732, DOI 10.1091/mbc.E08-07-0682; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Christensen AK, 1999, ANAT REC, V255, P116, DOI 10.1002/(SICI)1097-0185(19990601)255:2<116::AID-AR2>3.0.CO;2-O; Dawson TR, 2009, J CELL BIOL, V184, P659, DOI 10.1083/jcb.200806174; Fawcett D.W., 1981, CELL; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HINMAN ND, 1970, SCIENCE, V170, P1222, DOI 10.1126/science.170.3963.1222; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Nikonov AV, 2007, J CELL SCI, V120, P2248, DOI 10.1242/jcs.008979; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Senda T, 1998, ANAT REC, V251, P339; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sparkes I, 2010, PLANT CELL, V22, P1333, DOI 10.1105/tpc.110.074385; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Ueno T, 2010, J BIOL CHEM, V285, P29941, DOI 10.1074/jbc.M109.094607; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; VOGEL F, 1990, EUR J CELL BIOL, V53, P197; [No title captured]	38	324	331	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					774	788		10.1016/j.cell.2010.11.007	http://dx.doi.org/10.1016/j.cell.2010.11.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111237	Bronze, Green Accepted			2022-12-01	WOS:000284583500019
J	Heymann, DL; Fine, PE; Griffiths, UK; Hall, AJ; Mounier-Jack, S				Heymann, David L.; Fine, Paul E.; Griffiths, Ulla K.; Hall, Andrew J.; Mounier-Jack, Sandra			Measles eradication: past is prologue	LANCET			English	Editorial Material							POLIO; HEALTH		[Heymann, David L.; Fine, Paul E.; Griffiths, Ulla K.; Hall, Andrew J.; Mounier-Jack, Sandra] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Heymann, David L.] Chatham House Ctr Global Hlth Secur, London, England	University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	david.heymann@hpa.org.uk						Closser S, 2010, CHASING POLIO PAKIST; de Quadros CA, 2008, EXPERT REV VACCINES, V7, P355, DOI 10.1586/14760584.7.3.355; *FORT WORLD HLTH A, 1988, GLOB ER POL YEAR 200; Heymann DL, 2006, BIOLOGICALS, V34, P75, DOI 10.1016/j.biologicals.2006.03.005; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; Meissner HC, 2004, PEDIATRICS, V114, P1065, DOI 10.1542/peds.2004-0440; MORLEY D, 1969, BMJ-BRIT MED J, V1, P363, DOI 10.1136/bmj.1.5640.363; MORLEY D, 1969, BRIT MED J, V1, P291; Moss WJ, 2009, CURR TOP MICROBIOL, V330, P173; Renne E, 2006, SOC SCI MED, V63, P1857, DOI 10.1016/j.socscimed.2006.04.025; Unger Jean-Pierre, 2006, Int J Integr Care, V6, pe14; Unger JP, 2003, INT J HEALTH PLAN M, V18, pS27, DOI 10.1002/hpm.723; *WHO, 2010, EXP ASS MEASL ER FEA; *WHO, 2010, WHO EP BRIEF, V8; World Health Organization, 2010, WHO UNICEF EST NAT I	15	22	22	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1719	1720		10.1016/S0140-6736(10)61934-4	http://dx.doi.org/10.1016/S0140-6736(10)61934-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690EI	21093636				2022-12-01	WOS:000284984900008
J	Ting, DT; Lipson, D; Paul, S; Brannigan, BW; Akhavanfard, S; Coffman, EJ; Contino, G; Deshpande, V; Iafrate, AJ; Letovsky, S; Rivera, MN; Bardeesy, N; Maheswaran, S; Haber, DA				Ting, David T.; Lipson, Doron; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Letovsky, Stan; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.			Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers	SCIENCE			English	Article							PERVASIVE TRANSCRIPTION; DIFFERENTIATION; ELEMENTS; DATABASE; RNAS	Satellite repeats in heterochromatin are transcribed into noncoding RNAs that have been linked to gene silencing and maintenance of chromosomal integrity. Using digital gene expression analysis, we showed that these transcripts are greatly overexpressed in mouse and human epithelial cancers. In 8 of 10 mouse pancreatic ductal adenocarcinomas (PDACs), pericentromeric satellites accounted for a mean 12% (range 1 to 50%) of all cellular transcripts, a mean 40-fold increase over that in normal tissue. In 15 of 15 human PDACs, alpha satellite transcripts were most abundant and HSATII transcripts were highly specific for cancer. Similar patterns were observed in cancers of the lung, kidney, ovary, colon, and prostate. Derepression of satellite transcripts correlated with overexpression of the long interspersed nuclear element 1 (LINE-1) retrotransposon and with aberrant expression of neuroendocrine-associated genes proximal to LINE-1 insertions. The overexpression of satellite transcripts in cancer may reflect global alterations in heterochromatin silencing and could potentially be useful as a biomarker for cancer detection.	[Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02114 USA; [Lipson, Doron; Letovsky, Stan] Helicos BioSci Corp, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	haber@helix.mgh.harvard.edu	Akhavanfard, Sara/R-2032-2017; Akhavanfard, Sara/AAP-6475-2020; Ting, David/F-4389-2017	Akhavanfard, Sara/0000-0003-1659-8185; Akhavanfard, Sara/0000-0003-1659-8185; Ting, David/0000-0002-3261-2322; Contino, Gianmarco/0000-0001-5874-0405	Pancreatic Cancer Action Network-American Association for Cancer Research; Warshaw Institute for Pancreatic Cancer Research; Fond. Veronesi; Howard Hughes Medical Institute; National Cancer Institute [CA129933]; NATIONAL CANCER INSTITUTE [P01CA117969, R01CA133557, R01CA129933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010023] Funding Source: NIH RePORTER	Pancreatic Cancer Action Network-American Association for Cancer Research; Warshaw Institute for Pancreatic Cancer Research; Fond. Veronesi(Fondazione Umberto Veronesi); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship and the Warshaw Institute for Pancreatic Cancer Research (D.T.T.); Fond. Veronesi (G.C.); Howard Hughes Medical Institute (D.A.H. and M.N.R.); and National Cancer Institute CA129933 (D.A.H). We thank T. Raz, P. Kapranov, E. Giladi, and J. Whetstine for helpful discussions and K. Haigis and K. Wong for providing mouse colon and lung tumors, respectively. Massachusetts General Hospital and the authors (D.A.H., D.L., S.M., D.T.T.) have filed a patent application relating to detection of satellite and LINE sequences in human cancers.	Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Cindolo L, 2007, UROL INT, V79, P287, DOI 10.1159/000109711; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Montoya-Durango DE, 2009, MUTAT RES-FUND MOL M, V665, P20, DOI 10.1016/j.mrfmmm.2009.02.011; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Tezel E, 2000, CANCER, V89, P2230, DOI 10.1002/1097-0142(20001201)89:11<2230::AID-CNCR11>3.0.CO;2-X; Ugarkovic D, 2005, EMBO REP, V6, P1035, DOI 10.1038/sj.embor.7400558; Valgardsdottir R, 2008, NUCLEIC ACIDS RES, V36, P423, DOI 10.1093/nar/gkm1056	23	336	367	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					593	596		10.1126/science.1200801	http://dx.doi.org/10.1126/science.1200801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21233348	Green Accepted			2022-12-01	WOS:000286933600056
J	Cang, H; Labno, A; Lu, CG; Yin, XB; Liu, M; Gladden, C; Liu, YM; Zhang, X				Cang, Hu; Labno, Anna; Lu, Changgui; Yin, Xiaobo; Liu, Ming; Gladden, Christopher; Liu, Yongmin; Zhang, Xiang			Probing the electromagnetic field of a 15-nanometre hotspot by single molecule imaging	NATURE			English	Article							ENHANCED RAMAN-SCATTERING; SURFACE-PLASMONS; SILVER ELECTRODE; DIFFRACTION-LIMIT; ENERGY-TRANSFER; MICROSCOPY; SPECTROSCOPY; PYRIDINE; LOCALIZATION; EXCITATION	When light illuminates a rough metallic surface, hotspots can appear, where the light is concentrated on the nanometre scale, producing an intense electromagnetic field. This phenomenon, called the surface enhancement effect(1,2), has a broad range of potential applications, such as the detection of weak chemical signals. Hotspots are believed to be associated with localized electromagnetic modes(3,4), caused by the randomness of the surface texture. Probing the electromagnetic field of the hotspots would offer much insight towards uncovering the mechanism generating the enhancement; however, it requires a spatial resolution of 1-2 nm, which has been a long-standing challenge in optics. The resolution of an optical microscope is limited to about half the wavelength of the incident light, approximately 200-300 nm. Although current state-of-the-art techniques, including near-field scanning optical microscopy(5), electron energy-loss spectroscopy(6), cathode luminescence imaging(7) and two-photon photoemission imaging(8) have subwavelength resolution, they either introduce a non-negligible amount of perturbation, complicating interpretation of the data, or operate only in a vacuum. As a result, after more than 30 years since the discovery of the surface enhancement effect(9-11), how the local field is distributed remains unknown. Here we present a technique that uses Brownian motion of single molecules to probe the local field. It enables two-dimensional imaging of the fluorescence enhancement profile of single hotspots on the surfaces of aluminium thin films and silver nanoparticle clusters, with accuracy down to 1.2 nm. Strong fluorescence enhancements, up to 54 and 136 times respectively, are observed in those two systems. This strong enhancement indicates that the local field, which decays exponentially from the peak of a hotspot, dominates the fluorescence enhancement profile.	[Cang, Hu; Yin, Xiaobo; Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Cang, Hu; Labno, Anna; Lu, Changgui; Yin, Xiaobo; Liu, Ming; Gladden, Christopher; Liu, Yongmin; Zhang, Xiang] Univ Calif Berkeley, NSF Nano Scale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Labno, Anna] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Science Foundation (NSF); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Zhang, Xiang/F-6905-2011; Yin, Xiaobo/A-4142-2011; Liu, Yongmin/F-5322-2010	Liu, Ming/0000-0001-9849-1845; Zhang, Xiang/0000-0002-3272-894X	US Department of Energy Office of Science, Basic Energy Sciences and Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	US Department of Energy Office of Science, Basic Energy Sciences and Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	We thank G. Bartal and A. Niv for discussions. This research was supported by the US Department of Energy Office of Science, Basic Energy Sciences and Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231.	ALBRECHT MG, 1977, J AM CHEM SOC, V99, P5215, DOI 10.1021/ja00457a071; Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; BETZIG E, 1992, SCIENCE, V257, P189, DOI 10.1126/science.257.5067.189; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; CHANCE RR, 1975, J CHEM PHYS, V62, P2245, DOI 10.1063/1.430748; CHANG CC, 1978, J ELECTROCHEM SOC, V125, pC136; CREIGHTON JA, 1979, J CHEM SOC FARAD T 2, V75, P790, DOI 10.1039/f29797500790; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; GERSTEN J, 1980, J CHEM PHYS, V73, P3023, DOI 10.1063/1.440560; Hell S. W., 2009, SINGLE MOL SPECTROSC, P365; Hutchison JA, 2009, NANO LETT, V9, P995, DOI 10.1021/nl8030696; JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Kubo A, 2007, J PHYS B-AT MOL OPT, V40, pS259, DOI 10.1088/0953-4075/40/11/S02; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/NMETH.1447, 10.1038/nmeth.1447]; MOSKOVITS M, 1978, J CHEM PHYS, V69, P4159, DOI 10.1063/1.437095; Nelayah J, 2007, NAT PHYS, V3, P348, DOI 10.1038/nphys575; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Roeffaers MBJ, 2009, ANGEW CHEM INT EDIT, V48, P9285, DOI 10.1002/anie.200904944; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sarychev AK, 1999, PHYS REV B, V60, P16389, DOI 10.1103/PhysRevB.60.16389; Seal K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.206103; SHALAEV VM, 1988, Z PHYS D ATOM MOL CL, V10, P71, DOI 10.1007/BF01425582; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Stockman MI, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.167401; Taminiau TH, 2008, NAT PHOTONICS, V2, P234, DOI 10.1038/nphoton.2008.32; Vesseur EJR, 2007, NANO LETT, V7, P2843, DOI 10.1021/nl071480w; WOKAUN A, 1983, J CHEM PHYS, V79, P509, DOI 10.1063/1.445550; Wu DM, 2008, NANO LETT, V8, P1159, DOI 10.1021/nl0733280	30	208	208	2	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					385	+		10.1038/nature09698	http://dx.doi.org/10.1038/nature09698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248848				2022-12-01	WOS:000286385600049
J	Fewtrell, M; Wilson, DC; Booth, I; Lucas, A				Fewtrell, Mary; Wilson, David C.; Booth, Ian; Lucas, Alan			Six months of exclusive breast feeding: how good is the evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IRON-DEFICIENCY; DURATION; RISK; HOSPITALIZATION; INFANTS; HEALTH; CONSUMPTION; INFECTION; EXPOSURE; CHILDREN		[Fewtrell, Mary; Lucas, Alan] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London WC1N 1EH, England; [Wilson, David C.] Univ Edinburgh, Coll Med & Vet Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Booth, Ian] Univ Birmingham, Inst Child Hlth, Birmingham B15 2TT, W Midlands, England	University of London; University College London; University of Edinburgh; University of Birmingham	Fewtrell, M (corresponding author), UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London WC1N 1EH, England.	m.fewtrell@ich.ucl.ac.uk			Medical Research Council [G1002033] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Agostoni C, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1423; Bolling K, 2007, INFANT FEEDING SURVE; British Dietetic Association, 2010, BDA PAED GROUP POS S; Chantry CJ, 2007, BREASTFEED MED, V2, P63, DOI 10.1089/bfm.2007.0002; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Garza C, 2002, NUTRIENT ADEQUACY EX; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Kramer MS, 2009, AM J CLIN NUTR, V90, P1070, DOI 10.3945/ajcn.2009.28021; Kramer MS, 2003, AM J CLIN NUTR, V78, P291, DOI 10.1093/ajcn/78.2.291; KRAMER MS, 2002, OPTIMAL DURATION EXC; Lanigan JA, 2001, EUR J CLIN NUTR, V55, P309, DOI 10.1038/sj.ejcn.1601168; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Lucas A, 1998, J NUTR, V128, p401S, DOI 10.1093/jn/128.2.401S; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; [OECD Directorate for Employment Labour and Social Affairs Social Policy Division], 2009, OECD FAM DAT CO1 5 B; Olsson C, 2008, PEDIATRICS, V122, P528, DOI 10.1542/peds.2007-2989; Talayero JMP, 2006, PEDIATRICS, V118, pE92, DOI 10.1542/peds.2005-1629; Platt MPW, 2009, ARCH DIS CHILD, V94, P79, DOI 10.1136/adc.2008.150011; Poole JA, 2006, J ALLERGY CLIN IMMUN, V117, pS42, DOI 10.1016/j.jaci.2005.12.174; Prescott SL, 2008, PEDIAT ALLERG IMM-UK, V19, P375, DOI 10.1111/j.1399-3038.2008.00718.x; Quigley MA, 2009, ARCH DIS CHILD, V94, P148, DOI 10.1136/adc.2008.146126; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Rebhan B, 2009, ACTA PAEDIATR, V98, P974, DOI 10.1111/j.1651-2227.2009.01281.x; Reilly JJ, 2005, BRIT J NUTR, V94, P56, DOI 10.1079/BJN20051464; Reilly JJ, 2005, BRIT J NUTR, V94, P869, DOI 10.1079/BJN20051601; Schack-Nielsen L, 2010, AM J CLIN NUTR, V91, P619, DOI 10.3945/ajcn.2008.27078; [Scientific Advisory Committee on Nutrition (SACN) Subgroup on Maternal and Child Nutrition (SMCN)], 2003, SMCN0308 SACN; [Scientific Advisory Committee on Nutrition (SACN) Subgroup on Maternal and Child Nutrition (SMCN)], 2003, 2 M SUBGR MAT CHILD; WHO, 1998, WHONUT981; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; World Health Organization (WHO), 2002, 55 WORLD HLTH ASS IN	34	79	80	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2011	342								c5955	10.1136/bmj.c5955	http://dx.doi.org/10.1136/bmj.c5955			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708TG	21233152	Green Published			2022-12-01	WOS:000286386600005
J	Mizuno, H; Higashida, C; Yuan, YF; Ishizaki, T; Narumiya, S; Watanabe, N				Mizuno, Hiroaki; Higashida, Chiharu; Yuan, Yunfeng; Ishizaki, Toshimasa; Narumiya, Shuh; Watanabe, Naoki			Rotational Movement of the Formin mDia1 Along the Double Helical Strand of an Actin Filament	SCIENCE			English	Article							ADP-ACTIN; ATP-ACTIN; MECHANISM; DYNAMICS; POLYMERIZATION; NUCLEATION; PROFILIN; TWIST	Formin homology proteins (formins) elongate actin filaments (F-actin) by continuously associating with filament tips, potentially harnessing actin-generated pushing forces. During this processive elongation, formins are predicted to rotate along the axis of the double helical F-actin structure (referred to here as helical rotation), although this has not yet been definitively shown. We demonstrated helical rotation of the formin mDia1 by single-molecule fluorescence polarization (FLP). FLP of labeled F-actin, both elongating and depolymerizing from immobilized mDia1, oscillated with a periodicity corresponding to that of the F-actin long-pitch helix, and this was not altered by actin-bound nucleotides or the actin-binding protein profilin. Thus, helical rotation is an intrinsic property of formins. To harness pushing forces from growing F-actin, formins must be anchored flexibly to cell structures.	[Mizuno, Hiroaki; Watanabe, Naoki] Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Higashida, Chiharu; Yuan, Yunfeng; Ishizaki, Toshimasa; Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan	Tohoku University; Kyoto University	Watanabe, N (corresponding author), Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	nwatanabe@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Uehara Memorial Foundation; Human Frontier Science Program	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Human Frontier Science Program(Human Frontier Science Program)	We thank H. Honda for rabbit muscle acetone powder and T. M. Watanabe for customizing the G-track software. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and grants from the Uehara Memorial Foundation (N.W.) and the Human Frontier Science Program (N.W.).	Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higashida C, 2008, J CELL SCI, V121, P3403, DOI 10.1242/jcs.030940; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2009, NATURE, V457, P389, DOI 10.1038/457389a; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe N, 2010, P JPN ACAD B-PHYS, V86, P62, DOI 10.2183/pjab.86.62	27	79	80	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					80	83		10.1126/science.1197692	http://dx.doi.org/10.1126/science.1197692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21148346				2022-12-01	WOS:000285974000040
J	Nichols, D				Nichols, David			Legal highs: the dark side of medicinal chemistry	NATURE			English	Editorial Material									Purdue Univ, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nichols, D (corresponding author), Purdue Univ, W Lafayette, IN 47907 USA.	drdave@purdue.edu							0	15	15	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					7	7		10.1038/469007a	http://dx.doi.org/10.1038/469007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	702UO	21209630	Bronze			2022-12-01	WOS:000285921600002
J	Li, WT; Chetelat, RT				Li, Wentao; Chetelat, Roger T.			A Pollen Factor Linking Inter- and Intraspecific Pollen Rejection in Tomato	SCIENCE			English	Article							SELF-INCOMPATIBILITY; S-RNASE; LYCOPERSICON-ESCULENTUM; UNILATERAL INCOMPATIBILITY; SOLANUM-LYCOPERSICOIDES; IDENTIFICATION; COMPATIBILITY; EXPRESSION; INCONGRUITY; PERUVIANUM	Self-incompatibility (SI)-intraspecific pollen recognition systems that allow plants to avoid inbreeding-in the Solanaceae (the nightshade family) is controlled by a polymorphic S locus where "self" pollen is rejected on pistils with matching S alleles. In contrast, unilateral interspecific incompatibility (UI) prevents hybridization between related species, most commonly when the pollen donor is self-compatible (SC) and the recipient is SI. We observed that in Solanum, a pollen-expressed Cullin1 gene with high similarity to Petunia SI factors interacts genetically with a gene at or near the S locus to control UI. Cultivated tomato and related red-or orange-fruited species (all SC) exhibit the same loss-of-function mutation in this gene, whereas the green-fruited species (mostly SI) contain a functional allele; hence, similar biochemical mechanisms underlie the rejection of both "self" and interspecific pollen.	[Li, Wentao; Chetelat, Roger T.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Chetelat, RT (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	trchetelat@ucdavis.edu			NSF [DBI 0605200]	NSF(National Science Foundation (NSF))	We thank J. DeVerna, P. March, K. Smith, and the C. M. Rick Tomato Genetics Resource Center (TGRC) staff for providing seed or cuttings of key genotypes; P. March for photos of fruit; B. McClure and P. Bedinger for comments on the manuscript; and S. Tanksley for providing seed of S. habrochaites introgression lines. Supported by NSF grant DBI 0605200. Sequence data have been deposited in GenBank under accession numbers HQ610200 and HQ610201. Seed requests submitted to the TGRC are subject to a material transfer agreement (http://tgrc.ucdavis.edu/MTA/TGRC-MTA.pdf).	Bernacchi D, 1997, GENETICS, V147, P861; Canady MA, 2005, GENOME, V48, P685, DOI 10.1139/G05-032; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; CHETELAT RT, 1991, THEOR APPL GENET, V82, P704, DOI 10.1007/BF00227314; Covey PA, 2010, PLANT J, V64, P367, DOI 10.1111/j.1365-313X.2010.04340.x; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; HO JY, 1992, PLANT J, V2, P971; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; LEWIS D., 1958, HEREDITY, V12, P233, DOI 10.1038/hdy.1958.26; Li WT, 2010, GENETICS, V185, P1069, DOI 10.1534/genetics.110.116343; Liedl BE, 1996, SEX PLANT REPROD, V9, P299, DOI 10.1007/BF02152705; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McClure B, 2009, J EXP BOT, V60, P1069, DOI 10.1093/jxb/erp024; Monforte AJ, 2000, GENOME, V43, P803, DOI 10.1139/gen-43-5-803; Murfett J, 1996, PLANT CELL, V8, P943, DOI 10.1105/tpc.8.6.943; Mutschler M. A., 1994, Genetic control of self-incompatibility and reproductive development in flowering plants., P164; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Rick C.M., 1988, PLANT EVOLUTIONARY B, P133, DOI DOI 10.1007/978-94-009-1207-6_6; RICK CM, 1986, P NATL ACAD SCI USA, V83, P3580, DOI 10.1073/pnas.83.11.3580; RICK CM, 1986, SOLANACEAE BIOL SYST, P475; ROYO J, 1994, P NATL ACAD SCI USA, V91, P6511, DOI 10.1073/pnas.91.14.6511; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; TWELL D, 1990, DEVELOPMENT, V109, P705; van Heusden AW, 1999, THEOR APPL GENET, V99, P1068, DOI 10.1007/s001220051416; Zhao L, 2010, PLANT J, V62, P52, DOI 10.1111/j.1365-313X.2010.04123.x; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	27	81	85	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1827	1830		10.1126/science.1197908	http://dx.doi.org/10.1126/science.1197908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205670				2022-12-01	WOS:000285603700042
J	Teolis, BD; Jones, GH; Miles, PF; Tokar, RL; Magee, BA; Waite, JH; Roussos, E; Young, DT; Crary, FJ; Coates, AJ; Johnson, RE; Tseng, WL; Baragiola, RA				Teolis, B. D.; Jones, G. H.; Miles, P. F.; Tokar, R. L.; Magee, B. A.; Waite, J. H.; Roussos, E.; Young, D. T.; Crary, F. J.; Coates, A. J.; Johnson, R. E.; Tseng, W-L; Baragiola, R. A.			Cassini Finds an Oxygen-Carbon Dioxide Atmosphere at Saturn's Icy Moon Rhea	SCIENCE			English	Article							CONDENSED O-2; SATELLITES; OZONE; EUROPA	The flyby measurements of the Cassini spacecraft at Saturn's moon Rhea reveal a tenuous oxygen (O-2)-carbon dioxide (CO2) atmosphere. The atmosphere appears to be sustained by chemical decomposition of the surface water ice under irradiation from Saturn's magnetospheric plasma. This in situ detection of an oxidizing atmosphere is consistent with remote observations of other icy bodies, such as Jupiter's moons Europa and Ganymede, and suggestive of a reservoir of radiolytic O-2 locked within Rhea's ice. The presence of CO2 suggests radiolysis reactions between surface oxidants and organics or sputtering and/or outgassing of CO2 endogenic to Rhea's ice. Observations of outflowing positive and negative ions give evidence for pickup ionization as a major atmospheric loss mechanism.	[Teolis, B. D.; Miles, P. F.; Magee, B. A.; Waite, J. H.; Young, D. T.; Crary, F. J.] SW Res Inst, Space Sci & Engn Div, San Antonio, TX 78238 USA; [Jones, G. H.; Coates, A. J.] Univ Coll London, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; [Jones, G. H.; Coates, A. J.] UCL Birkbeck, Ctr Planetary Sci, London WC1E 6BT, England; [Tokar, R. L.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Roussos, E.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Johnson, R. E.; Tseng, W-L; Baragiola, R. A.] Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA 22903 USA	Southwest Research Institute; University of London; University College London; University of London; Birkbeck University London; University College London; United States Department of Energy (DOE); Los Alamos National Laboratory; Max Planck Society; University of Virginia	Teolis, BD (corresponding author), SW Res Inst, Space Sci & Engn Div, 6220 Culebra Rd, San Antonio, TX 78238 USA.	ben.teolis@swri.org	Jones, Geraint H./C-1682-2008; Coates, Andrew/C-2396-2008; Roussos, Elias/H-2249-2011	Jones, Geraint H./0000-0002-5859-1136; Coates, Andrew/0000-0002-6185-3125; Roussos, Elias/0000-0002-5699-0678	NASA under SwRI [1283095]; Jet Propulsion Laboratory under SwRI [1356497]; UK Science and Technology Facilities Council; NSF [AST0807830]; STFC [PP/D005213/1, ST/H00260X/1, PP/E001173/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H00260X/1, PP/D005213/1, PP/E001173/1] Funding Source: researchfish; UK Space Agency [PP/D00084X/1, ST/I002642/1] Funding Source: researchfish	NASA under SwRI; Jet Propulsion Laboratory under SwRI; UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NSF(National Science Foundation (NSF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	We thank E. Roussos, D. Mitchell, and the Cassini MIMI team for providing the MIMI data used in figs. S1 and S4 and N. G. Petrik, A. G. Kavetsky, and G. A. Kimmel at Pacific Northwest National Laboratory, Richland, Washington, USA, for contributing the O<INF>2</INF> electron-stimulated desorption measurements in fig. S9. The INMS and CAPS teams acknowledge support from NASA and the Jet Propulsion Laboratory under SwRI subcontracts 1283095 and 1356497, respectively. G.H.J. and A.J.C. acknowledge support for CAPS-ELS operations and analysis by the United Kingdom Space Agency, and G.H.J. was supported by a UK Science and Technology Facilities Council Advanced Fellowship. B.D.T. and R.A.B. acknowledge support by the NSF Astronomy and Astrophysics Program through grant AST0807830.	Carlson RW, 1999, SCIENCE, V283, P820, DOI 10.1126/science.283.5403.820; Clark RN, 2008, ICARUS, V193, P372, DOI 10.1016/j.icarus.2007.08.035; Coates AJ, 2010, ICARUS, V206, P618, DOI 10.1016/j.icarus.2009.07.013; Cruikshank DP, 2010, ICARUS, V206, P561, DOI 10.1016/j.icarus.2009.07.012; Cruikshank DP, 2005, ICARUS, V175, P268, DOI 10.1016/j.icarus.2004.09.003; Glein CR, 2008, ICARUS, V197, P157, DOI 10.1016/j.icarus.2008.03.021; Hall DT, 1998, ASTROPHYS J, V499, P475, DOI 10.1086/305604; Jones GH, 2008, SCIENCE, V319, P1380, DOI 10.1126/science.1151524; Khurana KK, 2008, ICARUS, V193, P465, DOI 10.1016/j.icarus.2007.08.005; Noll KS, 1997, NATURE, V388, P45, DOI 10.1038/40348; Noll KS, 1996, SCIENCE, V273, P341, DOI 10.1126/science.273.5273.341; Saur J, 2005, ASTROPHYS J, V620, pL115, DOI 10.1086/428665; Spencer J, 1998, ICARUS, V136, P349, DOI 10.1006/icar.1998.6024; Spencer JR, 2002, ASTRON J, V124, P3400, DOI 10.1086/344307; SPENCER JR, 1995, J GEOPHYS RES-PLANET, V100, P19049, DOI 10.1029/95JE01503; Stephan K., 2009, 40 LUN PLAN SCI C LU; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; Teolis BD, 2006, ASTROPHYS J, V644, pL141, DOI 10.1086/505743; Teolis BD, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3091998; Tseng WL, 2010, ICARUS, V206, P382, DOI 10.1016/j.icarus.2009.05.019; Waite JH, 2004, SPACE SCI REV, V114, P113, DOI 10.1007/s11214-004-1408-2; Wilson RJ, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014679; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	23	110	110	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1813	1815		10.1126/science.1198366	http://dx.doi.org/10.1126/science.1198366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21109635				2022-12-01	WOS:000285603700038
J	Van Overwalle, G				Van Overwalle, Geertrui			Turning Patent Swords into Shares	SCIENCE			English	Editorial Material							INTELLECTUAL PROPERTY; LIABILITY RULES; UNCERTAINTY; INNOVATION; GENETICS; SOCIETY; RIGHTS; VIEW		[Van Overwalle, Geertrui] Univ Louvain, Ctr Intellectual Property Rights, B-3000 Louvain, Belgium; [Van Overwalle, Geertrui] Tilburg Univ, Tilburg Inst Law Technol & Soc, NL-5000 LE Tilburg, Netherlands	Tilburg University	Van Overwalle, G (corresponding author), Univ Louvain, Ctr Intellectual Property Rights, B-3000 Louvain, Belgium.	geertrui.vanoverwalle@law.kuleuven.be						AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Barton JH, 2006, NAT BIOTECHNOL, V24, P939, DOI 10.1038/nbt0806-939; Burk Daniel L., 2009, PATENT CRISIS COURTS; CALABRESI G, 1972, HARVARD LAW REV, V85, P1089, DOI 10.2307/1340059; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1352, DOI 10.1038/nbt1106-1352; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Drahos P, 1996, PHILOS INTELLECTUAL; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; HOLMAN CH, 2008, BIOTECH BRIEF, V5, P1; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Merges RP, 1996, CALIF LAW REV, V84, P1293, DOI 10.2307/3480996; MERGES RP, 2001, EXPANDING BOUNDARIES, P123; RAI K, 2003, LAW CONTEMP PROBL, V66, P289; Reichman JH, 2000, VANDERBILT LAW REV, V53, P1743; *SACGHS, 2010, REV DRAFT REP GE PAT; Shapiro C., 2001, INNOVATION POLICY EC, V4, P119, DOI DOI 10.1086/ipe.1.25056143; Van Overwalle G, 2006, NAT REV GENET, V7, P143, DOI 10.1038/nrg1765; VanOverwalle G, 2009, CAM INTELLECT PROP, P1, DOI 10.1017/CBO9780511581182; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; 2010, GENET MED S, V12, pS1	23	27	27	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1630	1631		10.1126/science.1189592	http://dx.doi.org/10.1126/science.1189592			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695RO	21164001				2022-12-01	WOS:000285390500049
J	Nazarian, R; Shi, HB; Wang, Q; Kong, XJ; Koya, RC; Lee, H; Chen, ZG; Lee, MK; Attar, N; Sazegar, H; Chodon, T; Nelson, SF; McArthur, G; Sosman, JA; Ribas, A; Lo, RS				Nazarian, Ramin; Shi, Hubing; Wang, Qi; Kong, Xiangju; Koya, Richard C.; Lee, Hane; Chen, Zugen; Lee, Mi-Kyung; Attar, Narsis; Sazegar, Hooman; Chodon, Thinle; Nelson, Stanley F.; McArthur, Grant; Sosman, Jeffrey A.; Ribas, Antoni; Lo, Roger S.			Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation	NATURE			English	Article							BRAF; MUTATIONS; KINASE; SENSITIVITY; PATHWAY; CRAF; MEK	Activating B-RAF(V600E) (also known as BRAF) kinase mutations occur in similar to 7% of human malignancies and similar to 60% of melanomas(1). Early clinical experience with a novel class I RAF-selective inhibitor, PLX4032, demonstrated an unprecedented 80% anti-tumour response rate among patients with B-RAF(V600E)-positive melanomas, but acquired drug resistance frequently develops after initial responses(2). Hypotheses for mechanisms of acquired resistance to B-RAF inhibition include secondary mutations in B-RAF(V600E), MAPK reactivation, and activation of alternative survival pathways(3-5). Here we show that acquired resistance to PLX4032 develops by mutually exclusive PDGFR beta (also known as PDGFRB) upregulation or N-RAS (also known as NRAS) mutations but not through secondary mutations in B-RAF(V600E). We used PLX4032-resistant sub-lines artificially derived from B-RAF(V600E)-positive melanoma cell lines and validated key findings in PLX4032-resistant tumours and tumour-matched, short-term cultures from clinical trial patients. Induction of PDGFR beta RNA, protein and tyrosine phosphorylation emerged as a dominant feature of acquired PLX4032 resistance in a subset of melanoma sub-lines, patient-derived biopsies and short-term cultures. PDGFR beta-upregulated tumour cells have low activated RAS levels and, when treated with PLX4032, do not reactivate the MAPK pathway significantly. In another subset, high levels of activated N-RAS resulting from mutations lead to significant MAPK pathway reactivation upon PLX4032 treatment. Knockdown of PDGFR beta or N-RAS reduced growth of the respective PLX4032-resistant subsets. Overexpression of PDGFR beta or N-RAS(Q61K) conferred PLX4032 resistance to PLX4032-sensitive parental cell lines. Importantly, MAPK reactivation predicts MEK inhibitor sensitivity. Thus, melanomas escape B-RAF(V600E) targeting not through secondary B-RAF(V600E) mutations but via receptor tyrosine kinase (RTK)-mediated activation of alternative survival pathway(s) or activated RAS-mediated reactivation of the MAPK pathway, suggesting additional therapeutic strategies.	[Nazarian, Ramin; Shi, Hubing; Wang, Qi; Kong, Xiangju; Lee, Mi-Kyung; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Nazarian, Ramin; Shi, Hubing; Wang, Qi; Kong, Xiangju; Koya, Richard C.; Lee, Hane; Chen, Zugen; Lee, Mi-Kyung; Attar, Narsis; Sazegar, Hooman; Chodon, Thinle; Nelson, Stanley F.; Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Koya, Richard C.; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA; [Lee, Hane; Chen, Zugen; Nelson, Stanley F.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Human Genet, Los Angeles, CA 90095 USA; [Attar, Narsis; Sazegar, Hooman; Chodon, Thinle; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Pediat, Los Angeles, CA 90095 USA; [McArthur, Grant] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Sosman, Jeffrey A.] Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Peter Maccallum Cancer Center; Vanderbilt University	Lo, RS (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, 52-121 CHS, Los Angeles, CA 90095 USA.	rlo@mednet.ucla.edu	Nelson, Stanley F/D-4771-2009; Shi, Hubing/B-8445-2014	Nelson, Stanley F/0000-0002-2082-3114; McArthur, Grant/0000-0001-8908-6071; Wang, Qi/0000-0002-6420-1720; Shi, Hubing/0000-0002-2926-3440	Dermatology Foundation; Burroughs Wellcome Fund; STOP CANCER Foundation; Margaret E. Early Medical Trust; Ian Copeland Memorial Melanoma Fund; V Foundation for Cancer Research; Melanoma Research Foundation; American Skin Association; Caltech-UCLA Joint Center for Translational Medicine; Wesley Coyle Memorial Fund; Melanoma Research Alliance; T32 Tumor Immunology Training Grant; California Institute for Regenerative Medicine (CIRM); Jonsson Cancer Center Foundation (JCCF); NATIONAL CANCER INSTITUTE [K22CA151638, K24CA097588] Funding Source: NIH RePORTER	Dermatology Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); STOP CANCER Foundation; Margaret E. Early Medical Trust; Ian Copeland Memorial Melanoma Fund; V Foundation for Cancer Research; Melanoma Research Foundation; American Skin Association; Caltech-UCLA Joint Center for Translational Medicine; Wesley Coyle Memorial Fund; Melanoma Research Alliance; T32 Tumor Immunology Training Grant; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Jonsson Cancer Center Foundation (JCCF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to G. Bollag and P. Lin (Plexxikon) for providing PLX4032, J.S. Economou for biopsies, B. Comin-Anduix for FACS assistance, S. Mok for assistance with virus production, C. Ng for tissue acquisition and culture establishment, R. Huang for patient tissue processing, N. Doan for immunohistochemistry, P. Mischel for discussion, B. Chmielowski for coordinated patient care, T. L. Toy for technical help with library generation for deep sequencing, and B. Harry for help with analysis of deep sequence data. R. S. L. acknowledges funding from the following: Dermatology Foundation, Burroughs Wellcome Fund, STOP CANCER Foundation, Margaret E. Early Medical Trust, Ian Copeland Memorial Melanoma Fund, V Foundation for Cancer Research, Melanoma Research Foundation, American Skin Association, Caltech-UCLA Joint Center for Translational Medicine, Wesley Coyle Memorial Fund, and Melanoma Research Alliance. R. N. is supported by a post-doctoral fellowship from the T32 Tumor Immunology Training Grant (S. Dubinett). A. R. is supported by the California Institute for Regenerative Medicine (CIRM), the Jonsson Cancer Center Foundation (JCCF), and Caltech-UCLA Joint Center for Translational Medicine. Array and sequence work were performed within the Jonsson Comprehensive Cancer Center Gene Expression Shared Resource. Patient-informed consent was obtained for the research performed in this study. We would like to thank all the patients that participated in this study.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794	18	1622	1686	4	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					973	U377		10.1038/nature09626	http://dx.doi.org/10.1038/nature09626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21107323	Green Accepted			2022-12-01	WOS:000285344600049
J	Prinz, WA				Prinz, William A.			Lipid Trafficking sans Vesicles: Where, Why, How?	CELL			English	Article							OXYSTEROL-BINDING PROTEIN; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; GLYCOSPHINGOLIPID SYNTHESIS; NONVESICULAR TRAFFICKING; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR-TRANSPORT; GOLGI-APPARATUS; STEROL TRANSFER; CHOLESTEROL	Eukaryotic cells possess a remarkable diversity of lipids, which distribute among cellular membranes by well-characterized vesicle trafficking pathways. However, transport of lipids by alternate, or "nonvesicular," routes is also critical for lipid synthesis, metabolism, and proper membrane partitioning. In the past few years, considerable progress has been made in characterizing the mechanisms of nonvesicular lipid transport and how it may go awry in particular diseases, but many fundamental questions remain for this rising field.	NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Prinz, WA (corresponding author), NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA.	williamp@intra.niddk.nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060004] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I thank Ted Steck, Jim Hurley, and Tim Schulz for reading the manuscript. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.	Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Choi JY, 2006, BIOCHEM SOC T, V34, P404, DOI 10.1042/BST0340404; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; HECHTBERGER P, 1995, FEBS LETT, V367, P201, DOI 10.1016/0014-5793(95)00567-S; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; Kok JW, 1998, BIOCHEM J, V333, P779, DOI 10.1042/bj3330779; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Raychaudhuri S, 2008, P NATL ACAD SCI USA, V105, P15785, DOI 10.1073/pnas.0808321105; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; SLEIGHT RG, 1983, J BIOL CHEM, V258, P9050; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; WARNOCK DE, 1994, P NATL ACAD SCI USA, V91, P2708, DOI 10.1073/pnas.91.7.2708; WATTENBERG BW, 1990, J CELL BIOL, V111, P421, DOI 10.1083/jcb.111.2.421; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83	39	84	84	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					870	874		10.1016/j.cell.2010.11.031	http://dx.doi.org/10.1016/j.cell.2010.11.031			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145454	Green Accepted, Bronze			2022-12-01	WOS:000285182600005
J	Ricci-Vitiani, L; Pallini, R; Biffoni, M; Todaro, M; Invernici, G; Cenci, T; Maira, G; Parati, EA; Stassi, G; Larocca, LM; De Maria, R				Ricci-Vitiani, Lucia; Pallini, Roberto; Biffoni, Mauro; Todaro, Matilde; Invernici, Gloria; Cenci, Tonia; Maira, Giulio; Parati, Eugenio Agostino; Stassi, Giorgio; Larocca, Luigi Maria; De Maria, Ruggero			Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells	NATURE			English	Article							VASCULOGENIC MIMICRY; IN-VIVO; CANCER; IDENTIFICATION; ANGIOGENESIS; RESISTANCE; MECHANISMS; MELANOMA; NICHE	Glioblastoma is a highly angiogenetic malignancy, the neoformed vessels of which are thought to arise by sprouting of pre-existing brain capillaries. The recent demonstration that a population of glioblastoma stem-like cells (GSCs) maintains glioblastomas(1,2) indicates that the progeny of these cells may not be confined to the neural lineage(3). Normal neural stem cells are able to differentiate into functional endothelial cells(4). The connection between neural stem cells and the endothelial compartment seems to be critical in glioblastoma, where cancer stem cells closely interact with the vascular niche and promote angiogenesis through the release of vascular endothelial growth factor (VEGF) and stromal-derived factor 1 (refs 5-9). Here we show that a variable number (range 20-90%, mean 60.7%) of endothelial cells in glioblastoma carry the same genomic alteration as tumour cells, indicating that a significant portion of the vascular endothelium has a neoplastic origin. The vascular endothelium contained a subset of tumorigenic cells that produced highly vascularized anaplastic tumours with areas of vasculogenic mimicry in immunocompromised mice. In vitro culture of GSCs in endothelial conditions generated progeny with phenotypic and functional features of endothelial cells. Likewise, orthotopic or subcutaneous injection of GSCs in immunocompromised mice produced tumour xenografts, the vessels of which were primarily composed of human endothelial cells. Selective targeting of endothelial cells generated by GSCs in mouse xenografts resulted in tumour reduction and degeneration, indicating the functional relevance of the GSC-derived endothelial vessels. These findings describe a new mechanism for tumour vasculogenesis and may explain the presence of cancer-derived endothelial-like cells in several malignancies.	[Ricci-Vitiani, Lucia; Biffoni, Mauro; De Maria, Ruggero] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Pallini, Roberto; Maira, Giulio] Univ Cattolica Sacro Cuore, Dept Neurosurg, I-00168 Rome, Italy; [Todaro, Matilde; Stassi, Giorgio] Univ Palermo, Dept Surg & Oncol Sci, I-90127 Palermo, Italy; [Invernici, Gloria; Parati, Eugenio Agostino] Neurol Inst Carlo Besta, Fdn IRCCS, UO Cerebrovasc Dis Cellular Neurobiol Lab, I-20133 Milan, Italy; [Cenci, Tonia; Larocca, Luigi Maria] Univ Cattolica Sacro Cuore, Inst Pathol, I-00168 Rome, Italy; [Stassi, Giorgio] Carattere Sci Fdn Salvatore Maugeri, Ist Ricovero & Cura, I-27100 Pavia, Italy; [De Maria, Ruggero] Mediterranean Inst Oncol, I-95029 Catania, Italy	Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Palermo; IRCCS Istituto Neurologico Besta; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Mediterranean Institute of Oncology	De Maria, R (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	pallini@rm.unicatt.it; demaria@iss.it	Pallini, Roberto/AAA-3760-2019; Cenci, Tonia/K-1010-2016; Larocca, Luigi M/A-1577-2008; Biffoni, Mauro/J-8318-2016; Parati, Eugenio A/G-8765-2011; De Maria, Ruggero/S-6385-2019; Ricci Vitiani, Lucia/J-8320-2016; Parati, Eugenio Agostino/AAN-5893-2021; Stassi, Giorgio/AAC-1175-2022; PALLINI, Roberto/AAA-3747-2019; Cenci, Tonia/AAC-1372-2019; Larocca, Luigi Maria/M-9590-2019; todaro, matilde/AAC-1003-2022	Cenci, Tonia/0000-0003-2838-8433; Larocca, Luigi M/0000-0003-1739-4758; Biffoni, Mauro/0000-0002-1304-9060; De Maria, Ruggero/0000-0003-2255-0583; Ricci Vitiani, Lucia/0000-0001-7336-5615; Parati, Eugenio Agostino/0000-0001-5020-6523; PALLINI, Roberto/0000-0002-4611-8827; Cenci, Tonia/0000-0002-6272-4587; Larocca, Luigi Maria/0000-0003-1739-4758; todaro, matilde/0000-0001-8686-8043	Associazione Italiana per la Ricerca sul Cancro	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank L. Naldini for providing the lentiviral vectors and S. Forte for gene array data elaboration. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Ricci-Vitiani L, 2008, CELL DEATH DIFFER, V15, P1491, DOI 10.1038/cdd.2008.72; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604	23	927	974	5	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					824	U121		10.1038/nature09557	http://dx.doi.org/10.1038/nature09557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21102434				2022-12-01	WOS:000285093700046
J	Kind, AJH; Bartels, C; Mell, MW; Mullahy, J; Smith, M				Kind, Amy J. H.; Bartels, Christie; Mell, Matthew W.; Mullahy, John; Smith, Maureen			For-Profit Hospital Status and Rehospitalizations at Different Hospitals: An Analysis of Medicare Data	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE PHYSICIANS; CONFIDENCE-INTERVALS; INSURANCE STATUS; PATIENT SAFETY; VOLUME; MORTALITY; QUALITY; MARKET; RISK; OPPORTUNITIES	Background: About one quarter of rehospitalized Medicare patients are admitted to hospitals different from their original hospital. The extent to which this practice is related to for-profit hospital status and affects payments and mortality is unknown. Objective: To describe and examine predictors of and payments for rehospitalization at a different hospital among Medicare patients rehospitalized within 30 days at for-profit and nonprofit or public hospitals. Design: Cohort study of patients discharged and rehospitalized from January 2005 to November 2006. Setting: Medicare fee-for-service hospitals throughout the United States. Participants: A 5% random national sample of Medicare patients with acute care rehospitalizations within 30 days of discharge (n = 74 564). Measurements: 30-day rehospitalizations at different hospitals and total payments or mortality over the subsequent 30 days. Multivariate logistic and quantile regression models included index hospital for-profit status, discharge counts, geographic region, rural-urban commuting area, and teaching status; patient socio-demographic characteristics, disability status, and comorbid conditions; and a measure of risk adjustment. Results: 16 622 patients (22%) in the sample were rehospitalized at a different hospital. Factors associated with increased risk for rehospitalization at a different hospital included index hospitalization at a for-profit, major medical school-affiliated, or low-volume hospital and having a Medicare-defined disability. Compared with patients rehospitalized at the same hospital, patients rehospitalized at different hospitals had higher adjusted 30-day total payments (median additional cost, $1308 per patient; P < 0.001) but no statistically significant differences in 30-day mortality, regardless of index hospital for-profit status. Limitation: The database lacked detailed clinical information about patients and did not include information about specific provider practice motivations or the role of patient choice in hospitalization venues. Conclusion: Rehospitalizations at different hospitals are common among Medicare patients, are more likely among those initially hospitalized at a for-profit hospital, and are related to increased overall payments without improved mortality.	[Kind, Amy J. H.] William S Middleton Vet Affairs Hosp, Geriatr Res Educ & Clin Ctr, Madison, WI 53705 USA; [Bartels, Christie; Smith, Maureen] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Mell, Matthew W.] Stanford Univ, Stanford, CA 94305 USA; [Mullahy, John] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53726 USA	Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Kind, AJH (corresponding author), William S Middleton Vet Affairs Hosp, Geriatr Res Educ & Clin Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA.	ajk@medicine.wisc.edu	Bartels, Christie Michels/ABG-4072-2020	Bartels, Christie Michels/0000-0001-6523-0374; Kind, Amy/0000-0002-7183-610X	University of Wisconsin (UW) Hartford Center of Excellence in Geriatrics; UW Health Innovation Program; National Center for Research Resources, National Institutes of Health through UW-Madison [1KL2RR025012-01, 1UL1RR025011]; UW Institute for Clinical and Translational Research; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025012, UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034551] Funding Source: NIH RePORTER	University of Wisconsin (UW) Hartford Center of Excellence in Geriatrics; UW Health Innovation Program; National Center for Research Resources, National Institutes of Health through UW-Madison(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UW Institute for Clinical and Translational Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the University of Wisconsin (UW) Hartford Center of Excellence in Geriatrics; the UW Health Innovation Program; a KL-2 grant from the National Center for Research Resources, National Institutes of Health (1KL2RR025012-01) through the Institutional Clinical and Translational Science Award (UW-Madison) program (1UL1RR025011 to Dr. Kind); and the Community-Academic Partnerships core of the UW Institute for Clinical and Translational Research.; University of Wisconsin Hartford Center of Excellence in Geriatrics, National Institutes of Health.	[Anonymous], 2009, CLIN CLASS SOFTW CCS; [Anonymous], 2008, ECONOMETRIC ANAL; Archdeacon MT, 2007, J BONE JOINT SURG AM, V89A, P2625, DOI 10.2106/JBJS.F.01499; Berman L, 2010, J PEDIATR SURG, V45, P38, DOI 10.1016/j.jpedsurg.2009.10.006; Bhalla R, 2010, ANN INTERN MED, V152, P114, DOI 10.7326/0003-4819-152-2-201001190-00185; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Casalino LP, 2003, HEALTH AFFAIR, V22, P56, DOI 10.1377/hlthaff.22.6.56; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care; Board on Health Sciences Policy; Institute on Medicine, 2003, UN TREATM CONFR RAC; Cram P, 2008, MED CARE, V46, P467, DOI 10.1097/MLR.0b013e31816c43d9; Duggan M, 2002, RAND J ECON, V33, P433, DOI 10.2307/3087466; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elixhauser A, 2003, HEALTH AFFAIR, V22, P167, DOI 10.1377/hlthaff.22.2.167; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Goldsmith J, 2003, HEALTH AFFAIR, V22, P44, DOI 10.1377/hlthaff.22.4.44; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kessler DP, 2002, RAND J ECON, V33, P488, DOI 10.2307/3087469; Kind AJH, 2007, J AM GERIATR SOC, V55, P365, DOI 10.1111/j.1532-5415.2007.01091.x; Kind AJH, 2010, ARCH PHYS MED REHAB, V91, P189, DOI 10.1016/j.apmr.2009.10.015; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Kolstad JT, 2009, MED CARE RES REV, V66, p28S, DOI 10.1177/1077558708325887; Koval KJ, 2006, J BONE JOINT SURG AM, V88A, P2124, DOI 10.2106/JBJS.F.00245; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; LUFT HS, 1990, JAMA-J AM MED ASSOC, V263, P2899, DOI 10.1001/jama.263.21.2899; *MED PAYM ADV COMM, 2009, C IMPR  INC MED PROG; Medicare Payment Advisory Commission, 2008, C REF DEL SYST WASH; Medicare Payment Advisory Commission, 2007, C PROM GREAT EFF MED; Mukamel DB, 2007, MED CARE, V45, P1227, DOI 10.1097/MLR.0b013e31812f56bb; Nathens AB, 2001, J TRAUMA, V50, P776, DOI 10.1097/00005373-200105000-00002; PETERSON ED, 1994, ANN INTERN MED, V121, P919, DOI 10.7326/0003-4819-121-12-199412150-00003; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; United States Department of Agriculture (USDA) Economic Research Service, 2005, MEAS RUR RUR URB COM; *WA STAT DEP HLTH, 2010, 4 TIER CONS RUCA SYS; Weiss SJ, 2004, ACAD EMERG MED, V11, P38, DOI 10.1197/S1069-6563(03)00583-9; Yuan Z, 2000, MED CARE, V38, P231, DOI 10.1097/00005650-200002000-00012	44	55	55	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 7	2010	153	11					718	727		10.7326/0003-4819-153-11-201012070-00005	http://dx.doi.org/10.7326/0003-4819-153-11-201012070-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690KN	21135295	Green Accepted			2022-12-01	WOS:000285003800004
J	Connaughton, M; Rivett, JG				Connaughton, Mark; Rivett, John G.			Easily Missed? Infective endocarditis	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL PRESENTATION; DIAGNOSIS		[Connaughton, Mark] St Marys Hosp, Cardiol Dept, Newport PO30 5TG, Wight, England; [Rivett, John G.] Martins Oak Surg, Battle TN33 0EA, England		Connaughton, M (corresponding author), St Marys Hosp, Cardiol Dept, Newport PO30 5TG, Wight, England.	mark.connaughton@iow.nhs.uk						Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Dodds GA, 1996, AM J CARDIOL, V77, P403, DOI 10.1016/S0002-9149(97)89372-1; Gouriet F, 2006, CLIN VACCINE IMMUNOL, V13, P301, DOI 10.1128/CVI.13.2.301.2006; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hill EE, 2006, CLIN MICROBIOL INFEC, V12, P5, DOI 10.1111/j.1469-0691.2005.01289.x; Hill EE, 2007, MAYO CLIN PROC, V82, P1165, DOI 10.4065/82.10.1165; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Netzer ROM, 2002, HEART, V88, P61, DOI 10.1136/heart.88.1.61; Rozich JD, 2003, J AM SOC ECHOCARDIOG, V16, P97, DOI 10.1067/mje.2003.36; San Martin J, 2010, J HEART VALVE DIS, V19, P131; Verhagen DWM, 2006, J ANTIMICROB CHEMOTH, V57, P819, DOI 10.1093/jac/dkl087	11	5	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 1	2010	341								c6596	10.1136/bmj.c6596	http://dx.doi.org/10.1136/bmj.c6596			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691OU	21123344				2022-12-01	WOS:000285091500014
J	Reis, PM; Jung, SH; Aristoff, JM; Stocker, R				Reis, Pedro M.; Jung, Sunghwan; Aristoff, Jeffrey M.; Stocker, Roman			How Cats Lap: Water Uptake by Felis catus	SCIENCE			English	Article							MECHANICAL DETERMINANTS; LICKING BEHAVIOR; DRINKING; TONGUE; MORPHOLOGY; SIZE; ENERGETICS; FREQUENCY; TRANSPORT; SURFACE	Animals have developed a range of drinking strategies depending on physiological and environmental constraints. Vertebrates with incomplete cheeks use their tongue to drink; the most common example is the lapping of cats and dogs. We show that the domestic cat (Felis catus) laps by a subtle mechanism based on water adhesion to the dorsal side of the tongue. A combined experimental and theoretical analysis reveals that Felis catus exploits fluid inertia to defeat gravity and pull liquid into the mouth. This competition between inertia and gravity sets the lapping frequency and yields a prediction for the dependence of frequency on animal mass. Measurements of lapping frequency across the family Felidae support this prediction, which suggests that the lapping mechanism is conserved among felines.	[Reis, Pedro M.; Stocker, Roman] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Reis, Pedro M.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Jung, Sunghwan] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA; [Aristoff, Jeffrey M.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Virginia Polytechnic Institute & State University; Princeton University	Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Jung, Sunghwan/E-8752-2010; Stocker, Roman/N-8987-2019; Stocker, Roman/T-9456-2017; Reis, Pedro/F-1176-2010	Stocker, Roman/0000-0002-3199-0508; Reis, Pedro/0000-0003-3984-828X				AHL AS, 1986, VET RES COMMUN, V10, P245, DOI 10.1007/BF02213989; [Anonymous], 1940, QUICK N WINK; Attenborough David, 2011, LECT ROYAL SOC ENCOU; BENTLEY PJ, 1979, J EXP BIOL, V79, P41; CHIEL HJ, 1992, BIOL CYBERN, V67, P403, DOI 10.1007/BF00200984; Christiansen P, 2005, J ZOOL, V266, P133, DOI 10.1017/S0952836905006643; Cundall D, 2000, J EXP BIOL, V203, P2171; DANIEL TL, 1989, OECOLOGIA, V79, P66, DOI 10.1007/BF00378241; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; Dilger W. C., 1962, ROOTS BEHAVIOR, P35; Doube M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004742; Glasheen JW, 1996, J EXP BIOL, V199, P2611; Gussekloo SWS, 2005, J EXP BIOL, V208, P3395, DOI 10.1242/jeb.01769; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; HEIDWEILLER J, 1990, CONDOR, V92, P1, DOI 10.2307/1368379; HEIDWEILLER J, 1992, ZOOMORPHOLOGY, V111, P141, DOI 10.1007/BF01632904; Hiiemae K.M., 1985, P262; KINGSOLVER JG, 1983, OECOLOGIA, V60, P214, DOI 10.1007/BF00379523; KOOLOOS JGM, 1989, J MORPHOL, V199, P327, DOI 10.1002/jmor.1051990308; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; Ojima K, 2000, ANN ANAT, V182, P47, DOI 10.1016/S0940-9602(00)80120-X; Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023; PRANGE HD, 1970, J EXP BIOL, V53, P763; RUSSELL AP, 1995, J ZOOL, V236, P161, DOI 10.1111/j.1469-7998.1995.tb01791.x; Smith K.K., 1989, American Scientist, V77, P28; THEXTON AJ, 1988, ARCH ORAL BIOL, V33, P331, DOI 10.1016/0003-9969(88)90066-0; Thexton AJ, 1998, J EXP ZOOL, V280, P327, DOI 10.1002/(SICI)1097-010X(19980401)280:5&lt;327::AID-JEZ2&gt;3.0.CO;2-Q; Trivedi Deepak, 2008, Applied Bionics and Biomechanics, V5, P99, DOI 10.1080/11762320802557865; Weijnen JAWM, 1998, NEUROSCI BIOBEHAV R, V22, P751, DOI 10.1016/S0149-7634(98)00003-7	29	85	87	10	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1231	1234		10.1126/science.1195421	http://dx.doi.org/10.1126/science.1195421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21071630				2022-12-01	WOS:000284613700038
J	Aaron, SD; Vandemheen, KL; Ramotar, K; Giesbrecht-Lewis, T; Tullis, E; Freitag, A; Paterson, N; Jackson, M; Lougheed, MD; Dowson, C; Kumar, V; Ferris, W; Chan, F; Doucette, S; Fergusson, D				Aaron, Shawn D.; Vandemheen, Katherine L.; Ramotar, Karam; Giesbrecht-Lewis, Tracy; Tullis, Elizabeth; Freitag, Andreas; Paterson, Nigel; Jackson, Mary; Lougheed, M. Diane; Dowson, Christopher; Kumar, Vijay; Ferris, Wendy; Chan, Francis; Doucette, Steve; Fergusson, Dean			Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLONIZATION; EPIDEMIOLOGY; CEPACIA; SPREAD; CF; IDENTIFICATION; MORBIDITY; MORTALITY; PATIENT; CANADA	Context Studies from Australia and the United Kingdom have shown that some patients with cystic fibrosis are infected with common transmissible strains of Pseudomonas aeruginosa. Objectives To determine the prevalence and incidence of infection with transmissible strains of P aeruginosa and whether presence of the organism was associated with adverse clinical outcomes in Canada. Design, Setting, and Participants Prospective observational cohort study of adult patients cared for at cystic fibrosis clinics in Ontario, Canada, with enrollment from September 2005 to September 2008. Sputum was collected at baseline, 3 months, and yearly thereafter for 3 years; and retrieved P aeruginosa isolates were genotyped. Vital status (death or lung transplant) was assessed for all enrolled patients until December 31, 2009. Main Outcome Measures Incidence and prevalence of P aeruginosa isolation, rates of decline in lung function, and time to death or lung transplantation. Results Of the 446 patients with cystic fibrosis studied, 102 were discovered to be infected with 1 of 2 common transmissible strains of P aeruginosa at study entry. Sixty-seven patients were infected with strain A (15%), 32 were infected with strain B (7%), and 3 were simultaneously infected with both strains (0.6%). Strain A was found to be genetically identical to the Liverpool epidemic strain but strain B has not been previously described as an epidemic strain. The incidence rate of new infections with these 2 transmissible strains was relatively low (7.0 per 1000 person-years; 95% confidence interval [CI], 1.8-12.2 per 1000 person-years). Compared with patients infected with unique strains of P aeruginosa, patients infected with the Liverpool epidemic strain (strain A) and strain B had similar declines in lung function (difference in decline in percent predicted forced expiratory volume in the first second of expiration of 0.64% per year [95% CI, -1.52% to 2.80% per year] and 1.66% per year [95% CI, -1.00% to 4.30%], respectively). However, the 3-year rate of death or lung transplantation was greater in those infected with the Liverpool epidemic strain (18.6%) compared with those infected with unique strains (8.7%) (adjusted hazard ratio, 3.26 [95% CI, 1.41 to 7.54]; P = .01). Conclusions A common strain of P aeruginosa (Liverpool epidemic strain/strain A) infects patients with cystic fibrosis in Canada and the United Kingdom. Infection with this strain in adult Canadian patients with cystic fibrosis was associated with a greater risk of death or lung transplantation. JAMA, 2010;304(19):2145-2153 www.jama.com	[Aaron, Shawn D.; Vandemheen, Katherine L.; Ramotar, Karam; Giesbrecht-Lewis, Tracy; Doucette, Steve; Fergusson, Dean] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Tullis, Elizabeth] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Freitag, Andreas] McMaster Univ, Hamilton, ON, Canada; [Paterson, Nigel] Univ Western Ontario, London, ON, Canada; [Jackson, Mary] Grand River Hosp, Kitchener, ON, Canada; [Lougheed, M. Diane] Queens Univ, Kingston, ON, Canada; [Dowson, Christopher] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Kumar, Vijay] Sudbury Reg Hosp, Sudbury, ON, Canada; [Ferris, Wendy; Chan, Francis] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; Western University (University of Western Ontario); Queens University - Canada; University of Warwick; Health Sciences North; University of Ottawa; Children's Hospital of Eastern Ontario	Aaron, SD (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Gen Campus,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	saaron@ohri.ca	Dowson, Christopher/ABG-5083-2021; Dowson, Chris/N-6195-2014	Dowson, Christopher/0000-0002-8294-8836; Dowson, Chris/0000-0002-8294-8836; Aaron, Shawn/0000-0002-4762-3542; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research; Canadian Cystic Fibrosis Foundation; Ontario Thoracic Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; Ontario Thoracic Society	Funded by the Canadian Institutes of Health Research, the Canadian Cystic Fibrosis Foundation, and the Ontario Thoracic Society.	Aaron SD, 2004, AM J RESP CRIT CARE, V169, P811, DOI 10.1164/rccm.200309-1306OC; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; GROTHUES D, 1988, J CLIN MICROBIOL, V26, P1973, DOI 10.1128/JCM.26.10.1973-1977.1988; JOHN M, 1994, PEDIATR PULM, V18, P108, DOI 10.1002/ppul.1950180210; Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Jones AM, 2010, CHEST, V137, P1405, DOI 10.1378/chest.09-2406; LAING FPY, 1995, J CLIN MICROBIOL, V33, P513, DOI 10.1128/JCM.33.3.513-518.1995; LIPUMA JJ, 1990, LANCET, V336, P1094, DOI 10.1016/0140-6736(90)92571-X; McCallum SJ, 2002, THORAX, V57, P559, DOI 10.1136/thorax.57.6.559; Mohan K, 2008, THORAX, V63, P839, DOI 10.1136/thx.2007.092486; Ramsey BW, 2002, AM J RESP CRIT CARE, V166, P906, DOI 10.1164/rccm.2207005; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Speert DP, 2002, AM J RESP CRIT CARE, V166, P988, DOI 10.1164/rccm.2203011; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Waine DJ, 2009, J CLIN MICROBIOL, V47, P3444, DOI 10.1128/JCM.00459-09; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108	28	132	133	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2145	2153		10.1001/jama.2010.1665	http://dx.doi.org/10.1001/jama.2010.1665			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21081727	Bronze			2022-12-01	WOS:000284269800025
J	Gilchrist, DA; Dos Santos, G; Fargo, DC; Xie, B; Gao, YA; Li, LP; Adelman, K				Gilchrist, Daniel A.; Dos Santos, Gilberto; Fargo, David C.; Xie, Bin; Gao, Yuan; Li, Leping; Adelman, Karen			Pausing of RNA Polymerase II Disrupts DNA-Specified Nucleosome Organization to Enable Precise Gene Regulation	CELL			English	Article							DROSOPHILA-MELANOGASTER; PROMOTER ARCHITECTURE; GAGA FACTOR; POL-II; P-TEFB; TRANSCRIPTION; ELONGATION; CHROMATIN; BINDING; NELF	Metazoan transcription is controlled through either coordinated recruitment of transcription machinery to the gene promoter or regulated pausing of RNA polymerase II (Pol II) in early elongation. We report that a striking difference between genes that use these distinct regulatory strategies lies in the "default" chromatin architecture specified by their DNA sequences. Pol II pausing is prominent at highly regulated genes whose sequences inherently disfavor nucleosome formation within the gene but favor occlusion of the promoter by nucleosomes. In contrast, housekeeping genes that lack pronounced Pol II pausing show higher nucleosome occupancy downstream, but their promoters are deprived of nucleosomes regardless of polymerase binding. Our results indicate that a key role of paused Pol II is to compete with nucleosomes for occupancy of highly regulated promoters, thereby preventing the formation of repressive chromatin architecture	[Gilchrist, Daniel A.; Dos Santos, Gilberto; Adelman, Karen] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Fargo, David C.] NIEHS, Lib Informat Serv, NIH, Res Triangle Pk, NC 27709 USA; [Li, Leping] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Gao, Yuan] Johns Hopkins Univ, Inst Cell Engn, Neurogenerat & Stem Cell Biol Program, Baltimore, MD 21205 USA; [Xie, Bin; Gao, Yuan] Johns Hopkins Univ, Lieber Inst Brain Dev, Div Genom Epigenom & Bioinformat, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Johns Hopkins University; Johns Hopkins University	Adelman, K (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	adelmank@niehs.nih.gov	Gao, Yuan/E-1706-2011; Li, Leping/F-6497-2019	Li, Leping/0000-0003-4208-0259; Gilchrist, Daniel/0000-0003-1668-2790; Adelman, Karen/0000-0001-5364-334X	NIH, National Institute of Environmental Health Sciences [Z01 ES101987, ES101765]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101987, ZICES102445, ZIAES101765, Z01ES101765, ZIAES101987] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Nechaev, T. Kunkel, and G. Hu for critical reading of the manuscript. We acknowledge L. Pederson for production of the NELF-B protein, J. Tucker and the NIEHS microarray core for help with arrays, and S. Dai and J. Grovenstein for computational support. This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (grant Z01 ES101987 to K.A. and grant ES101765 to L.L.). D.A.G. and K.A. designed experiments, D.A.G., G.D.S., B.X., and Y.G. performed experiments, D.A.G., D.C.F., L.L., and K.A. performed data analysis, and D.A.G. and K.A. prepared the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dimarcq JL, 1997, INSECT BIOCHEM MOLEC, V27, P877, DOI 10.1016/S0965-1748(97)00072-6; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2009, METHODS, V48, P398, DOI 10.1016/j.ymeth.2009.02.024; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	42	290	292	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					540	551		10.1016/j.cell.2010.10.004	http://dx.doi.org/10.1016/j.cell.2010.10.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074046	Green Accepted, Bronze			2022-12-01	WOS:000284149100012
J	Kitzman, DW; Rich, MW				Kitzman, Dalane W.; Rich, Michael W.			Age Disparities in Heart Failure Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRESERVED EJECTION FRACTION; RANDOMIZED CONTROLLED-TRIAL; ASSOCIATION; UPDATE		[Kitzman, Dalane W.] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Rich, Michael W.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Wake Forest University; Washington University (WUSTL)	Kitzman, DW (corresponding author), Wake Forest Univ, Sch Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	dkitzman@wfubmc.edu	Rich, Michael/AAD-6167-2022	Rich, Michael/0000-0002-4243-9391	NATIONAL INSTITUTE ON AGING [R37AG018915, P30AG021332, R01AG018915] Funding Source: NIH RePORTER; NIA NIH HHS [R37AG18915, R37 AG018915, R01 AG018915, P30 AG021332, P30AG21332] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282	10	52	51	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2010	304	17					1950	1951		10.1001/jama.2010.1592	http://dx.doi.org/10.1001/jama.2010.1592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674GT	21045104	Green Accepted			2022-12-01	WOS:000283725900028
J	da Fonseca, PCA; Kong, EH; Zhang, ZG; Schreiber, A; Williams, MA; Morris, EP; Barford, D				da Fonseca, Paula C. A.; Kong, Eric H.; Zhang, Ziguo; Schreiber, Anne; Williams, Mark. A.; Morris, Edward P.; Barford, David			Structures of APC/C-Cdh1 with substrates identify Cdh1 and Apc10 as the D-box co-receptor	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; DESTRUCTION BOX; CRYSTAL-STRUCTURE; CYCLIN-B; KEN BOX; RECOGNITION; SUBUNIT; BINDING; YEAST; COMPLEX/CYCLOSOME	The ubiquitylation of cell-cycle regulatory proteins by the large multimeric anaphase-promoting complex (APC/C) controls sister chromatid segregation and the exit from mitosis(1,2). Selection of APC/C targets is achieved through recognition of destruction motifs, predominantly the destruction (D)-box(3) and KEN (Lys-Glu-Asn)-box(4). Although this process is known to involve a coactivator protein (either Cdc20 or Cdh1) together with core APC/C subunits(1,2), the structural basis for substrate recognition and ubiquitylation is not understood. Here we investigate budding yeast APC/C using single-particle electron microscopy and determine a cryo-electron microscopy map of APC/C in complex with the Cdh1 co-activator protein (APC/C-Cdh1) bound to a D-box peptide at similar to 10 angstrom resolution. We find that a combined catalytic and substrate-recognition module is located within the central cavity of the APC/C assembled from Cdh1, Apc10-a core APC/C subunit previously implicated in substrate recognition(5-7)-and the cullin domain of Apc2. Cdh1 and Apc10, identified from difference maps, create a co-receptor for the D-box following repositioning of Cdh1 towards Apc10. Using NMR spectroscopy we demonstrate specific D-box-Apc10 interactions, consistent with a role for Apc10 in directly contributing towards D-box recognition by the APC/C-Cdh1 complex. Our results rationalize the contribution of both co-activator and core APC/C subunits to D-box recognition(8,9) and provide a structural framework for understanding mechanisms of substrate recognition and catalysis by the APC/C.	[da Fonseca, Paula C. A.; Kong, Eric H.; Zhang, Ziguo; Schreiber, Anne; Morris, Edward P.; Barford, David] Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; [Williams, Mark. A.] Univ London, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 7HX, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Birkbeck University London	Barford, D (corresponding author), Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk		Morris, Edward/0000-0003-3544-0041; Williams, Mark/0000-0002-1645-2189; da Fonseca, Paula/0000-0001-8656-5747	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK grant to D. B. We thank F. Beuron for help with the early stages of this project and for EM support. We are grateful to J. Kirkpatrick for the use of the facilities of the UCL/Birkbeck Institute of Structural Molecular Biology (ISMB) Biomolecular NMR Centre.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Baryshnikova OK, 2008, J BIOMOL NMR, V41, P5, DOI 10.1007/s10858-008-9234-6; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	38	147	149	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					274	+		10.1038/nature09625	http://dx.doi.org/10.1038/nature09625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21107322	Green Accepted			2022-12-01	WOS:000287144200047
J	Anderson, K; Lutz, C; van Delft, FW; Bateman, CM; Guo, YP; Colman, SM; Kempski, H; Moorman, AV; Titley, I; Swansbury, J; Kearney, L; Enver, T; Greaves, M				Anderson, Kristina; Lutz, Christoph; van Delft, Frederik W.; Bateman, Caroline M.; Guo, Yanping; Colman, Susan M.; Kempski, Helena; Moorman, Anthony V.; Titley, Ian; Swansbury, John; Kearney, Lyndal; Enver, Tariq; Greaves, Mel			Genetic variegation of clonal architecture and propagating cells in leukaemia	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER STEM-CELLS; BREAST-CANCER; CHILDHOOD LEUKEMIA; INTRATUMORAL HETEROGENEITY; PROSTATE-CANCER; TUMOR-CELLS; PROGRESSION; EVOLUTION; DIVERSITY	Little is known of the genetic architecture of cancer at the subclonal and single-cell level or in the cells responsible for cancer clonemaintenance and propagation. Here we have examined this issue in childhood acute lymphoblastic leukaemia in which the ETV6-RUNX1 gene fusion is an early or initiating genetic lesion followed by a modest number of recurrent or 'driver' copy number alterations. By multiplexing fluorescence in situ hybridization probes for these mutations, up to eight genetic abnormalities can be detected in single cells, a genetic signature of subclones identified and a composite picture of subclonal architecture and putative ancestral trees assembled. Subclones in acute lymphoblastic leukaemia have variegated genetics and complex, nonlinear or branching evolutionary histories. Copy number alterations are independently and reiteratively acquired in subclones of individual patients, and in no preferential order. Clonal architecture is dynamic and is subject to change in the lead-upto a diagnosis and in relapse. Leukaemia propagating cells, assayed by serial transplantation in NOD/SCID IL2R gamma(null) mice, are also genetically variegated, mirroring subclonal patterns, and vary in competitive regenerative capacity in vivo. These data have implications for cancer genomics and for the targeted therapy of cancer.	[Anderson, Kristina; van Delft, Frederik W.; Bateman, Caroline M.; Colman, Susan M.; Titley, Ian; Swansbury, John; Kearney, Lyndal; Greaves, Mel] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England; [Lutz, Christoph; Guo, Yanping; Enver, Tariq] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Kempski, Helena] Great Ormond St Hosp Sick Children, Paediat Malignancy Unit, London WC1N 3JH, England; [Kempski, Helena] UCL Inst Child Hlth, London WC1N 3JH, England; [Moorman, Anthony V.] Newcastle Univ, No Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of London; Institute of Cancer Research - UK; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Newcastle University - UK	Greaves, M (corresponding author), Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England.	mel.greaves@icr.ac.uk	Moorman, Anthony/F-5518-2010; Moorman, Anthony/G-1468-2014; Bateman, Caroline/AAE-6007-2022	Moorman, Anthony/0000-0002-9781-6107; van Delft, Frederik Willem/0000-0002-3704-3720; Greaves, Melvyn/0000-0002-7239-1384	Kay Kendall Leukaemia Fund; Leukaemia & Lymphoma Research; Deutsche Forschungsgemeinschaft [LU 1474/1-1]; Oxford BRC; MRC [MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137973817] Funding Source: researchfish	Kay Kendall Leukaemia Fund; Leukaemia & Lymphoma Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Oxford BRC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by specialist programme grants from The Kay Kendall Leukaemia Fund (M.G.) and Leukaemia & Lymphoma Research (M.G., T.E.) and a Deutsche Forschungsgemeinschaft fellowship LU 1474/1-1 (to C.L.). T. E. and C.L. acknowledge support from the Oxford BRC.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Aubele M, 1999, CANCER GENET CYTOGEN, V110, P94, DOI 10.1016/S0165-4608(98)00205-2; Barrett Paul H., 1987, C DARWINS NOTEBOOKS; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BOLAND CR, 1995, NAT MED, V1, P902, DOI 10.1038/nm0995-902; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Cottu PH, 2008, ANN ONCOL, V19, P596, DOI 10.1093/annonc/mdn021; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; Fox EJ, 2009, CANCER RES, V69, P4948, DOI 10.1158/0008-5472.CAN-09-1231; Gatenby RA, 2003, CANCER RES, V63, P6212; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Horsley SW, 2008, GENE CHROMOSOME CANC, V47, P333, DOI 10.1002/gcc.20537; Kearney Lyndal, 2009, V538, P57, DOI 10.1007/978-1-59745-418-6_4; Kitagawa Y, 2002, J BIOL CHEM, V277, P46289, DOI 10.1074/jbc.M208353200; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Loncarevic IF, 1999, GENE CHROMOSOME CANC, V24, P272, DOI 10.1002/(SICI)1098-2264(199903)24:3<272::AID-GCC13>3.3.CO;2-L; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Maenhaut C, 2010, CARCINOGENESIS, V31, P149, DOI 10.1093/carcin/bgp259; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Takahashi T, 1998, CANCER RES, V58, P5835; Teixeira MR, 1996, CANCER RES, V56, P855; Tsao JL, 1999, AM J PATHOL, V154, P1815, DOI 10.1016/S0002-9440(10)65437-5; van Dongen J. J. M, 2002, LEUKEMIA, P85; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	53	591	612	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					356	+		10.1038/nature09650	http://dx.doi.org/10.1038/nature09650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21160474				2022-12-01	WOS:000286385600043
J	Spence, D				Spence, Des			From the Frontline Overweening on weaning	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								d334	10.1136/bmj.d334	http://dx.doi.org/10.1136/bmj.d334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248011				2022-12-01	WOS:000286602400016
J	Regot, S; Macia, J; Conde, N; Furukawa, K; Kjellen, J; Peeters, T; Hohmann, S; de Nadal, E; Posas, F; Sole, R				Regot, Sergi; Macia, Javier; Conde, Nuria; Furukawa, Kentaro; Kjellen, Jimmy; Peeters, Tom; Hohmann, Stefan; de Nadal, Eulalia; Posas, Francesc; Sole, Ricard			Distributed biological computation with multicellular engineered networks	NATURE			English	Article							SYNTHETIC BIOLOGY; COMMUNICATION; PARTS	Ongoing efforts within synthetic and systems biology have been directed towards the building of artificial computational devices(1) using engineered biological units as basic building blocks(2,3). Such efforts, inspired in the standard design of electronic circuits(4-7), are limited by the difficulties arising from wiring the basic computational units (logic gates) through the appropriate connections, each one to be implemented by a different molecule. Here, we show that there is a logically different form of implementing complex Boolean logic computations that reduces wiring constraints thanks to a redundant distribution of the desired output among engineered cells. A practical implementation is presented using a library of engineered yeast cells, which can be combined in multiple ways. Each construct defines a logic function and combining cells and their connections allow building more complex synthetic devices. As a proof of principle, we have implemented many logic functions by using just a few engineered cells. Of note, small modifications and combination of those cells allowed for implementing more complex circuits such as a multiplexer or a 1-bit adder with carry, showing the great potential for re-utilization of small parts of the circuit. Our results support the approach of using cellular consortia as an efficient way of engineering complex tasks not easily solvable using single-cell implementations.	[Macia, Javier; Conde, Nuria; Sole, Ricard] UPF, ICREA Complex Syst Lab, E-08003 Barcelona, Spain; [Regot, Sergi; Conde, Nuria; Peeters, Tom; de Nadal, Eulalia; Posas, Francesc] UPF, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain; [Furukawa, Kentaro; Kjellen, Jimmy; Hohmann, Stefan] Univ Gothenburg, Dept Cell & Mol Biol Microbiol, S-40530 Gothenburg, Sweden; [Sole, Ricard] Santa Fe Inst, Santa Fe, NM 87501 USA; [Sole, Ricard] UPF, CSIC, Inst Biol Evolut, E-08003 Barcelona, Spain	ICREA; Pompeu Fabra University; Pompeu Fabra University; University of Gothenburg; The Santa Fe Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Sole, R (corresponding author), UPF, ICREA Complex Syst Lab, E-08003 Barcelona, Spain.	francesc.posas@upf.edu; ricard.sole@upf.edu	Conde, Núria/ABC-5973-2021; Posas, Francesc/K-1364-2013; de Nadal, Eulalia/J-8178-2014; Hohmann, Stefan/K-9895-2013	Posas, Francesc/0000-0002-4164-7076; Sole, Ricard/0000-0001-6974-1008; Peeters, Tom/0000-0003-3929-9559; de Nadal, Eulalia/0000-0003-0039-5607; Furukawa, Kentaro/0000-0002-1551-1538; Conde, Nuria/0000-0001-5766-309X; Regot, Sergi/0000-0001-9786-3897; Hohmann, Stefan/0000-0002-0809-1985	FPU (Spanish Government); James McDonnell Foundation; MICINN [BIO2009-07762, FIS2009-12365]; Consolider Ingenio 2010 programme [CSD2007-0015]; ESF [ERAS-CT-2003-980409]; CELLCOMPUT (FP6) project; FP7 UNICELLSYS [201142]; Santa Fe Institute; Fundacion Marcelino Botin (FMB); ICREA Academia (Generalitat de Catalunya); ICREA Funding Source: Custom	FPU (Spanish Government)(Spanish Government); James McDonnell Foundation; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Consolider Ingenio 2010 programme(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ESF(European Commission); CELLCOMPUT (FP6) project(European Commission); FP7 UNICELLSYS; Santa Fe Institute; Fundacion Marcelino Botin (FMB); ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); ICREA(ICREA)	We thank L. Subirana and S. Ovejas for technical support and S. Pellet and M. Peter for their help in setting up the microfluidics platform, and K. Kuchler for the FUS1-mCherry construct. S. R. is recipient of a FPU fellowship (Spanish Government). This work was supported by grants from the James McDonnell Foundation to R. S., the MICINN (BIO2009-07762 and FIS2009-12365); Consolider Ingenio 2010 programme (grant CSD2007-0015), from the ESF (ERAS-CT-2003-980409) FP6 as part of a EURYI scheme award (www.esf.org/euryi) to F. P. and the CELLCOMPUT (FP6) project to F. P., R. S. and S. H., and FP7 UNICELLSYS grant (#201142) to F. P. and S. H., and The Santa Fe Institute to R. S.; F. P. and R. S. laboratories are also supported by the Fundacion Marcelino Botin (FMB). F. P. is recipient of an ICREA Academia (Generalitat de Catalunya).	Amos M, 2004, SER SYST BIOL, P3; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; ARKIN A, 1994, BIOPHYS J, V67, P560, DOI 10.1016/S0006-3495(94)80516-8; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Chin JW, 2006, CURR OPIN STRUC BIOL, V16, P551, DOI 10.1016/j.sbi.2006.06.011; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Greber D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq671; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	27	211	219	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					207	211		10.1038/nature09679	http://dx.doi.org/10.1038/nature09679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21150900				2022-12-01	WOS:000286143400037
J	Vergeer, M; Korporaal, SJA; Franssen, R; Meurs, I; Out, R; Hovingh, GK; Hoekstra, M; Sierts, JA; Dallinga-Thie, GM; Motazacker, MM; Holleboom, AG; Van Berkel, TJC; Kastelein, JJP; Van Eck, M; Kuivenhoven, JA				Vergeer, Menno; Korporaal, Suzanne J. A.; Franssen, Remco; Meurs, Illiana; Out, Ruud; Hovingh, G. Kees; Hoekstra, Menno; Sierts, Jeroen A.; Dallinga-Thie, Geesje M.; Motazacker, Mohammad Mahdi; Holleboom, Adriaan G.; Van Berkel, Theo J. C.; Kastelein, John J. P.; Van Eck, Miranda; Kuivenhoven, Jan Albert			Genetic Variant of the Scavenger Receptor BI in Humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; MARROW-DERIVED CELLS; TRANSPORT IN-VIVO; SR-BI; CHOLESTEROL EFFLUX; FAMILIAL HYPERCHOLESTEROLEMIA; LIPID-METABOLISM; TRANSFER PROTEIN; RAISING HDL; DEFICIENCY	BACKGROUND In mice, the scavenger receptor class B type I (SR-BI) is essential for the delivery of high-density lipoprotein (HDL) cholesterol to the liver and steroidogenic organs. Paradoxically, elevated HDL cholesterol levels are associated with increased atherosclerosis in SR-BI-knockout mice. It is unclear what role SR-BI plays in human metabolism. METHODS We sequenced the gene encoding SR-BI in persons with elevated HDL cholesterol levels and identified a family with a new missense mutation (P297S). The functional effects of the P297S mutation on HDL binding, cellular cholesterol uptake and efflux, atherosclerosis, platelet function, and adrenal function were studied. RESULTS Cholesterol uptake from HDL by primary murine hepatocytes that expressed mutant SR-BI was reduced to half of that of hepatocytes expressing wild-type SR-BI. Carriers of the P297S mutation had increased HDL cholesterol levels (70.4 mg per deciliter [1.8 mmol per liter], vs. 53.4 mg per deciliter [1.4 mmol per liter] in noncarriers; P<0.001) and a reduced capacity for efflux of cholesterol from macrophages, but the carotid artery intima-media thickness was similar in carriers and in family noncarriers. Platelets from carriers had increased unesterified cholesterol content and impaired function. In carriers, adrenal steroidogenesis was attenuated, as evidenced by decreased urinary excretion of sterol metabolites, a decreased response to corticotropin stimulation, and symptoms of diminished adrenal function. CONCLUSIONS We identified a family with a functional mutation in SR-BI. The mutation carriers had increased HDL cholesterol levels and a reduction in cholesterol efflux from macrophages but no significant increase in atherosclerosis. Reduced SR-BI function was associated with altered platelet function and decreased adrenal steroidogenesis.	[Vergeer, Menno; Franssen, Remco; Hovingh, G. Kees; Sierts, Jeroen A.; Dallinga-Thie, Geesje M.; Motazacker, Mohammad Mahdi; Holleboom, Adriaan G.; Kastelein, John J. P.; Kuivenhoven, Jan Albert] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Korporaal, Suzanne J. A.; Meurs, Illiana; Out, Ruud; Hoekstra, Menno; Van Berkel, Theo J. C.; Van Eck, Miranda] Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC	Kuivenhoven, JA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9,G1-113, NL-1105 AZ Amsterdam, Netherlands.	j.a.kuivenhoven@amc.uva.nl	Van Berkel, Theo/ABD-7677-2021; Kastelein, John/AAF-7950-2020	dallinga-thie, geesje/0000-0001-5412-5923; van Eck, Miranda/0000-0003-3936-3194; Hoekstra, Menno/0000-0001-7463-2893; Holleboom, A.G. (Onno)/0000-0002-2911-2917	European Community [037631]; Netherlands Heart Foundation [2006B107, 2007T056, 2008T070, 2009B027]; Netherlands Organization for Scientific Research [021.001.035, 917.66.301]	European Community(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Supported by grants from the European Community (FP6-2005-LifeSciHealth-6; STREP contract number 037631), the Netherlands Heart Foundation (2006B107, 2007T056, 2008T070, and 2009B027), and the Netherlands Organization for Scientific Research (project numbers 021.001.035 and 917.66.301).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Covey SD, 2003, ARTERIOSCLER THROMB, V23, P1950; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Duong M, 2006, ARTERIOSCL THROM VAS, V26, P541, DOI 10.1161/01.ATV.0000203515.25574.19; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Hsu LA, 2003, ARTERIOSCL THROM VAS, V23, P1869, DOI 10.1161/01.ATV.0000082525.84814.A9; ILLINGWORTH DR, 1984, J CLIN ENDOCR METAB, V58, P206, DOI 10.1210/jcem-58-1-206; ILLINGWORTH DR, 1983, METABOLISM, V32, P1045, DOI 10.1016/0026-0495(83)90075-6; Imachi H, 2003, ARTERIOSCL THROM VAS, V23, P898, DOI 10.1161/01.ATV.0000067429.46333.7B; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Lange K, 2001, AM J HUM GENET, V69, P504; Masson D, 2009, ARTERIOSCL THROM VAS, V29, P2054, DOI 10.1161/ATVBAHA.109.191320; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; NORUM KR, 1967, SCAND J CLIN LAB INV, V20, P231, DOI 10.3109/00365516709076948; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Pirillo A, 2006, BBA-MOL CELL BIOL L, V1761, P292, DOI 10.1016/j.bbalip.2006.03.009; Rader DJ, 2009, CIRCULATION, V120, P549, DOI 10.1161/CIRCULATIONAHA.109.881979; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; West M, 2009, J CLIN ENDOCR METAB, V94, P1451, DOI 10.1210/jc.2008-1223; Wild S, 2008, HEART, V94, P692, DOI 10.1136/hrt.2007.126326; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	39	246	253	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					136	145		10.1056/NEJMoa0907687	http://dx.doi.org/10.1056/NEJMoa0907687			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226579	Bronze			2022-12-01	WOS:000286142900007
J	Zhou, RB; Yazdi, AS; Menu, P; Tschopp, J				Zhou, Rongbin; Yazdi, Amir S.; Menu, Philippe; Tschopp, Juerg			A role for mitochondria in NLRP3 inflammasome activation	NATURE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; OXYGEN SPECIES PRODUCTION; NALP3 INFLAMMASOME; DISEASE; CELLS; PATHOGENESIS; DYSFUNCTION; APOPTOSIS; AUTOPHAGY; CHANNEL	An inflammatory response initiated by the NLRP3 inflammasome is triggered by a variety of situations of host 'danger', including infection and metabolic dysregulation(1,2). Previous studies suggested that NLRP3 inflammasome activity is negatively regulated by autophagy and positively regulated by reactive oxygen species (ROS) derived from an uncharacterized organelle. Here we show that mitophagy/autophagy blockade leads to the accumulation of damaged, ROS-generating mitochondria, and this in turn activates the NLRP3 inflammasome. Resting NLRP3 localizes to endoplasmic reticulum structures, whereas on inflammasome activation both NLRP3 and its adaptor ASC redistribute to the perinuclear space where they co-localize with endoplasmic reticulum and mitochondria organelle clusters. Notably, both ROS generation and inflammasome activation are suppressed when mitochondrial activity is dysregulated by inhibition of the voltage-dependent anion channel. This indicates that NLRP3 inflammasome senses mitochondrial dysfunction and may explain the frequent association of mitochondrial damage with inflammatory diseases.	[Zhou, Rongbin; Yazdi, Amir S.; Menu, Philippe; Tschopp, Juerg] Univ Lausanne, Ctr Immun & Infect, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Ctr Immun & Infect, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Zhou, Rongbin/B-1430-2013		Swiss National Science Foundation; Institute for Arthritis Research; DFG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute for Arthritis Research; DFG(German Research Foundation (DFG))	This study was supported by grants of the Swiss National Science Foundation and by the Institute for Arthritis Research. A.S.Y. is a recipient of a stipend of the DFG. We would like to thank K. Schroder, C. Thomas and J. Vince for critical reading of the manuscript and G. W. Knott, EPFL, Lausanne, for help in collecting electron micrographs.	Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Latz E, 2010, BLOOD, V116, P1393, DOI 10.1182/blood-2010-06-287342; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Restivo NL, 2004, J PEDIATR GASTR NUTR, V38, P534, DOI 10.1097/00005176-200405000-00014; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yamagata H, 2009, ONCOGENE, V28, P3563, DOI 10.1038/onc.2009.213; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	28	3275	3413	24	683	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					221	225		10.1038/nature09663	http://dx.doi.org/10.1038/nature09663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21124315				2022-12-01	WOS:000286143400040
J	Berkes, P; Orban, G; Lengyel, M; Fiser, J				Berkes, Pietro; Orban, Gergo; Lengyel, Mate; Fiser, Jozsef			Spontaneous Cortical Activity Reveals Hallmarks of an Optimal Internal Model of the Environment	SCIENCE			English	Article							BAYESIAN-INFERENCE; NATURAL SCENES; VISUAL-CORTEX; POPULATION; PERCEPTION; EMERGENCE	The brain maintains internal models of its environment to interpret sensory inputs and to prepare actions. Although behavioral studies have demonstrated that these internal models are optimally adapted to the statistics of the environment, the neural underpinning of this adaptation is unknown. Using a Bayesian model of sensory cortical processing, we related stimulus-evoked and spontaneous neural activities to inferences and prior expectations in an internal model and predicted that they should match if the model is statistically optimal. To test this prediction, we analyzed visual cortical activity of awake ferrets during development. Similarity between spontaneous and evoked activities increased with age and was specific to responses evoked by natural scenes. This demonstrates the progressive adaptation of internal models to the statistics of natural stimuli at the neural level.	[Berkes, Pietro; Orban, Gergo; Fiser, Jozsef] Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA; [Orban, Gergo] Hungarian Acad Sci, Res Inst Particle & Nucl Phys, Dept Biophys, H-1121 Budapest, Hungary; [Orban, Gergo; Lengyel, Mate] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Fiser, Jozsef] Brandeis Univ, Dept Psychol, Waltham, MA 02454 USA; [Fiser, Jozsef] Brandeis Univ, Neurosci Program, Waltham, MA 02454 USA; [Fiser, Jozsef] Coll Budapest Inst Adv Study, H-1014 Budapest, Hungary	Brandeis University; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; University of Cambridge; Brandeis University; Brandeis University	Berkes, P (corresponding author), Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA.	berkes@brandeis.edu	Lengyel, Mate/A-6665-2013	Lengyel, Mate/0000-0001-7266-0049; Fiser, Jozsef/0000-0002-7064-0690; Berkes, Pietro/0000-0002-2827-3911; Orban, Gergo/0000-0002-2406-5912	Swartz Foundation; Swiss National Science Foundation; EU; Wellcome Trust; NIH; NATIONAL EYE INSTITUTE [R01EY018196] Funding Source: NIH RePORTER	Swartz Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Wolpert and D. Katz for suggestions on the manuscript, C. Chiu and M. Weliky for help with the data collection, and D. Lisitsyn for technical help. This work was supported by the Swartz Foundation (J.F., G.O., and P.B.), the Swiss National Science Foundation (P.B.), an EU-FP7 Marie Curie Intra-European Fellowship (G.O.), the Wellcome Trust (M.L.), and NIH (J.F.).	Barlow H.B., 1961, SENSORY COMMUNICATIO; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Dayan P., 1999, THEORETICAL NEUROSCI; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Goldberg JA, 2004, NEURON, V42, P489, DOI 10.1016/S0896-6273(04)00197-7; Hoyer P., 2003, ADV NEURAL INFORM PR, V16, P293; Jaynes E.T., 2003, PROBABILITY THEORY L; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Sobel DM, 2004, COGNITIVE SCI, V28, P303, DOI 10.1016/j.cogsci.2003.11.001; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Teh YW, 2004, J MACH LEARN RES, V4, P1235; Trommershauser J, 2008, TRENDS COGN SCI, V12, P291, DOI 10.1016/j.tics.2008.04.010; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	22	396	397	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					83	87		10.1126/science.1195870	http://dx.doi.org/10.1126/science.1195870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212356	Green Accepted			2022-12-01	WOS:000285974000041
J	Patel, V; Chatterji, S; Chisholm, D; Ebrahim, S; Gopalakrishna, G; Mathers, C; Mohan, V; Prabhakaran, D; Ravindran, RD; Reddy, KS				Patel, Vikram; Chatterji, Somnath; Chisholm, Dan; Ebrahim, Shah; Gopalakrishna, Gururaj; Mathers, Colin; Mohan, Viswanathan; Prabhakaran, Dorairaj; Ravindran, Ravilla D.; Reddy, K. Srinath			India: Towards Universal Health Coverage 3 Chronic diseases and injuries in India	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; COST-EFFECTIVENESS; MYOCARDIAL-INFARCTION; GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; EDUCATIONAL STATUS; HEART-DISEASE; RISK-FACTORS; TOBACCO USE; ALCOHOL-USE	Chronic diseases (eg, cardiovascular diseases, mental health disorders, diabetes, and cancer) and injuries are the leading causes of death and disability in India, and we project pronounced increases in their contribution to the burden of disease during the next 25 years. Most chronic diseases are equally prevalent in poor and rural populations and often occur together. Although a wide range of cost-effective primary and secondary prevention strategies are available, their coverage is generally low, especially in poor and rural populations. Much of the care for chronic diseases and injuries is provided in the private sector and can be very expensive. Sufficient evidence exists to warrant immediate action to scale up interventions for chronic diseases and injuries through private and public sectors; improved public health and primary health-care systems are essential for the implementation of cost-effective interventions. We strongly advocate the need to strengthen social and policy frameworks to enable the implementation of interventions such as taxation on bidis (small hand-rolled cigarettes), smokeless tobacco, and locally brewed alcohols. We also advocate the integration of national programmes for various chronic diseases and injuries with one another and with national health agendas. India has already passed the early stages of a chronic disease and injury epidemic; in view of the implications for future disease burden and the demographic transition that is in progress in India, the rate at which effective prevention and control is implemented should be substantially increased. The emerging agenda of chronic diseases and injuries should be a political priority and central to national consciousness, if universal health care is to be achieved.	[Patel, Vikram; Ebrahim, Shah] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Patel, Vikram] Sangath, Porvorim, Goa, India; [Chisholm, Dan] WHO, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Ebrahim, Shah; Prabhakaran, Dorairaj; Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Gopalakrishna, Gururaj] WHO Collaborating Ctr Injury Prevent & Safety Pro, Natl Inst Mental Hlth & Neurosci, Dept Epidemiol, Bengaluru, India; [Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Madras, Tamil Nadu, India; [Mohan, Viswanathan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control India, New Delhi, India; [Ravindran, Ravilla D.] Aravind Eye Care Syst, Madurai, Tamil Nadu, India	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Public Health Foundation of India; National Institute of Mental Health & Neurosciences - India; Madras Diabetes Research Foundation	Patel, V (corresponding author), Sangath Ctr, Alto Porvorim 403521, Goa, India.	vikram.patel@lshtm.ac.uk	Prabhakaran, Dorairaj/B-4147-2011; CHATTERJI, Somnath/ABE-6832-2020	Prabhakaran, Dorairaj/0000-0002-3172-834X; Patel, Vikram/0000-0003-1066-8584; Mathers, Colin/0000-0002-0617-6731; Reddy, K Srinath/0000-0003-3416-3548	Wellcome Trust; John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	VP is supported by a Wellcome Trust Senior Clinical Research Fellowship in Tropical Medicine. We acknowledge the contribution of Krishna Rao who collated economic data for the cost-effectiveness estimates; the India World Health Survey team (P Arokiasamy) for doing the survey; and Emese Verdes for assisting with the World Health Survey analysis. The views expressed in this report are solely the responsibility of the named authors and do not necessarily reflect the decisions or stated policy of the WHO or its member states. The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], 2000, TOB IND IND EC AN; [Anonymous], 2009, INT DIABETES FEDERAT; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Baltussen R, 2009, INT J AUDIOL, V48, P144, DOI 10.1080/14992020802538081; Baltussen R, 2009, HEALTH POLICY, V89, P201, DOI 10.1016/j.healthpol.2008.06.003; Bang A, 1995, HLTH ACTION, V11, P2; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bidi Smoking and Public Health, 2008, BIDI SMOKING PUBLIC; BRILLIANT GE, 1991, ARCH OPHTHALMOL-CHIC, V109, P584, DOI 10.1001/archopht.1991.01080040152048; Cecchini M, 2010, LANCET          1111, DOI [10.1016/S0140-6736(10)61514-0, DOI 10.1016/50140-6736(10)61514-0]; Chang DF, 2005, BRIT J OPHTHALMOL, V89, P1073, DOI 10.1136/bjo.2005.068213; Chatterjee S, 2003, BRIT J PSYCHIAT, V182, P57, DOI 10.1192/bjp.182.1.57; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chisholm D, 2004, BRIT J PSYCHIAT, V184, P393, DOI 10.1192/bjp.184.5.393; Chisholm D, 2008, ROAD TRAFFIC INJURY, P4; Chisholm D, 2008, B WORLD HEALTH ORGAN, V86, P542, DOI 10.2471/BLT.07.045377; Chow J, 2007, COST EFFECTIVENESS D; Crime National Records, 2007, ACC DEATHS SUIC IND, V11; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Gajalakshmi V, 2007, INT J EPIDEMIOL, V36, P203, DOI 10.1093/ije/dyl308; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Gill A, 2006, EC POLIT WKLY, V26, P27662; Ginsberg Gary M, 2010, Cost Eff Resour Alloc, V8, P2, DOI 10.1186/1478-7547-8-2; Ginsberg GM, 2009, VACCINE, V27, P6060, DOI 10.1016/j.vaccine.2009.07.026; Go R, 2005, STRIKING RIGHT BALAN; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Grover A, 2011, LANCET, V377, P976, DOI 10.1016/S0140-6736(10)62042-9; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta PC, 2008, BIDI SMOKING PUBLIC; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Gupta R, 2006, INDIAN J MED RES, V124, P15; Gururaj G., 2006, ROAD TRAFFIC INJURY; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; John R, EC TOBACCO TOBACCO T; John RM, 2008, HEALTH POLICY PLANN, V23, P200, DOI 10.1093/heapol/czn007; John TJ, 2011, LANCET          0112, DOI [10.1016/S0140-6736(10)61265-2, DOI 10.1016/50140-6736(10)61265-2]; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Jose R, 2008, COMMUNITY EYE HLTH, V21, ps103; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kapur A, 2007, INDIAN J MED RES, V125, P473; Karthikeyan G, 2007, HEART, V93, P1334, DOI 10.1136/hrt.2007.131193; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Leeder S, 2004, RACE TIME CHALLENGE; Levesque JF, 2007, INT J HEALTH PLAN M, V22, P159, DOI 10.1002/hpm.879; Levesque JF, 2006, FOR 9 M MUMB; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Maselko J, 2008, J EPIDEMIOL COMMUN H, V62, P817, DOI 10.1136/jech.2007.069351; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Ministry of Road Transport and Highways Government of India, 2007, REP COMM ROAD SAF TR; Ministry of Road Transport and Highways Government of India, 2007, NAT ROAD TRANSP POL; Ministry of Urban Development Government of India, NAT URB TRANSP POL; Mock C, 2003, J TRAUMA, V54, P1197, DOI 10.1097/01.TA.0000033492.48190.7A; Mock C., 2004, GUIDELINES ESSENTIAL; Mohan Dinesh, 2004, ROAD AHEAD TRAFFIC I; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Murray CJ, LANCET, V361, P717; Murthy RS, 2007, INDIAN J MED RES, V125, P707; Nagpal J, 2006, DIABETES CARE, V29, P2341, DOI 10.2337/dc06-0783; NATCHIAR G, 1994, ARCH OPHTHALMOL-CHIC, V112, P987, DOI 10.1001/archopht.1994.01090190135035; O'Heagarty M, 2008, BIDI SMOKING PUBLIC, P13; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Patel V, 2001, SOCIOECONOMIC FACTOR; Patel V, 2011, LANCET          1214; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2007, TROP MED INT HEALTH, V12, P130, DOI 10.1111/j.1365-3156.2006.01756.x; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Peden M., 2004, WORLD REPORT ROAD TR; Pednekar MS, 2008, BIDI SMOKING PUBLIC, P113; Planning Commission Government of India, 2007, 11 5 YEAR PLAN, VII; Prabhakaran Dorairaj, 2005, Indian Heart J, V57, P217; Purohit BC, 2001, HEALTH POLICY PLANN, V16, P87, DOI 10.1093/heapol/16.1.87; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2007, EPIDEMIOLOGY DIABETE; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Rastogi T, 2005, TOB CONTROL, V14, P356, DOI 10.1136/tc.2005.011965; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reddy KS, 2006, LANCET, V367, P589, DOI 10.1016/S0140-6736(06)68225-1; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Rees K, 2004, COCHRANE DB SYST REV, V2; Rehm J, 1995, ALCOHOL CAPITA CONSU; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Sasser S, PREHOSPITAL TRAUMA C; Shastri SS, 2008, BIDI SMOKING PUBLIC, P143; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Singh RB, 2005, ACTA CARDIOL, V60, P611, DOI 10.2143/AC.60.6.2004933; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub3; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Sunley E., 2008, INDIA TAX TREATMENT; Tan Torres Edejer T, 2003, MAKING CHOICE HLTH W; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thomas A, 2004, INVOLVEMENT IMPACT R; UNAIDS, 2007, AIDS EP UPD DEC 2007; Ustun TB., 2003, WORLD HLTH SURVEYS H; Vijayakumar L, 2005, CRISIS, V26, P120, DOI 10.1027/0227-5910.26.3.120; WHO, 2005, CHRON DIS HLTH PROM; WHO Global Infobase Team, 2005, 2 WHO SURF GLOB INF; World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1; World Health Organisation, 2008, CLOS GAP GEN; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization, 2003, FRAM CONV TOB CONTR; World Health Organization, GLOB HLTH RISKS MORT; World Health Organization, GUID TRAUM QUAL IMPR; World Health Organization, 2004, GLOB BURD DIS 2004 U; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	122	219	221	3	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2011	377	9763					413	428		10.1016/S0140-6736(10)61188-9	http://dx.doi.org/10.1016/S0140-6736(10)61188-9			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21227486				2022-12-01	WOS:000287337000031
J	Richly, H; Rocha-Viegas, L; Ribeiro, JD; Demajo, S; Gundem, G; Lopez-Bigas, N; Nakagawa, T; Rospert, S; Ito, T; Di Croce, L				Richly, Holger; Rocha-Viegas, Luciana; Domingues Ribeiro, Joana; Demajo, Santiago; Gundem, Gunes; Lopez-Bigas, Nuria; Nakagawa, Tekeya; Rospert, Sabine; Ito, Takashi; Di Croce, Luciano			Transcriptional activation of polycomb-repressed genes by ZRF1	NATURE			English	Article							RNA-POLYMERASE-II; H2A UBIQUITINATION; HISTONE H2B; PROTEIN; CHROMATIN; DIFFERENTIATION; MONOUBIQUITINATION; DEMETHYLATION; INITIATION; LEUKEMIA	Covalent modification of histones is fundamental in orchestrating chromatin dynamics and transcription(1-3). One example of such an epigenetic mark is the mono-ubiquitination of histones, which mainly occurs at histone H2A and H2B(4-6). Ubiquitination of histone H2A has been implicated in polycomb-mediated transcriptional silencing(7-9). However, the precise role of the ubiquitin mark during silencing is still elusive. Here we show in human cell lines that ZRF1 (zuotin-related factor 1) is specifically recruited to histone H2A when it is ubiquitinated at Lys 119 by means of a novel ubiquitin-interacting domain that is located in the evolutionarily conserved zuotin domain. At the onset of differentiation, ZRF1 specifically displaces polycomb-repressive complex 1 (PRC1) from chromatin and facilitates transcriptional activation. A genome-wide mapping of ZRF1, RING1B and H2A-ubiquitin targets revealed its involvement in the regulation of a large set of polycomb target genes, emphasizing the key role ZRF1 has in cell fate decisions. We provide here a model of the molecular mechanism of switching polycomb-repressed genes to an active state.	[Richly, Holger; Rocha-Viegas, Luciana; Domingues Ribeiro, Joana; Demajo, Santiago; Di Croce, Luciano] UPF, CRG, Barcelona 08003, Spain; [Gundem, Gunes; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Nakagawa, Tekeya; Ito, Takashi] Nagasaki Univ, Sch Med, Nagasaki 8528523, Japan; [Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol ZBMZ, D-79104 Freiburg, Germany; [Di Croce, Luciano] PRBB, CRG, ICREA, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Nagasaki University; University of Freiburg; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Di Croce, L (corresponding author), UPF, CRG, Barcelona 08003, Spain.	luciano.dicroce@crg.es	Lopez-Bigas, Nuria/F-6193-2011; Di Croce, Luciano/E-7759-2015; Demajo, Santiago/AAB-1999-2021; Ribeiro, Joana/K-3357-2014	Lopez-Bigas, Nuria/0000-0003-4925-8988; Di Croce, Luciano/0000-0003-3488-6228; Ribeiro, Joana/0000-0003-2221-4002; Demajo Meseguer, Santiago/0000-0003-3998-8784; Rocha-Viegas, Luciana/0000-0001-7857-0212; Rospert, Sabine/0000-0002-3089-9614	Spanish "Ministerio de Educacion y Ciencia'' [BFU2007-63059]; Association for International Cancer Research [10-0177]; AGAUR; Consolider; FEBS fellowship; Fundacao para a Ciencia e Tecnologia; Juan de la Cierva Fellowship; PFIS fellowship;  [FOR967]; ICREA Funding Source: Custom	Spanish "Ministerio de Educacion y Ciencia''(Spanish Government); Association for International Cancer Research; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEBS fellowship; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Juan de la Cierva Fellowship; PFIS fellowship; ; ICREA(ICREA)	We are indebted to S. Jentsch, S. Berger, K. Helin, J. Hasskarl, R. Shiekattar, T. Zimmermann and V. Raker for antibodies and plasmids and for discussions; and to the CRG Microarray facility and Light Microscopy Facility. This work was supported by the Spanish "Ministerio de Educacion y Ciencia'' (BFU2007-63059), the Association for International Cancer Research (10-0177), by the AGAUR and Consolider to L. D. C., and by FOR967 to S. R.; H. R. was supported by a FEBS fellowship; J. R. by a fellowship from Fundacao para a Ciencia e Tecnologia; L. R.-V. by a Juan de la Cierva Fellowship; S. D. by a PFIS fellowship.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1984, LAB INVEST, V50, P147; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Gibbons FD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r96; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Greiner J, 2003, INT J CANCER, V106, P224, DOI 10.1002/ijc.11200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue T, 1999, BIOCHEM BIOPH RES CO, V266, P147, DOI 10.1006/bbrc.1999.1779; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P958, DOI 10.1021/bi00429a006; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Resto VA, 2000, CANCER RES, V60, P5529; Saito S, 2008, INT J CANCER, V123, P633, DOI 10.1002/ijc.23490; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	33	103	105	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1124	U533		10.1038/nature09574	http://dx.doi.org/10.1038/nature09574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179169				2022-12-01	WOS:000285553800063
J	Verbrugge, I; Johnstone, RW; Smyth, MJ				Verbrugge, Inge; Johnstone, Ricky W.; Smyth, Mark J.			SnapShot: Extrinsic Apoptosis Pathways	CELL			English	Editorial Material							DEATH RECEPTORS; MITOCHONDRIA; INDUCTION; LIGAND; TRAIL		[Verbrugge, Inge; Johnstone, Ricky W.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center	Verbrugge, I (corresponding author), Peter MacCallum Canc Ctr, Div Res, St Andrews Pl, Melbourne, Vic 3002, Australia.		Smyth, Mark J/H-8709-2014; Johnstone, Ricky w/H-3748-2014	Smyth, Mark J/0000-0001-7098-7240; Johnstone, Ricky w/0000-0001-7053-9237				ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386	10	50	52	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1192	+	1192.e1	10.1016/j.cell.2010.12.004	http://dx.doi.org/10.1016/j.cell.2010.12.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183080	Bronze			2022-12-01	WOS:000285625400016
J	Premaor, MO; Compston, JE				Premaor, Melissa O.; Compston, Juliet E.			Rational Testing Testing for secondary causes of osteoporosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							CELIAC-DISEASE; FRACTURE RISK; WOMEN		[Compston, Juliet E.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; [Premaor, Melissa O.] Univ Fed Santa Maria, Dept Clin Med, BR-97105900 Santa Maria, RS, Brazil	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidade Federal de Santa Maria (UFSM)	Compston, JE (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Box 157, Cambridge CB2 0QQ, England.	jec1001@cam.ac.uk	Premaor, Melissa/K-7401-2016	Premaor, Melissa/0000-0002-0770-9202				ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; CAPLAN GA, 1994, J ROY SOC MED, V87, P200; Francis RM, 2004, QJM-INT J MED, V97, P63, DOI 10.1093/qjmed/hch012; Jafri MR, 2008, DIGEST DIS SCI, V53, P964, DOI 10.1007/s10620-007-9976-0; Kanis JA, 2010, OSTEOPOROSIS INT, V21, P407, DOI 10.1007/s00198-010-1253-y; Kristinsson SY, 2010, BLOOD, V116, P2651, DOI 10.1182/blood-2010-04-282848; Nolla JM, 2001, J RHEUMATOL, V28, P2289; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Tannenbaum C, 2002, J CLIN ENDOCR METAB, V87, P4431, DOI 10.1210/jc.2002-020275; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549	10	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 16	2010	341								c6959	10.1136/bmj.c6959	http://dx.doi.org/10.1136/bmj.c6959			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XM	21163836				2022-12-01	WOS:000285553100009
J	Song, Y; Altarejos, J; Goodarzi, MO; Inoue, H; Guo, XQ; Berdeaux, R; Kim, JH; Goode, J; Igata, M; Paz, JC; Hogan, MF; Singh, PK; Goebel, N; Vera, L; Miller, N; Cui, JR; Jones, MR; Chen, YDI; Taylor, KD; Hsueh, WA; Rotter, JI; Montminy, M				Song, Youngsup; Altarejos, Judith; Goodarzi, Mark O.; Inoue, Hiroshi; Guo, Xiuqing; Berdeaux, Rebecca; Kim, Jeong-Ho; Goode, Jason; Igata, Motoyuki; Paz, Jose C.; Hogan, Meghan F.; Singh, Pankaj K.; Goebel, Naomi; Vera, Lili; Miller, Nina; Cui, Jinrui; Jones, Michelle R.; Chen, Yii-Der I.; Taylor, Kent D.; Hsueh, Willa A.; Rotter, Jerome I.; Montminy, Marc		CHARGE Consortium; GIANT Consortium	CRTC3 links catecholamine signalling to energy balance	NATURE			English	Article							CREB COACTIVATOR CRTC2; BROWN ADIPOSE-TISSUE; ADENYLYL-CYCLASE; INSULIN-RESISTANCE; LIPOPROTEIN-LIPASE; MEXICAN-AMERICANS; OBESITY; GENE; TRANSCRIPTION; CELLS	The adipose-derived hormone leptin maintains energy balance in part through central nervous system-mediated increases in sympathetic outflow that enhance fat burning. Triggering of beta-adrenergic receptors in adipocytes stimulates energy expenditure by cyclic AMP (cAMP)-dependent increases in lipolysis and fatty-acid oxidation. Although the mechanism is unclear, catecholamine signalling is thought to be disrupted in obesity, leading to the development of insulin resistance. Here we show that the cAMP response element binding (CREB) coactivator Crtc3 promotes obesity by attenuating beta-adrenergic receptor signalling in adipose tissue. Crtc3 was activated in response to catecholamine signals, when it reduced adenyl cyclase activity by upregulating the expression of Rgs2, a GTPase-activating protein that also inhibits adenyl cyclase activity. As a common human CRTC3 variant with increased transcriptional activity is associated with adiposity in two distinct Mexican-American cohorts, these results suggest that adipocyte CRTC3 may play a role in the development of obesity in humans.	[Song, Youngsup; Altarejos, Judith; Inoue, Hiroshi; Berdeaux, Rebecca; Kim, Jeong-Ho; Goode, Jason; Igata, Motoyuki; Paz, Jose C.; Hogan, Meghan F.; Singh, Pankaj K.; Goebel, Naomi; Vera, Lili; Miller, Nina; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Goodarzi, Mark O.; Jones, Michelle R.] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Guo, Xiuqing; Cui, Jinrui; Chen, Yii-Der I.; Taylor, Kent D.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Hsueh, Willa A.] Methodist Hosp, Res Inst, Diabet Res Ctr, Div Diabet Obes & Lipids, Houston, TX 77030 USA	Salk Institute; Cedars Sinai Medical Center; Cedars Sinai Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Rotter, Jerome/AAY-6598-2021; Paz, Jose Carlos/I-5783-2015; Goodarzi, Mark/AAH-7106-2021; Hogan, Meghan/AAD-4425-2020	Paz, Jose Carlos/0000-0001-9684-9735; Goodarzi, Mark/0000-0001-6364-5103; Inoue, Hiroshi/0000-0002-7724-6637; Hogan, Meghan/0000-0002-5767-1599; Song, Youngsup/0000-0002-6268-5223; Berdeaux, Rebecca/0000-0002-9929-1711	National Institutes of Health [R01-DK049777, R01-DK083834, P30-DK063491, R01-HL088457, R01-DK79888, R01-HL071205, N01-HC95159, N02-HL64278, M01-RR00425]; Cedars-Sinai Board of Governor's Chair in Medical Genetics; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088457, R01HL064278, R01HL071205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R01DK083834, P30DK063491, R01DK079888, R01DK049777, R37DK083834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Board of Governor's Chair in Medical Genetics; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by National Institutes of Health grants R01-DK049777, R01-DK083834, P30-DK063491, R01-HL088457, R01-DK79888, R01-HL071205, N01-HC95159, N02-HL64278 and M01-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources, The J.W. Kieckhefer Foundation, The Clayton Medical Research Foundation, Inc., The Helmsley Foundation, the Cedars-Sinai Winnick Clinical Scholars Award (to M.O.G.) and the Cedars-Sinai Board of Governor's Chair in Medical Genetics (J.I.R.). We thank B. Beutler and O. Siggs (The Scripps Research Institute) for help with macrophage studies.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Fu A, 2008, CELL CYCLE, V7, P3823, DOI 10.4161/cc.7.24.7241; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Goodarzi MO, 2003, GENET MED, V5, P322, DOI 10.1097/01.GIM.0000076971.55421.AD; GRANNEMAN JG, 1995, ENDOCRINOLOGY, V136, P2007, DOI 10.1210/en.136.5.2007; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Landsberg L, 2006, CELL MOL NEUROBIOL, V26, P497, DOI 10.1007/s10571-006-9010-7; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; ROHLFS EM, 1995, J BIOL CHEM, V270, P10723, DOI 10.1074/jbc.270.18.10723; Roy AA, 2006, CELL SIGNAL, V18, P336, DOI 10.1016/j.cellsig.2005.05.004; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	48	111	121	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					933	U329		10.1038/nature09564	http://dx.doi.org/10.1038/nature09564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164481	Green Accepted			2022-12-01	WOS:000285344600040
J	Xiang, Y; Yuan, QA; Vogt, N; Looger, LL; Jan, LY; Jan, YN				Xiang, Yang; Yuan, Quan; Vogt, Nina; Looger, Loren L.; Jan, Lily Yeh; Jan, Yuh Nung			Light-avoidance-mediating photoreceptors tile the Drosophila larval body wall	NATURE			English	Article							DEG/ENAC PROTEIN PICKPOCKET1; PROGRAMMED CELL-DEATH; SENSORY NEURONS; C-ELEGANS; GENE; EXPRESSION; CHANNELS; TRANSDUCTION; NOCICEPTION; VERTEBRATES	Photoreceptors for visual perception, phototaxis or light avoidance are typically clustered in eyes or related structures such as the Bolwig organ of Drosophila larvae. Unexpectedly, we found that the class IV dendritic arborization neurons of Drosophila melanogaster larvae respond to ultraviolet, violet and blue light, and are major mediators of light avoidance, particularly at high intensities. These class IV dendritic arborization neurons, which are present in every body segment, have dendrites tiling the larval body wall nearly completely without redundancy. Dendritic illumination activates class IV dendritic arborization neurons. These novel photoreceptors use phototransduction machinery distinct from other photoreceptors in Drosophila and enable larvae to sense light exposure over their entire bodies and move out of danger.	[Xiang, Yang; Yuan, Quan; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA; [Xiang, Yang; Yuan, Quan; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94158 USA; [Xiang, Yang; Yuan, Quan; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94158 USA; [Vogt, Nina] NYU, Ctr Dev Genet, New York, NY 10003 USA; [Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; New York University; Howard Hughes Medical Institute	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA.	yuhnung.jan@ucsf.edu	Yuan, Quan/E-7688-2013	Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Vogt, Nina/0000-0002-2658-9138	Human Frontier Science Program; Deutsche Forschungsgemeinschaft; NIH [2R37NS040929]; Howard Hughes Medical Institute, Janelia Farm Campus; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute, Janelia Farm Campus(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Garrity, C. Desplan, J. Blau, C. Montell, J. Hall, H. Amrein, L. Tian, S. Younger and S. Zhu for fly stocks and reagents; T. Jin for technical support; C. Han for generating whole larval images; H. H. Lee for collaboration to identify the 19-12-GAL4 and 21-7-GAL4 lines; R. Yang, H. H. Lee, B. Ye, J. Parrish, P. Soba, B. Schroeder and J. Bagley for discussions and advice; B. Ye, R. Yang, W. Ge and J. Berg for critical reading of the manuscript; and Jan laboratory members for discussions. Y.X. was a recipient of a Long-term Fellowship from the Human Frontier Science Program, N.V. is supported by Deutsche Forschungsgemeinschaft. This work is supported by a NIH grant (2R37NS040929) to Y.N.J. Y.X. and Q.Y. are associates, L.Y.J. and Y.N.J. are investigators of the Howard Hughes Medical Institute. L. L. L. is supported by the Howard Hughes Medical Institute, Janelia Farm Campus.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bai JW, 2009, NAT PROTOC, V4, P1502, DOI 10.1038/nprot.2009.147; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Fu YB, 2005, CURR OPIN NEUROBIOL, V15, P415, DOI 10.1016/j.conb.2005.06.011; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Millott N., 1968, Symposia of the Zoological Society of London, VNo. 23, P1; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Phillips JB, 2001, J EXP BIOL, V204, P2543; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SAITO M, 1991, J NEUROSCI, V11, P2135; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; STEVEN DM, 1963, BIOL REV, V38, P204, DOI 10.1111/j.1469-185X.1963.tb00783.x; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Ueda A, 2008, J NEUROGENET, V22, P103, DOI 10.1080/01677060701807954; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WILLSON RC, 1981, SCIENCE, V211, P700, DOI 10.1126/science.211.4483.700; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057; [No title captured]	49	294	298	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					921	U312		10.1038/nature09576	http://dx.doi.org/10.1038/nature09576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21068723	Green Accepted			2022-12-01	WOS:000285344600038
J	Suzuki, J; Umeda, M; Sims, PJ; Nagata, S				Suzuki, Jun; Umeda, Masato; Sims, Peter J.; Nagata, Shigekazu			Calcium-dependent phospholipid scrambling by TMEM16F	NATURE			English	Article							SCOTT-SYNDROME; BLOOD-COAGULATION; APOPTOTIC CELLS; EXPRESSION CLONING; PHOSPHATIDYLSERINE; FAMILY; PHOSPHATIDYLETHANOLAMINE; LYMPHOCYTES; DISORDER; EXPOSURE	In all animal cells, phospholipids are asymmetrically distributed between the outer and inner leaflets of the plasma membrane(1). This asymmetrical phospholipid distribution is disrupted in various biological systems. For example, when blood platelets are activated, they expose phosphatidylserine (PtdSer) to trigger the clotting system(2,3). The PtdSer exposure is believed to be mediated by Ca2+-dependent phospholipid scramblases that transport phospholipids bidirectionally(1,4), but its molecular mechanism is still unknown. Here we show that TMEM16F (transmembrane protein 16F) is an essential component for the Ca2+-dependent exposure of PtdSer on the cell surface. When a mouse B-cell line, Ba/F3, was treated with a Ca2+ ionophore under low-Ca2+ conditions, it reversibly exposed PtdSer. Using this property, we established a Ba/F3 subline that strongly exposed PtdSer by repetitive fluorescence-activated cell sorting. A complementary DNA library was constructed from the subline, and a cDNA that caused Ba/F3 to expose PtdSer spontaneously was identified by expression cloning. The cDNA encoded a constitutively active mutant of TMEM16F, a protein with eight transmembrane segments(5). Wild-type TMEM16F was localized on the plasma membrane and conferred Ca2+-dependent scrambling of phospholipids. A patient with Scott syndrome(6,7), which results from a defect in phospholipid scrambling activity(8,9), was found to carry a mutation at a splice-acceptor site of the gene encoding TMEM16F, causing the premature termination of the protein.	[Suzuki, Jun; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Suzuki, Jun; Nagata, Shigekazu] Japan Sci & Technology Corp, Core Res Evolut Sci & Technol, Kyoto 6068501, Japan; [Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Sims, Peter J.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; University of Rochester	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science; National Institutes of Health, USA	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Wiedmer for critical reading of our manuscript, and M. Fujii and M. Harayama for secretarial assistance. This work was supported in part by Grants-in-Aid for Specially Promoted Research (to S.N.) and for Young Scientists Start-up (to J.S.) from the Japan Society for the Promotion of Science. J.S. is supported by a research fellowship from the Japan Society for the Promotion of Science. P.J.S. was supported by grants from the National Institutes of Health, USA.	AOKI Y, 1994, J BIOCHEM-TOKYO, V116, P291, DOI 10.1093/oxfordjournals.jbchem.a124522; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; FUKUNAGA R, 1990, J BIOL CHEM, V265, P14008; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; KAVATHAS P, 1983, NATURE, V306, P385, DOI 10.1038/306385a0; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KOJIMA H, 1994, J CLIN INVEST, V94, P2237, DOI 10.1172/JCI117586; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Weiss HJ, 1997, BLOOD, V90, P475, DOI 10.1182/blood.V90.1.475; Wielders SJH, 2009, THROMB HAEMOSTASIS, V102, P76, DOI 10.1160/TH08-11-0719; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	36	587	607	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					834	U135		10.1038/nature09583	http://dx.doi.org/10.1038/nature09583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21107324	Green Submitted			2022-12-01	WOS:000285093700048
J	Harris, KM; Maurer, J; Kellermann, AL				Harris, Katherine M.; Maurer, Juergen; Kellermann, Arthur L.			Influenza Vaccine -- Safe, Effective, and Mistrusted.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Harris, Katherine M.; Maurer, Juergen; Kellermann, Arthur L.] RAND Corp, Arlington, VA USA	RAND Corporation	Harris, KM (corresponding author), RAND Corp, Arlington, VA USA.			/0000-0002-3923-677X				Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080; MOYER CS, 2010, AM MED NEWS     0719; SteelFisher GK, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1005102	5	40	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2183	2185		10.1056/NEJMp1012333	http://dx.doi.org/10.1056/NEJMp1012333			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688EP	21105831				2022-12-01	WOS:000284832900002
J	Matsuki, T; Matthews, RT; Cooper, JA; van der Brug, MP; Cookson, MR; Hardy, JA; Olson, EC; Howell, BW				Matsuki, Tohru; Matthews, Russell T.; Cooper, Jonathan A.; van der Brug, Marcel P.; Cookson, Mark R.; Hardy, John A.; Olson, Eric C.; Howell, Brian W.			Reelin and Stk25 Have Opposing Roles in Neuronal Polarization and Dendritic Golgi Deployment	CELL			English	Article							MATRIX PROTEIN GM130; APOE RECEPTOR 2; TYROSINE PHOSPHORYLATION; TAU PHOSPHORYLATION; BRAIN-DEVELOPMENT; CORTICAL-NEURONS; VLDL RECEPTOR; SAD KINASES; POLARITY; MOUSE	The Reelin ligand regulates a Dab1-dependent signaling pathway required for brain lamination and normal dendritogenesis, but the specific mechanisms underlying these actions remain unclear. We find that Stk25, a modifier of Reelin-Dab1 signaling, regulates Golgi morphology and neuronal polarization as part of an LKB1-Stk25-Golgi matrix protein 130 (GM130) signaling pathway. Overexpression of Stk25 induces Golgi condensation and multiple axons, both of which are rescued by Reelin treatment. Reelin stimulation of cultured neurons induces the extension of the Golgi into dendrites, which is suppressed by Stk25 overexpression. In vivo, Reelin and Dab1 are required for the normal extension of the Golgi apparatus into the apical dendrites of hippocampal and neocortical pyramidal neurons. This demonstrates that the balance between Reelin-Dab1 signaling and LKB1-Stk25-GM130 regulates Golgi dispersion, axon specification, and dendrite growth and provides insights into the importance of the Golgi apparatus for cell polarization.	[Matsuki, Tohru; Matthews, Russell T.; Olson, Eric C.; Howell, Brian W.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [van der Brug, Marcel P.; Cookson, Mark R.; Hardy, John A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Cooper, Jonathan A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Fred Hutchinson Cancer Center	Howell, BW (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.	howellb@upstate.edu	Hardy, John/C-2451-2009; Cookson, Mark/AAW-2516-2021	Hardy, John/0000-0002-3122-0423; Cookson, Mark/0000-0002-1058-3831; Matsuki, Tohru/0000-0003-1832-2406; Howell, Brian/0000-0002-0204-0773	NINDS; SUNY Upstate Medical University; NIH [NS066071, NS069660, CA41072]; NIA; NATIONAL CANCER INSTITUTE [R37CA041072, R01CA041072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066071, R01NS069660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000947] Funding Source: NIH RePORTER; Medical Research Council [G0701075] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); SUNY Upstate Medical University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Zainab Mansaray and Kristin Giamanco for experimental assistance, Michael Zuber for comments on the manuscript, Hans Clevers for cell lines, Louis Cantley and Jun-ichi Miyazaki for DNA vectors, Arvydas Matiukas and Melissa Pepling for assistance with confocal microscopy, and Bonnie Lee Howell for editing. This work was supported by funds from the NINDS intramural program and SUNY Upstate Medical University to B.W.H.; NIH grants NS066071 to E.C.O., NS069660 to R.T.M., and CA41072 to J.A.C.; and NIA intramural funds for M.R.C.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Asada N, 2007, J NEUROSCI, V27, P11769, DOI 10.1523/JNEUROSCI.1938-07.2007; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Brich J, 2003, J NEUROSCI, V23, P187; CAVINESS VS, 1973, J COMP NEUROL, V147, P235, DOI 10.1002/cne.901470206; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Anda FC, 2010, J NEUROSCI, V30, P10391, DOI 10.1523/JNEUROSCI.0381-10.2010; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; Nichols AJ, 2010, CEREB CORTEX, V20, P2213, DOI 10.1093/cercor/bhp303; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Sanchez-Ponce D, 2008, MOL CELL NEUROSCI, V37, P832, DOI 10.1016/j.mcn.2008.01.010; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sutterlin C, 2010, J CELL BIOL, V188, P621, DOI 10.1083/jcb.200910001; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	57	113	117	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					826	836		10.1016/j.cell.2010.10.029	http://dx.doi.org/10.1016/j.cell.2010.10.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111240	Green Accepted, Bronze			2022-12-01	WOS:000284583500023
J	Neely, GG; Hess, A; Costigan, M; Keene, AC; Goulas, S; Langeslag, M; Griffin, RS; Belfer, I; Dai, F; Smith, SB; Diatchenko, L; Gupta, V; Xia, CP; Amann, S; Kreitz, S; Heindl-Erdmann, C; Wolz, S; Ly, CV; Arora, S; Sarangi, R; Dan, D; Novatchkova, M; Rosenzweig, M; Gibson, DG; Truong, D; Schramek, D; Zoranovic, T; Cronin, SJF; Angjeli, B; Brune, K; Dietzl, G; Maixner, W; Meixner, A; Thomas, W; Pospisilik, JA; Alenius, M; Kress, M; Subramaniam, S; Garrity, PA; Bellen, HJ; Woolf, CJ; Penninger, JM				Neely, G. Gregory; Hess, Andreas; Costigan, Michael; Keene, Alex C.; Goulas, Spyros; Langeslag, Michiel; Griffin, Robert S.; Belfer, Inna; Dai, Feng; Smith, Shad B.; Diatchenko, Luda; Gupta, Vaijayanti; Xia, Cui-Ping; Amann, Sabina; Kreitz, Silke; Heindl-Erdmann, Cornelia; Wolz, Susanne; Ly, Cindy V.; Arora, Suchir; Sarangi, Rinku; Dan, Debasis; Novatchkova, Maria; Rosenzweig, Mark; Gibson, Dustin G.; Truong, Darwin; Schramek, Daniel; Zoranovic, Tamara; Cronin, Shane J. F.; Angjeli, Belinda; Brune, Kay; Dietzl, Georg; Maixner, William; Meixner, Arabella; Thomas, Winston; Pospisilik, J. Andrew; Alenius, Mattias; Kress, Michaela; Subramaniam, Sai; Garrity, Paul A.; Bellen, Hugo J.; Woolf, Clifford J.; Penninger, Josef M.			A Genome-wide Drosophila Screen for Heat Nociception Identifies alpha 2 delta 3 as an Evolutionarily Conserved Pain Gene	CELL			English	Article							BLOOD OXYGENATION; NEUROPATHIC PAIN; BARREL CORTEX; MECHANISMS; SYNESTHESIA; MORPHOGENESIS; TRANSDUCTION; STIMULATION; PERCEPTION; MANAGEMENT	Worldwide, acute, and chronic pain affects 20% of the adult population and represents an enormous financial and emotional burden. Using genome-wide neuronal-specific RNAi knockdown in Drosophila, we report a global screen for an innate behavior and identify hundreds of genes implicated in heat nociception, including the alpha 2 delta family calcium channel subunit straightjacket (stj). Mice mutant for the stj ortholog CACNA2D3 (alpha 2 delta 3) also exhibit impaired behavioral heat pain sensitivity. In addition, in humans, alpha 2 delta 3 SNP variants associate with reduced sensitivity to acute noxious heat and chronic back pain. Functional imaging in alpha 2 delta 3 mutant mice revealed impaired transmission of thermal pain-evoked signals from the thalamus to higher-order pain centers. Intriguingly, in alpha 2 delta 3 mutant mice, thermal pain and tactile stimulation triggered strong cross-activation, or synesthesia, of brain regions involved in vision, olfaction, and hearing.	[Costigan, Michael; Woolf, Clifford J.] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Neurobiol, Boston, MA 02115 USA; [Costigan, Michael; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Neely, G. Gregory; Goulas, Spyros; Xia, Cui-Ping; Amann, Sabina; Novatchkova, Maria; Truong, Darwin; Schramek, Daniel; Zoranovic, Tamara; Cronin, Shane J. F.; Angjeli, Belinda; Meixner, Arabella; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Neely, G. Gregory] Garvan Inst Med Res, Neurosci Program, Sydney, NSW 2010, Australia; [Hess, Andreas; Kreitz, Silke; Heindl-Erdmann, Cornelia; Wolz, Susanne; Brune, Kay] Univ Erlangen Nurnberg, Dept Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Keene, Alex C.] NYU, Dept Biol, New York, NY 10003 USA; [Langeslag, Michiel; Kress, Michaela] Innsbruck Med Univ, Dept Physiol, Div Physiol & Med Phys, A-6020 Innsbruck, Austria; [Griffin, Robert S.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02129 USA; [Belfer, Inna; Dai, Feng] Univ Pittsburgh, Dept Anesthesiol, Mol Epidemiol Pain Program, Pittsburgh, PA USA; [Smith, Shad B.; Diatchenko, Luda; Gibson, Dustin G.; Maixner, William] Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC 27599 USA; [Gupta, Vaijayanti; Arora, Suchir; Sarangi, Rinku; Dan, Debasis; Subramaniam, Sai] Strand Life Sci Pvt Ltd, Bangalore, Karnataka, India; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Dept Mol & Human Genet, HHMI, Houston, TX 77030 USA; [Rosenzweig, Mark; Garrity, Paul A.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02458 USA; [Dietzl, Georg] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Thomas, Winston] Deltagen Inc, San Mateo, CA 94403 USA; [Pospisilik, J. Andrew] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Alenius, Mattias] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Garvan Institute of Medical Research; University of Erlangen Nuremberg; New York University; Medical University of Innsbruck; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Howard Hughes Medical Institute; Brandeis University; Howard Hughes Medical Institute; Stanford University; Max Planck Society; Linkoping University	Woolf, CJ (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Program Neurobiol, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu; josef.penninger@imba.oeaw.ac.at	Neely, Greg/AAB-4642-2020; neely, graham/A-6511-2011; Woolf, Clifford/A-9784-2010; Schramek, Daniel/J-5792-2014; Penninger, Josef M/I-6860-2013; Schramek, Daniel/AAL-1470-2020; Pryjda, Tamara/O-5714-2019; Heindl-Erdmann, Cornelia/F-4809-2018; Smith, Shad/AAO-8760-2020	Neely, Greg/0000-0002-1957-9732; Penninger, Josef M/0000-0002-8194-3777; Schramek, Daniel/0000-0001-9977-2104; zoranovic, tamara/0000-0002-5369-6385; Langeslag, Michiel/0000-0003-4883-7339; Goulas, Spyros/0000-0002-7445-8917; Garrity, Paul/0000-0002-8274-6564; Kress, Michaela/0000-0002-8921-7470; Bellen, Hugo/0000-0001-5992-5989; Gibson, Dustin/0000-0002-9073-3376	National Institute of Health NRSA [1 F32GM086207-01]; NIH [NS039518, NS038253, NS044232]; Mary Curie IIF; EuroThymaide; DFG [661/TP4]; BMBF [01EM0514, 01GQ0731, 0314102]; Doerenkamp Foundation for Innovations in Animal and Consumer Protection; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS039518, R01NS039518, R01NS058870, P01NS072040, P01NS044232, R01NS038253] Funding Source: NIH RePORTER	National Institute of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Curie IIF; EuroThymaide(European Commission); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Doerenkamp Foundation for Innovations in Animal and Consumer Protection; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of our laboratories and the VDRC for helpful discussions and excellent technical support. We thank Ricardo de Matos Simoes for support with statistical analysis. We thank B.J. Dickson for elav/UAS Dicer 2 stocks. alpha 2 delta 3 mutant mice were generated by Deltagen (San Mateo, CA). J.M.P. is supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU (AustroMouse), ApoSys, and an EU ERC Advanced Grant. A.C.K. is supported by National Institute of Health NRSA 1 F32GM086207-01. C.J.W. is supported by NIH NS039518 and NS038253. G.G.N. was supported by a Mary Curie IIF Fellowship and EuroThymaide. A.H. is supported by DFG 661/TP4 and BMBF (01EM0514, 01GQ0731, 0314102) and K.B. by the Doerenkamp Foundation for Innovations in Animal and Consumer Protection. P.A.G. is supported by NIH NS044232.	Aleman A, 2001, NEUROREPORT, V12, P2827, DOI 10.1097/00001756-200109170-00015; Arthurs OJ, 2002, TRENDS NEUROSCI, V25, P27, DOI 10.1016/S0166-2236(00)01995-0; Atlas SJ, 2001, SPINE, V26, P1179, DOI 10.1097/00007632-200105150-00017; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beauchamp MS, 2008, J NEUROSCI, V28, P13696, DOI 10.1523/JNEUROSCI.3872-08.2008; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dudycha GJ, 1935, J ABNORM SOC PSYCH, V30, P57, DOI 10.1037/h0060678; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Hess A, 2000, J NEUROSCI, V20, P3328, DOI 10.1523/JNEUROSCI.20-09-03328.2000; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Koester SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-212; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Ly CV, 2008, J CELL BIOL, V181, P157, DOI 10.1083/jcb.200712152; Manev H, 2004, EUR J PHARMACOL, V491, P207, DOI 10.1016/j.ejphar.2004.03.030; MELZACK R., 1999, PAIN S, V6, pS121, DOI [10.1016/s0304-3959(99)00145-1, DOI 10.1016/S0304-3959(99)00145-1]; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; PITCHER GM, 1995, NEUROSCIENCE, V65, P273, DOI 10.1016/0306-4522(94)00477-M; Premkumar LS, 2010, AAPS J, V12, P361, DOI 10.1208/s12248-010-9196-y; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Stuurman N, 1999, EXP CELL RES, V248, P350, DOI 10.1006/excr.1999.4396; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x	44	193	199	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					628	638		10.1016/j.cell.2010.09.047	http://dx.doi.org/10.1016/j.cell.2010.09.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074052	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000284149100019
J	Srivastava, R				Srivastava, Ranjana			The Power Proxy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Melbourne, Vic, Australia.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1786	1789		10.1056/NEJMp1003221	http://dx.doi.org/10.1056/NEJMp1003221			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YK	21047221				2022-12-01	WOS:000283787800003
J	Lazarus, MB; Nam, YS; Jiang, JY; Sliz, P; Walker, S				Lazarus, Michael B.; Nam, Yunsun; Jiang, Jiaoyang; Sliz, Piotr; Walker, Suzanne			Structure of human O-GlcNAc transferase and its complex with a peptide substrate	NATURE			English	Article							N-ACETYLGLUCOSAMINE; CRYSTAL-STRUCTURE; PROTEIN; GLYCOSYLATION; GLCNACYLATION; NUCLEAR; GENE; REPLACEMENT; PROMOTERS; MECHANISM	The essential mammalian enzyme O-linked beta-N-acetylglucosamine transferase (O-GlcNAc transferase, here OGT) couples metabolic status to the regulation of a wide variety of cellular signalling pathways by acting as a nutrient sensor(1). OGT catalyses the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine (UDP-GlcNAc) to serines and threonines of cytoplasmic, nuclear and mitochondrial proteins(2,3), including numerous transcription factors(4), tumour suppressors, kinases(5), phosphatases(1) and histone-modifying proteins(6). Aberrant glycosylation by OGT has been linked to insulin resistance(7), diabetic complications(8), cancer(9) and neurodegenerative diseases including Alzheimer's(10). Despite the importance of OGT, the details of how it recognizes and glycosylates its protein substrates are largely unknown. We report here two crystal structures of human OGT, as a binary complex with UDP (2.8 angstrom resolution) and as a ternary complex with UDP and a peptide substrate (1.95 angstrom). The structures provide clues to the enzyme mechanism, show how OGT recognizes target peptide sequences, and reveal the fold of the unique domain between the two halves of the catalytic region. This information will accelerate the rational design of biological experiments to investigate OGT's functions; it will also help the design of inhibitors for use as cellular probes and help to assess its potential as a therapeutic target.	[Lazarus, Michael B.; Jiang, Jiaoyang; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lazarus, Michael B.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Nam, Yunsun; Sliz, Piotr] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Nam, Yunsun; Sliz, Piotr] Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Walker, S (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	piotr_sliz@hms.harvard.edu; suzanne_walker@hms.harvard.edu		Nam, Yunsun/0000-0002-7939-8626; Sliz, Piotr/0000-0002-6522-0835; Lazarus, Michael/0000-0002-6738-2563	US National Institutes of Health; US National Science Foundation; Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076710, R01GM078477, R01GM094263] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Gross and C. Drennan for advice. We also thank the US National Institutes of Health, the US National Science Foundation, and the Harvard Biomedical Accelerator Fund for financial support. This work is based on research conducted at the Advanced Photon Source (Northeastern Collaborative Access Team beamlines) and Brookhaven National Laboratory (X25 and X29 beamlines).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, P331; Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4; Bowers K. J., 2006, SC 06 P 2006 ACM IEE, P43; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Goldberg HJ, 2006, ENDOCRINOLOGY, V147, P222, DOI 10.1210/en.2005-0523; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	48	311	325	5	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					564	U168		10.1038/nature09638	http://dx.doi.org/10.1038/nature09638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21240259	Green Accepted			2022-12-01	WOS:000286596500039
J	Gregory, SM; Davis, BK; West, JA; Taxman, DJ; Matsuzawa, S; Reed, JC; Ting, JPY; Damania, B				Gregory, Sean M.; Davis, Beckley K.; West, John A.; Taxman, Debra J.; Matsuzawa, Shu-ichi; Reed, John C.; Ting, Jenny P. Y.; Damania, Blossom			Discovery of a Viral NLR Homolog that Inhibits the Inflammasome	SCIENCE			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; PATTERN-RECOGNITION RECEPTORS; KAPOSIS-SARCOMA; CASPASE-1 ACTIVATION; MURAMYL DIPEPTIDE; DNA-SEQUENCES; INFECTION; GENE; HUMAN-HERPESVIRUS-8; DISEASE	The NLR (nucleotide binding and oligomerization, leucine-rich repeat) family of proteins senses microbial infections and activates the inflammasome, a multiprotein complex that promotes microbial clearance. Kaposi's sarcoma-associated herpesvirus (KSHV) is linked to several human malignancies. We found that KSHV Orf63 is a viral homolog of human NLRP1. Orf63 blocked NLRP1-dependent innate immune responses, including caspase-1 activation and processing of interleukins IL-1 beta and IL-18. KSHV Orf63 interacted with NLRP1, NLRP3, and NOD2. Inhibition of Orf63 expression resulted in increased expression of IL-1 beta during the KSHV life cycle. Furthermore, inhibition of NLRP1 was necessary for efficient reactivation and generation of progeny virus. The viral homolog subverts the function of cellular NLRs, which suggests that modulation of NLR-mediated innate immunity is important for the lifelong persistence of herpesviruses.	[Gregory, Sean M.; Davis, Beckley K.; West, John A.; Taxman, Debra J.; Ting, Jenny P. Y.; Damania, Blossom] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gregory, Sean M.; West, John A.; Taxman, Debra J.; Ting, Jenny P. Y.; Damania, Blossom] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Matsuzawa, Shu-ichi; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Damania, Blossom] Univ N Carolina, UNC Ctr AIDS Res, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Sanford Burnham Prebys Medical Discovery Institute; University of North Carolina; University of North Carolina Chapel Hill	Damania, B (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	damania@med.unc.edu			NIH [DE018281, CA096500, AI057157, AI077437, CA156330, AI56324, AI91967, T32-AI007419, T32-AI007001, 5R21CA131645, F32-AI78735]; American Heart Association [0640041N]; Burroughs Wellcome Fund; UNC; Crohn's & Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA096500, R01CA156330, R21CA131645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, R01AI056324, T32AI007001, U19AI077437, T32AI007419, F32AI078735, R01AI091967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Burroughs Wellcome Fund(Burroughs Wellcome Fund); UNC(Secretaria de Ciencia y Tecnologia (SECYT)); Crohn's & Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank S. Krall for assistance with tissue culture, Y. Matsuzawa for plasmid preparation, and D. Dittmer for proofreading. Supported by NIH grants DE018281 and CA096500, American Heart Association grant 0640041N, and a Burroughs Wellcome Fund grant (B.D.); NIH grants AI057157, AI077437, and CA156330 and the UNC University Cancer Research Fund (J.P.Y.T.); NIH grants AI56324 and AI91967 (J.C.R.); NIH training grants T32-AI007419 and T32-AI007001 (S.M.G.); the Crohn's & Colitis Foundation of America and NIH grant 5R21CA131645 (B.K.D.); and NIH grant F32-AI78735 (J.A.W.). B.D. is a Leukemia & Lymphoma Society Scholar and Burroughs Wellcome Fund Investigator in Infectious Disease. The NLRP1 and mutant NLRP1 expression plasmids as well as purified GST-NLRP1 protein were obtained from J.C.R. and require a material transfer agreement. The NLRP3, NOD1, NOD2, mutant NOD2, ASC, procaspase-1, and pro-IL-1 beta expression plasmids were obtained from J.P.Y.T. and also require a material transfer agreement. B.D., J.P.Y.T., and S.M.G. have filed a provisional patent on the KSHV Orf63 protein and/or any peptides derived from this protein in treatment for human disease.	Blasig C, 1997, J VIROL, V71, P7963, DOI 10.1128/JVI.71.10.7963-7968.1997; Boschan C, 2006, AM J MED GENET A, V140A, P883, DOI 10.1002/ajmg.a.31148; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Coscoy L, 2007, NAT REV IMMUNOL, V7, P391, DOI 10.1038/nri2076; Damania B, 1996, GENE DEV, V10, P1369, DOI 10.1101/gad.10.11.1369; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lequerre T, 2007, RHEUMATOLOGY, V46, P709, DOI 10.1093/rheumatology/kel399; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Monini P, 1999, BLOOD, V93, P4044; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; West J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07	29	154	167	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					330	334		10.1126/science.1199478	http://dx.doi.org/10.1126/science.1199478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252346	Green Accepted, Green Submitted			2022-12-01	WOS:000286636300037
J	Ambraseys, N; Bilham, R				Ambraseys, Nicholas; Bilham, Roger			Corruption kills	NATURE			English	Editorial Material							EARTHQUAKES		[Ambraseys, Nicholas] Univ London Imperial Coll Sci Technol & Med, Dept Civil & Environm Engn, London SW5 2BU, England; [Bilham, Roger] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Bilham, Roger] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	Imperial College London; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ambraseys, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Civil & Environm Engn, London SW5 2BU, England.	n.ambraseys@imperial.ac.uk; rogerbilham@googlemail.com		Bilham, Roger/0000-0002-5547-4102				Allen TI, 2009, SEISMOL RES LETT, V80, P57, DOI 10.1785/gssrl.80.1.57; AMBRASEYS N, 2010, P ACAD ATHENS, V85; AMBRASEYS N, 1978, ASSESSMENT MITIGATIO, P140; Bilham R, 2009, B EARTHQ ENG, V7, P839, DOI 10.1007/s10518-009-9147-0; BURTON I, 1964, NAT RESOUR J, V3, P412; Escaleras M, 2007, PUBLIC CHOICE, V132, P209, DOI 10.1007/s11127-007-9148-y; *GLOB CONSTR PERSP, 2010, GLOB CONSTR 2020 GLO; Green P, 2005, BRIT J CRIMINOL, V45, P528, DOI 10.1093/bjc/azi036; JACKSON EL, 1978, ASSESSMENT MITIGATIO, P241; Kaufmann D., 1998, POLITICAL EC CORRUPT; LEWIS J, 2005, GLOBAL CORRUPTION RE, P23; LOMNITZ C, 1970, B SEISMOL SOC AM, V60, P1309; Marano KD, 2010, NAT HAZARDS, V52, P319, DOI 10.1007/s11069-009-9372-5; The World Bank, GNI PER CAP ATL METH; Transparency International, 2010, 2010 CORR PERC IND	15	96	96	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					153	155		10.1038/469153a	http://dx.doi.org/10.1038/469153a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	705NO	21228851				2022-12-01	WOS:000286143400014
J	Sedlak, DL; von Gunten, U				Sedlak, David L.; von Gunten, Urs			The Chlorine Dilemma	SCIENCE			English	Editorial Material							N-NITROSODIMETHYLAMINE NDMA; WATER-TREATMENT; CHEMICALS; TRICLOSAN; KINETICS		[Sedlak, David L.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [von Gunten, Urs] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [von Gunten, Urs] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Sedlak, DL (corresponding author), Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA.	sedlak@berkeley.edu; vongunten@eawag.ch	von Gunten, Urs/O-1637-2013	von Gunten, Urs/0000-0001-6852-8977				[Anonymous], 1998, FED REG, V40, P69390; Buth JM, 2010, ENVIRON SCI TECHNOL, V44, P4545, DOI 10.1021/es1001105; Deborde M, 2004, ENVIRON SCI TECHNOL, V38, P5577, DOI 10.1021/es040006e; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; Edwards M, 2004, J AM WATER WORKS ASS, V96, P69; Lee BC, 2004, WATER RES, V38, P733, DOI 10.1016/j.watres.2003.10.010; Lee Y, 2008, ENVIRON SCI TECHNOL, V42, P6333, DOI 10.1021/es7023302; Liu HZ, 2009, ENVIRON SCI TECHNOL, V43, P3278, DOI 10.1021/es803179b; Mitch WA, 2002, ENVIRON SCI TECHNOL, V36, P588, DOI 10.1021/es010684q; Park SH, 2009, ENVIRON SCI TECHNOL, V43, P1360, DOI 10.1021/es802732z; Rule KL, 2005, ENVIRON SCI TECHNOL, V39, P3176, DOI 10.1021/es048943+; Sumpter JP, 2006, ENVIRON SCI TECHNOL, V40, P5478, DOI 10.1021/es052554d	12	268	275	17	315	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					42	43		10.1126/science.1196397	http://dx.doi.org/10.1126/science.1196397			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212347				2022-12-01	WOS:000285974000028
J	Chen, CA; Wang, TY; Varadharaj, S; Reyes, LA; Hemann, C; Talukder, MAH; Chen, YR; Druhan, LJ; Zweier, JL				Chen, Chun-An; Wang, Tse-Yao; Varadharaj, Saradhadevi; Reyes, Levy A.; Hemann, Craig; Talukder, M. A. Hassan; Chen, Yeong-Renn; Druhan, Lawrence J.; Zweier, Jay L.			S-glutathionylation uncouples eNOS and regulates its cellular and vascular function	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT RELAXATION; SUPEROXIDE GENERATION; ENDOGENOUS METHYLARGININES; TETRAHYDROBIOPTERIN; REDUCTASE; OXIDATION; CELLS; PHOSPHORYLATION; GLUTATHIOLATION	Endothelial nitric oxide synthase (eNOS) is critical in the regulation of vascular function, and can generate both nitric oxide (NO) and superoxide (O-2(center dot-)), which are key mediators of cellular signalling. In the presence of Ca2+/calmodulin, eNOS produces NO, endothelial-derived relaxing factor, from L-arginine (L-Arg) by means of electron transfer from NADPH through a flavin containing reductase domain to oxygen bound at the haem of an oxygenase domain, which also contains binding sites for tetrahydrobiopterin (BH4) and L-Arg(1-3). In the absence of BH4, NO synthesis is abrogated and instead O-2(center dot-) is generated(4-7). While NOS dysfunction occurs in diseases with redox stress, BH4 repletion only partly restores NOS activity and NOS-dependent vasodilation(7). This suggests that there is an as yet unidentified redox-regulated mechanism controlling NOS function. Protein thiols can undergo S-glutathionylation, a reversible protein modification involved in cellular signalling and adaptation(8,9). Under oxidative stress, S-glutathionylation occurs through thiol-disulphide exchange with oxidized glutathione or reaction of oxidant-induced protein thiyl radicals with reduced glutathione(10,11). Cysteine residues are critical for the maintenance of eNOS function(12,13); we therefore speculated that oxidative stress could alter eNOS activity through S-glutathionylation. Here we show that S-glutathionylation of eNOS reversibly decreases NOS activity with an increase in O-2(center dot-) generation primarily from the reductase, in which two highly conserved cysteine residues are identified as sites of S-glutathionylation and found to be critical for redox-regulation of eNOS function. We show that eNOS S-glutathionylation in endothelial cells, with loss of NO and gain of O-2(center dot-) generation, is associated with impaired endothelium-dependent vasodilation. In hypertensive vessels, eNOS S-glutathionylation is increased with impaired endothelium-dependent vasodilation that is restored by thiol-specific reducing agents, which reverse this S-glutathionylation. Thus, S-glutathionylation of eNOS is a pivotal switch providing redox regulation of cellular signalling, endothelial function and vascular tone.	[Chen, Chun-An; Wang, Tse-Yao; Varadharaj, Saradhadevi; Reyes, Levy A.; Hemann, Craig; Talukder, M. A. Hassan; Chen, Yeong-Renn; Druhan, Lawrence J.; Zweier, Jay L.] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Chen, Chun-An; Wang, Tse-Yao; Varadharaj, Saradhadevi; Reyes, Levy A.; Hemann, Craig; Talukder, M. A. Hassan; Chen, Yeong-Renn; Druhan, Lawrence J.; Zweier, Jay L.] Ohio State Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Zweier, JL (corresponding author), Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	jay.zweier@osumc.edu	Druhan, Lawrence/E-2994-2011	Hemann, Craig/0000-0002-7380-4072	National Institutes of Health [HL63744, HL65608, HL38324, HL83237, HL103846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103846, R01HL083237, R00HL103846, R01HL063744, P01HL065608, R01HL038324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank L. Zhang and K. Green-Church for support with mass spectrometric analysis. This work was supported by R01 grants HL63744, HL65608, HL38324 (J.L.Z.), HL83237 (Y.-R.C.) and HL103846 (C.-A. C.) from the National Institutes of Health.	Alzawahra WF, 2008, AM J PHYSIOL-HEART C, V295, pH499, DOI 10.1152/ajpheart.00374.2008; Berka V, 1998, BIOCHEMISTRY-US, V37, P6136, DOI 10.1021/bi980133l; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Cardounel AJ, 2005, J BIOL CHEM, V280, P7540, DOI 10.1074/jbc.M410241200; Caruso RL, 2005, TOXICOL SCI, V86, P417, DOI 10.1093/toxsci/kfi208; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen CA, 2006, BBA-GEN SUBJECTS, V1760, P1857, DOI 10.1016/j.bbagen.2006.08.002; Chen CL, 2007, BIOCHEMISTRY-US, V46, P5754, DOI 10.1021/bi602580c; Druhan LJ, 2008, BIOCHEMISTRY-US, V47, P7256, DOI 10.1021/bi702377a; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Giraldez RR, 1997, J BIOL CHEM, V272, P21420, DOI 10.1074/jbc.272.34.21420; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Harbrecht BG, 1997, ANN SURG, V225, P76, DOI 10.1097/00000658-199701000-00009; Hill BG, 2007, IUBMB LIFE, V59, P21, DOI 10.1080/15216540701196944; HOFMANN H, 1995, BIOCHEMISTRY-US, V34, P13443, DOI 10.1021/bi00041a023; Huang AN, 2001, AM J PHYSIOL-CELL PH, V281, pC719, DOI 10.1152/ajpcell.2001.281.2.C719; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Kugiyama K, 1998, CIRCULATION, V97, P2299, DOI 10.1161/01.CIR.97.23.2299; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; Roubaud V, 1997, ANAL BIOCHEM, V247, P404, DOI 10.1006/abio.1997.2067; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Sugiyama T, 2010, AM J PHYSIOL-HEART C, V298, pH194, DOI 10.1152/ajpheart.00767.2009; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Takizawa T, 2003, J HISTOCHEM CYTOCHEM, V51, P707, DOI 10.1177/002215540305100602; Vanin AF, 2000, BBA-GEN SUBJECTS, V1474, P365, DOI 10.1016/S0304-4165(00)00033-7; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vita JA, 1998, J CLIN INVEST, V101, P1408, DOI 10.1172/JCI1155; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Wang YM, 2006, FREE RADICAL BIO MED, V41, P775, DOI 10.1016/j.freeradbiomed.2006.05.029; Xia Y, 2000, FREE RADICAL BIO MED, V29, P793, DOI 10.1016/S0891-5849(00)00427-5; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014	42	417	427	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1115	U521		10.1038/nature09599	http://dx.doi.org/10.1038/nature09599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179168	Green Accepted, Green Published			2022-12-01	WOS:000285553800061
J	Coudreuse, D; Nurse, P				Coudreuse, Damien; Nurse, Paul			Driving the cell cycle with a minimal CDK control network	NATURE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; B-TYPE CYCLIN; FISSION YEAST; S-PHASE; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; DEPENDENT KINASES; GENETIC-ANALYSIS; DNA-REPLICATION; MITOTIC CONTROL	Control of eukaryotic cell proliferation involves an extended regulatory network, the complexity of which has made it difficult to understand the basic principles of the cell cycle. To investigate the core engine of the mitotic cycle we have generated a minimal control network in fission yeast that efficiently sustains cellular reproduction. Here we demonstrate that orderly progression through the major events of the cell cycle can be driven by oscillation of an engineered monomolecular cyclin-dependent protein kinase (CDK) module lacking much of the canonical regulation. We show further that the CDK oscillator acts as the primary organizer of the cell cycle, imposing timing and directionality to a system of two CDK activity thresholds that define independent cell cycle phases. We propose that this simple core architecture forms the basic control of the eukaryotic cell cycle.	[Coudreuse, Damien; Nurse, Paul] Rockefeller Univ, Lab Yeast Genet & Cell Biol, New York, NY 10065 USA	Rockefeller University	Coudreuse, D (corresponding author), Rockefeller Univ, Lab Yeast Genet & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	dcoudreuse@rockefeller.edu		Coudreuse, Damien/0000-0003-2534-1621	EMBO [ALTF 899-2007]; Human Frontier Science Program [LT00623/2008]; Breast Cancer Research Foundation; Rockefeller University; Anderson Cancer Center Research at Rockefeller University	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Breast Cancer Research Foundation; Rockefeller University; Anderson Cancer Center Research at Rockefeller University	We thank J. Hayles, P.-Y. Wu and F. Navarro for critically reading the manuscript, and N. Rhind for the anti-Cds1 antibody. D. C. was supported by post-doctoral fellowships from EMBO (ALTF 899-2007) and the Human Frontier Science Program (LT00623/2008) and P. N. by the Breast Cancer Research Foundation, The Rockefeller University and the Anderson Cancer Center Research at Rockefeller University.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Bhaumik D, 1998, MOL BIOL CELL, V9, P2107, DOI 10.1091/mbc.9.8.2107; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; BOOHER R, 1988, EMBO J, V7, P2321, DOI 10.1002/j.1460-2075.1988.tb03075.x; BOOHER RN, 1989, CELL, V58, P485, DOI 10.1016/0092-8674(89)90429-7; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; Buck V, 1995, EMBO J, V14, P6173, DOI 10.1002/j.1460-2075.1995.tb00308.x; BUENO A, 1991, CELL, V66, P149, DOI 10.1016/0092-8674(91)90147-Q; CorreaBordes J, 1997, EMBO J, V16, P4657, DOI 10.1093/emboj/16.15.4657; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Decottignies A, 2001, J CELL SCI, V114, P2627; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; DENHAESE GJ, 1995, MOL BIOL CELL, V6, P371, DOI 10.1091/mbc.6.4.371; Dischinger S, 2008, J CELL SCI, V121, P843, DOI 10.1242/jcs.021584; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; FANTES PA, 1978, EXP CELL RES, V115, P317, DOI 10.1016/0014-4827(78)90286-0; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; FORSBURG SL, 1991, NATURE, V351, P245, DOI 10.1038/351245a0; FORSBURG SL, 1994, J CELL SCI, V107, P601; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; HAYLES J, 1992, ANNU REV GENET, V26, P373, DOI 10.1146/annurev.ge.26.120192.002105; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Martin-Castellanos C, 2000, MOL BIOL CELL, V11, P543, DOI 10.1091/mbc.11.2.543; Martin-Castellanos C, 1996, EMBO J, V15, P839, DOI 10.1002/j.1460-2075.1996.tb00419.x; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORENO S, 1994, NATURE, V367, P236, DOI 10.1038/367236a0; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; OBARAISHIHARA T, 1994, EMBO J, V13, P1863, DOI 10.1002/j.1460-2075.1994.tb06455.x; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rhind N, 1998, MOL CELL BIOL, V18, P3782, DOI 10.1128/MCB.18.7.3782; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SAZER S, 1990, J CELL SCI, V97, P509; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Snaith HA, 1999, GENETICS, V152, P839; Stern B, 1996, TRENDS GENET, V12, P345; Tanaka K, 2000, MOL BIOL CELL, V11, P2845, DOI 10.1091/mbc.11.9.2845; THURIAUX P, 1980, J GEN MICROBIOL, V116, P525; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; Watt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001428; WOODS A, 1989, J CELL SCI, V93, P491; Yamano H, 1996, EMBO J, V15, P5268, DOI 10.1002/j.1460-2075.1996.tb00912.x; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; Zarzov P, 2002, EMBO J, V21, P3370, DOI 10.1093/emboj/cdf346	67	264	269	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1074	U474		10.1038/nature09543	http://dx.doi.org/10.1038/nature09543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179163				2022-12-01	WOS:000285553800052
J	Nicodeme, E; Jeffrey, KL; Schaefer, U; Beinke, S; Dewell, S; Chung, CW; Chandwani, R; Marazzi, I; Wilson, P; Coste, H; White, J; Kirilovsky, J; Rice, CM; Lora, JM; Prinjha, RK; Lee, K; Tarakhovsky, A				Nicodeme, Edwige; Jeffrey, Kate L.; Schaefer, Uwe; Beinke, Soren; Dewell, Scott; Chung, Chun-wa; Chandwani, Rohit; Marazzi, Ivan; Wilson, Paul; Coste, Herve; White, Julia; Kirilovsky, Jorge; Rice, Charles M.; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin; Tarakhovsky, Alexander			Suppression of inflammation by a synthetic histone mimic	NATURE			English	Article							BROMODOMAIN PROTEIN BRD4; TRANSCRIPTIONAL ELONGATION; GENE-EXPRESSION; BINDING MODULES; P-TEFB; CHROMATIN; COMPLEXES; MACHINES	Interaction of pathogens with cells of the immune system results in activation of inflammatory gene expression. This response, although vital for immune defence, is frequently deleterious to the host due to the exaggerated production of inflammatory proteins. The scope of inflammatory responses reflects the activation state of signalling proteins upstream of inflammatory genes as well as signal-induced assembly of nuclear chromatin complexes that support mRNA expression(1-4). Recognition of post-translationally modified histones by nuclear proteins that initiate mRNA transcription and support mRNA elongation is a critical step in the regulation of gene expression(5-10). Here we present a novel pharmacological approach that targets inflammatory gene expression by interfering with the recognition of acetylated histones by the bromodomain and extra terminal domain (BET) family of proteins. We describe a synthetic compound (I-BET) that by 'mimicking' acetylated histones disrupts chromatin complexes responsible for the expression of key inflammatory genes in activated macrophages, and confers protection against lipopolysaccharide-induced endotoxic shock and bacteria-induced sepsis. Our findings suggest that synthetic compounds specifically targeting proteins that recognize post-translationally modified histones can serve as a new generation of immunomodulatory drugs.	[Jeffrey, Kate L.; Schaefer, Uwe; Chandwani, Rohit; Marazzi, Ivan; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA; [Nicodeme, Edwige; Coste, Herve; Kirilovsky, Jorge] Ctr Res GSK, F-91140 Villebon Sur Yvette, France; [Beinke, Soren; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin] GlaxoSmithKline, Med Res Ctr, Epinova DPU, Immunoinflammat Ctr Excellence Drug Discovery, Stevenage SG1 2NY, Herts, England; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA; [Chung, Chun-wa; Wilson, Paul; White, Julia] GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England; [Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA	Rockefeller University; GlaxoSmithKline; GlaxoSmithKline; Rockefeller University; GlaxoSmithKline; Rockefeller University	Tarakhovsky, A (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10065 USA.	Kevin.2.Lee@gsk.com; tarakho@rockefeller.edu		Jeffrey, Kate/0000-0001-5746-0153; marazzi, ivan/0000-0003-3376-0922; Chandwani, Rohit/0000-0003-4781-6069	NIHKL2 Career Development Award; American Italian Cancer Foundation; National Health and Medical Research Council of Australia	NIHKL2 Career Development Award; American Italian Cancer Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We would like to acknowledge R. Grimley and C. Patel for supplying FRET data and R. Woodward, C. Delves, E. Jones and P. Holmes for protein production. J. Witherington, N. Smithers, S. Baddeley, J. Seal and L. Cutler provided compound selectivity and pharmacokinetics data. G. Krysa, O. Mirguet and R. Gosmini contributed to the discovery, development and characterization of the compound. We thank R. Anthony and S. McCleary for assistance with animal models, R. Gejman for bioinformatics analysis of gene expression kinetics and A. Santana and T. Chapman for technical assistance. We would like to thank C. Nathan, R. Medzhitov, S. Rudensky and S. Smale for helpful discussions and S. Sampath for his contribution to the concept of 'histone mimicry'. R. C. is supported by an NIHKL2 Career Development Award and I. M. is supported by the American Italian Cancer Foundation. K. L. J. is supported by the National Health and Medical Research Council of Australia and is currently a Rockefeller University Women in Science Fellow.	Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Huang HD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-57; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; RITTIRSCH D, 2008, NAT PROTOC, V4, P31, DOI DOI 10.1038/NPROT.2008.214; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029	27	1126	1262	4	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1119	1123		10.1038/nature09589	http://dx.doi.org/10.1038/nature09589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21068722	Green Accepted			2022-12-01	WOS:000285553800062
J	Chen, SD; Zhang, YE; Long, MY				Chen, Sidi; Zhang, Yong E.; Long, Manyuan			New Genes in Drosophila Quickly Become Essential	SCIENCE			English	Article							EVOLUTION; MELANOGASTER; GENOME; MOUSE; DIVERGENCE; PHYLOGENY; DUPLICATE; INSIGHTS; ORIGIN	To investigate the origin and evolution of essential genes, we identified and phenotyped 195 young protein-coding genes, which originated 3 to 35 million years ago in Drosophila. Knocking down expression with RNA interference showed that 30% of newly arisen genes are essential for viability. The proportion of genes that are essential is similar in every evolutionary age group that we examined. Under constitutive silencing of these young essential genes, lethality was high in the pupal stage and also found in the larval stages. Lethality was attributed to diverse cellular and developmental defects, such as organ formation and patterning defects. These data suggest that new genes frequently and rapidly evolve essential functions and participate in development.	[Chen, Sidi; Zhang, Yong E.; Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	mlong@uchicago.edu	Zhang, Yong/A-7855-2011; Zhang, Yong E./AAC-8610-2019; CHEN, SIDI/D-8284-2016	Zhang, Yong E./0000-0003-3770-2383; CHEN, SIDI/0000-0002-3819-5005	University of Chicago Biological Sciences Division; National Institutes of Health [R01GM065429-01A1, R01GM078070-01A1]; National Science Foundation [MCB 0238168]; Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065429, R01GM078070] Funding Source: NIH RePORTER	University of Chicago Biological Sciences Division(University of Chicago); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. H. Langley and D. Begun for providing polymorphism data; W. Du, J. Gavin-Smyth, Q. Guo, and M. Guffey for technical assistance and discussion; J. Coyne, M. Kreitman, and X. Ni for critically reading and/or revising the manuscript; and the members of the Manyuan Long laboratory, C. Ferguson, R. Hudson, C. I. Wu, and T. Nagylaki, for valuable discussion. S. C. was supported by University of Chicago Biological Sciences Division Fellowships. This research was supported by National Institutes of Health (R01GM065429-01A1 and R01GM078070-01A1) and National Science Foundation (CAREER Award MCB 0238168) to M. L. Y.E.Z. was also supported by the Searle Funds from Chicago Biomedical Consortium (2009, Spark).	Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gauhar Z., 2008, COMMUNICATION; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Ida H, 2009, NUCLEIC ACIDS RES, V37, P1423, DOI 10.1093/nar/gkn1068; Jones CD, 2005, P NATL ACAD SCI USA, V102, P11373, DOI 10.1073/pnas.0503528102; Joppich C, 2009, CHROMOSOME RES, V17, P19, DOI 10.1007/s10577-008-9002-1; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Keleman K, 2009, COMMUNICATION; Kilpatrick S. T., 2009, LEWINS ESSENTIAL GEN; Kreitman M, 1999, CURR OPIN GENET DEV, V9, P637, DOI 10.1016/S0959-437X(99)00034-9; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; Lynch M, 2001, GENETICS, V159, P1789; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Perrimon N, 1996, GENETICS, V144, P1681; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Su ZX, 2008, J MOL EVOL, V67, P705, DOI 10.1007/s00239-008-9170-9; WALSH JB, 1995, GENETICS, V139, P421; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041	28	203	213	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1682	1685		10.1126/science.1196380	http://dx.doi.org/10.1126/science.1196380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164016	Green Accepted			2022-12-01	WOS:000285390500068
J	Morewedge, CK; Huh, YE; Vosgerau, J				Morewedge, Carey K.; Huh, Young Eun; Vosgerau, Joachim			Thought for Food: Imagined Consumption Reduces Actual Consumption	SCIENCE			English	Article							SENSORY-SPECIFIC SATIETY; ELABORATED INTRUSION THEORY; MENTAL PRACTICE; IMAGERY; HABITUATION; BEHAVIOR; CHILDREN; LIKING; HUMANS; MEMORY	The consumption of a food typically leads to a decrease in its subsequent intake through habituation-a decrease in one's responsiveness to the food and motivation to obtain it. We demonstrated that habituation to a food item can occur even when its consumption is merely imagined. Five experiments showed that people who repeatedly imagined eating a food (such as cheese) many times subsequently consumed less of the imagined food than did people who repeatedly imagined eating that food fewer times, imagined eating a different food (such as candy), or did not imagine eating a food. They did so because they desired to eat it less, not because they considered it less palatable. These results suggest that mental representation alone can engender habituation to a stimulus.	[Morewedge, Carey K.] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Huh, Young Eun; Vosgerau, Joachim] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Morewedge, CK (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Porter Hall 208, Pittsburgh, PA 15213 USA.	morewedge@cmu.edu	Huh, Young Eun/O-9359-2017	Huh, Young Eun/0000-0002-3069-319X	Carnegie Mellon University	Carnegie Mellon University	This work benefited from financial support from a grant to C. K. M. from the Berkman Faculty Development Fund at Carnegie Mellon University. We thank A. Kim, K. Khanna, M. Fei, L. Mosca, M. Christian, and Center for Behavioral Decision Research summer interns in 2008 and 2009 for help with the data collection. We thank C. Janiszewski, D. Kahneman, G. Loewenstein, B. Rolls, and L. Williams for helpful comments.	Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BRICKMAN P, 1978, J PERS SOC PSYCHOL, V36, P917, DOI 10.1037/0022-3514.36.8.917; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dadds MR, 1997, PSYCHOL BULL, V122, P89, DOI 10.1037/0033-2909.122.1.89; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; DEGRANDPRE RJ, 1993, J EXP ANAL BEHAV, V60, P641, DOI 10.1901/jeab.1993.60-641; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Epstein LH, 2009, PSYCHOL REV, V116, P384, DOI 10.1037/a0015074; Epstein LH, 2003, APPETITE, V41, P283, DOI 10.1016/S0195-6663(03)00106-5; Ernst MM, 2002, APPETITE, V38, P224, DOI 10.1006/appe.2001.0484; Frederick S., 1999, WELL BEING FDN HEDON, P302; Havermans RC, 2009, APPETITE, V52, P222, DOI 10.1016/j.appet.2008.09.020; Higgs S, 2008, PSYCHOL SCI, V19, P623, DOI 10.1111/j.1467-9280.2008.02132.x; Huber DE, 2008, J EXP PSYCHOL LEARN, V34, P1305, DOI 10.1037/a0013370; Kavanagh DJ, 2005, PSYCHOL REV, V112, P446, DOI 10.1037/0033-295X.112.2.446; Kemps E, 2007, J EXP PSYCHOL-APPL, V13, P95, DOI 10.1037/1076-898X.13.2.95; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; LANG PJ, 1977, BEHAV THER, V8, P862, DOI 10.1016/S0005-7894(77)80157-3; McSweeney FK, 2000, J EXP ANAL BEHAV, V74, P347, DOI 10.1901/jeab.2000.74-347; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; ROLLS BJ, 1982, PHYSIOL BEHAV, V29, P409, DOI 10.1016/0031-9384(82)90259-1; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rozin P, 1998, PSYCHOL SCI, V9, P392, DOI 10.1111/1467-9280.00073; Soetens B, 2006, J HEALTH PSYCHOL, V11, P655, DOI 10.1177/1359105306066615; TIFFANY ST, 1990, ADDICT BEHAV, V15, P531, DOI 10.1016/0306-4603(90)90053-Z; Williams LE, 2008, PSYCHOL SCI, V19, P302, DOI 10.1111/j.1467-9280.2008.02084.x; Wohldmann EL, 2007, J EXP PSYCHOL LEARN, V33, P254, DOI 10.1037/0278-7393.33.1.254; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	28	193	196	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1530	1533		10.1126/science.1195701	http://dx.doi.org/10.1126/science.1195701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692LE	21148388				2022-12-01	WOS:000285153500062
J	Takano, K; Watanabe-Takano, H; Suetsugu, S; Kurita, S; Tsujita, K; Kimura, S; Karatsu, T; Takenawa, T; Endo, T				Takano, Kazunori; Watanabe-Takano, Haruko; Suetsugu, Shiro; Kurita, Souichi; Tsujita, Kazuya; Kimura, Sumiko; Karatsu, Takashi; Takenawa, Tadaomi; Endo, Takeshi			Nebulin and N-WASP Cooperate to Cause IGF-1-Induced Sarcomeric Actin Filament Formation	SCIENCE			English	Article							SKELETAL-MUSCLE; ELONGATION-FACTORS; NUCLEATION	Insulin-like growth factor 1 (IGF-1) induces skeletal muscle maturation and enlargement (hypertrophy). These responses require protein synthesis and myofibril formation (myofibrillogenesis). However, the signaling mechanisms of myofibrillogenesis remain obscure. We found that IGF-1-induced phosphatidylinositol 3-kinase-Akt signaling formed a complex of nebulin and N-WASP at the Z bands of myofibrils by interfering with glycogen synthase kinase-3 beta in mice. Although N-WASP is known to be an activator of the Arp2/3 complex to form branched actin filaments, the nebulin-N-WASP complex caused actin nucleation for unbranched actin filament formation from the Z bands without the Arp2/3 complex. Furthermore, N-WASP was required for IGF-1-induced muscle hypertrophy. These findings present the mechanisms of IGF-1-induced actin filament formation in myofibrillogenesis required for muscle maturation and hypertrophy and a mechanism of actin nucleation.	[Takano, Kazunori; Watanabe-Takano, Haruko; Kurita, Souichi; Kimura, Sumiko; Endo, Takeshi] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba 2638522, Japan; [Takano, Kazunori; Watanabe-Takano, Haruko; Suetsugu, Shiro; Takenawa, Tadaomi; Endo, Takeshi] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Suetsugu, Shiro] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Suetsugu, Shiro] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan; [Tsujita, Kazuya; Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Karatsu, Takashi] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan	Chiba University; Japan Science & Technology Agency (JST); University of Tokyo; Japan Science & Technology Agency (JST); Kobe University; Chiba University	Endo, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, 1-33 Yayoicho, Chiba 2638522, Japan.	t.endo@faculty.chiba-u.jp	Suetsugu, Shiro/AAF-4427-2019; Suetsugu, Shiro/ABB-6033-2020; Karatsu, Takashi/M-6937-2017; Suetsugu, Shiro/B-3300-2010	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; Karatsu, Takashi/0000-0002-8515-9584	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan [17A-10, 20B-13]; Grants-in-Aid for Scientific Research [22770185, 22570153] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Watanabe and T. Itoh for comments. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Research Grants (17A-10 and 20B-13) for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare of Japan.	Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1006/jmbi.1995.0223; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McElhinny AS, 2003, TRENDS CARDIOVAS MED, V13, P195, DOI 10.1016/S1050-1738(03)00076-8; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Ojima K, 2000, J CELL BIOL, V150, P553, DOI 10.1083/jcb.150.3.553; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Pfuhl M, 1996, J MOL BIOL, V257, P367, DOI 10.1006/jmbi.1996.0169; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242	17	63	67	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1536	1540		10.1126/science.1197767	http://dx.doi.org/10.1126/science.1197767			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148390				2022-12-01	WOS:000285153500064
J	Cunningham, AL; Jones, CP; Ansell, J; Barry, JD				Cunningham, Andrew L.; Jones, Christopher P.; Ansell, James; Barry, Jonathan D.			Christmas 2010: Surgery Red for danger: the effects of red hair in surgical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BRITTLE CORNEA SYNDROME; RECEPTOR GENE; VARIANTS; REDHEADS; HUMANS; COLOR; PAIN		[Cunningham, Andrew L.; Jones, Christopher P.; Barry, Jonathan D.] Abertawe Bro Morgannwg NHS Trust, Morriston Hosp, Dept Gen Surg, Welsh Inst Metab & Obes Surg,Fdn Programme, Swansea SA6 6NL, W Glam, Wales	Morriston Hospital	Barry, JD (corresponding author), Abertawe Bro Morgannwg NHS Trust, Morriston Hosp, Dept Gen Surg, Welsh Inst Metab & Obes Surg,Fdn Programme, Swansea SA6 6NL, W Glam, Wales.	jbarry@doctors.org.uk						Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; Abu A, 2006, INVEST OPHTH VIS SCI, V47, P5283, DOI 10.1167/iovs.06-0206; [Anonymous], 2007, NATL GEOGRAPHIC  SEP; EIBERG H, 1987, CLIN GENET, V32, P125; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Klinge U, 2006, Hernia, V10, P472, DOI 10.1007/s10029-006-0145-8; Kumar VV, 2004, LARYNGOSCOPE, V114, P2031, DOI 10.1097/01.mlg.0000147942.82626.1c; Liem EB, 2006, ANESTH ANALG, V102, P313, DOI 10.1213/01.ANE.0000180769.51576.CD; Liem EB, 2005, ANESTHESIOLOGY, V102, P509, DOI 10.1097/00000542-200503000-00006; Liem EB, 2004, ANESTHESIOLOGY, V101, P279, DOI 10.1097/00000542-200408000-00006; Missmer SA, 2006, FERTIL STERIL, V85, P866, DOI 10.1016/j.fertnstert.2005.12.008; Mogil JS, 2005, J MED GENET, V42, P583, DOI 10.1136/jmg.2004.027698; ROYCE PM, 1990, EUR J PEDIATR, V149, P465, DOI 10.1007/BF01959396; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; *WIK, 2010, KISS JUD; 2010, HARMAN SAYS SORRY GI	16	6	6	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2010	341								c6931	10.1136/bmj.c6931	http://dx.doi.org/10.1136/bmj.c6931			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZU	21148222				2022-12-01	WOS:000285341200011
J	Gan, BY; Hu, JA; Jiang, S; Liu, YC; Sahin, E; Zhuang, L; Fletcher-Sananikone, E; Colla, S; Wang, YA; Chin, L; DePinho, RA				Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.			Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells	NATURE			English	Article							MITOCHONDRIAL BIOGENESIS; ENERGY; RESISTANCE; PATHWAY; BIOLOGY; STRESS; KINASE; FOXOS	The capacity to fine-tune cellular bioenergetics with the demands of stem-cell maintenance and regeneration is central to normal development and ageing, and to organismal survival during periods of acute stress. How energy metabolism and stem-cell homeostatic processes are coordinated is not well understood. Lkb1 acts as an evolutionarily conserved regulator of cellular energy metabolism in eukaryotic cells and functions as the major upstream kinase to phosphorylate AMP-activated protein kinase (AMPK) and 12 other AMPK-related kinases(1-3). Whether Lkb1 regulates stem-cell maintenance remains unknown. Here we show that Lkb1 has an essential role in haematopoietic stem cell (HSC) homeostasis. We demonstrate that ablation of Lkb1 in adult mice results in severe pancytopenia and subsequent lethality. Loss of Lkb1 leads to impaired survival and escape from quiescence of HSCs, resulting in exhaustion of the HSC pool and a marked reduction of HSC repopulating potential in vivo. Lkb1 deletion has an impact on cell proliferation in HSCs, but not on more committed compartments, pointing to context-specific functions for Lkb1 in haematopoiesis. The adverse impact of Lkb1 deletion on haematopoiesis was predominantly cell-autonomous and mTOR complex 1 (mTORC1)-independent, and involves multiple mechanisms converging on mitochondrial apoptosis and possibly downregulation of PGC-1 coactivators and their transcriptional network, which have critical roles in mitochondrial biogenesis and function. Thus, Lkb1 serves as an essential regulator of HSCs and haematopoiesis, and more generally, points to the critical importance of coupling energy metabolism and stem-cell homeostasis.	[Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gan, Boyi; Hu, Jian; Jiang, Shan; Liu, Yingchun; Sahin, Erguen; Zhuang, Li; Fletcher-Sananikone, Eliot; Colla, Simona; Wang, Y. Alan; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Gan, Boyi/HDM-4206-2022	Colla, Simona/0000-0001-6583-8910; DePinho, Ronald/0000-0002-5625-577X	DOD [TS093049]; Multiple Myeloma Research Foundation; Robert A. and Renee E. Belfer Foundation;  [U01CA141508];  [R21CA135057]; NATIONAL CANCER INSTITUTE [R21CA135057, U01CA141508] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Multiple Myeloma Research Foundation; Robert A. and Renee E. Belfer Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to A. Berns for providing the Rosa26-creERt2 mouse strain. We are also grateful to S. Zhou for assistance in the animal facility and C. Lim for assistance with genotyping. We thank S. Lazo-Kallanian, J. Daley and P. Schow for assistance with flow cytometry. We also thank N. Bardeesy and S. Morrison for communicating unpublished information; A. Stegh for comments on apoptosis; and D. Nakada for western blotting protocol from sorted HSCs. This research was supported by U01CA141508 (R.A.D. and L.C.), R21CA135057 (R.A.D. and B.G.) and DOD TSCRP Career Transition Award (TS093049) (B.G.). B.G. and J.H. are the Research Fellows of the Leukemia and Lymphoma Society. Y.A.W. is supported by Multiple Myeloma Research Foundation. R.A.D. was supported by an American Cancer Society Research Professorship and the Robert A. and Renee E. Belfer Foundation.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Gan B, 2009, CELL CYCLE, V8, P1003, DOI 10.4161/cc.8.7.8045; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Li C., 2003, ANAL GENE EXPRESSION; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	24	316	330	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2010	468	7324					701	U125		10.1038/nature09595	http://dx.doi.org/10.1038/nature09595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124456	Green Accepted			2022-12-01	WOS:000284836700042
J	Guzman, JN; Sanchez-Padilla, J; Wokosin, D; Kondapalli, J; Ilijic, E; Schumacker, PT; Surmeier, DJ				Guzman, Jaime N.; Sanchez-Padilla, Javier; Wokosin, David; Kondapalli, Jyothisri; Ilijic, Ema; Schumacker, Paul T.; Surmeier, D. James			Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1	NATURE			English	Article							CALCIUM-CHANNEL BLOCKERS; MITOCHONDRIA; DISEASE; CELLS; MUTATIONS	Parkinson's disease is a pervasive, ageing-related neurodegenerative disease the cardinal motor symptoms of which reflect the loss of a small group of neurons, the dopaminergic neurons in the substantia nigra pars compacta(1) (SNc). Mitochondrial oxidant stress is widely viewed as being responsible for this loss(2), but why these particular neurons should be stressed is a mystery. Here we show, using transgenic mice that expressed a redox-sensitive variant of green fluorescent protein targeted to the mitochondrial matrix, that the engagement of plasma membrane L-type calcium channels during normal autonomous pacemaking created an oxidant stress that was specific to vulnerable SNc dopaminergic neurons. The oxidant stress engaged defences that induced transient, mild mitochondrial depolarization or uncoupling. The mild uncoupling was not affected by deletion of cyclophilin D, which is a component of the permeability transition pore, but was attenuated by genipin and purine nucleotides, which are antagonists of cloned uncoupling proteins. Knocking out DJ-1 (also known as PARK7 in humans and Park7 in mice), which is a gene associated with an early-onset form of Parkinson's disease, downregulated the expression of two uncoupling proteins (UCP4 (SLC25A27) and UCP5 (SLC25A14)), compromised calcium-induced uncoupling and increased oxidation of matrix proteins specifically in SNc dopaminergic neurons. Because drugs approved for human use can antagonize calcium entry through L-type channels, these results point to a novel neuroprotective strategy for both idiopathic and familial forms of Parkinson's disease.	[Guzman, Jaime N.; Sanchez-Padilla, Javier; Wokosin, David; Ilijic, Ema; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Kondapalli, Jyothisri; Schumacker, Paul T.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Tuluc, Petronel/C-2527-2011	Schumacker, Paul T/0000-0001-9591-2034	Picower Foundation; Hartman Foundation; Falk Trust; Parkinson's Disease Foundation; NIH [NS047085, NS 054850, K12GM088020, HL35440, RR025355]; DOD [W81XWH-07-1-0170]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS054850, P50NS047085] Funding Source: NIH RePORTER	Picower Foundation; Hartman Foundation; Falk Trust(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Parkinson's Disease Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge the technical help of P. Hockberger, N. Schwarz, S. Ulrich, Y. Chen, C. S. Chan, D. Dryanovskiand K. Saporito. We acknowledge S. Chan for supplying quantitative PCR primer sets. We acknowledge the gifts of DJ-1 knockout mice from T. and V. Dawson, Ucp2 knockout mice from D. Kong and B. Lowell, and cyclophilin D knockout mice from S. J. Korsmeyer. This work was supported by the Picower Foundation, the Hartman Foundation, the Falk Trust, the Parkinson's Disease Foundation, NIH grants NS047085 (D.J.S.), NS 054850 (D.J.S.), K12GM088020 (J.S.-P.), HL35440 (P.T.S.) and RR025355 (P.T.S.), and DOD contract W81XWH-07-1-0170 (D.J.S.).	ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cookson MR, 2010, MOVEMENT DISORD, V25, pS44, DOI 10.1002/mds.22713; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Eisenberg MJ, 2004, AM J MED, V116, P35, DOI 10.1016/j.amjmed.2003.08.027; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Khaliq ZM, 2010, J NEUROSCI, V30, P7401, DOI 10.1523/JNEUROSCI.0143-10.2010; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Nicholls D., 2002, BIOENERGETICS, V3; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	33	571	584	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					696	U119		10.1038/nature09536	http://dx.doi.org/10.1038/nature09536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21068725	Green Accepted			2022-12-01	WOS:000284836700041
J	Casillas, CE; Kammen, DM				Casillas, Christian E.; Kammen, Daniel M.			The Energy-Poverty-Climate Nexus	SCIENCE			English	Editorial Material									[Casillas, Christian E.; Kammen, Daniel M.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Kammen, Daniel M.] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA; [Casillas, Christian E.; Kammen, Daniel M.] Univ Calif Berkeley, Renewable & Appropriate Energy Lab, Berkeley, CA 94720 USA; [Kammen, Daniel M.] World Bank, Washington, DC 20443 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; The World Bank	Kammen, DM (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	dkammen@worldbank.org						Alteri MA, 2002, AGR ECOSYST ENVIRON, V93, P1, DOI 10.1016/S0167-8809(02)00085-3; [Anonymous], EN SUST FUT SECR GEN; [Anonymous], 2005, ENERGY SERVICES MILL; Bierbaum R.M., 2010, WORLD DEV REPORT 201; Cabraal RA, 2005, ANNU REV ENV RESOUR, V30, P117, DOI 10.1146/annurev.energy.30.050504.144228; Cecelski E., 2000, ENABBING EQUITABLE A; Energy Sector Management Assistance Programme, 2007, TECHN EC ASS OFF GRI; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Flavin C., 2005, ENERGY DEV POTENTIAL; Independent Evaluation Group, 2008, WELF IMP RUR EL REAS; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; Jacobson A, 2005, ENERG POLICY, V33, P1825, DOI 10.1016/j.enpol.2004.02.017; JAFFE AB, 1994, ENERG POLICY, V22, P804, DOI 10.1016/0301-4215(94)90138-4; Johnson T., 2009, LOW CARBON DEV MEXIC; Kirubi C, 2009, WORLD DEV, V37, P1208, DOI 10.1016/j.worlddev.2008.11.005; McKinsey & Company, 2009, PATHW LOW CARB EC; Mills E, 2005, SCIENCE, V308, P1263, DOI 10.1126/science.1113090; Mostert W., 2007, UNLOCKING POTENTIAL; Romijn H, 2010, ENVIRON SCI POLICY, V13, P326, DOI 10.1016/j.envsci.2010.03.006; Smith KR, 2010, J EXPO SCI ENV EPID, V20, P406, DOI 10.1038/jes.2009.30; Stern PC, 2010, ENVIRON SCI TECHNOL, V44, P4847, DOI 10.1021/es100896p; [No title captured]	22	132	135	8	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1181	1182		10.1126/science.1197412	http://dx.doi.org/10.1126/science.1197412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	685FE	21109654				2022-12-01	WOS:000284613700021
J	Gerrett, D; Lamont, T; Paton, C; Barnes, TRE; Shah, A				Gerrett, David; Lamont, Tara; Paton, Carol; Barnes, Thomas R. E.; Shah, Amar			Safety Alerts Prescribing and monitoring lithium therapy: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHARMACOKINETICS		[Gerrett, David; Lamont, Tara] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Paton, Carol; Barnes, Thomas R. E.] Royal Coll Psychiatrists, Prescribing Observ Mental Hlth, London E1 8AA, England; [Paton, Carol] Oxleas NHS Fdn Trust, Dartford DA2 7WG, England; [Barnes, Thomas R. E.] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8RP, England; [Shah, Amar] Barnet Enfield & Haringey Mental Hlth Trust, N London Forensic Serv, London, England	Imperial College London	Gerrett, D (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	david.gerrett@npsa.nhs.uk						*HLTH SOC CAR INF, 2009, PRESCR COST AN DAT; Johnston AM, 1999, BRIT J PSYCHIAT, V175, P336, DOI 10.1192/bjp.175.4.336; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I HLTH, V38; National Patient Safety Agency, 2009, SAF LITH THER PAT SA; *PRESCR OBS MENT H, 2009, CRTUO69 PRESCR OBS M; Sproule BA, 2000, DRUG AGING, V16, P165, DOI 10.2165/00002512-200016030-00002; THAU K, 1993, LITHIUM, V4, P149; WARD ME, 1994, J CLIN PHARMACOL, V34, P280, DOI 10.1002/j.1552-4604.1994.tb01994.x	8	13	13	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 19	2010	341								c6258	10.1136/bmj.c6258	http://dx.doi.org/10.1136/bmj.c6258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684WU	21097572				2022-12-01	WOS:000284586800006
J	Levene, LS; Baker, R; Bankart, MJG; Khunti, K				Levene, Louis S.; Baker, Richard; Bankart, M. John G.; Khunti, Kamlesh			Association of Features of Primary Health Care With Coronary Heart Disease Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OUTCOMES FRAMEWORK; SOCIAL INEQUALITIES; CANCER-MORTALITY; RISK-FACTORS; US COUNTIES; ALL-CAUSE; QUALITY; DEPRIVATION; ENGLAND; INDICATORS	Context The goal of US health care reform is to extend access. In England, with a universal access health system, coronary heart disease (CHD) mortality rates have decreased by more than two-fifths in the last decade, but variations in rates between local populations persist. Objective To identify which features of populations and primary health care explain variations in CHD mortality rates between the 152 primary care trust populations in England. Design, Setting, and Participants A cross-sectional study in England of all 152 primary care trusts (total registered population, 54.3 million in 2008) using a hierarchical regression model with age-standardized CHD mortality rate as the dependent variable, and population characteristics (index of multiple deprivation, smoking, ethnicity, and registers of individuals with diabetes) and service characteristics (level of provision of primary care services, levels of detected hypertension, pay for performance data) as candidate explanatory variables. Main Outcome Measures Age-standardized CHD mortality rates in 2006, 2007, and 2008. Results The mean age-standardized CHD mortality rates per 100 000 European Standard Population were 97.9 (95% confidence interval [CI], 94.9-100.9) in 2006, 93.5 (95% CI, 90.4-96.5) in 2007, and 88.4 (95% CI, 85.7-91.1) in 2008. In all 3 years, 4 population characteristics were significantly positively associated with CHD mortality (index of multiple deprivation, smoking, white ethnicity, and registers of individuals with diabetes), and 1 service characteristic (levels of detected hypertension) was significantly negatively associated with CHD mortality (adjusted r(2) = 0.66 in 2006, adjusted r(2) = 0.68 in 2007, and adjusted r(2) = 0.67 in 2008). Other service characteristics did not contribute significantly to the model. Conclusion In England, variations in CHD mortality are predominantly explained by population characteristics; however, greater detection of hypertension is associated with lower CHD mortality. JAMA. 2010;304(18):2028-2034 www.jama.com	[Levene, Louis S.; Baker, Richard; Bankart, M. John G.; Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Levene, Louis S.; Baker, Richard; Bankart, M. John G.; Khunti, Kamlesh] Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Rutland, England	University of Leicester	Levene, LS (corresponding author), Univ Leicester, Dept Hlth Sci, 22-28 Princess Rd W, Leicester LE1 6TP, Leics, England.	lsl7@le.ac.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099	NIHR	NIHR(National Institute for Health Research (NIHR))	The study formed part of the program of the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Research and Care (CLARHC) in Leicestershire, Northamptonshire, and Rutland. The CLARHC is funded by the NIHR.	[Anonymous], QUAL OUTC FRAM; Ashworth M, 2007, BRIT J GEN PRACT, V57, P441; Ashworth Mark, 2006, BMC Fam Pract, V7, P68, DOI 10.1186/1471-2296-7-68; Ashworth M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2030; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Cohen J., 1983, APPL MULTIPLE REGRES, V2nd ed.; *COMM LOC GOV, ENGL IND DEPR 2007 S; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Gostin LO, 2010, JAMA-J AM MED ASSOC, V303, P1188, DOI 10.1001/jama/2010.375; Gulliford MC, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-12; Huxley R, 2006, INT J EPIDEMIOL, V35, P1025, DOI 10.1093/ije/dyl058; Lomax RG., 2007, STAT CONCEPTS 2 COUR; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; *NHS EMPL QUAL OUT, QUAL OUTC FRAM GUID; NHS Employers, QUAL OUTC FRAM GUID; *NHS INC CTR, NEIGH STAT MOD BAS E; *NHS INF CTR, NHS STAFF NUMB; *NHS NAT STAT, HLTH SURV ENGL 2006; *NHS NAT STAT, HLTH SURV ENGL 2008; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; *OFF NAT STAT, NAT STAT ONL POP EST; *OFF NAT STAT E RE, PCO POP 2008 RES INT; Saxena S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-96; *SECR STAT, 2000, NAT SERV FRAM COR HE; Shi L, 2005, PUBLIC HEALTH, V119, P699, DOI 10.1016/j.puhe.2004.12.007; Shi LY, 2005, AM J PUBLIC HEALTH, V95, P674, DOI 10.2105/AJPH.2003.031716; Strong M, 2006, J PUBLIC HEALTH, V28, P39, DOI 10.1093/pubmed/fdi065; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; World Health Organization (WHO), INT STAT CLASS DIS R; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2028	2034		10.1001/jama.2010.1636	http://dx.doi.org/10.1001/jama.2010.1636			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	677OB	21063012	Bronze			2022-12-01	WOS:000284000600021
J	Keshavjee, S; Farmer, PE				Keshavjee, Salmaan; Farmer, Paul E.			GLOBAL HEALTH Picking Up the Pace - Scale-Up of MDR Tuberculosis Treatment Programs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Keshavjee, Salmaan] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; Partners Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA.			Keshavjee, Salmaan/0000-0002-6967-3305				FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Keshavjee S., 2009, ADDRESSING THREAT DR, P141; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, PAND H1N1 2009 UPD 1; World Health Organization, 2010, WHOHTMTB20103	5	45	47	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1781	1784		10.1056/NEJMp1010023	http://dx.doi.org/10.1056/NEJMp1010023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YK	21047219				2022-12-01	WOS:000283787800001
J	Quinn, TC; Serwadda, D				Quinn, Thomas C.; Serwadda, David			The future of HIV/AIDS in Africa: a shared responsibility	LANCET			English	Editorial Material									[Quinn, Thomas C.] NIAID, Bethesda, MD 20892 USA; [Quinn, Thomas C.] Johns Hopkins Univ, Ctr Global Hlth, Baltimore, MD 21205 USA; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Makerere University	Quinn, TC (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	tquinn@jhmi.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Institute of Medicine (US) Committee on Envisioning a Strategy for the Long-Term Burden of HIV/AIDS: African Needs and U.S. Interests, 2011, PREP FUT HIV AIDS AF; *UNAIDS, 2009, AIDS EP UPD	2	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1133	1134		10.1016/S0140-6736(10)62183-6	http://dx.doi.org/10.1016/S0140-6736(10)62183-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	21126758				2022-12-01	WOS:000289539300008
J	Bredel, M; Scholtens, DM; Yadav, AK; Alvarez, AA; Renfrow, JJ; Chandler, JP; Yu, ILY; Carro, MS; Dai, FP; Tagge, MJ; Ferrarese, R; Bredel, C; Phillips, HS; Lukac, PJ; Robe, PA; Weyerbrock, A; Vogel, H; Dubner, S; Mobley, B; He, XL; Scheck, AC; Sikic, BI; Aldape, KD; Chakravarti, A; Harsh, GR				Bredel, Markus; Scholtens, Denise M.; Yadav, Ajay K.; Alvarez, Angel A.; Renfrow, Jaclyn J.; Chandler, James P.; Yu, Irene L. Y.; Carro, Maria S.; Dai, Fangping; Tagge, Michael J.; Ferrarese, Roberto; Bredel, Claudia; Phillips, Heidi S.; Lukac, Paul J.; Robe, Pierre A.; Weyerbrock, Astrid; Vogel, Hannes; Dubner, Steven; Mobley, Bret; He, Xiaolin; Scheck, Adrienne C.; Sikic, Branimir I.; Aldape, Kenneth D.; Chakravarti, Arnab; Harsh, Griffith R.			NFKBIA Deletion in Glioblastomas.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KAPPA-B-ALPHA; INTEGRATED GENOMIC ANALYSIS; HODGKIN LYMPHOMA; ADJUVANT TEMOZOLOMIDE; MULTIPLE-MYELOMA; STERNBERG CELLS; EGF RECEPTOR; GENE; MUTATIONS; GROWTH	Background: Amplification and activating mutations of the epidermal growth factor receptor (EGFR) oncogene are molecular hallmarks of glioblastomas. We hypothesized that deletion of NFKBIA (encoding nuclear factor of (kappa)-light polypeptide gene enhancer in B-cells inhibitor-(alpha)), an inhibitor of the EGFR-signaling pathway, promotes tumorigenesis in glioblastomas that do not have alterations of EGFR. Methods: We analyzed 790 human glioblastomas for deletions, mutations, or expression of NFKBIA and EGFR. We studied the tumor-suppressor activity of NFKBIA in tumor-cell culture. We compared the molecular results with the outcome of glioblastoma in 570 affected persons. Results: NFKBIA is often deleted but not mutated in glioblastomas; most deletions occur in nonclassical subtypes of the disease. Deletion of NFKBIA and amplification of EGFR show a pattern of mutual exclusivity. Restoration of the expression of NFKBIA attenuated the malignant phenotype and increased the vulnerability to chemotherapy of cells cultured from tumors with NFKBIA deletion; it also reduced the viability of cells with EGFR amplification but not of cells with normal gene dosages of both NFKBIA and EGFR. Deletion and low expression of NFKBIA were associated with unfavorable outcomes. Patients who had tumors with NFKBIA deletion had outcomes that were similar to those in patients with tumors harboring EGFR amplification. These outcomes were poor as compared with the outcomes in patients with tumors that had normal gene dosages of NFKBIA and EGFR. A two-gene model that was based on expression of NFKBIA and O(sup 6)-methylguanine DNA methyltransferase was strongly associated with the clinical course of the disease. Conclusions: Deletion of NFKBIA has an effect that is similar to the effect of EGFR amplification in the pathogenesis of glioblastoma and is associated with comparatively short survival. N Engl J Med 2011;364:627-37.	[Bredel, Markus; Yu, Irene L. Y.; Carro, Maria S.; Dai, Fangping; Ferrarese, Roberto; Bredel, Claudia; Weyerbrock, Astrid] Univ Freiburg, Dept Neurosurg, Neuroctr, Freiburg, Germany; [Bredel, Markus; Yu, Irene L. Y.; Carro, Maria S.; Dai, Fangping; Ferrarese, Roberto; Bredel, Claudia; Weyerbrock, Astrid] Univ Freiburg, Ctr Comprehens Canc, Freiburg, Germany; [Bredel, Markus; Alvarez, Angel A.] Univ Alabama, UAB Comprehens Canc Ctr, Dept Radiat Oncol, Birmingham, AL USA; [Bredel, Markus; Yadav, Ajay K.; Renfrow, Jaclyn J.; Chandler, James P.; Tagge, Michael J.; Lukac, Paul J.] Northwestern Univ, Feinberg Sch Med, Lurie Ctr Canc Genet Res, NW Brain Tumor Inst,Dept Neurol Surg, Chicago, IL 60611 USA; [Bredel, Markus; Yadav, Ajay K.; Renfrow, Jaclyn J.; Chandler, James P.; Tagge, Michael J.; Lukac, Paul J.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Scholtens, Denise M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Biostat, Chicago, IL 60611 USA; [Dubner, Steven] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Bredel, Markus; Harsh, Griffith R.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Vogel, Hannes; Mobley, Bret] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Sikic, Branimir I.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Phillips, Heidi S.] Genentech Inc, San Francisco, CA 94080 USA; [Robe, Pierre A.] Univ Liege, Dept Neurosurg, Liege, Belgium; [Robe, Pierre A.] Univ Liege, Dept Human Genet, Liege, Belgium; [Robe, Pierre A.] Univ Utrecht, Dept Neurosurg, Utrecht, Netherlands; [Scheck, Adrienne C.] Barrow Neurol Inst, Ina Levine Brain Tumor Ctr, Phoenix, AZ 85013 USA; [Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Chakravarti, Arnab] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA; [Chakravarti, Arnab] Ohio State Univ, Richard L Solove Res Inst, Columbus, OH 43210 USA	University of Freiburg; University of Freiburg; University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Stanford University; Stanford University; Stanford University; Roche Holding; Genentech; University of Liege; University of Liege; Utrecht University; Barrow Neurological Institute; University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Bredel, M (corresponding author), Univ Freiburg, Dept Neurosurg, Neuroctr, Freiburg, Germany.	markus.bredel@uniklinik-freiburg.de	Stella, Maria Stella/GVS-1585-2022; Scheck, Adrienne/AAH-5040-2020; Lukac, Pavel/P-4068-2017; Weyerbrock, Astrid/E-8493-2014; Weyerbrock, Astrid/AAI-1731-2020; Ferrarese, Roberto/GSJ-3449-2022	Lukac, Pavel/0000-0001-8412-1931; Weyerbrock, Astrid/0000-0001-9060-4462; Ferrarese, Roberto/0000-0003-0625-3319; Yadav, Ajay/0000-0003-3321-4198; Vogel, Otto Hannes/0000-0002-0960-3508; Carro, Maria Stella/0000-0002-8570-7691; Scheck, Adrienne/0000-0003-3497-1895	Accelerate Brain Cancer Cure; Mike Gardner/American Brain Tumor Association; German Cancer Aid [107714]; State of Illinois Excellence in Academic Medicine Program Award [211]; State of Alabama Investment Pool for Action (IMPACT); National Cancer Institute [RO1CA108633, RC2CA148190, P50CA127001, RTOG U10CA21661, CCOP U10CA37422]; Goldhirsh Brain Tumor Research Award; Leach Foundation; Brain Tumor Funders' Collaborative; Lou Malnati's Cancer Benefit Committee; Mazza Foundation; NATIONAL CANCER INSTITUTE [P50CA127001, U10CA037422, RC2CA148190, R01CA108633, U10CA021661] Funding Source: NIH RePORTER	Accelerate Brain Cancer Cure; Mike Gardner/American Brain Tumor Association; German Cancer Aid(Deutsche Krebshilfe); State of Illinois Excellence in Academic Medicine Program Award; State of Alabama Investment Pool for Action (IMPACT); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Goldhirsh Brain Tumor Research Award; Leach Foundation; Brain Tumor Funders' Collaborative; Lou Malnati's Cancer Benefit Committee; Mazza Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a Project Award of Accelerate Brain Cancer Cure, a Mike Gardner/American Brain Tumor Association Grant Award, a German Cancer Aid Grant Award (107714), a State of Illinois Excellence in Academic Medicine Program Award (211), State of Alabama Investment Pool for Action (IMPACT) funds, grants from the National Cancer Institute (RO1CA108633, RC2CA148190, P50CA127001, RTOG U10CA21661, and CCOP U10CA37422), a Goldhirsh Brain Tumor Research Award, a Leach Foundation Research Award, the Brain Tumor Funders' Collaborative, the Lou Malnati's Cancer Benefit Committee, and the Mazza Foundation.	Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bredel M, 2006, J CLIN ONCOL, V24, P274, DOI 10.1200/JCO.2005.02.9405; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Bu H, 2007, J CANCER RES CLIN, V133, P859, DOI 10.1007/s00432-007-0228-7; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Chakravarti A, 2002, CANCER RES, V62, P4307; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Emmerich F, 1999, BLOOD, V94, P3129, DOI 10.1182/blood.V94.9.3129.421k03_3129_3134; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Fulci G, 2000, ONCOGENE, V19, P3816, DOI 10.1038/sj.onc.1203700; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Kapoor GS, 2004, MOL CELL BIOL, V24, P823, DOI 10.1128/MCB.24.2.823-836.2004; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Lake A, 2009, INT J CANCER, V125, P1334, DOI 10.1002/ijc.24502; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Liu XJ, 2010, CANCER GENET CYTOGEN, V197, P152, DOI 10.1016/j.cancergencyto.2009.11.005; MIKESKA T, 1955, ANN HUM GENET, V19, P251; Nagai S, 2002, J NEUROSURG, V96, P909, DOI 10.3171/jns.2002.96.5.0909; Osborne J, 2005, INT J CANCER, V116, P646, DOI 10.1002/ijc.21036; Parker KM, 2002, CANCER GENET CYTOGEN, V137, P43, DOI 10.1016/S0165-4608(02)00541-1; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Raychaudhuri B, 2007, J NEURO-ONCOL, V85, P39, DOI 10.1007/s11060-007-9390-7; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Spink CF, 2007, CANCER LETT, V246, P92, DOI 10.1016/j.canlet.2006.02.001; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tsunoda Keishi, 2005, Brain Tumor Pathol, V22, P79, DOI 10.1007/s10014-005-0186-1; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wen PY, 2008, NEW ENGL J MED, V359, P877; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yadav AK, 2009, JAMA-J AM MED ASSOC, V302, P276, DOI 10.1001/jama.2009.1022; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	39	180	185	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					627	637		10.1056/NEJMoa1006312	http://dx.doi.org/10.1056/NEJMoa1006312			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21175304	Green Accepted			2022-12-01	WOS:000287406000008
J	Kaiser, JT; Hu, YL; Wiig, JA; Rees, DC; Ribbe, MW				Kaiser, Jens T.; Hu, Yilin; Wiig, Jared A.; Rees, Douglas C.; Ribbe, Markus W.			Structure of Precursor-Bound NifEN: A Nitrogenase FeMo Cofactor Maturase/Insertase	SCIENCE			English	Article							IRON-MOLYBDENUM COFACTOR; MOFE-PROTEIN	NifEN plays an essential role in the biosynthesis of the nitrogenase iron-molybdenum (FeMo) cofactor (M cluster). It is an alpha(2)beta(2) tetramer that is homologous to the catalytic molybdenum-iron (MoFe) protein (NifDK) component of nitrogenase. NifEN serves as a scaffold for the conversion of an iron-only precursor to a matured form of the M cluster before delivering the latter to its target location within NifDK. Here, we present the structure of the precursor-bound NifEN of Azotobacter vinelandii at 2.6 angstrom resolution. From a structural comparison of NifEN with des-M-cluster NifDK and holo NifDK, we propose similar pathways of cluster insertion for the homologous NifEN and NifDK proteins.	[Kaiser, Jens T.; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hu, Yilin; Wiig, Jared A.; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; University of California System; University of California Irvine; California Institute of Technology; Howard Hughes Medical Institute	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu; mribbe@uci.edu			NIH [GM-67626, GM-45162]; U.S. Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626, R01GM045162, R37GM045162] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM-67626 (M.W.R.) and GM-45162 (D.C.R.) D.C.R. is an investigator of the Howard Hughes Medical Institute. We acknowledge the Gordon and Betty Moore Foundation for support of the Molecular Observatory at California Institute of Technology. Operations at the Stanford Synchrotron Radiation Lightsource are supported by the U.S. Department of Energy and NIH. The coordinates and structure factors have been deposited with the Protein Data Bank (PDB), accession number 3PDI.	Brocker MJ, 2010, J BIOL CHEM, V285, P8268, DOI 10.1074/jbc.M109.087874; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2005, P NATL ACAD SCI USA, V102, P3236, DOI 10.1073/pnas.0409201102; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Lee CC, 2009, P NATL ACAD SCI USA, V106, P18474, DOI 10.1073/pnas.0909149106; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302	17	77	79	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					91	94		10.1126/science.1196954	http://dx.doi.org/10.1126/science.1196954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212358	Green Accepted			2022-12-01	WOS:000285974000043
J	Maillet, F; Poinsot, V; Andre, O; Puech-Pages, V; Haouy, A; Gueunier, M; Cromer, L; Giraudet, D; Formey, D; Niebel, A; Martinez, EA; Driguez, H; Becard, G; Denarie, J				Maillet, Fabienne; Poinsot, Verena; Andre, Olivier; Puech-Pages, Virginie; Haouy, Alexandra; Gueunier, Monique; Cromer, Laurence; Giraudet, Delphine; Formey, Damien; Niebel, Andreas; Martinez, Eduardo Andres; Driguez, Hugues; Becard, Guillaume; Denarie, Jean			Fungal lipochitooligosaccharide symbiotic signals in arbuscular mycorrhiza	NATURE			English	Article							CHITOOLIGOSACCHARIDE NODULATION FACTORS; MEDICAGO-TRUNCATULA; NODULE DEVELOPMENT; DIFFUSIBLE FACTOR; ESCHERICHIA-COLI; RHIZOBIUM; GENES; LEGUMES; BACTERIAL; PROTEIN	Arbuscular mycorrhiza (AM) is a root endosymbiosis between plants and glomeromycete fungi. It is the most widespread terrestrial plant symbiosis, improving plant uptake of water and mineral nutrients. Yet, despite its crucial role in land ecosystems, molecular mechanisms leading to its formation are just beginning to be unravelled. Recent evidence suggests that AM fungi produce diffusible symbiotic signals. Here we show that Glomus intraradices secretes symbiotic signals that are a mixture of sulphated and non-sulphated simple lipochitooligosaccharides (LCOs), which stimulate formation of AM in plant species of diverse families (Fabaceae, Asteraceae and Umbelliferae). In the legume Medicago truncatula these signals stimulate root growth and branching by the symbiotic DMI signalling pathway. These findings provide a better understanding of the evolution of signalling mechanisms involved in plant root endosymbioses and will greatly facilitate their molecular dissection. They also open the way to using these natural and very active molecules in agriculture.	[Maillet, Fabienne; Andre, Olivier; Haouy, Alexandra; Gueunier, Monique; Cromer, Laurence; Giraudet, Delphine; Niebel, Andreas; Denarie, Jean] INRA, CNRS 2594, UMR 441, Lab Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France; [Poinsot, Verena] Univ Toulouse 3, CNRS, UMR 5623, Lab IMRCP, F-31062 Toulouse, France; [Puech-Pages, Virginie; Gueunier, Monique; Formey, Damien; Becard, Guillaume] Univ Toulouse, UPS, UMR 5546, F-31326 Castanet Tolosan, France; [Puech-Pages, Virginie; Gueunier, Monique; Formey, Damien; Becard, Guillaume] CNRS, UMR 5546, F-31326 Castanet Tolosan, France; [Martinez, Eduardo Andres; Driguez, Hugues] Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Denarie, J (corresponding author), INRA, CNRS 2594, UMR 441, Lab Interact Plantes Microorganismes, BP 52627, F-31326 Castanet Tolosan, France.	jean.denarie@toulouse.inra.fr	cromer, Laurence/I-4814-2014; NIEBEL, Andreas/AAL-7687-2020; Formey, Damien/X-5542-2019; poinssot, benoit/B-2569-2009; Poinsot, Verena/AAU-2614-2021	Formey, Damien/0000-0003-2852-4706; poinssot, benoit/0000-0001-5890-4318; Poinsot, Verena/0000-0002-9746-6768; Niebel, Andreas/0000-0002-3402-8381	EMD Crop BioScience; Charles-Leopold Mayer Prize; French Academy of Sciences; Institut National de la Recherche Agronomique	EMD Crop BioScience; Charles-Leopold Mayer Prize; French Academy of Sciences; Institut National de la Recherche Agronomique	This work was supported in part by a grant from EMD Crop BioScience and by the Charles-Leopold Mayer Prize (2005) attributed to J.D. by the French Academy of Sciences. M. G. was supported by an Institut National de la Recherche Agronomique fellowship. We are grateful to C. Gough and G. Oldroyd for providing seeds of M. truncatula mutants, and to S. Roy and J. Loubradou for providing sterile mycorrhized roots and spores of G. intraradices. The UPLC/QToF mass spectrometer was made available to us by the Institut des Technologies Avancees du Vivant and the QTRAP mass spectrometer by the Metabolomics and fluxomics platform (MetaToul). We thank S. Danoun for her help with UPLC/QToF mass spectrometry, F. Letisse for his advice and help in setting up experiments on the QTrap mass spectrometer, P. Lavedan for NMR measurements, C. Herve for her advice and help for quantitative PCR with reverse transcription experiments and C. Briere for his advice for statistical analysis. We thank C. Gough, J. Cullimore and G. Oldroyd for their comments on this manuscript.	Andriankaja A, 2007, PLANT CELL, V19, P2866, DOI 10.1105/tpc.107.052944; Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; CHABOT S, 1992, MYCOLOGIA, V84, P315, DOI 10.2307/3760183; Chen CY, 2008, NEW PHYTOL, V180, P311, DOI 10.1111/j.1469-8137.2008.02612.x; Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; DEMONT N, 1993, J BIOL CHEM, V268, P20134; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gutjahr C, 2009, NEW PHYTOL, V183, P53, DOI 10.1111/j.1469-8137.2009.02871.x; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Hewitt E., 1966, SAND WATER CULTURE M, V187-237, P430; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Journet EP, 2001, MOL PLANT MICROBE IN, V14, P737, DOI 10.1094/MPMI.2001.14.6.737; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kosuta S, 2003, PLANT PHYSIOL, V131, P952, DOI 10.1104/pp.011882; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Kuhn H, 2010, NEW PHYTOL, V185, P716, DOI 10.1111/j.1469-8137.2009.03116.x; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oldroyd GED, 2006, CURR OPIN PLANT BIOL, V9, P351, DOI 10.1016/j.pbi.2006.05.003; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Olsthoorn MMA, 1998, BIOCHEMISTRY-US, V37, P9024, DOI 10.1021/bi972937r; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Poinsot V, 2001, J BACTERIOL, V183, P3721, DOI 10.1128/JB.183.12.3721-3728.2001; PRICE NPJ, 1992, MOL MICROBIOL, V6, P3575, DOI 10.1111/j.1365-2958.1992.tb01793.x; R Development Core Team, 2020, R VERS 4 0 3 LANG EN; Rasmussen MO, 2004, ORG BIOMOL CHEM, V2, P1908, DOI 10.1039/b403575e; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Riely BK, 2004, CURR OPIN PLANT BIOL, V7, P408, DOI 10.1016/j.pbi.2004.04.005; ROCHE P, 1991, J BIOL CHEM, V266, P10933; Samain E, 1999, J BIOTECHNOL, V72, P33, DOI 10.1016/S0168-1656(99)00048-6; Samain E, 1997, CARBOHYD RES, V302, P35, DOI 10.1016/S0008-6215(97)00107-9; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P145, DOI 10.1016/B978-012370526-6.50007-6; SPAINK HP, 1995, J BACTERIOL, V177, P6276, DOI 10.1128/jb.177.21.6276-6281.1995; SPAINK HP, 1994, MOL MICROBIOL, V13, P821, DOI 10.1111/j.1365-2958.1994.tb00474.x; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Wang B, 2010, NEW PHYTOL, V186, P514, DOI 10.1111/j.1469-8137.2009.03137.x; Weidmann S, 2004, MOL PLANT MICROBE IN, V17, P1385, DOI 10.1094/MPMI.2004.17.12.1385	55	611	666	6	342	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					58	U1501		10.1038/nature09622	http://dx.doi.org/10.1038/nature09622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	702UO	21209659				2022-12-01	WOS:000285921600030
J	Carone, BR; Fauquier, L; Habib, N; Shea, JM; Hart, CE; Li, RW; Bock, C; Li, CJ; Gu, HC; Zamore, PD; Meissner, A; Weng, ZP; Hofmann, HA; Friedman, N; Rando, OJ				Carone, Benjamin R.; Fauquier, Lucas; Habib, Naomi; Shea, Jeremy M.; Hart, Caroline E.; Li, Ruowang; Bock, Christoph; Li, Chengjian; Gu, Hongcang; Zamore, Phillip D.; Meissner, Alexander; Weng, Zhiping; Hofmann, Hans A.; Friedman, Nir; Rando, Oliver J.			Paternally Induced Transgenerational Environmental Reprogramming of Metabolic Gene Expression in Mammals	CELL			English	Article							DNA METHYLATION; EPIGENETIC INHERITANCE; HUMAN GENOME; MOUSE; MICE; DROSOPHILA; CHROMATIN; PROMOTER; ALLELE; CELLS	Epigenetic information can be inherited through the mammalian germline and represents a plausible transgenerational carrier of environmental information. To test whether transgenerational inheritance of environmental information occurs in mammals, we carried out an expression profiling screen for genes in mice that responded to paternal diet. Offspring of males fed a low-protein diet exhibited elevated hepatic expression of many genes involved in lipid and cholesterol biosynthesis and decreased levels of cholesterol esters, relative to the offspring of males fed a control diet. Epigenomic profiling of offspring livers revealed numerous modest (similar to 20%) changes in cytosine methylation depending on paternal diet, including reproducible changes in methylation over a likely enhancer for the key lipid regulator Ppara. These results, in conjunction with recent human epidemiological data, indicate that parental diet can affect cholesterol and lipid metabolism in offspring and define a model system to study environmental reprogramming of the heritable epigenome.	[Carone, Benjamin R.; Fauquier, Lucas; Shea, Jeremy M.; Hart, Caroline E.; Li, Chengjian; Zamore, Phillip D.; Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Li, Ruowang; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Habib, Naomi; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; [Habib, Naomi] Hebrew Univ Jerusalem, Dept Mol Genet & Biotechnol, Fac Med, IL-91120 Jerusalem, Israel; [Bock, Christoph; Gu, Hongcang; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hofmann, Hans A.] Univ Texas Austin, Inst Neurosci, Sect Integrat Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Texas System; University of Texas Austin; Hebrew University of Jerusalem	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu	Bock, Christoph/AAE-7618-2019; Habib, Naomi/AAA-8937-2020; Friedman, Nir/H-9692-2012; Zamore, Phillip D/A-8941-2013; Hofmann, Hans A/E-4538-2016	Bock, Christoph/0000-0001-6091-3088; Friedman, Nir/0000-0002-9678-3550; Hofmann, Hans A/0000-0002-3335-330X; Carone, Benjamin/0000-0002-9822-4218; Gu, Hongcang/0000-0002-1439-7606; Zamore, Phillip/0000-0002-4505-9618; Rando, Oliver/0000-0003-1516-9397	Burroughs Wellcome Fund; NIGMS [GM088618, GM62862, GM65236]; NIH; US-Israel Binational Science Foundation (BSF); NSF; Alfred P. Sloan Foundation; Meidan fellowship; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R01GM088618, R37GM062862, R01GM065236] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Meidan fellowship; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Haig for initial discussions motivating this experiment and K. Ahmad, P. Kaufman, C. Meiklejohn, Y. Nahmias, and members of the Rando lab for critical reading of the manuscript. O.J.R. is supported in part by a Career Award in Biomedical Sciences from the Burroughs Wellcome Fund, by grant GM088618 from NIGMS, and by the Mathers Foundation and is a member of the UMass Diabetes Endocrinology Research Center (DK32520). N.F. is supported by grants from the NIH and the US-Israel Binational Science Foundation (BSF). H. A. H. is supported by NSF, an Alfred P. Sloan Foundation Fellowship and a Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology. P.D.Z. is supported by grants GM62862 and GM65236 from the NIGMS. N.H. is supported by the Meidan fellowship. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Arpanahi A, 2009, GENOME RES, V19, P1338, DOI 10.1101/gr.094953.109; Avital E., 2000, ANIMAL TRADITIONS BE, DOI 10-1017/CBO9780511542251; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Champagne F, 2001, Prog Brain Res, V133, P287; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Horton TH, 2005, AM J HUM BIOL, V17, P34, DOI 10.1002/ajhb.20092; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; JABLONKA ELM, 1995, EPIGENETIC INHERITAN; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; Madsen MA, 2004, BIOCHEM BIOPH RES CO, V318, P998, DOI 10.1016/j.bbrc.2004.04.126; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ooi SL, 2007, CURR OPIN CELL BIOL, V19, P257, DOI 10.1016/j.ceb.2007.04.015; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Torrisani J, 2007, CURR GENOMICS, V8, P229; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Yamaguchi R, 2010, HORM METAB RES, V42, P821, DOI 10.1055/s-0030-1261954; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	56	766	807	4	177	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1084	1096		10.1016/j.cell.2010.12.008	http://dx.doi.org/10.1016/j.cell.2010.12.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183072	Green Accepted, Bronze			2022-12-01	WOS:000285625400007
J	Eisenstein, M				Eisenstein, Michael			Of beans and genes	NATURE			English	Editorial Material																		Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; QIN J, NATURE, V464, P59	4	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S13	S15		10.1038/468S13a	http://dx.doi.org/10.1038/468S13a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179077	Bronze			2022-12-01	WOS:000285553800005
J	Reich, D; Green, RE; Kircher, M; Krause, J; Patterson, N; Durand, EY; Viola, B; Briggs, AW; Stenzel, U; Johnson, PLF; Maricic, T; Good, JM; Marques-Bonet, T; Alkan, C; Fu, QM; Mallick, S; Li, H; Meyer, M; Eichler, EE; Stoneking, M; Richards, M; Talamo, S; Shunkov, MV; Derevianko, AP; Hublin, JJ; Kelso, J; Slatkin, M; Paabo, S				Reich, David; Green, Richard E.; Kircher, Martin; Krause, Johannes; Patterson, Nick; Durand, Eric Y.; Viola, Bence; Briggs, Adrian W.; Stenzel, Udo; Johnson, Philip L. F.; Maricic, Tomislav; Good, Jeffrey M.; Marques-Bonet, Tomas; Alkan, Can; Fu, Qiaomei; Mallick, Swapan; Li, Heng; Meyer, Matthias; Eichler, Evan E.; Stoneking, Mark; Richards, Michael; Talamo, Sahra; Shunkov, Michael V.; Derevianko, Anatoli P.; Hublin, Jean-Jacques; Kelso, Janet; Slatkin, Montgomery; Paeaebo, Svante			Genetic history of an archaic hominin group from Denisova Cave in Siberia	NATURE			English	Article							MITOCHONDRIAL-DNA; GENOME SEQUENCE; NEANDERTHAL; PATTERNS; FLORES; SIMA	Using DNA extracted from a finger bone found in Denisova Cave in southern Siberia, we have sequenced the genome of an archaic hominin to about 1.9-fold coverage. This individual is from a group that shares a common origin with Neanderthals. This population was not involved in the putative gene flow from Neanderthals into Eurasians; however, the data suggest that it contributed 4-6% of its genetic material to the genomes of present-day Melanesians. We designate this hominin population 'Denisovans' and suggest that it may have been widespread in Asia during the Late Pleistocene epoch. A tooth found in Denisova Cave carries a mitochondrial genome highly similar to that of the finger bone. This tooth shares no derived morphological features with Neanderthals or modern humans, further indicating that Denisovans have an evolutionary history distinct from Neanderthals and modern humans.	[Reich, David; Briggs, Adrian W.; Mallick, Swapan] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Reich, David; Patterson, Nick; Mallick, Swapan; Li, Heng] MIT, Broad Inst, Cambridge, MA 02142 USA; [Reich, David; Patterson, Nick; Mallick, Swapan; Li, Heng] Harvard Univ, Cambridge, MA 02142 USA; [Green, Richard E.; Kircher, Martin; Krause, Johannes; Viola, Bence; Briggs, Adrian W.; Stenzel, Udo; Maricic, Tomislav; Fu, Qiaomei; Meyer, Matthias; Stoneking, Mark; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Krause, Johannes] Univ Tubingen, Inst Nat Wissensch Archaol, D-72070 Tubingen, Germany; [Durand, Eric Y.; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Viola, Bence; Richards, Michael; Talamo, Sahra; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Marques-Bonet, Tomas; Alkan, Can; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; [Marques-Bonet, Tomas] Inst Evolutionary Biol UPF CSIC, Barcelona 08003, Spain; [Fu, Qiaomei] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, CAS MPS Joint Lab Human Evolut & Archeometry, Beijing 100044, Peoples R China; [Richards, Michael] Univ British Columbia, Dept Anthropol, Vancouver, BC V6T 1Z1, Canada; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Inst Archaeol Ethnog, Siberian Branch, Palaeolith Dept, Novosibirsk 630090, Russia	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Max Planck Society; University of California System; University of California Santa Cruz; Eberhard Karls University of Tubingen; University of California System; University of California Berkeley; Max Planck Society; Emory University; University of Montana System; University of Montana; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of British Columbia; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu; bence.viola@eva.mpg.de; paabo@eva.mpg.de	Kircher, Martin/H-6909-2019; Derevianko, Anatoly P./Q-5975-2016; Richards, Michael/A-9374-2008; Kelso, Janet/N-1812-2019; Marques-Bonet, Tomas/I-4618-2014; Hug, Balthasar L./G-1568-2010; Viola, Bence/B-7390-2011; Richards, Michael/O-3717-2016; Krause, Johannes/E-6640-2015; Marques-Bonet, Tomas/ABF-3734-2020; Ganesh, Dunna Sai/AGX-5170-2022; Li, Heng/D-9344-2011; Talamo, Sahra/AAD-1774-2022; Krause, Johannes/AFP-2642-2022; Alkan, Can/D-2982-2009; Kircher, Martin/HDL-9392-2022; Shunkov, Mikhail V./Q-6576-2016	Kircher, Martin/0000-0001-9278-5471; Derevianko, Anatoly P./0000-0003-1156-8331; Richards, Michael/0000-0001-5274-8887; Kelso, Janet/0000-0002-3618-322X; Marques-Bonet, Tomas/0000-0002-5597-3075; Richards, Michael/0000-0001-5274-8887; Krause, Johannes/0000-0001-5475-4690; Marques-Bonet, Tomas/0000-0002-5597-3075; Li, Heng/0000-0003-4874-2874; Talamo, Sahra/0000-0002-2406-3132; Krause, Johannes/0000-0001-9144-3920; Alkan, Can/0000-0002-5443-0706; Shunkov, Mikhail V./0000-0003-1388-2308; Green, Richard/0000-0003-0516-5827; Viola, Bence/0000-0001-8052-707X	Max Planck Society; Krekeler Foundation; US National Institutes of Health [R01-GM40282]; National Science Foundation [OISE-0754461, 1032255]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER; Direct For Biological Sciences [0906041] Funding Source: National Science Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Krekeler Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. Bustamante, A. I. Krivoshapkin, M. Lachmann, R. Nielsen, K. Pruefer, A. Tsybankov, L. Vigilant and W. Zhai for comments; K. Finstermeier for graphics work; the MPI-EVA sequencing group, R. Schultz and S. Weihnachtsmann for technical support; and P. Fujita, A. Hinrichs and K. Learned for designing the UCSC genome browser portal to the Denisova data. The Presidential Innovation Fund of the Max Planck Society and the Krekeler Foundation provided financial support. M.S. was supported by a US National Institutes of Health grant (R01-GM40282). The National Science Foundation provided an International Postdoctoral Fellowship (OISE-0754461) to J.M.G., a Fellowship in Biological Informatics to P.L.F.J. and a HOMINID grant (1032255) to D.R.	Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Bischoff JL, 2003, J ARCHAEOL SCI, V30, P275, DOI 10.1006/jasc.2002.0834; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Derevianko AP, 2008, ARCHAEOL ETHNOL ANTH, V34, P13, DOI 10.1016/j.aeae.2008.07.002; Derevianko A.P., 1998, PALAEOLITHIC SIBERIA; Derevianko A.P., 2003, PALEOENVIRONMENT PAL; DEREVIANKO AP, 1998, ARCHAEOLOGY GEOLOGY; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Morwood MJ, 2009, J HUM EVOL, V57, P437, DOI 10.1016/j.jhevol.2009.07.003; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; POPE GG, 1992, AM J PHYS ANTHR S15, V15, P243; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; WU X, 1995, HUMAN EVOLUTION ASI	40	1022	1068	25	491	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1053	1060		10.1038/nature09710	http://dx.doi.org/10.1038/nature09710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179161	Green Published, Green Accepted, hybrid			2022-12-01	WOS:000285553800049
J	Tagami, S; Sekine, S; Kumarevel, T; Hino, N; Murayama, Y; Kamegamori, S; Yamamoto, M; Sakamoto, K; Yokoyama, S				Tagami, Shunsuke; Sekine, Shun-ichi; Kumarevel, Thirumananseri; Hino, Nobumasa; Murayama, Yuko; Kamegamori, Syunsuke; Yamamoto, Masaki; Sakamoto, Kensaku; Yokoyama, Shigeyuki			Crystal structure of bacterial RNA polymerase bound with a transcription inhibitor protein	NATURE			English	Article							3.3 ANGSTROM RESOLUTION; II ELONGATION COMPLEX; THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; CRYSTALLOGRAPHIC ANALYSIS; ACTIVE-CENTER; COILED-COIL; GRE FACTORS; AMINO-ACID; NMR SYSTEM	The multi-subunit DNA-dependent RNA polymerase (RNAP) is the principal enzyme of transcription for gene expression. Transcription is regulated by various transcription factors. Gre factor homologue 1 (Gfh1), found in the Thermus genus, is a close homologue of the well-conserved bacterial transcription factor GreA, and inhibits transcription initiation and elongation by binding directly to RNAP(1-8). The structural basis of transcription inhibition by Gfh1 has remained elusive, although the crystal structures of RNAP and Gfh1 have been determined separately(6-9). Here we report the crystal structure of Thermus thermophilus RNAP complexed with Gfh1. The amino-terminal coiled-coil domain of Gfh1 fully occludes the channel formed between the two central modules of RNAP; this channel would normally be used for nucleotide triphosphate (NTP) entry into the catalytic site. Furthermore, the tip of the coiled-coil domain occupies the NTP beta-gamma phosphate-binding site. The NTP-entry channel is expanded, because the central modules are 'ratcheted' relative to each other by similar to 7 degrees, as compared with the previously reported elongation complexes. This 'ratcheted state' is an alternative structural state, defined by a newly acquired contact between the central modules. Therefore, the shape of Gfh1 is appropriate to maintain RNAP in the ratcheted state. Simultaneously, the ratcheting expands the nucleic-acid-binding channel, and kinks the bridge helix, which connects the central modules. Taken together, the present results reveal that Gfh1 inhibits transcription by preventing NTP binding and freezing RNAP in the alternative structural state. The ratcheted state might also be associated with other aspects of transcription, such as RNAP translocation and transcription termination.	[Tagami, Shunsuke; Sekine, Shun-ichi; Murayama, Yuko; Kamegamori, Syunsuke; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Tagami, Shunsuke; Sekine, Shun-ichi; Hino, Nobumasa; Murayama, Yuko; Kamegamori, Syunsuke; Sakamoto, Kensaku; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Kumarevel, Thirumananseri] RIKEN SPring 8 Ctr, Harima Inst, Struct & Mol Biol Lab, Sayo, Hyogo 6795148, Japan; [Yamamoto, Masaki] RIKEN SPring 8 Ctr, Harima Inst, SR Life Sci Instrumentat Unit, Sayo, Hyogo 6795148, Japan	University of Tokyo; RIKEN; University of Tokyo; RIKEN; RIKEN	Sekine, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sekine@biochem.s.u-tokyo.ac.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Sakamoto, Kensaku/N-7496-2015; Yamamoto, Masaki/B-7844-2015; Sekine, Shun-ichi/N-5450-2015; Kumarevel, Thirumananseri/C-6275-2012; Tagami, Shunsuke/N-5057-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Sakamoto, Kensaku/0000-0003-2866-5031; Yamamoto, Masaki/0000-0002-1311-1768; Sekine, Shun-ichi/0000-0001-8174-8704; Kumarevel, Thirumananseri/0000-0001-9326-6585; Tagami, Shunsuke/0000-0002-1720-3627; Hino, Nobumasa/0000-0002-7072-1183	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JSPS Global Centers of Excellence; Grants-in-Aid for Scientific Research [22570175] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Global Centers of Excellence; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is based on experiments performed at SPring-8 (with the approval of the Japan Synchrotron Radiation Research Institute) and at the Swiss Light Source (SLS). We thank N. Shimizu for supporting our data collection at SPring-8 beamline BL41XU; T. Tomizaki and C. Schulze-Briese for supporting our data collection at SLS beamline X06SA; and Y. Fujii for assisting with our data collection and for comments. We thank T. Tanaka and K. Sakamoto for assistance in protein preparation. This work was supported in part by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (to S.-i.S.), a JSPS Grant-in-Aid for Scientific Research (to S.i.-S. and S. Y.), and the Targeted Proteins Research Program (TPRP), the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. S. T. was supported by the JSPS Global Centers of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms).	Abyzov A, 2010, PROTEINS, V78, P309, DOI 10.1002/prot.22544; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chumpolkulwong Namthip, 2006, Journal of Structural and Functional Genomics, V7, P31, DOI 10.1007/s10969-006-9007-y; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Lamour V, 2006, J MOL BIOL, V356, P179, DOI 10.1016/j.jmb.2005.10.083; Laptenko O, 2003, METHOD ENZYMOL, V371, P219; Laptenko O, 2006, EMBO J, V25, P2131, DOI 10.1038/sj.emboj.7601094; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Sakamoto K, 2009, STRUCTURE, V17, P335, DOI 10.1016/j.str.2009.01.008; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Symersky J, 2006, J BIOL CHEM, V281, P1309, DOI 10.1074/jbc.C500405200; Tagami S, 2010, ACTA CRYSTALLOGR F, V66, P64, DOI 10.1107/S1744309109049215; Tan Lin, 2008, J Biol, V7, P40, DOI 10.1186/jbiol98; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vassylyeva MN, 2007, EMBO REP, V8, P1038, DOI 10.1038/sj.embor.7401079; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	41	119	123	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					978	U282		10.1038/nature09573	http://dx.doi.org/10.1038/nature09573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21124318				2022-12-01	WOS:000285344600050
J	Hankinson, AL; Daviglus, ML; Bouchard, C; Carnethon, M; Lewis, CE; Schreiner, PJ; Liu, KA; Sidney, S				Hankinson, Arlene L.; Daviglus, Martha L.; Bouchard, Claude; Carnethon, Mercedes; Lewis, Cora E.; Schreiner, Pamela J.; Liu, Kiang; Sidney, Stephen			Maintaining a High Physical Activity Level Over 20 Years and Weight Gain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ENERGY-BALANCE; PUBLIC-HEALTH; UNITED-STATES; FOLLOW-UP; EXERCISE; MEN; OBESITY; ADULTS; ASSOCIATIONS	Context Data supporting physical activity guidelines to prevent long-term weight gain are sparse, particularly during the period when the highest risk of weight gain occurs. Objective To evaluate the relationship between habitual activity levels and changes in body mass index (BMI) and waist circumference over 20 years. Design, Setting, and Participants The Coronary Artery Risk Development in Young Adults (CARDIA) study is a prospective longitudinal study with 20 years of follow-up, 1985-1986 to 2005-2006. Habitual activity was defined as maintaining high, moderate, and low activity levels based on sex-specific tertiles of activity scores at baseline. Participants comprised a population-based multicenter cohort (Chicago, Illinois; Birmingham, Alabama; Minneapolis, Minnesota; and Oakland, California) of 3554 men and women aged 18 to 30 years at baseline. Main Outcome Measures Average annual changes in BMI and waist circumference. Results Over 20 years, maintaining high levels of activity was associated with smaller gains in BMI and waist circumference compared with low activity levels after adjustment for race, baseline BMI, age, education, cigarette smoking status, alcohol use, and energy intake. Men maintaining high activity gained 2.6 fewer kilograms per year (+0.15 BMI units; 95% confidence interval [CI], 0.11-0.18 vs +0.20 in the lower activity group; 95% CI, 0.17-0.23), and women maintaining higher activity gained 6.1 fewer kilograms per year (+0.17 BMI units; 95% CI, 0.12-0.21 vs +0.30 in the lower activity group; 95% CI, 0.25-0.34). Men maintaining high activity gained 3.1 fewer centimeters in waist circumference per year (+0.52 cm; 95% CI, 0.43-0.61 cm vs 0.67 cm in the lower activity group; 95% CI, 0.60-0.75 cm) and women maintaining higher activity gained 3.8 fewer centimeters per year (+0.49 cm; 95% CI, 0.39-0.58 cm vs 0.67 cm in the lower activity group; 95% CI, 0.60-0.75 cm). Conclusion Maintaining high activity levels through young adulthood may lessen weight gain as young adults transition to middle age, particularly in women. JAMA. 2010;304(23):2603-2610 www.jama.com	[Hankinson, Arlene L.; Daviglus, Martha L.; Carnethon, Mercedes; Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Bouchard, Claude] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Lewis, Cora E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Schreiner, Pamela J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Sidney, Stephen] Kaiser Permanente, Div Res, Oakland, CA USA	Northwestern University; Feinberg School of Medicine; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Kaiser Permanente	Hankinson, AL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	alhankinson@northwestern.edu	Bouchard, Claude/AAE-2035-2019; s, s/GYR-2278-2022; Bouchard, Claude/A-7637-2009	Bouchard, Claude/0000-0002-0048-491X; Schreiner, Pamela/0000-0002-9920-6257; Carnethon, Mercedes/0000-0001-7035-0848	National Heart, Lung, and Blood Institute [N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, R01 HL078972]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048050, N01HC048049, N01HC048048, N01HC048047, N01HC095095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048050, R01HL048049, R29HL048048, R01HL078972, R01HL048048] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the following contracts and grants from the National Heart, Lung, and Blood Institute: N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, and R01 HL078972.	Ball K, 2001, INT J OBESITY, V25, P914, DOI 10.1038/sj.ijo.0801622; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P2743, DOI 10.1001/jama.292.22.2743; Di Pietro L, 2004, INT J OBESITY, V28, P1541, DOI 10.1038/sj.ijo.0802821; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Droyvold WB, 2004, INT J OBESITY, V28, P410, DOI 10.1038/sj.ijo.0802569; Erlichman J, 2002, Obes Rev, V3, P273, DOI 10.1046/j.1467-789X.2002.00078.x; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gordon-Larsen P, 2009, AM J CLIN NUTR, V89, P19, DOI 10.3945/ajcn.2008.26147; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Jakicic JM, 2003, JAMA-J AM MED ASSOC, V290, P1323, DOI 10.1001/jama.290.10.1323; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; Kimm SYS, 2005, LANCET, V366, P301, DOI 10.1016/S0140-6736(05)66837-7; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; Littman AJ, 2005, INT J OBESITY, V29, P524, DOI 10.1038/sj.ijo.0802886; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; McTiernan A, 2007, OBESITY, V15, P1496, DOI 10.1038/oby.2007.178; Parker ED, 2007, AM J PUBLIC HEALTH, V97, P703, DOI 10.2105/AJPH.2004.055889; Physical Activity Guidelines Committee, 2008, PHYS ACT GUID ADV CO; Pratt M, 1999, MED SCI SPORT EXER, V31, pS526, DOI 10.1097/00005768-199911001-00007; Ross R, 2001, MED SCI SPORT EXER, V33, pS521, DOI 10.1097/00005768-200106001-00023; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Schmitz KH, 2000, INT J OBESITY, V24, P1475, DOI 10.1038/sj.ijo.0801415; Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263; Sherwood NE, 2000, INT J OBESITY, V24, P395, DOI 10.1038/sj.ijo.0801169; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Sternfeld B, 2004, AM J EPIDEMIOL, V160, P912, DOI 10.1093/aje/kwh299; VAUGHAN L, 1991, AM J CLIN NUTR, V53, P821, DOI 10.1093/ajcn/53.4.821; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wenche Droyvold B, 2004, J Womens Health (Larchmt), V13, P55; Westerterp KR, 1997, INT J OBESITY, V21, P184, DOI 10.1038/sj.ijo.0800385; Westerterp KR, 1998, AM J CLIN NUTR, V68, p970S, DOI 10.1093/ajcn/68.4.970S; Williams PT, 2006, INT J OBESITY, V30, P543, DOI 10.1038/sj.ijo.0803172; WILLIAMSON DF, 1993, INT J OBESITY, V17, P279; World Health Organization, 1999, OB PREV MAN GLOB EP; 2002, CARBOHYDRATE FIBER F	39	186	192	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2603	2610		10.1001/jama.2010.1843	http://dx.doi.org/10.1001/jama.2010.1843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156948	Green Accepted, Bronze			2022-12-01	WOS:000285303400023
J	Ren, DC; Tu, HC; Kim, H; Wang, GX; Bean, GR; Takeuchi, O; Jeffers, JR; Zambetti, GP; Hsieh, JJD; Cheng, EHY				Ren, Decheng; Tu, Ho-Chou; Kim, Hyungjin; Wang, Gary X.; Bean, Gregory R.; Takeuchi, Osamu; Jeffers, John R.; Zambetti, Gerard P.; Hsieh, James J. -D.; Cheng, Emily H. -Y.			BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program	SCIENCE			English	Article							BCL-2 FAMILY-MEMBERS; MITOCHONDRIAL APOPTOSIS; MEMBRANE PERMEABILIZATION; NEURONAL APOPTOSIS; CYTOCHROME-C; JNK PATHWAY; BH3 DOMAINS; PROTEINS; MECHANISM; RELEASE	Although the proteins BAX and BAK are required for initiation of apoptosis at the mitochondria, how BAX and BAK are activated remains unsettled. We provide in vivo evidence demonstrating an essential role of the proteins BID, BIM, and PUMA in activating BAX and BAK. Bid, Bim, and Puma triple-knockout mice showed the same developmental defects that are associated with deficiency of Bax and Bak, including persistent interdigital webs and imperforate vaginas. Genetic deletion of Bid, Bim, and Puma prevented the homo-oligomerization of BAX and BAK, and thereby cytochrome c-mediated activation of caspases in response to diverse death signals in neurons and T lymphocytes, despite the presence of other BH3-only molecules. Thus, many forms of apoptosis require direct activation of BAX and BAK at the mitochondria by a member of the BID, BIM, or PUMA family of proteins.	[Ren, Decheng; Tu, Ho-Chou; Kim, Hyungjin; Wang, Gary X.; Bean, Gregory R.; Hsieh, James J. -D.; Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Takeuchi, Osamu] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Jeffers, John R.; Zambetti, Gerard P.] St Jude Childrens Hosp, Memphis, TN 38105 USA; [Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Osaka University; St Jude Children's Research Hospital; Washington University (WUSTL)	Cheng, EHY (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	chenge1@mskcc.org	Takeuchi, Osamu/AAG-9359-2019; Zambetti, Gerard/N-8093-2018; Takeuchi, Osamu/D-6007-2011; Ren, decheng/B-8310-2011	Takeuchi, Osamu/0000-0002-1260-6232; Zambetti, Gerard/0000-0002-0929-5007; Wang, Gary/0000-0002-8013-0766	NIH [R01CA125562, R01GM083159, P30CA21765]; Searle Scholars Program; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA125562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to all the investigators whose research could not be appropriately cited owing to space limitation. We thank T. D. Westergard and H.-F. Chen for technical assistance. This work was supported by grants to E.H.-Y.C. from NIH (R01CA125562) and the Searle Scholars Program, and to G.P.Z. from NIH (R01GM083159 and P30CA21765)	Besirli CG, 2005, J CELL BIOL, V170, P401, DOI 10.1083/jcb.200501138; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gross A., 1999, Genes Dev, V13, P1899; Harris CA, 2001, J BIOL CHEM, V276, P37754; Kim HA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1972; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	30	344	372	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1390	1393		10.1126/science.1190217	http://dx.doi.org/10.1126/science.1190217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127253	Green Accepted			2022-12-01	WOS:000284902100045
J	Giulivi, C; Zhang, YF; Omanska-Klusek, A; Ross-Inta, C; Wong, S; Hertz-Picciotto, I; Tassone, F; Pessah, IN				Giulivi, Cecilia; Zhang, Yi-Fan; Omanska-Klusek, Alicja; Ross-Inta, Catherine; Wong, Sarah; Hertz-Picciotto, Irva; Tassone, Flora; Pessah, Isaac N.			Mitochondrial Dysfunction in Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-CHAIN DISORDERS; COPY NUMBER; SPECTRUM; DNA; DEFICIENCY; METABOLISM; CHILDREN; MUSCLE; CELLS	Context Impaired mitochondrial function may influence processes highly dependent on energy, such as neurodevelopment, and contribute to autism. No studies have evaluated mitochondrial dysfunction and mitochondrial DNA (mtDNA) abnormalities in a well-defined population of children with autism. Objective To evaluate mitochondrial defects in children with autism. Design, Setting, and Patients Observational study using data collected from patients aged 2 to 5 years who were a subset of children participating in the Childhood Autism Risk From Genes and Environment study in California, which is a population-based, case-control investigation with confirmed autism cases and age-matched, genetically unrelated, typically developing controls, that was launched in 2003 and is still ongoing. Mitochondrial dysfunction and mtDNA abnormalities were evaluated in lymphocytes from 10 children with autism and 10 controls. Main Outcome Measures Oxidative phosphorylation capacity, mtDNA copy number and deletions, mitochondrial rate of hydrogen peroxide production, and plasma lactate and pyruvate. Results The reduced nicotinamide adenine dinucleotide (NADH) oxidase activity (normalized to citrate synthase activity) in lymphocytic mitochondria from children with autism was significantly lower compared with controls (mean, 4.4 [95% confidence interval {CI}, 2.8-6.0] vs 12 [95% CI, 8-16], respectively; P=.001). The majority of children with autism (6 of 10) had complex I activity below control range values. Higher plasma pyruvate levels were found in children with autism compared with controls (0.23 mM [95% CI, 0.15-0.31 mM] vs 0.08 mM [95% CI, 0.04-0.12 mM], respectively; P=.02). Eight of 10 cases had higher pyruvate levels but only 2 cases had higher lactate levels compared with controls. These results were consistent with the lower pyruvate dehydrogenase activity observed in children with autism compared with controls (1.0 [95% CI, 0.6-1.4] nmol x [min x mg protein](-1) vs 2.3 [95% CI, 1.7-2.9] nmol x [min x mg protein](-1), respectively; P=.01). Children with autism had higher mitochondrial rates of hydrogen peroxide production compared with controls (0.34 [95% CI, 0.26-0.42] nmol x [min x mg of protein](-1) vs 0.16 [95% CI, 0.12-0.20] nmol x [min x mg protein](-1) by complex III; P=.02). Mitochondrial DNA overreplication was found in 5 cases (mean ratio of mtDNA to nuclear DNA: 239 [95% CI, 217239] vs 179 [95% CI, 165-193] in controls; P=10(-4)). Deletions at the segment of cytochrome b were observed in 2 cases (ratio of cytochrome b to ND1: 0.80 [95% CI, 0.68-0.92] vs 0.99 [95% CI, 0.93-1.05] for controls; P=.01). Conclusion In this exploratory study, children with autism were more likely to have mitochondrial dysfunction, mtDNA overreplication, and mtDNA deletions than typically developing children. JAMA. 2010;304(21):2389-2396 www.jama.com	[Giulivi, Cecilia; Zhang, Yi-Fan; Omanska-Klusek, Alicja; Ross-Inta, Catherine; Wong, Sarah; Pessah, Isaac N.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Hertz-Picciotto, Irva] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Hertz-Picciotto, Irva; Tassone, Flora] Univ Calif Davis, Sch Med, Davis, CA 95616 USA; [Hertz-Picciotto, Irva; Pessah, Isaac N.] Univ Calif Davis, Ctr Childrens Environm Hlth & Dis Prevent, Davis, CA 95616 USA; [Hertz-Picciotto, Irva; Tassone, Flora; Pessah, Isaac N.] Univ Calif Davis, Med Invest Neurodev Disorders Inst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Giulivi, C (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, 1 Shields Ave,1120 Haring Hall, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/ABB-7809-2020; Giulivi, Cecilia/AAV-6774-2021; Pessah, Isaac N/K-7985-2017	Giulivi, Cecilia/0000-0003-1033-7435; Pessah, Isaac N/0000-0002-8149-588X; Hertz-Picciotto, Irva/0000-0001-6952-2390	University of California, Davis; MIND Institute [FT19900]; National Institute of Environmental Health Sciences [P01 ES11269, R01 ES015359]; Autism Speaks; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269, R01ES015359, R01ES012691] Funding Source: NIH RePORTER	University of California, Davis(University of California System); MIND Institute; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Autism Speaks; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study received funding from the 2008 Medical Investigations of Neurodevelopmental Disorders Institute Pilot Research Grant, University of California, Davis, and support from Autism Speaks awarded to Dr Giulivi. Additional funding was provided by the MIND Institute Gift Funds FT19900 to Dr Tassone. Additional support was provided by grants P01 ES11269 and R01 ES015359 from the National Institute of Environmental Health Sciences. Additional funding was received by Dr Pessah through an Environmental Innovator Award from Autism Speaks.	Aldred S, 2003, J AUTISM DEV DISORD, V33, P93, DOI 10.1023/A:1022238706604; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; DEMEIRLEIR L, 1993, PEDIATR NEUROL, V9, P216, DOI 10.1016/0887-8994(93)90088-T; Erecinska M, 1996, BBA-BIOENERGETICS, V1277, P13, DOI 10.1016/S0005-2728(96)00103-X; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Filipek PA, 2004, J AUTISM DEV DISORD, V34, P615, DOI 10.1007/s10803-004-5283-1; Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596; FISCHER JC, 1985, CLIN CHIM ACTA, V145, P89, DOI 10.1016/0009-8981(85)90022-1; GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122; GIULIVI C, 2003, SIGNAL TRANSDUCTION, P311; Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117; Haynes V, 2010, AM J PHYSIOL-ENDOC M, V298, pE978, DOI 10.1152/ajpendo.00739.2009; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Hertz-Picciotto I, 2006, ENVIRON HEALTH PERSP, V114, P1119, DOI 10.1289/ehp.8483; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Krebs H A, 1973, Symp Soc Exp Biol, V27, P299; Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.3.CO;2-B; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Meng XM, 2005, NEUROLOGY, V64, P1644, DOI 10.1212/01.WNL.0000160391.58004.D4; Ming X, 2010, BRAIN DEV-JPN, V32, P105, DOI 10.1016/j.braindev.2008.12.017; Mullen E. M., 1995, MULLEN SCALES EARLY; National Institute of Neurological Disorders and Stroke, AUT FACT SHEET; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P1; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; SHAY JW, 1990, J BIOL CHEM, V265, P14802; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; SPARROW SS, 1985, J PEDIATR PSYCHOL, V10, P215, DOI 10.1093/jpepsy/10.2.215; STJERNHOLM RL, 1967, J BACTERIOL, V93, P1657, DOI 10.1128/JB.93.5.1657-1661.1967; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; World Medical Association, DECL HELS ETH PRINC; Zecavati N, 2009, CURR NEUROL NEUROSCI, V9, P129, DOI 10.1007/s11910-009-0021-x; Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2	43	278	284	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2389	2396		10.1001/jama.2010.1706	http://dx.doi.org/10.1001/jama.2010.1706			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119085	Green Accepted, Bronze			2022-12-01	WOS:000284763900020
J	Mitton-Fry, RM; DeGregorio, SJ; Wang, JM; Steitz, TA; Steitz, JA				Mitton-Fry, Rachel M.; DeGregorio, Suzanne J.; Wang, Jimin; Steitz, Thomas A.; Steitz, Joan A.			Poly(A) Tail Recognition by a Viral RNA Element Through Assembly of a Triple Helix	SCIENCE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; HUMAN TELOMERASE RNA; TERTIARY INTERACTIONS; KAPOSIS-SARCOMA; NUCLEAR-RNA; PSEUDOKNOT; BINDING; DECAY	Kaposi's sarcoma-associated herpesvirus produces a highly abundant, nuclear noncoding RNA, polyadenylated nuclear (PAN) RNA, which contains an element that prevents its decay. The 79-nucleotide expression and nuclear retention element (ENE) was proposed to adopt a secondary structure like that of a box H/ACA small nucleolar RNA (snoRNA), with a U-rich internal loop that hybridizes to and protects the PAN RNA poly(A) tail. The crystal structure of a complex between the 40-nucleotide ENE core and oligo(A)(9) RNA at 2.5 angstrom resolution reveals that unlike snoRNAs, the U-rich loop of the ENE engages its target through formation of a major-groove triple helix. A-minor interactions extend the binding interface. Deadenylation assays confirm the functional importance of the triple helix. Thus, the ENE acts as an intramolecular RNA clamp, sequestering the PAN poly(A) tail and preventing the initiation of RNA decay.	[Mitton-Fry, Rachel M.; DeGregorio, Suzanne J.; Steitz, Joan A.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, New Haven, CT 06536 USA; [Wang, Jimin; Steitz, Thomas A.] Yale Univ, Bass Ctr Mol & Struct Biol, Dept MB&B, New Haven, CT 06536 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Bass Ctr Mol & Struct Biol, HHMI, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu	Steitz, Thomas A./C-6559-2009		NIH [CA16038, GM022778]; Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026154, P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Borah, K. Tycowski, K. Herbert, and K. Riley for critical reading of the manuscript and the entire Steitz laboratories for helpful discussion. We thank S. Strobel and G. Conn for the generous gifts of iridium(III) hexamine and 3'-hepatitis delta virus (HDV) plasmid, respectively. Special thanks to Y. Zuo and G. Blaha for crystallography assistance, P. Moore and E. Paulson for NMR assistance, and M.-D. Shu, D. Mishler, and K. Durniak for technical assistance. X-ray data were collected at the National Synchrotron Light Source (X29A) at Brookhaven National Laboratory (13). Financial support for this research was provided by NIH grant CA16038 to J.A.S. and NIH grant GM022778 to T. A. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. R.M.M.-F. is supported by a Jane Coffin Childs Memorial Fund Postdoctoral fellowship. J.A.S. and T. A. S. are investigators of the Howard Hughes Medical Institute. Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 3P22.	Conrad NK, 2007, P NATL ACAD SCI USA, V104, P10412, DOI 10.1073/pnas.0704187104; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Conrad NK, 2005, EMBO J, V24, P1831, DOI 10.1038/sj.emboj.7600662; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; DSOUZA DJ, 1992, J BIOMOL STRUCT DYN, V10, P141, DOI 10.1080/07391102.1992.10508634; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; FELSENFELD G, 1957, J AM CHEM SOC, V79, P2023, DOI 10.1021/ja01565a074; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Jin H, 2007, MOL CELL, V26, P205, DOI 10.1016/j.molcel.2007.03.014; Kim NK, 2008, J MOL BIOL, V384, P1249, DOI 10.1016/j.jmb.2008.10.005; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; Sun R, 1996, P NATL ACAD SCI USA, V93, P11883, DOI 10.1073/pnas.93.21.11883; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Viejo-Borbolla Abel, 2004, Curr HIV/AIDS Rep, V1, P5, DOI 10.1007/s11904-004-0001-3; Wu HH, 2007, P NATL ACAD SCI USA, V104, P6655, DOI 10.1073/pnas.0701534104; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641	25	124	128	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1244	1247		10.1126/science.1195858	http://dx.doi.org/10.1126/science.1195858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109672	Green Accepted			2022-12-01	WOS:000284613700042
J	Smith, MD; Asche, F; Guttormsen, AG; Wiener, JB				Smith, Martin D.; Asche, Frank; Guttormsen, Atle G.; Wiener, Jonathan B.			Genetically Modified Salmon and Full Impact Assessment	SCIENCE			English	Editorial Material									[Smith, Martin D.; Wiener, Jonathan B.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Smith, Martin D.] Duke Univ, Dept Econ, Durham, NC 27708 USA; [Asche, Frank] Univ Stavanger, Dept Ind Econ, N-4036 Stavanger, Norway; [Guttormsen, Atle G.] Norwegian Univ Life Sci, Dept Econ & Resource Management, N-1432 As, Norway; [Wiener, Jonathan B.] Duke Univ, Sch Law, Durham, NC 27708 USA; [Wiener, Jonathan B.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Wiener, Jonathan B.] Resources Future Inc, Washington, DC 20036 USA	Duke University; Duke University; Universitetet i Stavanger; Norwegian University of Life Sciences; Duke University; Duke University; Resources for the Future	Smith, MD (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	marsmith@duke.edu	Guttormsen, Atle/GZG-2356-2022; Asche, Frank/AAG-9920-2020; Smith, Martin D/D-9168-2016	Asche, Frank/0000-0002-1540-9728; Smith, Martin D/0000-0002-4714-463X				*AQUABOUNTY TECHN, 2010, ENV ASS AQUADVANTAG; Asche F, 2008, MAR RESOUR ECON, V23, P527, DOI 10.1086/mre.23.4.42629678; CHALFANT JA, 1988, J POLIT ECON, V96, P391, DOI 10.1086/261543; *CVM, 2009, 187 CVM FDA; Food and Nutrition Board, 2007, SEAF CHOIC BAL BEN R; Guttormsen A. G., 2002, Marine Resource Economics, V17, P91; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Muir WM, 2004, EMBO REP, V5, P654, DOI 10.1038/sj.embor.7400197; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P18040, DOI 10.1073/pnas.0910577106; Pollack A, 2010, NY TIMES        0627, pA1; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Smith MD, 2010, SCIENCE, V327, P784, DOI 10.1126/science.1185345; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tveteras S., 2002, Marine Resource Economics, V17, P121; *VMAC, 2010, VMAC BRIEF PACK AQUA; Wilen JE, 2006, B MAR SCI, V78, P529	19	53	54	5	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1052	1053		10.1126/science.1197769	http://dx.doi.org/10.1126/science.1197769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097923				2022-12-01	WOS:000284374700025
J	Rittle, J; Green, MT				Rittle, Jonathan; Green, Michael T.			Cytochrome P450 Compound I: Capture, Characterization, and C-H Bond Activation Kinetics	SCIENCE			English	Article							BIOINORGANIC CHEMISTRY; LAURIC ACID; CHLOROPEROXIDASE; P450CAM; HYDROXYLATION; INTERMEDIATE; SPECTROSCOPY; RESONANCE; FUNCTIONALIZATION; OXIDATIONS	Cytochrome P450 enzymes are responsible for the phase I metabolism of approximately 75% of known pharmaceuticals. P450s perform this and other important biological functions through the controlled activation of C-H bonds. Here, we report the spectroscopic and kinetic characterization of the long-sought principal intermediate involved in this process, P450 compound I (P450-I), which we prepared in approximately 75% yield by reacting ferric CYP119 with m-chloroperbenzoic acid. The Mossbauer spectrum of CYP119-I is similar to that of chloroperoxidase compound I, although its electron paramagnetic resonance spectrum reflects an increase in vertical bar J vertical bar/D, the ratio of the exchange coupling to the zero-field splitting. CYP119-I hydroxylates the unactivated C-H bonds of lauric acid [D(C-H) similar to 100 kilocalories per mole], with an apparent second-order rate constant of k(app) = 1.1 x 10(7) per molar per second at 4 degrees C. Direct measurements put a lower limit of k >= 210 per second on the rate constant for bound substrate oxidation, whereas analyses involving kinetic isotope effects predict a value in excess of 1400 per second.	[Rittle, Jonathan; Green, Michael T.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Green, MT (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	mtg10@psu.edu			NSF	NSF(National Science Foundation (NSF))	This work was supported by NSF. We thank T. Grove and J. C. Calixto Moreno for assistance with GC-MS and C. Krest for help with preliminary EPR experiments. The CYP119 plasmid was graciously provided by P. R. Ortiz de Montellano.	Behan RK, 2007, J AM CHEM SOC, V129, P5855, DOI 10.1021/ja064590y; Chandrasena REP, 2004, J AM CHEM SOC, V126, P115, DOI 10.1021/ja038237t; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Davydov R, 2005, J AM CHEM SOC, V127, P1403, DOI 10.1021/ja045351i; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Denisov IG, 2001, J BIOL CHEM, V276, P11648, DOI 10.1074/jbc.M010219200; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Denisov IG, 2001, J INORG BIOCHEM, V87, P215, DOI 10.1016/S0162-0134(01)00328-2; EGAWA T, 1992, FEBS LETT, V305, P206, DOI 10.1016/0014-5793(92)80668-7; EGAWA T, 1994, BIOCHEM BIOPH RES CO, V201, P1464, DOI 10.1006/bbrc.1994.1868; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Green MT, 2001, J AM CHEM SOC, V123, P9218, DOI 10.1021/ja010105h; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Hoffman BM, 2003, P NATL ACAD SCI USA, V100, P3575, DOI 10.1073/pnas.0636464100; Karlin KD, 2010, NATURE, V463, P168, DOI 10.1038/463168a; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; Kim SH, 2005, DALTON T, P3464, DOI 10.1039/b506764m; Kim SH, 2006, J AM CHEM SOC, V128, P5598, DOI 10.1021/ja060776l; Klinman Judith P., 2009, P132, DOI 10.1039/9781847559975-00132; Koo LS, 2002, J AM CHEM SOC, V124, P5684, DOI 10.1021/ja017174g; Lim YR, 2010, J MICROBIOL BIOTECHN, V20, P574, DOI 10.4014/jmb.0909.09007; Makris TM, 2006, J INORG BIOCHEM, V100, P507, DOI 10.1016/j.jinorgbio.2006.01.025; McLean MA, 1998, BIOCHEM BIOPH RES CO, V252, P166, DOI 10.1006/bbrc.1998.9584; Newcomb M, 2003, J AM CHEM SOC, V125, P6064, DOI 10.1021/ja0343858; Ortiz de Montellano PR, 2005, CYTOCHROME P450 STRU, V3rd; Que L, 2001, SCIENCE, V292, P651; Rabe KS, 2008, CHEMBIOCHEM, V9, P420, DOI 10.1002/cbic.200700450; Rittle J, 2010, INORG CHEM, V49, P3610, DOI 10.1021/ic902062d; RUTTER R, 1984, BIOCHEMISTRY-US, V23, P6809, DOI 10.1021/bi00321a082; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schunemann V, 2002, J INORG BIOCHEM, V91, P586, DOI 10.1016/S0162-0134(02)00476-2; Sligar SG, 2005, BIOCHEM BIOPH RES CO, V338, P346, DOI 10.1016/j.bbrc.2005.08.094; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Stone KL, 2006, P NATL ACAD SCI USA, V103, P12307, DOI 10.1073/pnas.0603159103; Stone KL, 2005, P NATL ACAD SCI USA, V102, P16563, DOI 10.1073/pnas.0507069102; van Rantwijk F, 2000, CURR OPIN BIOTECH, V11, P554, DOI 10.1016/S0958-1669(00)00143-9; Wang Q, 2009, J AM CHEM SOC, V131, P10629, DOI 10.1021/ja9031105; Wright RL, 1996, FEBS LETT, V384, P235, DOI 10.1016/0014-5793(96)00322-5; ZAKS A, 1995, J AM CHEM SOC, V117, P10419, DOI 10.1021/ja00147a001; Zhang R, 2006, ORG LETT, V8, P2731, DOI 10.1021/ol060762k	43	916	916	16	488	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					933	937		10.1126/science.1193478	http://dx.doi.org/10.1126/science.1193478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071661				2022-12-01	WOS:000284118000033
J	Rada-Iglesias, A; Bajpai, R; Swigut, T; Brugmann, SA; Flynn, RA; Wysocka, J				Rada-Iglesias, Alvaro; Bajpai, Ruchi; Swigut, Tomek; Brugmann, Samantha A.; Flynn, Ryan A.; Wysocka, Joanna			A unique chromatin signature uncovers early developmental enhancers in humans	NATURE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION ANALYSIS; GENE-EXPRESSION; TRANSCRIPTION; IDENTIFICATION; ZEBRAFISH; PROMOTERS; GENOME; EOMESODERMIN; DATABASE	Cell-fate transitions involve the integration of genomic information encoded by regulatory elements, such as enhancers, with the cellular environment(1,2). However, identification of genomic sequences that control human embryonic development represents a formidable challenge(3). Here we show that in human embryonic stem cells (hESCs), unique chromatin signatures identify two distinct classes of genomic elements, both of which are marked by the presence of chromatin regulators p300 and BRG1, monomethylation of histone H3 at lysine 4 (H3K4me1), and low nucleosomal density. In addition, elements of the first class are distinguished by the acetylation of histone H3 at lysine 27 (H3K27ac), overlap with previously characterized hESC enhancers, and are located proximally to genes expressed in hESCs and the epiblast. In contrast, elements of the second class, which we term 'poised enhancers', are distinguished by the absence of H3K27ac, enrichment of histone H3 lysine 27 trimethylation (H3K27me3), and are linked to genes inactive in hESCs and instead are involved in orchestrating early steps in embryogenesis, such as gastrulation, mesoderm formation and neurulation. Consistent with the poised identity, during differentiation of hESCs to neuroepithelium, a neuroectoderm-specific subset of poised enhancers acquires a chromatin signature associated with active enhancers. When assayed in zebrafish embryos, poised enhancers are able to direct cell-type and stage-specific expression characteristic of their proximal developmental gene, even in the absence of sequence conservation in the fish genome. Our data demonstrate that early developmental enhancers are epigenetically pre-marked in hESCs and indicate an unappreciated role of H3K27me3 at distal regulatory elements. Moreover, the wealth of new regulatory sequences identified here provides an invaluable resource for studies and isolation of transient, rare cell populations representing early stages of human embryogenesis.	[Rada-Iglesias, Alvaro; Bajpai, Ruchi; Swigut, Tomek; Brugmann, Samantha A.; Flynn, Ryan A.; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu	Li, Yapeng/N-1042-2017	Li, Yapeng/0000-0002-5042-6881; Swigut, Tomek/0000-0002-7649-6781; Bajpai, Ruchi/0000-0001-7737-3567; Rada-Iglesias, Alvaro/0000-0001-7137-1341	WM Keck Foundation; CIRM [RN1 00579-1]; EMBO; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE019853] Funding Source: NIH RePORTER	WM Keck Foundation(W.M. Keck Foundation); CIRM(California Institute for Regenerative Medicine); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Wysocka laboratory members for ideas and manuscript comments; I. A. Shestopalov and J. K. Chen for sharing zebrafish resources, equipment and knowledge; T. Howes and D. M. Kingsley for the pT2HE vector; Z. Weng and A. Sidow for Illumina sequencing; and A. Valouev for discussion on ChIP-seq data analysis. This work was supported by WM Keck Foundation Distinguished Young Scholar in Biomedical Research Award and CIRM RN1 00579-1 grant to J.W.A.R.-I. was supported by an EMBO long-term fellowship.	Bajpai R, 2009, CELL DEATH DIFFER, V16, P807, DOI 10.1038/cdd.2009.18; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Itani HA, 2007, ENDOCRINOLOGY, V148, P1424, DOI 10.1210/en.2006-1381; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Marin O, 2002, DEVELOPMENT, V129, P761; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Nakabayashi H, 2004, BIOCHEM BIOPH RES CO, V318, P773, DOI 10.1016/j.bbrc.2004.04.096; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Segawa K, 2009, J ENDOCRINOL, V200, P107, DOI 10.1677/JOE-08-0376; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Yeom YI, 1996, DEVELOPMENT, V122, P881	39	1464	1496	4	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					279	+		10.1038/nature09692	http://dx.doi.org/10.1038/nature09692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21160473	Green Accepted			2022-12-01	WOS:000287144200048
J	Kaeser, PS; Deng, LB; Wang, Y; Dulubova, I; Liu, XR; Rizo, J; Sudhof, TC				Kaeser, Pascal S.; Deng, Lunbin; Wang, Yun; Dulubova, Irina; Liu, Xinran; Rizo, Josep; Suedhof, Thomas C.			RIM Proteins Tether Ca2+ Channels to Presynaptic Active Zones via a Direct PDZ-Domain Interaction	CELL			English	Article							CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; RAB3 EFFECTOR; RIM1-ALPHA; COMPLEX; BINDING; CALYX; DELETION; FAMILY	At a synapse, fast synchronous neurotransmitter release requires localization of Ca2+ channels to presynaptic active zones. How Ca2+ channels are recruited to active zones, however, remains unknown. Using unbiased yeast two-hybrid screens, we here identify a direct interaction of the central PDZ domain of the active-zone protein RIM with the C termini of presynaptic N- and P/Q-type Ca2+ channels but not L-type Ca2+ channels. To test the physiological significance of this interaction, we generated conditional knockout mice lacking all multidomain RIM isoforms. Deletion of RIM proteins ablated most neurotransmitter release by simultaneously impairing the priming of synaptic vesicles and by decreasing the presynaptic localization of Ca2+ channels. Strikingly, rescue of the decreased Ca2+-channel localization required the RIM PDZ domain, whereas rescue of vesicle priming required the RIM N terminus. We propose that RIMs tether N- and P/Q-type Ca2+ channels to presynaptic active zones via a direct PDZ-domain-mediated interaction, thereby enabling fast, synchronous triggering of neurotransmitter release at a synapse.	[Kaeser, Pascal S.; Deng, Lunbin; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kaeser, Pascal S.; Deng, Lunbin; Wang, Yun; Liu, Xinran; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Dulubova, Irina; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Lorry Lokey Bldg,265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu			NIH [NINDS 33564, NS37200, DA029044]; Swiss National Science Foundation; NARSAD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NARSAD(NARSAD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Borowicz, I. Kornblum, L. Fan, J. Mitchell, H. Ly, and I. Huryeva for technical assistance, Dr. R.E. Hammer for blastocyst injections, Dr. N. Brose for Munc 13-1 antibodies, Dr. C. Acuna-Goycolea for advice on Ca<SUP>2+</SUP>-imaging experiments, Dr. Z. Ma for assistance with yeast two-hybrid screening, Drs. Z. Pang, T. Bacaj, and C. Foldy for help with data analysis, and Dr. R. Schneggenburger for comments. This work was supported by grants from the NIH (NINDS 33564 to T.C.S., NS37200 to J.R., DA029044 to P.S.K.), a Swiss National Science Foundation Postdoctoral Fellowship (to P.S.K.), and a NARSAD Young Investigator Award (to P.S.K.).	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; DENG L, 2011, NEURON IN PRESS, V69, DOI DOI 10.1016/J.NEURON.2011.01.005; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; HAN Y, 2011, NEURON IN PRESS, V69, DOI DOI 10.1016/J.NEURON.2010.12.014; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Kaeser PS, 2009, NEURON, V64, P227, DOI 10.1016/j.neuron.2009.09.019; Kaeser PS, 2008, J NEUROSCI, V28, P13435, DOI 10.1523/JNEUROSCI.3235-08.2008; Katz B., 1969, RELEASE NEURAL TRANS; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lu J, 2005, J MOL BIOL, V352, P455, DOI 10.1016/j.jmb.2005.07.047; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mittelstaedt T, 2010, BIOL CHEM, V391, P599, DOI 10.1515/BC.2010.064; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Qian J, 2000, J NEUROSCI, V20, P163, DOI 10.1523/JNEUROSCI.20-01-00163.2000; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Wu LG, 1999, J NEUROSCI, V19, P726	42	372	381	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					282	295		10.1016/j.cell.2010.12.029	http://dx.doi.org/10.1016/j.cell.2010.12.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241895	Bronze, Green Accepted			2022-12-01	WOS:000286459900012
J	Huang, PY; Ruiz-Vargas, CS; van der Zande, AM; Whitney, WS; Levendorf, MP; Kevek, JW; Garg, S; Alden, JS; Hustedt, CJ; Zhu, Y; Park, J; McEuen, PL; Muller, DA				Huang, Pinshane Y.; Ruiz-Vargas, Carlos S.; van der Zande, Arend M.; Whitney, William S.; Levendorf, Mark P.; Kevek, Joshua W.; Garg, Shivank; Alden, Jonathan S.; Hustedt, Caleb J.; Zhu, Ye; Park, Jiwoong; McEuen, Paul L.; Muller, David A.			Grains and grain boundaries in single-layer graphene atomic patchwork quilts	NATURE			English	Article							CHEMICAL-VAPOR-DEPOSITION; ELECTRONIC TRANSPORT; CARBON NANOTUBES; LARGE-AREA; DEFECTS; FILMS; MICROSCOPY; STRENGTH; GROWTH; FOILS	The properties of polycrystalline materials are often dominated by the size of their grains and by the atomic structure of their grain boundaries. These effects should be especially pronounced in two-dimensional materials, where even a line defect can divide and disrupt a crystal. These issues take on practical significance in graphene, which is a hexagonal, two-dimensional crystal of carbon atoms. Single-atom-thick graphene sheets can now be produced by chemical vapour deposition(1-3) on scales of up to metres(4), making their polycrystallinity almost unavoidable. Theoretically, graphene grain boundaries are predicted to have distinct electronic(5-8), magnetic(9), chemical(10) and mechanical(11-13) properties that strongly depend on their atomic arrangement. Yet because of the five-order-of-magnitude size difference between grains and the atoms at grain boundaries, few experiments have fully explored the graphene grain structure. Here we use a combination of old and new transmission electron microscopy techniques to bridge these length scales. Using atomic-resolution imaging, we determine the location and identity of every atom at a grain boundary and find that different grains stitch together predominantly through pentagon-heptagon pairs. Rather than individually imaging the several billion atoms in each grain, we use diffraction-filtered imaging(14) to rapidly map the location, orientation and shape of several hundred grains and boundaries, where only a handful have been previously reported(15-19). The resulting images reveal an unexpectedly small and intricate patchwork of grains connected by tilt boundaries. By correlating grain imaging with scanning probe and transport measurements, we show that these grain boundaries severely weaken the mechanical strength of graphene membranes but do not as drastically alter their electrical properties. These techniques open a new window for studies on the structure, properties and control of grains and grain boundaries in graphene and other two-dimensional materials.	[Huang, Pinshane Y.; Ruiz-Vargas, Carlos S.; Alden, Jonathan S.; Zhu, Ye; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [van der Zande, Arend M.; Whitney, William S.; McEuen, Paul L.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Levendorf, Mark P.; Garg, Shivank; Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Kevek, Joshua W.] Oregon State Univ, Dept Phys, Corvallis, OR 97331 USA; [Hustedt, Caleb J.] Brigham Young Univ, Dept Phys & Astron, Provo, UT 84602 USA; [Park, Jiwoong; McEuen, Paul L.; Muller, David A.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Oregon State University; Brigham Young University	Muller, DA (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	david.a.muller@cornell.edu	Zhu, Ye/A-1844-2011; van der Zande, Arend M/C-1989-2016; Zhu, Ye/U-3836-2019; Muller, David/A-7745-2010; Park, Jiwoong/C-2327-2013	Zhu, Ye/0000-0002-5217-493X; van der Zande, Arend M/0000-0001-5104-9646; Zhu, Ye/0000-0002-5217-493X; Muller, David/0000-0003-4129-0473; Huang, Pinshane/0000-0002-1095-1833	National Science Foundation through the Cornell Center for Materials Research; Nanoscale Science and Engineering Initiative of the National Science Foundation [EEC-0117770, 064654]; NSF	National Science Foundation through the Cornell Center for Materials Research; Nanoscale Science and Engineering Initiative of the National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	The authors acknowledge discussions with M. Blees, J. Cha, S. Gerbode, J. Grazul, E. Kirkland, L. Fitting-Kourkoutis, O. Krivanek, S. Shi, S. Wang and H. Zhuang. This work was supported in part by the National Science Foundation through the Cornell Center for Materials Research and the Nanoscale Science and Engineering Initiative of the National Science Foundation under NSF Award EEC-0117770, 064654. Additional support was provided by the Army Research Office, CONACYT-Mexico, the Air Force Office of Scientific Research, DARPA-MTO and the MARCO Focused Research Center on Materials, Structures, and Devices. Sample fabrication was performed at the Cornell node of the National Nanofabrication Infrastructure Network, funded by the NSF. Additional facilities support was provided by the Cornell Center for Materials Research (NSF DMR-0520404 and IMR-0417392) and NYSTAR.	Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/NNANO.2010.132, 10.1038/nnano.2010.132]; Cervenka J, 2009, NAT PHYS, V5, P840, DOI 10.1038/NPHYS1399; Cervenka J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195429; Cockayne E., 2010, ROTATIONAL GRAIN BOU; de Villeneuve VWA, 2005, J PHYS-CONDENS MAT, V17, pS3371, DOI 10.1088/0953-8984/17/45/024; Gao L, 2010, NANO LETT, V10, P3512, DOI 10.1021/nl1016706; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Grantab R, 2010, SCIENCE, V330, P946, DOI 10.1126/science.1196893; Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817; Hirsch P.B., 1965, ELECT MICROSCOPY THI; Jiao LY, 2008, J AM CHEM SOC, V130, P12612, DOI 10.1021/ja805070b; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li XS, 2010, NANO LETT, V10, P4328, DOI 10.1021/nl101629g; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liu YY, 2010, NANO LETT, V10, P2178, DOI 10.1021/nl100988r; Malola S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165447; Mesaros A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205119; Meyer J. C., 2009, MC2009, V3, P347; Meyer JC, 2008, NANO LETT, V8, P3582, DOI 10.1021/nl801386m; Park HJ, 2010, CARBON, V48, P1088, DOI 10.1016/j.carbon.2009.11.030; Park S, 2010, CARBON, V48, P797, DOI 10.1016/j.carbon.2009.10.030; Peres NMR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125411; Regan W, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3337091; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Suenaga K, 2007, NAT NANOTECHNOL, V2, P358, DOI 10.1038/nnano.2007.141; Thiel S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046809; van der Zande AM, 2010, NANO LETT, V10, P4869, DOI 10.1021/nl102713c; Wofford JM, 2010, NANO LETT, V10, P4890, DOI 10.1021/nl102788f; Yazyev OV, 2010, NAT MATER, V9, P806, DOI [10.1038/nmat2830, 10.1038/NMAT2830]; Yazyev OV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195420; Zhao L., 2010, ATOMIC SCALE GROWTH	33	1584	1619	33	1244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					389	+		10.1038/nature09718	http://dx.doi.org/10.1038/nature09718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21209615	Green Submitted			2022-12-01	WOS:000286385600050
J	Kavalier, F				Kavalier, Fred			Personal View Why do pharmacists sell homoeopathic remedies?	BRITISH MEDICAL JOURNAL			English	Editorial Material												kavalier@btinternet.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								d349	10.1136/bmj.d349	http://dx.doi.org/10.1136/bmj.d349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248013				2022-12-01	WOS:000286602400025
J	Mor, V; Besdine, RW				Mor, Vincent; Besdine, Richard W.			Policy Options to Improve Discharge Planning and Reduce Rehospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROLLED-TRIAL; CARE; HOSPITALISTS		[Mor, Vincent; Besdine, Richard W.] Brown Univ, Sch Med, Dept Community Hlth, Providence, RI 02912 USA; [Mor, Vincent; Besdine, Richard W.] Brown Univ, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Besdine, Richard W.] Brown Univ, Sch Med, Dept Med, Div Geriatr, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Mor, V (corresponding author), Brown Univ, Sch Med, Dept Community Hlth, Box G-S121, Providence, RI 02912 USA.	vincent_mor@brown.edu			NIA NIH HHS [P0-1 AG027296, P01 AG027296] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG027296] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; *COMM MP, 2008, DAT BOOK HEALTHC SPE; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Hamel MB, 2009, NEW ENGL J MED, V360, P1141, DOI 10.1056/NEJMe0900796; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kane RL, 2011, JAMA-J AM MED ASSOC, V305, P284, DOI 10.1001/jama.2010.2015; Mor V, 2010, HEALTH AFFAIR, V29, P57, DOI 10.1377/hlthaff.2009.0629; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Peterson MC, 2009, MAYO CLIN PROC, V84, P248, DOI 10.1016/S0025-6196(11)61142-7	9	28	28	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					302	303		10.1001/jama.2010.2006	http://dx.doi.org/10.1001/jama.2010.2006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707YY	21245187	Green Accepted			2022-12-01	WOS:000286328700029
J	Rasmussen, SGF; Choi, HJ; Fung, JJ; Pardon, E; Casarosa, P; Chae, PS; DeVree, BT; Rosenbaum, DM; Thian, FS; Kobilka, TS; Schnapp, A; Konetzki, I; Sunahara, RK; Gellman, SH; Pautsch, A; Steyaert, J; Weis, WI; Kobilka, BK				Rasmussen, Soren G. F.; Choi, Hee-Jung; Fung, Juan Jose; Pardon, Els; Casarosa, Paola; Chae, Pil Seok; DeVree, Brian T.; Rosenbaum, Daniel M.; Thian, Foon Sun; Kobilka, Tong Sun; Schnapp, Andreas; Konetzki, Ingo; Sunahara, Roger K.; Gellman, Samuel H.; Pautsch, Alexander; Steyaert, Jan; Weis, William I.; Kobilka, Brian K.			Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor	NATURE			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; PROTEIN; RHODOPSIN; CONFORMATIONS; ACTIVATION	G protein coupled receptors (GPCRs) exhibit a spectrum of functional behaviours in response to natural and synthetic ligands. Recent crystal structures provide insights into inactive states of several GPCRs. Efforts to obtain an agonist-bound active-state GPCR structure have proven difficult due to the inherent instability of this state in the absence of a G protein. We generated a camelid antibody fragment (nanobody) to the human beta(2) adrenergic receptor (beta(2)AR) that exhibits G protein-like behaviour, and obtained an agonist-bound, active-state crystal structure of the receptor-nanobody complex. Comparison with the inactive beta(2)AR structure reveals subtle changes in the binding pocket; however, these small changes are associated with an 11 angstrom outward movement of the cytoplasmic end of transmembrane segment 6, and rearrangements of transmembrane segments 5 and 7 that are remarkably similar to those observed in opsin, an active form of rhodopsin. This structure provides insights into the process of agonist binding and activation.	[Rasmussen, Soren G. F.; Choi, Hee-Jung; Fung, Juan Jose; Rosenbaum, Daniel M.; Thian, Foon Sun; Kobilka, Tong Sun; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Rasmussen, Soren G. F.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Vlaams Inst Biotechnol, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Casarosa, Paola; Schnapp, Andreas; Konetzki, Ingo; Pautsch, Alexander] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Chae, Pil Seok; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [DeVree, Brian T.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	Stanford University; University of Copenhagen; Stanford University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Boehringer Ingelheim; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	bill.weis@stanford.edu; kobilka@stanford.edu	DeVree, Brian T/F-6205-2011; Weis, William I/G-1437-2011; Steyaert, Jan/H-4662-2011; Sunahara, Roger/AAJ-8667-2020; steyaert, jan/GQP-7811-2022	Weis, William I/0000-0002-5583-6150; Steyaert, Jan/0000-0002-3825-874X; Rasmussen, Soren/0000-0002-1853-1841; Pardon, Els/0000-0002-2466-0172; Kobilka, Brian/0000-0001-5958-3990; DeVree, Brian/0000-0003-0582-8125; Choi, Hee-Jung/0000-0002-1167-1526	National Institutes of Health [NS028471, GM083118, GM56169, P01 GM75913, P60DK-20572]; Mathers Foundation; Lundbeck Foundation; University of Michigan; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, R01GM083118, R01GM068603, P01GM075913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); University of Michigan(University of Michigan System); Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health Grants NS028471 and GM083118 (B. K. K.), GM56169 (W. I. W.), P01 GM75913 (S. H. G), and P60DK-20572 (R. K. S.), the Mathers Foundation (B. K. K. and W. I. W.), the Lundbeck Foundation (Junior Group Leader Fellowship, S. G. F. R.), the University of Michigan Biomedical Sciences Scholars Program (R. K. S.), the Fund for Scientific Research of Flanders (FWO-Vlaanderen) and the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) (E.P. and J.S.).	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	31	1243	1283	5	393	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					175	180		10.1038/nature09648	http://dx.doi.org/10.1038/nature09648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228869	Green Accepted, Green Published			2022-12-01	WOS:000286143400030
J	Durieux, J; Wolff, S; Dillin, A				Durieux, Jenni; Wolff, Suzanne; Dillin, Andrew			The Cell-Non-Autonomous Nature of Electron Transport Chain-Mediated Longevity	CELL			English	Article							ELEGANS LIFE-SPAN; GENE-EXPRESSION; ENDOCRINE REGULATION; OXIDATIVE STRESS; DROSOPHILA; IDENTIFICATION; REQUIREMENTS; DETERMINANT; MUTANTS; DAF-16	The life span of C. elegans can be increased via reduced function of the mitochondria; however, the extent to which mitochondrial alteration in a single, distinct tissue may influence aging in the whole organism remains unknown. We addressed this question by asking whether manipulations to ETC function can modulate aging in a cell-non-autonomous fashion. We report that the alteration of mitochondrial function in key tissues is essential for establishing and maintaining a prolongevity cue. We find that regulators of mitochondrial stress responses are essential and specific genetic requirements for the electron transport chain (ETC) longevity pathway. Strikingly, we find that mitochondrial perturbation in one tissue is perceived and acted upon by the mitochondrial stress response pathway in a distal tissue. These results suggest that mitochondria may establish and perpetuate the rate of aging for the whole organism independent of cell-autonomous functions.	[Durieux, Jenni; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, La Jolla, CA 92037 USA; [Wolff, Suzanne] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Scripps Research Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Wolff, Suzanne/A-2839-2012		NIA [R01 AG024365]; NIH; HHMI; NATIONAL INSTITUTE ON AGING [R01AG024365] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. W. Mair, S. Panowski, M. Raices, P. Douglas, and N. Baird for thoughtful editing and scientific insight. We thank Z. Liu for cloning and strain integration. We are grateful to Drs. C. Hunter, C. Haynes, D. Ron, and K. Shen for strains and reagents; and anonymous reviewers for their insight. This work was supported by NIA R01 AG024365, NIH Developmental Biology Training Grant, and HHMI. A.D. is cofounder of Proteostasis Therapeutics, Inc. and declares no financial interest related to this work.	AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Burglin TR, 2002, INT J DEV BIOL, V46, P115; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; COPELAND JM, 2009, CURRENT BIOL; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Gems David, 2008, P81, DOI 10.1007/978-1-59745-420-9_6; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kirchman PA, 1999, GENETICS, V152, P179; LAPOINTE J, 2009, J BIOL CHEM, pM109; LARSEN PL, 1995, GENETICS, V139, P1567; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Liu XF, 2005, FASEB J, V19, pA1391; MADURO M, 1995, GENETICS, V141, P977; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; Nonet ML, 1997, J NEUROSCI, V17, P8061; OKKEMA PG, 1993, GENETICS, V135, P385; PEARL R, 2007, GENE, V400, P166; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubner M, 1908, PROBLEM LEBENSDAUER; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; VANRAAMSDONK JM, 2009, PLOS GENET, P5; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	54	681	693	4	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					79	91		10.1016/j.cell.2010.12.016	http://dx.doi.org/10.1016/j.cell.2010.12.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215371	Bronze, Green Accepted			2022-12-01	WOS:000285993600009
J	Kruta, I; Landman, N; Rouget, I; Cecca, F; Tafforeau, P				Kruta, Isabelle; Landman, Neil; Rouget, Isabelle; Cecca, Fabrizio; Tafforeau, Paul			The Role of Ammonites in the Mesozoic Marine Food Web Revealed by Jaw Preservation	SCIENCE			English	Article							ZOOPLANKTON; CEPHALOPODA; BEHAVIOR	Ammonites are prominent in macroevolutionary studies because of their abundance and diversity in the fossil record, but their paleobiology and position in the marine food web are not well understood due to the lack of preserved soft tissue. We present three-dimensional reconstructions of the buccal apparatus in the Mesozoic ammonite Baculites with the use of synchrotron x-ray microtomography. Buccal mass morphology, combined with the coexistence of food remains found in the buccal mass, suggests that these ammonites fed on plankton. This diet may have extended to all aptychophoran ammonites, which share the same buccal mass morphology. Understanding the role of these ammonites in the Mesozoic food web provides insights into their radiation in the Early Jurassic, as well as their extinction at the end of the Cretaceous/early Paleogene.	[Kruta, Isabelle] Museum Natl Hist Nat, Dept Hist Terre, CNRS, UMR 7207, F-75231 Paris 05, France; [Landman, Neil] Amer Museum Nat Hist, Dept Paleontol Invertebrates, New York, NY 10024 USA; [Rouget, Isabelle; Cecca, Fabrizio] Univ Paris 06, CNRS, UMR 7207, F-75252 Paris 05, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; American Museum of Natural History (AMNH); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; European Synchrotron Radiation Facility (ESRF)	Kruta, I (corresponding author), Museum Natl Hist Nat, Dept Hist Terre, CNRS, UMR 7207, 47 Rue Cuvier, F-75231 Paris 05, France.	kruta@mnhn.fr		Tafforeau, Paul/0000-0002-5962-1683	ESRF; UMR CNRS [7207]; Annette Kade Fellowship (AMNH)	ESRF; UMR CNRS(Centre National de la Recherche Scientifique (CNRS)); Annette Kade Fellowship (AMNH)	This work was supported by ESRF, UMR CNRS 7207, its 3D platform, and the Annette Kade Fellowship (AMNH). P. Janvier and C. Klug reviewed an earlier draft of the manuscript; A. Lethiers helped produce the figures and movie; N. Larson and K. Cochran helped in field work; and D. Defaye, N. Bruce, R. Feldmann, and K. Bandel helped in the identification of non-ammonite material. Data are available at the ESRF database http://paleo.esrf.eu.	ALLDREDGE AL, 1985, MAR BIOL, V84, P253, DOI 10.1007/BF00392494; Arkell W. J., 1957, MOLLUSCA, pL80; CASTRO JJ, 1995, SCI MAR, V59, P347; Cecca F, 1997, CR ACAD SCI II A, V325, P629, DOI 10.1016/S1251-8050(97)89465-7; Doguzhaeva Larisa A., 1992, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V223, P167; Engeser T, 2002, LETHAIA, V35, P79, DOI 10.1080/002411602317345894; Huber BT, 2002, GEOL SOC AM SPEC PAP, V356, P277; Jacobs D. K., 1996, AMMONOID PALEOBIOLOG, P169; JACOBS DK, 1993, LETHAIA, V26, P101, DOI 10.1111/j.1502-3931.1993.tb01799.x; Jager M, 1997, PALAEONTOLOGY, V40, P557; Kennedy William J., 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P113; Korn D, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P57, DOI 10.1007/978-1-4020-6806-5_3; Lalli C.M., 1989, PELAGIC SNAILS BIOL; Landman NH, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P257, DOI 10.1007/978-1-4020-6806-5_13; Lehmann U, 1981, AMMONITES THEIR LIFE; Machalski M, 2005, B GEOL SOC DENMARK, V52, P97; MILLER AK, 1949, EVOLUTION, V3, P231, DOI 10.2307/2405560; NIXON M, 1995, J ZOOL, V236, P73, DOI 10.1111/j.1469-7998.1995.tb01785.x; Nixon M., 2003, BRAINS LIVES CEPHALO; Owen G., 1966, PHYSL MOLLUSCA, V2, P1; Rigby S, 2000, ANNU REV ECOL SYST, V31, P293, DOI 10.1146/annurev.ecolsys.31.1.293; Runham N. W., 1997, Scientia Marina, V61, P67; Tanabe Kazushige, 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P157; Tanabe Kazushige, 1999, P245; Thore S., 1949, Dana Reports, VNo. 33, P1; Ward P. D., 1987, NATURAL HIST NAUTILU; Westermann GEG, 1996, AMMONOID PALEOBIOLOG, P607; Wright C. W., 1996, TREATISE INVERTEBR L, P1	28	116	122	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					70	72		10.1126/science.1198793	http://dx.doi.org/10.1126/science.1198793			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212354				2022-12-01	WOS:000285974000037
J	Petherick, A				Petherick, Anna			Mother's milk: A rich opportunity	NATURE			English	Editorial Material							LARGE RANDOMIZED-TRIAL											Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010; Koletzko B, 2009, ADV EXP MED BIOL, V646, P15, DOI 10.1007/978-1-4020-9173-5_2; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; KRAMER MS, 2007, BRIT MED J; LEFEVRE CM, 2010, GENOMICS HUMAN GENET, V11, P219; Powe CE, 2010, AM J HUM BIOL, V22, P50, DOI 10.1002/ajhb.20941; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sullivan EC, 2011, DEV PSYCHOBIOL, V53, P96, DOI 10.1002/dev.20483; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05	11	62	69	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S5	S7		10.1038/468S5a	http://dx.doi.org/10.1038/468S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179083	Bronze			2022-12-01	WOS:000285553800002
J	Sacco, A; Mourkioti, F; Tran, R; Choi, J; Llewellyn, M; Kraft, P; Shkreli, M; Delp, S; Pomerantz, JH; Artandi, SE; Blau, HM				Sacco, Alessandra; Mourkioti, Foteini; Tran, Rose; Choi, Jinkuk; Llewellyn, Michael; Kraft, Peggy; Shkreli, Marina; Delp, Scott; Pomerantz, Jason H.; Artandi, Steven E.; Blau, Helen M.			Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice	CELL			English	Article							MEDIATED GENE-THERAPY; SKELETAL-MUSCLE REGENERATION; REPLICATIVE LIFE-SPAN; SELF-RENEWAL; HUMAN LIVER; SPINAL DEFORMITY; SATELLITE CELLS; MITOTIC CLOCK; MOUSE; MDX	In Duchenne muscular dystrophy (DMD), dystrophin mutation leads to progressive lethal skeletal muscle degeneration. For unknown reasons, dystrophin deficiency does not recapitulate DMD in mice (mdx), which have mild skeletal muscle defects and potent regenerative capacity. We postulated that human DMD progression is a consequence of loss of functional muscle stem cells (MuSC), and the mild mouse mdx phenotype results from greater MuSC reserve fueled by longer telomeres. We report that mdx mice lacking the RNA component of telomerase (mdx/mTR) have shortened telomeres in muscle cells and severe muscular dystrophy that progressively worsens with age. Muscle wasting severity parallels a decline in MuSC regenerative capacity and is ameliorated histologically by transplantation of wild-type MuSC. These data show that DMD progression results, in part, from a cell-autonomous failure of MuSC to maintain the damage-repair cycle initiated by dystrophin deficiency. The essential role of MuSC function has therapeutic implications for DMD.	[Sacco, Alessandra; Mourkioti, Foteini; Tran, Rose; Kraft, Peggy; Pomerantz, Jason H.; Blau, Helen M.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med,Sch Med, Stanford, CA 94305 USA; [Choi, Jinkuk; Shkreli, Marina; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Canc Biol Program, Stanford, CA 94305 USA; [Llewellyn, Michael; Delp, Scott] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, BioX Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pomerantz, JH (corresponding author), Univ Calif San Francisco, Div Plast & Reconstruct Surg, Craniofacial & Mesenchymal Biol Program, Eli & Edythe Broad Ctr Regenerat Med,Dept Surg, San Francisco, CA 94143 USA.	jason.pomerantz@ucsfmedctr.org; hblau2@stanford.edu		Choi, Jinkuk/0000-0002-2449-8291; Delp, Scott/0000-0002-9643-7551; Mourkioti, Foteini/0000-0002-7119-6640	American Heart Association [10SDG3510024]; NIH [AG009521, AG020961]; Muscular Dystrophy Association [4320]; Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009521, R37AG009521, R01AG020961] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Kassie Koleckar for excellent technical support; Fabio Rossi for providing the alpha 7-integrin-PE-conjugated antibody; Jackie Kustan for help with the scheme; and Frezghi Habte at the Stanford Small Imaging Facility for help with the CT-Scan. This work was supported by American Heart Association Scientist Development Grant 10SDG3510024 to F. M.; NIH grants AG009521 and AG020961; Muscular Dystrophy Association grant 4320; and the Baxter Foundation to H.M.B.	Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HARRIS JB, 1981, TOXICON, V19, P419, DOI 10.1016/0041-0101(81)90046-5; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; ODA T, 1993, J PEDIATR ORTHOPED, V13, P478, DOI 10.1097/01241398-199307000-00012; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Renault V, 2002, EXP GERONTOL, V37, P1513, DOI 10.1016/S0531-5565(02)00095-5; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533; VAZIRI H, 1993, AM J HUM GENET, V52, P661; WEBSTER C, 1986, HUM GENET, V74, P74; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Westerman KA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-96; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; WILKINS KE, 1976, J BONE JOINT SURG AM, V58, P24, DOI 10.2106/00004623-197658010-00004; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; ZATZ M, 1991, J NEUROL SCI, V102, P190, DOI 10.1016/0022-510X(91)90068-I	57	337	347	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1059	1071		10.1016/j.cell.2010.11.039	http://dx.doi.org/10.1016/j.cell.2010.11.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21145579	Green Accepted, Bronze			2022-12-01	WOS:000285625400005
J	Sillanpaa, M; Shinnar, S				Sillanpaa, Matti; Shinnar, Shlomo			Long-Term Mortality in Childhood-Onset Epilepsy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUDDEN UNEXPECTED DEATH; UNEXPLAINED DEATH; RISK-FACTORS; CHILDREN; SEIZURE; PROGNOSIS; COHORT; TERMINOLOGY; DUTCH	Background: There are few studies on long-term mortality in prospectively followed, well-characterized cohorts of children with epilepsy. We report on long-term mortality in a Finnish cohort of subjects with a diagnosis of epilepsy in childhood. Methods: We assessed seizure outcomes and mortality in a population-based cohort of 245 children with a diagnosis of epilepsy in 1964; this cohort was prospectively followed for 40 years. Rates of sudden, unexplained death were estimated. The very high autopsy rate in the cohort allowed for a specific diagnosis in almost all subjects. Results: Sixty subjects died (24%); this rate is three times as high as the expected age- and sex-adjusted mortality in the general population. The subjects who died included 51 of 107 subjects (48%) who were not in 5-year terminal remission (i.e., greater/equal 5 years seizure-free at the time of death or last follow-up). A remote symptomatic cause of epilepsy (i.e., a major neurologic impairment or insult) was also associated with an increased risk of death as compared with an idiopathic or cryptogenic cause (37% vs. 12%, P<0.001). Of the 60 deaths, 33 (55%) were related to epilepsy, including sudden, unexplained death in 18 subjects (30%), definite or probable seizure in 9 (15%), and accidental drowning in 6 (10%). The deaths that were not related to epilepsy occurred primarily in subjects with remote symptomatic epilepsy. The cumulative risk of sudden, unexplained death was 7% at 40 years overall and 12% in an analysis that was limited to subjects who were not in long-term remission and not receiving medication. Among subjects with idiopathic or cryptogenic epilepsy, there were no sudden, unexplained deaths in subjects younger than 14 years of age. Conclusions: Childhood-onset epilepsy was associated with a substantial risk of epilepsy-related death, including sudden, unexplained death. The risk was especially high among children who were not in remission. (Funded by the Finnish Epilepsy Research Foundation.) N Engl J Med 2010;363:2522-9.	[Shinnar, Shlomo] Albert Einstein Coll Med, Montefiore Med Ctr, Comprehens Epilepsy Management Ctr, Bronx, NY 10467 USA; [Sillanpaa, Matti] Univ Turku, Dept Pediat Neurol, Turku, Finland; [Sillanpaa, Matti] Univ Turku, Dept Publ Hlth, Turku, Finland; [Sillanpaa, Matti] Turku Univ Hosp, FIN-20520 Turku, Finland; [Shinnar, Shlomo] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Neurol Pediat & Epidemiol, Bronx, NY 10467 USA; [Shinnar, Shlomo] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Turku; University of Turku; University of Turku; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Shinnar, S (corresponding author), Albert Einstein Coll Med, Montefiore Med Ctr, Comprehens Epilepsy Management Ctr, 111 E 210th St, Bronx, NY 10467 USA.	sshinnar@montefiore.org	Sillanpaa, Matti L/G-4708-2015	Sillanpaa, Matti L/0000-0003-4190-3698; Sillanpaa, Matti/0000-0002-1521-3602	Finnish Epilepsy Research Foundation	Finnish Epilepsy Research Foundation	Supported by a grant from the Finnish Epilepsy Research Foundation.	Annegers JF, 1997, EPILEPSIA, V38, pS9, DOI 10.1111/j.1528-1157.1997.tb06137.x; [Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berg AT, 2004, ARCH PEDIAT ADOL MED, V158, P1147, DOI 10.1001/archpedi.158.12.1147; BRORSON LO, 1987, EPILEPSIA, V28, P324, DOI 10.1111/j.1528-1157.1987.tb03651.x; Callenbach PMC, 2001, PEDIATRICS, V107, P1259, DOI 10.1542/peds.107.6.1259; Camfield CS, 2002, LANCET, V359, P1891, DOI 10.1016/S0140-6736(02)08779-2; Central Statistical Office of Finland, 2003, STAT YB FINL; Cockerell OC, 1997, EPILEPSIA, V38, P31, DOI 10.1111/j.1528-1157.1997.tb01075.x; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; COX DR, 1972, J R STAT SOC B, V34, P187; Derby LE, 1996, EPILEPSIA, V37, P931, DOI 10.1111/j.1528-1157.1996.tb00529.x; Donner EJ, 2001, NEUROLOGY, V57, P430, DOI 10.1212/WNL.57.3.430; Elandt-Johnson RC, 1980, SURVIVAL MODELS DATA, P150; Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270; Fleiss J, 2003, STAT METHODS RATES P, P638; Foreman AJ, 2003, SAS STAT USERS GUIDE; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Lhatoo SD, 2001, ANN NEUROL, V49, P336; NASHEF L, 1995, EPILEPSIA, V36, P1187, DOI 10.1111/j.1528-1157.1995.tb01061.x; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Shackleton DP, 1999, J NEUROL NEUROSUR PS, V66, P636, DOI 10.1136/jnnp.66.5.636; Shinnar S, 2005, NEUROLOGY, V64, P880, DOI 10.1212/01.WNL.0000152893.72146.92; Sillanpaa M, 1999, PEDIATR NEUROL, V21, P533, DOI 10.1016/S0887-8994(99)00031-4; Sillanpaa M, 2002, ANN NEUROL, V52, P303, DOI 10.1002/ana.10286; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; TENNIS P, 1995, EPILEPSIA, V36, P29, DOI 10.1111/j.1528-1157.1995.tb01661.x; Tomson T, 2005, EPILEPSIA, V46, P54, DOI 10.1111/j.1528-1167.2005.00411.x; Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519; ZIELINSKI JJ, 1974, EPILEPSIA, V15, P191, DOI 10.1111/j.1528-1157.1974.tb04941.x	36	248	253	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2522	2529		10.1056/NEJMoa0911610	http://dx.doi.org/10.1056/NEJMoa0911610			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21175314				2022-12-01	WOS:000285555600007
J	Taelman, VF; Dobrowolski, R; Plouhinec, JL; Fuentealba, LC; Vorwald, PP; Gumper, I; Sabatini, DD; De Robertis, EM				Taelman, Vincent F.; Dobrowolski, Radoslaw; Plouhinec, Jean-Louis; Fuentealba, Luis C.; Vorwald, Peggy P.; Gumper, Iwona; Sabatini, David D.; De Robertis, Edward M.			Wnt Signaling Requires Sequestration of Glycogen Synthase Kinase 3 inside Multivesicular Endosomes	CELL			English	Article							ENDOCYTIC TRAFFICKING; DESTRUCTION COMPLEX; BODY BIOGENESIS; RECEPTOR; LRP6; WINGLESS; INTERNALIZATION; MECHANISM; PATHWAY; TARGETS	Canonical Wnt signaling requires inhibition of Glycogen Synthase Kinase 3 (GSK3) activity, but the molecular mechanism by which this is achieved remains unclear. Here, we report that Wnt signaling triggers the sequestration of GSK3 from the cytosol into multivesicular bodies (MVBs), so that this enzyme becomes separated from its many cytosolic substrates. Endocytosed Wnt colocalized with GSK3 in acidic vesicles positive for endosomal markers. After Wnt addition, endogenous GSK3 activity decreased in the cytosol, and GSK3 became protected from protease treatment inside membrane-bounded organelles. Cryoimmunoelectron microscopy showed that these corresponded to MVBs. Two proteins essential for MVB formation, HRS/Vps27 and Vps4, were required for Wnt signaling. The sequestration of GSK3 extended the half-life of many other proteins in addition to beta-Catenin, including an artificial Wnt-regulated reporter protein containing GSK3 phosphorylation sites. We conclude that multivesicular endosomes are essential components of the Wnt signal-transduction pathway.	[Taelman, Vincent F.; Dobrowolski, Radoslaw; Plouhinec, Jean-Louis; Fuentealba, Luis C.; Vorwald, Peggy P.; De Robertis, Edward M.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Taelman, Vincent F.; Dobrowolski, Radoslaw; Plouhinec, Jean-Louis; Fuentealba, Luis C.; Vorwald, Peggy P.; De Robertis, Edward M.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Gumper, Iwona; Sabatini, David D.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		Dobrowolski, Radek/0000-0002-1805-5806; De Robertis, Edward/0000-0002-7843-1869	Deutsche Forschungsgemeinschaft [DO1429/1-1]; NIH [HD21502-24]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502, R01HD021502] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Drs. R. Moon for beta-Catenin-GFP and SuperTopFlash reporter, X. He for CA-LRP6, B. van Deurs for dog Rab7-GFP, S. Sokol for Myc-xDvl, M. Bienz for DIX > Ctail-GFP, M. Taira for xWnt8-Venus, P. Woodman for Vps4-EQ-GFP, R. Pagano for Rab5-DsRed-WT, P. De Camilli for DN-Dynamin-GFP, H. Stenmark for FYVE-GFP, H. Clevers for DN-xTcf3, O. Wessely for beta-Catenin-DN-xTcf3, P. Lemaire for Siamois, and R. Nusse for Wnt3a-producing L cells. We thank three anonymous referees and members of our laboratories for improving the manuscript, H. Snitkin for her help in processing cultured cells for electron microscopy, U. Lendahl for suggesting the HRS depletion experiments, the Deutsche Forschungsgemeinschaft for supporting R. D. (DO1429/1-1), and the NIH (HD21502-24) for funding. E. M. D. R. is an Investigator of the Howard Hughes Medical Institute.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; DUNN LA, 1983, J BIOL CHEM, V258, P4989; Falguieres T, 2009, EXP CELL RES, V315, P1567, DOI 10.1016/j.yexcr.2008.12.006; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MCKANNA JA, 1979, P NATL ACAD SCI USA, V76, P5689, DOI 10.1073/pnas.76.11.5689; Metcalfe C, 2010, J CELL SCI, V123, P1588, DOI 10.1242/jcs.067546; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Ryves WJ, 1998, ANAL BIOCHEM, V264, P124, DOI 10.1006/abio.1998.2832; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	42	496	503	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1136	1148		10.1016/j.cell.2010.11.034	http://dx.doi.org/10.1016/j.cell.2010.11.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183076	Green Accepted, Bronze			2022-12-01	WOS:000285625400011
J	Gharbi-Ayachi, A; Labbe, JC; Burgess, A; Vigneron, S; Strub, JM; Brioudes, E; Van-Dorsselaer, A; Castro, A; Lorca, T				Gharbi-Ayachi, Aicha; Labbe, Jean-Claude; Burgess, Andrew; Vigneron, Suzanne; Strub, Jean-Marc; Brioudes, Estelle; Van-Dorsselaer, Alain; Castro, Anna; Lorca, Thierry			The Substrate of Greatwall Kinase, Arpp19, Controls Mitosis by Inhibiting Protein Phosphatase 2A	SCIENCE			English	Article							ALPHA-ENDOSULFINE; ARREST; ENTRY; EXIT	Initiation and maintenance of mitosis require the activation of protein kinase cyclin B-Cdc2 and the inhibition of protein phosphatase 2A (PP2A), which, respectively, phosphorylate and dephosphorylate mitotic substrates. The protein kinase Greatwall (Gwl) is required to maintain mitosis through PP2A inhibition. We describe how Gwl activation results in PP2A inhibition. We identified cyclic adenosine monophosphate-regulated phosphoprotein 19 (Arpp19) and alpha-Endosulfine as two substrates of Gwl that, when phosphorylated by this kinase, associate with and inhibit PP2A, thus promoting mitotic entry. Conversely, in the absence of Gwl activity, Arpp19 and alpha-Endosulfine are dephosphorylated and lose their capacity to bind and inhibit PP2A. Although both proteins can inhibit PP2A, endogenous Arpp19, but not alpha-Endosulfine, is responsible for PP2A inhibition at mitotic entry in Xenopus egg extracts.	[Gharbi-Ayachi, Aicha; Labbe, Jean-Claude; Burgess, Andrew; Vigneron, Suzanne; Brioudes, Estelle; Castro, Anna; Lorca, Thierry] Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS,UMR 5237, F-34293 Montpellier 5, France; [Gharbi-Ayachi, Aicha; Labbe, Jean-Claude; Burgess, Andrew; Vigneron, Suzanne; Brioudes, Estelle; Castro, Anna; Lorca, Thierry] Univ Montpellier 1, Ctr Rech Biochim Macromol, IFR 122, CNRS,UMR 5237, F-34293 Montpellier 5, France; [Strub, Jean-Marc; Van-Dorsselaer, Alain] Inst Pluridisciplinaire Hubert Curien, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Castro, A (corresponding author), Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS,UMR 5237, 1919 Route Mende, F-34293 Montpellier 5, France.	anna.castro@crbm.cnrs.fr; thierry.lorca@crbm.cnrs.fr	Burgess, Andrew/H-3339-2019; labbe, jean-claude/B-2277-2009; CASTRO, ANNA/F-4350-2010; Burgess, Andrew/C-7952-2009; Gharbi, Aicha/C-5521-2011	Burgess, Andrew/0000-0003-4536-9226; CASTRO, ANNA/0000-0002-3655-1352; Burgess, Andrew/0000-0003-4536-9226; Lorca, Thierry/0000-0003-2007-8924; Strub, Jean-Marc/0000-0001-6224-3428	Ligue Regionale Contre le Cancer (Comite du Gard); Association pour la Recherche sur le Cancer	Ligue Regionale Contre le Cancer (Comite du Gard); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank L. Gros and A. Virsolvy for providing the pBKS-Arpp19, pBKS-alpha-Endosulfine constructs, and antibodies to human alpha-Endosulfine and T. Hunt and S. Mochida for the antibody to phosphoS67/62 Endo-Arp. This work was supported by the Ligue Regionale Contre le Cancer (Comite du Gard) and the "Association pour la Recherche sur le Cancer". A. B. and E. B. are "Fondation pour la Recherche Medicale" and "Ligue Nationale Contre le Cancer" fellows, respectively. There is a patent pending that pertains to results presented in this paper.	Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Bataille D, 1999, CELL MOL LIFE SCI, V56, P78, DOI 10.1007/s000180050008; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Gros L, 2002, DIABETOLOGIA, V45, P703, DOI 10.1007/s00125-002-0794-9; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Lorca T, 2010, J CELL SCI, V123, P2281, DOI 10.1242/jcs.064527; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Von Stetina JR, 2008, DEVELOPMENT, V135, P3697, DOI 10.1242/dev.025114; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871	11	299	308	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1673	1677		10.1126/science.1197048	http://dx.doi.org/10.1126/science.1197048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164014	Green Published			2022-12-01	WOS:000285390500066
J	Halpern, SD; Barnes, B; Hasz, RD; Abt, PL				Halpern, Scott D.; Barnes, Barbara; Hasz, Richard D.; Abt, Peter L.			Estimated Supply of Organ Donors After Circulatory Determination of Death: A Population-Based Cohort Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CARDIAC DEATH; TRANSPLANTATION; DONATION		[Halpern, Scott D.] Univ Penn, Sch Med, Div Pulm & Crit Care Med, Philadelphia, PA 19104 USA; [Barnes, Barbara; Hasz, Richard D.] Gift Life Donor Program, Philadelphia, PA USA; [Abt, Peter L.] Univ Penn, Sch Med, Div Transplant Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Sch Med, Div Pulm & Crit Care Med, Philadelphia, PA 19104 USA.	shalpern@exchange.upenn.edu	Abt, Peter/AAD-6856-2019		AHRQ HHS [K08 HS018406, K08HS018406] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018406] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Campbell GMD, 1999, CAN MED ASSOC J, V160, P1573; Durall AL, 2007, PEDIATRICS, V119, pE219, DOI 10.1542/peds.2006-0375; Childress James F., 2006, ORG DON OPP ACT; Koogler T, 1998, PEDIATRICS, V101, P1049, DOI 10.1542/peds.101.6.1049; Lacroix JD, 2004, CAN J SURG, V47, P10; Reich DJ, 2009, AM J TRANSPLANT, V9, P2004, DOI 10.1111/j.1600-6143.2009.02739.x	6	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2592	2594		10.1001/jama.2010.1824	http://dx.doi.org/10.1001/jama.2010.1824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156947	Bronze			2022-12-01	WOS:000285303400021
J	Harris, JB; LaRocque, RC; Charles, RC; Mazumder, RN; Khan, AI; Bardhan, PK				Harris, Jason B.; LaRocque, Regina C.; Charles, Richelle C.; Mazumder, Ramendra N.; Khan, Azharul I.; Bardhan, Pradip K.			Cholera's western front	LANCET			English	Editorial Material							TETRACYCLINE; VACCINES		[Harris, Jason B.; LaRocque, Regina C.; Charles, Richelle C.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Harris, Jason B.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [LaRocque, Regina C.; Charles, Richelle C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Mazumder, Ramendra N.; Khan, Azharul I.; Bardhan, Pradip K.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; International Centre for Diarrhoeal Disease Research (ICDDR)	Harris, JB (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	jbharris@partners.org	Charles, Richelle/W-4342-2019; Harris, Jason/ABF-2684-2020	Charles, Richelle/0000-0002-8881-1849; Harris, Jason/0000-0003-3642-5126	FIC NIH HHS [K01 TW007409] Funding Source: Medline; NIAID NIH HHS [K08 AI089721] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [K01TW007409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089721] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1473; [Anonymous], 2005, TREATM DIARRH MAN PH; Hossain MS, 2002, J HEALTH POPUL NUTR, V20, P18; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; *PAN AM HLTH ORG, 2010, EP AL UPD SIT HAIT; RABBANI GH, 1989, ANTIMICROB AGENTS CH, V33, P1447, DOI 10.1128/AAC.33.9.1447; Ryan ET, 2000, AM J TROP MED HYG, V63, P12, DOI 10.4269/ajtmh.2000.63.12; Sack DA, 2006, NEW ENGL J MED, V355, P649, DOI 10.1056/NEJMp068144; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; *VACC RES LIB, 2010, CHOL OUTBR TRAIN SHI; *WHO, 2004, 1 STEPS MAN OUTBR AC; WHO U., 2010, PROGR SAN DRINK WAT; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P117; World Health Organization, 2010, WORLD HLTH STAT 2010	15	36	39	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					1961	1965		10.1016/S0140-6736(10)62172-1	http://dx.doi.org/10.1016/S0140-6736(10)62172-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	701GZ	21112083	Green Accepted			2022-12-01	WOS:000285807700004
J	Canfield, DE; Stewart, FJ; Thamdrup, B; De Brabandere, L; Dalsgaard, T; Delong, EF; Revsbech, NP; Ulloa, O				Canfield, Don E.; Stewart, Frank J.; Thamdrup, Bo; De Brabandere, Loreto; Dalsgaard, Tage; Delong, Edward F.; Revsbech, Niels Peter; Ulloa, Osvaldo			A Cryptic Sulfur Cycle in Oxygen-Minimum-Zone Waters off the Chilean Coast	SCIENCE			English	Article							NITRATE REDUCTION; SULFATE-REDUCTION; MOLECULAR ANALYSIS; HYDROGEN-SULFIDE; PROKARYOTES; PHYLOGENY; DIVERSITY; OXIDATION; SEDIMENTS; SYMBIONT	Nitrogen cycling is normally thought to dominate the biogeochemistry and microbial ecology of oxygen-minimum zones in marine environments. Through a combination of molecular techniques and process rate measurements, we showed that both sulfate reduction and sulfide oxidation contribute to energy flux and elemental cycling in oxygen-free waters off the coast of northern Chile. These processes may have been overlooked because in nature, the sulfide produced by sulfate reduction immediately oxidizes back to sulfate. This cryptic sulfur cycle is linked to anammox and other nitrogen cycling processes, suggesting that it may influence biogeochemical cycling in the global ocean.	[Canfield, Don E.; Thamdrup, Bo; De Brabandere, Loreto] Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; [Canfield, Don E.; Thamdrup, Bo; De Brabandere, Loreto] Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark; [Stewart, Frank J.; Delong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02138 USA; [Stewart, Frank J.; Delong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02138 USA; [Dalsgaard, Tage] Aarhus Univ, Natl Environm Res Inst, DK-8600 Silkeborg, Denmark; [Revsbech, Niels Peter] Aarhus Univ, Dept Biol Sci, Microbiol Sect, DK-8000 Aarhus C, Denmark; [Ulloa, Osvaldo] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Ulloa, Osvaldo] Univ Concepcion, Ctr Invest Oceanog Pacifico Sur Oriental, Concepcion, Chile	University of Southern Denmark; University of Southern Denmark; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Aarhus University; Aarhus University; Universidad de Concepcion; Universidad de Concepcion	Canfield, DE (corresponding author), Univ So Denmark, Inst Biol, Campusvej 55, DK-5230 Odense M, Denmark.	dec@biology.sdu.dk	Dalsgaard, Tage/J-6258-2014; Revsbech, Niels P/I-8040-2013; Ulloa, Osvaldo/E-1821-2011; Thamdrup, Bo/F-3889-2016; Canfield, Don/C-1735-2012; De Brabandere, Loreto C/A-8134-2014	Dalsgaard, Tage/0000-0003-2604-6499; Ulloa, Osvaldo/0000-0002-9501-5576; Thamdrup, Bo/0000-0002-1221-7077; Canfield, Don/0000-0001-7602-8366; Revsbech, Niels Peter/0000-0002-2193-262X	Agouron Institute; Danish National Research Foundation; Gordon and Betty Moore Foundation; Chilean Fondap Program	Agouron Institute(Pfizer); Danish National Research Foundation(Danmarks Grundforskningsfond); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Chilean Fondap Program(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	We thank the captain and crew of the Agor Vidal Gormaz from the Chilean Navy for their kind support, and the Agouron Institute, the Danish National Research Foundation, the Gordon and Betty Moore Foundation, and the Chilean Fondap Program for financial support. Additional thanks to G. Alarcon, G. Friederich, and J. Jennings for operational and experimental support. The genome sequence data are accessible on NCBI's Sequence Read Archive via accession number SRA025088.	ALBERT DB, 1995, DEEP-SEA RES PT I, V42, P1239, DOI 10.1016/0967-0637(95)00042-5; Bruchert V, 2003, GEOCHIM COSMOCHIM AC, V67, P4505, DOI 10.1016/S0016-7037(03)00275-8; Bulow SE, 2010, DEEP-SEA RES PT I, V57, P384, DOI 10.1016/j.dsr.2009.10.014; CALVERT SE, 1971, DEEP-SEA RES, V18, P505, DOI 10.1016/0011-7471(71)90074-X; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; DALSGAARD T, 1994, APPL ENVIRON MICROB, V60, P291, DOI 10.1128/AEM.60.1.291-297.1994; DUGDALE RC, 1977, DEEP-SEA RES, V24, P601, DOI 10.1016/0146-6291(77)90530-6; Escribano R, 2004, DEEP-SEA RES PT II, V51, P2389, DOI 10.1016/j.dsr2.2004.08.011; Finster KW, 2010, ANTON LEEUW INT J G, V97, P221, DOI 10.1007/s10482-009-9403-y; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grimm F, 2008, MICROBIAL SULFUR METABOLISM, P101, DOI 10.1007/978-3-540-72682-1_9; Jensen MM, 2009, MAR CHEM, V113, P102, DOI 10.1016/j.marchem.2009.01.002; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Lavin P, 2010, ENV MICROBIOL REP, V2, P728, DOI 10.1111/j.1758-2229.2010.00167.x; MCCREADY RGL, 1983, ARCH MICROBIOL, V135, P182, DOI 10.1007/BF00414476; Meyer B, 2007, APPL ENVIRON MICROB, V73, P7664, DOI 10.1128/AEM.01272-07; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Meyer B, 2007, MICROBIOL-SGM, V153, P2026, DOI 10.1099/mic.0.2006/003152-0; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; OLSON DB, 1993, DEEP-SEA RES PT II, V40, P673, DOI 10.1016/0967-0645(93)90051-N; Redfield AC., 1963, SEA, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Stevens H, 2008, ENVIRON MICROBIOL, V10, P1244, DOI 10.1111/j.1462-2920.2007.01539.x; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; WYRTKI K, 1962, DEEP-SEA RES, V9, P11, DOI 10.1016/0011-7471(62)90243-7	30	411	423	11	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1375	1378		10.1126/science.1196889	http://dx.doi.org/10.1126/science.1196889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21071631	Green Published			2022-12-01	WOS:000284902100041
J	Dehaene, S; Pegado, F; Braga, LW; Ventura, P; Nunes, G; Jobert, A; Dehaene-Lambertz, G; Kolinsky, R; Morais, J; Cohen, L				Dehaene, Stanislas; Pegado, Felipe; Braga, Lucia W.; Ventura, Paulo; Nunes Filho, Gilberto; Jobert, Antoinette; Dehaene-Lambertz, Ghislaine; Kolinsky, Regine; Morais, Jose; Cohen, Laurent			How Learning to Read Changes the Cortical Networks for Vision and Language	SCIENCE			English	Article							CHILDREN LEARN; VISUAL-CORTEX; SPEECH SOUNDS; BRAIN; RECOGNITION; LITERACY; REORGANIZATION; ACTIVATION; REGIONS; WRITE	Does literacy improve brain function? Does it also entail losses? Using functional magnetic resonance imaging, we measured brain responses to spoken and written language, visual faces, houses, tools, and checkers in adults of variable literacy (10 were illiterate, 22 became literate as adults, and 31 were literate in childhood). As literacy enhanced the left fusiform activation evoked by writing, it induced a small competition with faces at this location, but also broadly enhanced visual responses in fusiform and occipital cortex, extending to area V1. Literacy also enhanced phonological activation to speech in the planum temporale and afforded a top-down activation of orthography from spoken inputs. Most changes occurred even when literacy was acquired in adulthood, emphasizing that both childhood and adult education can profoundly refine cortical organization.	[Dehaene, Stanislas; Pegado, Felipe; Jobert, Antoinette; Dehaene-Lambertz, Ghislaine] INSERM, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas; Pegado, Felipe; Jobert, Antoinette; Dehaene-Lambertz, Ghislaine] CEA, Direct Sci Vivant, I2BM, Neurospin Ctr, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas; Pegado, Felipe; Jobert, Antoinette; Dehaene-Lambertz, Ghislaine] Univ Paris 11, F-91405 Orsay, France; [Dehaene, Stanislas] Coll France, F-75005 Paris, France; [Braga, Lucia W.; Nunes Filho, Gilberto] Int Ctr Neurosci & Rehabil, SARAH Network, BR-71535005 Brasilia, DF, Brazil; [Ventura, Paulo] Univ Lisbon, Fac Psychol, P-1600214 Lisbon, Portugal; [Kolinsky, Regine; Morais, Jose] Univ Libre Bruxelles, Fac Psychol, B-1050 Brussels, Belgium; [Kolinsky, Regine] Fonds Rech Sci FNRS, B-1000 Brussels, Belgium; [Cohen, Laurent] Univ Paris 06, Fac Med Pitie Salpetriere, F-75013 Paris, France; [Cohen, Laurent] Grp Hosp Pitie Salpetriere, AP HP, Dept ofNeurol, F-75651 Paris, France; [Cohen, Laurent] INSERM, Inst Cerveau & Moelle Epiniere, Ctr Rech, UMRS 975, Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; Universidade de Lisboa; Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Dehaene, S (corresponding author), INSERM, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France.	stanislas.dehaene@gmail.com	Ventura, Paulo/D-8585-2013; Dehaene, Ghislaine/O-3633-2017; Nunes Filho, Gilberto/J-1535-2012; Braga, Lucia/AAQ-1030-2020	Dehaene, Ghislaine/0000-0003-2221-9081; Ventura, Paulo/0000-0003-0150-6268; Pegado, Felipe/0000-0001-9203-8687; Ventura, Paulo/0000-0002-4059-4419; cohen, laurent/0000-0002-5010-9085	Institut National de la Sante et de la Recherche Medicale (INSERM); Commissariat a l'Energie Atomique (CEA); College de France; Agence Nationale de la Recherche; Fundacao para a Ciencia e a Tecnologia; European Community [PTDC/PSI/66077/2006]; SARAH Network of Rehabilitation Hospitals; Belgian French community [2.4586.07, 06/11-342]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission); College de France; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission); SARAH Network of Rehabilitation Hospitals; Belgian French community	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Commissariat a l'Energie Atomique (CEA), College de France, Agence Nationale de la Recherche (project CORELEX), Fundacao para a Ciencia e a Tecnologia, the European Community FEDER funding (Project PTDC/PSI/66077/2006, "Cognitive consequences of literacy"), SARAH Network of Rehabilitation Hospitals, and by two grants from the Belgian French community (Fonds de la Recherche Fondamentale Collective 2.4586.07 and Action de Recherche Concertee 06/11-342). We gratefully acknowledge A. Amadon, M.-H. Baju, L. Labruna, D. Le Bihan, L. Hertz-Pannier, P. Pinel, and the NeuroSpin infrastructure groups at NeuroSpin; C. Carvalho, L. Querido, S. Fernandes, and T. Fernandes at the Faculty of Psychology, University of Lisbon; and D. Y. Suguieda, R. S. Vera, A. G. Tauil, E. Amemiya, L. G. N. Nunes, S. B. de Oliveira, and C. L. M. Gillis at SARAH Brasilia.	Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Blau V, 2010, BRAIN, V133, P868, DOI 10.1093/brain/awp308; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Booth JR, 2003, HUM BRAIN MAPP, V19, P155, DOI 10.1002/hbm.10111; Brem S, 2010, P NATL ACAD SCI USA, V107, P7939, DOI 10.1073/pnas.0904402107; Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461; Castro-Caldas A, 1999, EUR J NEUROL, V6, P23, DOI 10.1046/j.1468-1331.1999.610023.x; Castro-Caldas A, 1998, BRAIN, V121, P1053, DOI 10.1093/brain/121.6.1053; Cheung H, 2004, LANG COGNITIVE PROC, V19, P1, DOI 10.1080/01690960344000071; Cohen L, 2004, NEUROIMAGE, V23, P1256, DOI 10.1016/j.neuroimage.2004.07.052; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2008, NEUROIMAGE, V40, P353, DOI 10.1016/j.neuroimage.2007.11.036; Dehaene S, 2009, READING BRAIN; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Desroches AS, 2010, BRAIN RES, V1356, P73, DOI 10.1016/j.brainres.2010.07.097; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Eger E, 2005, NEUROIMAGE, V26, P1128, DOI 10.1016/j.neuroimage.2005.03.010; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; Harel A, 2010, CEREB CORTEX, V20, P2304, DOI 10.1093/cercor/bhp316; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Jacquemot C, 2003, J NEUROSCI, V23, P9541; Kherif F, 2011, CEREB CORTEX, V21, P103, DOI 10.1093/cercor/bhq063; Li G, 2006, HUM BRAIN MAPP, V27, P144, DOI 10.1002/hbm.20173; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; Maurer U, 2006, NEUROIMAGE, V33, P749, DOI 10.1016/j.neuroimage.2006.06.025; MORAIS J, 1986, COGNITION, V24, P45, DOI 10.1016/0010-0277(86)90004-1; Nazir TA, 2004, BRAIN LANG, V88, P294, DOI 10.1016/S0093-934X(03)00168-8; Perre L, 2009, BRAIN RES, V1275, P73, DOI 10.1016/j.brainres.2009.04.018; Petersson KM, 2007, EUR J NEUROSCI, V26, P791, DOI 10.1111/j.1460-9568.2007.05701.x; Petersson KM, 1999, NEUROIMAGE, V10, P45, DOI 10.1006/nimg.1999.0446; Petersson KM, 2000, J COGNITIVE NEUROSCI, V12, P364, DOI 10.1162/089892900562147; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rossion B, 2004, P NATL ACAD SCI USA, V101, P14521, DOI 10.1073/pnas.0405613101; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; Ventura P, 2007, COGNITION, V105, P547, DOI 10.1016/j.cognition.2006.12.005; Yoncheva YN, 2010, CEREB CORTEX, V20, P622, DOI 10.1093/cercor/bhp129; Ziegler JC, 2008, J EXP PSYCHOL LEARN, V34, P643, DOI 10.1037/0278-7393.34.3.643	44	744	770	11	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1359	1364		10.1126/science.1194140	http://dx.doi.org/10.1126/science.1194140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	689BK	21071632	Green Published			2022-12-01	WOS:000284902100037
J	Raveh, A; Cooper, A; Guy-David, L; Reuveny, E				Raveh, Adi; Cooper, Ayelet; Guy-David, Liora; Reuveny, Eitan			Nonenzymatic Rapid Control of GIRK Channel Function by a G Protein-Coupled Receptor Kinase	CELL			English	Article							G-BETA-GAMMA; PLECKSTRIN HOMOLOGY DOMAIN; SHORT-TERM DESENSITIZATION; K+-CURRENT; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CONFORMATIONAL REARRANGEMENTS; MUTATIONAL ANALYSIS; POTASSIUM CHANNEL; ACTIVATION; MEMBRANE	G protein-coupled receptors (GPCRs) respond to agonists to activate downstream enzymatic pathways or to gate ion channel function. Turning off GPCR signaling is known to involve phosphorylation of the GPCR by GPCR kinases (GRKs) to initiate their internalization. The process, however, is relatively slow and cannot account for the faster desensitization responses required to regulate channel gating. Here, we show that GRKs enable rapid desensitization of the G protein-coupled potassium channel (GIRK/Kir3.x) through a mechanism independent of their kinase activity. On GPCR activation, GRKs translocate to the membrane and quench channel activation by competitively binding and titrating G protein beta gamma subunits away from the channel. Of interest, the ability of GRKs to effect this rapid desensitization depends on the receptor type. The findings thus reveal a stimulus-specific, phosphorylation-independent mechanism for rapidly downregulating GPCR activity at the effector level.	[Raveh, Adi; Cooper, Ayelet; Guy-David, Liora; Reuveny, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il			Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF) [207/09]; Minerva Foundation; Human Frontier Science Program	Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation; Human Frontier Science Program(Human Frontier Science Program)	The authors like to thank Ruth Meller and Elisha Shalgi for technical help, and the Reuveny laboratory for helpful comments. We are grateful to Drs. J.L. Benovic for GRK2 and GRK6, W.C. Claycomb for HL-1 cells, D.E. Logothetis for PtdIns(4,5)P2 GIRK mutants, C. Barlot for G alpha<INF>s</INF> mutant, S. Nakanishi for the mGluR2, Z. Vogel for mu OR, and R. Tsien for mCherry cDNAs. The work was supported in part by the Josef Cohn Center for Biomembrane Research, The Israeli Science Foundation (ISF grant 207/09), The Minerva Foundation, and the Human Frontier Science Program.	Aragay AM, 1998, FEBS LETT, V430, P37, DOI 10.1016/S0014-5793(98)00495-5; Bender K, 2001, J BIOL CHEM, V276, P28873, DOI 10.1074/jbc.M102328200; Berlot CH, 2002, J BIOL CHEM, V277, P21080, DOI 10.1074/jbc.M201330200; Blanchet C, 2002, P NATL ACAD SCI USA, V99, P4674, DOI 10.1073/pnas.072075399; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cordeaux Y, 2004, BRIT J PHARMACOL, V143, P705, DOI 10.1038/sj.bjp.0705925; Dang VC, 2009, J NEUROSCI, V29, P3322, DOI 10.1523/JNEUROSCI.4749-08.2009; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Doupnik CA, 2008, J RECEPT SIG TRANSD, V28, P83, DOI [10.1080/10799890801941970, 10.1080/10799890801941970 ]; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; GARCIAHIGUERA I, 1994, J BIOL CHEM, V269, P1348; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Keselman I, 2007, CHANNELS, V1, P113, DOI 10.4161/chan.4321; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Koike-Tani M, 2005, J PHYSIOL-LONDON, V564, P489, DOI 10.1113/jphysiol.2004.079285; KONG GH, 1994, J BIOL CHEM, V269, P13084; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Li JL, 2003, J BIOL CHEM, V278, P30219, DOI 10.1074/jbc.M302385200; Lleres David, 2007, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1210s42; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Meyer T, 2001, J BIOL CHEM, V276, P5650, DOI 10.1074/jbc.M009179200; Murga C, 1998, NEUROSCIENCE, V87, P631, DOI 10.1016/S0306-4522(98)00145-6; Nikolov EN, 2004, J BIOL CHEM, V279, P23630, DOI 10.1074/jbc.M312861200; Nobles M, 2010, PFLUG ARCH EUR J PHY, V460, P99, DOI 10.1007/s00424-010-0799-z; Palczewski K, 1997, EUR J BIOCHEM, V248, P261, DOI 10.1111/j.1432-1033.1997.00261.x; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Raveh Adi, 2008, V491, P199, DOI 10.1007/978-1-59745-526-8_16; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Sadja R, 2009, CHANNELS, V3, P205, DOI 10.4161/chan.3.3.9136; Shui Z, 1998, J PHYSIOL-LONDON, V507, P325, DOI 10.1111/j.1469-7793.1998.325bt.x; Sickmann T, 2003, J NEUROPHYSIOL, V90, P2494, DOI 10.1152/jn.00112.2003; Sickmann T, 2008, NEUROSCI LETT, V436, P102, DOI 10.1016/j.neulet.2008.02.067; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; TOUHARA K, 1995, J BIOL CHEM, V270, P17000, DOI 10.1074/jbc.270.28.17000; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	63	46	47	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					750	760		10.1016/j.cell.2010.10.018	http://dx.doi.org/10.1016/j.cell.2010.10.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111235	Bronze			2022-12-01	WOS:000284583500017
J	Reid, WV; Chen, D; Goldfarb, L; Hackmann, H; Lee, YT; Mokhele, K; Ostrom, E; Raivio, K; Rockstrom, J; Schellnhuber, HJ; Whyte, A				Reid, W. V.; Chen, D.; Goldfarb, L.; Hackmann, H.; Lee, Y. T.; Mokhele, K.; Ostrom, E.; Raivio, K.; Rockstrom, J.; Schellnhuber, H. J.; Whyte, A.			Earth System Science for Global Sustainability: Grand Challenges	SCIENCE			English	Editorial Material							FRAMEWORK		[Reid, W. V.] David & Lucile Packard Fdn, Los Altos, CA 94022 USA; [Chen, D.; Goldfarb, L.; Lee, Y. T.; Raivio, K.] Int Council Sci ICSU, F-75116 Paris, France; [Hackmann, H.] Int Social Sci Council, F-75732 Paris, France; [Mokhele, K.] Natl Res Fdn S Africa, ZA-0001 Pretoria, South Africa; [Ostrom, E.] Indiana Univ, Bloomington, IN 47408 USA; [Rockstrom, J.] Stockholm Environm Inst, SE-10691 Stockholm, Sweden; [Schellnhuber, H. J.] Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; [Whyte, A.] Int Dev Res Ctr, Ottawa, ON K1G 3H9, Canada	National Research Foundation - South Africa; Indiana University System; Indiana University Bloomington; Stockholm Environment Institute; Potsdam Institut fur Klimafolgenforschung	Reid, WV (corresponding author), David & Lucile Packard Fdn, Los Altos, CA 94022 USA.	wreid@packard.org	Lee, Yuan-Tseh/F-7914-2012; Chen, Deliang/A-5107-2013; currie, morgan/G-1449-2011; Schellnhuber, Hans Joachim/O-3873-2019; Schellnhuber, Hans Joachim/B-2607-2012	Chen, Deliang/0000-0003-0288-5618; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Rockstrom, Johan/0000-0001-8988-2983				CLARK WC, 2004, EARTH SYSTEM ANAL SU, P1; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Reid WV, 2009, SCIENCE, V325, P245, DOI 10.1126/science.1178591; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Schellnhuber H. J., 2002, GLOBAL CHANGE NEWSLE, V49, P20; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Walker B, 2009, SCIENCE, V325, P1345, DOI 10.1126/science.1175325	8	343	376	9	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					916	917		10.1126/science.1196263	http://dx.doi.org/10.1126/science.1196263			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	678XY	21071651				2022-12-01	WOS:000284118000023
J	Kharchenko, PV; Alekseyenko, AA; Schwartz, YB; Minoda, A; Riddle, NC; Ernst, J; Sabo, PJ; Larschan, E; Gorchakov, AA; Gu, TT; Linder-Basso, D; Plachetka, A; Shanower, G; Tolstorukov, MY; Luquette, LJ; Xi, RB; Jung, YL; Park, RW; Bishop, EP; Canfield, TK; Sandstrom, R; Thurman, RE; MacAlpine, DM; Stamatoyannopoulos, JA; Kellis, M; Elgin, SCR; Kuroda, MI; Pirrotta, V; Karpen, GH; Park, PJ				Kharchenko, Peter V.; Alekseyenko, Artyom A.; Schwartz, Yuri B.; Minoda, Aki; Riddle, Nicole C.; Ernst, Jason; Sabo, Peter J.; Larschan, Erica; Gorchakov, Andrey A.; Gu, Tingting; Linder-Basso, Daniela; Plachetka, Annette; Shanower, Gregory; Tolstorukov, Michael Y.; Luquette, Lovelace J.; Xi, Ruibin; Jung, Youngsook L.; Park, Richard W.; Bishop, Eric P.; Canfield, Theresa K.; Sandstrom, Richard; Thurman, Robert E.; MacAlpine, David M.; Stamatoyannopoulos, John A.; Kellis, Manolis; Elgin, Sarah C. R.; Kuroda, Mitzi I.; Pirrotta, Vincenzo; Karpen, Gary H.; Park, Peter J.			Comprehensive analysis of the chromatin landscape in Drosophila melanogaster	NATURE			English	Article							HISTONE MODIFICATIONS; GENE-EXPRESSION; HUMAN GENOME; SHORT RNAS; DNASE-I; TRANSCRIPTION; POLYCOMB; SEQUENCE; ENHANCERS; COHESIN	Chromatin is composed of DNA and a variety of modified histones and non-histone proteins, which have an impact on cell differentiation, gene regulation and other key cellular processes. Here we present a genome-wide chromatin landscape for Drosophila melanogaster based on eighteen histone modifications, summarized by nine prevalent combinatorial patterns. Integrative analysis with other data (non-histone chromatin proteins, DNase I hypersensitivity, GRO-Seq reads produced by engaged polymerase, short/long RNA products) reveals discrete characteristics of chromosomes, genes, regulatory elements and other functional domains. We find that active genes display distinct chromatin signatures that are correlated with disparate gene lengths, exon patterns, regulatory functions and genomic contexts. We also demonstrate a diversity of signatures among Polycomb targets that include a subset with paused polymerase. This systematic profiling and integrative analysis of chromatin signatures provides insights into how genomic elements are regulated, and will serve as a resource for future experimental investigations of genome structure and function.	[Kharchenko, Peter V.; Tolstorukov, Michael Y.; Luquette, Lovelace J.; Xi, Ruibin; Jung, Youngsook L.; Park, Richard W.; Bishop, Eric P.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kharchenko, Peter V.; Tolstorukov, Michael Y.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Larschan, Erica; Gorchakov, Andrey A.; Plachetka, Annette; Jung, Youngsook L.; Kuroda, Mitzi I.; Park, Peter J.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Larschan, Erica; Gorchakov, Andrey A.; Plachetka, Annette; Kuroda, Mitzi I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Schwartz, Yuri B.; Linder-Basso, Daniela; Shanower, Gregory; Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Minoda, Aki; Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Minoda, Aki; Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Riddle, Nicole C.; Gu, Tingting; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Ernst, Jason; Kellis, Manolis] MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ernst, Jason; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sabo, Peter J.; Canfield, Theresa K.; Sandstrom, Richard; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Larschan, Erica] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02906 USA; [Park, Richard W.; Bishop, Eric P.] Boston Univ, Grad Program Bioinformat, Boston, MA 02115 USA; [MacAlpine, David M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle; Brown University; Boston University; Duke University; University of Washington; University of Washington Seattle	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	karpen@fruitfly.org; peter_park@harvard.edu	Minoda, Aki/D-5335-2017; Gorchakov, Andrey A/N-5840-2015; Minoda, Aki/Q-4454-2019; Kellis, Manolis/ABE-7385-2020	Minoda, Aki/0000-0002-2927-5791; Gorchakov, Andrey A/0000-0003-2830-4236; Minoda, Aki/0000-0002-2927-5791; Kellis, Manolis/0000-0001-7113-9630; Riddle, Nicole/0000-0003-1827-9145; Xi, Ruibin/0000-0001-7545-7361; Sandstrom, Richard/0000-0002-3356-1547; Park, Peter/0000-0001-9378-960X; Elgin, Sarah C. R./0000-0002-5176-2510	modENCODE [U01HG004258]; Department of Energy [DE-AC02-05CH11231];  [RC2 HG005639];  [U01 HG004279];  [R01 GM082798];  [R37 GM45744];  [RC1 HG005334];  [R01 GM071923];  [U54 HG004592];  [NSF 0905968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004258, R01HG004037, RC1HG005334, U54HG004592, U01HG004279, RC2HG005639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082798, R01GM071923, R37GM045744] Funding Source: NIH RePORTER	modENCODE; Department of Energy(United States Department of Energy (DOE)); ; ; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our technicians D. Acevedo, S. Gadel, C. Kennedy, O.-K. Lee, S. Marchetti, S. Vong and M. Weaver, and Rutgers BRTC. We also thank our colleagues who donated antibodies: J. Kadonaga (H1), A. L. Greenleaf (RNA pol II), G. Reuter (SU(VAR)3-9), G. Cavalli (GAF) and I. F. Zhimulev/H. Saumweber (Chromator). The major support for this work came from the modENCODE grant U01HG004258 to G.H.K. (Principal Investigator) and S.C.R.E., M.I.K., P.J.P. and V.P. (co-Principal Investigators), administered under Department of Energy contract no. DE-AC02-05CH11231. Additional funding came from RC2 HG005639, U01 HG004279, R01 GM082798, R37 GM45744, RC1 HG005334, R01 GM071923, U54 HG004592 and NSF 0905968.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anders S, 2009, BIOINFORMATICS, V25, P1231, DOI 10.1093/bioinformatics/btp152; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	46	605	621	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					480	+		10.1038/nature09725	http://dx.doi.org/10.1038/nature09725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21179089	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000288702200055
J	Churchman, LS; Weissman, JS				Churchman, L. Stirling; Weissman, Jonathan S.			Nascent transcript sequencing visualizes transcription at nucleotide resolution	NATURE			English	Article							RNA-POLYMERASE-II; ACTIVE PROMOTERS; BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; HUMAN GENOME; HISTONE H3; IN-VIVO; POL II; ELONGATION; METHYLATION	Recent studies of transcription have revealed a level of complexity not previously appreciated even a few years ago, both in the intricate use of post-initiation control and the mass production of rapidly degraded transcripts. Dissection of these pathways requires strategies for precisely following transcripts as they are being produced. Here we present an approach (native elongating transcript sequencing, NET-seq), based on deep sequencing of 3' ends of nascent transcripts associated with RNA polymerase, to monitor transcription at nucleotide resolution. Application of NET-seq in Saccharomyces cerevisiae reveals that although promoters are generally capable of divergent transcription, the Rpd3S deacetylation complex enforces strong directionality to most promoters by suppressing antisense transcript initiation. Our studies also reveal pervasive polymerase pausing and backtracking throughout the body of transcripts. Average pause density shows prominent peaks at each of the first four nucleosomes, with the peak location occurring in good agreement with in vitro biophysical measurements. Thus, nucleosome-induced pausing represents a major barrier to transcriptional elongation in vivo.	[Churchman, L. Stirling; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Churchman, L. Stirling; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	Damon Runyon Cancer Research Foundation [DRG-1997-08]; Howard Hughes Medical Institute	Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Guthrie, N. Krogan, S. Luo, G. Schroth, J. Steitz and K. Yamamoto for advice and discussions; D. Breslow, P. Fordyce, A. Frost, J. Huff, M. Kampmann and M. Pufall for critical comments on the manuscript; C. Chu and N. Ingolia for help with sequencing and analysis; and S. Rouskin for help developing the ligation protocol. This research was supported by the Damon Runyon Cancer Research Foundation (DRG-1997-08 to L.S.C.) and by the Howard Hughes Medical Institute (to J.S.W.)	Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CAI H, 1987, J BIOL CHEM, V262, P298; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; LANGMEAD B, 2009, GENOME BIOL, V10, pR25, DOI DOI 10.1186/gb-2009-10-11-r134; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; MARKHAM R, 1952, BIOCHEM J, V52, P552, DOI 10.1042/bj0520552; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Reines D, 1999, CURR OPIN CELL BIOL, V11, P342, DOI 10.1016/S0955-0674(99)80047-7; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	45	530	536	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					368	+		10.1038/nature09652	http://dx.doi.org/10.1038/nature09652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248844	Green Accepted			2022-12-01	WOS:000286385600045
J	Bostrom, P; Mann, N; Wu, J; Quintero, PA; Plovie, ER; Panakova, D; Gupta, RK; Xiao, CY; MacRae, CA; Rosenzweig, A; Spiegelman, BM				Bostroem, Pontus; Mann, Nina; Wu, Jun; Quintero, Pablo A.; Plovie, Eva R.; Panakova, Daniela; Gupta, Rana K.; Xiao, Chunyang; MacRae, Calum A.; Rosenzweig, Anthony; Spiegelman, Bruce M.			C/EBP beta Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling	CELL			English	Article							SERUM RESPONSE FACTOR; HEART; MUSCLE; ROLES	The heart has the ability to growin size in response to exercise, but little is known about the transcriptional mechanisms underlying physiological hypertrophy. Adult cardiomyocytes have also recently been proven to hold the potential for proliferation, a process that could be of great importance for regenerative medicine. Using a unique RT-PCR-based screen against all transcriptional components, we showed that C/EBP beta was downregulated with exercise, whereas the expression of CITED4 was increased. Reduction of C/EBP beta in vitro and in vivo resulted in a phenocopy of endurance exercise with cardiomyocyte hypertrophy and proliferation. This proliferation was mediated, at least in part, by the increased CITED4. Importantly, mice with reduced cardiac C/EBP beta levels displayed substantial resistance to cardiac failure upon pressure overload. These data indicate that C/EBP beta represses cardiomyocyte growth and proliferation in the adult mammalian heart and that reduction in C/EBP beta is a central signal in physiologic hypertrophy and proliferation.	[Mann, Nina; Quintero, Pablo A.; Xiao, Chunyang; Rosenzweig, Anthony] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Mann, Nina; Quintero, Pablo A.; Xiao, Chunyang; Rosenzweig, Anthony] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Bostroem, Pontus; Wu, Jun; Gupta, Rana K.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bostroem, Pontus; Wu, Jun; Gupta, Rana K.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Plovie, Eva R.; Panakova, Daniela; MacRae, Calum A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Rosenzweig, A (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc, 330 Brookline Ave, Boston, MA 02215 USA.	arosenzw@bidmc.harvard.edu; bruce_spiegelman@dfci.harvard.edu	Rosenzweig, Anthony/AAD-7893-2019	Gupta, Rana/0000-0002-9001-4531; Panakova, Daniela/0000-0002-8739-6225	NIH [R01 HL085593]; Swedish Heart and Lung foundation; SSMF; Wenner-Gren Foundation; American Heart Association [09POST2010078]; Howard Hughes Postdoctoral Fellowship; T32 training grant; Leducq Foundation Network of Research Excellence; Maxwell Hurston Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076361, R01HL109264, R01HL085593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); SSMF; Wenner-Gren Foundation; American Heart Association(American Heart Association); Howard Hughes Postdoctoral Fellowship; T32 training grant; Leducq Foundation Network of Research Excellence(Leducq Foundation); Maxwell Hurston Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shingo Kajimura for valuable discussion during the progression of the manuscript. This project was supported by NIH grant R01 HL085593. P. B. was supported by the Swedish Heart and Lung foundation, SSMF, and the Wenner-Gren Foundation. J.W. was supported by a postdoctoral fellowship from the American Heart Association (Founders Affiliate #09POST2010078). N.M. is a trainee the Harvard/MIT Health Sciences and Technology Program and is supported by a Howard Hughes Postdoctoral Fellowship. P. A. Q. is supported by a T32 training grant. This research was supported in part by a Leducq Foundation Network of Research Excellence (B. M. S. and A. R.) and grants from the NIH (A. R. and B. W. S.). A. R. also gratefully acknowledges support from Judith and David Ganz and the Maxwell Hurston Charitable Foundation. A. R. is a principal faculty member of the Harvard Stem Cell Institute.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bostrom P, 2010, DIABETES, V59, pA12; Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hanlon M, 1999, J BIOL CHEM, V274, P14224, DOI 10.1074/jbc.274.20.14224; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Liao Ronglih, 2007, V139, P251; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Taniike M, 2008, CIRCULATION, V117, P545, DOI 10.1161/CIRCULATIONAHA.107.710434; Yahata T, 2002, GENOMICS, V80, P601, DOI 10.1006/geno.2002.7005	27	283	299	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1072	1083		10.1016/j.cell.2010.11.036	http://dx.doi.org/10.1016/j.cell.2010.11.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183071	Bronze, Green Accepted			2022-12-01	WOS:000285625400006
J	Ozsolak, F; Kapranov, P; Foissac, S; Kim, SW; Fishilevich, E; Monaghan, AP; John, B; Milos, PM				Ozsolak, Fatih; Kapranov, Philipp; Foissac, Sylvain; Kim, Sang Woo; Fishilevich, Elane; Monaghan, A. Paula; John, Bino; Milos, Patrice M.			Comprehensive Polyadenylation Site Maps in Yeast and Human Reveal Pervasive Alternative Polyadenylation	CELL			English	Article							MESSENGER-RNA POLYADENYLATION; NONCODING RNAS; BIDIRECTIONAL PROMOTERS; GENE-EXPRESSION; TRANSCRIPTION; POLY(A); DNA; POLYMERASE; SEQUENCE; CLEAVAGE	The emerging discoveries on the link between polyadenylation and disease states underline the need to fully characterize genome-wide polyadenylation states. Here, we report comprehensive maps of global polyadenylation events inhuman and yeast generated using refinements to the Direct RNA Sequencing technology. This direct approach provides a quantitative view of genome-wide polyadenylation states in a strand-specific manner and requires only attomole RNA quantities. The polyadenylation profiles revealed an abundance of unannotated polyadenylation sites, alternative polyadenylation patterns, and regulatory element-associated poly(A)(+) RNAs. We observed differences in sequence composition surrounding canonical and noncanonical human polyadenylation sites, suggesting novel noncoding RNA-specific polyadenylation mechanisms in humans. Furthermore, we observed the correlation level between sense and antisense transcripts to depend on gene expression levels, supporting the view that overlapping transcription from opposite strands may play a regulatory role. Our data provide a comprehensive view of the polyadenylation state and overlapping transcription.	[Ozsolak, Fatih; Kapranov, Philipp; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA; [Foissac, Sylvain] Integromics, Madrid 28760, Spain; [Kim, Sang Woo; Fishilevich, Elane; John, Bino] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Monaghan, A. Paula] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ozsolak, F (corresponding author), Helicos BioSci Corp, Cambridge, MA 02139 USA.	fatihozsolak@gmail.com; pmilos@helicosbio.com		Foissac, Sylvain/0000-0002-2631-5356; Kapranov, Philipp/0000-0003-2647-4856; Kim, Sang Woo/0000-0002-3144-4822	National Human Genome Research Institute [R01-HG005230]; National Institutes of Health [GM079756, MH60774]; American Cancer Society [RSG0905401]; Spanish Ministry of Science and Innovation-FEDER (CDTI) [IDI-20091293]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060774] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Spanish Ministry of Science and Innovation-FEDER (CDTI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank our Helicos and Integromics colleagues for technical assistance and discussions. This work was supported by the National Human Genome Research Institute (grant R01-HG005230 to F.O. and P.M.M.). B.J. is supported by the National Institutes of Health (grant GM079756) and the American Cancer Society (grant RSG0905401), A.P.M. is supported by the National Institutes of Health (grant MH60774), and S.F. is supported by the Spanish Ministry of Science and Innovation-FEDER (CDTI loan IDI-20091293). F.O., P.K., and P.M.M. are employees of Helicos BioSciences Corporation. S.F. is an employee of Integromics.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bennett CL, 2001, IMMUNOGENETICS, V53, P435, DOI 10.1007/s002510100358; BHAT BM, 1987, J VIROL, V61, P3938, DOI 10.1128/JVI.61.12.3938-3945.1987; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Costessi L, 2006, NUCLEIC ACIDS RES, V34, P243, DOI 10.1093/nar/gkj425; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Graber JH, 2002, NUCLEIC ACIDS RES, V30, P1851, DOI 10.1093/nar/30.8.1851; GUBLER U, 1987, METHOD ENZYMOL, V152, P330; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; HIGGS DR, 1983, NATURE, V306, P398, DOI 10.1038/306398a0; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Liu DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-77; Lopez F, 2006, RNA, V12, P1794, DOI 10.1261/rna.136206; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Mahadevan S, 1997, GENE, V190, P69, DOI 10.1016/S0378-1119(96)00708-1; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mondal N, 2001, NATURE, V413, P435, DOI 10.1038/35096590; MOREIRA A, 1995, EMBO J, V14, P3809, DOI 10.1002/j.1460-2075.1995.tb00050.x; Muro EM, 2008, P NATL ACAD SCI USA, V105, P20286, DOI 10.1073/pnas.0807813105; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; ORKIN SH, 1985, EMBO J, V4, P453, DOI 10.1002/j.1460-2075.1985.tb03650.x; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; Rigault C, 2006, BBA-MOL CELL BIOL L, V1761, P1469, DOI 10.1016/j.bbalip.2006.09.014; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Slomovic S, 2010, P NATL ACAD SCI USA, V107, P7407, DOI 10.1073/pnas.0910621107; Slomovic S, 2008, METHOD ENZYMOL, V447, P501, DOI 10.1016/S0076-6879(08)02224-6; SPIEGELMAN S, 1970, NATURE, V227, P1029, DOI 10.1038/2271029a0; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yoon OK, 2010, RNA, V16, P1256, DOI 10.1261/rna.2038810; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	69	286	299	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					1018	1029		10.1016/j.cell.2010.11.020	http://dx.doi.org/10.1016/j.cell.2010.11.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145465	Green Accepted, Bronze			2022-12-01	WOS:000285182600017
J	de Gonzalez, AB; Hartge, P; Cerhan, JR; Flint, AJ; Hannan, L; MacInnis, RJ; Moore, SC; Tobias, GS; Anton-Culver, H; Freeman, LB; Beeson, WL; Clipp, SL; English, DR; Folsom, AR; Freedman, DM; Giles, G; Hakansson, N; Henderson, KD; Hoffman-Bolton, J; Hoppin, JA; Koenig, KL; Lee, IM; Linet, MS; Park, Y; Pocobelli, G; Schatzkin, A; Sesso, HD; Weiderpass, E; Willcox, BJ; Wolk, A; Zeleniuch-Jacquotte, A; Willett, WC; Thun, MJ				de Gonzalez, Amy Berrington; Hartge, Patricia; Cerhan, James R.; Flint, Alan J.; Hannan, Lindsay; MacInnis, Robert J.; Moore, Steven C.; Tobias, Geoffrey S.; Anton-Culver, Hoda; Freeman, Laura Beane; Beeson, W. Lawrence; Clipp, Sandra L.; English, Dallas R.; Folsom, Aaron R.; Freedman, D. Michal; Giles, Graham; Hakansson, Niclas; Henderson, Katherine D.; Hoffman-Bolton, Judith; Hoppin, Jane A.; Koenig, Karen L.; Lee, I-Min; Linet, Martha S.; Park, Yikyung; Pocobelli, Gaia; Schatzkin, Arthur; Sesso, Howard D.; Weiderpass, Elisabete; Willcox, Bradley J.; Wolk, Alicja; Zeleniuch-Jacquotte, Anne; Willett, Walter C.; Thun, Michael J.			Body-Mass Index and Mortality among 1.46 Million White Adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; BREAST-CANCER; PREDICTING MORTALITY; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; WOMENS HEALTH; BETA-CAROTENE; EARLY MARKER	Background: A high body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) is associated with increased mortality from cardiovascular disease and certain cancers, but the precise relationship between BMI and all-cause mortality remains uncertain. Methods: We used Cox regression to estimate hazard ratios and 95% confidence intervals for an association between BMI and all-cause mortality, adjusting for age, study, physical activity, alcohol consumption, education, and marital status in pooled data from 19 prospective studies encompassing 1.46 million white adults, 19 to 84 years of age (median, 58). Results: The median baseline BMI was 26.2. During a median follow-up period of 10 years (range, 5 to 28), 160,087 deaths were identified. Among healthy participants who never smoked, there was a J-shaped relationship between BMI and all-cause mortality. With a BMI of 22.5 to 24.9 as the reference category, hazard ratios among women were 1.47 (95 percent confidence interval [CI], 1.33 to 1.62) for a BMI of 15.0 to 18.4; 1.14 (95% CI, 1.07 to 1.22) for a BMI of 18.5 to 19.9; 1.00 (95% CI, 0.96 to 1.04) for a BMI of 20.0 to 22.4; 1.13 (95% CI, 1.09 to 1.17) for a BMI of 25.0 to 29.9; 1.44 (95% CI, 1.38 to 1.50) for a BMI of 30.0 to 34.9; 1.88 (95% CI, 1.77 to 2.00) for a BMI of 35.0 to 39.9; and 2.51 (95% CI, 2.30 to 2.73) for a BMI of 40.0 to 49.9. In general, the hazard ratios for the men were similar. Hazard ratios for a BMI below 20.0 were attenuated with longer-term follow-up. Conclusions: In white adults, overweight and obesity (and possibly underweight) are associated with increased all-cause mortality. All-cause mortality is generally lowest with a BMI of 20.0 to 24.9. N Engl J Med 2010;363:2211-9.	[de Gonzalez, Amy Berrington] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Cerhan, James R.] Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN USA; [Flint, Alan J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sesso, Howard D.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Sesso, Howard D.] Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA; [Lee, I-Min] Harvard Univ, Sch Med, Boston, MA USA; [Hannan, Lindsay; Thun, Michael J.] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [MacInnis, Robert J.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Giles, Graham] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [MacInnis, Robert J.] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge, England; [Anton-Culver, Hoda] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Beeson, W. Lawrence] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA; [Henderson, Katherine D.] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA 91010 USA; [Clipp, Sandra L.; Hoffman-Bolton, Judith] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Hakansson, Niclas; Wolk, Alicja] Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, Stockholm, Sweden; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hoppin, Jane A.] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC USA; [Koenig, Karen L.; Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Pocobelli, Gaia] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Pocobelli, Gaia] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Weiderpass, Elisabete] Canc Registry Norway, Oslo, Norway; [Weiderpass, Elisabete] Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland; [Willcox, Bradley J.] Pacific Hlth Res Inst, Honolulu, HI USA; [Willcox, Bradley J.] Queens Med Ctr, Honolulu, HI USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; American Cancer Society; University of Melbourne; Cancer Council Victoria; Cancer Research UK; University of Cambridge; University of California System; University of California Irvine; Loma Linda University; City of Hope; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; Karolinska Institutet; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); New York University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Oslo; Samfundet Folkhalsan; Pacific Health Research & Education Institute; The Queen's Medical Center	de Gonzalez, AB (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Rm 7034,6120 Execut Blvd, Bethesda, MD 20892 USA.	berringtona@mail.nih.gov	Håkansson, Niclas/L-7913-2013; Weiderpass, Elisabete/AAP-2747-2021; de gonzalez, amy berrington/L-7017-2017; Freeman, Laura E. Beane/C-4468-2015; Tobias, Geoffrey S/M-4135-2016; English, Dallas/AAH-5005-2019; Lee, I-Min/ABD-5409-2021; Weiderpass, Elisabete/M-4029-2016; Moore, Steven/D-8760-2016	Håkansson, Niclas/0000-0001-7673-5554; Weiderpass, Elisabete/0000-0003-2237-0128; de gonzalez, amy berrington/0000-0002-7332-8387; Freeman, Laura E. Beane/0000-0003-1294-4124; Tobias, Geoffrey S/0000-0002-2878-8253; English, Dallas/0000-0001-7828-8188; Weiderpass, Elisabete/0000-0003-2237-0128; Moore, Steven/0000-0002-8169-1661; Cerhan, James/0000-0002-7482-178X; MacInnis, Robert/0000-0002-1627-5047; Park, Yikyung/0000-0002-6281-489X; Giles, Graham/0000-0003-4946-9099; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Hoppin, Jane/0000-0001-8456-0969	National Institutes of Health (NIH); Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), NIH; Iovate Health Sciences USA; NATIONAL CANCER INSTITUTE [R01CA077398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049030] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); Iovate Health Sciences USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Intramural Research Program of the National Institutes of Health (NIH) and the Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), NIH. Details regarding funding for the individual studies are listed in the Supplementary Appendix.; Dr. Sesso reports receiving consulting fees from Iovate Health Sciences USA. No other potential conflict of interest relevant to this article was reported.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BEESON WL, 1989, CANCER, V64, P570, DOI 10.1002/1097-0142(19890801)64:3<570::AID-CNCR2820640303>3.0.CO;2-4; Bernstein L, 2002, CANCER CAUSE CONTROL, V13, P625, DOI 10.1023/A:1019552126105; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Comstock GW, 1997, CANCER EPIDEM BIOMAR, V6, P907; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; *DEP HLTH HUM SERV, 2006, NAT HLTH NUTR EX SUR; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P1254; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P483, DOI 10.1001/jama.269.4.483; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; Giles G G, 2002, IARC Sci Publ, V156, P69; Hayes RB, 2005, MUTAT RES-FUND MOL M, V592, P147, DOI 10.1016/j.mrfmmm.2005.06.013; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; *INT OB TASK FORC, GLOB PREV AD OB; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Moore SC, 2008, INT J OBESITY, V32, P730, DOI 10.1038/sj.ijo.0803801; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Orsini N, 2008, J INTERN MED, V264, P442, DOI 10.1111/j.1365-2796.2008.01985.x; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pischon T, 2010, NEW ENGL J MED, V362, P2433; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; SAS, 2009, SAS VERS 9 0; SCHAIRER C, 1994, CANCER CAUSE CONTROL, V5, P491, DOI 10.1007/BF01831376; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; TONIOLO PG, 1995, JNCI-J NATL CANCER I, V87, P190, DOI 10.1093/jnci/87.3.190; Weiderpass E, 2004, CANCER EPIDEM BIOMAR, V13, P1121; White E, 2004, AM J EPIDEMIOL, V159, P83, DOI 10.1093/aje/kwh010; Whitlock G, 2009, LANCET, V374, P114, DOI 10.1016/S0140-6736(09)61280-0; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2004, LANCET, V363, P902; Wolk A, 2006, JAMA-J AM MED ASSOC, V296, P1371, DOI 10.1001/jama.296.11.1371	44	1516	1548	2	129	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2211	2219		10.1056/NEJMoa1000367	http://dx.doi.org/10.1056/NEJMoa1000367			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121834	Bronze, Green Accepted			2022-12-01	WOS:000284832900008
J	Ben-Shem, A; Jenner, L; Yusupova, G; Yusupov, M				Ben-Shem, Adam; Jenner, Lasse; Yusupova, Gulnara; Yusupov, Marat			Crystal Structure of the Eukaryotic Ribosome	SCIENCE			English	Article							TRANSFER-RNA; TRANSLATION INITIATION; MESSENGER-RNA; ANGSTROM RESOLUTION; 70S RIBOSOME; 80S RIBOSOME; E-SITE; SUBUNIT; TRANSLOCATION; MOVEMENT	Crystal structures of prokaryotic ribosomes have described in detail the universally conserved core of the translation mechanism. However, many facets of the translation process in eukaryotes are not shared with prokaryotes. The crystal structure of the yeast 80S ribosome determined at 4.15 angstrom resolution reveals the higher complexity of eukaryotic ribosomes, which are 40% larger than their bacterial counterparts. Our model shows how eukaryote-specific elements considerably expand the network of interactions within the ribosome and provides insights into eukaryote-specific features of protein synthesis. Our crystals capture the ribosome in the ratcheted state, which is essential for translocation of mRNA and transfer RNA (tRNA), and in which the small ribosomal subunit has rotated with respect to the large subunit. We describe the conformational changes in both ribosomal subunits that are involved in ratcheting and their implications in coordination between the two associated subunits and in mRNA and tRNA translocation.	[Ben-Shem, Adam] IGBMC, F-67400 Illkirch Graffenstaden, France; INSERM, U964, F-67400 Illkirch Graffenstaden, France; CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ben-Shem, A (corresponding author), IGBMC, 1 Rue Laurent Fries,BP10142, F-67400 Illkirch Graffenstaden, France.	adam@igbmc.fr; marat@igbmc.fr	Yusupov, Marat/I-6126-2013; Yusupova, Gulnara/E-1877-2014; Jenner, Lasse/H-1584-2017	Yusupov, Marat/0000-0001-5544-0597; Ben-Shem, Adam/0000-0003-0297-8662; Jenner, Lasse/0000-0003-3917-8853	European Molecular Biology Organization; Human Frontier Science Program; French National Research Agency [ANR BLAN07-3_190451, ANR-07-PCVI-0015-01]; European Commission	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); French National Research Agency(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. Meskauskas and J. Dinman for providing the strain of S. cerevisiae and for support at the early stages of efforts in development of yeast ribosome purification protocol; A. Urzhumtzev for numerous invaluable crystallographic discussions; and R. Jackson for pointing out to us the possible benefits of glucose depletion in yeast. We gratefully acknowledge help with crystallographic programs from P. Afonine, K. Cowtan, G. Kleywegt, A. Lebedev, S. Panjikar, N. Pannu, R. Read, T. Terwilliger, L. Tong, A. Vagin, C. Vonrhein, and T. Yeates. We thank S. Melnikov and N. Garreau de Loubresse for help during the final stages of this work; M. Iskakova and N. Demeshkina for their participation and encouragement in early stages of this work; the staff of the Structural Biology Department core facility at IGBMC, Strasbourg; and S. Uge for assistance with computer infrastructure; C. Schulze-Briese and the staff at the Swiss Light Source, Switzerland; and A. Thompson and P. Legrand from the Soleil Synchrotron, France, for help with data collection. This work was supported by a European Molecular Biology Organization Long-Term Fellowship (A.B.-S.), Human Frontier Science Program, French National Research Agency grants ANR BLAN07-3_190451 and ANR-07-PCVI-0015-01, and the European Commission SPINE2. Coordinates and structure factors have been deposited with the Protein Data Bank with accession codes 3O2Z, 3O30, 3O58, and 3O5H.	Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Halic M, 2005, NAT STRUCT MOL BIOL, V12, P467, DOI 10.1038/nsmb933; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Korostelev A, 2007, P NATL ACAD SCI USA, V104, P16840, DOI 10.1073/pnas.0707850104; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SPIRIN AS, 1969, COLD SPRING HARB SYM, V34, P197, DOI 10.1101/SQB.1969.034.01.026; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	40	304	371	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1203	1209		10.1126/science.1194294	http://dx.doi.org/10.1126/science.1194294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109664				2022-12-01	WOS:000284613700031
J	Choudhry, NK; Shrank, WH				Choudhry, Niteesh K.; Shrank, William H.			Four-Dollar Generics -- Increased Accessibility, Impaired Quality Assurance.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Choudhry, Niteesh K.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.							[Anonymous], 2008, US TODAY; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; *KAIS FAM FDN HLTH, EMPL HLTH BEN 2009 A; Kohl H, 2007, J AM GERIATR SOC, V55, P1106, DOI 10.1111/j.1532-5415.2007.01286.x; *NAT ASS CHAIN DRU, 2008, RX SAL	5	69	69	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2010	363	20					1885	1887		10.1056/NEJMp1006189	http://dx.doi.org/10.1056/NEJMp1006189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	678CR	21067379				2022-12-01	WOS:000284047600003
J	McCartney, M				McCartney, Margaret			Medicine and the Media Men and midlife crises	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaretmccartney@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2010	341								c5661	10.1136/bmj.c5661	http://dx.doi.org/10.1136/bmj.c5661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	681KO	21068110				2022-12-01	WOS:000284312700010
J	Marciniak, SJ; Lomas, DA				Marciniak, Stefan J.; Lomas, David A.			Alpha(sub 1)-Antitrypsin Deficiency and Autophagy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marciniak, Stefan J.; Lomas, David A.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England	University of Cambridge	Marciniak, SJ (corresponding author), Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England.		Marciniak, Stefan J/F-1855-2010	Marciniak, Stefan/0000-0001-8472-7183	Medical Research Council [G0500306, G0601840] Funding Source: Medline; MRC [G0500306, G0601840] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	4	38	38	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1863	1864		10.1056/NEJMcibr1008007	http://dx.doi.org/10.1056/NEJMcibr1008007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674YK	21047232				2022-12-01	WOS:000283787800014
J	Parsons, DW; Li, M; Zhang, XS; Jones, S; Leary, RJ; Lin, JCH; Boca, SM; Carter, H; Samayoa, J; Bettegowda, C; Gallia, GL; Jallo, GI; Binder, ZA; Nikolsky, Y; Hartigan, J; Smith, DR; Gerhard, DS; Fults, DW; VandenBerg, S; Berger, MS; Marie, SKN; Shinjo, SMO; Clara, C; Phillips, PC; Minturn, JE; Biegel, JA; Judkins, AR; Resnick, AC; Storm, PB; Curran, T; He, YP; Rasheed, BA; Friedman, HS; Keir, ST; McLendon, R; Northcott, PA; Taylor, MD; Burger, PC; Riggins, GJ; Karchin, R; Parmigiani, G; Bigner, DD; Yan, H; Papadopoulos, N; Vogelstein, B; Kinzler, KW; Velculescu, VE				Parsons, D. Williams; Li, Meng; Zhang, Xiaosong; Jones, Sian; Leary, Rebecca J.; Lin, Jimmy Cheng-Ho; Boca, Simina M.; Carter, Hannah; Samayoa, Josue; Bettegowda, Chetan; Gallia, Gary L.; Jallo, George I.; Binder, Zev A.; Nikolsky, Yuri; Hartigan, James; Smith, Doug R.; Gerhard, Daniela S.; Fults, Daniel W.; VandenBerg, Scott; Berger, Mitchel S.; Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba; Clara, Carlos; Phillips, Peter C.; Minturn, Jane E.; Biegel, Jaclyn A.; Judkins, Alexander R.; Resnick, Adam C.; Storm, Phillip B.; Curran, Tom; He, Yiping; Rasheed, B. Ahmed; Friedman, Henry S.; Keir, Stephen T.; McLendon, Roger; Northcott, Paul A.; Taylor, Michael D.; Burger, Peter C.; Riggins, Gregory J.; Karchin, Rachel; Parmigiani, Giovanni; Bigner, Darell D.; Yan, Hai; Papadopoulos, Nick; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.			The Genetic Landscape of the Childhood Cancer Medulloblastoma	SCIENCE			English	Article							SOMATIC MUTATIONS; HUMAN BREAST; GENOME; AMPLIFICATION; METHYLATION; PROGRESSION; SEQUENCES; COMPLEX; ARID1A; OTX2	Medulloblastoma (MB) is the most common malignant brain tumor of children. To identify the genetic alterations in this tumor type, we searched for copy number alterations using high-density microarrays and sequenced all known protein-coding genes and microRNA genes using Sanger sequencing in a set of 22 MBs. We found that, on average, each tumor had 11 gene alterations, fewer by a factor of 5 to 10 than in the adult solid tumors that have been sequenced to date. In addition to alterations in the Hedgehog and Wnt pathways, our analysis led to the discovery of genes not previously known to be altered in MBs. Most notably, inactivating mutations of the histone-lysine N-methyltransferase genes MLL2 or MLL3 were identified in 16% of MB patients. These results demonstrate key differences between the genetic landscapes of adult and childhood cancers, highlight dysregulation of developmental pathways as an important mechanism underlying MBs, and identify a role for a specific type of histone methylation in human tumorigenesis.	[Parsons, D. Williams; Li, Meng; Zhang, Xiaosong; Jones, Sian; Leary, Rebecca J.; Lin, Jimmy Cheng-Ho; Bettegowda, Chetan; Riggins, Gregory J.; Papadopoulos, Nick; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Parsons, D. Williams; Li, Meng; Zhang, Xiaosong; Jones, Sian; Leary, Rebecca J.; Lin, Jimmy Cheng-Ho; Bettegowda, Chetan; Riggins, Gregory J.; Papadopoulos, Nick; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Parsons, D. Williams] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Boca, Simina M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Carter, Hannah; Samayoa, Josue; Karchin, Rachel] Johns Hopkins Med Inst, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA; [Bettegowda, Chetan; Gallia, Gary L.; Jallo, George I.; Binder, Zev A.; Riggins, Gregory J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21231 USA; [Nikolsky, Yuri] GeneGo Inc, St Joseph, MI 49085 USA; [Hartigan, James; Smith, Doug R.] Beckman Coulter Genom Inc, Danvers, MA 01923 USA; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Fults, Daniel W.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84132 USA; [VandenBerg, Scott] Univ Calif San Diego, Dept Pathol, Div Neuropathol, San Diego, CA 92103 USA; [Berger, Mitchel S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil; [Clara, Carlos] Barretos Canc Hosp, Pio XII Fdn, Sao Paulo, Brazil; [Phillips, Peter C.; Minturn, Jane E.; Biegel, Jaclyn A.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Resnick, Adam C.; Storm, Phillip B.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Judkins, Alexander R.; Curran, Tom] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [He, Yiping; Rasheed, B. Ahmed; Friedman, Henry S.; Keir, Stephen T.; McLendon, Roger; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Pediat Brain Tumor Fdn Inst, Preston Robert Tisch Brain Tumor Ctr,Dept Pathol, Durham, NC 27710 USA; [He, Yiping; Rasheed, B. Ahmed; Friedman, Henry S.; Keir, Stephen T.; McLendon, Roger; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Northcott, Paul A.; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1L7, Canada; [Burger, Peter C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Parmigiani, Giovanni] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Parmigiani, Giovanni] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Beckman Coulter Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; University of California System; University of California San Francisco; Universidade de Sao Paulo; Hospital de Cancer de Barretos; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; Duke University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Vogelstein, B (corresponding author), Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	vogelbe@gmail.com; kinzlke@jhmi.edu; velculescu@jhmi.edu	Jones, Sian/A-5050-2012; Oba-Shinjo, Sueli M./C-4017-2012; Curran, Tom/F-5234-2018; Velculescu, Victor/ABF-4846-2020; Curran, Thomas/AAE-7631-2019; Marie, Suely Kazue Nagahashi/D-1870-2012; Papadopoulos, Nickolas/K-7272-2012; Boca, Simina/ABE-3747-2020; Karchin, Rachel/A-3385-2010; Curran, Tom/D-7515-2011; Curran, Tom/C-1164-2008; Northcott, Paul A/N-4022-2018; Carter, Hannah/R-8425-2017	Oba-Shinjo, Sueli M./0000-0002-1650-5973; Curran, Tom/0000-0003-1444-7551; Velculescu, Victor/0000-0003-1195-438X; Curran, Thomas/0000-0003-1444-7551; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Boca, Simina/0000-0002-1400-3398; Curran, Tom/0000-0003-1444-7551; Northcott, Paul A/0000-0002-1220-5252; Parsons, Donald/0000-0002-8775-3501; Karchin, Rachel/0000-0002-5069-1239; Carter, Hannah/0000-0002-1729-2463; Taylor, Michael/0000-0001-7009-3466	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Virginia and D. K. Ludwig Fund for Cancer Research; Alex's Lemonade Stand Foundation; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins; Hoglund Foundation; Ready or Not Foundation; Children's Brain Tumor Foundation; Pediatric Brain Tumor Foundation Institute; David and Barbara B. Hirschhorn Foundation; American Association for Cancer Research; Johns Hopkins Sommer Scholar Program; NIH [CA121113, CA096832, CA057345, CA118822, CA135877, GM074906-01A1/B7BSCW]; NSF [DBI 0845275]; DOD NDSEG [32 CFR 168a]; NATIONAL CANCER INSTITUTE [R21CA135877, R01CA057345, R01CA121113, P01CA096832, R37CA057345, R01CA108622, R01CA118822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074906] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Virginia and D. K. Ludwig Fund for Cancer Research; Alex's Lemonade Stand Foundation; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins; Hoglund Foundation; Ready or Not Foundation; Children's Brain Tumor Foundation; Pediatric Brain Tumor Foundation Institute; David and Barbara B. Hirschhorn Foundation; American Association for Cancer Research; Johns Hopkins Sommer Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DOD NDSEG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Ptak, N. Silliman, L. Dobbyn, and M. Whalen for technical assistance with sequencing analyses, and M. Ehinger, D. Satterfield, E. Lipp, D. Lister, and M. J. Dougherty for help with sample preparation and data collection. This project has been funded in part by the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. This work was supported by the Virginia and D. K. Ludwig Fund for Cancer Research, Alex's Lemonade Stand Foundation, the American Brain Tumor Association, the Brain Tumor Research Fund at Johns Hopkins, the Hoglund Foundation, the Ready or Not Foundation, the Children's Brain Tumor Foundation, the Pediatric Brain Tumor Foundation Institute, the David and Barbara B. Hirschhorn Foundation, American Association for Cancer Research Stand Up To Cancer Dream Team Translational Cancer Research Grant, Johns Hopkins Sommer Scholar Program, NIH grants CA121113, CA096832, CA057345, CA118822, CA135877, and GM074906-01A1/B7BSCW, NSF grant DBI 0845275, and DOD NDSEG Fellowship 32 CFR 168a. D. W. P. is a Graham Cancer Research Scholar at Texas Children's Cancer Center. Under licensing agreements between the Johns Hopkins University and Beckman Coulter, B.V., K.W.K., and V.E.V. are entitled to a share of royalties received by the university on sales of products related to research described in this paper. N.P., B.V., K.W.K., and V.E.V are cofounders of Inostics and Personal Genome Diagnostics and are members of their Scientific Advisory Boards. N.P., B.V., K.W.K., and V.E.V. own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under university policy. The terms of these arrangements are managed by Johns Hopkins University in accordance with its conflict-of-interest policies.	Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; BIGNER SH, 1990, CANCER RES, V50, P2347; Boca SM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r112; Boon K, 2005, CANCER RES, V65, P703; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Di CH, 2005, CANCER RES, V65, P919; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eberhart CG, 2002, CANCER-AM CANCER SOC, V94, P552, DOI 10.1002/cncr.10189; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Giangaspero F., 2007, WHO CLASSIFICATION C; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09218; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; SAYLORS RL, 1991, CANCER RES, V51, P4721; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soussi T, 2003, HUM MUTAT, V21, P192, DOI 10.1002/humu.10189; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI [10.2217/epi.10.11, 10.2217/EPI.10.11]; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	43	552	561	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					435	439		10.1126/science.1198056	http://dx.doi.org/10.1126/science.1198056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21163964	Green Accepted			2022-12-01	WOS:000286635900045
J	Paul, VK; Sachdev, HS; Mavalankar, D; Ramachandran, P; Sankar, MJ; Bhandari, N; Sreenivas, V; Sundararaman, T; Govil, D; Osrin, D; Kirkwood, B				Paul, Vinod Kumar; Sachdev, Harshpal Singh; Mavalankar, Dileep; Ramachandran, Prema; Sankar, Mari Jeeva; Bhandari, Nita; Sreenivas, Vishnubhatla; Sundararaman, Thiagarajan; Govil, Dipti; Osrin, David; Kirkwood, Betty			India: Towards Universal Health Coverage 2 Reproductive health, and child health and nutrition in India: meeting the challenge	LANCET			English	Article							REDUCING MATERNAL MORTALITY; IMPAIRED GLUCOSE-TOLERANCE; SEVERE ACUTE MALNUTRITION; NEONATAL-MORTALITY; MANAGEMENT; PREVALENCE; SURVIVAL; DISEASES; NEWBORN	India, with a population of more than 1 billion people, has many challenges in improving the health and nutrition of its citizens. Steady declines have been noted in fertility, maternal, infant and child mortalities, and the prevalence of severe manifestations of nutritional deficiencies, but the pace has been slow and falls short of national and Millennium Development Goal targets. The likely explanations include social inequities, disparities in health systems between and within states, and consequences of urbanisation and demographic transition. In 2005, India embarked on the National Rural Health Mission, an extraordinary effort to strengthen the health systems. However, coverage of priority interventions remains insufficient, and the content and quality of existing interventions are suboptimum. Substantial unmet need for contraception remains, adolescent pregnancies are common, and access to safe abortion is inadequate. Increases in the numbers of deliveries in institutions have not been matched by improvements in the quality of intrapartum and neonatal care. Infants and young children do not get the health care they need; access to effective treatment for neonatal illness, diarrhoea, and pneumonia shows little improvement; and the coverage of nutrition programmes is inadequate. Absence of well functioning health systems is indicated by the inadequacies related to planning, financing, human resources, infrastructure, supply systems, governance, information, and monitoring. We provide a case for transformation of health systems through effective stewardship, decentralised planning in districts, a reasoned approach to financing that affects demand for health care, a campaign to create awareness and change health and nutrition behaviour, and revision of programmes for child nutrition on the basis of evidence. This agenda needs political commitment of the highest order and the development of a people's movement.	[Paul, Vinod Kumar] All India Inst Med Sci, Dept Paediat, New Delhi 110029, India; [Sachdev, Harshpal Singh] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Mavalankar, Dileep] Indian Inst Management, Ahmadabad 380015, Gujarat, India; [Ramachandran, Prema] Nutr Fdn India, New Delhi, India; [Bhandari, Nita] Soc Appl Studies, New Delhi, India; [Sundararaman, Thiagarajan] Natl Hlth Syst Resources Ctr, New Delhi, India; [Govil, Dipti] Inst Hlth Management & Res, Jaipur, Rajasthan, India; [Osrin, David] UCL, Ctr Int Hlth & Dev, London, England; [Kirkwood, Betty] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	All India Institute of Medical Sciences (AIIMS) New Delhi; Sitaram Bhartia Institute of Science & Research; Indian Institute of Management (IIM System); Indian Institute of Management Ahmedabad; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Paul, VK (corresponding author), All India Inst Med Sci, Dept Paediat, New Delhi 110029, India.	vinodkpaul@hotmail.com	Govil, Dipti/ABC-7928-2020; Sankar, Jeeva/Q-1007-2019; Mavalankar, Dileep/AAX-6931-2020	Govil, Dipti/0000-0002-0599-0045; Sankar, Jeeva/0000-0003-1474-1451; Mavalankar, Dileep/0000-0003-0498-3799; Kirkwood, Betty/0000-0001-5274-6072; Osrin, David/0000-0001-9691-9684; Sachdev, Harshpal Singh/0000-0002-4956-9391	University College London Institute of Child Health; Wellcome Trust [081052]; John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	University College London Institute of Child Health; Wellcome Trust(Wellcome TrustEuropean Commission); John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	DO was originally a reviewer of this report and was requested to join as a co-author after the first draft; he has received payment for employment from the University College London Institute of Child Health, grants from a Wellcome Trust Fellowship, and payment for visiting lectures at the London School of Hygiene and Tropical Medicine. The other authors declare that they have no conflicts of interest.; The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India. DO is supported by Wellcome Trust Fellowship (grant number 081052). We thank Shireen J Jejeebhoy for major inputs for sections about reproductive health and Rajiv Bahl for child health; S K Bhargava for providing access to the data for the New Delhi Birth Cohort; Pavitra Mohan for highly valuable comments about the report; Armida Fernandez, Thomas Cherian, Jose Martines, and Satish Gupta for suggestions and inputs; and Manju Saksena for assistance with the research.	Agarwal RK, 2008, INDIAN PEDIATR, V45, P625; [Anonymous], 2009, REP CAUS DEATH IND 2; Arnold F, 2002, POPUL DEV REV, V28, P759, DOI 10.1111/j.1728-4457.2002.00759.x; Arun Gupta, 2007, Economic and Political Weekly, V42, P87; BAJPAI N, 2009, IMPROVING ACCESS SER; BALARAJAN Y, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)618946; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BARGE K, 1998, INT WORKSH AB FAC PO; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bhatnagar S, 2007, INDIAN PEDIATR, V44, P443; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; CHHABRA R, 1994, ABORTION INDIA OVERV; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; *DRUGS CONTR GEN I, 2006, NUMB PERM DAT ISS MF; ELUL B, 2003, UNINTENDED PREGNANCY; GANATRA B, 2000, WOMENS REPROD HLTH I; GANATRA BR, 2000, ASIA PAC POPUL J, V16, P109; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; *GOV IND, 2003, MED TERM PREGN RUL A; *GOV IND MIN HLTH, 2010, 3 COMM REV MISS REP; *GOV IND MIN WOM C, 2006, STRENGTH ICDS RED CH; Government of India Ministry of Women and Child Development, INT CHILD DEV SERV S; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *IHME, CHILD MORT GLOB; *IIPS, 2008, DISTR LEV HOUS SURV; *IIPS, 2005, IND FAC SURV; *IIPS MACR, 2007, NFHS3 IIPS MACR, V1; Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS SURV; *INT I POP SCI POP, 2009, YOUTH IND SIT NEEDS; International Institute for Population Sciences (IIPS), 2006, DISTR LEV HOUS SURV; International Institute for Population Sciences (IIPS), 1995, NAT FAM HLTH SURV NF, P199293; International Institute for Population Sciences (IIPS) and ORC Macro, 2000, NATL FAMILY HLTH SUR; Jain S, 2004, J TROP PEDIATRICS, V50, P170, DOI 10.1093/tropej/50.3.170; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Jones Gareth, 2006, Indian Journal of Pediatrics, V73, P479, DOI 10.1007/BF02759891; Kalyanwala S, 2010, INT PERSPECT SEX R H, V36, P62, DOI 10.1363/ipsrh.36.062.10; Kapil U, 2010, INDIAN PEDIATR, V47, P651, DOI 10.1007/s13312-010-0099-x; Kapil U, 2009, INDIAN PEDIATR, V46, P381; Khanna SK, 1997, SOC SCI MED, V44, P171, DOI 10.1016/S0277-9536(96)00144-X; KOSH JS, 2009, IND PARTN POP STAB; Krishna U R, 1995, J Indian Med Assoc, V93, P34; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; MALHOTRA A, 2003, REALIZING REPROD CHO; Mavalankar D, 2008, LANCET, V371, P631, DOI 10.1016/S0140-6736(08)60282-2; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; *MIN HLTH FAM WELF, 2009, NRHM PROGRE SO FAR; *MIN HUM RES DEV D, 2005, NAT PLAN ACT CHILDR; *MIN WOM CHILD DEV, INT CHILD DEV SERV; MOHAN P, 1999, THESIS U N CAROLINA; *MOHFW, 2008, NAT HLTH PROF 2008; *MOHFW, 2008, NAT TRAIN STRAT INS; *MOHFW, 2000, NAT POP POL 2000; *MOHFW, 2008, NAT COLD CHAIN ASS; *MOHFW STAT DIV, 2007, B RUR HLTH STAT IND; *MOHFW STAT DIV, 2008, B RUR HLTH STAT, P26; *NCEAR, 2001, CONC EV INT CHILD DE; *NHSRC, 2008, CHILD HLTH STAT PIPS; *NNBM, 2002, NNMB MICR SURV; *NRHM, 2008, KEY FIND 2 COMM REV; Oomman N, 2002, REPROD HEALTH MATTER, V10, P184, DOI 10.1016/S0968-8080(02)00029-0; Padmanaban P, 2009, J HEALTH POPUL NUTR, V27, P202; Paul VK, 2010, LANCET, V375, P1943, DOI 10.1016/S0140-6736(10)60901-4; Prabhakaran D, 2005, NATL MED J INDIA, V18, P59; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; *REG GEN IND, 2006, MAT MORT IND 1997 20; *REG GEN IND, 1999, COMP IND FERT MORT I; *REG GEN IND, POP PROJ 2001 26; *REG GEN IND, 2009, SAMPL REG SYST SRS S; *REG GEN IND, CENS IND 2001; Registrar General of India, 2009, SPEC B MAT MORT 2004; Sachdev HPS, 2010, INDIAN PEDIATR, V47, P661, DOI 10.1007/s13312-010-0097-z; Sachdev HPS, 2004, INDIAN J MED RES, V119, pIII; SACHDEV HPS, 2003, NFI B, V24, P6; Santhya K. G., 2003, Economic and Political Weekly, V38, P4370; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI [10.1363/3613210, 10.1363/ipsrh.36.132.10]; SANTHYA KG, 2010, TIMING 1 SEX MARRIAG; SANTHYA KG, 2005, LOOKING BACK LOOKING; SHARMA BB, 1998, 18 ANN CONV NAT NEON; Shobha Malini, 2008, Health and Population - Perspectives and Issues, V31, P126; SNTHYA KG, 2009, UNDERSTANDING PREGNA; Sundararaman T, 2007, LANCET, V369, P2058, DOI 10.1016/S0140-6736(07)60326-2; *UNFPA, 2007, ASS ASHA JAN SUR YOJ; *UNFPA, ASS ASHA JAN SUR YOJ; *UNFPA, 2005, MISS MAPP ADV CHILD; UNICEF, 2009, STATE WORLDS CHILDRE; UNICEF/WHO, 2004, LOW BIRTHW COUNTR RE; *URB HLTH RES CTR, KEY IND URB POOR IND; *WHO, 2009, HOME VIS NEWB CHILD; *WHO, 2009, WORLD HLTH STAT 2009; WHO, 2006, WORLD HLTH REPORT 20; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; *WORLD BANK, 2006, IND UND CHILDDR CALL; World Health Organization, 2000, WORLD HLTH REP 2000; 2010, INDIAN EXPRESS  0412, P5; NAT NEONATAL PERINAT	102	166	167	1	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					332	349		10.1016/S0140-6736(10)61492-4	http://dx.doi.org/10.1016/S0140-6736(10)61492-4			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714ZO	21227494	Green Accepted			2022-12-01	WOS:000286850400030
J	Braun, S; Garcia, JF; Rowley, M; Rougemaille, M; Shankar, S; Madhani, HD				Braun, Sigurd; Garcia, Jennifer F.; Rowley, Margot; Rougemaille, Mathieu; Shankar, Smita; Madhani, Hiten D.			The Cul4-Ddb1(Cdt2) Ubiquitin Ligase Inhibits Invasion of a Boundary-Associated Antisilencing Factor into Heterochromatin	CELL			English	Article							JMJC DOMAIN PROTEIN; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; DNA-DAMAGE; S-PHASE; TRANSCRIPTION FACTOR; CHROMATIN DOMAINS; BINDING-PROTEIN; H3 METHYLATION; DDB1	Partitioning of chromosomes into euchromatic and heterochromatic domains requires mechanisms that specify boundaries. The S. pombe JmjC family protein Epe1 prevents the ectopic spread of heterochromatin and is itself concentrated at boundaries. Paradoxically, Epe1 is recruited to heterochromatin by HP1 silencing factors that are distributed throughout heterochromatin. We demonstrate here that the selective enrichment of Epe1 at boundaries requires its regulation by the conserved Cul4-Ddb1(Cdt2) ubiquitin ligase, which directly recognizes Epe1 and promotes its polyubiquitylation and degradation. Strikingly, in cells lacking the ligase, Epe1 persists in the body of heterochromatin thereby inducing a defect in gene silencing. Epe1 is the sole target of the Cul4-Ddb1(Cdt2) complex whose destruction is necessary for the preservation of heterochromatin. This mechanism acts parallel with phosphorylation of HP1/Swi6 by CK2 to restrict Epe1. We conclude that the ubiquitin-dependent sculpting of the chromosomal distribution of an antisilencing factor is critical for heterochromatin boundaries to form correctly.	[Braun, Sigurd; Garcia, Jennifer F.; Rowley, Margot; Rougemaille, Mathieu; Shankar, Smita; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,GH-N372C, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com	Garcia, Jennifer/HDN-4569-2022	Braun, Sigurd/0000-0001-6399-8574; Rougemaille, Mathieu/0000-0002-9675-3888; Garcia, Jennifer/0000-0002-0620-0594; Madhani, Hiten/0000-0001-7400-6657	German Research Foundation [BR 3511/1-1]; Human Frontier Science Program; Leukemia and Lymphoma Society; NIH/NIGMS IMSD [R25-GM56847]; National Institutes of Health [GM071801]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847, R01GM071801] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH/NIGMS IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael Rape, Stefan Jentsch, Geeta Narlikar, David Morgan, members of their labs, and Ulrike Boettcher for critical reading of the manuscript. We are grateful to Danesh Moazed, Karl Ekwall, and Takashi Toda for strains, plasmids, and protocols. S.B., M. Rougemaille, and S.S. were supported by postdoctoral fellowships of the German Research Foundation (BR 3511/1-1), the Human Frontier Science Program, and the Leukemia and Lymphoma Society, respectively. J.F.G. was supported by an NIH/NIGMS IMSD predoctoral fellowship (R25-GM56847). This work was supported by a grant to H.D.M. from the National Institutes of Health (GM071801) and a scholar's award to H.D.M. from the Leukemia and Lymphoma Society.	Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; Ekwall K, 1999, GENETICS, V153, P1153; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Golemis EA, 2009, CURR PROTOC PROTEIN; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Ishii K, 2003, MOL CELL, V11, P237, DOI 10.1016/S1097-2765(03)00010-8; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Rougemaille M, 2008, J BIOL CHEM, V283, P25770, DOI 10.1074/jbc.C800140200; Sacher M, 2005, METHOD ENZYMOL, V399, P392, DOI 10.1016/S0076-6879(05)99027-7; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Shimada A, 2009, GENE DEV, V23, P18, DOI 10.1101/gad.1708009; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	46	71	71	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					41	54		10.1016/j.cell.2010.11.051	http://dx.doi.org/10.1016/j.cell.2010.11.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215368	Green Accepted, Bronze			2022-12-01	WOS:000285993600006
J	Nichols, RJ; Sen, S; Choo, YJ; Beltrao, P; Zietek, M; Chaba, R; Lee, S; Kazmierczak, KM; Lee, KJ; Wong, A; Shales, M; Lovett, S; Winkler, ME; Krogan, NJ; Typas, A; Gross, CA				Nichols, Robert J.; Sen, Saunak; Choo, Yoe Jin; Beltrao, Pedro; Zietek, Matylda; Chaba, Rachna; Lee, Sueyoung; Kazmierczak, Krystyna M.; Lee, Karis J.; Wong, Angela; Shales, Michael; Lovett, Susan; Winkler, Malcolm E.; Krogan, Nevan J.; Typas, Athanasios; Gross, Carol A.			Phenotypic Landscape of a Bacterial Cell	CELL			English	Article							SYSTEMATIC GENETIC-ANALYSIS; TRANSPOSON MUTANT LIBRARY; ANTIBIOTIC-RESISTANCE MAR; ESCHERICHIA-COLI; MARA/SOXS/ROB REGULON; MEMBRANE-PROTEINS; DRUG-INTERACTIONS; FISSION YEAST; E. COLI; GENOME	The explosion of sequence information in bacteria makes developing high-throughput, cost-effective approaches to matching genes with phenotypes imperative. Using E. coli as proof of principle, we show that combining large-scale chemical genomics with quantitative fitness measurements provides a high-quality data set rich in discovery. Probing growth profiles of a mutant library in hundreds of conditions in parallel yielded > 10,000 phenotypes that allowed us to study gene essentiality, discover leads for gene function and drug action, and understand higher-order organization of the bacterial chromosome. We highlight new information derived from the study, including insights into a gene involved in multiple antibiotic resistance and the synergy between a broadly used combinatory antibiotic therapy, trimethoprim and sulfonamides. This data set, publicly available at http://ecoliwiki.net/tools/chemgen/, is a valuable resource for both the microbiological and bioinformatic communities, as it provides high-confidence associations between hundreds of annotated and uncharacterized genes as well as inferences about the mode of action of several poorly understood drugs.	[Nichols, Robert J.; Choo, Yoe Jin; Zietek, Matylda; Chaba, Rachna; Lee, Sueyoung; Lee, Karis J.; Wong, Angela; Typas, Athanasios; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Nichols, Robert J.] Univ Calif San Francisco, Oral & Craniofacial Sci Grad Program, San Francisco, CA 94143 USA; [Sen, Saunak] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Beltrao, Pedro; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Beltrao, Pedro; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Kazmierczak, Krystyna M.; Winkler, Malcolm E.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Lovett, Susan] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Lovett, Susan] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; Brandeis University; Brandeis University; University of California System; University of California San Francisco	Typas, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 600 16th St, San Francisco, CA 94158 USA.	athanasios.typas@ucsf.edu; cgrossucsf@gmail.com	Lovett, Susan/AAC-1810-2021; Beltrao, Pedro/B-3342-2010	Lovett, Susan/0000-0003-2792-1857; Beltrao, Pedro/0000-0002-2724-7703; Typas, Athanasios/0000-0002-0797-9018	NIH [R01 GM085697, R01 GM036278, K99GM092984, AI060744, GM078338, F31 DE020206-01, T32 DE007306]; ARRA [GM085697-01S1]; European Molecular Biology Organization; Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE020206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085697, K99GM092984, R01GM078338, R01GM036278] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Kishony, J. Weissman, A. Hochschild, and R.G. Martin for critically reading this manuscript; J. Hu and P. Thomas for hosting these data on E. coli Wiki; C. Raetz for CHIR-090 and M. Gottesman for Bicyclomycin; H. Mori for the Keio Collection; G. Storz for sharing the sRNA deletion library prior to publication; J. Greenblatt and A. Emili for SPA-tagged alleles; W. Margolin, R. Misra, T. Silhavy, and B. Palsson for mutants; and T. Baker and R. Sauer for controllable degradation plasmids. This work was supported by NIH R01 GM085697 and ARRA GM085697-01S1 to C.A.G. and N.J.K.; NIH R01 GM036278 to C.A.G.; NIH K99GM092984 to A.T.; NIH AI060744 to M.E.W.; NIH GM078338 to S.S.; NIH F31 DE020206-01 and NIH T32 DE007306 (R.J.N. support); European Molecular Biology Organization long-term fellowship (to A.T.); and Human Frontier Science Program Long-Term Postdoctoral Fellowship (to P.B.). In loving memory of S.R. Bartlett and J.T. Blair.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barker CA, 2010, CHEM BIOL, V17, P624, DOI 10.1016/j.chembiol.2010.05.010; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Carpentier AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-84; Couturier E, 2006, MOL MICROBIOL, V59, P1506, DOI 10.1111/j.1365-2958.2006.05046.x; D'Elia MA, 2009, TRENDS MICROBIOL, V17, P433, DOI 10.1016/j.tim.2009.08.005; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; GILONI L, 1981, J BIOL CHEM, V256, P8608; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Griffith KL, 2004, MOL MICROBIOL, V51, P1801, DOI 10.1046/j.1365-2958.2003.03952.x; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hobbs EC, 2010, J BACTERIOL, V192, P59, DOI 10.1128/JB.00873-09; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Jeanguenin L, 2010, J BIOL CHEM, V285, P41557, DOI 10.1074/jbc.M110.190504; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Kwon YK, 2010, ACS CHEM BIOL, V5, P787, DOI 10.1021/cb100096f; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; Martin RG, 2008, J MOL BIOL, V380, P278, DOI 10.1016/j.jmb.2008.05.015; MCOSKER CC, 1994, J ANTIMICROB CHEMOTH, V33, P23, DOI 10.1093/jac/33.suppl_A.23; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nicoloff H, 2007, ANTIMICROB AGENTS CH, V51, P1293, DOI 10.1128/AAC.01128-06; Nicoloff H, 2006, J BACTERIOL, V188, P4413, DOI 10.1128/JB.01502-05; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; SCHIRCH V, 1985, J BACTERIOL, V163, P1; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; TU Y, 1975, BIOCHIM BIOPHYS ACTA, V402, P142, DOI 10.1016/0005-2787(75)90032-5; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Warner DM, 2010, MICROBIOL-SGM, V156, P570, DOI 10.1099/mic.0.033415-0; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133	70	456	462	1	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					143	156		10.1016/j.cell.2010.11.052	http://dx.doi.org/10.1016/j.cell.2010.11.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21185072	Bronze, Green Accepted			2022-12-01	WOS:000285993600014
J	Studenski, S; Perera, S; Patel, K; Rosano, C; Faulkner, K; Inzitari, M; Brach, J; Chandler, J; Cawthon, P; Connor, EB; Nevitt, M; Visser, M; Kritchevsky, S; Badinelli, S; Harris, T; Newman, AB; Cauley, J; Ferrucci, L; Guralnik, J				Studenski, Stephanie; Perera, Subashan; Patel, Kushang; Rosano, Caterina; Faulkner, Kimberly; Inzitari, Marco; Brach, Jennifer; Chandler, Julie; Cawthon, Peggy; Connor, Elizabeth Barrett; Nevitt, Michael; Visser, Marjolein; Kritchevsky, Stephen; Badinelli, Stefania; Harris, Tamara; Newman, Anne B.; Cauley, Jane; Ferrucci, Luigi; Guralnik, Jack			Gait Speed and Survival in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL PERFORMANCE-MEASURES; LOWER-EXTREMITY FUNCTION; LOWER-BODY FUNCTION; WALKING SPEED; MUSCLE STRENGTH; MOBILITY LIMITATIONS; 5-YEAR MORTALITY; LIFE EXPECTANCY; ELDERLY PERSONS; HEALTH	Context Survival estimates help individualize goals of care for geriatric patients, but life tables fail to account for the great variability in survival. Physical performance measures, such as gait speed, might help account for variability, allowing clinicians to make more individualized estimates. Objective To evaluate the relationship between gait speed and survival. Design, Setting, and Participants Pooled analysis of 9 cohort studies (collected between 1986 and 2000), using individual data from 34 485 community-dwelling older adults aged 65 years or older with baseline gait speed data, followed up for 6 to 21 years. Participants were a mean (SD) age of 73.5 (5.9) years; 59.6%, women; and 79.8%, white; and had a mean (SD) gait speed of 0.92 (0.27) m/s. Main Outcome Measures Survival rates and life expectancy. Results There were 17 528 deaths; the overall 5-year survival rate was 84.8% (confidence interval [CI], 79.6%-88.8%) and 10-year survival rate was 59.7% (95% CI, 46.5%-70.6%). Gait speed was associated with survival in all studies (pooled hazard ratio per 0.1 m/s, 0.88; 95% CI, 0.87-0.90; P<.001). Survival increased across the full range of gait speeds, with significant increments per 0.1 m/s. At age 75, predicted 10-year survival across the range of gait speeds ranged from 19% to 87% in men and from 35% to 91% in women. Predicted survival based on age, sex, and gait speed was as accurate as predicted based on age, sex, use of mobility aids, and self-reported function or as age, sex, chronic conditions, smoking history, blood pressure, body mass index, and hospitalization. Conclusion In this pooled analysis of individual data from 9 selected cohorts, gait speed was associated with survival in older adults. JAMA. 2011;305(1):50-58 www.jama.com	[Studenski, Stephanie; Perera, Subashan] Univ Pittsburgh, Sch Med, Dept Med, Div Geriatr Med, Pittsburgh, PA 15260 USA; [Rosano, Caterina; Newman, Anne B.; Cauley, Jane] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Brach, Jennifer] Univ Pittsburgh, Sch Hlth & Rehabil, Dept Phys Therapy, Pittsburgh, PA 15260 USA; [Faulkner, Kimberly] Natl Personal Protect Technol Lab, Pittsburgh, PA USA; [Patel, Kushang; Harris, Tamara; Guralnik, Jack] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Ferrucci, Luigi] NIA, Clin Res Branch, Intramural Res Program, Bethesda, MD 20892 USA; [Inzitari, Marco] Autonomous Univ Barcelona, Pere Virgili Hosp, Barcelona, Spain; [Inzitari, Marco] Autonomous Univ Barcelona, Inst Aging, Barcelona, Spain; [Chandler, Julie] Merck Res Labs, N Wales, PA USA; [Nevitt, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Connor, Elizabeth Barrett] Univ Calif San Diego, La Jolla, CA 92093 USA; [Kritchevsky, Stephen] Wake Forest Univ, Winston Salem, NC 27109 USA; [Badinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Autonomous University of Barcelona; Autonomous University of Barcelona; Merck & Company; University of California System; University of California San Francisco; University of California System; University of California San Diego; Wake Forest University; Azienda Sanitaria di Firenze	Studenski, S (corresponding author), Kaufmann Bldg,Ste 500,3471 5th Ave, Pittsburgh, PA 15143 USA.	sas33@pitt.edu	Visser, Marjolein/AAP-3224-2020; Newman, Anne B./C-6408-2013; Inzitari, Marco/ABC-1529-2021; Perera, Subashan/D-7603-2014; Brach, Jennifer/A-6912-2009	Newman, Anne B./0000-0002-0106-1150; Brach, Jennifer/0000-0002-7793-2004; Rosano, Caterina/0000-0002-4271-6010; Visser, Marjolein/0000-0002-5136-298X; Cauley, Jane A/0000-0003-0752-4408; Inzitari, Marco/0000-0002-3796-0625; Rosano, Caterina/0000-0002-0909-1506; Kritchevsky, Stephen/0000-0003-3336-6781	Merck; Novartis; GTX; Merck Research Lab; Amgen; National Institute on Aging, NIH NIA Professional Services Contract Health and Human Services [11200800292P];  [AG023641];  [AG024827]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K07AG023641, P30AG021332, P30AG024827] Funding Source: NIH RePORTER	Merck(Merck & Company); Novartis(Novartis); GTX; Merck Research Lab; Amgen(Amgen); National Institute on Aging, NIH NIA Professional Services Contract Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Studenski reported receiving institutional grant support, travel expenses, and consultancy fees from Merck; consultlancy fees from Novartis and GTX; and royalties from Hazzart Text McGraw Hill. Dr Perera reported receiving institutional grant support from Merck Research Lab. Dr Inzitari reported receiving insitutional grant support from Merck. Dr Brach reported receiving institutional grant support from Merck. Dr Cawthon reported receiving consultancy fees from Amgen and Merck. Dr Cauley reported receiving consultancy fees and institutional grant support from Novartis. Drs Patel, Faulkner, Barett-Connor, Nevitt, Visser, Bandellini, Harris, Newman, Ferrucci, and Gurlanik reported no disclosures.; Additional support for the pooled analyses was provided by grants AG023641, AG024827 and the Intramural Research Program, National Institute on Aging, NIH NIA Professional Services Contract Health and Human Services number 11200800292P. Dr Studenski received grant support from Merck to perform this work.	Apfel CC, 2001, BRIT J ANAESTH, V86, P822, DOI 10.1093/bja/86.6.822; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Buchman Aron S, 2009, Proc Am Thorac Soc, V6, P581, DOI 10.1513/pats.200905-030RM; Callisaya ML, 2009, AGE AGEING, V38, P290, DOI 10.1093/ageing/afp017; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari Matteo, 2008, BMC Geriatr, V8, P34, DOI 10.1186/1471-2318-8-34; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Cham R, 2008, EXP BRAIN RES, V185, P391, DOI 10.1007/s00221-007-1161-3; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; Cuoco A, 2004, J GERONTOL A-BIOL, V59, P1200, DOI 10.1093/gerona/59.11.1200; DEAR KBG, 1994, BIOMETRICS, V50, P989, DOI 10.2307/2533438; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Fitzpatrick AL, 2007, J GERONTOL A-BIOL, V62, P1244, DOI 10.1093/gerona/62.11.1244; Fried LF, 2006, J AM GERIATR SOC, V54, P750, DOI 10.1111/j.1532-5415.2006.00727.x; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gill TM, 2010, J AM GERIATR SOC, V58, pS308, DOI 10.1111/j.1532-5415.2010.02914.x; Graham JE, 2008, ARCH PHYS MED REHAB, V89, P865, DOI 10.1016/j.apmr.2007.11.029; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hall WJ, 2006, ANN INTERN MED, V145, P538, DOI 10.7326/0003-4819-145-7-200610030-00012; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Jones LM, 2009, J PHYS ACT HEALTH, V6, P327, DOI 10.1123/jpah.6.3.327; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Katsahian S, 2008, CONTEMP CLIN TRIALS, V29, P220, DOI 10.1016/j.cct.2007.08.002; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; Kerrigan DC, 2001, ARCH PHYS MED REHAB, V82, P26, DOI 10.1053/apmr.2001.18584; Klein JP., 2003, SURVIVAL ANAL TECHNI, DOI 10.1007/b97377; Kuo Chen-Ko, 2009, BMC Geriatr, V9, P49, DOI 10.1186/1471-2318-9-49; LAVSKYSHULAN M, 1985, J AM GERIATR SOC, V33, P23, DOI 10.1111/j.1532-5415.1985.tb02855.x; Lawless J. F., 2002, STAT MODELS METHODS, V2nd, DOI DOI 10.1002/9781118033005; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Lubitz J, 2003, NEW ENGL J MED, V349, P1048, DOI 10.1056/NEJMsa020614; Markides KS, 1999, SERVING MINORITY ELDERS IN THE 21ST CENTURY, P72; Markides KS, 2001, J GERONTOL A-BIOL, V56, pM243, DOI 10.1093/gerona/56.4.M243; Martin FC, 2005, AGE AGEING, V34, P281, DOI 10.1093/ageing/afi074; Mazzaglia G, 2007, J AM GERIATR SOC, V55, P1955, DOI 10.1111/j.1532-5415.2007.01446.x; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Nebes RD, 2007, J GERONTOL A-BIOL, V62, P83, DOI 10.1093/gerona/62.1.83; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Ostbye T, 1999, J AM GERIATR SOC, V47, P1249, DOI 10.1111/j.1532-5415.1999.tb05207.x; Ostir GV, 2007, AM J EPIDEMIOL, V166, P599, DOI 10.1093/aje/kwm121; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Rolland Y, 2006, EUR J EPIDEMIOL, V21, P113, DOI 10.1007/s10654-005-5458-x; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Rosano C, 2007, J GERONTOL A-BIOL, V62, P1048, DOI 10.1093/gerona/62.9.1048; Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y; Simonsick EM, 2008, J GERONTOL A-BIOL, V63, P841, DOI 10.1093/gerona/63.8.841; Solway S, 2001, CHEST, V119, P256, DOI 10.1378/chest.119.1.256; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Thernau TM, 2000, MODELING SURVIVAL DA; *US DEP HHS, 2004, 941308 PHS US DEP HL; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 2000, J AM GERIATR SOC, V48, P381, DOI 10.1111/j.1532-5415.2000.tb04694.x; Volpato S, 2002, DIABETES CARE, V25, P678, DOI 10.2337/diacare.25.4.678; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Woo J, 1999, J AM GERIATR SOC, V47, P1257, DOI 10.1111/j.1532-5415.1999.tb05209.x; 2010, US LIFE TABLES	67	2540	2587	7	233	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					50	58		10.1001/jama.2010.1923	http://dx.doi.org/10.1001/jama.2010.1923			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702VN	21205966	Bronze, Green Accepted			2022-12-01	WOS:000285924100024
J	Phelps, J; Webb, EL; Bickford, D; Nijman, V; Sodhi, NS				Phelps, Jacob; Webb, Edward L.; Bickford, David; Nijman, Vincent; Sodhi, Navjot S.			Boosting CITES	SCIENCE			English	Editorial Material							INTERNATIONAL WILDLIFE TRADE; CONSERVATION; DYNAMICS		[Phelps, Jacob; Webb, Edward L.; Bickford, David; Sodhi, Navjot S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Nijman, Vincent] Oxford Brookes Univ, Sch Social Sci & Law, Oxford OX3 0BP, England	National University of Singapore; Oxford Brookes University	Phelps, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	jacob.phelps@gmail.com; dbsbdp@nus.edu.sg	Nijman, Vincent/AHD-8685-2022; Bickford, David P/A-5306-2011; Webb, Edward L/E-8343-2011	Bickford, David P/0000-0003-1478-3387; Webb, Edward L/0000-0001-5554-9955; Phelps, Jacob/0000-0001-6489-1103; Nijman, Vincent/0000-0002-5600-4276				Amir O. G., 2006, WILDLIFE TRADE SOMAL; [Anonymous], WILDLIFE TRADE POLIC; [Anonymous], RESOLUTION FINANCING; [Anonymous], GATHERING ANAL DATA; Blundell AG, 2004, ORYX, V38, P84, DOI 10.1017/S0030605304000134; Brito D, 2010, BIOL CONSERV, V143, P1154, DOI 10.1016/j.biocon.2010.02.015; Carpenter AI, 2004, BIOL CONSERV, V120, P291, DOI 10.1016/j.biocon.2004.03.002; CITES, NOND FIND; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davenport TRB, 2003, ORYX, V37, P55, DOI 10.1017/S0030605303000127; Dickson B, 2008, ORYX, V42, P548, DOI 10.1017/S0030605307000786; Gehring T, 2008, GLOBAL ENVIRON POLIT, V8, P123, DOI 10.1162/glep.2008.8.2.123; Gerson H, 2008, CONSERV BIOL, V22, P4, DOI 10.1111/j.1523-1739.2007.00857.x; Giles BG, 2006, BIODIVERS CONSERV, V15, P2497, DOI 10.1007/s10531-005-2432-6; Green EP, 1999, CORAL REEFS, V18, P403, DOI 10.1007/s003380050218; IUCN Species Survival Commission, 2009, ORCH SPEC GROUP GEN; Li YM, 1998, BIODIVERS CONSERV, V7, P895, DOI 10.1023/A:1008873119651; Milius S., 2010, SCI NEWS        0326; Mohneke M., 2010, Traffic Bulletin, V22, P117; Moyle B, 2009, GLOB CRIME, V10, P124, DOI 10.1080/17440570902783921; Nguyen Van Song, 2008, Journal of Environment & Development, V17, P145, DOI 10.1177/1070496508316220; Nijman V., 2010, WILDLIFE TRADE ASEAN; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Olsen CS, 2005, MT RES DEV, V25, P37, DOI 10.1659/0276-4741(2005)025[0037:ATOEAI]2.0.CO;2; Parsons ECM, 2010, MAR POLICY, V34, P384, DOI 10.1016/j.marpol.2009.08.008; Pistoni Juliana, 2010, South American Journal of Herpetology, V5, P51, DOI 10.2994/057.005.0106; Reeve R, 2006, INT AFF, V82, P881, DOI 10.1111/j.1468-2346.2006.00576.x; RENCTAS (Rede Nacional de Combate ao Trafico de Animais, 2001, 1 REL NAC TRAF FAUN; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Sand P H, 1997, EUR J INT LAW, V8, P29, DOI [10.1093/oxfordjournals.ejil.a015561, DOI 10.1093/OXFORDJOURNALS.EJIL.A015561]; Shepherd CR, 2008, BIODIVERS CONSERV, V17, P35, DOI 10.1007/s10531-007-9228-9; *SING MIN ED HS TR, R154000400133 SING M; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Sodhi NS., 2007, TROPICAL CONSERVATIO; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; United Nations Environment Programme-World Conservation Monitoring Centre (UNEP-WCMC), 2010, THREAT SPEC DAT; Veith M, 2000, BIODIVERS CONSERV, V9, P333, DOI 10.1023/A:1008906918236; Vitousek PM, 1996, AM SCI, V84, P468; Warkentin IG, 2009, CONSERV BIOL, V23, P1056, DOI 10.1111/j.1523-1739.2008.01165.x; Wilson-Wilde L, 2010, FORENSIC SCI MED PAT, V6, P221, DOI 10.1007/s12024-010-9167-8	41	79	82	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1752	1753		10.1126/science.1195558	http://dx.doi.org/10.1126/science.1195558			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21205655				2022-12-01	WOS:000285603700020
J	Thanukos, A; Scotchmoor, JG; Caldwell, R; Lindberg, DR				Thanukos, Anastasia; Scotchmoor, Judith G.; Caldwell, Roy; Lindberg, David R.			Science 101: Building the Foundations for Real Understanding	SCIENCE			English	Editorial Material									[Thanukos, Anastasia; Scotchmoor, Judith G.; Caldwell, Roy; Lindberg, David R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Caldwell, Roy; Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Caldwell, R (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.	rlcaldwell@berkeley.edu	Lindberg, David R/D-8138-2011		Howard Hughes Medical Institute [51003439] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bybee R, 2009, J RES SCI TEACH, V46, P865, DOI 10.1002/tea.20333; Lederman NG., 2007, HDB RES SCI ED, P831, DOI DOI 10.4324/9780203824696; Mooney C., 2009, UNSCIENTIFIC AM; National Science Board, 2010, SCI ENG IND 2010; ROCKMAN, UNDERSTANDING EVOLUT; STUHLSATZ MAM, 2010, 201008 ER BIOL SCI C	6	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1764	1765		10.1126/science.1186994	http://dx.doi.org/10.1126/science.1186994			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21127217				2022-12-01	WOS:000285603700028
J	Maiklem, A; Nicol, E				Maiklem, Andrew; Nicol, Ed			A Patient's Journey Heart transplant	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nicol, Ed] Royal Brompton Hosp, Dept Cardiol & Radiol, London SW3 6NP, England	Royal Brompton Hospital	Nicol, E (corresponding author), Royal Brompton Hosp, Dept Cardiol & Radiol, Sydney St, London SW3 6NP, England.	amaiklem@caci.co.uk; cyprusdoc@doctors.org.uk							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2010	341								c4918	10.1136/bmj.c4918	http://dx.doi.org/10.1136/bmj.c4918			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XO	21169319				2022-12-01	WOS:000285553300007
J	Johannessen, CM; Boehm, JS; Kim, SY; Thomas, SR; Wardwell, L; Johnson, LA; Emery, CM; Stransky, N; Cogdill, AP; Barretina, J; Caponigro, G; Hieronymus, H; Murray, RR; Salehi-Ashtiani, K; Hill, DE; Vidal, M; Zhao, JJ; Yang, XP; Alkan, O; Kim, S; Harris, JL; Wilson, CJ; Myer, VE; Finan, PM; Root, DE; Roberts, TM; Golub, T; Flaherty, KT; Dummer, R; Weber, BL; Sellers, WR; Schlegel, R; Wargo, JA; Hahn, WC; Garraway, LA				Johannessen, Cory M.; Boehm, Jesse S.; Kim, So Young; Thomas, Sapana R.; Wardwell, Leslie; Johnson, Laura A.; Emery, Caroline M.; Stransky, Nicolas; Cogdill, Alexandria P.; Barretina, Jordi; Caponigro, Giordano; Hieronymus, Haley; Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc; Zhao, Jean J.; Yang, Xiaoping; Alkan, Ozan; Kim, Sungjoon; Harris, Jennifer L.; Wilson, Christopher J.; Myer, Vic E.; Finan, Peter M.; Root, David E.; Roberts, Thomas M.; Golub, Todd; Flaherty, Keith T.; Dummer, Reinhard; Weber, Barbara L.; Sellers, William R.; Schlegel, Robert; Wargo, Jennifer A.; Hahn, William C.; Garraway, Levi A.			COT drives resistance to RAF inhibition through MAP kinase pathway reactivation	NATURE			English	Article							TUMOR PROGRESSION; SIGNALING PATHWAY; BRAF; MUTATIONS; CANCER; CELLS; GENE; TRANSFORMATION; SENSITIVITY; ACTIVATION	Oncogenic mutations in the serine/threonine kinase B-RAF (also known as BRAF) are found in 50-70% of malignant melanomas(1). Pre-clinical studies have demonstrated that the B-RAF(V600E) mutation predicts a dependency on the mitogen-activated protein kinase (MAPK) signalling cascade in melanoma(2-6)-an observation that has been validated by the success of RAF and MEK inhibitors in clinical trials(7-9). However, clinical responses to targeted anticancer therapeutics are frequently confounded by de novo or acquired resistance(10-12). Identification of resistance mechanisms in a manner that elucidates alternative 'druggable' targets may inform effective long-term treatment strategies(13). Here we expressed similar to 600 kinase and kinase-related open reading frames (ORFs) in parallel to interrogate resistance to a selective RAF kinase inhibitor. We identified MAP3K8 (the gene encoding COT/Tpl2) as a MAPK pathway agonist that drives resistance to RAF inhibition in B-RAF(V600E) cell lines. COT activates ERK primarily through MEK-dependent mechanisms that do not require RAF signalling. Moreover, COT expression is associated with de novo resistance in B-RAF(V600E) cultured cell lines and acquired resistance in melanoma cells and tissue obtained from relapsing patients following treatment with MEK or RAF inhibitors. We further identify combinatorial MAPK pathway inhibition or targeting of COT kinase activity as possible therapeutic strategies for reducing MAPK pathway activation in this setting. Together, these results provide new insights into resistance mechanisms involving the MAPK pathway and articulate an integrative approach through which high-throughput functional screens may inform the development of novel therapeutic strategies.	[Johannessen, Cory M.; Boehm, Jesse S.; Kim, So Young; Thomas, Sapana R.; Johnson, Laura A.; Stransky, Nicolas; Barretina, Jordi; Hieronymus, Haley; Yang, Xiaoping; Alkan, Ozan; Root, David E.; Golub, Todd; Hahn, William C.; Garraway, Levi A.] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Johannessen, Cory M.; Kim, So Young; Thomas, Sapana R.; Wardwell, Leslie; Johnson, Laura A.; Emery, Caroline M.; Barretina, Jordi; Hahn, William C.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, So Young; Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc; Hahn, William C.] Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; [Cogdill, Alexandria P.; Flaherty, Keith T.; Wargo, Jennifer A.] Massachusetts Gen Hosp, Div Surg Oncol Med Oncol & Dermatol, Boston, MA 02114 USA; [Barretina, Jordi; Golub, Todd; Hahn, William C.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Caponigro, Giordano; Wilson, Christopher J.; Myer, Vic E.; Finan, Peter M.; Weber, Barbara L.; Sellers, William R.; Schlegel, Robert] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Hieronymus, Haley; Golub, Todd] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc; Zhao, Jean J.; Roberts, Thomas M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Murray, Ryan R.; Salehi-Ashtiani, Kourosh; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhao, Jean J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kim, Sungjoon; Harris, Jennifer L.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Novartis; University of Zurich; University Zurich Hospital	Garraway, LA (corresponding author), Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA.	Levi_Garraway@dfci.harvard.edu	Hill, David E/B-6617-2011; Barretina, Jordi/A-7192-2013	Barretina, Jordi/0000-0002-3478-4080; Wilson, Christopher/0000-0002-9146-522X; Boehm, Jesse/0000-0002-6795-6336; Cogdill, Alexandria/0000-0001-8917-9462; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243	NIH [CA134502]; Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; US National Cancer Institute [R33 CA128625, RC2 CA148268]; Swiss National Foundation [310040-103671]; Gottfried and Julia Bangerter Rhyner Stiftung; Ellison Foundation; DFCI Strategic Initiative; NATIONAL CANCER INSTITUTE [RC2CA148268, R33CA128625, P50CA093683, R01CA134502, K08CA115927] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Gottfried and Julia Bangerter Rhyner Stiftung; Ellison Foundation(Lawrence Ellison Foundation); DFCI Strategic Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Broad Institute/Novartis Cancer Cell Line Encyclopedia (CCLE) for contributing cell line genomic data, expression data and pharmacological cell line sensitivity data; J. Thibault and A. Shipway for CCLE related tissue culture; R. Depinho, G. Dunn, S. Ethier, H. Greulich, A. Henderson, D. Kaplan, R. Levine, C. Miller, H. Piwnica-Worms, H. Suzuki, M. Vigny, D. Vollrath and the Harvard Institute of Proteomics for contributing templates for the kinase collection; J. Du and D. B. Wheeler for assistance with functional testing of kinases; D. A. Barbie for helpful discussions, S. E. Moody and H. W. Cheung for technical assistance, and J. K. Grenier and S. J. Silver for compiling and annotating the list of kinases. This work was supported by the NIH Director's New Innovator Award (L. A. G.), grants from the Novartis Institutes for Biomedical Research (L. A. G.), Melanoma Research Alliance (L. A. G.), Starr Cancer Consortium(L. A. G.) the US National Cancer Institute (R33 CA128625, RC2 CA148268) (W. C. H.), NIH (CA134502) (J.J.Z) the Swiss National Foundation (310040-103671) (R. D.), the Gottfried and Julia Bangerter Rhyner Stiftung (R. D.) the Ellison Foundation (M. V. and CCSB) and institute sponsored research funds from the DFCI Strategic Initiative (M. V. and CCSB).	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; George D, 2008, BIOORG MED CHEM LETT, V18, P4952, DOI 10.1016/j.bmcl.2008.08.037; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hirata K, 2010, BIOL PHARM BULL, V33, P133, DOI 10.1248/bpb.33.133; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Infante JR, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.2503; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Lee KM, 2009, CANCER RES, V69, P8043, DOI 10.1158/0008-5472.CAN-09-2316; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Schwartz GK, 2009, J CLIN ONCOL, V27; Seth R, 2009, GUT, V58, P1234, DOI 10.1136/gut.2008.159137; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433	29	1097	1140	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					968	U370		10.1038/nature09627	http://dx.doi.org/10.1038/nature09627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21107320	Green Accepted			2022-12-01	WOS:000285344600048
J	Ley, TJ; Ding, L; Walter, MJ; McLellan, MD; Lamprecht, T; Larson, DE; Kandoth, C; Payton, JE; Baty, J; Welch, J; Harris, CC; Lichti, CF; Townsend, RR; Fulton, RS; Dooling, DJ; Koboldt, DC; Schmidt, H; Zhang, QY; Osborne, JR; Lin, L; O'Laughlin, M; McMichael, JF; Delehaunty, KD; McGrath, SD; Fulton, LA; Magrini, VJ; Vickery, TL; Hundal, J; Cook, LL; Conyers, JJ; Swift, GW; Reed, JP; Alldredge, PA; Wylie, T; Walker, J; Kalicki, J; Watson, MA; Heath, S; Shannon, WD; Varghese, N; Nagarajan, R; Westervelt, P; Tomasson, MH; Link, DC; Graubert, TA; DiPersio, JF; Mardis, ER; Wilson, RK				Ley, Timothy J.; Ding, Li; Walter, Matthew J.; McLellan, Michael D.; Lamprecht, Tamara; Larson, David E.; Kandoth, Cyriac; Payton, Jacqueline E.; Baty, Jack; Welch, John; Harris, Christopher C.; Lichti, Cheryl F.; Townsend, R. Reid; Fulton, Robert S.; Dooling, David J.; Koboldt, Daniel C.; Schmidt, Heather; Zhang, Qunyuan; Osborne, John R.; Lin, Ling; O'Laughlin, Michelle; McMichael, Joshua F.; Delehaunty, Kim D.; McGrath, Sean D.; Fulton, Lucinda A.; Magrini, Vincent J.; Vickery, Tammi L.; Hundal, Jasreet; Cook, Lisa L.; Conyers, Joshua J.; Swift, Gary W.; Reed, Jerry P.; Alldredge, Patricia A.; Wylie, Todd; Walker, Jason; Kalicki, Joelle; Watson, Mark A.; Heath, Sharon; Shannon, William D.; Varghese, Nobish; Nagarajan, Rakesh; Westervelt, Peter; Tomasson, Michael H.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Mardis, Elaine R.; Wilson, Richard K.			DNMT3A Mutations in Acute Myeloid Leukemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DNA-METHYLTRANSFERASES; PROGNOSTIC IMPACT; CLINICAL-RESPONSE; ADULT PATIENTS; CANCER; TRANSCRIPTION; RECRUITMENT; SCHEDULE; ICF	Background: The genetic alterations responsible for an adverse outcome in most patients with acute myeloid leukemia (AML) are unknown. Methods: Using massively parallel DNA sequencing, we identified a somatic mutation in DNMT3A, encoding a DNA methyltransferase, in the genome of cells from a patient with AML with a normal karyotype. We sequenced the exons of DNMT3A in 280 additional patients with de novo AML to define recurring mutations. Results: A total of 62 of 281 patients (22.1%) had mutations in DNMT3A that were predicted to affect translation. We identified 18 different missense mutations, the most common of which was predicted to affect amino acid R882 (in 37 patients). We also identified six frameshift, six nonsense, and three splice-site mutations and a 1.5-Mbp deletion encompassing DNMT3A. These mutations were highly enriched in the group of patients with an intermediate-risk cytogenetic profile (56 of 166 patients, or 33.7%) but were absent in all 79 patients with a favorable-risk cytogenetic profile (P<0.001 for both comparisons). The median overall survival among patients with DNMT3A mutations was significantly shorter than that among patients without such mutations (12.3 months vs. 41.1 months, P<0.001). DNMT3A mutations were associated with adverse outcomes among patients with an intermediate-risk cytogenetic profile or FLT3 mutations, regardless of age, and were independently associated with a poor outcome in Cox proportional-hazards analysis. Conclusions: DNMT3A mutations are highly recurrent in patients with de novo AML with an intermediate-risk cytogenetic profile and are independently associated with a poor outcome. (Funded by the National Institutes of Health and others.) N Engl J Med 2010;363:2424-33.	[Ley, Timothy J.; Ding, Li; Zhang, Qunyuan; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Ley, Timothy J.; Ding, Li; McLellan, Michael D.; Larson, David E.; Kandoth, Cyriac; Harris, Christopher C.; Fulton, Robert S.; Dooling, David J.; Koboldt, Daniel C.; Schmidt, Heather; Zhang, Qunyuan; Osborne, John R.; Lin, Ling; O'Laughlin, Michelle; McMichael, Joshua F.; Delehaunty, Kim D.; McGrath, Sean D.; Fulton, Lucinda A.; Magrini, Vincent J.; Vickery, Tammi L.; Hundal, Jasreet; Cook, Lisa L.; Conyers, Joshua J.; Swift, Gary W.; Reed, Jerry P.; Alldredge, Patricia A.; Wylie, Todd; Walker, Jason; Kalicki, Joelle; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Ctr, St Louis, MO 63110 USA; [Ley, Timothy J.; Walter, Matthew J.; Lamprecht, Tamara; Welch, John; Lichti, Cheryl F.; Townsend, R. Reid; Heath, Sharon; Shannon, William D.; Westervelt, Peter; Tomasson, Michael H.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Ley, Timothy J.; Walter, Matthew J.; Townsend, R. Reid; Watson, Mark A.; Shannon, William D.; Varghese, Nobish; Nagarajan, Rakesh; Westervelt, Peter; Tomasson, Michael H.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Payton, Jacqueline E.; Watson, Mark A.; Varghese, Nobish; Nagarajan, Rakesh] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Baty, Jack] Washington Univ, Div Biostat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Dept Genet, 660 S Euclid Ave,Campus Box 8007, St Louis, MO 63110 USA.	timley@wustl.edu	Magrini, Vincent/AAT-5830-2020; Lichti, Cheryl/C-6359-2013; Mardis, Elaine/W-2202-2019; McGrath, Sean David/AAT-3540-2020; Wilson, Richard K./AAF-4139-2019; Walker, Jason/A-9702-2013; Walter, Matthew J/S-7758-2018	Magrini, Vincent/0000-0002-2019-4872; McGrath, Sean David/0000-0001-9064-8449; Wilson, Richard K./0000-0002-1992-1358; Walker, Jason/0000-0001-7547-5789; MCLELLAN, MICHAEL/0000-0002-2703-8784; Westover, Tamara/0000-0002-1000-6698; Graubert, Timothy/0000-0002-7710-1171; Larson, David/0000-0001-7934-5906; Tomasson, Michael/0000-0003-4518-7123; Kandoth, Cyriac/0000-0002-1345-3573; Lichti, Cheryl/0000-0003-4099-4954	National Center for Research Resources [UL1 RR024992]; National Institutes of Health [UL1 RR024992, P41RR000954, PO1 CA101937, U54 HG003079]; Barnes-Jewish Hospital Foundation [00335-0505-02]; Washington University Cancer Genome Initiative; NATIONAL CANCER INSTITUTE [P01CA101937] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, P41RR000954] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; Washington University Cancer Genome Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Center for Research Resources (UL1 RR024992), the National Institutes of Health (P41RR000954 and UL1 RR024992, to Dr. Townsend; PO1 CA101937, to Dr. Ley; and U54 HG003079, to Dr. Wilson), and the Barnes-Jewish Hospital Foundation (00335-0505-02, to Dr. Ley).; We thank Nancy Reidelberger for administrative support; Todd Hepler, William Schroeder, Justin Lolofie, Scott Abbott, Shawn Leonard, Ken Swanson, Indraniel Das, and Michael Kiwala for their contributions to the Laboratory Information Management System; Gary Stiehr, Richard Wohlstadter, Matt Weil, and Kelly Fallon for information-technology support; Jin Shao for statistical support; Clara Bloomfield, Michael Caligiuri, and James Vardiman for providing the AML samples from the CALGB Leukemia Bank; the Washington University Cancer Genome Initiative for support; Alvin J. Siteman for supporting the sequencing of the original AML genome that is further described in this study; and our patients.	Blum W, 2010, P NATL ACAD SCI USA, V107, P7473, DOI 10.1073/pnas.1002650107; Boissel N, 2010, J CLIN ONCOL, V28, P3717, DOI 10.1200/JCO.2010.28.2285; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Chou WC, 2010, BLOOD, V115, P2749, DOI 10.1182/blood-2009-11-253070; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Ehrlich M, 2008, AUTOIMMUNITY, V41, P253, DOI 10.1080/08916930802024202; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2005, NEW ENGL J MED, V352, P740; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; Fazi F, 2007, BLOOD, V109, P4432, DOI 10.1182/blood-2006-09-045781; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Jiang YL, 2005, HUM MUTAT, V25, P56, DOI 10.1002/humu.20113; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Liu SJ, 2005, CANCER RES, V65, P1277, DOI 10.1158/0008-5472.CAN-04-4532; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Wang YA, 2005, CANCER BIOL THER, V4, P1138, DOI 10.4161/cbt.4.10.2073; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117	37	1385	1428	5	118	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2424	2433		10.1056/NEJMoa1005143	http://dx.doi.org/10.1056/NEJMoa1005143			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21067377	Green Accepted, Green Published			2022-12-01	WOS:000285340200008
J	Moellering, RC				Moellering, Robert C., Jr.			NDM-1 - A Cause for Worldwide Concern	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANCE		[Moellering, Robert C., Jr.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Moellering, Robert C., Jr.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Moellering, RC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	5	212	223	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2377	2379		10.1056/NEJMp1011715	http://dx.doi.org/10.1056/NEJMp1011715			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158655				2022-12-01	WOS:000285340200001
J	Cannuscio, CC				Cannuscio, Carolyn C.			A Perfect Place to Die, Revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												carolyncannu@gmail.com	Cannuscio, Carolyn/A-1123-2007						0	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2452	2453		10.1001/jama.2010.1766	http://dx.doi.org/10.1001/jama.2010.1766			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139101				2022-12-01	WOS:000285053300002
J	Gurumurthy, S; Xie, SZ; Alagesan, B; Kim, J; Yusuf, RZ; Saez, B; Tzatsos, A; Ozsolak, F; Milos, P; Ferrari, F; Park, PJ; Shirihai, OS; Scadden, DT; Bardeesy, N				Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Ozsolak, Fatih; Milos, Patrice; Ferrari, Francesco; Park, Peter J.; Shirihai, Orian S.; Scadden, David T.; Bardeesy, Nabeel			The Lkb1 metabolic sensor maintains haematopoietic stem cell survival	NATURE			English	Article							PEUTZ-JEGHERS-SYNDROME; GLUCOSE-HOMEOSTASIS; TUMOR SUPPRESSION; IN-VIVO; PATHWAY; KINASE; MICE; APOPTOSIS; SYSTEM; ENERGY	Haematopoietic stem cells (HSCs) can convert between growth states that have marked differences in bioenergetic needs. Although often quiescent in adults, these cells become proliferative upon physiological demand. Balancing HSC energetics in response to nutrient availability and growth state is poorly understood, yet essential for the dynamism of the haematopoietic system. Here we show that the Lkb1 tumour suppressor is critical for the maintenance of energy homeostasis in haematopoietic cells. Lkb1 inactivation in adult mice causes loss of HSC quiescence followed by rapid depletion of all haematopoietic subpopulations. Lkb1-deficient bone marrow cells exhibit mitochondrial defects, alterations in lipid and nucleotide metabolism, and depletion of cellular ATP. The haematopoietic effects are largely independent of Lkb1 regulation of AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling. Instead, these data define a central role for Lkb1 in restricting HSC entry into cell cycle and in broadly maintaining energy homeostasis in haematopoietic cells through a novel metabolic checkpoint.	[Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Scadden, David T.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Scadden, David T.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Gurumurthy, Sushma; Xie, Stephanie Z.; Alagesan, Brinda; Kim, Judith; Yusuf, Rushdia Z.; Saez, Borja; Tzatsos, Alexandros; Scadden, David T.; Bardeesy, Nabeel] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Xie, Stephanie Z.; Yusuf, Rushdia Z.; Saez, Borja; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Xie, Stephanie Z.; Yusuf, Rushdia Z.; Saez, Borja; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA; [Ozsolak, Fatih; Milos, Patrice] Hel BioSci Corp, Cambridge, MA 02139 USA; [Ferrari, Francesco; Park, Peter J.] Childrens Hosp, Ctr Biomed Informat, Boston, MA 02115 USA; [Ferrari, Francesco; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Ferrari, Francesco; Park, Peter J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shirihai, Orian S.] Boston Univ, Med Ctr, Mitochondria ARC, Evans Res Ctr,Dept Med, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Boston University	Bardeesy, N (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	Scadden.David@MGH.Harvard.edu; Bardeesy.Nabeel@MGH.Harvard.edu	Ferrari, Francesco/H-5007-2012; Saez, Borja/L-7411-2015	Ferrari, Francesco/0000-0002-9811-3753; Park, Peter/0000-0001-9378-960X; Saez, Borja/0000-0001-7908-7089; Xie, Stephanie/0000-0002-0284-494X; Shirihai, Orian/0000-0002-9502-2661	NIH [U01 CA141576-01, DK050234]; Ellison Medical Foundation; Massachusetts Biotechnology Research Council; NATIONAL CANCER INSTITUTE [U01CA141576] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Massachusetts Biotechnology Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank the Harvard Stem Cell Institute Flow Cytometry Core and D. Brown and the MGH Electron Microscope Imaging Core for expertise and advice. V. Levy and M. Leisa provided technical assistance in the SeaHorse measurements. D. Van Buren provided advice and assistance in pilot experiments. We thank A. Camacho for mouse colony assistance. We would also like to thank A. Kimmelman, R. Mostoslavsky, M. Vander Heiden, L. Ellisen, W. Kim and M. Ivan for discussions and critical review of the manuscript. We are grateful to S. Morrison and R. DePinho for sharing unpublished data. N.B. would like to acknowledge support from NIH U01 CA141576-01. D.T.S would like to acknowledge support from NIH DK050234 and Ellison Medical Foundation. S.G. was supported by a Massachusetts Biotechnology Research Council Tosteson Fellowship. S.Z.X. was supported by an NIH Ruth L. Kirschstein National Research Service Award.	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Torchia EC, 2007, MOL CELL BIOL, V27, P7918, DOI 10.1128/MCB.00099-07; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09	35	296	310	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					659	U75		10.1038/nature09572	http://dx.doi.org/10.1038/nature09572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124451	Green Accepted			2022-12-01	WOS:000284836700033
J	Van Raamsdonk, CD; Griewank, KG; Crosby, MB; Garrido, MC; Vemula, S; Wiesner, T; Obenauf, AC; Wackernagel, W; Green, G; Bouvier, N; Sozen, MM; Baimukanova, G; Roy, R; Heguy, A; Dolgalev, I; Khanin, R; Busam, K; Speicher, MR; O'Brien, J; Bastian, BC				Van Raamsdonk, Catherine D.; Griewank, Klaus G.; Crosby, Michelle B.; Garrido, Maria C.; Vemula, Swapna; Wiesner, Thomas; Obenauf, Anna C.; Wackernagel, Werner; Green, Gary; Bouvier, Nancy; Sozen, M. Mert; Baimukanova, Gail; Roy, Ritu; Heguy, Adriana; Dolgalev, Igor; Khanin, Raya; Busam, Klaus; Speicher, Michael R.; O'Brien, Joan; Bastian, Boris C.			Mutations in GNA11 in Uveal Melanoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOMATIC MUTATIONS; ALPHA-SUBUNIT; HUMAN CANCER; BRAF; SKIN; MELANOCYTES; ACTIVATION; FREQUENCY; EXPOSURE; TUMORS	Background: Uveal melanoma is the most common intraocular cancer. There are no effective therapies for metastatic disease. Mutations in GNAQ, the gene encoding an alpha subunit of heterotrimeric G proteins, are found in 40% of uveal melanomas. Methods: We sequenced exon 5 of GNAQ and GNA11, a paralogue of GNAQ, in 713 melanocytic neoplasms of different types (186 uveal melanomas, 139 blue nevi, 106 other nevi, and 282 other melanomas). We sequenced exon 4 of GNAQ and GNA11 in 453 of these samples and in all coding exons of GNAQ and GNA11 in 97 uveal melanomas and 45 blue nevi. Results: We found somatic mutations in exon 5 (affecting Q209) and in exon 4 (affecting R183) in both GNA11 and GNAQ, in a mutually exclusive pattern. Mutations affecting Q209 in GNA11 were present in 7% of blue nevi, 32% of primary uveal melanomas, and 57% of uveal melanoma metastases. In contrast, we observed Q209 mutations in GNAQ in 55% of blue nevi, 45% of uveal melanomas, and 22% of uveal melanoma metastases. Mutations affecting R183 in either GNAQ or GNA11 were less prevalent (2% of blue nevi and 6% of uveal melanomas) than the Q209 mutations. Mutations in GNA11 induced spontaneously metastasizing tumors in a mouse model and activated the mitogen-activated protein kinase pathway. Conclusions: Of the uveal melanomas we analyzed, 83% had somatic mutations in GNAQ or GNA11. Constitutive activation of the pathway involving these two genes appears to be a major contributor to the development of uveal melanoma. (Funded by the National Institutes of Health and others.) N Engl J Med 2010;363:2191-9.	[Van Raamsdonk, Catherine D.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Griewank, Klaus G.; Crosby, Michelle B.; Garrido, Maria C.; Vemula, Swapna; Green, Gary; Bouvier, Nancy; Baimukanova, Gail; Bastian, Boris C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [O'Brien, Joan] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Bastian, Boris C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Roy, Ritu; O'Brien, Joan; Bastian, Boris C.] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Wiesner, Thomas] Med Univ Graz, Dept Dermatol, Graz, Austria; [Obenauf, Anna C.; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, Graz, Austria; [Wackernagel, Werner] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Bouvier, Nancy; Sozen, M. Mert; Heguy, Adriana; Dolgalev, Igor; Bastian, Boris C.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Bastian, Boris C.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	University of British Columbia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Medical University of Graz; Medical University of Graz; Medical University of Graz; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Van Raamsdonk, CD (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada.	bastianb@mskcc.org	Van Raamsdonk, Catherine D./B-6207-2017; Speicher, Michael R/B-5362-2013; Wackernagel, Werner/I-8581-2012; Sozen, Mert M./E-7278-2011; Heguy, Adriana/GPP-3907-2022; Dolgalev, Igor/AAY-6406-2020; Griewank, Klaus G/A-9097-2017	Van Raamsdonk, Catherine D./0000-0002-4309-3513; Speicher, Michael R/0000-0003-0105-955X; Wackernagel, Werner/0000-0002-4524-4012; Sozen, Mert M./0000-0002-1672-2206; Dolgalev, Igor/0000-0003-4451-126X; Griewank, Klaus G/0000-0003-3899-9449; Obenauf, Anna/0000-0002-9556-5914; Wiesner, Thomas/0000-0001-5877-2992; Bastian, Boris/0000-0003-1836-6062	National Institutes of Health [R01 CA131524]; Melanoma Research Alliance; Canadian Institutes of Health Research [MOP-79511]; Canadian Cancer Society [019055]; European Commission [HEALTH-F2-2008-202230]; Jubilaumsfonds of the Oesterreichische Nationalbank [12480, 13837]; Medical University Graz; Deutsche Forschungsgemeinschaft [GR 3671/1-1]; NATIONAL CANCER INSTITUTE [R01CA142873, R01CA131524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); European Commission(European CommissionEuropean Commission Joint Research Centre); Jubilaumsfonds of the Oesterreichische Nationalbank; Medical University Graz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Institutes of Health (R01 CA131524) and the Melanoma Research Alliance (both to Dr. Bastian), the Canadian Institutes of Health Research (MOP-79511) and the Canadian Cancer Society (019055) (both to Dr. Van Raamsdonk), the European Commission (GENINCA, contract no. HEALTH-F2-2008-202230), the Jubilaumsfonds of the Oesterreichische Nationalbank (12480 and 13837), and the Molecular Medicine program of Medical University Graz (to Dr. Obenauf), and Deutsche Forschungsgemeinschaft (research stipend GR 3671/1-1, to Dr. Griewank).	ABRAMSON DH, 2003, CANC MED 6, V2, P1242; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Bauer J, 2009, BRIT J CANCER, V101, P813, DOI 10.1038/sj.bjc.6605226; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; HORSMAN DE, 1993, CANCER, V71, P811, DOI 10.1002/1097-0142(19930201)71:3<811::AID-CNCR2820710325>3.0.CO;2-F; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; KUSTERSVANDEVEL.HV, 2009, ACTA NEUROPATHO 1122; Lamba S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006833; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Li WJ, 2000, CANCER RES, V60, P3757; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Mainster MA, 2010, AM J OPHTHALMOL, V149, P543, DOI 10.1016/j.ajo.2009.11.028; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; Mudhar HS, 2004, HISTOPATHOLOGY, V45, P1, DOI 10.1111/j.1365-2559.2004.01874.x; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Saldanha G, 2004, INT J CANCER, V111, P705, DOI 10.1002/ijc.20325; Singh AD, 2004, SURV OPHTHALMOL, V49, P419, DOI 10.1016/j.survophthal.2004.04.009; Singh AD, 1998, OPHTHALMOLOGY, V105, P195, DOI 10.1016/S0161-6420(98)92205-9; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Vajdic CM, 2002, INT J CANCER, V101, P175, DOI 10.1002/ijc.10579; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; White VA, 1998, CANCER, V83, P354, DOI 10.1002/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.3.CO;2-C; Zembowicz A, 2004, HISTOPATHOLOGY, V45, P433, DOI 10.1111/j.1365-2559.2004.01975.x; Zuidervaart W, 2005, BRIT J CANCER, V92, P2032, DOI 10.1038/sj.bjc.6602598	36	963	980	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2191	2199		10.1056/NEJMoa1000584	http://dx.doi.org/10.1056/NEJMoa1000584			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21083380	Green Accepted, Bronze			2022-12-01	WOS:000284832900006
J	Luk, E; Ranjan, A; FitzGerald, PC; Mizuguchi, G; Huang, Y; Wei, D; Wu, C				Luk, Ed; Ranjan, Anand; FitzGerald, Peter C.; Mizuguchi, Gaku; Huang, Yingzi; Wei, Debbie; Wu, Carl			Stepwise Histone Replacement by SWR1 Requires Dual Activation with Histone H2A.Z and Canonical Nucleosome	CELL			English	Article							VARIANT H2A.Z; CHROMATIN; TRANSCRIPTION; REPLICATION; PROMOTERS; EXCHANGE; COMPLEX; ACETYLATION; STABILITY; DYNAMICS	Histone variant H2A.Z-containing nucleosomes are incorporated at most eukaryotic promoters. This incorporation is mediated by the conserved SWR1 complex, which replaces histone H2A in canonical nucleosomes with H2A.Z in an ATP-dependent manner. Here, we show that promoter-proximal nucleosomes are highly heterogeneous for H2A.Z in Saccharomyces cerevisiae, with substantial representation of nucleosomes containing one, two, or zero H2A.Z molecules. SWR1-catalyzed H2A.Z replacement in vitro occurs in a stepwise and unidirectional fashion, one H2A.Z-H2B dimer at a time, producing heterotypic nucleosomes as intermediates and homotypic H2A.Z nucleosomes as end products. The ATPase activity of SWR1 is specifically stimulated by H2A-containing nucleosomes without ensuing histone H2A eviction. Remarkably, further addition of free H2A.Z-H2B dimer leads to hyperstimulation of ATPase activity, eviction of nucleosomal H2A-H2B, and deposition of H2A.Z-H2B. These results suggest that the combination of H2A-containing nucleosome and free H2A.Z-H2B dimer acting as both effector and substrate for SWR1 governs the specificity and outcome of the replacement reaction.	[Luk, Ed; Ranjan, Anand; Mizuguchi, Gaku; Huang, Yingzi; Wei, Debbie; Wu, Carl] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [FitzGerald, Peter C.] NCI, Genome Anal Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Luk, E (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	luked@mail.nih.gov; carlwu@helix.nih.gov		Luk, Ed/0000-0002-6619-2258	National Cancer Institute; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [ZIABC005263] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W.H. Wu for the yeast strain SWR1-FL htz1 Delta and J. Landry for the yeast strain yJL036. We also thank H. Cam and C. Rubin for advice on microarray techniques, F. Pugh and members of the Wu lab for critical reading of the manuscript, and anonymous reviewers for helpful suggestions. This work was supported by the intramural research program of the National Cancer Institute (C.W.) and by the Leukemia and Lymphoma Society (E.L. and A.R.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Chakravarthy S, 2004, COLD SPRING HARB SYM, V69, P227, DOI 10.1101/sqb.2004.69.227; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Gutierrez JL, 2007, EMBO J, V26, P730, DOI 10.1038/sj.emboj.7601524; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Jackson JD, 2000, NUCLEIC ACIDS RES, V28, P3811, DOI 10.1093/nar/28.19.3811; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yoshida T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000910; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	50	153	157	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					725	736		10.1016/j.cell.2010.10.019	http://dx.doi.org/10.1016/j.cell.2010.10.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111233	Green Accepted			2022-12-01	WOS:000284583500015
J	Freiwald, WA; Tsao, DY				Freiwald, Winrich A.; Tsao, Doris Y.			Functional Compartmentalization and Viewpoint Generalization Within the Macaque Face-Processing System	SCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; INFEROTEMPORAL CORTEX; OBJECT RECOGNITION; SINGLE NEURONS; VISUAL-CORTEX; MONKEY; AREA; REPRESENTATION; PERCEPTION; MEMORY	Primates can recognize faces across a range of viewing conditions. Representations of individual identity should thus exist that are invariant to accidental image transformations like view direction. We targeted the recently discovered face-processing network of the macaque monkey that consists of six interconnected face-selective regions and recorded from the two middle patches (ML, middle lateral, and MF, middle fundus) and two anterior patches (AL, anterior lateral, and AM, anterior medial). We found that the anatomical position of a face patch was associated with a unique functional identity: Face patches differed qualitatively in how they represented identity across head orientations. Neurons in ML and MF were view-specific; neurons in AL were tuned to identity mirror-symetrically across views, thus achieving partial view invariance; and neurons in AM, the most anterior face patch, achieved almost full view invariance.	[Freiwald, Winrich A.] Rockefeller Univ, New York, NY 10065 USA; [Tsao, Doris Y.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Rockefeller University; California Institute of Technology	Freiwald, WA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	wfreiwald@rockefeller.edu; dortsao@caltech.edu			Humboldt Foundation; German Science Foundation [FR 1437/3-1]; German Ministry of Science, Bremen Center for Advanced Imaging [01GO0506]; NIH [1R01EY019702]; Alfred Sloan Foundation; John Merck Foundation; Searle Foundation; Klingenstein Foundation; NSF [BCS-0847798]; Alexander von Humboldt Foundation; Irma T. Hirschl Trust; Monique Weill-Caulier Trust; Klingenstein Fellowship; Sinsheimer Scholar Award; Pew Scholar Award; NATIONAL EYE INSTITUTE [R01EY019702] Funding Source: NIH RePORTER	Humboldt Foundation(Alexander von Humboldt Foundation); German Science Foundation(German Research Foundation (DFG)); German Ministry of Science, Bremen Center for Advanced Imaging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred Sloan Foundation(Alfred P. Sloan Foundation); John Merck Foundation; Searle Foundation; Klingenstein Foundation(Klingenstein Philanthropies); NSF(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Irma T. Hirschl Trust; Monique Weill-Caulier Trust; Klingenstein Fellowship(Klingenstein Philanthropies); Sinsheimer Scholar Award; Pew Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to M. Livingstone, S. Moeller, C. Cadieu, and A. Tsao for discussions; N. Schweers for outstanding technical assistance; S. Chang and the late D. Freeman for stimulus programming; the Humboldt Foundation Sofia Kovalevskaya Award, German Science Foundation grant FR 1437/3-1, the German Ministry of Science (Grant 01GO0506, Bremen Center for Advanced Imaging), and NIH 1R01EY019702 for financial support; and the Otto Loewi Minerva Center for logistic support. D. Y. T. is supported by the Alfred Sloan Foundation, the John Merck Foundation, the Searle Foundation, the Klingenstein Foundation, and NSF CAREER Award BCS-0847798. W. A. F. is supported by a Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation, an Irma T. Hirschl and Monique Weill-Caulier Trusts Award, a Klingenstein Fellowship Award, a Sinsheimer Scholar Award, and a Pew Scholar Award.	Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Biederman I, 2000, SPATIAL VISION, V13, P241, DOI 10.1163/156856800741063; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Eifuku S, 2004, J NEUROPHYSIOL, V91, P358, DOI 10.1152/jn.00198.2003; HASSELMO ME, 1989, EXP BRAIN RES, V75, P417; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Li N, 2008, SCIENCE, V321, P1502, DOI 10.1126/science.1160028; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; McKone E, 2005, J EXP PSYCHOL HUMAN, V31, P1181, DOI 10.1037/0096-1523.31.6.1181; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rollenhagen JE, 2000, SCIENCE, V287, P1506, DOI 10.1126/science.287.5457.1506; Rolls ET, 2007, NEUROPSYCHOLOGIA, V45, P124, DOI 10.1016/j.neuropsychologia.2006.04.019; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; SALEEM KS, 1993, CEREB CORTEX, V3, P454, DOI 10.1093/cercor/3.5.454; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; VETTER T, 1994, CURR BIOL, V4, P18, DOI 10.1016/S0960-9822(00)00004-X; Wallis G, 2001, P NATL ACAD SCI USA, V98, P4800, DOI 10.1073/pnas.071028598; YAMANE S, 1988, EXP BRAIN RES, V73, P209, DOI 10.1007/BF00279674; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	34	408	412	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					845	851		10.1126/science.1194908	http://dx.doi.org/10.1126/science.1194908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051642	Green Accepted			2022-12-01	WOS:000283855700050
J	Song, JK; Rechkoblit, O; Bestor, TH; Patel, DJ				Song, Jikui; Rechkoblit, Olga; Bestor, Timothy H.; Patel, Dinshaw J.			Structure of DNMT1-DNA Complex Reveals a Role for Autoinhibition in Maintenance DNA Methylation	SCIENCE			English	Article							CXXC DOMAIN; METHYLTRANSFERASE; LEUKEMIA	Maintenance of genomic methylation patterns is mediated primarily by DNA methyltransferase-1 (DNMT1). We have solved structures of mouse and human DNMT1 composed of CXXC, tandem bromo-adjacent homology (BAH1/2), and methyltransferase domains bound to DNA-containing unmethylated CpG sites. The CXXC specifically binds to unmethylated CpG dinucleotide and positions the CXXC-BAH1 linker between the DNA and the active site of DNMT1, preventing de novo methylation. In addition, a loop projecting from BAH2 interacts with the target recognition domain (TRD) of the methyltransferase, stabilizing the TRD in a retracted position and preventing it from inserting into the DNA major groove. Our studies identify an autoinhibitory mechanism, in which unmethylated CpG dinucleotides are occluded from the active site to ensure that only hemimethylated CpG dinucleotides undergo methylation.	[Song, Jikui; Rechkoblit, Olga; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Bestor, Timothy H.] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Columbia University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org		Rechkoblit, Olga/0000-0003-4270-7242	Abby Rockefeller Mauze Trust; Maloris Foundation; NIH; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Trust; Maloris Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by funds from the Abby Rockefeller Mauze Trust and Maloris Foundation to D.J.P. and from NIH to T.H.B. We thank S. Murakami for technical assistance and Z. Wang and H. Li for their assistance with x-ray data collection and structure determination. We would also like to thank the staff of NE-CAT beamlines at the Advanced Photon Source, Argonne National Laboratory, and the X-29 beamline at the Brookhaven National Laboratory, for access and assistance with data collection. The structures of the complexes have been deposited in the Protein Data Bank (PDB). The accession codes are mDNMT1(650-1602)-DNA complex with bound AdoHcy (3PT6), hDNMT1(646-1600)-DNA complex with bound AdoHcy (3PTA) and mDNMT1(731-1602) with bound AdoHcy (3PT9).	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hou ZG, 2005, P NATL ACAD SCI USA, V102, P8489, DOI 10.1073/pnas.0503525102; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Zhang ZG, 2002, EMBO J, V21, P4600, DOI 10.1093/emboj/cdf468	17	292	303	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1036	1040		10.1126/science.1195380	http://dx.doi.org/10.1126/science.1195380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21163962	Green Accepted			2022-12-01	WOS:000287699000054
J	Stewart, MP; Helenius, J; Toyoda, Y; Ramanathan, SP; Muller, DJ; Hyman, AA				Stewart, Martin P.; Helenius, Jonne; Toyoda, Yusuke; Ramanathan, Subramanian P.; Muller, Daniel J.; Hyman, Anthony A.			Hydrostatic pressure and the actomyosin cortex drive mitotic cell rounding	NATURE			English	Article							ATOMIC-FORCE MICROSCOPE; SHAPE; FLOW; MORPHOGENESIS; OSCILLATIONS; RETRACTION; MEMBRANE; RIGIDITY; DIVISION; MOESIN	During mitosis, adherent animal cells undergo a drastic shape change, from essentially flat to round(1-3). Mitotic cell rounding is thought to facilitate organization within the mitotic cell and be necessary for the geometric requirements of division(4-7). However, the forces that drive this shape change remain poorly understood in the presence of external impediments, such as a tissue environment(2). Here we use cantilevers to track cell rounding force and volume. We show that cells have an outward rounding force, which increases as cells enter mitosis. We find that this mitotic rounding force depends both on the actomyosin cytoskeleton and the cells' ability to regulate osmolarity. The rounding force itself is generated by an osmotic pressure. However, the actomyosin cortex is required to maintain this rounding force against external impediments. Instantaneous disruption of the actomyosin cortex leads to volume increase, and stimulation of actomyosin contraction leads to volume decrease. These results show that in cells, osmotic pressure is balanced by inwardly directed actomyosin cortex contraction. Thus, by locally modulating actomyosin-cortex-dependent surface tension and globally regulating osmotic pressure, cells can control their volume, shape and mechanical properties.	[Toyoda, Yusuke; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-1307 Dresden, Germany; [Stewart, Martin P.; Helenius, Jonne; Ramanathan, Subramanian P.; Muller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Stewart, Martin P.] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technische Universitat Dresden	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-1307 Dresden, Germany.	daniel.muller@bsse.ethz.ch	Hyman, Anthony A/B-3917-2017; Stewart, Martin Philip/E-8059-2011; Hyman, Tony/F-1923-2011; Müller, Daniel J./A-5967-2010; Ramanathan, Subramanian/AAE-9817-2020	Hyman, Anthony A/0000-0003-3664-154X; Stewart, Martin Philip/0000-0003-4112-6622; Müller, Daniel J./0000-0003-3075-0665; Toyoda, Yusuke/0000-0003-0534-6898; Ramanathan, Subu/0000-0002-2876-0322	DFG; BMBF; SNF; JSPS; Max Planck Society	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); SNF; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Max Planck Society(Max Planck SocietyFoundation CELLEX)	DFG, BMBF and SNF supported this project. JSPS supported Y.T. A. A. H. is funded by the Max Planck Society. We thank S. Bhakdi for toxins and advice on their use, T. J. Mitchison for extensive discussions on osmotic pressure and critical reading of the manuscript, M. Krieg for valuable insights into cell blebbing, and B. Baum, C. Brangwynne, S. Grill, A. Helenius, J. Howard, F. Julicher, Z. Maliga and E. Paluch for discussions and critical reading of the manuscript.	Bereiter-Hahn J, 2005, MED ENG PHYS, V27, P743, DOI 10.1016/j.medengphy.2005.04.021; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; Fujibuchi T, 2005, BIOCHEM BIOPH RES CO, V327, P268, DOI 10.1016/j.bbrc.2004.11.156; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; HAROLD FM, 1990, MICROBIOL REV, V54, P381, DOI 10.1128/MMBR.54.4.381-431.1990; HARRIS A, 1973, DEV BIOL, V35, P97, DOI 10.1016/0012-1606(73)90009-2; Hertz H., 1882, J REINE ANGEW MATH, V1882, P156, DOI [10.1515/crll.1882.92.156, DOI 10.1515/CRLL.1882.92.156]; HIRAMOTO Y, 1963, EXP CELL RES, V32, P59, DOI 10.1016/0014-4827(63)90069-7; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lang F., 2006, MECH SIGNIFICANCE CE; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6; RUTA M, 1986, MOL CELL BIOL, V6, P1706, DOI 10.1128/MCB.6.5.1706; Salbreux G, 2007, PHYS BIOL, V4, P268, DOI 10.1088/1478-3975/4/4/004; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Valeva A, 2000, MOL MICROBIOL, V36, P467, DOI 10.1046/j.1365-2958.2000.01865.x; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x	35	436	444	3	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					226	230		10.1038/nature09642	http://dx.doi.org/10.1038/nature09642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21196934				2022-12-01	WOS:000286143400041
J	Frio, TR; Bahubeshi, A; Kanellopoulou, C; Hamel, N; Niedziela, M; Sabbaghian, N; Pouchet, C; Gilbert, L; O'Brien, PK; Serfas, K; Broderick, P; Houlston, RS; Lesueur, F; Bonora, E; Muljo, S; Schimke, RN; Bouron-Dal Soglio, D; Arseneau, J; Schultz, KA; Priest, JR; Nguyen, VH; Harach, HR; Livingston, DM; Foulkes, WD; Tischkowitz, M				Frio, Thomas Rio; Bahubeshi, Amin; Kanellopoulou, Chryssa; Hamel, Nancy; Niedziela, Marek; Sabbaghian, Nelly; Pouchet, Carly; Gilbert, Lucy; O'Brien, Paul K.; Serfas, Kim; Broderick, Peter; Houlston, Richard S.; Lesueur, Fabienne; Bonora, Elena; Muljo, Stefan; Schimke, R. Neil; Bouron-Dal Soglio, Dorothee; Arseneau, Jocelyne; Schultz, Kris Ann; Priest, John R.; Nguyen, Van-Hung; Ruben Harach, H.; Livingston, David M.; Foulkes, William D.; Tischkowitz, Marc			DICER1 Mutations in Familial Multinodular Goiter With and Without Ovarian Sertoli-Leydig Cell Tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLEUROPULMONARY BLASTOMA; THYROID-CARCINOMA; DOMINANT FORM; CANCER; GERMLINE; DISEASE; ARRHENOBLASTOMA; DISORDERS; MICRORNAS; FEMALE	Context Nontoxic multinodular goiter (MNG) is frequently observed in the general population, but little is known about the underlying genetic susceptibility to this disease. Familial cases of MNG have been reported, and published reports describe 5 families that also contain at least 1 individual with a Sertoli-Leydig cell tumor of the ovary (SLCT). Germline mutations in DICER1, a gene that codes for an RNase III endoribonuclease, have been identified in families affected by pleuropulmonary blastoma (PPB), some of whom include cases of MNG and gonadal tumors such as SLCTs. Objective To determine whether familial MNG with or without SLCT in the absence of PPB was associated with mutations in DICER1. Design, Setting, and Patients From September 2009 to September 2010, we screened 53 individuals from 2 MNG and 3 MNG/SLCT families at McGill University for mutations in DICER1. We investigated blood lymphocytes and MNG and SLCT tissue from family members for loss of the wild-type DICER1 allele (loss of heterozygosity), DICER1 expression, and microRNA (miRNA) dysregulation. Main Outcome Measure Detection of germline DICER1 gene mutations in familial MNG with and without SLCT. Results We identified and characterized germline DICER1 mutations in 37 individuals from 5 families. Two mutations were predicted to be protein truncating, 2 resulted in inframe deletions, and 1 was a missense mutation. Molecular analysis of the 3 SLCTs showed no loss of heterozygosity of DICER1, and immunohistochemical analysis in 2 samples showed strong expression of DICER1 in Sertoli cells but weak staining of Leydig cells. miRNA profiling of RNA from lymphoblastoid cell lines from both affected and unaffected members of the familial MNG cases revealed miRNA perturbations in DICER1 mutation carriers. Conclusions DICER1 mutations are associated with both familial MNG and MNG with SLCT, independent of PPB. These germline DICER1 mutations are associated with dysregulation of miRNA expression patterns. JAMA. 2011;305(1):68-77 www.jama.com	[Foulkes, William D.] McGill Univ, Ctr Hlth, Gerald Bronfman Ctr Clin Res Oncol, Program Canc Genet,Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Gilbert, Lucy] McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H2W 1S6, Canada; [Arseneau, Jocelyne; Nguyen, Van-Hung] McGill Univ, Ctr Hlth, Dept Pathol, Montreal, PQ H2W 1S6, Canada; [Frio, Thomas Rio; Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Dept Med Genet, Montreal, PQ H2W 1S6, Canada; [Frio, Thomas Rio; Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H2W 1S6, Canada; [Bahubeshi, Amin; Sabbaghian, Nelly; Pouchet, Carly; Foulkes, William D.; Tischkowitz, Marc] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H2W 1S6, Canada; [Kanellopoulou, Chryssa; Livingston, David M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Niedziela, Marek] Poznan Univ Med Sci, Dept Pediat Endocrinol & Rheumatol, Poznan, Poland; [O'Brien, Paul K.] Etobicoke Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Serfas, Kim] Hlth Sci Ctr Winnipeg, Hereditary Breast Hlth Clin, Winnipeg, MB, Canada; [Broderick, Peter; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Surrey, England; [Lesueur, Fabienne] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Bonora, Elena] Univ Bologna, S Orsola M Malpighi Hosp, Dept Gynaecol, Med Genet Unit, Bologna, Italy; [Muljo, Stefan] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Schimke, R. Neil] Univ Kansas, Med Ctr, Dept Internal Med, Div Endocrinol Metab & Genet, Kansas City, KS 66103 USA; [Bouron-Dal Soglio, Dorothee] CHU St Justine, Dept Pathol, Montreal, PQ, Canada; [Schultz, Kris Ann] Childrens Hosp & Clin Minnesota, St Paul, MN USA; [Priest, John R.] Int Pleuropulm Blastoma Registry, St Paul, MN USA; [Ruben Harach, H.] Hosp Dr A Onativia, Sector Patol, Salta, Argentina; [Frio, Thomas Rio; Bahubeshi, Amin; Hamel, Nancy; Sabbaghian, Nelly; Pouchet, Carly; Foulkes, William D.; Tischkowitz, Marc] McGill Univ, Ctr Hlth, Program Canc Genet, Dept Human Genet, Montreal, PQ H2W 1S6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Harvard University; Dana-Farber Cancer Institute; Poznan University of Medical Sciences; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of London; Institute of Cancer Research - UK; World Health Organization; International Agency for Research on Cancer (IARC); IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Kansas; University of Kansas Medical Center; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Children's Hospitals & Clinics of Minnesota; McGill University	Foulkes, WD (corresponding author), McGill Univ, Ctr Hlth, Gerald Bronfman Ctr Clin Res Oncol, Program Canc Genet,Dept Oncol, 546 Ave Pins, Montreal, PQ H2W 1S6, Canada.	william.foulkes@mcgill.ca	Gilbert, Lucy/M-6879-2019; Muljo, Stefan A/F-5671-2015; Foulkes, William D./AAR-9586-2021; Lesueur, Fabienne/R-2178-2017; Hamel, Nancy/L-5122-2016; Niedziela, Marek/A-1155-2011; Tischkowitz, Marc/O-4452-2018	Gilbert, Lucy/0000-0001-8605-5472; Muljo, Stefan A/0000-0003-1013-446X; Foulkes, William D./0000-0001-7427-4651; Lesueur, Fabienne/0000-0001-7404-4549; Hamel, Nancy/0000-0001-8971-0428; Niedziela, Marek/0000-0001-8862-6937; Tischkowitz, Marc/0000-0002-7880-0628; Bonora, Elena/0000-0001-6132-7734; Broderick, Peter/0000-0002-8348-5829; Nguyen, Van-Hung/0000-0001-5318-2416; Houlston, Richard/0000-0002-5268-0242	Jewish General Hospital; Turner Family Cancer Research Fund; Fonds de la Recherche en Sante du Quebec (FRSQ); Canadian Institutes of Health Research/FRSQ [FRN53888]; Research Institute of the McGill University Health Centre; Cedars Cancer Institute; Pine Tree Apple Tennis Classic; Theodora H. Lang Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001131] Funding Source: NIH RePORTER	Jewish General Hospital(General Electric); Turner Family Cancer Research Fund; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research/FRSQ(Fonds de la Recherche en Sante du QuebecCanadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Centre; Cedars Cancer Institute; Pine Tree Apple Tennis Classic; Theodora H. Lang Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by the Jewish General Hospital Weekend to End Women's Cancers, the Turner Family Cancer Research Fund, and les Fonds de la Recherche en Sante du Quebec (FRSQ). Mr Bahubeshi is funded by the Canadian Institutes of Health Research/FRSQ training grant in cancer research (FRN53888) of the McGill Integrated Cancer Research Training Program. Dr Rio Frio was funded by the Research Institute of the McGill University Health Centre and by the Henry R. Shibata Fellowship of the Cedars Cancer Institute. Dr Priest receives funding support from the Pine Tree Apple Tennis Classic and the Theodora H. Lang Charitable trust. Dr Foulkes holds an FRSQ national scientist award and Dr Tischkowitz holds an FRSQ clinician-scientist award.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bahubeshi A, 2010, J MED GENET, V47, P863, DOI 10.1136/jmg.2010.081216; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Capon F, 2000, AM J HUM GENET, V67, P1004, DOI 10.1086/303095; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; COUCH RM, 1986, AM J HUM GENET, V39, P811; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Druker HA, 1997, AM J MED GENET, V72, P30, DOI 10.1002/(SICI)1096-8628(19971003)72:1<30::AID-AJMG6>3.0.CO;2-Z; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hill DA, 2010, LAB INVEST, V90, P311; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; JENSEN RD, 1974, CANCER, V33, P218, DOI 10.1002/1097-0142(197401)33:1<218::AID-CNCR2820330132>3.0.CO;2-Z; Knobel M, 2003, THYROID, V13, P771, DOI 10.1089/105072503768499671; KOONINGS PP, 1989, OBSTET GYNECOL, V74, P921; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lau PW, 2009, STRUCTURE, V17, P1326, DOI 10.1016/j.str.2009.08.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Ngan ESW, 2009, JNCI-J NATL CANCER I, V101, P162, DOI 10.1093/jnci/djn471; Niedziela M, 2008, PEDIATR BLOOD CANCER, V51, P543, DOI 10.1002/pbc.21675; OBRIEN PK, 1981, AM J CLIN PATHOL, V75, P578; Pinchera A., 1996, Annali Italiani di Chirurgia, V67, P317; Priest JR, 2009, PEDIATR PULM, V44, P14, DOI 10.1002/ppul.20917; Priest JR, 1996, J PEDIATR-US, V128, P220, DOI 10.1016/S0022-3476(96)70393-1; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schultz K, 2010, AM SOC PED ONC HEM M; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; WHITCOMB RW, 1986, OBSTET GYNECOL, V67, pS89, DOI 10.1097/00006250-198603001-00026; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Young RH, 2005, MODERN PATHOL, V18, pS81, DOI 10.1038/modpathol.3800311; YOUNG RH, 1985, AM J SURG PATHOL, V9, P543, DOI 10.1097/00000478-198508000-00001; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	41	191	194	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					68	77		10.1001/jama.2010.1910	http://dx.doi.org/10.1001/jama.2010.1910			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205968	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000285924100026
J	Huttlin, EL; Jedrychowski, MP; Elias, JE; Goswami, T; Rad, R; Beausoleil, SA; Villen, J; Haas, W; Sowa, ME; Gygi, SP				Huttlin, Edward L.; Jedrychowski, Mark P.; Elias, Joshua E.; Goswami, Tapasree; Rad, Ramin; Beausoleil, Sean A.; Villen, Judit; Haas, Wilhelm; Sowa, Mathew E.; Gygi, Steven P.			A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression	CELL			English	Article							KINASE; PREDICTION; LIPOLYSIS; DATABASE	Although most tissues in an organism are genetically identical, the biochemistry of each is optimized to fulfill its unique physiological roles, with important consequences for human health and disease. Each tissue's unique physiology requires tightly regulated gene and protein expression coordinated by specialized, phosphorylation-dependent intracellular signaling. To better understand the role of phosphorylation in maintenance of physiological differences among tissues, we performed proteomic and phosphoproteomic characterizations of nine mouse tissues. We identified 12,039 proteins, including 6296 phosphoproteins harboring nearly 36,000 phosphorylation sites. Comparing protein abundances and phosphorylation levels revealed specialized, interconnected phosphorylation networks within each tissue while suggesting that many proteins are regulated by phosphorylation independently of their expression. Our data suggest that the "typical'' phosphoprotein is widely expressed yet displays variable, often tissue-specific phosphorylation that tunes protein activity to the specific needs of each tissue. We offer this dataset as an online resource for the biological research community.	[Huttlin, Edward L.; Jedrychowski, Mark P.; Elias, Joshua E.; Goswami, Tapasree; Beausoleil, Sean A.; Villen, Judit; Haas, Wilhelm; Sowa, Mathew E.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rad, Ramin; Gygi, Steven P.] Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; [Sowa, Mathew E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu		Villen, Judit/0000-0002-1005-1739; Huttlin, Edward/0000-0002-1822-1173	NIH [HG3456]; ThermoFisher Scientific; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ThermoFisher Scientific; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank Xue Li and Abir Mukherjee for help with phosphorylation studies and acknowledge Julian Mintseris, Deepak Kolippikam, Noah Dephoure, Younghao Yu, and other Gygi lab members for insightful discussions. This work was funded in part by a grant from the NIH to S. P. G. (HG3456) and by an industry-sponsored research project with ThermoFisher Scientific.	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Castellanos-Serra L, 2002, ELECTROPHORESIS, V23, P1745, DOI 10.1002/1522-2683(200206)23:11<1745::AID-ELPS1745>3.0.CO;2-A; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Dehmelt L, 2005, GENOME BIOL, V6; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Duta F, 2006, HISTOCHEM CELL BIOL, V126, P495, DOI 10.1007/s00418-006-0188-z; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Itoh TJ, 1997, BIOCHEMISTRY-US, V36, P12574, DOI 10.1021/bi962606z; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Lienhard GE, 2008, TRENDS BIOCHEM SCI, V33, P351, DOI 10.1016/j.tibs.2008.05.004; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Pasini EM, 2008, MOL CELL PROTEOMICS, V7, P1317, DOI 10.1074/mcp.M700458-MCP200; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; *ROCH APPL SCI, 2004, COMPL GUID PROT INH; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Ulanova M, 2005, AM J PHYSIOL-LUNG C, V288, pL497, DOI 10.1152/ajplung.00246.2004; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Watt MJ, 2008, BIOCHEM J, V414, P313, DOI 10.1042/BJ20080305; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Wu CH, 2003, NUCLEIC ACIDS RES, V31, P345, DOI 10.1093/nar/gkg040	51	1146	10073	18	382	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1174	1189		10.1016/j.cell.2010.12.001	http://dx.doi.org/10.1016/j.cell.2010.12.001			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183079	Bronze, Green Accepted			2022-12-01	WOS:000285625400014
J	Gentles, AJ; Plevritis, SK; Majeti, R; Alizadeh, AA				Gentles, Andrew J.; Plevritis, Sylvia K.; Majeti, Ravindra; Alizadeh, Ash A.			Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INITIATING CELLS; PROGENITOR CELLS; BREAST-CANCER; MUTATIONS; SURVIVAL; AML; HETEROGENEITY; PROLIFERATION; INDUCTION; FREQUENCY	Context In many cancers, specific subpopulations of cells appear to be uniquely capable of initiating and maintaining tumors. The strongest support for this cancer stem cell model comes from transplantation assays in immunodeficient mice, which indicate that human acute myeloid leukemia (AML) is driven by self-renewing leukemic stem cells (LSCs). This model has significant implications for the development of novel therapies, but its clinical relevance has yet to be determined. Objective To identify an LSC gene expression signature and test its association with clinical outcomes in AML. Design, Setting, and Patients Retrospective study of global gene expression (microarray) profiles of LSC-enriched subpopulations from primary AML and normal patient samples, which were obtained at a US medical center between April 2005 and July 2007, and validation data sets of global transcriptional profiles of AML tumors from 4 independent cohorts (n=1047). Main Outcome Measures Identification of genes discriminating LSC-enriched populations from other subpopulations in AML tumors; and association of LSC-specific genes with overall, event-free, and relapse-free survival and with therapeutic response. Results Expression levels of 52 genes distinguished LSC-enriched populations from other subpopulations in cell-sorted AML samples. An LSC score summarizing expression of these genes in bulk primary AML tumor samples was associated with clinical outcomes in the 4 independent patient cohorts. High LSC scores were associated with worse overall, event-free, and relapse-free survival among patients with either normal karyotypes or chromosomal abnormalities. For the largest cohort of patients with normal karyotypes (n=163), the LSC score was significantly associated with overall survival as a continuous variable (hazard ratio [HR], 1.15; 95% confidence interval [CI], 1.08-1.22; log-likelihood P<.001). The absolute risk of death by 3 years was 57% (95% CI, 43%-67%) for the low LSC score group compared with 78% (95% CI, 66%-86%) for the high LSC score group (HR, 1.9 [95% CI, 1.3-2.7]; log-rank P=.002). In another cohort with available data on event-free survival for 70 patients with normal karyotypes, the risk of an event by 3 years was 48% (95% CI, 27%-63%) in the low LSC score group vs 81% (95% CI, 60%-91%) in the high LSC score group (HR, 2.4 [95% CI, 1.3-4.5]; log-rank P=.006). In multivariate Cox regression including age, mutations in FLT3 and NPM1, and cytogenetic abnormalities, the HRs for LSC score in the 3 cohorts with data on all variables were 1.07 (95% CI, 1.01-1.13; P=.02), 1.10 (95% CI, 1.03-1.17; P=.005), and 1.17 (95% CI, 1.05-1.30; P=.005). Conclusion High expression of an LSC gene signature is independently associated with adverse outcomes in patients with AML. JAMA. 2010;304(24):2706-2715 www.jama.com	[Majeti, Ravindra; Alizadeh, Ash A.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94305 USA; [Gentles, Andrew J.; Plevritis, Sylvia K.] Stanford Univ, Lucas Ctr MR Spect & Imaging, Dept Radiol, Palo Alto, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Ctr Canc, Dept Internal Med, Div Oncol, Palo Alto, CA 94305 USA; [Majeti, Ravindra; Alizadeh, Ash A.] Stanford Univ, Ctr Canc, Dept Internal Med, Div Hematol, Palo Alto, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Alizadeh, AA (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94305 USA.	rmajeti@stanford.edu; arasha@stanford.edu	Alizadeh, Ash A/C-5594-2009	Alizadeh, Ash A/0000-0002-5153-5625; Majeti, Ravindra/0000-0002-5814-0984	National Institutes of Health [1U54CA149145, U56-CA112973]; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [U54CA149145, U56CA112973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Integrative Cancer Biology Program through National Institutes of Health awards 1U54CA149145 and U56-CA112973 (Dr Plevritis). Dr Majeti holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. Dr Alizadeh holds a Career Development Award from the Leukemia and Lymphoma Society.	Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cleary ML, 2009, BEST PRACT RES CL HA, V22, P483, DOI 10.1016/j.beha.2009.08.005; Costello RT, 1999, LEUKEMIA, V13, P1513, DOI 10.1038/sj.leu.2401519; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dufour A, 2010, J CLIN ONCOL, V28, P570, DOI 10.1200/JCO.2008.21.6010; Ellis L, 2008, CLIN CANCER RES, V14, P4500, DOI 10.1158/1078-0432.CCR-07-4262; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gentles AJ, 2009, BLOOD, V114, P3158, DOI 10.1182/blood-2009-02-202465; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade David, 2009, Hematology Am Soc Hematol Educ Program, P385, DOI 10.1182/asheducation-2009.1.385; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Langer C, 2008, BLOOD, V111, P5371, DOI 10.1182/blood-2007-11-124958; LEE EJ, 1987, BLOOD, V70, P1400; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Lodygin D, 2002, J CLIN INVEST, V110, P1717, DOI 10.1172/JCI200216588; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; OSHITA AK, 1977, BLOOD, V49, P585; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Wilson CS, 2006, BLOOD, V108, P685, DOI 10.1182/blood-2004-12-4633; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895	55	254	271	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2706	2715		10.1001/jama.2010.1862	http://dx.doi.org/10.1001/jama.2010.1862			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177505	Green Accepted, Bronze			2022-12-01	WOS:000285518000015
J	Ivers, LC; Farmer, P; Almazor, CP; Leandre, F				Ivers, Louise C.; Farmer, Paul; Almazor, Charles Patrick; Leandre, Fernet			Five complementary interventions to slow cholera: Haiti	LANCET			English	Editorial Material									[Ivers, Louise C.; Farmer, Paul] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Almazor, Charles Patrick; Leandre, Fernet] Partners Hlth Zanmi Lasante, Port Au Prince, Haiti	Harvard University; Harvard Medical School	Farmer, P (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	paul_farmer@hms.harvard.edu	Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230				[Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; CDC, 2010, AC WAT DIARRH CHOL H; d'Adestcy AC., 2004, MOVING MOUNTAINS RAC, P93; Dorell C., 2010, Morbidity and Mortality Weekly Report, V59, P1018; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Farmer P, 2003, LANCET, V361, P420, DOI 10.1016/S0140-6736(03)12380-X; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; Farmer P., 2006, AIDS ACCUSATION HAIT; Fraser B, 2010, LANCET, V376, P1813, DOI 10.1016/S0140-6736(10)62151-4; Frew SE, 2009, HEALTH AFFAIR, V28, P1760, DOI 10.1377/hlthaff.28.6.1760; Harris JB, 2010, LANCET, V376, P1961, DOI 10.1016/S0140-6736(10)62172-1; Ivers LC, 2010, CURBING CERVICAL CAN; Lasante Zanmi, 2008, WOCH NAN SOL DEN RIG; Lawrence P.R., 2002, WATER POVERTY INDEX; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; Soni A, 2009, HEALTH AFFAIR, V28, P1617, DOI 10.1377/hlthaff.28.6.1617; *UNAIDS WHO, 2005, AIDS EP UPD DEC 2005; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013	18	40	41	2	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2048	2051		10.1016/S0140-6736(10)62243-X	http://dx.doi.org/10.1016/S0140-6736(10)62243-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702LA	21146206				2022-12-01	WOS:000285895000007
J	Finkelstein, IJ; Visnapuu, ML; Greene, EC				Finkelstein, Ilya J.; Visnapuu, Mari-Liis; Greene, Eric C.			Single-molecule imaging reveals mechanisms of protein disruption by a DNA translocase	NATURE			English	Article							RNA-POLYMERASE; RECBCD ENZYME; REPLICATION FORK; LAC REPRESSOR; TRANSCRIPTION; BINDING; REPLISOME; HELICASE; OPERATOR; MOTOR	In physiological settings, nucleic-acid translocases must act on substrates occupied by other proteins, and an increasingly appreciated role of translocases is to catalyse protein displacement from RNA andDNA(1-4). However, little is known regarding the inevitable collisions that must occur, and the fate of protein obstacles and the mechanisms by which they are evicted from DNA remain unexplored. Here we sought to establish the mechanistic basis for protein displacement from DNA using RecBCD as a model system. Using nanofabricated curtains of DNA and multicolour single-molecule microscopy, we visualized collisions between a model translocase and different DNA-bound proteins in real time. We show that the DNA translocase RecBCD can disrupt core RNA polymerase, holoenzymes, stalled elongation complexes and transcribing RNA polymerases in either head-to-head or head-to-tail orientations, as well as EcoRI(E111Q), lac repressor and even nucleosomes. RecBCD did not pause during collisions and often pushed proteins thousands of base pairs before evicting them from DNA. We conclude that RecBCD overwhelms obstacles through direct transduction of chemomechanical force with no need for specific protein-protein interactions, and that proteins can be removed from DNA through active disruption mechanisms that act on a transition state intermediate as they are pushed from one nonspecific site to the next.	[Greene, Eric C.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Finkelstein, Ilya J.; Visnapuu, Mari-Liis; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Greene, EC (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.	ecg2108@columbia.edu			NIH [F32GM80864, GM074739, GM082848]; Columbia University; Nanoscale Science and Engineering Initiative of the National Science Foundation [CHE-0641523]; New York State Office of Science, Technology, and Academic Research; NATIONAL CANCER INSTITUTE [R01CA146940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080864, R01GM082848, R01GM074739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University; Nanoscale Science and Engineering Initiative of the National Science Foundation(National Science Foundation (NSF)); New York State Office of Science, Technology, and Academic Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Gottesman, R. Gonzalez and members of the Greene laboratory for discussion and assistance throughout this work. We thank P. Modrich for providing an expression construct encoding EcoRI<SUP>E111Q</SUP>, R. Landick and K. Adelmanfor providing RNAP constructs, and J. Gelles for providing plasmids encoding RecBCD. I.J.F. was supported by an NIH Fellowship (F32GM80864). Funding was provided by the National Institutes of Health (GM074739 and GM082848 to E.C.G.). This work was partially supported by the Initiatives in Science and Engineering program through Columbia University, the Nanoscale Science and Engineering Initiative of the National Science Foundation under NSF Award Number CHE-0641523, and by the New York State Office of Science, Technology, and Academic Research. E.C.G is an Early Career Scientist with the Howard Hughes Medical Institute. We apologize to colleagues whose work we were unable to cite owing to length restrictions.	Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BONNEANDREA C, 1990, NATURE, V343, P719, DOI 10.1038/343719a0; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; EGGLESTON AK, 1995, J BIOL CHEM, V270, P2024, DOI 10.1074/jbc.270.5.2024; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LIN SY, 1970, NATURE, V228, P1184, DOI 10.1038/2281184a0; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LIU B, 1994, P NATL ACAD SCI USA, V91, P10660, DOI 10.1073/pnas.91.22.10660; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; Marquis KA, 2008, GENE DEV, V22, P1786, DOI 10.1101/gad.1684008; Mollazadeh-Beidokhti L, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031922; Noom MC, 2007, NAT METHODS, V4, P1031, DOI 10.1038/nmeth1126; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; PAVCO PA, 1991, NUCLEIC ACIDS RES, V19, P4639, DOI 10.1093/nar/19.17.4639; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816	30	125	126	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					983	987		10.1038/nature09561	http://dx.doi.org/10.1038/nature09561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21107319	Green Accepted			2022-12-01	WOS:000285344600051
J	Pereyra, FP; Jia, XM; McLaren, PJ; Telenti, A; de Bakker, PIW; Walker, BD; Ripke, S; Brumme, CJ; Pulit, SL; Carrington, M; Kadie, CM; Carlson, JM; Heckerman, D; Graham, RR; Plenge, RM; Deeks, SG; Gianniny, L; Crawford, G; Sullivan, J; Gonzalez, E; Davies, L; Camargo, A; Moore, JM; Beattie, N; Gupta, S; Crenshaw, A; Burtt, NP; Guiducci, C; Gupta, N; Carrington, M; Gao, XJ; Qi, Y; Yuki, Y; Piechocka-Trocha, A; Cutrell, E; Rosenberg, R; Moss, KL; Lemay, P; O'Leary, J; Schaefer, T; Verma, P; Toth, I; Block, B; Baker, B; Rothchild, A; Lian, J; Proudfoot, J; Alvino, DML; Vine, S; Addo, MM; Allen, TM; Altfeld, M; Henn, MR; Le Gall, S; Streeck, H; Haas, DW; Kuritzkes, DR; Robbins, GK; Shafer, RW; Gulick, RM; Shikuma, CM; Haubrich, R; Riddler, S; Sax, PE; Daar, ES; Ribaudo, HJ; Agan, B; Agarwal, S; Ahern, RL; Allen, BL; Altidor, S; Altschuler, EL; Ambardar, S; Anastos, K; Anderson, B; Anderson, V; Andrady, U; Antoniskis, D; Bangsberg, D; Barbaro, D; Barrie, W; Bartczak, J; Barton, S; Basden, P; Basgoz, N; Bazner, S; Bellos, NC; Benson, AM; Berger, J; Bernard, NF; Bernard, AM; Birch, C; Bodner, SJ; Bolan, RK; Boudreaux, ET; Bradley, M; Braun, JF; Brndjar, JE; Brown, SJ; Brown, K; Brown, ST; Burack, J; Bush, LM; Cafaro, V; Campbell, O; Campbell, J; Carlson, RH; Carmichael, JK; Casey, KK; Cavacuiti, C; Celestin, G; Chambers, ST; Chez, N; Chirch, LM; Cimoch, PJ; Cohen, D; Cohn, LE; Conway, B; Cooper, DA; Cornelson, B; Cox, DT; Cristofano, MV; Cuchural, G; Czartoski, JL; Dahman, JM; Daly, JS; Davis, BT; Davis, K; Davod, SM; Deeks, SG; DeJesus, E; Dietz, CA; Dunham, E; Dunn, ME; Ellerin, TB; Eron, JJ; Fangman, JJW; Farel, CE; Ferlazzo, H; Fidler, S; Fleenor-Ford, A; Frankel, R; Freedberg, KA; French, NK; Fuchs, JD; Fuller, JD; Gaberman, J; Gallant, JE; Gandhi, RT; Garcia, E; Garmon, D; Gathe, JC; Gaultier, CR; Gebre, W; Gilman, FD; Gilson, I; Goepfert, PA; Gottlieb, MS; Goulston, C; Groger, RK; Gurley, TD; Haber, S; Hardwicke, R; Hardy, WD; Harrigan, PR; Hawkins, TN; Heath, S; Hecht, FM; Henry, WK; Hladek, M; Hoffman, RP; Horton, JM; Hsu, RK; Huhn, GD; Hunt, P; Hupert, MJ; Illeman, ML; Jaeger, H; Jellinger, RM; John, M; Johnson, JA; Johnson, KL; Johnson, H; Johnson, K; Joly, J; Jordan, WC; Kauffman, CA; Khanlou, H; Killian, RK; Kim, AY; Kim, DD; Kinder, CA; Kirchner, JT; Kogelman, L; Kojic, EM; Korthuis, T; Kurisu, W; Kwon, DS; LaMar, M; Lampiris, H; Lanzafame, M; Lederman, MM; Lee, DM; Lee, JML; Lee, MJ; Lee, ETY; Lemoine, J; Levy, JA; Llibre, JM; Liguori, MA; Little, SJ; Liu, AY; Lopez, AJ; Loutfy, MR; Loy, D; Mohammed, DY; Man, A; Mansour, MK; Marconi, VC; Markowitz, M; Marques, R; Martin, JN; Martin, HL; Mayer, KH; McElrath, MJ; McGhee, TA; McGovern, BH; McGowan, K; McIntyre, D; Mcleod, GX; Menezes, P; Mesa, G; Metroka, CE; Meyer-Olson, D; Miller, AO; Montgomery, K; Mounzer, KC; Nagami, EH; Nagin, I; Nahass, RG; Nelson, MO; Nielsen, C; Norene, DL; O'Connor, DH; Ojikutu, BO; Okulicz, J; Oladehin, OO; Oldfield, EC; Olender, SA; Ostrowski, M; Owen, WF; Pae, E; Parsonnet, J; Pavlatos, AM; Perlmutter, AM; Pierce, MN; Pincus, JM; Pisani, L; Price, LJ; Proia, L; Prokesch, RC; Pujet, HC; Ramgopal, M; Rathod, A; Rausch, M; Ravishankar, J; Rhame, FS; Richards, CS; Richman, DD; Robbins, GK; Rodes, B; Rodriguez, M; Rose, RC; Rosenberg, ES; Rosenthal, D; Ross, PE; Rubin, DS; Rumbaugh, E; Saenz, L; Salvaggio, MR; Sanchez, WC; Sanjana, VM; Santiago, S; Schmidt, W; Schuitemaker, H; Sestak, PM; Shalit, P; Shay, W; Shirvani, VN; Silebi, VI; Sizemore, JM; Skolnik, PR; Sokol-Anderson, M; Sosman, JM; Stabile, P; Stapleton, JT; Starrett, S; Stein, F; Stellbrink, HJ; Sterman, FL; Stone, VE; Stone, DR; Tambussi, G; Taplitz, RA; Tedaldi, EM; Telenti, A; Theisen, W; Torres, R; Tosiello, L; Tremblay, C; Tribble, MA; Trinh, PD; Tsao, A; Ueda, P; Vaccaro, A; Valadas, E; Vanig, TJ; Vecino, I; Vega, VM; Veikley, W; Wade, BH; Walworth, C; Wanidworanun, C; Ward, DJ; Warner, DA; Weber, RD; Webster, D; Weis, S; Wheeler, DA; White, DJ; Wilkins, E; Winston, A; Wlodaver, CG; van't Wout, A; Wright, DP; Yang, OO; Yurdin, DL; Zabukovic, BW; Zachary, KC; Zeeman, B; Zhao, M				Pereyra, Florencia; Jia, Xiaoming; McLaren, Paul J.; Telenti, Amalio; de Bakker, Paul I. W.; Walker, Bruce D.; Ripke, Stephan; Brumme, Chanson J.; Pulit, Sara L.; Carrington, Mary; Kadie, Carl M.; Carlson, Jonathan M.; Heckerman, David; Graham, Robert R.; Plenge, Robert M.; Deeks, Steven G.; Gianniny, Lauren; Crawford, Gabriel; Sullivan, Jordan; Gonzalez, Elena; Davies, Leela; Camargo, Amy; Moore, Jamie M.; Beattie, Nicole; Gupta, Supriya; Crenshaw, Andrew; Burtt, Noel P.; Guiducci, Candace; Gupta, Namrata; Carrington, Mary; Gao, Xiaojiang; Qi, Ying; Yuki, Yuko; Piechocka-Trocha, Alicja; Cutrell, Emily; Rosenberg, Rachel; Moss, Kristin L.; Lemay, Paul; O'Leary, Jessica; Schaefer, Todd; Verma, Pranshu; Toth, Ildiko; Block, Brian; Baker, Brett; Rothchild, Alissa; Lian, Jeffrey; Proudfoot, Jacqueline; Alvino, Donna Marie L.; Vine, Seanna; Addo, Marylyn M.; Allen, Todd M.; Altfeld, Marcus; Henn, Matthew R.; Le Gall, Sylvie; Streeck, Hendrik; Haas, David W.; Kuritzkes, Daniel R.; Robbins, Gregory K.; Shafer, Robert W.; Gulick, Roy M.; Shikuma, Cecilia M.; Haubrich, Richard; Riddler, Sharon; Sax, Paul E.; Daar, Eric S.; Ribaudo, Heather J.; Agan, Brian; Agarwal, Shanu; Ahern, Richard L.; Allen, Brady L.; Altidor, Sherly; Altschuler, Eric L.; Ambardar, Sujata; Anastos, Kathryn; Anderson, Ben; Anderson, Val; Andrady, Ushan; Antoniskis, Diana; Bangsberg, David; Barbaro, Daniel; Barrie, William; Bartczak, J.; Barton, Simon; Basden, Patricia; Basgoz, Nesli; Bazner, Suzane; Bellos, Nicholaos C.; Benson, Anne M.; Berger, Judith; Bernard, Nicole F.; Bernard, Annette M.; Birch, Christopher; Bodner, Stanley J.; Bolan, Robert K.; Boudreaux, Emilie T.; Bradley, Meg; Braun, James F.; Brndjar, Jon E.; Brown, Stephen J.; Brown, Katherine; Brown, Sheldon T.; Burack, Jedidiah; Bush, Larry M.; Cafaro, Virginia; Campbell, Omobolaji; Campbell, John; Carlson, Robert H.; Carmichael, J. Kevin; Casey, Kathleen K.; Cavacuiti, Chris; Celestin, Gregory; Chambers, Steven T.; Chez, Nancy; Chirch, Lisa M.; Cimoch, Paul J.; Cohen, Daniel; Cohn, Lillian E.; Conway, Brian; Cooper, David A.; Cornelson, Brian; Cox, David T.; Cristofano, Michael V.; Cuchural, George, Jr.; Czartoski, Julie L.; Dahman, Joseph M.; Daly, Jennifer S.; Davis, Benjamin T.; Davis, Kristine; Davod, Sheila M.; Deeks, Steven G.; DeJesus, Edwin; Dietz, Craig A.; Dunham, Eleanor; Dunn, Michael E.; Ellerin, Todd B.; Eron, Joseph J.; Fangman, John J. W.; Farel, Claire E.; Ferlazzo, Helen; Fidler, Sarah; Fleenor-Ford, Anita; Frankel, Renee; Freedberg, Kenneth A.; French, Neel K.; Fuchs, Jonathan D.; Fuller, Jon D.; Gaberman, Jonna; Gallant, Joel E.; Gandhi, Rajesh T.; Garcia, Efrain; Garmon, Donald; Gathe, Joseph C., Jr.; Gaultier, Cyril R.; Gebre, Wondwoosen; Gilman, Frank D.; Gilson, Ian; Goepfert, Paul A.; Gottlieb, Michael S.; Goulston, Claudia; Groger, Richard K.; Gurley, T. Douglas; Haber, Stuart; Hardwicke, Robin; Hardy, W. David; Harrigan, P. Richard; Hawkins, Trevor N.; Heath, Sonya; Hecht, Frederick M.; Henry, W. Keith; Hladek, Melissa; Hoffman, Robert P.; Horton, James M.; Hsu, Ricky K.; Huhn, Gregory D.; Hunt, Peter; Hupert, Mark J.; Illeman, Mark L.; Jaeger, Hans; Jellinger, Robert M.; John, Mina; Johnson, Jennifer A.; Johnson, Kristin L.; Johnson, Heather; Johnson, Kay; Joly, Jennifer; Jordan, Wilbert C.; Kauffman, Carol A.; Khanlou, Homayoon; Killian, Robert K.; Kim, Arthur Y.; Kim, David D.; Kinder, Clifford A.; Kirchner, Jeffrey T.; Kogelman, Laura; Kojic, Erna Milunka; Korthuis, Todd; Kurisu, Wayne; Kwon, Douglas S.; LaMar, Melissa; Lampiris, Harry; Lanzafame, Massimiliano; Lederman, Michael M.; Lee, David M.; Lee, Jean M. L.; Lee, Marah J.; Lee, Edward T. Y.; Lemoine, Janice; Levy, Jay A.; Llibre, Josep M.; Liguori, Michael A.; Little, Susan J.; Liu, Anne Y.; Lopez, Alvaro J.; Loutfy, Mono R.; Loy, Dawn; Mohammed, Debbie Y.; Man, Alan; Mansour, Michael K.; Marconi, Vincent C.; Markowitz, Martin; Marques, Rui; Martin, Jeffrey N.; Martin, Harold L., Jr.; Mayer, Kenneth Hugh; McElrath, M. Juliana; McGhee, Theresa A.; McGovern, Barbara H.; McGowan, Katherine; McIntyre, Dawn; Mcleod, Gavin X.; Menezes, Prema; Mesa, Greg; Metroka, Craig E.; Meyer-Olson, Dirk; Miller, Andy O.; Montgomery, Kate; Mounzer, Karam C.; Nagami, Ellen H.; Nagin, Iris; Nahass, Ronald G.; Nelson, Margret O.; Nielsen, Craig; Norene, David L.; O'Connor, David H.; Ojikutu, Bisola O.; Okulicz, Jason; Oladehin, Olakunle O.; Oldfield, Edward C., III; Olender, Susan A.; Ostrowski, Mario; Owen, William F., Jr.; Pae, Eunice; Parsonnet, Jeffrey; Pavlatos, Andrew M.; Perlmutter, Aaron M.; Pierce, Michael N.; Pincus, Jonathan M.; Pisani, Leandro; Price, Lawrence Jay; Proia, Laurie; Prokesch, Richard C.; Pujet, Heather Calderon; Ramgopal, Moti; Rathod, Almas; Rausch, Michael; Ravishankar, J.; Rhame, Frank S.; Richards, Constance Shamuyarira; Richman, Douglas D.; Robbins, Gregory K.; Rodes, Berta; Rodriguez, Milagros; Rose, Richard C., III; Rosenberg, Eric S.; Rosenthal, Daniel; Ross, Polly E.; Rubin, David S.; Rumbaugh, Elease; Saenz, Luis; Salvaggio, Michelle R.; Sanchez, William C.; Sanjana, Veeraf M.; Santiago, Steven; Schmidt, Wolfgang; Schuitemaker, Hanneke; Sestak, Philip M.; Shalit, Peter; Shay, William; Shirvani, Vivian N.; Silebi, Vanessa I.; Sizemore, James M., Jr.; Skolnik, Paul R.; Sokol-Anderson, Marcia; Sosman, James M.; Stabile, Paul; Stapleton, Jack T.; Starrett, Sheree; Stein, Francine; Stellbrink, Hans-Jurgen; Sterman, F. Lisa; Stone, Valerie E.; Stone, David R.; Tambussi, Giuseppe; Taplitz, Randy A.; Tedaldi, Ellen M.; Telenti, Amalio; Theisen, William; Torres, Richard; Tosiello, Lorraine; Tremblay, Cecile; Tribble, Marc A.; Trinh, Phuong D.; Tsao, Alice; Ueda, Peggy; Vaccaro, Anthony; Valadas, Emilia; Vanig, Thanes J.; Vecino, Isabel; Vega, Vilma M.; Veikley, Wenoah; Wade, Barbara H.; Walworth, Charles; Wanidworanun, Chingchai; Ward, Douglas J.; Warner, Daniel A.; Weber, Robert D.; Webster, Duncan; Weis, Steve; Wheeler, David A.; White, David J.; Wilkins, Ed; Winston, Alan; Wlodaver, Clifford G.; van't Wout, Angelique; Wright, David P.; Yang, Otto O.; Yurdin, David L.; Zabukovic, Brandon W.; Zachary, Kimon C.; Zeeman, Beth; Zhao, Meng		Int HIV Controllers Study	The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation	SCIENCE			English	Article							DISEASE PROGRESSION; SURFACE EXPRESSION; INFECTION; AIDS; ALLELES; MHC; RESTRICTION; ASSOCIATION; THERAPY; ABSENCE	Infectious and inflammatory diseases have repeatedly shown strong genetic associations within the major histocompatibility complex (MHC); however, the basis for these associations remains elusive. To define host genetic effects on the outcome of a chronic viral infection, we performed genome-wide association analysis in a multiethnic cohort of HIV-1 controllers and progressors, and we analyzed the effects of individual amino acids within the classical human leukocyte antigen (HLA) proteins. We identified >300 genome-wide significant single-nucleotide polymorphisms (SNPs) within the MHC and none elsewhere. Specific amino acids in the HLA-B peptide binding groove, as well as an independent HLA-C effect, explain the SNP associations and reconcile both protective and risk HLA alleles. These results implicate the nature of the HLA-viral peptide interaction as the major factor modulating durable control of HIV infection.	[Pereyra, Florencia; Walker, Bruce D.; Brumme, Chanson J.; Carrington, Mary; Piechocka-Trocha, Alicja; Cutrell, Emily; Rosenberg, Rachel; Moss, Kristin L.; Lemay, Paul; O'Leary, Jessica; Schaefer, Todd; Verma, Pranshu; Toth, Ildiko; Block, Brian; Baker, Brett; Rothchild, Alissa; Lian, Jeffrey; Proudfoot, Jacqueline; Alvino, Donna Marie L.; Vine, Seanna; Addo, Marylyn M.; Allen, Todd M.; Altfeld, Marcus; Le Gall, Sylvie; Streeck, Hendrik; Bazner, Suzane; Birch, Christopher; Bradley, Meg; Kwon, Douglas S.; Nagami, Ellen H.; Pae, Eunice; Rathod, Almas; Tsao, Alice; Ueda, Peggy; Zeeman, Beth] Massachusetts Inst Technol & Harvard, Massachusetts Gen Hosp, Regon Inst, Boston, MA USA; [Pereyra, Florencia; Kuritzkes, Daniel R.; Sax, Paul E.; Farel, Claire E.; Johnson, Jennifer A.; Liu, Anne Y.; McGowan, Katherine; Theisen, William] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Infect Dis, Boston, MA 02115 USA; [Jia, Xiaoming] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [McLaren, Paul J.; de Bakker, Paul I. W.; Ripke, Stephan; Pulit, Sara L.; Plenge, Robert M.; Gianniny, Lauren; Crawford, Gabriel; Sullivan, Jordan; Gonzalez, Elena; Davies, Leela; Camargo, Amy; Moore, Jamie M.; Beattie, Nicole; Gupta, Supriya; Crenshaw, Andrew; Burtt, Noel P.; Guiducci, Candace; Gupta, Namrata; Henn, Matthew R.] Harvard & MIT, Broad Inst, Cambridge, MA USA; [McLaren, Paul J.; de Bakker, Paul I. W.; Pulit, Sara L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA; [Telenti, Amalio] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Div Biomed Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ripke, Stephan] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Dept Med, Boston, MA USA; [Gao, Xiaojiang; Qi, Ying; Yuki, Yuko] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick, Frederick, MD 21701 USA; [Kadie, Carl M.] Microsoft Res, Redmond, WA USA; [Carlson, Jonathan M.; Heckerman, David] Microsoft Res, Los Angeles, CA USA; [Graham, Robert R.] Genentech Inc, San Francisco, CA 94080 USA; [Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Deeks, Steven G.; Hecht, Frederick M.; Hunt, Peter; Lampiris, Harry; Levy, Jay A.; Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Haas, David W.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Shafer, Robert W.] Stanford Univ, Palo Alto, CA 94304 USA; [Gulick, Roy M.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Shikuma, Cecilia M.] Univ Hawaii, John A Burns Sch Med, Hawaii Ctr AIDS, Honolulu, HI 96822 USA; [Haubrich, Richard; Little, Susan J.; Richman, Douglas D.; Taplitz, Randy A.] Univ Calif San Diego, San Diego, CA 92103 USA; [Riddler, Sharon] Univ Pittsburgh, Pittsburgh, PA USA; [Daar, Eric S.; Hardy, W. David; Yang, Otto O.] Univ Calif Los Angeles, Los Angeles, CA USA; [Ribaudo, Heather J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Agan, Brian] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Agarwal, Shanu] Summa Hlth Syst, Akron, OH USA; [Allen, Brady L.; Lee, David M.] Uptown Phys Grp, Dallas, TX USA; [Altidor, Sherly; Metroka, Craig E.] St Lukes Roosevelt Hosp, New York, NY 10025 USA; [Altschuler, Eric L.; Mohammed, Debbie Y.] Univ Med & Dent New Jersey, New Jersey Med Sch, Univ Hosp, Newark, NJ 07103 USA; [Anastos, Kathryn] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Anderson, Ben] St Leonards Med Ctr, St Leonards, NSW, Australia; [Anderson, Val; Andrady, Ushan] Ysbyty Gwynedd Hosp, Bangor, Gwynedd, Wales; [Antoniskis, Diana; Man, Alan; Rumbaugh, Elease] Kaiser Permanente, Portland, OR USA; [Barbaro, Daniel; Hupert, Mark J.; Johnson, Heather] Tarrant Cty Infect Dis Associates, Ft Worth, TX USA; [Bartczak, J.] Rowan Tree Med, Wilton Manors, FL USA; [Barton, Simon] Chelsea & Westminster Hosp, St Stephens Ctr, London, England; [Bellos, Nicholaos C.] SW Infect Dis Associates, Dallas, TX USA; [Berger, Judith] St Barnabas Hosp, Bronx, NY USA; [Bernard, Nicole F.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; [Bernard, Annette M.] Thacker Thompson & Bernard, Atlanta, GA USA; [Bodner, Stanley J.] Vanderbilt Univ, Sch ofMedicine, Hermitage, TN USA; [Bolan, Robert K.] LA Gay & Lesbian Ctr, Los Angeles, CA USA; [Boudreaux, Emilie T.] Louisiana State Univ, Hlth Sci Ctr, Univ Med Ctr E Clin, Lafayatte, LA USA; [Braun, James F.] Callen Lorde Community Hlth Ctr, Phys Res Network, New York, NY USA; [Brndjar, Jon E.] Brndjar Med Associates, Allentown, PA USA; [Brown, Stephen J.] AIDS Res Alliance, Los Angeles, CA USA; [Brown, Katherine] David Powell Community Hlth Ctr, Austin, TX USA; [Brown, Sheldon T.] James J Peters VA Med Ctr, Bronx, NY USA; [Burack, Jedidiah] Sunrise Med Grp, Brooklyn, NY USA; [Bush, Larry M.] Univ Miami, Miller Sch Med, Lake Worth, FL USA; [Cafaro, Virginia] WellSpring Med Grp, San Francisco, CA USA; [Campbell, John] Moses Cone Hlth Syst, Greensboro, NC USA; [Carlson, Robert H.] HealthPartners Infect Dis, St Paul, MN USA; [Carmichael, J. Kevin] El Rio Special Immunol Associates, Tucson, AZ USA; [Casey, Kathleen K.; McIntyre, Dawn] Jersey Shore Univ, Med Ctr, Neptune, NJ USA; [Cavacuiti, Chris; Cornelson, Brian] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Celestin, Gregory] PATH Ctr, Brooklyn Hosp Ctr, Brooklyn, NY USA; [Chambers, Steven T.] Univ Otago, Christchurch, New Zealand; [Chez, Nancy] HELP Project Samaritan, Bronx, NY USA; [Chirch, Lisa M.; Dunham, Eleanor; Joly, Jennifer] David E Rogers Ctr HIV AIDS Care, Southampton, NY USA; [Cimoch, Paul J.; Walworth, Charles] Ctr Special Immunol, Fountain Valley, CA USA; [Cohen, Daniel; Mayer, Kenneth Hugh] Fenway Community Hlth, Boston, MA USA; [Cohn, Lillian E.] 9th St Internal Med Associates, Philadelphia, PA USA; [Conway, Brian] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Cooper, David A.] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Cox, David T.] Metro Infect Dis Consultants, Indianapolis, IN USA; [Cristofano, Michael V.] John H Stroger Hosp Cook Cty, Chicago, IL USA; [Cuchural, George, Jr.] New England Qual Care Alliance, Braintree, MA USA; [Czartoski, Julie L.; Lee, Jean M. L.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Dahman, Joseph M.] Desert AIDS Project, Palm Springs, CA USA; [Daly, Jennifer S.] Univ Massachusetts, Mem Med Ctr, Worcester, MA 01605 USA; [Davis, Kristine] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Dietz, Craig A.] Kansas City Free Hlth Clin, Kansas City, MO USA; [Ellerin, Todd B.] S Shore Hosp, Weymouth, MA USA; [Eron, Joseph J.; Menezes, Prema] Univ N Carolina, Chapel Hill, NC USA; [Fangman, John J. W.] AIDS Resource Ctr Wisconsin, Milwaukee, WI USA; [Ferlazzo, Helen; Stein, Francine] Visiting Nurse Assoc Cent New Jersey, Ctr Community Hlth, Asbury Pk, NJ USA; [Fidler, Sarah; Winston, Alan] Univ London Imperial Coll Sci Technol & Med, London, England; [Fleenor-Ford, Anita] Heartland Clin, Paducah, KY USA; [Frankel, Renee] Morristown Mem Hosp, Morristown, NJ USA; [Fuchs, Jonathan D.] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Fuller, Jon D.; Skolnik, Paul R.] Boston Univ, Med Ctr, Boston, MA USA; [Gaberman, Jonna] Baystate Med Ctr, Springfield, MA USA; [Gallant, Joel E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Gaultier, Cyril R.] Tower Infect Dis, Los Angeles, CA USA; [Gebre, Wondwoosen] Nassau Univ Med Ctr, E Meadow, NY USA; [Gilman, Frank D.; Kurisu, Wayne] Sharp Rees Stealy Med Ctr, San Diego, CA USA; [Gilson, Ian] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Goepfert, Paul A.; Heath, Sonya] Univ Alabama, Birmingham, AL USA; [Gottlieb, Michael S.] Synergy Hematol & Oncol, Los Angeles, CA USA; [Goulston, Claudia] Univ Utah, Salt Lake City, UT USA; [Groger, Richard K.] S Dayton Acute Care Consultants, Dayton, OH USA; [Haber, Stuart; Shay, William] St Vincents Hosp, New York, NY USA; [Hardwicke, Robin] Univ Texas Hlth Sci Ctr, Houston, TX USA; [Harrigan, P. Richard] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Hawkins, Trevor N.; Veikley, Wenoah] SW CARE Ctr, Santa Fe, NM USA; [Henry, W. Keith] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Hladek, Melissa] Catholic Univ Amer, Sch Nursing, Washington, DC 20064 USA; [Hoffman, Robert P.] St Johns Mercy Med Ctr, Springfield, MA USA; [Horton, James M.] CMC Myers Pk Med Ctr, Charlotte, NC USA; [Hsu, Ricky K.; Liguori, Michael A.] NYU, Med Ctr, New York, NY 10016 USA; [Huhn, Gregory D.] Ruth M Rothshon Care Ctr, Chicago, IL USA; [Illeman, Mark L.] Feldman Med Grp, San Francisco, CA USA; [Jaeger, Hans] HIV Res & Clin Care Ctr, Munich, Germany; [Jellinger, Robert M.] Albany Med Coll, Albany, NY 12208 USA; [John, Mina] Murdoch Univ, Murdoch, WA 6150, Australia; [Johnson, Kay] Univ Cincinnati, Cincinnati, OH USA; [Jordan, Wilbert C.] OASIS Clin, Los Angeles, CA USA; [Kauffman, Carol A.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Khanlou, Homayoon] AIDS Healthcare Fdn, Los Angeles, CA USA; [Killian, Robert K.] Capitol Hill Med, Seattle, WA USA; [Kim, David D.] Astor Med Grp, New York, NY USA; [Kinder, Clifford A.] Kinder Med Grp, Miami, FL USA; [Kirchner, Jeffrey T.] Lancaster Gen Hosp, Lancaster, PA USA; [Kogelman, Laura; McGovern, Barbara H.] Tufts Med Ctr, Boston, MA USA; [Kojic, Erna Milunka] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Korthuis, Todd] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Lanzafame, Massimiliano] GB Rossi Hosp, Verona, Italy; [Lederman, Michael M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Lee, Marah J.] LifeWay, Ft Lauderdale, FL USA; [Lee, Edward T. Y.] St Claire Med Associate, Toronto, ON, Canada; [Lemoine, Janice] Greater Lawrence Family Hlth Ctr, Lawrence, MA USA; [Llibre, Josep M.] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; [Lopez, Alvaro J.] Infect Dis Consultants, Tucker, GA USA; [Loutfy, Mono R.; Ostrowski, Mario] Univ Toronto, Toronto, ON, Canada; [Loy, Dawn; Prokesch, Richard C.; Vega, Vilma M.] Infect Dis Associates, Sarasota, FL USA; [Marconi, Vincent C.] Emory Univ, Sch Med, Atlanta, GA USA; [Markowitz, Martin] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Martin, Harold L., Jr.] Pk Nicollet Clin, St Louis, MN USA; [McGhee, Theresa A.] Absolute Care, Atlanta, GA USA; [Mcleod, Gavin X.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Mesa, Greg] Highland Med Associates, Hendersonville, NC USA; [Meyer-Olson, Dirk] Hannover Med Sch, Abt Klin Immunol, D-30623 Hannover, Germany; [Miller, Andy O.] Hosp Special Surg, New York, NY 10021 USA; [Mounzer, Karam C.] Philadelphia FIGHT, Philadelphia, PA USA; [Nagin, Iris] Lower E Side Serv Ctr, New York, NY USA; [Nielsen, Craig] Univ Colorado, Aurora, CO USA; [Norene, David L.] Sutter Med Grp, Sacramento, CA USA; [O'Connor, David H.; Sosman, James M.] Univ Wisconsin, Madison, WI USA; [Okulicz, Jason] Brooke Army Med Ctr, San Antonio, TX USA; [Oldfield, Edward C., III] Eastern Virginia Med Sch, Norfolk, VA 23501 USA; [Olender, Susan A.] Columbia Univ, Med Ctr, New York, NY USA; [Owen, William F., Jr.] CA Pacific Med Ctr, San Francisco, CA USA; [Parsonnet, Jeffrey] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Pavlatos, Andrew M.] St Joseph Hosp, Chicago, IL USA; [Pincus, Jonathan M.] Codman Sq Hlth Ctr, Dorchester, MA USA; [Pisani, Leandro; Rodriguez, Milagros; Saenz, Luis; Santiago, Steven] CARE Resource, Miami, FL USA; [Price, Lawrence Jay] Castro Mission Hlth Ctr, San Francisco, CA USA; [Proia, Laurie] Rush Med Coll, Chicago, IL 60612 USA; [Pujet, Heather Calderon] Boulder Community Hosp, Boulder, CO USA; [Ramgopal, Moti] Midway Immunol & Res Ctr, Ft Pierce, FL USA; [Rausch, Michael] Aerztezentrum Nollendorfpl, Berlin, Germany; [Ravishankar, J.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Rhame, Frank S.] Clin 42, Minneapolis, MN USA; [Richards, Constance Shamuyarira] King Edward Mem Hosp, Paget, Bermuda; [Rodes, Berta] Hosp Carlos III, Fdn Invest Biomed, Madrid, Spain; [Rose, Richard C., III] Summit Med Grp, Knoxville, TN USA; [Rosenthal, Daniel] Med Consultants S Florida, Coral Springs, FL USA; [Ross, Polly E.] Western N Carolina Community Hlth Serv, Asheville, NC USA; [Rubin, David S.] New York Hosp, Queens Med Ctr, Flushing, NY USA; [Salvaggio, Michelle R.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Sanchez, William C.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Sanjana, Veeraf M.] Village Care Hlth Ctr, New York, NY USA; [Schuitemaker, Hanneke; van't Wout, Angelique] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Sestak, Philip M.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Shalit, Peter] Swedish Med Ctr, Seattle, WA USA; [Shirvani, Vivian N.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Silebi, Vanessa I.] Mercy Hosp, Miami, FL USA; [Sizemore, James M., Jr.] Univ Tennessee, Chattanooga, TN USA; [Sokol-Anderson, Marcia] St Louis Univ, St Louis, MO 63103 USA; [Stabile, Paul] William F Ryan Community Hlth Ctr, New York, NY USA; [Stapleton, Jack T.] Univ Iowa, Iowa City, IA USA; [Starrett, Sheree] Rivington House & Village Care, New York, NY USA; [Stellbrink, Hans-Jurgen] Infekt Med Ctr Hamburg, Hamburg, Germany; [Sterman, F. Lisa] Calif Pacific Med Ctr, San Francisco, CA USA; [Stone, David R.] Lemuel Shattuck Hosp, Boston, MA USA; [Tambussi, Giuseppe] Fdn San Raffaele Del Monte Tabor, Milan, Italy; [Tedaldi, Ellen M.] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Torres, Richard] Yale Univ, Sch Med, Bridgeport, CT USA; [Tosiello, Lorraine] Jersey City Med Ctr, Jersey City, NJ USA; [Tremblay, Cecile] Univ Montreal, Montreal, PQ, Canada; [Tribble, Marc A.] Baylor Univ, Med Ctr, Dallas, TX USA; [Trinh, Phuong D.] Montgomery Infect Dis Associates, Silver Spring, MD USA; [Vaccaro, Anthony] Northwestern Univ, Chicago, IL 60611 USA; [Valadas, Emilia] Hosp Santa Maria, Fac Med Lisboa, Lisbon, Portugal; [Vanig, Thanes J.] Spectrum Med Grp, Phoenix, AZ USA; [Vecino, Isabel; Weis, Steve] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA; [Wade, Barbara H.] Infect Dis Associates NW Florida, Pensacola, FL USA; [Ward, Douglas J.] Dupont Circle Phys Grp, Washington, DC USA; [Weber, Robert D.] Infect Dis Specialists, Colorado Springs, CO USA; [Webster, Duncan] St Johns Hosp, St John, NB, Canada; [Wheeler, David A.] Clin Alliance Res & Educ Infect Dis, Annandale, VA USA; [White, David J.] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England; [Wilkins, Ed] N Manchester Grp Hosp, Manchester, Lancs, England; [Wright, David P.] Cent Texas Clin Res, Austin, TX USA; [Yurdin, David L.] Primary Hlth Care, Des Moines, IA USA; [Zabukovic, Brandon W.] Mem Neighborhood Hlth Ctr Cent Clin, South Bend, IN USA; [Zhao, Meng] United Hlth Serv Hosp, Binghamton, NY USA; [Pierce, Michael N.] All Med & Rehabil New York, Bronx, NY USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Lausanne; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Microsoft; Microsoft; Roche Holding; Genentech; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco; Vanderbilt University; Stanford University; Cornell University; University of Hawaii System; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; Uniformed Services University of the Health Sciences - USA; Summa Health System; Mount Sinai St. Luke's; Mount Sinai West; Rutgers State University New Brunswick; Rutgers State University Medical Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Kaiser Permanente; Imperial College London; Saint Barnabas Hospital; McGill University; Vanderbilt University; Louisiana State University System; Louisiana State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Jersey Shore University Medical Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Brooklyn Hospital Center; University of Otago; University of British Columbia; University of New South Wales Sydney; Kirby Institute; John H Stroger Junior Hospital Cook County; Fred Hutchinson Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; University of Iowa; Orlando Immunology Center; University of North Carolina; University of North Carolina Chapel Hill; Imperial College London; Atlantic Health System; San Francisco Department of Public Health; Boston University; Baystate Medical Center; Johns Hopkins University; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Saint Vincents Hospital Manhattan; University of Texas System; University of Texas Health Science Center Houston; B.C. Centre for Excellence in HIV/AIDS; Hennepin County Medical Center; Catholic University of America; New York University; Albany Medical College; Murdoch University; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Tufts Medical Center; Brown University; Oregon Health & Science University; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Case Western Reserve University; Hospital Germans Trias i Pujol; University of Toronto; Emory University; Rockefeller University; Columbia University; Hannover Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Wisconsin System; University of Wisconsin Madison; San Antonio Military Medical Center; United States Department of Defense; United States Army; Eastern Virginia Medical School; Columbia University; California Pacific Medical Center; Dartmouth College; Rush University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Hospital Carlos III; NewYork-Presbyterian Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; Georgetown University; University of Amsterdam; Academic Medical Center Amsterdam; St. Paul's Hospital; University of Saskatchewan; Swedish Medical Center; Cedars Sinai Medical Center; University of Tennessee System; University of Tennessee at Chattanooga; Saint Louis University; University of Iowa; California Pacific Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Yale University; Universite de Montreal; Baylor University; Baylor University Medical Center; Northwestern University; Universidade de Lisboa; Hospital Santa Maria; University of North Texas System; University of North Texas Health Science Center; Heart of England NHS Foundation Trust; University of Birmingham	Walker, BD (corresponding author), Massachusetts Inst Technol & Harvard, Massachusetts Gen Hosp, Regon Inst, Boston, MA USA.	pdebakker@rics.bwh.harvard.edu; bwalker@partners.org	Lewin, Jonathan S/A-4331-2009; Bolan, Robert/AAD-4716-2020; VALLET, Yannick/F-9979-2011; Hardy, W. David/AHD-8960-2022; Allen, Todd/F-5473-2011; Addo, Marylyn M./GNP-2548-2022; de Bakker, Paul IW/B-8730-2009; Marconi, Vincent/GRJ-4553-2022; Rothchild, Alissa/AAM-2635-2020; Telenti, Amalio/AAY-1674-2021; Marconi, Vincent/N-3210-2014; Little, Susan/AAA-6116-2019; Lanzafame, Massimiliano/AAU-5736-2021; Winston, Alan/AGZ-3015-2022; Marconi, Vincent/AFK-5812-2022; Miller, Andy/AAE-2500-2022; Ripke, Stephan/AAK-5486-2021; Block, Brian/L-4001-2019; Hunt, Peter W./P-2976-2017; Altfeld, Marcus/AAE-7306-2019; Robbins, Gregory/F-7988-2011	Allen, Todd/0000-0002-6609-1318; de Bakker, Paul IW/0000-0001-7735-7858; Marconi, Vincent/0000-0001-8409-4689; Rothchild, Alissa/0000-0001-7484-1193; Marconi, Vincent/0000-0001-8409-4689; Winston, Alan/0000-0002-5847-8416; Miller, Andy/0000-0003-2762-0878; Block, Brian/0000-0002-0779-1170; Hunt, Peter W./0000-0002-4571-4870; Altfeld, Marcus/0000-0001-5972-2997; Lian, Jeffrey/0000-0001-9470-7864; Hladek, Melissa/0000-0002-0625-2474; Tambussi, Giuseppe/0000-0002-0604-2960; Gonzalez, Elena/0000-0003-4380-663X; van 't Wout, Angelique/0000-0003-3705-2392; Fuller, Jon/0000-0001-9475-1902; Farel, Claire/0000-0002-4678-7713; Jia, Xiaoming/0000-0002-5104-5431; Le Gall, Sylvie/0000-0003-0385-926X; Brumme, Chanson/0000-0003-2722-5288; Valadas, Emilia/0000-0001-5213-1473; ripke, stephan/0000-0003-3622-835X; Addo, Marylyn/0000-0003-2836-9224; Campbell, Mobola/0000-0002-5772-2368; Pulit, Sara/0000-0002-2502-3669; Birch, Christopher/0000-0001-5824-2676; Korthuis, Philip/0000-0001-5556-3597; McLaren, Paul/0000-0001-6019-7018; Stapleton, Jack/0000-0002-2302-9055; Fidler, Sarah/0000-0003-1676-7583; Robbins, Gregory/0000-0001-7545-5817; Ojikutu, Bisola/0000-0001-7957-8881	Mark and Lisa Schwartz Foundation; Bill and Melinda Gates Foundation; Harvard University Center for AIDS Research [P-30-AI060354]; University of California San Francisco (UCSF) Center for AIDS Research [P-30 AI27763]; UCSF Clinical and Translational Science Institute [UL1 RR024131]; Center for AIDS Research Network of Integrated Clinical Systems [R24 AI067039]; NIH [AI28568, AI030914, AI087145, K24AI069994, AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI069465, AI069511]; Swiss National Science Foundation (SNF) [33CSC0-108787, 310000-110012]; NIH/National Institute of Mental Health [MH085520]; National Cancer Institute/NIH [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131, UL1RR024975, KL2RR024977, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034835, UM1AI069484, U01AI069484, U01AI027661, U01AI025859, UM1AI069474, U01AI069423, UM1AI069511, U01AI068636, UM1AI069556, U01AI069502, UM1AI069432, U01AI069415, U01AI069432, U01AI069452, UM1AI069434, U01AI069532, U01AI069424, UM1AI069452, UM1AI069415, U01AI069495, UM1AI069532, UM1AI069495, U01AI069474, UM1AI069472, U01AI069501, R01AI030914, R01AI028568, UM1AI069513, UM1AI069423, UM1AI069471, UM1AI069501, K24AI064086, U01AI069450, UM1AI068636, UM1AI069450, UM1AI069502, U01AI069556, UM1AI069428, U01AI069511, UM1AI069467, K24AI069994, U01AI069513, U01AI069419, UM1AI069419, T32AI007061, P30AI027763, P30AI050410, U01AI069467, R01AI087145, P30AI060354, R24AI106039, U01AI046370, U01AI068634, U01AI069471, U01AI069434, UM1AI069424, R24AI067039, K24AI051966, U01AI038844, U01AI032782, U01AI069428, U01AI069465, UM1AI069477, R01AI077505, UM1AI068634, U01AI069472, U01AI069477, R37AI028568, U01AI034853, UM1AI069465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907, R01MH071205, U01MH085520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA019809] Funding Source: NIH RePORTER	Mark and Lisa Schwartz Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Harvard University Center for AIDS Research; University of California San Francisco (UCSF) Center for AIDS Research; UCSF Clinical and Translational Science Institute; Center for AIDS Research Network of Integrated Clinical Systems; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NIH/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was made possible through a generous donation from the Mark and Lisa Schwartz Foundation and a subsequent award from the Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation. This work was also supported in part by the Harvard University Center for AIDS Research (grant P-30-AI060354); University of California San Francisco (UCSF) Center for AIDS Research (grant P-30 AI27763); UCSF Clinical and Translational Science Institute (grant UL1 RR024131); Center for AIDS Research Network of Integrated Clinical Systems (grant R24 AI067039); and NIH grants AI28568 and AI030914 (B. D. W.); AI087145 and K24AI069994 (S. G. D.); AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI68634, AI069502, AI069419, AI068636, and RR024975 (AIDS Clinical Trials Group); and AI077505 and MH071205 (D. W. H.). The Swiss HIV Cohort Study is supported by the Swiss National Science Foundation (SNF grants 33CSC0-108787 and 310000-110012). S. Ripke acknowledges support from NIH/National Institute of Mental Health (grant MH085520). This project has been funded in whole or in part with funds from National Cancer Institute/NIH (grant HHSN261200800001E to M. Carrington). The content of this publication does not necessarily reflect the views or policies of the U. S. Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U. S. government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Blanco-Gelaz MA, 2006, INT IMMUNOL, V18, P211, DOI 10.1093/intimm/dxh364; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Costello C, 1999, AIDS, V13, P1990, DOI 10.1097/00002030-199910010-00031; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; KLEIN MR, 1994, J INFECT DIS, V169, P1244, DOI 10.1093/infdis/169.6.1244; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Stewart-Jones GBE, 2005, J IMMUNOL, V175, P2459, DOI 10.4049/jimmunol.175.4.2459; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898	31	849	862	7	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1551	1557		10.1126/science.1195271	http://dx.doi.org/10.1126/science.1195271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21051598	Green Accepted, Green Published			2022-12-01	WOS:000285153500069
J	Bates, M				Bates, Mark			A New Approach to Fluorescence Microscopy	SCIENCE			English	Editorial Material							OPTICAL RECONSTRUCTION MICROSCOPY; LOCALIZATION; PROBES; RESOLUTION; CELLS		Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany	Max Planck Society	Bates, M (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany.	mbates@ggweg.de						Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bates M, 2008, CURR OPIN CHEM BIOL, V12, P505, DOI 10.1016/j.cbpa.2008.08.008; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	17	2	2	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1334	1335		10.1126/science.1200252	http://dx.doi.org/10.1126/science.1200252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127240	Green Published			2022-12-01	WOS:000284902100030
J	Kanchanawong, P; Shtengel, G; Pasapera, AM; Ramko, EB; Davidson, MW; Hess, HF; Waterman, CM				Kanchanawong, Pakorn; Shtengel, Gleb; Pasapera, Ana M.; Ramko, Ericka B.; Davidson, Michael W.; Hess, Harald F.; Waterman, Clare M.			Nanoscale architecture of integrin-based cell adhesions	NATURE			English	Article							FOCAL ADHESIONS; ACTIN-FILAMENTS; PROTEIN; FORCE; TALIN; MICROSCOPY; PROBES	Cell adhesions to the extracellular matrix (ECM) are necessary for morphogenesis, immunity and wound healing(1,2). Focal adhesions are multifunctional organelles that mediate cell-ECM adhesion, force transmission, cytoskeletal regulation and signalling(1-3). Focal adhesions consist of a complex network(4) of trans-plasma-membrane integrins and cytoplasmic proteins that form a <200-nm plaque(5,6) linking the ECM to the actin cytoskeleton. The complexity of focal adhesion composition and dynamics implicate an intricate molecular machine(7,8). However, focal adhesion molecular architecture remains unknown. Here we used three-dimensional super-resolution fluorescence microscopy (interferometric photo-activated localization microscopy)(9) to map nanoscale protein organization in focal adhesions. Our results reveal that integrins and actin are vertically separated by a similar to 40-nm focal adhesion core region consisting of multiple protein-specific strata: a membrane-apposed integrin signalling layer containing integrin cytoplasmic tails, focal adhesion kinase and paxillin; an intermediate force-transduction layer containing talin and vinculin; and an uppermost actin-regulatory layer containing zyxin, vasodilator-stimulated phosphoprotein and alpha-actinin. By localizing amino- and carboxyterminally tagged talins, we reveal talin's polarized orientation, indicative of a role in organizing the focal adhesion strata. The composite multilaminar protein architecture provides a molecular blueprint for understanding focal adhesion functions.	[Kanchanawong, Pakorn; Pasapera, Ana M.; Waterman, Clare M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Shtengel, Gleb; Hess, Harald F.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Ramko, Ericka B.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Waterman, CM (corresponding author), NHLBI, NIH, Bethesda, MD 20892 USA.	davidson@magnet.fsu.edu; hessh@janelia.hhmi.org; watermancm@nhlbi.nih.gov	Kanchanawong, Pakorn/M-1315-2017	Kanchanawong, Pakorn/0000-0001-8765-3861; Waterman, Clare/0000-0001-6142-6775	Division of Intramural Research, NHLBI; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005105] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Lippincott-Schwartz, G. Patterson and M. Parsons for sharing DNA; S. Xie for help with automation software; K. Jaqaman for MATLAB code; and HHMI Janelia Farm Scientific Computing and NIH Helix systems for computing resources. Funding: Division of Intramural Research, NHLBI (P.K., A.M.P. and C.M.W.); Howard Hughes Medical Institute (G.S. and H.F.H.).	AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHEN WT, 1982, J CELL BIOL, V95, P205, DOI 10.1083/jcb.95.1.205; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dulkeith E, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205424; Franz CM, 2005, J CELL SCI, V118, P5315, DOI 10.1242/jcs.02653; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hell SW, 2009, NAT PHOTONICS, V3, P381, DOI 10.1038/NPHOTON.2009.112; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; PALADE GE, 1954, J EXP MED, V100, P641, DOI 10.1084/jem.100.6.641; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pollard TD, 2009, J BIOL CHEM, V284, P5433, DOI 10.1074/jbc.R800043200; Press WH., 1986, NUMERICAL RECIPES FO; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Wang Yu-li, 2007, Sci STKE, V2007, ppe10; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 1999, J CELL SCI, V112, P1655	35	980	1001	8	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					580	U262		10.1038/nature09621	http://dx.doi.org/10.1038/nature09621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107430	Green Accepted			2022-12-01	WOS:000284584200046
J	Runguphan, W; Qu, XD; O'Connor, SE				Runguphan, Weerawat; Qu, Xudong; O'Connor, Sarah E.			Integrating carbon-halogen bond formation into medicinal plant metabolism	NATURE			English	Article							INDOLE ALKALOID BIOSYNTHESIS; FLAVIN-DEPENDENT HALOGENASES; CATHARANTHUS-ROSEUS; BENZYLISOQUINOLINE ALKALOIDS; IMMATURE SEEDS; PISUM SATIVUM; REBH; CHLORINATION; PERIWINKLE; STRATEGIES	Halogenation, which was once considered a rare occurrence in nature, has now been observed in many natural product biosynthetic pathways(1). However, only a small fraction of halogenated compounds have been isolated from terrestrial plants(2). Given the impact that halogenation can have on the biological activity of natural products(1), we reasoned that the introduction of halides into medicinal plant metabolism would provide the opportunity to rationally bioengineer a broad variety of novel plant products with altered, and perhaps improved, pharmacological properties. Here we report that chlorination biosynthetic machinery from soil bacteria can be successfully introduced into the medicinal plant Catharanthus roseus (Madagascar periwinkle). These prokaryotic halogenases function within the context of the plant cell to generate chlorinated tryptophan, which is then shuttled into monoterpene indole alkaloid metabolism to yield chlorinated alkaloids. A new functional group-a halide-is thereby introduced into the complex metabolism of C. roseus, and is incorporated in a predictable and regioselective manner onto the plant alkaloid products. Medicinal plants, despite their genetic and developmental complexity, therefore seem to be a viable platform for synthetic biology efforts.	[Runguphan, Weerawat; Qu, Xudong; O'Connor, Sarah E.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	O'Connor, SE (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	soc@mit.edu	Qu, Xudong/E-1778-2016; Runguphan, Weerawat/GSM-9179-2022; O'Connor, Sarah Ellen/X-2893-2019; O'Connor, Sarah/O-5850-2016	Qu, Xudong/0000-0002-3301-8536; Runguphan, Weerawat/0000-0001-5707-3516; O'Connor, Sarah/0000-0003-0356-6213	NIH [GM074820]; American Cancer Society [RSG-07-025-01-CDD]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074820] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the NIH (GM074820) and the American Cancer Society (RSG-07-025-01-CDD). We thank H.-Y. Lee and M. Tjandra for assistance with NMR characterizations and L. Li for high-resolution mass spectroscopy analysis.	AMAT M, 1990, J ORG CHEM, V55, P6299, DOI 10.1021/jo00313a017; Bernhardt P, 2007, CHEM BIOL, V14, P888, DOI 10.1016/j.chembiol.2007.07.008; Bitto E, 2008, PROTEINS, V70, P289, DOI 10.1002/prot.21627; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; DELUCA V, 1987, PLANT PHYSIOL, V85, P1099, DOI 10.1104/pp.85.4.1099; DELUCA V, 1989, P NATL ACAD SCI USA, V86, P2582; Frederich M, 2002, J NAT PROD, V65, P1381, DOI 10.1021/np020070e; GANDAR JC, 1967, CR ACAD SCI D NAT, V265, P1795; Gribble GW, 2003, CHEMOSPHERE, V52, P289, DOI 10.1016/S0045-6535(03)00207-8; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hughes EH, 2002, BIOTECHNOL PROGR, V18, P1183, DOI 10.1021/bp025603o; Li SW, 2004, CURR MED RES OPIN, V20, P409, DOI 10.1185/030079904125003080; Loris EA, 2007, CHEM BIOL, V14, P979, DOI 10.1016/j.chembiol.2007.08.009; MARUMO S, 1968, NATURE, V219, P959, DOI 10.1038/219959b0; Mccoy E, 2006, J AM CHEM SOC, V128, P14276, DOI 10.1021/ja066787w; Menzies JRW, 1998, EUR J PHARMACOL, V350, P101, DOI 10.1016/S0014-2999(98)00232-5; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Roy AD, 2010, J AM CHEM SOC, V132, P12243, DOI 10.1021/ja1060406; Runguphan W, 2009, P NATL ACAD SCI USA, V106, P13673, DOI 10.1073/pnas.0903393106; Runguphan W, 2009, NAT CHEM BIOL, V5, P151, DOI 10.1038/nchembio.141; Sanchez C, 2005, P NATL ACAD SCI USA, V102, P461, DOI 10.1073/pnas.0407809102; Schumacher RW, 1999, TETRAHEDRON, V55, P935, DOI 10.1016/S0040-4020(98)01100-4; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; van Pee KH, 2006, APPL MICROBIOL BIOT, V70, P631, DOI 10.1007/s00253-005-0232-2; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zehner S, 2005, CHEM BIOL, V12, P445, DOI 10.1016/j.chembiol.2005.02.005; Zhu WM, 2005, J INTEGR PLANT BIOL, V47, P892, DOI 10.1111/j.1744-7909.2005.00042.x; Zhu XF, 2009, J MOL BIOL, V391, P74, DOI 10.1016/j.jmb.2009.06.008	32	159	163	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2010	468	7322					461	U294		10.1038/nature09524	http://dx.doi.org/10.1038/nature09524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	681KP	21048708	Green Submitted, Green Accepted			2022-12-01	WOS:000284313100048
J	Shopsowitz, KE; Qi, H; Hamad, WY; MacLachlan, MJ				Shopsowitz, Kevin E.; Qi, Hao; Hamad, Wadood Y.; MacLachlan, Mark J.			Free-standing mesoporous silica films with tunable chiral nematic structures	NATURE			English	Article							CHOLESTERIC LIQUID-CRYSTALS; CELLULOSE; ORDER; SUSPENSIONS; GERMANIUM; BAND	Chirality at the molecular level is found in diverse biological structures, such as polysaccharides, proteins and DNA, and is responsible for many of their unique properties(1). Introducing chirality into porous inorganic solids may produce new types of materials that could be useful for chiral separation, stereospecific catalysis, chiral recognition (sensing) and photonic materials(2-5). Template synthesis of inorganic solids using the self-assembly of lyotropic liquid crystals offers access to materials with well-defined porous structures(6-12), but only recently has chirality been introduced into hexagonal mesostructures through the use of a chiral surfactant(13,14). Efforts to impart chirality at a larger length scale using self-assembly are almost unknown. Here we describe the development of a photonic mesoporous inorganic solid that is a cast of a chiral nematic liquid crystal formed from nanocrystalline cellulose. These materials may be obtained as free-standing films with high surface area. The peak reflected wavelength of the films can be varied across the entire visible spectrum and into the near-infrared through simple changes in the synthetic conditions. To the best of our knowledge these are the first materials to combine mesoporosity with long-range chiral ordering that produces photonic properties. Our findings could lead to the development of new materials for applications in, for example, tuneable reflective filters and sensors. In addition, this type of material could be used as a hard template to generate other new materials with chiral nematic structures.	[Shopsowitz, Kevin E.; Qi, Hao; MacLachlan, Mark J.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Hamad, Wadood Y.] FPInnovations, Vancouver, BC V6S 2L9, Canada	University of British Columbia	MacLachlan, MJ (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	mmaclach@chem.ubc.ca	Hatzikiriakos, Savvas/AAD-2672-2019; MacLachlan, Mark J/I-2961-2013; MacLachlan, Mark/Z-2069-2019; Shopsowitz, Kevin/A-2915-2013	Hatzikiriakos, Savvas/0000-0002-1456-7927; MacLachlan, Mark J/0000-0002-3546-7132; MacLachlan, Mark/0000-0002-3546-7132; 	Natural Sciences and Engineering Research Council (NSERC) of Canada; FPInnovations; UBC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); FPInnovations(German Research Foundation (DFG)); UBC	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada and FPInnovations. K.E.S. is grateful to UBC for a graduate fellowship.	Akagi K, 1998, SCIENCE, V282, P1683, DOI 10.1126/science.282.5394.1683; Armatas GS, 2006, SCIENCE, V313, P817, DOI 10.1126/science.1130101; ATTARD GS, 1995, NATURE, V378, P366, DOI 10.1038/378366a0; BROER DJ, 1995, NATURE, V378, P467, DOI 10.1038/378467a0; Che S, 2004, NATURE, V429, P281, DOI 10.1038/nature02529; DEVRIES H, 1951, ACTA CRYSTALLOGR, V4, P219, DOI 10.1107/S0365110X51000751; Dong XM, 1996, LANGMUIR, V12, P2076, DOI 10.1021/la950133b; Dujardin E, 2003, J MATER CHEM, V13, P696, DOI 10.1039/b212689c; Edgar CD, 2001, CELLULOSE, V8, P5, DOI 10.1023/A:1016624330458; Fireman-Shoresh S, 2005, J AM CHEM SOC, V127, P2650, DOI 10.1021/ja0454384; Gabashvili A, 2007, J PHYS CHEM B, V111, P11105, DOI 10.1021/jp072480n; Hodgkinson I, 2001, ADV MATER, V13, P889, DOI 10.1002/1521-4095(200107)13:12/13<889::AID-ADMA889>3.0.CO;2-K; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Johnson BFG, 1999, CHEM COMMUN, P1167, DOI 10.1039/a902441g; JOHNSON LN, 2005, EUR REV, V13, P77; Kopp VI, 1998, OPT LETT, V23, P1707, DOI 10.1364/OL.23.001707; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; MUKHERJEE SM, 1953, BIOCHIM BIOPHYS ACTA, V10, P499, DOI 10.1016/0006-3002(53)90295-9; Qiu HB, 2009, ANGEW CHEM INT EDIT, V48, P3069, DOI 10.1002/anie.200900303; Revol JF, 1998, J PULP PAP SCI, V24, P146; REVOL JF, 1992, INT J BIOL MACROMOL, V14, P170, DOI 10.1016/S0141-8130(05)80008-X; Robbie K, 1999, NATURE, V399, P764, DOI 10.1038/21612; Sharma V, 2009, SCIENCE, V325, P449, DOI 10.1126/science.1172051; Sun D, 2006, NATURE, V441, P1126, DOI 10.1038/nature04891; Thomas A, 2003, ADV FUNCT MATER, V13, P763, DOI 10.1002/adfm.200304383; YANG DK, 1994, J APPL PHYS, V76, P1331, DOI 10.1063/1.358518; Yang H, 1996, NATURE, V381, P589, DOI 10.1038/381589a0; Yang PD, 1998, NATURE, V396, P152	28	691	714	46	1083	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2010	468	7322					422	U246		10.1038/nature09540	http://dx.doi.org/10.1038/nature09540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085176				2022-12-01	WOS:000284313100039
J	Karlawish, J				Karlawish, Jason			Desktop Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Karlawish, Jason] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Karlawish, Jason] Univ Penn, Dept Med Eth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Karlawish, J (corresponding author), Univ Penn, Dept Med, 3615 Chestnut St, Philadelphia, PA 19104 USA.	Jason.Karlawish@uphs.upenn.edu						Aronowitz RA, 2009, MILBANK Q, V87, P417, DOI 10.1111/j.1468-0009.2009.00563.x; Greene JWC, 2007, PROCEEDINGS IEEE SOUTHEASTCON 2007, VOLS 1 AND 2, P221; Linnenbringer E, 2010, GENET MED, V12, P219, DOI 10.1097/GIM.0b013e3181cef9e1; National Heart Lung and Blood Institute, RISK ASS TOOL EST 10; Phillips LS, 2008, ANN INTERN MED, V148, P783, DOI 10.7326/0003-4819-148-10-200805200-00011; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; Vijan S, 2008, ANN INTERN MED, V149, P839, DOI 10.7326/0003-4819-149-11-200812020-00019; Volpp KG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-272; World Health Organization Collaborating Centre for Metabolic Bone Diseases, WHO FRACT RISK ASS T	9	9	10	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2061	2062		10.1001/jama.2010.1624	http://dx.doi.org/10.1001/jama.2010.1624			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063017				2022-12-01	WOS:000284000600027
J	Garneau, JE; Dupuis, ME; Villion, M; Romero, DA; Barrangou, R; Boyaval, P; Fremaux, C; Horvath, P; Magadan, AH; Moineau, S				Garneau, Josiane E.; Dupuis, Marie-Eve; Villion, Manuela; Romero, Dennis A.; Barrangou, Rodolphe; Boyaval, Patrick; Fremaux, Christophe; Horvath, Philippe; Magadan, Alfonso H.; Moineau, Sylvain			The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA	NATURE			English	Article							ESCHERICHIA-COLI; REPEATS; IDENTIFICATION; RNAS; EXPRESSION; RESISTANCE; DEFENSE; GENE; DIVERSITY; SEQUENCES	Bacteria and Archaea have developed several defence strategies against foreign nucleic acids such as viral genomes and plasmids. Among them, clustered regularly interspaced short palindromic repeats (CRISPR) loci together with cas (CRISPR-associated) genes form the CRISPR/Cas immune system, which involves partially palindromic repeats separated by short stretches of DNA called spacers, acquired from extrachromosomal elements. It was recently demonstrated that these variable loci can incorporate spacers from infecting bacteriophages and then provide immunity against subsequent bacteriophage infections in a sequence-specific manner. Here we show that the Streptococcus thermophilus CRISPR1/Cas system can also naturally acquire spacers from a self-replicating plasmid containing an antibiotic-resistance gene, leading to plasmid loss. Acquired spacers that match antibiotic-resistance genes provide a novel means to naturally select bacteria that cannot uptake and disseminate such genes. We also provide in vivo evidence that the CRISPR1/Cas system specifically cleaves plasmid and bacteriophage double-stranded DNA within the proto-spacer, at specific sites. Our data show that the CRISPR/Cas immune system is remarkably adapted to cleave invading DNA rapidly and has the potential for exploitation to generate safer microbial strains.	[Garneau, Josiane E.; Dupuis, Marie-Eve; Villion, Manuela; Magadan, Alfonso H.; Moineau, Sylvain] Univ Laval, Felix dHerelle Reference Ctr Bacterial Viruses, Dept Biochim Microbiol & Bioinformat, Fac Med Dent,Grp Rech Ecol Buccale,Fac Sci & Geni, Quebec City, PQ G1V 0A6, Canada; [Romero, Dennis A.; Barrangou, Rodolphe] Danisco USA Inc, Madison, WI 53716 USA; [Boyaval, Patrick; Fremaux, Christophe; Horvath, Philippe] Danisco France SAS, F-86220 Dange St Romain, France	Laval University	Moineau, S (corresponding author), Univ Laval, Felix dHerelle Reference Ctr Bacterial Viruses, Dept Biochim Microbiol & Bioinformat, Fac Med Dent,Grp Rech Ecol Buccale,Fac Sci & Geni, Quebec City, PQ G1V 0A6, Canada.	Sylvain.Moineau@bcm.ulaval.ca	Moineau, Sylvain/N-3578-2013; HORVATH, Philippe/K-5266-2015; Moineau, Sylvain/I-7231-2019; Magadan, Alfonso Hernandez/M-5994-2019; Barrangou, Rodolphe/I-2878-2014; Magadán, Alfonso Hernández/K-4455-2012	HORVATH, Philippe/0000-0003-2015-8123; Moineau, Sylvain/0000-0002-2832-5101; Magadan, Alfonso Hernandez/0000-0003-2556-7890; Barrangou, Rodolphe/0000-0002-0648-3504; Magadán, Alfonso Hernández/0000-0003-2556-7890	Novalait/FQRNT; Clarin/FICYT; NSERC; CIHR	Novalait/FQRNT(FQRNT); Clarin/FICYT; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	We thank T.R. Klaenhammer for pTRK687, B. Conway for editorial assistance, D. Tremblay, A. Fleury and B. Stahl for technical assistance. M.-E.D. is the recipient of a Novalait/FQRNT graduate scholarship and A.H.M. of a Clarin/FICYT postdoctoral scholarship. S.M. acknowledges funding from NSERC (Discovery program) and CIHR (Team Grant-Emerging: Novel Alternatives to Antibiotics).	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buckley ND, 1999, APPL ENVIRON MICROB, V65, P3800; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Duplessis M, 2005, VIROLOGY, V340, P192, DOI 10.1016/j.virol.2005.05.033; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Girard SL, 2007, PLASMID, V58, P174, DOI 10.1016/j.plasmid.2007.03.003; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; KIEWIET R, 1993, APPL ENVIRON MICROB, V59, P358, DOI 10.1128/AEM.59.2.358-364.1993; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MOINEAU S, 1992, CAN J MICROBIOL, V38, P875, DOI 10.1139/m92-143; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Nieto C, 2000, PLASMID, V43, P205, DOI 10.1006/plas.2000.1465; OCHMAN H, 1988, GENETICS, V120, P621; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Sambrook JF., 2001, MOL CLONING LAB MANU; SOMKUTI GA, 1986, J IND MICROBIOL, V1, P157, DOI 10.1007/BF01569267; Sturino JM, 2002, APPL ENVIRON MICROB, V68, P588, DOI 10.1128/AEM.68.2.588-596.2002; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Turgeon N, 2001, PLASMID, V45, P171, DOI 10.1006/plas.2001.1517; Vaillancourt K, 2008, APPL ENVIRON MICROB, V74, P1264, DOI 10.1128/AEM.01585-07	36	1368	1659	31	786	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					67	71		10.1038/nature09523	http://dx.doi.org/10.1038/nature09523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	21048762				2022-12-01	WOS:000283786900036
J	King, AC; Guralnik, JM				King, Abby C.; Guralnik, Jack M.			Maximizing the Potential of an Aging Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISABILITY		[King, Abby C.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA; [King, Abby C.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	King, AC (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, 159 Campus Dr,HRP Redwood Bldg,T221, Stanford, CA 94305 USA.	king@stanford.edu	King, Abby/AAD-5257-2021	King, Abby/0000-0002-7949-8811	NATIONAL INSTITUTE ON AGING [U01AG022376] Funding Source: NIH RePORTER; NIA NIH HHS [U01 AG022376, 2U01 AG022376-05A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Fried LP, 2004, J URBAN HEALTH, V81, P64, DOI 10.1093/jurban/jth094; Fuller-Thomson E, 2009, J GERONTOL A-BIOL, V64, P1333, DOI 10.1093/gerona/glp130; Kerse N, 2005, J AM GERIATR SOC, V53, P1951, DOI 10.1111/j.1532-5415.2005.00466.x; King AC, 2007, HEALTH PSYCHOL, V26, P718, DOI 10.1037/0278-6133.26.6.718; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Minkler M, 2006, NEW ENGL J MED, V355, P695, DOI 10.1056/NEJMsa044316; Nguyen Huong Q, 2008, Prev Chronic Dis, V5, pA14; Physical Activity Guidelines Advisory Committee, 2008, REP PHYS ACT GUID AD; *US DEP HHS, 2008, ODPHP PUBL U, V42	10	39	40	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2010	304	17					1944	1945		10.1001/jama.2010.1577	http://dx.doi.org/10.1001/jama.2010.1577			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674GT	21045101	Green Accepted			2022-12-01	WOS:000283725900025
J	Haigo, SL; Bilder, D				Haigo, Saori L.; Bilder, David			Global Tissue Revolutions in a Morphogenetic Movement Controlling Elongation	SCIENCE			English	Article							DROSOPHILA FOLLICULAR EPITHELIUM; OVARIAN FOLLICLES; PLANAR POLARITY; CELL-MIGRATION; AXIS; INTERCALATION; MECHANISMS; EXTENSION; INTEGRIN; PATHWAY	Polarized cell behaviors drive axis elongation in animal embryos, but the mechanisms underlying elongation of many tissues remain unknown. Eggs of Drosophila undergo elongation from a sphere to an ellipsoid during oogenesis. We used live imaging of follicles (developing eggs) to elucidate the cellular basis of egg elongation. We find that elongating follicles undergo repeated rounds of circumferential rotation around their long axes. Follicle epithelia mutant for integrin or collagen IV fail to rotate and elongate, which results in round eggs. We present evidence that polarized rotation is required to build a polarized, fibrillar extracellular matrix (ECM) that constrains tissue shape. Thus, global tissue rotation is a morphogenetic behavior that uses planar polarity information in the ECM to control tissue elongation.	[Haigo, Saori L.; Bilder, David] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bilder, D (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 379 Life Sci Addit 3200, Berkeley, CA 94720 USA.	bilder@berkeley.edu		Bilder, David/0000-0002-1842-4966	Berkeley Graduate Fellowship; American Heart Association; NIH [R01 GM068675]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068675] Funding Source: NIH RePORTER	Berkeley Graduate Fellowship; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kimbrell, L. Cooley, A. Spradling, M. Buszczak, J. Lipsick, and the Bloomington Drosophila Stock Center for kindly providing fly stocks and M. Welch for providing reagents. We thank members of the Bilder laboratory, I. Hariharan, and R. Harland for providing feedback and S. Windler for comments on the manuscript. We apologize to those whose work could only be cited in review articles. This work is supported by a Berkeley Graduate Fellowship and an American Heart Association Predoctoral Fellowship to S.L.H. and by NIH grant R01 GM068675 to D.B.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Bastock R, 2007, DEVELOPMENT, V134, P3055, DOI 10.1242/dev.010447; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Conder R, 2007, DEV BIOL, V305, P470, DOI 10.1016/j.ydbio.2007.02.034; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; GUTZEIT HO, 1990, EUR J CELL BIOL, V53, P349; GUTZEIT HO, 1991, J CELL SCI, V100, P781; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; King RC., 1970, OVARIAN DEV DROSOPHI; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Mirouse V, 2009, DEV CELL, V16, P83, DOI 10.1016/j.devcel.2008.11.006; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; SHIH J, 1992, DEVELOPMENT, V116, P901; Spradling Allan C., 1993, P1; Viktorinova I, 2009, DEVELOPMENT, V136, P4123, DOI 10.1242/dev.039099; Wallingford JB, 2005, AM J MED GENET C, V135C, P59, DOI 10.1002/ajmg.c.30054; WENT DF, 1978, J EXP ZOOL, V205, P149, DOI 10.1002/jez.1402050118	30	210	212	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1071	1074		10.1126/science.1199424	http://dx.doi.org/10.1126/science.1199424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21212324	Green Accepted			2022-12-01	WOS:000287699000065
J	Aguilera, C; Nakagawa, K; Sancho, R; Chakraborty, A; Hendrich, B; Behrens, A				Aguilera, Cristina; Nakagawa, Kentaro; Sancho, Rocio; Chakraborty, Atanu; Hendrich, Brian; Behrens, Axel			c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex	NATURE			English	Article							BINDING DOMAIN; MAP KINASES; STEM-CELLS; MBD3; NURD; TUMORIGENESIS; ACTIVATION; COMPONENT; MI-2/NURD; COLON	AP-1 (activator protein 1) activity is strongly induced in response to numerous signals, including growth factors, cytokines and extracellular stresses(1). The proto-oncoprotein c-Jun belongs to the AP-1 group of transcription factors and it is a crucial regulator of intestinal progenitor proliferation and tumorigenesis(2-4). An important mechanism of AP-1 stimulation is phosphorylation of c-Jun by the Jun amino-terminal kinases (JNKs)(1). N-terminal phosphorylation of the c-Jun transactivation domain increases target gene transcription(5,6), but a molecular explanation was elusive. Here we show that unphosphorylated, but not N-terminally phosphorylated c-Jun, interacts with Mbd3 and thereby recruits the nucleosome remodelling and histone deacetylation (NuRD) repressor complex. Mbd3 depletion in colon cancer cells increased histone acetylation at AP-1-dependent promoters, which resulted in increased target gene expression. The intestinal stem cell marker lgr5 was identified as a novel target gene controlled by c-Jun/Mbd3. Gut-specific conditional deletion of mbd3 (mbd3(Delta G/Delta G) mice) stimulated c-Jun activity and increased progenitor cell proliferation. In response to inflammation, mdb3 deficiency resulted in colonic hyperproliferation and mbd3(Delta G/Delta G) mice showed markedly increased susceptibility to colitis-induced tumorigenesis. Notably, concomitant inactivation of a single allele of c-jun reverted physiological and pathological hyperproliferation, as well as the increased tumorigenesis in mbd3(Delta G/Delta G) mice. Thus the transactivation domain of c-Jun recruits Mbd3/NuRD to AP-1 target genes to mediate gene repression, and this repression is relieved by JNK-mediated c-Jun N-terminal phosphorylation.	[Aguilera, Cristina; Nakagawa, Kentaro; Sancho, Rocio; Chakraborty, Atanu; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England; [Nakagawa, Kentaro] Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Bunkyo Ku, Tokyo 1138519, Japan; [Hendrich, Brian] Univ Cambridge, Dept Biochem, MRC,Wellcome Trust Ctr Stem Cell Res, Ctr Stem Cell Biol & Regenerat Med, Cambridge CB2 1QR, England	Cancer Research UK; Tokyo Medical & Dental University (TMDU); University of Cambridge	Behrens, A (corresponding author), Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk	Hendrich, Brian/AAG-5898-2020	Hendrich, Brian/0000-0002-0231-3073; Sancho, Rocio/0000-0002-4894-5391; Behrens, Axel/0000-0002-1557-1143	Marie Curie Intraeuropean Fellowships [PIEF-GA-2008-220566, MEIF-CT-2006-041119]; Cancer Research UK; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Marie Curie Intraeuropean Fellowships(European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the LRI Animal Unit, Equipment Park, FACS, Peptide synthesis and the Experimental Histopathology unit for technical help and O. S. Gabrielsen for reagents. We thank C. Hill and H. Van Dam for critical reading of the manuscript. C. A. and R. S. were funded by Marie Curie Intraeuropean Fellowships (PIEF-GA-2008-220566 and MEIF-CT-2006-041119). The London Research Institute is funded by Cancer Research UK.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BAICHWAL VR, 1992, GENE DEV, V6, P1493, DOI 10.1101/gad.6.8.1493; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; D'Orazio D, 1997, GENE, V201, P179, DOI 10.1016/S0378-1119(97)00445-9; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364	28	92	99	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					231	235		10.1038/nature09607	http://dx.doi.org/10.1038/nature09607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21196933				2022-12-01	WOS:000286143400042
J	Poste, G				Poste, George			Bring on the biomarkers	NATURE			English	Editorial Material							MEDICINE		[Poste, George] Complex Adapt Syst Initiat, Scottsdale, AZ 85257 USA; [Poste, George] Arizona State Univ, Scottsdale, AZ 85257 USA	Arizona State University	Poste, G (corresponding author), Complex Adapt Syst Initiat, Scottsdale, AZ 85257 USA.	george.poste@asu.edu						Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Davis JC, 2009, NAT REV DRUG DISCOV, V8, P279, DOI 10.1038/nrd2825; Javitt G, 2010, NATURE, V466, P817, DOI 10.1038/466817a; Meckley LM, 2010, HEALTH POLICY, V94, P91, DOI 10.1016/j.healthpol.2009.09.006; Moore Helen M, 2009, Cancer Res, V69, P6770, DOI 10.1158/0008-5472.CAN-09-1795; Ransohoff DF, 2010, J CLIN ONCOL, V28, P698, DOI 10.1200/JCO.2009.25.6065; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Vaught J., 2009, RES POLICY INITIATIV	9	385	392	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					156	157		10.1038/469156a	http://dx.doi.org/10.1038/469156a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228852				2022-12-01	WOS:000286143400015
J	Prudic, KL; Jeon, C; Cao, H; Monteiro, A				Prudic, Kathleen L.; Jeon, Cheonha; Cao, Hui; Monteiro, Antonia			Developmental Plasticity in Sexual Roles of Butterfly Species Drives Mutual Sexual Ornamentation	SCIENCE			English	Article							BICYCLUS-ANYNANA; ROLE REVERSAL; PHENOTYPIC PLASTICITY; SELECTION; MALES; PATTERN; POLYPHENISM; INVESTMENT; INSECTS; CHOICE	Current explanations for why sexual ornaments are found in both sexes include genetic correlation, same sex competition, and mutual mate choice. In this study, we report developmental plasticity in mating behavior as induced by temperature during development in the butterfly Bicyclus anynana. Males and females reciprocally change their sexual roles depending on their larval rearing temperatures. This switch is correlated with a change in mating benefits to females and costs to males. The discrete seasonal environments, wet season and dry season, are known to produce the two developmental forms and as a consequence impose alternating, symmetrical patterns of sexual selection, one season on male ornaments, the following season on female ornaments. Thus, reciprocal selection through time may result in mutual sexual ornamentation.	[Prudic, Kathleen L.] Yale Univ, Yale Inst Biospher Studies, New Haven, CT 06511 USA; [Monteiro, Antonia] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06511 USA	Yale University; Yale University	Prudic, KL (corresponding author), Yale Univ, Yale Inst Biospher Studies, 165 Prospect St, New Haven, CT 06511 USA.	Kathleen.prudic@yale.edu; antonia.monteiro@yale.edu	Cao, Hui/F-4815-2012; Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Prudic, Kathleen/0000-0001-8242-7769	American Association of University Women; Yale Institute of Biospheric Studies; Yale University; Yale NSF-MRSEC [DMR-0520495]	American Association of University Women; Yale Institute of Biospheric Studies; Yale University; Yale NSF-MRSEC	Visual recordings of O. anynana courtship displays are available online at www.youtube.com/watch?v=_1AjNkJuyX0. We thank A. Alonzo, H. Kindsvater, J. Oliver, D. Papaj, E. Snell-Rood, A. Stoehr, and three anonymous reviewers for comments and R. Rak and C. Bolick for rearing host plants. Funding was provided by the American Association of University Women and Yale Institute of Biospheric Studies to K.L.P., Yale University to A.M., and the Yale NSF-MRSEC (DMR-0520495) to H.C.	Berglund A, 2005, BEHAV ECOL, V16, P649, DOI 10.1093/beheco/ari038; Billing AM, 2007, BEHAV ECOL, V18, P535, DOI 10.1093/beheco/arm007; BOGGS CL, 1990, AM NAT, V136, P598, DOI 10.1086/285118; BRAKEFIELD PM, 1995, J EVOLUTION BIOL, V8, P559, DOI 10.1046/j.1420-9101.1995.8050559.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Brakefield PM, 2008, PHENOTYPIC PLASTICIT, P121; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Friberg M, 2007, BEHAV ECOL, V18, P758, DOI 10.1093/beheco/arm037; GWYNNE DT, 1984, EVOLUTION, V38, P1011, DOI 10.2307/2408435; GWYNNE DT, 1990, NATURE, V346, P172, DOI 10.1038/346172a0; KAITALA A, 1994, BEHAV ECOL SOCIOBIOL, V35, P385, DOI 10.1007/BF00165840; Karlsson B, 1998, ECOLOGY, V79, P2931, DOI 10.1890/0012-9658(1998)079[2931:NGRBAR]2.0.CO;2; KINGSOLVER JG, 1995, EVOLUTION, V49, P932, DOI 10.1111/j.1558-5646.1995.tb02328.x; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Lewis Z, 2007, J INSECT BEHAV, V20, P201, DOI 10.1007/s10905-007-9075-2; Molleman F, 2004, BEHAV ECOL SOCIOBIOL, V56, P404, DOI 10.1007/s00265-004-0789-2; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Obara Y, 2008, ZOOL SCI, V25, P1, DOI 10.2108/zsj.25.1; Oliver JC, 2009, P ROY SOC B-BIOL SCI, V276, P2369, DOI 10.1098/rspb.2009.0182; Ritchie MG, 1998, J INSECT BEHAV, V11, P481, DOI 10.1023/A:1022359228537; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Shapiro A. M., 1976, EVOL BIOL, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; SIMMONS LW, 1992, NATURE, V358, P61, DOI 10.1038/358061a0; West-Eberhard Mary Jane, 2003, pi; Wiklund C, 2004, ANIM BEHAV, V68, P621, DOI 10.1016/j.anbehav.2003.12.008	30	101	101	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					73	75		10.1126/science.1197114	http://dx.doi.org/10.1126/science.1197114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212355				2022-12-01	WOS:000285974000038
J	Koksal, M; Jin, YH; Coates, RM; Croteau, R; Christianson, DW				Koeksal, Mustafa; Jin, Yinghua; Coates, Robert M.; Croteau, Rodney; Christianson, David W.			Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis	NATURE			English	Article							ENT-COPALYL DIPHOSPHATE; CRYSTAL-STRUCTURE; TAXOL BIOSYNTHESIS; COMMITTED STEP; GERANYLGERANYL DIPHOSPHATE; DITERPENE CYCLASE; CYCLIZATION; MECHANISM; CATALYZES; TAXA-4(5),11(12)-DIENE	With more than 55,000 members identified so far in all forms of life, the family of terpene or terpenoid natural products represents the epitome of molecular biodiversity. A well-known and important member of this family is the polycyclic diterpenoid Taxol (paclitaxel), which promotes tubulin polymerization(1) and shows remarkable efficacy in cancer chemotherapy(2). The first committed step of Taxol biosynthesis in the Pacific yew (Taxus brevifolia)(3) is the cyclization of the linear isoprenoid substrate geranylgeranyl diphosphate (GGPP) to form taxa-4(5), 11(12) diene(4), which is catalysed by taxadiene synthase(5). The full-length form of this diterpene cyclase contains 862 residues, but a roughly 80-residue amino-terminal transit sequence is cleaved on maturation in plastids(6). We now report the X-ray crystal structure of a truncation variant lacking the transit sequence and an additional 27 residues at the N terminus, hereafter designated TXS. Specifically, we have determined structures of TXS complexed with 13-aza-13,14-dihydrocopalyl diphosphate (1.82 angstrom resolution) and 2-fluorogeranylgeranyl diphosphate (2.25 angstrom resolution). The TXS structure reveals a modular assembly of three alpha-helical domains. The carboxy-terminal catalytic domain is a class I terpenoid cyclase, which binds and activates substrate GGPP with a three-metal ion cluster. The N-terminal domain and a third 'insertion' domain together adopt the fold of a vestigial class II terpenoid cyclase. A class II cyclase activates the isoprenoid substrate by protonation instead of ionization, and the TXS structure reveals a definitive connection between the two distinct cyclase classes in the evolution of terpenoid biosynthesis.	[Koeksal, Mustafa; Christianson, David W.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; [Jin, Yinghua; Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Jin, Yinghua] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Croteau, Rodney] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder; Washington State University	Christianson, DW (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, 231 S 34th St, Philadelphia, PA 19104 USA.	chris@sas.upenn.edu	jin, Yinghua/T-7461-2019	JIN, YINGHUA/0000-0002-8446-8350	US National Institutes of Health [GM56838, GM13956, CA55254]; University of Illinois; NATIONAL CANCER INSTITUTE [R37CA055254, R01CA055254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056838, R01GM013956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. MacDermaid and J. Saven for advice and assistance with molecular modelling calculations, and E. Oldfield for helpful comments on the manuscript. We thank the National Synchrotron Light Source at Brookhaven National Laboratory for beamline access. The US National Institutes of Health provided grants GM56838 (D.W.C.), GM13956 (R.M.C.) and CA55254 (R.C.) in support of this research. Y.J. thanks the University of Illinois for support through the John C. Bailar and R. C. Fuson Fellowships.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARBUCK SG, 1995, TAXOL SCI APPL, P379; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao Q, 1996, TETRAHEDRON LETT, V37, P3425, DOI 10.1016/0040-4039(96)00585-0; HEZARI M, 1995, ARCH BIOCHEM BIOPHYS, V322, P437, DOI 10.1006/abbi.1995.1486; Jin QW, 2005, J ORG CHEM, V70, P4667, DOI 10.1021/jo0502091; Jin YH, 2005, J AM CHEM SOC, V127, P7834, DOI 10.1021/ja050592r; Keeling CI, 2010, PLANT PHYSIOL, V152, P1197, DOI 10.1104/pp.109.151456; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koksal M, 2010, J MOL BIOL, V402, P363, DOI 10.1016/j.jmb.2010.07.009; KOEPP AE, 1995, J BIOL CHEM, V270, P8686, DOI 10.1074/jbc.270.15.8686; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Lin XY, 1996, BIOCHEMISTRY-US, V35, P2968, DOI 10.1021/bi9526239; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Trapp SC, 2001, GENETICS, V158, P811; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.3.CO;2-R; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Wildung MR, 1996, J BIOL CHEM, V271, P9201, DOI 10.1074/jbc.271.16.9201; Williams DC, 2000, ARCH BIOCHEM BIOPHYS, V379, P137, DOI 10.1006/abbi.2000.1865; Williams DC, 2000, CHEM BIOL, V7, P969, DOI 10.1016/S1074-5521(00)00046-6	40	199	213	9	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					116	U138		10.1038/nature09628	http://dx.doi.org/10.1038/nature09628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21160477	Green Accepted			2022-12-01	WOS:000285921600043
J	Walton, DA; Ivers, LC				Walton, David A.; Ivers, Louise C.			Responding to Cholera in Post-Earthquake Haiti.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Walton, David A.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; Partners Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Walton, DA (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.		Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230				*MIN SANT PUBL POP, 2005, ENQ MORT MORB UT SER; Sullivan CA, 2003, NAT RESOUR FORUM, V27, P189, DOI 10.1111/1477-8947.00054; 2010, 101112 WASH CLUSTER	3	61	66	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					3	5		10.1056/NEJMp1012997	http://dx.doi.org/10.1056/NEJMp1012997			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702UY	21142690	Bronze			2022-12-01	WOS:000285922600002
J	Bosworth, AM; Steuer, A				Bosworth, Ailsa M.; Steuer, Alan			A Patient's Journey Rheumatoid arthritis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bosworth, Ailsa M.] Natl Rheumatoid Arthrit Soc, Maidenhead SL6 3RT, Berks, England; [Steuer, Alan] Wexham Pk Hosp, Slough SL2 4HL, Berks, England		Bosworth, AM (corresponding author), Natl Rheumatoid Arthrit Soc, Westacott Business Ctr, Maidenhead SL6 3RT, Berks, England.	Ailsa@nras.org.uk							0	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 31	2010	341								c7095	10.1136/bmj.c7095	http://dx.doi.org/10.1136/bmj.c7095			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702VB	21196483				2022-12-01	WOS:000285922900008
J	Gibson, P; Tong, YA; Robinson, G; Thompson, MC; Currle, DS; Eden, C; Kranenburg, TA; Hogg, T; Poppleton, H; Martin, J; Finkelstein, D; Pounds, S; Weiss, A; Patay, Z; Scoggins, M; Ogg, R; Pei, YX; Yang, ZJ; Brun, S; Lee, Y; Zindy, F; Lindsey, JC; Taketo, MM; Boop, FA; Sanford, RA; Gajjar, A; Clifford, SC; Roussel, MF; McKinnon, PJ; Gutmann, DH; Ellison, DW; Wechsler-Reya, R; Gilbertson, RJ				Gibson, Paul; Tong, Yiai; Robinson, Giles; Thompson, Margaret C.; Currle, D. Spencer; Eden, Christopher; Kranenburg, Tanya A.; Hogg, Twala; Poppleton, Helen; Martin, Julie; Finkelstein, David; Pounds, Stanley; Weiss, Aaron; Patay, Zoltan; Scoggins, Matthew; Ogg, Robert; Pei, Yanxin; Yang, Zeng-Jie; Brun, Sonja; Lee, Youngsoo; Zindy, Frederique; Lindsey, Janet C.; Taketo, Makoto M.; Boop, Frederick A.; Sanford, Robert A.; Gajjar, Amar; Clifford, Steven C.; Roussel, Martine F.; McKinnon, Peter J.; Gutmann, David H.; Ellison, David W.; Wechsler-Reya, Robert; Gilbertson, Richard J.			Subtypes of medulloblastoma have distinct developmental origins	NATURE			English	Article							CELL; PROGENITORS; P53; HINDBRAIN; MODEL; MICE	Medulloblastoma encompasses a collection of clinically and molecularly diverse tumour subtypes that together comprise the most common malignant childhood brain tumour(1-4). These tumours are thought to arise within the cerebellum, with approximately 25% originating from granule neuron precursor cells (GNPCs) after aberrant activation of the Sonic Hedgehog pathway (hereafter, SHH subtype)(3-8). The pathological processes that drive heterogeneity among the other medulloblastoma subtypes are not known, hindering the development of much needed new therapies. Here we provide evidence that a discrete subtype of medulloblastoma that contains activating mutations in the WNT pathway effector CTNNB1 (hereafter, WNT subtype) 1,3,4 arises outside the cerebellum from cells of the dorsal brainstem. We found that genes marking human WNT-subtype medulloblastomas are more frequently expressed in the lower rhombic lip (LRL) and embryonic dorsal brainstem than in the upper rhombic lip (URL) and developing cerebellum. Magnetic resonance imaging (MRI) and intra-operative reports showed that human WNT-subtype tumours infiltrate the dorsal brainstem, whereas SHH-subtype tumours are located within the cerebellar hemispheres. Activating mutations in Ctnnb1 had little impact on progenitor cell populations in the cerebellum, but caused the abnormal accumulation of cells on the embryonic dorsal brainstem which included aberrantly proliferating Zic1(+) precursor cells. These lesions persisted in all mutant adult mice; moreover, in 15% of cases in which Tp53 was concurrently deleted, they progressed to form medulloblastomas that recapitulated the anatomy and gene expression profiles of human WNT-subtype medulloblastoma. We provide the first evidence, to our knowledge, that subtypes of medulloblastoma have distinct cellular origins. Our data provide an explanation for the marked molecular and clinical differences between SHH- and WNT-subtype medulloblastomas and have profound implications for future research and treatment of this important childhood cancer.	[Gibson, Paul; Tong, Yiai; Robinson, Giles; Currle, D. Spencer; Eden, Christopher; Kranenburg, Tanya A.; Hogg, Twala; Poppleton, Helen; Martin, Julie; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Robinson, Giles; Gajjar, Amar; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Pounds, Stanley] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Patay, Zoltan; Scoggins, Matthew; Ogg, Robert] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Lee, Youngsoo; Zindy, Frederique; Roussel, Martine F.; McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Boop, Frederick A.; Sanford, Robert A.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Thompson, Margaret C.] Cleveland Clin, Dept Pediat Hematol Oncol, Cleveland, OH 44195 USA; [Weiss, Aaron] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA; [Pei, Yanxin; Yang, Zeng-Jie; Brun, Sonja; Wechsler-Reya, Robert] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lindsey, Janet C.; Clifford, Steven C.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Cleveland Clinic Foundation; Rutgers State University New Brunswick; Rutgers State University Medical Center; Duke University; Newcastle University - UK; Kyoto University; Washington University (WUSTL)	Gilbertson, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Richard.Gilbertson@stjude.org	Kranenburg, Tanya/F-7138-2012; Gilbertson, Richard James/ABE-1346-2021; Patay, Zoltan/N-6994-2018; Pounds, Stanley/N-2480-2018; Robinson, Giles/N-8095-2018	Kranenburg, Tanya/0000-0002-5329-4968; Gilbertson, Richard James/0000-0001-7539-9472; Lee, Youngsoo/0000-0003-4773-6464; Clifford, Steve/0000-0003-4893-2184; Gutmann, David/0000-0002-3127-5045; Patay, Zoltan/0000-0003-1479-9864; Pounds, Stanley/0000-0002-9167-2114; Robinson, Giles/0000-0001-7441-9486	National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA129541, P01CA096832, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	R.J.G. holds the Howard C. Schott Research Chair from the Malia's Cord Foundation, and is supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765), the Collaborative Ependymoma Research Network and by the American Lebanese Syrian Associated Charities. We are grateful to A. Chenn, J. Johnson and C. Birchmeier for their gifts of reagents and the staff of the Hartwell Center for Bioinformatics and Biotechnology and ARC at St Jude Children's Research Hospital for technical assistance.	Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Dipietrantonio HJ, 2009, NEUROSCIENCE, V162, P560, DOI 10.1016/j.neuroscience.2009.02.082; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lee Y, 2003, CANCER RES, V63, P5428; Louis D. N., 2007, WHO CLASSIFICATION T; Morales D, 2006, J NEUROSCI, V26, P12226, DOI 10.1523/JNEUROSCI.3493-06.2006; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Ray RS, 2009, CURR OPIN CELL BIOL, V21, P741, DOI 10.1016/j.ceb.2009.10.003; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Storm R, 2009, DEVELOPMENT, V136, P295, DOI 10.1242/dev.027193; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Wetmore C, 2001, CANCER RES, V61, P513; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	29	537	552	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1095	1099		10.1038/nature09587	http://dx.doi.org/10.1038/nature09587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21150899	Green Accepted			2022-12-01	WOS:000285553800057
J	Raffaele, S; Farrer, RA; Cano, LM; Studholme, DJ; MacLean, D; Thines, M; Jiang, RHY; Zody, MC; Kunjeti, SG; Donofrio, NM; Meyers, BC; Nusbaum, C; Kamoun, S				Raffaele, Sylvain; Farrer, Rhys A.; Cano, Liliana M.; Studholme, David J.; MacLean, Daniel; Thines, Marco; Jiang, Rays H. Y.; Zody, Michael C.; Kunjeti, Sridhara G.; Donofrio, Nicole M.; Meyers, Blake C.; Nusbaum, Chad; Kamoun, Sophien			Genome Evolution Following Host Jumps in the Irish Potato Famine Pathogen Lineage	SCIENCE			English	Article							PHYTOPHTHORA-INFESTANS; HISTONE METHYLATION; RXLR EFFECTORS; SEQUENCES; DISEASE	Many plant pathogens, including those in the lineage of the Irish potato famine organism Phytophthora infestans, evolve by host jumps followed by specialization. However, how host jumps affect genome evolution remains largely unknown. To determine the patterns of sequence variation in the P. infestans lineage, we resequenced six genomes of four sister species. This revealed uneven evolutionary rates across genomes with genes in repeat-rich regions showing higher rates of structural polymorphisms and positive selection. These loci are enriched in genes induced in planta, implicating host adaptation in genome evolution. Unexpectedly, genes involved in epigenetic processes formed another class of rapidly evolving residents of the gene-sparse regions. These results demonstrate that dynamic repeat-rich genome compartments underpin accelerated gene evolution following host jumps in this pathogen lineage.	[Raffaele, Sylvain; Farrer, Rhys A.; Cano, Liliana M.; Studholme, David J.; MacLean, Daniel; Thines, Marco; Kamoun, Sophien] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Thines, Marco] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Thines, Marco] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Dept Biol Sci, D-60323 Frankfurt, Germany; [Jiang, Rays H. Y.; Zody, Michael C.; Nusbaum, Chad] Massachusetts Inst Technol & Harvard, Broad Inst, Cambridge, MA 02141 USA; [Kunjeti, Sridhara G.; Donofrio, Nicole M.; Meyers, Blake C.] Univ Delaware, Newark, DE 19716 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Delaware	Kamoun, S (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	sophien.kamoun@tsl.ac.uk	Raffaele, Sylvain/K-6673-2019; Kamoun, Sophien/B-3529-2009; Studholme, David/H-6790-2019; Kunjeti, Sridhara/AFU-0653-2022; Meyers, Blake C/B-6535-2012; Cano, Liliana M/O-7041-2016; Raffaele, Sylvain/F-7187-2012; Thines, Marco/H-1685-2011; MacLean, Dan/C-7046-2013	Raffaele, Sylvain/0000-0002-2442-9632; Kamoun, Sophien/0000-0002-0290-0315; Studholme, David/0000-0002-3010-6637; Meyers, Blake C/0000-0003-3436-6097; Cano, Liliana M/0000-0002-7996-4181; Raffaele, Sylvain/0000-0002-2442-9632; MacLean, Dan/0000-0003-1032-0887; Kunjeti, Sridhara/0000-0002-6326-2644; Farrer, Rhys/0000-0001-8456-7458	Gatsby Charitable Foundation; Marie-Curie IEF [255104]; National Research Initiative of the U.S. Department of Agriculture [2006-35600-16623]; NSF [EF-0523670]; Ministry of Research, Science and the Arts of Hesse (Germany)	Gatsby Charitable Foundation; Marie-Curie IEF(European Commission); National Research Initiative of the U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Ministry of Research, Science and the Arts of Hesse (Germany)	We thank the Broad Institute Sequencing Platform and J. Pike for sequencing; G. Kessel and V. Vleeshouwers for biomaterial; and D. Weigel, J. Dangl, and J. Ecker for useful comments. This project was funded by the Gatsby Charitable Foundation, Marie-Curie IEF contract 255104, National Research Initiative of the U.S. Department of Agriculture grant 2006-35600-16623, NSF grant EF-0523670, and research funding program LOEWE of the Ministry of Research, Science and the Arts of Hesse (Germany). Sequences are deposited in GenBank under the submission accession numbers SRA02326-2329 and SRA024355 and in the Short Read Archive under study accession numbers ERP000341-344.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Elango N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000015; Elizondo LI, 2009, CURR GENOMICS, V10, P64, DOI 10.2174/138920209787581271; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Liu ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/molbev/msi049; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zeh DW, 2009, BIOESSAYS, V31, P715, DOI 10.1002/bies.200900026; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	20	282	288	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1540	1543		10.1126/science.1193070	http://dx.doi.org/10.1126/science.1193070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148391				2022-12-01	WOS:000285153500065
J	Qi, XX; Lan, SY; Wang, WJ; Schelde, LM; Dong, HH; Wallat, GD; Ly, H; Liang, YY; Dong, CJ				Qi, Xiaoxuan; Lan, Shuiyun; Wang, Wenjian; Schelde, Lisa McLay; Dong, Haohao; Wallat, Gregor D.; Ly, Hinh; Liang, Yuying; Dong, Changjiang			Cap binding and immune evasion revealed by Lassa nucleoprotein structure	NATURE			English	Article							CRYSTAL-STRUCTURE; VIRUS NUCLEOPROTEIN; L-PROTEIN; DENDRITIC CELLS; RNA; TREX1; TRANSCRIPTION; ENDONUCLEASE; REPLICATION; RECOGNITION	Lassa virus, the causative agent of Lassa fever, causes thousands of deaths annually and is a biological threat agent, for which there is no vaccine and limited therapy. The nucleoprotein (NP) of Lassa virus has essential roles in viral RNA synthesis and immune suppression, the molecular mechanisms of which are poorly understood. Here we report the crystal structure of Lassa virus NP at 1.80 angstrom resolution, which reveals amino (N)- and carboxy (C)-terminal domains with structures unlike any of the reported viral NPs. The N domain folds into a novel structure with a deep cavity for binding the m7GpppN cap structure that is required for viral RNA transcription, whereas the C domain contains 3'-5' exoribonuclease activity involved in suppressing interferon induction. To our knowledge this is the first X-ray crystal structure solved for an arenaviral NP, which reveals its unexpected functions and indicates unique mechanisms in cap binding and immune evasion. These findings provide great potential for vaccine and drug development.	[Qi, Xiaoxuan; Dong, Haohao; Wallat, Gregor D.; Dong, Changjiang] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Lan, Shuiyun; Schelde, Lisa McLay; Ly, Hinh; Liang, Yuying] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, Guangzhou 510080, Guangdong, Peoples R China	University of St Andrews; Emory University; Sun Yat Sen University	Dong, CJ (corresponding author), Univ St Andrews, Sch Chem, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	hly@emory.edu; yliang5@emory.edu; cd26@st-andrews.ac.uk		Qi, Xiaoxuan/0000-0001-5191-3713	Southeast Regional Center of Excellence for Emerging Infections and Biodefense [5-U54-AI-057157-06]; Emory University Research Committee (URC); Emory DDRDC [DK64399]; American Cancer Society [RSG-06-162-01-GMC]; NIH [R01AI083409, AI067704];  [5-U19-AI057266-07]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083409, R01AI093580, U19AI057266, U54AI057157, R01AI067704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399] Funding Source: NIH RePORTER	Southeast Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory University Research Committee (URC); Emory DDRDC; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	C.D. wishes to thank J. Naismith for his continuing support, encouragement and advice; R. M. Elliott for providing the human beta-globin containing plasmid phRL-CMV and his critical reading of the manuscript; H. Liu for discussions; and L. Major for the pLou3 plasmid. C.D. is a Wellcome trust career development fellow (083501/Z/07/Z). We thank the staff at IO2 and IO3 beam stations of Diamond light sources for their assistance with data collection. This work was supported in part by funds from the Southeast Regional Center of Excellence for Emerging Infections and Biodefense (5-U54-AI-057157-06), the pilot component of the U19 grant (5-U19-AI057266-07), and the Emory University Research Committee (URC) to Y.L. and H. L.; a seed grant from the Emory DDRDC (DK64399) and a research scholar grant from the American Cancer Society (RSG-06-162-01-GMC) to H.L.; NIH grant R01AI083409 to Y.L.; and NIH grant AI067704 to T. G. Parslow and Y.L. We thank K. Curtis and T. W. Geisbert for providing us with non-infectious genomic RNA samples of LASV, and J. Aronson for the PICV virus.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Baize S, 2004, J IMMUNOL, V172, P2861, DOI 10.4049/jimmunol.172.5.2861; Baize S, 2009, J VIROL, V83, P5890, DOI 10.1128/JVI.01948-08; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Cisneros GA, 2009, J AM CHEM SOC, V131, P1550, DOI 10.1021/ja8082818; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; EDINGTON GM, 1972, T ROY SOC TROP MED H, V66, P381, DOI 10.1016/0035-9203(72)90268-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; FISHERHOCH S, 1988, J MED VIROL, V26, P127, DOI 10.1002/jmv.1890260204; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; JIN H, 1993, J VIROL, V67, P1396, DOI 10.1128/JVI.67.3.1396-1404.1993; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Lan SY, 2008, ARCH VIROL, V153, P1241, DOI 10.1007/s00705-008-0101-2; Lan SY, 2009, J VIROL, V83, P6357, DOI 10.1128/JVI.00019-09; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Lelke M, 2010, J VIROL, V84, P1934, DOI 10.1128/JVI.01657-09; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MEYER BJ, 1993, J VIROL, V67, P2621, DOI 10.1128/JVI.67.5.2621-2627.1993; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Muller S, 2007, J GEN VIROL, V88, P1568, DOI 10.1099/vir.0.82529-0; Pinschewer DD, 2003, J VIROL, V77, P3882, DOI 10.1128/JVI.77.6.3882-3887.2003; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POLYAK SJ, 1995, J VIROL, V69, P3211, DOI 10.1128/JVI.69.5.3211-3215.1995; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	50	199	208	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					779	U65		10.1038/nature09605	http://dx.doi.org/10.1038/nature09605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21085117	Green Accepted			2022-12-01	WOS:000285093700036
J	Mudur, G				Mudur, Ganapati			Save the Children BMJ Christmas Appeal Mobile clinics in Delhi	BRITISH MEDICAL JOURNAL			English	Editorial Material												gsmudur@hotmail.com						Agarwal S, 2005, Indian J Public Health, V49, P141	1	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2010	341								c6800	10.1136/bmj.c6800	http://dx.doi.org/10.1136/bmj.c6800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	691OG	21118876				2022-12-01	WOS:000285090100015
J	Gutierrez, NL; Hilborn, R; Defeo, O				Gutierrez, Nicolas L.; Hilborn, Ray; Defeo, Omar			Leadership, social capital and incentives promote successful fisheries	NATURE			English	Article							MANAGEMENT; COMANAGEMENT; PRINCIPLES; GOVERNANCE; QUOTAS	One billion people depend on seafood as their primary source of protein and 25% of the world's total animal protein comes from fisheries(1). Yet a third of fish stocks worldwide are overexploited or depleted(1,2). Using individual case studies, many have argued that community-based co-management(3) should prevent the tragedy of the commons(4) because cooperative management by fishers, managers and scientists often results in sustainable fisheries(3,5,6). However, general and multidisciplinary evaluations of co-management regimes and the conditions for social, economic and ecological success within such regimes are lacking. Here we examine 130 co-managed fisheries in a wide range of countries with different degrees of development, ecosystems, fishing sectors and type of resources. We identified strong leadership as the most important attribute contributing to success, followed by individual or community quotas, social cohesion and protected areas. Less important conditions included enforcement mechanisms, long-term management policies and life history of the resources. Fisheries were most successful when at least eight co-management attributes were present, showing a strong positive relationship between the number of these attributes and success, owing to redundancy in management regulations. Our results demonstrate the critical importance of prominent community leaders and robust social capital(7), combined with clear incentives through catch shares and conservation benefits derived from protected areas, for successfully managing aquatic resources and securing the livelihoods of communities depending on them. Our study offers hope that co-management, the only realistic solution for the majority of the world's fisheries, can solve many of the problems facing global fisheries.	[Gutierrez, Nicolas L.; Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Defeo, Omar] Fac Ciencias, UNDECIMAR, Montevideo 11400, Uruguay	University of Washington; University of Washington Seattle; Universidad de la Republica, Uruguay	Gutierrez, NL (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	nicolasg@uw.edu	Hilborn, Ray W/D-6332-2013; Gutierrez, Nicolas/D-4026-2009	Defeo, Omar/0000-0001-8318-528X	National Science Foundation [0308440]; Fulbright-OAS Initiative in Ecology; Pew Charitable Trusts	National Science Foundation(National Science Foundation (NSF)); Fulbright-OAS Initiative in Ecology; Pew Charitable Trusts	N.L.G. was partially funded by the National Science Foundation (award 0308440) and a Fulbright-OAS Initiative in Ecology fellowship. O.D. acknowledges support by the Pew Charitable Trusts. We thank E. Ostrom, T. A. Branch, and X. Basurto for comments on the manuscript and A. E. Punt, W. N. Venables, R. Perera and S. Sethi for discussions on the methodological and statistical approach.	Basurto X., 2009, J NATURAL RESOURCES, V1, P255, DOI DOI 10.1080/19390450903040447; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Borrini-Feyerabend G., 2004, SHARING POWER LEARNI; Branch TA, 2009, FISH FISH, V10, P39, DOI 10.1111/j.1467-2979.2008.00294.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Castilla JC, 2005, SCIENCE, V309, P1324; Chetty RK, 2010, CLIN PHARMACOL THER, V88, P260, DOI 10.1038/clpt.2010.77; Costanza R, 1998, SCIENCE, V281, P198, DOI 10.1126/science.281.5374.198; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Defeo O, 2005, REV FISH BIOL FISHER, V15, P265, DOI 10.1007/s11160-005-4865-0; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Essington TE, 2010, P NATL ACAD SCI USA, V107, P754, DOI 10.1073/pnas.0907252107; Food and Agriculture Organization of the United Nations, 2009, FAO YB FISH AQ STAT; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; Levin S, 2010, PHILOS T R SOC B, V365, P13, DOI 10.1098/rstb.2009.0197; Olsson P, 2004, ECOL SOC, V9; Olsson P, 2004, ENVIRON MANAGE, V34, P75, DOI 10.1007/s00267-003-0101-7; Ostrom E, 1990, GOVERNING COMMONS EV, DOI DOI 10.1017/CBO9780511807763; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pollnac R., 2010, P NATL ACAD SCI US; Pomeroy R.S., 1994, FISHERIES COMANAGEME; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Stefansson G, 2005, PHILOS T R SOC B, V360, P133, DOI 10.1098/rstb.2004.1579; United Nations Development Program, 2009, HUM DEV IND; Wilson J, 2007, P NATL ACAD SCI USA, V104, P15212, DOI 10.1073/pnas.0702241104; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	30	826	841	13	573	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					386	389		10.1038/nature09689	http://dx.doi.org/10.1038/nature09689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21209616				2022-12-01	WOS:000287409100040
J	Engineer, ND; Riley, JR; Seale, JD; Vrana, WA; Shetake, JA; Sudanagunta, SP; Borland, MS; Kilgard, MP				Engineer, Navzer D.; Riley, Jonathan R.; Seale, Jonathan D.; Vrana, Will A.; Shetake, Jai A.; Sudanagunta, Sindhu P.; Borland, Michael S.; Kilgard, Michael P.			Reversing pathological neural activity using targeted plasticity	NATURE			English	Article							VAGUS NERVE-STIMULATION; CORTICAL MAP REORGANIZATION; PHANTOM-LIMB PAIN; AUDITORY-CORTEX; HEARING-LOSS; ASSESSING TINNITUS; TRAUMA; HYPERACTIVITY; SELECTIVITY; NUCLEUS	Brain changes in response to nerve damage or cochlear trauma can generate pathological neural activity that is believed to be responsible for many types of chronic pain and tinnitus(1-3). Several studies have reported that the severity of chronic pain and tinnitus is correlated with the degree of map reorganization in somatosensory and auditory cortex, respectively(1,4). Direct electrical or transcranial magnetic stimulation of sensory cortex can temporarily disrupt these phantom sensations(5). However, there is as yet no direct evidence for a causal role of plasticity in the generation of pain or tinnitus. Here we report evidence that reversing the brain changes responsible can eliminate the perceptual impairment in an animal model of noise-induced tinnitus. Exposure to intense noise degrades the frequency tuning of auditory cortex neurons and increases cortical synchronization. Repeatedly pairing tones with brief pulses of vagus nerve stimulation completely eliminated the physiological and behavioural correlates of tinnitus in noise-exposed rats. These improvements persisted for weeks after the end of therapy. This method for restoring neural activity to normal may be applicable to a variety of neurological disorders.	[Engineer, Navzer D.; Riley, Jonathan R.; Seale, Jonathan D.; Vrana, Will A.; Shetake, Jai A.; Sudanagunta, Sindhu P.; Borland, Michael S.; Kilgard, Michael P.] Univ Texas Dallas, Cort Plast Lab, Richardson, TX 75080 USA; [Engineer, Navzer D.] MicroTransponder Inc, Austin, TX 78738 USA	University of Texas System; University of Texas Dallas	Engineer, ND (corresponding author), Univ Texas Dallas, Cort Plast Lab, Richardson, TX 75080 USA.	navzer@utdallas.edu		Kilgard, Michael/0000-0002-6699-1818; Riley, Jonathan/0000-0003-0129-3071	James S. McDonnell Foundation; Texas Advanced Research Program; National Institute for Deafness and other Communication Disorders; MicroTransponder Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R43DC010084, R44DC010084] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Texas Advanced Research Program; National Institute for Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); MicroTransponder Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank A. Kuzu, J. Omana, D. Vuppala, H. Rasul, M. Fink, E. Hanacik, R. Miller and C. Walker for help with rat behavioural training. We would also like to thank J. Eggermont, A. Moller, C. Bauer, J. Fritz, H. Reed, C. Engineer, A. Reed, M. Brosch, R. Rennaker, R. Beitel, V. Miller, C. McIntyre, G. White, P. Pandya, R. Tyler and D. deRidder for suggestions about earlier versions of the manuscript. This work was supported by the James S. McDonnell Foundation, the Texas Advanced Research Program, the National Institute for Deafness and other Communication Disorders, and MicroTransponder Inc.	Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Bauer CA, 2007, J NEUROSCI RES, V85, P1489, DOI 10.1002/jnr.21259; Ben-Menachem E, 2001, J CLIN NEUROPHYSIOL, V18, P415, DOI 10.1097/00004691-200109000-00005; Bollinger J. J., 2006, THESIS U CALIFORNIA; BURNS EM, 1984, AUDIOLOGY, V23, P426; Clark KB, 1999, NAT NEUROSCI, V2, P94, DOI 10.1038/4600; DAUMAN R, 1989, ARCH OTO-RHINO-LARYN, V246, P252, DOI 10.1007/BF00463566; De Ridder D, 2007, PROG BRAIN RES, V166, P377, DOI 10.1016/S0079-6123(07)66036-1; Diesch E, 2010, NEUROSCIENCE, V167, P540, DOI 10.1016/j.neuroscience.2010.02.003; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Dorr AE, 2006, J PHARMACOL EXP THER, V318, P890, DOI 10.1124/jpet.106.104166; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2007, PROG BRAIN RES, V166, P19, DOI 10.1016/S0079-6123(07)66002-6; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kilgard MP, 2007, HEARING RES, V229, P171, DOI 10.1016/j.heares.2007.01.005; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Konig O, 2006, HEARING RES, V221, P59, DOI 10.1016/j.heares.2006.07.007; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Moore BCJ, 2010, HEARING RES, V261, P51, DOI 10.1016/j.heares.2010.01.003; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; MURPHY WJ, 2001, J ACOUST SOC AM, V109, P2373; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Ochi K, 2003, LARYNGOSCOPE, V113, P427, DOI 10.1097/00005537-200303000-00007; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013	34	402	441	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					101	U114		10.1038/nature09656	http://dx.doi.org/10.1038/nature09656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21228773	Green Accepted			2022-12-01	WOS:000286886400042
J	Bodemann, BO; Orvedahl, A; Cheng, TL; Ram, RR; Ou, YH; Formstecher, E; Maiti, M; Hazelett, CC; Wauson, EM; Balakireva, M; Camonis, JH; Yeaman, C; Levine, B; White, MA				Bodemann, Brian O.; Orvedahl, Anthony; Cheng, Tzuling; Ram, Rosalyn R.; Ou, Yi-Hung; Formstecher, Etienne; Maiti, Mekhala; Hazelett, C. Clayton; Wauson, Eric M.; Balakireva, Maria; Camonis, Jacques H.; Yeaman, Charles; Levine, Beth; White, Michael A.			RalB and the Exocyst Mediate the Cellular Starvation Response by Direct Activation of Autophagosome Assembly	CELL			English	Article							PROTEIN CONJUGATION SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASE; EFFECTOR COMPLEX; DISTINCT ROLES; BECLIN 1; MEMBRANE; KINASE; YEAST; GTPASES; MACROAUTOPHAGY	The study of macroautophagy in mammalian cells has described induction, vesicle nucleation, and membrane elongation complexes as key signaling intermediates driving autophagosome biogenesis. How these components are recruited to nascent autophagosomes is poorly understood, and although much is known about signaling mechanisms that restrain autophagy, the nature of positive inductive signals that can promote autophagy remain cryptic. We find that the Ras-like small G protein, RalB, is localized to nascent autophagosomes and is activated on nutrient deprivation. RalB and its effector Exo84 are required for nutrient starvation-induced autophagocytosis, and RalB activation is sufficient to promote autophagosome formation. Through direct binding to Exo84, RalB induces the assembly of catalytically active ULK1 and Beclin1-VPS34 complexes on the exocyst, which are required for isolation membrane formation and maturation. Thus, RalB signaling is a primary adaptive response to nutrient limitation that directly engages autophagocytosis through mobilization of the core vesicle nucleation machinery.	[Bodemann, Brian O.; Cheng, Tzuling; Ram, Rosalyn R.; Ou, Yi-Hung; Maiti, Mekhala; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Orvedahl, Anthony; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Microbiol, Dallas, TX 75390 USA; [Orvedahl, Anthony; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Wauson, Eric M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Formstecher, Etienne] Hybrigenics Inc, F-75014 Paris, France; [Hazelett, C. Clayton; Yeaman, Charles] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Balakireva, Maria; Camonis, Jacques H.] INSERM, Inst Curie, U548, F-75248 Paris, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Yeaman, Charles A/A-1624-2009	Yeaman, Charles/0000-0001-6149-628X; Ou, Yi-Hung/0000-0002-9909-7791	National Institutes of Health [CA71443, CA129451, CA84254, CA109618]; GenHomme Network [02490-6088]; Welch Foundation [I-1414]; DOD [W81XWH-06-1-0749]; CPRIT [RP101496];  [ARC4845];  [T32GM008203]; NATIONAL CANCER INSTITUTE [R56CA109618, R01CA109618, R01CA129451, R01CA071443, R01CA084254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067002, T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GenHomme Network; Welch Foundation(The Welch Foundation); DOD(United States Department of Defense); CPRIT; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Noboru Mishuzima for GFP-Atg5 and GFP-LC3, Zhenyu Yue for Flag-ATG14L and Flag-RUBICON, and Noriko Okazaki for HA-ULK1 and HA-ULK1(K46N). We thank members of the White and Levine labs for productive discussions. We thank Melanie Cobb for helpful discussion and assistance with kinase assays. This work was supported by grants from the National Institutes of Health (CA71443 and CA129451 to M.W. and CA84254 and CA109618 to B.L.), ARC4845 and GenHomme Network Grant 02490-6088 to J.C., and the Welch Foundation (I-1414 to M.W.). B.B. was supported by DOD Award Number W81XWH-06-1-0749. R.R. was supported by T32GM008203. Y.O. was supported by CPRIT RP101496.	Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; Balakireva M, 2006, MOL CELL BIOL, V26, P8953, DOI 10.1128/MCB.00506-06; Bhuvanakantham R, 2010, CELL MICROBIOL, V12, P453, DOI 10.1111/j.1462-5822.2009.01407.x; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Frische EW, 2007, EMBO J, V26, P5083, DOI 10.1038/sj.emboj.7601922; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; George MD, 2000, MOL BIOL CELL, V11, P969, DOI 10.1091/mbc.11.3.969; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jung C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/3/035607; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Lalli G, 2005, J CELL BIOL, V171, P857, DOI 10.1083/jcb.200507061; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Voss M, 1999, J BIOL CHEM, V274, P34691, DOI 10.1074/jbc.274.49.34691; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	61	229	239	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					253	267		10.1016/j.cell.2010.12.018	http://dx.doi.org/10.1016/j.cell.2010.12.018			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241894	Green Accepted, Bronze			2022-12-01	WOS:000286459900010
J	Sergio, F; Blas, J; Blanco, G; Tanferna, A; Lopez, L; Lemus, JA; Hiraldo, F				Sergio, F.; Blas, J.; Blanco, G.; Tanferna, A.; Lopez, L.; Lemus, J. A.; Hiraldo, F.			Raptor Nest Decorations Are a Reliable Threat Against Conspecifics	SCIENCE			English	Article							BOWERBIRDS; COST; REPEATABILITY; DISPLAY; BIRD	Individual quality is often signaled by phenotypic flags, such as bright plumage patches in birds. Extended phenotype signals can similarly show quality, but in these cases the signals are external to the individual, often taking the form of objects scavenged from the environment. Through multiple manipulative experiments, we showed that objects used for nest decoration by a territorial raptor, the black kite (Milvus migrans), act as reliable threats to conspecifics, revealing the viability, territory quality, and conflict dominance of the signaler. Our results suggest that animal-built structures may serve as signaling devices much more frequently than currently recognized.	[Sergio, F.; Blas, J.; Tanferna, A.; Lopez, L.; Lemus, J. A.; Hiraldo, F.] CSIC, Estn Biol Donana, Dept Conservat Biol, Seville 41092, Spain; [Blanco, G.] CSIC, Museum Nat Sci, Dept Evolutionary Ecol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC)	Sergio, F (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, C Amer Vespucio, Seville 41092, Spain.	fsergio@ebd.csic.es	Blas, Julio/A-2487-2012; Tanferna, Alessandro/L-6648-2015; Blanco, Guillermo/L-3170-2014; Sergio, Fabrizio/B-3952-2015; Hiraldo, Fernando/AAA-8314-2019	Blas, Julio/0000-0003-0589-3322; Tanferna, Alessandro/0000-0003-0799-301X; Blanco, Guillermo/0000-0001-5742-4929; Sergio, Fabrizio/0000-0002-8024-1773; Lopez-Jimenez, Lidia/0000-0002-4109-3034	Junta de Andalucia [CGL2008-01781, JA-58, RNM 1790, RNM 03822]; Ministerio de Ciencia e Innovacion; Natural Research Limited	Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Natural Research Limited	We thank F. J. Chicano, J. Giralt, and F. G. Vilches for help in the field. S. N. Vignieri and three anonymous reviewers greatly improved a previous draft of the manuscript. The study was funded by the research projects CGL2008-01781, JA-58, RNM 1790, and RNM 03822 granted by the Junta de Andalucia, Ministerio de Ciencia e Innovacion, and Natural Research Limited.	ADAMS ES, 1995, J THEOR BIOL, V175, P405, DOI 10.1006/jtbi.1995.0151; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; BORGIA G, 1993, AM NAT, V141, P729, DOI 10.1086/285502; Bradbury Jack W., 1998, pi; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; COLLIAS ELSIE C., 1964, AUK, V81, P42; DIAMOND J, 1986, P NATL ACAD SCI USA, V83, P3042, DOI 10.1073/pnas.83.9.3042; Doerr NR, 2010, ANIM BEHAV, V79, P747, DOI 10.1016/j.anbehav.2009.12.032; Enquist M, 1998, ANIM BEHAV, V56, P749, DOI 10.1006/anbe.1998.0820; Hansell M., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; HANSELL MH, 2005, ANIMAL ARCHITECTURE; JOHNSTONE RA, 1993, BEHAV ECOL SOCIOBIOL, V32, P127, DOI 10.1007/BF00164045; Levey DJ, 2004, NATURE, V431, P39, DOI 10.1038/431039a; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; Madden JR, 2008, ANIM COGN, V11, P1, DOI 10.1007/s10071-007-0092-5; Madden JR, 2002, P ROY SOC B-BIOL SCI, V269, P1347, DOI 10.1098/rspb.2002.1988; Maynard-Smith J., 2003, ANIMAL SIGNALS; MORENO J, 1994, ANIM BEHAV, V47, P1297, DOI 10.1006/anbe.1994.1178; Ostlund-Nilsson S, 2003, BEHAV ECOL SOCIOBIOL, V53, P214, DOI 10.1007/s00265-002-0574-z; Rushbrook BJ, 2008, ANIM BEHAV, V75, P547, DOI 10.1016/j.anbehav.2007.06.011; Schaedelin FC, 2009, BIOL REV, V84, P293, DOI 10.1111/j.1469-185X.2008.00075.x; Schuetz JG, 2005, BEHAV ECOL, V16, P133, DOI 10.1093/beheco/arh139; Searcy W.A., 2005, EVOLUTION ANIMAL COM; Sergio F, 2009, OECOLOGIA, V160, P507, DOI 10.1007/s00442-009-1314-0; Sergio F, 2009, J ANIM ECOL, V78, P109, DOI 10.1111/j.1365-2656.2008.01484.x; Walsh PT, 2010, BIOL LETTERS, V6, P149, DOI 10.1098/rsbl.2009.0664; WIMBERGER PH, 1984, AUK, V101, P615, DOI 10.1093/auk/101.3.615; Wojcieszek JM, 2007, BEHAV ECOL, V18, P689, DOI 10.1093/beheco/arm031	28	96	103	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					327	330		10.1126/science.1199422	http://dx.doi.org/10.1126/science.1199422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252345	Green Submitted			2022-12-01	WOS:000286636300036
J	Gelstein, S; Yeshurun, Y; Rozenkrantz, L; Shushan, S; Frumin, I; Roth, Y; Sobel, N				Gelstein, Shani; Yeshurun, Yaara; Rozenkrantz, Liron; Shushan, Sagit; Frumin, Idan; Roth, Yehudah; Sobel, Noam			Human Tears Contain a Chemosignal	SCIENCE			English	Article							PULSATILE SECRETION; CHEMOSENSORY CUES; HORMONE; WOMEN; MOOD	Emotional tearing is a poorly understood behavior that is considered uniquely human. In mice, tears serve as a chemosignal. We therefore hypothesized that human tears may similarly serve a chemosignaling function. We found that merely sniffing negative-emotion-related odorless tears obtained from women donors induced reductions in sexual appeal attributed by men to pictures of women's faces. Moreover, after sniffing such tears, men experienced reduced self-rated sexual arousal, reduced physiological measures of arousal, and reduced levels of testosterone. Finally, functional magnetic resonance imaging revealed that sniffing women's tears selectively reduced activity in brain substrates of sexual arousal in men.	[Gelstein, Shani; Yeshurun, Yaara; Rozenkrantz, Liron; Shushan, Sagit; Frumin, Idan; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Shushan, Sagit; Roth, Yehudah] Edith Wolfson Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, IL-58100 Holon, Israel	Weizmann Institute of Science	Sobel, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	noam.sobel@weizmann.ac.il	Frumin, Idan/N-7049-2014	Frumin, Idan/0000-0002-6293-1586; Rozenkrantz, Liron/0000-0002-6496-4592; Yeshurun, Yaara/0000-0002-0843-6998; Sobel, Noam/0000-0002-3232-9391	Minerva Stiftung Foundation	Minerva Stiftung Foundation	This work was supported by a grant from the Minerva Stiftung Foundation.	Bensafi M, 2003, BEHAV NEUROSCI, V117, P1125, DOI 10.1037/0735-7044.117.6.1125; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/10001-000, DOI 10.1037/10001-000]; FREY WH, 1981, AM J OPHTHALMOL, V92, P559, DOI 10.1016/0002-9394(81)90651-6; Frey William H., 1985, CRYING MYSTERY TEARS; Frijda N.H., 1986, EMOTIONS STUDIES EMO; GROSS JJ, 1994, PSYCHOPHYSIOLOGY, V31, P460, DOI 10.1111/j.1469-8986.1994.tb01049.x; Hendriks MCP, 2008, J SOC PSYCHOL, V148, P22, DOI 10.3200/SOCP.148.1.22-42; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; LEVENSON RW, 1990, PSYCHOPHYSIOLOGY, V27, P363, DOI 10.1111/j.1469-8986.1990.tb02330.x; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; McCarthy Susan, 1995, ELEPHANTS WEEP EMOTI; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; MONTAGU A, 1959, SCIENCE, V130, P1572, DOI 10.1126/science.130.3388.1572; Preti G, 2003, BIOL REPROD, V68, P2107, DOI 10.1095/biolreprod.102.008268; Provine RR, 2009, EVOL PSYCHOL, V7, P52, DOI 10.1177/147470490900700107; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; STOLERU SG, 1993, PSYCHONEUROENDOCRINO, V18, P205, DOI 10.1016/0306-4530(93)90005-6; Thompson RN, 2007, PHYSIOL BEHAV, V90, P797, DOI 10.1016/j.physbeh.2007.01.008; VANHAERINGEN NJ, 1981, SURV OPHTHALMOL, V26, P84, DOI 10.1016/0039-6257(81)90145-4; Vingerhoets A.J.J.M., 2000, REV GEN PSYCHOL, V4, P354, DOI [10.1037/1089-2680.4.4.354, DOI 10.1037/1089-2680.4.4.354]; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Zhou W, 2008, J NEUROSCI, V28, P14416, DOI 10.1523/JNEUROSCI.3148-08.2008	30	136	139	1	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					226	230		10.1126/science.1198331	http://dx.doi.org/10.1126/science.1198331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21212322				2022-12-01	WOS:000286433100046
J	Rust, MJ; Golden, SS; O'Shea, EK				Rust, Michael J.; Golden, Susan S.; O'Shea, Erin K.			Light-Driven Changes in Energy Metabolism Directly Entrain the Cyanobacterial Circadian Oscillator	SCIENCE			English	Article							SYNECHOCOCCUS-ELONGATUS; KAIC PHOSPHORYLATION; CLOCK PROTEIN; ATP LEVEL; RHYTHMS; INHIBITORS; FIXATION; LDPA; PH	Circadian clocks are self-sustained biological oscillators that can be entrained by environmental cues. Although this phenomenon has been studied in many organisms, the molecular mechanisms of entrainment remain unclear. Three cyanobacterial proteins and adenosine triphosphate (ATP) are sufficient to generate oscillations in phosphorylation in vitro. We show that changes in illumination that induce a phase shift in cultured cyanobacteria also cause changes in the ratio of ATP to adenosine diphosphate (ADP). When these nucleotide changes are simulated in the in vitro oscillator, they cause phase shifts similar to those observed in vivo. Physiological concentrations of ADP inhibit kinase activity in the oscillator, and a mathematical model constrained by data shows that this effect is sufficient to quantitatively explain entrainment of the cyanobacterial circadian clock.	[Rust, Michael J.; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Rust, Michael J.; O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Golden, Susan S.] Univ Calif San Diego, Div Biol Sci, Ctr Chronobiol, La Jolla, CA 92093 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; University of California System; University of California San Diego	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.	eoshea@mcb.harvard.edu			NIH [GM62419]; Helen Hay Whitney Foundation; Burroughs-Wellcome Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062419] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Burroughs-Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Dong for advice on culture conditions, and K. Cook, V. Denic, Q. Justman, J. Markson, A. Rizvi, and V. Vijayan for valuable discussions and comments on the manuscript. E.K.O. is an investigator of the Howard Hughes Medical Institute. Supported by NIH grant GM62419 (S. S. G.), a Helen Hay Whitney Foundation postdoctoral fellowship (M. J. R.), and a Burroughs-Wellcome Foundation Career Award at the Scientific Interface (M.J.R.).	Andersson CR, 2000, METHOD ENZYMOL, V305, P527; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BORNEFELD T, 1974, PLANTA, V115, P309, DOI 10.1007/BF00388613; IHLENFELDT MJA, 1975, ARCH MICROBIOL, V102, P13, DOI 10.1007/BF00428339; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Ivleva NB, 2006, P NATL ACAD SCI USA, V103, P17468, DOI 10.1073/pnas.0606639103; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; Katayama M, 2003, J BACTERIOL, V185, P1415, DOI 10.1128/JB.185.4.1415-1422.2003; Kiyohara YB, 2005, J BACTERIOL, V187, P2559, DOI 10.1128/JB.187.8.2559-2564.2005; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LUBBERDING HJ, 1984, FEMS MICROBIOL LETT, V22, P93; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; SCHERER S, 1988, PHOTOSYNTH RES, V15, P95, DOI 10.1007/BF00035255; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Wood TL, 2010, P NATL ACAD SCI USA, V107, P5804, DOI 10.1073/pnas.0910141107; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101	27	140	140	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					220	223		10.1126/science.1197243	http://dx.doi.org/10.1126/science.1197243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233390	Green Accepted			2022-12-01	WOS:000286433100044
J	Eklind-Cervenka, M; Benson, L; Dahlstrom, U; Edner, M; Rosenqvist, M; Lund, LH				Eklind-Cervenka, Maria; Benson, Lina; Dahlstrom, Ulf; Edner, Magnus; Rosenqvist, Marten; Lund, Lars H.			Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANGIOTENSIN-RECEPTOR BLOCKERS; VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; RANDOMIZED-TRIAL; BLOOD-PRESSURE; TASK-FORCE; DIAGNOSIS; GUIDELINES; MANAGEMENT; BINDING	Context Angiotensin II receptor blockers (ARBs) reduce combined mortality and hospitalization in patients with heart failure (HF) with reduced left ventricular ejection fraction. Different agents have different affinity for the AT(1) receptor and may have different clinical effects, but have not been tested against each other in HF. Objective To assess the association of candesartan vs losartan with all-cause mortality in patients with HF. Design, Setting, and Patients An HF registry (the Swedish Heart Failure Registry) of 30 254 unique patients registered from 62 hospitals and 60 outpatient clinics between 2000 and 2009. A total of 5139 patients (mean [SD] age, 74 [11] years; 39% women) were treated with candesartan (n=2639) or losartan (n=2500). Survival as of December 14, 2009, by ARB agent was analyzed by Kaplan-Meier method and predictors of survival determined by univariate and multivariate proportional hazard regression models, with and without adjustment for propensity scores and interactions. Stratified analyses and quantification of residual confounding were also performed. Main Outcome Measures All-cause mortality at 1 and 5 years. Results One-year survival was 90% (95% confidence interval [CI], 89%-91%) for patients receiving candesartan and 83% (95% CI, 81%-84%) for patients receiving losartan, and 5-year survival was 61% (95% CI, 54%-68%) and 44% (95% CI, 41%-48%), respectively (log-rank P<.001). In multivariate analysis with adjustment for propensity scores, the hazard ratio for mortality for losartan compared with candesartan was 1.43 (95% CI, 1.23-1.65; P<.001). The results persisted in stratified analyses. Conclusion In this registry of patients with HF, the use of candesartan compared with losartan was associated with a lower mortality risk. JAMA. 2011; 305(2): 175-182	[Lund, Lars H.] Karolinska Univ Hosp, Dept Cardiol, S-17176 Stockholm, Sweden; [Eklind-Cervenka, Maria; Rosenqvist, Marten] Soder Sjukhuset, Dept Cardiol, Stockholm, Sweden; [Eklind-Cervenka, Maria; Benson, Lina; Rosenqvist, Marten] Karolinska Inst, Dept Clin Sci & Educ, SoS, Stockholm, Sweden; [Dahlstrom, Ulf] Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Edner, Magnus] Danderyd Hosp, Div Cardiovasc Med, Stockholm, Sweden; [Edner, Magnus] Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Lund, Lars H.] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital; Karolinska Institutet; Linkoping University; Linkoping University; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet	Lund, LH (corresponding author), Karolinska Univ Hosp, Dept Cardiol, N305, S-17176 Stockholm, Sweden.	lars.lund@alumni.duke.edu		Benson, Lina/0000-0002-5393-0055	Astra-Zeneca; Linkoping University; Research Foundation SouthEastern Sweden; Swedish Heart-Lung Foundation; Merck Sharp and Dohme; Karolinska Institutet; Stockholm County Council; Medtronic; St Jude; Boston Scientific; Vinnova; Swedish Order of Free Mason; Sanofi-Aventis; Boehringer Ingelheim; Orion Pharma; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Roche; Merck; ResMed	Astra-Zeneca(AstraZeneca); Linkoping University; Research Foundation SouthEastern Sweden; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Merck Sharp and Dohme(Merck & Company); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Medtronic(Medtronic); St Jude(St. Jude Medical); Boston Scientific(Boston Scientific); Vinnova(Vinnova); Swedish Order of Free Mason; Sanofi-Aventis(Sanofi-Aventis); Boehringer Ingelheim(Boehringer Ingelheim); Orion Pharma; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Roche(Roche Holding); Merck(Merck & Company); ResMed	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Eklind-Cervenka reported receiving speaker's fees from Astra-Zeneca. Dr Dahlstrom reported receiving speaker's fees from Astra-Zeneca and research grants from Linkoping University, Research Foundation SouthEastern Sweden, and Swedish Heart-Lung Foundation. Dr Edner reported receiving speaker's fees from Merck Sharp and Dohme, and research grants from Karolinska Institutet, Stockholm County Council, Medtronic, St Jude, Boston Scientific, and Merck Sharp and Dohme. Dr Rosenqvist reported receiving consulting fees from Merck Sharp and Dohme, speaker's fees from Astra-Zeneca and Merck Sharp and Dohme, and research grants from Karolinska Institutet, Stockholm County Council, Swedish Heart-Lung Foundation, Vinnova, Swedish Order of Free Mason, Sanofi-Aventis, and Boehringer Ingelheim. Dr Lund reported receiving consulting fees and speaker's fees from Astra-Zeneca, and research grants from Karolinska Institutet, Stockholm County Council, Swedish Heart-Lung Foundation, Astra-Zeneca, and Orion Pharma. Ms Benson reported no financial disclosures.; This study received no specific funding. However, establishment of the Swedish Heart Failure Registry was supported by the Swedish National Board of Health and Welfare, the Swedish Association of Local Authorities and Regions, the Swedish Society of Cardiology, AstraZeneca, Roche, Merck, Orion Pharma, and ResMed.	Bhuiyan MA, 2009, LIFE SCI, V85, P136, DOI 10.1016/j.lfs.2009.05.001; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fabiani ME, 2000, AM J HYPERTENS, V13, P1005, DOI 10.1016/S0895-7061(00)00286-7; Fierens F, 1999, EUR J PHARMACOL, V367, P413, DOI 10.1016/S0014-2999(98)00965-0; Fierens F L, 2000, J Renin Angiotensin Aldosterone Syst, V1, P283, DOI 10.3317/jraas.2000.044; Fridman KUB, 2002, BLOOD PRESSURE, V11, P244, DOI 10.1080/08037050213766; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Hudson M, 2007, PHARMACOTHERAPY, V27, P526, DOI 10.1592/phco.27.4.526; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kjeldsen SE, 2010, J HUM HYPERTENS, V24, P263, DOI 10.1038/jhh.2009.77; Koh KK, 2004, AM J CARDIOL, V93, P1432, DOI 10.1016/j.amjcard.2004.02.050; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lacourciere Y, 1999, AM J HYPERTENS, V12, P1181, DOI 10.1016/S0895-7061(99)00142-9; Lee VC, 2004, ANN INTERN MED, V141, P693, DOI 10.7326/0003-4819-141-9-200411020-00011; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2010, EUR J HEART FAIL, V12, P99, DOI 10.1093/eurjhf/hfp197; Meredith PA, 2010, J HUM HYPERTENS, V24, P525, DOI 10.1038/jhh.2009.99; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Van Liefde I, 2009, MOL CELL ENDOCRINOL, V302, P237, DOI 10.1016/j.mce.2008.06.006; Vanderheyden PML, 1999, BRIT J PHARMACOL, V126, P1057, DOI 10.1038/sj.bjp.0702398; Vauquelin G, 2006, J HYPERTENS, V24, pS23, DOI 10.1097/01.hjh.0000220403.61493.18; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	30	51	52	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					175	182		10.1001/jama.2010.1949	http://dx.doi.org/10.1001/jama.2010.1949			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224459	Bronze			2022-12-01	WOS:000286103400023
J	Heo, JB; Sung, S				Heo, Jae Bok; Sung, Sibum			Vernalization-Mediated Epigenetic Silencing by a Long Intronic Noncoding RNA	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; X-CHROMOSOME; POLYCOMB; REQUIRES; FLC; TRANSCRIPTION; COMPLEX; GENES	Vernalization is an environmentally-induced epigenetic switch in which winter cold triggers epigenetic silencing of floral repressors and thus provides competence to flower in spring. In Arabidopsis, winter cold triggers enrichment of tri-methylated histone H3 Lys(27) at chromatin of the floral repressor, FLOWERING LOCUS C (FLC), and results in epigenetically stable repression of FLC. This epigenetic change is mediated by an evolutionarily conserved repressive complex, polycomb repressive complex 2 (PRC2). Here, we show that a long intronic noncoding RNA [termed COLD ASSISTED INTRONIC NONCODING RNA (COLDAIR)] is required for the vernalization-mediated epigenetic repression of FLC. COLDAIR physically associates with a component of PRC2 and targets PRC2 to FLC. Our results show that COLDAIR is required for establishing stable repressive chromatin at FLC through its interaction with PRC2.	[Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Sung, S (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	sbsung@mail.utexas.edu	Sung, Sibum/AAM-6500-2020		University of Texas at Austin; NSF	University of Texas at Austin; NSF(National Science Foundation (NSF))	We thank the members of Sung lab and E. Huq for helpful discussions, C. Pikaard for RNAPIV and RNAPV mutant seeds, and J. Goodrich for GFP::CLF seeds. S.S. thanks R. Amasino for encouragement and mentoring on the vernalization study. This work was supported by the start-up funds from the University of Texas at Austin and in part by the NSF to S.S.	De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Doyle MR, 2009, PLANT PHYSIOL, V151, P1688, DOI 10.1104/pp.109.145581; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Hsieh TF, 2003, TRENDS PLANT SCI, V8, P439, DOI 10.1016/S1360-1385(03)00189-4; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Khaitovich P, 2006, PLOS GENET, V2, P1590, DOI 10.1371/journal.pgen.0020171; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Lang A., 1965, PHYSL FLOWE INITIATI, P1371; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Sheldon CC, 2009, PLANT J, V59, P488, DOI 10.1111/j.1365-313X.2009.03883.x; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	27	737	794	19	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					76	79		10.1126/science.1197349	http://dx.doi.org/10.1126/science.1197349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21127216				2022-12-01	WOS:000285974000039
J	Reddy, MM; Wilson, R; Wilson, J; Connell, S; Gocke, A; Hynan, L; German, D; Kodadek, T				Reddy, M. Muralidhar; Wilson, Rosemary; Wilson, Johnnie; Connell, Steven; Gocke, Anne; Hynan, Linda; German, Dwight; Kodadek, Thomas			Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening	CELL			English	Article							PROTEIN MICROARRAYS; MULTIPLE-SCLEROSIS; PEPTOID LIBRARIES; CANCER; AUTOIMMUNITY; DISCOVERY; LESSONS; ARRAY	The adaptive immune system is thought to be a rich source of protein biomarkers, but diagnostically useful antibodies remain unknown for a large number of diseases. This is, in part, because the antigens that trigger an immune response in many diseases remain unknown. We present here a general and unbiased approach to the identification of diagnostically useful antibodies that avoids the requirement for antigen identification. This method involves the comparative screening of combinatorial libraries of unnatural, synthetic molecules against serum samples obtained from cases and controls. Molecules that retain far more IgG antibodies from the case samples than the controls are identified and subsequently tested as capture agents for diagnostically useful antibodies. The utility of this method is demonstrated using a mouse model for multiple sclerosis and via the identification of two candidate IgG biomarkers for Alzheimer's disease.	[Reddy, M. Muralidhar; Kodadek, Thomas] Scripps Florida, Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Reddy, M. Muralidhar; Kodadek, Thomas] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Reddy, M. Muralidhar; Wilson, Rosemary; Wilson, Johnnie] Opko Hlth Labs, Jupiter, FL 33458 USA; [Connell, Steven; Gocke, Anne] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA; [Hynan, Linda] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [German, Dwight] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	Scripps Research Institute; State University System of Florida; University of Florida; Scripps Research Institute; State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), Scripps Florida, Scripps Res Inst, Dept Chem, 130 Scripps Way,3A2, Jupiter, FL 33458 USA.	kodadek@scripps.edu	Hynan, Linda S/P-6473-2016	Hynan, Linda/0000-0002-4642-7769; Kodadek, Thomas/0000-0003-1930-4795	NIH [DP1OD000663, AG12300]; NHLBI Proteomics Initiative of the National Heart, Lung & Blood Institute, National Institutes of Health [NO1-HV-28185]; NATIONAL INSTITUTE ON AGING [P30AG012300] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Proteomics Initiative of the National Heart, Lung & Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Mike Racke, Amy Lovett-Racke, and Ward Wakeland for contributing EAE and SLE samples in the early phase of this project. We thank Kristin Martin-Cook of the UT Southwestern Medical Center's Alzheimer's Disease Center for selecting the normal and AD serum samples for analysis and Dr. Padraig O'Suilleabhain for diagnosis and collection of the PD serum samples. This work was supported by an NIH Director Pioneer Award to T.K. (DP1OD000663) and the NHLBI Proteomics Initiative of the National Heart, Lung & Blood Institute, National Institutes of Health (contract No. NO1-HV-28185). Human serum sample collection was supported by grant NIH grant AG12300.	Alluri PG, 2003, J AM CHEM SOC, V125, P13995, DOI 10.1021/ja036417x; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Figliozzi GM, 1996, METHOD ENZYMOL, V267, P437; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gibson DS, 2010, J PROTEOMICS, V73, P1045, DOI 10.1016/j.jprot.2009.11.013; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hauser SL, 2008, NEW ENGL J MED, V359, P1838, DOI 10.1056/NEJMe0806738; Hudson ME, 2007, P NATL ACAD SCI USA, V104, P17494, DOI 10.1073/pnas.0708572104; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Knittelfelder R, 2009, EXPERT OPIN BIOL TH, V9, P493, DOI [10.1517/14712590902870386 , 10.1517/14712590902870386]; Liu K, 2001, ADV EXP MED BIOL, V490, P1; Lueking A, 2003, MOL CELL PROTEOMICS, V2, P1342, DOI 10.1074/mcp.T300001-MCP200; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Olivos HJ, 2002, ORG LETT, V4, P4057, DOI 10.1021/ol0267578; Ransohoff DF, 2005, J NATL CANCER I, V97, P315, DOI 10.1093/jnci/dji054; Reddy MM, 2005, P NATL ACAD SCI USA, V102, P12672, DOI 10.1073/pnas.0501208102; Robinson WH, 2002, BIOTECHNIQUES, P66; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Steller S, 2005, PROTEOMICS, V5, P2048, DOI 10.1002/pmic.200401097; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3	28	165	183	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					132	142		10.1016/j.cell.2010.11.054	http://dx.doi.org/10.1016/j.cell.2010.11.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215375	Green Accepted, Bronze			2022-12-01	WOS:000285993600013
J	Jan, CH; Friedman, RC; Ruby, JG; Bartel, DP				Jan, Calvin H.; Friedman, Robin C.; Ruby, J. Graham; Bartel, David P.			Formation, regulation and evolution of Caenorhabditis elegans 3 ' UTRs	NATURE			English	Article							3' UNTRANSLATED REGIONS; GENE-EXPRESSION; MESSENGER-RNAS; POLYADENYLATION; COMPLEX; SEQUENCES; TARGETS; SWITCH	Post-transcriptional gene regulation frequently occurs through elements in mRNA 3' untranslated regions (UTRs)(1,2). Although crucial roles for 3'UTR-mediated gene regulation have been found in Caenorhabditis elegans(3-5), most C. elegans genes have lacked annotated 3'UTRs(6,7). Here we describe a high-throughput method for reliable identification of polyadenylated RNA termini, and we apply this method, called poly(A)-position profiling by sequencing (3P-Seq), to determine C. elegans 3'UTRs. Compared to standard methods also recently applied to C. elegans UTRs(8), 3P-Seq identified 8,580 additional UTRs while excluding thousands of shorter UTR isoforms that do not seem to be authentic. Analysis of this expanded and corrected data set suggested that the high A/U content of C. elegans 3'UTRs facilitated genome compaction, because the elements specifying cleavage and polyadenylation, which are A/U rich, can more readily emerge in A/U-rich regions. Indeed, 30% of the protein-coding genes have mRNAs with alternative, partially overlapping end regions that generate another 10,480 cleavage and polyadenylation sites that had gone largely unnoticed and represent potential evolutionary intermediates of progressive UTR shortening. Moreover, a third of the convergently transcribed genes use palindromic arrangements of bidirectional elements to specify UTRs with convergent overlap, which also contributes to genome compaction by eliminating regions between genes. Although nematode 3'UTRs have median length only one-sixth that of mammalian 3'UTRs, they have twice the density of conserved microRNA sites, in part because additional types of seed-complementary sites are preferentially conserved. These findings reveal the influence of cleavage and polyadenylation on the evolution of genome architecture and provide resources for studying post-transcriptional gene regulation.	[Jan, Calvin H.; Friedman, Robin C.; Ruby, J. Graham; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jan, Calvin H.; Friedman, Robin C.; Ruby, J. Graham; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Jan, Calvin H.; Friedman, Robin C.; Ruby, J. Graham; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Friedman, Robin C.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Friedman, Robin/0000-0003-2097-8332	NIH [GM067031]; National Science Foundation; Krell Institute/Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Krell Institute/Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Burge and members of the Bartel lab for discussions and the WIBR Genome Technology Core for sequencing. This work was supported by NIH grant GM067031 (D.P.B.), a National Science Foundation predoctoral fellowship (C.H.J.) and a Krell Institute/Department of Energy Computational Sciences Graduate Fellowship (R.C.F.).	Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Blumenthal Thomas, 2005, WormBook, P1, DOI 10.1895/wormbook.1.5.1; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Clark AM, 2010, NUCLEIC ACIDS RES, V38, P3780, DOI 10.1093/nar/gkq083; Evans D, 2001, GENE DEV, V15, P2562, DOI 10.1101/gad.920501; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Mangone M, 2008, NUCLEIC ACIDS RES, V36, pD57, DOI 10.1093/nar/gkm946; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Nunes NM, 2010, EMBO J, V29, P1523, DOI 10.1038/emboj.2010.42; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	36	313	329	2	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					97	U114		10.1038/nature09616	http://dx.doi.org/10.1038/nature09616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21085120	Green Accepted, Green Submitted			2022-12-01	WOS:000285921600039
J	Barnett, BP; Hwang, YS; Taylor, MS; Kirchner, H; Pfluger, PT; Bernard, V; Lin, YY; Bowers, EM; Mukherjee, C; Song, WJ; Longo, PA; Leahy, DJ; Hussain, MA; Tschop, MH; Boeke, JD; Cole, PA				Barnett, Brad P.; Hwang, Yousang; Taylor, Martin S.; Kirchner, Henriette; Pfluger, Paul T.; Bernard, Vincent; Lin, Yu-yi; Bowers, Erin M.; Mukherjee, Chandrani; Song, Woo-Jin; Longo, Patti A.; Leahy, Daniel J.; Hussain, Mehboob A.; Tschoep, Matthias H.; Boeke, Jef D.; Cole, Philip A.			Glucose and Weight Control in Mice with a Designed Ghrelin O-Acyltransferase Inhibitor	SCIENCE			English	Article							DES-ACYL GHRELIN; INSULIN-SECRETION; OBESITY; GOAT; HORMONE; ADIPOSITY; PHENOTYPE; RELEASE; PEPTIDE; HUMANS	Ghrelin is a gastric peptide hormone that stimulates weight gain in vertebrates. The biological activities of ghrelin require octanoylation of the peptide on Ser(3), an unusual posttranslational modification that is catalyzed by the enzyme ghrelin O-acyltransferase (GOAT). Here, we describe the design, synthesis, and characterization of GO-CoA-Tat, a peptide-based bisubstrate analog that antagonizes GOAT. GO-CoA-Tat potently inhibits GOAT in vitro, in cultured cells, and in mice. Intraperitoneal administration of GO-CoA-Tat improves glucose tolerance and reduces weight gain in wild-type mice but not in ghrelin-deficient mice, supporting the concept that its beneficial metabolic effects are due specifically to GOAT inhibition. In addition to serving as a research tool for mapping ghrelin actions, GO-CoA-Tat may help pave the way for clinical targeting of GOAT in metabolic diseases.	[Barnett, Brad P.; Hwang, Yousang; Taylor, Martin S.; Bowers, Erin M.; Mukherjee, Chandrani; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Barnett, Brad P.; Taylor, Martin S.; Bernard, Vincent; Lin, Yu-yi; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Barnett, Brad P.; Taylor, Martin S.; Bernard, Vincent; Lin, Yu-yi; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Kirchner, Henriette; Pfluger, Paul T.; Tschoep, Matthias H.] Univ Cincinnati, Dept Internal Med, Metab Dis Inst, Obes Res Ctr, Cincinnati, OH 45237 USA; [Song, Woo-Jin; Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21205 USA; [Song, Woo-Jin; Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Metab, Baltimore, MD 21205 USA; [Song, Woo-Jin; Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Div Metab, Baltimore, MD 21205 USA; [Longo, Patti A.; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Lin, Yu-yi] Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan; [Kirchner, Henriette; Tschoep, Matthias H.] German Inst Human Nutr, Dept Pharmacol, D-14558 Nuthetal, Germany	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Taiwan University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Cole, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	pcole@jhmi.edu	Pfluger, Paul T/A-3770-2019; Tschoep, Matthias H/I-5443-2014; Kirchner, Henriette/D-6699-2011; Barnett, Bradley/AAN-1628-2020; song, woojin/G-3357-2013; Barnett, Brad/AAY-2578-2020	Pfluger, Paul T/0000-0002-8118-7588; Barnett, Bradley/0000-0002-8301-404X; Tschoep, Matthias/0000-0002-4744-371X; Bernard, Vincent/0000-0003-1555-608X; Taylor, Martin/0000-0001-5824-142X; song, woojin/0000-0003-3197-6682; Boeke, Jef/0000-0001-5322-4946; Taylor, Martin/0000-0003-1560-9276	NIH; Pfeiffer Foundation; Kaufman Foundation; Keck Foundation; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK081472, P60DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfeiffer Foundation; Kaufman Foundation; Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Shamblott, S. Bhat, A. Chambers, C. Schrum, J. Hembree, N. Forbes, M. Li, J. McClellan, M. Miller, K. O'Donnell-Mendell, J. Jabbari, W. Gibson, J. Liu, and D. Gladowski for advice and assistance; G. Ronnett, J. Liu, and R. Alani for critical reading of the manuscript; and the NIH Common Fund, Pfeiffer Foundation, Kaufman Foundation, and Keck Foundation for financial support. The authors (P. A. C., J. D. B., Y.H., and B. P. B.) and Johns Hopkins University have filed a patent on the GOAT inhibitors described here. The inhibitors have been licensed to the biotechnology company Acylin Therapeutics, Inc. P. A. C., J. D. B., and M. H. T. are on the Scientific Advisory Board and have equity in Acylin Therapeutics. M. H. T. also has equity in and is a member of the Scientific Advisory Boards of Marcadia Biotech, Inc., and Ambrx, Inc.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Ariyasu H, 2005, ENDOCRINOLOGY, V146, P355, DOI 10.1210/en.2004-0629; Broglio F, 2004, J CLIN ENDOCR METAB, V89, P3062, DOI 10.1210/jc.2003-031964; Dezaki K, 2008, PHARMACOL THERAPEUT, V118, P239, DOI 10.1016/j.pharmthera.2008.02.008; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Granata R, 2010, J MOL ENDOCRINOL, V45, P107, DOI 10.1677/JME-10-0019; Gualillo O, 2008, TRENDS PHARMACOL SCI, V29, P398, DOI 10.1016/j.tips.2008.06.003; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lu SC, 2009, MOL PHARMACOL, V75, P901, DOI 10.1124/mol.108.052852; Parang K, 2001, NAT STRUCT BIOL, V8, P37; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Tong J, 2010, DIABETES, V59, P2145, DOI 10.2337/db10-0504; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Yada T, 2008, CURR DIABETES REV, V4, P18, DOI 10.2174/157339908783502352; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang WZ, 2008, ENDOCRINOLOGY, V149, P4710, DOI 10.1210/en.2008-0263; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	28	198	207	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1689	1692		10.1126/science.1196154	http://dx.doi.org/10.1126/science.1196154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21097901	Green Accepted			2022-12-01	WOS:000285390500070
J	Cafaro, J; Rieke, F				Cafaro, Jon; Rieke, Fred			Noise correlations improve response fidelity and stimulus encoding	NATURE			English	Article							RETINAL GANGLION-CELLS; FEEDFORWARD INHIBITION; FIRING RATE; CORTEX; VARIABILITY; SELECTIVITY; EXCITATION; NEURONS; INFORMATION; INTEGRATION	Computation in the nervous system often relies on the integration of signals from parallel circuits with different functional properties. Correlated noise in these inputs can, in principle, have diverse and dramatic effects on the reliability of the resulting computations(1-8). Such theoretical predictions have rarely been tested experimentally because of a scarcity of preparations that permit measurement of both the covariation of a neuron's input signals and the effect on a cell's output of manipulating such covariation. Here we introduce a method to measure covariation of the excitatory and inhibitory inputs a cell receives. This method revealed strong correlated noise in the inputs to two types of retinal ganglion cell. Eliminating correlated noise without changing other input properties substantially decreased the accuracy with which a cell's spike outputs encoded light inputs. Thus, covariation of excitatory and inhibitory inputs can be a critical determinant of the reliability of neural coding and computation.	[Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Cafaro, Jon; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	rieke@u.washington.edu			HHMI; NIH [EY-11850]; NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Dacey, O. Packer, J. Crook, B. Peterson and T. Haun for providing primate tissue; P. Newman and E. Martinson for technical assistance; T. Azevedo, E. J. Chichilnisky, F. Dunn, G. Murphy, S. Kuo, E. Shea-Brown, M. Shadlen and W. Spain for comments on the manuscript and discussions. Support was provided by HHMI and NIH (EY-11850).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Calkins DJ, 1996, NATURE, V381, P613, DOI 10.1038/381613a0; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Leary CJ, 2008, J NEUROSCI, V28, P5481, DOI 10.1523/JNEUROSCI.5041-07.2008; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; POLYAK S., 1949, DOCUMENTA OPHTHALMOL, V3, P24, DOI 10.1007/BF00162597; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Taylor WR, 2002, J NEUROSCI, V22, P7712; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545	32	96	97	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					964	U363		10.1038/nature09570	http://dx.doi.org/10.1038/nature09570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21131948	Green Accepted			2022-12-01	WOS:000285344600047
J	Reiter, NJ; Osterman, A; Torres-Larios, A; Swinger, KK; Pan, T; Mondragon, A				Reiter, Nicholas J.; Osterman, Amy; Torres-Larios, Alfredo; Swinger, Kerren K.; Pan, Tao; Mondragon, Alfonso			Structure of a bacterial ribonuclease P holoenzyme in complex with tRNA	NATURE			English	Article							PRECURSOR TRANSFER-RNA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; 2-METAL-ION MECHANISM; THERMOTOGA-MARITIMA; PROTEIN-COMPONENT; CONSERVED CORE; BINDING-SITE; ACTIVE-SITE; SUBSTRATE	Ribonuclease (RNase) P is the universal ribozyme responsible for 5'-end tRNA processing. We report the crystal structure of the Thermotoga maritima RNase P holoenzyme in complex with tRNA(Phe). The 154 kDa complex consists of a large catalytic RNA (P RNA), a small protein cofactor and a mature tRNA. The structure shows that RNA-RNA recognition occurs through shape complementarity, specific intermolecular contacts and base-pairing interactions. Soaks with a pre-tRNA 5' leader sequence with and without metal help to identify the 5' substrate path and potential catalytic metal ions. The protein binds on top of a universally conserved structural module in P RNA and interacts with the leader, but not with the mature tRNA. The active site is composed of phosphate backbone moieties, a universally conserved uridine nucleobase, and at least two catalytically important metal ions. The active site structure and conserved RNase P-tRNA contacts suggest a universal mechanism of catalysis by RNase P.	[Reiter, Nicholas J.; Osterman, Amy; Torres-Larios, Alfredo; Swinger, Kerren K.; Mondragon, Alfonso] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Mondragon, A (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu		Torres-Larios, Alfredo/0000-0002-0702-350X	NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058443, F32GM087055] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Sontheimer and O. Uhlenbeck for comments and suggestions, N. Pace for the gift of the T. maritima RNase P protein plasmid, Obiter Research, A. Davis and M. E. Duban for advice and preparation of iridium hexammine, and A. Samelson for discussions and assistance. In addition, we are grateful for data collection assistance from S. Anderson, Z. Wawrzak, and staff at LS-CAT. Research was supported by the NIH. N.J.R. is an NRSA postdoctoral fellow.	Biswas R, 2000, J MOL BIOL, V296, P19, DOI 10.1006/jmbi.1999.3443; BROWN JW, 1990, CELL, V62, P407, DOI 10.1016/0092-8674(90)90003-W; Buck AH, 2005, NAT STRUCT MOL BIOL, V12, P958, DOI 10.1038/nsmb1004; Buck AH, 2005, EMBO J, V24, P3360, DOI 10.1038/sj.emboj.7600805; BURKARD U, 1988, NUCLEIC ACIDS RES, V16, P11617, DOI 10.1093/nar/16.24.11617; Chen JL, 1997, RNA, V3, P557; Chen Y, 1997, BIOCHEMISTRY-US, V36, P2425; Christian EL, 2000, RNA, V6, P511, DOI 10.1017/S1355838200000042; Christian EL, 2006, RNA, V12, P1463, DOI 10.1261/rna.158606; Crary SM, 2002, RNA, V8, P933, DOI 10.1017/S1355838202025025; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Ferre-D'Amare AR, 1998, J MOL BIOL, V279, P621, DOI 10.1006/jmbi.1998.1789; Gaur RK, 1996, RNA, V2, P674; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hsieh J, 2010, J MOL BIOL, V400, P38, DOI 10.1016/j.jmb.2010.04.050; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Kazantsev AV, 2009, RNA, V15, P266, DOI 10.1261/rna.1331809; Kazantsev AV, 2005, P NATL ACAD SCI USA, V102, P13392, DOI 10.1073/pnas.0506662102; Kazantsev AV, 2003, P NATL ACAD SCI USA, V100, P7497, DOI 10.1073/pnas.0932597100; KIRSEBOM LA, 1994, EMBO J, V13, P4870, DOI 10.1002/j.1460-2075.1994.tb06814.x; Kirsebom LA, 2010, PROTEIN REV, V10, P113, DOI 10.1007/978-1-4419-1142-1_7; Koutmou KS, 2010, J MOL BIOL, V396, P195, DOI 10.1016/j.jmb.2009.11.039; Krasilnikov AS, 2004, SCIENCE, V306, P104, DOI 10.1126/science.1101489; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Krivenko AA, 2002, ACTA CRYSTALLOGR D, V58, P1234, DOI 10.1107/S0907444902007965; Krummel DAP, 2000, J MOL BIOL, V295, P1113, DOI 10.1006/jmbi.1999.3424; Kurz JC, 1998, BIOCHEMISTRY-US, V37, P2393, DOI 10.1021/bi972530m; LAGRANDEUR TE, 1994, EMBO J, V13, P3945, DOI 10.1002/j.1460-2075.1994.tb06710.x; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LIU F, 2010, PROTEIN REV, V10; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mondragon A, 2010, PROTEIN REV, V10, P63, DOI 10.1007/978-1-4419-1142-1_4; Niranjanakumari S, 1998, P NATL ACAD SCI USA, V95, P15212, DOI 10.1073/pnas.95.26.15212; Pan T, 1995, P NATL ACAD SCI USA, V92, P12510, DOI 10.1073/pnas.92.26.12510; PECKMILLER KA, 1991, J MOL BIOL, V221, P1; REICH C, 1988, SCIENCE, V239, P178, DOI 10.1126/science.3122322; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; Stams T, 1998, SCIENCE, V280, P752, DOI 10.1126/science.280.5364.752; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Sun L, 2006, EMBO J, V25, P3998, DOI 10.1038/sj.emboj.7601290; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Torres-Larios A, 2006, CURR OPIN STRUC BIOL, V16, P327, DOI 10.1016/j.sbi.2006.04.002; Tsai HY, 2003, J MOL BIOL, V325, P661, DOI 10.1016/S0022-2836(02)01267-6; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Warnecke JM, 1996, P NATL ACAD SCI USA, V93, P8924, DOI 10.1073/pnas.93.17.8924	50	202	203	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					784	789		10.1038/nature09516	http://dx.doi.org/10.1038/nature09516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21076397	Green Accepted			2022-12-01	WOS:000285093700037
J	McKnight, SL				McKnight, Steven L.			On Getting There from Here	SCIENCE			English	Editorial Material							FAMILY; HIF; PROTEIN; CANCER; DOMAIN	Studies on a variety of interesting biological problems, ranging from circadian rhythm to cancer cell growth to longevity, have begun to give evidence that the physiological state of cells and tissues reflects both the cell's regulatory systems and its state of intermediary metabolism. It is appreciated that the regulatory state of a cell or tissue, as driven by transcription factors and signaling pathways, can impose itself upon the dynamics of metabolic state. It follows that the reciprocal must also be the case, that metabolic state will feed back to impose itself on regulatory state. An appreciation and understanding of this reciprocity may be required to crack open problems in biological research that have heretofore been insoluble.	Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu						Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	16	80	81	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1338	1339		10.1126/science.1199908	http://dx.doi.org/10.1126/science.1199908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127243				2022-12-01	WOS:000284902100032
J	Ai, M; Min, S; Grosjean, Y; Leblanc, C; Bell, R; Benton, R; Suh, GSB				Ai, Minrong; Min, Soohong; Grosjean, Yael; Leblanc, Charlotte; Bell, Rati; Benton, Richard; Suh, Greg S. B.			Acid sensing by the Drosophila olfactory system	NATURE			English	Article							CARBON-DIOXIDE; CHEMOSENSORY RECEPTORS; TARGETED EXPRESSION; AVOIDANCE; NEURONS; TRANSMISSION; BEHAVIOR; REVEALS; MINOS; MAP	The odour of acids has a distinct quality that is perceived as sharp, pungent and often irritating(1). How acidity is sensed and translated into an appropriate behavioural response is poorly understood. Here we describe a functionally segregated population of olfactory sensory neurons in the fruitfly, Drosophila melanogaster, that are highly selective for acidity. These olfactory sensory neurons express IR64a, a member of the recently identified ionotropic receptor (IR) family of putative olfactory receptors(2). In vivo calcium imaging showed that IR64a+ neurons projecting to the DC4 glomerulus in the antennal lobe are specifically activated by acids. Flies in which the function of IR64a+ neurons or the IR64a gene is disrupted had defects in acid-evoked physiological and behavioural responses, but their responses to non-acidic odorants remained unaffected. Furthermore, artificial stimulation of IR64a+ neurons elicited avoidance responses. Taken together, these results identify cellular and molecular substrates for acid detection in the Drosophila olfactory system and support a labelled-line mode of acidity coding at the periphery.	[Ai, Minrong; Min, Soohong; Leblanc, Charlotte; Suh, Greg S. B.] NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA; [Grosjean, Yael; Bell, Rati; Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	New York University; University of Lausanne	Suh, GSB (corresponding author), NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA.	greg.suh@med.nyu.edu	Suh, Seong Bae/K-2434-2016; Min, Soohong/AEK-2200-2022; Grosjean, Yael/E-2634-2017; Min, Soohong/I-1607-2018	Grosjean, Yael/0000-0003-0689-8344; Min, Soohong/0000-0003-0683-2935; Suh, Greg/0000-0003-4381-658X	National Research Service Award; Boehringer Ingelheim Foundation; Centre National de la Recherche Scientifique; European Research Council; Swiss National Science Foundation; Alfred P. Sloan Foundation; Whitehall Foundation; Whitehead President Award; NIH [1RO1GM089746]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC010936] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Whitehall Foundation; Whitehead President Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Dus for helpful discussions and technical support for making anti-IR64a antibody; M. Kim for technical assistance; J. Treisman, N. Ringstad, C. Desplan, M. Warman, G. Fishell, M. Chesler, A. Wong, L. Vosshall and D. Anderson for discussions and comments on the manuscript; and R. Lehmann for sharing her two-photon microscope. This work was initiated in D. Anderson's laboratory at California Institute of Technology. G.S.B.S. thanks H.-R. Song for support. Financial support was provided by a National Research Service Award fellowship (M.A.), the Boehringer Ingelheim Foundation (R. Bell), the Centre National de la Recherche Scientifique (Y.G.), a European Research Council Starting Independent Researcher Grant (R. Benton), the Swiss National Science Foundation (R. Benton), the Alfred P. Sloan Foundation (G.S.), the Whitehall Foundation (G.S.), a Whitehead President Award (G.S.) and NIH grant 1RO1GM089746 (G.S).	Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; DRAVNIEKS A, 1982, SCIENCE, V218, P799, DOI 10.1126/science.7134974; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; FRANZ G, 1994, P NATL ACAD SCI USA, V91, P4746, DOI 10.1073/pnas.91.11.4746; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Sambongi Y, 2000, NEUROREPORT, V11, P2229, DOI 10.1097/00001756-200007140-00033; SHANBHAG SR, 1995, CELL TISSUE RES, V282, P237, DOI 10.1007/BF00319115; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	25	223	234	7	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					691	U112		10.1038/nature09537	http://dx.doi.org/10.1038/nature09537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21085119	Green Accepted, Green Submitted			2022-12-01	WOS:000284836700040
J	Gray, MW; Lukes, J; Archibald, JM; Keeling, PJ; Doolittle, WF				Gray, Michael W.; Lukes, Julius; Archibald, John M.; Keeling, Patrick J.; Doolittle, W. Ford			Irremediable Complexity?	SCIENCE			English	Editorial Material							EVOLUTION; INTRONS		[Gray, Michael W.; Archibald, John M.; Doolittle, W. Ford] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada; [Lukes, Julius] Univ S Bohemia, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	Dalhousie University; University of South Bohemia Ceske Budejovice; University of British Columbia	Gray, MW (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada.	ford@dal.ca	Lukes, Julius/H-6760-2012	Lukes, Julius/0000-0002-0578-6618; Gray, Michael/0000-0001-7125-2625; Keeling, Patrick/0000-0002-7644-0745; Doolittle, W. Ford/0000-0002-4675-8832				AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; COVELLO PS, 1993, TRENDS GENET, V9, P265, DOI 10.1016/0168-9525(93)90011-6; Fox GE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003483; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lynch M., 2007, ORIGINS GENOME ARCHI; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Paukstelis PJ, 2008, P NATL ACAD SCI USA, V105, P6010, DOI 10.1073/pnas.0801722105; Sancar A, 2008, NAT STRUCT MOL BIOL, V15, P23, DOI 10.1038/nsmb0108-23; Speijer D, 2006, IUBMB LIFE, V58, P91, DOI 10.1080/15216540600551355; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540	13	168	167	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					920	921		10.1126/science.1198594	http://dx.doi.org/10.1126/science.1198594			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071654				2022-12-01	WOS:000284118000026
J	Rogowski, K; van Dijk, J; Magiera, MM; Bosc, C; Deloulme, JC; Bosson, A; Peris, L; Gold, ND; Lacroix, B; Grau, MB; Bec, N; Larroque, C; Desagher, S; Holzer, M; Andrieux, A; Moutin, MJ; Janke, C				Rogowski, Krzysztof; van Dijk, Juliette; Magiera, Maria M.; Bosc, Christophe; Deloulme, Jean-Christophe; Bosson, Anouk; Peris, Leticia; Gold, Nicholas D.; Lacroix, Benjamin; Grau, Montserrat Bosch; Bec, Nicole; Larroque, Christian; Desagher, Solange; Holzer, Max; Andrieux, Annie; Moutin, Marie-Jo; Janke, Carsten			A Family of Protein-Deglutamylating Enzymes Associated with Neurodegeneration	CELL			English	Article							PURKINJE-CELL-DEGENERATION; LIGHT-CHAIN KINASE; BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATION; ALPHA-TUBULIN; POLYGLUTAMYLATION; MOUSE; GLUTAMYLATION; EXPRESSION; TISSUES	Polyglutamylation is a posttranslational modification that generates glutamate side chains on tubulins and other proteins. Although this modification has been shown to be reversible, little is known about the enzymes catalyzing deglutamylation. Here we describe the enzymatic mechanism of protein deglutamylation by members of the cytosolic carboxypeptidase (CCP) family. Three enzymes (CCP1, CCP4, and CCP6) catalyze the shortening of polyglutamate chains and a fourth (CCP5) specifically removes the branching point glutamates. In addition, CCP1, CCP4, and CCP6 also remove gene-encoded glutamates from the carboxyl termini of proteins. Accordingly, we show that these enzymes convert detyrosinated tubulin into Delta 2-tubulin and also modify other substrates, including myosin light chain kinase 1. We further analyze Purkinje cell degeneration (pcd) mice that lack functional CCP1 and show that microtubule hyperglutamylation is directly linked to neurodegeneration. Taken together, our results reveal that controlling the length of the polyglutamate side chains on tubulin is critical for neuronal survival.	[Rogowski, Krzysztof; van Dijk, Juliette; Magiera, Maria M.; Gold, Nicholas D.; Lacroix, Benjamin; Grau, Montserrat Bosch; Janke, Carsten] Univ Montpellier 2 & 1, CNRS, UMR 5237, CRBM, F-34293 Montpellier, France; [Bosc, Christophe; Deloulme, Jean-Christophe; Bosson, Anouk; Peris, Leticia; Andrieux, Annie; Moutin, Marie-Jo] Univ Grenoble 1, CEA IRTSV GPC, Grenoble Inst Neurosci, INSERM U836, F-38042 Grenoble, France; [Bec, Nicole; Larroque, Christian] INSERM, Inst Rech Cancerol Montpellier, CRLC Val Aurelle, F-34298 Montpellier, France; [Desagher, Solange] Univ Montpellier 2, IGMM, CNRS, UMR 5535, F-34293 Montpellier, France; [Holzer, Max] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Leipzig University	Rogowski, K (corresponding author), Univ Montpellier 2 & 1, CNRS, UMR 5237, CRBM, F-34293 Montpellier, France.	krzysztof.rogowski@crbm.cnrs.fr; carsten.janke@curie.fr	Magiera, Maria M./Y-8754-2019; Holzer, Max/A-1729-2008; Deloulme, Jean Christophe/P-6858-2017; ANDRIEUX, ANNIE/B-2134-2017; Bosc, Christophe/Q-8877-2019; Lacroix, Benjamin/AAL-8428-2020; peris, leticia/P-9249-2017; Moutin, Marie-Jo/P-7518-2017; Bosc, Christophe/P-3401-2017; Janke, Carsten/A-7279-2011	Magiera, Maria M./0000-0003-4847-3053; Holzer, Max/0000-0003-1754-9932; Deloulme, Jean Christophe/0000-0002-2234-5865; ANDRIEUX, ANNIE/0000-0002-4022-6405; Bosc, Christophe/0000-0002-3195-6692; Lacroix, Benjamin/0000-0003-2533-9150; peris, leticia/0000-0002-0668-1252; Moutin, Marie-Jo/0000-0003-2681-9818; Bosc, Christophe/0000-0002-3195-6692; Janke, Carsten/0000-0001-7053-2000; bec, nicole/0000-0001-7608-2434; Bosch Grau, Montserrat/0000-0002-8990-9485; Rogowski, Krzysztof/0000-0002-0206-3289	CNRS; Universities Montpellier; Institut Curie; Association pour la Recherche sur le Cancer (ARC) [3140, 4892, 7927]; French National Research Agency (ANR) [05-JCJC-0035, 08-JCJC-0007]; Fondation pour la Recherche Medicale (FRM) [DEQ20081213977]; HFSP [RGP 23/2008]; EMBO [R07Job, ASTF 157-2007, ALTF 546-2006]; Alzheimer Forschung Initiative [06825]; La Ligue contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universities Montpellier; Institut Curie; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); French National Research Agency (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); HFSP(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Alzheimer Forschung Initiative; La Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the CNRS, the Universities Montpellier 2 and 1, the Institut Curie, the Association pour la Recherche sur le Cancer (ARC) award 3140 to C.J. and awards 4892 and 7927 to A.A., the French National Research Agency (ANR) awards 05-JCJC-0035 and 08-JCJC-0007 to C.J. and "Tyr-Tips" to A.A., the Fondation pour la Recherche Medicale (FRM) research grant DEQ20081213977, the HFSP program grant RGP 23/2008, and the EMBO Young Investigator Program grant to C.J., the La Ligue contre le cancer research grant R07Job to A.A., and the Alzheimer Forschung Initiative project 06825 to M.H. B.L. was supported by a fellowship from the La Ligue contre le Cancer and the EMBO short-term fellowship ASTF 157-2007. K.R. received two postdoctoral fellowships from the La Ligue contre le Cancer and the EMBO long-term fellowship ALTF 546-2006.	AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.0.CO;2-5; BRE MH, 1994, CELL MOTIL CYTOSKEL, V27, P337, DOI 10.1002/cm.970270406; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Gao Y, 2001, IUBMB LIFE, V51, P337; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; Redeker V, 2004, BIOCHEMISTRY-US, V43, P12265, DOI 10.1021/bi049070z; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; Rusconi F, 1997, BIOCHEMISTRY-US, V36, P11021, DOI 10.1021/bi970752e; Smith AF, 1998, AM J PHYSIOL-CELL PH, V274, pC1188, DOI 10.1152/ajpcell.1998.274.5.C1188; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wloga D, 2010, EUKARYOT CELL, V9, P184, DOI 10.1128/EC.00176-09; WOLFF A, 1992, EUR J CELL BIOL, V59, P425	36	206	217	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					564	578		10.1016/j.cell.2010.10.014	http://dx.doi.org/10.1016/j.cell.2010.10.014			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074048	Green Submitted, Bronze			2022-12-01	WOS:000284149100014
J	Maertens, GN; Hare, S; Cherepanov, P				Maertens, Goedele N.; Hare, Stephen; Cherepanov, Peter			The mechanism of retroviral integration from X-ray structures of its key intermediates	NATURE			English	Article							VIRUS INTEGRASE; DNA INTEGRATION; AMINO-ACID; SITES; TRANSPOSITION; INTASOME; COMPLEX; HIV-1	To establish productive infection, a retrovirus must insert a DNA replica of its genome into host cell chromosomal DNA(1,2). This process is operated by the intasome, a nucleoprotein complex composed of an integrase tetramer (IN) assembled on the viral DNA ends(3,4). The intasome engages chromosomal DNA within a target capture complex to carry out strand transfer, irreversibly joining the viral and cellular DNA molecules. Although several intasome/transpososome structures from the DDE(D) recombinase superfamily have been reported(4-6), the mechanics of target DNA capture and strand transfer by these enzymes remained unclear. Here we report crystal structures of the intasome from prototype foamy virus in complex with target DNA, elucidating the pre-integration target DNA capture and post-catalytic strand transfer intermediates of the retroviral integration process. The cleft between IN dimers within the intasome accommodates chromosomal DNA in a severely bent conformation, allowing widely spaced IN active sites to access the scissile phosphodiester bonds. Our results resolve the structural basis for retroviral DNA integration and provide a framework for the design of INs with altered target sequences.	[Maertens, Goedele N.; Hare, Stephen; Cherepanov, Peter] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, London W2 1PG, England	Imperial College London	Cherepanov, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, St Marys Campus,Norfolk Pl, London W2 1PG, England.	p.cherepanov@imperial.ac.uk	Maertens, Goedele/D-8628-2015; Cherepanov, Peter P/F-6859-2010	Maertens, Goedele/0000-0002-1963-8026; Cherepanov, Peter P/0000-0002-0634-538X; Hare, Stephen/0000-0003-2951-1595	UK Medical Research Council; Medical Research Council [G0900116] Funding Source: researchfish; MRC [G0900116] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Engelman and F. Dyda for critical reading of the manuscript, J. Sanchez-Weatherby for assistance with X-ray data collection at the I02 beamline of the Diamond Light Source and J. Moore for help with crystallization screening and the X-ray generator. This work was funded by the UK Medical Research Council.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Craigie R, 2002, MOBILE DNA, P613; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Harper AL, 2003, J VIROL, V77, P3838, DOI 10.1128/JVI.77.6.3838-3845.2003; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Johnson RC, 2008, RSC BIOMOL SCI, P176; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konsavage WM, 2005, J VIROL, V79, P4691, DOI 10.1128/JVI.79.8.4691-4699.2005; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lim KI, 2010, P NATL ACAD SCI USA, V107, P12475, DOI 10.1073/pnas.1001402107; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Trobridge GD, 2006, P NATL ACAD SCI USA, V103, P1498, DOI 10.1073/pnas.0510046103; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005	26	240	242	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					326	U217		10.1038/nature09517	http://dx.doi.org/10.1038/nature09517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068843	Green Submitted, Green Accepted			2022-12-01	WOS:000284051000055
J	Mitrovich, QM; Tuch, BB; De La Vega, FM; Guthrie, C; Johnson, AD				Mitrovich, Quinn M.; Tuch, Brian B.; De La Vega, Francisco M.; Guthrie, Christine; Johnson, Alexander D.			Evolution of Yeast Noncoding RNAs Reveals an Alternative Mechanism for Widespread Intron Loss	SCIENCE			English	Article							SMALL NUCLEOLAR RNAS; CANDIDA-ALBICANS; SNORNAS; GENOME	The evolutionary forces responsible for intron loss are unresolved. Whereas research has focused on protein-coding genes, here we analyze noncoding small nucleolar RNA ( snoRNA) genes in which introns, rather than exons, are typically the functional elements. Within the yeast lineage exemplified by the human pathogen Candida albicans, we find-through deep RNA sequencing and genome-wide annotation of splice junctions-extreme compaction and loss of associated exons, but retention of snoRNAs within introns. In the Saccharomyces yeast lineage, however, we find it is the introns that have been lost through widespread degeneration of splicing signals. This intron loss, perhaps facilitated by innovations in snoRNA processing, is distinct from that observed in protein-coding genes with respect to both mechanism and evolutionary timing.	[Mitrovich, Quinn M.; Guthrie, Christine; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Mitrovich, Quinn M.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Tuch, Brian B.; De La Vega, Francisco M.] Life Technol, Res & Dev, Genet Syst Div, Foster City, CA 94404 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Thermo Fisher Scientific	Guthrie, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	christineguthrie@gmail.com; ajohnson@cgl.ucsf.edu	De La Vega, Francisco/H-3832-2011		NIH [GM021119, GM37049]; Life Technologies Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM021119, R37GM021119] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Technologies Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Barbacioru, O. Homann, S. Kuersten, S. Ledoux, I. Listerman, T. Lowe, C. Maeder, K. Pande, A. Price, S. Roy, J. Steitz, and members of the Guthrie and Johnson laboratories for helpful discussions and support; and M. Barker and C. Monighetti for providing sequence reads. This work was supported by NIH grants GM021119 (C. G.) and GM37049 (A. D. J.) and by Life Technologies Corp. C. G. is an American Cancer Society Research Professor of Molecular Genetics. Sequence data are available at the Gene Expression Omnibus (accession number GSE21291).	Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Brown JWS, 2008, TRENDS PLANT SCI, V13, P335, DOI 10.1016/j.tplants.2008.04.010; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Liu N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-515; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Marck C, 2006, NUCLEIC ACIDS RES, V34, P1816, DOI 10.1093/nar/gkl085; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Penny D, 2009, J MOL EVOL, V69, P527, DOI 10.1007/s00239-009-9279-5; Piekna-Przybylska D, 2007, RNA, V13, P305, DOI 10.1261/rna.373107; Qu LH, 1999, MOL CELL BIOL, V19, P1144; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Tuch BB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001070; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2	21	29	420	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					838	841		10.1126/science.1194554	http://dx.doi.org/10.1126/science.1194554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051641	Green Accepted			2022-12-01	WOS:000283855700048
J	Gill, TM; Allore, HG; Gahbauer, EA; Murphy, TE				Gill, Thomas M.; Allore, Heather G.; Gahbauer, Evelyne A.; Murphy, Terrence E.			Change in Disability After Hospitalization or Restricted Activity in Older Persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL PERFORMANCE; CONTROLLED-TRIAL; LIFE EXPECTANCY; ELDERLY-PEOPLE; GAIT SPEED; ADULTS; RISK; CARE; REHABILITATION; FORECASTS	Context Disability among older persons is a complex and highly dynamic process, with high rates of recovery and frequent transitions between states of disability. The role of intervening illnesses and injuries (ie, events) on these transitions is uncertain. Objectives To evaluate the relationship between intervening events and transitions among states of no disability, mild disability, severe disability, and death and to determine the association of physical frailty with these transitions. Design, Setting, and Participants Prospective cohort study conducted in greater New Haven, Connecticut, from March 1998 to December 2008 of 754 community-living persons aged 70 years or older who were nondisabled at baseline in 4 essential activities of daily living: bathing, dressing, walking, and transferring. Telephone interviews were completed monthly for more than 10 years to assess disability and ascertain exposure to intervening events, which included illnesses and injuries leading to either hospitalization or restricted activity. Physical frailty (defined as gait speed > 10 seconds on the rapid gait test) was assessed every 18 months through 108 months. Main Outcome Measure Transitions between no disability, mild disability, and severe disability and 3 transitions from each of these states to death, evaluated each month. Results Hospitalization was strongly associated with 8 of the 9 possible transitions, with increased multivariable hazard ratios (HRs) as high as 168 (95% confidence interval [CI], 118-239) for the transition from no disability to severe disability and decreased HRs as low as 0.41 (95% CI, 0.30-0.54) for the transition from mild disability to no disability. Restricted activity also increased the likelihood of transitioning from no disability to both mild and severe disability (HR, 2.59; 95% CI, 2.23-3.02; and HR, 8.03; 95% CI, 5.28-12.21), respectively, and from mild disability to severe disability (HR, 1.45; 95% CI, 1.14-1.84), but was not associated with recovery from mild or severe disability. For all 9 transitions, the presence of physical frailty accentuated the associations of the intervening events. For example, the absolute risk of transitioning from no disability to mild disability within 1 month after hospitalization for frail individuals was 34.9% (95% CI, 34.5%-35.3%) vs 4.9% (95% CI, 4.7%-5.1%) for non-frail individuals. Among the possible reasons for hospitalization, fall-related injury conferred the highest likelihood of developing new or worsening disability. Conclusions Among older persons, particularly those who were physically frail, intervening illnesses and injuries greatly increased the likelihood of developing new or worsening disability. Only the most potent events, ie, those leading to hospitalization, reduced the likelihood of recovery from disability. JAMA. 2010; 304(17): 1919-1928	[Gill, Thomas M.] Yale Univ, Sch Med, Dept Internal Med, Adler Geriatr Ctr, New Haven, CT 06504 USA	Yale University	Gill, TM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Adler Geriatr Ctr, 20 York St, New Haven, CT 06504 USA.	thomas.gill@yale.edu	Gill, Thomas M./H-7043-2019; Murphy, Terrence E/A-9394-2009	Gill, Thomas M./0000-0002-6450-0368; Allore, Heather/0000-0001-7685-8175	National Institute on Aging [R37AG17560, R01AG022993, K24AG021507]; NATIONAL INSTITUTE ON AGING [R01AG022993, P30AG021342, R37AG017560, K24AG021507] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work for this report was funded by grants from the National Institute on Aging (R37AG17560, R01AG022993). The study was conducted at the Yale Claude D. Pepper Older Americans Independence Center (P30AG21342). Dr Gill is the recipient of a Midcareer Investigator Award in Patient-Oriented Research (K24AG021507) from the National Institute on Aging.	Allison P.D., 2010, SURVIVAL ANAL USING; Baker CJ, 2010, ANN INTERN MED, V152, P36, DOI 10.7326/0003-4819-152-1-201001050-00008; Barry LC, 2008, ARCH GEN PSYCHIAT, V65, P172, DOI 10.1001/archgenpsychiatry.2007.17; BENICHOU J, 1990, BIOMETRICS, V46, P813, DOI 10.2307/2532098; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Ferrucci Luigi, 1997, JAMA (Journal of the American Medical Association), V277, P728, DOI 10.1001/jama.277.9.728; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Gill TM, 2008, J AM GERIATR SOC, V56, P436, DOI 10.1111/j.1532-5415.2007.01603.x; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Gill TM, 2001, J AM GERIATR SOC, V49, P1039, DOI 10.1046/j.1532-5415.2001.49206.x; Goodwin James S, 2002, Lancet, V359, P1358, DOI 10.1016/S0140-6736(02)08318-6; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Hardy SE, 2005, AM J EPIDEMIOL, V161, P575, DOI 10.1093/aje/kwi083; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Hoenig H, 1997, J AM GERIATR SOC, V45, P1371, DOI 10.1111/j.1532-5415.1997.tb02939.x; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lin HQ, 2008, BIOMETRICS, V64, P1032, DOI 10.1111/j.1541-0420.2008.01011.x; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; MANTON KG, 1993, J GERONTOL, V48, P11, DOI 10.1093/geronj/48.Special_Issue.11; Olshansky SJ, 2009, MILBANK Q, V87, P842, DOI 10.1111/j.1468-0009.2009.00581.x; Rich MW, 2001, J GERONTOL A-BIOL, V56, pM88, DOI 10.1093/gerona/56.2.M88; ROCKWOOD K, 1994, CAN MED ASSOC J, V150, P489; Straus SE, 2002, JAMA-J AM MED ASSOC, V288, P1396, DOI 10.1001/jama.288.11.1396; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Tinetti ME, 2002, JAMA-J AM MED ASSOC, V287, P2098, DOI 10.1001/jama.287.16.2098; United States Census Bureau, AM FACTFINDER; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881	40	334	339	1	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2010	304	17					1919	1928		10.1001/jama.2010.1568	http://dx.doi.org/10.1001/jama.2010.1568			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674GT	21045098	Bronze, Green Accepted			2022-12-01	WOS:000283725900022
J	Bloss, CS; Schork, NJ; Topol, EJ				Bloss, Cinnamon S.; Schork, Nicholas J.; Topol, Eric J.			Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROPHYLACTIC SURGERY; ALZHEIMERS-DISEASE; IMPACT	Background: The use of direct-to-consumer genomewide profiling to assess disease risk is controversial, and little is known about the effect of this technology on consumers. We examined the psychological, behavioral, and clinical effects of risk scanning with the Navigenics Health Compass, a commercially available test of uncertain clinical validity and utility. Methods: We recruited subjects from health and technology companies who elected to purchase the Health Compass at a discounted rate. Subjects reported any changes in symptoms of anxiety, intake of dietary fat, and exercise behavior at a mean (+/-SD) of 5.6+/-2.4 months after testing, as compared with baseline, along with any test-related distress and the use of health-screening tests. Results: From a cohort of 3639 enrolled subjects, 2037 completed follow-up. Primary analyses showed no significant differences between baseline and follow-up in anxiety symptoms (P=0.80), dietary fat intake (P=0.89), or exercise behavior (P=0.61). Secondary analyses revealed that test-related distress was positively correlated with the average estimated lifetime risk among all the assessed conditions ((beta)=0.117, P<0.001). However, 90.3% of subjects who completed follow-up had scores indicating no test-related distress. There was no significant increase in the rate of use of screening tests associated with genomewide profiling, most of which are not considered appropriate for screening asymptomatic persons in any case. Conclusions: In a selected sample of subjects who completed follow-up after undergoing consumer genomewide testing, such testing did not result in any measurable short-term changes in psychological health, diet or exercise behavior, or use of screening tests. Potential effects of this type of genetic testing on the population at large are not known. (Funded by the National Institutes of Health and Scripps Health.) N Engl J Med 2011;364:524-34.	[Bloss, Cinnamon S.; Schork, Nicholas J.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Bloss, Cinnamon S.; Schork, Nicholas J.; Topol, Eric J.] Scripps Hlth, La Jolla, CA USA; [Schork, Nicholas J.; Topol, Eric J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Topol, Eric J.] Scripps Clin, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Ct,Suite 300, La Jolla, CA 92037 USA.	etopol@scripps.edu		Topol, Eric/0000-0002-1478-4729; Schork, Nicholas/0000-0003-0920-5013	National Center for Research Resources of the National Institutes of Health (NIH) [1UL1RR025774-01]; NIH's National Human Genome Research Institute [1R21HG005747-01]; Scripps Genomic Medicine Division of Scripps Health; National Institutes of Health and Scripps Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005747] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH's National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Scripps Genomic Medicine Division of Scripps Health; National Institutes of Health and Scripps Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported in part by grants from the National Center for Research Resources of the National Institutes of Health (NIH) (1UL1RR025774-01, to Dr. Topol) and the NIH's National Human Genome Research Institute (1R21HG005747-01, to Dr. Bloss) and by the Scripps Genomic Medicine Division of Scripps Health.; Funded by the National Institutes of Health and Scripps Health.	Block G, 2000, AM J PREV MED, V18, P284, DOI 10.1016/S0749-3797(00)00119-7; Bloss CS, 2010, GENET MED, V12, P556, DOI 10.1097/GIM.0b013e3181eb51c6; Botkin JR, 2003, AM J MED GENET A, V118A, P201, DOI 10.1002/ajmg.a.10102; Collins VR, 2007, GENET MED, V9, P290, DOI 10.1097/GIM.0b013e31804b45db; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Healy M, 2009, LOS ANGELES TIM 1024, P4; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lerman C, 2000, PREV MED, V31, P75, DOI 10.1006/pmed.2000.0684; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; Pollack A, 2010, NY TIMES        0611, pB2; Roberts JS, 2005, J GERIATR PSYCH NEUR, V18, P250, DOI 10.1177/0891988705281883; Spielberger CD., 1983, STATE TRAIT ANXIETY; Weiss Daniel S., 1997, P399	18	382	382	0	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					524	534		10.1056/NEJMoa1011893	http://dx.doi.org/10.1056/NEJMoa1011893			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21226570	Green Accepted			2022-12-01	WOS:000287139900006
J	Ukai-Tadenuma, M; Yamada, RG; Xu, HY; Ripperger, JA; Liu, AC; Ueda, HR				Ukai-Tadenuma, Maki; Yamada, Rikuhiro G.; Xu, Haiyan; Ripperger, Juergen A.; Liu, Andrew C.; Ueda, Hiroki R.			Delay in Feedback Repression by Cryptochrome 1 Is Required for Circadian Clock Function	CELL			English	Article							GENE-EXPRESSION; TRANSCRIPTION; PROTEINS; CRY1; PAR; COMPONENTS; BINDING; LIMB	Direct evidence for the requirement of delay in feedback repression in the mammalian circadian clock has been elusive. Cryptochrome 1 (Cry1), an essential clock component, displays evening-time expression and serves as a strong repressor at morning-time elements (E box/E' box). In this study, we reveal that a combination of day-time elements (D box) within the Cry1-proximal promoter and night-time elements (RREs) within its intronic enhancer gives rise to evening-time expression. A synthetic composite promoter produced evening-time expression, which was further recapitulated by a simple phase-vector model. Of note, coordination of day-time with night-time elements can modulate the extent of phase delay. A genetic complementation assay in Cry1(-/-):Cry2(-/-) cells revealed that substantial delay of Cry1 expression is required to restore circadian rhythmicity, and its prolonged delay slows circadian oscillation. Taken together, our data suggest that phase delay in Cry1 transcription is required for mammalian clock function.	[Ukai-Tadenuma, Maki; Yamada, Rikuhiro G.; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Funct Genom Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Xu, Haiyan; Liu, Andrew C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Ripperger, Juergen A.] Univ Fribourg, Dept Med, Biochem Unit, CH-1700 Fribourg, Switzerland; [Ueda, Hiroki R.] Osaka Univ, Grad Sch Sci, Osaka 5600043, Japan; [Ueda, Hiroki R.] Kyoto Univ, Dept Math, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	RIKEN; RIKEN; RIKEN; University of Memphis; University of Fribourg; Osaka University; Kyoto University	Ueda, HR (corresponding author), RIKEN Ctr Dev Biol, Lab Syst Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	uedah-tky@umin.ac.jp	Liu, Andrew C/B-3548-2009; Ueda, Hiroki R/C-5037-2014	Liu, Andrew C/0000-0003-1927-0900; Ueda, Hiroki R/0000-0001-8342-9176	RIKEN Center for Developmental Biology (CDB); Uehara Memorial Foundation; Mitsubishi Foundation; RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Science Foundation [IOS-0920417]; SNF/FNS; Direct For Biological Sciences [0920417] Funding Source: National Science Foundation	RIKEN Center for Developmental Biology (CDB); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Science Foundation(National Science Foundation (NSF)); SNF/FNS(Swiss National Science Foundation (SNSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology (CDB) (H.R.U.), Uehara Memorial Foundation (H.R.U.), The Mitsubishi Foundation (H.R.U.), the President's Fund from RIKEN (H.R.U.), KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Systems Genomics'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H.R.U.), the National Science Foundation (IOS-0920417) (A.C.L.), and the SNF/FNS (J.A.R.). We thank Ueli Schibler, Urs Albrecht, and Frederic Gachon for their valuable reagents; Akira Yasui and Gijsbertus T.J. van der Horst for Cry1<SUP>-/-</SUP>:Cry2<SUP>-/-</SUP> double-knockout mice; Hideki Ukai and Koh-hei Masumoto for technical support in establishment of Cry1<SUP>-/-</SUP>:Cry2<SUP>-/-</SUP> cells; Yohei Koyama for critical comments on the theoretical analysis of delayed negative feedback loop; Hajime Tei for Cry1 and Cry2 expression vectors; and David K. Welsh for critical reading of the manuscript.	Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bernard S, 2006, PHILOS T R SOC A, V364, P1155, DOI 10.1098/rsta.2006.1761; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Falvey E, 1996, BIOL CHEM, V377, P797; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Fustin JM, 2009, J BIOL RHYTHM, V24, P16, DOI 10.1177/0748730408329267; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	39	183	188	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					268	281		10.1016/j.cell.2010.12.019	http://dx.doi.org/10.1016/j.cell.2010.12.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21236481	Green Submitted, Bronze			2022-12-01	WOS:000286459900011
J	Gostin, LO; Kim, SC				Gostin, Lawrence O.; Kim, Susan C.			Ethical Allocation of Preexposure HIV Prophylaxis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Kim, Susan C.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Dabis F, 2005, AIDS, V19, P309; Gostin LO, 2010, JAMA-J AM MED ASSOC, V304, P789, DOI 10.1001/jama.2010.1164; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; MCNEILL DG, 2010, NY TIMES        0510, pA10; Obengo T.J., 2020, UTILITARIAN ASSESSME; *UNAIDS, REP G UNAIDS REP GLO; *US CDCP, PREL RES 1 SAF STUD; *US PRES EM PLAN A, EX SUMM PEPFARS STRA; Vassall A, 2022, BMJ, V378, DOI [10.1136/bmj.o2320, DOI 10.1136/BMJ.O2320]	10	18	18	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					191	192		10.1001/jama.2010.1975	http://dx.doi.org/10.1001/jama.2010.1975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224461	Green Published			2022-12-01	WOS:000286103400025
J	Leonard, TA; Rozycki, B; Saidi, LF; Hummer, G; Hurley, JH				Leonard, Thomas A.; Rozycki, Bartosz; Saidi, Layla F.; Hummer, Gerhard; Hurley, James H.			Crystal Structure and Allosteric Activation of Protein Kinase C beta II	CELL			English	Article							MEMBRANE-BINDING; CATALYTIC DOMAIN; BIOLOGICAL MACROMOLECULES; INDUCED TRANSLOCATION; SOLUTION SCATTERING; PKC; ALPHA; PHOSPHORYLATION; ROLES; SIMULATIONS	Protein kinase C (PKC) isozymes are the paradigmatic effectors of lipid signaling. PKCs translocate to cell membranes and are allosterically activated upon binding of the lipid diacylglycerol to their C1A and C1B domains. The crystal structure of full-length protein kinase C beta II was determined at 4.0 angstrom, revealing the conformation of an unexpected intermediate in the activation pathway. Here, the kinase active site is accessible to substrate, yet the conformation of the active site corresponds to a low-activity state because the ATP-binding side chain of Phe629 of the conserved NFD motif is displaced. The C1B domain clamps the NFD helix in a low-activity conformation, which is reversed upon membrane binding. A low-resolution solution structure of the closed conformation of PKC beta II was derived from small-angle X-ray scattering. Together, these results show how PKC beta II is allosterically regulated in two steps, with the second step defining a novel protein kinase regulatory mechanism.	[Leonard, Thomas A.; Saidi, Layla F.; Hurley, James H.] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Rozycki, Bartosz; Hummer, Gerhard] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Hummer, Gerhard/A-2546-2013; Rozycki, Bartosz/B-7005-2009; Leonard, Thomas/A-5143-2013	Hummer, Gerhard/0000-0001-7768-746X; Rozycki, Bartosz/0000-0001-5938-7308; Leonard, Thomas/0000-0001-6853-666X	NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; EMBO; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029033, ZIADK036127] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Chang for technical assistance, J. Lloyd and D. E. Anderson for assistance with mass spectrometry, J. F. Mushinski and A. Toker for DNAs, E. Boura for assistance with SAXS data collection, H. Tsuruta and T. Weiss for user support at BL4-2, SSRL, M. Becker for user support at GM/CA-CAT, APS, H. Mischak and M. Pearson for early efforts, A. Newton for discussions, and A. Brunger for a prerelease version of CNS 1.3. GM/CA-CAT has been funded in whole or in part with Federal funds from the NCI (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357. SAXS data were collected at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. T.A.L. was supported in part by an EMBO long term fellowship. B.R. was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme. This research was supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health to J.H.H. and G.H.	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bogi K, 1999, FEBS LETT, V456, P27, DOI 10.1016/S0014-5793(99)00927-8; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; Hurley JH, 1997, PROTEIN SCI, V6, P477; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Kim YC, 2008, J MOL BIOL, V375, P1416, DOI 10.1016/j.jmb.2007.11.063; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Littler DR, 2006, BIOCHEM BIOPH RES CO, V349, P1182, DOI 10.1016/j.bbrc.2006.08.160; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ochoa WF, 2001, J MOL BIOL, V311, P837, DOI 10.1006/jmbi.2001.4910; ORR JW, 1994, J BIOL CHEM, V269, P8383; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; TSUTAKAWA SE, 1995, J BIOL CHEM, V270, P26807, DOI 10.1074/jbc.270.45.26807; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	56	148	149	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					55	66		10.1016/j.cell.2010.12.013	http://dx.doi.org/10.1016/j.cell.2010.12.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215369	Bronze, Green Accepted			2022-12-01	WOS:000285993600007
J	Roy, S; Ernst, J; Kharchenko, PV; Kheradpour, P; Negre, N; Eaton, ML; Landolin, JM; Bristow, CA; Ma, LJ; Lin, MF; Washietl, S; Arshinoff, BI; Ay, F; Meyer, PE; Robine, N; Washington, NL; Di Stefano, L; Berezikov, E; Brown, CD; Candeias, R; Carlson, JW; Carr, A; Jungreis, I; Marbach, D; Sealfon, R; Tolstorukov, MY; Will, S; Alekseyenko, AA; Artieri, C; Booth, BW; Brooks, AN; Dai, Q; Davis, CA; Duff, MO; Feng, X; Gorchakov, AA; Gu, TT; Henikoff, JG; Kapranov, P; Li, RH; MacAlpine, HK; Malone, J; Minoda, A; Nordman, J; Okamura, K; Perry, M; Powell, SK; Riddle, NC; Sakai, A; Samsonova, A; Sandler, JE; Schwartz, YB; Sher, N; Spokony, R; Sturgill, D; van Baren, M; Wan, KH; Yang, L; Yu, C; Feingold, E; Good, P; Guyer, M; Lowdon, R; Ahmad, K; Andrews, J; Berger, B; Brenner, SE; Brent, MR; Cherbas, L; Elgin, SCR; Gingeras, TR; Grossman, R; Hoskins, RA; Kaufman, TC; Kent, W; Kuroda, MI; Orr-Weaver, T; Perrimon, N; Pirrotta, V; Posakony, JW; Ren, B; Russell, S; Cherbas, P; Graveley, BR; Lewis, S; Micklem, G; Oliver, B; Park, PJ; Celniker, SE; Henikoff, S; Karpen, GH; Lai, EC; MacAlpine, DM; Stein, LD; White, KP; Kellis, M				Roy, Sushmita; Ernst, Jason; Kharchenko, Peter V.; Kheradpour, Pouya; Negre, Nicolas; Eaton, Matthew L.; Landolin, Jane M.; Bristow, Christopher A.; Ma, Lijia; Lin, Michael F.; Washietl, Stefan; Arshinoff, Bradley I.; Ay, Ferhat; Meyer, Patrick E.; Robine, Nicolas; Washington, Nicole L.; Di Stefano, Luisa; Berezikov, Eugene; Brown, Christopher D.; Candeias, Rogerio; Carlson, Joseph W.; Carr, Adrian; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Tolstorukov, Michael Y.; Will, Sebastian; Alekseyenko, Artyom A.; Artieri, Carlo; Booth, Benjamin W.; Brooks, Angela N.; Dai, Qi; Davis, Carrie A.; Duff, Michael O.; Feng, Xin; Gorchakov, Andrey A.; Gu, Tingting; Henikoff, Jorja G.; Kapranov, Philipp; Li, Renhua; MacAlpine, Heather K.; Malone, John; Minoda, Aki; Nordman, Jared; Okamura, Katsutomo; Perry, Marc; Powell, Sara K.; Riddle, Nicole C.; Sakai, Akiko; Samsonova, Anastasia; Sandler, Jeremy E.; Schwartz, Yuri B.; Sher, Noa; Spokony, Rebecca; Sturgill, David; van Baren, Marijke; Wan, Kenneth H.; Yang, Li; Yu, Charles; Feingold, Elise; Good, Peter; Guyer, Mark; Lowdon, Rebecca; Ahmad, Kami; Andrews, Justen; Berger, Bonnie; Brenner, Steven E.; Brent, Michael R.; Cherbas, Lucy; Elgin, Sarah C. R.; Gingeras, Thomas R.; Grossman, Robert; Hoskins, Roger A.; Kaufman, Thomas C.; Kent, William; Kuroda, Mitzi I.; Orr-Weaver, Terry; Perrimon, Norbert; Pirrotta, Vincenzo; Posakony, James W.; Ren, Bing; Russell, Steven; Cherbas, Peter; Graveley, Brenton R.; Lewis, Suzanna; Micklem, Gos; Oliver, Brian; Park, Peter J.; Celniker, Susan E.; Henikoff, Steven; Karpen, Gary H.; Lai, Eric C.; MacAlpine, David M.; Stein, Lincoln D.; White, Kevin P.; Kellis, Manolis		modENCODE Consortium	Identification of Functional Elements and Regulatory Circuits by Drosophila modENCODE	SCIENCE			English	Article							PREDICTIVE CHROMATIN SIGNATURES; TRANSCRIPTION FACTORS; SOMATIC-CELLS; HUMAN GENOME; DNA-BINDING; RNA PATHWAY; MELANOGASTER; SEQUENCE; REGIONS; NETWORK	To gain insight into how genomic information is translated into cellular and developmental programs, the Drosophila model organism Encyclopedia of DNA Elements (modENCODE) project is comprehensively mapping transcripts, histone modifications, chromosomal proteins, transcription factors, replication proteins and intermediates, and nucleosome properties across a developmental time course and in multiple cell lines. We have generated more than 700 data sets and discovered protein-coding, noncoding, RNA regulatory, replication, and chromatin elements, more than tripling the annotated portion of the Drosophila genome. Correlated activity patterns of these elements reveal a functional regulatory network, which predicts putative new functions for genes, reveals stage-and tissue-specific regulators, and enables gene-expression prediction. Our results provide a foundation for directed experimental and computational studies in Drosophila and related species and also a model for systematic data integration toward comprehensive genomic and functional annotation.	[Roy, Sushmita; Ernst, Jason; Kheradpour, Pouya; Bristow, Christopher A.; Lin, Michael F.; Washietl, Stefan; Ay, Ferhat; Meyer, Patrick E.; Di Stefano, Luisa; Candeias, Rogerio; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Will, Sebastian; Berger, Bonnie; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Roy, Sushmita; Ernst, Jason; Kheradpour, Pouya; Bristow, Christopher A.; Lin, Michael F.; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Berger, Bonnie; Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02140 USA; [Roy, Sushmita; Ernst, Jason; Kheradpour, Pouya; Bristow, Christopher A.; Lin, Michael F.; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Berger, Bonnie; Kellis, Manolis] Harvard Univ, Cambridge, MA 02140 USA; [Kharchenko, Peter V.; Tolstorukov, Michael Y.; Schwartz, Yuri B.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Negre, Nicolas; Ma, Lijia; Brown, Christopher D.; Spokony, Rebecca; Grossman, Robert; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, Chicago, IL 60637 USA; [Eaton, Matthew L.; MacAlpine, Heather K.; Powell, Sara K.; MacAlpine, David M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Landolin, Jane M.; Carlson, Joseph W.; Booth, Benjamin W.; Minoda, Aki; Sandler, Jeremy E.; Wan, Kenneth H.; Yu, Charles; Hoskins, Roger A.; Celniker, Susan E.; Karpen, Gary H.] Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Arshinoff, Bradley I.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Robine, Nicolas; Dai, Qi; Henikoff, Jorja G.; Okamura, Katsutomo; Lai, Eric C.] Sloan Kettering Inst, New York, NY 10065 USA; [Washington, Nicole L.; Lewis, Suzanna] LBNL, Genome Sci Div, Berkeley, CA 94720 USA; [Carr, Adrian; Russell, Steven; Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Carr, Adrian; Russell, Steven; Micklem, Gos] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 3EH, England; [Alekseyenko, Artyom A.; Gorchakov, Andrey A.; Kuroda, Mitzi I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Gorchakov, Andrey A.; Kuroda, Mitzi I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Genet, Boston, MA 02115 USA; [Artieri, Carlo; Malone, John; Sturgill, David; Oliver, Brian] NIDDK, Sect Dev Genom, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Davis, Carrie A.; Feng, Xin; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Duff, Michael O.; Yang, Li; Graveley, Brenton R.] Univ Connecticut, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Gu, Tingting; Riddle, Nicole C.; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kapranov, Philipp; Gingeras, Thomas R.] Affymetrix, Santa Clara, CA 95051 USA; [Li, Renhua; Feingold, Elise; Good, Peter; Guyer, Mark; Lowdon, Rebecca] NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; [Arshinoff, Bradley I.; Feng, Xin; Perry, Marc; Stein, Lincoln D.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Samsonova, Anastasia; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Samsonova, Anastasia; Perrimon, Norbert] Harvard Univ, Sch Med, Drosophila RNAi Screening Ctr, Boston, MA 02115 USA; [van Baren, Marijke; Brent, Michael R.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; [Andrews, Justen; Cherbas, Lucy; Kaufman, Thomas C.; Cherbas, Peter] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Nordman, Jared; Sher, Noa; Orr-Weaver, Terry] Whitehead Inst, Cambridge, MA 02142 USA; [Berezikov, Eugene] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Berezikov, Eugene] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Cherbas, Lucy; Cherbas, Peter] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Posakony, James W.; Ren, Bing] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Brooks, Angela N.; Brenner, Steven E.; Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Sakai, Akiko; Ahmad, Kami] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Meyer, Patrick E.] Univ Libre Bruxelles, Machine Learning Grp, B-1050 Brussels, Belgium; [Di Stefano, Luisa] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ay, Ferhat] Univ Florida, Gainesville, FL 32611 USA; [Kent, William] Univ Calif Santa Cruz, Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Kent, William] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Feng, Xin] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; University of Chicago; Duke University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Toronto; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Cambridge; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cold Spring Harbor Laboratory; University of Connecticut; Washington University (WUSTL); Affymetrix; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Massachusetts Institute of Technology (MIT); Whitehead Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Indiana University System; Indiana University Bloomington; Fred Hutchinson Cancer Center; University of California System; University of California San Diego; Rutgers State University New Brunswick; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Universite Libre de Bruxelles; Harvard University; Massachusetts General Hospital; University of California System; University of California Berkeley; State University System of Florida; University of Florida; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Kellis, M (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	celniker@fruitfly.org; steveh@fhcrc.org; karpen@fruitfly.org; laie@mskcc.org; david.macalpine@duke.edu; lincoln.stein@gmail.com; kpwhite@uchicago.edu; manoli@mit.edu	Eng, Thomas/AAV-5157-2020; Brent, Michael/AAK-3702-2020; Venken, Koen/B-9909-2013; Kellis, Manolis/ABE-7385-2020; Rutherford, Kim/Y-7995-2018; Samsonova, Anastasia/Q-7591-2016; Eaton, Matthew/C-4408-2011; Berezikov, Eugene/D-3363-2013; Di Stefano, Luisa/ABB-6457-2020; Brooks, Angela/B-6173-2011; Spokony, Rebecca/AAD-3014-2020; Gorchakov, Andrey A/N-5840-2015; Minoda, Aki/D-5335-2017; Marra, Marco A/B-5987-2008; Brenner, Steven E/A-8729-2008; Chateigner, Aurelien/AAC-9143-2020; Minoda, Aki/Q-4454-2019; Hirst, Martin/B-7684-2016; Lai, Eric C/A-3412-2008; dai, qi/AAB-6637-2020; Hinrichs, Angie S./H-9159-2019; Graveley, Brenton R/C-3108-2013; Lai, Eric/AAO-1143-2021; Sakai, Akiko/A-8929-2010; Ay, Ferhat/J-7800-2019; White, Rob A H/G-4835-2012; Russell, Steve/A-4072-2011; Samsonova, Anastasia/AAU-7269-2021; jiang, lichun/F-3776-2012; Hansen, Kasper D/E-6094-2011; Grossman, Robert/B-1865-2009	Eng, Thomas/0000-0002-4974-3863; Brent, Michael/0000-0002-8689-0299; Venken, Koen/0000-0003-0741-4698; Kellis, Manolis/0000-0001-7113-9630; Rutherford, Kim/0000-0001-6277-726X; Samsonova, Anastasia/0000-0002-9353-9173; Berezikov, Eugene/0000-0002-1145-2884; Di Stefano, Luisa/0000-0003-3437-9066; Gorchakov, Andrey A/0000-0003-2830-4236; Minoda, Aki/0000-0002-2927-5791; Marra, Marco A/0000-0001-7146-7175; Brenner, Steven E/0000-0001-7559-6185; Minoda, Aki/0000-0002-2927-5791; Hinrichs, Angie S./0000-0002-1697-1130; Lai, Eric/0000-0002-8432-5851; Sakai, Akiko/0000-0003-3120-0104; Ay, Ferhat/0000-0002-0708-6914; Russell, Steve/0000-0003-0546-3031; Samsonova, Anastasia/0000-0002-9353-9173; jiang, lichun/0000-0003-2462-7636; Hansen, Kasper D/0000-0003-0086-0687; Elgin, Sarah C. R./0000-0002-5176-2510; Dobin, Alexander/0000-0002-4115-9128; McKay, Sheldon/0000-0002-4011-3160; Washington, Nicole/0000-0001-8936-9143; Fagegaltier, Delphine/0000-0001-9154-6786; Micklem, Gos/0000-0002-6883-6168; Park, Peter/0000-0001-9378-960X; Meyer, Folker/0000-0003-1112-2284; Henikoff, Steven/0000-0002-7621-8685; Graveley, Brenton/0000-0001-5777-5892; Zieba, Jennifer/0000-0003-1650-1830; Brown, Christopher/0000-0002-3785-5008; Bellen, Hugo/0000-0001-5992-5989; contrino, sergio/0000-0003-3409-5231; Lin, Wei/0000-0002-7506-3466; Clawson, Hiram/0000-0002-0480-0545; Perrimon, Norbert/0000-0001-7542-472X; Grossman, Robert/0000-0003-3741-5739; Kapranov, Philipp/0000-0003-2647-4856; Lloyd, Paul/0000-0003-3508-5553; yang, li/0000-0001-8833-7473; Robine, Nicolas/0000-0001-5698-8183; Lewis, Suzanna/0000-0002-8343-612X; Negre, Nicolas/0000-0001-9727-3416; Gingeras, Thomas/0000-0001-9106-3573; Dai, Qi/0000-0002-2082-0693; Sturgill, David/0000-0002-7902-3605	National Human Genome Research Institute [RC2HG005639, U01HG004271, U01HG004258, U01HG004264, U01HG004279, U01HG004261, U01HG004274, U41HG004269]; LBNL [DE-AC02-05CH11231]; NSF [0937060, 0905968, 0644282]; Natural Sciences and Engineering Research Council of Canada (NSERC); Japan Society for the Promotion of Science; Swedish Research Council; NIH National Research Service; National Defense Science and Engineering; Austrian Fonds zur Forderung der wissenschaftlichen Forschung; Leukemia and Lymphoma Society; Lilly-Life Sciences Research Foundation; Affymetrix; Swiss National Science Foundation; German Research Foundation [WI 3628/1-1]; HHMI; Indiana Genomics Initiative; NIDDK genomics core laboratory; NIH [R01HG004037]; Sloan Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG004269, U01HG004261, U01HG004258, RC2HG005639, U01HG004271, U01HG004279, R01HG004037, U01HG004264, U01HG004274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); LBNL; NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering; Austrian Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lilly-Life Sciences Research Foundation; Affymetrix; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); HHMI(Howard Hughes Medical Institute); Indiana Genomics Initiative; NIDDK genomics core laboratory; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Human Genome Research Institute as part of the modENCODE project under RC2HG005639 (M.K.), U01HG004271 (S.E.C.), U01HG004258 (G.H.K.), U01HG004264 (K.P.W.), U01HG004279 (D.M.M.), U01HG004261 (E.L.), U01HG004274 (S.H.), and U41HG004269 (L.S.). Awards to S.E.C. and G.H.K. were carried out at LBNL under contract no. DE-AC02-05CH11231. Additional support was provided by the NSF under grant 0937060 to the Computing Research Association for the CIFellows Project (S.R.) and under award no. 0905968 (J.E.), a Natural Sciences and Engineering Research Council of Canada (NSERC) fellowship (B.A.), T. Kahveci (F.A.), the Japan Society for the Promotion of Science (K.O.), the Swedish Research Council (Q.D.), a NIH National Research Service Award postdoctoral fellowship (C.A.B.), a National Defense Science and Engineering Graduate Fellowship (R.S.), an Erwin Schrodinger Fellowship of the Austrian Fonds zur Forderung der wissenschaftlichen Forschung (S.W.), a Leukemia and Lymphoma Society fellowship (S.W.), a Lilly-Life Sciences Research Foundation fellowship (C.D.B.), a NSERC postdoctoral fellowship (C. G. A.), Affymetrix (T.G.R.), a fellowship from the Swiss National Science Foundation (D.M.), a German Research Foundation grant WI 3628/1-1 (S.W.), a HHMI Damon Runyon Cancer Research fellowship (J.T.N.), the Indiana Genomics Initiative (T.C.K.), H. Smith and the NIDDK genomics core laboratory (B.O.), NIH R01HG004037, NSF CAREER award 0644282, and the Sloan Foundation (M.K.). A full list of author contributions is available in the SOM.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; [Anonymous], 2008, COMP FLYB REL 5 12, DOI http://fb2008_09.flybase.org/; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Berbenetz NM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001092; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Flynt AS, 2010, MOL CELL, V38, P900, DOI 10.1016/j.molcel.2010.06.014; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; GRAVELEY BR, 2010, NATURE, V471, P473, DOI DOI 10.1038/NATURE09715; HARRISON DA, 1993, GENE DEV, V7, P1966, DOI 10.1101/gad.7.10.1966; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Lee LA, 2003, ANNU REV GENET, V37, P545, DOI 10.1146/annurev.genet.37.110801.143149; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Scott KS, 1995, EMBO J, V14, P6258, DOI 10.1002/j.1460-2075.1995.tb00316.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spradling AC, 2006, GENETICS, V174, P1; STAPLETON M, 2002, GENOME BIOL, V0003; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Wan KH, 2006, NAT PROTOC, V1, P624, DOI 10.1038/nprot.2006.90; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	69	853	863	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1787	1797		10.1126/science.1198374	http://dx.doi.org/10.1126/science.1198374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21177974	Green Accepted, Green Published			2022-12-01	WOS:000285603700032
J	Hansen, CS; Faerch, LH; Kristensen, PL				Hansen, Christian Stevns; Faerch, Louise Holmsgaard; Kristensen, Peter Lommer			CHRISTMAS 2010: RESEARCH Testing the validity of the Danish urban myth that alcohol can be absorbed through feet: open labelled self experimental study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To determine the validity of the Danish urban myth that it is possible to get drunk by submerging feet in alcohol. Design Open labelled, self experimental study, with no control group. Setting Office of a Danish hospital. Participants Three adults, median age 32 (range 31-35), free of chronic skin and liver disease and non-dependent on alcohol and psychoactive drugs. Main outcome measures The primary end point was the concentration of plasma ethanol (detection limit 2.2 mmol/L (10 mg/100 mL)), measured every 30 minutes for three hours while feet were submerged in a washing-up bowl containing the contents of three 700 mL bottles of vodka. The secondary outcome was self assessment of intoxication related symptoms (self confidence, urge to speak, and number of spontaneous hugs), scored on a scale of 0 to 10. Results Plasma ethanol concentrations were below the detection limit of 2.2 mmol/L (10 mg/100 mL) throughout the experiment. No significant changes were observed in the intoxication related symptoms, although self confidence and urge to speak increased slightly at the start of the study, probably due to the setup. Conclusion Our results suggest that feet are impenetrable to the alcohol component of vodka. We therefore conclude that the Danish urban myth of being able to get drunk by submerging feet in alcoholic beverages is just that; a myth. The implications of the study are many though.	[Hansen, Christian Stevns; Faerch, Louise Holmsgaard; Kristensen, Peter Lommer] Hillerod Hosp, Dept Cardiol & Endocrinol, Endocrinol Sect, DK-3400 Hillerod, Denmark	University of Copenhagen	Kristensen, PL (corresponding author), Hillerod Hosp, Dept Cardiol & Endocrinol, Endocrinol Sect, Dyrehavevej 29, DK-3400 Hillerod, Denmark.	pelk@hih.regionh.dk	Kristensen, Peter L/B-4218-2009; Kristensen, Peter/V-5630-2019	Kristensen, Peter/0000-0001-5431-824X; Hansen, Christian Stevns/0000-0002-5782-3476	Department of Clinical Biochemistry, Hillerod Hospital	Department of Clinical Biochemistry, Hillerod Hospital	The measurement of ethanol concentrations was funded by the Department of Clinical Biochemistry, Hillerod Hospital.	Miller MA, 2006, AM J EMERG MED, V24, P815, DOI 10.1016/j.ajem.2006.05.006; Saghir SA, 2010, INT J TOXICOL, V29, P268, DOI 10.1177/1091581810366604; Yu CY, 2009, APPL ERGON, V40, P767, DOI 10.1016/j.apergo.2008.08.004	3	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6812	10.1136/bmj.c6812	http://dx.doi.org/10.1136/bmj.c6812			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XD	21156749	Green Published, hybrid			2022-12-01	WOS:000285552200015
J	Domazet-Loso, T; Tautz, D				Domazet-Loso, Tomislav; Tautz, Diethard			A phylogenetically based transcriptome age index mirrors ontogenetic divergence patterns	NATURE			English	Article							CONSERVED EMBRYONIC STAGE; DROSOPHILA-MELANOGASTER; PHYLOTYPIC STAGE; GENE-EXPRESSION; DEVELOPMENTAL HOURGLASS; ZEBRAFISH DEVELOPMENT; LIFE-CYCLE; EVOLUTION; VERTEBRATES; HISTORY	Parallels between phylogeny and ontogeny have been discussed for almost two centuries, and a number of theories have been proposed to explain such patterns(1). Especially elusive is the phylotypic stage, a phase during development where species within a phylum are particularly similar to each other(2-6). Although this has formerly been interpreted as a recapitulation of phylogeny(1), it is now thought to reflect an ontogenetic progression phase(2), where strong constraints on developmental regulation and gene interactions exist(2,3). Several studies have shown that genes expressed during this stage evolve at a slower rate, but it has so far not been possible to derive an unequivocal molecular signature associated with this stage(7-15). Here we use a combination of phylostratigraphy(16) and stage-specific gene expression data to generate a cumulative index that reflects the evolutionary age of the transcriptome at given ontogenetic stages. Using zebrafish ontogeny and adult development as a model, we find that the phylotypic stage does indeed express the oldest transcriptome set and that younger sets are expressed during early and late development, thus faithfully mirroring the hourglass model of morphological divergence(2,3). Reproductively active animals show the youngest transcriptome, with major differences between males and females. Notably, ageing animals express increasingly older genes. Comparisons with similar data sets from flies and nematodes show that this pattern occurs across phyla. Our results indicate that an old transcriptome marks the phylotypic phase and that phylogenetic differences at other ontogenetic stages correlate with the expression of newly evolved genes.	[Domazet-Loso, Tomislav; Tautz, Diethard] Max Planck Inst Evolut Biol, D-24306 Plon, Germany; [Domazet-Loso, Tomislav] Rudjer Boskovic Inst, Div Mol Biol, Lab Evolutionary Genet, Zagreb 10002, Croatia	Max Planck Society; Rudjer Boskovic Institute	Domazet-Loso, T (corresponding author), Max Planck Inst Evolut Biol, August Thienemannstr 2, D-24306 Plon, Germany.	tdomazet@irb.hr	Tautz, Diethard/D-4304-2011; Tautz, Diethard/H-8436-2014	Tautz, Diethard/0000-0002-0460-5344	Adris Foundation [49]; Max-Planck Society	Adris Foundation; Max-Planck Society(Max Planck Society)	We thank B. Walderich for providing zebrafish, A. Nolte, E. Blohm-Sievers, B. Kleinhenz, L. Turner and J. Bryk for laboratory support, R. Bakaric has provided the phylostratigraphic map of C. elegans, and M. Domazet-Loso and V. Dunjko have helped with statistics. L. Boell, F. Chang and A. Pozhitkov have made suggestions on the manuscript. This work was supported by Unity Through Knowledge Fund (grant No. 49), Adris Foundation and funds of the Max-Planck Society. Computational resources were provided by CSTMB and RBI (Phylostrat Cluster).	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Artieri CG, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-42; Bininda-Emonds ORP, 2003, P ROY SOC B-BIOL SCI, V270, P341, DOI 10.1098/rspb.2002.2242; Comte A, 2010, EVOL DEV, V12, P144, DOI 10.1111/j.1525-142X.2010.00400.x; Cruickshank T, 2008, EVOL DEV, V10, P583, DOI 10.1111/j.1525-142X.2008.00273.x; Davis JC, 2005, J MOL EVOL, V60, P774, DOI 10.1007/s00239-004-0241-2; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Domazet-Loso T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-66; DUBOULE D, 1994, DEVELOPMENT, P135; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Flatt T, 2006, INTEGR COMP BIOL, V46, P777, DOI 10.1093/icb/icl034; Gould S.J., 1977, ONTOGENY PHYLOGENY; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Hall BK, 1997, TRENDS ECOL EVOL, V12, P461, DOI 10.1016/S0169-5347(97)01222-6; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; Hazkani-Covo E, 2005, J EXP ZOOL PART B, V304B, P150, DOI 10.1002/jez.b.21033; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Irie N, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-1; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koutsos AC, 2007, P NATL ACAD SCI USA, V104, P11304, DOI 10.1073/pnas.0703988104; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Leys SP, 2005, INTEGR COMP BIOL, V45, P342, DOI 10.1093/icb/45.2.342; Nolte AW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-59; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Raff R.A., 1996, SHAPE LIFE GENES DEV; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Roux J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000311; Sander K., 1983, DEV EVOLUTION, P137; Yassin A, 2010, EVOL DEV, V12, P288, DOI 10.1111/j.1525-142X.2010.00414.x	32	249	254	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2010	468	7325					815	U107		10.1038/nature09632	http://dx.doi.org/10.1038/nature09632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150997				2022-12-01	WOS:000285093700044
J	Devos, DP; Reynaud, EG				Devos, Damien P.; Reynaud, Emmanuel G.			Intermediate Steps	SCIENCE			English	Editorial Material							COMPARATIVE GENOMICS; BUDDING BACTERIA; RIBOSOMAL-RNA; CELL-WALL; EUKARYOTES; MEMBRANE; ARCHAEA; ORIGIN; VERRUCOMICROBIA; PLANCTOMYCES		[Devos, Damien P.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Reynaud, Emmanuel G.] UCD Sci Ctr, Sch Biol & Environm Sci, Dublin 4, Ireland	European Molecular Biology Laboratory (EMBL)	Devos, DP (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	devos@embl.de; emmanuel.reynaud@ucd.ie	Reynaud, Emamnuel/H-2928-2019; devos, damien/ABH-5348-2020	Reynaud, Emamnuel/0000-0003-1502-661X; Devos, Damien/0000-0002-9453-4753				Aravind L, 2006, CURR OPIN STRUC BIOL, V16, P409, DOI 10.1016/j.sbi.2006.04.006; Bauer M, 2004, J MOL EVOL, V59, P571, DOI 10.1007/s00239-004-2643-6; Chistoserdova L, 2004, MOL BIOL EVOL, V21, P1234, DOI 10.1093/molbev/msh113; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; FERST JA, 1991, P NATL ACAD SCI USA, V88, P8184; Forterre P, 2011, RES MICROBIOL, V162, P77, DOI 10.1016/j.resmic.2010.10.005; Fuerst JA, 1998, FEMS MICROBIOL LETT, V166, P29, DOI 10.1016/S0378-1097(98)00307-3; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; HACKSTADT T, 1991, P NATL ACAD SCI USA, V88, P3937, DOI 10.1073/pnas.88.9.3937; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; KERGER BD, 1988, ARCH MICROBIOL, V149, P255, DOI 10.1007/BF00422014; KONIG E, 1984, ARCH MICROBIOL, V138, P200, DOI 10.1007/BF00402120; Lee KC, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-4; Lee KC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-5; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Pearson A, 2003, P NATL ACAD SCI USA, V100, P15352, DOI 10.1073/pnas.2536559100; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Pilhofer M, 2008, J BACTERIOL, V190, P3192, DOI 10.1128/JB.01797-07; Pilhofer M, 2007, MOL BIOL EVOL, V24, P1439, DOI 10.1093/molbev/msm069; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; SANCHEZAMAT A, 1990, APPL ENVIRON MICROB, V56, P2717; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Wachtershauser G, 2003, MOL MICROBIOL, V47, P13, DOI 10.1046/j.1365-2958.2003.03267.x; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yee B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-37	30	60	60	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 26	2010	330	6008					1187	1188		10.1126/science.1196720	http://dx.doi.org/10.1126/science.1196720			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109658				2022-12-01	WOS:000284613700025
J	Matyas, F; Sreenivasan, V; Marbach, F; Wacongne, C; Barsy, B; Mateo, C; Aronoff, R; Petersen, CCH				Matyas, Ferenc; Sreenivasan, Varun; Marbach, Fred; Wacongne, Catherine; Barsy, Boglarka; Mateo, Celine; Aronoff, Rachel; Petersen, Carl C. H.			Motor Control by Sensory Cortex	SCIENCE			English	Article							WHISKER MOVEMENTS; BEHAVING MICE; BARREL CORTEX; CORTICAL-NEURONS; TRANSGENIC MICE; CEREBRAL-CORTEX; RAT; STIMULATION; CHANNELRHODOPSIN-2; MICROSTIMULATION	Classical studies of mammalian movement control define a prominent role for the primary motor cortex. Investigating the mouse whisker system, we found an additional and equally direct pathway for cortical motor control driven by the primary somatosensory cortex. Whereas activity in primary motor cortex directly evokes exploratory whisker protraction, primary somatosensory cortex directly drives whisker retraction, providing a rapid negative feedback signal for sensorimotor integration. Motor control by sensory cortex suggests the need to reevaluate the functional organization of cortical maps.	[Matyas, Ferenc; Sreenivasan, Varun; Marbach, Fred; Wacongne, Catherine; Barsy, Boglarka; Mateo, Celine; Aronoff, Rachel; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland; [Matyas, Ferenc] Hungarian Acad Sci, Inst Expt Med, Lab Thalamus Res, H-1450 Budapest, Hungary; [Wacongne, Catherine] INSERM, U992, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Barsy, Boglarka] Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017; Mateo, Celine/V-4619-2019	Petersen, Carl/0000-0003-3344-4495; Aronoff, Rachel/0000-0001-5813-2899; Sreenivasan, Varun/0000-0003-0559-9713	Swiss National Science Foundation; Human Frontiers in Science Program; SystemsX.ch; European Molecular Biology Organization	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank H. Bokor and L. Acsady for advice on brainstem anatomy and lesions and K. Svoboda (Addgene plasmid 20071) and C. Luscher (virus) for AAV-ChR2. This work was funded by grants from the Swiss National Science Foundation (C. C. H. P.), Human Frontiers in Science Program (C. C. H. P.), SystemsX.ch (C. C. H. P.), and a European Molecular Biology Organization long-term fellowship (F. Matyas).	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; COULTER JD, 1977, BRAIN RES, V129, P335, DOI 10.1016/0006-8993(77)90012-9; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; JACQUIN MF, 1990, J NEUROPHYSIOL, V64, P3, DOI 10.1152/jn.1990.64.1.3; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinganaud G, 1999, J COMP NEUROL, V415, P91, DOI 10.1002/(SICI)1096-9861(19991206)415:1<91::AID-CNE7>3.0.CO;2-A; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; WELKER WI, 1957, J NEUROPHYSIOL, V20, P347, DOI 10.1152/jn.1957.20.4.347; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	32	257	260	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1240	1243		10.1126/science.1195797	http://dx.doi.org/10.1126/science.1195797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109671				2022-12-01	WOS:000284613700041
J	Shah, ND; Montori, VM; Krumholz, HM; Tu, K; Alexander, GC; Jackevicius, CA				Shah, Nilay D.; Montori, Victor M.; Krumholz, Harlan M.; Tu, Karen; Alexander, G. Caleb; Jackevicius, Cynthia A.			Responding to an FDA Warning - Geographic Variation in the Use of Rosiglitazone.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shah, Nilay D.; Montori, Victor M.] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Tu, Karen; Jackevicius, Cynthia A.] Univ Toronto, Toronto, ON, Canada; [Tu, Karen] Toronto Western Hosp, Family Hlth Team, Toronto, ON M5T 2S8, Canada; [Tu, Karen; Jackevicius, Cynthia A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Alexander, G. Caleb] Univ Chicago, Chicago, IL 60637 USA; [Alexander, G. Caleb] Univ Illinois, Chicago Sch Pharm, Chicago, IL USA; [Jackevicius, Cynthia A.] Western Univ Hlth Sci, Los Angeles, CA USA; [Jackevicius, Cynthia A.] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA	Mayo Clinic; Yale University; Yale University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Western University of Health Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Shah, ND (corresponding author), Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA.		, Harlan/AAI-2875-2020					Congress of The United States Congressional Budget Office, 2008, GEOGR VAR HLTH CAR S; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Wagner AK, 2006, PHARMACOEPIDEM DR S, V15, P369, DOI 10.1002/pds.1193; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344	6	53	53	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2081	2084		10.1056/NEJMp1011042	http://dx.doi.org/10.1056/NEJMp1011042			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684XE	21083379				2022-12-01	WOS:000284587800001
J	Branch, TA; Watson, R; Fulton, EA; Jennings, S; McGilliard, CR; Pablico, GT; Ricard, D; Tracey, SR				Branch, Trevor A.; Watson, Reg; Fulton, Elizabeth A.; Jennings, Simon; McGilliard, Carey R.; Pablico, Grace T.; Ricard, Daniel; Tracey, Sean R.			The trophic fingerprint of marine fisheries	NATURE			English	Article							FOOD WEBS; ECOLOGICAL INDICATORS; GLOBAL FISHERIES; WORLD FISHERIES; GULF; BIODIVERSITY; PERSPECTIVE; AQUACULTURE; ECOSYSTEMS; IMPACTS	Biodiversity indicators provide a vital window on the state of the planet, guiding policy development and management(1,2). The most widely adopted marine indicator is mean trophic level (MTL) from catches, intended to detect shifts from high-trophic-level predators to low-trophic-level invertebrates and plankton-feeders(3-5). This indicator underpins reported trends in human impacts, declining when predators collapse ("fishing down marine food webs'')(3) and when low-trophic-level fisheries expand ("fishing through marine food webs'')(6). The assumption is that catch MTL measures changes in ecosystem MTL and biodiversity(2,5). Here we combine model predictions with global assessments of MTL from catches, trawl surveys and fisheries stock assessments(7) and find that catch MTL does not reliably predict changes in marine ecosystems. Instead, catch MTL trends often diverge from ecosystem MTL trends obtained from surveys and assessments. In contrast to previous findings of rapid declines in catch MTL3, we observe recent increases in catch, survey and assessment MTL. However, catches from most trophic levels are rising, which can intensify fishery collapses even when MTL trends are stable or increasing. To detect fishing impacts on marine biodiversity, we recommend greater efforts to measure true abundance trends for marine species, especially those most vulnerable to fishing.	[Branch, Trevor A.; McGilliard, Carey R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Watson, Reg; Pablico, Grace T.] Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada; [Fulton, Elizabeth A.] CSIRO Wealth Oceans, Hobart, Tas 7001, Australia; [Jennings, Simon] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Jennings, Simon] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Ricard, Daniel] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Tracey, Sean R.] Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Marine Res Labs, Hobart, Tas 7001, Australia	University of Washington; University of Washington Seattle; University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; Dalhousie University; University of Tasmania	Branch, TA (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	tbranch@uw.edu	Watson, Reg A/F-4850-2012; Ricard, Daniel/G-1814-2014; Fulton, Beth/A-2871-2008; Jennings, Simon/F-5085-2012; Fulton, Beth/AAJ-1398-2021; Branch, Trevor/A-5691-2009	Watson, Reg A/0000-0001-7201-8865; Fulton, Beth/0000-0002-5904-7917; Jennings, Simon/0000-0002-2390-7225; Fulton, Beth/0000-0002-5904-7917; McGilliard, Carey/0000-0001-5708-8283	University of California Santa Barbara; US National Science Foundation (NSF); Moore Foundation; School of Aquatic and Fishery Sciences, University of Washington; Canadian Natural Sciences and Engineering Research Council; Canadian Foundation for Innovation; Pew Charitable Trusts	University of California Santa Barbara(University of California System); US National Science Foundation (NSF)(National Science Foundation (NSF)); Moore Foundation(Gordon and Betty Moore Foundation); School of Aquatic and Fishery Sciences, University of Washington(University of Washington); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Pew Charitable Trusts	This work arose out of a working group at the National Center for Ecological Analysis and Synthesis (NCEAS), funded by the University of California Santa Barbara, the US National Science Foundation (NSF), and the Moore Foundation. T.A.B. was additionally funded by the School of Aquatic and Fishery Sciences, University of Washington. The RAM Legacy stock assessment database was funded by the Canadian Natural Sciences and Engineering Research Council and the Canadian Foundation for Innovation; the Sea Around Us Project was funded by Pew Charitable Trusts. Additional collaborators and data contributors are acknowledged in the Supplementary Information.	Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caddy J.F., 1998, SCIENCE, V282, P1383, DOI DOI 10.1126/SCIENCE.282.5393.1383A; Caddy JF, 2000, OCEAN COAST MANAGE, V43, P615, DOI 10.1016/S0964-5691(00)00052-1; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V, 1998, J FISH BIOL, V53, P128, DOI 10.1006/jfbi.1998.0809; de Mutsert K, 2008, P NATL ACAD SCI USA, V105, P2740, DOI 10.1073/pnas.0704354105; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; JIMING Y, 1982, MAR ECOL PROG SER, V7, P247, DOI 10.3354/meps007247; Litzow MA, 2009, CAN J FISH AQUAT SCI, V66, P201, DOI 10.1139/F08-207; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 2005, PHILOS T ROY SOC B, V360, P415, DOI 10.1098/rstb.2004.1597; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Powers JE, 2010, MAR POLICY, V34, P723, DOI 10.1016/j.marpol.2009.11.009; Rochet MJ, 2003, CAN J FISH AQUAT SCI, V60, P86, DOI 10.1139/F02-164; Secretariat of the Convention on Biological Diversity, 2006, GLOB BIOD OUTL 2; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Shannon LJ, 2009, ECOL INDIC, V9, P1078, DOI 10.1016/j.ecolind.2008.12.007; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; Tacon AGJ, 2010, REV FISH SCI, V18, P94, DOI 10.1080/10641260903325680; Tacon AGJ, 2009, REV FISH SCI, V17, P305, DOI 10.1080/10641260802677074; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x	29	262	273	1	312	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					431	435		10.1038/nature09528	http://dx.doi.org/10.1038/nature09528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085178				2022-12-01	WOS:000284313100041
J	Haubensak, W; Kunwar, PS; Cai, HJ; Ciocchi, S; Wall, NR; Ponnusamy, R; Biag, J; Dong, HW; Deisseroth, K; Callaway, EM; Fanselow, MS; Luthi, A; Anderson, DJ				Haubensak, Wulf; Kunwar, Prabhat S.; Cai, Haijiang; Ciocchi, Stephane; Wall, Nicholas R.; Ponnusamy, Ravikumar; Biag, Jonathan; Dong, Hong-Wei; Deisseroth, Karl; Callaway, Edward M.; Fanselow, Michael S.; Luethi, Andreas; Anderson, David J.			Genetic dissection of an amygdala microcircuit that gates conditioned fear	NATURE			English	Article							CENTRAL EXTENDED AMYGDALA; RAT CENTRAL NUCLEUS; BACTERIAL ARTIFICIAL CHROMOSOMES; NEURONS IN-VITRO; PERIAQUEDUCTAL GRAY; NEURAL CIRCUITS; BASAL GANGLIA; RABIES VIRUS; EXPRESSION; VIVO	The role of different amygdala nuclei (neuroanatomical subdivisions) in processing Pavlovian conditioned fear has been studied extensively, but the function of the heterogeneous neuronal subtypes within these nuclei remains poorly understood. Here we use molecular genetic approaches to map the functional connectivity of a subpopulation of GABA-containing neurons, located in the lateral subdivision of the central amygdala (CEl), which express protein kinase C-delta (PKC-delta). Channelrhodopsin-2-assisted circuit mapping in amygdala slices and cell-specific viral tracing indicate that PKC-delta(+) neurons inhibit output neurons in the medial central amygdala (CEm), and also make reciprocal inhibitory synapses with PKC-delta(-) neurons in CEl. Electrical silencing of PKC-delta(+) neurons in vivo suggests that they correspond to physiologically identified units that are inhibited by the conditioned stimulus, called CEl(off) units. This correspondence, together with behavioural data, defines an inhibitory microcircuit in CEl that gates CEm output to control the level of conditioned freezing.	[Haubensak, Wulf; Kunwar, Prabhat S.; Cai, Haijiang; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Ciocchi, Stephane; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Wall, Nicholas R.; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Ponnusamy, Ravikumar; Fanselow, Michael S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Ponnusamy, Ravikumar; Fanselow, Michael S.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Biag, Jonathan; Dong, Hong-Wei] Univ Calif Los Angeles, Lab Neuroimaging, Los Angeles, CA 90095 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Friedrich Miescher Institute for Biomedical Research; Salk Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Haubensak, Wulf/0000-0002-2034-9184; Wall, Nicholas/0000-0003-2039-8258; Cai, Haijiang/0000-0003-3775-903X; Ciocchi, Stephane/0000-0002-5701-9250; Biag, Jonathan/0000-0003-0891-9567	NIH [1 R01 MH085082-01A1]; Caltech; Human Frontier Science Program; Jane Coffin Childs Memorial Fund for Medical Research; Novartis Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912, R01MH085082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech; Human Frontier Science Program(Human Frontier Science Program); Jane Coffin Childs Memorial Fund for Medical Research; Novartis Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Heinz and X. Gong for generating BAC transgenic mice; C. Saper for providing the Cre-dependent hrGFP AAV construct; C. Xiao for training in slice electrophysiology and preliminary experiments; H. Lester for advice on the GluCl system; L. van Tright for performing in situ hybridizations; W. Lerchner for providing a CAG-driven GluCl beta construct; A. Chang for help with behavioural scoring; M. Martinez for tail genotyping; G. Mosconi for laboratory management; and J. Alex, R. Bayon and R. Sauza for animal care. This work was supported by NIH grant 1 R01 MH085082-01A1 and by funds from the Caltech 'Conscious Mouse' project. W.H. was supported by a fellowship of the Human Frontier Science Program and P.S.K. by the Jane Coffin Childs Memorial Fund for Medical Research. S.C. and A.L. were supported by the Novartis Research Foundation. D.J.A. is an Investigator of the Howard Hughes Medical Institute.	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Chieng BCH, 2006, J COMP NEUROL, V497, P910, DOI 10.1002/cne.21025; Davis M, 2003, ANN NY ACAD SCI, V985, P218; Day HEW, 1999, J COMP NEUROL, V413, P113; Day HEW, 2005, EUR J NEUROSCI, V21, P441, DOI 10.1111/j.1460-9568.2005.03865.x; De Armentia ML, 2004, J NEUROPHYSIOL, V92, P1285, DOI 10.1152/jn.00211.2004; De Oca BM, 1998, J NEUROSCI, V18, P3426; EDWARDS AL, 1972, EXPT DESIGN PSYCHOL, P249; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; Gautron L, 2010, J COMP NEUROL, V518, P2090, DOI 10.1002/cne.22323; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Marchant NJ, 2007, J COMP NEUROL, V504, P702, DOI 10.1002/cne.21464; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Schiess MC, 1999, J NEUROSCI RES, V58, P663, DOI 10.1002/(SICI)1097-4547(19991201)58:5<663::AID-JNR7>3.3.CO;2-1; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; SUN N, 1994, J COMP NEUROL, V340, P43, DOI 10.1002/cne.903400105; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tsetsenis T, 2007, NAT NEUROSCI, V10, P896, DOI 10.1038/nn1919; Veinante P, 2003, ANN NY ACAD SCI, V985, P552; Wagstaff MJD, 1998, GENE THER, V5, P1566, DOI 10.1038/sj.gt.3300754; Wickens JR, 2007, PROG BRAIN RES, V160, P313, DOI 10.1016/S0079-6123(06)60018-6; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zirlinger M, 2003, GENES BRAIN BEHAV, V2, P282, DOI 10.1034/j.1601-183X.2003.00039.x; Zirlinger M, 2001, P NATL ACAD SCI USA, V98, P5270, DOI 10.1073/pnas.091094698	53	552	564	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					270	U230		10.1038/nature09553	http://dx.doi.org/10.1038/nature09553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068836	Green Accepted, Green Submitted			2022-12-01	WOS:000284051000044
J	Douglas, NR; Reissmann, S; Zhang, JJ; Chen, B; Jakana, J; Kumar, R; Chiu, W; Frydman, J				Douglas, Nicholai R.; Reissmann, Stefanie; Zhang, Junjie; Chen, Bo; Jakana, Joanita; Kumar, Ramya; Chiu, Wah; Frydman, Judith			Dual Action of ATP Hydrolysis Couples Lid Closure to Substrate Release into the Group II Chaperonin Chamber	CELL			English	Article							EUKARYOTIC CHAPERONIN; IN-VIVO; CONFORMATIONAL-CHANGE; FOLDING CHAMBER; CRYO-EM; PROTEIN; MECHANISM; TRIC/CCT; GROEL; THERMOSOME	Group II chaperonins are ATP-dependent ring-shaped complexes that bind nonnative polypeptides and facilitate protein folding in archaea and eukaryotes. A built-in lid encapsulates substrate proteins within the central chaperonin chamber. Here, we describe the fate of the substrate during the nucleotide cycle of group II chaperonins. The chaperonin substrate-binding sites are exposed, and the lid is open in both the ATP-free and ATP-bound prehydrolysis states. ATP hydrolysis has a dual function in the folding cycle, triggering both lid closure and substrate release into the central chamber. Notably, substrate release can occur in the absence of a lid, and lid closure can occur without substrate release. However, productive folding requires both events, so that the polypeptide is released into the confined space of the closed chamber where it folds. Our results show that ATP hydrolysis coordinates the structural and functional determinants that trigger productive folding.	[Douglas, Nicholai R.; Reissmann, Stefanie; Kumar, Ramya; Frydman, Judith] Stanford Univ, Dept Biol & BioX Program, Stanford, CA 94305 USA; [Chen, Bo; Chiu, Wah] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Zhang, Junjie; Jakana, Joanita; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA	Stanford University; Baylor College of Medicine; Baylor College of Medicine	Frydman, J (corresponding author), Stanford Univ, Dept Biol & BioX Program, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Zhang, Junjie/V-3855-2019	Zhang, Junjie/0000-0002-7912-0819; , judith/0000-0003-2302-6943	NIH [GM74074, 5PN2EY016525, P41RR002250, T32-007276, R90 DK071054, T90 DA022885]; ARCS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. W.E. Moerner for providing Nile Red maleimide and advice on fluorescence microscopy. We also thank members of the J.F. laboratory and Raul Andino for critical reading of the manuscript; Frank DiMaio and David Baker for advice on modeling; Erik Miller for useful discussions; and Jeremy England and Erik Miller for providing PepB. This work was supported by NIH Grants GM74074 (to J.F.), 5PN2EY016525 (to J.F. and W.C.), and P41RR002250 (to W.C.). N.R.D. was a recipient of predoctoral ARCS fellowships and was supported by an NIH training grant (T32-007276). J.Z. was a recipient of NIH training grants on nanobiology (R90 DK071054 and T90 DA022885).	Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Bigotti MG, 2008, ARCH BIOCHEM BIOPHYS, V474, P331, DOI 10.1016/j.abb.2008.03.015; Bigotti MG, 2006, J MOL BIOL, V362, P835, DOI 10.1016/j.jmb.2006.07.064; Bigotti MG, 2005, J MOL BIOL, V348, P13, DOI 10.1016/j.jmb.2005.01.066; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gomez-Puertas P, 2004, J MOL RECOGNIT, V17, P85, DOI 10.1002/jmr.654; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hayer-Hartl M, 2000, METH MOL B, V140, P127; Iizuka R, 2003, J BIOL CHEM, V278, P44959, DOI 10.1074/jbc.M305484200; Kanzaki T, 2008, J BIOL CHEM, V283, P34773, DOI 10.1074/jbc.M805303200; Kim SY, 2005, J PHYS CHEM B, V109, P24517, DOI 10.1021/jp0534232; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Stuart SF, 2011, J BIOL CHEM, V286, P178, DOI 10.1074/jbc.M110.166256; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Villebeck L, 2007, BIOCHEMISTRY-US, V46, P5083, DOI 10.1021/bi062093o; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	32	68	70	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					240	252		10.1016/j.cell.2010.12.017	http://dx.doi.org/10.1016/j.cell.2010.12.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241893	Green Accepted, Bronze			2022-12-01	WOS:000286459900009
J	Lu, JC; Unwin, DM; Deeming, DC; Jin, XS; Liu, YQ; Ji, QA				Lue, Junchang; Unwin, David M.; Deeming, D. Charles; Jin, Xingsheng; Liu, Yongqing; Ji, Qiang			An Egg-Adult Association, Gender, and Reproduction in Pterosaurs	SCIENCE			English	Article							EGGSHELL STRUCTURE; EVOLUTION; ONTOGENY	A sexually mature individual of Darwinopterus preserved together with an egg from the Jurassic of China provides direct evidence of gender in pterosaurs and insights into the reproductive biology of these extinct fliers. This new find and several other examples of Darwinopterus demonstrate that males of this pterosaur had a relatively small pelvis and a large cranial crest, whereas females had a relatively large pelvis and no crest. The ratio of egg mass to adult mass is relatively low, as in extant reptiles, and is comparable to values for squamates. A parchment-like eggshell points to burial and significant uptake of water after oviposition. This evidence for low parental investment contradicts the widespread assumption that reproduction in pterosaurs was like that of birds and shows that it was essentially like that of reptiles.	[Lue, Junchang; Liu, Yongqing; Ji, Qiang] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Unwin, David M.] Univ Leicester, Sch Museum Studies, Leicester LE1 7LF, Leics, England; [Deeming, D. Charles] Lincoln Univ, Dept Biol Sci, Lincoln LN2 2LG, England; [Jin, Xingsheng] Zhejiang Museum Nat Hist, Hangzhou 310012, Zhejiang, Peoples R China	Chinese Academy of Geological Sciences; University of Leicester; University of Lincoln	Lu, JC (corresponding author), Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China.	lujc2008@126.com; dmu1@le.ac.uk		Deeming, Denis Charles/0000-0002-9587-6149; Liu, Yongqing/0000-0002-9131-0172	National Natural Science Foundation of China [40872017, 90914003]; 973 Project [2006CB701405]; Ministry of Science and Technology [J1003, J0703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank X. M. Kang (Zhejiang Museum of Natural History, Hangzhou) for access to specimens and G. Birchard for access to his data set on reptile eggs. J.L. and Y.L. were supported by grants from the National Natural Science Foundation of China (40872017 and 90914003), the 973 Project (2006CB701405), and the Basic Outlay of Scientific Research Work from the Ministry of Science and Technology (J1003 and J0703); D.M.U. by the Royal Society and the University of Leicester; and D.C.D by the University of Lincoln.	Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Bennett S.C., 1992, Journal of Vertebrate Paleontology, V12, P422; Bennett S. Christopher, 2003, Palaeontologische Zeitschrift, V77, P61; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Chinsamy A, 2009, ANAT REC, V292, P1462, DOI 10.1002/ar.20990; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Codorniu L, 2004, CAN J EARTH SCI, V41, P9, DOI 10.1139/E03-080; Cogburn Larry A., 2000, P635, DOI 10.1016/B978-012747605-6/50026-2; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; Deeming DC, 2007, J ZOOL, V271, P78, DOI 10.1111/j.1469-7998.2006.00219.x; [段冶 DUAN Ye], 2009, [世界地质, World Geology], V28, P143; Grellet-Tinner Gerald, 2007, Historical Biology, V19, P273, DOI 10.1080/08912960701189800; Kunz Thomas H., 2000, P415, DOI 10.1016/B978-012195670-7/50011-4; Lu Junchang, 2009, Acta Geologica Sinica English Edition, V83, P1; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; PADIAN K, 1993, AM J SCI, V293A, P91, DOI 10.2475/ajs.293.A.91; SHINE R, 1992, EVOLUTION, V46, P62, DOI 10.1111/j.1558-5646.1992.tb01985.x; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin D. M., 2006, 2005 HEYUAN INT DIN, P141; Unwin David M., 2008, Zitteliana Reihe B, V28, P199; Wang XL, 2004, NATURE, V429, P621, DOI 10.1038/429621a; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Xu L., 2010, ACTA GEOSCI SINICA S, V31, P82	27	81	89	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					321	324		10.1126/science.1197323	http://dx.doi.org/10.1126/science.1197323			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252343				2022-12-01	WOS:000286636300034
J	Tursun, B; Patel, T; Kratsios, P; Hobert, O				Tursun, Baris; Patel, Tulsi; Kratsios, Paschalis; Hobert, Oliver			Direct Conversion of C. elegans Germ Cells into Specific Neuron Types	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HISTONE CHAPERONES; STEM-CELLS; GENE; EXPRESSION; DIFFERENTIATION; TOTIPOTENCY; INDUCTION; ENCODES; PATHWAY	The ability of transcription factors to directly reprogram the identity of cell types is usually restricted and is defined by cellular context. Through the ectopic expression of single Caenorhabditis elegans transcription factors, we found that the identity of mitotic germ cells can be directly converted into that of specific neuron types: glutamatergic, cholinergic, or GABAergic. This reprogramming event requires the removal of the histone chaperone LIN-53 (RbAp46/48 in humans), a component of several histone remodeling and modifying complexes, and this removal can be mimicked by chemical inhibition of histone deacetylases. Our findings illustrate the ability of germ cells to be directly converted into individual, terminally differentiated neuron types and demonstrate that a specific chromatin factor provides a barrier for cellular reprogramming.	[Tursun, Baris; Patel, Tulsi; Kratsios, Paschalis; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Tursun, B (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.	bt2189@columbia.edu; or38@columbia.edu		Tursun, Baris/0000-0001-7293-8629; Kratsios, Paschalis/0000-0002-1363-9271; Hobert, Oliver/0000-0002-7634-2854	NIH [R01NS039996-05, R01NS050266-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039996, R01NS050266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants R01NS039996-05 and R01NS050266-03. O.H. is an Investigator of the HHMI and B.T. is a Francis Goelet Research Scientist. We thank T. Schedl, M. Krause, J. McGhee, P. Sengupta, Y. B. Qi, Y. Jin, M. Nonet, S. Strome, and members of the Hobert lab for reagents; I. Greenwald and members of the Hobert lab for comments on the manuscript; and Q. Chen for expert assistance in strain generation.	AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BARTON MK, 1987, GENETICS, V115, P107; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Cinar H, 2005, CURR BIOL, V15, P340, DOI 10.1016/j.cub.2005.02.025; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; CUI M, 2007, WORMBOOK, DOI DOI 10.1895/W0RMB00K.1.139.1; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Prasad B, 2008, DEV BIOL, V323, P207, DOI 10.1016/j.ydbio.2008.08.029; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	28	153	153	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2011	331	6015					304	308		10.1126/science.1199082	http://dx.doi.org/10.1126/science.1199082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21148348	Green Accepted			2022-12-01	WOS:000286636300029
J	Nury, H; Van Renterghem, C; Weng, Y; Tran, A; Baaden, M; Dufresne, V; Changeux, JP; Sonner, JM; Delarue, M; Corringer, PJ				Nury, Hugues; Van Renterghem, Catherine; Weng, Yun; Tran, Alphonso; Baaden, Marc; Dufresne, Virginie; Changeux, Jean-Pierre; Sonner, James M.; Delarue, Marc; Corringer, Pierre-Jean			X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MOLECULAR-DYNAMICS; BINDING-SITE; ALLOSTERIC TRANSITIONS; CRYSTAL-STRUCTURES; GLYCINE RECEPTORS; GABA(A) RECEPTORS; HIGH-RESOLUTION; IDENTIFICATION; MODULATION	General anaesthetics have enjoyed long and widespread use but their molecular mechanism of action remains poorly understood. There is good evidence that their principal targets are pentameric ligand-gated ion channels(1,2) (pLGICs) such as inhibitory GABA(A) (gamma-aminobutyric acid) receptors and excitatory nicotinic acetylcholine receptors, which are respectively potentiated and inhibited by general anaesthetics. The bacterial homologue from Gloeobacter violaceus(3) (GLIC), whose X-ray structure was recently solved(4,5), is also sensitive to clinical concentrations of general anaesthetics(6). Here we describe the crystal structures of the complexes propofol/GLIC and desflurane/GLIC. These reveal a common general-anaesthetic binding site, which pre-exists in the apo-structure in the upper part of the transmembrane domain of each protomer. Both molecules establish van der Waals interactions with the protein; propofol binds at the entrance of the cavity whereas the smaller, more flexible, desflurane binds deeper inside. Mutations of some amino acids lining the binding site profoundly alter the ionic response of GLIC to protons, and affect its general-anaesthetic pharmacology. Molecular dynamics simulations, performed on the wild type (WT) and two GLIC mutants, highlight differences in mobility of propofol in its binding site and help to explain these effects. These data provide a novel structural framework for the design of general anaesthetics and of allosteric modulators of brain pLGICs.	[Nury, Hugues; Van Renterghem, Catherine; Dufresne, Virginie; Corringer, Pierre-Jean] Inst Pasteur, Grp Recepteurs Canaux, F-75015 Paris, France; [Nury, Hugues; Van Renterghem, Catherine; Dufresne, Virginie; Changeux, Jean-Pierre; Corringer, Pierre-Jean] CNRS, URA2182, F-75015 Paris, France; [Nury, Hugues; Delarue, Marc] Inst Pasteur, Unite Dynam Struct Macromol, F-75015 Paris, France; [Nury, Hugues; Delarue, Marc] CNRS, URA2185, F-75015 Paris, France; [Weng, Yun; Tran, Alphonso; Sonner, James M.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Baaden, Marc] CNRS, UPR 9080, Inst Biol Physicochim, F-75005 Paris, France; [Changeux, Jean-Pierre] Coll France, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Corringer, PJ (corresponding author), Inst Pasteur, Grp Recepteurs Canaux, F-75015 Paris, France.	delarue@pasteur.fr; pjcorrin@pasteur.fr	Baaden, Marc/C-6623-2008	Baaden, Marc/0000-0001-6472-0486; Nury, Hugues/0000-0002-3433-256X	Commission of the European Communities; Louis D. Foundation of the Institut de France; Network of European Neuroscience Institutes (ENI-NET); National Institutes of Health [NIGMS R01 GM069379]; Grand Equipement National de Calcul Intensif, Institut du Developpement et des Ressources en Informatique Scientifique (GENCI-IDRIS) [2009-072292]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069379] Funding Source: NIH RePORTER	Commission of the European Communities(European Commission); Louis D. Foundation of the Institut de France; Network of European Neuroscience Institutes (ENI-NET); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Equipement National de Calcul Intensif, Institut du Developpement et des Ressources en Informatique Scientifique (GENCI-IDRIS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Commission of the European Communities (Neurocypres project; to H.N.), the Louis D. Foundation of the Institut de France, the Network of European Neuroscience Institutes (ENI-NET) and a National Institutes of Health grant NIGMS R01 GM069379 (to J.M.S.). We thank J. Brallet for the gift of desflurane, the European Synchrotron Radiation Facility and Soleil staff for assistance during data collection, and G. Brannigan for providing propofol simulation parameters. Simulations were performed using high-performance computing resources from the Grand Equipement National de Calcul Intensif, Institut du Developpement et des Ressources en Informatique Scientifique (GENCI-IDRIS, grant 2009-072292).	Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; BARTH LG, 1959, J EMBRYOL EXP MORPH, V7, P210; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bricogne G., 2009, BUSTER VERSION 2 8 0; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis I. W., 2007, NUCLEIC ACIDS RES, V35, pW375; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; HUMPHREY W, 1996, J MOL GRAPH MODEL, V14, P33, DOI DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nievas GAF, 2008, J BIOL CHEM, V283, P21478, DOI 10.1074/jbc.M800345200; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Schrodinger L., 2020, PYMOL; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Trudell JR, 2004, J MOL GRAPH MODEL, V23, P39, DOI 10.1016/j.jmgm.2004.03.004; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Violet JM, 1997, ANESTHESIOLOGY, V86, P866, DOI 10.1097/00000542-199704000-00017; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Zhang HM, 2009, FASEB J, V23, P2735, DOI 10.1096/fj.09-129908; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	47	346	348	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					428	+		10.1038/nature09647	http://dx.doi.org/10.1038/nature09647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248852				2022-12-01	WOS:000286385600059
J	Wei, W; Hamby, AM; Zhou, KL; Feller, MB				Wei, Wei; Hamby, Aaron M.; Zhou, Kaili; Feller, Marla B.			Development of asymmetric inhibition underlying direction selectivity in the retina	NATURE			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; VISUAL EXPERIENCE; IDENTIFICATION; ORGANIZATION; CONNECTIONS; MECHANISMS; DENDRITES	Establishing precise synaptic connections is crucial to the development of functional neural circuits. The direction-selective circuit in the retina relies upon highly selective wiring of inhibitory inputs from starburst amacrine cells(1) (SACs) onto four subtypes of ON-OFF direction-selective ganglion cells (DSGCs), each preferring motion in one of four cardinal directions(2). It has been reported in rabbit that the SACs on the 'null' sides of DSGCs form functional GABA (c-aminobutyric acid)-mediated synapses, whereas those on the preferred sides do not(3). However, it is not known how the asymmetric wiring between SACs and DSGCs is established during development. Here we report that in transgenic mice with cell-type-specific labelling, the synaptic connections from SACs to DSGCs were of equal strength during the first postnatal week, regardless of whether the SAC was located on the preferred or null side of the DSGC. However, by the end of the second postnatal week, the strength of the synapses made from SACs on the null side of a DSGC significantly increased whereas those made from SACs located on the preferred side remained constant. Blocking retinal activity by intraocular injections of muscimol or gabazine during this period did not alter the development of direction selectivity. Hence, the asymmetric inhibition between the SACs and DSGCs is achieved by a developmental program that specifically strengthens the GABA-mediated inputs from SACs located on the null side, in a manner not dependent on neural activity.	[Wei, Wei; Hamby, Aaron M.; Zhou, Kaili; Feller, Marla B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Feller, Marla B.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Feller, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mfeller@berkeley.edu			National Institutes of Health [RO1EY013528, ARRA EY019498]; NATIONAL EYE INSTITUTE [R01EY013528, R01EY019498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Nakanishi for mGluR2-GFP mice, A. Huberman for Drd4-GFP mice, J. Elstrott for help with MATLAB software, X. Han for mouse genotyping, J. Ledue for imaging assistance and A. Blankenship for reading the manuscript. This work was supported by grants RO1EY013528 and ARRA EY019498 from the National Institutes of Health.	Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Elstrott J, 2010, J NEUROSCI, V30, P11197, DOI 10.1523/JNEUROSCI.2302-10.2010; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Famiglietti EV, 2002, VISUAL NEUROSCI, V19, P145, DOI 10.1017/S0952523802191139; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; VANEY DI, 1989, NEUROBIOLOGY INNER R, P157; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Wei W, 2010, NAT PROTOC, V5, P1347, DOI 10.1038/nprot.2010.106; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	30	131	133	4	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					402	+		10.1038/nature09600	http://dx.doi.org/10.1038/nature09600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21131947	Green Accepted			2022-12-01	WOS:000286385600053
J	Turner, K; Adams, E; Grant, A; Macleod, J; Bell, G; Clarke, J; Horner, P				Turner, Katy; Adams, Elisabeth; Grant, Arabella; Macleod, John; Bell, Gill; Clarke, Jan; Horner, Paddy			Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRACHOMATIS; INFECTION; POPULATION; PREVALENCE	Objectives To compare the cost, cost effectiveness, and sex equity of different intervention strategies within the English National Chlamydia Screening Programme. To develop a tool for calculating cost effectiveness of chlamydia control programmes at a local, national, or international level. Design An economic and mathematical modelling study with cost effectiveness analysis. Costs were restricted to those of screening and partner notification from the perspective of the NHS and excluded patient costs, the costs of reinfection, and costs of complications arising from initial infection. Setting England. Population Individuals eligible for the National Chlamydia Screening Programme. Main outcome measures Cost effectiveness of National Chlamydia Screening Programme in 2008-9 (as cost per individual tested, cost per positive diagnosis, total cost of screening, number screened, number infected, sex ratio of those tested and treated). Comparison of baseline programme with two different interventions-(i) increased coverage of primary screening in men and (ii) increased efficacy of partner notification. Results In 2008-9 screening was estimated to cost about 46.3m pound in total and 506 pound per infection treated. Provision for partner notification within the screening programme cost between 9 pound and 27 pound per index case, excluding treatment and testing. The model results suggest that increasing male screening coverage from 8% (baseline value) to 24% (to match female coverage) would cost an extra 22.9m pound and increase the cost per infection treated to 528 pound. In contrast, increasing partner notification efficacy from 0.4 (baseline value) to 0.8 partners per index case would cost an extra 3.3m pound and would reduce the cost per infection diagnosed to 449 pound. Increasing screening coverage to 24% in men would cost over six times as much as increasing partner notification to 0.8 but only treat twice as many additional infections. Conclusions In the English National Chlamydia Screening Programme increasing the effectiveness of partner notification is likely to cost less than increasing male coverage but also improve the ratio of women to men diagnosed. Further evaluation of the cost effectiveness of partner notification and screening is urgently needed. The spreadsheet tool developed in this study can be easily modified for use in other settings to evaluate chlamydia control programmes.	[Turner, Katy] Univ Bristol, Dept Social Med, NIHR, Bristol BS8 2PS, Avon, England; [Grant, Arabella] Pathway Analyt, London, England; [Bell, Gill] Royal Hallamshire Hosp, NHS Fdn Trust, Sheffield Teaching Hosp, Sheffield S10 2JF, S Yorkshire, England; [Clarke, Jan] Leeds Teaching Hosp Trust, Dept Genitourinary Med, Leeds LS1 3EX, W Yorkshire, England; [Horner, Paddy] Univ Hosp Bristol NHS Fdn Trust, Bristol Sexual Hlth Ctr, Bristol BS2 OJD, Avon, England	University of Bristol; Oxford University Hospitals NHS Foundation Trust; University of Sheffield; University of Leeds	Turner, K (corresponding author), Univ Bristol, Dept Social Med, NIHR, Bristol BS8 2PS, Avon, England.	katy.turner@bristol.ac.uk	Turner, Katy/R-3853-2019	Turner, Katy/0000-0002-8152-6017; Horner, Paddy/0000-0003-0411-8332; Macleod, John/0000-0001-8202-1144	Bristol Sexual Health Centre; NIHR [07/42/02]; National Institute for Health Research [PDF-2009-02-55, 07/42/02] Funding Source: researchfish	Bristol Sexual Health Centre; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a grant from the Bristol Sexual Health Centre Capacity Building Research Fund. KT is supported by an NIHR PDF fellowship. KT and GB also received funding from the NIHR Health Technology Assessment programme (project number 07/42/02). All authors in this paper are independent of their funders for publication purposes. The views and opinions expressed here are those of the authors and do not necessarily reflect those of the funders.; JC, PH, and JM are board members of the National Chlamydia Screening Advisory Group of the Department of Health and receive expenses for travel to meetings. JC also receives compensation for secondment as chair on NCSAG paid directly to Leeds Hospital Teaching Hospitals Trust. AG and EA received consultancy fees from Bristol Sexual Health Centre Capacity Building Research Fund for the additional cost data analysis and travel to a meeting with the other authors. EA and AG did consultancy work for the NCSP in spring 2009 on a project to estimate the cost of chlamydia screening. KT received consultancy fees from Bristol Sexual Health Centre Capacity Building Research Fund for additional days worked to develop the model and write the paper outside funded time. KT and EA were previously employed by the Health Protection Agency to work on economic and mathematical models of the impact of chlamydia screening. PH collaborated in a multicentre evaluation of a new molecular diagnostic test for chlamydia and gonorrhoea by Siemens Healthcare Diagnostics, for which his department received funding.	Apoola A, 2007, INT J STD AIDS, V18, P493, DOI 10.1258/095646207781147238; Bilardi JE, 2010, SEX TRANSM DIS, V37, P563, DOI 10.1097/OLQ.0b013e3181d707f1; Carre H, 2008, SEX TRANSM INFECT, V84, P239, DOI 10.1136/sti.2007.028068; Cassell JA, 2003, SEX TRANSM INFECT, V79, P264, DOI 10.1136/sti.79.3.264-a; Clarke J, 2009, PARTNER NOTIFICATION; European Centre for Disease Control and Prevention (ECDC), 2008, REV CHLAM CONTR ACT; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Kretzschmar M, 2009, SEX TRANSM INFECT, V85, P359, DOI 10.1136/sti.2009.036251; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; LaMontagne DS, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.022053; Low N, 2009, INT J EPIDEMIOL, V38, P435, DOI 10.1093/ije/dyn222; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; National Audit Office, 2009, YOUNG PEOPL SEX HLTH; National Chlamydia Screening Programme, 2010, VSI DAT TABL 08 09 E; National Chlamydia Screening Programme, 2010, INV YOUNG MEN CHLAM; National Chlamydia Screening Programme, 2009, GUID COMM COSTS PROV; National Chlamydia Screening Programme, 2010, MEN TOO; National Chlamydia Screening Programme, 2009, NCSP ANN REPORT 2008; Quinn TC, 1996, JAMA-J AM MED ASSOC, V276, P1737, DOI 10.1001/jama.276.21.1737; Trelle S, 2007, BMJ-BRIT MED J, V334, P354, DOI 10.1136/bmj.39079.460741.7C; Turner KME, 2006, SEX TRANSM INFECT, V82, P496, DOI 10.1136/sti.2005.019067; van Bergen J, 2005, SEX TRANSM INFECT, V81, P17, DOI 10.1136/sti.2004.010173	22	34	34	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2011	342								c7250	10.1136/bmj.c7250	http://dx.doi.org/10.1136/bmj.c7250			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NF	21205807	Green Submitted, hybrid			2022-12-01	WOS:000286142400001
J	Nurok, M; Czeisler, CA; Lehmann, LS				Nurok, Michael; Czeisler, Charles A.; Lehmann, Lisa Soleymani			Sleep Deprivation, Elective Surgical Procedures, and Informed Consent.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nurok, Michael] Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA; [Nurok, Michael] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Czeisler, Charles A.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Ctr Bioeth, Boston, MA 02115 USA; [Nurok, Michael; Lehmann, Lisa Soleymani] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Czeisler, Charles A.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Lehmann, Lisa Soleymani] Harvard Univ, Sch Med, Div Med Eth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Nurok, M (corresponding author), Hosp Special Surg, Dept Anesthesiol, 535 E 70th St, New York, NY 10021 USA.			Czeisler, Charles Andrew/0000-0002-7408-1849				Blum AB, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-33; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Rothschild JM, 2009, JAMA-J AM MED ASSOC, V302, P1565, DOI 10.1001/jama.2009.1423; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	5	59	59	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2577	2579		10.1056/NEJMp1007901	http://dx.doi.org/10.1056/NEJMp1007901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	700SD	21190452				2022-12-01	WOS:000285763700001
J	Forneris, F; Ricklin, D; Wu, J; Tzekou, A; Wallace, RS; Lambris, JD; Gros, P				Forneris, Federico; Ricklin, Daniel; Wu, Jin; Tzekou, Apostolia; Wallace, Rachel S.; Lambris, John D.; Gros, Piet			Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation	SCIENCE			English	Article							ALTERNATIVE PATHWAY CONVERTASE; CONFORMATIONAL-CHANGES; SERINE-PROTEASE; PROVIDES INSIGHTS; ACTIVATION; SYSTEM; BINDING; DOMAIN; THERAPEUTICS; THIOESTER	Activation of the complement cascade induces inflammatory responses and marks cells for immune clearance. In the central complement-amplification step, a complex consisting of surface-bound C3b and factor B is cleaved by factor D to generate active convertases on targeted surfaces. We present crystal structures of the pro-convertase C3bB at 4 angstrom resolution and its complex with factor D at 3.5 angstrom resolution. Our data show how factor B binding to C3b forms an open "activation" state of C3bB. Factor D specifically binds the open conformation of factor B through a site distant from the catalytic center and is activated by the substrate, which displaces factor D's self-inhibitory loop. This concerted proteolytic mechanism, which is cofactor-dependent and substrate-induced, restricts complement amplification to C3b-tagged target cells.	[Ricklin, Daniel; Tzekou, Apostolia; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Forneris, Federico; Wu, Jin; Wallace, Rachel S.; Gros, Piet] Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	University of Pennsylvania; Utrecht University	Lambris, JD (corresponding author), Univ Penn, Dept Pathol & Lab Med, 401 Stellar Chance, Philadelphia, PA 19104 USA.	lambris@upenn.edu; p.gros@uu.nl	Mohammed, Imran/J-8271-2012; Gros, Piet/I-5569-2016; Forneris, Federico/B-1145-2011; Gros, Piet/AAD-6452-2019; Lambris, John/Q-5633-2018; Forneris, Federico/AAL-5361-2020; Ricklin, Daniel/F-5104-2011	Mohammed, Imran/0000-0002-8412-0768; Gros, Piet/0000-0002-7782-2585; Forneris, Federico/0000-0002-7818-1804; Gros, Piet/0000-0002-7782-2585; Lambris, John/0000-0002-9370-5776; Forneris, Federico/0000-0002-7818-1804; Ricklin, Daniel/0000-0001-6140-0233	Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW) [700.54.304]; NIH [AI030040, AI068730, AI072106, GM062134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072106, P01AI068730, R01AI030040, N01AI030040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062134] Funding Source: NIH RePORTER	Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Coordinates and structure factors of C3bB, C3bBD*, FD (S183A), and FD (R202A) have been deposited in the Protein Data Bank (PDB) with accession numbers 2XWJ, 2XWB, 2XW9, and 2XWA, respectively. We gratefully thank the European Synchrotron Radiation Facility (ESRF) and the Swiss Light source (SLS) for the provision of synchrotron radiation facilities and beamline scientists of the SLS, ESRF, and the European Molecular Biology Laboratory for assistance. This work was supported by a "Top" grant (700.54.304 to P.G.) by the Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW) and NIH grants (AI030040, AI068730, AI072106, and GM062134 to J.D.L.). Author contributions: F.F. expressed and purified all FB and FD mutants, purified C3b, generated protein complexes, performed crystallization experiments, collected diffraction data, and solved the structures; F.F. and P.G. analyzed the structures; J.W. and R.S.W. helped with cloning and optimization of protein expression and purification; F.F. performed kinetic studies; D.R. and A.T. performed the SPR binding studies and hemolytic assays; F.F., D.R., J.D.L., and P.G. conceived the experiments; F. F. prepared the figures; and F.F., D.R., and P.G. wrote the manuscript. P.G. and J.D.L. co-supervised this work. Competing financial interests: P.G., F.F., D.R., and J.D.L. are co-inventors of a patent application titled "Structure of C3bB-factor D complex and use for rational drug design."	Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Carroll MC, 2004, MOL IMMUNOL, V41, P141, DOI 10.1016/j.molimm.2004.03.017; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Haas PJ, 2007, IMMUNOL RES, V37, P161, DOI 10.1007/BF02697367; Hinshelwood J, 2000, J MOL BIOL, V298, P135, DOI 10.1006/jmbi.2000.3632; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; Jing H, 1999, EMBO J, V18, P804, DOI 10.1093/emboj/18.4.804; KAM CM, 1987, J BIOL CHEM, V262, P3444; KIM S, 1994, BIOCHEMISTRY-US, V33, P14393, DOI 10.1021/bi00252a004; Kim SG, 1999, JPN J APPL PHYS 2, V38, pL38; KIM SH, 1995, J IMMUNOL, V154, P6073; Law SKA, 1997, PROTEIN SCI, V6, P263; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Torreira E, 2009, J IMMUNOL, V183, P7347, DOI 10.4049/jimmunol.0902310; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x	36	183	184	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1816	1820		10.1126/science.1195821	http://dx.doi.org/10.1126/science.1195821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205667	Green Accepted			2022-12-01	WOS:000285603700039
J	Amstrup, SC; DeWeaver, ET; Douglas, DC; Marcot, BG; Durner, GM; Bitz, CM; Bailey, DA				Amstrup, Steven C.; DeWeaver, Eric T.; Douglas, David C.; Marcot, Bruce G.; Durner, George M.; Bitz, Cecilia M.; Bailey, David A.			Greenhouse gas mitigation can reduce sea-ice loss and increase polar bear persistence	NATURE			English	Article							CLIMATE-CHANGE; 21ST-CENTURY; SYSTEM; POLICY	On the basis of projected losses of their essential sea-ice habitats, a United States Geological Survey research team concluded in 2007 that two-thirds of the world's polar bears (Ursus maritimus) could disappear by mid-century if business-as-usual greenhouse gas emissions continue(1-3). That projection, however, did not consider the possible benefits of greenhouse gas mitigation. A key question is whether temperature increases lead to proportional losses of sea-ice habitat, or whether sea-ice cover crosses a tipping point and irreversibly collapses when temperature reaches a critical threshold(4-6). Such a tipping point would mean future greenhouse gas mitigation would confer no conservation benefits to polar bears. Here we show, using a general circulation model(7), that substantially more sea-ice habitat would be retained if greenhouse gas rise is mitigated. We also show, with Bayesian network model outcomes, that increased habitat retention under greenhouse gas mitigation means that polar bears could persist throughout the century in greater numbers and more areas than in the business-as-usual case(3). Our general circulation model outcomes did not reveal thresholds leading to irreversible loss of ice(6); instead, a linear relationship between global mean surface air temperature and sea-ice habitat substantiated the hypothesis that sea-ice thermodynamics can overcome albedo feedbacks proposed to cause sea-ice tipping points(5,6,8). Our outcomes indicate that rapid summer ice losses in models(9) and observations(6,10) represent increased volatility of a thinning sea-ice cover, rather than tipping-point behaviour. Mitigation-driven Bayesian network outcomes show that previously predicted declines in polar bear distribution and numbers(3) are not unavoidable. Because polar bears are sentinels of the Arctic marine ecosystem(11) and trends in their sea-ice habitats foreshadow future global changes, mitigating greenhouse gas emissions to improve polar bear status would have conservation benefits throughout and beyond the Arctic(12).	[Amstrup, Steven C.; Durner, George M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [DeWeaver, Eric T.] Natl Sci Fdn, Arlington, VA 22230 USA; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, Juneau, AK 99801 USA; [Marcot, Bruce G.] US Forest Serv, USDA, PNW Res Stn, Portland, OR 97205 USA; [Bitz, Cecilia M.] Univ Washington, Seattle, WA 98195 USA; [Bailey, David A.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	United States Department of the Interior; United States Geological Survey; National Science Foundation (NSF); United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; University of Washington; University of Washington Seattle; National Center Atmospheric Research (NCAR) - USA	Amstrup, SC (corresponding author), Polar Bears Int, 810 N Wallace,Suite E,POB 3008, Bozeman, MT 59772 USA.	samstrup@pbears.org	Daniel, Emily M/A-7387-2012; Douglas, David C./AAU-1087-2021; Bitz, Cecilia M/S-8423-2016	Douglas, David C./0000-0003-0186-1104; Bitz, Cecilia M/0000-0002-9477-7499; Bailey, David/0000-0002-6584-0663	USGS; USDA Forest Service, Pacific Northwest Research Station; Office of Science (BER), US Department of Energy [ER64735]; National Science Foundation (NSF); NSF Office of Polar Programs [0908675]; Directorate For Geosciences [0908675] Funding Source: National Science Foundation	USGS(United States Geological Survey); USDA Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Office of Science (BER), US Department of Energy(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Office of Polar Programs(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Principal funding for this project was provided by the USGS. B. G. M. acknowledges support from the USDA Forest Service, Pacific Northwest Research Station. E. T. D. acknowledges the support of the Office of Science (BER), US Department of Energy, under grant ER64735 to the University of Maryland. E.D.'s work also was supported by the National Science Foundation (NSF) during his employment there. The findings reported here, however, are not endorsed by and do not necessarily reflect the views of the NSF. CCSM3 simulations were performed using computing resources provided by the National Center for Atmospheric Research and the Earth Simulator in Japan. D. A. B. was supported under a grant from the NSF Office of Polar Programs, award number 0908675. M. Holland provided comments regarding model design and analysis. We acknowledge the Program for Climate Model Diagnosis and Intercomparison and the World Climate Research Programme's Working Group on Coupled Modeling for their roles in making available the Coupled Model Intercomparison Project phase 3 multi-model data set (support of this data set is provided by the Office of Science, US Department of Energy). We thank W. Washington and L. Buja for running the AS and providing us with the output from the CCSP integrations. We thank D. Vongraven and S. Vavrus for comments on earlier versions of this manuscript, and we thank N. Lunn and L. Peacock for providing the peer reviews necessary for the beta version of our Bayesian network model. Any use of trade names is for descriptive purposes only and does not represent endorsement by the US government.	Aars J., 2006, POL BEARS P 14 WORK, P189; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Amstrup SC, 2009, INTERFACES, V39, P353, DOI 10.1287/inte.1090.0444; Cavalieri DJ., 1996, SEA ICE CONCENTRATIO; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Deser C, 2008, GEOPHYS MONOGR SER, V180, P7, DOI 10.1029/180GM03; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Eisenman I, 2009, P NATL ACAD SCI USA, V106, P28, DOI 10.1073/pnas.0806887106; Grosell M., 2006, OCEANOGRAPHY WASH DC, V19, P127; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Holland MM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028024; Holland MM, 2008, GEOPHYS MONOGR SER, V180, P133, DOI 10.1029/180GM10; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Kerr RA, 2007, SCIENCE, V318, P33, DOI 10.1126/science.318.5847.33a; Kizzia T., 2007, ANCHORAGE DAILY 0908, pA1; Lawrence DM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033985; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Manly B.F.J., 2002, RESOURCE SELECTION A, V2; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Meehl GA, 2004, J CLIMATE, V17, P3721, DOI 10.1175/1520-0442(2004)017<3721:CONAAF>2.0.CO;2; Meehl GA, 2006, J CLIMATE, V19, P2597, DOI 10.1175/JCLI3746.1; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Nakicenovic N., 2000, SPECIAL REPORT EMISS, V1, P595; National Snow and Ice Data Center, 2009, 69 NSIDC, V69; Notz D, 2009, P NATL ACAD SCI USA, V106, P20590, DOI 10.1073/pnas.0902356106; Ramanathan V, 2008, P NATL ACAD SCI USA, V105, P14245, DOI 10.1073/pnas.0803838105; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Stirling I, 1999, ARCTIC, V52, P294; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Thiemann GW, 2008, ORYX, V42, P504, DOI 10.1017/S0030605308001877; U.S. Climate Change Science Program, 2007, SCEN GREENH GAS EM A; Washington WM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037074; Wigley TML, 2005, SCIENCE, V307, P1766, DOI 10.1126/science.1103934; Winton M, 2008, GEOPHYS MONOGR SER, V180, P111, DOI 10.1029/180GM09	37	95	99	6	300	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					955	958		10.1038/nature09653	http://dx.doi.org/10.1038/nature09653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164484				2022-12-01	WOS:000285344600045
J	Booth, LN; Tuch, BB; Johnson, AD				Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.			Intercalation of a new tier of transcription regulation into an ancient circuit	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; YEAST CANDIDA-ALBICANS; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; GENE-EXPRESSION; EVOLUTION; PHEROMONE; IDENTIFICATION; MEIOSIS	Changes in gene regulatory networks are a major source of evolutionary novelty(1-3). Here we describe a specific type of network rewiring event, one that intercalates a new level of transcriptional control into an ancient circuit. We deduce that, over evolutionary time, the direct ancestral connections between a regulator and its target genes were broken and replaced by indirect connections, preserving the overall logic of the ancestral circuit but producing a new behaviour. The example was uncovered through a series of experiments in three ascomycete yeasts: the bakers' yeast Saccharomyces cerevisiae, the dairy yeast Kluyveromyces lactis and the human pathogen Candida albicans. All three species have three cell types: two mating-competent cell forms (a and alpha) and the product of their mating (a/alpha), which is mating-incompetent. In the ancestral mating circuit, two homeodomain proteins, Mata1 and Mat alpha 2, form a heterodimer that directly represses four genes that are expressed only in a and alpha cells and are required for mating(4-6). In a relatively recent ancestor of K. lactis, a reorganization occurred. The Mata1-Mat alpha 2 heterodimer represses the same four genes (known as the core haploid-specific genes) but now does so indirectly through an intermediate regulatory protein, Rme1. The overall logic of the ancestral circuit is preserved (haploid-specific genes ON in a and alpha cells and OFF in a/alpha cells), but a new phenotype was produced by the rewiring: unlike S. cerevisiae and C. albicans, K. lactis integrates nutritional signals, by means of Rme1, into the decision of whether or not to mate.	[Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	ajohnson@cgl.ucsf.edu			National Institutes of Health [RO1 GM037049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Mitrovich, O. Homann, A. Hernday, M. Miller, C. Cain, T. Sorrells and H. Madhani for helpful discussions and technical contributions; and S. Astrom for generously providing the K. lactis strains used in this study. The S. cerevisiae strains were a gift from the H. Madhani and J. Li laboratories. The work was funded by grant RO1 GM037049 from the National Institutes of Health. L.N.B. is a National Science Foundation Graduate Research Fellow.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barsoum E, 2010, GENETICS, V184, P999, DOI 10.1534/genetics.110.114678; Barsoum E, 2010, GENE DEV, V24, P33, DOI 10.1101/gad.557310; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Coria R, 2006, FEMS YEAST RES, V6, P336, DOI 10.1111/j.1567-1364.2005.00022.x; Cote P, 2008, MOL MICROBIOL, V68, P392, DOI 10.1111/j.1365-2958.2008.06158.x; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dignard D, 2008, EUKARYOT CELL, V7, P1591, DOI 10.1128/EC.00077-08; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Falcone C., 2003, SPRINGER LAB MANUAL, P195; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gojkovic Z, 2000, J MOL BIOL, V295, P1073, DOI 10.1006/jmbi.1999.3393; GOUTTE C, 1994, EMBO J, V13, P1434, DOI 10.1002/j.1460-2075.1994.tb06397.x; HERMAN AI, 1970, ANTON VAN LEE J M S, V36, P421, DOI 10.1007/BF02069042; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hickman MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000710; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KASSIR Y, 1976, GENETICS, V82, P187; KURTZMAN CP, 2000, YEASTS TAXONOMIC STU; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Srikantha T, 2006, EUKARYOT CELL, V5, P1674, DOI 10.1128/EC.00252-06; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	43	57	65	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					959	U358		10.1038/nature09560	http://dx.doi.org/10.1038/nature09560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164485	Green Accepted			2022-12-01	WOS:000285344600046
J	Linsel-Nitschke, P; Samani, NJ; Schunkert, H				Linsel-Nitschke, Patrick; Samani, Nilesh J.; Schunkert, Heribert			Sorting Out Cholesterol and Coronary Artery Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LOCUS		[Linsel-Nitschke, Patrick; Schunkert, Heribert] Univ Lubeck, Med Klin 2, Lubeck, Germany; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Univ Leicester, Leicester Natl Inst Hlth Res, Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Leicester; University of Leicester	Linsel-Nitschke, P (corresponding author), Univ Lubeck, Med Klin 2, Lubeck, Germany.							Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366	5	26	28	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2462	2463		10.1056/NEJMcibr1010765	http://dx.doi.org/10.1056/NEJMcibr1010765			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694ZK	21158662	Green Published			2022-12-01	WOS:000285340200016
J	Rothberg, MB; Arora, A; Hermann, J; Kleppel, R; St Marie, P; Visintainer, P				Rothberg, Michael B.; Arora, Ashish; Hermann, Jodie; Kleppel, Reva; St Marie, Peter; Visintainer, Paul			CHRISTMAS 2010: THE LIVES OF DOCTORS Phantom vibration syndrome among medical staff: a cross sectional survey	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To describe the prevalence of and risk factors for experiencing "phantom vibrations," the sensory hallucination sometimes experienced by people carrying pagers or cell phones when the device is not vibrating. Design Cross sectional survey. Setting Academic medical centre. Participants 176 medical staff who responded to questionnaire (76% of the 232 people invited). Measurements Electronic survey consisting of 17 questions about demographics, device use, phantom vibrations experienced, and attempts to stop them. Results Of the 169 participants who answered the question, 115 (68%, 95% confidence interval 61% to 75%) reported having experienced phantom vibrations. Most (68/112) who experienced phantom vibrations did so after carrying the device between 1 month and 1 year, and 13% experienced them daily. Four factors were independently associated with phantom vibrations: occupation (resident v attending physician, prevalence ratio 1.47, 95% confidence interval 1.10 to 1.97), device location (breast pocket v belt, prevalence ratio 1.66, 1.29 to 2.14), hours carried (per 6 hour increment, prevalence ratio 1.30, 1.07 to 1.58), and more frequent use in vibrate mode (per frequency category, prevalence ratio 1.18, 1.03 to 1.34). Of those who experienced phantom vibrations, 43 (39%, 30% to 48%) were able to stop them. Strategies for stopping phantom vibrations included taking the device off vibrate mode, changing the location of the device, and using a different device (success rates 75% v 63% v 50%, respectively, P=0.217). However, 39% (30% to 49%) of respondents did not attempt any strategies. Conclusions Phantom vibration syndrome is common among those who use electronic devices.	[Rothberg, Michael B.; Arora, Ashish; Hermann, Jodie; Kleppel, Reva; St Marie, Peter; Visintainer, Paul] Baystate Med Ctr, Div Gen Med, Springfield, MA 01199 USA; [Rothberg, Michael B.; Arora, Ashish; Hermann, Jodie; Kleppel, Reva; St Marie, Peter; Visintainer, Paul] Tufts Univ, Sch Med, Boston, MA 02111 USA	Baystate Medical Center; Tufts University	Rothberg, MB (corresponding author), Baystate Med Ctr, Div Gen Med & Geriatr, 759 Chestnut St, Springfield, MA 01199 USA.	Michael.Rothberg@bhs.org	ARORA, ASHISH/ABE-6212-2021	Visintainer, Paul/0000-0002-2491-1242; St. Marie, Peter/0000-0002-3567-2582				Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Goodman B, 2006, NY TIMES        0504; Haupt A., 2007, US TODAY        0612; Laramie D., 2007, THESIS ALLIANT INT U; Market Information and Statistics Division TDB International Telecommunication Union, 2009, WORLD 2009 ICT FACTS; PENNEBAKER JW, 1981, J PERS SOC PSYCHOL, V41, P213, DOI 10.1037/0022-3514.41.2.213	7	35	35	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c6914	10.1136/bmj.c6914	http://dx.doi.org/10.1136/bmj.c6914			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XJ	21159761	hybrid			2022-12-01	WOS:000285552800008
J	Chakraborty, A; Koldobskiy, MA; Bello, NT; Maxwell, M; Potter, JJ; Juluri, KR; Maag, D; Kim, S; Huang, AS; Dailey, MJ; Saleh, M; Snowman, AM; Moran, TH; Mezey, E; Snyder, SH				Chakraborty, Anutosh; Koldobskiy, Michael A.; Bello, Nicholas T.; Maxwell, Micah; Potter, James J.; Juluri, Krishna R.; Maag, David; Kim, Seyun; Huang, Alex S.; Dailey, Megan J.; Saleh, Masoumeh; Snowman, Adele M.; Moran, Timothy H.; Mezey, Esteban; Snyder, Solomon H.			Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain	CELL			English	Article							PROTEIN-KINASE-B; MICE LACKING; PPAR-GAMMA; FAT MASS; PHOSPHORYLATION; ACTIVATION; MTOR; PHOSPHOINOSITIDES; RESISTANCE; MEMBRANE	The inositol pyrophosphate IP7 (5-diphosphoinositolpentakisphosphate), formed by a family of three inositol hexakisphosphate kinases (IP6Ks), modulates diverse cellular activities. We now report that IP7 is a physiologic inhibitor of Akt, a serine/threonine kinase that regulates glucose homeostasis and protein translation, respectively, via the GSK3 beta and mTOR pathways. Thus, Akt and mTOR signaling are dramatically augmented and GSK3b signaling reduced in skeletal muscle, white adipose tissue, and liver of mice with targeted deletion of IP6K1. IP7 affects this pathway by potently inhibiting the PDK1 phosphorylation of Akt, preventing its activation and thereby affecting insulin signaling. IP6K1 knockout mice manifest insulin sensitivity and are resistant to obesity elicited by high-fat diet or aging. Inhibition of IP6K1 may afford a therapeutic approach to obesity and diabetes.	[Chakraborty, Anutosh; Koldobskiy, Michael A.; Maxwell, Micah; Juluri, Krishna R.; Maag, David; Kim, Seyun; Huang, Alex S.; Saleh, Masoumeh; Snowman, Adele M.; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Bello, Nicholas T.; Dailey, Megan J.; Moran, Timothy H.; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Potter, James J.; Mezey, Esteban] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Kim, Seyun/B-3387-2012	Bello, Nicholas/0000-0001-5300-5604	U.S. Public Health Service [MH18501, DA-000266]; Research Scientist Award [DA00074]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074, P50DA000266] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Robert Luo for providing the pCDNA-TOPO-V5/His full-length and Delta PH Akt constructs; Susan Aja for the Oxymax experiments; Cory Brayton for histological analysis; Molee Chakraborty, Nadine Forbes, Kent Werner, and Gary Ho for technical support; and Asif Mustafa for helpful discussions. This work was supported by U.S. Public Health Service Grants MH18501 and DA-000266 and Research Scientist Award DA00074 (to S.H.S.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; BENNETT M, 2000, NAT REV MOL CELL BIO, V1, P11; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; CURRIE RA, 2001, BIOCHEM J, V337, P575; DEPINTO FL, 2010, LIVER INT, V30, P603; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Downes CP, 2005, BIOCHEM SOC T, V33, P1303, DOI 10.1042/BST0331303; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; FRUMAN DA, 1985, BIOCHEM SOC T, V27, P624; Funai K, 2006, AM J PHYSIOL-REG I, V290, pR1080, DOI 10.1152/ajpregu.00277.2005; Hand CE, 2007, BIOORG MED CHEM LETT, V17, P183, DOI 10.1016/j.bmcl.2006.09.066; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoffler U, 2009, ENDOCRINE, V36, P311, DOI 10.1007/s12020-009-9224-9; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Ito M, 2008, J ENDOCRINOL, V198, P309, DOI 10.1677/JOE-08-0087; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shao J, 2000, J ENDOCRINOL, V167, P107, DOI 10.1677/joe.0.1670107; Shay KP, 2009, BIOGERONTOLOGY, V10, P443, DOI 10.1007/s10522-008-9187-x; Shears SB, 2007, BIOCHEM SOC SYMP, V74, P211, DOI 10.1042/BSS2007c18; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Welsh GL, 2005, BIOCHEM SOC T, V33, P346, DOI 10.1042/BST0330346; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	65	239	254	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					897	910		10.1016/j.cell.2010.11.032	http://dx.doi.org/10.1016/j.cell.2010.11.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145457	Bronze, Green Accepted			2022-12-01	WOS:000285182600008
J	Denoeud, F; Henriet, S; Mungpakdee, S; Aury, JM; Da Silva, C; Brinkmann, H; Mikhaleva, J; Olsen, LC; Jubin, C; Canestro, C; Bouquet, JM; Danks, G; Poulain, J; Campsteijn, C; Adamski, M; Cross, I; Yadetie, F; Muffato, M; Louis, A; Butcher, S; Tsagkogeorga, G; Konrad, A; Singh, S; Jensen, MF; Cong, EH; Eikeseth-Otteraa, H; Noel, B; Anthouard, V; Porcel, BM; Kachouri-Lafond, R; Nishino, A; Ugolini, M; Chourrout, P; Nishida, H; Aasland, R; Huzurbazar, S; Westhof, E; Delsuc, F; Lehrach, H; Reinhardt, R; Weissenbach, J; Roy, SW; Artiguenave, F; Postlethwait, JH; Manak, JR; Thompson, EM; Jaillon, O; Du Pasquier, L; Boudinot, P; Liberles, DA; Volff, JN; Philippe, H; Lenhard, B; Roest Crollius, H; Wincker, P; Chourrout, D				Denoeud, France; Henriet, Simon; Mungpakdee, Sutada; Aury, Jean-Marc; Da Silva, Corinne; Brinkmann, Henner; Mikhaleva, Jana; Olsen, Lisbeth Charlotte; Jubin, Claire; Canestro, Cristian; Bouquet, Jean-Marie; Danks, Gemma; Poulain, Julie; Campsteijn, Coen; Adamski, Marcin; Cross, Ismael; Yadetie, Fekadu; Muffato, Matthieu; Louis, Alexandra; Butcher, Stephen; Tsagkogeorga, Georgia; Konrad, Anke; Singh, Sarabdeep; Jensen, Marit Flo; Cong, Evelyne Huynh; Eikeseth-Otteraa, Helen; Noel, Benjamin; Anthouard, Veronique; Porcel, Betina M.; Kachouri-Lafond, Rym; Nishino, Atsuo; Ugolini, Matteo; Chourrout, Pascal; Nishida, Hiroki; Aasland, Rein; Huzurbazar, Snehalata; Westhof, Eric; Delsuc, Frederic; Lehrach, Hans; Reinhardt, Richard; Weissenbach, Jean; Roy, Scott W.; Artiguenave, Francois; Postlethwait, John H.; Manak, J. Robert; Thompson, Eric M.; Jaillon, Olivier; Du Pasquier, Louis; Boudinot, Pierre; Liberles, David A.; Volff, Jean-Nicolas; Philippe, Herve; Lenhard, Boris; Roest Crollius, Hugues; Wincker, Patrick; Chourrout, Daniel			Plasticity of Animal Genome Architecture Unmasked by Rapid Evolution of a Pelagic Tunicate	SCIENCE			English	Article							ORIGINS; INTRON; GENES	Genomes of animals as different as sponges and humans show conservation of global architecture. Here we show that multiple genomic features including transposon diversity, developmental gene repertoire, physical gene order, and intron-exon organization are shattered in the tunicate Oikopleura, belonging to the sister group of vertebrates and retaining chordate morphology. Ancestral architecture of animal genomes can be deeply modified and may therefore be largely nonadaptive. This rapidly evolving animal lineage thus offers unique perspectives on the level of genome plasticity. It also illuminates issues as fundamental as the mechanisms of intron gain.	[Denoeud, France; Aury, Jean-Marc; Da Silva, Corinne; Jubin, Claire; Poulain, Julie; Noel, Benjamin; Anthouard, Veronique; Porcel, Betina M.; Weissenbach, Jean; Artiguenave, Francois; Jaillon, Olivier; Wincker, Patrick] CEA, Inst Genom, Evry, France; [Denoeud, France; Aury, Jean-Marc; Da Silva, Corinne; Jubin, Claire; Poulain, Julie; Noel, Benjamin; Anthouard, Veronique; Porcel, Betina M.; Weissenbach, Jean; Artiguenave, Francois; Jaillon, Olivier; Wincker, Patrick] CNRS, UMR 8030, Evry, France; [Denoeud, France; Aury, Jean-Marc; Da Silva, Corinne; Jubin, Claire; Poulain, Julie; Noel, Benjamin; Anthouard, Veronique; Porcel, Betina M.; Weissenbach, Jean; Artiguenave, Francois; Jaillon, Olivier; Wincker, Patrick] Univ Evry, Evry, France; [Henriet, Simon; Mungpakdee, Sutada; Mikhaleva, Jana; Olsen, Lisbeth Charlotte; Bouquet, Jean-Marie; Danks, Gemma; Campsteijn, Coen; Adamski, Marcin; Yadetie, Fekadu; Jensen, Marit Flo; Cong, Evelyne Huynh; Eikeseth-Otteraa, Helen; Ugolini, Matteo; Thompson, Eric M.; Lenhard, Boris; Chourrout, Daniel] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Brinkmann, Henner; Philippe, Herve] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Canestro, Cristian; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Danks, Gemma; Lenhard, Boris] Univ Bergen, Bergen Ctr Computat Sci, Bergen, Norway; [Cross, Ismael] Univ Cadiz, Genet Lab, Cadiz, Spain; [Muffato, Matthieu; Louis, Alexandra; Roest Crollius, Hugues] Ecole Normale Super, CNRS, IBENS, Dyogen Lab,UMR8197, Paris, France; [Butcher, Stephen; Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Tsagkogeorga, Georgia; Delsuc, Frederic] Univ Montpellier 2, CNRS, Inst Sci Evolut, Lab Paleontol Phylogenie & Paleobiol,UMR 5554, Montpellier, France; [Singh, Sarabdeep; Huzurbazar, Snehalata] Univ Wyoming, Dept Stat, Laramie, WY 82071 USA; [Kachouri-Lafond, Rym; Westhof, Eric] Univ Strasbourg, CNRS, Inst Biol Cellulaire & Mol, Strasbourg, France; [Nishino, Atsuo; Nishida, Hiroki] Osaka Univ, Dept Biol Sci, Osaka, Japan; [Chourrout, Pascal] Ctr Hosp Albi, Albi, France; [Aasland, Rein] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Lehrach, Hans; Reinhardt, Richard] Max Planck Inst Mol Genet, Berlin, Germany; [Roy, Scott W.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Thompson, Eric M.; Lenhard, Boris] Univ Bergen, Dept Biol, Bergen, Norway; [Du Pasquier, Louis] Univ Basel, Inst Zool & Evolutionary Biol, Basel, Switzerland; [Boudinot, Pierre] INRA Virol & Immunol Mol, Jouy En Josas, France; [Konrad, Anke; Liberles, David A.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Volff, Jean-Nicolas] Univ Lyon 1, Ecole Normale Super Lyon, Ecole Normale Super, Inst Genom Fonct Lyon,UMR 5242,CNRS,INRA, F-69365 Lyon, France; [Canestro, Cristian] Univ Barcelona, Dept Genet, E-08007 Barcelona, Spain	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Bergen; Universite de Montreal; University of Oregon; University of Bergen; Universidad de Cadiz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; University of Iowa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Wyoming; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Osaka University; University of Bergen; Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Bergen; University of Basel; INRAE; University of Wyoming; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); University of Barcelona	Wincker, P (corresponding author), CEA, Inst Genom, Evry, France.	pwincker@genoscope.cns.fr; Daniel.Chourrout@sars.uib.no	Cañestro, Cristian/L-9661-2014; Nishino, Atsuo/F-5393-2013; Yadetie, Fekadu/HDL-8798-2022; Aury, Jean-Marc/N-1621-2019; Nishino, Atsuo/AAH-1387-2019; Cross, Ismael/K-1674-2014; Konrad, Anke/X-9107-2019; Konrad, Anke/AAP-4688-2020; Delsuc, Frederic/B-4381-2009; Nishida, Hiroki/B-1851-2008; boudinot, pierre/L-4246-2016; Singh, Sarabdeep/D-7881-2017; Jaillon, Olivier/GRY-6287-2022	Cañestro, Cristian/0000-0003-4623-8105; Nishino, Atsuo/0000-0003-2818-4377; Aury, Jean-Marc/0000-0003-1718-3010; Nishino, Atsuo/0000-0003-2818-4377; Cross, Ismael/0000-0002-2291-5629; Konrad, Anke/0000-0003-3994-460X; Delsuc, Frederic/0000-0002-6501-6287; Nishida, Hiroki/0000-0002-7249-1668; Henriet, Simon/0000-0001-8792-6639; DA SILVA, Corinne/0000-0002-7618-7831; Huzurbazar, Snehalata/0000-0001-9637-5445; Noel, Benjamin/0000-0002-5830-3253; Porcel, Betina/0000-0003-0169-5302; Yadetie, Fekadu/0000-0002-2484-9047; Muffato, Matthieu/0000-0002-7860-3560; Manak, John/0000-0002-6562-7694; Olsen, Lisbeth Charlotte/0000-0002-7469-0169; Denoeud, France/0000-0001-8819-7634; Mikhaleva, Yana/0000-0002-5872-0495; Jaillon, Olivier/0000-0002-7237-9596; Reinhardt, Richard/0000-0001-9376-2132; boudinot, pierre/0000-0002-7490-9677; Poulain, Julie/0000-0002-8744-3116; Lenhard, Boris/0000-0002-1114-1509; Louis, Alexandra/0000-0001-7032-5650; ROEST CROLLIUS, Hugues/0000-0002-8209-173X; Danks, Gemma/0000-0001-7004-0065	Sars Centre; Norwegian Research Council; Genoscope; NSF [IOS-0719577, DBI-0743374]; NATIONAL LIBRARY OF MEDICINE [Z01LM000073, ZIALM000073] Funding Source: NIH RePORTER	Sars Centre; Norwegian Research Council(Research Council of NorwayEuropean Commission); Genoscope; NSF(National Science Foundation (NSF)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The Sars Centre budget, the Functional Genomics (FUGE) Programme of the Norwegian Research Council, Genoscope, and NSF grants IOS-0719577 and DBI-0743374 supported the research. This is publication ISEM-2010-123 of the Institut des Sciences de l'Evolution de Montpellier. GENBANK/European Molecular Biology Laboratory sequence accession numbers are CABV01000001-CABV01005917, CABW01000001-CABW01006678, FN653015-FN654274, FN654275-FN658470, FP700189-FP710243, FP710258-FP791398, and FP791400-FP884219. The sequence data for Capitella teleta, Daphnia pulex, Helobdella robusta and Lottia gigantea were produced by the U.S. Department of Energy Joint Genome Institute (www.jgi.doe.gov/) in collaboration with the community of users. We thank I. Ahel, B. Haubold, and one anonymous reviewer for generous advice. This article is dedicated to Hans Prydz and Kare Rommetveit for their pioneer roles in the Sars Centre establishment.	Bouquet JM, 2009, J PLANKTON RES, V31, P359, DOI 10.1093/plankt/fbn132; Cousineau B, 1998, CELL, V94, P451, DOI 10.1016/S0092-8674(00)81586-X; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Edvardsen RB, 2005, CURR BIOL, V15, pR12, DOI 10.1016/j.cub.2004.12.010; Eickbush TH, 2002, CURR OPIN GENET DEV, V12, P669, DOI 10.1016/S0959-437X(02)00359-3; Hughes T, 2007, J MOL EVOL, V65, P574, DOI 10.1007/s00239-007-9041-9; Katju V, 2003, GENETICS, V165, P1793; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Marz M, 2008, J MOL EVOL, V67, P594, DOI 10.1007/s00239-008-9149-6; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Nguyen HD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-69; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Roy SW, 2009, TRENDS GENET, V25, P67, DOI 10.1016/j.tig.2008.11.004; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Satou Y, 2003, DEV GENES EVOL, V213, P211, DOI 10.1007/s00427-003-0330-z; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Thompson EM, 2001, DEV BIOL, V238, P260, DOI 10.1006/dbio.2001.0414; Volff JN, 2004, MOL BIOL EVOL, V21, P2022, DOI 10.1093/molbev/msh207; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	25	197	201	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1381	1385		10.1126/science.1194167	http://dx.doi.org/10.1126/science.1194167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21097902	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000284902100043
J	Feldser, DM; Kostova, KK; Winslow, MM; Taylor, SE; Cashman, C; Whittaker, CA; Sanchez-Rivera, FJ; Resnick, R; Bronson, R; Hemann, MT; Jacks, T				Feldser, David M.; Kostova, Kamena K.; Winslow, Monte M.; Taylor, Sarah E.; Cashman, Chris; Whittaker, Charles A.; Sanchez-Rivera, Francisco J.; Resnick, Rebecca; Bronson, Roderick; Hemann, Michael T.; Jacks, Tyler			Stage-specific sensitivity to p53 restoration during lung cancer progression	NATURE			English	Article							ONCOGENIC K-RAS; TUMOR PROGRESSION; IN-VIVO; SENESCENCE; PROLIFERATION; AMPLIFICATION; EXPRESSION; MICE	Tumorigenesis is a multistep process that results from the sequential accumulation of mutations in key oncogene and tumour suppressor pathways. Personalized cancer therapy that is based on targeting these underlying genetic abnormalities presupposes that sustained inactivation of tumour suppressors and activation of oncogenes is essential in advanced cancers. Mutations in the p53 tumour-suppressor pathway are common in human cancer and significant efforts towards pharmaceutical reactivation of defective p53 pathways are underway(1-3). Here we show that restoration of p53 in established murine lung tumours leads to significant but incomplete tumour cell loss specifically in malignant adenocarcinomas, but not in adenomas. We define amplification of MAPK signalling as a critical determinant of malignant progression and also a stimulator of Arf tumour-suppressor expression. The response to p53 restoration in this context is critically dependent on the expression of Arf. We propose that p53 not only limits malignant progression by suppressing the acquisition of alterations that lead to tumour progression, but also, in the context of p53 restoration, responds to increased oncogenic signalling to mediate tumour regression. Our observations also underscore that the p53 pathway is not engaged by low levels of oncogene activity that are sufficient for early stages of lung tumour development. These data suggest that restoration of pathways important in tumour progression, as opposed to initiation, may lead to incomplete tumour regression due to the stage-heterogeneity of tumour cell populations.	[Feldser, David M.; Kostova, Kamena K.; Winslow, Monte M.; Taylor, Sarah E.; Cashman, Chris; Whittaker, Charles A.; Sanchez-Rivera, Francisco J.; Resnick, Rebecca; Hemann, Michael T.; Jacks, Tyler] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Feldser, David M.; Kostova, Kamena K.; Winslow, Monte M.; Taylor, Sarah E.; Cashman, Chris; Whittaker, Charles A.; Sanchez-Rivera, Francisco J.; Resnick, Rebecca; Hemann, Michael T.; Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Bronson, Roderick] Tufts Univ, Boston, MA 02115 USA; [Bronson, Roderick] Harvard Univ, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Tufts University; Harvard University; Harvard Medical School	Jacks, T (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Kostova, Kamena/AAK-9431-2020; Sánchez-Rivera, Francisco J./AAV-6985-2020	Kostova, Kamena/0000-0001-9973-401X; Sánchez-Rivera, Francisco J./0000-0002-8466-8563; Feldser, David/0000-0001-5975-864X; Whittaker, Charles/0000-0002-2400-0094; Resnick, Rebecca/0000-0001-5804-4418	National Cancer Institute [P30-CA14051]; American Cancer Society; MIT; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); MIT; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank M. DuPage and C. Kim for critical reading of the manuscript. We are indebted to D. Crowley, E. Vasile and M. Griffin at the Koch Institute Core facilities (supported by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute). We are grateful to M. Luo for microarray support. We thank M. Leversha at MSKCC for FISH. D. M. F. has been supported by the American Cancer Society (New England Area Fellow), and is a current Fellow of the Leukemia and Lymphoma Society. K. K. K. is supported by the John Reed Fund of the MIT undergraduate research program. M.M.W. was a Merck Fellow of the Damon Runyon Cancer Research Foundation and a Genentech postdoctoral fellow. T.J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar. The Howard Hughes Medical Institute supported this work.	Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Bolstad BM, 2005, STAT BIOL HEALTH, P13; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu ML, 1998, ONCOGENE, V17, P2403, DOI 10.1038/sj.onc.1202456; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107	25	208	214	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					572	U249		10.1038/nature09535	http://dx.doi.org/10.1038/nature09535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107428	Green Accepted, Green Submitted			2022-12-01	WOS:000284584200044
J	Gooley, TA; Chien, JW; Pergam, SA; Hingorani, S; Sorror, ML; Boeckh, M; Martin, PJ; Sandmaier, BM; Marr, KA; Appelbaum, FR; Storb, R; McDonald, GB				Gooley, Ted A.; Chien, Jason W.; Pergam, Steven A.; Hingorani, Sangeeta; Sorror, Mohamed L.; Boeckh, Michael; Martin, Paul J.; Sandmaier, Brenda M.; Marr, Kieren A.; Appelbaum, Frederick R.; Storb, Rainer; McDonald, George B.			Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; INVASIVE FUNGAL-INFECTIONS; RISK-FACTORS; IMMUNE RECONSTITUTION; CONDITIONING REGIMEN; URSODEOXYCHOLIC ACID; RECIPIENTS; CYTOMEGALOVIRUS; COMPLICATIONS	Background: Over the past decade, advances have been made in the care of patients undergoing transplantation. We conducted a study to determine whether these advances have improved the outcomes of transplantation. Methods: We analyzed overall mortality, mortality not preceded by relapse, recurrent malignant conditions, and the frequency and severity of major complications of transplantation, including graft-versus-host disease (GVHD) and hepatic, renal, pulmonary, and infectious complications, among 1418 patients who received their first allogeneic transplants at our center in Seattle in the period from 1993 through 1997 and among 1148 patients who received their first allogeneic transplants in the period from 2003 through 2007. Components of the Pretransplant Assessment of Mortality (PAM) score were used in regression models to adjust for the severity of illness at the time of transplantation. Results: In the 2003-2007 period, as compared with the 1993-1997 period, we observed significant decreases in mortality not preceded by relapse, both at day 200 (by 60%) and overall (by 52%), the rate of relapse or progression of a malignant condition (by 21%), and overall mortality (by 41%), after adjustment for components of the PAM score. The results were similar when the analyses were limited to patients who received myeloablative conditioning therapy. We also found significant decreases in the risk of severe GVHD; disease caused by viral, bacterial, and fungal infections; and damage to the liver, kidneys, and lungs. Conclusions: We found a substantial reduction in the hazard of death related to allogeneic hematopoietic-cell transplantation, as well as increased long-term survival, over the past decade. Improved outcomes appear to be related to reductions in organ damage, infection, and severe acute GVHD. (Funded by the National Institutes of Health.) N Engl J Med 2010;363:2091-101.	[McDonald, George B.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Gastroenterol Hepatol Sect D2 190, Seattle, WA 98109 USA; [Pergam, Steven A.; Boeckh, Michael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [Chien, Jason W.; Pergam, Steven A.; Sorror, Mohamed L.; Boeckh, Michael; Martin, Paul J.; Sandmaier, Brenda M.; Marr, Kieren A.; Appelbaum, Frederick R.; Storb, Rainer; McDonald, George B.] Univ Washington, Dept Med, Seattle, WA USA; [Hingorani, Sangeeta] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Gooley, Ted A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McDonald, GB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, Gastroenterol Hepatol Sect D2 190, 1100 Fairview Ave N, Seattle, WA 98109 USA.		Boeckh, Michael/AAA-1607-2022; Pergam, Steven A/C-2286-2008	Pergam, Steven A/0000-0002-6333-5196	National Institutes of Health [CA 18029, CA 15704, CA78902, HL36444, HL088201, HL088021, HL096831, DK063038]; American Society for Blood and Marrow Transplantation; ViroPharma; Roche/Genentech; Astellas; Pfizer; Merck; Vical; Chimerix; AiCuris; Boehringer Ingelheim; Theraclone Sciences; Soligenix; Basilea; Evolva; Gentium; NATIONAL CANCER INSTITUTE [P30CA015704, P01CA018029, P01CA078902] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088201, K99HL088021, P01HL036444, R00HL088021, K23HL096831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK063038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Blood and Marrow Transplantation; ViroPharma; Roche/Genentech(Roche HoldingGenentech); Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer); Merck(Merck & Company); Vical; Chimerix; AiCuris; Boehringer Ingelheim(Boehringer Ingelheim); Theraclone Sciences; Soligenix; Basilea; Evolva; Gentium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (CA 18029, CA 15704, CA78902, HL36444, HL088201, HL088021, HL096831, and DK063038) from the National Institutes of Health.; Dr. Gooley reports serving as a statistical consultant to DOR BioPharma; Dr. Pergam, receiving research funding from Chimerix and ViroPharma (through a sponsored American Society for Blood and Marrow Transplantation New Investigator Award), and consulting fees from ViroPharma; Dr. Boeckh, receiving grant support, consulting fees, or both from Roche/Genentech, ViroPharma, Astellas, Pfizer, Merck, Vical, Chimerix, AiCuris, Boehringer Ingelheim, and Theraclone Sciences; Dr. Martin, receiving grant support from Roche and Soligenix and payments for serving on data and safety monitoring boards for Pfizer; Dr. Marr, receiving grant support from Astellas and Merck and consulting fees from Astellas, Basilea, Evolva, Merck, and Pfizer; and Dr. McDonald, being a consultant to and holding an equity position with Soligenix and receiving consulting fees from Gentium. No other potential conflict of interest relevant to this article was reported.	al-Jurf M, 2005, J CLIN ONCOL, V23, P5074, DOI 10.1200/JCO.2005.09.020; Appelbaum FR, 2009, THOMAS HEMATOPOIETIC; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Boeckh M, 1999, BLOOD, V93, P1781, DOI 10.1182/blood.V93.5.1781; Chien JW, 2010, BONE MARROW TRANSPL, V45, P317, DOI 10.1038/bmt.2009.129; Chien JW, 2008, BLOOD, V111, P2462, DOI 10.1182/blood-2007-09-101709; Clark JG, 1999, CRIT CARE MED, V27, P1800, DOI 10.1097/00003246-199909000-00016; de Lima M, 2004, BLOOD, V104, P857, DOI 10.1182/blood-2004-02-0414; Freudenberger TD, 2003, BLOOD, V102, P3822, DOI 10.1182/blood-2002-06-1813; FRIED RH, 1992, ANN INTERN MED, V116, P624, DOI 10.7326/0003-4819-116-8-624; Fukuda T, 2003, BLOOD, V102, P827, DOI 10.1182/blood-2003-02-0456; Gooley TA, 2005, HEPATOLOGY, V41, P345, DOI 10.1002/hep.20529; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Hakki M, 2003, BLOOD, V102, P3060, DOI 10.1182/blood-2002-11-3472; Hingorani SR, 2008, BIOL BLOOD MARROW TR, V14, P1365, DOI 10.1016/j.bbmt.2008.09.015; Hingorani SR, 2005, KIDNEY INT, V67, P272, DOI 10.1111/j.1523-1755.2005.00078.x; Hockenbery DM, 2007, BLOOD, V109, P4557, DOI 10.1182/blood-2006-05-021139; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Martin PJ, 2004, BIOL BLOOD MARROW TR, V10, P320, DOI 10.1016/j.bbmt.2003.12.304; McCune JS, 2009, CLIN PHARMACOL THER, V85, P615, DOI 10.1038/clpt.2009.27; McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860; McDonald GB, 2010, HEPATOLOGY, V51, P1450, DOI 10.1002/hep.23533; Mielcarek M, 2009, BLOOD, V113, P2888, DOI 10.1182/blood-2008-07-168401; Nakamae H, 2009, BIOL BLOOD MARROW TR, V15, P694, DOI 10.1016/j.bbmt.2009.02.009; Narimatsu H, 2005, BIOL BLOOD MARROW TR, V11, P429, DOI 10.1016/j.bbmt.2005.01.010; Parimon T, 2006, ANN INTERN MED, V144, P407, DOI 10.7326/0003-4819-144-6-200603210-00007; Parimon T, 2005, AM J RESP CRIT CARE, V172, P384, DOI 10.1164/rccm.200502-212OC; Patriarca F, 2004, BONE MARROW TRANSPL, V33, P751, DOI 10.1038/sj.bmt.1704426; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Ruutu T, 2002, BLOOD, V100, P1977, DOI 10.1182/blood-2001-12-0159; Sandmaier B, 2009, THOMAS HEMATOPOIETIC, P1043; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Storek J, 2001, BLOOD, V97, P3380, DOI 10.1182/blood.V97.11.3380; Strasser SI, 2009, THOMAS HEMATOPOIETIC; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Yokoe D, 2009, BONE MARROW TRANSPL, V44, P495, DOI 10.1038/bmt.2009.261	40	1034	1055	1	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2091	2101		10.1056/NEJMoa1004383	http://dx.doi.org/10.1056/NEJMoa1004383			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684XE	21105791	Green Accepted			2022-12-01	WOS:000284587800004
J	Chien, EYT; Liu, W; Zhao, QA; Katritch, V; Han, GW; Hanson, MA; Shi, L; Newman, AH; Javitch, JA; Cherezov, V; Stevens, RC				Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Han, Gye Won; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.			Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; DRUG-SEEKING BEHAVIOR; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; BINDING-SITE; INDUCED REINSTATEMENT; COCAINE-SEEKING; IONIC LOCK; D-3; IDENTIFICATION	Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain. The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small molecule D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops. On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are observed. Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R. This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.	[Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katritch, Vsevolod] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Hanson, Michael A.] Receptos, San Diego, CA 92121 USA; [Shi, Lei] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Newman, Amy Hauck] Natl Inst Drug Abuse, Med Chem Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Columbia University; Columbia University; Columbia University	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLT-1531-2022; Shi, Lei/AAV-1321-2020; Katritch, Vsevolod/Y-2721-2019; soler, martha maricel m gomez/L-6025-2014; Katritch, Vsevolod/Q-8357-2016; Han, Gye Won/GLQ-8724-2022; Liu, Wei/F-1820-2011; Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013	Shi, Lei/0000-0002-4137-096X; soler, martha maricel m gomez/0000-0002-4412-8108; Katritch, Vsevolod/0000-0003-3883-4505; Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Javitch, Jonathan/0000-0001-7395-2967	Protein Structure Initiative (PSI) [U54 GM074961, U54 GM094618]; NIH Roadmap [P50 GM073197]; NIH [R21 RR025336, GM075915]; Pfizer; National Institute on Drug Abuse [DA022413, MH54137, DA023694]; National Science Foundation [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM074961, R01GM075915, R01GM089857, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000424, R00DA023694, K05DA022413] Funding Source: NIH RePORTER	Protein Structure Initiative (PSI); NIH Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Science Foundation(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by Protein Structure Initiative (PSI) grant U54 GM074961 and PSI: Biology grant U54 GM094618 for structure production, NIH Roadmap grant P50 GM073197 for technology development, NIH grant R21 RR025336 (V. C.), and Pfizer. Additional support was provided by the National Institute on Drug Abuse Intramural Research Program (A.H.N.), grants DA022413 and MH54137 (J.A.J.), and grant DA023694 (L. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Science or the NIH. We thank J. Velasquez for help with molecular biology, T. Trinh and K. Allin for help with baculovirus expression, D. Gray for assistance with eticlopride synthesis, M. Griffor for large-scale production of the receptor, X. Qiu for suggestions, and A. Walker for assistance with manuscript preparation. We acknowledge Y. Zheng, The Ohio State University and M. Caffrey, Trinity College (Dublin, Ireland), for the generous loan of the in meso robot (built with support from NIH grant GM075915), the National Science Foundation (grant IIS0308078), and Science Foundation Ireland (grant 02-IN1-B266); and J. Smith, R. Fischetti, and N. Sanishvili at the GM/CA-CAT beamline at the Advanced Photon Source, for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (grant Y1-CO-1020) and the National Institute of General Medical Sciences (grant Y1-GM-1104). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3PBL. A. H. N. is an inventor on a patent application from the National Institutes of Health that covers the use of R-22 and analogs as D3 receptor selective agents. R. C. S. is on the Board of Directors of Receptos, which does structure-directed drug discovery on GPCRs.	Alberts GL, 1998, MOL PHARMACOL, V54, P379, DOI 10.1124/mol.54.2.379; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Boeckler F, 2006, PHARMACOL THERAPEUT, V112, P281, DOI 10.1016/j.pharmthera.2006.04.007; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Civelli Olivier, 1995, P155; DEPAULIS T, 1985, EUR J MED CHEM, V20, P273; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Duman Ronald S., 1995, P303; Gilbert JG, 2005, SYNAPSE, V57, P17, DOI 10.1002/syn.20152; Griffon N, 1996, J NEURAL TRANSM, V103, P1163, DOI 10.1007/BF01271201; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Holmes A, 2004, NEUROPHARMACOLOGY, V47, P1117, DOI 10.1016/j.neuropharm.2004.07.034; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kuzhikandathil EV, 2004, MOL CELL NEUROSCI, V26, P144, DOI 10.1016/j.mcn.2004.01.014; Levant B, 1997, PHARMACOL REV, V49, P231; Newman AH, 2009, J MED CHEM, V52, P2559, DOI 10.1021/jm900095y; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pilla M, 1999, NATURE, V400, P371, DOI 10.1038/43944; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Shi L, 2001, BIOCHEMISTRY-US, V40, P12339, DOI 10.1021/bi011204a; Silvano E, 2010, MOL PHARMACOL, V78, P925, DOI 10.1124/mol.110.065755; Simpson MM, 1999, MOL PHARMACOL, V56, P1116, DOI 10.1124/mol.56.6.1116; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; Spiller K, 2008, PSYCHOPHARMACOLOGY, V196, P533, DOI 10.1007/s00213-007-0986-6; STRADER CD, 1991, J BIOL CHEM, V266, P5; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vorel SR, 2002, J NEUROSCI, V22, P9595; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xi ZX, 2006, NEUROPSYCHOPHARMACOL, V31, P1393, DOI 10.1038/sj.npp.1300912	39	916	931	2	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1091	1095		10.1126/science.1197410	http://dx.doi.org/10.1126/science.1197410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097933	Green Accepted			2022-12-01	WOS:000284374700040
J	Daffis, S; Szretter, KJ; Schriewer, J; Li, JQ; Youn, S; Errett, J; Lin, TY; Schneller, S; Zust, R; Dong, HP; Thiel, V; Sen, GC; Fensterl, V; Klimstra, WB; Pierson, TC; Buller, RM; Gale, M; Shi, PY; Diamond, MS				Daffis, Stephane; Szretter, Kristy J.; Schriewer, Jill; Li, Jianqing; Youn, Soonjeon; Errett, John; Lin, Tsai-Yu; Schneller, Stewart; Zust, Roland; Dong, Hongping; Thiel, Volker; Sen, Ganes C.; Fensterl, Volker; Klimstra, William B.; Pierson, Theodore C.; Buller, R. Mark; Gale, Michael, Jr.; Shi, Pei-Yong; Diamond, Michael S.			2 '-O methylation of the viral mRNA cap evades host restriction by IFIT family members	NATURE			English	Article							NILE-VIRUS-INFECTION; PROTEINS; GENES; METHYLTRANSFERASE; TRANSLATION; IDENTIFICATION; INITIATION; INDUCTION; PROTECTS; ALPHA	Cellular messenger RNA (mRNA) of higher eukaryotes and many viral RNAs are methylated at the N-7 and 2'-O positions of the 5' guanosine cap by specific nuclear and cytoplasmic methyltransferases (MTases), respectively. Whereas N-7 methylation is essential for RNA translation and stability(1), the function of 2'-O methylation has remained uncertain since its discovery 35 years ago(2-4). Here we show that a West Nile virus (WNV) mutant (E218A) that lacks 2'-O MTase activity was attenuated in wild-type primary cells and mice but was pathogenic in the absence of type I interferon (IFN) signalling. 2'-O methylation of viral RNA did not affect IFN induction in WNV-infected fibroblasts but instead modulated the antiviral effects of IFN-induced proteins with tetratricopeptide repeats (IFIT), which are interferon-stimulated genes (ISGs) implicated in regulation of protein translation. Poxvirus and coronavirus mutants that lacked 2'-O MTase activity similarly showed enhanced sensitivity to the antiviral actions of IFN and, specifically, IFIT proteins. Our results demonstrate that the 2'-O methylation of the 5' cap of viral RNA functions to subvert innate host antiviral responses through escape of IFIT-mediated suppression, and suggest an evolutionary explanation for 2'-O methylation of cellular mRNA: to distinguish self from non-self RNA. Differential methylation of cytoplasmic RNA probably serves as an example for pattern recognition and restriction of propagation of foreign viral RNA in host cells.	[Daffis, Stephane; Szretter, Kristy J.; Youn, Soonjeon; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Li, Jianqing; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Buller, R. Mark; Gale, Michael, Jr.; Shi, Pei-Yong; Diamond, Michael S.] Midw Reg Ctr Biodef & Emerging Infect Dis Res, St Louis, MO 63104 USA; [Schriewer, Jill; Buller, R. Mark] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Errett, John; Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Lin, Tsai-Yu; Pierson, Theodore C.] NIH, Viral Pathogenesis Sect, Viral Dis Lab, Bethesda, MD 20892 USA; [Schneller, Stewart] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA; [Zust, Roland; Thiel, Volker] Kantonal Hosp St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Thiel, Volker] Univ Zurich, Vetsuisse Fac, CH-8006 Zurich, Switzerland; [Dong, Hongping; Shi, Pei-Yong] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA; [Sen, Ganes C.; Fensterl, Volker] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Klimstra, William B.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Buller, R. Mark; Gale, Michael, Jr.; Shi, Pei-Yong; Diamond, Michael S.] Pacific NW Reg Ctr Biodef & Emerging Infect Dis R, St Louis, MO 63104 USA; [Buller, R. Mark; Gale, Michael, Jr.; Shi, Pei-Yong; Diamond, Michael S.] NE Reg Ctr Biodef & Emerging Infect Dis Res, St Louis, MO 63104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Saint Louis University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; Auburn University System; Auburn University; Kantonsspital St. Gallen; University of Zurich; State University of New York (SUNY) System; Wadsworth Center; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	diamond@borcim.wustl.edu	Thiel, Volker/AAI-2391-2019; Lin, Tsai-Yu/B-8873-2016; Diamond, Michael/AAH-1733-2019	Lin, Tsai-Yu/0000-0002-8076-1584; Diamond, Michael/0000-0002-8791-3165; Szretter, Kristy/0000-0003-0391-2307; Gale, Michael/0000-0002-6332-7436; Thiel, Volker/0000-0002-5783-0887	National Institutes of Health [U54 AI081680, U19 AI083019, R01 AI074973, R01 AI56540, U54 AI057160, U54 AI057158, R01 CA068782]; Swiss National Science Foundation [3100A0-118425/1]; Novartis Foundation; NATIONAL CANCER INSTITUTE [R01CA068782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, U54AI081680, ZIAAI000957, U19AI056540, R01AI074973, U54AI057158, U19AI083019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants U54 AI081680, U19 AI083019 and R01 AI074973 (to M.G. and M.S.D.), R01 AI56540 (to S.S.), U54 AI057160 (to R.M.B.) and U54 AI057158 (to P.Y.S.), R01 CA068782 (to G.C.S.) the Swiss National Science Foundation, 3100A0-118425/1, and the Novartis Foundation (to V.T. and R.Z.). We thank H. Virgin and B. Moss for reading the manuscript.	Coley SE, 2005, J VIROL, V79, P3097, DOI 10.1128/JVI.79.5.3097-3106.2005; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; LANGBERG SR, 1981, J BIOL CHEM, V256, P54; Latner DR, 2002, VIROLOGY, V301, P64, DOI 10.1006/viro.2002.1538; MUTHUKRISHNAN S, 1978, J BIOL CHEM, V253, P1710; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	25	559	584	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					452	456		10.1038/nature09489	http://dx.doi.org/10.1038/nature09489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085181	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000284313100046
J	Fornoni, A				Fornoni, Alessia			Proteinuria, the Podocyte, and Insulin Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GLOMERULAR PODOCYTE		[Fornoni, Alessia] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Fornoni, Alessia] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA	University of Miami; University of Miami	Fornoni, A (corresponding author), Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA.		Fornoni, Alessia/F-8350-2013	fornoni, Alessia/0000-0002-1313-7773				Coward RJM, 2005, DIABETES, V54, P3095, DOI 10.2337/diabetes.54.11.3095; Engel H, 1996, J NUCL MED, V37, P441; MOGENSEN CE, 1980, DIABETOLOGIA, V18, P453; Musso C, 2006, CLIN J AM SOC NEPHRO, V1, P616, DOI 10.2215/CJN.01271005; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015	6	34	45	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2010	363	21					2068	2069		10.1056/NEJMcibr1008395	http://dx.doi.org/10.1056/NEJMcibr1008395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	681KC	21083394				2022-12-01	WOS:000284310000015
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling Screening for early detection of lung cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				2010, BRIT MED J, V341, pC6480, DOI DOI 10.1136/BMJ.C6480	1	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 17	2010	341								c6544	10.1136/bmj.c6544	http://dx.doi.org/10.1136/bmj.c6544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684WO	21084372				2022-12-01	WOS:000284586200015
J	van Os, J; Kenis, G; Rutten, BPF				van Os, Jim; Kenis, Gunter; Rutten, Bart P. F.			The environment and schizophrenia	NATURE			English	Article							DAILY-LIFE STRESS; PSYCHOTIC SYMPTOMS; CHILDHOOD TRAUMA; CANNABIS USE; NONPSYCHOTIC DISORDERS; FAMILIAL LIABILITY; BIRTH-COHORT; BRAIN-INJURY; RISK-FACTORS; URBANICITY	Psychotic syndromes can be understood as disorders of adaptation to social context. Although heritability is often emphasized, onset is associated with environmental factors such as early life adversity, growing up in an urban environment, minority group position and cannabis use, suggesting that exposure may have an impact on the developing 'social' brain during sensitive periods. Therefore heritability, as an index of genetic influence, may be of limited explanatory power unless viewed in the context of interaction with social effects. Longitudinal research is needed to uncover gene-environment interplay that determines how expression of vulnerability in the general population may give rise to more severe psychopathology.	[van Os, Jim; Kenis, Gunter; Rutten, Bart P. F.] Maastricht Univ, Med Ctr, SEARCH, European Grad Sch Neurosci, NL-6200 MD Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London SE5 8AF, England	Maastricht University; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ, Med Ctr, SEARCH, European Grad Sch Neurosci, NL-6200 MD Maastricht, Netherlands.	j.vanos@sp.unimaas.nl	van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; van Os, Jim/I-9496-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Rutten, Bart/0000-0002-9834-6346	Dutch Health Research Council [10-000-1002]; European Community [HEALTH-F2-2009-241909]	Dutch Health Research Council; European Community(European Commission)	The authors thank P. R. Hof, C. Morgan and M. Wichers for comments on earlier versions of this paper. Supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002), and the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI).	Argyropoulos SV, 2008, ACTA PSYCHIAT SCAND, V118, P214, DOI 10.1111/j.1600-0447.2008.01205.x; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; ARSENEAULT L, AM J PSYCHI IN PRESS; Barkus E, 2010, ANNU REV CLIN PSYCHO, V6, P365, DOI 10.1146/annurev.clinpsy.121208.131220; Bendall S, 2008, SCHIZOPHRENIA BULL, V34, P568, DOI 10.1093/schbul/sbm121; Bourque F, 2011, PSYCHOL MED, V41, P897, DOI 10.1017/S0033291710001406; Boydell J, 2001, BMJ-BRIT MED J, V323, P1336, DOI 10.1136/bmj.323.7325.1336; Bresnahan M, 2007, INT J EPIDEMIOL, V36, P751, DOI 10.1093/ije/dym041; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Carboni E, 2010, NEUROSCIENCE, V168, P156, DOI 10.1016/j.neuroscience.2010.03.046; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chen LS, 2009, SCHIZOPHR RES, V111, P159, DOI 10.1016/j.schres.2009.03.030; Colvert E, 2008, J ABNORM CHILD PSYCH, V36, P1057, DOI 10.1007/s10802-008-9232-x; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; Darroch J, 1997, AM J EPIDEMIOL, V145, P661; DAVID A, 1995, SCHIZOPHR RES, V14, P247, DOI 10.1016/0920-9964(94)00068-J; Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Dominguez MDG, 2010, AM J PSYCHIAT, V167, P1075, DOI 10.1176/appi.ajp.2010.09060883; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Elklit A, 2011, SCHIZOPHRENIA BULL, V37, P1305, DOI 10.1093/schbul/sbq048; Ferdinand RF, 2005, ADDICTION, V100, P612, DOI 10.1111/j.1360-0443.2005.01070.x; Fergusson DM, 2003, PSYCHOL MED, V33, P15, DOI 10.1017/S0033291702006402; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Fisher HL, 2011, SCHIZOPHRENIA BULL, V37, P546, DOI 10.1093/schbul/sbp103; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Galdos M, 2011, SCHIZOPHRENIA BULL, V37, P1179, DOI 10.1093/schbul/sbq029; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; Goodwin RD, 2003, PSYCHOL MED, V33, P1089, DOI 10.1017/S0033291703007888; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Guo SW, 2000, HUM HERED, V50, P286, DOI 10.1159/000022931; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hanssen M, 2003, SOC PSYCH PSYCH EPID, V38, P149, DOI 10.1007/s00127-003-0622-7; Homer BD, 2008, PSYCHOL BULL, V134, P301, DOI 10.1037/0033-2909.134.2.301; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hutchinson G, 1996, BRIT J PSYCHIAT, V169, P776, DOI 10.1192/bjp.169.6.776; Jager G, 2010, J AM ACAD CHILD PSY, V49, P561, DOI 10.1016/j.jaac.2010.02.001; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132; Kaschube M, 2002, J NEUROSCI, V22, P7206; Keen DV, 2010, BRIT J PSYCHIAT, V196, P274, DOI 10.1192/bjp.bp.109.065490; Keller MC, 2010, BEHAV GENET, V40, P377, DOI 10.1007/s10519-009-9320-x; Kelly BD, 2010, SCHIZOPHR RES, V116, P75, DOI 10.1016/j.schres.2009.10.015; KENDLER KS, 1994, AM J PSYCHIAT, V151, P1605; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Lieberman JA, 1997, NEUROPSYCHOPHARMACOL, V17, P205, DOI 10.1016/S0893-133X(97)00045-6; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; March D, 2008, EPIDEMIOL REV, V30, P84, DOI 10.1093/epirev/mxn006; Maric N, 2004, SOC PSYCH PSYCH EPID, V39, P600, DOI 10.1007/s00127-004-0803-z; Mason OJ, 2009, J NERV MENT DIS, V197, P783, DOI 10.1097/NMD.0b013e3181b9760b; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; McMillan KA, 2009, CAN J PSYCHIAT, V54, P477, DOI 10.1177/070674370905400709; Minozzi S, 2010, DRUG ALCOHOL REV, V29, P304, DOI 10.1111/j.1465-3362.2009.00132.x; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Morgan C, 2010, SCHIZOPHRENIA BULL, V36, P655, DOI 10.1093/schbul/sbq051; Morrison PD, 2009, PSYCHOL MED, V39, P1607, DOI 10.1017/S0033291709005522; Mortensen PB, 2010, PSYCHOL MED, V40, P201, DOI 10.1017/S0033291709990419; Mueller SC, 2010, NEUROPSYCHOLOGIA, V48, P3037, DOI 10.1016/j.neuropsychologia.2010.06.013; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Nestor L, 2008, NEUROIMAGE, V40, P1328, DOI 10.1016/j.neuroimage.2007.12.059; Nestor L, 2010, NEUROIMAGE, V49, P1133, DOI 10.1016/j.neuroimage.2009.07.022; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; PETERSON CC, 1995, J CHILD PSYCHOL PSYC, V36, P459, DOI 10.1111/j.1469-7610.1995.tb01303.x; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; RODGERS B, 1990, J CHILD PSYCHOL PSYC, V31, P393, DOI 10.1111/j.1469-7610.1990.tb01577.x; Rutten BPF, 2009, SCHIZOPHRENIA BULL, V35, P1045, DOI 10.1093/schbul/sbp104; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Selten JP, 2005, BRIT J PSYCHIAT, V187, P101, DOI 10.1192/bjp.187.2.101; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Sheu YS, 2010, NEUROIMAGE, V53, P412, DOI 10.1016/j.neuroimage.2010.06.043; Stefanis N, 2006, SCHIZOPHR RES, V85, P266, DOI 10.1016/j.schres.2006.03.036; Taylor SE, 2006, BIOL PSYCHIAT, V60, P296, DOI 10.1016/j.biopsych.2005.09.027; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Toulopoulou T, 2007, ARCH GEN PSYCHIAT, V64, P1348, DOI 10.1001/archpsyc.64.12.1348; van Os J, 2003, AM J PSYCHIAT, V160, P477, DOI 10.1176/appi.ajp.160.3.477; Van Os J, 2000, BRIT J PSYCHIAT, V176, P243, DOI 10.1192/bjp.176.3.243; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; van Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(15)01121-6; VANWINKEL R, ARCH GEN PS IN PRESS; Veling W, 2008, PSYCHOL MED, V38, P1251, DOI 10.1017/S0033291708003474; Veling W, 2008, AM J PSYCHIAT, V165, P66, DOI 10.1176/appi.ajp.2007.07030423; Weiser M, 2004, ACTA PSYCHIAT SCAND, V110, P471, DOI 10.1111/j.1600-0447.2004.00385.x; Weiser M, 2008, BIOL PSYCHIAT, V63, P602, DOI 10.1016/j.biopsych.2007.05.029; Weiser M, 2007, BRIT J PSYCHIAT, V191, P320, DOI 10.1192/bjp.bp.106.031328; Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388; Wichers M, 2008, NEUROPSYCHOPHARMACOL, V33, P3030, DOI 10.1038/sj.npp.1301520; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101; [No title captured], DOI DOI 10.1093/SCHBUL/SBQ011	99	989	997	7	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					203	212		10.1038/nature09563	http://dx.doi.org/10.1038/nature09563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068828				2022-12-01	WOS:000284051000036
J	Gordon, LM; Joester, D				Gordon, Lyle M.; Joester, Derk			Nanoscale chemical tomography of buried organic-inorganic interfaces in the chiton tooth	NATURE			English	Article							SPECIMEN PREPARATION; RADULA TEETH; PROTEIN; MATRIX; BIOMINERALIZATION; CRYSTALS; BONE	Biological organisms possess an unparalleled ability to control the structure and properties of mineralized tissues. They are able, for example, to guide the formation of smoothly curving single crystals or tough, lightweight, self-repairing skeletal elements(1). In many biominerals, an organic matrix interacts with the mineral as it forms, controls its morphology and polymorph, and is occluded during mineralization(2-4). The remarkable functional properties of the resulting composites-such as outstanding fracture toughness and wear resistance-can be attributed to buried organic-inorganic interfaces at multiple hierarchical levels(5). Analysing and controlling such interfaces at the nanometre length scale is critical also in emerging organic electronic and photovoltaic hybrid materials(6). However, elucidating the structural and chemical complexity of buried organic-inorganic interfaces presents a challenge to state-of-the-art imaging techniques. Here we show that pulsed-laser atom-probe tomography reveals three-dimensional chemical maps of organic fibres with a diameter of 5-10 nm in the surrounding nano-crystalline magnetite (Fe3O4) mineral in the tooth of a marine mollusc, the chiton Chaetopleura apiculata. Remarkably, most fibres co-localize with either sodium or magnesium. Furthermore, clustering of these cations in the fibre indicates a structural level of hierarchy previously undetected. Our results demonstrate that in the chiton tooth, individual organic fibres have different chemical compositions, and therefore probably different functional roles in controlling fibre formation and matrix-mineral interactions. Atom-probe tomography is able to detect this chemical/structural heterogeneity by virtue of its high three-dimensional spatial resolution and sensitivity across the periodic table. We anticipate that the quantitative analysis and visualization of nanometre-scale interfaces by laser-pulsed atom-probe tomography will contribute greatly to our understanding not only of biominerals (such as bone, dentine and enamel), but also of synthetic organic-inorganic composites.	[Gordon, Lyle M.; Joester, Derk] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University	Joester, D (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.	d-joester@northwestern.edu	Joester, Derk/B-7525-2009	Gordon, Lyle/0000-0001-8335-0126	Canadian National Sciences and Engineering Research Council; US National Science Foundation [DMR-0805313]; NSF-NSEC; NSF-MRSEC; Keck Foundation; State of Illinois; Northwestern University; NSF-MRI [DMR-0420532]; ONR-DURIP [N00014-0400798, N00014-0610539, N00014-0910781]; Division Of Materials Research [0805313] Funding Source: National Science Foundation	Canadian National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF)); NSF-NSEC(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Keck Foundation(W.M. Keck Foundation); State of Illinois; Northwestern University; NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); ONR-DURIP(Office of Naval Research); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by the Canadian National Sciences and Engineering Research Council and the US National Science Foundation (DMR-0805313). FIB, SEM and (S) TEM work was performed in the Northwestern University Atomic and Nanoscale Characterization and Experimental Center (NUANCE) supported by NSF-NSEC, NSF-MRSEC, the Keck Foundation, the State of Illinois, and Northwestern University. APT measurements were performed at the Northwestern University Center for Atom Probe Tomography (NUCAPT) supported by NSF-MRI (DMR-0420532) and ONR-DURIP (N00014-0400798, N00014-0610539, N00014-0910781). We thank A. Tayi for help in preparing chitin thin film samples; B. Myers (NUANCE) for help with FIB; D. Isheim (NUCAPT), and D. Lawrence, R. Ulfig, T. Prosa and M. Greene (Cameca) for their assistance with APT; and D. Seidman for discussions.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Aizenberg J, 2006, Nanomechanics of Materials and Structures, P99, DOI 10.1007/1-4020-3951-4_10; BAS P, 1995, APPL SURF SCI, V87-8, P298, DOI 10.1016/0169-4332(94)00561-3; Chen YM, 2009, SCRIPTA MATER, V61, P693, DOI 10.1016/j.scriptamat.2009.05.043; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; EVANS LA, 1991, MAR BIOL, V109, P281, DOI 10.1007/BF01319396; EVANS LA, 1990, PHILOS T ROY SOC B, V329, P87, DOI 10.1098/rstb.1990.0153; Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; FLEET ME, 1981, ACTA CRYSTALLOGR B, V37, P917, DOI 10.1107/S0567740881004597; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Hellman OC, 2000, MICROSC MICROANAL, V6, P437, DOI 10.1007/s100050010051; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Koch N, 2007, CHEMPHYSCHEM, V8, P1438, DOI 10.1002/cphc.200700177; Kuhlman KR, 2001, ULTRAMICROSCOPY, V89, P169, DOI 10.1016/S0304-3991(01)00116-4; Larson DJ., 2008, MICROSC MICROANAL, V14, P1254, DOI DOI 10.1017/S1431927608083657; Law NA, 1999, ADV INORG CHEM, V46, P305; LEHN JM, 1994, P INDIAN AS-CHEM SCI, V106, P915; Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583; Li J, 1997, J APPL POLYM SCI, V65, P373; Lowenstam H.A., 1989, BIOMINERALISATION; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Miller M. K., 2000, ATOM PROBE TOMOGRAPH, P139; Miller MK, 2007, MICROSC MICROANAL, V13, P428, DOI 10.1017/S1431927607070845; Miller MK, 2005, ULTRAMICROSCOPY, V102, P287, DOI [10.1016/j.ultramic.2004.10.011, 10.1016/J.ULTRAMIC.2004.10.011]; Omelon SJ, 2008, CHEM REV, V108, P4694, DOI 10.1021/cr0782527; Seidman D., 2009, MAT RES SOC B, V34, P717; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e; Tao JH, 2009, P NATL ACAD SCI USA, V106, P22096, DOI 10.1073/pnas.0909040106; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; Tsai GJ, 2002, FISHERIES SCI, V68, P170, DOI 10.1046/j.1444-2906.2002.00404.x; van der Wal P, 2000, MAT SCI ENG C-BIO S, V7, P129, DOI 10.1016/S0928-4931(99)00129-0; Wang DB, 2009, P NATL ACAD SCI USA, V106, P21511, DOI 10.1073/pnas.0906741106; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001	40	180	183	6	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					194	197		10.1038/nature09686	http://dx.doi.org/10.1038/nature09686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228873				2022-12-01	WOS:000286143400034
J	Saraux, C; Le Bohec, C; Durant, JM; Viblanc, VA; Gauthier-Clerc, M; Beaune, D; Park, YH; Yoccoz, NG; Stenseth, NC; Le Maho, Y				Saraux, Claire; Le Bohec, Celine; Durant, Joel M.; Viblanc, Vincent A.; Gauthier-Clerc, Michel; Beaune, David; Park, Young-Hyang; Yoccoz, Nigel G.; Stenseth, Nils C.; Le Maho, Yvon			Reliability of flipper-banded penguins as indicators of climate change	NATURE			English	Article							POPULATION-DYNAMICS; KING PENGUIN; REPRODUCTION; SURVIVAL; BEHAVIOR	In 2007, the Intergovernmental Panel on Climate Change highlighted an urgent need to assess the responses of marine ecosystems to climate change(1). Because they lie in a high-latitude region, the Southern Ocean ecosystems are expected to be strongly affected by global warming. Using top predators of this highly productive ocean(2) (such as penguins) as integrative indicators may help us assess the impacts of climate change on marine ecosystems(3,4). Yet most available information on penguin population dynamics is based on the controversial use of flipper banding. Although some reports have found the effects of flipper bands to be deleterious(5-8), some short-term (one-year) studies have concluded otherwise(9-11), resulting in the continuation of extensive banding schemes and the use of data sets thus collected to predict climate impact on natural populations(12,13). Here we show that banding of free-ranging king penguins (Aptenodytes patagonicus) impairs both survival and reproduction, ultimately affecting population growth rate. Over the course of a 10-year longitudinal study, banded birds produced 39% fewer chicks and had a survival rate 16% lower than non-banded birds, demonstrating a massive long-term impact of banding and thus refuting the assumption that birds will ultimately adapt to being banded(6,12). Indeed, banded birds still arrived later for breeding at the study site and had longer foraging trips even after 10 years. One of our major findings is that responses of flipper-banded penguins to climate variability (that is, changes in sea surface temperature and in the Southern Oscillation index) differ from those of non-banded birds. We show that only long-term investigations may allow an evaluation of the impact of flipper bands and that every major life-history trait can be affected, calling into question the banding schemes still going on. In addition, our understanding of the effects of climate change on marine ecosystems based on flipper-band data should be reconsidered.	[Saraux, Claire; Le Bohec, Celine; Viblanc, Vincent A.; Beaune, David; Le Maho, Yvon] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, F-67087 Strasbourg, France; [Saraux, Claire; Le Bohec, Celine; Viblanc, Vincent A.; Beaune, David; Le Maho, Yvon] CNRS, UMR7178, F-67037 Strasbourg, France; [Saraux, Claire; Le Bohec, Celine; Durant, Joel M.; Stenseth, Nils C.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Saraux, Claire] ENGREF, AgroParisTech, F-75732 Paris, France; [Gauthier-Clerc, Michel] Ctr Rech Tour Valat, F-13200 Arles, France; [Park, Young-Hyang] Museum Natl Hist Nat, USM LOCEAN 0402, Dept Milieux & Peuplements Aquat, F-75231 Paris, France; [Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, N-9037 Tromso, Norway; [Stenseth, Nils C.] Inst Marine Res, Flodevigen Marine Res Stn, N-4817 His, Norway	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oslo; AgroParisTech; Museum National d'Histoire Naturelle (MNHN); UiT The Arctic University of Tromso; Institute of Marine Research - Norway	Saraux, C (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, 23 Rue Becquerel, F-67087 Strasbourg, France.	claire.saraux@c-strasbourg.fr; yvon.lemaho@iphc.cnrs.fr	Durant, Joël/D-3821-2013; Yoccoz, Nigel/C-8561-2014; saraux, claire/AAX-8709-2020; LE BOHEC, CELINE/AAD-3589-2022; Stenseth, Nils Christian/G-5212-2016	Durant, Joël/0000-0002-1129-525X; Yoccoz, Nigel/0000-0003-2192-1039; saraux, claire/0000-0001-5061-4009; Viblanc, Vincent/0000-0002-4953-659X; Stenseth, Nils Christian/0000-0002-1591-5399; Beaune, David/0000-0002-2329-1598; LE BOHEC, Celine/0000-0003-0149-6477	Institut Polaire Francais-Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique; European Commission; Norwegian Research Council; YGGDRASIL programme	Institut Polaire Francais-Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Commission(European CommissionEuropean Commission Joint Research Centre); Norwegian Research Council(Research Council of NorwayEuropean Commission); YGGDRASIL programme	We thank P. Trathan for his comments on the paper. We are grateful to C. Salmon for his help in pre-analysing data. We thank M. Ballesteros, C. Bricaud, N. Chatelain, G. Conan, S. Descamps, J. Dutel, C. Gilbert, S. Gravier, A. Hergott, G. Kuntz, N. Lambert, T. Lebard, N. Lecomte, J. Legrand, S. Mangin, V. Mosch, S. Quemeneur, A. Simon, E. Taquet and C. Villemin, for their help with field work. We also thank I. Durant for her help with chlorophyll data. This work was supported by the Institut Polaire Francais-Paul-Emile Victor, the Fondation Bettencourt-Schueller, the Fondation des Treilles and the Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique), and grants from the European Commission (Marie Curie, to C. L. B.), the Norwegian Research Council through the Match/Mismatch and Ecosystem project (to J. M. D.) and the YGGDRASIL programme (to C.S.).	Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; BARRAT A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; Bates D., 2009, CRAN PACKAGE LME4; Boersma PD, 2010, J FIELD ORNITHOL, V81, P195, DOI 10.1111/j.1557-9263.2010.00277.x; Boersma PD, 2009, J FIELD ORNITHOL, V80, P408, DOI 10.1111/j.1557-9263.2009.00248.x; Boulinier T, 2008, BIOL LETTERS, V4, P538, DOI 10.1098/rsbl.2008.0291; Caswell H., 2001, MATRIX POPULATION MO, P72; Croxall J.P., 1988, P261; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Descamps Sebastien, 2002, Avian Science, V2, P87; DESER C, 1987, J GEOPHYS RES-OCEANS, V92, P14189, DOI 10.1029/JC092iC13p14189; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Fallow PM, 2009, J WILDLIFE MANAGE, V73, P1348, DOI 10.2193/2008-146; Froget G, 1998, POLAR BIOL, V20, P409, DOI 10.1007/s003000050322; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Gendner JP, 2005, J FIELD ORNITHOL, V76, P138, DOI 10.1648/0273-8570-76.2.138; Groscolas R, 2001, COMP BIOCHEM PHYS A, V128, P645, DOI 10.1016/S1095-6433(00)00341-X; Hindell MA, 1996, IBIS, V138, P557, DOI 10.1111/j.1474-919X.1996.tb08080.x; Jackson S, 2002, FUNCT ECOL, V16, P141, DOI 10.1046/j.0269-8463.2001.00606.x; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; KOZLOV AN, 1989, J ICHTHYOL, V29, P160; Le Bohec C, 2008, P NATL ACAD SCI USA, V105, P2493, DOI 10.1073/pnas.0712031105; Lebreton J.-D., 1991, BIRD POPULATION STUD, P105; LEMAHO Y, 1993, MAR ECOL PROG SER, V95, P1, DOI 10.3354/meps095001; May RM, 2004, NATURE, V431, P403, DOI 10.1038/431403a; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Olsson O, 1996, J AVIAN BIOL, V27, P7, DOI 10.2307/3676955; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Stearns S.C., 1992, pi; Stonehouse B., 1960, SCI REPT FALKLAND IS, V23, P1; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; Wolfaardt Anton C., 2003, P18	36	145	147	1	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					203	206		10.1038/nature09630	http://dx.doi.org/10.1038/nature09630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228875				2022-12-01	WOS:000286143400036
J	Zha, S; Guo, CG; Boboila, C; Oksenych, V; Cheng, HL; Zhang, Y; Wesemann, DR; Yuen, G; Patel, H; Goff, PH; Dubois, RL; Alt, FW				Zha, Shan; Guo, Chunguang; Boboila, Cristian; Oksenych, Valentyn; Cheng, Hwei-Ling; Zhang, Yu; Wesemann, Duane R.; Yuen, Grace; Patel, Harin; Goff, Peter H.; Dubois, Richard L.; Alt, Frederick W.			ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks	NATURE			English	Article							DOUBLE-STRAND BREAKS; GENOMIC INSTABILITY; V(D)J RECOMBINATION; HISTONE H2AX; TRANSLOCATIONS; LYMPHOCYTES; CERNUNNOS; MECHANISM; PATHWAY; MICE	Classical non-homologous DNA end-joining (NHEJ) is a major mammalian DNA double-strand-break (DSB) repair pathway. Deficiencies for classical NHEJ factors, such as XRCC4, abrogate lymphocyte development, owing to a strict requirement for classical NHEJ to join V(D) J recombination DSB intermediates(1,2). The XRCC4-like factor (XLF; also called NHEJ1) is mutated in certain immunodeficient human patients and has been implicated in classical NHEJ(3-6); however, XLF-deficient mice have relatively normal lymphocyte development and their lymphocytes support normal V(D) J recombination(5). The ataxia telangiectasia-mutated protein (ATM) detects DSBs and activates DSB responses by phosphorylating substrates including histone H2AX(7). However, ATM deficiency causes only modest V(D) J recombination and lymphocyte developmental defects, and H2AX deficiency does not have a measurable impact on these processes(7-9). Here we show that XLF, ATM and H2AX all have fundamental roles in processing and joining DNA ends during V(D) J recombination, but that these roles have been masked by unanticipated functional redundancies. Thus, combined deficiency of ATM and XLF nearly blocks mouse lymphocyte development due to an inability to process and join chromosomal V(D) J recombination DSB intermediates. Combined XLF and ATM deficiency also severely impairs classical NHEJ, but not alternative end-joining, during IgH class switch recombination. Redundant ATM and XLF functions in classical NHEJ are mediated by ATM kinase activity and are not required for extra-chromosomal V(D) J recombination, indicating a role for chromatin-associated ATM substrates. Correspondingly, conditional H2AX inactivation in XLF-deficient pro-B lines leads to V(D) J recombination defects associated with marked degradation of unjoined V(D) J ends, revealing that H2AX has a role in this process.	[Zha, Shan; Guo, Chunguang; Boboila, Cristian; Oksenych, Valentyn; Cheng, Hwei-Ling; Zhang, Yu; Wesemann, Duane R.; Yuen, Grace; Patel, Harin; Goff, Peter H.; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Boston, MA 02115 USA; [Zha, Shan; Guo, Chunguang; Boboila, Cristian; Oksenych, Valentyn; Cheng, Hwei-Ling; Zhang, Yu; Wesemann, Duane R.; Yuen, Grace; Patel, Harin; Goff, Peter H.; Alt, Frederick W.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Dubois, Richard L.] Columbia Univ, Inst Canc Genet, Dept Pediat, Dept Pathol & Cell Biol, New York, NY 10032 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Columbia University	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Oksenych, Valentyn/J-6216-2019; Yuen, Grace/M-9383-2019	Oksenych, Valentyn/0000-0002-5088-3791; Yuen, Grace/0000-0002-3253-9575; Wesemann, Duane/0000-0002-6690-944X; Goff, Peter/0000-0002-3488-4997; Zha, Shan/0000-0002-6568-1818	NIH [AI076210, AI020047, AI007376]; Cancer Research Institute; AAAI/GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089972, R01AI020047, R37AI020047, T32AI007376, P01AI076210] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; AAAI/GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Fujiwara and P. Huang for technical support. We thank B. Sleckman for advice, reagents and for critical review of this manuscript. This work is supported by NIH grant AI076210 and AI020047 to F. W. A. F. W. A. is an investigator of the Howard Hughes Medical Institute. S.Z. was a fellow, then senior fellow of Leukemia and Lymphomas Society of America and a St Baldrick Scholar. C. G. and Y.Z. are fellows of Cancer Research Institute. C. B. receives support from the pre-doctoral training program of Cancer Research Institute. D. R. W. is supported by a career development award from AAAI/GlaxoSmithKline and by NIH training grant AI007376.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; GELLERT M, 1992, ANNU REV GENET, V26, P425, DOI 10.1146/annurev.ge.26.120192.002233; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104	26	151	152	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					250	254		10.1038/nature09604	http://dx.doi.org/10.1038/nature09604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21160472	Green Accepted			2022-12-01	WOS:000286143400046
J	Kuhns, DB; Alvord, WG; Heller, T; Feld, JJ; Pike, KM; Marciano, BE; Uzel, G; DeRavin, SS; Priel, DAL; Soule, BP; Zarember, KA; Malech, HL; Holland, SM; Gallin, JI				Kuhns, Douglas B.; Alvord, W. Gregory; Heller, Theo; Feld, Jordan J.; Pike, Kristen M.; Marciano, Beatriz E.; Uzel, Gulbu; DeRavin, Suk See; Priel, Debra A. Long; Soule, Benjamin P.; Zarember, Kol A.; Malech, Harry L.; Holland, Steven M.; Gallin, John I.			Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOLOGICALLY IMPORTANT MUTATIONS; MARROW-TRANSPLANTATION; RESPIRATORY-BURST; INVOLVEMENT; DEFICIENCY; GP91-PHOX; DOMAIN; RISK	Background: Failure to generate phagocyte-derived superoxide and related reactive oxygen intermediates (ROIs) is the major defect in chronic granulomatous disease, causing recurrent infections and granulomatous complications. Chronic granulomatous disease is caused by missense, nonsense, frameshift, splice, or deletion mutations in the genes for p22(sup phox), p40(sup phox), p47(sup phox), p67(sup phox) (autosomal chronic granulomatous disease), or gp91(sup phox) (X-linked chronic granulomatous disease), which result in variable production of neutrophil-derived ROIs. We hypothesized that residual ROI production might be linked to survival in patients with chronic granulomatous disease. Methods: We assessed the risks of illness and death among 287 patients with chronic granulomatous disease from 244 kindreds. Residual ROI production was measured with the use of superoxide-dependent ferricytochrome c reduction and flow cytometry with dihydrorhodamine oxidation assays. Expression of NADPH oxidase component protein was detected by means of immunoblotting, and the affected genes were sequenced to identify causal mutations. Results: Survival of patients with chronic granulomatous disease was strongly associated with residual ROI production as a continuous variable, independently of the specific gene affected. Patients with mutations in p47(sup phox) and most missense mutations in gp91(sup phox) (with the exception of missense mutations in the nucleotide-binding and heme-binding domains) had more residual ROI production than patients with nonsense, frameshift, splice, or deletion mutations in gp91(sup phox). After adolescence, mortality curves diverged according to the extent of residual ROI production. Conclusions: Patients with chronic granulomatous disease and modest residual production of ROI have significantly less severe illness and a greater likelihood of long-term survival than patients with little residual ROI production. The production of residual ROI is predicted by the specific NADPH oxidase mutation, regardless of the specific gene affected, and it is a predictor of survival in patients with chronic granulomatous disease. (Funded by the National Institutes of Health.) N Engl J Med 2010;363:2600-10.	[DeRavin, Suk See; Soule, Benjamin P.; Zarember, Kol A.; Malech, Harry L.; Gallin, John I.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Kuhns, Douglas B.; Priel, Debra A. Long] SAIC Frederick, Clin Serv Program, Frederick, MD USA; [Pike, Kristen M.] SAIC Frederick, Lab Mol Technol, Frederick, MD USA; [Alvord, W. Gregory] NCI Frederick, Biostat Consulting Div, Data Management Serv, Frederick, MD USA; [Heller, Theo] NIDDKD, Liver Dis Branch, Bethesda, MD USA; [Marciano, Beatriz E.; Uzel, Gulbu; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [DeRavin, Suk See; Soule, Benjamin P.; Zarember, Kol A.; Malech, Harry L.; Gallin, John I.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Feld, Jordan J.] Univ Toronto, Toronto Western Hosp, McLaughlin Rotman Ctr Global Hlth, Ctr Liver, Toronto, ON M5T 2S8, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Science Applications International Corporation (SAIC); SAIC-Frederick; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gallin, JI (corresponding author), NIAID, Host Def Lab, NIH, Bldg 10,Rm 6-2551, Bethesda, MD 20892 USA.	jgallin@cc.nih.gov	Feld, Jordan/AAH-5628-2020	Feld, Jordan/0000-0003-2640-2211; De Ravin, Suk See/0000-0002-9800-774X; Malech, Harry/0000-0001-5874-5775; Heller, Theo/0000-0002-2643-6289; Zarember, Kol/0000-0002-9624-7096	National Institute of Allergy and Infectious Diseases [Z01-AI-000155, Z01-AI-000645, Z01-AI-00646-06]; National Institute of Diabetes and Digestive and Kidney Diseases [ZIA DK075008-04 LDB]; National Cancer Institute [HH-SN261200800001E]; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000645, ZIAAI000646, Z01AI000646, Z01AI000155, Z01AI000645, ZIAAI000155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075008] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by intramural grants from the National Institute of Allergy and Infectious Diseases (Z01-AI-000155, Z01-AI-000645, and Z01-AI-00646-06), a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (ZIA DK075008-04 LDB), and a contract from the National Cancer Institute (HH-SN261200800001E).; Funded by the National Institutes of Health	Anderson-Cohen M, 2003, CLIN IMMUNOL, V109, P308, DOI 10.1016/j.clim.2003.08.002; BERENDES H, 1957, Minn Med, V40, P309; Cale CM, 2000, CLIN EXP IMMUNOL, V120, P351, DOI 10.1046/j.1365-2249.2000.01234.x; Carnide EG, 2005, PEDIATR ALLERGY IMMU, V16, P5, DOI 10.1111/j.1399-3038.2005.00225.x; Collett, 2014, MODELLING SURVIVAL D; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COOPER MR, 1972, J CLIN INVEST, V51, P769, DOI 10.1172/JCI106871; Cross AR, 1996, BLOOD CELL MOL DIS, V22, P268, DOI 10.1006/bcmd.1996.0109; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; Feld JJ, 2008, GASTROENTEROLOGY, V134, P1917, DOI 10.1053/j.gastro.2008.02.081; Foster CB, 1998, J CLIN INVEST, V102, P2146, DOI 10.1172/JCI5084; FREY D, 1988, BLOOD, V71, P252; Gallin JI, 2003, NEW ENGL J MED, V348, P2416, DOI 10.1056/NEJMoa021931; Guide SV, 2003, J INFECT DIS, V187, P845, DOI 10.1086/368388; Han CH, 2001, J BIOCHEM-TOKYO, V129, P513, DOI 10.1093/oxfordjournals.jbchem.a002885; Heyworth PG, 2001, BLOOD CELL MOL DIS, V27, P16, DOI 10.1006/bcmd.2000.0347; Jirapongsananuruk O, 2003, J ALLERGY CLIN IMMUN, V111, P374, DOI 10.1067/mai.2003.58; Kang EM, 2009, IMMUNOL RES, V43, P77, DOI 10.1007/s12026-008-8051-z; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kaufman L, 2009, FINDING GROUPS DATA; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lekstrom-Himes JA, 2005, J IMMUNOL, V174, P411, DOI 10.4049/jimmunol.174.1.411; LUCARELLI G, 1993, NEW ENGL J MED, V329, P840, DOI 10.1056/NEJM199309163291204; Marciano BE, 2004, CLIN INFECT DIS, V39, P692, DOI 10.1086/422993; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; MARGOLIS DM, 1990, J INFECT DIS, V162, P723, DOI 10.1093/infdis/162.3.723; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Mauch L, 2007, CLIN CHEM, V53, P890, DOI 10.1373/clinchem.2006.083444; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Rae J, 1998, AM J HUM GENET, V62, P1320, DOI 10.1086/301874; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; SCHAPIRO BL, 1991, NEW ENGL J MED, V325, P1786, DOI 10.1056/NEJM199112193252506; Sodani P, 2004, BLOOD, V104, P1201, DOI 10.1182/blood-2003-08-2800; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; VOLPP BD, 1993, J CLIN INVEST, V91, P201, DOI 10.1172/JCI116171; Weening RS, 2000, CLIN EXP IMMUNOL, V122, P410, DOI 10.1046/j.1365-2249.2000.01405.x; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Yoshida LS, 1998, J BIOL CHEM, V273, P27879, DOI 10.1074/jbc.273.43.27879	40	356	369	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2600	2610		10.1056/NEJMoa1007097	http://dx.doi.org/10.1056/NEJMoa1007097			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190454	Green Accepted			2022-12-01	WOS:000285763700005
J	Eisenstein, M				Eisenstein, Michael			The first supper	NATURE			English	Editorial Material																		Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504	3	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S8	S9		10.1038/468S8a	http://dx.doi.org/10.1038/468S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179084	Bronze			2022-12-01	WOS:000285553800003
J	Fiumara, F; Fioriti, L; Kandel, ER; Hendrickson, WA				Fiumara, Ferdinando; Fioriti, Luana; Kandel, Eric R.; Hendrickson, Wayne A.			Essential Role of Coiled Coils for Aggregation and Activity of Q/N-Rich Prions and PolyQ Proteins	CELL			English	Article							CRYSTAL-STRUCTURE; SECONDARY STRUCTURE; TERMINAL DOMAIN; GLUTAMINE-RICH; APLYSIA CPEB; YEAST; SEQUENCE; PEPTIDES; ANGSTROM; FIBRILS	The functional switch of glutamine/asparagine (Q/N)-rich prions and the neurotoxicity of polyQ-expanded proteins involve complex aggregation-prone structural transitions, commonly presumed to be forming beta sheets. By analyzing sequences of interaction partners of these proteins, we discovered a recurrent presence of coiled-coil domains both in the partners and in segments that flank or overlap Q/N-rich and polyQ domains. Since coiled coils can mediate protein interactions and multimerization, we studied their possible involvement in Q/N-rich and polyQ aggregations. Using circular dichroism and chemical crosslinking, we found that Q/N-rich and polyQ peptides form alpha-helical coiled coils in vitro and assemble into multimers. Using structure-guided mutagenesis, we found that coiled-coil domains modulate in vivo properties of two Q/N-rich prions and polyQ-expanded huntingtin. Mutations that disrupt coiled coils impair aggregation and activity, whereas mutations that enhance coiled-coil propensity promote aggregation. These findings support a coiled-coil model for the functional switch of Q/N-rich prions and for the pathogenesis of polyQ-expansion diseases.	[Fiumara, Ferdinando; Fioriti, Luana; Kandel, Eric R.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Fioriti, Luana; Kandel, Eric R.; Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Fiumara, Ferdinando] Univ Turin, Dept Neurosci, I-10124 Turin, Italy	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; University of Turin	Kandel, ER (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	erk5@columbia.edu; wayne@convex.hhmi.columbia.edu	Fioriti, Luana/AAN-7207-2021; Fiumara, Ferdinando/AAE-3074-2022	fioriti, luana/0000-0003-2429-8967; FIUMARA, Ferdinando/0000-0003-0715-7863	HHMI; Mathers Foundation; Broitman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060762] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Mathers Foundation; Broitman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Emi Ling for technical support; Francisco Monje, Burkhard Rost, and Ann McDermott for helpful discussions and suggestions; and Craig Bailey, Christoph Kellendonk, and Radegonda Mazzitelli for critical reading of the manuscript. This work was supported by grants from HHMI, Mathers Foundation, and Broitman Foundation.	Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Chang DK, 1999, J STRUCT BIOL, V128, P270, DOI 10.1006/jsbi.1999.4182; COLLOCH N, 1991, J MOL BIOL, V221, P603, DOI 10.1016/0022-2836(91)80075-6; Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042; Deng YQ, 2007, PROTEIN SCI, V16, P323, DOI 10.1110/ps.062590807; Frost DWH, 2005, BIOPOLYMERS, V80, P26, DOI 10.1002/bip.20188; Gazi AD, 2008, J BIOL CHEM, V283, P34062, DOI 10.1074/jbc.M803408200; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1002, DOI 10.1038/nsb1296-1002; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Harada N, 2010, J STEROID BIOCHEM, V118, P77, DOI 10.1016/j.jsbmb.2009.10.003; Hicks MR, 2002, J STRUCT BIOL, V137, P73, DOI 10.1006/jsbi.2002.4462; Kelley NW, 2009, J MOL BIOL, V388, P919, DOI 10.1016/j.jmb.2009.01.032; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Krammer C, 2009, P NATL ACAD SCI USA, V106, P462, DOI 10.1073/pnas.0811571106; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; Lathrop R H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P105; Leitgeb B, 2007, J MOL MODEL, V13, P1141, DOI 10.1007/s00894-007-0241-4; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martin J, 2004, TRENDS BIOCHEM SCI, V29, P455, DOI 10.1016/j.tibs.2004.07.004; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Narayanan S, 2006, CHEMBIOCHEM, V7, P757, DOI 10.1002/cbic.200500382; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Niu Q, 2008, J MOL BIOL, V375, P1197, DOI 10.1016/j.jmb.2007.11.036; Odgren PR, 1996, PROTEINS, V24, P467, DOI 10.1002/(SICI)1097-0134(199604)24:4<467::AID-PROT6>3.0.CO;2-B; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; Ono BI, 2008, PRION, V2, P37, DOI 10.4161/pri.2.1.6436; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Potekhin SA, 2001, CHEM BIOL, V8, P1025, DOI 10.1016/S1074-5521(01)00073-4; PRUSINER SB, 1987, ANNU REV MED, V38, P381, DOI 10.1146/annurev.me.38.020187.002121; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Schwalbe M, 2010, PROTEINS, V78, P2433, DOI 10.1002/prot.22752; Shin DH, 2006, PROTEIN SCI, V15, P921, DOI 10.1110/ps.051993506; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Xu SH, 2007, AMYLOID, V14, P119, DOI 10.1080/13506120701260059; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang ZN, 1999, J STRUCT BIOL, V126, P131, DOI 10.1006/jsbi.1999.4116	53	170	170	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1121	1135		10.1016/j.cell.2010.11.042	http://dx.doi.org/10.1016/j.cell.2010.11.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183075	Green Accepted, Bronze			2022-12-01	WOS:000285625400010
J	Nijhout, HF; Grunert, LW				Nijhout, H. Frederik; Grunert, Laura W.			The Cellular and Physiological Mechanism of Wing-Body Scaling in Manduca sexta	SCIENCE			English	Article							PROTHORACIC GLAND; TOBACCO HORNWORM; CRITICAL WEIGHT; IMAGINAL DISKS; SIZE; DROSOPHILA; GROWTH; ECDYSONE; INSECTS; NUTRITION	In animals, appendages develop in proportion to overall body size; when individual size varies, appendages covary proportionally. In insects with complete metamorphosis, adult appendages develop from precursor tissues called imaginal disks that grow after somatic growth has ceased. It is unclear, however, how the growth of these appendages is matched to the already established body size. We studied the pattern of cell division in the tobacco hornworm Manduca sexta and found that both the rate of cell division and the duration of growth of the wing imaginal disks depend on the size of the body in which they develop. Moreover, we found that both of these processes are controlled by the level and duration of secretion of the steroid hormone ecdysone. Thus, proportional growth is under hormonal control and indirectly regulated by the central nervous system.	[Nijhout, H. Frederik; Grunert, Laura W.] Duke Univ, Dept Biol, Durham, NC 27705 USA	Duke University	Nijhout, HF (corresponding author), Duke Univ, Dept Biol, Durham, NC 27705 USA.	hfn@duke.edu			NSF [IOS-0641144, IOS-0744952]	NSF(National Science Foundation (NSF))	We thank C. Shreve, V. Callier, R. Dilling, K. Preuss, and I. Jalli for assistance and helpful discussions. Supported by NSF grants IOS-0641144 and IOS-0744952.	ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/S0065-2504(08)60212-3; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Champlin DT, 1998, DEVELOPMENT, V125, P2009; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; KATO Y, 1987, DEVELOPMENT, V100, P227; Kingan TG, 2000, J EXP BIOL, V203, P3011; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Leopold P, 2006, SCIENCE, V312, P1317, DOI 10.1126/science.1128343; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2009, DEVELOPMENT, V136, P2345, DOI 10.1242/dev.032672; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43; NIJHOUT H.F., 1994, INSECT HORMONES; Nijhout HF, 2007, DEV BIOL, V302, P569, DOI 10.1016/j.ydbio.2006.10.023; NIJHOUT HF, 1979, J INSECT PHYSIOL, V25, P277, DOI 10.1016/0022-1910(79)90055-6; NIJHOUT HF, 1984, J INSECT PHYSIOL, V30, P629, DOI 10.1016/0022-1910(84)90047-7; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Orme MH, 2005, CELL METAB, V2, P277, DOI 10.1016/j.cmet.2005.10.005; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SCHWARTZ LM, 1983, DEV BIOL, V99, P103, DOI 10.1016/0012-1606(83)90257-9; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Stern DL, 1999, DEVELOPMENT, V126, P1091; TRUMAN JW, 1981, AM ZOOL, V21, P655; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	34	55	55	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	2010	330	6011					1693	1695		10.1126/science.1197292	http://dx.doi.org/10.1126/science.1197292			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21109634				2022-12-01	WOS:000285390500071
J	Moravcevic, K; Mendrola, JM; Schmitz, KR; Wang, YH; Slochower, D; Janmey, PA; Lemmon, MA				Moravcevic, Katarina; Mendrola, Jeannine M.; Schmitz, Karl R.; Wang, Yu-Hsiu; Slochower, David; Janmey, Paul A.; Lemmon, Mark A.			Kinase Associated-1 Domains Drive MARK/PAR1 Kinases to Membrane Targets by Binding Acidic Phospholipids	CELL			English	Article							PROTEIN-KINASE; MOLECULAR DISSECTION; PLASMA-MEMBRANE; SEPTIN; CHECKPOINT; ORGANIZATION; MORPHOGENESIS; LOCALIZATION; RECOGNITION; ACTIVATION	Phospholipid-binding modules such as PH, C1, and C2 domains play crucial roles in location-dependent regulation of many protein kinases. Here, we identify the KA1 domain (kinase associated-1 domain), found at the C terminus of yeast septin-associated kinases (Kcc4p, Gin4p, and Hsl1p) and human MARK/PAR1 kinases, as a membrane association domain that binds acidic phospholipids. Membrane localization of isolated KA1 domains depends on phosphatidylserine. Using X-ray crystallography, we identified a structurally conserved binding site for anionic phospholipids in KA1 domains from Kcc4p and MARK1. Mutating this site impairs membrane association of both KA1 domains and intact proteins and reveals the importance of phosphatidylserine for bud neck localization of yeast Kcc4p. Our data suggest that KA1 domains contribute to "coincidence detection," allowing kinases to bind other regulators (such as septins) only at the membrane surface. These findings have important implications for understanding MARK/PAR1 kinases, which are implicated in Alzheimer's disease, cancer, and autism.	[Moravcevic, Katarina; Mendrola, Jeannine M.; Lemmon, Mark A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Moravcevic, Katarina; Schmitz, Karl R.; Slochower, David; Janmey, Paul A.; Lemmon, Mark A.] Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA; [Janmey, Paul A.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Wang, Yu-Hsiu] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Wang, Yu-Hsiu; Slochower, David; Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Wang, Yu-Hsiu/N-8094-2013	Wang, Yu-Hsiu/0000-0001-9753-5535; Schmitz, Karl/0000-0003-1411-7624; Lemmon, Mark/0000-0002-3379-5319	NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy [DE-AC02-06CH11357]; NIGMS; NSF [DMR-0936384]; NIH [RR-01646, R01-GM056846]; American Heart Association Great Rivers Affiliate; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275, R01GM056846] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Great Rivers Affiliate(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Lemmon, Ferguson, and Bi laboratories and Ben Black, Jim Shorter, and Greg Van Duyne for constructive comments. Erfei Bi, Scott Emr, and Daryll DeWald provided yeast strains used in this study. Crystallographic data were collected in part at the GM/CA Collaborative Access Team at the Advanced Photon Source (APS), funded by NCI (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of APS was supported by the U.S. Department of Energy, under contract No. DE-AC02-06CH11357. Additional crystallographic data were collected at beamline F2 at the Cornell High Energy Synchrotron Source (CHESS), supported by NIGMS and the NSF (under award DMR-0936384), using the Macromolecular Diffraction at CHESS (MacCHESS) facility, supported by the NIH (award RR-01646). This work was funded in part by NIH grant R01-GM056846 (to M. A. L.) and a predoctoral fellowship from the American Heart Association Great Rivers Affiliate (K.M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Crutchley J, 2009, MOL BIOL CELL, V20, P1926, DOI 10.1091/mbc.E08-08-0848; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Demel R A, 1994, Subcell Biochem, V23, P83; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Elbert M, 2005, MOL BIOL CELL, V16, P532, DOI 10.1091/mbc.E04-07-0549; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Halstead JR, 2005, TRENDS PHARMACOL SCI, V26, P654, DOI 10.1016/j.tips.2005.10.004; Hanrahan J, 2003, MOL CELL, V12, P663, DOI 10.1016/j.molcel.2003.08.006; HIKIJI T, 1988, J BIOCHEM-TOKYO, V104, P894, DOI 10.1093/oxfordjournals.jbchem.a122579; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Okuzaki D, 2001, FEBS LETT, V489, P197, DOI 10.1016/S0014-5793(01)02104-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; Sanchez-Barrena MJ, 2007, MOL CELL, V26, P427, DOI 10.1016/j.molcel.2007.04.013; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shulewitz MJ, 1999, MOL CELL BIOL, V19, P7123; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stahelin RV, 2007, J BIOL CHEM, V282, P25737, DOI 10.1074/jbc.M702861200; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Szkotnicki L, 2008, MOL BIOL CELL, V19, P4675, DOI 10.1091/mbc.E08-06-0663; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	61	119	124	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					966	977		10.1016/j.cell.2010.11.028	http://dx.doi.org/10.1016/j.cell.2010.11.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145462	Green Accepted, Bronze			2022-12-01	WOS:000285182600013
J	Coll, NS; Vercammen, D; Smidler, A; Clover, C; Van Breusegem, F; Dangl, JL; Epple, P				Coll, Nuria S.; Vercammen, Dominique; Smidler, Andrea; Clover, Charles; Van Breusegem, Frank; Dangl, Jeffery L.; Epple, Petra			Arabidopsis Type I Metacaspases Control Cell Death	SCIENCE			English	Article							DISEASE RESISTANCE; SIGNALING COMPONENTS; THALIANA; PROTEASE; LESION-SIMULATING-DISEASE1; ACCLIMATION; SPECIFICITY; BACTERIAL; PATHOGEN; FAMILIES	Metacaspases are distant relatives of animal caspases found in protozoa, fungi, and plants. Limited experimental data exist defining their function(s), despite their discovery by homology modeling a decade ago. We demonstrated that two type I metacaspases, AtMC1 and AtMC2, antagonistically control programmed cell death in Arabidopsis. AtMC1 is a positive regulator of cell death and requires conserved caspase-like putative catalytic residues for its function. AtMC2 negatively regulates cell death. This function is independent of the putative catalytic residues. Manipulation of the Arabidopsis type I metacaspase regulatory module can nearly eliminate the hypersensitive cell death response (HR) activated by plant intracellular immune receptors. This does not lead to enhanced pathogen proliferation, decoupling HR from restriction of pathogen growth.	[Coll, Nuria S.; Smidler, Andrea; Clover, Charles; Dangl, Jeffery L.; Epple, Petra] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Vercammen, Dominique; Van Breusegem, Frank] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Vercammen, Dominique; Van Breusegem, Frank] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, 108 Coker Hall,CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu; pepple@email.unc.edu	Coll, Núria Sánchez/L-4961-2015; Van Breusegem, Frank/Y-2999-2019; Van Breusegem, Frank/AAJ-2647-2020; Coll, Nuria S./Y-6326-2019	Coll, Núria Sánchez/0000-0002-8889-0399; Van Breusegem, Frank/0000-0002-3147-0860; Coll, Nuria S./0000-0002-8889-0399; Smidler, Andrea/0000-0002-3281-1161	NIH [RO1 GM057171]; Swiss National Science Foundation [PBEZA-115173]; Ghent University [12051403]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057171] Funding Source: NIH RePORTER; Direct For Biological Sciences [0639964] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ghent University(Ghent University); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. McDowell (Virginia Tech, Blacksburg, VA) and M. Nishimura (UNC) for critical reading of the manuscript. This work was funded by NIH RO1 GM057171 to J. L. D.; a Swiss National Science Foundation Fellowship (PBEZA-115173) to N.S.C.; and the Research Fund, Ghent University (grant 12051403), and Fonds voor Wetenschappelijk Onderzoek-Vlaanderen to F. V. B. and D. V., respectively. We thank D. Baltrus for statistical analysis, T. Perdue of the UNC Biology Microscope Facility for patient and expert assistance, E. Washington and T. Eitas for pMDC7 vectors, B. van de Cotte for technical assistance, and K. Overmyer for early contributions to this work.	Aravind L, 2002, PROTEINS, V46, P355, DOI 10.1002/prot.10060; Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chichkova NV, 2010, EMBO J, V29, P1149, DOI 10.1038/emboj.2010.1; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hatsugai N, 2009, GENE DEV, V23, P2496, DOI 10.1101/gad.1825209; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Lam E, 2000, PLANT MOL BIOL, V44, pVII; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; Muhlenbock P, 2008, PLANT CELL, V20, P2339, DOI 10.1105/tpc.108.059618; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200	31	287	315	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1393	1397		10.1126/science.1194980	http://dx.doi.org/10.1126/science.1194980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21097903				2022-12-01	WOS:000284902100046
J	Schindler, D				Schindler, David			Tar sands need solid science	NATURE			English	Editorial Material							EARLY-LIFE STAGES; CYP1A INDUCTION; ATHABASCA RIVER; OIL		Univ Alberta, Edmonton, AB T6G 2E9, Canada	University of Alberta	Schindler, D (corresponding author), Univ Alberta, Edmonton, AB T6G 2E9, Canada.	d.schindler@ualberta.ca						Chen, 2009, CANC INCIDENCE FORT; Colavecchia MV, 2007, J TOXICOL ENV HEAL A, V70, P1542, DOI 10.1080/15287390701384726; Colavecchia MV, 2006, J TOXICOL ENV HEAL A, V69, P967, DOI 10.1080/15287390500362154; Kelly EN, 2010, P NATL ACAD SCI USA, V107, P16178, DOI 10.1073/pnas.1008754107; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; *LIB PART CAN, 2010, HIDD DIM WAT OIL SAN; *NEW DEM PART CAN, 2010, MISS ACT FED GOV PRO; Rosenberg, 2004, OIL SANDS REGIONAL A; Squires Allison J., 2010, Integrated Environmental Assessment and Management, V6, P119, DOI 10.1897/IEAM_2008-081.1; Timoney Kevin P., 2009, Open Conservation Biology Journal, V3, P65, DOI 10.2174/1874839200903010065	10	96	96	0	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					499	501		10.1038/468499a	http://dx.doi.org/10.1038/468499a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684WA	21107404	Bronze			2022-12-01	WOS:000284584200016
J	Fang, M; Shen, ZR; Huang, S; Zhao, LP; Chen, S; Mak, TW; Wang, XD				Fang, Min; Shen, Zhirong; Huang, Song; Zhao, Liping; Chen, She; Mak, Tak W.; Wang, Xiaodong			The ER UDPase ENTPD5 Promotes Protein N-Glycosylation, the Warburg Effect, and Proliferation in the PTEN Pathway	CELL			English	Article							SECRETORY PATHWAY; ENDOPLASMIC-RETICULUM; TUMOR-SUPPRESSOR; QUALITY-CONTROL; CELL-SURVIVAL; AKT; KINASE; CANCER; METABOLISM; GROWTH	PI3K and PTEN lipid phosphatase control the level of cellular phosphatidylinositol (3,4,5)-trisphosphate, an activator of AKT kinases that promotes cell growth and survival. Mutations activating AKT are commonly observed in human cancers. We report here that ENTPD5, an endoplasmic reticulum (ER) enzyme, is upregulated in cell lines and primary human tumor samples with active AKT. ENTPD5 hydrolyzes UDP to UMP to promote protein N-glycosylation and folding in ER. Knockdown of ENTPD5 in PTEN null cells causes ER stress and loss of growth factor receptors. ENTPD5, together with cytidine monophosphate kinase-1 and adenylate kinase-1, constitute an ATP hydrolysis cycle that converts ATP to AMP, resulting in a compensatory increase in aerobic glycolysis known as the Warburg effect. The growth of PTEN null cells is inhibited both in vitro and in mouse xenograft tumor models. ENTPD5 is therefore an integral part of the PI3K/PTEN regulatory loop and a potential target for anti-cancer therapy.	[Fang, Min; Shen, Zhirong; Huang, Song; Zhao, Liping; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Fang, Min; Shen, Zhirong; Huang, Song; Zhao, Liping; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, She; Wang, Xiaodong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Mak, Tak W.] Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institute of Biological Sciences, Beijing; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Wang, XD (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	xiaodong.wang@utsouthwestern.edu		Shen, Zhirong/0000-0003-4552-1670; Wang, Xiaodong/0000-0001-9885-356X	National Cancer Institute (NCI) [PO1 CA 95471]; Chinese Ministry of Science and Technology; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to express our gratitude to Drs. Fenghe Du and Liping Liu for excellent technical assistance. We are grateful for Dr. Aijun Liu from the 301 Hospital in Beijing for providing the human prostate tumor samples and Dr. Benjamin Tu from University of Texas Southwestern for help with the phosphofructose sugar measurement. We thank Mr. Gregory Kunkel and Dr. Lai Wang for critical reading of the manuscript. This work is also supported by a grant from the National Cancer Institute (NCI) (PO1 CA 95471) and the National High Technology Projects 863 from Chinese Ministry of Science and Technology.	Bermudo R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-315; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GEVERS W, 1966, BIOCHEM J, V98, P720, DOI 10.1042/bj0980720; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Read R, 2009, VET PATHOL, V46, P491, DOI 10.1354/vp.08-VP-0201-R-AM; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; Warburg O, 1925, KLIN WOCHENSCHR, V4, P534, DOI DOI 10.1007/BF01726151; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	27	148	157	3	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					711	724		10.1016/j.cell.2010.10.010	http://dx.doi.org/10.1016/j.cell.2010.10.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21074248	Bronze			2022-12-01	WOS:000284583500014
J	Someya, S; Yu, W; Hallows, WC; Xu, JZ; Vann, JM; Leeuwenburgh, C; Tanokura, M; Denu, JM; Prolla, TA				Someya, Shinichi; Yu, Wei; Hallows, William C.; Xu, Jinze; Vann, James M.; Leeuwenburgh, Christiaan; Tanokura, Masaru; Denu, John M.; Prolla, Tomas A.			Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric Restriction	CELL			English	Article							GLUTATHIONE REDOX STATE; DIETARY RESTRICTION; CELL-DEATH; RAT-LIVER; LIFE-SPAN; MICE; DISEASE; STRESS; MITOCHONDRIA; DEACETYLASE	Caloric restriction (CR) extends the life span and health span of a variety of species and slows the progression of age-related hearing loss (AHL), a common age-related disorder associated with oxidative stress. Here, we report that CR reduces oxidative DNA damage in multiple tissues and prevents AHL in wild-type mice but fails to modify these phenotypes in mice lacking the mitochondrial deacetylase Sirt3, a member of the sirtuin family. In response to CR, Sirt3 directly deacetylates and activates mitochondrial isocitrate dehydrogenase 2 (Idh2), leading to increased NADPH levels and an increased ratio of reduced-to-oxidized glutathione in mitochondria. In cultured cells, overexpression of Sirt3 and/or Idh2 increases NADPH levels and protects from oxidative stress-induced cell death. Therefore, our findings identify Sirt3 as an essential player in enhancing the mitochondrial glutathione antioxidant defense system during CR and suggest that Sirt3-dependent mitochondrial adaptations may be a central mechanism of aging retardation in mammals.	[Yu, Wei; Hallows, William C.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Someya, Shinichi; Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Someya, Shinichi; Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Someya, Shinichi; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Xu, Jinze; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr, Gainesville, FL 32611 USA; [Xu, Jinze; Leeuwenburgh, Christiaan] Univ Florida, Inst Aging, Gainesville, FL 32611 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Denu, JM (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	jmdenu@wisc.edu; taprolla@wisc.edu	YU, WEI/G-4128-2013; Xu, Jinze/G-7868-2011; YU, WEI/C-3822-2012	YU, WEI/0000-0001-9898-4607; Tanokura, Masaru/0000-0001-5072-2480; Leeuwenburgh, Christiaan/0000-0003-0826-4257	NIH [AG021905, GM065386]; Ministry of Education, Culture, Sports, Science, and Technologies of Japan; Marine Bio Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021905, P30AG028740] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technologies of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Marine Bio Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Kinoshita for histological processing. This research was supported by NIH grants AG021905 (T.A.P.) and GM065386 (J.M.D.), the National Projects on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science, and Technologies of Japan, and Marine Bio Foundation.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Halliwell B., 2007, FREE RADICALS BIOL M; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014; HUNTER KP, 1987, HEARING RES, V30, P207, DOI 10.1016/0378-5955(87)90137-7; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Johnson KR, 2010, HEARING RES, V268, P85, DOI 10.1016/j.heares.2010.05.002; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; KORNBERG A, 1955, METHOD ENZYMOL, V1, P705, DOI 10.1016/0076-6879(55)01122-1; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McFadden SL, 1999, NEUROBIOL AGING, V20, P1, DOI 10.1016/S0197-4580(99)00018-4; McNeill DR, 2007, MOL CANCER RES, V5, P61, DOI 10.1158/1541-7786.MCR-06-0329; Meira LB, 2009, P NATL ACAD SCI USA, V106, P888, DOI 10.1073/pnas.0807030106; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; OLAFSDOTTIR K, 1988, BIOCHIM BIOPHYS ACTA, V964, P377, DOI 10.1016/0304-4165(88)90038-4; Paeratakul S, 2002, INT J OBESITY, V26, P1205, DOI 10.1038/sj.ijo.0802026; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Rebrin I, 2008, ADV DRUG DELIVER REV, V60, P1545, DOI 10.1016/j.addr.2008.06.001; Rebrin I, 2007, BRAIN RES, V1127, P10, DOI 10.1016/j.brainres.2006.10.040; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024; Someya S, 2010, MECH AGEING DEV, V131, P480, DOI 10.1016/j.mad.2010.04.006; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; STEEL KP, 1983, ARCH OTOLARYNGOL, V109, P22; STEEL KP, 1996, HEARING RES, V28, P227; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; SWEET RJ, 1988, AUDIOLOGY, V27, P305; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weindruch R., 1988, RETARDATION AGING DI; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhu HY, 1999, BRAIN RES, V842, P224, DOI 10.1016/S0006-8993(99)01827-2	63	840	884	7	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					802	812		10.1016/j.cell.2010.10.002	http://dx.doi.org/10.1016/j.cell.2010.10.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21094524	Green Accepted, Bronze			2022-12-01	WOS:000284583500021
J	Dhruva, SS; Redberg, RF				Dhruva, Sanket S.; Redberg, Rita F.			Accelerated Approval and Possible Withdrawal of Midodrine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Redberg, Rita F.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Sch Med, Dept Med, 505 Parnassus Ave,Ste M-1180, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu						Fleming TR, 2005, HEALTH AFFAIR, V24, P67, DOI 10.1377/hlthaff.24.1.67; *GEN, 2010, GEN PROV UPD AV ADV; HARRIS G, 2010, NY TIMES        0903; NAINGGOLAN L, FDA DOES U TURN MIDO; POLLACK A, 2010, NY TIMES        0917; Temple R, 1999, JAMA-J AM MED ASSOC, V282, P790, DOI 10.1001/jama.282.8.790; U.S. Government Accounting Office, 2009, NEW DRUG APPR FDA NE; *US FDA, 2010, FDA PROP WITHDR LOW; *US FDA, 2010, MID UPD SEPT 10	9	29	29	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2172	2173		10.1001/jama.2010.1695	http://dx.doi.org/10.1001/jama.2010.1695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21081731				2022-12-01	WOS:000284269800029
J	Zaidi, MR; Davis, S; Noonan, FP; Graff-Cherry, C; Hawley, TS; Walker, RL; Feigenbaum, L; Fuchs, E; Lyakh, L; Young, HA; Hornyak, TJ; Arnheiter, H; Trinchieri, G; Meltzer, PS; De Fabo, EC; Merlino, G				Zaidi, M. Raza; Davis, Sean; Noonan, Frances P.; Graff-Cherry, Cari; Hawley, Teresa S.; Walker, Robert L.; Feigenbaum, Lionel; Fuchs, Elaine; Lyakh, Lyudmila; Young, Howard A.; Hornyak, Thomas J.; Arnheiter, Heinz; Trinchieri, Giorgio; Meltzer, Paul S.; De Fabo, Edward C.; Merlino, Glenn			Interferon-gamma links ultraviolet radiation to melanomagenesis in mice	NATURE			English	Article							HLA-G; MOUSE; MELANOCYTES; EXPRESSION; CELLS; SEQUENCE; EXPOSURE; LEVEL; NICHE	Cutaneous malignant melanoma is a highly aggressive and frequently chemoresistant cancer, the incidence of which continues to rise. Epidemiological studies show that the major aetiological melanoma risk factor is ultraviolet (UV) solar radiation, with the highest risk associated with intermittent burning doses, especially during childhood(1,2). We have experimentally validated these epidemiological findings using the hepatocyte growth factor/scatter factor transgenic mouse model, which develops lesions in stages highly reminiscent of human melanoma with respect to biological, genetic and aetiological criteria, but only when irradiated as neonatal pups with UVB, not UVA(3,4). However, the mechanisms underlying UVB-initiated, neonatal-specific melanomagenesis remain largely unknown. Here we introduce a mouse model permitting fluorescence-aided melanocyte imaging and isolation following in vivo UV irradiation. We use expression profiling to show that activated neonatal skin melanocytes isolated following a melanomagenic UVB dose bear a distinct, persistent interferon response signature, including genes associated with immunoevasion. UVB-induced melanocyte activation, characterized by aberrant growth and migration, was abolished by antibody-mediated systemic blockade of interferon-gamma (IFN-gamma), but not type-I interferons. IFN-gamma was produced by macrophages recruited to neonatal skin by UVB-induced ligands to the chemokine receptor Ccr2. Admixed recruited skin macrophages enhanced transplanted melanoma growth by inhibiting apoptosis; notably, IFN-gamma blockade abolished macrophage-enhanced melanoma growth and survival. IFN-gamma-producing macrophages were also identified in 70% of human melanomas examined. Our data reveal an unanticipated role for IFN-gamma in promoting melanocytic cell survival/immunoevasion, identifying a novel candidate therapeutic target for a subset of melanoma patients.	[Zaidi, M. Raza; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Davis, Sean; Walker, Robert L.; Meltzer, Paul S.] NCI, Genet Branch, Bethesda, MD 20892 USA; [Noonan, Frances P.; De Fabo, Edward C.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA; [Graff-Cherry, Cari; Feigenbaum, Lionel] NCI, Lab Anim Sci Program, Frederick, MD 21702 USA; [Fuchs, Elaine] Rockefeller Univ, New York, NY 10021 USA; [Lyakh, Lyudmila; Young, Howard A.; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Hornyak, Thomas J.] NCI, Dermatol Branch, Bethesda, MD 20892 USA; [Arnheiter, Heinz] NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.	drmecd@gwumc.edu; gmerlino@helix.nih.gov	Trinchieri, Giorgio/F-9369-2015; Young, Howard/R-5140-2019; Fuchs, Elaine/G-1565-2016; Davis, Sean/AAD-1801-2021; Zaidi, M. Raza/H-1386-2016; Young, Howard/A-6350-2008	Trinchieri, Giorgio/0000-0001-5892-7464; Davis, Sean/0000-0002-8991-6458; Noonan, Frances/0000-0002-3302-7280; Zaidi, M. Raza/0000-0003-0480-3188; Young, Howard/0000-0002-3118-5111; Arnheiter, Heinz/0000-0003-2537-1134; Walker, Robert/0000-0001-8235-4686	NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute; National Institutes of Health [CA53765, CA92258]; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC010565, ZIABC010479, R01CA053765, ZIABC010734, ZIABC010720, ZIABC008756, ZIABC011091, R01CA092258, ZIABC010733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003021] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the following individuals for their support: S. Yuspa for primary keratinocytes; C. Toniatti and H. Bujard for the rtTA2sM2 construct; V. Hearing for melan-c cell line; S. Hewitt for the human melanoma tissue microarray; M. Anver for immunohistochemical staining and production/analysis of mouse melanoma tissue microarray; K. Blas and E. Vega-Valle for technical help; N. Restifo and A. Hurwitz for suggestions and discussions. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. M.R.Z. was supported by a National Cancer Institute Director's Innovation Career Development Award. E.C.D. and F.P.N. were supported by grants from the National Institutes of Health (awards CA53765 and CA92258), and the Melanoma Research Foundation.	Serrano MA, 2010, PHOTOCHEM PHOTOBIOL, V86, P716, DOI 10.1111/j.1751-1097.2009.00693.x; Aoki H, 2005, J INVEST DERMATOL, V124, P1053, DOI 10.1111/j.0022-202X.2005.23721.x; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; BUDD PS, 1995, GENOMICS, V29, P35, DOI 10.1006/geno.1995.1212; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; De Fabo EC, 2004, CANCER RES, V64, P6372, DOI 10.1158/0008-5472.CAN-04-1454; DEFABO EC, 1990, PHOTOCHEM PHOTOBIOL, V52, P811; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Derre L, 2006, J IMMUNOL, V177, P3100, DOI 10.4049/jimmunol.177.5.3100; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Garibyan L, 2010, CURR ONCOL REP, V12, P319, DOI 10.1007/s11912-010-0119-y; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goldszmid RS, 2007, J EXP MED, V204, P2591, DOI 10.1084/jem.20070634; Gramzinski RA, 2001, INFECT IMMUN, V69, P1643, DOI 10.1128/IAI.69.3.1643-1649.2001; He YF, 2005, CANCER IMMUNOL IMMUN, V54, P891, DOI 10.1007/s00262-004-0654-1; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; MEYSKENS FL, 1995, J NATL CANCER I, V87, P1710, DOI 10.1093/jnci/87.22.1710; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Porter GA, 2001, ANN SURG ONCOL, V8, P116, DOI 10.1007/s10434-001-0116-3; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; R Core Team,, 2021, R LANG ENV STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rebmann V, 2007, SEMIN CANCER BIOL, V17, P422, DOI 10.1016/j.semcancer.2007.06.010; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shah KV, 2008, J INVEST DERMATOL, V128, P2870, DOI 10.1038/jid.2008.170; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Walker GJ, 2009, J INVEST DERMATOL, V129, P184, DOI 10.1038/jid.2008.210; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928; Wischhusell J, 2007, SEMIN CANCER BIOL, V17, P459, DOI 10.1016/j.semcancer.2007.07.005; Wolnicka-Glubisz A, 2006, PHOTOCH PHOTOBIO SCI, V5, P254, DOI 10.1039/b506974b; Wolnicka-Glubisz A, 2005, J INVEST DERMATOL, V125, P383, DOI 10.1111/j.0022-202X.2005.23781.x; Wolnicka-Glubisz A, 2007, J LEUKOCYTE BIOL, V81, P1352, DOI 10.1189/jlb.1206729	43	199	209	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					548	U129		10.1038/nature09666	http://dx.doi.org/10.1038/nature09666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21248750	Green Accepted			2022-12-01	WOS:000286596500036
J	Miller, KM; Li, SR; Kaukinen, KH; Ginther, N; Hammill, E; Curtis, JMR; Patterson, DA; Sierocinski, T; Donnison, L; Pavlidis, P; Hinch, SG; Hruska, KA; Cooke, SJ; English, KK; Farrell, AP				Miller, Kristina M.; Li, Shaorong; Kaukinen, Karia H.; Ginther, Norma; Hammill, Edd; Curtis, Janelle M. R.; Patterson, David A.; Sierocinski, Thomas; Donnison, Louise; Pavlidis, Paul; Hinch, Scott G.; Hruska, Kimberly A.; Cooke, Steven J.; English, Karl K.; Farrell, Anthony P.			Genomic Signatures Predict Migration and Spawning Failure in Wild Canadian Salmon	SCIENCE			English	Article							SOCKEYE-SALMON; FRASER-RIVER; PHYSIOLOGICAL CONDITION; ONCORHYNCHUS-NERKA; TEMPERATURE; MORTALITY; SURVIVAL; BEHAVIOR	Long-term population viability of Fraser River sockeye salmon (Oncorhynchus nerka) is threatened by unusually high levels of mortality as they swim to their spawning areas before they spawn. Functional genomic studies on biopsied gill tissue from tagged wild adults that were tracked through ocean and river environments revealed physiological profiles predictive of successful migration and spawning. We identified a common genomic profile that was correlated with survival in each study. In ocean-tagged fish, a mortality-related genomic signature was associated with a 13.5-fold greater chance of dying en route. In river-tagged fish, the same genomic signature was associated with a 50% increase in mortality before reaching the spawning grounds in one of three stocks tested. At the spawning grounds, the same signature was associated with 3.7-fold greater odds of dying without spawning. Functional analysis raises the possibility that the mortality-related signature reflects a viral infection.	[Miller, Kristina M.; Li, Shaorong; Kaukinen, Karia H.; Ginther, Norma] Fisheries & Oceans Canada, Mol Genet Sect, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Miller, Kristina M.; Hinch, Scott G.; Hruska, Kimberly A.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada; [Hammill, Edd; Curtis, Janelle M. R.] Fisheries & Oceans Canada, Conservat Biol Sect, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Patterson, David A.] Simon Fraser Univ, Sch Resource & Environm Management, Fisheries & Oceans Canada, Cooperat Resource Management Inst, Burnaby, BC V5A 1S6, Canada; [Sierocinski, Thomas; Donnison, Louise; Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [English, Karl K.] LGL Ltd Environm Res Associates, Sidney, BC V8L 3Y8, Canada; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada	Fisheries & Oceans Canada; University of British Columbia; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia; Carleton University; University of British Columbia; University of British Columbia	Miller, KM (corresponding author), Fisheries & Oceans Canada, Mol Genet Sect, Pacific Biol Stn, 3190 Hammond Bay Rd, Nanaimo, BC V9T 6N7, Canada.	kristi.miller@dfo-mpo.gc.ca	Cooke, Steven J/F-4193-2010; Hammill, Edd/F-9030-2013; Pavlidis, Paul/H-8406-2013	Cooke, Steven J/0000-0002-5407-0659; Hammill, Edd/0000-0001-8247-6106; Pavlidis, Paul/0000-0002-0426-5028	Pacific Salmon Commission; Department of Fisheries and Oceans; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada	Pacific Salmon Commission; Department of Fisheries and Oceans; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Microarray data were deposited (according to Microarray Gene Expression Data Society Standard) in the National Center for Biotechnology Information Gene Expression Omnibus (GEO, www.ncbi.nlm.nih.gov/geo/) with the saltwater experimental accession number GSE22171, freshwater GSE22177, spawning GSE22347, and Superseries ID GSE22179. We thank the Pacific Salmon Commission Southern Endowment Fund, Department of Fisheries and Oceans Genomics Research and Development Fund, Genome British Columbia, and Natural Sciences and Engineering Research Council of Canada for research support. All procedures used were developed with approvals and guidance from the Canadian Council on Animal Care administered by the University of British Columbia and Fisheries and Oceans Canada. We thank M. Donaldson, I. Olsson, G. Crossin, K. Hanson, R. Alexander, D. Robichaud, S. Tyerman, D. Welch, and J. Hills for tagging and biopsies; L. Stenhouse and A. Schulze for RNA extractions; M. Shrimpton for gill Na<SUP>+</SUP>/K<SUP>+</SUP> ATPase activity levels; C. Wallace for figure preparation; M. Lapointe and C. McConnell for organizational assistance; and the skippers and crews of the ocean vessels Sunfisher and Belina.	Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Cooke SJ, 2008, FISHERIES, V33, P321, DOI 10.1577/1548-8446-33.7.321; Cooke SJ, 2006, CAN J FISH AQUAT SCI, V63, P1469, DOI 10.1139/F06-042; Cooperman MS, 2010, PHYSIOL BIOCHEM ZOOL, V83, P459, DOI 10.1086/650473; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Crossin GT, 2009, PHYSIOL BIOCHEM ZOOL, V82, P635, DOI 10.1086/605878; English KK, 2005, T AM FISH SOC, V134, P1342, DOI 10.1577/T04-119.1; HINCH SG, 2009, C EARL MIGR PREM MOR, P8; Irvine JR, 2005, FISHERIES, V30, P11, DOI 10.1577/1548-8446(2005)30[11:CSARA]2.0.CO;2; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; MARTINS EG, GLOBAL CHAN IN PRESS, DOI DOI 10.1111/J.1365-2486.2010.02241.X; Mathes MT, 2010, CAN J FISH AQUAT SCI, V67, P70, DOI 10.1139/F09-158; Miller KM, 2009, COMP BIOCHEM PHYS D, V4, P75, DOI 10.1016/j.cbd.2008.11.002; Portner HO, 2009, SCIENCE, V323, P876; Rand P. S., IUCN 2010 IUCN RED L; von Schalburg KR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-126; Wagner GN, 2005, CAN J FISH AQUAT SCI, V62, P2124, DOI 10.1139/F05-126	18	145	152	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					214	217		10.1126/science.1196901	http://dx.doi.org/10.1126/science.1196901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233388				2022-12-01	WOS:000286433100042
J	Gravel, D; Bell, T; Barbera, C; Bouvier, T; Pommier, T; Venail, P; Mouquet, N				Gravel, Dominique; Bell, Thomas; Barbera, Claire; Bouvier, Thierry; Pommier, Thomas; Venail, Patrick; Mouquet, Nicolas			Experimental niche evolution alters the strength of the diversity-productivity relationship	NATURE			English	Article							PSEUDOMONAS-FLUORESCENS; ECOSYSTEM PRODUCTIVITY; PLANT DIVERSITY; BIODIVERSITY; GENERALISTS; ASSEMBLAGES; SPECIALISTS; RESOURCE; SERVICES; MODEL	The relationship between biodiversity and ecosystem functioning (BEF) has become a cornerstone of community and ecosystem ecology(1-3) and an essential criterion for making decisions in conservation biology and policy planning(4,5). It has recently been proposed that evolutionary history should influence the BEF relationship because it determines species traits and, thus, species' ability to exploit resources(6,7). Here we test this hypothesis by combining experimental evolution with a BEF experiment. We isolated 20 bacterial strains from a marine environment and evolved each to be generalists or specialists(8). We then tested the effect of evolutionary history on the strength of the BEF relationship with assemblages of 1 to 20 species constructed from the specialists, generalists and ancestors(9). Assemblages of generalists were more productive on average because of their superior ability to exploit the environmental heterogeneity(10). The slope of the BEF relationship was, however, stronger for the specialist assemblages because of enhanced niche complementarity. These results show how the BEF relationship depends critically on the legacy of past evolutionary events.	[Gravel, Dominique] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Gravel, Dominique; Barbera, Claire; Venail, Patrick; Mouquet, Nicolas] Univ Montpellier 2, CNRS, Inst Sci Evolut UMR 5554, F-34095 Montpellier 05, France; [Bell, Thomas] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Bouvier, Thierry; Pommier, Thomas] Univ Montpellier 2, CNRS, Ecosyst Langunaires UMR 5119, F-34095 Montpellier 05, France; [Pommier, Thomas] Univ Lyon 1, CNRS, INRA, UMR 5557,USC 1193,Lab Ecol Microbienne, F-69622 Villeurbanne, France	University of Quebec; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Gravel, D (corresponding author), Univ Quebec, Dept Biol Chim & Geog, 300 Alee Ursulines, Rimouski, PQ G5L 3A1, Canada.	dominique_gravel@uqar.qc.ca; nmouquet@univ-montp2.fr	Pommier, Thomas/AAR-1115-2021; Venail, Patrick/D-2968-2018; MOUQUET, Nicolas/AAL-1440-2021; Bouvier, Thierry/A-1895-2013	Pommier, Thomas/0000-0003-2986-5326; Venail, Patrick/0000-0003-1126-280X; bouvier, thierry/0000-0002-7151-5680; Bell, Thomas/0000-0002-2615-3932; Mouquet, Nicolas/0000-0003-1840-6984	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Program;  [ANR-09-JCJC-0110-01]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); 	We thank T. Barraclough, G. Bell, M. Loreau, R. C. MacLean and A. Paquette for comments on earlier versions of the manuscript. This work was supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada and a research grant from the Canada Research Chair Program, to D.G., and research grant ANR-09-JCJC-0110-01, to N.M.	Abrams PA, 2006, EVOLUTION, V60, P427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barrett RDH, 2005, AM NAT, V166, P470, DOI 10.1086/444440; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bell T., 2009, BIODIVERSITY ECOSYST; Bell T, 2009, AM NAT, V174, P836, DOI 10.1086/647931; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kinzig A. P., 2002, FUNCTIONAL CONSEQUEN; LANE D.J., 1991, 16S 23S RRNA SEQUENC, P115, DOI DOI 10.1007/S00227-012-2133-0; LEVINS RICHARD, 1968; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, P ROY SOC B-BIOL SCI, V268, P303, DOI 10.1098/rspb.2000.1366; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; MacLean RC, 2005, J EVOLUTION BIOL, V18, P1376, DOI 10.1111/j.1420-9101.2005.00931.x; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; Naeem S., 2009, BIODIVERSITY ECOSYST; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	38	137	139	8	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					89	U1601		10.1038/nature09592	http://dx.doi.org/10.1038/nature09592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21131946				2022-12-01	WOS:000285921600037
J	Piscitelli, CL; Krishnamurthy, H; Gouaux, E				Piscitelli, Chayne L.; Krishnamurthy, Harini; Gouaux, Eric			Neurotransmitter/sodium symporter orthologue LeuT has a single high-affinity substrate site	NATURE			English	Article							BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; ACID TRANSPORTER; BINDING-SITE; MECHANISM; REVEALS; PROTEINS; NA+	Neurotransmitter/sodium symporters (NSSs) couple the uptake of neurotransmitter with one or more sodium ions(1-3), removing neurotransmitter from the synaptic cleft. NSSs are essential to the function of chemical synapses, are associated with multiple neurological diseases and disorders(4), and are the targets of therapeutic and illicit drugs(5). LeuT, a prokaryotic orthologue of the NSS family, is a model transporter for understanding the relationships between molecular mechanism and atomic structure in a broad range of sodium-dependent and sodium-independent secondary transporters(6-13). At present there is a controversy over whether there are one or two high-affinity substrate binding sites in LeuT. The first-reported crystal structure of LeuT, together with subsequent functional and structural studies, provided direct evidence for a single, high-affinity, centrally located substrate-binding site, defined as the S1 site(14,15). Recent binding, flux and molecular simulation studies, however, have been interpreted in terms of a model where there are two high-affinity binding sites: the central, S1, site and a second, the S2 site, located within the extracellular vestibule(16). Furthermore, it was proposed that the S1 and S2 sites are allosterically coupled such that occupancy of the S2 site is required for the cytoplasmic release of substrate from the S1 site(16). Here we address this controversy by performing direct measurement of substrate binding to wild-type LeuT and to S2 site mutants using isothermal titration calorimetry, equilibrium dialysis and scintillation proximity assays. In addition, we perform uptake experiments to determine whether the proposed allosteric coupling between the putative S2 site and the S1 site manifests itself in the kinetics of substrate flux. We conclude that LeuT harbours a single, centrally located, high-affinity substrate-binding site and that transport is well described by a simple, single-substrate kinetic mechanism.	[Piscitelli, Chayne L.; Krishnamurthy, Harini; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Piscitelli, Chayne L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	ARCS foundation; NIH [T32 DK007680]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	ARCS foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Pan and R. Hibbs for comments and L. Vaskalis for assistance with figures. C. L. P. was supported by the ARCS foundation and NIH training grant T32 DK007680. This work was supported by the NIH. E. G. is an investigator with the Howard Hughes Medical Institute.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; CHRISTENSEN JJ, 1971, SCIENCE, V174, P459, DOI 10.1126/science.174.4008.459; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; SEGEL IH, 1975, ENZYME KINETICS, P398; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	25	104	104	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1129	U538		10.1038/nature09581	http://dx.doi.org/10.1038/nature09581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179170	Green Accepted			2022-12-01	WOS:000285553800064
J	Phillips, JS; Mason, MJ; Dixon, H				Phillips, John S.; Mason, Matthew J.; Dixon, Heather			Christmas 2010: Surgery Middle ear instrument nomenclature: a taxonomic approach	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Phillips, John S.] Univ British Columbia, Rotary Hearing Clin, Vancouver, BC V6Z 1Y6, Canada; [Mason, Matthew J.; Dixon, Heather] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of British Columbia; University of Cambridge	Phillips, JS (corresponding author), Univ British Columbia, Rotary Hearing Clin, Vancouver, BC V6Z 1Y6, Canada.	john.phillips@mac.com	Mason, Matthew James/AAX-9783-2021	Mason, Matthew James/0000-0001-7845-0720				Bill J.H., 1882, INT ENCY SURG SYSTEM, V2, P101; Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; Bryson Bill, 1990, MOTHER TONGUE ENGLIS; GOULEY JWS, 1877, MED REC, V12, P529; HELMUTH WT, 1875, DOCUMENTS ASSEMBLY S, V8, P195; JONES HM, 1881, TREATISE AURAL SURG; JONES HM, 1889, LANCET, V134, P159; JONES HM, 1889, LANCET, V134, P209; KEYES EL, 1875, MED REC, V10, P163; KINLOCH RA, 1877, AM J MED SCI, V74, P125; Knight Edward Henry, 1884, KNIGHTS NEW MECH DIC; PEMBERTON O, 1884, LANCET, V123, P927; RYERSON T, 1876, T MED SOC NEW JERSEY, P302; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; STEARN WT, 1959, SYST ZOOL, V8, P4, DOI 10.2307/2411603; Wilkinson DM, 2001, NATURE, V412, P485, DOI 10.1038/35087676	16	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2010	341								c5137	10.1136/bmj.c5137	http://dx.doi.org/10.1136/bmj.c5137			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XA	21149463				2022-12-01	WOS:000285551900009
J	Bloomfield, G; Skelton, J; Ivens, A; Tanaka, Y; Kay, RR				Bloomfield, Gareth; Skelton, Jason; Ivens, Alasdair; Tanaka, Yoshimasa; Kay, Robert R.			Sex Determination in the Social Amoeba Dictyostelium discoideum	SCIENCE			English	Article							CELLULAR SLIME-MOLD; UNIPARENTAL INHERITANCE; MACROCYST FORMATION; MITOCHONDRIAL-DNA; POLYMORPHISM	The genetics of sex determination remain mysterious in many organisms, including some that are otherwise well studied. Here we report the discovery and analysis of the mating-type locus of the model organism Dictyostelium discoideum. Three forms of a single genetic locus specify this species' three mating types: two versions of the locus are entirely different in sequence, and the third resembles a composite of the other two. Single, unrelated genes are sufficient to determine two of the mating types, whereas homologs of both these genes are required in the composite type. The key genes encode polypeptides that possess no recognizable similarity to established protein families. Sex determination in the social amoebae thus appears to use regulators that are unrelated to any others currently known.	[Bloomfield, Gareth; Tanaka, Yoshimasa; Kay, Robert R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Bloomfield, Gareth; Skelton, Jason; Ivens, Alasdair] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Tanaka, Yoshimasa] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; University of Tsukuba	Bloomfield, G (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	garethb@mrc-lmb.cam.ac.uk		Bloomfield, Gareth/0000-0003-4269-8059; Ivens, Al/0000-0002-0112-3876; Kay, Robert R/0000-0001-9836-7967	Wellcome Trust [06724]; Medical Research Council; MRC [MC_U105115237] Funding Source: UKRI; Medical Research Council [MC_U105115237] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust grant number 06724 and core funding from the Medical Research Council. We thank the Dicty Stock Center (www.dictybase.org/StockCenter/StockCenter.html), D. Francis, H. Hagiwara, and P. Schaap for providing strains; T. Feltwell, N. Nikolaidou-Katsaridou, and K. Jagels for technical assistance; and M. Fookes, C. Carret, K. Brooks, C. Pears, N. Barry, and the members and associate members of the Dictyostelium group at the Laboratory of Molecular Biology for valuable advice and discussions. A. I. is now at Fios Genomics, ETTC, King's Buildings, Edinburgh EH9 3JL, UK. We are grateful to the U.S. Department of Energy Joint Genome Institute (www.jgi.doe.gov/) and co-workers, and to the Actyostelium Genome Consortium for making the Dictyostelium purpureum and Acytostelium subglobosum genome data available before publication. Microarray data are available under accession no. E-TABM-394 and the array design under A-SGRP-3 at www.ebi.ac.uk/arrayexpress/, and DNA sequences have been deposited in EMBL-Bank under accessions nos. FN543120 to FN543124, FN994780, FR666792, and FR666793.	BLASKOVICS JC, 1957, BIOL BULL-US, V113, P58, DOI 10.2307/1538802; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ERDOS GW, 1973, P NATL ACAD SCI USA, V70, P1828, DOI 10.1073/pnas.70.6.1828; FILOSA MF, 1972, DEV BIOL, V29, P1, DOI 10.1016/0012-1606(72)90038-3; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Hurst LD, 1996, P ROY SOC B-BIOL SCI, V263, P415, DOI 10.1098/rspb.1996.0063; KAWANO S, 1987, J GEN MICROBIOL, V133, P3175; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; MIRFAKHRAI M, 1990, GENETICS, V124, P607; Muramoto T, 2003, MECH DEVELOP, V120, P965, DOI 10.1016/S0925-4773(03)00136-9; ODAY DH, 1979, CAN J MICROBIOL, V25, P1416, DOI 10.1139/m79-221; RAPER KB, 1984, DICTYOSTELIDS, pCH9; ROBSON GE, 1979, GENETICS, V93, P861; ROBSON GE, 1980, CURR GENET, V1, P229, DOI 10.1007/BF00390948; SAGA Y, 1983, J CELL SCI, V60, P157; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Urushihara H, 2006, EUR J CELL BIOL, V85, P961, DOI 10.1016/j.ejcb.2006.05.012; WALLACE MA, 1979, J GEN MICROBIOL, V113, P327, DOI 10.1099/00221287-113-2-327; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	23	64	65	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1533	1536		10.1126/science.1197423	http://dx.doi.org/10.1126/science.1197423			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148389	Green Accepted			2022-12-01	WOS:000285153500063
J	Hatch, AJ; York, JD				Hatch, Ace J.; York, John D.			SnapShot: Inositol Phosphates	CELL			English	Editorial Material									[Hatch, Ace J.; York, John D.] Duke Univ, HHMI, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Hatch, AJ (corresponding author), Duke Univ, HHMI, Durham, NC 27710 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL055672] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Michell RH, 2009, CELL CALCIUM, V45, P521, DOI 10.1016/j.ceca.2009.03.007; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Sauer K, 2010, NAT REV IMMUNOL, V10, P257, DOI 10.1038/nri2745; Shears SB, 2009, ADV ENZYME REGUL, V49, P87, DOI 10.1016/j.advenzreg.2008.12.008	10	61	67	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					1030	U183	1030.e1	10.1016/j.cell.2010.11.045	http://dx.doi.org/10.1016/j.cell.2010.11.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145466	Bronze, Green Accepted			2022-12-01	WOS:000285182600018
J	Nishiyama, T; Ladurner, R; Schmitz, J; Kreidl, E; Schleiffer, A; Bhaskara, V; Bando, M; Shirahige, K; Hyman, AA; Mechtler, K; Peters, JM				Nishiyama, Tomoko; Ladurner, Rene; Schmitz, Julia; Kreidl, Emanuel; Schleiffer, Alexander; Bhaskara, Venugopal; Bando, Masashige; Shirahige, Katsuhiko; Hyman, Anthony A.; Mechtler, Karl; Peters, Jan-Michael			Sororin Mediates Sister Chromatid Cohesion by Antagonizing Wapl	CELL			English	Article							DNA-REPLICATION; COMPLEX; ESTABLISHMENT; ACETYLATION; DROSOPHILA; ANAPHASE; PROTEIN; ROLES; PROPHASE; BINDING	Sister chromatid cohesion is essential for chromosome segregation and is mediated by cohesin bound to DNA. Cohesin-DNA interactions can be reversed by the cohesion-associated protein Wapl, whereas a stably DNA-bound form of cohesin is thought to mediate cohesion. In vertebrates, Sororin is essential for cohesion and stable cohesin-DNA interactions, but how Sororin performs these functions is unknown. We show that DNA replication and cohesin acetylation promote binding of Sororin to cohesin, and that Sororin displaces Wapl from its binding partner Pds5. In the absence of Wapl, Sororin becomes dispensable for cohesion. We propose that Sororin maintains cohesion by inhibiting Wapl's ability to dissociate cohesin from DNA. Sororin has only been identified in vertebrates, but we show that many invertebrate species contain Sororin-related proteins, and that one of these, Dalmatian, is essential for cohesion in Drosophila. The mechanism we describe here may therefore be widely conserved among different species.	[Nishiyama, Tomoko; Ladurner, Rene; Schmitz, Julia; Kreidl, Emanuel; Schleiffer, Alexander; Bhaskara, Venugopal; Mechtler, Karl; Peters, Jan-Michael] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Bando, Masashige; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Tokyo; Max Planck Society	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	peters@imp.univie.ac.at	Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Mechtler, Karl/AAF-2717-2019	Hyman, Anthony A/0000-0003-3664-154X; Mechtler, Karl/0000-0002-3392-9946; Ladurner, Rene/0000-0001-9261-7304; Shirahige, Katsuhiko/0000-0002-7862-1144; Schleiffer, Alexander/0000-0001-6251-2747; /0000-0002-8002-9967; Kreidl, Emanuel/0000-0002-4037-5881; Bhaskara, Venugopal/0000-0002-8807-3292	European Molecular Biology Organization (EMBO); Japanese Society for the Promotion of Science (JSPS); Boehringer Ingelheim; Austrian Science Fund [F34-B03]; EC	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund(Austrian Science Fund (FWF)); EC(European CommissionEuropean Commission Joint Research Centre)	We are grateful to O. Hudecz, P. Huis in't Veld, I. Poser, and M. Sykora for assistance and reagents; to G. Karpen, J. Knoblich, C. Lehner, and C. Sunkel for reagents and advice on Drosophila experiments; and to N. Kraut for BI 2536. T.N. is supported by the European Molecular Biology Organization (EMBO) and the Japanese Society for the Promotion of Science (JSPS). K.S. is supported by Grant-in-Aid for Scientific Research (S). Research in the groups of J.-M.P. and K.M. is supported by Boehringer Ingelheim and the Austrian Science Fund via the special research program "Chromosome Dynamics'' (F34-B03). Work in the groups of J.-M.P., K.M., and A.A.H. was also supported by the EC via the Integrated Project "MitoCheck.''	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Diaz-Martinez LA, 2007, CELL CYCLE, V6, P714, DOI 10.4161/cc.6.6.3935; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Prokopenko SN, 2000, GENETICS, V156, P1691; Rankin S, 2005, MOL CELL, V18, P185, DOI 10.1016/j.molcel.2005.03.017; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Sakuno T, 2009, CHROMOSOME RES, V17, P239, DOI 10.1007/s10577-008-9013-y; Schmitz J, 2007, CURR BIOL, V17, P630, DOI 10.1016/j.cub.2007.02.029; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	29	242	255	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					737	749		10.1016/j.cell.2010.10.031	http://dx.doi.org/10.1016/j.cell.2010.10.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111234	Bronze			2022-12-01	WOS:000284583500016
J	Teschke, R; Schulze, J				Teschke, Rolf; Schulze, Johannes			Risk of Kava Hepatotoxicity and the FDA Consumer Advisory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Teschke, Rolf] Goethe Univ Frankfurt, Teaching Hosp, Dept Internal Med 2, Div Gastroenterol & Hepatol,Klinikum Hanau, D-63450 Hanau, Germany; [Schulze, Johannes] Goethe Univ Frankfurt, Fac Med, Off Dean, D-63450 Hanau, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Teschke, R (corresponding author), Goethe Univ Frankfurt, Teaching Hosp, Dept Internal Med 2, Div Gastroenterol & Hepatol,Klinikum Hanau, Leimenstr 20, D-63450 Hanau, Germany.	rolf.teschke@gmx.de						*AUSTR GOV DEP HLT, 2005, KAV FACT SHEET; Lasme P, 2008, J AGR FOOD CHEM, V56, P4976, DOI 10.1021/jf800439g; Sarris J, 2009, PSYCHOPHARMACOLOGY, V205, P399, DOI 10.1007/s00213-009-1549-9; Schmidt M., 2007, HERBALGRAM, V73, P45; Teschke R, 2010, LIVER INT, V30, P1270, DOI 10.1111/j.1478-3231.2010.02308.x; Teschke R, 2010, ANN HEPATOL, V9, P251, DOI 10.1016/S1665-2681(19)31634-5; U.S. Food and Drug Administration, CONS ADV KAV CONT DI; *WHO, 2007, ASS RISK HEP KAV PRO; Zhou P, 2010, FASEB J, V24, P4722, DOI 10.1096/fj.10-163311	9	32	33	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2174	2175		10.1001/jama.2010.1689	http://dx.doi.org/10.1001/jama.2010.1689			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21081732				2022-12-01	WOS:000284269800030
J	Carvalho, P; Stanley, AM; Rapoport, TA				Carvalho, Pedro; Stanley, Ann Marie; Rapoport, Tom A.			Retrotranslocation of a Misfolded Luminal ER Protein by the Ubiquitin-Ligase Hrd1p	CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; AAA-ATPASE; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; RETRO-TRANSLOCATION; COMPLEX; GLYCOPROTEINS; DISLOCATION	Misfolded, luminal endoplasmic reticulum (ER) proteins are retrotranslocated into the cytosol and degraded by the ubiquitin/proteasome system. This ERAD-L pathway requires a protein complex consisting of the ubiquitin ligase Hrd1p, which spans the ER membrane multiple times, and the membrane proteins Hrd3p, Usa1p, and Der1p. Here, we show that Hrd1p is the central membrane component in ERAD-L; its overexpression bypasses the need for the other components of the Hrd1p complex. Hrd1p function requires its oligomerization, which in wildtype cells is facilitated by Usa1p. Site-specific photo-crosslinking indicates that, at early stages of retro-translocation, Hrd1p interacts with a substrate segment close to the degradation signal. This interaction follows the delivery of substrate through other ERAD components, requires the presence of transmembrane segments of Hrd1p, and depends on both the ubiquitin ligase activity of Hrd1p and the function of the Cdc48p ATPase complex. Our results suggest a model for how Hrd1p promotes polypeptide movement through the ER membrane.	[Carvalho, Pedro; Stanley, Ann Marie; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Carvalho, Pedro; Stanley, Ann Marie; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Carvalho, P (corresponding author), CRG, Dept Cell & Dev Biol, Dr Aiguader 88, Barcelona 08003, Spain.	pedro.carvalho@crg.es; tom_rapoport@hms.harvard.edu		Carvalho, Pedro/0000-0002-9691-5277	Jane Coffin Child Memorial fund; Ruth L. Kirschstein National Research Service Award; NIH [GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	Jane Coffin Child Memorial fund; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Hampton, D. Ng, D. Pellman, P. Schultz, J. Weissman, and Y. Ye for reagents. We thank D. Pellman, Y. Ye, A. Stein, and D. Finley for critical reading of the manuscript. P.C. was supported by the Jane Coffin Child Memorial fund and is currently a special fellow of the Leukemia and Lymphoma Society, and A.M.S. is supported by a Ruth L. Kirschstein National Research Service Award postdoctoral fellowship. T.A.R. is supported by NIH grant GM052586 and is a Howard Hughes Medical Institute Investigator.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Plemper RK, 1999, J CELL SCI, V112, P4123; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	47	217	225	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 12	2010	143	4					579	591		10.1016/j.cell.2010.10.028	http://dx.doi.org/10.1016/j.cell.2010.10.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074049	Green Accepted, Bronze			2022-12-01	WOS:000284149100015
J	Tsukagoshi, H; Busch, W; Benfey, PN				Tsukagoshi, Hironaka; Busch, Wolfgang; Benfey, Philip N.			Transcriptional Regulation of ROS Controls Transition from Proliferation to Differentiation in the Root	CELL			English	Article							REACTIVE OXYGEN; ARABIDOPSIS ROOT; HYDROGEN-PEROXIDE; CELL-DIVISION; THIOREDOXIN; SUPEROXIDE; EXPRESSION; OXIDASE; INTERPLAY; PATHWAY	The balance between cellular proliferation and differentiation is a key aspect of development in multicellular organisms. Using high-resolution expression data from the Arabidopsis root, we identified a transcription factor, UPBEAT1 (UPB1), that regulates this balance. Genomewide expression profiling coupled with ChIP-chip analysis revealed that UPB1 directly regulates the expression of a set of peroxidases that modulate the balance of reactive oxygen species (ROS) between the zones of cell proliferation and the zone of cell elongation where differentiation begins. Disruption of UPB1 activity alters this ROS balance, leading to a delay in the onset of differentiation. Modulation of either ROS balance or peroxidase activity through chemical reagents affects the onset of differentiation in a manner consistent with the postulated UPB1 function. This pathway functions independently of auxin and cytokinin plant hormonal signaling. Comparison to ROS-regulated growth control in animals suggests that a similar mechanism is used in plants and animals.	[Tsukagoshi, Hironaka; Busch, Wolfgang; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Tsukagoshi, Hironaka; Busch, Wolfgang; Benfey, Philip N.] Duke Univ, Inst Genome Sci, Durham, NC 27708 USA; [Tsukagoshi, Hironaka; Busch, Wolfgang; Benfey, Philip N.] Duke Univ, Policy Ctr Syst Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Tsukagoshi, Hironaka/D-5832-2018; Busch, Wolfgang/B-8593-2008	Tsukagoshi, Hironaka/0000-0003-0058-4926; Busch, Wolfgang/0000-0003-2042-7290	NSF; JSPS	NSF(National Science Foundation (NSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the NSF Arabidopsis 2010 program. H.T. was supported by a JSPS Postdoctoral Fellowship for Research Abroad. We thank H. Cui for advice on ChIP-chip; R. Mittler for the apx1 mutant; M.A. Torres for AtrbohC, D, and F mutants; K.D. Birnbaum, Y. Helariutta, Y. Tada, X. Dong, and B. Scheres for comments on the manuscript; and members of the Benfey laboratory for discussions and advice. P.N.B. is a founder and CEO of GrassRoots Biotechnology.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Barcelo AR, 1997, INT REV CYTOL, V176, P87, DOI 10.1016/S0074-7696(08)61609-5; Bashandy T, 2010, PLANT CELL, V22, P376, DOI 10.1105/tpc.109.071225; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Bestwick CS, 1997, PLANT CELL, V9, P209, DOI 10.1105/tpc.9.2.209; BIELSKI BHJ, 1980, J PHYS CHEM-US, V84, P830, DOI 10.1021/j100445a006; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; BROUWER KS, 1986, PLANT PHYSIOL, V82, P236, DOI 10.1104/pp.82.1.236; Burch PM, 2005, ANTIOXID REDOX SIGN, V7, P741, DOI 10.1089/ars.2005.7.741; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Caliskan M, 1998, PLANT J, V15, P165, DOI 10.1046/j.1365-313X.1998.00191.x; CHEN GX, 1989, PLANT CELL PHYSIOL, V30, P987; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; FEDERICO R, 1986, PLANTA, V167, P300, DOI 10.1007/BF00391430; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Maeda H, 2008, ANN NY ACAD SCI, V1130, P149, DOI 10.1196/annals.1430.012; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Owusu-Ansah E., 2008, NATURE PROTOCOLS, DOI [10.1038/nprot.2008.23, DOI 10.1038/NPROT.2008.23]; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Passardi F, 2006, PLANTA, V223, P965, DOI 10.1007/s00425-005-0153-4; Pitzschke A, 2006, ANTIOXID REDOX SIGN, V8, P1757, DOI 10.1089/ars.2006.8.1757; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Tognolli M, 2002, GENE, V288, P129, DOI 10.1016/S0378-1119(02)00465-1; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Ubeda-Tomas S, 2009, CURR BIOL, V19, P1194, DOI 10.1016/j.cub.2009.06.023; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019	41	642	675	8	182	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					606	616		10.1016/j.cell.2010.10.020	http://dx.doi.org/10.1016/j.cell.2010.10.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074051	Bronze			2022-12-01	WOS:000284149100017
J	Joesch, M; Schnell, B; Raghu, SV; Reiff, DF; Borst, A				Joesch, Maximilian; Schnell, Bettina; Raghu, Shamprasad Varija; Reiff, Dierk F.; Borst, Alexander			ON and OFF pathways in Drosophila motion vision	NATURE			English	Article							OPTIC LOBE; VISUAL INTERNEURONS; RESPONSE PROPERTIES; WILD-TYPE; MELANOGASTER; EXPRESSION; MEDULLA; CHANNEL; NEURONS; SYSTEM	Motion vision is a major function of all visual systems, yet the underlying neural mechanisms and circuits are still elusive. In the lamina, the first optic neuropile of Drosophila melanogaster, photoreceptor signals split into five parallel pathways, L1-L5(1). Here we examine how these pathways contribute to visual motion detection by combining genetic block and reconstitution of neural activity in different lamina cell types with whole-cell recordings from downstream motion-sensitive neurons(2,3). We find reduced responses to moving gratings if L1 or L2 is blocked; however, reconstitution of photoreceptor input to only L1 or L2 results in wild-type responses. Thus, the first experiment indicates the necessity of both pathways, whereas the second indicates sufficiency of each single pathway. This contradiction can be explained by electrical coupling between L1 and L2, allowing for activation of both pathways even when only one of them receives photoreceptor input. A fundamental difference between the L1 pathway and the L2 pathway is uncovered when blocking L1 or L2 output while presenting moving edges of positive (ON) or negative (OFF) contrast polarity: blocking L1 eliminates the response to moving ON edges, whereas blocking L2 eliminates the response to moving OFF edges. Thus, similar to the segregation of photoreceptor signals in ON and OFF bipolar cell pathways in the vertebrate retina(4), photoreceptor signals segregate into ON-L1 and OFF-L2 channels in the lamina of Drosophila.	[Joesch, Maximilian; Schnell, Bettina; Raghu, Shamprasad Varija; Reiff, Dierk F.; Borst, Alexander] MPI Neurobiol, Dept Syst & Computat Neurobiol, D-82152 Martinsried, Germany		Borst, A (corresponding author), MPI Neurobiol, Dept Syst & Computat Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	borst@neuro.mpg.de	Raghu, Shamprasad Varija/AAV-3044-2020	Schnell, Bettina/0000-0001-7700-2600; Joesch, Maximilian/0000-0002-3937-1330				BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BRAND AH, 1993, DEVELOPMENT, V118, P401; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Haag J, 2005, J COMP PHYSIOL A, V191, P445, DOI 10.1007/s00359-005-0605-0; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Johns DC, 1999, J NEUROSCI, V19, P1691; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Reichardt W, 1961, SENS COMMUN, P303; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	30	213	214	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					300	U186		10.1038/nature09545	http://dx.doi.org/10.1038/nature09545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068841				2022-12-01	WOS:000284051000050
J	Yi, CQ; Jia, GF; Hou, GH; Dai, Q; Zhang, W; Zheng, GQ; Jian, X; Yang, CG; Cui, QA; He, CA				Yi, Chengqi; Jia, Guifang; Hou, Guanhua; Dai, Qing; Zhang, Wen; Zheng, Guanqun; Jian, Xing; Yang, Cai-Guang; Cui, Qiang; He, Chuan			Iron-catalysed oxidation intermediates captured in a DNA repair dioxygenase	NATURE			English	Article							BASE-EXCISION-REPAIR; CRYSTAL-STRUCTURES; ALKB PROTEIN; FTO GENE; DEMETHYLATION; 3-METHYLTHYMINE; RECOGNITION; BACTERIAL; LESIONS; DAMAGE	Mononuclear iron-containing oxygenases conduct a diverse variety of oxidationfunctions in biology(1,2), includingthe oxidative demethylation of methylated nucleic acids and histones(3,4). Escherichia coli AlkB is the first such enzyme that was discovered to repair methylated nucleic acids(5,6), which are otherwise cytotoxic and/or mutagenic. AlkB human homologues are known to play pivotal roles in various processes(7-11). Here we present structural characterization of oxidation intermediates for these demethylases. Using a chemical cross-linking strategy(12,13), complexes of AlkB-double stranded DNA (dsDNA) containing 1,N-6-etheno adenine (epsilon A), N-3-methyl thymine (3-meT) and N-3-methyl cytosine (3-meC) are stabilized and crystallized, respectively. Exposing these crystals, grown under anaerobic conditions containing iron(II) and alpha-ketoglutarate (alpha KG), to dioxygen initiates oxidation in crystallo. Glycol (from epsilon A) and hemiaminal (from 3-meT) intermediates are captured; a zwitterionic intermediate (from 3-meC) is also proposed, based on crystallographic observations and computational analysis. The observation of these unprecedented intermediates provides direct support for the oxidative demethylation mechanism for these demethylases. This study also depicts a general mechanistic view of how a methyl group is oxidatively removed from different biological substrates.	[Yi, Chengqi; Jia, Guifang; Zhang, Wen; Zheng, Guanqun; Jian, Xing; Yang, Cai-Guang; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yi, Chengqi; Jia, Guifang; Zhang, Wen; Zheng, Guanqun; Jian, Xing; Yang, Cai-Guang; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Hou, Guanhua; Cui, Qiang] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Hou, Guanhua; Cui, Qiang] Univ Wisconsin, Inst Theoret Chem, Madison, WI 53706 USA; [Dai, Qing] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Yang, Cai-Guang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Chicago; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	He, CA (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Jian, Xing/N-3753-2018; Dai, Qing/ABD-8444-2021	Jian, Xing/0000-0002-0043-8729; Yi, Chengqi/0000-0003-2540-9729	National Institutes of Health [GM071440, GM084028]; Advanced Photon Source at Argonne National Laboratory; United States Department of Energy; Division Of Chemistry [0840494] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084028, R01GM071440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced Photon Source at Argonne National Laboratory; United States Department of Energy(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (GM071440 to C.H.; GM084028 to Q.C.), beamlines 23ID-B (General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT)), 19BM-D (Structual Biology Center (SBC-CAT)), 14BM-C (BioCARS) and 21ID-D (Life Sciences Collaborative Access Team (LS-CAT)) at the Advanced Photon Source at Argonne National Laboratory, the National Institutes of Health and the United States Department of Energy. Computational resources from the National Center for Supercomputing Applications at the University of Illinois and the Center of High Throughput Computing at UW-Madison are appreciated. We also thank X. Yang, Z. Ren and E. Duguid for crystallographic discussions.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burzlaff NI, 1999, NATURE, V401, P721, DOI 10.1038/44400; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Mishina Y, 2003, J AM CHEM SOC, V125, P8730, DOI 10.1021/ja034636c; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Searls T, 1999, TETRAHEDRON, V55, P11985, DOI 10.1016/S0040-4020(99)00703-6; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; YI C, 2009, ACCOUNTS CHEM RES, V42, P530; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106	38	110	112	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					330	U223		10.1038/nature09497	http://dx.doi.org/10.1038/nature09497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068844	Green Accepted			2022-12-01	WOS:000284051000056
J	Ouslander, JG				Ouslander, Joseph G.			A Murmur of Music	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												joseph.ouslander@fau.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 3	2010	304	17					1875	1875		10.1001/jama.2010.1141	http://dx.doi.org/10.1001/jama.2010.1141			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674GT	21045087				2022-12-01	WOS:000283725900001
J	Lenzer, J; Brownlee, S				Lenzer, Jeanne; Brownlee, Shannon			Post-marketing Surveillance Why the FDA can't protect the public	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EPILEPSY; SUDDEN		[Brownlee, Shannon] Dartmouth Inst Hlth Policy & Clin Practice, Washington, DC USA			jeanne.lenzer@gmail.com						Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x; BUNKER M, 2010, COMMUNICATION   0503; DASHEIFF RM, 1991, J CLIN NEUROPHYSIOL, V8, P216, DOI 10.1097/00004691-199104000-00010; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; DRAZEN JM, 2007, FORUM DRUG DISCOVERY; *FDA, 2010, MAN US FAC DEV EXP; *FDA CTR DEV RAD H, 1997, 10 M FDAS CTR DEV RA; Levinson Daniel, 2009, ADVERSE EVENT REPORT; MAISEL WH, 2008, COMMUNICATION   0514; MALISOW C, 2005, EXPOSED NERVE; Nikolas H, 2007, EPILEPSY BEHAV, V10, P363, DOI 10.1016/j.yebeh.2007.01.005; STINE N, 2005, COMMUNICATION   0511; *US FDA, 1997, PREM APPR VAG NERV S; US Food Drug Adm, 1999, MAN RISKS MED PROD U	14	19	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2010	341								c4753	10.1136/bmj.c4753	http://dx.doi.org/10.1136/bmj.c4753			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	678CU	21045048				2022-12-01	WOS:000284048200030
J	Allotey, P; Reidpath, DD; Yasin, S; Chan, CK; Aikins, AD				Allotey, Pascale; Reidpath, Daniel D.; Yasin, Shajahan; Chan, Carina K.; Aikins, Ama de-Graft			Rethinking health-care systems: a focus on chronicity	LANCET			English	Editorial Material							AFRICA		[Allotey, Pascale; Reidpath, Daniel D.; Yasin, Shajahan; Chan, Carina K.] Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Selangor 46150, De, Malaysia; [Aikins, Ama de-Graft] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana; [Aikins, Ama de-Graft] London Sch Econ & Polit Sci, LSE Hlth, London, England	Monash University; Monash University Sunway; University of Ghana; University of London; London School Economics & Political Science	Allotey, P (corresponding author), Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Sunway Campus, Selangor 46150, De, Malaysia.	pascale.allotey@monash.edu	Chan, Carina/O-6258-2014; Chan, Carina/AAO-6804-2021	Chan, Carina/0000-0002-1799-7877; 				Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; MBANYA JC, 2006, DIS MORTALITY SUBSAH, DOI DOI 10.1596/978-0-8213-6397-3; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mbeh George N, 2010, Glob Health Promot, V17, P17, DOI 10.1177/1757975910363925; Nattrass N, 2008, J PUBLIC HEALTH-UK, V30, P398, DOI 10.1093/pubmed/fdn075; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; RIFKIN SB, 1986, SOC SCI MED, V23, P559, DOI 10.1016/0277-9536(86)90149-8; SAMB B, 2010, LANCET          1111; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340	10	74	74	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					450	451		10.1016/S0140-6736(10)61856-9	http://dx.doi.org/10.1016/S0140-6736(10)61856-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721TX	21074257				2022-12-01	WOS:000287381800009
J	Dowell, SF; Tappero, JW; Frieden, TR				Dowell, Scott F.; Tappero, Jordan W.; Frieden, Thomas R.			Public Health in Haiti - Challenges and Progress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dowell, Scott F.] Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA 30333 USA; [Tappero, Jordan W.] Ctr Dis Control & Prevent, Hlth Syst Reconstruct Off, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Dowell, SF (corresponding author), Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA 30333 USA.			Frieden, Thomas/0000-0002-4759-2256				Rapid establishment of an internally displaced persons disease surveillance system after an earthquake-Haiti, 2010, MMWR MORB MORTAL WKL, V59, P939; *WHO UNICEF JMP WA, PROGR SAN DRINK WAT; 2010, MMWR MORB MORTAL WKL, V59, P1372; 2011, DONNEES PRELIMINAIRE; 2010, MMWR MORB MORTAL WKL, V59, P1637	5	40	40	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					300	301		10.1056/NEJMp1100118	http://dx.doi.org/10.1056/NEJMp1100118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711LH	21219131	Bronze			2022-12-01	WOS:000286592600004
J	Afek, Y; Alon, N; Barad, O; Hornstein, E; Barkai, N; Bar-Joseph, Z				Afek, Yehuda; Alon, Noga; Barad, Omer; Hornstein, Eran; Barkai, Naama; Bar-Joseph, Ziv			A Biological Solution to a Fundamental Distributed Computing Problem	SCIENCE			English	Article							LATERAL INHIBITION; PARALLEL ALGORITHM; PATTERN-FORMATION; SET; PATHWAY	Computational and biological systems are often distributed so that processors (cells) jointly solve a task, without any of them receiving all inputs or observing all outputs. Maximal independent set (MIS) selection is a fundamental distributed computing procedure that seeks to elect a set of local leaders in a network. A variant of this problem is solved during the development of the fly's nervous system, when sensory organ precursor (SOP) cells are chosen. By studying SOP selection, we derived a fast algorithm for MIS selection that combines two attractive features. First, processors do not need to know their degree; second, it has an optimal message complexity while only using one-bit messages. Our findings suggest that simple and efficient algorithms can be developed on the basis of biologically derived insights.	[Barad, Omer; Hornstein, Eran; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Afek, Yehuda; Alon, Noga] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Afek, Yehuda; Alon, Noga] Tel Aviv Univ, Sackler Sch Math, IL-69978 Tel Aviv, Israel; [Alon, Noga] Inst Adv Study, Princeton, NJ 08544 USA; [Bar-Joseph, Ziv] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA	Weizmann Institute of Science; Tel Aviv University; Tel Aviv University; Institute for Advanced Study - USA; Carnegie Mellon University	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il; zivbj@cs.cmu.edu	Alon, Noga/GOV-5970-2022; Bar-Joseph, Ziv/GWN-2754-2022; HORNSTEIN, ERAN/K-1340-2012	Alon, Noga/0000-0003-1332-4883; HORNSTEIN, ERAN/0000-0002-5534-1924; Bar-Joseph, Ziv/0000-0003-3430-6051	European Research Council (ERC); Oswald Veblen Fund; Bell Companies Fellowship; Azrieli Foundation; Israel Science Foundation; Hellen and Martin Kimmel award for innovative investigations; NIH [1RO1 GM085022]; NSF [0448453]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085022] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)); Oswald Veblen Fund; Bell Companies Fellowship; Azrieli Foundation; Israel Science Foundation(Israel Science Foundation); Hellen and Martin Kimmel award for innovative investigations; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. W. Posakony for fly stock and D. Rosin for help in experiments. This work was supported by a European Research Council (ERC) Advanced grant, the Oswald Veblen Fund, and the Bell Companies Fellowship (N.A.), the Azrieli Foundation (O.B.), the Israel Science Foundation (E. H. and N.B.), ERC (IDEA), the Hellen and Martin Kimmel award for innovative investigations (N.B.), NIH grant 1RO1 GM085022, and NSF CAREER award 0448453 (Z.B.-J.).	ALON N, 1986, J ALGORITHM, V7, P567, DOI 10.1016/0196-6774(86)90019-2; Alon U, 2006, INTRO SYSTEMS BIOL D; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barad O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000857; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; COHEN S, 1984, THEOR COMPUT SCI, V34, P215, DOI 10.1016/0304-3975(84)90118-X; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; LUBY M, 1986, SIAM J COMPUT, V15, P1036, DOI 10.1137/0215074; Lynch N., 1996, DISTRIBUTED ALGORITH; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; Moscibroda T., 2005, P 24 ANN ACM S PRINC, P148; Plahte E, 2001, J MATH BIOL, V43, P411, DOI 10.1007/s002850100105; RENDEL JM, 1965, GENETICS, V52, P1137; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Valiant Leslie G., 1982, P 7 IBM S MATH FDN C; Wan PJ, 2004, MOBILE NETW APPL, V9, P141, DOI 10.1023/B:MONE.0000013625.87793.13; Yves Metivier, 2009, Structural Information and Communication Complexity. 16th International Colloquium, SIROCCO 2009. Revised Selected Papers, P323	23	89	93	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					183	185		10.1126/science.1193210	http://dx.doi.org/10.1126/science.1193210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233379				2022-12-01	WOS:000286433100033
J	Becerra, MC; Appleton, SC; Franke, MF; Chalco, K; Arteaga, F; Bayona, J; Murray, M; Atwood, SS; Mitnick, CD				Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Chalco, Katiuska; Arteaga, Fernando; Bayona, Jaime; Murray, Megan; Atwood, Sidney S.; Mitnick, Carole D.			Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study	LANCET			English	Article							CLOSE CONTACTS	Background Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis have emerged as major global health threats. WHO recommends contact investigation in close contacts of patients with MDR and XDR tuberculosis. We aimed to assess the burden of tuberculosis disease in household contacts of such patients. Methods We undertook a retrospective cohort study of household contacts of patients treated for MDR or XDR tuberculosis in Lima, Peru, in 1996-2003. The primary outcome was active tuberculosis in household contacts at the time the index patient began MDR tuberculosis treatment and during the 4-year follow-up. We examined whether the occurrence of active tuberculosis in the household contacts differed by resistance pattern of the index patient: either MDR or XDR tuberculosis. Findings 693 households of index patients with MDR tuberculosis were enrolled in the study. In 48 households, the Mycobacterium tuberculosis isolate from the index patient was XDR. Of the 4503 household contacts, 117 (2.60%) had active tuberculosis at the time the index patient began MDR tuberculosis treatment there was no difference in prevalence between XDR and MDR tuberculosis households. During the 4-year follow-up, 242 contacts developed active tuberculosis the frequency of active tuberculosis was nearly two times higher in contacts of patients with XDR tuberculosis than it was in contacts of patients with MDR tuberculosis (hazard ratio 1.88, 95% CI 1.10-3.21). In the 359 contacts with active tuberculosis, 142 (40%) had had isolates tested for resistance against first-line drugs, of whom 129 (90.9%, 95% CI 85.0-94.6) had MDR tuberculosis. Interpretation In view of the high risk of disease recorded in household contacts of patients with MDR or XDR tuberculosis, tuberculosis programmes should implement systematic household contact investigations for all patients identified as having MDR or XDR tuberculosis. If shown to have active tuberculosis, these household contacts should be suspected as having MDR tuberculosis until proven otherwise.	[Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Bayona, Jaime; Mitnick, Carole D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Chalco, Katiuska; Arteaga, Fernando; Bayona, Jaime; Murray, Megan; Mitnick, Carole D.] Socios Salud Sucursal Peru, Lima, Peru; [Becerra, Mercedes C.; Appleton, Sasha C.; Franke, Molly F.; Chalco, Katiuska; Arteaga, Fernando; Bayona, Jaime; Murray, Megan; Mitnick, Carole D.] Partners Hlth, Boston, MA USA; [Becerra, Mercedes C.; Murray, Megan; Atwood, Sidney S.; Mitnick, Carole D.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital	Becerra, MC (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	mbecerra@post.harvard.edu	Franke, Molly/AAK-7559-2020; Mitnick, Carole/GRO-1991-2022	Franke, Molly/0000-0002-4890-5728; Mitnick, Carole/0000-0002-3455-658X; Atwood, Sidney/0000-0001-8865-6300	Charles H Hood Foundation; David Rockefeller Center for Latin American Studies at Harvard University; Bill & Melinda Gates Foundation; National Heart, Lung, and Blood Institute [K01 HL080939]; National Institute of Allergy and Infectious Diseases [K01 A1065836]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL080939] Funding Source: NIH RePORTER	Charles H Hood Foundation; David Rockefeller Center for Latin American Studies at Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Charles H Hood Foundation, the David Rockefeller Center for Latin American Studies at Harvard University, and the Bill & Melinda Gates Foundation funded this study. The authors also acknowledge the support of career development awards from the National Heart, Lung, and Blood Institute (K01 HL080939, to MCB) and the National Institute of Allergy and Infectious Diseases (K01 A1065836, to CDM).	Centers for Disease Control and Prevention, 2000, MMWR Recomm Rep, V49, P1; Attamna A, 2009, THORAX, V64, P271, DOI 10.1136/thx.2008.100974; Bayona J, 2003, INT J TUBERC LUNG D, V7, pS501; Cobelens FGJ, 2008, PLOS MED, V5, P1037, DOI 10.1371/journal.pmed.0050150; Fraser A, 2006, Cochrane Database Syst Rev, pCD005435; Furin JJ, 2000, EUR J CLIN MICROBIOL, V19, P132, DOI 10.1007/s100960050445; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Kritski AL, 1996, AM J RESP CRIT CARE, V153, P331, DOI 10.1164/ajrccm.153.1.8542139; Medical Research Council, 1974, B WORLD HEALTH ORGAN, V51, P473; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mohammadi A., 2008, Eastern Mediterranean Health Journal, V14, P1238; Rothman K. J., 2008, MODERN EPIDEMIOLOGY; Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Teixeira L, 2001, INT J TUBERC LUNG D, V5, P321; Tuberculosis Coalition for Technical Assistance, INT STAND TUB CAR IS; *UNAIDS WHO, UNAIDS WHO EP FACT S; [World Health Organization International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance], 1997, WHOCDSTB1997229 INT; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization (WHO), GUID PROGR MAN DRUG	21	97	98	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					147	152		10.1016/S0140-6736(10)61972-1	http://dx.doi.org/10.1016/S0140-6736(10)61972-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21145581				2022-12-01	WOS:000286292800027
J	Mold, JE; Venkatasubrahmanyam, S; Burt, TD; Michaelsson, J; Rivera, JM; Galkina, SA; Weinberg, K; Stoddart, CA; McCune, JM				Mold, Jeff E.; Venkatasubrahmanyam, Shivkumar; Burt, Trevor D.; Michaelsson, Jakob; Rivera, Jose M.; Galkina, Sofiya A.; Weinberg, Kenneth; Stoddart, Cheryl A.; McCune, Joseph M.			Fetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in Humans	SCIENCE			English	Article							MATERNAL HLA ANTIGENS; EARLY EVENTS; HUMAN FETUS; LONG-TERM; IN-UTERO; IDENTIFICATION; EXPRESSION; TOLERANCE; RESPONSES; ONTOGENY	Although the mammalian immune system is generally thought to develop in a linear fashion, findings in avian and murine species argue instead for the developmentally ordered appearance (or "layering") of distinct hematopoietic stem cells (HSCs) that give rise to distinct lymphocyte lineages at different stages of development. Here we provide evidence of an analogous layered immune system in humans. Our results suggest that fetal and adult T cells are distinct populations that arise from different populations of HSCs that are present at different stages of development. We also provide evidence that the fetal T cell lineage is biased toward immune tolerance. These observations offer a mechanistic explanation for the tolerogenic properties of the developing fetus and for variable degrees of immune responsiveness at birth.	[Mold, Jeff E.; Burt, Trevor D.; Rivera, Jose M.; Galkina, Sofiya A.; Stoddart, Cheryl A.; McCune, Joseph M.] Univ Calif San Francisco, Div Expt Med, Dept Med, San Francisco, CA 94143 USA; [Venkatasubrahmanyam, Shivkumar] Stanford Univ, Sch Med, Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Burt, Trevor D.] Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA 94143 USA; [Michaelsson, Jakob] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Weinberg, Kenneth] Stanford Univ, Sch Med, Dept Pediat, Div Hematol Oncol & Stem Cell Transplantat, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; Karolinska Institutet; Stanford University	McCune, JM (corresponding author), Univ Calif San Francisco, Div Expt Med, Dept Med, UCSF Box 1234,SFGH Bldg 3, San Francisco, CA 94143 USA.	mike.mccune@ucsf.edu		Burt, Trevor/0000-0001-7933-529X; Mold, Jeffrey/0000-0003-2195-2978	NIH [OD000329, AI40312, CA049605, AG033314]; Harvey V. Berneking Living Trust; National Institute of Allergy and Infectious Diseases, NIH [N01-AI-70002]; Deborah Addicott Fellowship for Bioinformatics and Stem Cell Biology; Swedish Research Council; American Pediatric Society; American Academy of Pediatrics; March of Dimes; NIH, NIH Roadmap for Medical Research [DPI OD00329]; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R37AI040312, R01AI040312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033314] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvey V. Berneking Living Trust; National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Deborah Addicott Fellowship for Bioinformatics and Stem Cell Biology; Swedish Research Council(Swedish Research CouncilEuropean Commission); American Pediatric Society; American Academy of Pediatrics; March of Dimes(March of Dimes); NIH, NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all of the patients who generously donated tissue that was used in these studies. We also thank S. J. Fisher and D. F. Nixon for valuable discussions; A. J. Butte, M. E. Moreno, and G. Kosikova for technical support; and the Gladstone Genomics Core for microarray analysis. Support for this work was provided by grants from NIH to J. M. M. (OD000329 and AI40312) and to K. W. and A. J. Butte (CA049605 and AG033314) and from the Harvey V. Berneking Living Trust. This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, NIH, under contract no. N01-AI-70002. S. V. is supported by the Deborah Addicott Fellowship for Bioinformatics and Stem Cell Biology. J. M. is supported by the Swedish Research Council. T. D. B. received funding from American Pediatric Society, the American Academy of Pediatrics, and the March of Dimes as a fellow of the Pediatric Scientist Development Program. J. M. M. is a recipient of the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, through grant DPI OD00329. The microarray data have been deposited in the Gene Expression Omnibus with accession code GSE25119.	BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BRENT L, 1989, IMMUNOL LETT, V21, P55, DOI 10.1016/0165-2478(89)90012-6; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; BYRNE JA, 1994, J IMMUNOL, V152, P3098; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Harrison DE, 1997, EXP HEMATOL, V25, P293; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; HAYNES BF, 1988, J EXP MED, V168, P1061, DOI 10.1084/jem.168.3.1061; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; LUCIVERO G, 1991, Fetal Diagnosis and Therapy, V6, P101; Martin MA, 2005, STEM CELLS DEV, V14, P493, DOI 10.1089/scd.2005.14.493; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Muench MO, 2003, DEV COMP IMMUNOL, V27, P899, DOI 10.1016/S0145-305X(03)00081-8; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; SILVERSTEIN AM, 1964, SCIENCE, V144, P1423, DOI 10.1126/science.144.3625.1423; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Tavian M, 2005, EXP HEMATOL, V33, P1062, DOI 10.1016/j.exphem.2005.06.025; ZANJANI ED, 1993, BLOOD, V81, P399	26	281	284	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1695	1699		10.1126/science.1196509	http://dx.doi.org/10.1126/science.1196509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164017	Green Accepted			2022-12-01	WOS:000285390500072
J	Moon, JC; Flett, AS; Godman, BB; Grosso, AM; Wierzbicki, AS				Moon, James C.; Flett, Andrew S.; Godman, Brian B.; Grosso, Anthony M.; Wierzbicki, Anthony S.			Getting better value from the NHS drug budget	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SWITCHING STATINS; INITIATIVES; SIMVASTATIN; EFFICIENCY; REFORMS; ENHANCE; IMPACT; COST		[Moon, James C.; Flett, Andrew S.] Univ Coll London Hosp, Heart Hosp, London W1M 8PH, England; [Godman, Brian B.] Mario Negri Inst Pharmacol Res, Milan, Italy; [Godman, Brian B.] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Grosso, Anthony M.] Univ Coll London Hosp, Dept Pharm, London NW1 2PG, England; [Wierzbicki, Anthony S.] Guys & St Thomas NHS Trust, St Thomas Hosp, London SE1 7EH, England	University College London Hospitals NHS Foundation Trust; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Karolinska Institutet; University College London Hospitals NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Moon, JC (corresponding author), Univ Coll London Hosp, Heart Hosp, London W1M 8PH, England.	james.moon@uclh.nhs.uk	Wierzbicki, Anthony/AAP-1735-2020; Godman, Brian/R-8897-2019; Moon, James/AAA-9905-2020; Moon, James C/F-1031-2014	Wierzbicki, Anthony/0000-0003-2756-372X; Moon, James/0000-0001-8071-1491; Moon, James C/0000-0001-8071-1491				British Hypertension Society, 2010, GUID MAN HYP; Erhardt LR, 2005, INT J CLIN PRACT, V59, P571, DOI 10.1111/j.1368-5031.2005.00513.x; Godman B, 2008, PHARMACOECONOMICS, V26, P91, DOI 10.2165/00019053-200826020-00001; Godman B, 2010, PHARMACEUTICALS, V3, P2470, DOI 10.3390/ph3082470; Godman B, 2010, EXPERT REV PHARM OUT, V10, P199, DOI 10.1586/ERP.10.6; Godman Brian, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P475, DOI 10.1586/erp.09.43; Gumbs PD, 2007, BRIT J CLIN PHARMACO, V64, P680, DOI 10.1111/j.1365-2125.2007.02958.x; HERAN BS, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003822.PUB2; Kjeldsen SE, 2010, J HUM HYPERTENS, V24, P263, DOI 10.1038/jhh.2009.77; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Light D., 2010, RISKS PRESCRIPTION D; McGinn D, 2010, EXPERT REV PHARM OUT, V10, P73, DOI 10.1586/ERP.09.73; Meredith PA, 2010, J HUM HYPERTENS, V24, P525, DOI 10.1038/jhh.2009.99; Moon JC, 2006, BMJ-BRIT MED J, V332, P1344, DOI 10.1136/bmj.332.7554.1344; NHS Information Centre, 2010, PRESCR COST AN 2009; Prosser H, 2005, SOC SCI MED, V60, P1335, DOI 10.1016/j.socscimed.2004.07.013; Sakshaug S, 2007, BRIT J CLIN PHARMACO, V64, P476, DOI 10.1111/j.1365-2125.2007.02907.x; Sermet C, 2010, APPL HEALTH ECON HEA, V8, P7, DOI 10.2165/11313900-000000000-00000; Universtiy College London Hospital NHS Trust, 2010, UCLH GUID ANG 2 REC; Usher-Smith J, 2008, INT J CLIN PRACT, V62, P480, DOI 10.1111/j.1742-1241.2007.01690.x; Wettermark B, 2008, PHARMACOECONOMICS, V26, P537, DOI 10.2165/00019053-200826070-00001	21	14	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2010	341								c6449	10.1136/bmj.c6449	http://dx.doi.org/10.1136/bmj.c6449			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XO	21169320				2022-12-01	WOS:000285553300006
J	Park, H; Pontius, W; Guet, CC; Marko, JF; Emonet, T; Cluzel, P				Park, Heungwon; Pontius, William; Guet, Calin C.; Marko, John F.; Emonet, Thierry; Cluzel, Philippe			Interdependence of behavioural variability and response to small stimuli in bacteria	NATURE			English	Article							SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; CHEMOTAXIS; NOISE; SENSITIVITY; ROBUSTNESS; NETWORKS; SYSTEMS; GENE	The chemotaxis signalling network in Escherichia coli that controls the locomotion of bacteria is a classic model system for signal transduction(1,2). This pathway modulates the behaviour of flagellar motors to propel bacteria towards sources of chemical attractants. Although this system relaxes to a steady state in response to environmental changes, the signalling events within the chemotaxis network are noisy and cause large temporal variations of the motor behaviour even in the absence of stimulus(3). That the same signalling network governs both behavioural variability and cellular response raises the question of whether these two traits are independent. Here, we experimentally establish a fluctuation-response relationship in the chemotaxis system of living bacteria. Using this relationship, we demonstrate the possibility of inferring the cellular response from the behavioural variability measured before stimulus. In monitoring the pre- and post-stimulus switching behaviour of individual bacterial motors, we found that variability scales linearly with the response time for different functioning states of the cell. This study highlights that the fundamental relationship between fluctuation and response is not constrained to physical systems at thermodynamic equilibrium(4) but is extensible to living cells(5). Such a relationship not only implies that behavioural variability and cellular response can be coupled traits, but it also provides a general framework within which we can examine how the selection of a network design shapes this interdependence.	[Guet, Calin C.; Cluzel, Philippe] Harvard Univ, FAS Ctr Syst Biol, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Guet, Calin C.; Cluzel, Philippe] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Park, Heungwon] Univ Chicago, James Franck Inst, Inst Biophys Dynam, Chicago, IL 60637 USA; [Park, Heungwon] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Pontius, William; Emonet, Thierry] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pontius, William; Emonet, Thierry] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Marko, John F.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Marko, John F.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	Harvard University; Harvard University; University of Chicago; University of Chicago; Yale University; Yale University; Northwestern University; Northwestern University	Cluzel, P (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	cluzel@mcb.harvard.edu	Emonet, Thierry/AAI-3740-2020; Marko, John F./AAY-7111-2021	Marko, John F./0000-0003-4151-9530	NSF DMR [0213745]; NIH [R01AI059195-03, 1U54CA143869-01]; NSF [CCF0829836, PHY-0852130, DMR-0715099]; Alfred P. Sloan Research Fellowship; National Academies Keck Futures Initiative; Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	NSF DMR(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); National Academies Keck Futures Initiative; Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by an NSF DMR award 0213745 to the Materials Research Science and Engineering Center at the University of Chicago, and NIH award R01AI059195-03 (to P.C.). W.P. and T.E. were supported by NSF CCF0829836, an Alfred P. Sloan Research Fellowship, and a National Academies Keck Futures Initiative award (to T.E.). J.F.M. was supported by NSF awards PHY-0852130 and DMR-0715099 and NIH grant 1U54CA143869-01. This work was also supported by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. D. Trentham supplied caged L-aspartate. We thank J. S. Parkinson for ADCheB mutant strains RP4972 and RP4992. We thank T. Shimizu for discussions and sharing unpublished work. We thank H. Lee for help with the HPLC measurements. We thank J. Moffitt and K. Wood for comments on the manuscript and all members of the Cluzel laboratory for many discussions. W. Grus provided editorial assistance.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Anderson RL, 1942, ANN MATH STAT, V13, P1, DOI 10.1214/aoms/1177731638; Andrews BW, 2006, PLOS COMPUT BIOL, V2, P1407, DOI 10.1371/journal.pcbi.0020154; Bainer R, 2003, J MICROBIOL METH, V55, P315, DOI 10.1016/S0167-7012(03)00112-X; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Berg HC, 2000, PHYS TODAY, V53, P24, DOI 10.1063/1.882934; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; CALLEN HB, 1951, PHYS REV, V83, P34, DOI 10.1103/PhysRev.83.34; Chetrite R, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/08/P08005; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Cugliandolo LF, 1997, PHYS REV LETT, V79, P2168, DOI 10.1103/PhysRevLett.79.2168; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Dorignac J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.186105; Emonet T, 2008, P NATL ACAD SCI USA, V105, P3304, DOI 10.1073/pnas.0705463105; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Jasuja R, 1999, P NATL ACAD SCI USA, V96, P11346, DOI 10.1073/pnas.96.20.11346; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Prost J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.090601; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Ratnam R, 2000, J NEUROSCI, V20, P6672, DOI 10.1523/JNEUROSCI.20-17-06672.2000; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Speck T, 2006, EUROPHYS LETT, V74, P391, DOI 10.1209/epl/i2005-10549-4	35	52	52	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					819	U114		10.1038/nature09551	http://dx.doi.org/10.1038/nature09551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21076396	Green Accepted			2022-12-01	WOS:000285093700045
J	Moller, BL				Moller, Birger Lindberg			Dynamic Metabolons	SCIENCE			English	Editorial Material							CYANOGENIC GLUCOSIDE DHURRIN; SORGHUM-BICOLOR; BIOSYNTHESIS; CONVERSION; EXPRESSION; CATALYZES; CLONING; COMPLEX		Univ Copenhagen, Dept Plant Biol & Biotechnol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark	University of Copenhagen	Moller, BL (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark.	blm@life.ku.dk	Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022	Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119				An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; Bartosova L, 2006, NEUROTOX RES, V9, P291, DOI 10.1007/BF03033319; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006; DRUMM JE, 1995, ACS SYM SER, V584, P396; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Moller BL, 2010, CURR OPIN PLANT BIOL, V13, P338, DOI 10.1016/j.pbi.2010.01.009; MOLLER BL, 1980, J BIOL CHEM, V255, P3049; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Rusch GM, 2009, DRUG CHEM TOXICOL, V32, P381, DOI 10.1080/01480540903154187; Sakurada K, 2009, TOXICOL LETT, V189, P110, DOI 10.1016/j.toxlet.2009.05.007; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; Thellier M, 2006, FEBS J, V273, P4287, DOI 10.1111/j.1742-4658.2006.05425.x; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659	18	97	98	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1328	1329		10.1126/science.1194971	http://dx.doi.org/10.1126/science.1194971			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127236				2022-12-01	WOS:000284902100026
J	Xiong, P; Nocek, JM; Vura-Weis, J; Lockard, JV; Wasielewski, MR; Hoffman, BM				Xiong, Peng; Nocek, Judith M.; Vura-Weis, Josh; Lockard, Jenny V.; Wasielewski, Michael R.; Hoffman, Brian M.			Faster Interprotein Electron Transfer in a [Myoglobin, b(5)] Complex with a Redesigned Interface	SCIENCE			English	Article							CYTOCHROME-OXIDASE; PROTEINS; STATE	Direct measurements of electron transfer (ET) within a protein-protein complex with a redesigned interface formed by physiological partner proteins myoglobin (Mb) and cytochrome b(5) (b(5)) reveal interprotein ET rates comparable to those observed within the photosynthetic reaction center. Brownian dynamics simulations show that Mb in which three surface acid residues are mutated to lysine binds b(5) in an ensemble of configurations distributed around a reactive most-probable structure. Correspondingly, charge-separation ET from a photoexcited singlet zinc porphyrin incorporated within Mb to the heme of b(5) and the follow-up charge-recombination exhibit distributed kinetics, with median rate constants, k(f)(s) = 2.1 x 10(9) second(-1) and k(b)(s) = 4.3 x 10(10) second(-1), respectively. The latter approaches that for the initial step in photosynthetic charge separation, k = 3.3 x 10(11) second(-1).	[Xiong, Peng; Nocek, Judith M.; Vura-Weis, Josh; Lockard, Jenny V.; Wasielewski, Michael R.; Hoffman, Brian M.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Xiong, Peng] Huaiyin Inst Technol, Sch Life Sci & Chem Engn, Huaian 223003, Jiangsu Prov, Peoples R China; [Vura-Weis, Josh; Lockard, Jenny V.; Wasielewski, Michael R.] Northwestern Univ, Argonne NW Solar Energy Res Ctr, Evanston, IL 60208 USA	Northwestern University; Huaiyin Institute of Technology; Northwestern University	Wasielewski, MR (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	bmh@northwestern.edu	xiong, peng/AAF-1569-2021; xiong, peng/AAT-6376-2020; Nocek, Judith/D-1254-2010		National Institute of Health [HL063203]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001059]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063203] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided as follows: P. X., J.M.N., and B. M. H., the National Institute of Health (grant HL063203); J.V.-W., J.V.L., and M. R. W., as part of the ANSER Center, an Energy Frontier Research Center funded by U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences (DE-SC0001059).	[Anonymous], 2002, PHOTOSYNTHETICA; Beratan DN, 2009, ACCOUNTS CHEM RES, V42, P1669, DOI 10.1021/ar900123t; Berberan-Santos MN, 2005, CHEM PHYS, V315, P171, DOI 10.1016/j.chemphys.2005.04.006; Davidson VL, 2008, ACCOUNTS CHEM RES, V41, P730, DOI 10.1021/ar700252c; Geren L, 2009, METHOD ENZYMOL, V456, P507, DOI 10.1016/S0076-6879(08)04428-5; Gong XM, 2003, BIOCHEMISTRY-US, V42, P14492, DOI 10.1021/bi035603c; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Ivkovic-Jensen MM, 1999, BIOCHEMISTRY-US, V38, P1589, DOI 10.1021/bi9817156; Lukoyanov D, 2007, P NATL ACAD SCI USA, V104, P1451, DOI 10.1073/pnas.0610975104; NOCEK JM, 1991, J AM CHEM SOC, V113, P6822, DOI 10.1021/ja00018a017; Nocek JM, 1997, J AM CHEM SOC, V119, P2146, DOI 10.1021/ja9630811; Nocek JM, 2010, J AM CHEM SOC, V132, P6165, DOI 10.1021/ja100499j; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; PAPP S, 1990, BIOPHYS J, V58, P177, DOI 10.1016/S0006-3495(90)82363-8; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; WINKLER JR, 1995, BIOPHYS CHEM, V54, P199, DOI 10.1016/0301-4622(94)00156-E	16	50	50	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2010	330	6007					1075	1078		10.1126/science.1197054	http://dx.doi.org/10.1126/science.1197054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097931	Green Accepted			2022-12-01	WOS:000284374700035
J	Shrank, WH; Choudhry, NK; Fischer, MA; Avorn, J; Powell, M; Schneeweiss, S; Liberman, JN; Dollear, T; Brennan, TA; Brookhart, MA				Shrank, William H.; Choudhry, Niteesh K.; Fischer, Michael A.; Avorn, Jerry; Powell, Mark; Schneeweiss, Sebastian; Liberman, Joshua N.; Dollear, Timothy; Brennan, Troyen A.; Brookhart, M. Alan			The Epidemiology of Prescriptions Abandoned at the Pharmacy	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICATION ADHERENCE; NONADHERENCE; PERSISTENCE; MORTALITY; VALIDITY; DRUGS; PROXY	Background: Picking up prescriptions is an essential but previously unstudied component of adherence for patients who use retail pharmacies. Understanding the epidemiology and correlates of prescription abandonment may have an important effect on health care quality. Objective: To evaluate the rates and correlates of prescription abandonment. Design: Cross-sectional cohort study. Setting: One large retail pharmacy chain and one large pharmacy benefits manager (PBM) in the United States. Measurements: Prescriptions bottled at the retail pharmacy chain between 1 July 2008 and 30 September 2008 by patients insured by the PBM were identified. Pharmacy data were used to identify medications that were bottled and either dispensed or returned to stock (RTS) or abandoned. Data from the PBM were used to identify previous or subsequent dispensing at any pharmacy. The first (index) prescription in a class for each patient was assigned to 1 of 3 mutually exclusive outcomes: filled, RTS, or RTS with fill (in the 30 days after abandonment, the patient purchased a prescription for a medication in the same medication class at any pharmacy). Outcome rates were assessed by drug class, and generalized estimating equations were used to assess patient, neighborhood, insurance, and prescription characteristics associated with abandonment. Results: 10 349 139 index prescriptions were filled by 5 249 380 patients. Overall, 3.27% of index prescriptions were abandoned; 1.77% were RTS and 1.50% were RTS with fill. Patients were least likely to abandon opiate prescriptions. Prescriptions with copayments of $40 to $50 and prescriptions costing more than $50 were 3.40 times and 4.68 times more likely, respectively, to be abandoned than prescriptions with no copayment (P < 0.001 for both comparisons). New users of medications had a 2.74 times greater probability of abandonment than prevalent users (P < 0.001), and prescriptions delivered electronically were 1.64 times more likely to be abandoned than those that were not electronic (P < 0.001). Limitation: The study included mainly insured patients and analyzed data collected during the summer months only. Conclusion: Although prescription abandonment represents a small component of medication nonadherence, the correlates to abandonment highlight important opportunities to intervene and thereby improve medication taking.	[Shrank, William H.] Brigham & Womens Hosp, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Ctr Amer Polit Studies, Cambridge, MA 02138 USA; CVS Caremark, Woonsocket, RI USA; CVS Caremark, Hunt Valley, MD USA; Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; University of North Carolina; University of North Carolina Chapel Hill	Shrank, WH (corresponding author), Brigham & Womens Hosp, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	wshrank@partners.org			CVS Caremark; National Heart, Lung, and Blood Institute [HL-090505]; National Institutes of Health [AG-027400]; Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL090505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG027400] Funding Source: NIH RePORTER	CVS Caremark; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By a research grant from CVS Caremark. Dr. Shrank is supported by a career development award from the National Heart, Lung, and Blood Institute (HL-090505), and Dr. Brookhart is supported by a career development grant from the National Institutes of Health (AG-027400).; Dr. Shrank: Grants (money to institution): National Institutes of Health (National Heart, Lung, and Blood career development award), CVS Caremark. Drs. Choudhry, Fischer, Avorn, and Brookhart: Grants (money to institution): CVS Caremark. Dr. Schneeweiss: Grants (money to institution): CVS Caremark. Board membership: HealthCore. Consultancy: WHISCON, RTI Health Solutions, The Lewin Group. Grants/grants pending: Pfizer. Drs. Liberman, Dollear, and Brennan: Employment: CVS Caremark. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOf InterestForms.do?msNum = M10-1125.	Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Choudhry NK, 2007, HEALTH AFFAIR, V26, P186, DOI 10.1377/hlthaff.26.1.186; CHOUDHRY NK, 2010, ARCH INTERN IN PRESS, P27953; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Gellad WF, 2009, HEALTH SERV RES, V44, P606, DOI 10.1111/j.1475-6773.2008.00917.x; Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; *GRANT THORNT, 2007, COST DISP STUD IND C, P27953; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; *KAIS FAM FDN, US PRESCR DRUGS, P27953; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Lee JY, 1996, AM J HYPERTENS, V9, P719, DOI 10.1016/0895-7061(96)00056-8; Lee TJ, 2004, ALIMENT PHARM THER, V20, P1241, DOI 10.1111/j.1365-2036.2004.02289.x; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Organization WH, 2003, ADHERENCE LONG TERM; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Shah NR, 2009, J GEN INTERN MED, V24, P233, DOI 10.1007/s11606-008-0870-z; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shrank WH, 2005, AM J MANAG CARE, V11, P16; Shrank WH, 2006, ANN PHARMACOTHER, V40, P1534, DOI 10.1345/aph.1H158; Shrank WH, 2009, MED CARE, V47, P319, DOI 10.1097/MLR.0b013e31818af850; Soobader MJ, 2001, AM J PUBLIC HEALTH, V91, P632, DOI 10.2105/AJPH.91.4.632; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; U. S. Bureau of the Census, 2002, CENS 2000 URB RUR CL	28	78	78	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 16	2010	153	10					633	640		10.7326/0003-4819-153-10-201011160-00005	http://dx.doi.org/10.7326/0003-4819-153-10-201011160-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680ES	21079218				2022-12-01	WOS:000284215800015
J	Jiao, YC; Shi, CJ; Edil, BH; de Wilde, RF; Klimstra, DS; Maitra, A; Schulick, RD; Tang, LH; Wolfgang, CL; Choti, MA; Velculescu, VE; Diaz, LA; Vogelstein, B; Kinzler, KW; Hruban, RH; Papadopoulos, N				Jiao, Yuchen; Shi, Chanjuan; Edil, Barish H.; de Wilde, Roeland F.; Klimstra, David S.; Maitra, Anirban; Schulick, Richard D.; Tang, Laura H.; Wolfgang, Christopher L.; Choti, Michael A.; Velculescu, Victor E.; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Hruban, Ralph H.; Papadopoulos, Nickolas			DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; ENDOCRINE TUMORS; TUBEROUS SCLEROSIS; EXPRESSION; CANCER; ATRX; H3.3; LOCALIZATION; SUPPRESSOR; MUTATIONS	Pancreatic neuroendocrine tumors (PanNETs) are a rare but clinically important form of pancreatic neoplasia. To explore the genetic basis of PanNETs, we determined the exomic sequences of 10 nonfamilial PanNETs and then screened the most commonly mutated genes in 58 additional PanNETs. The most frequently mutated genes specify proteins implicated in chromatin remodeling: 44% of the tumors had somatic inactivating mutations in MEN1, which encodes menin, a component of a histone methyltransferase complex, and 43% had mutations in genes encoding either of the two subunits of a transcription/chromatin remodeling complex consisting of DAXX (death-domain-associated protein) and ATRX (alpha thalassemia/mental retardation syndrome X-linked). Clinically, mutations in the MEN1 and DAXX/ATRX genes were associated with better prognosis. We also found mutations in genes in the mTOR (mammalian target of rapamycin) pathway in 14% of the tumors, a finding that could potentially be used to stratify patients for treatment with mTOR inhibitors.	[Jiao, Yuchen; Velculescu, Victor E.; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21231 USA; [Jiao, Yuchen; Velculescu, Victor E.; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Shi, Chanjuan; de Wilde, Roeland F.; Maitra, Anirban; Hruban, Ralph H.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA; [Edil, Barish H.; Schulick, Richard D.; Wolfgang, Christopher L.; Choti, Michael A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA; [Klimstra, David S.; Tang, Laura H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Maitra, Anirban; Hruban, Ralph H.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Diaz, Luis A., Jr.] Johns Hopkins Univ, Swim Amer Lab, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Kinzler, KW (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21231 USA.	kinzlke@jhmi.edu; rhruban@jhmi.edu; npapado1@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012; Velculescu, Victor/ABF-4846-2020; jiao, yuchen/H-6313-2011	Velculescu, Victor/0000-0003-1195-438X; Jiao, Yuchen/0000-0001-7917-8810; Diaz, Luis/0000-0002-7079-8914	Caring for Carcinoid Foundation; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Pancreatic Cancer Research Center; Joseph L. Rabinowitz Fund for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Raymond and Beverly Sackler Research Foundation; American Associatoion for Cancer Research; National Institutes of Health [CA121113, P50CA062924, P01CA134292, R01CA113669]; NATIONAL CANCER INSTITUTE [R01CA057345, P01CA134292, R37CA057345, R01CA113669, R01CA121113, P50CA062924] Funding Source: NIH RePORTER	Caring for Carcinoid Foundation; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Pancreatic Cancer Research Center; Joseph L. Rabinowitz Fund for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Raymond and Beverly Sackler Research Foundation; American Associatoion for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Whalen for expert technical assistance. This work was supported by a research grant from the Caring for Carcinoid Foundation, by the Lustgarten Foundation for Pancreatic Cancer Research, the Sol Goldman Pancreatic Cancer Research Center, the Joseph L. Rabinowitz Fund for Pancreatic Cancer Research, the Virginia and D. K. Ludwig Fund for Cancer Research, the Raymond and Beverly Sackler Research Foundation, the American Associatoion for Cancer Research Stand Up To Cancer-Dream Team Translational Cancer Research Grant, and by National Institutes of Health grants CA121113, P50CA062924, P01CA134292, and R01CA113669. N.P. B.V., L.D., V.E.V., and K.W.K. are members of the Scientific Advisory Board of Inostics, a company that is developing technologies for the molecular diagnosis of cancer. N.P. B.V., L.D., V.E.V., and K.W.K. are co-founders of Inostics and Personal Genome Diagnostics and are members of their Scientific Advisory Boards. The authors are entitled to a share of the royalties received by the university on sales of products related to genes described in this manuscript. N.P., B.V., K.W.K., L.A.D., and V.E.V. own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under university policy. The terms of these arrangements are managed by Johns Hopkins University in accordance with its conflict-of-interest policies. D.S.K. is a paid advisor for Novartis, which produces drugs for treatment of neuroendocrine tumors.	Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Capelli P, 2009, ARCH PATHOL LAB MED, V133, P350, DOI 10.1043/1543-2165-133.3.350; Chung DC, 1998, CANCER RES, V58, P3706; Corbo V, 2010, ENDOCR-RELAT CANCER, V17, P771, DOI 10.1677/ERC-10-0028; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Ekeblad S, 2008, CLIN CANCER RES, V14, P7798, DOI 10.1158/1078-0432.CCR-08-0734; Floridia G, 2005, CANCER GENET CYTOGEN, V156, P23, DOI 10.1016/j.cancergencyto.2004.04.015; Francalanci P, 2003, AM J SURG PATHOL, V27, P1386, DOI 10.1097/00000478-200310000-00012; Fredrich M, 2009, EXP BRAIN RES, V195, P241, DOI 10.1007/s00221-009-1776-7; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hruban RH, 2007, TUMORS PANCREAS ATLA, P191; Hu Wenwei, 2010, Genes Cancer, V1, P360; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim H, 2003, CANCER RES, V63, P6135; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Yao JC, 2010, ANN ONCOL, V21, P4; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	29	1169	1220	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1199	1203		10.1126/science.1200609	http://dx.doi.org/10.1126/science.1200609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21252315	Green Accepted			2022-12-01	WOS:000287971200044
J	Gilbert, NC; Bartlett, SG; Waight, MT; Neau, DB; Boeglin, WE; Brash, AR; Newcomer, ME				Gilbert, Nathaniel C.; Bartlett, Sue G.; Waight, Maria T.; Neau, David B.; Boeglin, William E.; Brash, Alan R.; Newcomer, Marcia E.			The Structure of Human 5-Lipoxygenase	SCIENCE			English	Article							PURIFIED HUMAN 5-LIPOXYGENASE; CRYSTAL-STRUCTURE; SOYBEAN LIPOXYGENASE-1; C2-LIKE DOMAIN; PROTEIN; SPECIFICITY; OXYGENATION; 8R-LIPOXYGENASE; BIOSYNTHESIS; DETERMINANTS	The synthesis of both proinflammatory leukotrienes and anti-inflammatory lipoxins requires the enzyme 5-lipoxygenase (5-LOX). 5-LOX activity is short-lived, apparently in part because of an intrinsic instability of the enzyme. We identified a 5-LOX-specific destabilizing sequence that is involved in orienting the carboxyl terminus, which binds the catalytic iron. Here, we report the crystal structure at 2.4 angstrom resolution of human 5-LOX stabilized by replacement of this sequence.	[Gilbert, Nathaniel C.; Bartlett, Sue G.; Waight, Maria T.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Neau, David B.] Argonne Natl Lab, NE Collaborat Access Team, Argonne, IL 60439 USA; [Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Argonne National Laboratory; Vanderbilt University	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu	Gilbert, Nathaniel/I-8223-2018	Gilbert, Nathaniel/0000-0002-6706-811X	American Heart Association [MCB 08553920E]; NSF [0818387]; NIH [GM-15431]; Louisiana Governors' Biotechnology Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Governors' Biotechnology Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by grants from the American Heart Association (MCB 08553920E) and NSF (0818387) to M.E.N. and from NIH (GM-15431) to A. R. B. Preliminary work was performed at the Center for Advanced Microstructures and Devices (Baton Rouge), funded in part by the Louisiana Governors' Biotechnology Initiative. X-ray data were collected at Beam Line 24-ID-E of NE-CAT at the Advanced Photon Source. Atomic coordinates and structure factors have been deposited in the Protein Data Bank under accession number 3O8Y. M.E.N., N.C.G., and S. G. B, have applied for a patent on the modified enzyme (Stable-5-LOX). For noncommercial use, the construct will be supplied subject to a material transfer agreement.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; AHARONY D, 1986, J BIOL CHEM, V261, P1512; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Chen XS, 1998, J BIOL CHEM, V273, P31237, DOI 10.1074/jbc.273.47.31237; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Hammarberg T, 2002, ADV EXP MED BIOL, V507, P117; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Kuhn H, 2003, ARTERIOSCL THROM VAS, V23, P1072, DOI 10.1161/01.ATV.0000074167.01184.48; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Neau DB, 2007, ACTA CRYSTALLOGR F, V63, P972, DOI 10.1107/S1744309107050993; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; PERCIVAL MD, 1992, EUR J BIOCHEM, V210, P109, DOI 10.1111/j.1432-1033.1992.tb17397.x; Radmark O, 2009, J LIPID RES, V50, pS40, DOI 10.1194/jlr.R800062-JLR200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; Walther M, 2001, CHEM BIOL, V8, P779, DOI 10.1016/S1074-5521(01)00050-3; ZHANG YY, 1994, ANAL BIOCHEM, V220, P28, DOI 10.1006/abio.1994.1294	29	299	307	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					217	219		10.1126/science.1197203	http://dx.doi.org/10.1126/science.1197203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233389	Green Accepted, Green Submitted			2022-12-01	WOS:000286433100043
J	Khera, AV; Cuchel, M; de la Llera-Moya, M; Rodrigues, A; Burke, MF; Jafri, K; French, BC; Phillips, JA; Mucksavage, ML; Wilensky, RL; Mohler, ER; Rothblat, GH; Rader, DJ				Khera, Amit V.; Cuchel, Marina; de la Llera-Moya, Margarita; Rodrigues, Amrith; Burke, Megan F.; Jafri, Kashif; French, Benjamin C.; Phillips, Julie A.; Mucksavage, Megan L.; Wilensky, Robert L.; Mohler, Emile R.; Rothblat, George H.; Rader, Daniel J.			Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; PHOSPHOLIPID TRANSFER PROTEIN; APOLIPOPROTEIN-A-I; METABOLIC SYNDROME; MACROPHAGE ABCA1; HDL; PLASMA; ABCG1; SERUM; ABILITY	BACKGROUND High-density lipoprotein (HDL) may provide cardiovascular protection by promoting reverse cholesterol transport from macrophages. We hypothesized that the capacity of HDL to accept cholesterol from macrophages would serve as a predictor of atherosclerotic burden. METHODS We measured cholesterol efflux capacity in 203 healthy volunteers who underwent assessment of carotid artery intima-media thickness, 442 patients with angiographically confirmed coronary artery disease, and 351 patients without such angiographically confirmed disease. We quantified efflux capacity by using a validated ex vivo system that involved incubation of macrophages with apolipoprotein B-depleted serum from the study participants. RESULTS The levels of HDL cholesterol and apolipoprotein A-I were significant determinants of cholesterol efflux capacity but accounted for less than 40% of the observed variation. An inverse relationship was noted between efflux capacity and carotid intima-media thickness both before and after adjustment for the HDL cholesterol level. Furthermore, efflux capacity was a strong inverse predictor of coronary disease status (adjusted odds ratio for coronary disease per 1-SD increase in efflux capacity, 0.70; 95% confidence interval [CI], 0.59 to 0.83; P<0.001). This relationship was attenuated, but remained significant, after additional adjustment for the HDL cholesterol level (odds ratio per 1-SD increase, 0.75; 95% CI, 0.63 to 0.90; P = 0.002) or apolipoprotein A-I level (odds ratio per 1-SD increase, 0.74; 95% CI, 0.61 to 0.89; P = 0.002). Additional studies showed enhanced efflux capacity in patients with the metabolic syndrome and low HDL cholesterol levels who were treated with pioglitazone, but not in patients with hypercholesterolemia who were treated with statins. CONCLUSIONS Cholesterol efflux capacity from macrophages, a metric of HDL function, has a strong inverse association with both carotid intima-media thickness and the likelihood of angiographic coronary artery disease, independently of the HDL cholesterol level.	[Cuchel, Marina; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Khera, Amit V.; Rodrigues, Amrith; Burke, Megan F.; Jafri, Kashif; French, Benjamin C.; Mucksavage, Megan L.; Wilensky, Robert L.; Mohler, Emile R.; Rader, Daniel J.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [French, Benjamin C.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Mucksavage, Megan L.; Rothblat, George H.] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; [Phillips, Julie A.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08903 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Rutgers State University New Brunswick	Cuchel, M (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, 654 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	mcuchel@mail.med.upenn.edu; rader@mail.med.upenn.edu			National Heart, Lung, and Blood Institute (NHLBI) [HL22633, P50 HL70128, HL077146]; National Center for Research Resources [M01 RR00040, UL1-RR-024134]; Doris Duke Charitable Foundation; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, M01RR000040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL070128, K23HL077146, P01HL022633] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (HL22633 and P50 HL70128) and the National Center for Research Resources (M01 RR00040 and UL1-RR-024134) and a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation. Dr. Khera was supported by a medical student research fellowship from the Howard Hughes Medical Institute, and Dr. Cuchel by a K23 award (HL077146) from the NHLBI.	Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Calabresi L, 2009, CIRCULATION, V120, P628, DOI 10.1161/CIRCULATIONAHA.108.818143; Chirinos JA, 2005, CIRCULATION, V112, P2446, DOI 10.1161/CIRCULATIONAHA.104.521815; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Cui D, 2007, J LEUKOCYTE BIOL, V82, P1040, DOI 10.1189/jlb.0307192; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; de Vries R, 2008, ATHEROSCLEROSIS, V196, P733, DOI 10.1016/j.atherosclerosis.2006.12.027; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Dullaart RPF, 2008, EUR J ENDOCRINOL, V158, P53, DOI 10.1530/EJE-07-0451; Fournier N, 1997, ARTERIOSCL THROM VAS, V17, P2685, DOI 10.1161/01.ATV.17.11.2685; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khera AV, 2010, CURR ATHEROSCLER REP, V12, P73, DOI 10.1007/s11883-009-0080-0; Ky B, 2008, J AM COLL CARDIOL, V51, P1653, DOI 10.1016/j.jacc.2008.01.026; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Mikkola TS, 2003, ATHEROSCLEROSIS, V170, P31, DOI 10.1016/S0021-9150(03)00247-8; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Pajunen P, 2001, SCAND CARDIOVASC J, V35, P96; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P1516; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Syvanne M, 1996, ATHEROSCLEROSIS, V127, P245, DOI 10.1016/S0021-9150(96)05962-X; Szapary PO, 2006, ARTERIOSCL THROM VAS, V26, P182, DOI 10.1161/01.ATV.0000195790.24531.4f; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang LH, 2010, J LIPID RES, V51, P2211, DOI 10.1194/jlr.M004481; Zhou HL, 2008, DIABETES-METAB RES, V24, P617, DOI 10.1002/dmrr.895	39	1463	1517	5	168	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					127	135		10.1056/NEJMoa1001689	http://dx.doi.org/10.1056/NEJMoa1001689			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226578	Green Accepted			2022-12-01	WOS:000286142900006
J	Oberg, M; Jaakkola, MS; Woodward, A; Peruga, A; Pruss-Ustun, A				Oberg, Mattias; Jaakkola, Maritta S.; Woodward, Alistair; Peruga, Armando; Pruess-Ustuen, Annette			Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries	LANCET			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; PASSIVE SMOKING; LEGISLATION; CHILDREN; HEALTH; IMPACT	Background Exposure to second-hand smoke is common in many countries but the magnitude of the problem worldwide is poorly described. We aimed to estimate the worldwide exposure to second-hand smoke and its burden of disease in children and adult non-smokers in 2004. Methods The burden of disease from second-hand smoke was estimated as deaths and disability-adjusted life-years (DALYs) for children and adult non-smokers. The calculations were based on disease-specific relative risk estimates and area-specific estimates of the proportion of people exposed to second-hand smoke, by comparative risk assessment methods, with data from 192 countries during 2004. Findings Worldwide, 40% of children, 33% of male non-smokers, and 35% of female non-smokers were exposed to second-hand smoke in 2004. This exposure was estimated to have caused 379 000 deaths from ischaemic heart disease, 165 000 from lower respiratory infections, 36 900 from asthma, and 21 400 from lung cancer. 603 000 deaths were attributable to second-hand smoke in 2004, which was about 1.0% of worldwide mortality. 47% of deaths from second-hand smoke occurred in women, 28% in children, and 26% in men. DALYs lost because of exposure to second-hand smoke amounted to 10.9 million, which was about 0.7% of total worldwide burden of diseases in DALYs in 2004. 61% of DALYs were in children. The largest disease burdens were from lower respiratory infections in children younger than 5 years (5 939 000), ischaemic heart disease in adults (2 836 000), and asthma in adults (1 246 000) and children (651 000). Interpretation These estimates of worldwide burden of disease attributable to second-hand smoke suggest that substantial health gains could be made by extending effective public health and clinical interventions to reduce passive smoking worldwide.	[Pruess-Ustuen, Annette] WHO, Dept Publ Hlth & Environm, CH-1211 Geneva 27, Switzerland; [Oberg, Mattias] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Jaakkola, Maritta S.] Univ Oulu, Resp Med Unit, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Jaakkola, Maritta S.] Univ Oulu, Inst Clin Med, Oulu, Finland; [Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	World Health Organization; Karolinska Institutet; University of Oulu; University of Oulu; University of Auckland	Pruss-Ustun, A (corresponding author), WHO, Dept Publ Hlth & Environm, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	pruessa@who.int	Peruga, Armando/G-9739-2019	Oberg, Mattias/0000-0001-5377-530X; Jaakkola, Maritta S./0000-0003-1373-7784; Woodward, Alistair/0000-0001-5425-6018	Swedish National Board of Health and Welfare; Bloomberg Philanthropies	Swedish National Board of Health and Welfare; Bloomberg Philanthropies	We thank the Swedish National Board of Health and Welfare and the Bloomberg Philanthropies for their funding support. The authors alone are responsible for the views expressed in this publication, which do not necessarily reflect the decisions or the stated policy of WHO or of its Member States. (C) World Health Organization, 2010.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 1999, INT CONS ENV TOB SMO; [Anonymous], WORLD HLTH REP 2002; California Environmental Protection Agency, 2005, PROP ID ENV TOB SMOK; Centers for Disease Control and Prevention, GLOB YOUTH TOB SURV; Eriksen MP, 2008, ANNU REV PUBL HEALTH, V29, P171, DOI 10.1146/annurev.publhealth.29.020907.090920; ETZEL RA, 1992, PEDIATRICS, V90, P228; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M., 2004, COMP QUANTIFICATION; Fontana L, 2007, G Ital Med Lav Ergon, V29, P484; Gan Q, 2007, TOB CONTROL, V16, P417, DOI 10.1136/tc.2007.021477; Institute of Medicine, 2009, SECONDH SMOK EXP CAR; Intenational Labour Office, 2008, GLOB EMPL TRENDS WOM; International Agency for Research on Cancer, 2009, EV EFF SMOK FREE POL; International Agency for Research on Cancer, 2004, TOB SMOK INV SMOK; Jaakkola MS, 2006, EUR RESPIR J, V28, P397, DOI 10.1183/09031936.06.00001306; Jaakkola MS, 2003, AM J PUBLIC HEALTH, V93, P2055, DOI 10.2105/AJPH.93.12.2055; Jaakkola MS, 1999, ENVIRON HEALTH PERSP, V107, P829, DOI 10.2307/3434561; Li JS, 1999, PEDIATR PULM, V27, P5, DOI 10.1002/(SICI)1099-0496(199901)27:1<5::AID-PPUL3>3.0.CO;2-5; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Lopez MJ, 2007, TOB CONTROL, V16, P373, DOI 10.1136/tc.2006.019679; McNabola A, 2009, INT J ENV RES PUB HE, V6, P741, DOI 10.3390/ijerph6020741; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Musk AW, 2003, RESPIROLOGY, V8, P286, DOI 10.1046/j.1440-1843.2003.00483.x; Oberg M, GLOBAL ESTI IN PRESS; Pell Jill P, 2008, N Engl J Med, V359, P482, DOI 10.1056/NEJMsa0706740; Pr?ss-?st?n, 2010, 2 HAND SMOKE ASSESSI; SCHONHERR E., 1928, ZEITSCHR KREBSFORSCH, V27, P436, DOI 10.1007/BF02125480; The Gallup Organization, 2009, SURV TOB AN REP; The US Surgeon General, 2006, HLTH CONS INV EXP TO; United Nations, 2009, MILL DEV GOALS REP 2; US Department of Health Education and Welfare, 1972, DHEW PUBL; Wipfli H, 2008, AM J PUBLIC HEALTH, V98, P672, DOI 10.2105/AJPH.2007.126631; Woodward A, 2001, TOB CONTROL, V10, P383, DOI 10.1136/tc.10.4.383; World Health Organization, 2009, WHO FRAM CONV TOB CO; World Health Organization, 2009, GLOB BURD DIS 2004 U; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization (WHO), 2009, GUID IMPL WHO FRAM C	38	1131	1175	4	198	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					139	146		10.1016/S0140-6736(10)61388-8	http://dx.doi.org/10.1016/S0140-6736(10)61388-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21112082				2022-12-01	WOS:000286292800026
J	Bastviken, D; Tranvik, LJ; Downing, JA; Crill, PM; Enrich-Prast, A				Bastviken, David; Tranvik, Lars J.; Downing, John A.; Crill, Patrick M.; Enrich-Prast, Alex			Freshwater Methane Emissions Offset the Continental Carbon Sink	SCIENCE			English	Article							LAKES		[Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58183 Linkoping, Sweden; [Tranvik, Lars J.] Uppsala Univ, Evolutionary Biol Ctr, Dept Limnol, SE-75236 Uppsala, Sweden; [Downing, John A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Crill, Patrick M.] Stockholm Univ, Dept Geol Sci, SE-10691 Stockholm, Sweden; [Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Dept Ecol, BR-68020 Rio De Janeiro, Brazil	Linkoping University; Uppsala University; Iowa State University; Stockholm University; Universidade Federal do Rio de Janeiro	Bastviken, D (corresponding author), Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58183 Linkoping, Sweden.	david.bastviken@liu.se	Enrich-Prast, Alex/H-5391-2012; Magaña, Felipe/B-6966-2013; Prast, Alex Enrich/AAL-4722-2021; Crill, Patrick/ABC-1357-2021; Tranvik, Lars J/H-2222-2011	Prast, Alex Enrich/0000-0003-3561-0936; Bastviken, David/0000-0003-0038-2152; Crill, Patrick/0000-0003-1110-3059; Tranvik, Lars J./0000-0003-3509-8266; Downing, John/0000-0001-8547-0789	Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (Formas); NSF [DEB-94-21535]; University of California at Santa Barbara; state of California	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (Formas)(Swedish Research Council Formas); NSF(National Science Foundation (NSF)); University of California at Santa Barbara; state of California	We thank J. Cole, N. Than Duc, and H. Marotta for valuable input. This study was supported by the Swedish Research Council (VR) and the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (Formas). Analyses of global surface water area come from the ITAC (Integrating the Terrestrial and Aquatic Carbon Cycle) Working Group supported by the National Center for Ecological Analysis and Synthesis, a center funded by NSF (grant DEB-94-21535), the University of California at Santa Barbara, and the state of California.	Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benoy G, 2007, ENVIRON REV, V15, P175, DOI 10.1139/A07-006; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Downing J. A., 2009, ENCY INLAND WATERS, V1; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Guerin F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027929; International Commission on Large Dams, 2006, DAMS NEWSL       MAY, P2; Kemenes A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029479; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298	13	899	963	70	835	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					50	50		10.1126/science.1196808	http://dx.doi.org/10.1126/science.1196808			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212349	Green Submitted			2022-12-01	WOS:000285974000030
J	Nelson, EJ; Nelson, DS; Salam, MA; Sack, DA				Nelson, Eric J.; Nelson, Danielle S.; Salam, Mohammed A.; Sack, David A.			Antibiotics for Both Moderate and Severe Cholera.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nelson, Eric J.] Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA; [Nelson, Danielle S.] Santa Clara Valley Med Ctr, Milpitas, CA USA; [Salam, Mohammed A.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Sack, David A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Lucile Packard Children's Hospital (LPCH); Stanford University; Santa Clara Valley Medical Center; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nelson, EJ (corresponding author), Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA.							KHAN MU, 1982, J TROP MED HYG, V85, P27; LINDENBA.J, 1967, B WORLD HEALTH ORGAN, V36, P871; RAHAMAN MM, 1976, ANTIMICROB AGENTS CH, V10, P610, DOI 10.1128/AAC.10.4.610; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; Weil AA, 2009, CLIN INFECT DIS, V49, P1473, DOI 10.1086/644779	5	64	64	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					5	7		10.1056/NEJMp1013771	http://dx.doi.org/10.1056/NEJMp1013771			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21142691				2022-12-01	WOS:000285922600003
J	Zaratiegui, M; Vaughn, MW; Irvine, DV; Goto, D; Watt, S; Bahler, J; Arcangioli, B; Martienssen, RA				Zaratiegui, Mikel; Vaughn, Matthew W.; Irvine, Danielle V.; Goto, Derek; Watt, Stephen; Baehler, Juerg; Arcangioli, Benoit; Martienssen, Robert A.			CENP-B preserves genome integrity at replication forks paused by retrotransposon LTR	NATURE			English	Article							FISSION YEAST HOMOLOGS; SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; CHROMOSOME SEGREGATION; FRAGILE SITES; PROTEIN SAP1; RECOMBINATION; CENTROMERE; IDENTIFICATION; PURIFICATION	Centromere-binding protein B (CENP-B) is a widely conserved DNA binding factor associated with heterochromatin and centromeric satellite repeats(1). In fission yeast, CENP-B homologues have been shown to silence long terminal repeat (LTR) retrotransposons by recruiting histone deacetylases(2). However, CENP-B factors also have unexplained roles in DNA replication(3,4). Here we show that a molecular function of CENP-B is to promote replication-fork progression through the LTR. Mutants have increased genomic instability caused by replication-fork blockage that depends on the DNA binding factor switch-activating protein 1 (Sap1), which is directly recruited by the LTR. The loss of Sap1-dependent barrier activity allows the unhindered progression of the replication fork, but results in rearrangements deleterious to the retrotransposon. We conclude that retrotransposons influence replication polarity through recruitment of Sap1 and transposition near replication-fork blocks, whereas CENP-B counteracts this activity and promotes fork stability. Our results may account for the role of LTR in fragile sites, and for the association of CENP-B with pericentromeric heterochromatin and tandem satellite repeats.	[Zaratiegui, Mikel; Vaughn, Matthew W.; Irvine, Danielle V.; Goto, Derek; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Watt, Stephen; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Watt, Stephen; Baehler, Juerg] UCL Canc Inst, London WC1E 6BT, England; [Arcangioli, Benoit] Inst Pasteur, Dynam GenomeUnit, CNRS URA2171, Dept Genomes & Genet, F-75015 Paris, France; [Arcangioli, Benoit] Inst Pasteur, Dynam GenomeUnit, CNRS URA2171, Dept Dev Biol, F-75015 Paris, France	Cold Spring Harbor Laboratory; University of London; University College London; University of London; University College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Bahler, Jurg/B-4572-2009; Goto, Derek B/B-7053-2009	Bahler, Jurg/0000-0003-4036-1532; Vaughn, Matthew/0000-0002-1384-4283; Zaratiegui, Mikel/0000-0002-0342-0268	National Institutes of Health [RO1GM076396]; Cancer Research UK [C9546/A6517]; Agence Nationale de la Recherche [ANR-06-BLAN-0271]; National Health and Medical Research Council; Spanish Ministry of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Agence Nationale de la Recherche(French National Research Agency (ANR)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Education(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Martienssen laboratory, V. Aranda, E. Mejia-Ramirez and F. Antequera for technical advice and discussions, and R. Allshire, E. Noguchi, M. O'Connell, P. Espenshade and the National BioResource Project (T. Nakamura, Japan) for strains. This work was supported by National Institutes of Health grant RO1GM076396 to R.A.M., Cancer Research UK grant C9546/A6517 to J.B., l'Agence Nationale de la Recherche grant ANR-06-BLAN-0271 to B.A., a National Health and Medical Research Council C.J. Martin Fellowship to D.V.I. and a Postdoctoral Fellowship from the Spanish Ministry of Education to M.Z.	Aguilar-Arnal L, 2008, EMBO J, V27, P1029, DOI 10.1038/emboj.2008.53; ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; Baum M, 2000, MOL CELL BIOL, V20, P2852, DOI 10.1128/MCB.20.8.2852-2864.2000; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; de Lahondes R, 2003, EUKARYOT CELL, V2, P910, DOI 10.1128/EC.2.5.910-921.2003; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; GHAZVINI M, 1995, MOL CELL BIOL, V15, P4939; Gomez EB, 2008, GENETICS, V179, P757, DOI 10.1534/genetics.107.085779; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Irelan JT, 2001, GENETICS, V157, P1191; Irvine DV, 2009, GENOME RES, V19, P1077, DOI 10.1101/gr.089318.108; Krings G, 2005, J BIOL CHEM, V280, P39135, DOI 10.1074/jbc.M508996200; KUPIEC M, 1988, GENETICS, V119, P549; Lee JK, 1997, P NATL ACAD SCI USA, V94, P8427, DOI 10.1073/pnas.94.16.8427; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Locovei AM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-27; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Mejia-Ramirez E, 2005, MOL CELL BIOL, V25, P8755, DOI 10.1128/MCB.25.19.8755-8761.2005; Murakami Y, 1996, P NATL ACAD SCI USA, V93, P502, DOI 10.1073/pnas.93.1.502; Noguchi C, 2007, GENETICS, V175, P553, DOI 10.1534/genetics.106.065334; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Segurado M, 2002, MOL CELL, V10, P907, DOI 10.1016/S1097-2765(02)00684-6; Sehgal A, 2007, PLOS GENET, V3, P1389, DOI 10.1371/journal.pgen.0030131; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Ton-Hoang B, 2010, CELL, V142, P398, DOI 10.1016/j.cell.2010.06.034; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wong LH, 2004, TRENDS GENET, V20, P611, DOI 10.1016/j.tig.2004.09.011	30	66	67	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					112	115		10.1038/nature09608	http://dx.doi.org/10.1038/nature09608			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21151105	Green Submitted, Green Accepted			2022-12-01	WOS:000285921600042
J	Fabbri, M; Bottoni, A; Shimizu, M; Spizzo, R; Nicoloso, MS; Rossi, S; Barbarotto, E; Cimmino, A; Adair, B; Wojcik, SE; Valeri, N; Calore, F; Sampath, D; Fanini, F; Vannini, I; Musuraca, G; Dell'Aquila, M; Alder, H; Davuluri, RV; Rassenti, LZ; Negrini, M; Nakamura, T; Amadori, D; Kay, NE; Rai, KR; Keating, MJ; Kipps, TJ; Calin, GA; Croce, CM				Fabbri, Muller; Bottoni, Arianna; Shimizu, Masayoshi; Spizzo, Riccardo; Nicoloso, Milena S.; Rossi, Simona; Barbarotto, Elisa; Cimmino, Amelia; Adair, Brett; Wojcik, Sylwia E.; Valeri, Nicola; Calore, Federica; Sampath, Deepa; Fanini, Francesca; Vannini, Ivan; Musuraca, Gerardo; Dell'Aquila, Marie; Alder, Hansjuerg; Davuluri, Ramana V.; Rassenti, Laura Z.; Negrini, Massimo; Nakamura, Tatsuya; Amadori, Dino; Kay, Neil E.; Rai, Kanti R.; Keating, Michael J.; Kipps, Thomas J.; Calin, George A.; Croce, Carlo M.			Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGRESSION; SURVIVAL; DISEASE; ZAP-70	Context Chromosomal abnormalities (namely 13q, 17p, and 11q deletions) have prognostic implications and are recurrent in chronic lymphocytic leukemia (CLL), suggesting that they are involved in a common pathogenetic pathway; however, the molecular mechanism through which chromosomal abnormalities affect the pathogenesis and outcome of CLL is unknown. Objective To determine whether the microRNA miR-15a/miR-16-1 cluster (located at 13q), tumor protein p53 (TP53, located at 17p), and miR-34b/miR-34c cluster (located at 11q) are linked in a molecular pathway that explains the pathogenetic and prognostic implications (indolent vs aggressive form) of recurrent 13q, 17p, and 11q deletions in CLL. Design, Setting, and Patients CLL Research Consortium institutions provided blood samples from untreated patients (n=206) diagnosed with B-cell CLL between January 2000 and April 2008. All samples were evaluated for the occurrence of cytogenetic abnormalities as well as the expression levels of the miR-15a/miR-16-1 cluster, miR-34b/miR-34c cluster, TP53, and zeta-chain (TCR)-associated protein kinase 70kDa (ZAP70), a surrogate prognostic marker of CLL. The functional relationship between these genes was studied using in vitro gain-and loss-of-function experiments in cell lines and primary samples and was validated in a separate cohort of primary CLL samples. Main Outcome Measures Cytogenetic abnormalities; expression levels of the miR15a/miR-16-1 cluster, miR-34 family, TP53 gene, downstream effectors cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A) and B-cell CLL/lymphoma 2 binding component 3 (BBC3), and ZAP70 gene; genetic interactions detected by chromatin immunoprecipitation. Results In CLLs with 13q deletions the miR-15a/miR-16-1 cluster directly targeted TP53 (mean luciferase activity for miR-15a vs scrambled control, 0.68 relative light units (RLU) [95% confidence interval {CI}, 0.63-0.73]; P=.02; mean for miR-16 vs scrambled control, 0.62 RLU [95% CI, 0.59-0.65]; P=.02) and its downstream effectors. In leukemic cell lines and primary CLL cells, TP53 stimulated the transcription of miR-15/miR-16-1 as well as miR-34b/miR-34c clusters, and the miR-34b/miR-34c cluster directly targeted the ZAP70 kinase(mean luciferase activity for miR-34a vs scrambled control, 0.33 RLU [95% CI, 0.30-0.36]; P=.02; mean for miR-34b vs scrambled control, 0.31 RLU [95% CI, 0.30-0.32]; P=.01; and mean for miR-34c vs scrambled control, 0.35 RLU [95% CI, 0.33-0.37]; P=.02). Conclusions A microRNA/TP53 feedback circuitry is associated with CLL pathogenesis and outcome. This mechanism provides a novel pathogenetic model for the association of 13q deletions with the indolent form of CLL that involves microRNAs, TP53, and ZAP70. JAMA. 2011;305(1):59-67 www.jama.com	[Shimizu, Masayoshi; Spizzo, Riccardo; Nicoloso, Milena S.; Rossi, Simona; Barbarotto, Elisa; Sampath, Deepa; Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Shimizu, Masayoshi; Spizzo, Riccardo; Nicoloso, Milena S.; Rossi, Simona; Barbarotto, Elisa; Sampath, Deepa; Calin, George A.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Keating, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Fabbri, Muller; Bottoni, Arianna; Adair, Brett; Wojcik, Sylwia E.; Valeri, Nicola; Calore, Federica; Alder, Hansjuerg; Nakamura, Tatsuya; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Barbarotto, Elisa] Univ Ferrara, Dept Morphol & Embryol, Human Anat Sect, I-44100 Ferrara, Italy; [Negrini, Massimo] Univ Ferrara, Dept Expt & Diagnost Med, Interdept Ctr Canc Res, I-44100 Ferrara, Italy; [Cimmino, Amelia] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Fabbri, Muller; Fanini, Francesca; Vannini, Ivan; Musuraca, Gerardo; Amadori, Dino] Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy; [Dell'Aquila, Marie; Rassenti, Laura Z.; Kipps, Thomas J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Davuluri, Ramana V.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Kay, Neil E.] Mayo Clin, Coll Med, Dept Internal Med, Div Hematol, Rochester, MN USA; [Rai, Kanti R.] Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara; University of Ferrara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Meldola (IRST); University of California System; University of California San Diego; The Wistar Institute; Mayo Clinic; Northwell Health	Calin, GA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gcalin@mdanderson.org; carlo.croce@osumc.edu	Sampath, Deepa/J-3298-2016; Vannini, Ivan/T-7226-2019; Negrini, Massimo/J-2377-2016; Young, Richard A/F-6495-2012; Sampath, Deepa/T-5069-2019; Spizzo, Riccardo/V-1057-2019; Musuraca, Gerardo/ADK-9808-2022; Nicoloso, Milena S/K-6411-2012; Davuluri, Ramana/D-7348-2011; Fanini, Francesca/H-6973-2019; Calin, George/E-9390-2011	Vannini, Ivan/0000-0002-9279-1801; Negrini, Massimo/0000-0002-0007-1920; Young, Richard A/0000-0001-8855-8647; Spizzo, Riccardo/0000-0001-7772-0960; Musuraca, Gerardo/0000-0003-1947-1032; Nicoloso, Milena S/0000-0003-4231-9303; Sampath, Deepa/0000-0002-4366-8436; Calin, George/0000-0001-6704-5615; valeri, nicola/0000-0002-5426-5683; Cimmino, Amelia/0000-0002-0004-9299	Kimmel Scholar Award; FIRC (Federazione Italiana Ricerca sul Cancro); University of Texas M. D. Anderson Research Trust; University of Texas; CLL Global Research Foundation; National Institutes of Health; US Department of Defense; Leukemia SPORE Developmental Research Award; National Institutes of Health [R01 CA111953]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA151319, P01CA129242, R01CA111953] Funding Source: NIH RePORTER	Kimmel Scholar Award; FIRC (Federazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); University of Texas M. D. Anderson Research Trust; University of Texas; CLL Global Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Leukemia SPORE Developmental Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Fabbri is supported by a 2009 Kimmel Scholar Award. Dr Cimmino is supported by a fellowship from FIRC (Federazione Italiana Ricerca sul Cancro). Dr Calin is supported by a fellowship from the University of Texas M. D. Anderson Research Trust, a fellowship from The University of Texas System Regents Research Scholar Program, and a grant from the CLL Global Research Foundation. Dr Calin's laboratory is supported in part by the National Institutes of Health, the US Department of Defense, and a Leukemia SPORE Developmental Research Award. Drs Kay and Croce are supported by National Institutes of Health grant R01 CA111953.	Ambros Victor, 2004, Methods Mol Biol, V265, P131; Auer RL, 2007, BRIT J HAEMATOL, V137, P443, DOI 10.1111/j.1365-2141.2007.06600.x; BINET JL, 1977, CANCER-AM CANCER SOC, V40, P855, DOI 10.1002/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; CALL TG, 1994, MAYO CLIN PROC, V69, P323, DOI 10.1016/S0025-6196(12)62215-0; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Dewald GW, 2003, BRIT J HAEMATOL, V121, P287, DOI 10.1046/j.1365-2141.2003.04265.x; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Rossi S, 2010, BLOOD, V116, P945, DOI 10.1182/blood-2010-01-263889	18	216	233	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					59	67		10.1001/jama.2010.1919	http://dx.doi.org/10.1001/jama.2010.1919			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205967	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000285924100025
J	Brenner, H; Chang-Claude, J; Seiler, CM; Rickert, A; Hoffmeister, M				Brenner, Hermann; Chang-Claude, Jenny; Seiler, Christoph M.; Rickert, Alexander; Hoffmeister, Michael			Protection From Colorectal Cancer After Colonoscopy A Population-Based, Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							SIDED COLON-CANCER; SCREENING COLONOSCOPY; OUTPATIENT COLONOSCOPY; UNITED-STATES; RISK-FACTORS; PREVENTION; SIGMOIDOSCOPY; SURVEILLANCE; POLYPECTOMY; ENDOSCOPY	Background: Colonoscopy with detection and removal of adenomas is considered a powerful tool to reduce colorectal cancer (CRC) incidence. However, the degree of protection achievable in a population setting with high-quality colonoscopy resources remains to be quantified. Objective: To assess the association between previous colonoscopy and risk for CRC. Design: Population-based case-control study. Setting: Rhine-Neckar region of Germany. Patients: A total of 1688 case patients with colorectal cancer and 1932 control participants aged 50 years or older. Measurements: A detailed lifetime history of CRC risk factors and preventive factors, including history and results of previous colonoscopies, and of medical data obtained by self-reports and medical records. Odds ratios of CRC associated with colonoscopy in the preceding 10 years were estimated, after adjustment for sex, age, education level, participation in a general health screening examination, family history of CRC, smoking status, body mass index, and use of nonsteroidal anti-inflammatory drugs or hormone replacement therapy. Results: Overall, colonoscopy in the preceding 10 years was associated with 77% lower risk for CRC. Adjusted odds ratios for any CRC, right-sided CRC, and left-sided CRC were 0.23 (95% CI, 0.19 to 0.27), 0.44 (CI, 0.35 to 0.55), and 0.16 (CI, 0.12 to 0.20), respectively. Strong risk reduction was observed for all cancer stages and all ages, except for right-sided cancer in persons aged 50 to 59 years. Risk reduction increased over the years in both the right and the left colon. Limitation: The study was observational, with potential for residual confounding and selection bias. Conclusion: Colonoscopy with polypectomy can be associated with strongly reduced risk for CRC in the population setting. Aside from strong risk reduction with respect to left-sided CRC, risk reduction of more than 50% was also seen for right-sided colon cancer.	[Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; Heidelberg Univ, Univ Clin Heidelberg, Heidelberg, Germany; Univ Hosp Mannheim, Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	h.brenner@Dkfz-Heidelberg.de	Brenner, Hermann/B-4627-2017; Hoffmeister, Michael/T-7187-2019; Hoffmeister, Michael/AAB-2321-2022; Seiler, Christoph/AAG-7056-2021; Hoffmeister, Michael/B-5745-2012; Brenner, Hermann/ABE-6383-2020	Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572	German Research Council [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]	German Research Council(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Grant Support: By the German Research Council (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, and CH 117/1-1) and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814).	Ahmadi AA, 2007, SURG CLIN N AM, V87, P743, DOI 10.1016/j.suc.2007.03.013; Arain MA, 2010, AM J GASTROENTEROL, V105, P1189, DOI 10.1038/ajg.2009.699; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2010, J NATL CANCER I, V102, P70, DOI 10.1093/jnci/djp469; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Brenner H, 2001, BRIT J CANCER, V85, P972, DOI 10.1038/sj.bjc.6692023; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2007, AM J GASTROENTEROL, V102, P1739, DOI 10.1111/j.1572-0241.2007.01231.x; Brenner H, 2007, CANCER EPIDEM BIOMAR, V16, P494, DOI 10.1158/1055-9965.EPI-06-0460; Brenner H, 2010, ANN INTERN MED, V152, P697, DOI 10.7326/0003-4819-152-11-201006010-00002; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Gondos A, 2007, INT J CANCER, V121, P395, DOI 10.1002/ijc.22683; Hoffmeister M, 2007, AM J EPIDEMIOL, V166, P130, DOI 10.1093/aje/kwm062; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Karlitz JJ, 2009, ANN INTERN MED, V150, P816, DOI 10.7326/0003-4819-150-11-200906020-00012; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Mulder SA, 2010, EUR J GASTROEN HEPAT, V22, P437, DOI 10.1097/MEG.0b013e328333fc6a; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pox C, 2008, Z GASTROENTEROL, V46, pS31, DOI 10.1055/s-2007-963563; Pox C, 2007, ENDOSCOPY, V39, P168, DOI 10.1055/s-2007-966182; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Taylor DP, 2010, GASTROENTEROLOGY, V138, P877, DOI 10.1053/j.gastro.2009.11.044; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	42	587	603	1	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					22	U156		10.7326/0003-4819-154-1-201101040-00004	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200035				2022-12-01	WOS:000285830900003
J	Summers, ZM; Fogarty, HE; Leang, C; Franks, AE; Malvankar, NS; Lovley, DR				Summers, Zarath M.; Fogarty, Heather E.; Leang, Ching; Franks, Ashley E.; Malvankar, Nikhil S.; Lovley, Derek R.			Direct Exchange of Electrons Within Aggregates of an Evolved Syntrophic Coculture of Anaerobic Bacteria	SCIENCE			English	Article							GEOBACTER-SULFURREDUCENS; SP-NOV; REDUCTION; OXIDATION; METHANE; HYDROGEN; ARCHAEA; FE(III); MICROORGANISM; CONSTRAINTS	Microbial consortia that cooperatively exchange electrons play a key role in the anaerobic processing of organic matter. Interspecies hydrogen transfer is a well-documented strategy for electron exchange in dispersed laboratory cultures, but cooperative partners in natural environments often form multispecies aggregates. We found that laboratory evolution of a coculture of Geobacter metallireducens and Geobacter sulfurreducens metabolizing ethanol favored the formation of aggregates that were electrically conductive. Sequencing aggregate DNA revealed selection for a mutation that enhances the production of a c-type cytochrome involved in extracellular electron transfer and accelerates the formation of aggregates. Aggregate formation was also much faster in mutants that were deficient in interspecies hydrogen transfer, further suggesting direct interspecies electron transfer.	[Summers, Zarath M.; Fogarty, Heather E.; Leang, Ching; Franks, Ashley E.; Malvankar, Nikhil S.; Lovley, Derek R.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Malvankar, Nikhil S.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	dlovley@microbio.umass.edu		Franks, Ashley/0000-0003-1664-6060	Office of Science (Office of Biological and Environmental Research), U.S. Department of Energy [DE-FC02-02ER63446, DE-FC-0004485]	Office of Science (Office of Biological and Environmental Research), U.S. Department of Energy(United States Department of Energy (DOE))	We thank P. Brown, C. Barrett, K. Zengler, and Y. Qiu for sequence analysis; L. Raboin for SEM assistance; and K. Rubin for photography assistance. Supported by the Office of Science (Office of Biological and Environmental Research), U.S. Department of Energy, Cooperative Agreement DE-FC02-02ER63446 and Award DE-FC-0004485.	Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; BRYANT MP, 1967, ARCH MIKROBIOL, V59, P20, DOI 10.1007/BF00406313; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Butler JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-103; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Coppi MV, 2004, J BACTERIOL, V186, P3022, DOI 10.1128/JB.186.10.3022-3028.2004; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Holmes DE, 2006, ENVIRON MICROBIOL, V8, P1805, DOI 10.1111/j.1462-2920.2006.01065.x; Juarez K, 2009, J MOL MICROB BIOTECH, V16, P146, DOI 10.1159/000115849; Kartal B, 2010, SCIENCE, V328, P702, DOI 10.1126/science.1185941; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Leang C, 2010, APPL ENVIRON MICROB, V76, P4080, DOI 10.1128/AEM.00023-10; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Marx CJ, 2009, SCIENCE, V324, P1150, DOI 10.1126/science.1173088; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Mehta T, 2005, APPL ENVIRON MICROB, V71, P8634, DOI 10.1128/AEM.71.12.8634-8641.2005; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; OZTURK SS, 1989, BIOTECHNOL BIOENG, V33, P745, DOI 10.1002/bit.260330612; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; Schink B, 2006, PROKARYOTES, V3, P5, DOI DOI 10.1007/0-387-30747-8_1; Schmidt JE, 1996, BIOTECHNOL BIOENG, V49, P229, DOI [10.1002/(SICI)1097-0290(19960205)49:3<229::AID-BIT1>3.0.CO;2-M, 10.1002/(SICI)1097-0290(19960205)49:3&lt;229::AID-BIT1&gt;3.0.CO;2-M]; Sorensen KB, 2001, MICROBIAL ECOL, V42, P1; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166	27	606	662	60	785	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1413	1415		10.1126/science.1196526	http://dx.doi.org/10.1126/science.1196526			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127257				2022-12-01	WOS:000284902100052
J	de Boer, Y				de Boer, Yvo			Copenhagen shows we need caution in Cancun	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					477	477		10.1038/468477a	http://dx.doi.org/10.1038/468477a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684WA	21107383	Bronze			2022-12-01	WOS:000284584200006
J	Puthenveedu, MA; Lauffer, B; Temkin, P; Vistein, R; Carlton, P; Thorn, K; Taunton, J; Weiner, OD; Parton, RG; von Zastrow, M				Puthenveedu, Manojkumar A.; Lauffer, Benjamin; Temkin, Paul; Vistein, Rachel; Carlton, Peter; Thorn, Kurt; Taunton, Jack; Weiner, Orion D.; Parton, Robert G.; von Zastrow, Mark			Sequence-Dependent Sorting of Recycling Proteins by Actin-Stabilized Endosomal Microdomains	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; COUPLED-RECEPTORS; ARP2/3 COMPLEX; DYNAMIC ACTIN; MULTIVESICULAR BODIES; PLASMA-MEMBRANE; CORTACTIN; RESENSITIZATION; CYTOSKELETON; PATHWAY	The functional consequences of signaling receptor endocytosis are determined by the endosomal sorting of receptors between degradation and recycling pathways. How receptors recycle efficiently, in a sequence-dependent manner that is distinct from bulk membrane recycling, is not known. Here, in live cells, we visualize the sorting of a prototypical sequence-dependent recycling receptor, the beta-2 adrenergic receptor, from bulk recycling proteins and the degrading delta-opioid receptor. Our results reveal a remarkable diversity in recycling routes at the level of individual endosomes, and indicate that sequence-dependent recycling is an active process mediated by distinct endosomal subdomains distinct from those mediating bulk recycling. We identify a specialized subset of tubular microdomains on endosomes, stabilized by a highly localized but dynamic actin machinery, that mediate this sorting, and provide evidence that these actin-stabilized domains provide the physical basis for a two-step kinetic and affinity-based model for protein sorting into the sequence-dependent recycling pathway.	[Puthenveedu, Manojkumar A.; Vistein, Rachel] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Lauffer, Benjamin; Temkin, Paul; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Carlton, Peter] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Thorn, Kurt; Weiner, Orion D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Taunton, Jack; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld 4072, Australia	Carnegie Mellon University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Queensland; University of Queensland	Puthenveedu, MA (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	map3@andrew.cmu.edu	Weiner, Orion D/F-2576-2011; Carlton, Peter/AAD-2403-2021; Parton, Robert G/C-5673-2009; Temkin, Paul A/F-9262-2011; Puthenveedu, Manojkumar/A-3795-2016	Weiner, Orion D/0000-0002-1778-6543; Carlton, Peter/0000-0002-5320-6024; Parton, Robert G/0000-0002-7494-5248; Vistein, Rachel/0000-0002-2172-9947; Thorn, Kurt/0000-0001-9310-288X; Puthenveedu, Manojkumar/0000-0002-3177-4231	NIH [DA024698, DA010711, GM084040]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA024698, R37DA010711, R00DA024698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The majority of the imaging was performed at the Nikon Imaging Center at UCSF. We thank David Drubin, Matt Welch, John Sedat, Aylin Hanyaloglu, Aaron Marley, and James Hislop for essential reagents and valuable help. M.A.P. was supported by a K99/R00 grant DA024698, M.v.Z. by an R37 grant DA010711, and O.D.W. by an RO1 grant GM084040, all from the NIH. J.T. is an investigator of the Howard Hughes Medical Institute.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; FARQUHAR MG, 1983, METHOD ENZYMOL, V98, P1; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Ikonen E, 1996, MOL BIOL CELL, V7, P961, DOI 10.1091/mbc.7.6.961; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kaksonen M, 2000, J CELL SCI, V113, P4421; Lauffer BEL, 2009, J BIOL CHEM, V284, P2448, DOI 10.1074/jbc.M806370200; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; PARTON RG, 1991, J CELL BIOL, V113, P261, DOI 10.1083/jcb.113.2.261; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SCITA G, 2010, TRAFFIC, V7, P1539; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	56	233	235	1	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					761	773		10.1016/j.cell.2010.10.003	http://dx.doi.org/10.1016/j.cell.2010.10.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111236	Green Accepted, Bronze			2022-12-01	WOS:000284583500018
J	Aoki, SK; Diner, EJ; de Roodenbeke, CT; Burgess, BR; Poole, SJ; Braaten, BA; Jones, AM; Webb, JS; Hayes, CS; Cotter, PA; Low, DA				Aoki, Stephanie K.; Diner, Elie J.; de Roodenbeke, Claire t'Kint; Burgess, Brandt R.; Poole, Stephen J.; Braaten, Bruce A.; Jones, Allison M.; Webb, Julia S.; Hayes, Christopher S.; Cotter, Peggy A.; Low, David A.			A widespread family of polymorphic contact-dependent toxin delivery systems in bacteria	NATURE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI; INHIBITION; GROWTH	Bacteria have developed mechanisms to communicate and compete with one another in diverse environments(1). A new form of intercellular communication, contact-dependent growth inhibition (CDI), was discovered recently in Escherichia coli(2). CDI is mediated by the CdiB/CdiA two-partner secretion (TPS) system. CdiB facilitates secretion of the CdiA 'exoprotein' onto the cell surface. An additional small immunity protein (CdiI) protects CDI+ cells from autoinhibition(2,3). The mechanisms by which CDI blocks cell growth and by which CdiI counteracts this growth arrest are unknown. Moreover, the existence of CDI activity in other bacteria has not been explored. Here we show that the CDI growth inhibitory activity resides within the carboxy-terminal region of CdiA (CdiA-CT), and that CdiI binds and inactivates cognate CdiA-CT, but not heterologous CdiA-CT. Bioinformatic and experimental analyses show that multiple bacterial species encode functional CDI systems with high sequence variability in the CdiA-CT and CdiI coding regions. CdiA-CT heterogeneity implies that a range of toxic activities are used during CDI. Indeed, CdiA-CTs from uropathogenic E. coli and the plant pathogen Dickeya dadantii have different nuclease activities, each providing a distinct mechanism of growth inhibition. Finally, we show that bacteria lacking the CdiA-CT and CdiI coding regions are unable to compete with isogenic wild-type CDI+ cells both in laboratory media and on a eukaryotic host. Taken together, these results suggest that CDI systems constitute an intricate immunity network with an important function in bacterial competition.	[Aoki, Stephanie K.; de Roodenbeke, Claire t'Kint; Burgess, Brandt R.; Poole, Stephen J.; Braaten, Bruce A.; Jones, Allison M.; Webb, Julia S.; Hayes, Christopher S.; Cotter, Peggy A.; Low, David A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Diner, Elie J.; Hayes, Christopher S.; Cotter, Peggy A.; Low, David A.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Low, DA (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	low@lifesci.ucsb.edu	Pacific-Southwest, RCE/B-6155-2009; Hayes, Christopher/A-5505-2009		National Science Foundation [0642052]; Tri-Counties Blood Bank; National Institutes of Health [GM078634, AI043986, U54AI065359]; United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2001-52100-11316]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043986, U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Tri-Counties Blood Bank; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Charkowski, A. Collmer, J. Roth and H. Schweizer for plasmids, bacterial strains and helpful discussions; W. Lathem for Y. pestis CO92 DNA; and R. Christoffersen for helpful advice on plant experiments. This work was supported by National Science Foundation grant 0642052 (D.A.L.), a Tri-Counties Blood Bank Postdoctoral Fellowship (S.K.A.) and National Institutes of Health grants GM078634 (C.S.H.), AI043986 (P.A.C.) and U54AI065359 (D.A.L., P.A.C. and C.S.H.). The content is the sole responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. This project made use of preliminary sequences from the Dickeya dadantii 3937 genome project supported by the Initiative for Future Agriculture and Food Systems grant no. 2001-52100-11316 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service.	Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; BRAATEN BA, 1994, CELL, V76, P577, DOI 10.1016/0092-8674(94)90120-1; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; DUPORT C, 1995, J BIOL CHEM, V270, P8920, DOI 10.1074/jbc.270.15.8920; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ham JH, 2004, MOL PLANT MICROBE IN, V17, P184, DOI 10.1094/MPMI.2004.17.2.184; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Luo CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-552; Pagni M, 2001, Brief Bioinform, V2, P51, DOI 10.1093/bib/2.1.51; Rojas CM, 2004, MOL PLANT MICROBE IN, V17, P644, DOI 10.1094/MPMI.2004.17.6.644; Yap MN, 2006, J BACTERIOL, V188, P2280, DOI 10.1128/JB.188.6.2280-2284.2006	14	213	226	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					439	442		10.1038/nature09490	http://dx.doi.org/10.1038/nature09490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085179	Green Accepted			2022-12-01	WOS:000284313100043
J	Clark, WF; Sontrop, JM; Macnab, JJ; Salvadori, M; Moist, L; Suri, R; Garg, AX				Clark, William F.; Sontrop, Jessica M.; Macnab, Jennifer J.; Salvadori, Marina; Moist, Louise; Suri, Rita; Garg, Amit X.			Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEMOLYTIC-UREMIC SYNDROME; O157-H7 INFECTION; HEALTH SEQUELAE; KIDNEY-FUNCTION; OUTBREAK; CONSUMPTION; PREVALENCE; PREDICTION; CONTINUUM; ILLNESS	Objectives To evaluate the risk for hypertension, renal impairment, and cardiovascular disease within eight years of gastroenteritis from drinking water contaminated with Escherichia coli O157:H7 and Campylobacter. Design A prospective cohort study. Setting Walkerton, Ontario, Canada. Participants 1977 adult participants in the Walkerton Health Study recruited between 2002 and 2005 after an outbreak of gastroenteritis in May 2000, when a municipal water system was contaminated, with no pre-outbreak history of outcome measures. Outcome measures Information was collected annually via survey, physical examination, and laboratory assessment. Primary measures were acute gastroenteritis (diarrhoeal illness lasting >3 days, bloody diarrhoea, or >3 loose stools/day), hypertension (blood pressure >= 140/90 mm Hg), and renal impairment (microalbuminuria or estimated glomerular filtration rate <60 ml/min/1.73 m(2)). Self reported physician diagnosis of cardiovascular disease (myocardial infarction, stroke, or congestive heart failure) was a secondary outcome. Results Acute gastroenteritis at the time of the outbreak was reported by 1067 (54%) of participants. Incident hypertension was detected in 697 (35%) (294 (32%) of group not exposed to acute gastroenteritis v 403 (38%) of exposed group). While 572 (29%) had at least one indicator of renal impairment (266 (29%) of unexposed v 306 (29%) of exposed), only 30 (1.5%) had both (8 (0.9%) of unexposed v 22 (2.1%) of exposed). Cardiovascular disease was reported by 33/1749 (1.9%). The adjusted hazard ratios for hypertension and cardiovascular disease after acute gastroenteritis were 1.33 (95% confidence interval 1.14 to 1.54) and 2.13 (1.03 to 4.43) respectively. The adjusted hazard ratio for the presence of either indicator of renal impairment was 1.15 (0.97 to 1.35) and was 3.41 (1.51 to 7.71) for the presence of both. Conclusion Gastroenteritis from drinking water contaminated with E coli O157:H7 and Campylobacter was associated with an increased risk for hypertension, renal impairment, and self reported cardiovascular disease. Annual monitoring of blood pressure and periodic monitoring of renal function may be warranted for individuals who experience E coli O157:H7 gastroenteritis.	[Clark, William F.; Sontrop, Jessica M.; Moist, Louise; Suri, Rita; Garg, Amit X.] London Hlth Sci Ctr, Dept Med, Div Nephrol, London, ON, Canada; [Clark, William F.; Sontrop, Jessica M.; Moist, Louise; Suri, Rita; Garg, Amit X.] London Hlth Sci Ctr, London Kidney Clin Res Unit, London, ON, Canada; [Sontrop, Jessica M.; Macnab, Jennifer J.; Moist, Louise; Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Salvadori, Marina] Childrens Hosp, London Hlth Sci Ctr, Dept Pediat Infect Dis, London, ON, Canada	London Health Sciences Centre; London Health Sciences Centre; Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario)	Clark, WF (corresponding author), Victoria Hosp, A2-343 Westminster Tower,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	William.Clark@lhsc.on.ca	Suri, Rita S/G-3348-2011; Moist, Louise/G-3334-2011; Garg, Amit X/G-3295-2011; Clark, Bill/G-3287-2011	Suri, Rita S/0000-0002-0519-3927; Sontrop, Jessica M./0000-0001-7784-2028	Ontario Ministry of Health and Long term Care	Ontario Ministry of Health and Long term Care(Ministry of Health and Long-Term Care, Ontario)	This study was funded by the Ontario Ministry of Health and Long term Care, which had no role in design and conduct of the study; collection, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Blair A, 2007, AM J IND MED, V50, P199, DOI 10.1002/ajim.20281; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Breslow N E, 1980, IARC Sci Publ, P5; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P803; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Dzau VJ, 2004, CIRCULATION, V109, P1, DOI 10.1161/01.CIR.0000133445.78855.aa; Effler P, 2001, EMERG INFECT DIS, V7, P812; Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602; *EXP COMM DIAGN CL, 2003, DIABETES CARE, V261, P5; *FDA, 2009, BBB CAMP JEJ; Frenzen PD, 2005, J FOOD PROTECT, V68, P2623, DOI 10.4315/0362-028X-68.12.2623; Garg AX, 2006, KIDNEY INT, V70, P807, DOI 10.1038/sj.ki.5001645; Garg AX, 2006, J CLIN EPIDEMIOL, V59, P421, DOI 10.1016/j.jclinepi.2005.08.014; Garg AX, 2005, CAN MED ASSOC J, V173, P261, DOI 10.1503/cmaj.050581; Garg AX, 2005, CAN J PUBLIC HEALTH, V96, P125, DOI 10.1007/BF03403675; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; Germani Y, 1997, LANCET, V349, P1670, DOI 10.1016/S0140-6736(05)62636-0; Groenwold RHH, 2010, INT J EPIDEMIOL, V39, P107, DOI 10.1093/ije/dyp332; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hamner S, 2007, APPL ENVIRON MICROB, V73, P2369, DOI 10.1128/AEM.00141-07; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hirsch AT, 2004, CIRCULATION, V110, P2774, DOI 10.1161/01.CIR.0000147616.76919.99; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Karmali MA, 2009, KIDNEY INT, V75, pS4, DOI 10.1038/ki.2008.608; Kehl SC, 2002, J CLIN MICROBIOL, V40, P2711, DOI 10.1128/JCM.40.8.2711-2715.2002; Kleinbaum DG., 2005, SURVIVAL ANAL SELF L, P131, DOI [10.1007/0-387-29150-4, DOI 10.1007/0-387-29150-4]; Leotta GA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-46; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Liuzzo G, 2001, Rays, V26, P221; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Ohmi K, 1998, BIOCHEM BIOPH RES CO, V251, P137, DOI 10.1006/bbrc.1998.9417; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Olsen SJ, 2002, EMERG INFECT DIS, V8, P370, DOI 10.3201/eid0804.000218; Petruzziello TN, 2009, KIDNEY INT, V75, pS17, DOI 10.1038/ki.2008.612; Powell M, 2001, INT J FOOD MICROBIOL, V69, P209, DOI 10.1016/S0168-1605(01)00495-0; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Salvadori MI, 2009, KIDNEY INT, V75, pS33, DOI 10.1038/ki.2008.616; Sehgal R, 2008, T ROY SOC TROP MED H, V102, P380, DOI 10.1016/j.trstmh.2008.01.015; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; Tarr PI, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133817; TARR PI, 1990, J INFECT DIS, V162, P553, DOI 10.1093/infdis/162.2.553; *US FDA, 2009, BBB ESCH COL O157 H7; Vassalotti JA, 2007, AM J KIDNEY DIS, V50, P169, DOI 10.1053/j.ajkd.2007.06.013; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; Whittaker PJ, 2009, EPIDEMIOL INFECT, V137, P375, DOI 10.1017/S0950268808001702; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363	56	40	44	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2010	341								c6020	10.1136/bmj.c6020	http://dx.doi.org/10.1136/bmj.c6020			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684WO	21084368	Green Published, hybrid			2022-12-01	WOS:000284586200004
J	The, NS; Suchindran, C; North, KE; Popkin, BM; Gordon-Larsen, P				The, Natalie S.; Suchindran, Chirayath; North, Kari E.; Popkin, Barry M.; Gordon-Larsen, Penny			Association of Adolescent Obesity With Risk of Severe Obesity in Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOR-DISEASE-CONTROL; BODY-MASS INDEX; UNITED-STATES; US ADULTS; MORBID-OBESITY; PREVALENCE; INCREASES; CHILDREN; TRENDS; OVERWEIGHT	Context Although the prevalence of obesity has increased in recent years, individuals who are obese early in life have not been studied over time to determine whether they develop severe obesity in adulthood, thus limiting effective interventions to reduce severe obesity incidence and its potentially life-threatening associated conditions. Objective To determine incidence and risk of severe obesity in adulthood by adolescent weight status. Design, Setting, and Participants A cohort of 8834 individuals aged 12 to 21 years enrolled in 1996 in wave II of the US National Longitudinal Study of Adolescent Health, followed up into adulthood (ages 18-27 years during wave III [2001-2002] and ages 24-33 years during wave IV [2007-2009]). Height and weight were obtained via anthropometry and surveys administered in study participants' homes using standardized procedures. Main Outcome Measures New cases of adult-onset severe obesity were calculated by sex, race/ethnicity, and adolescent weight status. Sex-stratified, discrete time hazard models estimated the net effect of adolescent obesity (aged <20 years; body mass index [BMI] >= 95th percentile of the sex-specific BMI-for-age growth chart or BMI >= 30.0) on risk of severe obesity incidence in adulthood (aged <20 years; BMI >= 40.0), adjusting for race/ethnicity and age and weighted for national representation. Results In 1996, 79 (1.0%; 95% confidence interval [CI], 0.7%-1.4%) adolescents were severely obese; 60 (70.5%; 95% CI, 57.2%-83.9%) remained severely obese in adulthood. By 2009, 703 (7.9%; 95% CI, 7.4%-8.5%) non-severely obese adolescents had become severely obese in adulthood, with the highest rates for non-Hispanic black women. Obese adolescents were significantly more likely to develop severe obesity in young adulthood than normal-weight or overweight adolescents (hazard ratio, 16.0; 95% CI, 12.4-20.5). Conclusion In this cohort, obesity in adolescence was significantly associated with increased risk of incident severe obesity in adulthood, with variations by sex and race/ethnicity. JAMA. 2010;304(18):2042-2047 www.jama.com	[The, Natalie S.; Suchindran, Chirayath; Popkin, Barry M.; Gordon-Larsen, Penny] Univ N Carolina, Gillings Sch Global Publ Hlth, Carolina Populat Ctr, Chapel Hill, NC 27516 USA; [The, Natalie S.; Popkin, Barry M.; Gordon-Larsen, Penny] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27516 USA; [Suchindran, Chirayath] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27516 USA; [North, Kari E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27516 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gordon-Larsen, P (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Carolina Populat Ctr, 123 W Franklin St, Chapel Hill, NC 27516 USA.	pglarsen@unc.edu	Popkin, Barry/T-6633-2019	popkin, barry/0000-0001-9495-9324	National Institutes of Health [R01-HD057194]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, R01HD057194, R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grant R01-HD057194.; This research uses data from Add Health, a program project directed by Kathleen Mullan Harris, PhD, and designed by J. Richard Udry, PhD, Peter S. Bearman, PhD, and Kathleen Mullan Harris, PhD at the University of North Carolina, Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss, PhD, and Barbara Entwisle, PhD, both from the University of North Carolina, Chapel Hill, for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health Web site (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis. None of the acknowledged individuals received compensation for their assistance.	Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Bray G A, 2001, Rev Endocr Metab Disord, V2, P403, DOI 10.1023/A:1011808701117; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Chantala K, NONRESPONSE WAVE 3 A; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758; Freedman DS, 2007, J PEDIAT, V150, pe2; Gordon-Larsen P, 2007, OBESITY, V15, P2790, DOI 10.1038/oby.2007.331; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; McTigue KM, 2002, ANN INTERN MED, V136, P857, DOI 10.7326/0003-4819-136-12-200206180-00006; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NIH, 2000, PRACT GUID ID EV TRE; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Popkin BM, 1998, J NUTR, V128, P701, DOI 10.1093/jn/128.4.701; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Richardson DB, 2010, OCCUP ENVIRON MED, V67, P67, DOI 10.1136/oem.2008.044834; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Stevens J, 2003, INT J OBESITY, V27, P287, DOI 10.1038/sj.ijo.0802255; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Tanner BD, 2009, AM SURGEON, V75, P103; The NS, 2009, OBESITY, V17, P1441, DOI 10.1038/oby.2009.97; Tourangeau R, 1999, NATL LONGITUDINAL ST; Wang YC, 2011, INT J PEDIATR OBES, V6, P12, DOI 10.3109/17477161003587774; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65	33	288	291	4	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2042	2047		10.1001/jama.2010.1635	http://dx.doi.org/10.1001/jama.2010.1635			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063014	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000284000600023
J	Kraman, M; Bambrough, PJ; Arnold, JN; Roberts, EW; Magiera, L; Jones, JO; Gopinathan, A; Tuveson, DA; Fearon, DT				Kraman, Matthew; Bambrough, Paul J.; Arnold, James N.; Roberts, Edward W.; Magiera, Lukasz; Jones, James O.; Gopinathan, Aarthi; Tuveson, David A.; Fearon, Douglas T.			Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-alpha	SCIENCE			English	Article							IFN-GAMMA; T-CELLS; TUMOR PROGRESSION; HUMAN-MELANOMA; BONE-MARROW; CANCER; INHIBITION; GROWTH; DIFFERENTIATION; IMMUNOGENICITY	The stromal microenvironment of tumors, which is a mixture of hematopoietic and mesenchymal cells, suppresses immune control of tumor growth. A stromal cell type that was first identified in human cancers expresses fibroblast activation protein-alpha (FAP). We created a transgenic mouse in which FAP-expressing cells can be ablated. Depletion of FAP-expressing cells, which made up only 2% of all tumor cells in established Lewis lung carcinomas, caused rapid hypoxic necrosis of both cancer and stromal cells in immunogenic tumors by a process involving interferon-gamma and tumor necrosis factor-alpha. Depleting FAP-expressing cells in a subcutaneous model of pancreatic ductal adenocarcinoma also permitted immunological control of growth. Therefore, FAP-expressing cells are a nonredundant, immune-suppressive component of the tumor microenvironment.	[Kraman, Matthew; Bambrough, Paul J.; Arnold, James N.; Roberts, Edward W.; Magiera, Lukasz; Jones, James O.; Fearon, Douglas T.] Univ Cambridge, MRC Ctr, Dept Med, Wellcome Trust Immunol Unit, Cambridge CB2 2QH, England; [Gopinathan, Aarthi; Tuveson, David A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Gopinathan, Aarthi] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	MRC Laboratory Molecular Biology; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine	Fearon, DT (corresponding author), Univ Cambridge, MRC Ctr, Dept Med, Wellcome Trust Immunol Unit, Hills Rd, Cambridge CB2 2QH, England.	dtf1000@cam.ac.uk	Arnold, James/ABE-3900-2021	Arnold, James/0000-0002-6949-0613; Magiera, Lukasz/0000-0002-8234-5066; Kraman, Matthew/0000-0002-5040-0067; Roberts, Edward/0000-0002-8229-1715	Wellcome Trust; National Institutes for Health Research Cambridge Biomedical Research Centre; Cancer Research UK; Hutchison Whampoa; University of Cambridge	Wellcome Trust(Wellcome Trust); National Institutes for Health Research Cambridge Biomedical Research Centre; Cancer Research UK(Cancer Research UK); Hutchison Whampoa; University of Cambridge(University of Cambridge)	We thank A. Betz, F. Randow, and C. Feig for their discussions. This research was supported by the Wellcome Trust and the National Institutes for Health Research Cambridge Biomedical Research Centre. D. A. T. was supported by Cancer Research UK, Hutchison Whampoa, and the University of Cambridge.	Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Bauer S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2080; BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69; Zhang B, 2008, J CLIN INVEST, V118, P1398, DOI 10.1172/JCI33522; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Dolznig Helmut, 2005, Cancer Immun, V5, P10; DOUKAS J, 1990, J IMMUNOL, V145, P1727; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; KLEIN G, 1960, CANCER RES, V20, P1561; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Nelson DJ, 2001, J IMMUNOL, V166, P5557, DOI 10.4049/jimmunol.166.9.5557; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Schuler T, 2003, J IMMUNOL, V170, P4427, DOI 10.4049/jimmunol.170.9.4427; Speiser DE, 2006, J IMMUNOL, V177, P1338, DOI 10.4049/jimmunol.177.2.1338; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684	30	766	802	5	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					827	830		10.1126/science.1195300	http://dx.doi.org/10.1126/science.1195300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051638				2022-12-01	WOS:000283855700045
J	Wallace, BD; Wang, HW; Lane, KT; Scott, JE; Orans, J; Koo, JS; Venkatesh, M; Jobin, C; Yeh, LA; Mani, S; Redinbo, MR				Wallace, Bret D.; Wang, Hongwei; Lane, Kimberly T.; Scott, John E.; Orans, Jillian; Koo, Ja Seol; Venkatesh, Madhukumar; Jobin, Christian; Yeh, Li-An; Mani, Sridhar; Redinbo, Matthew R.			Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme	SCIENCE			English	Article							BETA-GLUCURONIDASE; METABOLISM; PHARMACOGENETICS; DIARRHEA; COLITIS; COLON	The dose-limiting side effect of the common colon cancer chemotherapeutic CPT-11 is severe diarrhea caused by symbiotic bacterial beta-glucuronidases that reactivate the drug in the gut. We sought to target these enzymes without killing the commensal bacteria essential for human health. Potent bacterial beta-glucuronidase inhibitors were identified by high-throughput screening and shown to have no effect on the orthologous mammalian enzyme. Crystal structures established that selectivity was based on a loop unique to bacterial beta-glucuronidases. Inhibitors were highly effective against the enzyme target in living aerobic and anaerobic bacteria, but did not kill the bacteria or harm mammalian cells. Finally, oral administration of an inhibitor protected mice from CPT-11-induced toxicity. Thus, drugs may be designed to inhibit undesirable enzyme activities in essential microbial symbiotes to enhance chemotherapeutic efficacy.	[Wallace, Bret D.; Lane, Kimberly T.; Orans, Jillian; Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Wang, Hongwei; Venkatesh, Madhukumar; Mani, Sridhar] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Wang, Hongwei; Venkatesh, Madhukumar; Mani, Sridhar] Albert Einstein Coll Med, Dept Oncol, Bronx, NY 10461 USA; [Wang, Hongwei; Venkatesh, Madhukumar; Mani, Sridhar] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Scott, John E.; Yeh, Li-An] N Carolina Cent Univ, BRITE, Durham, NC 27707 USA; [Koo, Ja Seol; Jobin, Christian] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; North Carolina Central University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Redinbo, MR (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	redinbo@unc.edu		Wallace, Bret/0000-0002-9107-5045; Koo, Ja Seol/0000-0002-1202-075X	NIH [CA98468, CA127231]; UNC Chapel Hill; Damon Runyon Cancer Research Foundation [CI15-02]; Golden Leaf Foundation; State of North Carolina; NATIONAL CANCER INSTITUTE [R01CA098468, R01CA127231, R01CA161879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Chapel Hill; Damon Runyon Cancer Research Foundation; Golden Leaf Foundation; State of North Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Redinbo Laboratory at UNC Chapel Hill, the Mani lab and Einstein College of Medicine, and the BRITE Institute for experimental assistance and helpful discussions; B. Allard at UNC Chapel Hill for her expert help with the cytotoxicity assay; B. Sartor at UNC for providing bacterial cell lines; and E. Burgos in the Schramm lab at Einstein for use of the HPLC. Supported by NIH grant CA98468 ( M. R. R.), the SPIRE Postdoctoral Fellowship Program at UNC Chapel Hill (K. T. L.), Damon Runyon Cancer Research Foundation grant CI15-02 and NIH grant CA127231 ( S. M.), and a grant from the Golden Leaf Foundation and the State of North Carolina (L.-A.Y.). Atomic coordinates and structure factors have been deposited with the PDB ( accession codes: 3K4A, 3K46, 3K4D, 3LPF, and 3LPG). The authors remember Lisa Benkowski and Stacey Micoli, for whom CPT-11's efficacy was limited by its toxicity.	Basinska Agnieszka, 2003, Ann Univ Mariae Curie Sklodowska Med, V58, P386; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cummings JH, 1997, JPEN-PARENTER ENTER, V21, P357, DOI 10.1177/0148607197021006357; Farnleitner AH, 2002, WATER RES, V36, P975, DOI 10.1016/S0043-1354(01)00288-3; Fittkau M, 2004, J CANCER RES CLIN, V130, P388, DOI 10.1007/s00432-004-0557-8; Flieger D, 2007, ONCOLOGY-BASEL, V72, P10, DOI 10.1159/000111083; GRILL JP, 1995, CURR MICROBIOL, V31, P23, DOI 10.1007/BF00294629; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Hu ZP, 2006, TOXICOL APPL PHARM, V216, P225, DOI 10.1016/j.taap.2006.05.020; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Kurita A, 2011, CANCER CHEMOTH PHARM, V67, P201, DOI 10.1007/s00280-010-1310-4; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; Ma MK, 2003, CURR MED CHEM, V10, P41, DOI 10.2174/0929867033368619; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; Nagar S, 2006, DRUG METAB REV, V38, P393, DOI 10.1080/03602530600739835; NIWA T, 1972, J BIOCHEM-TOKYO, V72, P207, DOI 10.1093/oxfordjournals.jbchem.a129889; NORD CE, 1984, AM J MED, V76, P99, DOI 10.1016/0002-9343(84)90250-X; Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Ray J, 1999, J HERED, V90, P119, DOI 10.1093/jhered/90.1.119; Redinbo Matthew R., 1999, Current Opinion in Structural Biology, V9, P29, DOI 10.1016/S0959-440X(99)80005-0; Russell WM, 2001, APPL ENVIRON MICROB, V67, P1253, DOI 10.1128/AEM.67.3.1253-1261.2001; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Sears S, 1999, GASTROINTEST ENDOSC, V50, P841, DOI 10.1016/S0016-5107(99)70171-9; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Smith NF, 2006, TOXICOL IN VITRO, V20, P163, DOI 10.1016/j.tiv.2005.06.045; Stamp D, 2004, MED HYPOTHESES, V63, P555, DOI 10.1016/j.mehy.2004.05.005; Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164; Tobin PJ, 2003, ONCOL REP, V10, P1977; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	573	604	11	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					831	835		10.1126/science.1191175	http://dx.doi.org/10.1126/science.1191175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051639	Green Published, Green Accepted			2022-12-01	WOS:000283855700046
J	Lewis, SL				Lewis, Simon L.			How to beat the media in the climate street fight	NATURE			English	Editorial Material									[Lewis, Simon L.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of Leeds		s.l.lewis@leeds.ac.uk		Lewis, Simon/0000-0002-8066-6851					0	1	1	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					7	7		10.1038/468007a	http://dx.doi.org/10.1038/468007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	674YF	21048720	Bronze			2022-12-01	WOS:000283786900006
J	Brodribb, TJ; McAdam, SAM				Brodribb, Tim J.; McAdam, Scott A. M.			Passive Origins of Stomatal Control in Vascular Plants	SCIENCE			English	Article							RESPONSES; EVOLUTION; LAND; CO2; TRANSPIRATION; DIVERSITY; CLOSURE; ABA	Carbon and water flow between plants and the atmosphere is regulated by the opening and closing of minute stomatal pores in surfaces of leaves. By changing the aperture of stomata, plants regulate water loss and photosynthetic carbon gain in response to many environmental stimuli, but stomatal movements cannot yet be reliably predicted. We found that the complexity that characterizes stomatal control in seed plants is absent in early-diverging vascular plant lineages. Lycophyte and fern stomata are shown to lack key responses to abscisic acid and epidermal cell turgor, making their behavior highly predictable. These results indicate that a fundamental transition from passive to active metabolic control of plant water balance occurred after the divergence of ferns about 360 million years ago.	[Brodribb, Tim J.; McAdam, Scott A. M.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia	University of Tasmania	Brodribb, TJ (corresponding author), Univ Tasmania, Sch Plant Sci, Private Bag 55, Hobart, Tas 7001, Australia.	timothyb@utas.edu.au	McAdam, Scott/J-7197-2014; Brodribb, Timothy John/C-6797-2013	McAdam, Scott/0000-0002-9625-6750; Brodribb, Timothy John/0000-0002-4964-6107	Australian Research Council [DP0878177, DP0559266]; APA	Australian Research Council(Australian Research Council); APA	We thank K. Mott and G. Jordan for discussion and comments on the manuscript, and J. Ross and N. Davies for assistance with ABA quantification techniques. Supported by Australian Research Council grants DP0878177 and DP0559266 (T.J.B.) and an APA award (S.A.M.M.).	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Buckley TN, 2005, NEW PHYTOL, V168, P275, DOI 10.1111/j.1469-8137.2005.01543.x; Buckley TN, 2003, PLANT CELL ENVIRON, V26, P1767, DOI 10.1046/j.1365-3040.2003.01094.x; Cowan I R, 1977, Symp Soc Exp Biol, V31, P471; Darwin, 1898, P R SOC LOND, V190, P531, DOI [10.1098/RSTB.1898.0009, DOI 10.1098/RSPL.1898.0053]; Dewar RC, 2002, PLANT CELL ENVIRON, V25, P1383, DOI 10.1046/j.1365-3040.2002.00909.x; Doi M, 2008, PLANT PHYSIOL, V147, P922, DOI 10.1104/pp.108.118950; Duan BL, 2007, J EXP BOT, V58, P3025, DOI 10.1093/jxb/erm160; Duckett JG, 2009, NEW PHYTOL, V183, P1053, DOI 10.1111/j.1469-8137.2009.02905.x; Edwards D, 1998, J EXP BOT, V49, P255, DOI 10.1093/jexbot/49.suppl_1.255; Edwards D, 2003, PLANT CELL ENVIRON, V26, P57, DOI 10.1046/j.1365-3040.2003.00878.x; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Hartung W, 2010, FUNCT PLANT BIOL, V37, P806, DOI 10.1071/FP10058; HICKOK LG, 1983, CAN J BOT, V61, P888, DOI 10.1139/b83-098; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lin BL, 2005, J EXP BOT, V56, P2935, DOI 10.1093/jxb/eri290; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; MEIDNER H, 1965, BIOL REV, V40, P483, DOI 10.1111/j.1469-185X.1965.tb00813.x; MITTELHEUSER CJ, 1969, NATURE, V221, P281, DOI 10.1038/221281a0; Mott KA, 2008, PLANT CELL ENVIRON, V31, P1299, DOI 10.1111/j.1365-3040.2008.01845.x; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pieruschka R, 2010, P NATL ACAD SCI USA, V107, P13372, DOI 10.1073/pnas.0913177107; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; REYNOLDS TL, 1993, J EXP BOT, V44, P1771, DOI 10.1093/jxb/44.12.1771; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sharpe P. J. H., 1987, STOMATAL FUNCTION, P92; Shope JC, 2008, PLANT CELL ENVIRON, V31, P1290, DOI 10.1111/j.1365-3040.2008.01844.x; TARDIEU F, 1993, PLANT CELL ENVIRON, V16, P341, DOI 10.1111/j.1365-3040.1993.tb00880.x	32	283	294	9	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					582	585		10.1126/science.1197985	http://dx.doi.org/10.1126/science.1197985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21163966				2022-12-01	WOS:000286933600053
J	Egan, DF; Shackelford, DB; Mihaylova, MM; Gelino, S; Kohnz, RA; Mair, W; Vasquez, DS; Joshi, A; Gwinn, DM; Taylor, R; Asara, JM; Fitzpatrick, J; Dillin, A; Viollet, B; Kundu, M; Hansen, M; Shaw, RJ				Egan, Daniel F.; Shackelford, David B.; Mihaylova, Maria M.; Gelino, Sara; Kohnz, Rebecca A.; Mair, William; Vasquez, Debbie S.; Joshi, Aashish; Gwinn, Dana M.; Taylor, Rebecca; Asara, John M.; Fitzpatrick, James; Dillin, Andrew; Viollet, Benoit; Kundu, Mondira; Hansen, Malene; Shaw, Reuben J.			Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy	SCIENCE			English	Article							CATALYTIC SUBUNIT; AUTOPHAGY; COMPLEX; ROLES; METABOLISM; DOMAINS; TARGET; LIVER	Adenosine monophosphate-activated protein kinase (AMPK) is a conserved sensor of intracellular energy activated in response to low nutrient availability and environmental stress. In a screen for conserved substrates of AMPK, we identified ULK1 and ULK2, mammalian orthologs of the yeast protein kinase Atg1, which is required for autophagy. Genetic analysis of AMPK or ULK1 in mammalian liver and Caenorhabditis elegans revealed a requirement for these kinases in autophagy. In mammals, loss of AMPK or ULK1 resulted in aberrant accumulation of the autophagy adaptor p62 and defective mitophagy. Reconstitution of ULK1-deficient cells with a mutant ULK1 that cannot be phosphorylated by AMPK revealed that such phosphorylation is required for mitochondrial homeostasis and cell survival during starvation. These findings uncover a conserved biochemical mechanism coupling nutrient status with autophagy and cell survival.	[Egan, Daniel F.; Shackelford, David B.; Mihaylova, Maria M.; Kohnz, Rebecca A.; Mair, William; Vasquez, Debbie S.; Gwinn, Dana M.; Taylor, Rebecca; Dillin, Andrew; Shaw, Reuben J.] Salk Inst Biol Studies, Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Mihaylova, Maria M.; Dillin, Andrew; Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Fitzpatrick, James] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Gelino, Sara; Hansen, Malene] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, Grad Sch Biomed Sci, La Jolla, CA 92037 USA; [Joshi, Aashish; Kundu, Mondira] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Viollet, Benoit] Univ Paris 05, CNRS, Inst Cochin, INSERM,U1016,UMR 8104, Paris, France	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Sanford Burnham Prebys Medical Discovery Institute; St Jude Children's Research Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu	Mihaylova, Maria M./ACZ-4949-2022; Kundu, Mondira/N-8139-2018; Fitzpatrick, James/C-2268-2009; Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019	Mihaylova, Maria M./0000-0002-2725-767X; Kundu, Mondira/0000-0001-9946-2472; Fitzpatrick, James/0000-0002-7907-3602; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Mair, William/0000-0002-0661-1342; Taylor, Rebecca/0000-0003-3429-3123	CMG; NIH [R01 DK080425, 1P01CA120964]; National Cancer Institute [P30CA014195]; American Cancer Society; American Diabetes Association [1-08-JF-47]; Howard Hughes Medical Institute; NHBLI [K08]; Burroughs Welcome Fund; American Lebanese Syrian Association; Agence Nationale de la Recherche (ANR); Ellison Medical Foundation; Helmsley Charitable Trust;  [T32 CA009370];  [5P30CA006516-43];  [1P01CA120964-01A]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA014195, T32CA009370, P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425] Funding Source: NIH RePORTER	CMG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); American Diabetes Association(American Diabetes Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHBLI; Burroughs Welcome Fund(Burroughs Wellcome Fund); American Lebanese Syrian Association; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Charitable Trust; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Gerken for mouse colony assistance, F. Esterman for confocal assistance, C. Chu for assistance in scoring LGG-1 assays, M. Wood at The Scripps Research Institute EM facility, X. Yang in the Beth Israel Deaconess Medical Center mass spectometry facility, R. Chitta from St. Jude's proteomic core, and K. Lamia for comments on the manuscript. D.F.E., D.M.G., and M.M.M. were supported through the T32 CMG training grant to the UCSD-Salk Biological Sciences Graduate Program. D.B.S. was funded by T32 CA009370 to the Salk Institute Center for Cancer Research. R.J.S. is funded by the NIH grants R01 DK080425 and 1P01CA120964, National Cancer Institute grant P30CA014195, an American Cancer Society Research Scholar Award, the American Diabetes Association Junior Faculty Award 1-08-JF-47, and a Howard Hughes Medical Institute Early Career Scientist Award. J.M.A. is supported by grants 5P30CA006516-43 and 1P01CA120964-01A. M.K. is funded by grant NHBLI K08, Burroughs Welcome Fund, and the American Lebanese Syrian Association. B.V. is supported by Agence Nationale de la Recherche (ANR). M.H. is an Ellison Medical Foundation New Scholar in Aging. We also thank the Leona M. and Harry B. Helmsley Charitable Trust for their generous support. Several of the authors (D.F.E., D.B.S., M.M.M, and R.J.S.) have filed a patent related to this work (U.S. patent application 61/325361).	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781	32	1746	1831	10	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					456	461		10.1126/science.1196371	http://dx.doi.org/10.1126/science.1196371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21205641	Green Accepted			2022-12-01	WOS:000286635900052
J	Horie, T; Shinki, R; Ogura, Y; Kusakabe, TG; Satoh, N; Sasakura, Y				Horie, Takeo; Shinki, Ryoko; Ogura, Yosuke; Kusakabe, Takehiro G.; Satoh, Nori; Sasakura, Yasunori			Ependymal cells of chordate larvae are stem-like cells that form the adult nervous system	NATURE			English	Article							ASCIDIAN CIONA-INTESTINALIS; ORIGIN; EXPRESSION; PLACODES; GENES; BRAIN; IDENTIFICATION; TRANSGENESIS; NETWORKS; INSIGHTS	In ascidian tunicates, the metamorphic transition from larva to adult is accompanied by dynamic changes in the body plan. For instance, the central nervous system (CNS) is subjected to extensive rearrangement because its regulating larval organs are lost and new adult organs are created(1). To understand how the adult CNS is reconstructed, we traced the fate of larval CNS cells during ascidian metamorphosis by using transgenic animals and imaging technologies with photoconvertible fluorescent proteins(2). Here we show that most parts of the ascidian larval CNS, except for the tail nerve cord, are maintained during metamorphosis and recruited to form the adult CNS. We also show that most of the larval neurons disappear and only a subset of cholinergic motor neurons and glutamatergic neurons are retained. Finally, we demonstrate that ependymal cells of the larval CNS contribute to the construction of the adult CNS and that some differentiate into neurons in the adult CNS. An unexpected role of ependymal cells highlighted by this study is that they serve as neural stem-like cells to reconstruct the adult nervous network during chordate metamorphosis. Consequently, the plasticity of non-neuronal ependymal cells and neuronal cells in chordates should be re-examined by future studies(3,4).	[Horie, Takeo; Shinki, Ryoko; Ogura, Yosuke; Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; [Kusakabe, Takehiro G.] Konan Univ, Dept Biol, Kobe, Hyogo 6588501, Japan; [Satoh, Nori] Sci & Technol Promot Corp, Okinawa Inst, Marine Genom Unit, Okinawa 9040412, Japan	University of Tsukuba; Konan University	Horie, T (corresponding author), Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan.	horie@kurofune.shimoda.tsukuba.ac.jp	Horie, Takeo/AAN-6967-2020; Satoh, Nori/C-4123-2009; Kusakabe, Takehiro/H-7178-2012	Horie, Takeo/0000-0002-4843-3775; Satoh, Nori/0000-0002-4480-3572; Kusakabe, Takehiro/0000-0002-8325-3665; Ogura, Yosuke/0000-0002-5251-9176	Japan Society for the Promotion of Science; MEXT; National Institute of Genetics; Grants-in-Aid for Scientific Research [22310120] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Genetics; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge the members of the Shimoda Marine Research Center at the University of Tsukuba for their cooperation with our study. We also thank National Bio-resource Project, Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), S. Fujiwara and all members of the Maizuru Fishery Research Station of Kyoto University and the Education and Research Center of Marine Bioresources of Tohoku University for providing us with Ciona adults, and C. Savakis for providing Minos. This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and MEXT to T.H., T.G.K., N.S. and Y.S. Y.S. was supported by the National Institute of Genetics Cooperative Research Program.	Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Cole AG, 2004, DEV BIOL, V271, P239, DOI 10.1016/j.ydbio.2004.04.001; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Dufour HD, 2006, P NATL ACAD SCI USA, V103, P8727, DOI 10.1073/pnas.0600805103; Gilbert S. F., 2006, DEV BIOL; Horie T, 2008, J COMP NEUROL, V508, P249, DOI 10.1002/cne.21678; Horie T, 2010, ZOOL SCI, V27, P181, DOI 10.2108/zsj.27.181; Horie T, 2009, DEV GROWTH DIFFER, V51, P207, DOI 10.1111/j.1440-169X.2009.01105.x; Hozumi A, 2010, DEV DYNAM, V239, P1076, DOI 10.1002/dvdy.22254; Ikuta T, 2007, DEV BIOL, V312, P631, DOI 10.1016/j.ydbio.2007.10.005; Imai KS, 2009, DEVELOPMENT, V136, P285, DOI 10.1242/dev.026419; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Joly JS, 2007, DEV DYNAM, V236, P1832, DOI 10.1002/dvdy.21124; KATZ MJ, 1983, BIOL BULL-US, V164, P1, DOI 10.2307/1541186; Konno A, 2010, DEV BIOL, V337, P42, DOI 10.1016/j.ydbio.2009.10.012; Kusakabe T, 2004, DEV BIOL, V276, P563, DOI 10.1016/j.ydbio.2004.09.037; Manni L, 2005, J EXP ZOOL PART B, V304B, P324, DOI 10.1002/jez.b.21039; Manni L, 2004, J EXP ZOOL PART B, V302B, P483, DOI 10.1002/jez.b.21013; Matsuoka T, 2005, GENESIS, V41, P67, DOI 10.1002/gene.20096; Moret F, 2005, DEV BIOL, V277, P567, DOI 10.1016/j.ydbio.2004.11.004; NICOL D, 1991, J COMP NEUROL, V309, P415, DOI 10.1002/cne.903090402; Nielsen C, 2005, EVOL DEV, V7, P483, DOI 10.1111/j.1525-142X.2005.05051.x; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Takamura K, 2002, DEV GENES EVOL, V212, P50, DOI 10.1007/s00427-001-0205-0; Tarallo R, 2004, DEV DYNAM, V230, P251, DOI 10.1002/dvdy.20055; Tsuda M, 2003, VISION RES, V43, P3045, DOI 10.1016/j.visres.2003.09.012; Wada H, 1998, DEVELOPMENT, V125, P1113; Yoshida R, 2004, GENESIS, V39, P130, DOI 10.1002/gene.20032	33	62	63	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					525	U256		10.1038/nature09631	http://dx.doi.org/10.1038/nature09631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21196932				2022-12-01	WOS:000286596500031
J	Wang, K; Diskin, SJ; Zhang, HT; Attiyeh, EF; Winter, C; Hou, CP; Schnepp, RW; Diamond, M; Bosse, K; Mayes, PA; Glessner, J; Kim, C; Frackelton, E; Garris, M; Wang, Q; Glaberson, W; Chiavacci, R; Nguyen, L; Jagannathan, J; Saeki, N; Sasaki, H; Grant, SFA; Iolascon, A; Mosse, YP; Cole, KA; Li, HZ; Devoto, M; McGrady, PW; London, WB; Capasso, M; Rahman, N; Hakonarson, H; Maris, JM				Wang, Kai; Diskin, Sharon J.; Zhang, Haitao; Attiyeh, Edward F.; Winter, Cynthia; Hou, Cuiping; Schnepp, Robert W.; Diamond, Maura; Bosse, Kristopher; Mayes, Patrick A.; Glessner, Joseph; Kim, Cecilia; Frackelton, Edward; Garris, Maria; Wang, Qun; Glaberson, Wendy; Chiavacci, Rosetta; Nguyen, Le; Jagannathan, Jayanti; Saeki, Norihisa; Sasaki, Hiroki; Grant, Struan F. A.; Iolascon, Achille; Mosse, Yael P.; Cole, Kristina A.; Li, Hongzhe; Devoto, Marcella; McGrady, Patrick W.; London, Wendy B.; Capasso, Mario; Rahman, Nazneen; Hakonarson, Hakon; Maris, John M.			Integrative genomics identifies LMO1 as a neuroblastoma oncogene	NATURE			English	Article							COPY NUMBER; CHROMOSOMAL TRANSLOCATIONS; ACTIVATING MUTATIONS; ALK KINASE; GENE; TRANSCRIPTION; CANCER; INTERACTS; TARGET; CELLS	Neuroblastoma is a childhood cancer of the sympathetic nervous system that accounts for approximately 10% of all paediatric oncology deaths(1,2). To identify genetic risk factors for neuroblastoma, we performed a genome-wide association study (GWAS) on 2,251 patients and 6,097 control subjects of European ancestry from four case series. Here we report a significant association within LIM domain only 1 (LMO1) at 11p15.4 (rs110419, combined P = 5.2 x 10(-16), odds ratio of risk allele = 1.34 (95% confidence interval 1.25-1.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P < 0.0001) and survival (P = 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression.	[Wang, Kai; Zhang, Haitao; Hou, Cuiping; Glessner, Joseph; Kim, Cecilia; Frackelton, Edward; Glaberson, Wendy; Chiavacci, Rosetta; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Attiyeh, Edward F.; Winter, Cynthia; Schnepp, Robert W.; Diamond, Maura; Bosse, Kristopher; Mayes, Patrick A.; Garris, Maria; Wang, Qun; Nguyen, Le; Jagannathan, Jayanti; Mosse, Yael P.; Cole, Kristina A.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Attiyeh, Edward F.; Winter, Cynthia; Schnepp, Robert W.; Diamond, Maura; Bosse, Kristopher; Mayes, Patrick A.; Garris, Maria; Wang, Qun; Nguyen, Le; Jagannathan, Jayanti; Mosse, Yael P.; Cole, Kristina A.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Nguyen, Le; Li, Hongzhe; Devoto, Marcella] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Saeki, Norihisa; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Nguyen, Le; Grant, Struan F. A.; Mosse, Yael P.; Cole, Kristina A.; Devoto, Marcella; Hakonarson, Hakon; Maris, John M.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Devoto, Marcella; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Iolascon, Achille; Capasso, Mario] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [McGrady, Patrick W.] Univ Florida, Dept Stat, Gainesville, FL 32603 USA; [McGrady, Patrick W.] Childrens Oncol Grp, Gainesville, FL 32603 USA; [London, Wendy B.] Dana Farber Childrens Hosp, Ctr Canc, Boston, MA 02115 USA; [London, Wendy B.] Childrens Oncol Grp, Boston, MA 02115 USA; [Iolascon, Achille; Capasso, Mario] Univ Naples Federico 2, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy; [Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; National Cancer Center - Japan; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; CEINGE Biotecnologie Avanzate; Sapienza University Rome; State University System of Florida; University of Florida; Children's Oncology Group (COG); Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Children's Oncology Group (COG); University of Naples Federico II; University of London; Institute of Cancer Research - UK	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu; maris@chop.edu	Cole, Kristina/M-3922-2015; Iolascon, Achille/A-4461-2014; London, Wendy Beth/ABA-8948-2021; Devoto, Marcella/AAP-7595-2021; London, Wendy/ABD-4624-2021; Capasso, Mario/D-1617-2014; Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	London, Wendy Beth/0000-0003-3571-6538; Rahman, Nazneen/0000-0003-4376-0440; Glessner, Joseph/0000-0001-5131-2811; Capasso, Mario/0000-0003-3306-1259; DEVOTO, MARCELLA/0000-0002-4431-5114; Grant, Struan/0000-0003-2025-5302; iolascon, achille/0000-0002-9558-0356; Mayes, Patrick/0000-0001-9104-4161	National Institutes of Health [R01-CA124709]; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute; Associazione Oncologia Pediatrica e Neuroblastoma; Cotswold Foundation; Children's Hospital of Philadelphia;  [UL1-RR024134-03]; NATIONAL CANCER INSTITUTE [U10CA098543, U10CA098413, R00CA151869, R01CA124709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Associazione Oncologia Pediatrica e Neuroblastoma; Cotswold Foundation; Children's Hospital of Philadelphia; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We acknowledge the Children's Oncology Group for providing most blood and tumour specimens and clinical and outcome data (U10-CA98543 and U10-CA98413) from neuroblastoma patients. We thank G. P. Tonini for providing neuroblastoma DNA samples in the Italian replication cohort. This work was supported in part by National Institutes of Health grant R01-CA124709 (to J.M.M.), the Giulio D'Angio Endowed Chair (J.M.M.), the Alex's Lemonade Stand Foundation (J.M.M.), the Evan Dunbar Foundation (J.M.M.), the Rally Foundation (J.M.M.), Andrew's Army Foundation (J.M.M.), the Abramson Family Cancer Research Institute (J.M.M.), a Howard Hughes Medical Institute Research Training Fellowship (K. B.), a fellowship from Associazione Oncologia Pediatrica e Neuroblastoma (M. C.), a Research Development Award from the Cotswold Foundation (H. H.), UL1-RR024134-03 (H. H.) and an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia (H.H.).	Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; FISCH P, 1992, ONCOGENE, V7, P2389; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Neale Geoffrey A. M., 1997, Leukemia (Basingstoke), V11, P289; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Rabbitts TH, 1999, CANCER RES, V59, p1794S; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618	22	216	222	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					216	220		10.1038/nature09609	http://dx.doi.org/10.1038/nature09609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21124317	Green Accepted			2022-12-01	WOS:000286143400039
J	Jefferson, T; Doshi, P; Thompson, M; Heneghan, C				Jefferson, Tom; Doshi, Peter; Thompson, Matthew; Heneghan, Carl		Cochrane Acute Resp Infections Grp	Ensuring safe and effective drugs: who can do what it takes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE INFLUENZA; OSELTAMIVIR; EFFICACY; ROSIGLITAZONE		[Doshi, Peter] MIT, Program Hist Anthropol Sci Technol & Soc, Cambridge, MA 02139 USA; [Jefferson, Tom] Cochrane Collaborat, Acute Resp Infect Grp, Rome, Italy; [Thompson, Matthew; Heneghan, Carl] Univ Oxford, Dept Primary Hlth Care, Oxford, England; [Thompson, Matthew] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA	Massachusetts Institute of Technology (MIT); University of Oxford; Oregon Health & Science University	Doshi, P (corresponding author), MIT, Program Hist Anthropol Sci Technol & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pnd@mit.edu			National Institute for Health Research [10/80/01] Funding Source: researchfish; Department of Health [10/80/01, HTA/10/80/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		COCHR ED UN, NEUR INH INFL HTA; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Godlee F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5405; Higgins JP, 2011, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1, DOI 10.1002/14651858.ED000049]; Ioannidis JPA, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4875; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Li LY, 2003, CHINESE MED J-PEKING, V116, P44; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nissen S, 2010, ROSIGLITAZONE CRITIC; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; van Driel ML, 2009, J CLIN EPIDEMIOL, V62, P838, DOI 10.1016/j.jclinepi.2008.09.010	20	33	33	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2011	342								c7258	10.1136/bmj.c7258	http://dx.doi.org/10.1136/bmj.c7258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708SO	21224325				2022-12-01	WOS:000286384800009
J	Cisse, M; Halabisky, B; Harris, J; Devidze, N; Dubal, DB; Sun, BG; Orr, A; Lotz, G; Kim, DH; Hamto, P; Ho, K; Yu, GQ; Mucke, L				Cisse, Moustapha; Halabisky, Brian; Harris, Julie; Devidze, Nino; Dubal, Dena B.; Sun, Binggui; Orr, Anna; Lotz, Gregor; Kim, Daniel H.; Hamto, Patricia; Ho, Kaitlyn; Yu, Gui-Qiu; Mucke, Lennart			Reversing EphB2 depletion rescues cognitive functions in Alzheimer model	NATURE			English	Article							AMYLOID-BETA-PROTEIN; DEPENDENT SYNAPTIC PLASTICITY; TRANSGENIC MOUSE MODEL; LONG-TERM POTENTIATION; PRECURSOR PROTEIN; CALCIUM INFLUX; BEHAVIORAL IMPAIRMENTS; CELLULAR PRION; IN-VITRO; DISEASE	Amyloid-beta oligomers may cause cognitive deficits in Alzheimer's disease by impairing neuronal NMDA-type glutamate receptors, whose function is regulated by the receptor tyrosine kinase EphB2. Here we show that amyloid-beta oligomers bind to the fibronectin repeats domain of EphB2 and trigger EphB2 degradation in the proteasome. To determine the pathogenic importance of EphB2 depletions in Alzheimer's disease and related models, we used lentiviral constructs to reduce or increase neuronal expression of EphB2 in memory centres of the mouse brain. In nontransgenic mice, knockdown of EphB2 mediated by short hairpin RNA reduced NMDA receptor currents and impaired long-term potentiation in the dentate gyrus, which are important for memory formation. Increasing EphB2 expression in the dentate gyrus of human amyloid precursor protein transgenic mice reversed deficits in NMDA receptor-dependent long-term potentiation and memory impairments. Thus, depletion of EphB2 is critical in amyloid-beta-induced neuronal dysfunction. Increasing EphB2 levels or function could be beneficial in Alzheimer's disease.	[Cisse, Moustapha; Halabisky, Brian; Harris, Julie; Devidze, Nino; Dubal, Dena B.; Sun, Binggui; Orr, Anna; Lotz, Gregor; Kim, Daniel H.; Hamto, Patricia; Ho, Kaitlyn; Yu, Gui-Qiu; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Cisse, Moustapha; Halabisky, Brian; Harris, Julie; Dubal, Dena B.; Sun, Binggui; Orr, Anna; Lotz, Gregor; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lmucke@gladstone.ucsf.edu	CISSE, Moustapha/AAM-1022-2021; Sun, Binggui/J-9028-2016; Dubal, Dena/AAL-2091-2021	Sun, Binggui/0000-0002-0386-6569; Lotz, Gregor/0000-0002-0231-5503; CISSE, Moustapha/0000-0003-3890-9183; Orr, Anna/0000-0002-4036-4277	NIH [AG011385, AG022074, NS041787]; McBean Family Foundation; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG011385, R01AG011385, P01AG022074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McBean Family Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank I. Ethell for the plasmid encoding the Flag-tagged EphB2 receptor; D. J. Selkoe and D. Walsh for CHO-7PA2 cells; S. Finkbeiner for the plasmid encoding the NMDA receptor subunit NR1; J. Palop for comments; H. Solanoy, M. Thwin and X. Wang for technical support; G. Howard and S. Ordway for editorial review; J. Carroll for preparation of graphics; and M. Dela Cruz for administrative assistance. The study was supported by NIH grants AG011385, AG022074 and NS041787 to L.M., a fellowship from the McBean Family Foundation to M. C., and the National Center for Research Resources Grant RR18928-01 to the Gladstone Institutes.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Chen Y, 2008, NEURON GLIA BIOL, V4, P211, DOI 10.1017/S1740925X09990287; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dere E, 2005, BRAIN RES PROTOC, V16, P10, DOI 10.1016/j.brainresprot.2005.08.001; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Ikonemevic MD, 1999, EXP NEUROL, V160, P194, DOI 10.1006/exnr.1999.7196; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Meilandt WJ, 2008, J NEUROSCI, V28, P5007, DOI 10.1523/JNEUROSCI.0590-08.2008; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nakajima R, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-7; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Raber J, 2000, J NEUROSCI, V20, P2064; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Scheff SW, 2006, J ALZHEIMERS DIS, V9, P101; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Sze CI, 2001, J NEUROL SCI, V182, P151, DOI 10.1016/S0022-510X(00)00467-6; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; WAKABAYASHI K, 1994, BRAIN RES, V667, P24, DOI 10.1016/0006-8993(94)91709-4; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wu JQ, 2001, J PHYSIOL-LONDON, V533, P745, DOI 10.1111/j.1469-7793.2001.t01-1-00745.x; Xia ZG, 1996, J NEUROSCI, V16, P5425	50	304	322	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					47	52		10.1038/nature09635	http://dx.doi.org/10.1038/nature09635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21113149	Green Accepted			2022-12-01	WOS:000285921600028
J	Paradis-Bleau, C; Markovski, M; Uehara, T; Lupoli, TJ; Walker, S; Kahne, DE; Bernhardt, TG				Paradis-Bleau, Catherine; Markovski, Monica; Uehara, Tsuyoshi; Lupoli, Tania J.; Walker, Suzanne; Kahne, Daniel E.; Bernhardt, Thomas G.			Lipoprotein Cofactors Located in the Outer Membrane Activate Bacterial Cell Wall Polymerases	CELL			English	Article							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; PEPTIDOGLYCAN BIOSYNTHESIS; PBP1B; IDENTIFICATION; MORPHOGENESIS; COMPLEXES; MUTANTS; DIMERS	Most bacteria surround themselves with a peptidoglycan (PG) exoskeleton synthesized by polysaccharide polymerases called penicillin-binding proteins (PBPs). Because they are the targets of penicillin and related antibiotics, the structure and biochemical functions of the PBPs have been extensively studied. Despite this, we still know surprisingly little about how these enzymes build the PG layer in vivo. Here, we identify the Escherichia coli outermembrane lipoproteins LpoA and LpoB as essential PBP cofactors. We show that LpoA and LpoB form specific trans-envelope complexes with their cognate PBP and are critical for PBP function in vivo. We further show that LpoB promotes PG synthesis by its partner PBP in vitro and that it likely does so by stimulating glycan chain polymerization. Overall, our results indicate that PBP accessory proteins play a central role in PG biogenesis, and like the PBPs they work with, these factors are attractive targets for antibiotic development.	[Paradis-Bleau, Catherine; Markovski, Monica; Uehara, Tsuyoshi; Walker, Suzanne; Bernhardt, Thomas G.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Kahne, Daniel E.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lupoli, Tania J.; Walker, Suzanne; Kahne, Daniel E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Bernhardt, TG (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	thomas_bernhardt@hms.harvard.edu		Uehara, Tsuyoshi/0000-0001-6994-4286	Massachusetts Life Science Center; Burroughs Wellcome Fund; National Institutes of Health [R01 AI083365-01A1, GM066174, GM076710]; FRSQ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076710, R01GM066174] Funding Source: NIH RePORTER	Massachusetts Life Science Center; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRSQ(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank D. Rudner, M. Waldor, and members of our laboratories for critical reading of the manuscript. We would also like to thank A. Typas, C. Gross, W. Vollmer, and coworkers for communicating their results in advance of publication. Special thanks to K. Suefuji and J.T. Park for generously providing the UDP-M-pep5. This work was supported by the Massachusetts Life Science Center (T. G. B.), the Burroughs Wellcome Fund (T. G. B.), and the National Institutes of Health (R01 AI083365-01A1 for T. G. B, GM066174 for D. E. K., and GM076710 for D. E. K and S. W.). T. G. B. holds a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund. C.P.-B. was supported in part by a fellowship from FRSQ.	Alaedini A, 1999, BIOCHEM BIOPH RES CO, V264, P191, DOI 10.1006/bbrc.1999.1509; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Charpentier X, 2002, J BACTERIOL, V184, P3749, DOI 10.1128/JB.184.13.3749-3752.2002; DELPORTILLO FG, 1990, J BACTERIOL, V172, P5863; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; DENBLAAUWEN T, 1990, J BACTERIOL, V172, P71, DOI 10.1128/JB.172.1.71-79.1990; Dougherty TJ, 1996, J BACTERIOL, V178, P6110, DOI 10.1128/jb.178.21.6110-6115.1996; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; GOODELL EW, 1975, J GEN MICROBIOL, V86, P201, DOI 10.1099/00221287-86-2-201; KATO J, 1985, MOL GEN GENET, V200, P272, DOI 10.1007/BF00425435; Lewenza S, 2006, J BACTERIOL, V188, P3516, DOI 10.1128/JB.188.10.3516-3524.2006; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; MIRELMAN D, 1976, BIOCHEMISTRY-US, V15, P1781, DOI 10.1021/bi00654a001; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; SCHMIDT LS, 1981, J BACTERIOL, V145, P632, DOI 10.1128/JB.145.1.632-637.1981; SCHWARZ U, 1971, J BACTERIOL, V106, P588, DOI 10.1128/JB.106.2.588-595.1971; SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0; TAMAKI S, 1977, P NATL ACAD SCI USA, V74, P5472, DOI 10.1073/pnas.74.12.5472; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Vijayalakshmi J, 2008, PROTEINS, V73, P204, DOI 10.1002/prot.22033; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Wong SM, 2003, GENE, V316, P177, DOI 10.1016/S0378-1119(03)00762-5; YOUSIF SY, 1985, J GEN MICROBIOL, V131, P2839	32	220	225	2	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1110	1120		10.1016/j.cell.2010.11.037	http://dx.doi.org/10.1016/j.cell.2010.11.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183074	Bronze, Green Accepted			2022-12-01	WOS:000285625400009
J	Sengupta, S; Peterson, TR; Laplante, M; Oh, S; Sabatini, DM				Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.			mTORC1 controls fasting-induced ketogenesis and its modulation by ageing	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; FATTY-ACID OXIDATION; RAT-LIVER; MICE; IDENTIFICATION; GENES	The multi-component mechanistic target of rapamycin complex 1 (mTORC1) kinase is the central node of a mammalian pathway that coordinates cell growth with the availability of nutrients, energy and growth factors(1). Progress has been made in the identification of mTORC1 pathway components and in understanding their functions in cells, but there is relatively little known about the role of the pathway in vivo. Specifically, we have little knowledge regarding the role mTOCR1 has in liver physiology. In fasted animals, the liver performs numerous functions that maintain whole-body homeostasis, including the production of ketone bodies for peripheral tissues to use as energy sources. Here we show that mTORC1 controls ketogenesis in mice in response to fasting. We find that liver-specific loss of TSC1 (tuberous sclerosis 1), an mTORC1 inhibitor(1), leads to a fasting-resistant increase in liver size, and to a pronounced defect in ketone body production and ketogenic gene expression on fasting. The loss of raptor (regulatory associated protein of mTOR, complex 1) an essential mTORC1 component(1), has the opposite effects. In addition, we find that the inhibition of mTORC1 is required for the fasting-induced activation of PPAR alpha (peroxisome proliferator activated receptor alpha), the master transcriptional activator of ketogenic genes(2), and that suppression of NCoR1 (nuclear receptor co-repressor 1), a co-repressor of PPAR alpha(3), reactivates ketogenesis in cells and livers with hyperactive mTORC1 signalling. Like livers with activated mTORC1, livers from aged mice have a defect in ketogenesis(4,5), which correlates with an increase in mTORC1 signalling. Moreover, we show that the suppressive effects of mTORC1 activation and ageing on PPAR alpha activity and ketone production are not additive, and that mTORC1 inhibition is sufficient to prevent the ageing-induced defect in ketogenesis. Thus, our findings reveal that mTORC1 is a key regulator of PPAR alpha function and hepatic ketogenesis and suggest a role for mTORC1 activity in promoting the ageing of the liver.	[Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		Oh, Stephanie/0000-0002-6287-9116; /0000-0002-1446-7256	American Diabetes Association; Ludwig Cancer Fund; Canadian Institutes of Health Research; NIH [CA103866, CA129105]; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Ludwig Cancer Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Biddinger and C. R. Kahn for providing the Ir<SUP>loxP/loxP</SUP> and Li-Ir<SUP>KO</SUP> mice; D. Kwiatkowski for the Tsc1<SUP>loxP/loxP</SUP> mice; R. Zoncu for assistance with imaging experiments and image analysis; F. Reinhardt for assistance in animal virus injections; and T. Jacks, L. Guarente, V. Mootha and members of the Sabatini laboratory for support and discussions. This research was supported by fellowships from the American Diabetes Association and Ludwig Cancer Fund to T. R. P.; a fellowship from the Canadian Institutes of Health Research to M. L.; and NIH grants CA103866 and CA129105 to D. M. S. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Faraj M, 2004, AM J PHYSIOL-ENDOC M, V287, pE150, DOI 10.1152/ajpendo.00398.2003; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Glass CK, 2000, GENE DEV, V14, P121; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; MCGARRY JD, 1973, J BIOL CHEM, V248, P270; MCGARRY JD, 1971, J BIOL CHEM, V246, P1149; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Osoegawa K, 2000, GENOME RES, V10, P116; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283	30	433	441	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1100	U502		10.1038/nature09584	http://dx.doi.org/10.1038/nature09584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179166				2022-12-01	WOS:000285553800058
J	Sury, M; Bullock, I; Rabar, S; DeMott, K				Sury, Mike; Bullock, Ian; Rabar, Silvia; DeMott, Kathleen			Guidelines Sedation for diagnostic and therapeutic procedures in children and young people: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sury, Mike] Great Ormond St Hosp Childrens NHS Trust, London WC1N 3JH, England; [Sury, Mike] UCL, Inst Child Hlth, PORTEX Unit Paediat Anaesthesia, London WC1N 1EH, England; [Bullock, Ian; Rabar, Silvia; DeMott, Kathleen] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Royal College of Physicians	Sury, M (corresponding author), Great Ormond St Hosp Childrens NHS Trust, London WC1N 3JH, England.	surym@gosh.nhs.uk						British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2011, BRIT NAT FORM CHILDR; National Institute for Health and Clinical Excellence, 2010, CLIN GUID, V112; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004	3	35	38	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 16	2010	341								c6819	10.1136/bmj.c6819	http://dx.doi.org/10.1136/bmj.c6819			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XM	21163835				2022-12-01	WOS:000285553100008
J	de Lemos, JA; Drazner, MH; Omland, T; Ayers, CR; Khera, A; Rohatgi, A; Hashim, I; Berry, JD; Das, SR; Morrow, DA; McGuire, DK				de Lemos, James A.; Drazner, Mark H.; Omland, Torbjorn; Ayers, Colby R.; Khera, Amit; Rohatgi, Anand; Hashim, Ibrahim; Berry, Jarett D.; Das, Sandeep R.; Morrow, David A.; McGuire, Darren K.			Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDES; STABILIZED PATIENTS; PROGNOSTIC VALUE; EARLY-DIAGNOSIS; HEART-DISEASE; I ELEVATION; MECHANISMS; SAMPLE	Context Detectable levels of cardiac troponin T (cTnT) are strongly associated with structural heart disease and increased risk of death and adverse cardiovascular events; however, cTnT is rarely detectable in the general population using standard assays. Objectives To determine the prevalence and determinants of detectable cTnT in the population using a new highly sensitive assay and to assess whether cTnT levels measured with the new assay associate with pathological cardiac phenotypes and subsequent mortality. Design, Setting, and Participants Cardiac troponin T levels were measured using both the standard and the highly sensitive assays in 3546 individuals aged 30 to 65 years enrolled between 2000 and 2002 in the Dallas Heart Study, a multiethnic, population-based cohort study. Mortality follow-up was complete through 2007. Participants were placed into 5 categories based on cTnT levels. Main Outcome Measures Magnetic resonance imaging measurements of cardiac structure and function and mortality through a median of 6.4 (interquartile range, 6.0-6.8) years of follow-up. Results In Dallas County, the prevalence of detectable cTnT (>= 0.003 ng/mL) was 25.0% (95% confidence interval [CI], 22.7%-27.4%) with the highly sensitive assay vs 0.7% (95% CI, 0.3%-1.1%) with the standard assay. Prevalence was 37.1% (95% CI, 33.3%-41.0%) in men vs 12.9% (95% CI, 10.6%-15.2%) in women and 14.0% (95% CI, 11.2%-16.9%) in participants younger than 40 years vs 57.6% (95% CI, 47.0%-68.2%) in those 60 years and older. Prevalence of left ventricular hypertrophy increased from 7.5% (95% CI, 6.4%-8.8%) in the lowest cTnT category (>= 0.003 ng/mL) to 48.1% (95% CI, 36.7%-59.6%) in the highest (>= 0.014 ng/mL) (P<.001); prevalence of left ventricular systolic dysfunction and chronic kidney disease also increased across categories (P<.001 for each). During a median follow-up of 6.4 years, there were 151 total deaths, including 62 cardiovascular disease deaths. All-cause mortality increased from 1.9% (95% CI, 1.5%-2.6%) to 28.4% (95% CI, 21.0%-37.8%) across higher cTnT categories (P<.001). After adjustment for traditional risk factors, C-reactive protein level, chronic kidney disease, and N-terminal pro-brain-type natriuretic peptide level, cTnT category remained independently associated with all-cause mortality (adjusted hazard ratio, 2.8 [95% CI, 1.4-5.2] in the highest category). Adding cTnT categories to the fully adjusted mortality model modestly improved model fit (P=.02) and the integrated discrimination index (0.010 [95% CI, 0.002-0.018]; P=.01). Conclusion In this population-based cohort, cTnT detected with a highly sensitive assay was associated with structural heart disease and subsequent risk for all-cause mortality. JAMA. 2010;304(22):2503-2512 www.jama.com	[de Lemos, James A.; Drazner, Mark H.; Ayers, Colby R.; Khera, Amit; Rohatgi, Anand; Berry, Jarett D.; Das, Sandeep R.; McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [de Lemos, James A.; Drazner, Mark H.; Ayers, Colby R.; Khera, Amit; Rohatgi, Anand; Berry, Jarett D.; Das, Sandeep R.; McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Hashim, Ibrahim] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Omland, Torbjorn] Aker Univ Hosp, Div Med, Oslo, Norway; [Omland, Torbjorn] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Morrow, David A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Oslo; University of Oslo; Harvard University; Brigham & Women's Hospital	de Lemos, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, 5909 Harry Hines Blvd,HA 9-133, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021; mcguire, darren keith/AAL-4172-2021		Roche Diagnostics; Biosite/Inverness; Tethys Biomedical; Johnson Johnson; Siemens; AstraZeneca; Pfizer; BMS/sanofi-aventis; Merck/Schering; Abbott Laboratories; Beckman-Coulter; Boerhinger Ingelheim; Instrumentation Laboratories; Menarini; Merck; Sanofi-aventis; Servier; Accumetrics; Amgen; Beckman Coulter; Bristol-Myers Squibb; CV Therapeutics; Daiichi Sankyo Co Ltd; Eli Lilly and Co; GlaxoSmithKline; Integrated Therapeutics; Merck and Co; Merck-Schering Plough Joint Venture; Nanosphere; Novartis Pharmaceuticals; Nuvelo; Ortho-Clinical Diagnostics; Singulex; Tethys Bioscience; Biosite; F. Hoffmann LaRoche/Genentech; Cardiovascular Therapeutics; Novo Nordisk; Daiichi-Sankyo; Mitsubishi Tanabe Pharma; Donald W. Reynolds Foundation; National Institutes of Health (NIH)/NCRR-CR [M01-RR00633]; North and Central Texas Clinical and Translational Science Initiative (NIH) [UL1 RR024982]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633, UL1RR024982] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092229] Funding Source: NIH RePORTER	Roche Diagnostics; Biosite/Inverness; Tethys Biomedical; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Siemens(Siemens AG); AstraZeneca(AstraZeneca); Pfizer(Pfizer); BMS/sanofi-aventis(Sanofi-Aventis); Merck/Schering(Merck & Company); Abbott Laboratories(Abbott Laboratories); Beckman-Coulter; Boerhinger Ingelheim; Instrumentation Laboratories; Menarini(Menarini Group); Merck(Merck & Company); Sanofi-aventis(Sanofi-Aventis); Servier(Servier); Accumetrics; Amgen(Amgen); Beckman Coulter; Bristol-Myers Squibb(Bristol-Myers Squibb); CV Therapeutics; Daiichi Sankyo Co Ltd(Daiichi Sankyo Company Limited); Eli Lilly and Co(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Integrated Therapeutics; Merck and Co(Merck & Company); Merck-Schering Plough Joint Venture; Nanosphere; Novartis Pharmaceuticals(Novartis); Nuvelo; Ortho-Clinical Diagnostics; Singulex; Tethys Bioscience; Biosite; F. Hoffmann LaRoche/Genentech(Hoffmann-La RocheRoche HoldingGenentech); Cardiovascular Therapeutics; Novo Nordisk(Novo Nordisk); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Donald W. Reynolds Foundation; National Institutes of Health (NIH)/NCRR-CR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); North and Central Texas Clinical and Translational Science Initiative (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr de Lemos reported receiving research grants from Roche Diagnostics and Biosite/Inverness and receiving consulting fees and/or lecture honoraria from Tethys Biomedical, Johnson & Johnson, Roche Diagnostics, Biosite/Inverness, Siemens, AstraZeneca, Pfizer, BMS/sanofi-aventis, and Merck/Schering. Dr Drazner reported receiving consulting fees from Biosite/Inverness and lecture honoraria from GlaxoSmithKline. Dr Omland reported receiving research support and lecture honoraria from Roche Diagnostics and Abbott Laboratories. Dr Morrow reported receiving honoraria for educational presentations from Beckman-Coulter, CV Therapeutics, and Eli Lilly and receiving consulting fees from Beckman-Coulter, Boerhinger Ingelheim, Instrumentation Laboratories, Menarini, Merck, sanofi-aventis, Servier, Roche Diagnostics, Siemens, and AstraZeneca. The TIMI Study Group, which supports Dr Morrow's salary, has received significant research grant support from Accumetrics, Amgen, AstraZeneca, Beckman Coulter, Bristol-Myers Squibb, CV Therapeutics, Daiichi Sankyo Co Ltd, Eli Lilly and Co, GlaxoSmithKline, Integrated Therapeutics, Merck and Co, Merck-Schering Plough Joint Venture, Nanosphere, Novartis Pharmaceuticals, Nuvelo, Ortho-Clinical Diagnostics, Pfizer, Roche Diagnostics, sanofi-aventis, Siemens, and Singulex. Dr McGuire reported receiving grant support from GlaxoSmithKline; receiving consulting fees from Tethys Bioscience, Biosite, F. Hoffmann LaRoche/Genentech, Cardiovascular Therapeutics, AstraZeneca, Novo Nordisk, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, Johnson & Johnson, and sanofi-aventis; and receiving lecture honoraria from Pfizer and Takeda. No other authors reported disclosures.; Grant support for the Dallas Heart Study was provided by the Donald W. Reynolds Foundation and by US Public Health Service General Clinical Research Center grant M01-RR00633 from National Institutes of Health (NIH)/NCRR-CR. This study was supported in part by the North and Central Texas Clinical and Translational Science Initiative (NIH grant UL1 RR024982). Financial and materials support for measurements of cardiac troponin T (cTnT) levels in the present study were provided by Roche Diagnostics (Indianapolis, Indiana). Roche Diagnostics also previously provided materials and support for measurement of levels of cTnT, N-terminal pro-brain-type natriuretic peptide, and C-reactive protein in the Dallas Heart Study. Role of the Sponsor: Roche Diagnostics and the NIH had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Abdullah SM, 2005, AM J CARDIOL, V96, P1284, DOI 10.1016/j.amjcard.2005.06.073; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Antolini L, 2005, STAT MED, V24, P3927, DOI 10.1002/sim.2427; Apple FS, 2003, CLIN CHEM, V49, pA61; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Colosimo EA, 2002, J STAT COMPUT SIM, V72, P299, DOI 10.1080/00949650212847; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1161/CIRCULATIONAHA.105.555573; de Lemos JA, 2009, AM HEART J, V157, P746, DOI 10.1016/j.ahj.2008.12.017; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327; Eggers KM, 2008, AM HEART J, V156, P588, DOI 10.1016/j.ahj.2008.04.022; Eggers KM, 2007, CIRCULATION, V116, P1907, DOI 10.1161/CIRCULATIONAHA.107.708529; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; JONCKHEERE AR, 1967, BRIT J MATH STAT PSY, V20, P163, DOI 10.1111/j.2044-8317.1967.tb00385.x; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Konstantinides S, 2002, CIRCULATION, V106, P1263, DOI 10.1161/01.CIR.0000028422.51668.A2; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Lindahl B, 2001, J AM COLL CARDIOL, V38, P979, DOI 10.1016/S0735-1097(01)01501-7; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Morrow DA, 2009, CLIN CHEM, V55, P5, DOI 10.1373/clinchem.2008.117218; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; See R, 2008, ARCH INTERN MED, V168, P1055, DOI 10.1001/archinte.168.10.1055; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wong GC, 2002, CIRCULATION, V106, P202, DOI 10.1161/01.CIR.0000021921.14653.28; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762	37	814	829	3	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2503	2512		10.1001/jama.2010.1768	http://dx.doi.org/10.1001/jama.2010.1768			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21139111	Green Accepted, Bronze			2022-12-01	WOS:000285053300024
J	Ruta, V; Datta, SR; Vasconcelos, ML; Freeland, J; Looger, LL; Axel, R				Ruta, Vanessa; Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Freeland, Jessica; Looger, Loren L.; Axel, Richard			A dimorphic pheromone circuit in Drosophila from sensory input to descending output	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; MALE COURTSHIP BEHAVIOR; RECEPTOR NEURONS; NEURAL CIRCUITRY; FRUITLESS GENE; MELANOGASTER; REPRESENTATION; AGGRESSION; ORGANIZATION; BRAIN	Drosophila show innate olfactory-driven behaviours that are observed in naive animals without previous learning or experience, suggesting that the neural circuits that mediate these behaviours are genetically programmed. Despite the numerical simplicity of the fly nervous system, features of the anatomical organization of the fly brain often confound the delineation of these circuits. Here we identify a neural circuit responsive to cVA, a pheromone that elicits sexually dimorphic behaviours(1-4). We have combined neural tracing using an improved photoactivatable green fluorescent protein (PA-GFP) with electrophysiology, optical imaging and laser-mediated microlesioning to map this circuit from the activation of sensory neurons in the antennae to the excitation of descending neurons in the ventral nerve cord. This circuit is concise and minimally comprises four neurons, connected by three synapses. Three of these neurons are overtly dimorphic and identify a male-specific neuropil that integrates inputs from multiple sensory systems and sends outputs to the ventral nerve cord. This neural pathway suggests a means by which a single pheromone can elicit different behaviours in the two sexes.	[Ruta, Vanessa; Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Freeland, Jessica; Axel, Richard] Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Ruta, Vanessa; Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Freeland, Jessica; Axel, Richard] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu		Ruta, Vanessa/0000-0002-4963-2768; Vasconcelos, Maria Luisa/0000-0001-6248-3667; Datta, Sandeep/0000-0002-8068-3862; Axel, Richard/0000-0002-3141-4076	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Helen Hay Whitney Foundation; Burroughs Welcome Fund; Howard Hughes Medical Institute	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Helen Hay Whitney Foundation; Burroughs Welcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank T. Jessell, C. Zuker and members of the Axel laboratory for discussion and comments on this manuscript; J. Flores for technical assistance; B. Dickson for reagents; P. Kisloff for assistance in the preparation of this manuscript; and M. Gutierrez and A. Nemes for general laboratory support. This work was funded in part by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative. Further financial support was provided by the Helen Hay Whitney Foundation (V.R. and S.R.D.), the Burroughs Welcome Fund (S.R.D.) and the Howard Hughes Medical Institute (R.A. and L.L.L.).	BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Chan YB, 2007, P NATL ACAD SCI USA, V104, P19577, DOI 10.1073/pnas.0709803104; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dulac C, 2007, CURR OPIN NEUROBIOL, V17, P675, DOI 10.1016/j.conb.2008.01.009; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Ito K, 1998, LEARN MEMORY, V5, P52; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	33	232	235	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					686	U106		10.1038/nature09554	http://dx.doi.org/10.1038/nature09554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124455				2022-12-01	WOS:000284836700039
J	Thumbs, A; Borgstein, E				Thumbs, Alexander; Borgstein, Eric			Commentary: managing oesophageal cancer in a resource poor setting-a Malawian example	BMJ-BRITISH MEDICAL JOURNAL			English	Review									[Thumbs, Alexander; Borgstein, Eric] Queen Elizabeth Cent Hosp, Dept Surg, Blantyre, Malawi; [Thumbs, Alexander; Borgstein, Eric] Univ Malawi, Coll Med, Blantyre, Malawi	University of Malawi; University of Malawi		alex_thumbs@hotmail.com						Lagergren J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6280; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; Sammon A, 2009, SQUAMOUS CANC ESOPHA	3	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2010	341								c6723	10.1136/bmj.c6723	http://dx.doi.org/10.1136/bmj.c6723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EH	21112910				2022-12-01	WOS:000284832100002
J	Tung, CC; Lobo, PA; Kimlicka, L; Van Petegem, F				Tung, Ching-Chieh; Lobo, Paolo A.; Kimlicka, Lynn; Van Petegem, Filip			The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule	NATURE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CALCIUM-RELEASE CHANNEL; MUTATION HOT-SPOT; S-NITROSYLATION; CA2+ RELEASE; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; ATOMIC MODELS; MUSCLE; DOMAIN	Many physiological events require transient increases in cytosolic Ca2+ concentrations. Ryanodine receptors (RyRs) are ion channels that govern the release of Ca2+ from the endoplasmic and sarcoplasmic reticulum(1). Mutations in RyRs can lead to severe genetic conditions that affect both cardiac and skeletal muscle, but locating the mutated residues in the full-length channel structure has been difficult(2,3). Here we show the 2.5 angstrom resolution crystal structure of a region spanning three domains of RyR type 1 (RyR1), encompassing amino acid residues 1-559. The domains interact with each other through a predominantly hydrophilic interface. Docking in RyR1 electron microscopy maps(4,5) unambiguously places the domains in the cytoplasmic portion of the channel, forming a 240-kDa cytoplasmic vestibule around the four-fold symmetry axis. We pinpoint the exact locations of more than 50 disease-associated mutations in full-length RyR1 and RyR2. The mutations can be classified into three groups: those that destabilize the interfaces between the three amino-terminal domains, disturb the folding of individual domains or affect one of six interfaces with other parts of the receptor. We propose a model whereby the opening of a RyR coincides with allosterically coupled motions within the N-terminal domains. This process can be affected by mutations that target various interfaces within and across subunits. The crystal structure provides a framework to understand the many disease-associated mutations in RyRs that have been studied using functional methods, and will be useful for developing new strategies to modulate RyR function in disease states.	[Tung, Ching-Chieh; Lobo, Paolo A.; Kimlicka, Lynn; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Van Petegem, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	filip.vanpetegem@gmail.com	Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	We thank the staff at beamline 08ID-1 of the Canadian Light source, the Stanford Synchrotron Radiation Lightsource, K. Beam for the rabbit RyR1 clone, K. Lau for assistance with preparing the figures and the movie file, and C. Ahern, E. Moore and R. Pancaroglu for comments on the manuscript. F.V.P. is funded by the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada, and is a CIHR new investigator and a Michael Smith Foundation for Health Research Scholar.	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Baker ML, 2002, P NATL ACAD SCI USA, V99, P12155, DOI 10.1073/pnas.182058899; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Bhuiyan ZA, 2007, CIRCULATION, V116, P1569, DOI 10.1161/CIRCULATIONAHA.107.711606; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; Marjamaa A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-12; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Serysheva I, 2005, J MOL BIOL, V345, P427, DOI 10.1016/j.jmb.2004.10.073; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Volkmann N, 2003, METHOD ENZYMOL, V374, P204, DOI 10.1016/S0076-6879(03)74010-5; Volkmann N, 2009, ACTA CRYSTALLOGR D, V65, P679, DOI 10.1107/S0907444909012876; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234	37	155	157	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					585	U267		10.1038/nature09471	http://dx.doi.org/10.1038/nature09471			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21048710				2022-12-01	WOS:000284584200047
J	Grover, A; Citro, B				Grover, Anand; Citro, Brian			India: access to affordable drugs and the right to health	LANCET			English	Editorial Material									[Grover, Anand; Citro, Brian] Lawyers Collect HIV AIDS Unit, Bombay 400001, Maharashtra, India		Grover, A (corresponding author), Lawyers Collect HIV AIDS Unit, Bombay 400001, Maharashtra, India.	anandgrover@gmail.com						[Anonymous], 2004, WHO MED STRAT COUNTR; [Anonymous], 2004, WORLD MED SIT; European Commission, 2009, ANT TRAD AGR ACTA FA; *IND DEP IND POL P, 2010, DISC PAP SUBJ COMP L; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Office of the United Nations High Commissioner for Human Rights, INT COV EC SOC CULT; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; VIVASEUGUI D, 2003, REGIONAL BILATERAL A; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; *WHO, 2004, EQ ACC ESS MED FRAM, V8	10	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					976	977		10.1016/S0140-6736(10)62042-9	http://dx.doi.org/10.1016/S0140-6736(10)62042-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	740FA	21227487				2022-12-01	WOS:000288775800008
J	Yanagitani, K; Kimata, Y; Kadokura, H; Kohno, K				Yanagitani, Kota; Kimata, Yukio; Kadokura, Hiroshi; Kohno, Kenji			Translational Pausing Ensures Membrane Targeting and Cytoplasmic Splicing of XBP1u mRNA	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN; TRANSLOCATION; TUNNEL; IRE1	Upon endoplasmic reticulum (ER) stress, an endoribonuclease, inositol-requiring enzyme-1 alpha, splices the precursor unspliced form of X-box-binding protein 1 messenger RNA (XBP1u mRNA) on the ER membrane to yield an active transcription factor (XBP1s), leading to the alleviation of the stress. The nascent peptide encoded by XBP1u mRNA drags the mRNA-ribosome-nascent chain (R-RNC) complex to the membrane for efficient cytoplasmic splicing. We found that translation of the XBP1u mRNA was briefly paused to stabilize the R-RNC complex. Mutational analysis of XBP1u revealed an evolutionarily conserved peptide module at the carboxyl terminus that was responsible for the translational pausing and was required for the efficient targeting and splicing of the XBP1u mRNA. Thus, translational pausing may be used for unexpectedly diverse cellular processes in mammalian cells.	[Yanagitani, Kota; Kimata, Yukio; Kadokura, Hiroshi; Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol & Cell Genet, Nara 6300192, Japan	Nara Institute of Science & Technology	Kohno, K (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol & Cell Genet, 8916-5 Takayama, Nara 6300192, Japan.	kkouno@bs.naist.jp	Yanagitani, Kota/N-4106-2018; Kadokura, Hiroshi/AAE-1645-2019; Kohno, Kenji/AAZ-6573-2020	Yanagitani, Kota/0000-0002-5905-9950; Kohno, Kenji/0000-0002-3503-6551; Kadokura, Hiroshi/0000-0001-7308-7141	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank J. Iida-Hashimoto and N. Fujimoto for technical assistance and K. Ito, S. Chiba, and H. Yoshida for discussions. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (K.K., Y.K.) and Scientific Research B (K.K.) of KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan. K.Y. is a special postdoctoral fellow supported by Global Center of Excellence program from the Japan Society for the Promotion of Science.	Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	7	138	139	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					586	589		10.1126/science.1197142	http://dx.doi.org/10.1126/science.1197142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21233347				2022-12-01	WOS:000286933600054
J	Caronia, LM; Martin, C; Welt, CK; Sykiotis, GP; Quinton, R; Thambundit, A; Avbelj, M; Dhruvakumar, S; Plummer, L; Hughes, VA; Seminara, SB; Boepple, PA; Sidis, Y; Crowley, WF; Martin, KA; Hall, JE; Pitteloud, N				Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Quinton, Richard; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly			A Genetic Basis for Functional Hypothalamic Amenorrhea.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; KALLMANN-SYNDROME; LUTEINIZING-HORMONE; EATING-DISORDERS; WOMEN; MUTATIONS; RECEPTOR; DEFICIENCY; WEIGHT	Background: Functional hypothalamic amenorrhea is a reversible form of gonadotropin-releasing hormone (GnRH) deficiency commonly triggered by stressors such as excessive exercise, nutritional deficits, or psychological distress. Women vary in their susceptibility to inhibition of the reproductive axis by such stressors, but it is unknown whether this variability reflects a genetic predisposition to hypothalamic amenorrhea. We hypothesized that mutations in genes involved in idiopathic hypogonadotropic hypogonadism, a congenital form of GnRH deficiency, are associated with hypothalamic amenorrhea. Methods: We analyzed the coding sequence of genes associated with idiopathic hypogonadotropic hypogonadism in 55 women with hypothalamic amenorrhea and performed in vitro studies of the identified mutations. Results: Six heterozygous mutations were identified in 7 of the 55 patients with hypothalamic amenorrhea: two variants in the fibroblast growth factor receptor 1 gene FGFR1 (G260E and R756H), two in the prokineticin receptor 2 gene PROKR2 (R85H and L173R), one in the GnRH receptor gene GNRHR (R262Q), and one in the Kallmann syndrome 1 sequence gene KAL1 (V371I). No mutations were found in a cohort of 422 controls with normal menstrual cycles. In vitro studies showed that FGFR1 G260E, FGFR1 R756H, and PROKR2 R85H are loss-of-function mutations, as has been previously shown for PROKR2 L173R and GNRHR R262Q. Conclusions: Rare variants in genes associated with idiopathic hypogonadotropic hypogonadism are found in women with hypothalamic amenorrhea, suggesting that these mutations may contribute to the variable susceptibility of women to the functional changes in GnRH secretion that characterize hypothalamic amenorrhea. Our observations provide evidence for the role of rare variants in common multifactorial disease. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; ClinicalTrials.gov number, NCT00494169.) N Engl J Med 2011;364:215-25.	[Sidis, Yisrael; Pitteloud, Nelly] Univ Lausanne, CHU Vaudois, Div Endocrine, CH-1011 Lausanne, Switzerland; [Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly] Massachusetts Gen Hosp, Harvard Ctr Reprod Endocrine Sci, Boston, MA 02114 USA; [Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Quinton, Richard] Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Quinton, Richard] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Newcastle University - UK; Newcastle University - UK	Pitteloud, N (corresponding author), Univ Lausanne, CHU Vaudois, Div Endocrine, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	nelly.pitteloud@chuv.ch	Hall, Janet E/F-3516-2019; PITTELOUD, Nelly/K-2709-2014; Sykiotis, Gerasimos P/E-7407-2017	Hall, Janet E/0000-0003-4644-3061; Welt, Corrine/0000-0002-8219-5504; Avbelj Stefanija, Magdalena/0000-0002-0836-5114; Sykiotis, Gerasimos/0000-0002-9565-4941	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) [5U54HD028138, 1R01HD056264, 5R01HD015788, 5R01HD42708]; National Center for Research Resources [1 UL1 RR025758-01, M01-RR-01066]; Newcastle University Teaching Hospitals Special Trustees; Pew Latin American Fellows Program in the Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043341, R01HD015788, R01HD056264, U54HD028138] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR001066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013241] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Newcastle University Teaching Hospitals Special Trustees; Pew Latin American Fellows Program in the Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) (through cooperative agreement 5U54HD028138 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research and NICHD-NIH grants 1R01HD056264, 5R01HD015788, and 5R01HD42708), by the National Center for Research Resources (grants 1 UL1 RR025758-01 and M01-RR-01066 to the Harvard Clinical and Translational Science Center), the Newcastle University Teaching Hospitals Special Trustees, and the Pew Latin American Fellows Program in the Biomedical Sciences (grant to Dr. Martin).	Beranova M, 2001, J CLIN ENDOCR METAB, V86, P1580, DOI 10.1210/jc.86.4.1580; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; BOYAR RM, 1974, NEW ENGL J MED, V291, P861, DOI 10.1056/NEJM197410242911701; BULLEN BA, 1985, NEW ENGL J MED, V312, P1349, DOI 10.1056/NEJM198505233122103; Canto P, 2009, J ANDROL, V30, P41, DOI 10.2164/jandrol.108.005314; Centeno ML, 2007, J NEUROENDOCRINOL, V19, P594, DOI 10.1111/j.1365-2826.2007.01566.x; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; Chung WCJ, 2008, ENDOCRINOLOGY, V149, P4997, DOI 10.1210/en.2007-1634; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949; Gardiner JV, 2010, DIABETES, V59, P397, DOI 10.2337/db09-1198; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; GILES DE, 1993, FERTIL STERIL, V60, P486; Hayes FJ, 1999, J CLIN ENDOCR METAB, V84, P1028, DOI 10.1210/jc.84.3.1028; Kim SH, 2008, J NEUROENDOCRINOL, V20, P141, DOI 10.1111/j.1365-2826.2007.01627.x; LOUCKS AB, 1989, J CLIN ENDOCR METAB, V68, P402, DOI 10.1210/jcem-68-2-402; Loucks AB, 2003, J CLIN ENDOCR METAB, V88, P297, DOI 10.1210/jc.2002-020369; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Mercader JM, 2008, HUM MOL GENET, V17, P1234, DOI 10.1093/hmg/ddn013; Miller KK, 1998, J CLIN ENDOCR METAB, V83, P2309, DOI 10.1210/jc.83.7.2309; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Nachtigall LB, 1997, NEW ENGL J MED, V336, P410, DOI 10.1056/NEJM199702063360604; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; Perkins RB, 2001, HUM REPROD, V16, P2198, DOI 10.1093/humrep/16.10.2198; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P1317, DOI 10.1210/jc.2004-1361; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; Raivio T, 2009, J CLIN ENDOCR METAB, V94, P4380, DOI 10.1210/jc.2009-0179; REINDOLLAR RH, 1986, AM J OBSTET GYNECOL, V155, P531, DOI 10.1016/0002-9378(86)90274-7; SANTORO N, 1986, ENDOCR REV, V7, P11, DOI 10.1210/edrv-7-1-11; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Sun HJD, 2007, AM J PHYSIOL-ENDOC M, V292, pE964, DOI 10.1152/ajpendo.00089.2006; Thome Jennifer L, 2007, Eat Behav, V8, P334, DOI 10.1016/j.eatbeh.2006.11.009; WARREN MP, 1980, J CLIN ENDOCR METAB, V51, P1150, DOI 10.1210/jcem-51-5-1150; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wilfley DE, 2007, INT J EAT DISORDER, V40, pS123, DOI 10.1002/eat.20436	45	132	139	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					215	225		10.1056/NEJMoa0911064	http://dx.doi.org/10.1056/NEJMoa0911064			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247312	Green Accepted, Bronze			2022-12-01	WOS:000286383900006
J	Dragoi, G; Tonegawa, S				Dragoi, George; Tonegawa, Susumu			Preplay of future place cell sequences by hippocampal cellular assemblies	NATURE			English	Article							RAT HIPPOCAMPUS; PYRAMIDAL CELLS; MEMORY; REPLAY; EXPERIENCE; REACTIVATION; SLEEP; CONSOLIDATION; DYNAMICS; STATE	During spatial exploration, hippocampal neurons show a sequential firing pattern in which individual neurons fire specifically at particular locations along the animal's trajectory (place cells(1,2)). According to the dominant model of hippocampal cell assembly activity, place cell firing order is established for the first time during exploration, to encode the spatial experience, and is subsequently replayed during rest(3-6) or slow-wave sleep(7-10) for consolidation of the encoded experience(11,12). Here we report that temporal sequences of firing of place cells expressed during a novel spatial experience occurred on a significant number of occasions during the resting or sleeping period preceding the experience. This phenomenon, which is called preplay, occurred in disjunction with sequences of replay of a familiar experience. These results suggest that internal neuronal dynamics during resting or sleep organize hippocampal cellular assemblies(13-15) into temporal sequences that contribute to the encoding of a related novel experience occurring in the future.	[Dragoi, George; Tonegawa, Susumu] MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Dragoi, George; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Dragoi, G (corresponding author), MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gdragoi@mit.edu; tonegawa@mit.edu			NIH [R01-MH078821, P50-MH58880]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078821, P50MH058880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. A. Wilson for assistance with data acquisition, discussions and comments on an earlier version of the manuscript; J. O'Keefe, A. Siapas, F. Kloosterman, D. L. Buhl for comments on earlier versions of the manuscript; and F. Kloosterman for providing assistance with the line detection for the Bayesian decoding. This work was supported by NIH grants R01-MH078821 and P50-MH58880 to S. T., who was an HHMI Investigator in an earlier part of this study.	BLACK JE, 1986, ADV DEV PSYCHOL; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	28	340	344	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					397	+		10.1038/nature09633	http://dx.doi.org/10.1038/nature09633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21179088	Green Submitted, Green Accepted			2022-12-01	WOS:000286385600052
J	Kaplan, LJ; Shaw, AD				Kaplan, Lewis J.; Shaw, Andrew D.			Standards for Education and Credentialing in Critical Care Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNIT; ILL		[Kaplan, Lewis J.] Yale Univ, Sch Med, Dept Surg, Sect Trauma Surg Crit Care & Surg Emergencies, New Haven, CT 06520 USA; [Shaw, Andrew D.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	Yale University; Duke University	Kaplan, LJ (corresponding author), Yale Univ, Sch Med, Dept Surg, Sect Trauma Surg Crit Care & Surg Emergencies, 330 Cedar St,BB-310, New Haven, CT 06520 USA.	lewis.kaplan@yale.edu		Shaw, Andrew/0000-0002-0566-8005				Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; [Anonymous], GRADUATE MED ED DATA; Kleinpell RM, 2008, CRIT CARE MED, V36, P2888, DOI 10.1097/CCM.0b013e318186ba8c; Milbrandt EB, 2008, CRIT CARE MED, V36, P2504, DOI 10.1097/CCM.0b013e318183ef84; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; *US DEP HHS, NAT HEALTHC EXP AGGR; *US DEP HHS, CRIT CAR WORKF STUD; NEUROCRITICAL CARE C	8	23	24	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					296	297		10.1001/jama.2010.1997	http://dx.doi.org/10.1001/jama.2010.1997			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21239762				2022-12-01	WOS:000286328700026
J	Flagel, SB; Clark, JJ; Robinson, TE; Mayo, L; Czuj, A; Willuhn, I; Akers, CA; Clinton, SM; Phillips, PEM; Akil, H				Flagel, Shelly B.; Clark, Jeremy J.; Robinson, Terry E.; Mayo, Leah; Czuj, Alayna; Willuhn, Ingo; Akers, Christina A.; Clinton, Sarah M.; Phillips, Paul E. M.; Akil, Huda			A selective role for dopamine in stimulus-reward learning	NATURE			English	Article							PAVLOVIAN APPROACH BEHAVIOR; NUCLEUS-ACCUMBENS CORE; INCENTIVE SALIENCE; NOVELTY-SEEKING; ACQUISITION; SENSITIZATION; PERFORMANCE; RECEPTORS; SYSTEMS; NMDA	Individuals make choices and prioritize goals using complex processes that assign value to rewards and associated stimuli. During Pavlovian learning, previously neutral stimuli that predict rewards can acquire motivational properties, becoming attractive and desirable incentive stimuli. However, whether a cue acts solely as a predictor of reward, or also serves as an incentive stimulus, differs between individuals. Thus, individuals vary in the degree to which cues bias choice and potentially promote maladaptive behaviour. Here we use rats that differ in the incentive motivational properties they attribute to food cues to probe the role of the neurotransmitter dopamine in stimulus-reward learning. We show that intact dopamine transmission is not required for all forms of learning in which reward cues become effective predictors. Rather, dopamine acts selectively in a form of stimulus-reward learning in which incentive salience is assigned to reward cues. In individuals with a propensity for this form of learning, reward cues come to powerfully motivate and control behaviour. This work provides insight into the neurobiology of a form of stimulus-reward learning that confers increased susceptibility to disorders of impulse control.	[Clark, Jeremy J.; Willuhn, Ingo; Akers, Christina A.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Clark, Jeremy J.; Willuhn, Ingo; Akers, Christina A.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Flagel, Shelly B.; Mayo, Leah; Clinton, Sarah M.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Robinson, Terry E.; Czuj, Alayna] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu; akil@umich.edu	Phillips, Paul/E-7813-2013; Clark, Jeremy/J-9552-2015; Willuhn, Ingo/AAP-4276-2021; Flagel, Shelly B/G-5561-2012; Mayo, Leah/AAX-5320-2020; Clinton, Sarah M/N-3953-2017; Phillips, Paul E. M./A-4463-2008	Phillips, Paul/0000-0002-8749-7026; Willuhn, Ingo/0000-0001-6540-6894; Flagel, Shelly B/0000-0002-7309-9908; Mayo, Leah/0000-0002-0645-4869; Clinton, Sarah M/0000-0001-7158-411X; Phillips, Paul E. M./0000-0002-8749-7026	National Institutes of Health [R01-MH079292, R01-DA027858, T32-DA07278, F32-DA24540, R37-DA04294, 5P01-DA021633-02]; Office of Naval Research [N00014-02-1-0879]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079292, R00MH085859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024540, R37DA004294, T32DA007278, R01DA027858, P01DA021633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R01-MH079292 (to P.E.M.P.), R01-DA027858 (to P.E.M.P.), T32-DA07278 (to J.J.C.), F32-DA24540 (to J.J.C.), R37-DA04294 (to T.E.R.), and 5P01-DA021633-02 (to T.E.R. and H.A.). The selective breeding colony was supported by a grant from the Office of Naval Research to H.A. (N00014-02-1-0879). We thank K. Berridge and J. Morrow for comments on earlier versions of the manuscript, and S. Ng-Evans for technical support.	Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Beckmann JS, 2011, BEHAV BRAIN RES, V216, P159, DOI 10.1016/j.bbr.2010.07.022; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Boakes RA., 1977, OPERANT PAVLOVIAN IN, P67; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Clinton SM, 2007, HORM BEHAV, V51, P655, DOI 10.1016/j.yhbeh.2007.03.009; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Hearst E., 1974, SIGN TRACKING STIMUL; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; Kuo WJ, 2009, SCIENCE, V324, P519, DOI 10.1126/science.1165598; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Stead JDH, 2006, BEHAV GENET, V36, P697, DOI 10.1007/s10519-006-9058-7; Tindell AJ, 2009, J NEUROSCI, V29, P12220, DOI 10.1523/JNEUROSCI.2499-09.2009; Tomie A, 1998, PSYCHOPHARMACOLOGY, V139, P376, DOI 10.1007/s002130050728; Verbeke G., 2000, LINEAR MIXED MODELS, P41; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zhang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000437	35	631	635	3	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					53	U63		10.1038/nature09588	http://dx.doi.org/10.1038/nature09588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21150898	Green Accepted			2022-12-01	WOS:000285921600029
J	Zumla, A				Zumla, Alimuddin			The white plague returns to London-with a vengeance	LANCET			English	Editorial Material							TUBERCULOSIS		UCL, Sch Med, Windeyer Inst Med Sci, Dept Infect, London W1T 4JF, England	University of London; University College London; UCL Medical School	Zumla, A (corresponding author), UCL, Sch Med, Windeyer Inst Med Sci, Dept Infect, London W1T 4JF, England.	a.zumla@ucl.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735				Anderson C, 2010, J EPIDEMIOL COMMUN H, V64, P373, DOI 10.1136/jech.2009.094375; Crofts JP, 2008, PUBLIC HEALTH, V122, P1302, DOI 10.1016/j.puhe.2008.04.011; DROBNIEWSKI F, 1995, LANCET, V346, P948, DOI 10.1016/S0140-6736(95)91562-1; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; Hayward J, 2010, LONDON TB SERVICE RE; Health Protection Agency (UK), TUB UK ANN REP TUB S; Hollo V, 2009, EUROSURVEILLANCE, V14; Mitchell SL, 2011, THORAX, V66, P630, DOI 10.1136/thx.2010.148866; *NEW YORK CIT DEP, 2008, CLIN POL PROT; World Health Organization, GLOB TUB CONTR EP ST; Zumla, 2009, TUBERCULOSIS COMPREH, P1	12	23	23	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 1	2011	377	9759					10	11		10.1016/S0140-6736(10)62176-9	http://dx.doi.org/10.1016/S0140-6736(10)62176-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709MQ	21168203				2022-12-01	WOS:000286445200008
J	Fraser, AG; Dunstan, FD				Fraser, Alan G.; Dunstan, Frank D.			Christmas 2010: Reading between the Lines On the impossibility of being expert	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fraser, Alan G.] Cardiff Univ, Sch Med, Wales Heart Res Inst, Cardiff CF14 4XN, S Glam, Wales; [Dunstan, Frank D.] Cardiff Univ, Sch Med, Dept Primary Care & Public Hlth, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Fraser, AG (corresponding author), Cardiff Univ, Sch Med, Wales Heart Res Inst, Cardiff CF14 4XN, S Glam, Wales.	fraserag@cf.ac.uk						Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Cullis J, 2010, NEPHROLOGY, V15, P269, DOI 10.1111/j.1440-1797.2010.01282.x; Domain Tools Inc, 2010, TOT LIST 12 SEPT 201; Fraser AG, 2006, EUR HEART J, V27, P1750, DOI 10.1093/eurheartj/ehl031; Garritty C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009914; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Hall Amanda, 2004, Health Info Libr J, V21, P102, DOI 10.1111/j.1471-1842.2004.00506.x; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Porrino JA, 2008, J HAND SURG-AM, V33A, P2, DOI 10.1016/j.jhsa.2007.10.007; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Shortliffe EH, 2010, JAMA-J AM MED ASSOC, V304, P1227, DOI 10.1001/jama.2010.1262; Straus S, 2009, CAN MED ASSOC J, V180, P942, DOI 10.1503/cmaj.081697; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Tenopir C, 2004, J MED LIBR ASSOC, V92, P233; Toffler Alvin, 1970, 3 WAVE; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Wager Elizabeth, 2008, COCHRANE DB SYST REV, V4; Ware M., 2009, STM REPORT OVERVIEW	19	53	54	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2010	341								c6815	10.1136/bmj.c6815	http://dx.doi.org/10.1136/bmj.c6815			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XD	21156739	Green Accepted			2022-12-01	WOS:000285552200012
J	Chen, JH; Stoltz, DA; Karp, PH; Ernst, SE; Pezzulo, AA; Moninger, TO; Rector, MV; Reznikov, LR; Launspach, JL; Chaloner, K; Zabner, J; Welsh, MJ				Chen, Jeng-Haur; Stoltz, David A.; Karp, Philip H.; Ernst, Sarah E.; Pezzulo, Alejandro A.; Moninger, Thomas O.; Rector, Michael V.; Reznikov, Leah R.; Launspach, Janice L.; Chaloner, Kathryn; Zabner, Joseph; Welsh, Michael J.			Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NASAL POTENTIAL DIFFERENCE; PSEUDOMONAS-AERUGINOSA; RESPIRATORY EPITHELIA; HYPERTONIC SALINE; SURFACE LIQUID; NA+ TRANSPORT; CHANNEL; DISEASE; ENAC	Defective transepithelial electrolyte transport is thought to initiate cystic fibrosis (CF) lung disease. Yet, how loss of CFTR affects electrolyte transport remains uncertain. CFTR-/- pigs spontaneously develop lung disease resembling human CF. At birth, their airways exhibit a bacterial host defense defect, but are not inflamed. Therefore, we studied ion transport in newborn nasal and tracheal/bronchial epithelia in tissues, cultures, and in vivo. CFTR-/- epithelia showed markedly reduced Cl- and HCO3- transport. However, in contrast to a widely held view, lack of CFTR did not increase transepithelial Na+ or liquid absorption or reduce periciliary liquid depth. Like human CF, CFTR-/- pigs showed increased amiloride-sensitive voltage and current, but lack of apical Cl- conductance caused the change, not increased Na+ transport. These results indicate that CFTR provides the predominant transcellular pathway for Cl- and HCO3- in porcine airway epithelia, and reduced anion permeability may initiate CF airway disease.	[Chen, Jeng-Haur; Stoltz, David A.; Karp, Philip H.; Ernst, Sarah E.; Pezzulo, Alejandro A.; Moninger, Thomas O.; Rector, Michael V.; Reznikov, Leah R.; Launspach, Janice L.; Zabner, Joseph; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Chaloner, Kathryn] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biostat, Iowa City, IA 52242 USA; [Chen, Jeng-Haur; Karp, Philip H.; Reznikov, Leah R.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Reznikov, Leah R./J-4314-2019; Chaloner, Kathryn/B-5090-2013; Chen, Jeng-Haur/E-1483-2011	Reznikov, Leah R./0000-0002-4074-9070; Welsh, Michael/0000-0002-1646-6206; Stoltz, David/0000-0003-0893-9015; Zabner, Joseph/0000-0002-9606-1339; Chen, Jeng-Haur/0000-0001-6756-6939; Pezzulo, Alejandro/0000-0001-7544-5109	National Heart Lung and Blood Institute [HL51670, HL091842, HL097622]; National Institute of Diabetes and Digestive and Kidney Diseases [DK54759]; Cystic Fibrosis Foundation; National Institute of Allergy and Infectious Diseases [AI076671]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670, P01HL091842, T15HL097622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Lisaurie Lopez Rivera, Paula Ludwig, Theresa Mayhew, Peter Taft, Jingyang Zhang, and Yuping Zhang for excellent assistance. We thank Drs. John B Stokes and Peter M Snyder for helpful discussions. GlyH-101 was a generous gift from the Cystic Fibrosis Foundation Therapeutics and R. Bridges. This work was supported by the National Heart Lung and Blood Institute (grants HL51670, HL091842, and HL097622), the National Institute of Diabetes and Digestive and Kidney Diseases (grant DK54759), and the Cystic Fibrosis Foundation. D.A.S. is a Parker B. Francis Fellow and was supported by the National Institute of Allergy and Infectious Diseases (grant AI076671). M.J.W. is an Investigator of the HHMI. M.J.W. was a cofounder of Exemplar Genetics, a company that is licensing materials and technology related to this work.	Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Baker E, 1998, J CLIN INVEST, V102, P10, DOI 10.1172/JCI1795; Bates D., 2009, IME4 LINEAR MIXED EF; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; CULLEN JJ, 1987, J CLIN INVEST, V79, P73, DOI 10.1172/JCI112811; Davies JC, 2005, AM J RESP CRIT CARE, V171, P1015, DOI 10.1164/rccm.200408-1116OC; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; DUSZYK M, 1991, J THEOR BIOL, V151, P231, DOI 10.1016/S0022-5193(05)80362-5; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Flynn AN, 2009, P NATL ACAD SCI USA, V106, P3591, DOI 10.1073/pnas.0813393106; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Gray T., 2004, AM J PHYSIOL-LUNG C, V286, pL320; Griesenbach U., 2010, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2009-0265OC, DOI 10.1165/RCMB.2009-02650C]; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; HELMAN SI, 1973, AM J PHYSIOL, V225, P972, DOI 10.1152/ajplegacy.1973.225.4.972; Horisberger JD, 2003, PFLUG ARCH EUR J PHY, V445, P522, DOI 10.1007/s00424-002-0956-0; Huber R, 2010, CELL PHYSIOL BIOCHEM, V25, P145, DOI 10.1159/000272059; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; Kunzelmann K, 2006, FASEB J, V20, P545, DOI 10.1096/fj.05-4454fje; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Meyerholz D.K., 2010, AM J RESP C IN PRESS; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; R Development Core Team, 2009, LANG ENV STAT COMP; Robinson M, 1997, THORAX, V52, P900, DOI 10.1136/thx.52.10.900; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SATIR P, 1963, J CELL BIOL, V18, P345, DOI 10.1083/jcb.18.2.345; Schaedel C, 1999, J PEDIATR-US, V135, P739, DOI 10.1016/S0022-3476(99)70094-6; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Sheridan MB, 2005, HUM MOL GENET, V14, P3493, DOI 10.1093/hmg/ddi374; Sims DE, 1997, AM J PHYSIOL-LUNG C, V273, pL1036; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Welsh MJ., 2001, METABOLIC MOL BASES, P5121; WIDDICOMBE JH, 1985, P NATL ACAD SCI USA, V82, P6167, DOI 10.1073/pnas.82.18.6167; WILLUMSEN NJ, 1991, AM J PHYSIOL, V261, pC319, DOI 10.1152/ajpcell.1991.261.2.C319; WILLUMSEN NJ, 1991, AM J PHYSIOL, V261, pC332, DOI 10.1152/ajpcell.1991.261.2.C332; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1	60	185	188	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					911	923		10.1016/j.cell.2010.11.029	http://dx.doi.org/10.1016/j.cell.2010.11.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145458	Bronze, Green Accepted			2022-12-01	WOS:000285182600009
J	Bitton, S; Roth, J				Bitton, Samuel; Roth, Jesse			Addressing Food Insecurity Freedom From Want, Freedom From Fear	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bitton, Samuel] N Shore Long Isl Jewish Hlth Syst, Cohen Childrens Med Ctr New York, New Hyde Pk, NY USA; [Roth, Jesse] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Roth, Jesse] Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health; Yeshiva University; Albert Einstein College of Medicine	Roth, J (corresponding author), 149-37 Powells Cove Blvd, Whitestone, NY 11357 USA.	jesserothmd@hotmail.com						Alaimo K, 2001, PEDIATRICS, V108, P44; [Anonymous], 2010, J AM DIET ASSOC, V110, P1368, DOI 10.1016/j.jada.2010.07.015; Casey PH, 2006, PEDIATRICS, V118, pE1406, DOI 10.1542/peds.2006-0097; Food Research and Action Center, 2010, FOOD HARDSH CLOS LOO; Laraia BA, 2010, J AM DIET ASSOC, V110, P692, DOI 10.1016/j.jada.2010.02.014; Lee JS, 2001, J NUTR, V131, P1503, DOI 10.1093/jn/131.5.1503; Nord M, 2009, EC RES SERVICE PUBLI; Seligman HK, 2010, NEW ENGL J MED, V363, P6, DOI 10.1056/NEJMp1000072; Young J, 2009, PUBLIC HEALTH NUTR, V12, P2129, DOI 10.1017/S1368980009005795; SNAP FOOD STAMP MONT	10	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2405	2406		10.1001/jama.2010.1747	http://dx.doi.org/10.1001/jama.2010.1747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119087				2022-12-01	WOS:000284763900022
J	Morishita, H; Miwa, JM; Heintz, N; Hensch, TK				Morishita, Hirofumi; Miwa, Julie M.; Heintz, Nathaniel; Hensch, Takao K.			Lynx1, a Cholinergic Brake, Limits Plasticity in Adult Visual Cortex	SCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; OCULAR-DOMINANCE PLASTICITY; LATERAL GENICULATE-NUCLEUS; MUSCARINIC RECEPTORS; PROTOTOXIN LYNX1; GABA RELEASE; MODULATION; INHIBITION; NEUROMODULATORS; INTERNEURONS	Experience-dependent brain plasticity typically declines after an early critical period during which circuits are established. Loss of plasticity with closure of the critical period limits improvement of function in adulthood, but the mechanisms that change the brain's plasticity remain poorly understood. Here, we identified an increase in expression of Lynx1 protein in mice that prevented plasticity in the primary visual cortex late in life. Removal of this molecular brake enhanced nicotinic acetylcholine receptor signaling. Lynx1 expression thus maintains stability of mature cortical networks in the presence of cholinergic innervation. The results suggest that modulating the balance between excitatory and inhibitory circuits reactivates visual plasticity and may present a therapeutic target.	[Morishita, Hirofumi; Hensch, Takao K.] Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Miwa, Julie M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Miwa, Julie M.; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Hensch, Takao K.] Harvard Univ, Dept Mol Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; California Institute of Technology; Howard Hughes Medical Institute; Rockefeller University; Harvard University	Hensch, TK (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	takao.hensch@childrens.harvard.edu	Hensch, Takao/L-4182-2019; Morishita, Hirofumi/J-9619-2015	Morishita, Hirofumi/0000-0002-1045-1337; Miwa, Julie/0000-0002-4418-3756	James S. McDonnell Foundation "Recovery from Amblyopia" network; NIH [1 DP1 OD 003699-01]; Ellison Medical Foundation; Howard Hughes Medical Institute; California Tobacco-Related Disease Research Program; Japanese Society for Promotion of Science;  [DA-17279]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003699] Funding Source: NIH RePORTER	James S. McDonnell Foundation "Recovery from Amblyopia" network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Tobacco-Related Disease Research Program(University of California System); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Fagiolini, H. A. Lester, and A. Takesian for their helpful comments on the manuscript and M. Marcotrigiano for animal maintenance. This study was supported by the James S. McDonnell Foundation "Recovery from Amblyopia" network (T. K. H.), NIH Director's Pioneer Award (1 DP1 OD 003699-01 to T. K. H.), the Ellison Medical Foundation (T. K. H.), Howard Hughes Medical Institute (N.H.), DA-17279 and California Tobacco-Related Disease Research Program (J.M.M.), and the Japanese Society for Promotion of Science (H.M.)	Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Aracri P, 2010, CEREB CORTEX, V20, P1539, DOI 10.1093/cercor/bhp214; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Davis JA, 2006, PSYCHOPHARMACOLOGY, V184, P345, DOI 10.1007/s00213-005-0047-y; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; GU Q, 1993, EUR J NEUROSCI, V5, P475, DOI 10.1111/j.1460-9568.1993.tb00514.x; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hess RF, 2009, EUR J NEUROSCI, V29, P1064, DOI 10.1111/j.1460-9568.2009.06650.x; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Kang JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005995; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Kuo MC, 2009, NEUROSCIENCE, V163, P430, DOI 10.1016/j.neuroscience.2009.06.026; Lempert P, 2005, OPHTHAL PHYSL OPT, V25, P592, DOI 10.1111/j.1475-1313.2005.00329.x; Levi DM, 2009, PHILOS T R SOC B, V364, P399, DOI 10.1098/rstb.2008.0203; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; Mann EO, 2008, CURR OPIN NEUROL, V21, P155, DOI 10.1097/WCO.0b013e3282f52f5f; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; PARKINSON D, 1988, EXP BRAIN RES, V73, P553, DOI 10.1007/BF00406614; Pfeffer CK, 2009, J NEUROSCI, V29, P3419, DOI 10.1523/JNEUROSCI.1377-08.2009; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Plessy C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003012; PRUSKY GT, 1987, BRAIN RES, V412, P131, DOI 10.1016/0006-8993(87)91447-8; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Satta R, 2008, P NATL ACAD SCI USA, V105, P16356, DOI 10.1073/pnas.0808699105; Silver MA, 2008, NEURON, V60, P904, DOI 10.1016/j.neuron.2008.09.038; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Wandell BA, 2009, NAT REV NEUROSCI, V10, P873, DOI 10.1038/nrn2741	36	274	284	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1238	1240		10.1126/science.1195320	http://dx.doi.org/10.1126/science.1195320			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21071629	Green Accepted			2022-12-01	WOS:000284613700040
J	Cohen, P; Tcherpakov, M				Cohen, Philip; Tcherpakov, Marianna			Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?	CELL			English	Article							SMALL-MOLECULE INHIBITOR; UNANCHORED POLYUBIQUITIN CHAINS; KAPPA-B ACTIVATION; DEUBIQUITINATING ENZYME; DNA-DAMAGE; LIGASE; PROTEASOME; MDM2; P53; IDENTIFICATION	Protein phosphorylation and protein ubiquitination regulate most aspects of cell life, and defects in these control mechanisms cause cancer and many other diseases. In the past decade, protein kinases have become one of the most important classes of drug targets for the pharmaceutical industry. In contrast, drug discovery programs that target components of the ubiquitin system have lagged behind. In this Perspective, we discuss the reasons for the delay in this pipeline, the drugs targeting the ubiquitin system that have been developed, and new approaches that may popularize this area of drug discovery in the future.	[Cohen, Philip] MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Cohen, Philip] Scottish Inst Cell Signalling, Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Tcherpakov, Marianna] BCC Res, Wellesley, MA 02481 USA	University of Dundee; University of Dundee	Cohen, P (corresponding author), MRC Prot Phosphorylat Unit, Dow St, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk			Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett EJ, 2008, NAT STRUCT MOL BIOL, V15, P20, DOI 10.1038/nsmb0108-20; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Everly MJ, 2008, TRANSPLANTATION, V86, P1754, DOI 10.1097/TP.0b013e318190af83; FISCHER EH, 1955, J BIOL CHEM, V216, P121; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; LAWLER B, 2009, BIO53B GLOB MARK BCC; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Lierman E, 2006, BLOOD, V108, P1374, DOI 10.1182/blood-2006-02-004457; Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Maguire M, 2008, CANCER RES, V68, P3232, DOI 10.1158/0008-5472.CAN-07-5271; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nakajima H, 2008, BIOCHEM BIOPH RES CO, V368, P1007, DOI 10.1016/j.bbrc.2008.01.166; Oliveira AM, 2006, J CLIN ONCOL, V24, pe2; Oliveira Andre M, 2006, J Clin Oncol, V24, pe2, DOI 10.1200/JCO.2005.04.4818; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; TCHERPAKOV M, 2010, PHM066A BCC; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	55	218	225	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					686	693		10.1016/j.cell.2010.11.016	http://dx.doi.org/10.1016/j.cell.2010.11.016			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111230	Bronze			2022-12-01	WOS:000284583500011
J	Resnic, FS; Gross, TP; Marinac-Dabic, D; Loyo-Berrios, N; Donnelly, S; Normand, SLT; Matheny, ME				Resnic, Frederic S.; Gross, Thomas P.; Marinac-Dabic, Danica; Loyo-Berrios, Nilsa; Donnelly, Sharon; Normand, Sharon-Lise T.; Matheny, Michael E.			Automated Surveillance to Detect Postprocedure Safety Signals of Approved Cardiovascular Devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERVENTIONAL CARDIOLOGY; RANDOMIZED-TRIAL; MEDICAL DEVICE; STENTS; CATHETERIZATION; COMPLICATIONS; METAANALYSIS; REGISTRY; HOLES; RISK	Context Ensuring the safety of medical devices challenges current surveillance approaches, which rely heavily on voluntary reporting of adverse events. Automated surveillance of clinical registries may provide early warnings in the postmarket evaluation of medical device safety. Objective To determine whether automated safety surveillance of clinical registries using a computerized tool can provide early warnings regarding the safety of new cardiovascular devices. Design, Setting, and Patients Prospective propensity-matched cohort analysis of 7 newly introduced cardiovascular devices, using clinical data captured in the Massachusetts implementation of the National Cardiovascular Data Repository CathPCI Registry for all adult patients undergoing percutaneous coronary intervention from April 2003 through September 2007 in Massachusetts. Main Outcome Measure Presence of any safety alert, triggered if the cumulative observed risk for a given device exceeded the upper 95% confidence interval (CI) of comparator control device. Predefined sensitivity analyses assessed robustness of alerts when triggered. Results We evaluated 74 427 consecutive interventional coronary procedures. Three of 21 safety analyses triggered sustained alerts in 2 implantable devices. Patients receiving Taxus Express2 drug-eluting stents experienced a 1.28-fold increased risk of post-procedural myocardial infarction (2.87% vs 2.25%; absolute risk increase, 0.62% [95% CI, 0.25%-0.99%]) and a 1.21-fold increased risk of major adverse cardiac events (4.24% vs 3.50%; absolute increase, 0.74% [95% CI, 0.29%-1.19%]) compared with those receiving alternative drug-eluting stents. Patients receiving Angio-Seal STS vascular closure devices experienced a 1.51-fold increased risk of major vascular complications (1.09% vs 0.72%; absolute increased risk, 0.37% [95% CI, 0.03%-0.71%]) compared with those receiving alternative vascular closure devices. Sensitivity analyses confirmed increased risk following use of the Taxus Express2 stent but not the Angio-Seal STS device. Conclusion Automated prospective surveillance of clinical registries is feasible and can identify low-frequency safety signals for new cardiovascular devices. JAMA. 2010;304(18):2019-2027 www.jama.com	[Resnic, Frederic S.; Donnelly, Sharon] Brigham & Womens Hosp, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Gross, Thomas P.; Marinac-Dabic, Danica; Loyo-Berrios, Nilsa] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Matheny, Michael E.] Tennessee Valley Healthcare Syst, Vet Adm Med Ctr, Nashville, TN USA; [Matheny, Michael E.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Food & Drug Administration (FDA); Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Resnic, FS (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	fresnic@partners.org	Matheny, Michael E/B-3541-2008	Matheny, Michael E/0000-0003-3217-4147; Normand, Sharon-Lise/0000-0001-7027-4769; Marinac-Dabic, Danica/0000-0002-1824-0104	Boston Scientific Inc; Abbott Vascular Inc; Cordis Corp; St Jude Medical; Medicines Company; National Library of Medicine [NIH R01-LM008142]; US Food and Drug Administration [HHSF 223200830058C]; Veterans Administration Health Services Research and Development Service [CDP 09-387]; Division of Healthcare Quality and Statistics, Massachusetts Department of Public Health; NATIONAL LIBRARY OF MEDICINE [R01LM008142] Funding Source: NIH RePORTER	Boston Scientific Inc(Boston Scientific); Abbott Vascular Inc(Abbott Laboratories); Cordis Corp; St Jude Medical(St. Jude Medical); Medicines Company; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); US Food and Drug Administration; Veterans Administration Health Services Research and Development Service; Division of Healthcare Quality and Statistics, Massachusetts Department of Public Health; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr Resnic and Dr Matheny reported filing a patent application, currently under review at the US Patent Office, for several key analytic components of the DELTA surveillance system; the intellectual property rights of Drs Resnic and Matheny (current and former employees of Brigham and Women's Hospital) related to the development of DELTA are assigned to the institution, and Partners Healthcare, the parent organization of Brigham and Women's Hospital, retains partial rights for DELTA use and licensing. Neither Dr Resnic nor Dr Matheny have previously received or anticipate any financial compensation, stock options, income, or ownership in DELTA, Coping Systems, or any other related commercial entity. Dr Resnic reported receiving modest consulting income from Boston Scientific Inc, Abbott Vascular Inc, Cordis Corp, and St Jude Medical and receiving research grants from The Medicines Company. No other authors reported dislosures.; This study was funded, in part, by grants from the National Library of Medicine (NIH R01-LM008142) and the US Food and Drug Administration (HHSF 223200830058C) as well as from the Veterans Administration Health Services Research and Development Service (CDP 09-387).; The National Institutes of Health, the Veterans Administration Health Services Research and Development Service, and the US Food and Drug Administration had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. However, the preliminary proposed study protocol was provided to the Veterans Administration Health Services Research and Development Service and the US Food and Drug Administration as part of the original grant and contract application process.; We acknowledge the significant system development and technical contributions of Richard Cope, BS, and Susan Robbins, BS, of Coping Systems Inc, Andover, Massachusetts. Coping Systems was a subcontractor to Brigham and Women's Hospital, and neither Mr Cope nor Ms Robbins received extra compensation for their contributions; Mr Cope is part owner of Coping Systems and is also named on the patent application filed by Dr Resnic and Dr Matheny. We also acknowledge the support of the Division of Healthcare Quality and Statistics, Massachusetts Department of Public Health.	Aggarwal A, 2009, HEART RHYTHM, V6, P1565, DOI 10.1016/j.hrthm.2009.08.006; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Garber AM, 2010, NEW ENGL J MED, V362, P1161, DOI 10.1056/NEJMp1000447; Gross T P, 1996, Stud Health Technol Inform, V28, P17; Hammill S, 2006, HEART RHYTHM, V3, P470, DOI 10.1016/j.hrthm.2006.01.019; Holman WL, 2009, J AM COLL SURGEONS, V208, P755, DOI 10.1016/j.jamcollsurg.2008.11.016; Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; *MA DAT AN CTR, 2009, PERC COR INT COMM MA; Maisel WH, 2007, NEW ENGL J MED, V356, P981, DOI 10.1056/NEJMp068305; Matheny ME, 2006, J AM MED INFORM ASSN, V13, P180, DOI 10.1197/jamia.M1908; Matheny ME, 2008, AM HEART J, V155, P114, DOI 10.1016/j.ahj.2007.08.022; Matheny Michael E, 2007, AMIA Annu Symp Proc, P518; Matheny ME, 2009, MED DECIS MAKING, V29, P247, DOI 10.1177/0272989X08327110; Mauri L, 2008, CIRCULATION, V118, P1817, DOI 10.1161/CIRCULATIONAHA.108.781377; Mauri L, 2008, NEW ENGL J MED, V359, P1330, DOI 10.1056/NEJMoa0801485; *NAT CARD DAT REG, 2010, DESCR NCDR CATHPCI R; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P1200, DOI 10.1016/j.jacc.2004.06.048; O'Shea JC, 2004, AM HEART J, V147, P977, DOI 10.1016/j.ahj.2004.03.001; Peterson ED, 2004, AM HEART J, V147, P985, DOI 10.1016/j.ahj.2004.03.002; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; Popma JJ, 2009, CIRC-CARDIOVASC INTE, V2, P133, DOI 10.1161/CIRCINTERVENTIONS.108.832048; Rao SV, 2008, AM HEART J, V156, P201, DOI 10.1016/j.ahj.2008.01.036; Resnic FS, 2004, MED DECIS MAKING, V24, P399, DOI 10.1177/0272989X04267012; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167; Samore MH, 2004, JAMA-J AM MED ASSOC, V291, P325, DOI 10.1001/jama.291.3.325; Shah JS, 2006, JAMA-J AM MED ASSOC, V296, P655, DOI 10.1001/jama.296.6.655; Stone GW, 2007, JAMA-J AM MED ASSOC, V298, P2497, DOI 10.1001/jama.298.21.2497; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Tavris Dale R, 2005, J Invasive Cardiol, V17, P644; Warren BS, 1999, CATHETER CARDIO INTE, V48, P162, DOI 10.1002/(SICI)1522-726X(199910)48:2<162::AID-CCD8>3.0.CO;2-2	33	50	50	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2019	2027		10.1001/jama.2010.1633	http://dx.doi.org/10.1001/jama.2010.1633			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063011	Bronze, Green Accepted			2022-12-01	WOS:000284000600020
J	Bredenoord, AL; Braude, P				Bredenoord, Annelien L.; Braude, Peter			Ethics of mitochondrial gene replacement: from bench to bedside	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DNA DISORDERS; DIAGNOSIS; RISKS		[Bredenoord, Annelien L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Braude, Peter] Kings Coll London, Dept Womens Hlth, London WC2R 2LS, England; [Braude, Peter] Guys Hosp, Ctr Preimplantat Genet Diag, London SE1 9RT, England	Utrecht University; Utrecht University Medical Center; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Bredenoord, AL (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Stratenum 6-131,PO Box 85500, NL-3508 GA Utrecht, Netherlands.	A.L.Bredenoord@umcutrecht.nl			MRC [G0801061, G0701172] Funding Source: UKRI; Medical Research Council [G0801061, G0701172] Funding Source: Medline; Wellcome Trust [086034] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		[Anonymous], 2008, NATURE, V452, P913, DOI 10.1038/452913a; BARRITT JA, 2001, REPROD BIOMED ONLINE, V3, P47; Bredenoord AL, 2008, HUM REPROD UPDATE, V14, P669, DOI 10.1093/humupd/dmn035; Bredenoord AL, 2008, HUM REPROD, V23, P2392, DOI 10.1093/humrep/den290; Bredenoord A, 2009, EUR J HUM GENET, V17, P1550, DOI 10.1038/ejhg.2009.88; Bredenoord AL, 2010, HUM REPROD, V25, P1354, DOI 10.1093/humrep/deq077; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Dresser Rebecca, 2004, IRB, V26, P1, DOI 10.2307/3563945; Dresser R, 2009, J LAW MED ETHICS, V37, P38, DOI 10.1111/j.1748-720X.2009.00349.x; Hawes SM, 2002, HUM REPROD, V17, P850, DOI 10.1093/humrep/17.4.850; Kimmelman J, 2008, NAT REV GENET, V9, P239, DOI 10.1038/nrg2317; Kimmelman Jonathan., 2010, GENE TRANSFER ETHICS; Malek J, 2007, J MED PHILOS, V32, P339, DOI 10.1080/03605310701515369; *MRC, 2004, ASS REPR SAF SOUND F; Parens E, 2001, SCIENCE, V292, P397, DOI 10.1126/science.292.5516.397; Pennings G, 2007, HUM REPROD, V22, P2585, DOI 10.1093/humrep/dem237; Pennings G, 2003, HUM REPROD UPDATE, V9, P397, DOI 10.1093/humupd/dmg031; Poulton J, 2010, NEUROMUSCULAR DISORD, V20, P559, DOI 10.1016/j.nmd.2010.05.008; Poulton J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b94; Sugarman J, 1999, SCIENCE, V285, P2071, DOI 10.1126/science.285.5436.2071; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; THE PRESIDENT'S COUNCIL ON BIOETHICS, 2004, REPR RESP REG NEW BI; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245	24	25	25	0	51	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2010	341								c6021	10.1136/bmj.c6021	http://dx.doi.org/10.1136/bmj.c6021			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	681KD	21059727				2022-12-01	WOS:000284310100003
J	Alwan, A; MacLean, DR; Riley, LM; d'Espaignet, ET; Mathers, CD; Stevens, GA; Bettcher, D				Alwan, Ala; MacLean, David R.; Riley, Leanne M.; d'Espaignet, Edouard Tursan; Mathers, Colin Douglas; Stevens, Gretchen Anna; Bettcher, Douglas			Chronic Diseases: Chronic Diseases and Development 5 Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries	LANCET			English	Article							PREVENTION	The burden of chronic, non-communicable diseases in low-income and middle-income countries is increasing. We outline a framework for monitoring of such diseases and review the mortality burden and the capacity of countries to respond to them. We show data from WHO data sources and published work for prevalence of tobacco use, overweight, and cause-specific mortality in 23 low-income and middle-income countries with a high burden of non-communicable disease. Data for national capacity for chronic disease prevention and control were generated from a global assessment that was done in WHO member states in 2009-10. Although reliable data for cause-specific mortality are scarce, non-communicable diseases were estimated to be responsible for 23.4 million (or 64% of the total) deaths in the 23 countries that we analysed, with 47% occurring in people who were younger than 70 years. Tobacco use and overweight are common in most of the countries and populations we examined, but coverage of cost-effective interventions to reduce these risk factors is low. Capacity for prevention and control of non-communicable diseases, including monitoring and surveillance operations nationally, is inadequate. A surveillance framework, including a minimum set of indicators covering exposures and outcomes, is essential for policy development and assessment and for monitoring of trends in disease. Technical, human, and fiscal resource constraints are major impediments to the establishment of effective prevention and control programmes. Despite increasing awareness and commitment to address chronic disease, concrete actions by global partners to plan and implement cost-effective interventions are inadequate.	[Alwan, Ala; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [d'Espaignet, Edouard Tursan; Bettcher, Douglas] WHO, Tobacco Free Initiat, CH-1211 Geneva, Switzerland; [Mathers, Colin Douglas; Stevens, Gretchen Anna] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization; World Health Organization	Alwan, A (corresponding author), WHO, Dept Chron Dis & Hlth Promot, 20 Ave Appia, CH-1211 Geneva, Switzerland.	alwana@who.int	d'Espaignet, Edouard Tursan/V-3857-2019; Harding, Richard/G-9729-2012	Mathers, Colin/0000-0002-0617-6731				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alleyne G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-15; [Anonymous], GLOB EC PROSP 2010; [Anonymous], CAUS DEATH IND 2001; [Anonymous], 2004, WHA5717 WHO; [Anonymous], WHO SURV MON; [Anonymous], 3 MIN HLTH; [Anonymous], WHO MORT DAT 2008; [Anonymous], 2008, ACT PLAN GLOB STRAT; [Anonymous], INT STAT CLASS DIS; [Anonymous], WHO GLOB INFOBASE; [Anonymous], DISC PAP NONC DIS PO; [Anonymous], GLOB RISKS 2010 GLOB; [Anonymous], WHA561 WHO; [Anonymous], INT FUT EXPL ALT GLO; [Anonymous], WHOMNC012; [Anonymous], B WHO; [Anonymous], WHAA5314 WHO; [Anonymous], 2 WHO GLOB INFOBASE; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; Ngo Anh D, 2010, BMC Res Notes, V3, P78, DOI 10.1186/1756-0500-3-78; Porapakkham Y, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-14; Strong K, 2008, EUR J CANCER PREV, V17, P162, DOI 10.1097/CEJ.0b013e3282b6fcc9; World Bank, 2009, GLOBAL ECONOMIC PROSPECTS: COMMODITIES AT THE CROSSROADS, P1, DOI 10.1596/978-0-8213-7799-4; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2010, WORLD HLTH STAT 2010; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization, 2005, PREVENTING CHRONIC D; World Health Organization, 2007, VERB AUT STAND ASC A; World Health Organization (WHO), WHO STEPS SURV MAN W	39	374	395	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1861	1868		10.1016/S0140-6736(10)61853-3	http://dx.doi.org/10.1016/S0140-6736(10)61853-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21074258				2022-12-01	WOS:000285439700035
J	Paynter, S; Ware, RS; Weinstein, P; Williams, G; Sly, PD				Paynter, Stuart; Ware, Robert S.; Weinstein, Philip; Williams, Gail; Sly, Peter D.			Childhood pneumonia: a neglected, climate-sensitive disease?	LANCET			English	Editorial Material									[Ware, Robert S.; Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia; [Paynter, Stuart; Ware, Robert S.; Williams, Gail] Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4029, Australia; [Weinstein, Philip] Univ S Australia, Grad Res Ctr, Adelaide, SA 5001, Australia	University of Queensland; University of Queensland; University of South Australia	Sly, PD (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia.	p.sly@uq.edu.au	Williams, Gail/S-8833-2019; Weinstein, Phil/C-9805-2011; Sly, Peter D/F-1486-2010; Ware, Robert S./B-2024-2014	Williams, Gail/0000-0002-4822-5263; Sly, Peter D/0000-0001-6305-2201; Ware, Robert S./0000-0002-6129-6736; Weinstein, Philip/0000-0001-9860-7166				Chan PWK, 2002, PEDIATR PULM, V34, P47, DOI 10.1002/ppul.10095; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Confalonieri U, 2007, CLIMATE CHANGE 2007; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Moura FEA, 2006, AM J TROP MED HYG, V74, P165, DOI 10.4269/ajtmh.2006.74.165; Naylor RL, 2007, P NATL ACAD SCI USA, V104, P7752, DOI 10.1073/pnas.0701825104; Omer SB, 2008, EPIDEMIOL INFECT, V136, P1319, DOI 10.1017/S0950268807000015; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; WHO, 2009, PROT HLTH CLIM CHANG; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2020, GLOBAL REPORT EPIDEM; Ye Y, 2009, AM J TROP MED HYG, V81, P770, DOI 10.4269/ajtmh.2009.09-0070; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	14	34	35	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1804	1805		10.1016/S0140-6736(10)62141-1	http://dx.doi.org/10.1016/S0140-6736(10)62141-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21111894				2022-12-01	WOS:000285439700006
J	Yudkin, JS; Richter, B; Gale, EAM				Yudkin, John S.; Richter, Bernd; Gale, Edwin A. M.			Intensified glucose control in type 2 diabetes-whose agenda?	LANCET			English	Editorial Material							SURVIVAL; TIME		[Yudkin, John S.] UCL, London WC1E 6BT, England; [Richter, Bernd] Univ Dusseldorf, Cochrane Metab & Endocrine Disorders Review Grp, Dusseldorf, Germany; [Gale, Edwin A. M.] Univ Bristol, Bristol, Avon, England	University of London; University College London; Heinrich Heine University Dusseldorf; University of Bristol	Yudkin, JS (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008	Richter, Bernd/0000-0002-7117-3983				*AM DIAB ASS, 2010, AM DIABETES ASS  SPR, P14; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gerstein HC, 1996, LANCET, V347, P949, DOI 10.1016/S0140-6736(96)91420-8; Hauber A, 2006, DIABETOLOGIA, V49, P247, DOI 10.1007/s00125-005-0108-0; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Royal College of Physicians, 2009, INN HLTH PAT PHYS PH; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	18	27	27	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1220	1222		10.1016/S0140-6736(10)61112-9	http://dx.doi.org/10.1016/S0140-6736(10)61112-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	751DI	21093903				2022-12-01	WOS:000289597300008
J	Graveley, BR; Brooks, AN; Carlson, J; Duff, MO; Landolin, JM; Yang, L; Artieri, CG; van Baren, MJ; Boley, N; Booth, BW; Brown, JB; Cherbas, L; Davis, CA; Dobin, A; Li, RH; Lin, W; Malone, JH; Mattiuzzo, NR; Miller, D; Sturgill, D; Tuch, BB; Zaleski, C; Zhang, DY; Blanchette, M; Dudoit, S; Eads, B; Green, RE; Hammonds, A; Jiang, LC; Kapranov, P; Langton, L; Perrimon, N; Sandler, JE; Wan, KH; Willingham, A; Zhang, Y; Zou, Y; Andrews, J; Bickel, PJ; Brenner, SE; Brent, MR; Cherbas, P; Gingeras, TR; Hoskins, RA; Kaufman, TC; Oliver, B; Celniker, SE				Graveley, Brenton R.; Brooks, Angela N.; Carlson, JosephW.; Duff, Michael O.; Landolin, Jane M.; Yang, Li; Artieri, Carlo G.; van Baren, Marijke J.; Boley, Nathan; Booth, Benjamin W.; Brown, James B.; Cherbas, Lucy; Davis, Carrie A.; Dobin, Alex; Li, Renhua; Lin, Wei; Malone, John H.; Mattiuzzo, Nicolas R.; Miller, David; Sturgill, David; Tuch, Brian B.; Zaleski, Chris; Zhang, Dayu; Blanchette, Marco; Dudoit, Sandrine; Eads, Brian; Green, Richard E.; Hammonds, Ann; Jiang, Lichun; Kapranov, Phil; Langton, Laura; Perrimon, Norbert; Sandler, Jeremy E.; Wan, Kenneth H.; Willingham, Aarron; Zhang, Yu; Zou, Yi; Andrews, Justen; Bickel, Peter J.; Brenner, Steven E.; Brent, Michael R.; Cherbas, Peter; Gingeras, Thomas R.; Hoskins, Roger A.; Kaufman, Thomas C.; Oliver, Brian; Celniker, Susan E.			The developmental transcriptome of Drosophila melanogaster	NATURE			English	Article							GENE-EXPRESSION; FUNCTIONAL ELEMENTS; BITHORAX COMPLEX; ABDOMINAL-B; IDENTIFICATION; GENOMES; TARGETS	Drosophila melanogaster is one of the most well studied genetic model organisms; nonetheless, its genome still contains unannotated coding and non-coding genes, transcripts, exons and RNA editing sites. Full discovery and annotation are pre-requisites for understanding how the regulation of transcription, splicing and RNA editing directs the development of this complex organism. Here we used RNA-Seq, tiling microarrays and cDNA sequencing to explore the transcriptome in 30 distinct developmental stages. We identified 111,195 new elements, including thousands of genes, coding and non-coding transcripts, exons, splicing and editing events, and inferred protein isoforms that previously eluded discovery using established experimental, prediction and conservation-based approaches. These data substantially expand the number of known transcribed elements in the Drosophila genome and provide a high-resolution view of transcriptome dynamics throughout development.	[Graveley, Brenton R.; Duff, Michael O.; Yang, Li] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA; [Brooks, Angela N.; Brenner, Steven E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Carlson, JosephW.; Landolin, Jane M.; Booth, Benjamin W.; Hammonds, Ann; Sandler, Jeremy E.; Wan, Kenneth H.; Hoskins, Roger A.; Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Artieri, Carlo G.; Li, Renhua; Malone, John H.; Mattiuzzo, Nicolas R.; Sturgill, David; Jiang, Lichun; Zhang, Yu; Oliver, Brian] NIDDK, Sect Dev Genom, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [van Baren, Marijke J.; Langton, Laura; Brent, Michael R.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; [van Baren, Marijke J.; Langton, Laura; Brent, Michael R.] Washington Univ, Dept Comp Sci, St Louis, MO 63108 USA; [Boley, Nathan; Brown, James B.; Bickel, Peter J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cherbas, Lucy; Zhang, Dayu; Cherbas, Peter] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Davis, Carrie A.; Dobin, Alex; Lin, Wei; Zaleski, Chris; Kapranov, Phil; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Miller, David; Eads, Brian; Andrews, Justen; Cherbas, Peter; Kaufman, Thomas C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Tuch, Brian B.] Life Technol, Res & Dev, Genet Syst Div, Foster City, CA 94404 USA; [Tuch, Brian B.] Amgen Inc, Genome Anal Unit, San Francisco, CA 94080 USA; [Blanchette, Marco] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Blanchette, Marco] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Dudoit, Sandrine] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA; [Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Willingham, Aarron; Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Gingeras, Thomas R.] Affymetrix, Santa Clara, CA 95051 USA	University of Connecticut; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Berkeley; Indiana University System; Indiana University Bloomington; Cold Spring Harbor Laboratory; Indiana University System; Indiana University Bloomington; Thermo Fisher Scientific; Amgen; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Affymetrix	Graveley, BR (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	graveley@neuron.uchc.edu; celniker@fruitfly.org	Brown, James/H-2971-2015; jiang, lichun/F-3776-2012; Lin, Wei/AAH-9924-2019; Brent, Michael/AAK-3702-2020	jiang, lichun/0000-0003-2462-7636; Lin, Wei/0000-0002-7506-3466; Brent, Michael/0000-0002-8689-0299; Sturgill, David/0000-0002-7902-3605; Dobin, Alexander/0000-0002-4115-9128; yang, li/0000-0001-8833-7473; Graveley, Brenton/0000-0001-5777-5892; Perrimon, Norbert/0000-0001-7542-472X; Green, Richard/0000-0003-0516-5827; Gingeras, Thomas/0000-0001-9106-3573	National Human Genome Research INstitute [U01 HB004271]; Department of Energy [DE-AC02-05CH11231]; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER	National Human Genome Research INstitute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Energy(United States Department of Energy (DOE)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Trapnell and L. Pachter for discussions and assistance with Cufflinks, and E. Clough for comments and feedback. A.N.B. was partially supported by an NSF graduate fellowship. This work was funded by an award from the National Human Genome Research INstitute modENCODE Project (U01 HB004271) to S.E.C. (Principal Investigator) and M.R.B., P.C., T.R.G., B.R.G. and N.P. (co-Principal Investigators) under Department of Energy contract no. DE-AC02-05CH11231, and by the National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program (B.O.).	ANDRES AJ, 1992, DEVELOPMENT, V116, P865; ANDRES AJ, 1993, DEV BIOL, V160, P388, DOI 10.1006/dbio.1993.1315; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bass BL, 2001, RNA EDITING; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Costantino BFB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000102; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hild M, 2004, GENOME BIOL, V5; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Jepson JEC, 2007, METHOD ENZYMOL, V424, P265, DOI 10.1016/S0076-6879(07)24012-1; KARCH F, 1985, CELL, V43, P81, DOI 10.1016/0092-8674(85)90014-5; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; LOCKETT TJ, 1989, DEV BIOL, V134, P430, DOI 10.1016/0012-1606(89)90115-2; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Padgett RA, 2002, RNA, V8, P125, DOI 10.1017/S1355838202017156; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Philipps DL, 2004, RNA, V10, P1838, DOI 10.1261/rna.7136104; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; SANCHEZHERRERO E, 1989, DEVELOPMENT, V107, P321; Spradling AC, 2006, GENETICS, V174, P1; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang JW, 2010, J NEUROGENET, V24, P67, DOI 10.3109/01677061003746341; Warren JT, 2006, DEV DYNAM, V235, P315, DOI 10.1002/dvdy.20626; Xie XH, 2006, P NATL ACAD SCI USA, V103, P11659, DOI 10.1073/pnas.0604768103; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	1033	1059	7	255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					473	479		10.1038/nature09715	http://dx.doi.org/10.1038/nature09715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21179090	Green Submitted, Green Accepted			2022-12-01	WOS:000288702200054
J	Santos, JM; Ferguson, DJP; Blackman, MJ; Soldati-Favre, D				Santos, Joana M.; Ferguson, David J. P.; Blackman, Michael J.; Soldati-Favre, Dominique			Intramembrane Cleavage of AMA1 Triggers Toxoplasma to Switch from an Invasive to a Replicative Mode	SCIENCE			English	Article							HOST-CELL INVASION; MICRONEME PROTEINS; GONDII; PROTEASES; MEMBRANE; PARASITE; SURFACE; CYCLE	Apicomplexan parasites invade host cells and immediately initiate cell division. The extracellular parasite discharges transmembrane proteins onto its surface to mediate motility and invasion. These are shed by intramembrane cleavage, a process associated with invasion but otherwise poorly understood. Functional analysis of Toxoplasma rhomboid 4, a surface intramembrane protease, by conditional overexpression of a catalytically inactive form produced a profound block in replication. This was completely rescued by expression of the cleaved cytoplasmic tail of Toxoplasma or Plasmodium apical membrane antigen 1 (AMA1). These results reveal an unexpected function for AMA1 in parasite replication and suggest that invasion proteins help to promote parasite switch from an invasive to a replicative mode.	[Santos, Joana M.; Soldati-Favre, Dominique] Univ Geneva, Fac Med, Dept Microbiol, CH-1211 Geneva 4, Switzerland; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Santos, Joana M.; Blackman, Michael J.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England	University of Geneva; University of Oxford; MRC National Institute for Medical Research	Soldati-Favre, D (corresponding author), Univ Geneva, Fac Med, Dept Microbiol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Dominique.Soldati-Favre@unige.ch	; M Santos, Joana/W-4149-2018	Ferguson, David/0000-0001-5045-819X; Soldati-Favre, Dominique/0000-0003-4156-2109; M Santos, Joana/0000-0002-5411-4439	Swiss National Foundation [FN3100A0-116722]; Medical Research Council, UK [U117532063]; MalParTraining [MEST-CT-2005-02049]; Wellcome Trust; Medical Research Council [MC_U117532063] Funding Source: researchfish; MRC [MC_U117532063] Funding Source: UKRI	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MalParTraining; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Meissner for providing us with the dd system and G. Ward and F. Parussini for sharing unpublished data and inspiring discussions. We thank P. Bradley and M. Gubbels for sharing antibodies, L. Sheiner and T. Dowse for previous study of ROM4, J. Limenitakis for technical assistance, and L. Kemp for critical reading of the manuscript. This work was supported by the Swiss National Foundation (grant FN3100A0-116722) and the Medical Research Council, UK (grant U117532063). J.M.S. was funded by MalParTraining, an FP6-funded Marie Curie Initial Training Network (contract number MEST-CT-2005-020492, The Challenge of Malaria in the Post-Genomic Era). D.S.-F. is an international Howard Hughes Medical Institute scholar. D.J.P.F. is supported by an equipment grant from the Wellcome Trust.	Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brossier F, 2008, EUKARYOT CELL, V7, P664, DOI 10.1128/EC.00331-07; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Dowse TJ, 2005, INT J PARASITOL, V35, P747, DOI 10.1016/j.ijpara.2005.04.001; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Howell SA, 2005, MOL MICROBIOL, V57, P1342, DOI 10.1111/j.1365-2958.2005.04772.x; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Opitz C, 2002, EMBO J, V21, P1577, DOI 10.1093/emboj/21.7.1577; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3	24	75	85	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					473	477		10.1126/science.1199284	http://dx.doi.org/10.1126/science.1199284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21205639	Green Accepted			2022-12-01	WOS:000286635900056
J	Pornillos, O; Ganser-Pornillos, BK; Yeager, M				Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark			Atomic-level modelling of the HIV capsid	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-TERMINAL DOMAIN; ROUS-SARCOMA-VIRUS; DIMERIZATION DOMAIN; IN-VITRO; STRUCTURE VALIDATION; ASSEMBLY PROPERTIES; PROTEIN; TYPE-1; CORE	The mature capsids of human immunodeficiency virus type 1 (HIV-1) and other retroviruses are fullerene shells, composed of the viral CA protein, that enclose the viral genome and facilitate its delivery into new host cells(1). Retroviral CA proteins contain independently folded amino (N)- and carboxy (C)-terminal domains (NTD and CTD) that are connected by a flexible linker(2-4). The NTD forms either hexameric or pentameric rings, whereas the CTD forms symmetric homodimers that connect the rings into a hexagonal lattice(3,5-13). We previously used a disulphide crosslinking strategy to enable isolation and crystallization of soluble HIV-1 CA hexamers(11,14). Here we use the same approach to solve the X-ray structure of the HIV-1 CA pentamer at 2.5 angstrom resolution. Two mutant CA proteins with engineered disulphides at different positions (P17C/T19C and N21C/A22C) converged onto the same quaternary structure, indicating that the disulphide-crosslinked proteins recapitulate the structure of the native pentamer. Assembly of the quasi-equivalent hexamers and pentamers requires remarkably subtle rearrangements in subunit interactions, and appears to be controlled by an electrostatic switch that favours hexamers over pentamers. This study completes the gallery of substructures describing the components of the HIV-1 capsid and enables atomic-level modelling of the complete capsid. Rigid-body rotations around two assembly interfaces appear sufficient to generate the full range of continuously varying lattice curvature in the fullerene cone.	[Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Yeager, Mark] Univ Virginia Hlth Syst, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22908 USA	University of Virginia; Scripps Research Institute; University of Virginia	Yeager, M (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	yeager@virginia.edu			US National Institutes of Health [R01-GM066087, P50-GM082545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, R01GM066087] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the US National Institutes of Health to M.Y. (R01-GM066087 and P50-GM082545). X-ray diffraction data were collected at beamlines 22-BM and 22-ID at the Advanced Photon Source, Argonne National Laboratory. Initial crystal screening was performed with the assistance of S. Banumathi through the Collaborative Crystallography Program, Lawrence Berkeley National Laboratory at the Advanced Light Source. We thank J.E. Johnson and D. Borek for crystallographic advice; Y. Hua for assistance with molecular biology experiments; and I. A. Wilson, C. P. Hill and W. I. Sundquist for critical reading of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alcaraz LA, 2007, BIOPHYS J, V93, P1264, DOI 10.1529/biophysj.106.101089; Bailey GD, 2009, STRUCTURE, V17, P737, DOI 10.1016/j.str.2009.03.010; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Hyun JK, 2010, J BIOL CHEM, V285, P15056, DOI 10.1074/jbc.M110.108209; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wong HC, 2008, BIOCHEMISTRY-US, V47, P2289, DOI 10.1021/bi7022128; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wriggers W, 1997, PROTEINS, V29, P1	37	274	278	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					424	+		10.1038/nature09640	http://dx.doi.org/10.1038/nature09640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248851	Green Accepted			2022-12-01	WOS:000286385600058
J	Yonehara, K; Balint, K; Noda, M; Nagel, G; Bamberg, E; Roska, B				Yonehara, Keisuke; Balint, Kamill; Noda, Masaharu; Nagel, Georg; Bamberg, Ernst; Roska, Botond			Spatially asymmetric reorganization of inhibition establishes a motion-sensitive circuit	NATURE			English	Article							SELECTIVE GANGLION-CELLS; STARBURST AMACRINE CELLS; DIRECTION SELECTIVITY; RABBIT RETINA; VISUAL EXPERIENCE; MAMMALIAN RETINA; MOUSE RETINA; CHANNELRHODOPSIN-2; ARCHITECTURE; MECHANISMS	Spatial asymmetries in neural connectivity have an important role in creating basic building blocks of neuronal processing(1,2). A key circuit module of directionally selective (DS) retinal ganglion cells is a spatially asymmetric inhibitory input from starburst amacrine cells(3-5). It is not known how and when this circuit asymmetry is established during development. Here we photostimulate mouse starburst cells targeted with channelrhodopsin-2 (refs 6-8) while recording from a single genetically labelled type of DS cell(9,10). We follow the spatial distribution of synaptic strengths between starburst and DS cells during early postnatal development before these neurons can respond to a physiological light stimulus, and confirm connectivity by monosynaptically restricted trans-synaptic rabies viral tracing. We show that asymmetry develops rapidly over a 2-day period through an intermediate state in which random or symmetric synaptic connections have been established. The development of asymmetry involves the spatially selective reorganization of inhibitory synaptic inputs. Intriguingly, the spatial distribution of excitatory synaptic inputs from starburst cells is significantly more symmetric than that of the inhibitory inputs at the end of this developmental period. Our work demonstrates a rapid developmental switch from a symmetric to asymmetric input distribution for inhibition in the neural circuit of a principal cell.	[Yonehara, Keisuke; Balint, Kamill; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan; [Nagel, Georg] Univ Wurzburg, D-97082 Wurzburg, Germany; [Bamberg, Ernst] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Bamberg, Ernst] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany	Friedrich Miescher Institute for Biomedical Research; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; University of Wurzburg; Max Planck Society; Goethe University Frankfurt	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland.	botond.roska@fmi.ch	Noda, Masaharu/D-7146-2016; Roska, Botond/AAD-7268-2021	Noda, Masaharu/0000-0002-3796-524X; Yonehara, Keisuke/0000-0001-9541-6671; Nagel, Georg/0000-0001-8174-8712	Friedrich Miescher Institute for Biomedical Research; US Office of Naval Research; Marie Curie Excellence grant; National Centre of Competence in Research; European Research Council; European Union; EMBO	Friedrich Miescher Institute for Biomedical Research; US Office of Naval Research(Office of Naval Research); Marie Curie Excellence grant(European Commission); National Centre of Competence in Research; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank B. G. Scherf, S. Djaffer and J. Juttner for technical assistance, T. Szikra for helping with light intensity calibration, V. Busskamp for suggesting the use of the 2A element and the cloning strategy for the 2A-based expression system, and V. Busskamp, K. Farrow, S. Oakeley and P. King for their comments on the manuscript. We thank E. Callaway for providing the rabies viruses and K. Conzelmann and S. Arber for discussion about rabies viruses. The study was supported by the Friedrich Miescher Institute for Biomedical Research, a US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology Program grant, a Marie Curie Excellence grant, a National Centre of Competence in Research Frontiers in Genetics grant, an European Research Council as well as RETICIRC, TREATRUSH and OPTONEURO grants from the European Union to B. R. and an EMBO Long-Term Fellowship to K.Y.	ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ivanova E, 2010, NEUROSCIENCE, V165, P233, DOI 10.1016/j.neuroscience.2009.10.021; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Vaney DI, 2002, CURR OPIN NEUROBIOL, V12, P405, DOI 10.1016/S0959-4388(02)00337-9; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	34	117	120	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					407	+		10.1038/nature09711	http://dx.doi.org/10.1038/nature09711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21170022				2022-12-01	WOS:000286385600054
J	John, TJ; Dandona, L; Sharma, VP; Kakkar, M				John, T. Jacob; Dandona, Lalit; Sharma, Vinod P.; Kakkar, Manish			India: Towards Universal Health Coverage 1 Continuing challenge of infectious diseases in India	LANCET			English	Article							VIBRIO-CHOLERAE O1; SEXUALLY-TRANSMITTED INFECTIONS; ANDHRA-PRADESH STATE; PUBLIC-HEALTH; TYPHOID-FEVER; VIRAL-HEPATITIS; SCRUB TYPHUS; TAMIL-NADU; CHIKUNGUNYA EPIDEMIC; TUBERCULOSIS-CONTROL	In India, the range and burden of infectious diseases are enormous. The administrative responsibilities of the health system are shared between the central (federal) and state governments. Control of diseases and outbreaks is the responsibility of the central Ministry of Health, which lacks a formal public health department for this purpose. Tuberculosis, malaria, filariasis, visceral leishmaniasis, leprosy, HIV infection, and childhood duster of vaccine-preventable diseases are given priority for control through centrally managed vertical programmes. Control of HIV infection and leprosy, but not of tuberculosis, seems to be on track. Early success of malaria control was not sustained, and visceral leishmaniasis prevalence has increased. Inadequate containment of the vector has resulted in recurrent outbreaks of dengue fever and re-emergence of Chikungunya virus disease and typhus fever. Other infectious diseases caused by faecally transmitted pathogens (enteric fevers, cholera, hepatitis A and E viruses) and zoonoses (rabies, leptospirosis, anthrax) are not in the process of being systematically controlled. Big gaps in the surveillance and response system for infectious diseases need to be addressed. Replication of the model of vertical single-disease control for all infectious diseases will not be efficient or viable. India needs to rethink and revise its health policy to broaden the agenda of disease control. A comprehensive review and redesign of the health system is needed urgently to ensure equity and quality in health care. We recommend the creation of a functional public health infrastructure that is shared between central and state governments, with professional leadership and a formally trained public health cadre of personnel who manage an integrated control mechanism of diseases in districts that includes infectious and noninfectious diseases, and injuries.	[Dandona, Lalit; Kakkar, Manish] Publ Hlth Fdn India, New Delhi 110070, India; [John, T. Jacob] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India; [John, T. Jacob] Christian Med Coll & Hosp, Dept Virol, Vellore, Tamil Nadu, India; [Dandona, Lalit] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Sharma, Vinod P.] Indian Inst Technol, Ctr Rural Dev & Technol, New Delhi, India	Public Health Foundation of India; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Dandona, L (corresponding author), Publ Hlth Fdn India, ISID Campus,4 Inst Area, New Delhi 110070, India.	lalit.dandona@phfi.org	Rivet, Catherine A/M-7978-2014		John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This report was prepared without any financial support. The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Abraham M, 1999, Indian Pediatr, V36, P697; Acharya SK, 2006, NATL MED J INDIA, V19, P203; [Anonymous], HIST TB CONTR; [Anonymous], TB IND 2008RNTCP STA; Arankalle V A, 2006, Indian J Med Res, V123, P760; Arora P, 2008, LANCET, V372, P289, DOI 10.1016/S0140-6736(08)61105-8; Bakshi D, 2007, ACTA TROP, V104, P63, DOI 10.1016/j.actatropica.2007.07.013; BALRAJ V, 1994, J TROP MED HYG, V97, P113; Bhatla N, 2008, VACCINE, V26, P2811, DOI 10.1016/j.vaccine.2008.03.047; Bhore J, 1946, REPORT HLTH SURVEY D; BHUSHAN N, 1994, INDIAN J MED RES, V99, P195; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; Chadha Mandeep S, 2003, Indian J Gastroenterol, V22, P11; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P569; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Chandy S, 2008, J BIOSCIENCES, V33, P495, DOI 10.1007/s12038-008-0068-x; Chowdhury A, 2005, J GASTROEN HEPATOL, V20, P1712, DOI 10.1111/j.1440-1746.2005.04070.x; Chu KM, 1998, J INFECT DIS, V177, P1314, DOI 10.1086/515273; Cooke FJ, 2007, T ROY SOC TROP MED H, V101, P398, DOI 10.1016/j.trstmh.2006.07.005; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Dandona L, 2009, AIDS, V23, P233, DOI 10.1097/QAD.0b013e328320accc; Dandona L, 2008, INT J EPIDEMIOL, V37, P1274, DOI 10.1093/ije/dyn161; Dandona L, 2007, LANCET, V370, P1811, DOI 10.1016/S0140-6736(07)61756-5; Dandona Lalit, 2010, BMC Health Serv Res, V10, P117, DOI 10.1186/1472-6963-10-117; Das Gupta M, 2009, POLICY RES WORKING P; DASGUPTA PR, 1994, AIDS, V8, pS83; Datta M, 1999, INDIAN J MED RES, V110, P56; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; deBora D, 2005, J COMMUN DIS, V37, P1; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Diamond-Smith Nadia, 2009, Malar J, V8, P24, DOI 10.1186/1475-2875-8-24; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Government of India, E MAIL DIR; Grabowsky M, 2008, NATURE, V451, P1051, DOI 10.1038/4511051a; International Society for Infectious Diseases, 2009, MEN MEN IND 04 N E; International Society for Infectious Diseases, 2009, HEP B VIR IND 08 GUJ; JACOB M, 1989, INDIAN J MED RES-A, V89, P4; Jain NK, 1992, IND J TUBERC, V92, P145; Jesudason MV, 1996, LANCET, V347, P1493, DOI 10.1016/S0140-6736(96)91733-X; Jesudason MV, 2001, INDIAN J MED MICROBI, V19, P20; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; John T J, 2000, Indian Pediatr, V37, P9; John TJ, 2008, INDIAN PEDIATR, V45, P261; John TJ, 2010, INDIAN J MED RES, V132, P4; John TJ, 2010, INDIAN J MED RES, V131, P377; John TJ, 2009, INDIAN J MED RES, V130, P101; John TJ, 2009, INDIAN J MED RES, V130, P9; John TJ, 2008, INDIAN J MED RES, V128, P669; JOHN TJ, 1971, INDIAN J MED RES, V59, P1727; JOHN TJ, 1987, LANCET, V1, P160; John TJ, 2004, INDIAN J MED RES, V120, P86; JOHN TJ, 1993, INDIAN J MED RES-A, V97, P227; JOHN TJ, 1989, INDIAN J MED RES-A, V89, P1; John TJ, 1996, INDIAN J MED RES, V103, P4; John TJ, 1996, INDIAN J MED RES, V103, P62; JOHN TJ, 1974, B WORLD HEALTH ORGAN, V51, P617; John TJ, 1998, LANCET, V352, P58, DOI 10.1016/S0140-6736(97)10494-9; JOHN TJ, 1993, AIDS, V7, P421, DOI 10.1097/00002030-199303000-00018; John TJ, 2003, GLOBAL PUBLIC HLTH N, P172; John TJ., 2008, P RANB SCI FDN ROUND, P3; John TJ, 2009, TROP MED INT HEALTH, V4, P1; Kalantri SP, 2006, NATL MED J INDIA, V19, P315; Kamarasu K, 2007, INDIAN J MED RES, V126, P128; Keller A, 2008, J TRAVEL MED, V15, P248, DOI 10.1111/j.1708-8305.2008.00216.x; Khan AM, 2005, CURR SCI INDIA, V88, P1718; Khatri GR., 2000, P 7 ROUND TABL C SEP, P15; Khuroo MS, 1997, NEW ENGL J MED, V337, P881, DOI 10.1056/NEJM199709253371303; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Kingston JJ, 2009, J MICROBIOL, V47, P110, DOI 10.1007/s12275-008-0162-7; Kumar P, 2009, J MED MICROBIOL, V58, P234, DOI 10.1099/jmm.0.002089-0; Mahajan RC, 2005, INDIAN J MED RES, V121, P716; Mantur BG, 2008, J BIOSCIENCES, V33, P539, DOI 10.1007/s12038-008-0072-1; Mathai E, 2003, ANN NY ACAD SCI, V990, P359, DOI 10.1111/j.1749-6632.2003.tb07391.x; MATHAI R, 1990, INDIAN J MED RES-A, V91, P239; Mathew JL, 2009, INDIAN PEDIATR, V46, P304; Mathur P, 2008, INDIAN J MED RES, V128, P699; Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720; *MIN HLTH FAM WELF, NAT VECT BORN DIS CO; Ministry of Health and Family Welfare Government of India, 2009, OP MAN IMPL MAL PROG; Ministry of Health and Family Welfare Government of India, 2006, GUID SURV AC ENC SYN; Ministry of Health and Family Welfare Government of India, 1995, REP EXP COMM PLAG AU; Ministry of Health and Family Welfare Government of India, INT DIS SURV PROJ PR; Ministry of Health and Family Welfare Government of India, URB MAL SCHEM ACC UR; Mohapatra SS, 2007, J MED MICROBIOL, V56, P260, DOI 10.1099/jmm.0.46868-0; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Mukhopadhya Ashis, 2006, Trop Gastroenterol, V27, P105; Nandakumar A, 2005, INT J CANCER, V116, P740, DOI 10.1002/ijc.21109; Narain JP, 2008, INDIAN J MED RES, V128, P1; Narain KL, 2003, CURR SCI INDIA, V84, P985; Narang P, 2008, INDIAN J MED MICROBI, V26, P40; National Aids Control Organisation and Government of India Ministry of Health Family Welfare, 2007, HIV SENT SURV HIV ES; National AIDS Control Organisation Ministry of Health and Family Welfare Government of India, 2006, NAT AIDS CONTR PROGR; National AIDS Control Organization, 2021, SANK STAT NAT AIDS R, V3rd; National AIDS Control Organization (NACO), 2019, IND HIV EST 2019; National Institute of Malaria Research and National Vector Borne Disease Control Programme, 2007, IN DEPTH REV MAL NAT; National Vector Borne Disease Control Programme, CHIK FEV; National Vector Borne Disease Control Programme Government of India, STAT NOT DENG FEV DE; National Vector Rome Disease Control Programme, KAL AZ VISC LEISHM; Oberoi A, 2007, Indian J Med Microbiol, V25, P75; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Pandey A, 2009, INDIAN J MED RES, V129, P50; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Pattanayak S., 1994, Indian Journal of Malariology, V31, P141; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Radha Krishna Y, 2009, LIVER INT, V29, P392, DOI 10.1111/j.1478-3231.2008.01887.x; Rajendran R, 2004, T ROY SOC TROP MED H, V98, P174, DOI 10.1016/S0035-9203(03)00042-7; Rajendran R, MASS DRUG ADM; Rajshekhar V, 2006, NEUROLOGY, V67, P2135, DOI 10.1212/01.wnl.0000249113.11824.64; Ramachandran J, 2004, J GASTROEN HEPATOL, V19, P134, DOI 10.1111/j.1440-1746.2004.03188.x; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; Ramasundaram S, 2001, WG523 COMM MACR HLTH, V23; Rao BL, 2003, NATL MED J INDIA, V16, P143; Rao G Raghu Rama, 2005, Indian J Dermatol Venereol Leprol, V71, P102; Rasheeda CA, 2008, EUR J GASTROEN HEPAT, V20, P362, DOI 10.1097/MEG.0b013e3282f246d6; Raza SA, 2007, BRIT J CANCER, V96, P1127, DOI 10.1038/sj.bjc.6603649; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reddy KS, 2006, NATL MED J INDIA, V19, P122; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Richard VS, 2001, J HOSP INFECT, V47, P243, DOI 10.1053/jhin.2000.0855; Roll Back Malaria, SIT AN MAL CONTR 5 S; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Satyanarayana, EVALUATION INTEGRATE; Schneider JA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-59; Sebastian B, 1998, INDIAN J GASTROENTER, V17, pS10; Sehgal PN, 1993, J COMM DIS, V5, P175; SEHGAL SC, 1995, INDIAN J MED RES, V102, P9; Sethi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000579; Shah NK, LANCET INFE IN PRESS; Sharma NC, 2007, INDIAN J MED RES, V125, P633; Sharma PK, 2009, T ROY SOC TROP MED H, V103, P1153, DOI 10.1016/j.trstmh.2009.02.006; Sharma R, 2000, BRIT MED J, V320, P668; Sharma VP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-281; Sharma VP, 1996, INDIAN J MED RES, V103, P26; Sharma VP., 2002, CONTEXTUAL DETERMINA; Sharma VP., 2005, GETTING GRIPS MALARI; Shetty PVD, 2008, INT J TUBERC LUNG D, V12, pS26; SIMOES EAF, 1993, J ACQ IMMUN DEF SYND, V6, P1030; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; Singh S, 2007, AIDS, V21, P2345, DOI 10.1097/QAD.0b013e3282f125c9; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Somashekar HR, 2006, J TROP PEDIATRICS, V52, P228, DOI 10.1093/tropej/fmi096; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Sudarshan MK, 2005, INDIAN J COMMUN MED, V30, P100, DOI DOI 10.4103/0970-0218.42864; Sundaram SP, 2002, INDIAN J MED RES, V116, P258; Sur D, 2004, INDIAN J MED RES, V120, P454; Sur D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-289; Tankhiwale SS, 2003, INDIAN J MED RES, V117, P10; Tarantola A, 2008, J TRAVEL MED, V15, P273, DOI 10.1111/j.1708-8305.2008.00210.x; TBC India, DOTS EXP IND; Thakur CP, 2007, INDIAN J MED RES, V126, P447; Thakur CP, 2009, INDIAN J MED RES, V129, P102; UN Development Program, HUM DEV REP 2009 HDI; UNAIDS, 2010, REP GLOB AIDS EP 201; UNAIDS, 2006, REP GLOB AIDS EP; van den Ent M, 2009, INDIAN PEDIATR, V46, P933; VENKITARAMAN AR, 1986, INT J EPIDEMIOL, V15, P561, DOI 10.1093/ije/15.4.561; Vyas RM, 2003, INT J TUBERC LUNG D, V7, P543; WHO, 1995, MAL COUNTR PROF IND; WHO, NEW CAS DET TRENDS L; WHO, 2004, REG STRAT FRAM EL KA; WHO, 2007, NEWS LETT        JUN; WHO, 2010, GLOB TUB CONTR 2010; WHO Regional Office for South East Asia, IMM VACC DEV; WHO SEARO, COMM DIS KAL AZ; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; World Bank, 2006, IMPL COMPL RES REP I; World Health Organization, 2020, GLOBAL REPORT EPIDEM; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008; Young F, 2009, INDIAN J MED RES, V130, P1	174	122	125	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					252	269		10.1016/S0140-6736(10)61265-2	http://dx.doi.org/10.1016/S0140-6736(10)61265-2			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712WG	21227500				2022-12-01	WOS:000286696400033
J	Coleman, MP; Forman, D; Bryant, H; Butler, J; Rachet, B; Maringe, C; Nur, U; Tracey, E; Coory, M; Hatcher, J; McGahan, CE; Turner, D; Marrett, L; Gjerstorff, ML; Johannesen, TB; Adolfsson, J; Lambe, M; Lawrence, G; Meechan, D; Morris, EJ; Middleton, R; Steward, J; Richards, MA				Coleman, M. P.; Forman, D.; Bryant, H.; Butler, J.; Rachet, B.; Maringe, C.; Nur, U.; Tracey, E.; Coory, M.; Hatcher, J.; McGahan, C. E.; Turner, D.; Marrett, L.; Gjerstorff, M. L.; Johannesen, T. B.; Adolfsson, J.; Lambe, M.; Lawrence, G.; Meechan, D.; Morris, E. J.; Middleton, R.; Steward, J.; Richards, M. A.		ICBP Module 1 Working Grp	Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data	LANCET			English	Article							BREAST-CANCER; DEATHS; STAGE; AGE; DIAGNOSIS; ENGLAND; EUROPE; TRENDS; CARE	Background Cancer survival is a key measure of the effectiveness of health-care systems. Persistent regional and international differences in survival represent many avoidable deaths. Differences in survival have prompted or guided cancer control strategies. This is the first study in a programme to investigate international survival disparities, with the aim of informing health policy to raise standards and reduce inequalities in survival. Methods Data from population-based cancer registries in 12 jurisdictions in six countries were provided for 2.4 million adults diagnosed with primary colorectal, lung, breast (women), or ovarian cancer during 1995-2007, with follow-up to Dec 31, 2007. Data quality control and analyses were done centrally with a common protocol, overseen by external experts. We estimated 1-year and 5-year relative survival, constructing 252 complete life tables to control for background mortality by age, sex, and calendar year. We report age-specific and age-standardised relative survival at 1 and 5 years, and 5-year survival conditional on survival to the first anniversary of diagnosis. We also examined incidence and mortality trends during 1985-2005. Findings Relative survival improved during 1995-2007 for all four cancers in all jurisdictions. Survival was persistently higher in Australia, Canada, and Sweden, intermediate in Norway, and lower in Denmark, England, Northern Ireland, and Wales, particularly in the first year after diagnosis and for patients aged 65 years and older. International differences narrowed at all ages for breast cancer, from about 9% to 5% at 1 year and from about 14% to 8% at 5 years, but less or not at all for the other cancers. For colorectal cancer, the international range narrowed only for patients aged 65 years and older, by 2-6% at 1 year and by 2-3% at 5 years. Interpretation Up-to-date survival trends show increases but persistent differences between countries. Trends in cancer incidence and modality are broadly consistent with these trends in survival. Data quality and changes in classification are not likely explanations. The patterns are consistent with later diagnosis or differences in treatment, particularly in Denmark and the UK, and in patients aged 65 years and older.	[Coleman, M. P.] Univ London London Sch Hyg & Trop Med, Canc Res UK Canc Survival Grp, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Forman, D.] Int Agcy Res Canc, Sect Canc Informat, F-69372 Lyon, France; [Bryant, H.] Canadian Partnership Against Canc, Toronto, ON, Canada; [Tracey, E.] Canc Inst New S Wales, Sydney, NSW, Australia; [Coory, M.] Canc Council Victoria, Melbourne, Vic, Australia; [Hatcher, J.] Alberta Hlth Serv, Edmonton, AB, Canada; [McGahan, C. E.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Turner, D.] CancerCare Manitoba, Winnipeg, MB, Canada; [Marrett, L.] Canc Care Ontario, Toronto, ON, Canada; [Gjerstorff, M. L.] Natl Board Hlth, Danish Canc Registry, Copenhagen, Denmark; [Johannesen, T. B.] Norwegian Canc Registry, Oslo, Norway; [Adolfsson, J.] Karolinska Univ Hosp, Ctr Oncol, Stockholm, Sweden; [Adolfsson, J.] Karolinska Inst, CLINTEC Dept, Stockholm, Sweden; [Lambe, M.] Univ Uppsala Hosp, Reg Oncol Ctr, Uppsala, Sweden; [Lawrence, G.] W Midlands Canc Intelligence Unit, Birmingham, W Midlands, England; [Meechan, D.] Trent Canc Registry, Sheffield, S Yorkshire, England; [Morris, E. J.] No & Yorkshire Canc Registrat & Informat Serv, Leeds, W Yorkshire, England; [Middleton, R.] No Ireland Canc Registry, Belfast, Antrim, North Ireland; [Steward, J.] Welsh Canc Intelligence & Surveillance Unit, Cardiff, S Glam, Wales; [Richards, M. A.] Dept Hlth, Natl Canc Act Team, London SE1 6TE, England	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; International Agency for Research on Cancer (IARC); Cancer Council Victoria; Alberta Health Services (AHS); British Columbia Cancer Agency; CancerCare Manitoba Foundation; Cancer Care Ontario; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital	Coleman, MP (corresponding author), Univ London London Sch Hyg & Trop Med, Canc Res UK Canc Survival Grp, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	michel.coleman@lshtm.ac.uk	Menon, Usha/C-4716-2008; Coleman, Michel/AAA-9543-2020	Menon, Usha/0000-0003-3708-1732; Coleman, Michel/0000-0001-8940-3807; Rachet, Bernard/0000-0001-5837-7773; Adolfsson, Jan/0000-0003-2992-1869; Lambe, Mats/0000-0002-4624-3767; Walters, Sarah/0000-0001-9929-1917; Quaresma, Manuela/0000-0002-5290-279X; Currow, David/0000-0003-1988-1250; Bergh, Jonas/0000-0001-5526-1847; Boyages, John/0000-0003-3208-3966	Department of Health; Department of Health, England (London, UK); Cancer Research UK (London, UK); Cancer Research UK [9805, 11700] Funding Source: researchfish	Department of Health; Department of Health, England (London, UK); Cancer Research UK (London, UK)(Cancer Research UK); Cancer Research UK(Cancer Research UK)	MAR is the National Cancer Director (England, funded by the Department of Health); and J Bu is Clinical Advisor to the Medical Director of the NHS (England, funded by the Department of Health). Other authors declare that they have no conflicts of interest.; This study was funded by the Department of Health, England (London, UK), and Cancer Research UK (London, UK). We thank the cancer registry staff in all jurisdictions, whose sustained efforts in data collection and quality control over many years have enabled trends in cancer patient survival to be analysed and compared in this study. We are grateful for the expert contributions from our Epidemiology Reference Group, who advised on protocol, study design, and analytical methods: Bruce Armstrong (Department of Public Health, University of Sydney, Sydney, NSW, Australia); Paul Dickman (Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden); Paul Lambert (Biostatistics Group, Department of Health Sciences, University of Leicester, Leicester, UK); Dianne O'Connell (Cancer Council New South Wales, Sydney, NSW, Australia); Milena Sant (Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy); and Hannah Weir (Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA). We also thank Jacques Ferlay (IARC, Lyon, France) for providing the incidence and mortality data for figure 3, and Max van Eijk (McKinsey) for sustained logistical support. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of any government agency.	Abdel-Rahman M, 2009, BRIT J CANCER, V101, pS115, DOI 10.1038/sj.bjc.6605401; Allemani C, 2010, EUR J CANCER, V46, P1528, DOI 10.1016/j.ejca.2010.02.016; [Anonymous], 2021, CANC INCIDENCE 5 CON; Beral V, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4112; Berrino F, 1995, IARC SCI PUBLICATION, V132; Berrino F, 1999, IARC SCI PUBLICATION, V151; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#; *CANC RES UK CANC, 2010, STREL COMP PROGR VER; Cavalli F, 2008, LANCET ONCOL, V9, P810, DOI 10.1016/S1470-2045(08)70213-4; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Coleman MP, 2000, LANCET, V356, P590, DOI 10.1016/S0140-6736(00)02593-9; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; *DEP HUM SERV, 2008, VICT CANC ACT PLAN 2; Dickman PW, 1997, J EPIDEMIOL BIOSTAT, V2, P87; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; FERLAY J, 2010, IARC CANC BASE, V9; Fritz A, 2000, INT CLASSIFICATION D, V3rd; Gatta G, 2010, ACTA ONCOL, V49, P776, DOI 10.3109/02841861003782009; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kaye JA, 2000, BRIT J CANCER, V83, P1556, DOI 10.1054/bjoc.2000.1493; Lavelle K, 2007, BRIT J CANCER, V96, P1197, DOI 10.1038/sj.bjc.6603709; Percy C., 1990, INT CLASSIFICATION D; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Pokhrel A, 2010, BRIT J CANCER, V103, P1109, DOI 10.1038/sj.bjc.6605861; Quaglia A, 2009, EUR J CANCER, V45, P1006, DOI 10.1016/j.ejca.2008.11.028; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Richards MA, 2000, BRIT MED J, V320, P895, DOI 10.1136/bmj.320.7239.895; Sanjoaquin MA, 2007, EUR J CANCER PREV, V16, P10, DOI 10.1097/01.cej.0000228398.30235.f5; Sant M, 2003, ANN ONCOL, V14, pV61, DOI 10.1093/annonc/mdg754; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sant M, 2001, INT J CANCER, V93, P894, DOI 10.1002/ijc.1408; Skirnisdottir I, 2008, INT J CANCER, V123, P1897, DOI 10.1002/ijc.23724; Storm HH, 2010, ACTA ONCOL, V49, P532, DOI 10.3109/02841861003801148; Storm Hans Henrik, 2008, Ugeskr Laeger, V170, P3065; Storm HH, 1999, EUR RESPIR J, V13, P430, DOI 10.1183/09031936.99.13243099; Williams MV, 2009, CLIN ONCOL-UK, V21, P431, DOI 10.1016/j.clon.2009.05.006; World Health Organization, 2008, WHO STAT INF SYST WH; World Health Organization, 1994, INT STAT CLASS DIS R	41	861	888	0	99	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					127	138		10.1016/S0140-6736(10)62231-3	http://dx.doi.org/10.1016/S0140-6736(10)62231-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21183212	Green Accepted, Green Published			2022-12-01	WOS:000286292800025
J	Cocinero, EJ; Carcabal, P; Vaden, TD; Simons, JP; Davis, BG				Cocinero, Emilio J.; Carcabal, Pierre; Vaden, Timothy D.; Simons, John P.; Davis, Benjamin G.			Sensing the anomeric effect in a solvent-free environment	NATURE			English	Article							CONFORMATIONAL-ANALYSIS; GAS-PHASE; GLUCOSE; SYSTEMS; MODEL; BOND	The anomeric effect is a chemical phenomenon(1-9) that refers to an observed stabilization(10) of six-membered carbohydrate rings when they contain an electronegative substituent at the C1 position of the ring. This stereoelectronic effect influences the three-dimensional shapes of many biological molecules. It can be manifested not only in this classical manner involving interaction of the endocyclic oxygen atom (O5) found in such sugars with the C1 substituent (endo-anomeric effect) but also through a corresponding interaction of the electronegative exocyclic substituent with O5 (exoanomeric effect). However, the underlying physical origin(s) of this phenomenon is still not clear(1,3,4,11-14). Here we show, using a combination of laser spectroscopy and computational analysis, that a truncated peptide motif can engage the two anomers of an isolated sugar in the gas phase, an environment lacking extraneous factors which could confound the analysis. (Anomers are isomers that differ in the orientation of the substituent at C1.) Complexes formed between the peptide and the alpha- or beta-anomers of D-galactose are nearly identical structurally; however, the strength of the polarization of their interactions with the peptide differs greatly. Natural bond order calculations support this observation, and together they reveal the dominance of the exo- over the endo-anomeric effect. As interactions between oxygen atoms at positions C1 and C2 (O1 and O2, respectively) on the pyranose ring can alter the exo/endo ratio of a carbohydrate, our results suggest that it will be important to reevaluate the influence, and biological effects, of substituents at position C2 in sugars.	[Davis, Benjamin G.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Cocinero, Emilio J.; Carcabal, Pierre; Vaden, Timothy D.; Simons, John P.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	University of Oxford; University of Oxford	Davis, BG (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	John.Simons@chem.ox.ac.uk; Ben.Davis@chem.ox.ac.uk	Davis, Benjamin G/C-5281-2011; Cocinero, Emilio J./C-6497-2009	Davis, Benjamin G/0000-0002-5056-407X; Cocinero, Emilio J./0000-0001-7632-3728; Vaden, Timothy/0000-0002-2648-0300	EPSRC [GR/T26542]; Leverhulme Trust; Spanish Ministry (MCINN) for a Juan de la Cierva; Royal Society for a USA/Canada; Linacre College; Royal Society; Biotechnology and Biological Sciences Research Council [BB/E004350/1, BB/C510824/1, EGA17763] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G026688/1, EP/D023335/1, EP/I500200/1, EP/G03088X/1, EP/E000614/1, GR/T26542/01, EP/D023343/1] Funding Source: researchfish; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/I500200/1, EP/G026688/1, EP/E000614/1, EP/G03088X/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Spanish Ministry (MCINN) for a Juan de la Cierva(Spanish Government); Royal Society for a USA/Canada(Royal Society of London); Linacre College; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the EPSRC for funding (GR/T26542), the Leverhulme Trust for the award of an Emeritus Fellowship (J.P.S.), the Spanish Ministry (MCINN) for a Juan de la Cierva contract (E.J.C.), the Royal Society for a USA/Canada Research Fellowship and Linacre College for a Junior Research Fellowship (T.D.V.), the STFC for the provision of equipment from the Laser Loan Pool, and the Oxford Supercomputing Centre for their services. B.G.D. is a Royal Society Wolfson Research Merit Award recipient and is supported by an EPSRC LSI Platform grant.	BOX VGS, 1990, HETEROCYCLES, V31, P1157; BRIGGS AJ, 1984, J AM CHEM SOC, V106, P6200, DOI 10.1021/ja00333a014; Cramer CJ, 1997, CARBOHYD RES, V298, P1, DOI 10.1016/S0008-6215(96)00297-2; Deslongchamps P., 1983, STEREOELECTRONIC EFF; EDWARD JT, 1955, CHEM IND-LONDON, P1102; ELIEL EL, 1968, J ORG CHEM, V33, P3754, DOI 10.1021/jo01274a015; Eliel EL., 1994, STEREOCHEMISTRY ORGA, DOI 10.1002/9780470147306; Gerhards M, 2004, PHYS CHEM CHEM PHYS, V6, P2682, DOI 10.1039/b316001g; Gillespie RJ, 2010, CHEM-EUR J, V16, P3663, DOI 10.1002/chem.200902599; JUARISTI E, 1992, TETRAHEDRON, V48, P5019, DOI 10.1016/S0040-4020(01)90118-8; Jungius CL, 1905, Z PHYS CHEM-STOCH VE, V52, P97; Kirby A. J., 1983, ANOMERIC EFFECT RELA; Lemieux R.U., 1971, PURE APPL CHEM, V25, P527; LEMIEUX RU, 1979, ACS SYM SER, P17; Mo YR, 2010, NAT CHEM, V2, P666, DOI [10.1038/NCHEM.721, 10.1038/nchem.721]; Robertson EG, 2001, PHYS CHEM CHEM PHYS, V3, P1, DOI 10.1039/b008225m; Romers C., 1969, TOP STEREOCHEM, V4, P39; SALZNER U, 1994, J ORG CHEM, V59, P2138, DOI 10.1021/jo00087a035; Takahashi O, 2007, CARBOHYD RES, V342, P1202, DOI 10.1016/j.carres.2007.02.032; Thatcher G. R. J., 1993, ANOMERIC EFFECT ASS; Vila A, 2007, J COMPUT CHEM, V28, P1516, DOI 10.1002/jcc.20585; WIBERG KB, 1989, J AM CHEM SOC, V111, P4821, DOI 10.1021/ja00195a038	22	124	124	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					76	U1400		10.1038/nature09693	http://dx.doi.org/10.1038/nature09693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209661				2022-12-01	WOS:000285921600034
J	Typas, A; Banzhaf, M; van Saparoea, BV; Verheul, J; Biboy, J; Nichols, RJ; Zietek, M; Beilharz, K; Kannenberg, K; von Rechenberg, M; Breukink, E; den Blaauwen, T; Gross, CA; Vollmer, W				Typas, Athanasios; Banzhaf, Manuel; van Saparoea, Bart van den Berg; Verheul, Jolanda; Biboy, Jacob; Nichols, Robert J.; Zietek, Matylda; Beilharz, Katrin; Kannenberg, Kai; von Rechenberg, Moritz; Breukink, Eefjan; den Blaauwen, Tanneke; Gross, Carol A.; Vollmer, Waldemar			Regulation of Peptidoglycan Synthesis by Outer-Membrane Proteins	CELL			English	Article							CELL-DIVISION MACHINERY; TOL-PAL COMPLEX; ESCHERICHIA-COLI; MUREIN SACCULUS; BACILLUS-SUBTILIS; SYNTHASE PBP1B; ELONGATION; BACTERIA; GROWTH; LYSIS	Growth of the mesh-like peptidoglycan (PG) sacculus located between the bacterial inner and outer membranes (OM) is tightly regulated to ensure cellular integrity, maintain cell shape, and orchestrate division. Cytoskeletal elements direct placement and activity of PG synthases from inside the cell, but precise spatiotemporal control over this process is poorly understood. We demonstrate that PG synthases are also controlled from outside of the sacculus. Two OM lipoproteins, LpoA and LpoB, are essential for the function, respectively, of PBP1A and PBP1B, the major E. coli bifunctional PG synthases. Each Lpo protein binds specifically to its cognate PBP and stimulates its transpeptidase activity, thereby facilitating attachment of new PG to the sacculus. LpoB shows partial septal localization, and our data suggest that the LpoB-PBP1B complex contributes to OM constriction during cell division. LpoA/ LpoB and their PBP-docking regions are restricted to gamma-proteobacteria, providing models for niche-specific regulation of sacculus growth.	[Typas, Athanasios; Nichols, Robert J.; Zietek, Matylda; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA; [Banzhaf, Manuel; Biboy, Jacob; Beilharz, Katrin; Vollmer, Waldemar] Univ Newcastle, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [van Saparoea, Bart van den Berg; Verheul, Jolanda; den Blaauwen, Tanneke] Univ Amsterdam, Swammerdam Inst Life Sci, Fac Sci, NL-1098 XH Amsterdam, Netherlands; [Nichols, Robert J.] Univ Calif San Francisco, Oral & Craniofacial Sci Grad Program, San Francisco, CA 94143 USA; [Kannenberg, Kai] Univ Tubingen, D-72076 Tubingen, Germany; [von Rechenberg, Moritz] Prolexys Pharmaceut Inc, Salt Lake City, UT 84116 USA; [Breukink, Eefjan] Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Dept Biochem Membranes, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Newcastle University - UK; University of Amsterdam; University of California System; University of California San Francisco; Eberhard Karls University of Tubingen; Utrecht University	Typas, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	athanasios.typas@ucsf.edu; w.vollmer@ncl.ac.uk	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; den Blaauwen, Tanneke/0000-0002-5403-5597; Banzhaf, Manuel/0000-0002-4682-1037; Typas, Athanasios/0000-0002-0797-9018; van den Berg van Saparoea, Bart/0000-0003-3337-5506	BBSRC [BB/F001231/1]; European Commission [LSHM-CT-2004-512138, HEALTH-F3-2009-223431]; NIH [R01 GM085697, ARRA GM085697-01S1, R01 GM036278, K99GM092984, F31 DE020206-01, T32 DE007306]; Biotechnology and Biological Sciences Research Council [BB/F001231/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE020206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085697, R01GM036278, K99GM092984] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jeff Errington, Dyche Mullins, and Monica Guo for critically reading this manuscript; H. Mori and his lab for sharing mutants of the second E. coli single-gene deletion (ASKA collection) prior to publishing; P. Born for PBP1A; N.K. Bui for PG sacculi; and Sarah Wittmer for help with the model illustration. We would like to thank T. Berhardt, D. Kahne, and their labs for communicating unpublished results. This work was supported by BBSRC BB/F001231/1 to W. V.; European Commission grants EUR-INTAFAR LSHM-CT-2004-512138 to W. V., T.d.B., and E. B. and DIVINOCELL HEALTH-F3-2009-223431 to W. V. and T.d.B.; NIH R01 GM085697, ARRA GM085697-01S1, and R01 GM036278 to C. A. G.; NIH K99GM092984 to A. T.; and NIH F31 DE020206-01 and NIH T32 DE007306 to R.J.N.	Aaron M, 2007, MOL MICROBIOL, V64, P938, DOI 10.1111/j.1365-2958.2007.05720.x; Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; BURMAN LG, 1984, P NATL ACAD SCI-BIOL, V81, P1844, DOI 10.1073/pnas.81.6.1844; CARBALLIDOLO PEZR, 2006, LYTE DEV CELL, V11, P399; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cayley DS, 2000, BIOPHYS J, V78, P1748, DOI 10.1016/S0006-3495(00)76726-9; Chung HS, 2009, P NATL ACAD SCI USA, V106, P21872, DOI 10.1073/pnas.0911674106; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DEJONGE BLM, 1989, J BACTERIOL, V171, P5783, DOI 10.1128/jb.171.11.5783-5794.1989; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; GLAUNER B, 1990, J BIOL CHEM, V265, P18988; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; KOCH AL, 1992, J BACTERIOL, V174, P4811, DOI 10.1128/JB.174.14.4811-4819.1992; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Meisel U, 2003, J BACTERIOL, V185, P5342, DOI 10.1128/JB.185.18.5342-5348.2003; Morlot C, 2010, GENE DEV, V24, P411, DOI 10.1101/gad.1878110; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Sung MT, 2009, P NATL ACAD SCI USA, V106, P8824, DOI 10.1073/pnas.0904030106; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Vasquez-Laslop N, 2001, J BACTERIOL, V183, P2399, DOI 10.1128/JB.183.8.2399-2404.2001; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10; YOUSIF SY, 1985, J GEN MICROBIOL, V131, P2839	44	254	259	2	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1097	1109		10.1016/j.cell.2010.11.038	http://dx.doi.org/10.1016/j.cell.2010.11.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183073	Green Submitted, Green Accepted, hybrid			2022-12-01	WOS:000285625400008
J	Witten, IB; Lin, SC; Brodsky, M; Prakash, R; Diester, I; Anikeeva, P; Gradinaru, V; Ramakrishnan, C; Deisseroth, K				Witten, Ilana B.; Lin, Shih-Chun; Brodsky, Matthew; Prakash, Rohit; Diester, Ilka; Anikeeva, Polina; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl			Cholinergic Interneurons Control Local Circuit Activity and Cocaine Conditioning	SCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; ACETYLCHOLINE-RECEPTORS; RAT NEOSTRIATUM; FIRING PATTERNS; NEURONS; ADDICTION; STRIATUM; NICOTINE; SYSTEMS; REINFORCEMENT	Cholinergic neurons are widespread, and pharmacological modulation of acetylcholine receptors affects numerous brain processes, but such modulation entails side effects due to limitations in specificity for receptor type and target cell. As a result, causal roles of cholinergic neurons in circuits have been unclear. We integrated optogenetics, freely moving mammalian behavior, in vivo electrophysiology, and slice physiology to probe the cholinergic interneurons of the nucleus accumbens by direct excitation or inhibition. Despite representing less than 1% of local neurons, these cholinergic cells have dominant control roles, exerting powerful modulation of circuit activity. Furthermore, these neurons could be activated by cocaine, and silencing this drug-induced activity during cocaine exposure (despite the fact that the manipulation of the cholinergic interneurons was not aversive by itself) blocked cocaine conditioning in freely moving mammals.	[Witten, Ilana B.; Lin, Shih-Chun; Brodsky, Matthew; Prakash, Rohit; Diester, Ilka; Anikeeva, Polina; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Lin, Shih-Chun] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Diester, Ilka/D-4473-2011		Deisseroth lab; Helen Hay Whitney Foundation; National Institute of Neurological Disorders and Stroke; DAAD; Human Frontier Science Program; Stanford Dean's fellowship; Bio-X SIGF; Keck Foundation; Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM; National Institute of Mental Health; National Institute on Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, R01MH086373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	Deisseroth lab; Helen Hay Whitney Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Human Frontier Science Program(Human Frontier Science Program); Stanford Dean's fellowship; Bio-X SIGF; Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM(California Institute for Regenerative Medicine); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the entire Deisseroth lab for their support. I. B. W. is supported by the Helen Hay Whitney Foundation; S.-C. L. is supported by the National Institute of Neurological Disorders and Stroke; I. D. is supported by DAAD and the Human Frontier Science Program; P. A. is supported by the Stanford Dean's fellowship; V. G. is supported by Bio-X SIGF; K. D. is supported by the Keck, Snyder, Woo, Yu, and McKnight Foundations, as well as by CIRM, the National Institute of Mental Health, and the National Institute on Drug Abuse.	Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CARELLI RM, 1994, J NEUROSCI, V14, P7735; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Changeux JP, 2009, CR BIOL, V332, P421, DOI 10.1016/j.crvi.2009.02.005; Chen BT, 2010, ANN NY ACAD SCI, V1187, P129, DOI 10.1111/j.1749-6632.2009.05154.x; Crespo JA, 2006, J NEUROSCI, V26, P6004, DOI 10.1523/JNEUROSCI.4494-05.2006; de Rover M, 2002, EUR J NEUROSCI, V16, P2279, DOI 10.1046/j.1460-9568.2002.02289.x; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Hoebel BG, 2007, CURR OPIN PHARMACOL, V7, P617, DOI 10.1016/j.coph.2007.10.014; Hrabovska A, 2010, CHEM-BIOL INTERACT, V183, P194, DOI 10.1016/j.cbi.2009.09.025; Ikemoto S, 1998, PHYSIOL BEHAV, V63, P811, DOI 10.1016/S0031-9384(98)00007-9; Inokawa H, 2010, NEUROSCIENCE, V168, P395, DOI 10.1016/j.neuroscience.2010.03.062; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Krause M, 2010, J NEUROSCI, V30, P4746, DOI 10.1523/JNEUROSCI.0197-10.2010; Maskos U, 2008, BRIT J PHARMACOL, V153, pS438, DOI 10.1038/bjp.2008.5; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Nisell M, 1997, J NEURAL TRANSM, V104, P1, DOI 10.1007/BF01271290; Peoples LL, 1996, J NEUROSCI, V16, P3459; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Pratt WE, 2007, BEHAV NEUROSCI, V121, P1215, DOI 10.1037/0735-7044.121.6.1215; Pratt WE, 2004, BEHAV NEUROSCI, V118, P730, DOI 10.1037/0735-7044.118.4.730; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Williams MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1779, DOI 10.1038/sj.npp.1301585; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wise R A, 1984, NIDA Res Monogr, V50, P15; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; Zhou FM, 2002, J NEUROBIOL, V53, P590, DOI 10.1002/neu.10150	39	329	372	0	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1677	1681		10.1126/science.1193771	http://dx.doi.org/10.1126/science.1193771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164015	Green Accepted			2022-12-01	WOS:000285390500067
J	Bennett, EJ; Rush, J; Gygi, SP; Harper, JW				Bennett, Eric J.; Rush, John; Gygi, Steven P.; Harper, J. Wade			Dynamics of Cullin-RING Ubiquitin Ligase Network Revealed by Systematic Quantitative Proteomics	CELL			English	Article							NEDD8; ACTIVATION; JAB1/CSN5; INHIBITOR; CSN; SCF	Dynamic reorganization of signaling systems frequently accompanies pathway perturbations, yet quantitative studies of network remodeling by pathway stimuli are lacking. Here, we report the development of a quantitative proteomics platform centered on multiplex absolute quantification (AQUA) technology to elucidate the architecture of the cullin-RING ubiquitin ligase (CRL) network and to evaluate current models of dynamic CRL remodeling. Current models suggest that CRL complexes are controlled by cycles of CRL deneddylation and CAND1 binding. Contrary to expectations, acute CRL inhibition with MLN4924, an inhibitor of the NEDD8-activating enzyme, does not result in a global reorganization of the CRL network. Examination of CRL complex stoichiometry reveals that, independent of cullin neddylation, a large fraction of cullins are assembled with adaptor modules, whereas only a small fraction are associated with CAND1. These studies suggest an alternative model of CRL dynamicity where the abundance of adaptor modules, rather than cycles of neddylation and CAND1 binding, drives CRL network organization.	[Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bennett, Eric J.; Gygi, Steven P.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rush, John] Cell Signaling Technol, Danvers, MA 01923 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	Millennium Pharmaceuticals; National Institutes of Health; Stewart Trust; Damon Runyon Cancer Research Foundation [DRG 1974-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565, R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stewart Trust; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Woong Kim, Ryan Kunz, and Fiona McAllister from the Gygi laboratory (Harvard Medical School) for assistance with the AQUA analysis, Harper lab members John Lydeard for reagents, Mat Sowa for bioinformatics assistance, and Brenda O'Connell for a critical reading of the manuscript. This work was supported by grants to J.W.H. from Millennium Pharmaceuticals, the National Institutes of Health, and the Stewart Trust. E.J.B. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG 1974-08). J.W.H. is a consultant for Millennium Pharmaceuticals. J.R. is an employee of Cell Signaling Technologies.	Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bosu DR, 2010, DEV BIOL, V346, P113, DOI 10.1016/j.ydbio.2010.07.020; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Olma MH, 2009, J CELL SCI, V122, P1035, DOI 10.1242/jcs.043539; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Siergiejuk E, 2009, EMBO J, V28, P3845, DOI 10.1038/emboj.2009.354; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhang WJ, 2008, P NATL ACAD SCI USA, V105, P8470, DOI 10.1073/pnas.0804144105; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	29	262	264	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					951	965		10.1016/j.cell.2010.11.017	http://dx.doi.org/10.1016/j.cell.2010.11.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145461	Bronze, Green Accepted			2022-12-01	WOS:000285182600012
J	van Wageningen, S; Kemmeren, P; Lijnzaad, P; Margaritis, T; Benschop, JJ; de Castro, IJ; van Leenen, D; Koerkamp, MJAG; Ko, CW; Miles, AJ; Brabers, N; Brok, MO; Lenstra, TL; Fiedler, D; Fokkens, L; Aldecoa, R; Apweiler, E; Taliadouros, V; Sameith, K; van de Pasch, LAL; van Hooff, SR; Bakker, LV; Krogan, NJ; Snel, B; Holstege, FCP				van Wageningen, Sake; Kemmeren, Patrick; Lijnzaad, Philip; Margaritis, Thanasis; Benschop, Joris J.; de Castro, Ines J.; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Ko, Cheuk W.; Miles, Antony J.; Brabers, Nathalie; Brok, Mariel O.; Lenstra, Tineke L.; Fiedler, Dorothea; Fokkens, Like; Aldecoa, Rodrigo; Apweiler, Eva; Taliadouros, Virginia; Sameith, Katrin; van de Pasch, Loes A. L.; van Hooff, Sander R.; Bakker, Linda V.; Krogan, Nevan J.; Snel, Berend; Holstege, Frank C. P.			Functional Overlap and Regulatory Links Shape Genetic Interactions between Signaling Pathways	CELL			English	Article							ACTIVATED PROTEIN-KINASE; 2C SER/THR PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHATASES; ACTIN CYTOSKELETON; DUPLICATED GENES; BACKUP CIRCUITS; YEAST; NETWORK; CELL	To understand relationships between phosphorylation-based signaling pathways, we analyzed 150 deletion mutants of protein kinases and phosphatases in S. cerevisiae using DNA microarrays. Downstream changes in gene expression were treated as a phenotypic readout. Double mutants with synthetic genetic interactions were included to investigate genetic buffering relationships such as redundancy. Three types of genetic buffering relationships are identified: mixed epistasis, complete redundancy, and quantitative redundancy. In mixed epistasis, the most common buffering relationship, different gene sets respond in different epistatic ways. Mixed epistasis arises from pairs of regulators that have only partial overlap in function and that are coupled by additional regulatory links such as repression of one by the other. Such regulatory modules confer the ability to control different combinations of processes depending on condition or context. These properties likely contribute to the evolutionary maintenance of paralogs and indicate a way in which signaling pathways connect for multiprocess control.	[van Wageningen, Sake; Kemmeren, Patrick; Lijnzaad, Philip; Margaritis, Thanasis; Benschop, Joris J.; de Castro, Ines J.; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Ko, Cheuk W.; Miles, Antony J.; Brabers, Nathalie; Brok, Mariel O.; Lenstra, Tineke L.; Aldecoa, Rodrigo; Apweiler, Eva; Taliadouros, Virginia; Sameith, Katrin; van de Pasch, Loes A. L.; van Hooff, Sander R.; Bakker, Linda V.; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Fiedler, Dorothea; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Fokkens, Like; Snel, Berend] Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Lijnzaad, Philip; Bakker, Linda V.] Netherlands Bioinformat Ctr, NL-6525 GA Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; Utrecht University	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Univ Weg 100, Utrecht, Netherlands.	f.c.p.holstege@umcutrecht.nl	Holstege, Frank/AAM-9944-2021; Aldecoa, Rodrigo/I-3569-2012; Lenstra, Tineke/L-3958-2016; Lenstra, Tineke/E-9429-2013; Benschop, Joris j/C-7809-2012; Lijnzaad, Philip/ABE-4205-2021; Snel, Berend/B-8886-2011	Lenstra, Tineke/0000-0002-4440-9962; Lijnzaad, Philip/0000-0002-7535-583X; Snel, Berend/0000-0002-5804-8547; Kemmeren, Patrick/0000-0003-2237-7354; Sameith, Katrin/0000-0003-4306-930X; Fokkens, Like/0000-0001-6696-4409; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Aldecoa, Rodrigo/0000-0002-8041-3416; de Castro, Ines/0000-0001-8710-3667	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO) [016.108.607, 817.02.015, 050.71.057, 911.06.009, 021.002.035, 863.07.007, 700.57.407]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Netherlands Bioinformatics Centre (NBIC) and the Netherlands Organization of Scientific Research (NWO), grants 016.108.607, 817.02.015, 050.71.057, 911.06.009, 021.002.035 (T. L. L.), 863.07.007 (P. K.), 700.57.407 (J.J.B.).	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; Erdman S, 2001, GENETICS, V159, P919; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; INNAN H, 1997, J BIOL CHEM, V1, P17749; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kiel C, 2010, CELL, V140, P33, DOI 10.1016/j.cell.2009.12.028; MA D, 1995, MOL BIOL CELL, V6, P889, DOI 10.1091/mbc.6.7.889; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rodriguez-Pena JM, 2005, MICROBIOL-SGM, V151, P2241, DOI 10.1099/mic.0.27989-0; ROTH FP, 2009, EMBO REP, V4, P246; van Bakel H, 2004, EMBO REP, V5, P964, DOI 10.1038/sj.embor.7400253; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Young C, 2002, EUKARYOT CELL, V1, P1032, DOI 10.1128/EC.1.6.1032-1040.2002; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759	44	98	101	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 10	2010	143	6					991	1004		10.1016/j.cell.2010.11.021	http://dx.doi.org/10.1016/j.cell.2010.11.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145464	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000285182600015
J	Ko, M; Huang, Y; Jankowska, AM; Pape, UJ; Tahiliani, M; Bandukwala, HS; An, J; Lamperti, ED; Koh, KP; Ganetzky, R; Liu, XS; Aravind, L; Agarwal, S; Maciejewski, JP; Rao, A				Ko, Myunggon; Huang, Yun; Jankowska, Anna M.; Pape, Utz J.; Tahiliani, Mamta; Bandukwala, Hozefa S.; An, Jungeun; Lamperti, Edward D.; Koh, Kian Peng; Ganetzky, Rebecca; Liu, X. Shirley; Aravind, L.; Agarwal, Suneet; Maciejewski, Jaroslaw P.; Rao, Anjana			Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2	NATURE			English	Article							DNA METHYLATION; MUTATIONS; MALIGNANCIES; THERAPY; COMMON; HYPOMETHYLATION; MYELOFIBROSIS; EPIGENETICS; CONVERSION; NEOPLASMS	TET2 is a close relative of TET1, an enzyme that converts 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA(1,2). The gene encoding TET2 resides at chromosome 4q24, in a region showing recurrent microdeletions and copy-neutral loss of heterozygosity (CN-LOH) in patients with diverse myeloid malignancies(3). Somatic TET2 mutations are frequently observed in myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), MDS/MPN overlap syndromes including chronic myelomonocytic leukaemia (CMML), acute myeloid leukaemias (AML) and secondary AML (sAML)(4-12). We show here that TET2 mutations associated with myeloid malignancies compromise catalytic activity. Bone marrow samples from patients with TET2 mutations displayed uniformly low levels of 5hmC in genomic DNA compared to bone marrow samples from healthy controls. Moreover, small hairpin RNA (shRNA)-mediated depletion of Tet2 in mouse haematopoietic precursors skewed their differentiation towards monocyte/macrophage lineages in culture. There was no significant difference in DNA methylation between bone marrow samples from patients with high 5hmC versus healthy controls, but samples from patients with low 5hmC showed hypomethylation relative to controls at the majority of differentially methylated CpG sites. Our results demonstrate that Tet2 is important for normal myelopoiesis, and suggest that disruption of TET2 enzymatic activity favours myeloid tumorigenesis. Measurement of 5hmC levels in myeloid malignancies may prove valuable as a diagnostic and prognostic tool, to tailor therapies and assess responses to anticancer drugs.	[Ko, Myunggon; Huang, Yun; Pape, Utz J.; Tahiliani, Mamta; Bandukwala, Hozefa S.; An, Jungeun; Lamperti, Edward D.; Koh, Kian Peng; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA; [Ko, Myunggon; Huang, Yun; Pape, Utz J.; Tahiliani, Mamta; Bandukwala, Hozefa S.; An, Jungeun; Lamperti, Edward D.; Koh, Kian Peng; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Jankowska, Anna M.; Ganetzky, Rebecca; Maciejewski, Jaroslaw P.] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44195 USA; [Jankowska, Anna M.; Ganetzky, Rebecca; Maciejewski, Jaroslaw P.] Cleveland Clin, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44195 USA; [Pape, Utz J.; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Pape, Utz J.; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Agarwal, Suneet] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet] Harvard Stem Cell Inst, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	maciejj@ccf.org; arao@idi.harvard.edu	Koh, Kian Peng/S-6279-2016	Koh, Kian Peng/0000-0003-2523-5175; Aravind, L/0000-0003-0771-253X; Ko, Myunggon/0000-0002-6007-2570; Ganetzky, Rebecca/0000-0001-6238-8109; Huang, Yun/0000-0001-5950-9168	NIH [R01 AI44432, RC1 DA028422, K24 HL077522, R01 HL098522, R01 HG4069]; Aplastic Anemia MDS Foundation; Bob Duggan Memorial Research Fund; Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH) [1 UL1 RR 025758-02]; GlaxoSmithKline-Immune Disease Institute (GSK-IDI) Alliance; Leukemia and Lymphoma Society of America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA042471] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150, K24HL077522] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aplastic Anemia MDS Foundation; Bob Duggan Memorial Research Fund; Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline-Immune Disease Institute (GSK-IDI) Alliance; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01 AI44432 and RC1 DA028422 (to A.R.), NIH grants K24 HL077522 and R01 HL098522, an Established Investigator award from the Aplastic Anemia & MDS Foundation, and an award from the Bob Duggan Memorial Research Fund (to J.P.M), NIH grant R01 HG4069 (to X.S.L.) and a pilot grant from Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH Grant #1 UL1 RR 025758-02, to S.A.). Y.H. was supported by postdoctoral fellowships from the GlaxoSmithKline-Immune Disease Institute (GSK-IDI) Alliance and the Leukemia and Lymphoma Society of America. H.S.B. is supported by a postdoctoral fellowship from the GSK-IDI Alliance.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lengauer C, 2003, SCIENCE, V300, P442, DOI 10.1126/science.1084468; Levine RL, 2009, NEW ENGL J MED, V360, P2355, DOI 10.1056/NEJMe0902257; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mullighan CG, 2009, NAT GENET, V41, P766, DOI 10.1038/ng0709-766; Smith LT, 2007, TRENDS GENET, V23, P449, DOI 10.1016/j.tig.2007.07.005; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Tefferi A, 2008, LEUKEMIA LYMPHOMA, V49, P2231, DOI 10.1080/10428190802578866; Viguie F, 2005, LEUKEMIA, V19, P1411, DOI 10.1038/sj.leu.2403818; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413	26	980	1029	1	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					839	843		10.1038/nature09586	http://dx.doi.org/10.1038/nature09586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21057493	Green Accepted			2022-12-01	WOS:000285093700049
J	Eden, E; Geva-Zatorsky, N; Issaeva, I; Cohen, A; Dekel, E; Danon, T; Cohen, L; Mayo, A; Alon, U				Eden, Eran; Geva-Zatorsky, Naama; Issaeva, Irina; Cohen, Ariel; Dekel, Erez; Danon, Tamar; Cohen, Lydia; Mayo, Avi; Alon, Uri			Proteome Half-Life Dynamics in Living Human Cells	SCIENCE			English	Article							ASSISTED LIGHT INACTIVATION; UBIQUITIN; OVEREXPRESSION; PROTEASOME; LIBRARY; CANCER; GENES; YEAST	Cells remove proteins by two processes: degradation and dilution due to cell growth. The balance between these basic processes is poorly understood. We addressed this by developing an accurate and noninvasive method for measuring protein half-lives, called "bleach-chase," that is applicable to fluorescently tagged proteins. Assaying 100 proteins in living human cancer cells showed half-lives that ranged between 45 minutes and 22.5 hours. A variety of stresses that stop cell division showed the same general effect: Long-lived proteins became longer-lived, whereas short-lived proteins remained largely unaffected. This effect is due to the relative strengths of degradation and dilution and suggests a mechanism for differential killing of rapidly growing cells by growth-arresting drugs. This approach opens a way to understand proteome half-life dynamics in living cells.	[Eden, Eran; Geva-Zatorsky, Naama; Issaeva, Irina; Cohen, Ariel; Dekel, Erez; Danon, Tamar; Cohen, Lydia; Mayo, Avi; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Eden, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	eraneden@gmail.com; urialon@weizmann.ac.il	mayo, avi/N-3756-2019; MAYO, AVI E/K-1736-2012; Geva-Zatorsky, Naama/AAP-9176-2021	mayo, avi/0000-0002-4479-3423; Geva-Zatorsky, Naama/0000-0002-7303-854X	European Research Council; Israel Science Foundation; Kahn Family Foundation	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Kahn Family Foundation	We thank Z. Yakhini, Z. Kam, R. Milo, S. Sela, and A. Ciechanover for discussions and P. Choukroun for technical assistance. We acknowledge support by the European Research Council, the Israel Science Foundation, and the Kahn Family Foundation. The Weizmann Institute of Science has filed for a patent on the technology described in this report for measuring protein half-lives.	Alon U., 2007, INTRO SYSTEMS BIOL; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; LIU HP, 1992, GENETICS, V132, P665; MONOD J, 1952, BIOCHIM BIOPHYS ACTA, V9, P648, DOI 10.1016/0006-3002(52)90227-8; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; SCHIMKE RT, 1970, ANNU REV BIOCHEM, V39, P929, DOI 10.1146/annurev.bi.39.070170.004433; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Tour O, 2003, NAT BIOTECHNOL, V21, P1505, DOI 10.1038/nbt914; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	17	219	220	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					764	768		10.1126/science.1199784	http://dx.doi.org/10.1126/science.1199784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21233346				2022-12-01	WOS:000287205700069
J	Varela, I; Tarpey, P; Raine, K; Huang, D; Ong, CK; Stephens, P; Davies, H; Jones, D; Lin, ML; Teague, J; Bignell, G; Butler, A; Cho, J; Dalgliesh, GL; Galappaththige, D; Greenman, C; Hardy, C; Jia, MM; Latimer, C; Lau, KW; Marshall, J; McLaren, S; Menzies, A; Mudie, L; Stebbings, L; Largaespada, DA; Wessels, LFA; Richard, S; Kahnoski, RJ; Anema, J; Tuveson, DA; Perez-Mancera, PA; Mustonen, V; Fischer, A; Adams, DJ; Rust, A; Chan-on, W; Subimerb, C; Dykema, K; Furge, K; Campbell, PJ; Teh, BT; Stratton, MR; Futreal, PA				Varela, Ignacio; Tarpey, Patrick; Raine, Keiran; Huang, Dachuan; Ong, Choon Kiat; Stephens, Philip; Davies, Helen; Jones, David; Lin, Meng-Lay; Teague, Jon; Bignell, Graham; Butler, Adam; Cho, Juok; Dalgliesh, Gillian L.; Galappaththige, Danushka; Greenman, Chris; Hardy, Claire; Jia, Mingming; Latimer, Calli; Lau, King Wai; Marshall, John; McLaren, Stuart; Menzies, Andrew; Mudie, Laura; Stebbings, Lucy; Largaespada, David A.; Wessels, L. F. A.; Richard, Stephane; Kahnoski, Richard J.; Anema, John; Tuveson, David A.; Perez-Mancera, Pedro A.; Mustonen, Ville; Fischer, Andrej; Adams, David J.; Rust, Alistair; Chan-on, Waraporn; Subimerb, Chutima; Dykema, Karl; Furge, Kyle; Campbell, Peter J.; Teh, Bin Tean; Stratton, Michael R.; Futreal, P. Andrew			Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma	NATURE			English	Article							TUMOR-SUPPRESSOR GENE; CELL CARCINOMA; CANCER; MUTAGENESIS; BAF180; ARID1A; MOUSE; INACTIVATION; SENESCENCE; INDUCTION	The genetics of renal cancer is dominated by inactivation of the VHL tumour suppressor gene in clear cell carcinoma (ccRCC), the commonest histological subtype. A recent large-scale screen of similar to 3,500 genes by PCR-based exon re-sequencing identified several new cancer genes in ccRCC including UTX (also known as KDM6A)(1), JARID1C (also known as KDM5C) and SETD2 (ref. 2). These genes encode enzymes that demethylate (UTX, JARID1C) or methylate (SETD2) key lysine residues of histone H3. Modification of the methylation state of these lysine residues of histone H3 regulates chromatin structure and is implicated in transcriptional control(3). However, together these mutations are present in fewer than 15% of ccRCC, suggesting the existence of additional, currently unidentified cancer genes. Here, we have sequenced the protein coding exome in a series of primary ccRCC and report the identification of the SWI/SNF chromatin remodelling complex gene PBRM1 (ref. 4) as a second major ccRCC cancer gene, with truncating mutations in 41% (92/227) of cases. These data further elucidate the somatic genetic architecture of ccRCC and emphasize the marked contribution of aberrant chromatin biology.	[Huang, Dachuan; Ong, Choon Kiat; Chan-on, Waraporn; Subimerb, Chutima; Teh, Bin Tean] Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, Singapore 169610, Singapore; [Varela, Ignacio; Tarpey, Patrick; Raine, Keiran; Stephens, Philip; Davies, Helen; Jones, David; Lin, Meng-Lay; Teague, Jon; Bignell, Graham; Butler, Adam; Cho, Juok; Dalgliesh, Gillian L.; Galappaththige, Danushka; Greenman, Chris; Hardy, Claire; Jia, Mingming; Latimer, Calli; Lau, King Wai; Marshall, John; McLaren, Stuart; Menzies, Andrew; Mudie, Laura; Stebbings, Lucy; Campbell, Peter J.; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Largaespada, David A.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Wessels, L. F. A.] Netherlands Canc Inst, Dept Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Richard, Stephane] Fac Med Paris Sud, INSERM, U753, Genet Oncol EPHE, F-94805 Villejuif, France; [Richard, Stephane] Inst Cancerol Gustave Roussy, F-94805 Villejuif, France; [Richard, Stephane] Hop Bicetre, AP HP, Serv Urol, Ctr Expert Natl Canc Rares INCa PREDIR, F-94276 Le Kremlin Bicetre, France; [Kahnoski, Richard J.; Anema, John] Spectrum Hlth Hosp, Dept Urol, Grand Rapids, MI 49503 USA; [Tuveson, David A.; Perez-Mancera, Pedro A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Mustonen, Ville; Fischer, Andrej; Adams, David J.; Rust, Alistair] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Fischer, Andrej] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany; [Dykema, Karl; Furge, Kyle] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI 49503 USA; [Teh, Bin Tean] DUKE NUS Grad Med Sch, Lab Canc Therapeut, Singapore, Singapore; [Teh, Bin Tean] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	National Cancer Centre Singapore (NCCS); Wellcome Trust Sanger Institute; University of Minnesota System; University of Minnesota Twin Cities; Netherlands Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Paris Saclay; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Cologne; Van Andel Institute; National University of Singapore; Van Andel Institute; University of London; Institute of Cancer Research - UK	Teh, BT (corresponding author), Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, 11 Hosp Dr, Singapore 169610, Singapore.	Bin.Teh@vai.org; mrs@sanger.ac.uk; paf@sanger.ac.uk	Mustonen, Ville/J-1155-2018; Varela, Ignacio/G-1699-2016; Mustonen, Ville/X-1599-2019; Varela, Ignacio/AAA-7680-2021; Largaespada, David/C-9832-2014; Dalgliesh, Gillian/B-7799-2008	Mustonen, Ville/0000-0002-7270-1792; Varela, Ignacio/0000-0002-0969-506X; Mustonen, Ville/0000-0002-7270-1792; Varela, Ignacio/0000-0002-0969-506X; Raine, Keiran/0000-0002-5634-1539; HUANG, DACHUAN/0000-0002-7518-4081; Ong, Choon Kiat/0000-0001-6402-4288; Rust, Alistair/0000-0001-7287-192X; Dalgliesh, Gillian/0000-0001-8526-5064; Adams, David/0000-0001-9490-0306; Teh, Bin Tean/0000-0003-1514-1124	Wellcome Trust [077012/Z/05/Z]; Lee Foundation; International Human Frontier Science Program Organization; Cancer Research UK; University of Cambridge; Van Andel Research Institute; NATIONAL CANCER INSTITUTE [R01CA113636, R01CA134759] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Lee Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program); Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); Van Andel Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P.A.F. and M.R.S. would like to acknowledge the Wellcome Trust for support under grant reference 077012/Z/05/Z and A. Coffey, D. Turner and L. Mamanova for assistance with the exon capture. K.F., K.D. and B.T.T. acknowledge the support of the Van Andel Research Institute. B.T.T. would like to acknowledge support from the Lee Foundation. I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. D.J.A. acknowledges the support of Cancer Research UK. D.A.T. and P.A.P.-M. acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampo and thank W. Howatt, A. Hazelhurst and colleagues in the CRI core facilities for their support. B.T.T. would like to dedicate this work to Tat Hock Teh.	Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Chandrasekaran R, 2007, BIOCHEM BIOPH RES CO, V355, P661, DOI 10.1016/j.bbrc.2007.01.193; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kenneth NS, 2009, J BIOL CHEM, V284, P4123, DOI 10.1074/jbc.M808491200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Sekine I, 2005, ONCOGENE, V24, P2735, DOI 10.1038/sj.onc.1207694; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Thompson M, 2009, BIOCHIMIE, V91, P309, DOI 10.1016/j.biochi.2008.10.019; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wong AKC, 2000, CANCER RES, V60, P6171; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	30	910	1025	1	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					539	542		10.1038/nature09639	http://dx.doi.org/10.1038/nature09639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21248752	Green Accepted, Green Submitted			2022-12-01	WOS:000286596500034
J	Kasten, MM; Clapier, CR; Cairns, BR				Kasten, Margaret M.; Clapier, Cedric R.; Cairns, Bradley R.			SnapShot: Chromatin Remodeling: SWI/SNF	CELL			English	Editorial Material							NUCLEOSOME COMPLEX		[Kasten, Margaret M.; Clapier, Cedric R.; Cairns, Bradley R.] Univ Utah, HHMI, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Kasten, MM (corresponding author), Univ Utah, HHMI, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060415] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Leschziner AE, 2005, STRUCTURE, V13, P267, DOI 10.1016/j.str.2004.12.008; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Skiniotis G, 2007, J BIOL CHEM, V282, P20804, DOI 10.1074/jbc.C700081200; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90300-S	10	34	38	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2								10.1016/j.cell.2011.01.007	http://dx.doi.org/10.1016/j.cell.2011.01.007			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241897	Bronze			2022-12-01	WOS:000286459900014
J	Novershtern, N; Subramanian, A; Lawton, LN; Mak, RH; Haining, WN; McConkey, ME; Habib, N; Yosef, N; Chang, CY; Shay, T; Frampton, GM; Drake, ACB; Leskov, I; Nilsson, B; Preffer, F; Dombkowski, D; Evans, JW; Liefeld, T; Smutko, JS; Chen, JZ; Friedman, N; Young, RA; Golub, TR; Regev, A; Ebert, BL				Novershtern, Noa; Subramanian, Aravind; Lawton, Lee N.; Mak, Raymond H.; Haining, W. Nicholas; McConkey, Marie E.; Habib, Naomi; Yosef, Nir; Chang, Cindy Y.; Shay, Tal; Frampton, Garrett M.; Drake, Adam C. B.; Leskov, Ilya; Nilsson, Bjorn; Preffer, Fred; Dombkowski, David; Evans, John W.; Liefeld, Ted; Smutko, John S.; Chen, Jianzhu; Friedman, Nir; Young, Richard A.; Golub, Todd R.; Regev, Aviv; Ebert, Benjamin L.			Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; ERYTHROID-DIFFERENTIATION; EXPRESSION PROFILES; MODULE NETWORKS; T-CELLS; GENE; BINDING; LINE; ERYTHROPOIESIS	Though many individual transcription factors are known to regulate hematopoietic differentiation, major aspects of the global architecture of hematopoiesis remain unknown. Here, we profiled gene expression in 38 distinct purified populations of human hematopoietic cells and used probabilistic models of gene expression and analysis of cis-elements in gene promoters to decipher the general organization of their regulatory circuitry. We identified modules of highly coexpressed genes, some of which are restricted to a single lineage but most of which are expressed at variable levels across multiple lineages. We found densely interconnected cis-regulatory circuits and a large number of transcription factors that are differentially expressed across hematopoietic states. These findings suggest a more complex regulatory system for hematopoiesis than previously assumed.	[Novershtern, Noa; Subramanian, Aravind; Mak, Raymond H.; Yosef, Nir; Chang, Cindy Y.; Shay, Tal; Nilsson, Bjorn; Liefeld, Ted; Golub, Todd R.; Regev, Aviv; Ebert, Benjamin L.] Broad Inst, Cambridge, MA 02142 USA; [Novershtern, Noa; Frampton, Garrett M.; Drake, Adam C. B.; Leskov, Ilya; Chen, Jianzhu; Young, Richard A.; Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [Novershtern, Noa; Habib, Naomi; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci, IL-91904 Jerusalem, Israel; [Lawton, Lee N.; Frampton, Garrett M.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Haining, W. Nicholas; Evans, John W.; Golub, Todd R.; Ebert, Benjamin L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [McConkey, Marie E.; Chang, Cindy Y.; Nilsson, Bjorn; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Drake, Adam C. B.; Leskov, Ilya; Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Dombkowski, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Smutko, John S.] Nugen Technol, San Carlos, CA 94070 USA; [Golub, Todd R.; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Regev, A (corresponding author), Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; bebert@partners.org	Friedman, Nir/H-9692-2012; Shay, Tal/J-4028-2016; Habib, Naomi/AAA-8937-2020; Young, Richard A/F-6495-2012	Friedman, Nir/0000-0002-9678-3550; Shay, Tal/0000-0003-0755-1350; Young, Richard A/0000-0001-8855-8647; Novershtern, Noa/0000-0002-2244-6877; Mak, Raymond/0000-0002-8754-0565; Frampton, Garrett/0000-0002-2361-2750	NIH [R01 HL082945, P01 CA108631]; Burroughs-Wellcome Fund; Landon and Lavinia Clay; HHMI; NATIONAL CANCER INSTITUTE [P01CA066996, RC1CA145229, P01CA108631] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL082448, R01HL082945] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Landon and Lavinia Clay; HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Lander, I. Amit, and I. Gat-Viks for critical review of the manuscript; D. Scadden for helpful discussions; L. Gaffney and S. Hart for assistance with figure generation; and D. Peck, J. Lamb, R. Onofrio, and the Broad Genetic Analysis Platform for assistance with expression arrays. The work was funded by the NIH (grants R01 HL082945 and P01 CA108631 to B.L.E. and the PIONEER award to A.R.), the Burroughs-Wellcome Fund (CAMS to B.L.E. and CASI to A.R.), funds from Landon and Lavinia Clay (R.A.Y.) and HHMI (T.R.G. and A.R.). A.R. is an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. J.S.S. is an employee of NuGEN Technologies, Inc.	Akashi K, 2005, ANN NY ACAD SCI, V1044, P125, DOI 10.1196/annals.1349.016; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Bakker WJ, 2007, MOL CELL BIOL, V27, P3839, DOI 10.1128/MCB.01662-06; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Davidson E. H., 2001, DEV EVOLUTION; Ebert BL, 2004, BLOOD, V104, P923, DOI 10.1182/blood-2004-01-0274; Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lee HM, 2010, BLOOD, V116, P720, DOI 10.1182/blood-2009-11-253872; Li QZ, 1998, BLOOD, V92, P3841, DOI 10.1182/blood.V92.10.3841.422k02_3841_3847; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mitelman F, 2010, MITELMAN DATABASE CH; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; QUESENBERRY PJ, 2005, WILLIAMS HEMATOLOGY, P153; Rincon-Arano H, 2005, J MOL BIOL, V349, P961, DOI 10.1016/j.jmb.2005.04.040; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Segal E, 2005, J MACH LEARN RES, V6, P557; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	56	621	637	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					296	309		10.1016/j.cell.2011.01.004	http://dx.doi.org/10.1016/j.cell.2011.01.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241896	Green Accepted, Bronze, Green Published, Green Submitted			2022-12-01	WOS:000286459900013
J	Levy, O; Kaniewska, P; Alon, S; Eisenberg, E; Karako-Lampert, S; Bay, LK; Reef, R; Rodriguez-Lanetty, M; Miller, DJ; Hoegh-Guldberg, O				Levy, O.; Kaniewska, P.; Alon, S.; Eisenberg, E.; Karako-Lampert, S.; Bay, L. K.; Reef, R.; Rodriguez-Lanetty, M.; Miller, D. J.; Hoegh-Guldberg, O.			Complex Diel Cycles of Gene Expression in Coral-Algal Symbiosis	SCIENCE			English	Article							ACROPORA-MILLEPORA; LIGHT		[Bay, L. K.; Miller, D. J.; Hoegh-Guldberg, O.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Levy, O.; Karako-Lampert, S.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Levy, O.; Kaniewska, P.; Reef, R.; Rodriguez-Lanetty, M.; Hoegh-Guldberg, O.] Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia; [Alon, S.] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Eisenberg, E.] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Reef, R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Rodriguez-Lanetty, M.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA	James Cook University; Bar Ilan University; University of Queensland; Tel Aviv University; Tel Aviv University; University of Queensland; University of Louisiana Lafayette	Miller, DJ (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	David.Miller@jcu.edu.au; oveh@uq.edu.au	Hoegh-Guldberg, Ove/H-6169-2011; Hoegh-Guldberg, Ove/ABA-5420-2020; Eisenberg, Eli/D-2587-2009; Bay, Line/D-4037-2009	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Eisenberg, Eli/0000-0001-8681-3202; Reef, Ruth/0000-0001-6639-520X	Australian Research Council; Israel Science Foundation [699/06]; Division Of Ocean Sciences [1321500] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); Israel Science Foundation(Israel Science Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Y. Gothilf for critical discussions and N. Simon-Blecher for assistance in collecting coral samples. This work was supported by the Australian Research Council (O.H.-G. and D.J.M.) and Israel Science Foundation grant no. 699/06. Microarray data are Minimum Information About a Microarray Experiment (MIAME)-compliant and deposited under accession number GSE21658 (National Center for Biotechnology Information GEO). HIF ortholog present in A. millepora (GenBank identification EZ037157).	Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241	9	96	96	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					175	175		10.1126/science.1196419	http://dx.doi.org/10.1126/science.1196419			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233378				2022-12-01	WOS:000286433100031
J	Murry, CE; Pu, WT				Murry, Charles E.; Pu, William T.			Reprogramming Fibroblasts into Cardiomyocytes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Murry, Charles E.] Univ Washington, Dept Pathol, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Pu, William T.] Harvard Stem Cell Inst, Cambridge, MA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard University	Murry, CE (corresponding author), Univ Washington, Dept Pathol, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.		Pu, William/AAJ-8301-2020	Pu, William/0000-0002-4551-8079	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094683, R01HL084642, RC1HL099618, U01HL100401] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL084642, U01 HL100401, R01 HL094683, RC1 HL099618] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	4	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					177	178		10.1056/NEJMcibr1013069	http://dx.doi.org/10.1056/NEJMcibr1013069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226585	Green Accepted			2022-12-01	WOS:000286142900015
J	Chell, JM; Brand, AH				Chell, James M.; Brand, Andrea H.			Nutrition-Responsive Glia Control Exit of Neural Stem Cells from Quiescence	CELL			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; DROSOPHILA INSULIN-RECEPTOR; ADULT MAMMALIAN BRAIN; PHOSPHOINOSITIDE 3-KINASE; LARVAL BRAIN; POSTEMBRYONIC NEUROBLASTS; PROLIFERATION ACTIVATION; TRANSCRIPTION FACTORS; TEMPORAL IDENTITY	The systemic regulation of stem cells ensures that they meet the needs of the organism during growth and in response to injury. A key point of regulation is the decision between quiescence and proliferation. During development, Drosophila neural stem cells (neuroblasts) transit through a period of quiescence separating distinct embryonic and postembryonic phases of proliferation. It is known that neuroblasts exit quiescence via a hitherto unknown pathway in response to a nutrition-dependent signal from the fat body. We have identified a population of glial cells that produce insulin/IGF-like peptides in response to nutrition, and we show that the insulin/IGF receptor pathway is necessary for neuroblasts to exit quiescence. The forced expression of insulin/IGF-like peptides in glia, or activation of PI3K/Akt signaling in neuroblasts, can drive neuroblast growth and proliferation in the absence of dietary protein and thus uncouple neuroblasts from systemic control.	[Chell, James M.; Brand, Andrea H.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Chell, James M.; Brand, Andrea H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Brand, AH (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ahb@mole.bio.cam.ac.uk	Brand, Andrea H/F-8220-2014	Brand, Andrea H/0000-0002-2089-6954	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank H. Stocker, E. Hafen, S. Bray, S. Leevers, T. Xu, E. Rulifson, C. Doe, J. Skeath, S. Baumgartner, Y. Bellaiche, S. Gronke, L. Partridge, L. Cooley, I. Miguel-Aliaga, the DSHB, and the Bloomington Drosophila Stock Center for reagents. We thank K. Edoff for assistance with confocal microscopy, T. Southall for assistance with microinjection, and Pao-Shu Wu for Q-PCR wisdom. This work was funded by a Wellcome Trust four-year PhD studentship to J. M. C. and a Wellcome Trust Programme Grant to A.H.B.	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alam S, 2004, BIOTECHNOL BIOENG, V88, P332, DOI 10.1002/bit.20246; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; DATTA S, 1995, DEVELOPMENT, V121, P1173; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Dumstrei K, 2003, J NEUROSCI, V23, P3325; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Friedrich MVK, 2000, EUR J BIOCHEM, V267, P3149, DOI 10.1046/j.1432-1327.2000.01337.x; GARCIAESTRADA J, 1992, BRAIN RES, V592, P343, DOI 10.1016/0006-8993(92)91695-B; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; Huang H, 1999, DEVELOPMENT, V126, P5365; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lindner JR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-121; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miron M, 2003, MOL CELL BIOL, V23, P9117, DOI 10.1128/MCB.23.24.9117-9126.2003; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nern C, 2006, STEM CELL REV, V2, P233, DOI 10.1007/s12015-006-0051-6; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2002, DEVELOPMENT, V129, P4103; Park Y, 2003, DEV BIOL, V253, P247, DOI 10.1016/S0012-1606(02)00019-2; PROKOP A, 1991, DEVELOPMENT, V111, P79; Prokop A, 1998, MECH DEVELOP, V74, P99, DOI 10.1016/S0925-4773(98)00068-9; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science.1068094; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Yan YP, 2006, EUR J NEUROSCI, V24, P45, DOI 10.1111/j.1460-9568.2006.04872.x; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu CC, 2008, DEVELOPMENT, V135, P513, DOI 10.1242/dev.010876	79	255	260	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1161	1173		10.1016/j.cell.2010.12.007	http://dx.doi.org/10.1016/j.cell.2010.12.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183078	Green Published, hybrid			2022-12-01	WOS:000285625400013
J	Fakhri, N; MacKintosh, FC; Lounis, B; Cognet, L; Pasquali, M				Fakhri, Nikta; MacKintosh, Frederick C.; Lounis, Brahim; Cognet, Laurent; Pasquali, Matteo			Brownian Motion of Stiff Filaments in a Crowded Environment	SCIENCE			English	Article							WALLED CARBON NANOTUBES; SEMIFLEXIBLE POLYMERS; AGAROSE GELS; DYNAMICS; DIFFUSION; MICROSCOPY; CHAIN; FLUORESCENCE; REPTATION; ROD	The thermal motion of stiff filaments in a crowded environment is highly constrained and anisotropic; it underlies the behavior of such disparate systems as polymer materials, nanocomposites, and the cell cytoskeleton. Despite decades of theoretical study, the fundamental dynamics of such systems remains a mystery. Using near-infrared video microscopy, we studied the thermal diffusion of individual single-walled carbon nanotubes (SWNTs) confined in porous agarose networks. We found that even a small bending flexibility of SWNTs strongly enhances their motion: The rotational diffusion constant is proportional to the filament-bending compliance and is independent of the network pore size. The interplay between crowding and thermal bending implies that the notion of a filament's stiffness depends on its confinement. Moreover, the mobility of SWNTs and other inclusions can be controlled by tailoring their stiffness.	[Fakhri, Nikta; Pasquali, Matteo] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [MacKintosh, Frederick C.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Lounis, Brahim; Cognet, Laurent] Univ Bordeaux, CNRS, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France	Rice University; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Pasquali, M (corresponding author), Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem, Dept Chem & Biomol Engn, Houston, TX 77005 USA.	mp@rice.edu	Lounis, Brahim/I-7862-2016; MacKintosh, Fred C/A-9450-2008; Cognet, Laurent/F-4163-2011; Fakhri, Nikta/B-4657-2008; Cognet, Laurent/M-4505-2019; Pasquali, Matteo/A-2489-2008; MacKintosh, Frederick/AAB-9332-2021	Lounis, Brahim/0000-0001-7501-0236; MacKintosh, Fred C/0000-0002-2607-9541; Cognet, Laurent/0000-0002-3573-5387; Fakhri, Nikta/0000-0003-1261-7465; Pasquali, Matteo/0000-0001-5951-395X; MacKintosh, Frederick/0000-0002-2607-9541	NSF Center for Biological and Environmental Nanotechnology [EEC-0118007, EEC-0647452]; Welch Foundation [C-1668]; Advanced Energy Consortium; Region Aquitaine; Agence Nationale pour la Recherche (ANR PNANO); European Research Council [232942]; Foundation for Fundamental Research on Matter (FOM); Netherlands Organisation for Scientific Research (NWO)	NSF Center for Biological and Environmental Nanotechnology(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Advanced Energy Consortium; Region Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale pour la Recherche (ANR PNANO)(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the NSF Center for Biological and Environmental Nanotechnology (EEC-0118007 and EEC-0647452), the Welch Foundation (grant C-1668), the Advanced Energy Consortium (www.beg.utexas.edu/aec), the Region Aquitaine, the Agence Nationale pour la Recherche (ANR PNANO), the European Research Council (grant n 232942), and the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO).	ATTWOOD TK, 1988, BIOPOLYMERS, V27, P201, DOI 10.1002/bip.360270204; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; Dogic Z, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.125503; DOI M, 1985, J POLYM SCI POL SYM, P93; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1789, DOI 10.1039/f29787401789; Doi M., 1986, THEORY POLYM DYNAMIC; Duggal R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.246104; Duque JG, 2008, J AM CHEM SOC, V130, P2626, DOI 10.1021/ja0777234; EDWARDS SF, 1967, P PHYS SOC LOND, V92, pR1; Fakhri N, 2009, P NATL ACAD SCI USA, V106, P14219, DOI 10.1073/pnas.0904148106; FARGE E, 1993, MACROMOLECULES, V26, P5041, DOI 10.1021/ma00071a009; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; Granek R, 1997, J PHYS II, V7, P1761, DOI 10.1051/jp2:1997214; Green MJ, 2009, POLYMER, V50, P4979, DOI 10.1016/j.polymer.2009.07.044; Han Y, 2006, SCIENCE, V314, P626, DOI 10.1126/science.1130146; Hofling F, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060904; Munk T, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/30003; ODIJK T, 1983, MACROMOLECULES, V16, P1340, DOI 10.1021/ma00242a015; PERKINS TT, 1994, SCIENCE, V264, P819, DOI 10.1126/science.8171335; Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111; Ramanathan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.010501; SATO T, 1991, MACROMOLECULES, V24, P6220, DOI 10.1021/ma00023a025; TRACY MA, 1992, ANNU REV PHYS CHEM, V43, P525, DOI 10.1146/annurev.physchem.43.1.525; Tsyboulski DA, 2005, NANO LETT, V5, P975, DOI 10.1021/nl050366f; WIJMENGA SS, 1986, BIOPOLYMERS, V25, P2173, DOI 10.1002/bip.360251110; ZERO KM, 1982, MACROMOLECULES, V15, P87, DOI 10.1021/ma00229a017	27	96	96	0	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1804	1807		10.1126/science.1197321	http://dx.doi.org/10.1126/science.1197321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205665				2022-12-01	WOS:000285603700035
J	Ghosh, S; Bachilo, SM; Simonette, RA; Beckingham, KM; Weisman, RB				Ghosh, Saunab; Bachilo, Sergei M.; Simonette, Rebecca A.; Beckingham, Kathleen M.; Weisman, R. Bruce			Oxygen Doping Modifies Near-Infrared Band Gaps in Fluorescent Single-Walled Carbon Nanotubes	SCIENCE			English	Article							STONE-WALES DEFECTS; OZONE ADSORPTION; OXIDATION; FUNCTIONALIZATION; PURIFICATION; OZONOLYSIS; MOBILITY; OZONIDES; C60O	Controlled chemical modifications of single-walled carbon nanotubes (SWCNTs) that tune their useful properties have been sought for multiple applications. We found that beneficial optical changes in SWCNTs resulted from introducing low concentrations of oxygen atoms. Stable covalently oxygen-doped nanotubes were prepared by exposure to ozone and then light. Treated samples showed distinct, structure-specific near-infrared fluorescence at wavelengths 10 to 15% longer than displayed by pristine semiconducting SWCNTs. Dopant sites harvest light energy absorbed in undoped nanotube regions by trapping mobile excitons. The oxygen-doped SWCNTs are much easier to detect and image than pristine SWCNTs because they give stronger near-infrared emission and do not absorb at the shifted emission wavelength.	[Ghosh, Saunab; Bachilo, Sergei M.; Weisman, R. Bruce] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Ghosh, Saunab; Bachilo, Sergei M.; Simonette, Rebecca A.; Beckingham, Kathleen M.; Weisman, R. Bruce] Rice Univ, RE Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA; [Simonette, Rebecca A.; Beckingham, Kathleen M.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University; Rice University; Rice University	Weisman, RB (corresponding author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA.	weisman@rice.edu	Ghosh, Saunab/DYO-7073-2022; Bachilo, Sergei/ABC-4606-2020	Bachilo, Sergei/0000-0001-5236-1383; Weisman, R. Bruce/0000-0001-8546-9980	NSF [CHE-0809020]; Welch Foundation [C-0807, C-1119]; NASA [NNX09AH43G]	NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NASA(National Aeronautics & Space Administration (NASA))	Supported by NSF grant CHE-0809020, Welch Foundation grants C-0807 and C-1119, and NASA grant NNX09AH43G. We thank J. K. Johnson for unpublished computational results, and C. Farach-Carson and D. Carson for providing the cultured cell line.	Akdim B, 2007, CHEM PHYS LETT, V445, P281, DOI 10.1016/j.cplett.2007.08.001; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; Banerjee S, 2002, J PHYS CHEM B, V106, P12144, DOI 10.1021/jp026304k; Cai LT, 2002, CHEM MATER, V14, P4235, DOI 10.1021/cm020273o; Chen ZY, 2006, J PHYS CHEM B, V110, P11624, DOI 10.1021/jp057494c; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; Ghosh S, 2010, NAT NANOTECHNOL, V5, P443, DOI [10.1038/nnano.2010.68, 10.1038/NNANO.2010.68]; Harutyunyan H, 2009, NANO LETT, V9, P2010, DOI 10.1021/nl9002798; Heymann D, 2002, J AM CHEM SOC, V124, P6317, DOI 10.1021/ja012488p; Heymann D, 2000, J AM CHEM SOC, V122, P11473, DOI 10.1021/ja0025651; Heymann D, 2006, CR CHIM, V9, P1107, DOI 10.1016/j.crci.2006.02.003; Hirsch A, 2005, TOP CURR CHEM, V245, P193; Kiowski O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.237402; Li MH, 2008, CARBON, V46, P466, DOI 10.1016/j.carbon.2007.12.012; Lu X, 2002, J PHYS CHEM B, V106, P2136, DOI 10.1021/jp015537t; Luer L, 2009, NAT PHYS, V5, P54, DOI [10.1038/nphys1149, 10.1038/NPHYS1149]; Mawhinney DB, 2000, J AM CHEM SOC, V122, P2383, DOI 10.1021/ja994094s; Murakami Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195407; Ogrin D, 2006, J AM CHEM SOC, V128, P11322, DOI 10.1021/ja061680u; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Picozzi S, 2004, J CHEM PHYS, V120, P7147, DOI 10.1063/1.1669381; Qin SH, 2004, MACROMOLECULES, V37, P3965, DOI 10.1021/ma049681z; Reich S., 2004, CARBON NANOTUBES BAS; Siitonen AJ, 2010, J PHYS CHEM LETT, V1, P2189, DOI 10.1021/jz100749c; Siitonen AJ, 2010, NANO LETT, V10, P1595, DOI 10.1021/nl9039845; Simmons JM, 2006, J PHYS CHEM B, V110, P7113, DOI 10.1021/jp0548422; Torrens ON, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.157401; Tsvaygboym K., 2007, THESIS RICE U; Weisman RB, 2001, J AM CHEM SOC, V123, P9720, DOI 10.1021/ja016267v; Yim WL, 2009, J PHYS CHEM C, V113, P17636, DOI 10.1021/jp908089c	31	272	277	6	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1656	1659		10.1126/science.1196382	http://dx.doi.org/10.1126/science.1196382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21109631				2022-12-01	WOS:000285390500061
J	Robertson, JL; Kolmakova-Partensky, L; Miller, C				Robertson, Janice L.; Kolmakova-Partensky, Ludmila; Miller, Christopher			Design, function and structure of a monomeric ClC transporter	NATURE			English	Article							EXCHANGE TRANSPORTER; AMMONIA TRANSPORT; CHLORIDE CHANNEL; MECHANISM; ENERGETICS; REVEALS; AMTB	Channels and transporters of the ClC family cause the transmembrane movement of inorganic anions in service of a variety of biological tasks, from the unusual-the generation of the kilowatt pulses with which electric fish stun their prey-to the quotidian-the acidification of endosomes, vacuoles and lysosomes(1). The homodimeric architecture of ClC proteins, initially inferred from single-molecule studies of an elasmobranch Cl- channel(2) and later confirmed by crystal structures of bacterial Cl-/H+ antiporters(3,4), is apparently universal. Moreover, the basic machinery that enables ion movement through these proteins-the aqueous pores for anion diffusion in the channels and the ion-coupling chambers that coordinate Cl- and H+ antiport in the transporters-are contained wholly within each subunit of the homodimer. The near-normal function of a bacterial ClC transporter straitjacketed by covalent cross-links across the dimer interface and the behaviour of a concatemeric human homologue argue that the transport cycle resides within each subunit and does not require rigid-body rearrangements between subunits(5,6). However, this evidence is only inferential, and because examples are known in which quaternary rearrangements of extramembrane ClC domains that contribute to dimerization modulate transport activity(7), we cannot declare as definitive a 'parallel-pathways' picture in which the homodimer consists of two singlesubunit transporters operating independently. A strong prediction of such a view is that it should in principle be possible to obtain a monomeric ClC. Here we exploit the known structure of a ClC Cl-/H+ exchanger, ClC-ec1 from Escherichia coli, to design mutants that destabilize the dimer interface while preserving both the structure and the transport function of individual subunits. The results demonstrate that the ClC subunit alone is the basic functional unit for transport and that cross-subunit interaction is not required for Cl-/H+ exchange in ClC transporters.	[Robertson, Janice L.; Kolmakova-Partensky, Ludmila; Miller, Christopher] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Miller, C (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	cmiller@brandeis.edu		Robertson, Janice/0000-0002-5499-9943	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM031768, R37 GM031768] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031768, R01GM031768] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Chen LR, 2009, BIOPHYS J, V96, P4622, DOI 10.1016/j.bpj.2009.03.004; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Elvington SM, 2009, EMBO J, V28, P3090, DOI 10.1038/emboj.2009.259; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; MacKenzie KR, 2008, CURR OPIN STRUC BIOL, V18, P412, DOI 10.1016/j.sbi.2008.04.007; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; Metcalf DG, 2009, J MOL BIOL, V392, P1087, DOI 10.1016/j.jmb.2009.06.032; Middleton Richard E., 1994, Methods (Orlando), V6, P28, DOI 10.1006/meth.1994.1005; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Nguitragool W, 2007, P NATL ACAD SCI USA, V104, P20659, DOI 10.1073/pnas.0708639104; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Theobald DL, 2010, NAT STRUCT MOL BIOL, V17, P2, DOI 10.1038/nsmb0110-2; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	30	82	84	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					844	847		10.1038/nature09556	http://dx.doi.org/10.1038/nature09556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21048711	Green Accepted			2022-12-01	WOS:000285093700050
J	Wang, R; Chadalavada, K; Wilshire, J; Kowalik, U; Hovinga, KE; Geber, A; Fligelman, B; Leversha, M; Brennan, C; Tabar, V				Wang, Rong; Chadalavada, Kalyani; Wilshire, Jennifer; Kowalik, Urszula; Hovinga, Koos E.; Geber, Adam; Fligelman, Boris; Leversha, Margaret; Brennan, Cameron; Tabar, Viviane			Glioblastoma stem-like cells give rise to tumour endothelium	NATURE			English	Article							NERVOUS-SYSTEM; RECURRENT GLIOBLASTOMA; IN-VIVO; ANGIOGENESIS; EGFR; IDENTIFICATION; RECRUITMENT; INHIBITION; PATHWAYS; MARKER	Glioblastoma (GBM) is among the most aggressive of human cancers(1). A key feature of GBMs is the extensive network of abnormal vasculature characterized by glomeruloid structures and endothelial hyperplasia(2). Yet the mechanisms of angiogenesis and the origin of tumour endothelial cells remain poorly defined(3-5). Here we demonstrate that a subpopulation of endothelial cells within glioblastomas harbour the same somatic mutations identified within tumour cells, such as amplification of EGFR and chromosome 7. We additionally demonstrate that the stem-cell-like CD133(+) fraction includes a subset of vascular endothelial-cadherin (CD144)-expressing cells that show characteristics of endothelial progenitors capable of maturation into endothelial cells. Extensive in vitro and in vivo lineage analyses, including single cell clonal studies, further show that a subpopulation of the CD133(+) stem-like cell fraction is multipotent and capable of differentiation along tumour and endothelial lineages, possibly via an intermediate CD133(+)/CD144(+) progenitor cell. The findings are supported by genetic studies of specific exons selected from The Cancer Genome Atlas(6), quantitative FISH and comparative genomic hybridization data that demonstrate identical genomic profiles in the CD133(+) tumour cells, their endothelial progenitor derivatives and mature endothelium. Exposure to the clinical anti-angiogenesis agent bevacizumab(7) or to a gamma-secretase inhibitor(8) as well as knockdown shRNA studies demonstrate that blocking VEGF or silencing VEGFR2 inhibits the maturation of tumour endothelial progenitors into endothelium but not the differentiation of CD133(+) cells into endothelial progenitors, whereas c-secretase inhibition or NOTCH1 silencing blocks the transition into endothelial progenitors. These data may provide new perspectives on the mechanisms of failure of anti-angiogenesis inhibitors currently in use. The lineage plasticity and capacity to generate tumour vasculature of the putative cancer stem cells within glioblastoma are novel findings that provide new insight into the biology of gliomas and the definition of cancer stemness, as well as the mechanisms of tumour neo-angiogenesis.	[Wang, Rong; Kowalik, Urszula; Hovinga, Koos E.; Geber, Adam; Fligelman, Boris; Brennan, Cameron; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Wang, Rong; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA; [Wang, Rong; Brennan, Cameron; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA; [Hovinga, Koos E.] Univ Amsterdam, Acad Med Ctr, Neurosurg Ctr Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Amsterdam; Academic Medical Center Amsterdam; Memorial Sloan Kettering Cancer Center	Tabar, V (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA.	tabarv@mskcc.org	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891; Geber, Adam/0000-0003-3022-0525	New York State Stem Cell Science Fund (NYSTEM); NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	New York State Stem Cell Science Fund (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank J. Imai, H. Xu, G. Lee, M. Tomishima and L. Studer for critical reading of the manuscript, P. Gutin for assistance with tissue acquisition and discussions, B. Weksler for the brain endothelial cell line (hCMEC), S. Jhanwar for the clinical cytogenetics data and M. Sadelain and E. Papapetrou for the lentiviral vectors. Funding was provided in part through a grant from the New York State Stem Cell Science Fund (NYSTEM).	Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Beaty RM, 2007, J NEURO-ONCOL, V81, P241, DOI 10.1007/s11060-006-9227-9; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Franco-Hernandez C, 2007, INT J ONCOL, V30, P209; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hendrix MJC, 2002, CANCER RES, V62, P665; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Iwamoto FM, 2009, NEUROLOGY, V73, P1200, DOI 10.1212/WNL.0b013e3181bc0184; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VOYTA JC, 1984, J CELL BIOL, V99, pA81; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604	31	862	911	2	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					829	U128		10.1038/nature09624	http://dx.doi.org/10.1038/nature09624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21102433				2022-12-01	WOS:000285093700047
J	Vispute, TP; Zhang, HY; Sanna, A; Xiao, R; Huber, GW				Vispute, Tushar P.; Zhang, Huiyan; Sanna, Aimaro; Xiao, Rui; Huber, George W.			Renewable Chemical Commodity Feedstocks from Integrated Catalytic Processing of Pyrolysis Oils	SCIENCE			English	Article							BIO-OIL; LIQUID-FUEL; BIOMASS; HYDROCARBONS; CONVERSION; ZEOLITE; AROMATIZATION; ALKYLATION; AROMATICS; ETHYLENE	Fast pyrolysis of lignocellulosic biomass produces a renewable liquid fuel called pyrolysis oil that is the cheapest liquid fuel produced from biomass today. Here we show that pyrolysis oils can be converted into industrial commodity chemical feedstocks using an integrated catalytic approach that combines hydroprocessing with zeolite catalysis. The hydroprocessing increases the intrinsic hydrogen content of the pyrolysis oil, producing polyols and alcohols. The zeolite catalyst then converts these hydrogenated products into light olefins and aromatic hydrocarbons in a yield as much as three times higher than that produced with the pure pyrolysis oil. The yield of aromatic hydrocarbons and light olefins from the biomass conversion over zeolite is proportional to the intrinsic amount of hydrogen added to the biomass feedstock during hydroprocessing. The total product yield can be adjusted depending on market values of the chemical feedstocks and the relative prices of the hydrogen and biomass.	[Vispute, Tushar P.; Zhang, Huiyan; Sanna, Aimaro; Huber, George W.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA; [Zhang, Huiyan; Xiao, Rui] Southeast Univ, Sch Energy & Environm, Nanjing 210096, Peoples R China; [Sanna, Aimaro] Univ Nottingham, Dept Chem & Environm Engn, Energy & Sustainabil Res Div, Nottingham NG7 2RD, England	University of Massachusetts System; University of Massachusetts Amherst; Southeast University - China; University of Nottingham	Vispute, TP (corresponding author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.		Zhang, Huiyan/A-8640-2011; Huber, George/D-2569-2018; Huber, George/Y-2473-2019	Huber, George/0000-0002-7838-6893; Zhang, Huiyan/0000-0002-4818-7156	U.S. Department of Energy Office of Energy Efficiency and Renewable Energy [DE-FG36-08GO18212]; Defense Advanced Research Projects Agency (DARPA) through the Defense Science Office [HR0011-09-C-0075]; National Basic Research Program of China (973 Program) [2010CB732206]; National Natural Science Foundation of China [51076031]	U.S. Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Defense Advanced Research Projects Agency (DARPA) through the Defense Science Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy, under grant DE-FG36-08GO18212; and by the Defense Advanced Research Projects Agency (DARPA) through the Defense Science Office Agreement HR0011-09-C-0075) (Approved for Public Release, Distribution Unlimited); the National Basic Research Program of China (973 Program, grant no. 2010CB732206); and the National Natural Science Foundation of China (grant no. 51076031). The views, opinions, and/or findings contained in this article/presentation are those of the author/presenter and should not be interpreted as representing the official views or policies, either expressed or implied, of the DARPA or the Department of Defense. We thank A. Javaid for the microfiltration of bio-oil, Y. Cheng for help with zeolite upgrading experiments, and the National Renewable Energy Laboratory and P. H. Steele from the Forest Products Department at Mississippi State University for providing us with bio-oil samples. The University of Massachusetts has filed a patent based on the methods presented here. G. W. H. has a financial interest in Anellotech, a privately held company focused on producing renewable petrochemicals from biomass.	ADJAYE JD, 1995, FUEL PROCESS TECHNOL, V45, P161, DOI 10.1016/0378-3820(95)00034-5; ADJAYE JD, 1995, FUEL PROCESS TECHNOL, V45, P185, DOI 10.1016/0378-3820(95)00040-E; Agrawal R, 2007, P NATL ACAD SCI USA, V104, P4828, DOI 10.1073/pnas.0609921104; Anex R. P., 2009, DIV FUEL CHEM, V54, P704; [Anonymous], ICIS PRIC REP; Bartholomew CH, 2006, FUNDAMENTALS OF INDUSTRIAL CATALYTIC PROCESSES, 2ND EDITION, P1, DOI 10.1002/9780471730071; Bayerbach R, 2009, J ANAL APPL PYROL, V85, P98, DOI 10.1016/j.jaap.2008.10.021; Carlson TR, 2008, CHEMSUSCHEM, V1, P397, DOI 10.1002/cssc.200800018; Carlson TR, 2011, ENERG ENVIRON SCI, V4, P145, DOI 10.1039/c0ee00341g; CHEN NY, 1986, CHEMTECH, V16, P506; Chornet, 2001, [No title captured], Patent No. [6172272B1, 6172272, 6,172,272 ]; Choudhary VR, 2001, MICROPOR MESOPOR MAT, V47, P253, DOI 10.1016/S1387-1811(01)00385-7; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Crossley S, 2010, SCIENCE, V327, P68, DOI 10.1126/science.1180769; Czernik S, 2004, ENERG FUEL, V18, P590, DOI 10.1021/ef034067u; Degnan TF, 2001, APPL CATAL A-GEN, V221, P283, DOI 10.1016/S0926-860X(01)00807-9; Elliott DC, 2007, ENERG FUEL, V21, P1792, DOI 10.1021/ef070044u; Gayubo AG, 2004, IND ENG CHEM RES, V43, P2610, DOI 10.1021/ie030791o; GUISNET M, 1992, APPL CATAL A-GEN, V89, P1, DOI 10.1016/0926-860X(92)80075-N; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Huber GW, 2003, SCIENCE, V300, P2075, DOI 10.1126/science.1085597; Klass D. L., 1998, BIOMASS RENEWABLE EN, DOI DOI 10.1016/B978-0-12-410950-6.X5000-4; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Lappin G., 1989, ALPHA OLEFINS APPL H; Li N, 2010, J CATAL, V270, P48, DOI 10.1016/j.jcat.2009.12.006; Marker T. L., 2005, DEFG3605GO15085 UOP; Miller JE, 1999, FUEL, V78, P1363, DOI 10.1016/S0016-2361(99)00072-1; Milne T.A., 1997, DEV THERMOCHEMICAL B, P409, DOI DOI 10.1007/978-94-009-1559-6_32; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; National Research Council and National Academy of Engineering, 2004, HYDR EC OPP COSTS BA; Oasmaa A, 1999, ENERG FUEL, V13, P914, DOI 10.1021/ef980272b; Olcay H, 2010, CHEMCATCHEM, V2, P1420, DOI 10.1002/cctc.201000134; Padro C, 1999, NRELTP57027079, DOI 10.2172/12212; Perego C, 2002, CATAL TODAY, V73, P3, DOI 10.1016/S0920-5861(01)00511-9; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Shabtai J. S., 1999, [No title captured], Patent No. [US 5959167 A, 5959167, US 5959167]; SZMANT H, 1989, ORGANIC BUILDING BLO; Vispute TP, 2009, GREEN CHEM, V11, P1433, DOI 10.1039/b912522c; Wright MM, 2010, FUEL, V89, pS11, DOI 10.1016/j.fuel.2010.07.029; Zhao C, 2010, CHEM COMMUN, V46, P412, DOI 10.1039/b916822b; Zhao C, 2009, ANGEW CHEM INT EDIT, V48, P3987, DOI 10.1002/anie.200900404	42	845	883	32	875	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1222	1227		10.1126/science.1194218	http://dx.doi.org/10.1126/science.1194218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109668				2022-12-01	WOS:000284613700036
J	Chen, ZC; Borek, D; Padrick, SB; Gomez, TS; Metlagel, Z; Ismail, AM; Umetani, J; Billadeau, DD; Otwinowski, Z; Rosen, MK				Chen, Zhucheng; Borek, Dominika; Padrick, Shae B.; Gomez, Timothy S.; Metlagel, Zoltan; Ismail, Ayman M.; Umetani, Junko; Billadeau, Daniel D.; Otwinowski, Zbyszek; Rosen, Michael K.			Structure and control of the actin regulatory WAVE complex	NATURE			English	Article							WASP/SCAR PROTEINS; TYROSINE KINASE; CELL-MIGRATION; WASP FAMILY; PHOSPHORYLATION; ACTIVATION; MEMBRANE; MODEL; RAC1; INTEGRATION	Members of the Wiskott-Aldrich syndrome protein (WASP) family control cytoskeletal dynamics by promoting actin filament nucleation with the Arp2/3 complex. The WASP relative WAVE regulates lamellipodia formation within a 400-kilodalton, hetero-pentameric WAVE regulatory complex (WRC). The WRC is inactive towards the Arp2/3 complex, but can be stimulated by the Rac GTPase, kinases and phosphatidylinositols. Here we report the 2.3-angstrom crystal structure of the WRC and complementary mechanistic analyses. The structure shows that the activity-bearing VCA motif of WAVE is sequestered by a combination of intramolecular and intermolecular contacts within the WRC. Rac and kinases appear to destabilize a WRC element that is necessary for VCA sequestration, suggesting the way in which these signals stimulate WRC activity towards the Arp2/3 complex. The spatial proximity of the Rac binding site and the large basic surface of the WRC suggests how the GTPase and phospholipids could cooperatively recruit the complex to membranes.	[Chen, Zhucheng; Borek, Dominika; Padrick, Shae B.; Metlagel, Zoltan; Ismail, Ayman M.; Umetani, Junko; Otwinowski, Zbyszek; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Zhucheng; Padrick, Shae B.; Metlagel, Zoltan; Ismail, Ayman M.; Umetani, Junko; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu	Otwinowski, Zbyszek/F-3665-2011; Borek, Dominika M/D-2943-2011	Borek, Dominika M/0000-0002-4321-6253; Otwinowski, Zbyszek/0000-0003-3640-8545; Padrick, Shae/0000-0002-6916-6194	Cancer Research Institute; NIH [1F32-GM06917902, R01-AI065474, R01-GM053163, R01-GM056322]; Allergic Diseases Training grant [AI07047]; Welch Foundation [I-1544]; Howard Hughes Medical Institute; US DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065474, T32AI007047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163, R01GM056322] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergic Diseases Training grant; Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Chen for providing samples of full-length WRC and VCA polypeptide for electron microscopy and some biochemical analyses, C. Pak for helping with the total internal reflection fluorescence experiment, D. Tomchick and C. Brautigam for technical assistance and N. Grishin for assistance with sequence analysis and discussion. Research was supported by fellowships from the Cancer Research Institute and the NIH (1F32-GM06917902) to Z.C. and S.B.P., respectively, an Allergic Diseases Training grant (AI07047) to T.S.G., grants from the NIH to D.D.B. (R01-AI065474), Z.O. (R01-GM053163) and M.K.R. (R01-GM056322), a grant from the Welch Foundation to M.K.R. (I-1544) and the Howard Hughes Medical Institute. D.D.B. is a Leukemia and Lymphoma Society Scholar. Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the US DOE under contract DE-AC02-06CH11357.	Ardern H, 2006, CELL MOTIL CYTOSKEL, V63, P6, DOI 10.1002/cm.20101; Borek D, 2007, J SYNCHROTRON RADIAT, V14, P24, DOI 10.1107/S0909049506046589; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stovold CF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-11; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Vartiainen MK, 2004, CURR OPIN CELL BIOL, V16, P174, DOI 10.1016/j.ceb.2004.02.004; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	50	307	320	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					533	U207		10.1038/nature09623	http://dx.doi.org/10.1038/nature09623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107423	Green Accepted			2022-12-01	WOS:000284584200035
J	Kaschube, M; Schnabel, M; Lowel, S; Coppola, DM; White, LE; Wolf, F				Kaschube, Matthias; Schnabel, Michael; Loewel, Siegrid; Coppola, David M.; White, Leonard E.; Wolf, Fred			Universality in the Evolution of Orientation Columns in the Visual Cortex	SCIENCE			English	Article							SELECTIVITY; ARRANGEMENT; EXPERIENCE; SYMMETRY	The brain's visual cortex processes information concerning form, pattern, and motion within functional maps that reflect the layout of neuronal circuits. We analyzed functional maps of orientation preference in the ferret, tree shrew, and galago-three species separated since the basal radiation of placental mammals more than 65 million years ago-and found a common organizing principle. A symmetry-based class of models for the self-organization of cortical networks predicts all essential features of the layout of these neuronal circuits, but only if suppressive long-range interactions dominate development. We show mathematically that orientation-selective long-range connectivity can mediate the required interactions. Our results suggest that self-organization has canalized the evolution of the neuronal circuitry underlying orientation preference maps into a single common design.	[Kaschube, Matthias; Schnabel, Michael; Wolf, Fred] Univ Gottingen, Fac Phys, Bernstein Ctr Computat Neurosci, Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; [Kaschube, Matthias; Schnabel, Michael; Wolf, Fred] Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Kaschube, Matthias] Princeton Univ, Dept Phys, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Schnabel, Michael] Northwestern Univ, Phys Sci Oncol Ctr, NW Inst Complex Syst, Dept Appl Math, Evanston, IL 60208 USA; [Schnabel, Michael] Northwestern Univ, Phys Sci Oncol Ctr, NW Inst Complex Syst, Dept Phys, Evanston, IL 60208 USA; [Loewel, Siegrid] Univ Jena, Inst Gen Zool & Anim Physiol, D-07743 Jena, Germany; [Loewel, Siegrid] Univ Gottingen, Sch Biol, D-37073 Gottingen, Germany; [Coppola, David M.] Randolph Macon Coll, Dept Biol, Ashland, VA 23005 USA; [White, Leonard E.] Duke Univ, Duke Inst Brain Sci, Dept Community & Family Med, Durham, NC 27710 USA	Max Planck Society; University of Gottingen; Princeton University; Northwestern University; Northwestern University; Friedrich Schiller University of Jena; University of Gottingen; Duke University	Kaschube, M (corresponding author), Univ Gottingen, Fac Phys, Bernstein Ctr Computat Neurosci, Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany.	kaschube@princeton.edu; fred-wl@nld.ds.mpg.de	Wolf, Fred/D-5771-2011	Wolf, Fred/0000-0002-7068-3762	Human Frontier Science Program; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie [01GQ0430, 01GQ0922]; NSF [0641433]; NIH/National Institute of General Medical Sciences [P50 GM071508]; Whitehall Foundation; National Science Foundation (NSF) [PHY05-51164]; NATIONAL EYE INSTITUTE [R01EY011488, R01EY006821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF)); NSF(National Science Foundation (NSF)); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Whitehall Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Crowley, J. Fischer, T. Geisel, H. Greenside, A. Grinvald, M. Gutnick, J. Kaas, T. Kottos, T. Moser, and J. Schmitz for discussions; B. Bosking for acquiring and processing imaging data; W. Keil and L. Reichl for calculations; B. Goetze for graphics; D. Fitzpatrick for support of imaging experiments (NIH/National Eye Institute (NEI) EY06821 and EY11488); and the Kavli Institute for Theoretical Physics for its hospitality. This work was funded by grants from the Human Frontier Science Program and Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie to S. L. and F. W. (01GQ0430 and 01GQ0922); NSF to D. M. C. (0641433); NIH/National Institute of General Medical Sciences to M. K. (P50 GM071508); and the Whitehall Foundation to L. E. W. and was supported in part by the National Science Foundation (NSF PHY05-51164).	Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Kaas JH, 2008, BRAIN RES BULL, V75, P384, DOI 10.1016/j.brainresbull.2007.10.009; Kaschube M, 2002, J NEUROSCI, V22, P7206; Kaschube M, 2009, P NATL ACAD SCI USA, V106, P17205, DOI 10.1073/pnas.0901615106; Kaschube M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015009; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Lee HY, 2003, P NATL ACAD SCI USA, V100, P16036, DOI 10.1073/pnas.2531343100; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Mayer N, 2002, NEUROCOMPUTING, V44, P533, DOI 10.1016/S0925-2312(02)00417-4; MAYNARDSMITH J, 1985, Q REV BIOL, V60, P265, DOI DOI 10.1086/414425); Niven JE, 2004, PLOS BIOL, V2, P22, DOI 10.1371/journal.pbio.0020019; Obermayer K, 1997, NEURAL COMPUT, V9, P555, DOI 10.1162/neco.1997.9.3.555; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Reichl L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.208101; Van Hooser SD, 2007, NEUROSCIENTIST, V13, P639, DOI 10.1177/1073858407306597; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wolf F, 1998, NATURE, V395, P73, DOI 10.1038/25736; Wolf F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208701	28	112	113	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1113	1116		10.1126/science.1194869	http://dx.doi.org/10.1126/science.1194869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21051599	Green Accepted			2022-12-01	WOS:000284374700046
J	Einstein, AJ; Weiner, SD; Bernheim, A; Kulon, M; Bokhari, S; Johnson, LL; Moses, JW; Balter, S				Einstein, Andrew J.; Weiner, Shepard D.; Bernheim, Adam; Kulon, Michal; Bokhari, Sabahat; Johnson, Lynne L.; Moses, Jeffrey W.; Balter, Stephen			Multiple Testing, Cumulative Radiation Dose, and Clinical Indications in Patients Undergoing Myocardial Perfusion Imaging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; NUCLEAR-MEDICINE; COMPUTED-TOMOGRAPHY; IONIZING-RADIATION; EXPOSURE; CANCER; RADIOLOGY; RISK; REVASCULARIZATION; ECHOCARDIOGRAPHY	Context Myocardial perfusion imaging (MPI) is the single medical test with the highest radiation burden to the US population. Although many patients undergoing MPI receive repeat MPI testing, or additional procedures involving ionizing radiation, no data are available characterizing their total longitudinal radiation burden and relating radiation burden with reasons for testing. Objectives To characterize procedure counts, cumulative estimated effective doses of radiation, and clinical indications for patients undergoing MPI. Design, Setting, and Patients A retrospective cohort study of 1097 consecutive patients undergoing index MPI during the first 100 days of 2006 (January 1-April 10) at Columbia University Medical Center, New York, New York, that evaluated all preceding medical imaging procedures involving ionizing radiation undergone beginning October 1988, and all subsequent procedures through June 2008, at the center. Main Outcome Measures Cumulative estimated effective dose of radiation, number of procedures involving radiation, and indications for testing. Results Patients underwent a median of 15 (interquartile range [IQR], 6-32; mean, 23.9) procedures involving radiation exposure; of which 4 (IQR, 2-8; mean, 6.5) were high-dose procedures (>= 3 mSv; ie, 1 year's background radiation), including 1 (IQR, 1-2; mean, 1.8) MPI study per patient. A total of 344 patients (31.4%) received cumulative estimated effective dose from all medical sources of more than 100 mSv. Multiple MPIs were performed in 424 patients (38.6%), for whom cumulative estimated effective dose was 121 mSv (IQR, 81-189; mean, 149 mSv). Men and white patients had higher cumulative estimated effective doses. More than 80% of initial and 90% of repeat MPI examinations were performed in patients with known cardiac disease or symptoms consistent with it. Conclusion In this institution, multiple testing with MPI was common and in many patients associated with high cumulative estimated doses of radiation. JAMA. 2010;304(19):2137-2144 www.jama.com	[Einstein, Andrew J.; Weiner, Shepard D.; Bernheim, Adam; Bokhari, Sabahat; Johnson, Lynne L.; Moses, Jeffrey W.; Balter, Stephen] Columbia Univ, Med Ctr, Div Cardiol, Dept Med, New York, NY 10032 USA; [Einstein, Andrew J.; Kulon, Michal; Balter, Stephen] Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10032 USA; [Bernheim, Adam] New York Presbyterian Hosp, New York, NY USA; [Bernheim, Adam] Staten Isl Univ Hosp, Dept Radiol, New York, NY USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital; Northwell Health	Einstein, AJ (corresponding author), Columbia Univ, Med Ctr, Div Cardiol, Dept Med, 622 W 168th St,PH 10-203A, New York, NY 10032 USA.	andrew.einstein@columbia.edu	Bokhari, Sabahat/GZM-2572-2022; Bokhari, Sabahat/GSI-6376-2022; Balter, S/P-6211-2019		Covidien; GE Healthcare; INVIA; Philips Medical Systems; Toshiba America Medical Systems; National Institutes of Health [KL2 RR024157]; Louis V. Gerstner, Jr. Scholars Program; Lewis Katz Cardiovascular Research Prize; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157] Funding Source: NIH RePORTER	Covidien; GE Healthcare(General ElectricGE Healthcare); INVIA; Philips Medical Systems; Toshiba America Medical Systems; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louis V. Gerstner, Jr. Scholars Program; Lewis Katz Cardiovascular Research Prize; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr Einstein reported having served as a consultant for the International Atomic Energy Agency and for GE Healthcare, having received support for other research from Spectrum Dynamics and a Nuclear Cardiology Foundation grant funded by Covidien, and having received travel funding from GE Healthcare, INVIA, Philips Medical Systems, and Toshiba America Medical Systems. Dr Moses reported having served as a consultant for GE Healthcare. Dr Balter reported having served as a consultant for the International Atomic Energy Agency and Siemens. All other authors reported no disclosures.; Dr Einstein was supported by a National Institutes of Health K12 institutional career development award (KL2 RR024157), by the Louis V. Gerstner, Jr. Scholars Program, and by the Lewis Katz Cardiovascular Research Prize for a Young Investigator.	[Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 1998, Ann ICRP, V28, P1; [Anonymous], 2008, MED MALADIES INFECT, V38, P1, DOI DOI 10.1038/455001A; Bedetti G, 2008, BRIT J RADIOL, V81, P699, DOI 10.1259/bjr/29507259; Berman DS, 2009, JACC-CARDIOVASC IMAG, V2, P273, DOI 10.1016/j.jcmg.2008.12.012; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chang SM, 2010, J AM COLL CARDIOL, V55, P221, DOI 10.1016/j.jacc.2009.09.022; Charles MW, 2006, J RADIOL PROT, V26, P325, DOI 10.1088/0952-4746/26/3/N02; Chen J, 2010, J AM COLL CARDIOL, V56, P702, DOI 10.1016/j.jacc.2010.05.014; DePuey G, 2009, CIRCULATION, V120, pS334; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Einstein AJ, 2009, JACC-CARDIOVASC IMAG, V2, P369, DOI 10.1016/j.jcmg.2008.10.008; *EUR COMM, 2008, RAD PROT 154 EUR GUI; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Fiscella K, 2001, MED CARE, V39, P8, DOI 10.1097/00005650-200101000-00003; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Griffey RT, 2009, AM J ROENTGENOL, V192, P887, DOI 10.2214/AJR.08.1351; Hachamovitch R, 2003, J AM COLL CARDIOL, V41, P1329, DOI 10.1016/S0735-1097(03)00125-6; Hendel RC, 2009, J AM COLL CARDIOL, V53, P2201, DOI 10.1016/j.jacc.2009.02.013; Hunter C, 2010, J NUCL MED, V51; Iglehart JK, 2006, NEW ENGL J MED, V354, P2822, DOI 10.1056/NEJMhpr061219; *IMV MED INF DIV, 2003, 2003 NUCL MED CENS M; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Lucas FL, 2007, AM HEART J, V154, P502, DOI 10.1016/j.ahj.2007.04.044; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Metz LD, 2007, J AM COLL CARDIOL, V49, P227, DOI 10.1016/j.jacc.2006.08.048; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; National Council on Radiation Protection and Measurements, 2009, 160 NCRP; National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Schinkel AFL, 2006, AM J CARDIOL, V97, P1, DOI 10.1016/j.amjcard.2005.07.102; Senthamizhchelvan S, 2010, J NUCL MED, V51, P1592, DOI 10.2967/jnumed.110.077669; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Stabin MG, 2001, J NUCL MED, V42, p243P; Stabin M, 2008, J NUCL MED, V49, p20N	40	128	128	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2137	2144		10.1001/jama.2010.1664	http://dx.doi.org/10.1001/jama.2010.1664			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21078807	Bronze, Green Accepted			2022-12-01	WOS:000284269800024
J	Spence, D				Spence, Des			From the Frontline Bad medicine: paediatric ear, nose, and throat surgery	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	4	4	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 17	2010	341								c6560	10.1136/bmj.c6560	http://dx.doi.org/10.1136/bmj.c6560			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684WO	21084364				2022-12-01	WOS:000284586200003
J	Ding, BS; Nolan, DJ; Butler, JM; James, D; Babazadeh, AO; Rosenwaks, Z; Mittal, V; Kobayashi, H; Shido, K; Lyden, D; Sato, TN; Rabbany, SY; Rafii, S				Ding, Bi-Sen; Nolan, Daniel J.; Butler, Jason M.; James, Daylon; Babazadeh, Alexander O.; Rosenwaks, Zev; Mittal, Vivek; Kobayashi, Hideki; Shido, Koji; Lyden, David; Sato, Thomas N.; Rabbany, Sina Y.; Rafii, Shahin			Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration	NATURE			English	Article							CELLS; ANGIOGENESIS; GROWTH; VEGF; DIFFERENTIATION; EXPRESSION; ID1	During embryogenesis, endothelial cells induce organogenesis before the development of circulation(1-4). These findings suggest that endothelial cells not only form passive conduits to deliver nutrients and oxygen, but also establish an instructive vascular niche, which through elaboration of paracrine trophogens stimulates organ regeneration, in a manner similar to endothelial-cell-derived angiocrine factors that support haematopoiesis(5-7). However, the precise mechanism by which tissue-specific subsets of endothelial cells promote organogenesis in adults is unknown. Here we demonstrate that liver sinusoidal endothelial cells (LSECs) constitute a unique population of phenotypically and functionally defined VEGFR3(+)CD34(-)VEGFR2(+)VE-cadherin(+)FactorVIII(+)CD452(-) endothelial cells, which through the release of angiocrine trophogens initiate and sustain liver regeneration induced by 70% partial hepatectomy. After partial hepatectomy, residual liver vasculature remains intact without experiencing hypoxia or structural damage, which allows study of physiological liver regeneration. Using this model, we show that inducible genetic ablation of vascular endothelial growth factor (VEGF)-A receptor-2 (VEGFR2) in the LSECs impairs the initial burst of hepatocyte proliferation (days 1-3 after partial hepatectomy) and subsequent reconstitution of the hepatovascular mass (days 4-8 after partial hepatectomy) by inhibiting upregulation of the endothelial-cell-specific transcription factor Id1. Accordingly, Id1-deficient mice also manifest defects throughout liver regeneration, owing to diminished expression of LSEC-derived angiocrine factors, including hepatocyte growth factor (HGF) and Wnt2. Notably, in in vitro co-cultures, VEGFR2-Id1 activation in LSECs stimulates hepatocyte proliferation. Indeed, intrasplenic transplantation of Id1(+/+) or Id1(-/-) LSECs transduced with Wnt2 and HGF (Id1(-/-)Wnt2(+)HGF(+) LSECs) re-establishes an inductive vascular niche in the liver sinusoids of the Id1(-/-) mice, initiating and restoring hepatovascular regeneration. Therefore, in the early phases of physiological liver regeneration, VEGFR2-Id1-mediated inductive angiogenesis in LSECs through release of angiocrine factors Wnt2 and HGF provokes hepatic proliferation. Subsequently, VEGFR2-Id1-dependent proliferative angiogenesis reconstitutes liver mass. Therapeutic co-transplantation of inductive VEGFR2(+)Id1(+)Wnt2(+)HGF(+) LSECs with hepatocytes provides an effective strategy to achieve durable liver regeneration.	[Ding, Bi-Sen; Nolan, Daniel J.; Butler, Jason M.; James, Daylon; Babazadeh, Alexander O.; Kobayashi, Hideki; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY 10065 USA; [Ding, Bi-Sen; Nolan, Daniel J.; Butler, Jason M.; James, Daylon; Babazadeh, Alexander O.; Kobayashi, Hideki; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Rosenwaks, Zev] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Mittal, Vivek] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Lyden, David] Weill Cornell Med Coll, Dept Pediat, New York, NY 10065 USA; [Sato, Thomas N.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11549 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; Nara Institute of Science & Technology; Hofstra University	Rafii, S (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY 10065 USA.	srafii@med.cornell.edu			Howard Hughes Medical Institute; Ansary Stem Cell Institute; National Institutes of Health [HL097797, U01 HL-66592-03, RC1 AI080309]; Qatar National Priorities Research Program; Anbinder and Newmans Own Foundations; Empire State Stem Cell Board; New York State Department of Health [NYS C024180]; MEXT; Takeda Science Foundation; Uehara Memorial Life Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059312, P01HL067839, P50HL084936, R01HL097797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Priorities Research Program(Qatar National Research Fund (QNRF)); Anbinder and Newmans Own Foundations; Empire State Stem Cell Board; New York State Department of Health; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Life Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S.R. is supported by the Howard Hughes Medical Institute, the Ansary Stem Cell Institute, National Institutes of Health grants HL097797, U01 HL-66592-03 and RC1 AI080309, the Qatar National Priorities Research Program, the Anbinder and Newmans Own Foundations, the Empire State Stem Cell Board and a New York State Department of Health grant, NYS C024180. T.N.S is supported by MEXT (Kiban-S), the Takeda Science Foundation and the Uehara Memorial Life Science Foundation. We are grateful to N. K. Hong for advice on mouse surgical procedure and F. Roth for editing the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Greene AK, 2003, ANN SURG, V237, P530, DOI 10.1097/00000658-200304000-00015; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Rafii S, 2008, SCIENCE, V319, P163, DOI 10.1126/science.1153615; Sakaguchi TF, 2008, CURR BIOL, V18, P1565, DOI 10.1016/j.cub.2008.08.065; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; van Buren G, 2008, J CLIN ONCOL, V26, P1836, DOI 10.1200/JCO.2007.11.6566; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	36	530	556	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					310	U240		10.1038/nature09493	http://dx.doi.org/10.1038/nature09493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068842	Green Accepted			2022-12-01	WOS:000284051000052
J	Fields, RD				Fields, R. Douglas			Change in the Brain's White Matter	SCIENCE			English	Editorial Material							MYELINATION; RELEASE; OLIGODENDROCYTES; ARCHITECTURE; MECHANISM; IMPULSES; NEURONS; CELLS		NICHHD, Nervous Syst Dev & Plast Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, RD (corresponding author), NICHHD, Nervous Syst Dev & Plast Sect, NIH, Bethesda, MD 20892 USA.	fieldsd@mail.nih.gov	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	Intramural NIH HHS [ZIA HD000713-23, Z99 HD999999] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Fields RD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001128; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Markham JA, 2009, BRAIN RES, V1288, P9, DOI 10.1016/j.brainres.2009.06.087; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 1998, J NEUROSCI, V18, P9303; Ullen F, 2009, NEURON GLIA BIOL, V5, P28, DOI 10.1017/S1740925X09990330	18	139	144	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					768	769		10.1126/science.1199139	http://dx.doi.org/10.1126/science.1199139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051624	Green Accepted			2022-12-01	WOS:000283855700028
J	Kubo, K; Entani, T; Takara, A; Wang, N; Fields, AM; Hua, ZH; Toyoda, M; Kawashima, S; Ando, T; Isogai, A; Kao, T; Takayama, S				Kubo, Ken-ichi; Entani, Tetsuyuki; Takara, Akie; Wang, Ning; Fields, Allison M.; Hua, Zhihua; Toyoda, Mamiko; Kawashima, Shin-ichi; Ando, Toshio; Isogai, Akira; Kao, Teh-hui; Takayama, Seiji			Collaborative Non-Self Recognition System in S-RNase-Based Self-Incompatibility	SCIENCE			English	Article							F-BOX GENE; POLLEN; LOCUS; IDENTIFICATION; DETERMINANT; REGION; SLF	Self-incompatibility in flowering plants prevents inbreeding and promotes outcrossing to generate genetic diversity. In Solanaceae, a multiallelic gene, S-locus F-box (SLF), was previously shown to encode the pollen determinant in self-incompatibility. It was postulated that an SLF allelic product specifically detoxifies its non-self S-ribonucleases (S-RNases), allelic products of the pistil determinant, inside pollen tubes via the ubiquitin-26S-proteasome system, thereby allowing compatible pollinations. However, it remained puzzling how SLF, with much lower allelic sequence diversity than S-RNase, might have the capacity to recognize a large repertoire of non-self S-RNases. We used in vivo functional assays and protein interaction assays to show that in Petunia, at least three types of divergent SLF proteins function as the pollen determinant, each recognizing a subset of non-self S-RNases. Our findings reveal a collaborative non-self recognition system in plants.	[Wang, Ning; Hua, Zhihua; Kao, Teh-hui] Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA; [Kubo, Ken-ichi; Entani, Tetsuyuki; Takara, Akie; Toyoda, Mamiko; Kawashima, Shin-ichi; Isogai, Akira; Takayama, Seiji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Fields, Allison M.; Kao, Teh-hui] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ando, Toshio] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nara Institute of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chiba University	Kao, T (corresponding author), Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA.	txk3@psu.edu; takayama@bs.naist.jp	Isogai, Akira/O-8897-2017; Hua, Zhihua/B-8835-2012; Messier, Claude/A-2322-2008; Hua, Zhihua/AAD-1146-2021; ANDO, Toshio/E-7054-2015	Isogai, Akira/0000-0001-8095-0441; Messier, Claude/0000-0002-4791-1763; ANDO, Toshio/0000-0001-8819-154X	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; NSF [IOB-0543201, IOS-0843195]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NSF(National Science Foundation (NSF))	We thank A. Miyawaki for Venus vectors; M. Iwano, H. Shiba, Y. Wada, P. Nakayama, M. Kakita, X. Meng, T. Tsuchimatsu, and K. K. Shimizu for discussion; and N. Katsui, M. Matsumura-Kawashima, M. Okamura, Y. Egusa, K. Kajihara, M. Bothe, and M. Goralczyk for technical assistance. Supported by Grant-in-Aid for Creative Scientific Research (A.I.) and Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (S.T.), Grant-in-Aid for the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan to the Nara Institute of Science and Technology, and NSF grants IOB-0543201 and IOS-0843195 (T.-h. K.). Sequence data have been deposited in GenBank under accession numbers AB568388 to AB568423.	Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; Entani T, 2003, GENES CELLS, V8, P203, DOI 10.1046/j.1365-2443.2003.00626.x; Entani T, 1999, BIOSCI BIOTECH BIOCH, V63, P1882, DOI 10.1271/bbb.63.1882; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; Hua ZH, 2008, MOL PLANT, V1, P575, DOI 10.1093/mp/ssn032; Hua ZH, 2007, PLANT CELL, V19, P3593, DOI 10.1105/tpc.107.055426; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; McClure B, 2009, J EXP BOT, V60, P1069, DOI 10.1093/jxb/erp024; Minamikawa M, 2010, PLANT MOL BIOL, V74, P143, DOI 10.1007/s11103-010-9662-z; Newbigin E, 2008, PLANT CELL, V20, P2286, DOI 10.1105/tpc.108.060327; Okada K, 2004, J JPN SOC HORTIC SCI, V73, P524, DOI 10.2503/jjshs.73.524; Okada K, 2008, PLANT MOL BIOL, V66, P389, DOI 10.1007/s11103-007-9277-1; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Sassa H, 2007, GENETICS, V175, P1869, DOI 10.1534/genetics.106.068858; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Tsukamoto T, 2005, PLANT MOL BIOL, V57, P141, DOI 10.1007/s11103-004-6852-6; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Wheeler MJ, 2009, NATURE, V459, P992, DOI 10.1038/nature08027; Zhou Z, 2003, APPL MATH LETT, V16, P165, DOI 10.1016/S0893-9659(03)80027-7	23	204	221	6	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					796	799		10.1126/science.1195243	http://dx.doi.org/10.1126/science.1195243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051632				2022-12-01	WOS:000283855700036
J	Bassani, DG; Kumar, R; Awasthi, S; Morris, SK; Paul, VK; Shet, A; Ram, U; Gaffey, MF; Black, RE; Jha, P; Mishra, B; Ramji, S; Subramaniyam, M				Bassani, Diego G.; Kumar, Rajesh; Awasthi, Shally; Morris, Shaun K.; Paul, Vinod K.; Shet, Anita; Ram, Usha; Gaffey, Michelle F.; Black, Robert E.; Jha, Prabhat; Mishra, Bhaskar; Ramji, Siddarth; Subramaniyam, Mani		Million Death Study Collaborators	Causes of neonatal and child mortality in India: a nationally representative mortality survey	LANCET			English	Article							DEATHS; MANAGEMENT; BANGLADESH; RATES	Background More than 2.3 million children died in India in 2005; however, the major causes of death have not been measured in the country. We investigated the causes of neonatal and child mortality in India and their differences by sex and region. Methods The Registrar General of India surveyed all deaths occurring in 2001-03 in 1.1 million nationally representative homes. Field staff interviewed household members and completed standard questions about events that preceded the death. Two of 130 physicians then independently assigned a cause to each death. Cause-specific mortality rates for 2005 were calculated nationally and for the six regions by combining the recorded proportions for each cause in the neonatal deaths and deaths at ages 1-59 months in the study with population and death totals from the United Nations. Findings There were 10 892 deaths in neonates and 12 260 in children aged 1-59 months in the study. When these details were projected nationally, three causes accounted for 78% (0.79 million of 1.01 million) of all neonatal deaths: prematurity and low birthweight (0.33 million, 99% CI 0.31 million to 0.35 million), neonatal infections (0.27 million, 0.25 million to 0.29 million), and birth asphyxia and birth trauma (0.19 million, 0.18 million to 0.21 million). Two causes accounted for 50% (0.67 million of 1.34 million) of all deaths at 1-59 months: pneumonia (0.37 million, 0.35 million to 0.39 million) and diarrhoeal diseases (0.30 million, 0.28 million to 0.32 million). In children aged 1-59 months, girls in central India had a five-times higher mortality rate (per 1000 livebirths) from pneumonia (20.9, 19.4-22.6) than did boys in south India (4.1, 3.0-5.6) and four-times higher mortality rate from diarrhoeal disease (17.7, 16.2-19.3) than did boys in west India (4.1, 3.0-5.5). Interpretation Five avoidable causes accounted for nearly 1.5 million child deaths in India in 2005, with substantial differences between regions and sexes. Expanded neonatal and intrapartum care, case management of diarrhoea and pneumonia, and addition of new vaccines to immunisation programmes could substantially reduce child deaths in India.	[Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	prabhat.jha@utoronto.ca	Ram, Usha/AAS-4140-2020; Bassani, Diego/G-2827-2015	Ram, Usha/0000-0001-6722-7347; Bassani, Diego/0000-0001-6704-3820; Shet, Anita/0000-0002-7204-8164; Jha, Prabhat/0000-0001-7067-8341	Fogarty International Centre of the US National Institutes of Health [R01 TW05991-01]; Canadian Institute of Health Research (CIHR) [IEG-53506]; International Development Research Centre [102172]; Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto; US Fund for UNICEF via Bill & Melinda Gates Foundation for CHERG [50140]; Canada Research Chair programme; FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER	Fogarty International Centre of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Development Research Centre; Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto; US Fund for UNICEF via Bill & Melinda Gates Foundation for CHERG; Canada Research Chair programme(Canada Research Chairs); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Registrar General of India established the SRS in 1971, has continued it ever since, and is collaborating with several of the authors on the ongoing Million Death Study. External funding is from the Fogarty International Centre of the US National Institutes of Health (grant R01 TW05991-01), Canadian Institute of Health Research (CIHR; IEG-53506), International Development Research Centre (Grant 102172), Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto, and the US Fund for UNICEF (via a grant from the Bill & Melinda Gates Foundation for CHERG; subgrant 50140). PJ is supported by the Canada Research Chair programme. SKM is a Fellow of the Pediatric Scientist Development Program. The opinions expressed in this paper are those of the authors and do not necessarily represent those of the Government of India. We thank Joy Lawn, Colin Mathers, Mikkel Oestergaard, Prem Mony, and Alvin Zipursky for comments; and Maya Kesler, Brendon Pezzack, Chinthanie Ramasundarahettige, Peter Rodriguez, and Wilson Suraweera for data support.	Ali M, 2005, B WORLD HEALTH ORGAN, V83, P27; ANKER M, 1999, STANDARD VERBAL AUTO; [Anonymous], 2005, SPEC FERT MORT SURV; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Baqui AH, 2006, B WORLD HEALTH ORGAN, V84, P706, DOI 10.2471/BLT.05.026443; Bassani DG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-491; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Corsi DJ, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S3; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; *IIPS MACR, 2008, NAT FAM HLTH SURV NF; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Jha P, 2002, NATL MED J INDIA, V15, P32; Jha P, 2009, CHOOS HLTH ENT ALL I; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Maude GH, 1997, INT J EPIDEMIOL, V26, P1097, DOI 10.1093/ije/26.5.1097; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; *REG GEN IND, 2005, MED CERT CAUS DEATH; *REG GEN IND, 2001, CENS IND 2001; [Registrar General of India Centre for Global Health Research Ministry of Home Affairs], 2009, CAUS DEATH IND 2001; Ronsmans C, 2008, PAEDIATR PERINAT EP, V22, P269, DOI 10.1111/j.1365-3016.2008.00939.x; United Nations Population Division, 2009, WORLD POP PROSP 2008; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8; World Health Organization, 1994, INT STAT CLASS DIS R; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; [No title captured]; [No title captured]	35	303	307	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1853	1860		10.1016/S0140-6736(10)61461-4	http://dx.doi.org/10.1016/S0140-6736(10)61461-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21075444	Green Accepted			2022-12-01	WOS:000285439700034
J	Lebreton, A; Lakisic, G; Job, V; Fritsch, L; To, NT; Camejo, A; Mattei, PJ; Regnault, B; Nahori, MA; Cabanes, D; Gautreau, A; Ait-Si-Ali, S; Dessen, A; Cossart, P; Bierne, H				Lebreton, Alice; Lakisic, Goran; Job, Viviana; Fritsch, Lauriane; To Nam Tham; Camejo, Ana; Mattei, Pierre-Jean; Regnault, Beatrice; Nahori, Marie-Anne; Cabanes, Didier; Gautreau, Alexis; Ait-Si-Ali, Slimane; Dessen, Andrea; Cossart, Pascale; Bierne, Helene			A Bacterial Protein Targets the BAHD1 Chromatin Complex to Stimulate Type III Interferon Response	SCIENCE			English	Article							LISTERIA-MONOCYTOGENES; LAMBDA; INFECTION	Intracellular pathogens such as Listeria monocytogenes subvert cellular functions through the interaction of bacterial effectors with host components. Here we found that a secreted listerial virulence factor, LntA, could target the chromatin repressor BAHD1 in the host cell nucleus to activate interferon (IFN)-stimulated genes (ISGs). IFN-lambda expression was induced in response to infection of epithelial cells with bacteria lacking LntA; however, the BAHD1-chromatin associated complex repressed downstream ISGs. In contrast, in cells infected with lntA-expressing bacteria, LntA prevented BAHD1 recruitment to ISGs and stimulated their expression. Murine listeriosis decreased in BAHD1(+/-) mice or when lntA was constitutively expressed. Thus, the LntA-BAHD1 interplay may modulate IFN-lambda-mediated immune response to control bacterial colonization of the host.	[Lebreton, Alice; To Nam Tham; Nahori, Marie-Anne; Cossart, Pascale; Bierne, Helene] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Lebreton, Alice; To Nam Tham; Nahori, Marie-Anne; Cossart, Pascale; Bierne, Helene] INRA, USC2020, F-75015 Paris, France; [Lebreton, Alice; To Nam Tham; Nahori, Marie-Anne; Cossart, Pascale; Bierne, Helene] INSERM, U604, F-75015 Paris, France; [Lakisic, Goran; Gautreau, Alexis] CNRS, UPR3082, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Job, Viviana; Mattei, Pierre-Jean; Dessen, Andrea] Inst Biol Struct, Bacterial Pathogenesis Grp, UMR 5075, CNRS CEA UJF, F-38027 Grenoble, France; [Fritsch, Lauriane; Ait-Si-Ali, Slimane] Univ Paris 07, CNRS, UMR7216, F-75013 Paris, France; [Camejo, Ana; Cabanes, Didier] Inst Mol & Cellular Biol, P-4150 Oporto, Portugal; [Regnault, Beatrice] Inst Pasteur, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Universidade do Porto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr; hbierne@pasteur.fr	Cabanes, Didier/P-3052-2019; Lebreton, Alice/M-8764-2015; Cabanes, Didier/K-3917-2013; Gautreau, Alexis/AAT-2751-2020	Cabanes, Didier/0000-0002-4001-1332; Lebreton, Alice/0000-0002-6643-902X; Cabanes, Didier/0000-0002-4001-1332; Gautreau, Alexis/0000-0002-2369-4362; Bierne, Helene/0000-0002-0525-0848; LAKISIC, Goran/0000-0002-0079-5072; Marie-Anne, Nahori/0000-0002-4066-4528; REGNAULT, Beatrice/0000-0002-3914-1914; Job, Viviana/0000-0001-8421-5292; Dessen, Andrea/0000-0001-6487-4020	Pasteur Institute, French National Institute for Agricultural Research (INRA); INSERM; The French National Research Agency (ANR)-European Research Area (ERA)-NET-PathoGenomics [SPATELIS]; French Ligue Nationale Contre le Cancer [LNCC RS10/75-76]; European Research Council [233348]; Region Rhone Alpes; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC-SAU/MII/65406/2006, SFRH/BD/29314/2006]; ERANET-PathoGenomics [SPATELIS]	Pasteur Institute, French National Institute for Agricultural Research (INRA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); The French National Research Agency (ANR)-European Research Area (ERA)-NET-PathoGenomics(French National Research Agency (ANR)); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); European Research Council(European Research Council (ERC)European Commission); Region Rhone Alpes(Region Auvergne-Rhone-Alpes); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); ERANET-PathoGenomics	We are very grateful to O. Dussurget for help in virulence assays. We thank E. Gouin for antibodies against LntA; J.-Y. Coppee for microarrays facilities at the IP Genopole; S. Jacquot and M. C. Birling at the Targeted Mutagenesis and Transgenesis department of the Mouse Clinical Institute (MCI/ICS), where the BAHD1<SUP>+/-</SUP> mouse line was generated. Work in the Cossart laboratory received financial support from the Pasteur Institute, French National Institute for Agricultural Research (INRA), INSERM, The French National Research Agency (ANR)-European Research Area (ERA)-NET-PathoGenomics (grant SPATELIS), French Ligue Nationale Contre le Cancer (LNCC RS10/75-76 Bierne), and European Research Council (Advanced Grant 233348). P.-J. M. received a Ph. D. fellowship from Region Rhone Alpes. Work in the Cabanes laboratory was supported by Fundacao para a Ciencia e a Tecnologia (FCT) (PTDC-SAU/MII/65406/2006; Ph. D. fellowship to A. C. SFRH/BD/29314/2006) and ERANET-PathoGenomics (grant SPATELIS). P. C. is an international research scholar of the Howard Hughes Medical Institute. The LntA molecular structure data are deposited at the Worldwide Protein Data Bank (http://www.wwpdb.org), ID no. 2xl4, structure factor file no. r2xl4sf.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bierne H, 2009, P NATL ACAD SCI USA, V106, P13826, DOI 10.1073/pnas.0901259106; Casola A, 2001, J VIROL, V75, P6428, DOI 10.1128/JVI.75.14.6428-6439.2001; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Dussurget O, 2008, INT REV CEL MOL BIO, V270, P1, DOI 10.1016/S1937-6448(08)01401-9; Gallagher G, 2010, J INTERF CYTOK RES, V30, P603, DOI 10.1089/jir.2010.0081; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Kamitani S, 2008, BIOCHEM BIOPH RES CO, V370, P366, DOI 10.1016/j.bbrc.2008.03.104; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952	18	125	134	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1319	1321		10.1126/science.1200120	http://dx.doi.org/10.1126/science.1200120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21252314	Green Submitted			2022-12-01	WOS:000288215200045
J	Papamichos-Chronakis, M; Watanabe, S; Rando, OJ; Peterson, CL				Papamichos-Chronakis, Manolis; Watanabe, Shinya; Rando, Oliver J.; Peterson, Craig L.			Global Regulation of H2A.Z Localization by the INO80 Chromatin-Remodeling Enzyme Is Essential for Genome Integrity	CELL			English	Article							HISTONE VARIANT H2A.Z; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; RECOMBINANT HISTONES; CELL-CYCLE; COMPLEX; ACETYLATION; REPAIR; YEAST; TRANSCRIPTION	INO80 is an evolutionarily conserved, ATP-dependent chromatin-remodeling enzyme that plays roles in transcription, DNA repair, and replication. Here, we show that yeast INO80 facilitates these diverse processes at least in part by controlling genome-wide distribution of the histone variant H2A.Z. In the absence of INO80, H2A.Z nucleosomes are mislocalized, and H2A.Z levels at promoters show reduced responsiveness to transcriptional changes, suggesting that INO80 controls H2A.Z dynamics. Additionally, we demonstrate that INO80 has a histone-exchange activity in which the enzyme can replace nucleosomal H2A.Z/H2B with free H2A/H2B dimers. Genetic interactions between ino80 and htz1 support a model in which INO80 catalyzes the removal of unacetylated H2A.Z from chromatin as a mechanism to promote genome stability.	[Papamichos-Chronakis, Manolis; Watanabe, Shinya; Peterson, Craig L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA.	craig.peterson@umassmed.edu		Rando, Oliver/0000-0003-1516-9397; Papamichos-Chronakis, Emmanouil/0000-0002-4144-2070	National Institutes of Health [GM54096]; Burroughs Wellcome Fund; National Institute of General Medical Sciences; Human Frontier Science Program; Inserm; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054096, R01GM079205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontier Science Program(Human Frontier Science Program); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to C.L.P. (GM54096). O.J.R. is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund and grants from the National Institute of General Medical Sciences and Human Frontier Science Program. M.P.-C. is supported by the Avenir Program from Inserm. We thank John Holik [University of Massachusetts Medical School (UMMS)] for assistance with the tiling array studies, Jerry Workman (Stowers Institute) for yeast histone expression vectors, John Lescyz (UMMS) for mass spectrometry analysis, Nicholas Adkins (UMMS) for the western blot with Millipore alpha-Htz1 sera (Figure S7), Erica Hong (Harvard Medical School) for help with Figure 7, members of the Peterson lab for helpful discussions throughout the course of this work, and Genevieve Almouzni (Curie Institute), Angela Taddei (Curie Institute), and Valerie Borde (Curie Institute) for critical reading of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Begley TJ, 2002, MOL CANCER RES, V1, P103; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Klopf E, 2009, MOL CELL BIOL, V29, P4994, DOI 10.1128/MCB.01858-08; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kurihara LJ, 1996, MOL CELL BIOL, V16, P3990; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Logie C, 1999, METHOD ENZYMOL, V304, P726; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1999, METH MOL B, V119, P1; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ren QH, 2001, MOL CELL, V7, P1329, DOI 10.1016/S1097-2765(01)00269-6; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Sinha M, 2009, CELL, V138, P1109, DOI 10.1016/j.cell.2009.07.013; Svotelis A, 2010, CELL CYCLE, V9, P364, DOI 10.4161/cc.9.2.10465; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Vincent JA, 2008, NAT STRUCT MOL BIOL, V15, P477, DOI 10.1038/nsmb.1419; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	51	287	295	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					200	213		10.1016/j.cell.2010.12.021	http://dx.doi.org/10.1016/j.cell.2010.12.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241891	Green Accepted, Bronze			2022-12-01	WOS:000286459900006
J	Dwyer, T; Ponsonby, AL; Ukoumunne, OC; Pezic, A; Venn, A; Dunstan, D; Barr, E; Blair, S; Cochrane, J; Zimmet, P; Shaw, J				Dwyer, T.; Ponsonby, A-L; Ukoumunne, O. C.; Pezic, A.; Venn, A.; Dunstan, D.; Barr, E.; Blair, S.; Cochrane, J.; Zimmet, P.; Shaw, J.			Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; LIFE-STYLE; METABOLIC SYNDROME; SEDENTARY TIME; OBESITY; INTENSITY; PEDOMETER; MODERATE; RISK	Objectives To investigate the association between change in daily step count and both adiposity and insulin sensitivity and the extent to which the association between change in daily step count and insulin sensitivity may be mediated by adiposity. Design Population based cohort study. Setting Tasmania, Australia. Participants 592 adults (men (n=267), mean age 51.4 (SD 12.2) years; women (n=325), mean age 50.3 (12.3) years) who participated in the Tasmanian component of the national AusDiab Study in 2000 and 2005. Main outcome measures Body mass index, waist to hip ratio, and HOMA insulin sensitivity at follow-up in 2005. Results Over the five year period, the daily step count decreased for 65% (n=382) of participants. Having a higher daily step count in 2005 than in 2000 was independently associated with lower body mass index (0.08 (95% confidence interval 0.04 to 0.12) lower per 1000 steps), lower waist to hip ratio (0.15 (0.07 to 0.23) lower), and greater insulin sensitivity (1.38 (0.14 to 2.63) HOMA units higher) in 2005. The mean increase in HOMA units fell to 0.34 (-0.79 to 1.47) after adjustment for body mass index in 2005. Conclusions Among community dwelling, middle aged adults, a higher daily step count at five year follow-up than at baseline was associated with better insulin sensitivity. This effect seems to be largely mediated through lower adiposity.	[Dwyer, T.; Ponsonby, A-L; Ukoumunne, O. C.; Pezic, A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Dwyer, T.; Ponsonby, A-L; Venn, A.; Cochrane, J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Dunstan, D.; Barr, E.; Zimmet, P.; Shaw, J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Blair, S.] Univ S Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Tasmania; Menzies Institute for Medical Research; Baker Heart and Diabetes Institute; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Dwyer, T (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	terry.dwyer@mcri.edu.au	Zimmet, Paul/O-8486-2019; Dunstan, David Wayne/E-8473-2010; Shaw, Jonathan/E-7388-2010; Ponsonby, Anne-Louise/AAE-4351-2019; Venn, Alison J/J-2803-2013	Zimmet, Paul/0000-0003-0627-0776; Dunstan, David Wayne/0000-0003-2629-9568; Shaw, Jonathan/0000-0002-6187-2203; Ponsonby, Anne-Louise/0000-0002-6581-3657	Commonwealth Department of Health and Aged Care; Abbott Australasia; Alphapharm; Aventis Pharmaceutical; AstraZeneca; Bristol-Myers Squibb Pharmaceuticals; Eli Lilly (Australia); GlaxoSmithKline; Janssen-Cilag (Australia); Merck Lipha; Merck Sharp & Dohme (Australia); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical,; Pharmacia and Upjohn; Pfizer; Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; HITECH Pathology; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia (Northern Territory); Queensland Health; South Australian Department of Human Services; Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Health Department of Western Australia; Victorian Health Promotion Foundation; NHMRC [436914]	Commonwealth Department of Health and Aged Care; Abbott Australasia(Abbott Laboratories); Alphapharm; Aventis Pharmaceutical; AstraZeneca(AstraZeneca); Bristol-Myers Squibb Pharmaceuticals(Bristol-Myers Squibb); Eli Lilly (Australia)(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag (Australia)(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Lipha; Merck Sharp & Dohme (Australia)(Merck & Company); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical,(Novo Nordisk); Pharmacia and Upjohn; Pfizer(Pfizer); Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; HITECH Pathology; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia (Northern Territory); Queensland Health; South Australian Department of Human Services(Department for Environment, Food & Rural Affairs (DEFRA)); Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Health Department of Western Australia; Victorian Health Promotion Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study received financial support from the Commonwealth Department of Health and Aged Care, Abbott Australasia, Alphapharm, Aventis Pharmaceutical, AstraZeneca, Bristol-Myers Squibb Pharmaceuticals, Eli Lilly (Australia), GlaxoSmithKline, Janssen-Cilag (Australia), Merck Lipha, Merck Sharp & Dohme (Australia), Novartis Pharmaceutical (Australia), Novo Nordisk Pharmaceutical, Pharmacia and Upjohn, Pfizer, Roche Diagnostics, Sanofi Synthelabo (Australia), Servier Laboratories (Australia), BioRad Laboratories, HITECH Pathology, the Australian Kidney Foundation, Diabetes Australia, Diabetes Australia (Northern Territory), Queensland Health, South Australian Department of Human Services, Tasmanian Department of Health and Human Services, Territory Health Services, Victorian Department of Human Services, and Health Department of Western Australia. DD is supported by a Victorian Health Promotion Foundation public health research fellowship. OCU is supported by NHMRC Population Health Capacity Building Grant 436914. JS is supported by an NHMRC senior research fellowship.	Ainsworth BE, 2002, COMPENDIUM PHYS ACTI; Australian Bureau of Statistics, 2001, SOC IND AR SEIFA; Australian Institute of Health and Welfare, 2003, ACT AUSTR SURV; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Coke LA, 2010, J CARDIOVASC NURS, V25, P238, DOI 10.1097/JCN.0b013e3181cec814; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Dwyer T, 2007, INT J OBESITY, V31, P797, DOI 10.1038/sj.ijo.0803472; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Hall AJ, 2002, INT J EPIDEMIOL, V31, P300, DOI 10.1093/ije/31.2.300; Hatano Y., 1993, J INT COMMITTEE HLTH, V29, P4; Hellie T, 2010, MEASURE YOUR STEP ST; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Little R.J.A., 2002, STAT ANAL MISSING DA, V2nd; Magliano DJ, 2008, DIABETES CARE, V31, P267, DOI 10.2337/dc07-0912; Marshall SJ, 2009, AM J PREV MED, V36, P410, DOI 10.1016/j.amepre.2009.01.021; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Timperio A., 2002, VALIDATION ADULT PHY; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wilkin TJ, 2004, J ROY SOC MED, V97, P511, DOI 10.1258/jrsm.97.11.511	30	52	52	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2011	342								c7249	10.1136/bmj.c7249	http://dx.doi.org/10.1136/bmj.c7249			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708TG	21233153	hybrid, Green Submitted			2022-12-01	WOS:000286386600002
J	Rauzi, M; Lenne, PF; Lecuit, T				Rauzi, Matteo; Lenne, Pierre-Francois; Lecuit, Thomas			Planar polarized actomyosin contractile flows control epithelial junction remodelling	NATURE			English	Article							ADHERENS JUNCTIONS; APICAL CONSTRICTION; CELL-SHAPE; TISSUE MORPHOGENESIS; ALPHA-CATENIN; E-CADHERIN; DROSOPHILA; NETWORK; FORCES; INTERCALATION	Force generation by Myosin-II motors on actin filaments drives cell and tissue morphogenesis(1-15). In epithelia, contractile forces are resisted at apical junctions by adhesive forces dependent on E-cadherin(16), which also transmits tension(6,17-19). During Drosophila embryonic germband extension, tissue elongation is driven by cell intercalation(20), which requires an irreversible and planar polarized remodelling of epithelial cell junctions(4,5). We investigate how cell deformations emerge from the interplay between force generation and cortical force transmission during this remodelling in Drosophila melanogaster. The shrinkage of dorsal-ventral-oriented ('vertical') junctions during this process is known to require planar polarized junctional contractility by Myosin II (refs 4,5,7,12). Here we show that this shrinkage is not produced by junctional Myosin II itself, but by the polarized flow of medial actomyosin pulses towards 'vertical' junctions. This anisotropic flow is oriented by the planar polarized distribution of E-cadherin complexes, in that medial Myosin II flows towards 'vertical' junctions, which have relatively less E-cadherin than transverse junctions. Our evidence suggests that the medial flow pattern reflects equilibrium properties of force transmission and coupling to E-cadherin by a-Catenin. Thus, epithelial morphogenesis is not properly reflected by Myosin II steady state distribution but by polarized contractile actomyosin flows that emerge from interactions between E-cadherin and actomyosin networks.	[Rauzi, Matteo; Lenne, Pierre-Francois; Lecuit, Thomas] Univ Aix Marseille 2, CNRS, IBDML, UMR6216, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Aix Marseille 2, CNRS, IBDML, UMR6216, Campus Luminy,Case 907, F-13288 Marseille 09, France.	lenne@ibdml.univ-mrs.fr; lecuit@ibdml.univ-mrs.fr		Rauzi, Matteo/0000-0002-6313-0668; Lenne, Pierre-Francois/0000-0003-1066-7506	HFSP; CNRS; Fondation pour la Recherche Medicale; ANR-Blanc; Region PACA; ANR-PCV; Amplitude Systems	HFSP(Human Frontier Science Program); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR-Blanc(French National Research Agency (ANR)); Region PACA(Region Provence-Alpes-Cote d'Azur); ANR-PCV(French National Research Agency (ANR)); Amplitude Systems	We thank R. Levayer, M. Mavrakis and J.-M. Philippe for making and sharing respectively the utrophin-GFP, GAP43-Venus and GAP43-Cherry transgenic lines. We are grateful to our colleagues for their gifts of reagents: B. Bement, R. Karess, H. Oda, A. Martin and E. Wieschaus. We thank E. Munro and all members of the Lecuit and Lenne groups for discussions, and comments on the manuscript. This work was supported by a Programme Grant from HFSP to T. L, P.-F.L and E. Munro, by the CNRS, the Fondation pour la Recherche Medicale (to T. L), the ANR-Blanc 2005 (to T. L. and P.-F.L), Region PACA and ANR-PCV 2008 (to P.-F.L and T. L.). M. R. was supported by a PhD fellowship by the Region PACA and Amplitude Systems.	Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bertet C, 2009, DEVELOPMENT, V136, P4199, DOI 10.1242/dev.040402; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cavey Matthieu, 2008, V420, P219, DOI 10.1007/978-1-59745-583-1_13; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Oda H, 2001, J CELL SCI, V114, P493; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	36	420	427	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1110	U515		10.1038/nature09566	http://dx.doi.org/10.1038/nature09566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21068726				2022-12-01	WOS:000285553800060
J	Stepney, R				Stepney, Rob			Christmas 2010: Reading Between the Lines A dose by any other name would not sell as sweet	BRITISH MEDICAL JOURNAL			English	Editorial Material												walcot2@freenetname.co.uk						*GLAXOSMITHKLINE, 2010, OUR HIST; HERPER M, 2004, FORBES          0316; Mills JG, 1997, ALIMENT PHARM THER, V11, P129, DOI 10.1046/j.1365-2036.1997.136312000.x; *WELLC TRUST, INV HIST; 2010, FASTEST CARS WORLD T	5	6	6	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c6895	10.1136/bmj.c6895	http://dx.doi.org/10.1136/bmj.c6895			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XJ	21159760				2022-12-01	WOS:000285552800001
J	Franks, TM; Singh, G; Lykke-Andersen, J				Franks, Tobias M.; Singh, Guramrit; Lykke-Andersen, Jens			Upf1 ATPase-Dependent mRNP Disassembly Is Required for Completion of Nonsense-Mediated mRNA Decay	CELL			English	Article							EXON-JUNCTION COMPLEX; ENDONUCLEOLYTIC CLEAVAGE; SACCHAROMYCES-CEREVISIAE; SURVEILLANCE COMPLEX; BINDING-PROTEIN; QUALITY-CONTROL; CAENORHABDITIS-ELEGANS; PROCESSING BODIES; BOX PROTEIN; P-BODIES	Cellular mRNAs exist in messenger ribonucleoprotein (mRNP) complexes, which undergo transitions during the lifetime of the mRNAs and direct posttranscriptional gene regulation. A final posttranscriptional step in gene expression is the turnover of the mRNP, which involves degradation of the mRNA and recycling of associated proteins. How tightly associated protein components are released from degrading mRNPs is unknown. Here, we demonstrate that the ATPase activity of the RNA helicase Upf1 allows disassembly of mRNPs undergoing nonsense-mediated mRNA decay (NMD). In the absence of Upf1 ATPase activity, partially degraded NMD mRNA intermediates accumulate in complex with NMD factors and concentrate in processing bodies. Thus, disassembly and completion of turnover of mRNPs undergoing NMD requires ATP hydrolysis by Upf1. This uncovers a previously unappreciated and potentially regulated step in mRNA decay and raises the question of how other mRNA decay pathways release protein components of substrate mRNPs.	[Franks, Tobias M.; Singh, Guramrit; Lykke-Andersen, Jens] Univ Colorado, Boulder, CO 80309 USA; [Franks, Tobias M.; Lykke-Andersen, Jens] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego	Lykke-Andersen, J (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	jlykkeandersen@ucsd.edu		Lykke-Andersen, Jens/0000-0003-1821-0754	National Institutes of Health [R01 GM077243]; National Institute of General Medical Sciences [GM-07135]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077243, T32GM007135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Tom Blumenthal (University of Colorado), Melissa Moore (University of Massachusetts Medical Center), and Sebastien Durand (UCSD) for comments on the manuscript. Alex Choe and Claire Egan are thanked for technical support and Joachim Weischenfeldt for production of the antigen for anti-Smg1 antibodies. Drs. Marv Fritzler, Ed Chan, and Donald Bloch are thanked for human IC-6 serum. Dr. Oliver Muhlemann is thanked for the HA-Smg6 construct. Work on P bodies in our laboratory is supported by funding from grant R01 GM077243 from the National Institutes of Health to J.L.-A. T.M.F. has been supported by National Institutes of Health NRSA Institutional Training grant number GM-07135 from the National Institute of General Medical Sciences.	Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; CEREGHINO GP, 1995, MOL BIOL CELL, V6, P1125, DOI 10.1091/mbc.6.9.1125; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; CZAPLINSKI K, 1995, RNA, V1, P610; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Liu YM, 2003, RNA, V9, P677, DOI 10.1261/rna.2128903; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Muhlemann O, 2010, RNA BIOL, V7, P28; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Page MF, 1999, MOL CELL BIOL, V19, P5943; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Stalder L, 2009, RNA, V15, P1265, DOI 10.1261/rna.1672509; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; VREKEN P, 1992, MOL CELL BIOL, V12, P2986, DOI 10.1128/MCB.12.7.2986; Weng YM, 1998, RNA, V4, P205; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wilusz J, 2009, NAT STRUCT MOL BIOL, V16, P9, DOI 10.1038/nsmb0109-9; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	71	164	167	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					938	950		10.1016/j.cell.2010.11.043	http://dx.doi.org/10.1016/j.cell.2010.11.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145460	Bronze, Green Accepted			2022-12-01	WOS:000285182600011
J	McLachlan, JC				McLachlan, John C.			Christmas 2010: Reading between the Lines Integrative medicine and the point of credulity	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McLachlan, John C.] Univ Durham, Sch Med & Hlth, Stockton On Tees TS17 6BH, England	Durham University	McLachlan, JC (corresponding author), Univ Durham, Sch Med & Hlth, Stockton On Tees TS17 6BH, England.	j.c.mclachlan@durham.ac.uk	McLachlan, John/AAF-4203-2021	McLachlan, John/0000-0001-5493-2645				DIXON M, 2009, SCI BASED MED; *HOUS COMM SCI TEC, 4 HOUS COMM SCI TECH; Sokal A., 1998, INTELLECTUAL IMPOSTU; Sokal A., 1996, SOCIAL TEXT, V46/47, P217, DOI [10.2307/466856, DOI 10.2307/466856]; Strauss S, 2005, EVIDENCE BASED MED P, V3rd; 2009, DCS IMPROBABLE SCI	6	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 8	2010	341								c6979	10.1136/bmj.c6979	http://dx.doi.org/10.1136/bmj.c6979			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZL	21147748				2022-12-01	WOS:000285340300006
J	Pin, PA; Benlloch, R; Bonnet, D; Wremerth-Weich, E; Kraft, T; Gielen, JJL; Nilsson, O				Pin, Pierre A.; Benlloch, Reyes; Bonnet, Dominique; Wremerth-Weich, Elisabeth; Kraft, Thomas; Gielen, Jan J. L.; Nilsson, Ove			An Antagonistic Pair of FT Homologs Mediates the Control of Flowering Time in Sugar Beet	SCIENCE			English	Article							ANNUAL HABIT; LOCUS-T; VERNALIZATION; REPRESSOR; GENE; ARABIDOPSIS	Cultivated beets (Beta vulgaris ssp. vulgaris) are unable to form reproductive shoots during the first year of their life cycle. Flowering only occurs if plants get vernalized, that is, pass through the winter, and are subsequently exposed to an increasing day length (photoperiod) in spring. Here, we show that the regulation of flowering time in beets is controlled by the interplay of two paralogs of the FLOWERING LOCUS T (FT) gene in Arabidopsis that have evolved antagonistic functions. BvFT2 is functionally conserved with FT and essential for flowering. In contrast, BvFT1 represses flowering and its down-regulation is crucial for the vernalization response in beets. These data suggest that the beet has evolved a different strategy relative to Arabidopsis and cereals to regulate vernalization.	[Pin, Pierre A.; Benlloch, Reyes; Nilsson, Ove] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Pin, Pierre A.; Wremerth-Weich, Elisabeth; Kraft, Thomas] Syngenta Seeds AB, S-26123 Landskrona, Sweden; [Bonnet, Dominique; Gielen, Jan J. L.] Syngenta Seeds SAS, F-31790 St Sauveur, France	Swedish University of Agricultural Sciences; Umea University; Syngenta; Syngenta	Nilsson, O (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden.	Ove.Nilsson@genfys.slu.se	Benlloch, Reyes/L-7526-2014; Benlloch, Reyes/K-1110-2019	Benlloch, Reyes/0000-0002-0364-1589; PIN, Pierre A./0000-0001-8933-1452; Nilsson, Ove/0000-0002-1033-1909	Swedish Research Council; Swedish Governmental Agency for Innovation Systems; Sudzucker	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Agency for Innovation Systems(Vinnova); Sudzucker	We thank F. Domene, J. Bensefelt, A. Karlsson, R. Sant, P. van Roggen, and A.-M. Nilsson for technical assistance, and Y. Fischer for help in preparing the manuscript. We also thank C. Bellini for critical reading of the manuscript. This work was supported by the Swedish Research Council and the Swedish Governmental Agency for Innovation Systems to O.N. and T. K., as well as by Sudzucker. Phylogenetic data have been deposited with Dryad Digital Repository (DOI: 10.5061/dryad.4930). Nucleotide sequences have been deposited with GenBank under accession numbers HM448909 to HM448918 and HQ148107 to HQ148132. The use of BvFT1 and BvFT2 in control of sugar beet flowering is the subject of the patent application WO2010/025888.	Abegg F. A., 1936, J AGR RES, V53, P493; Abegg FA, 1936, J AGRIC RES, V53, P0493; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; [Anonymous], 2010, The use of BvFT1 and BvFT2 in control of sugar beet flowering is the subject of the patent application, Patent No. [WO2010/025888, 2010025888]; Bell GDH, 1942, J AGR SCI, V32, P112, DOI 10.1017/S0021859600047584; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; BOUDRY P, 1994, THEOR APPL GENET, V88, P852, DOI 10.1007/BF01253996; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Gyllenstrand N, 2007, PLANT PHYSIOL, V144, P248, DOI 10.1104/pp.107.095802; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; JUNG C, 1993, THEOR APPL GENET, V86, P449, DOI 10.1007/BF00838560; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Letschert JPW, 1993, WAGENINGEN AGR U PAP, V93-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Tadege M, 2001, PLANT J, V28, P545, DOI 10.1046/j.1365-313X.2001.01182.x; Van Dijk H, 2009, J EXP BOT, V60, P3143, DOI 10.1093/jxb/erp142; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	24	301	323	8	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1397	1400		10.1126/science.1197004	http://dx.doi.org/10.1126/science.1197004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127254				2022-12-01	WOS:000284902100047
J	Saar, BG; Freudiger, CW; Reichman, J; Stanley, CM; Holtom, GR; Xie, XS				Saar, Brian G.; Freudiger, Christian W.; Reichman, Jay; Stanley, C. Michael; Holtom, Gary R.; Xie, X. Sunney			Video-Rate Molecular Imaging in Vivo with Stimulated Raman Scattering	SCIENCE			English	Article							HIGH-SENSITIVITY; LABEL-FREE; MICROSCOPY; STORAGE	Optical imaging in vivo with molecular specificity is important in biomedicine because of its high spatial resolution and sensitivity compared with magnetic resonance imaging. Stimulated Raman scattering (SRS) microscopy allows highly sensitive optical imaging based on vibrational spectroscopy without adding toxic or perturbative labels. However, SRS imaging in living animals and humans has not been feasible because light cannot be collected through thick tissues, and motion-blur arises from slow imaging based on backscattered light. In this work, we enable in vivo SRS imaging by substantially enhancing the collection of the backscattered signal and increasing the imaging speed by three orders of magnitude to video rate. This approach allows label-free in vivo imaging of water, lipid, and protein in skin and mapping of penetration pathways of topically applied drugs in mice and humans.	[Saar, Brian G.; Freudiger, Christian W.; Holtom, Gary R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Freudiger, Christian W.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Reichman, Jay; Stanley, C. Michael] Chroma Technol, Bellows Falls, VT 05101 USA	Harvard University; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu			Boehringer Ingelheim Fonds; Bill and Melinda Gates Foundation; NIH [1R01EB010244-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010244] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank J. MacArthur for advice on electronics and K. Sherwood, W. Faustino, and X. Zhang for helpful discussions. C. W. F. was supported by a Boehringer Ingelheim Fonds Ph.D. fellowship. This work was supported by the Bill and Melinda Gates Foundation and an NIH T-R01 award (1R01EB010244-01) to X. S. X. Patent applications based on this work have been filed by Harvard Univ. Imaging was performed in accordance with Harvard Univ. Faculty of Arts and Sciences Institutional Animal Care and Use Committee protocol number 29-01.	[Anonymous], 2010, ZEM US GUID; Cheng JX, 2002, J OPT SOC AM B, V19, P1363, DOI 10.1364/JOSAB.19.001363; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Combs CA, 2007, J MICROSC-OXFORD, V228, P330, DOI 10.1111/j.1365-2818.2007.01851.x; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fu D, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2780173; Ganikhanov F, 2006, OPT LETT, V31, P1872, DOI 10.1364/OL.31.001872; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Jacques S. L., 1987, Lasers in the Life Sciences, V1, P309; Konig K, 2007, MICROSC RES TECHNIQ, V70, P398, DOI 10.1002/jemt.20445; Lademann J, 2008, SKIN PHARMACOL PHYS, V21, P150, DOI 10.1159/000131079; Levenson M. D., 1988, INTRO NONLINEAR LASE; Li L, 2005, BIOPHYS J, V89, P3480, DOI 10.1529/biophysj.105.065607; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; Nandakumar P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033026; Ozeki Y, 2009, OPT EXPRESS, V17, P3651, DOI 10.1364/OE.17.003651; Ploetz E, 2007, APPL PHYS B-LASERS O, V87, P389, DOI 10.1007/s00340-007-2630-x; Prausnitz MR, 2004, NAT REV DRUG DISCOV, V3, P115, DOI 10.1038/nrd1304; Rawlings AV., 2004, DERMATOL THER S1, V17, P43, DOI [DOI 10.1111/J.1396-0296.2004.04S1005.X, 10.1111/j.1396-0296.2004.04s1005.x]; Rinia HA, 2006, J PHYS CHEM B, V110, P4472, DOI 10.1021/jp0564849; Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Slipchenko MN, 2010, ANALYST, V135, P2613, DOI 10.1039/c0an00252f; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	28	585	612	13	296	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1368	1370		10.1126/science.1197236	http://dx.doi.org/10.1126/science.1197236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127249	Green Submitted, Green Accepted			2022-12-01	WOS:000284902100039
J	Chen, LQ; Hou, BH; Lalonde, S; Takanaga, H; Hartung, ML; Qu, XQ; Guo, WJ; Kim, JG; Underwood, W; Chaudhuri, B; Chermak, D; Antony, G; White, FF; Somerville, SC; Mudgett, MB; Frommer, WB				Chen, Li-Qing; Hou, Bi-Huei; Lalonde, Sylvie; Takanaga, Hitomi; Hartung, Mara L.; Qu, Xiao-Qing; Guo, Woei-Jiun; Kim, Jung-Gun; Underwood, William; Chaudhuri, Bhavna; Chermak, Diane; Antony, Ginny; White, Frank F.; Somerville, Shauna C.; Mudgett, Mary Beth; Frommer, Wolf B.			Sugar transporters for intercellular exchange and nutrition of pathogens	NATURE			English	Article							FANCONI-BICKEL-SYNDROME; POWDERY MILDEW; ENDOPLASMIC-RETICULUM; GLUCOSE-TRANSPORTER; BACTERIAL-BLIGHT; PETUNIA-HYBRIDA; GENE; ARABIDOPSIS; SUCROSE; RESISTANCE	Sugar efflux transporters are essential for the maintenance of animal blood glucose levels, plant nectar production, and plant seed and pollen development. Despite broad biological importance, the identity of sugar efflux transporters has remained elusive. Using optical glucose sensors, we identified a new class of sugar transporters, named SWEETs, and show that at least six out of seventeen Arabidopsis, two out of over twenty rice and two out of seven homologues in Caenorhabditis elegans, and the single copy human protein, mediate glucose transport. Arabidopsis SWEET8 is essential for pollen viability, and the rice homologues SWEET11 and SWEET14 are specifically exploited by bacterial pathogens for virulence by means of direct binding of a bacterial effector to the SWEET promoter. Bacterial symbionts and fungal and bacterial pathogens induce the expression of different SWEET genes, indicating that the sugar efflux function of SWEET transporters is probably targeted by pathogens and symbionts for nutritional gain. The metazoan homologues may be involved in sugar efflux from intestinal, liver, epididymis and mammary cells.	[Chen, Li-Qing; Hou, Bi-Huei; Lalonde, Sylvie; Takanaga, Hitomi; Hartung, Mara L.; Qu, Xiao-Qing; Guo, Woei-Jiun; Chaudhuri, Bhavna; Chermak, Diane; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Kim, Jung-Gun; Mudgett, Mary Beth] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Antony, Ginny; White, Frank F.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Underwood, William; Somerville, Shauna C.] Energy Biosci Inst, Berkeley, CA 94720 USA	Carnegie Institution for Science; Stanford University; Kansas State University	Frommer, WB (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	wfrommer@carnegiescience.edu	GUO, WOEI-JIUN/F-8487-2012; Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017; Antony, Ginny/ABC-9539-2021	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Antony, Ginny/0000-0003-0619-3176; Underwood, William/0000-0002-9920-8228	Department of Energy [DE-FG02-04ER15542]; NIH (NIDDK) [1RO1DK079109]; Carnegie Institution; National Natural Science Foundation of China (NSFC) [30771288]; NSF [IOS-0821801]; NIH [ZRO1GM06886-06A1, F32GM083439-02]; NSF; USDA NIFA [2007-35319-18103]; NSF Plant Genome [DBI-0820831]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083439, R01GM068886] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Carnegie Institution; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); USDA NIFA(United States Department of Agriculture (USDA)); NSF Plant Genome(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was made possible by grants from the Department of Energy (DE-FG02-04ER15542) and NIH (NIDDK; 1RO1DK079109) to W.B.F., X.-Q.Q. was supported by The Carnegie Institution and the National Natural Science Foundation of China (NSFC; 30771288). NSF (IOS-0821801) and NIH (ZRO1GM06886-06A1) to M.B.M. and J.-G.K. was supported 50% by NIH and 50% by NSF. W.U. was supported in part by an NIH postdoctoral fellowship (F32GM083439-02). G.A. and F.F.W. were supported by grants from USDA NIFA (2007-35319-18103) and NSF Plant Genome (DBI-0820831).	AKED J, 1993, NEW PHYTOL, V123, P271, DOI 10.1111/j.1469-8137.1993.tb03735.x; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; ANTONY G, 2003, PLANT CELL IN PRESS; *AR, 2010, PLANT MEMBR PROT DAT; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ballatori N, 1996, AM J PHYSIOL-REG I, V270, pR1156, DOI 10.1152/ajpregu.1996.270.5.R1156; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bermejo C, 2010, BIOCHEM J, V432, P399, DOI 10.1042/BJ20100946; *BIOP, 2010, SLC TABL; Bisseling T, 2009, SCIENCE, V324, P691, DOI 10.1126/science.1174404; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Detaille D, 1999, EUR J PHARMACOL, V377, P127, DOI 10.1016/S0014-2999(99)00413-6; Engel ML, 2005, PLANT PHYSIOL, V138, P2124, DOI 10.1104/pp.104.054213; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Ge YX, 2001, MOL GENET GENOMICS, V265, P414, DOI 10.1007/s004380100449; Ge YX, 2000, PLANT J, V24, P725, DOI 10.1046/j.1365-313x.2000.00926.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guan YF, 2008, PLANT PHYSIOL, V147, P852, DOI 10.1104/pp.108.118026; Hamada M, 2005, DIFFERENTIATION, V73, P364, DOI 10.1111/j.1432-0436.2005.00037.x; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HESSE M, 2004, TAPETUM CYTOLOGY FUN, P1; Hosokawa M, 2002, AM J PHYSIOL-ENDOC M, V282, pE794, DOI 10.1152/ajpendo.00374.2001; Hou BH, 2009, CELL CALCIUM, V46, P130, DOI 10.1016/j.ceca.2009.06.003; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; *HUM PROT ATL, 2010, RAG1AP1 HUM PROT ATL; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Lalonde S, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; MANZ F, 1987, PEDIATR NEPHROL, V1, P509, DOI 10.1007/BF00849262; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; PATRICK JW, 1989, AUST J PLANT PHYSIOL, V16, P53, DOI 10.1071/PP9890053; Quirino BF, 1999, PLANT MOL BIOL, V40, P267, DOI 10.1023/A:1006199932265; Quirino BF, 2001, PLANT MOL BIOL, V46, P447, DOI 10.1023/A:1010639015959; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Song LF, 2009, PLANT SIGNAL BEHAV, V4, P1193, DOI 10.4161/psb.4.12.10063; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; Sutton PN, 2007, PHYSIOL PLANTARUM, V129, P787, DOI 10.1111/j.1399-3054.2007.00863.x; Sutton PN, 1999, PLANTA, V208, P426, DOI 10.1007/s004250050578; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Takanaga H, 2010, FASEB J, V24, P2849, DOI 10.1096/fj.09-146472; Tang DJ, 2005, J BACTERIOL, V187, P6231, DOI 10.1128/JB.187.17.6231-6237.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; UDVARDI MK, 1990, MOL PLANT MICROBE IN, V3, P334, DOI 10.1094/MPMI-3-334; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yuan M, 2009, PLANT CELL PHYSIOL, V50, P947, DOI 10.1093/pcp/pcp046; Zhou YC, 2007, PLANT J, V49, P750, DOI 10.1111/j.1365-313X.2006.03000.x	61	854	972	31	464	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					527	U199		10.1038/nature09606	http://dx.doi.org/10.1038/nature09606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107422	Green Accepted			2022-12-01	WOS:000284584200034
J	Nowack, B				Nowack, Bernd			Nanosilver Revisited Downstream	SCIENCE			English	Editorial Material							SILVER NANOPARTICLES; NANO-SILVER; EXPOSURE; SULFIDE; SLUDGE; RISK		Empa, Swiss Fed Labs Mat Sci & Technol, CH-9014 St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Nowack, B (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, CH-9014 St Gallen, Switzerland.	nowack@empa.ch	Nowack, Bernd/B-6425-2008	Nowack, Bernd/0000-0002-5676-112X				Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; Blaser SA, 2008, SCI TOTAL ENVIRON, V390, P396, DOI 10.1016/j.scitotenv.2007.10.010; Choi O, 2009, WATER RES, V43, P1879, DOI 10.1016/j.watres.2009.01.029; Faunce T, 2010, NANOMEDICINE-UK, V5, P617, DOI 10.2217/NNM.10.33; Geranio L, 2009, ENVIRON SCI TECHNOL, V43, P8113, DOI 10.1021/es9018332; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Impellitteri CA, 2009, J ENVIRON QUAL, V38, P1528, DOI 10.2134/jeq2008.0390; Kim B, 2010, ENVIRON SCI TECHNOL, V44, P7509, DOI 10.1021/es101565j; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Tiede K, 2010, J ANAL ATOM SPECTROM, V25, P1149, DOI 10.1039/b926029c; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914	11	110	113	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2010	330	6007					1054	1055		10.1126/science.1198074	http://dx.doi.org/10.1126/science.1198074			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097924				2022-12-01	WOS:000284374700026
J	Zhang, YT; Baicker, K; Newhouse, JP				Zhang, Yuting; Baicker, Katherine; Newhouse, Joseph P.			Geographic Variation in the Quality of Prescribing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zhang, Yuting] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA; [Baicker, Katherine; Newhouse, Joseph P.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Newhouse, Joseph P.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Newhouse, Joseph P.] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University	Zhang, YT (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA.		Newhouse, Joseph/AGJ-5632-2022; Newhouse, Joseph/AAD-9763-2019	Zhang, Yuting/0000-0002-6460-6779	NIMH NIH HHS [RC1 MH088510, RC1 MH088510-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088510] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*NAT COMM QUAL ASS, 2009, STAT HLTH CAR QUAL; National Committee for Quality Assurance, 2010, HEALTHC EFF DAT INF; Song YJ, 2010, NEW ENGL J MED, V363, P198; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Zhang YT, 2010, NEW ENGL J MED, V363, P405, DOI 10.1056/NEJMp1004872	5	93	93	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2010	363	21					1985	1988		10.1056/NEJMp1010220	http://dx.doi.org/10.1056/NEJMp1010220			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	681KC	21047217	Green Accepted			2022-12-01	WOS:000284310000002
J	Baerlocher, MO; Detsky, AS				Baerlocher, Mark Otto; Detsky, Allan S.			Discussing Radiation Risks Associated With CT Scans With Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPUTED-TOMOGRAPHY; EXPOSURE		[Baerlocher, Mark Otto; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Baerlocher, Mark Otto] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Baerlocher, MO (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	mark.baerlocher@utoronto.ca						Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Couchman GR, 2004, ACAD RADIOL, V11, P735, DOI 10.1016/j.acra.2004.03.050; EVAN KG, 2006, CONSENT GUIDE CANADI; Larson DB, 2007, AM J ROENTGENOL, V189, P271, DOI 10.2214/AJR.07.2248; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; National Research Council Committee, 2006, HLTH RISKS EXP LOW L; Prokop M, 2005, EUR RADIOL, V15, pE35, DOI 10.1007/s10406-005-0164-z; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Terry PB, 2007, CHEST, V131, P563, DOI 10.1378/chest.06-1955	9	48	48	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2010	304	19					2170	2171		10.1001/jama.2010.1591	http://dx.doi.org/10.1001/jama.2010.1591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680XC	21081730				2022-12-01	WOS:000284269800028
J	Rustagi, D; Engel, S; Kosfeld, M				Rustagi, Devesh; Engel, Stefanie; Kosfeld, Michael			Conditional Cooperation and Costly Monitoring Explain Success in Forest Commons Management	SCIENCE			English	Article							PUBLIC-GOODS EXPERIMENTS; CONFORMIST TRANSMISSION; ALTRUISTIC PUNISHMENT; LOCAL ENFORCEMENT; COLLECTIVE ACTION; EVOLUTION; GOVERNANCE; PEOPLE; INSTITUTIONS; SANCTIONS	Recent evidence suggests that prosocial behaviors like conditional cooperation and costly norm enforcement can stabilize large-scale cooperation for commons management. However, field evidence on the extent to which variation in these behaviors among actual commons users accounts for natural commons outcomes is altogether missing. Here, we combine experimental measures of conditional cooperation and survey measures on costly monitoring among 49 forest user groups in Ethiopia with measures of natural forest commons outcomes to show that (i) groups vary in conditional cooperator share, (ii) groups with larger conditional cooperator share are more successful in forest commons management, and (iii) costly monitoring is a key instrument with which conditional cooperators enforce cooperation. Our findings are consistent with models of gene-culture coevolution on human cooperation and provide external validity to laboratory experiments on social dilemmas.	[Rustagi, Devesh; Engel, Stefanie] ETH, Inst Environm Decis, CH-8092 Zurich, Switzerland; [Kosfeld, Michael] Goethe Univ Frankfurt, Fac Econ & Business Adm, D-60323 Frankfurt, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Goethe University Frankfurt	Rustagi, D (corresponding author), ETH, Inst Environm Decis, Univ Str 22, CH-8092 Zurich, Switzerland.	devesh.rustagi@env.ethz.ch; kosfeld@econ.uni-frankfurt.de	Engel, Stefanie/B-6533-2009; Engel, Stefanie/A-7397-2009		North-South Centre at ETH Zurich; German Federal Ministry of Education and Research (BMBF) [BioTEAM 01LM0201]; German Federal Ministry of Economic Cooperation and Development (BMZ) via the Centre for Development Research, Bonn; German Organization for Technical Cooperation (GTZ); Oromia State Forest Enterprises Supervising Agency	North-South Centre at ETH Zurich; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Economic Cooperation and Development (BMZ) via the Centre for Development Research, Bonn; German Organization for Technical Cooperation (GTZ); Oromia State Forest Enterprises Supervising Agency	We especially thank the communities that participated in our research and our research assistants. This study was financially supported by the North-South Centre at ETH Zurich, the German Federal Ministry of Education and Research (BMBF) (BioTEAM 01LM0201), and the German Federal Ministry of Economic Cooperation and Development (BMZ) via the Centre for Development Research, Bonn. We also acknowledge in-kind support from the German Organization for Technical Cooperation (GTZ) and the Oromia State Forest Enterprises Supervising Agency.	Agrawal A, 2006, WORLD DEV, V34, P149, DOI 10.1016/j.worlddev.2005.07.013; Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; AMENTE G, 2005, THESIS A LUDWIGS U F; [Anonymous], 1996, HALTING DEGRADATION; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Cardenas, 2000, ENVIRON DEV SUSTAIN, V2, P305, DOI [10.1023/a:1011422313042, DOI 10.1023/A:1011422313042]; Cardenas JC, 2003, J DEV ECON, V70, P263, DOI 10.1016/S0304-3878(02)00098-6; Chhatre A, 2008, P NATL ACAD SCI USA, V105, P13286, DOI 10.1073/pnas.0803399105; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Falk A, 2002, DRAMA COMMONS, P157; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gibson CC, 2005, WORLD DEV, V33, P273, DOI 10.1016/j.worlddev.2004.07.013; Gunnthorsdottir A, 2007, J ECON BEHAV ORGAN, V62, P304, DOI 10.1016/j.jebo.2005.03.008; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Gurven M, 2008, AM ANTHROPOL, V110, P179, DOI 10.1111/j.1548-1433.2008.00024.x; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2009, EXP ECON, V12, P87, DOI 10.1007/s10683-008-9197-1; Keser C, 2000, SCAND J ECON, V102, P23, DOI 10.1111/1467-9442.00182; Kocher MG, 2008, ECON LETT, V101, P175, DOI 10.1016/j.econlet.2008.07.015; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; Levitt SD, 2008, SCIENCE, V319, P909, DOI 10.1126/science.1153640; Olson, 1965, LOGIC COLLECT ACTION, V56, P603; Ones U, 2007, J ECON BEHAV ORGAN, V62, P495, DOI 10.1016/j.jebo.2005.04.018; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1992, CRAFTING I SELF GOVE; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Price ME, 2002, EVOL HUM BEHAV, V23, P203, DOI 10.1016/S1090-5138(01)00093-9; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Trainer J., 1996, FOREST INVENTORY IND; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	44	289	296	4	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					961	965		10.1126/science.1193649	http://dx.doi.org/10.1126/science.1193649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	678XY	21071668				2022-12-01	WOS:000284118000042
J	Chao, HT; Chen, HM; Samaco, RC; Xue, MS; Chahrour, M; Yoo, J; Neul, JL; Gong, SC; Lu, HC; Heintz, N; Ekker, M; Rubenstein, JLR; Noebels, JL; Rosenmund, C; Zoghbi, HY				Chao, Hsiao-Tuan; Chen, Hongmei; Samaco, Rodney C.; Xue, Mingshan; Chahrour, Maria; Yoo, Jong; Neul, Jeffrey L.; Gong, Shiaoching; Lu, Hui-Chen; Heintz, Nathaniel; Ekker, Marc; Rubenstein, John L. R.; Noebels, Jeffrey L.; Rosenmund, Christian; Zoghbi, Huda Y.			Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes	NATURE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CPG-BINDING PROTEIN-2; MOUSE MODEL; NEURONAL MECP2; YOUNG GIRLS; 67 KDA; MICE; GENE; SCHIZOPHRENIA; MUTATION	Mutations in the X-linked MECP2 gene, which encodes the transcriptional regulator methyl-CpG-binding protein 2 (MeCP2), cause Rett syndrome and several neurodevelopmental disorders including cognitive disorders, autism, juvenile-onset schizophrenia and encephalopathy with early lethality. Rett syndrome is characterized by apparently normal early development followed by regression, motor abnormalities, seizures and features of autism, especially stereotyped behaviours. The mechanisms mediating these features are poorly understood. Here we show that mice lacking Mecp2 from GABA (c-aminobutyric acid)-releasing neurons recapitulate numerous Rett syndrome and autistic features, including repetitive behaviours. Loss of MeCP2 from a subset of forebrain GABAergic neurons also recapitulates many features of Rett syndrome. MeCP2-deficient GABAergic neurons show reduced inhibitory quantal size, consistent with a presynaptic reduction in glutamic acid decarboxylase 1 (Gad1) and glutamic acid decarboxylase 2 (Gad2) levels, and GABA immunoreactivity. These data demonstrate that MeCP2 is critical for normal function of GABA-releasing neurons and that subtle dysfunction of GABAergic neurons contributes to numerous neuropsychiatric phenotypes.	[Chao, Hsiao-Tuan; Xue, Mingshan; Noebels, Jeffrey L.; Rosenmund, Christian; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Chao, Hsiao-Tuan; Chen, Hongmei; Samaco, Rodney C.; Chahrour, Maria; Noebels, Jeffrey L.; Rosenmund, Christian; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yoo, Jong; Noebels, Jeffrey L.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Neul, Jeffrey L.; Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Neul, Jeffrey L.; Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, New York, NY 10021 USA; [Gong, Shiaoching; Heintz, Nathaniel] Howard Hughes Med Inst, New York, NY 10021 USA; [Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada; [Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; University of Ottawa; University of California System; University of California San Francisco	Rosenmund, C (corresponding author), Charite, Neurosci Res Ctr, D-10117 Berlin, Germany.	christian.rosenmund@charite.de; hzoghbi@bcm.edu	Rosenmund, Christian/AAC-3596-2020; Neul, Jeffrey/AAF-5324-2020	Rosenmund, Christian/0000-0002-3905-2444; Chahrour, Maria/0000-0002-3174-1480; Xue, Mingshan/0000-0003-1463-8884; Zoghbi, Huda/0000-0002-0700-3349; Samaco, Rodney/0000-0001-5636-5314; Noebels, Jeffrey/0000-0002-2887-0839; Neul, Jeffrey/0000-0002-5628-5872	Howard Hughes Medical Institute; National Institute of Neurological Disorders and Stroke (NINDS) [HD053862, 29709]; Simons Foundation; Rett Syndrome Research Trust; Intellectual and Developmental Disability Research Centers [HD024064]; International Rett Syndrome Foundation; Autism Speaks; National Institute of Mental Health [F31MH078678]; Baylor Research Advocates for Student Scientists; McNair Fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, R01HD062553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH078678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048884, T32NS043124, K08NS052240, R01NS057819] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; Rett Syndrome Research Trust; Intellectual and Developmental Disability Research Centers; International Rett Syndrome Foundation; Autism Speaks; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Baylor Research Advocates for Student Scientists; McNair Fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Schuster for pronuclear injections; C. Spencer and R. Paylor for advice on behavioural assays; M. Albright for advice on slice electrophysiology; R. Atkinson, Y. Sun, J. Tang and S. Vaishnav for technical advice; V. Brandt for editorial advice. This work was supported by the Howard Hughes Medical Institute, the National Institute of Neurological Disorders and Stroke (NINDS) HD053862, the Simons Foundation, the Rett Syndrome Research Trust (H.Y.Z.); the Intellectual and Developmental Disability Research Centers HD024064 (H.Y.Z., C.R. and J. L. Noebels); NINDS 29709 (J. L. Noebels); the International Rett Syndrome Foundation (C.R.); Autism Speaks (R.C.S.); the National Institute of Mental Health F31MH078678, Baylor Research Advocates for Student Scientists and McNair Fellowships (H.-T.C.).	Adachi M, 2009, J NEUROSCI, V29, P4218, DOI 10.1523/JNEUROSCI.4225-08.2009; Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen D, 2002, AM J PSYCHIAT, V159, P148, DOI 10.1176/appi.ajp.159.1.148-a; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Deidrick Kathleen M, 2005, J Child Neurol, V20, P708, DOI 10.1177/08830738050200090201; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hagberg B, 2002, MENT RETARD DEV D R, V8, P61, DOI 10.1002/mrdd.10020; Jedele Kerry Baldwin, 2007, Semin Pediatr Neurol, V14, P108, DOI 10.1016/j.spen.2007.07.002; Klauck SM, 2002, AM J HUM GENET, V70, P1034, DOI 10.1086/339553; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; Lundorf MD, 2005, AM J MED GENET B, V135B, P94, DOI 10.1002/ajmg.b.30137; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Weese-Mayer DE, 2008, PEDIATR PULM, V43, P1045, DOI 10.1002/ppul.20866; Weese-Mayer DE, 2006, PEDIATR RES, V60, P443, DOI 10.1203/01.pdr.0000238302.84552.d0; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389	50	802	819	2	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					263	269		10.1038/nature09582	http://dx.doi.org/10.1038/nature09582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068835	Green Accepted, Green Submitted			2022-12-01	WOS:000284051000043
J	Nallamothu, BK; Krumholz, HM				Nallamothu, Brahmajee K.; Krumholz, Harlan M.			Putting Ad Hoc PCI on Pause	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTIONS; CARDIAC-CATHETERIZATION; AMERICAN-COLLEGE; MEDICAL THERAPY; ARTERY-DISEASE; CARDIOLOGISTS		[Nallamothu, Brahmajee K.] Vet Affairs Ann Arbor Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Div Cardiovasc Med, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, CHOP, Ann Arbor, MI USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Yale University	Nallamothu, BK (corresponding author), 1500 E Med Ctr Dr,SPC 5869, Ann Arbor, MI 48109 USA.	bnallamo@umich.edu	, Harlan/AAI-2875-2020					Blankenship JC, 2004, CATHETER CARDIO INTE, V63, P444, DOI 10.1002/ccd.20229; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Hannan EL, 2010, CIRCULATION, V121, P267, DOI 10.1161/CIRCULATIONAHA.109.887539; Hannan EL, 2009, JACC-CARDIOVASC INTE, V2, P350, DOI 10.1016/j.jcin.2009.01.006; Krone RJ, 2006, CATHETER CARDIO INTE, V68, P696, DOI 10.1002/ccd.20910; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; MYLER RK, 1986, CATHETER CARDIO DIAG, V12, P213, DOI 10.1002/ccd.1810120402; Peterson ED, 2008, NEW ENGL J MED, V359, P751, DOI 10.1056/NEJMe0804662; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626	10	32	34	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2059	2060		10.1001/jama.2010.1509	http://dx.doi.org/10.1001/jama.2010.1509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063016				2022-12-01	WOS:000284000600026
J	Gregg, C				Gregg, Christopher			Parental Control over the Brain	SCIENCE			English	Editorial Material									Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Gregg, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	cgregg@MCB.harvard.edu						Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Alter MD, 2009, BIOL PSYCHIAT, V66, P1061, DOI 10.1016/j.biopsych.2009.05.026; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Curley JP, 2010, DEV PSYCHOBIOL, V52, P312, DOI 10.1002/dev.20430; GREGG C, 2010, SCIENCE, V329, P5992; Hoppenbrouwers IA, 2008, ARCH NEUROL-CHICAGO, V65, P345, DOI 10.1001/archneurol.2007.63; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Keverne E B, 2001, Prog Brain Res, V133, P279; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Van Buggenhout G, 2009, EUR J HUM GENET, V17, P1367, DOI 10.1038/ejhg.2009.67	10	6	6	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					770	771		10.1126/science.1199054	http://dx.doi.org/10.1126/science.1199054			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051625				2022-12-01	WOS:000283855700029
J	Shahinian, VB; Kuo, YF; Gilbert, SM				Shahinian, Vahakn B.; Kuo, Yong-Fang; Gilbert, Scott M.			Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADIATION-THERAPY; HORMONAL-THERAPY; SUPPRESSION; MANAGEMENT; CARCINOMA; RADIOTHERAPY; ORCHIECTOMY; TRIAL	Background: The Medicare Modernization Act led to moderate reductions in reimbursement for androgen-deprivation therapy (ADT) for prostate cancer, starting in 2004 and followed by substantial changes in 2005. We hypothesized that these reductions would lead to decreases in the use of ADT for indications that were not evidence based. Methods: Using the Surveillance, Epidemiology, and End Results (SEER) Medicare database, we identified 54,925 men who received a diagnosis of incident prostate cancer from 2003 through 2005. We divided these men into groups according to the strength of the indication for ADT use. The use of ADT was deemed to be inappropriate as primary therapy for men with localized cancers of a low-to-moderate grade (for whom a survival benefit of such therapy was improbable), appropriate as adjuvant therapy with radiation therapy for men with locally advanced cancers (for whom a survival benefit was established), and discretionary for men receiving either primary or adjuvant therapy for localized but high-grade tumors. The proportion of men receiving ADT was calculated according to the year of diagnosis for each group. We used modified Poisson regression models to calculate the effect of the year of diagnosis on the use of ADT. Results: The rate of inappropriate use of ADT declined substantially during the study period, from 38.7% in 2003 to 30.6% in 2004 to 25.7% in 2005 (odds ratio for ADT use in 2005 vs. 2003, 0.72; 95% confidence interval [CI], 0.65 to 0.79). There was no decrease in the appropriate use of adjuvant ADT (odds ratio, 1.01; 95% CI, 0.86 to 1.19). In cases involving discretionary use, there was a significant decline in use in 2005 but not in 2004. Conclusions: Changes in the Medicare reimbursement policy in 2004 and 2005 were associated with reductions in ADT use, particularly among men for whom the benefits of such therapy were unclear. (Funded by the American Cancer Society.) N Engl J Med 2010;363:1822-32.	[Shahinian, Vahakn B.] Univ Michigan, Simpson Mem Inst 208, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kuo, Yong-Fang] Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA; [Kuo, Yong-Fang] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX USA; [Kuo, Yong-Fang] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX USA; [Gilbert, Scott M.] Univ Florida, Coll Med, Dept Urol, Gainesville, FL USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Florida	Shahinian, VB (corresponding author), Univ Michigan, Simpson Mem Inst 208, Dept Internal Med, 102 Observ Rd, Ann Arbor, MI 48109 USA.	vahakn@umich.edu			American Cancer Society [118244-RSGI-10-076-01-CPHPS]	American Cancer Society(American Cancer Society)	Supported by a Research Scholar Grant (118244-RSGI-10-076-01-CPHPS, to Dr. Shahinian) from the American Cancer Society.	Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Chang SL, 2009, J UROLOGY, V182, P255, DOI 10.1016/j.juro.2009.02.141; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Chodak GW, 2002, UROLOGY, V60, P201, DOI 10.1016/S0090-4295(02)01677-1; Christianson JB, 2006, J GEN INTERN MED, V21, pS9, DOI 10.1111/j.1525-1497.2006.00356.x; Conrad DA, 2004, MED CARE RES REV, V61, p37S, DOI 10.1177/1077558704266770; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P1420; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; General Accounting Office, 2001, GAO011118; Granfors T, 1998, J UROLOGY, V159, P2030, DOI 10.1016/S0022-5347(01)63235-X; Hillman AL, 1998, AM J PUBLIC HEALTH, V88, P1699, DOI 10.2105/AJPH.88.11.1699; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Loblaw DA, 2004, J CLIN ONCOL, V22, P2927, DOI 10.1200/jco.2004.04.579; LOBLAW DA, 2004, J CLIN ONCOL, V22, P4435; Lu-Yao G, 2006, J UROLOGY, V176, P526, DOI 10.1016/j.juro.2006.03.098; *MED PAYM ADV COMM, 2007, REP C EFF MED PAYM C; National Comprehensive Cancer Network, 2004, J Natl Compr Canc Netw, V2, P224; Painter M Ray, 2005, Rev Urol, V7 Suppl 5, pS44; Pilepich MV, 1997, J CLIN ONCOL, V15, P1013, DOI 10.1200/JCO.1997.15.3.1013; Scardino Peter, 2005, J Natl Compr Canc Netw, V3 Suppl 1, pS29; Scherr D, 2003, UROLOGY, V61, P14, DOI 10.1016/S0090-4295(02)02395-6; Shahinian VB, 2007, J CLIN ONCOL, V25, P5359, DOI 10.1200/JCO.2006.09.9580; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002/cncr.20955; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Shen J, 2004, MED CARE, V42, P297, DOI 10.1097/01.mlr.0000114918.50088.1c; Weight CJ, 2008, CANCER-AM CANCER SOC, V112, P2195, DOI 10.1002/cncr.23421; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	140	144	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1822	1832		10.1056/NEJMsa0910784	http://dx.doi.org/10.1056/NEJMsa0910784			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674YK	21047226				2022-12-01	WOS:000283787800007
J	Ngo, VN; Young, RM; Schmitz, R; Jhavar, S; Xiao, WM; Lim, KH; Kohlhammer, H; Xu, WH; Yang, YD; Zhao, H; Shaffer, AL; Romesser, P; Wright, G; Powell, J; Rosenwald, A; Muller-Hermelink, HK; Ott, G; Gascoyne, RD; Connors, JM; Rimsza, LM; Campo, E; Jaffe, ES; Delabie, J; Smeland, EB; Fisher, RI; Braziel, RM; Tubbs, RR; Cook, JR; Weisenburger, DD; Chan, WC; Staudt, LM				Ngo, Vu N.; Young, Ryan M.; Schmitz, Roland; Jhavar, Sameer; Xiao, Wenming; Lim, Kian-Huat; Kohlhammer, Holger; Xu, Weihong; Yang, Yandan; Zhao, Hong; Shaffer, Arthur L.; Romesser, Paul; Wright, George; Powell, John; Rosenwald, Andreas; Muller-Hermelink, Hans Konrad; Ott, German; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.; Weisenburger, Denny D.; Chan, Wing C.; Staudt, Louis M.			Oncogenically active MYD88 mutations in human lymphoma	NATURE			English	Article							B-CELL LYMPHOMA; NF-KAPPA-B; TNFAIP3 A20; GENE; INHIBITORS; SIGNATURES; PATHWAYS; SURVIVAL; SUBTYPES; KINASE	The activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) remains the least curable form of this malignancy despite recent advances in therapy(1). Constitutive nuclear factor (NF)-kappa B and JAK kinase signalling promotes malignant cell survival in these lymphomas, but the genetic basis for this signalling is incompletely understood. Here we describe the dependence of ABC DLBCLs on MYD88, an adaptor protein that mediates toll and interleukin (IL)-1 receptor signalling(2,3), and the discovery of highly recurrent oncogenic mutations affecting MYD88 in ABC DLBCL tumours. RNA interference screening revealed that MYD88 and the associated kinases IRAK1 and IRAK4 are essential for ABC DLBCL survival. High-throughput RNA resequencing uncovered MYD88 mutations in ABC DLBCL lines. Notably, 29% of ABC DLBCL tumours harboured the same amino acid substitution, L265P, in the MYD88 Toll/IL-1 receptor (TIR) domain at an evolutionarily invariant residue in its hydrophobic core. This mutation was rare or absent in other DLBCL subtypes and Burkitt's lymphoma, but was observed in 9% of mucosa-associated lymphoid tissue lymphomas. At a lower frequency, additional mutations were observed in the MYD88 TIR domain, occurring in both the ABC and germinal centre B-cell-like (GCB) DLBCL subtypes. Survival of ABC DLBCL cells bearing the L265P mutation was sustained by the mutant but not the wild-type MYD88 isoform, demonstrating that L265P is a gain-of-function driver mutation. The L265P mutant promoted cell survival by spontaneously assembling a protein complex containing IRAK1 and IRAK4, leading to IRAK4 kinase activity, IRAK1 phosphorylation, NF-kappa B signalling, JAK kinase activation of STAT3, and secretion of IL-6, IL-10 and interferon-beta. Hence, the MYD88 signalling pathway is integral to the pathogenesis of ABC DLBCL, supporting the development of inhibitors of IRAK4 kinase and other components of this pathway for the treatment of tumours bearing oncogenic MYD88 mutations.	[Ngo, Vu N.; Young, Ryan M.; Schmitz, Roland; Jhavar, Sameer; Lim, Kian-Huat; Kohlhammer, Holger; Xu, Weihong; Yang, Yandan; Zhao, Hong; Shaffer, Arthur L.; Romesser, Paul; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Xiao, Wenming; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Romesser, Paul] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, DCTD, NIH, Bethesda, MD 20892 USA; [Rosenwald, Andreas; Muller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Rimsza, Lisa M.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.] SW Oncol Grp, Ann Arbor, MI 48106 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Delabie, Jan] Univ Hosp, Rikshosp, Pathol Clin, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Hosp, Rikshosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, N-0310 Oslo, Norway; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Braziel, Rita M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Tubbs, Raymond R.; Cook, J. R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Weisenburger, Denny D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Weisenburger, Denny D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; British Columbia Cancer Agency; University of Arizona; Southwest Oncology Group; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Rochester; Oregon Health & Science University; Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Campo, Elias/AAC-5593-2019; Staudt, Louis/AAC-5324-2019; Smeland, Erlend/AAO-3214-2020; Connors, Joseph/AAF-5284-2019; Wright, George W/M-1660-2017; Jaffe, Elaine/G-8981-2014	Campo, Elias/0000-0001-9850-9793; Connors, Joseph/0000-0002-1361-7531; Romesser, Paul/0000-0001-8268-2903; Delabie, Jan/0000-0001-5023-0689; Jaffe, Elaine/0000-0003-4632-0301; Ngo, Vu/0000-0002-9501-6990; Lim, Kian-Huat/0000-0002-2766-200X	NIH, National Cancer Institute, Center for Cancer Research; NCI SPECS [UO1-CA 114778]; Foundation for NIH; Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe); CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011007, P30CA008748, U01CA114778] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI SPECS; Foundation for NIH; Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe)(Deutsche Krebshilfe); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant (UO1-CA 114778), and by the Foundation for NIH, through a gift from the Richard A. Lauderbaugh Memorial Fund. This study was conducted under the auspices of the Lymphoma/Leukemia Molecular Profiling Project (LLMPP). R.S. is supported by the Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe). P.R. was an HHMI-NIH Research Scholar. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, Maryland (http://biowulf.nih.gov). We thank D. Staudt for discussions, K. Meyer for help with the GEO submission, and X. Li for IRAK1 plasmids. We are grateful to B. Tran and the Center for Cancer Research Sequencing Facility for implementation of next generation RNA sequencing.	Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dierlamm J, 1997, LEUKEMIA, V11, P747, DOI 10.1038/sj.leu.2400635; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Schmidlin H, 2009, TRENDS IMMUNOL, V30, P277, DOI 10.1016/j.it.2009.03.008; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	27	1012	1109	1	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					115	U133		10.1038/nature09671	http://dx.doi.org/10.1038/nature09671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21179087	Green Accepted			2022-12-01	WOS:000286886400045
J	Rebbeck, CA; Leroi, AM; Burt, A				Rebbeck, Clare A.; Leroi, Armand M.; Burt, Austin			Mitochondrial Capture by a Transmissible Cancer	SCIENCE			English	Article							EVOLUTION; ORIGIN		[Rebbeck, Clare A.; Leroi, Armand M.; Burt, Austin] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	Imperial College London	Burt, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	a.burt@imperial.ac.uk		Burt, Austin/0000-0001-5146-9640; rebbeck, clare/0000-0002-2502-9622	Natural Environmental Research Council (NERC); Breakthrough Breast Cancer Research Centre, part of the Institute of Cancer Research (ICR)	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Breakthrough Breast Cancer Research Centre, part of the Institute of Cancer Research (ICR)	We thank E. C. Yeoh, J. Gilchrist, A. Ortega-Pacheco, B. Rivera, N. Trakrantungsie, and H. Ververidis for providing CTVT samples and A. Ashworth and C. Isacke. Supported by the Natural Environmental Research Council (NERC) and the Breakthrough Breast Cancer Research Centre, part of the Institute of Cancer Research (ICR). GenBank accession numbers for sequence data are given in table S1. Data were deposited at Dryad: DOI 10.5061/dryad.8081.	Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Mozos E, 1996, VET PATHOL, V33, P257, DOI 10.1177/030098589603300301; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103	8	74	78	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					303	303		10.1126/science.1197696	http://dx.doi.org/10.1126/science.1197696			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252340				2022-12-01	WOS:000286636300028
J	Driver, JA; Logroscino, G; Lu, LD; Gaziano, JM; Kurth, T				Driver, Jane A.; Logroscino, Giancarlo; Lu, Linda; Gaziano, J. Michael; Kurth, Tobias			Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; PHYSICIANS HEALTH; BETA-CAROTENE; COMORBIDITY; PROTECT; CANCER; NEUROPROTECTION; SALICYLATE; ADJUSTMENT; MORTALITY	Objective To evaluate the relation between Parkinson's disease and prior use of non-steroidal anti-inflammatory drugs (NSAIDs) in a large cohort of men. Design Case-control analysis nested in the Physicians' Health Study. Participants 22 007 male physicians aged 40-84 years without indications for or contraindications to regular NSAID use and free of Parkinson's disease at baseline. Cases and controls were matched by age alone or by age and scores for confounders (comorbidity and indicators of NSAID use). Up to five controls were matched to each of 616 cases by age and 565 cases by age and confounder scores. Setting United States. Main outcome measures Odds of having been exposed to prior non-aspirin NSAID or aspirin use by participants with Parkinson's disease and by their controls in each case-control set. Results Participants who had ever used non-aspirin NSAIDs had an increased risk of Parkinson's disease (odds ratio 1.28 (95% CI 1.05 to 1.56) in the age matched group but not in the group also matched on confounder scores (odds ratio 1.17 (0.94 to 1.46)). There was an increased risk of Parkinson's disease in men who had 12 years of regular non-aspirin NSAID use (odds ratio 1.35 (1.07 to 1.70)), a finding that remained significant after matching for confounder scores as well (odds ratio 1.35 (1.05 to 1.75)). In contrast, the significant association of use of non-aspirin NSAIDs for >= 5 years (odds ratio 1.48 (1.05 to 2.09)) in the age matched group was entirely attenuated in the group also matched on confounder scores (1.03 (0.70 to 1.53)). There was also a suggestion that men who regularly used aspirin had an increased risk of Parkinson's disease. Positive associations between non-aspirin NSAID or aspirin and risk of Parkinson's disease tended to disappear when analyses were limited to drug use >= 5 years before the disease diagnosis. Conclusions This case-control study did not find evidence that NSAID use reduces Parkinson's disease risk. The positive associations observed between NSAID use and Parkinson's disease might have been due to confounding by indication as the use was clustered in the few years before disease diagnosis.	[Driver, Jane A.; Lu, Linda; Gaziano, J. Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02120 USA; [Driver, Jane A.; Gaziano, J. Michael] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [Driver, Jane A.; Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res Informat Ctr, Boston, MA USA; [Logroscino, Giancarlo] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy; [Gaziano, J. Michael; Kurth, Tobias] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02120 USA; [Kurth, Tobias] INSERM, Neuroepidemiol U708, Paris, France; [Kurth, Tobias] Univ Paris 06, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Universita degli Studi di Bari Aldo Moro; Harvard University; Brigham & Women's Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Driver, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, 1620 Tremont St, Boston, MA 02120 USA.	jdriver@partners.org	Kurth, Tobias/A-9243-2012; LOGROSCINO, GIANCARLO/K-5148-2016	Kurth, Tobias/0000-0001-7169-2620; LOGROSCINO, GIANCARLO/0000-0003-0423-3242	Parkinson's Disease Foundation; National Cancer Institute [CA-34944, CA-40360, CA-097193]; National Heart, Lung, and Blood Institute, Bethesda, MD [HL-26490, HL-34595]; Hartford Foundation; Harvard Medical School; Veteran's Administration; Amyotrophic Lateral Sclerosis Association, Italian Ministry of Health; Apulia Region; Italian Ministry of Universities; National Institutes of Health; BASF; DSM Pharmaceuticals; Wyeth Pharmaceuticals; McNeil Consumer Products; Pliva; French National Research Agency; US National Institutes of Health; Merck; Migraine Research Foundation; Parkinson's Research Foundation; NATIONAL CANCER INSTITUTE [R01CA097193, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hartford Foundation; Harvard Medical School; Veteran's Administration(US Department of Veterans Affairs); Amyotrophic Lateral Sclerosis Association, Italian Ministry of Health(Ministry of Health, Italy); Apulia Region; Italian Ministry of Universities(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF(BASF); DSM Pharmaceuticals; Wyeth Pharmaceuticals(Wyeth); McNeil Consumer Products; Pliva(Teva Pharmaceutical Industries); French National Research Agency(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Migraine Research Foundation; Parkinson's Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is funded by a grant from the Parkinson's Disease Foundation. The Physicians' Health Study is supported by grants CA-34944, CA-40360, and CA-097193 from the National Cancer Institute and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, MD. The study sponsor had no role in study design; data collection, analysis, or interpretation; writing the article; or the decision to submit it for publication. The researchers are independent from funders and sponsors.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: JAD has support from the Parkinson's Disease Foundation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. We report a full disclosure for the past five years for each of the authors. JAD has a research grant from the Parkinson's Disease Foundation, the Hartford Foundation, Harvard Medical School, and a Career Development Award from the Veteran's Administration. LL has nothing to disclose. GL has received research funding from the Amyotrophic Lateral Sclerosis Association, Italian Ministry of Health, the Apulia Region, and special funding from the Italian Ministry of Universities and has received honorariums from Pfizer, Novartis, Glaxo, and Lilly Pharmaceutical for speaking engagements. JMG has received investigator initiated research funding and support as principal investigator from National Institutes of Health, BASF, DSM Pharmaceuticals, Wyeth Pharmaceuticals, McNeil Consumer Products, and Pliva; received honoraria from Bayer and Pfizer for speaking engagements; and is a consultant for Bayer, McNeil Consumer Products, Wyeth Pharmaceuticals, Merck, Nutraquest, and GlaxoSmithKline. TK has received investigator initiated research funding from the French National Research Agency, the US National Institutes of Health, Merck, the Migraine Research Foundation, and the Parkinson's Research Foundation; is a consultant to i3 Drug Safety and World Health Information Science Consultants, LLC; and has received honoraria from the American Academy of Neurology, Genzyme, Merck, and Pfizer for educational lectures.	Administration on Aging, 2005, PROF OLD AM 2005; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; Aubin N, 1998, J NEUROCHEM, V71, P1635, DOI 10.1046/j.1471-4159.1998.71041635.x; Bornebroek M, 2007, NEUROEPIDEMIOLOGY, V28, P193, DOI 10.1159/000108110; Bower JH, 2006, NEUROLOGY, V67, P494, DOI 10.1212/01.wnl.0000227906.99570.cc; Breitner JCS, 2009, NEUROLOGY, V72, P1899, DOI 10.1212/WNL.0b013e3181a18691; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Driver JA, 2008, NEUROLOGY, V70, P1423, DOI 10.1212/01.wnl.0000310414.85144.ee; Driver JA, 2007, CANCER CAUSE CONTROL, V18, P705, DOI 10.1007/s10552-007-9005-9; Ford B, 2009, NAT REV NEUROL, V5, P242, DOI 10.1038/nrneurol.2009.50; Frigerio R, 2005, NEUROLOGY, V65, P1575, DOI 10.1212/01.wnl.0000184520.21744.a2; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Hancock DB, 2007, ARCH NEUROL-CHICAGO, V64, P576, DOI 10.1001/archneur.64.4.576; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hernan MA, 2006, NEUROLOGY, V66, P1097, DOI 10.1212/01.wnl.0000204446.82823.28; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; KOLLER WC, 1984, NEUROLOGY, V34, P957, DOI 10.1212/WNL.34.7.957; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Mohanakumar KP, 2000, BRAIN RES, V864, P281, DOI 10.1016/S0006-8993(00)02189-2; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; ROYER GL, 1984, AM J MED, V77, P25, DOI 10.1016/S0002-9343(84)80015-7; SANDYK R, 1982, S AFR MED J, V61, P3; Schiess M, 2003, ARCH NEUROL-CHICAGO, V60, P1043, DOI 10.1001/archneur.60.8.1043; Snider SR, 1987, HDB PARKINSON DISEAS, P171; Teismann P, 2001, SYNAPSE, V39, P167, DOI 10.1002/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U; Ton TG, 2006, MOVEMENT DISORD, V21, P964, DOI 10.1002/mds.20856; Wahner AD, 2007, NEUROLOGY, V69, P1836, DOI 10.1212/01.wnl.0000279519.99344.ad; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	36	50	52	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2011	342								d198	10.1136/bmj.d198	http://dx.doi.org/10.1136/bmj.d198			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711PE	21252104	Green Published, hybrid			2022-12-01	WOS:000286603100002
J	Greely, HT				Greely, Henry T.			Get ready for the flood of fetal gene screening	NATURE			English	Editorial Material									Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA	Stanford University	Greely, HT (corresponding author), Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA.	hgreely@stanford.edu						Chitty LS, 2008, PRENATAL DIAG, V28, P83, DOI 10.1002/pd.1929; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Fan C, 2010, NATURE PRECEDINGS, DOI [10.1038/npre.2010.5373.1, DOI 10.1038/NPRE.2010.5373.1]; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; FUCHS F, 1956, NATURE, V177, P330, DOI 10.1038/177330a0; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Wright C., 2009, CELL FREE FETAL NUCL; RELIABLE ACCURATE PR; 2010, COM REV PREN GEN TES	10	71	85	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					289	291		10.1038/469289a	http://dx.doi.org/10.1038/469289a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708SW	21248817				2022-12-01	WOS:000286385600018
J	Ross, J; Grahame, R				Ross, Juliette; Grahame, Rodney			Easily Missed? Joint hypermobility syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CRITERIA; POPULATION; TESTS; AGE					rodney.grahame@uclh.nhs.uk						Adib N, 2005, RHEUMATOLOGY, V44, P744, DOI 10.1093/rheumatology/keh557; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Bravo JF, 2006, ARTHRITIS RHEUM, V54, P515, DOI 10.1002/art.21557; BRIDGES AJ, 1992, ANN RHEUM DIS, V51, P793, DOI 10.1136/ard.51.6.793; Coady D, 2004, RHEUMATOLOGY, V43, P633, DOI 10.1093/rheumatology/keh138; Daniel HC, 2010, HYPERMOBILITY FIBROM; DAVIDOVITCH M, 1994, J CHILD NEUROL, V9, P417, DOI 10.1177/088307389400900417; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIAZ MA, 1993, BRIT J RHEUMATOL, V32, P120; Ferrell WR, 2004, ARTHRITIS RHEUM-US, V50, P3323, DOI 10.1002/art.20582; Grahame R, 2006, ANN RHEUM DIS, V65, P263; Grahame R, 2000, J RHEUMATOL, V27, P1777; Grahame R, 2001, RHEUMATOLOGY, V40, P559, DOI 10.1093/rheumatology/40.5.559; Grahame R., 2010, HYPERMOBILITY FIBROM; Grahame R, 2009, CURR PAIN HEADACHE R, V13, P427, DOI 10.1007/s11916-009-0070-5; Hakim A, 2003, BEST PRACT RES CL RH, V17, P989, DOI 10.1016/j.berh.2003.08.001; Hudson N, 1995, BRIT J RHEUMATOL, V34, P1157; Juul-Kristensen B, 2007, RHEUMATOLOGY, V46, P1835, DOI 10.1093/rheumatology/kem290; Maillard S, 2010, HYPERMOBILITY FIBROM; McCulloch R, 2010, HYPERMOBILITY FIBROM; NORTON PA, 1995, OBSTET GYNECOL, V85, P225, DOI 10.1016/0029-7844(94)00386-R; Remvig L, 2007, J RHEUMATOL, V34, P804; Remvig L, 2007, J RHEUMATOL, V34, P798; RUNOW A, 1983, ACTA ORTHOP SCAND, V54, P1, DOI 10.3109/17453678309154170; Slmmonds JV, 2007, MANUAL THER, V12, P298, DOI 10.1016/j.math.2007.05.001; Tinkle BT, 2009, AM J MED GENET A, V149A, P2368, DOI 10.1002/ajmg.a.33070; WYNNEDAVIES R, 1971, P ROY SOC MED, V64, P689, DOI 10.1177/003591577106400649; Zarate N, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01421.x	29	54	56	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2011	342								c7167	10.1136/bmj.c7167	http://dx.doi.org/10.1136/bmj.c7167			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711PE	21252103				2022-12-01	WOS:000286603100008
J	Schroeder, BO; Wu, ZH; Nuding, S; Groscurth, S; Marcinowski, M; Beisner, J; Buchner, J; Schaller, M; Stange, EF; Wehkamp, J				Schroeder, Bjoern O.; Wu, Zhihong; Nuding, Sabine; Groscurth, Sandra; Marcinowski, Moritz; Beisner, Julia; Buchner, Johannes; Schaller, Martin; Stange, Eduard F.; Wehkamp, Jan			Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1	NATURE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; IMMUNE-RESPONSES; PEPTIDES; THIOREDOXIN; ASSOCIATION; BETA-DEFENSIN-1; DISEASE; ASSAYS; COLON	Human epithelia are permanently challenged by bacteria and fungi, including commensal and pathogenic microbiota(1,2). In the gut, the fraction of strict anaerobes increases from proximal to distal, reaching 99% of bacterial species in the colon(3). At colonic mucosa, oxygen partial pressure is below 25% of airborne oxygen content, moreover microbial metabolism causes reduction to a low redox potential of -200 mV to -300 mV in the colon(4). Defensins, characterized by three intramolecular disulphide-bridges, are key effector molecules of innate immunity that protect the host from infectious microbes and shape the composition of microbiota at mucosal surfaces(5-8). Human beta-defensin 1 (hBD-1) is one of the most prominent peptides of its class but despite ubiquitous expression by all human epithelia, comparison with other defensins suggested only minor antibiotic killing activity(9,10). Whereas much is known about the activity of antimicrobial peptides in aerobic environments, data about reducing environments are limited. Herein we show that after reduction of disulphide-bridges hBD-1 becomes a potent antimicrobial peptide against the opportunistic pathogenic fungus Candida albicans and against anaerobic, Gram-positive commensals of Bifidobacterium and Lactobacillus species. Reduced hBD-1 differs structurally from oxidized hBD-1 and free cysteines in the carboxy terminus seem important for the bactericidal effect. In vitro, the thioredoxin (TRX) system(11) is able to reduce hBD-1 and TRX co-localizes with reduced hBD-1 in human epithelia. Hence our study indicates that reduced hBD-1 shields the healthy epithelium against colonisation by commensal bacteria and opportunistic fungi. Accordingly, an intimate interplay between redox-regulation and innate immune defence seems crucial for an effective barrier protecting human epithelia.	[Schroeder, Bjoern O.; Nuding, Sabine; Beisner, Julia; Wehkamp, Jan] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Schroeder, Bjoern O.; Nuding, Sabine; Beisner, Julia; Wehkamp, Jan] Univ Tubingen, D-72076 Tubingen, Germany; [Wu, Zhihong] Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Groscurth, Sandra] Max Planck Inst Dev Biol, Dept Prot Evolut 1, D-72076 Tubingen, Germany; [Marcinowski, Moritz; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany; [Schaller, Martin] Univ Tubingen Hosp, Dept Dermatol, D-72076 Tubingen, Germany; [Stange, Eduard F.; Wehkamp, Jan] Robert Bosch Krankenhaus, Dept Internal Med 1, D-70376 Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bosch; Robert Bosch Krankenhaus	Wehkamp, J (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany.	jan.wehkamp@ikp-stuttgart.de	Buchner, Johannes/A-2651-2010; Wu, Zhihong/AAK-3433-2020; Schroeder, Bjoern O/F-3353-2011; Wu, Zhihong/G-3569-2011; Wehkamp, Jan/B-7319-2011; hongbo, yi/G-9615-2011	Schroeder, Bjoern O/0000-0002-6716-8284; Buchner, Johannes/0000-0003-1282-7737; Wehkamp, Jan/0000-0001-6788-841X	Deutsche Forschungsgemeinschaft [WE 436/1-1, SCH 897/1-3, SFB685]; Robert-Bosch Foundation (Stuttgart, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert-Bosch Foundation (Stuttgart, Germany)	We thank M. Katajew, H. Loffler, C. Martensen-Kerl, C. Mehrens, J. Quitzau and A. Rose for technical assistance, B. Fehrenbacher for performing electron microscopy and H.-P. Kreichgauer, C. Schafer, O. Muller, K. R. Herrlinger and M. Escher for collecting biopsies. Furthermore we thank M. Schwab for discussions and support, C. L. Bevins and J.-M. Schroder for discussions and reading of the manuscript and Ardeypharm GmbH for providing anaerobic bacterial strains and L. Zabel for providing C. albicans strains. This work was supported by Deutsche Forschungsgemeinschaft (WE 436/1-1, SCH 897/1-3 and SFB685) and the Robert-Bosch Foundation (Stuttgart, Germany). J. W. is an Emmy Noether Scholar of Deutsche Forschungsgemeinschaft.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Bevins C L, 2003, Contrib Microbiol, V10, P106; GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003; Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Nagy E, 2010, DRUGS, V70, P841, DOI 10.2165/11534490-000000000-00000; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nuding S, 2006, J MICROBIOL METH, V65, P335, DOI 10.1016/j.mimet.2005.08.004; Nuding S, 2009, MICROBES INFECT, V11, P384, DOI 10.1016/j.micinf.2009.01.001; Ozturk A, 2010, J DENT RES, V89, P631, DOI 10.1177/0022034510364491; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schaefer AS, 2010, GENES IMMUN, V11, P45, DOI 10.1038/gene.2009.75; Schroeder B. O., 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2010.204, DOI 10.1038/PROTEX.2010.204]; Schroder JM, 2010, METHODS MOL BIOL, V618, P15, DOI 10.1007/978-1-60761-594-1_2; Scudiero O, 2010, ANTIMICROB AGENTS CH, V54, P2312, DOI 10.1128/AAC.01550-09; Sido B, 2005, EUR J IMMUNOL, V35, P408, DOI 10.1002/eji.200424500; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Taylor K, 2008, BIOPOLYMERS, V90, P1, DOI 10.1002/bip.20900; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; WILSON M, 2005, MICROBIAL INHABITANT, P251; Wu Z., 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2010.205, DOI 10.1038/PROTEX.2010.205]; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	32	341	358	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					419	+		10.1038/nature09674	http://dx.doi.org/10.1038/nature09674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248850				2022-12-01	WOS:000286385600057
J	Yaffe, K; Weston, A; Graff-Radford, NR; Satterfield, S; Simonsick, EM; Younkin, SG; Younkin, LH; Kuller, L; Ayonayon, HN; Ding, JZ; Harris, TB				Yaffe, Kristine; Weston, Andrea; Graff-Radford, Neill R.; Satterfield, Suzanne; Simonsick, Eleanor M.; Younkin, Steven G.; Younkin, Linda H.; Kuller, Lewis; Ayonayon, Hilsa N.; Ding, Jingzhong; Harris, Tamara B.			Association of Plasma beta-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; CARDIOVASCULAR HEALTH; OLDER PERSONS; RISK; IMPAIRMENT; DEMENTIA; PROTEIN; EDUCATION; LITERACY; MEMORY	Context Lower plasma beta-amyloid 42 and 42/40 levels have been associated with incident dementia, but results are conflicting and few have investigated cognitive decline among elders without dementia. Objective To determine if plasma beta-amyloid is associated with cognitive decline and if this association is modified by measures of cognitive reserve. Design, Setting, and Participants We studied 997 black and white community-dwelling older adults from Memphis, Tennessee, and Pittsburgh, Pennsylvania, who were enrolled in the Health ABC Study, a prospective observational study begun in 1997-1998 with 10-year follow-up in 2006-2007. Participant mean age was 74.0 (SD, 3.0) years; 55.2% (n=550) were female; and 54.0% (n=538) were black. Main Outcome Measures Association of near-baseline plasma beta-amyloid levels (42 and 42/40 measured in 2010) and repeatedly measured Modified Mini-Mental State Examination (3MS) results. Results Low beta-amyloid 42/40 level was associated with greater 9-year 3MS cognitive decline (lowest beta-amyloid tertile: mean change in 3MS score, -6.59 [95% confidence interval [CI], -5.21 to -7.67] points; middle tertile: -6.16 [95% CI, -4.92 to -7.32] points; and highest tertile: -3.60 [95% CI, -2.27 to -4.73] points; P<.001). Results were similar after multivariate adjustment for age, race, education, diabetes, smoking, and apolipoprotein E [APOE] e4 status and after excluding the 72 participants with incident dementia. Measures of cognitive reserve modified this association whereby among those with high reserve (at least a high school diploma, higher than sixth-grade literacy, or no APOE e4 allele), beta-amyloid 42/40 was less associated with multivariate adjusted 9-year decline. For example, among participants with less than a high school diploma, the 3MS score decline was -8.94 (95% CI, -6.94 to -10.94) for the lowest tertile compared with -4.45 (95% CI, -2.31 to -6.59) for the highest tertile, but for those with at least a high school diploma, 3MS score decline was -4.60 (95% CI, -3.07 to -6.13) for the lowest tertile and -2.88 (95% CI, -1.41 to -4.35) for the highest tertile (P=.004 for interaction). Interactions were also observed for literacy (P=.005) and for APOE e4 allele (P=.02). Conclusion Lower plasma beta-amyloid 42/40 is associated with greater cognitive decline among elderly persons without dementia over 9 years, and this association is stronger among those with low measures of cognitive reserve. JAMA. 2011; 305(3): 261-266	[Yaffe, Kristine; Weston, Andrea] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Yaffe, Kristine; Ayonayon, Hilsa N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94121 USA; [Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Younkin, Steven G.; Younkin, Linda H.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Satterfield, Suzanne] Univ Tennessee, Dept Prevent Med, Memphis, TN USA; [Simonsick, Eleanor M.] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Baltimore, MD 21224 USA; [Kuller, Lewis] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ding, Jingzhong] Wake Forest Univ, Med Ctr, Dept Gerontol & Geriatr Med, Winston Salem, NC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Mayo Clinic; Mayo Clinic; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University	Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Psychiat, Box 181,4150 Clement St, San Francisco, CA 94121 USA.	kristine.yaffe@ucsf.edu	Simonsick, Eleanor/W-6864-2019		National Institute on Aging [N01-AG62101, N01-AG62103, N01-AG62106, K24AG031155]; NATIONAL INSTITUTE ON AGING [N01AG062106, ZIAAG000971, K24AG031155, ZIAAG007390, N01AG062103, N01AG062101] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by National Institute on Aging contracts N01-AG62101, N01-AG62103, and N01-AG62106. This research was supported in part by the Intramural Research Program of the National Institute on Aging. Dr Yaffe is supported in part by National Institute on Aging grant K24AG031155 and by an anonymous foundation.	Arvanitakis Z, 2002, ALZ DIS ASSOC DIS, V16, P187, DOI 10.1097/00002093-200207000-00009; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cosentino SA, 2010, ARCH NEUROL-CHICAGO, V67, P1485, DOI 10.1001/archneurol.2010.189; Davis T C, 1993, Fam Med, V25, P391; Davis TC, 1998, HEALTH EDUC BEHAV, V25, P613, DOI 10.1177/109019819802500508; Fukumoto H, 2003, ARCH NEUROL-CHICAGO, V60, P958, DOI 10.1001/archneur.60.7.958; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; Innogenetics, NEW PROSP RES ALZH D; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Kemppainen NM, 2008, ANN NEUROL, V63, P112, DOI 10.1002/ana.21212; Kuller LH, 2003, NEUROEPIDEMIOLOGY, V22, P13, DOI 10.1159/000067109; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Lewczuk P, 2010, EXP NEUROL, V223, P366, DOI 10.1016/j.expneurol.2009.07.024; Lopez OL, 2008, NEUROLOGY, V70, P1664, DOI 10.1212/01.wnl.0000306696.82017.66; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; Mehta KM, 2004, J AM GERIATR SOC, V52, P2120, DOI 10.1111/j.1532-5415.2004.52575.x; Pesaresi M, 2006, NEUROBIOL AGING, V27, P904, DOI 10.1016/j.neurobiolaging.2006.03.004; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Prince M, 2009, WORLD ALZHEIMER REPO; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rentz DM, 2010, ANN NEUROL, V67, P353, DOI 10.1002/ana.21904; Rothman R, 2004, DIABETES EDUCATOR, V30, P263, DOI 10.1177/014572170403000219; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Scarmeas Nikolaos, 2004, Curr Neurol Neurosci Rep, V4, P374, DOI 10.1007/s11910-004-0084-7; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; Yaffe K, 2007, NEUROBIOL AGING, V28, P171, DOI 10.1016/j.neurobiolaging.2006.10.004; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703	33	169	178	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					261	266		10.1001/jama.2010.1995	http://dx.doi.org/10.1001/jama.2010.1995			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21245181	Bronze, Green Accepted			2022-12-01	WOS:000286328700021
J	Kurth, T; Mohamed, S; Maillard, P; Zhu, YC; Chabriat, H; Mazoyer, B; Bousser, MG; Dufouil, C; Tzourio, C				Kurth, Tobias; Mohamed, Shajahal; Maillard, Pauline; Zhu, Yi-Cheng; Chabriat, Hugues; Mazoyer, Bernard; Bousser, Marie-Germaine; Dufouil, Carole; Tzourio, Christophe			Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHITE-MATTER HYPERINTENSITIES; CARDIOVASCULAR-DISEASE; RISK; PREVALENCE; STROKE; ABNORMALITIES; ASSOCIATION; DISABILITY; DECLINE; VOLUME	Objective To evaluate the association of overall and specific headaches with volume of white matter hyperintensities, brain infarcts, and cognition. Design Population based, cross sectional study. Setting Epidemiology of Vascular Ageing study, Nantes, France. Participants 780 participants (mean age 69, 58.5% women) with detailed headache assessment. Main outcome measures Brain scans were evaluated for volume of white matter hyperintensities (by fully automated imaging processing) and for classification of infarcts (by visual reading with a standardised assessment grid). Cognitive function was assessed by a battery of tests including the mini-mental state examination. Results 163 (20.9%) participants reported a history of severe headache and 116 had migraine, of whom 17 (14.7%) reported aura symptoms. An association was found between any history of severe headache and increasing volume of white matter hyperintensities. The adjusted odds ratio of being in the highest third for total volume of white matter hyperintensities was 2.0 (95% confidence interval 1.3 to 3.1, P for trend 0.002) for participants with any history of severe headache when compared with participants without severe headache being in the lowest third. The association pattern was similar for all headache types. Migraine with aura was the only headache type strongly associated with volume of deep white matter hyperintensities (highest third odds ratio 12.4, 1.6 to 99.4, P for trend 0.005) and with brain infarcts (3.4, 1.2 to 9.3). The location of infarcts was predominantly outside the cerebellum and brain stem. Evidence was lacking for cognitive impairment for any headache type with or without brain lesions. Conclusions In this population based study, any history of severe headache was associated with an increased volume of white matter hyperintensities. Migraine with aura was the only headache type associated with brain infarcts. Evidence that headache of any type by itself or in combination with brain lesions was associated with cognitive impairment was lacking.	[Kurth, Tobias; Mohamed, Shajahal; Zhu, Yi-Cheng; Dufouil, Carole; Tzourio, Christophe] Hop La Pitie Salpetriere, INSERM, Unit Neuroepidemiol 708, F-75651 Paris 13, France; [Kurth, Tobias; Zhu, Yi-Cheng; Dufouil, Carole; Tzourio, Christophe] Univ Paris 06, UMR S708, Paris, France; [Kurth, Tobias] Harvard Univ, Med Sch, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02215 USA; [Maillard, Pauline; Mazoyer, Bernard] CEA, CNRS, UMR 6194, Grp Imagerie Neurofonct, Caen, France; [Zhu, Yi-Cheng; Chabriat, Hugues; Bousser, Marie-Germaine; Tzourio, Christophe] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Neurol, Paris, France; [Zhu, Yi-Cheng] Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China; [Chabriat, Hugues; Bousser, Marie-Germaine] Univ Paris Denis Diderot, Paris, France; [Mazoyer, Bernard] Univ Caen Basse Normande, Caen, France; [Mazoyer, Bernard] Ctr Hosp & Univ Caen, Caen, France; [Mazoyer, Bernard] Inst Univ France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; CEA; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut Universitaire de France	Kurth, T (corresponding author), Hop La Pitie Salpetriere, INSERM, Unit Neuroepidemiol 708, 47 Blvd Hop, F-75651 Paris 13, France.	tobias.kurth@upmc.fr	Mazoyer, Bernard M/B-6303-2012; Kurth, Tobias/A-9243-2012; Tzourio, christophe/B-4015-2009; Dufouil, Carole/J-4968-2012; mazoyer, bernard m/A-5369-2009; Dufouil, Carole/F-5751-2014; Zhu, Yi-Cheng/L-3890-2013; Maillard, Pauline/N-7600-2018; Tzourio, christophe/L-6344-2019; Chabriat, Hugues/G-5699-2010	Mazoyer, Bernard M/0000-0003-0970-2837; Kurth, Tobias/0000-0001-7169-2620; Tzourio, christophe/0000-0002-6517-2984; mazoyer, bernard m/0000-0003-0970-2837; Dufouil, Carole/0000-0003-2442-4476; Maillard, Pauline/0000-0003-3516-6345; Tzourio, christophe/0000-0002-6517-2984; Chabriat, Hugues/0000-0001-8436-6074; Dichgans, Martin/0000-0002-0654-387X	French National Research Agency (ANR, Agence Nationale de la Recherche)	French National Research Agency (ANR, Agence Nationale de la Recherche)(French National Research Agency (ANR))	The Epidemiology of Vascular Ageing study was carried out under an agreement between INSERM (Institut National de la Sante et de la Recherche Medicale); Merck, Sharp, and Dohme-Chibret Laboratories (West Point, PA); and EISAI (Paris, France). This study was supported by a chair of excellence grant of the French National Research Agency (ANR, Agence Nationale de la Recherche) to TK. The sponsors were not involved in the design, data collection, analysis, or interpretation of the study nor were they involved in writing the manuscript.	Baars MAE, 2010, HEADACHE, V50, P176, DOI 10.1111/j.1526-4610.2009.01572.x; Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Buyck JF, 2009, STROKE, V40, P2327, DOI 10.1161/STROKEAHA.109.548222; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Cooney BS, 1996, HEADACHE, V36, P616, DOI 10.1046/j.1526-4610.1996.3610616.x; DEBENEDITTIS G, 1995, HEADACHE, V35, P264; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Dufouil C, 1997, AM J EPIDEMIOL, V146, P405, DOI 10.1093/oxfordjournals.aje.a009293; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Dufouil C, 2003, ANN NEUROL, V53, P214, DOI 10.1002/ana.10440; FAZEKAS F, 1992, HEADACHE, V32, P287, DOI 10.1111/j.1526-4610.1992.hed3206287.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gruber HJ, 2010, EUR J NEUROL, V17, P419, DOI 10.1111/j.1468-1331.2009.02861.x; Gudmundsson Larus S, 2010, BMJ, V341, pc3966, DOI 10.1136/bmj.c3966; IGARASHI H, 1991, CEPHALALGIA, V11, P69, DOI 10.1046/j.1468-2982.1991.1102069.x; Intiso D, 2006, EUR J NEUROL, V13, P1364, DOI 10.1111/j.1468-1331.2006.01519.x; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Jongen C, 2007, DIABETOLOGIA, V50, P1509, DOI 10.1007/s00125-007-0688-y; Kruit MC, 2006, STROKE, V37, P1109, DOI 10.1161/01.STR.0000206446.26702.e9; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3659; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Maillard P, 2008, NEURORADIOLOGY, V50, P31, DOI 10.1007/s00234-007-0312-3; Martins KM, 2006, HEADACHE, V46, P312, DOI 10.1111/j.1526-4610.2006.00343.x; Napoli R, 2009, NEUROLOGY, V72, P2111, DOI 10.1212/WNL.0b013e3181aa53ce; Nozari A, 2010, ANN NEUROL, V67, P221, DOI 10.1002/ana.21871; Olesen J, 2004, J NEUROL NEUROSUR PS, V75, P808, DOI 10.1136/jnnp.2003.031286; Paemeleire K, 2009, J NEUROL SCI, V283, P134, DOI 10.1016/j.jns.2009.02.333; Rocca MA, 2000, NEUROLOGY, V54, P507, DOI 10.1212/WNL.54.2.507; Rozen TD, 1999, NEUROLOGY, V53, P1468, DOI 10.1212/WNL.53.7.1468; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Schurks M, 2008, NEUROLOGY, V71, P505, DOI 10.1212/01.wnl.0000316198.34558.e5; Schwedt TJ, 2008, CEPHALALGIA, V28, P531, DOI 10.1111/j.1468-2982.2008.01554.x; SIBERT LC, 2008, NEUROLOGY, V71, P108; Soumare A, 2009, ANN NEUROL, V65, P706, DOI 10.1002/ana.21674; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; Swartz RH, 2004, ARCH NEUROL-CHICAGO, V61, P1366, DOI 10.1001/archneur.61.9.1366; Tietjen GE, 2007, NEUROLOGY, V68, P134, DOI 10.1212/01.wnl.0000251195.55563.02; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Tzourio C, 2003, J NEUROL NEUROSUR PS, V74, P238, DOI 10.1136/jnnp.74.2.238; Tzourio C, 2001, NEUROLOGY, V56, P1273, DOI 10.1212/WNL.56.10.1273; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	51	155	160	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2011	342								c7357	10.1136/bmj.c7357	http://dx.doi.org/10.1136/bmj.c7357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711OH	21245119	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000286600800023
J	Bissiere, S; Zelikowsky, M; Ponnusamy, R; Jacobs, NS; Blair, HT; Fanselow, MS				Bissiere, Stephanie; Zelikowsky, Moriel; Ponnusamy, Ravikumar; Jacobs, Nathan S.; Blair, Hugh T.; Fanselow, Michael S.			Electrical Synapses Control Hippocampal Contributions to Fear Learning and Memory	SCIENCE			English	Article							BASOLATERAL AMYGDALA; MAMMALIAN BRAIN; THETA-RHYTHM; OSCILLATIONS; CONNEXIN36; SYNCHRONIZATION; INTERNEURONS; IMPAIRMENT; MODULATION; PLASTICITY	The role of electrical synapses in synchronizing neuronal assemblies in the adult mammalian brain is well documented. However, their role in learning and memory processes remains unclear. By combining Pavlovian fear conditioning, activity-dependent immediate early gene expression, and in vivo electrophysiology, we discovered that blocking neuronal gap junctions within the dorsal hippocampus impaired context-dependent fear learning, memory, and extinction. Theta rhythms in freely moving rats were also disrupted. Our results show that gap junction-mediated neuronal transmission is a prominent feature underlying emotional memories.	[Bissiere, Stephanie; Zelikowsky, Moriel; Ponnusamy, Ravikumar; Jacobs, Nathan S.; Blair, Hugh T.; Fanselow, Michael S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Fanselow, MS (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	fanselow@psych.ucla.edu	Zelikowsky, Moriel/GQI-0022-2022	Zelikowsky, Moriel/0000-0002-0465-9027; Jacobs, Nathan S/0000-0003-2175-6627; Blair, Hugh/0000-0001-8256-5109	NIMH [RO1-MH62122, P01NS35985, RO1-MH079511]; Swiss National Fund [PA00A-115367]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062122, R01MH079511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035985] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swiss National Fund(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIMH grant RO1-MH62122 and P01NS35985 (M.S.F.), Swiss National Fund grant PA00A-115367 (S.B.), and NIMH grant RO1-MH079511 (H.T.B.).	Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Buhl DL, 2003, J NEUROSCI, V23, P1013; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2001, NEURON, V31, P342, DOI 10.1016/S0896-6273(01)00378-6; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Frisch C, 2005, BEHAV BRAIN RES, V157, P177, DOI 10.1016/j.bbr.2004.06.023; Kim JJ, 2007, P NATL ACAD SCI USA, V104, P18297, DOI 10.1073/pnas.0708644104; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Muller JF, 2005, J NEUROSCI, V25, P7366, DOI 10.1523/JNEUROSCI.0899-05.2005; Placantonakis DG, 2006, J NEUROSCI, V26, P5008, DOI 10.1523/JNEUROSCI.0146-06.2006; Quinn JJ, 2008, HIPPOCAMPUS, V18, P640, DOI 10.1002/hipo.20424; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sheth A, 2008, HIPPOCAMPUS, V18, P169, DOI 10.1002/hipo.20380; Stote DL, 2004, BEHAV NEUROSCI, V118, P253, DOI 10.1037/0735-7044.118.1.253; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004	26	92	95	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					87	91		10.1126/science.1193785	http://dx.doi.org/10.1126/science.1193785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212357	Green Accepted			2022-12-01	WOS:000285974000042
J	Hsu, YC; Pasolli, HA; Fuchs, E				Hsu, Ya-Chieh; Pasolli, H. Amalia; Fuchs, Elaine			Dynamics between Stem Cells, Niche, and Progeny in the Hair Follicle	CELL			English	Article							LABEL-RETAINING CELLS; SELF-RENEWAL; SKIN; REGENERATION; PROLIFERATION; MORPHOGENESIS; HOMEOSTASIS; ACTIVATION; EPIDERMIS; DISTINCT	Here, we exploit the hair follicle to define the point at which stem cells (SCs) become irreversibly committed along a differentiation lineage. Employing histone and nucleotide double-pulse-chase and lineage tracing, we show that the early SC descendents en route to becoming transit-amplifying cells retain stemness and slow-cycling properties and home back to the bulge niche when hair growth stops. These become the primary SCs for the next hair cycle, whereas initial bulge SCs become reserves for injury. Proliferating descendents further en route irreversibly lose their stemness, although they retain many SC markers and survive, unlike their transit-amplifying progeny. Remarkably, these progeny also home back to the bulge. Combining purification and gene expression analysis with differential ablation and functional experiments, we define critical functions for these non-SC niche residents and unveil the intriguing concept that an irreversibly committed cell in an SC lineage can become an essential contributor to the niche microenvironment.	[Hsu, Ya-Chieh; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Pasolli, Hilda Amalia/0000-0003-3899-3530	NIH [R01AR050452]; Starr Foundation; NYSTEM [N09G074]; Empire State Stem Cell fund through NYSDOH [C023046]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; NYSTEM; Empire State Stem Cell fund through NYSDOH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to colleagues who generously donated mice, especially B. de Crombrugghe (UTMD Anderson) and H. Akiyama (Kyoto University) for sharing Sox9-CreER mice prior to publication; S. Mazel, C. Bare, and RU's FCRC for FACS sorting; A. North (Bioimaging Resource Center) for advice in image acquisition; Comparative Biology Center (AAALAC-accredited) for health care to our mice; and members of the Fuchs' lab, in particular: T. Chen, D. Devenport, E. Ezhkova, and B. Keyes for comments on the manuscript; M. Schober for advice on image analyses and quantifications; N. Stokes and D. Oristian for assistance in mouse research. Y.-C.H. is a Starr Stem Cell Scholars Postdoctoral Fellow. This work was supported by grants from NIH (R01AR050452), Starr Foundation, and NYSTEM (N09G074) to E.F., who is an HHMI Investigator. RU FCRC is supported by the Empire State Stem Cell fund through NYSDOH Contract #C023046.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; UNNA PG, 1876, ARCH MIKROSK ANAT, V12, P665; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	39	415	424	3	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					92	105		10.1016/j.cell.2010.11.049	http://dx.doi.org/10.1016/j.cell.2010.11.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215372	Green Accepted, Bronze			2022-12-01	WOS:000285993600010
J	Jaskelioff, M; Muller, FL; Paik, JH; Thomas, E; Jiang, S; Adams, AC; Sahin, E; Kost-Alimova, M; Protopopov, A; Cadinanos, J; Horner, JW; Maratos-Flier, E; DePinho, RA				Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Adams, Andrew C.; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; Maratos-Flier, Eleftheria; DePinho, Ronald A.			Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice	NATURE			English	Article							NEURAL STEM-CELLS; OLFACTORY-BULB; DNA-DAMAGE; CHROMOSOMAL INSTABILITY; LIFE-SPAN; CANCER; NEUROGENESIS; ADULT; MOUSE; RECOMBINATION	An ageing world population has fuelled interest in regenerative remedies that may stem declining organ function and maintain fitness. Unanswered is whether elimination of intrinsic instigators driving age-associated degeneration can reverse, as opposed to simply arrest, various afflictions of the aged. Such instigators include progressively damaged genomes. Telomerase-deficient mice have served as a model system to study the adverse cellular and organismal consequences of wide-spread endogenous DNA damage signalling activation in vivo(1). Telomere loss and uncapping provokes progressive tissue atrophy, stem cell depletion, organ system failure and impaired tissue injury responses(1). Here, we sought to determine whether entrenched multi-system degeneration in adult mice with severe telomere dysfunction can be halted or possibly reversed by reactivation of endogenous telomerase activity. To this end, we engineered a knock-in allele encoding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-oestrogen receptor (TERT-ER) under transcriptional control of the endogenous TERT promoter. Homozygous TERT-ER mice have short dysfunctional telomeres and sustain increased DNA damage signalling and classical degenerative phenotypes upon successive generational matings and advancing age. Telomerase reactivation in such late generation TERT-ER mice extends telomeres, reduces DNA damage signalling and associated cellular checkpoint responses, allows resumption of proliferation in quiescent cultures, and eliminates degenerative phenotypes across multiple organs including testes, spleens and intestines. Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2(+) neural progenitors, Dcx(+) newborn neurons, and Olig2(+) oligodendrocyte populations. Consistent with the integral role of subventricular zone neural progenitors in generation and maintenance of olfactory bulb interneurons(2), this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses. Accumulating evidence implicating telomere damage as a driver of age-associated organ decline and disease risk(1,3) and the marked reversal of systemic degenerative phenotypes in adult mice observed here support the development of regenerative strategies designed to restore telomere integrity.	[Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Jaskelioff, Mariela; Muller, Florian L.; Paik, Ji-Hye; Thomas, Emily; Jiang, Shan; Sahin, Ergun; Kost-Alimova, Maria; Protopopov, Alexei; Cadinanos, Juan; Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA; [Adams, Andrew C.; Maratos-Flier, Eleftheria] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu		Cadinanos, Juan/0000-0001-7561-7759; DePinho, Ronald/0000-0002-5625-577X; Muller, Florian/0000-0001-7568-2948	Susan G. Komen for the Cure fellowship [PDF060881]; NIH National Cancer Institute [R01CA84628, U01CA141508]; Belfer Foundation; American Cancer Society (ACS) [PF-08-261-01-TBE]; NATIONAL CANCER INSTITUTE [U01CA141508, R01CA084628] Funding Source: NIH RePORTER	Susan G. Komen for the Cure fellowship(Susan G. Komen Breast Cancer Foundation); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Belfer Foundation; American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank R. Segal for critical comments, R. Bronson, K. Ligon and C. Maire for histological advice, S. S. Chae for assistance with neurosphere measurement studies and L. Cameron for time-lapse microscopy studies. M.J. was supported in part by a Susan G. Komen for the Cure fellowship (PDF060881). F.L.M. was supported by ACS fellowship PF-08-261-01-TBE. This work and R.A.D. was supported by R01CA84628 and U01CA141508 grants from the NIH National Cancer Institute and the Belfer Foundation. R.A.D. was supported by an American Cancer Society Research Professorship.	Abr?moff MD., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Best BP, 2009, REJUV RES, V12, P199, DOI 10.1089/rej.2009.0847; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Caporaso GL, 2003, MOL CELL NEUROSCI, V23, P693, DOI 10.1016/S1044-7431(03)00103-9; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Gorczyca W, 2001, METHOD CELL BIOL, V64, P421; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Ju ZY, 2008, BIOCHIMIE, V90, P24, DOI 10.1016/j.biochi.2007.09.006; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lafreniere D, 2009, OTOLARYNG CLIN N AM, V42, P123, DOI 10.1016/j.otc.2008.09.001; Lee J, 2010, NEUROCHEM RES, V35, P211, DOI 10.1007/s11064-009-0044-3; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Mahoney JE, 2008, PROC SPIE, V6859, DOI 10.1117/12.763858; Maser RS, 2007, MOL CELL BIOL, V27, P2253, DOI 10.1128/MCB.01354-06; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Potzner MR, 2007, MOL CELL BIOL, V27, P5316, DOI 10.1128/MCB.00339-07; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052	35	508	537	1	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					102	U1700		10.1038/nature09603	http://dx.doi.org/10.1038/nature09603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21113150	Green Accepted			2022-12-01	WOS:000285921600040
J	Scheel, PJ; Feeley, N; Sozio, SM				Scheel, Paul J., Jr.; Feeley, Nancy; Sozio, Stephen M.			Combined Prednisone and Mycophenolate Mofetil Treatment for Retroperitoneal Fibrosis A Case Series	ANNALS OF INTERNAL MEDICINE			English	Article							THERAPY	Background: Small case series suggest that a combination of mycophenolate mofetil and prednisone may be an effective treatment for patients with retroperitoneal fibrosis. Objective: To describe the outcomes of adults with retroperitoneal fibrosis who received a combination of prednisone and mycophenolate mofetil. Design: Prospective case series of patients followed between 1 April 2005 and 1 July 2009. Setting: Single tertiary care facility. Patients: 28 patients with retroperitoneal fibrosis. Intervention: Prednisone, 40 mg/d, tapered over 6 months, and mycophenolate mofetil, 1000 mg twice daily, for a mean of 24.3 months. Measurements: Clinical course, laboratory assessment, and measurement of periaortic mass. Mean follow-up was 1012 days, and no patients were lost to follow-up. Results: Systemic symptoms resolved in all patients; 89% had a 25% or greater reduction in periaortic mass. Elevated erythrocyte sedimentation rate and serum creatinine level and decreased hemoglobin level normalized in all patients. Disease recurred in 2 of 28 patients. Limitation: This was a small case series. Conclusion: Combined prednisone and mycophenolate mofetil therapy is a potentially effective treatment for retroperitoneal fibrosis that warrants evaluation in randomized trials.	[Scheel, Paul J., Jr.] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA	Johns Hopkins University	Scheel, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Nephrol, 1830 E Monument St,Room 416, Baltimore, MD 21205 USA.	PScheel1@jhmi.edu	Sozio, Stephen M./H-1214-2018	Sozio, Stephen M./0000-0002-0099-0484				Adler S, 2008, RHEUMATOLOGY, V47, P1535, DOI 10.1093/rheumatology/ken291; Goncalves RG, 2004, AM J NEPHROL, V24, P527, DOI 10.1159/000081706; Jois RN, 2007, RHEUMATOLOGY, V46, P717, DOI 10.1093/rheumatology/kel417; Kardar AH, 2002, J UROLOGY, V168, P550, DOI 10.1016/S0022-5347(05)64677-0; Khalil F, 2008, CLIN RHEUMATOL, V27, P679, DOI 10.1007/s10067-007-0826-4; Kramer S, 2005, AM J PHYSIOL-RENAL, V289, pF359, DOI 10.1152/ajprenal.00442.2004; Marcolongo R, 2004, AM J MED, V116, P194, DOI 10.1016/j.amjmed.2003.08.033; Marzano A, 2001, ANN RHEUM DIS, V60, P427, DOI 10.1136/ard.60.4.427; MCDOUGAL WS, 1991, J UROLOGY, V145, P112, DOI 10.1016/S0022-5347(17)38263-0; Moder KG, 2003, ANN ALLERG ASTHMA IM, V90, P15, DOI 10.1016/S1081-1206(10)63607-1; Morath C, 2006, CLIN TRANSPLANT, V20, P25, DOI 10.1111/j.1399-0012.2006.00597.x; Obrencevic Katarina, 2007, Vojnosanit Pregl, V64, P385, DOI 10.2298/VSP0706385O; Pescovitz MD, 2003, AM J TRANSPLANT, V3, P1581, DOI 10.1046/j.1600-6135.2003.00243.x; Plastiras SC, 2006, RHEUMATOLOGY, V45, P1572, DOI 10.1093/rheumatology/kel335; SCAVALLI AS, 1995, CLIN RHEUMATOL, V14, P481, DOI 10.1007/BF02207688; Scheel PJ, 2007, J UROLOGY, V178, P140, DOI 10.1016/j.juro.2007.03.057; Scheel PJ, 2009, MEDICINE, V88, P202, DOI 10.1097/MD.0b013e3181afc439; Swartz RD, 2008, CLIN NEPHROL, V69, P260; Vaglio A, 2006, LANCET, V367, P241, DOI 10.1016/S0140-6736(06)68035-5; van Bommel EFH, 2006, ANN INTERN MED, V144, P101, DOI 10.7326/0003-4819-144-2-200601170-00007; van Bommel EFH, 2007, AM J KIDNEY DIS, V49, P615, DOI 10.1053/j.ajkd.2007.02.268; Warnatz K, 2005, ANN RHEUM DIS, V64, P828, DOI 10.1136/ard.2004.029793; Wu Jamie, 2002, Cancer Control, V9, P432	23	66	67	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					31	U163		10.7326/0003-4819-154-1-201101040-00005	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200036				2022-12-01	WOS:000285830900004
J	Bennett, KL; Mester, J; Eng, C				Bennett, Kristi L.; Mester, Jessica; Eng, Charis			Germline Epigenetic Regulation of KILLIN in Cowden and Cowden-like Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HAMARTOMA-TUMOR-SYNDROME; PTEN; MUTATIONS; CANCER; DISEASE; INACTIVATION; BREAST; GENES; DNA	Context Germline loss-of-function phosphatase and tensin homolog gene (PTEN) mutations cause 80% of Cowden syndrome, a rare autosomal-dominant disorder (1 in 200 000 live births), characterized by high risks of breast, thyroid, and other cancers. A large heterogeneous group of individuals with Cowden-like syndrome, who have various combinations of Cowden syndrome features but who do not meet Cowden syndrome diagnostic criteria, have PTEN mutations less than 10% of the time, making molecular diagnosis, prediction, genetic counseling, and risk management challenging. Other mechanisms of loss of function such as hypermethylation, which should result in underexpression of PTEN or of KILLIN, a novel tumor suppressor transcribed in the opposite direction, may account for the remainder of Cowden syndrome and Cowden-like syndrome. Objective To determine whether germline methylation is found in Cowden syndrome or Cowden-like syndrome in individuals lacking germline PTEN mutations. Design, Setting, and Participants Nucleic acids from prospective nested series of 123 patients with Cowden syndrome or Cowden-like syndrome and 50 unaffected individuals without PTEN variants were analyzed for germline methylation and expression of PTEN and KILLIN at the Cleveland Clinic, August 2008-June 2010. Prevalence of component cancers between groups was compared using the Fisher exact test. Main Outcome Measures Frequency of germline methylation in PTEN mutation-negative Cowden syndrome and Cowden syndrome-like individuals. Prevalence of component cancers in methylation-positive and PTEN mutation-positive individuals. Results Of 123 patients with Cowden syndrome or Cowden-like syndrome, 45 (37%; 95% confidence interval [CI], 29%-45%) showed hypermethylation upstream of PTEN but no transcriptional repression. The germline methylation was found to transcriptionally down-regulate KILLIN by 250-fold (95% CI, 45-14 286; P=.007) and exclusively disrupted TP53 activation of KILLIN by 30% (95% CI, 7%-45%; P=.008). Demethylation treatment increased only KILLIN expression 4.88-fold (95% CI, 1.4-18.1; P=.05). Individuals with KILLIN-promoter methylation had a 3-fold increased prevalence of breast cancer (35/42 vs 24/64; P<.0001) and a greater than 2-fold increase of kidney cancer (4/45 vs 6/155; P=.004) over individuals with germline PTEN mutations. Conclusions Germline KILLIN methylation is common among patients with Cowden syndrome or Cowden-like syndrome and is associated with increased risks of breast and renal cancer over PTEN mutation-positive individuals. These observations need to be replicated. JAMA. 2010;304(24):2724-2732 www.jama.com	[Bennett, Kristi L.; Mester, Jessica; Eng, Charis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Taussig Canc Inst, Lerner Res Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Stanley Shalom Zielony Nursing Inst, Cleveland, OH 44195 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org		Eng, Charis/0000-0002-3693-5145	Breast Cancer Research Foundation; William Randolph Hearst Foundations; National Cancer Institute [P01CA124570]; FM Kirby Foundation; NATIONAL CANCER INSTITUTE [P01CA124570] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; William Randolph Hearst Foundations; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FM Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Eng reports receipt of funding for this study, in part, by the Breast Cancer Research Foundation, the William Randolph Hearst Foundations, and the National Cancer Institute (P01CA124570). Dr Eng is the Sondra J. and Stephen R. Hardis Chair of Cancer Genomic Medicine at the Cleveland Clinic, was a Doris Duke Distinguished Clinical Scientist, and is an American Cancer Society Clinical Research Professor, which is funded, in part, by the FM Kirby Foundation.	Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Cho YJ, 2008, P NATL ACAD SCI USA, V105, P5396, DOI 10.1073/pnas.0705410105; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Kikuno N, 2008, INT J CANCER, V123, P552, DOI 10.1002/ijc.23590; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Marsh DJ, 1998, J MED GENET, V35, P881, DOI 10.1136/jmg.35.11.881; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; STARINK TM, 1986, CLIN GENET, V29, P222; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Teresi RE, 2007, AM J HUM GENET, V81, P756, DOI 10.1086/521051; Yu L, 2004, GENOMICS, V84, P647, DOI 10.1016/j.ygeno.2004.06.010; Zhou XP, 2003, AM J HUM GENET, V73, P1191, DOI 10.1086/379382	23	106	110	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2724	2731		10.1001/jama.2010.1877	http://dx.doi.org/10.1001/jama.2010.1877			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177507	Green Accepted, Bronze			2022-12-01	WOS:000285518000017
J	White, NJ				White, Nicholas J.			Artemisinin resistance-the clock is ticking	LANCET			English	Editorial Material							MALARIA; AFRICA		Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand	Mahidol University	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	nickw@tropmedres.ac	White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978	Wellcome Trust [093956] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2010, SCIENCE, V328, P846, DOI 10.1126/science.328.5980.846; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WHO, ART RES CONT PROJ	9	76	80	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2051	2052		10.1016/S0140-6736(10)61963-0	http://dx.doi.org/10.1016/S0140-6736(10)61963-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702LA	21168039				2022-12-01	WOS:000285895000008
J	Hino, T; Matsumoto, Y; Nagano, S; Sugimoto, H; Fukumori, Y; Murata, T; Iwata, S; Shiro, Y				Hino, Tomoya; Matsumoto, Yushi; Nagano, Shingo; Sugimoto, Hiroshi; Fukumori, Yoshihiro; Murata, Takeshi; Iwata, So; Shiro, Yoshitsugu			Structural Basis of Biological N2O Generation by Bacterial Nitric Oxide Reductase	SCIENCE			English	Article							CYTOCHROME-C-OXIDASE; PARACOCCUS-DENITRIFICANS; SPECTROSCOPIC CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; NO REDUCTASE; BC COMPLEX; HEME; PATHWAY; GLUTAMATES; STUTZERI	Nitric oxide reductase (NOR) is an iron-containing enzyme that catalyzes the reduction of nitric oxide (NO) to generate a major greenhouse gas, nitrous oxide (N2O). Here, we report the crystal structure of NOR from Pseudomonas aeruginosa at 2.7 angstrom resolution. The structure reveals details of the catalytic binuclear center. The non-heme iron (Fe-B) is coordinated by three His and one Glu ligands, but a His-Tyr covalent linkage common in cytochrome oxidases (COX) is absent. This structural characteristic is crucial for NOR reaction. Although the overall structure of NOR is closely related to COX, neither the D-nor K-proton pathway, which connect the COX active center to the intracellular space, was observed. Protons required for the NOR reaction are probably provided from the extracellular side.	[Hino, Tomoya; Matsumoto, Yushi; Nagano, Shingo; Sugimoto, Hiroshi; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Hino, Tomoya; Murata, Takeshi; Iwata, So] Japan Sci & Technol Agcy, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Hino, Tomoya; Murata, Takeshi; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Matsumoto, Yushi] Kyushu Univ, Med Inst Bioregulat, Postgenome Sci Ctr, Div Prot Chem, Fukuoka 8128552, Japan; [Nagano, Shingo] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Fukumori, Yoshihiro] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Iwata, So] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Membrane Prot Crystallog Grp, London SW7 2AZ, England	RIKEN; Japan Science & Technology Agency (JST); Kyoto University; Kyushu University; Tottori University; Kanazawa University; Imperial College London	Hino, T (corresponding author), RIKEN SPring 8 Ctr, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.		Sugimoto, Hiroshi/AAR-5442-2021; Murata, Takeshi/J-6181-2017; Sugimoto, Hiroshi/K-4041-2017; Fukumori, Yoshihiro/J-2483-2014; Murata, Takeshi/F-6114-2011; Shiro, Yoshitsugu Y/J-3757-2014	Murata, Takeshi/0000-0002-5748-4670; Sugimoto, Hiroshi/0000-0002-3140-8362; Shiro, Yoshitsugu Y/0000-0003-0695-8327	Ministry of Education, Culture, Sports, Science and Technology (MEXT); RIKEN; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Atomic coordinates and structure factors have been deposited to the Protein Data Bank (PDB) with code 3O0R. We thank T. Tosha for measurements of the enzymatic activity of cNOR under various conditions and the staff of the SPring-8 beamlines for their help with diffraction measurements. S.N., H. S., and Y.S. are supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Y.S. also acknowledges financial support from the Structural Biology and Molecular Ensemble projects of RIKEN. A part of this work was also supported by a grant from the ERATO IWATA Human Receptor Crystallography Project from the Japan Science and Technology Agency.	BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Blomberg LM, 2006, BBA-BIOENERGETICS, V1757, P240, DOI 10.1016/j.bbabio.2006.04.008; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Butler CS, 1997, BIOCHEMISTRY-US, V36, P16259, DOI 10.1021/bi971481a; Collman JP, 2008, P NATL ACAD SCI USA, V105, P15660, DOI 10.1073/pnas.0808606105; DeBoer APN, 1996, EUR J BIOCHEM, V242, P592, DOI 10.1111/j.1432-1033.1996.0592r.x; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Flock U, 2009, J INORG BIOCHEM, V103, P845, DOI 10.1016/j.jinorgbio.2009.02.008; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Gronberg KLC, 1999, BIOCHEMISTRY-US, V38, P13780, DOI 10.1021/bi9916426; HEISS B, 1989, J BACTERIOL, V171, P3288, DOI 10.1128/jb.171.6.3288-3297.1989; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kakishima K, 2007, BIOCHEM BIOPH RES CO, V355, P587, DOI 10.1016/j.bbrc.2007.02.017; Kumita H, 2004, J BIOL CHEM, V279, P55247, DOI 10.1074/jbc.M409996200; Lin YW, 2010, P NATL ACAD SCI USA, V107, P8581, DOI 10.1073/pnas.1000526107; Moenne-Loccoz P, 2000, J AM CHEM SOC, V122, P9344, DOI 10.1021/ja0016295; Moenne-Loccoz P, 1998, J AM CHEM SOC, V120, P5147, DOI 10.1021/ja973671e; Moenne-Loccoz P, 2007, NAT PROD REP, V24, P610, DOI 10.1039/B604194A; Regan JJ, 1998, J BIOENERG BIOMEMBR, V30, P35, DOI 10.1023/A:1020551326307; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; SHAPLEIGH JP, 1985, J BACTERIOL, V163, P837, DOI 10.1128/JB.163.3.837-840.1985; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Wuebbles DJ, 2009, SCIENCE, V326, P56, DOI 10.1126/science.1179571; YE RW, 1994, APPL ENVIRON MICROB, V60, P1053, DOI 10.1128/AEM.60.4.1053-1058.1994; Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620; ZUMFT WG, 1994, EUR J BIOCHEM, V219, P481, DOI 10.1111/j.1432-1033.1994.tb19962.x	31	244	248	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1666	1670		10.1126/science.1195591	http://dx.doi.org/10.1126/science.1195591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21109633				2022-12-01	WOS:000285390500064
J	Yao, L; Schiavi, F; Cascon, A; Qin, YJ; Inglada-Perez, L; King, EE; Toledo, RA; Ercolino, T; Rapizzi, E; Ricketts, CJ; Mori, L; Giacche, M; Mendola, A; Taschin, E; Boaretto, F; Loli, P; Iacobone, M; Rossi, GP; Biondi, B; Lima, JV; Kater, CE; Bex, M; Vikkula, M; Grossman, AB; Gruber, SB; Barontini, M; Persu, A; Castellano, M; Toledo, SPA; Maher, ER; Mannelli, M; Opocher, G; Robledo, M; Dahia, PLM				Yao, Li; Schiavi, Francesca; Cascon, Alberto; Qin, Yuejuan; Inglada-Perez, Lucia; King, Elizabeth E.; Toledo, Rodrigo A.; Ercolino, Tonino; Rapizzi, Elena; Ricketts, Christopher J.; Mori, Luigi; Giacche, Mara; Mendola, Antonella; Taschin, Elisa; Boaretto, Francesca; Loli, Paola; Iacobone, Maurizio; Rossi, Gian-Paolo; Biondi, Bernadette; Lima-Junior, Jose Viana; Kater, Claudio E.; Bex, Marie; Vikkula, Miikka; Grossman, Ashley B.; Gruber, Stephen B.; Barontini, Marta; Persu, Alexandre; Castellano, Maurizio; Toledo, Sergio P. A.; Maher, Eamonn R.; Mannelli, Massimo; Opocher, Giuseppe; Robledo, Mercedes; Dahia, Patricia L. M.			Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-SUPPRESSOR; SUSCEPTIBILITY; 1P36	Context Pheochromocytomas and paragangliomas are genetically heterogeneous neural crest-derived neoplasms. We recently identified germline mutations of the novel transmembrane-encoding gene FP/TMEM127 in familial and sporadic pheochromocytomas consistent with a tumor suppressor effect. Objectives To examine the prevalence and spectrum of FP/TMEM127 mutations in pheochromocytomas and paragangliomas and to test the effect of mutations in vitro. Design, Setting, and Participants We sequenced the FP/TMEM127 gene in 990 individuals with pheochromocytomas and/or paragangliomas, including 898 previously unreported cases without mutations in other susceptibility genes from 8 independent worldwide referral centers between January 2009 and June 2010. A multiplex polymerase chain reaction-based method was developed to screen for large gene deletions in 545 of these samples. Confocal microscopy of 5 transfected mutant proteins was used to determine their subcellular localization. Main Outcome Measures The frequency and type of FP/TMEM127 mutation or deletion was assessed and correlated with clinical variables; the subcellular localization of 5 overexpressed mutants was compared with wild-type FP/TMEM127 protein. Results We identified 19 potentially pathogenic FP/TMEM127 germline mutations in 20 independent families, but no large deletions were detected. All mutation carriers had adrenal tumors, including 7 bilateral (P=2.7 x 10(-4)) and/or with familial disease (5 of 20 samples; P=.005). The median age at disease onset in the FP/TMEM127 mutation group was similar to that of patients without a mutation (41.5 vs 45 years, respectively; P=.54). The most common presentation was that of a single benign adrenal tumor in patients older than 40 years. Malignancy was seen in 1 mutation carrier (5%). Expression of 5 novel FP/TMEM127 mutations in cell lines revealed diffuse localization of the mutant proteins in contrast with the discrete multiorganelle distribution of wild-type TMEM127. Conclusions Germline mutations of FP/TMEM127 were associated with pheochromocytoma but not paraganglioma and occured in an age group frequently excluded from genetic screening algorithms. Disease-associated mutations disrupt intracellular distribution of the FP/TMEM127 protein. JAMA. 2010;304(23):2611-2619 www.jama.com	[Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Yao, Li; Qin, Yuejuan; King, Elizabeth E.; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Div Hematol & Med Oncol, San Antonio, TX 78229 USA; [King, Elizabeth E.] Univ Texas Hlth Sci Ctr San Antonio, Div Endocrinol, San Antonio, TX 78229 USA; [Yao, Li; Qin, Yuejuan; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Schiavi, Francesca; Taschin, Elisa; Boaretto, Francesca; Opocher, Giuseppe] Univ Padua, Veneto Inst Oncol, Familial Canc Clin, Padua, Italy; [Iacobone, Maurizio] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy; [Rossi, Gian-Paolo] Univ Padua, Dept Internal Med 4, Padua, Italy; [Opocher, Giuseppe] Univ Padua, Dept Med & Surg Sci, Padua, Italy; [Cascon, Alberto; Inglada-Perez, Lucia; Robledo, Mercedes] Spanish Natl Canc Res Ctr, Hereditary Endocrine Canc Grp, Madrid, Spain; [Cascon, Alberto; Inglada-Perez, Lucia; Robledo, Mercedes] Inst Salud Carlos III, Ctr Biomed Res Rare Dis, Madrid, Spain; [Toledo, Rodrigo A.; Toledo, Sergio P. A.] Univ Sao Paulo, Sch Med, Dept Med, Div Endocrinol,Endocrine Genet Unit LIM 25, Sao Paulo, Brazil; [Lima-Junior, Jose Viana; Kater, Claudio E.] Univ Fed Sao Paulo, Dept Med, Div Endocrinol, Sao Paulo, Brazil; [Ercolino, Tonino; Rapizzi, Elena; Mannelli, Massimo] Univ Florence, Dept Clin Pathophysiol, Florence, Italy; [Mannelli, Massimo] Ist Toscano Tumori, Florence, Italy; [Ricketts, Christopher J.; Maher, Eamonn R.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Ricketts, Christopher J.; Maher, Eamonn R.] Univ Birmingham, Ctr Rare Dis & Personalised Med, Birmingham, W Midlands, England; [Mori, Luigi; Giacche, Mara; Castellano, Maurizio] Univ Brescia, Endocrine & Metab Unit, Med Clin, Brescia, Italy; [Mendola, Antonella; Vikkula, Miikka] Catholic Univ Louvain, Clin Univ St Luc, Lab Human Mol Genet, de Duve Inst, B-1200 Brussels, Belgium; [Persu, Alexandre] Catholic Univ Louvain, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium; [Loli, Paola] Osped Niguarda Ca Granda, Dept Endocrinol, Milan, Italy; [Biondi, Bernadette] Univ Naples Federico II, Dept Clin & Mol Endocrinol & Oncol, Naples, Italy; [Bex, Marie] Katholieke Univ Leuven Hosp, Dept Endocrinol, Leuven, Belgium; [Grossman, Ashley B.] St Bartholomews Hosp, Barts & London Sch Med, Ctr Endocrinol, London, England; [Gruber, Stephen B.] Univ Michigan, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Barontini, Marta] Hosp Ninos Dr Ricardo Gutierrez, Ctr Invest Endocrinol, Buenos Aires, DF, Argentina	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; University of Padua; University of Padua; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Birmingham; University of Birmingham; University of Brescia; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Naples Federico II; KU Leuven; University Hospital Leuven; University of London; Queen Mary University London; University of Michigan System; University of Michigan; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires	Dahia, PLM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	dahia@uthscsa.edu	Opocher, Giuseppe/F-3950-2014; Ricketts, Christopher/AAV-9580-2020; Vikkula, Miikka/Q-1038-2018; Cascon, Alberto/G-3160-2014; Toledo, Rodrigo/N-4078-2013; Robledo, Mercedes/O-2230-2013; Iacobone, Maurizio/K-8714-2016; Schiavi, Francesca/AAB-9908-2022; inglada-perez, lucia/H-5378-2015; MAHER, EAMONN R/A-9507-2008; Inglada-Perez, Lucia/Z-3020-2019; Qin, Yuejuan/F-6801-2010; Toledo, Rodrigo/ABH-5248-2020; Toledo, Rodrigo/GQQ-1711-2022; Biondi, Bernadette/AAH-7664-2020; Castellano, Maurizio/C-1096-2011; boaretto, francesca/K-9811-2016; Toledo, Sergio P. A./S-9291-2018; taschin, elisa/K-3847-2016	Opocher, Giuseppe/0000-0002-9845-9623; Vikkula, Miikka/0000-0002-6236-338X; Cascon, Alberto/0000-0003-2119-891X; Toledo, Rodrigo/0000-0003-3070-6795; Robledo, Mercedes/0000-0001-6256-5902; Schiavi, Francesca/0000-0001-8529-4455; MAHER, EAMONN R/0000-0002-6226-6918; Toledo, Rodrigo/0000-0003-3070-6795; Castellano, Maurizio/0000-0002-4569-2659; boaretto, francesca/0000-0003-2015-929X; Persu, Alexandre/0000-0002-4007-9695; Biondi, Bernadette/0000-0001-8360-4464; Inglada-Perez, Lucia/0000-0001-9814-4368; ROSSI, GIAN PAOLO/0000-0002-7963-0931; Toledo, Sergio P. A./0000-0002-2590-3519; Iacobone, Maurizio/0000-0002-6057-4642; taschin, elisa/0000-0001-9426-4071; Mannelli, Massimo/0000-0002-8001-9857; INGLADA, LUCIA/0000-0001-9523-2717	University of Texas Health Science Center at San Antonio (UTHSCSA); National Cancer Institute (NCI) [P30 CA54174]; National Institute on Aging (NIA) [P30 AG013319, P01AG19316]; Department of Microbiology, UTHSCSA; Fundacao Faculdade de Medicina; Division of Endocrinology; Sao Paulo State Research Foundation (FAPESP) [2009/15386-6]; Cancer Research UK; Belgian Federal Science Policy, network [6/05]; Belgian French Community Ministry [07/12-005]; la Communaute Francaise de Wallonie-Bruxelles et la Lotterie Nationale; FRS-FNRS (Fonds de la Recherche Scientifique), Belgium; NCI [5 P30 CA465920]; Italian University and Research Ministry [2006060473]; Fondazione della Comunita Bresciana; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fondo de Investigaciones Sanitarias [PI 08/080883]; Fundacion Mutua Madrilena [AP2775/2008]; Voelcker Fund; Alex's Lemonade Stand Foundation; Concern Foundation; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, P01AG019316] Funding Source: NIH RePORTER	University of Texas Health Science Center at San Antonio (UTHSCSA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Microbiology, UTHSCSA; Fundacao Faculdade de Medicina; Division of Endocrinology; Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Cancer Research UK(Cancer Research UK); Belgian Federal Science Policy, network(Belgian Federal Science Policy Office); Belgian French Community Ministry; la Communaute Francaise de Wallonie-Bruxelles et la Lotterie Nationale; FRS-FNRS (Fonds de la Recherche Scientifique), Belgium(Fonds de la Recherche Scientifique - FNRS); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Italian University and Research Ministry(Ministry of Education, Universities and Research (MIUR)); Fondazione della Comunita Bresciana; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Voelcker Fund; Alex's Lemonade Stand Foundation; Concern Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Cancer Therapy and Research Center Pathology Core and the Optical Imaging Core are supported by University of Texas Health Science Center at San Antonio (UTHSCSA) and National Cancer Institute (NCI) grant P30 CA54174 (Cancer Therapy and Research Center at UTHSCSA). The Optical Imaging Core is also supported by National Institute on Aging (NIA) grant P30 AG013319 (Nathan Shock Center) and NIA grant P01AG19316. The Nucleic Acids Core Facility receives the support of the Department of Microbiology, UTHSCSA. Funds from the Fundacao Faculdade de Medicina and the Division of Endocrinology provided support for the screening of the Brazilian cohort. Dr R. A. Toledo is supported by a Sao Paulo State Research Foundation (FAPESP grant 2009/15386-6) postdoctoral fellowship. Drs Ricketts and Maher are supported by Cancer Research UK. Dr Vikkula is supported by the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network 6/05; Concerted Research Actions Convention No. 07/12-005 of the Belgian French Community Ministry; la Communaute Francaise de Wallonie-Bruxelles et la Lotterie Nationale. Drs Vikkula and Persu are supported by the FRS-FNRS (Fonds de la Recherche Scientifique), Belgium. Dr Gruber is supported by NCI grant 5 P30 CA465920. Dr Castellano is supported by funds from the Italian University and Research Ministry (grant 2006060473) and by the Fondazione della Comunita Bresciana. Dr S. P. A. Toledo is supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant. Dr Robledo is supported by Fondo de Investigaciones Sanitarias grant PI 08/080883 and Fundacion Mutua Madrilena (reference AP2775/2008). Dr Dahia is supported by the Voelcker Fund, Alex's Lemonade Stand Foundation, Concern Foundation, and Clinical Translational and Science Awards (National Institutes of Health).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bayley JP, 2010, LANCET ONCOL, V11, P366, DOI 10.1016/S1470-2045(10)70007-3; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Burnichon N, 2009, J CLIN ENDOCR METAB, V94, P2817, DOI 10.1210/jc.2008-2504; Cascon A, 2008, J MED GENET, V45, P233, DOI 10.1136/jmg.2007.054965; Cascon A, 2009, HORM METAB RES, V41, P672, DOI 10.1055/s-0029-1202814; Cascon A, 2009, J CLIN ENDOCR METAB, V94, P1701, DOI 10.1210/jc.2008-2756; Dahia PLM, 2005, CANCER RES, V65, P9651, DOI 10.1158/0008-5472.CAN-05-1427; Gimenez-Roqueplo AP, 2006, CLIN ENDOCRINOL, V65, P699, DOI 10.1111/j.1365-2265.2006.02714.x; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Manger WM, 2006, ANN NY ACAD SCI, V1073, P1, DOI 10.1196/annals.1353.001; Mannelli M, 2009, J CLIN ENDOCR METAB, V94, P1541, DOI 10.1210/jc.2008-2419; NEUMANN H, 2009, J CLIN ENDOCR METAB, V94, pA19; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Opocher G, 2003, HORM RES, V59, P56, DOI 10.1159/000067846; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Ya G, 2009, BIOL PHARM BULL, V32, P882, DOI 10.1248/bpb.32.882; Yeh IT, 2008, HUM GENET, V124, P279, DOI 10.1007/s00439-008-0553-1	22	132	143	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2010	304	23					2611	2619		10.1001/jama.2010.1830	http://dx.doi.org/10.1001/jama.2010.1830			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	694MX	21156949	Bronze			2022-12-01	WOS:000285303400024
J	Xia, LX; Jia, SJ; Huang, SJ; Wang, HL; Zhu, YX; Mu, YJ; Kan, LJ; Zheng, WJ; Wu, D; Li, XM; Sun, QM; Meng, AM; Chen, DH				Xia, Laixin; Jia, Shunji; Huang, Shoujun; Wang, Hailong; Zhu, Yuanxiang; Mu, Yanjun; Kan, Lijuan; Zheng, Wenjing; Wu, Di; Li, Xiaoming; Sun, Qinmiao; Meng, Anming; Chen, Dahua			The Fused/Smurf Complex Controls the Fate of Drosophila Germline Stem Cells by Generating a Gradient BMP Response	CELL			English	Article							BAG-OF-MARBLES; GENE; PROTEIN; NICHE; EXPRESSION; DIVISION; PIWI; DIFFERENTIATION; TRANSCRIPTION; DETERMINES	In the Drosophila ovary, germline stem cells (GSCs) are maintained primarily by bone morphogenetic protein (BMP) ligands produced by the stromal cells of the niche. This signaling represses GSC differentiation by blocking the transcription of the differentiation factor Bam. Remarkably, bam transcription begins only one cell diameter away from the GSC in the daughter cystoblasts (CBs). How this steep gradient of response to BMP signaling is formed has been unclear. Here, we show that Fused (Fu), a serine/threonine kinase that regulates Hedgehog, functions in concert with the E3 ligase Smurf to regulate ubiquitination and proteolysis of the BMP receptor Thickveins in CBs. This regulation generates a steep gradient of BMP activity between GSCs and CBs, allowing for bam expression on CBs and concomitant differentiation. We observed similar roles for Fu during embryonic development in zebrafish and in human cell culture, implying broad conservation of this mechanism.	[Xia, Laixin; Huang, Shoujun; Wang, Hailong; Zhu, Yuanxiang; Mu, Yanjun; Kan, Lijuan; Zheng, Wenjing; Chen, Dahua] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Xia, Laixin; Li, Xiaoming; Sun, Qinmiao; Meng, Anming] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Jia, Shunji; Wu, Di; Meng, Anming] Tsinghua Univ, Coll Life Sci, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Tsinghua University	Chen, DH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	chendh@ioz.ac.cn	Zheng, Wenjing/M-7580-2015; Wenjing, Zheng/H-9766-2013; Meng, Anming/A-4785-2012	Xia, Laixin/0000-0003-2735-9518; Meng, Anming/0000-0001-7228-3431	National Basic Research Program of China [2007CB947502, 2007CB507400]; NSFC [30630042, 30825026, 30830068]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	We thank Drs. Dennis McKearin, Duojia Pan, Peng Jin, and Zongping Xia for critical readings of the manuscript. This work was supported by grants from the National Basic Research Program of China (2007CB947502 and 2007CB507400 to D.C.) and from the NSFC (#30630042 and 30825026 to D.C. and #30830068 to A.M.).	Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Chen DS, 2009, DEVELOPMENT, V136, P4133, DOI 10.1242/dev.039032; Claret S, 2007, CURR BIOL, V17, P1326, DOI 10.1016/j.cub.2007.06.059; Cox DN, 2000, DEVELOPMENT, V127, P503; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Haley B, 2008, DEV BIOL, V321, P482, DOI 10.1016/j.ydbio.2008.06.015; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiang XY, 2008, DEV CELL, V14, P494, DOI 10.1016/j.devcel.2008.02.018; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Kitisin Krit, 2007, Sci STKE, V2007, pcm1, DOI 10.1126/stke.3992007cm1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Liu YJ, 2007, GENE DEV, V21, P1949, DOI 10.1101/gad.1557407; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Narbonne-Reveau K, 2006, MECH DEVELOP, V123, P197, DOI 10.1016/j.mod.2006.01.001; Nishikawa SI, 2008, COLD SH Q B, V73, P67, DOI 10.1101/sqb.2008.73.024; Nybakken KE, 2002, J BIOL CHEM, V277, P24638, DOI 10.1074/jbc.M110730200; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Ruel L, 2007, DEVELOPMENT, V134, P3677, DOI 10.1242/dev.011577; SanchezHerrero E, 1996, MECH DEVELOP, V55, P159, DOI 10.1016/0925-4773(96)00498-4; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Van Doren M, 1998, CURR BIOL, V8, P243; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	43	95	100	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					978	990		10.1016/j.cell.2010.11.022	http://dx.doi.org/10.1016/j.cell.2010.11.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145463	Bronze			2022-12-01	WOS:000285182600014
J	Kalinka, AT; Varga, KM; Gerrard, DT; Preibisch, S; Corcoran, DL; Jarrells, J; Ohler, U; Bergman, CM; Tomancak, P				Kalinka, Alex T.; Varga, Karolina M.; Gerrard, Dave T.; Preibisch, Stephan; Corcoran, David L.; Jarrells, Julia; Ohler, Uwe; Bergman, Casey M.; Tomancak, Pavel			Gene expression divergence recapitulates the developmental hourglass model	NATURE			English	Article							CONSERVED EMBRYONIC STAGE; PHYLOTYPIC STAGE; EVOLUTION; PATTERNS; VARIABILITY; SEQUENCE; LEVEL	The observation that animal morphology tends to be conserved during the embryonic phylotypic period (a period of maximal similarity between the species within each animal phylum) led to the proposition that embryogenesis diverges more extensively early and late than in the middle, known as the hourglass model(1,2). This pattern of conservation is thought to reflect a major constraint on the evolution of animal body plans(3). Despite a wealth of morphological data confirming that there is often remarkable divergence in the early and late embryos of species from the same phylum(4-7), it is not yet known to what extent gene expression evolution, which has a central role in the elaboration of different animal forms(8,9), underpins the morphological hourglass pattern. Here we address this question using species-specific microarrays designed from six sequenced Drosophila species separated by up to 40 million years. We quantify divergence at different times during embryogenesis, and show that expression is maximally conserved during the arthropod phylotypic period. By fitting different evolutionary models to each gene, we show that at each time point more than 80% of genes fit best to models incorporating stabilizing selection, and that for genes whose evolutionarily optimal expression level is the same across all species, selective constraint is maximized during the phylotypic period. The genes that conform most to the hourglass pattern are involved in key developmental processes. These results indicate that natural selection acts to conserve patterns of gene expression during mid-embryogenesis, and provide a genome-wide insight into the molecular basis of the hourglass pattern of developmental evolution.	[Kalinka, Alex T.; Varga, Karolina M.; Preibisch, Stephan; Jarrells, Julia; Tomancak, Pavel] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Gerrard, Dave T.; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Corcoran, David L.; Ohler, Uwe] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Max Planck Society; University of Manchester; Duke University	Tomancak, P (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	tomancak@mpi-cbg.de	Gerrard, Dave/C-6366-2008; Bergman, Casey/F-7854-2010; Tomancak, Pavel/C-2109-2009	Bergman, Casey/0000-0002-5462-9854; Tomancak, Pavel/0000-0002-2222-9370; Gerrard, Dave/0000-0001-6890-7213; Corcoran, David/0000-0001-7460-9247; Preibisch, Stephan/0000-0002-0276-494X	Human Frontier Science Program (HFSP) [RGY0084]	Human Frontier Science Program (HFSP)(Human Frontier Science Program)	We thank A. Alexa for providing modified code for his topGO R package, A. Larracuente and T. Sackton for sharing data with us, M. Weber for generating the embryo images for Fig. 2, and Carl Zeiss MicroImaging for providing the SPIM microscope. We also thank N. Barton, T. Bedford, D. Hartl, J. Howard, A. Oates and D. Robertson for providing useful comments and discussion on the manuscript. This work was funded by The Human Frontier Science Program (HFSP) Young Investigator's Grant RGY0084.	Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Artieri CG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-26; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; Bininda-Emonds ORP, 2003, P ROY SOC B-BIOL SCI, V270, P341, DOI 10.1098/rspb.2002.2242; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cruickshank T, 2008, EVOL DEV, V10, P583, DOI 10.1111/j.1525-142X.2008.00273.x; Darwin C., 1959, ORIGIN SPECIES; Davis JC, 2005, J MOL EVOL, V60, P774, DOI 10.1007/s00239-004-0241-2; DUBOULE D, 1994, DEVELOPMENT, P135; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Galis F, 2001, J EXP ZOOL, V291, P195, DOI 10.1002/jez.1069; Garstang W., 1922, Journal of the Linnean Society Zoology, V35, P81; Ge Y, 2003, RESAMPLING BASED MUL; Goldstein B, 1998, CURR BIOL, V8, P157, DOI 10.1016/S0960-9822(98)70062-4; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hall BK, 1997, TRENDS ECOL EVOL, V12, P461, DOI 10.1016/S0169-5347(97)01222-6; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Hazkani-Covo E, 2005, J EXP ZOOL PART B, V304B, P150, DOI 10.1002/jez.b.21033; Heger A, 2007, GENOME RES, V17, P1837, DOI 10.1101/gr.6249707; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jonnalagadda S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-267; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Lemos B, 2005, EVOLUTION, V59, P126; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Nelson CE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r25; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poe S, 2004, AM NAT, V164, P415, DOI 10.1086/422658; Raff R.A., 1996, SHAPE LIFE GENES DEV; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Sander K., 1976, Advances in insect physiology. Volume 12., P125, DOI 10.1016/S0065-2806(08)60255-6; Sander K., 1983, DEV EVOLUTION, P137; Schmidt K, 2004, J EXP ZOOL PART B, V302B, P446, DOI 10.1002/jez.b.21010; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; VONBAER KE, 1928, ENTWICKELUNGSGESCHIC; WRAY GA, 1991, EVOLUTION, V45, P1741, DOI 10.1111/j.1558-5646.1991.tb02684.x; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323	50	264	268	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					811	U102		10.1038/nature09634	http://dx.doi.org/10.1038/nature09634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21150996				2022-12-01	WOS:000285093700043
J	Weerapana, E; Wang, C; Simon, GM; Richter, F; Khare, S; Dillon, MBD; Bachovchin, DA; Mowen, K; Baker, D; Cravatt, BF				Weerapana, Eranthie; Wang, Chu; Simon, Gabriel M.; Richter, Florian; Khare, Sagar; Dillon, Myles B. D.; Bachovchin, Daniel A.; Mowen, Kerri; Baker, David; Cravatt, Benjamin F.			Quantitative reactivity profiling predicts functional cysteines in proteomes	NATURE			English	Article							COMPLEX PROTEIN MIXTURES; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; IDENTIFICATION; THIOL; ELECTROPHILES; PEPTIDES; RESIDUES	Cysteine is the most intrinsically nucleophilic amino acid in proteins, where its reactivity is tuned to perform diverse biochemical functions. The absence of a consensus sequence that defines functional cysteines in proteins has hindered their discovery and characterization. Here we describe a proteomics method to profile quantitatively the intrinsic reactivity of cysteine residues en masse directly in native biological systems. Hyper-reactivity was a rare feature among cysteines and it was found to specify a wide range of activities, including nucleophilic and reductive catalysis and sites of oxidative modification. Hyper-reactive cysteines were identified in several proteins of uncharacterized function, including a residue conserved across eukaryotic phylogeny that we show is required for yeast viability and is involved in iron-sulphur protein biogenesis. We also demonstrate that quantitative reactivity profiling can form the basis for screening and functional assignment of cysteines in computationally designed proteins, where it discriminated catalytically active from inactive cysteine hydrolase designs.	[Weerapana, Eranthie; Wang, Chu; Simon, Gabriel M.; Bachovchin, Daniel A.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Weerapana, Eranthie; Wang, Chu; Simon, Gabriel M.; Dillon, Myles B. D.; Bachovchin, Daniel A.; Mowen, Kerri; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Richter, Florian; Khare, Sagar; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Richter, Florian; Baker, David] Univ Washington, Interdisciplinary Program Biomol Struct & Design, Seattle, WA 98195 USA; [Khare, Sagar; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Scripps Research Institute; Scripps Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	wang, chu/GYJ-2191-2022; Wang, Chu/C-4442-2015; Wang, Chu/AAE-8759-2021; Baker, David/K-8941-2012	Wang, Chu/0000-0002-6925-1268; Wang, Chu/0000-0002-6925-1268; Baker, David/0000-0001-7896-6217	National Institutes of Health [CA087660, MH084512]; Pfizer; Koshland Graduate Fellowship; National Science Foundation; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R37CA087660, R01CA087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085117, R01GM090294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Koshland Graduate Fellowship; National Science Foundation(National Science Foundation (NSF)); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank T. Bartfai, I. Wilson and members of the B.F.C. laboratory for comments and critical reading of the manuscript, T. Ji for experimental assistance and J. Gallaher for expression of designed proteins. This work was supported by the National Institutes of Health (CA087660, MH084512), a Pfizer Postdoctoral Fellowship (E.W.), a Koshland Graduate Fellowship in Enzyme Biochemistry (G.M.S.), a National Science Foundation predoctoral fellowship (D.A.B.) and the Skaggs Institute for Chemical Biology.	Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Chen G, 2003, J AM CHEM SOC, V125, P8130, DOI 10.1021/ja034287m; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dennehy MK, 2006, CHEM RES TOXICOL, V19, P20, DOI 10.1021/tx050312l; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giles NM, 2003, BIOCHEM BIOPH RES CO, V300, P1, DOI 10.1016/S0006-291X(02)02770-5; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Isom DG, 2010, P NATL ACAD SCI USA, V107, P4908, DOI 10.1073/pnas.0910421107; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KNOWLES JR, 1976, CRC CR REV BIOCH MOL, V4, P165, DOI 10.3109/10409237609105457; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; LEWIS CT, 1989, J BIOL CHEM, V264, P27; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Ma S, 2007, J AM CHEM SOC, V129, P13633, DOI 10.1021/ja074222+; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Nazif T, 2001, P NATL ACAD SCI USA, V98, P2967, DOI 10.1073/pnas.061028898; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Okerberg ES, 2005, P NATL ACAD SCI USA, V102, P4996, DOI 10.1073/pnas.0501205102; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Shiio Y, 2006, NAT PROTOC, V1, P139, DOI 10.1038/nprot.2006.22; Shin NY, 2007, CHEM RES TOXICOL, V20, P859, DOI 10.1021/tx700031r; Silverman JA, 2002, J BIOL CHEM, V277, P30968, DOI 10.1074/jbc.M203172200; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; THOMPSON S, 1989, BIOCHEMISTRY-US, V28, P5735, DOI 10.1021/bi00440a006; VALLEE BL, 1955, P NATL ACAD SCI USA, V41, P327, DOI 10.1073/pnas.41.6.327; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; Weerapana E, 2008, NAT CHEM BIOL, V4, P405, DOI 10.1038/nchembio.91; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhao YM, 2009, PROTEOMICS, V9, P4632, DOI 10.1002/pmic.200900398	50	1027	1053	17	393	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 9	2010	468	7325					790	U79		10.1038/nature09472	http://dx.doi.org/10.1038/nature09472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691PQ	21085121	Green Accepted			2022-12-01	WOS:000285093700038
J	Szabo, E; Rampalli, S; Risueno, RM; Schnerch, A; Mitchell, R; Fiebig-Comyn, A; Levadoux-Martin, M; Bhatia, M				Szabo, Eva; Rampalli, Shravanti; Risueno, Ruth M.; Schnerch, Angelique; Mitchell, Ryan; Fiebig-Comyn, Aline; Levadoux-Martin, Marilyne; Bhatia, Mickie			Direct conversion of human fibroblasts to multilineage blood progenitors	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; MICE LACKING; IPS CELLS; EXPRESSION; TRANSCRIPTION; HEMATOPOIESIS; INDUCTION; TRANSPLANTATION; CIRCUITRY	As is the case for embryo-derived stem cells, application of reprogrammed human induced pluripotent stem cells is limited by our understanding of lineage specification. Here we demonstrate the ability to generate progenitors and mature cells of the haematopoietic fate directly from human dermal fibroblasts without establishing pluripotency. Ectopic expression of OCT4 (also called POU5F1)-activated haematopoietic transcription factors, together with specific cytokine treatment, allowed generation of cells expressing the pan-leukocyte marker CD45. These unique fibroblast-derived cells gave rise to granulocytic, monocytic, megakaryocytic and erythroid lineages, and demonstrated in vivo engraftment capacity. We note that adult haematopoietic programs are activated, consistent with bypassing the pluripotent state to generate blood fate: this is distinct from haematopoiesis involving pluripotent stem cells, where embryonic programs are activated. These findings demonstrate restoration of multipotency from human fibroblasts, and suggest an alternative approach to cellular reprogramming for autologous cell-replacement therapies that avoids complications associated with the use of human pluripotent stem cells.	[Szabo, Eva; Rampalli, Shravanti; Risueno, Ruth M.; Schnerch, Angelique; Mitchell, Ryan; Fiebig-Comyn, Aline; Levadoux-Martin, Marilyne; Bhatia, Mickie] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Schnerch, Angelique; Mitchell, Ryan; Bhatia, Mickie] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Bhatia, M (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca	Risueño, Ruth Muñoz/G-9969-2015	Risueño, Ruth Muñoz/0000-0003-4048-9536; Rampalli, Shravanti/0000-0002-6391-6409	Canadian Institute of Health Research (CIHR); Canadian Cancer Society Research Institute (CCS-RI); StemCell Network; Ontario Ministry of Research Innovation (MRI); Canadian Chair; Ministry of Research and Innovation (MRI); MITACS; Ontario Graduate Scholarship (OGS)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCS-RI); StemCell Network; Ontario Ministry of Research Innovation (MRI)(Ministry of Research and Innovation, Ontario); Canadian Chair; Ministry of Research and Innovation (MRI)(Ministry of Research and Innovation, Ontario); MITACS; Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship)	This work was supported by grants to M.B. from the Canadian Institute of Health Research (CIHR), the Canadian Cancer Society Research Institute (CCS-RI), the StemCell Network and the Ontario Ministry of Research Innovation (MRI). M.B. is supported by the Canadian Chair Program and holds the Canada Research Chair in human stem cell biology. E.S. is supported by Ministry of Research and Innovation (MRI) and MITACS fellowships, R.M.R is supported by a CCS-RI fellowship and R.M. is supported by an Ontario Graduate Scholarship (OGS). We thank T. Werbowetski-Ogilvie for her help.	Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brunner C, 2003, J EXP MED, V197, P1205, DOI 10.1084/jem.20022014; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Emslie D, 2008, J EXP MED, V205, P409, DOI 10.1084/jem.20072049; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Feugier P, 2003, TRANSFUSION, V43, P878, DOI 10.1046/j.1537-2995.2003.00446.x; Fried W, 2009, EXP HEMATOL, V37, P1007, DOI 10.1016/j.exphem.2009.05.010; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Ghozi MC, 1996, P NATL ACAD SCI USA, V93, P1935, DOI 10.1073/pnas.93.5.1935; Hassan HT, 1996, ACTA HAEMATOL-BASEL, V95, P257; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ichikawa M, 2004, CELL CYCLE, V3, P722; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanawaty A, 2009, BIOESSAYS, V31, P134, DOI 10.1002/bies.200800204; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; KISTLER B, 1995, ONCOGENE, V11, P1095; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; Kwon UK, 2006, BIOCHEM BIOPH RES CO, V344, P146, DOI 10.1016/j.bbrc.2006.03.119; Lebofsky R, 2007, CANCER CELL, V12, P102, DOI 10.1016/j.ccr.2007.07.013; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; Perlingeiro RCR, 2001, DEVELOPMENT, V128, P4597; Pfisterer P, 1996, MOL CELL BIOL, V16, P6160; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Strodtbeck D, 2005, BONE MARROW TRANSPL, V36, P1083, DOI 10.1038/sj.bmt.1705176; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vijayaragavan K, 2009, CELL STEM CELL, V4, P248, DOI 10.1016/j.stem.2008.12.011; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	47	529	614	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					521	U191		10.1038/nature09591	http://dx.doi.org/10.1038/nature09591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21057492				2022-12-01	WOS:000284584200033
J	Ali, S				Ali, Sabreen			Fast food feud at Golden Gate	LANCET			English	Editorial Material									Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Ali, S (corresponding author), Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England.	sabreenmaryam@gmail.com						[Anonymous], 2010, BBC NEWS        1110; NEWSOM G, 2010, SAN FRANCISCO C 1113; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; *RUDD FOOD CTR FOO, 2010, FAST FOOD FACTS EV F	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1723	1723		10.1016/S0140-6736(10)62114-9	http://dx.doi.org/10.1016/S0140-6736(10)62114-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690EI	21093638				2022-12-01	WOS:000284984900011
J	Nicholl, DJ; Hilton-Jones, D; Palace, J; Richmond, S; Finlayson, S; Winer, J; Weir, A; Maddison, P; Fletcher, N; Sussman, J; Silver, N; Nixon, J; Kullmann, D; Embleton, N; Beeson, D; Farrugia, ME; Hill, M; McDermott, C; Llewelyn, G; Leonard, J; Morris, M				Nicholl, David J.; Hilton-Jones, David; Palace, Jacqueline; Richmond, Sam; Finlayson, Sarah; Winer, John; Weir, Andrew; Maddison, Paul; Fletcher, Nick; Sussman, Jon; Silver, Nick; Nixon, John; Kullmann, Dimitri; Embleton, Nick; Beeson, David; Farrugia, Maria Elena; Hill, Marguerite; McDermott, Chris; Llewelyn, Gareth; Leonard, James; Morris, Michael			Orphan Drugs Open letter to prime minister David Cameron and health secretary Andrew Lansley	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nicholl, David J.] City Hosp, Birmingham, W Midlands, England; [Hilton-Jones, David; Palace, Jacqueline; Finlayson, Sarah] John Radcliffe Infirm, Oxford, England; [Richmond, Sam] Sunderland Royal Hosp, Sunderland, England; [Winer, John] Univ Hosp Birmingham, Birmingham, W Midlands, England; [Weir, Andrew] Royal Berkshire NHS Trust, Reading, Berks, England; [Maddison, Paul] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Fletcher, Nick; Silver, Nick] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England; [Sussman, Jon] Hope Hosp, Greater Manchester Neurosci Ctr, Salford M6 8HD, Lancs, England; [Nixon, John] Royal Preston Hosp, Preston, Lancs, England; [Kullmann, Dimitri] Inst Neurol, London, England; [Embleton, Nick] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Beeson, David] Weatherall Inst Mol Med, Oxford, England; [Farrugia, Maria Elena] So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland; [Hill, Marguerite] Abertawe Bro Morgannwg Univ, Local Hlth Board, Swansea, W Glam, Wales; [McDermott, Chris] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Llewelyn, Gareth] Royal Gwent Hosp, Newport, Gwent, Wales; [Leonard, James] UCL, Inst Child Hlth, London WC1E 6BT, England; [Morris, Michael] Myasthenia Gravis Assoc, Derby, England	University of Birmingham; Sunderland Royal Hospital; University of Birmingham; Royal Berkshire Hospital; Nottingham University Hospital NHS Trust; Walton Centre; Royal Preston Hospital; University of London; University College London; Newcastle University - UK; University of Oxford; University of Glasgow; University of Sheffield; Royal Gwent Hospital; University of London; University College London	Nicholl, DJ (corresponding author), City Hosp, Birmingham, W Midlands, England.	david.nicholl@nhs.net	Kullmann, Dimitri M/A-3162-2009; McDermott, Chris/GQZ-3919-2022; Embleton, Nicholas/D-4905-2011; McDermott, Christopher/AAU-4988-2020	Kullmann, Dimitri M/0000-0001-6696-3545; Embleton, Nicholas/0000-0003-3750-5566; McDermott, Christopher/0000-0002-1269-9053; Shaw, Pamela/0000-0002-8925-2567	MRC [G0701521] Funding Source: UKRI; Medical Research Council [G0701521] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BOSELEY S, 2002, GUARDIAN        0624; Leonard JV, 2009, LANCET, V373, P462, DOI 10.1016/S0140-6736(09)60169-0; MARTIN D, 2010, DAILY MAIL      0927	3	13	13	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 16	2010	341								c6466	10.1136/bmj.c6466	http://dx.doi.org/10.1136/bmj.c6466			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684WJ	21081599				2022-12-01	WOS:000284585600025
J	Rohani, P; Zhong, X; King, AA				Rohani, Pejman; Zhong, Xue; King, Aaron A.			Contact Network Structure Explains the Changing Epidemiology of Pertussis	SCIENCE			English	Article							BORDETELLA-PERTUSSIS; VACCINATION; ADULTS; IMMUNIZATION; RESURGENCE; ADOLESCENTS; INFANTS; MEASLES; SWEDEN; IMPACT	The epidemiology of whooping cough (pertussis) remains enigmatic. A leading cause of infant mortality globally, its resurgence in several developed nations-despite the availability and use of vaccines for many decades-has caused alarm. We combined data from a singular natural experiment and a detailed contact network study to show that age-specific contact patterns alone can explain shifts in prevalence and age-stratified incidence in the vaccine era. The practical implications of our results are notable: Ignoring age-structured contacts is likely to result in misinterpretation of epidemiological data and potentially costly policy missteps.	[Rohani, Pejman; Zhong, Xue; King, Aaron A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Rohani, Pejman; Zhong, Xue] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; [King, Aaron A.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Rohani, Pejman; King, Aaron A.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Rohani, P (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	rohani@umich.edu	King, Aaron A/B-8092-2012	King, Aaron A/0000-0001-6159-3207; rohani, pejman/0000-0002-7221-3801	Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Vaccine Modeling Initiative of the Bill & Melinda Gates Foundation	Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Vaccine Modeling Initiative of the Bill & Melinda Gates Foundation	We thank three anonymous reviewers for comments. P.R. and A.A.K. are supported by the Research and Policy in Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. P.R. was also supported by the Vaccine Modeling Initiative of the Bill & Melinda Gates Foundation.	ANDERSON R M, 1991; ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X; Broutin H, 2004, VACCINE, V22, P594, DOI 10.1016/j.vaccine.2003.07.018; Broutin H, 2010, P ROY SOC B-BIOL SCI, V277, P3239, DOI 10.1098/rspb.2010.0994; Carlsson Rose-Marie, 2009, Vaccine, V27, P5709, DOI 10.1016/j.vaccine.2009.07.092; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry JD, 2003, PEDIATRICS, V112, P405, DOI 10.1542/peds.112.2.405; CHERRY JD, 1989, WESTERN J MED, V150, P319; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; DEVILLE JG, 1995, CLIN INFECT DIS, V21, P639, DOI 10.1093/clinids/21.3.639; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Eidlitz-Markus T, 2007, CLIN PEDIATR, V46, P718, DOI 10.1177/0009922807302093; FINE PEM, 1982, LANCET, V1, P666; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Hallander HO, 2005, J CLIN MICROBIOL, V43, P2856, DOI 10.1128/JCM.43.6.2856-2865.2005; Keeling M. J., 2008, MODELLING INFECT DIS; Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; Ntezayabo B, 2003, PEDIATR INFECT DIS J, V22, P22, DOI 10.1097/00006454-200301000-00009; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; ROMANUS V, 1987, PEDIATR INFECT DIS J, V6, P364, DOI 10.1097/00006454-198704000-00005; Schellekens Joop, 2005, Pediatr Infect Dis J, V24, pS19, DOI 10.1097/01.inf.0000160909.24879.e6; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS83, DOI 10.1097/01.inf.0000160919.94330.1a; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Walllinga J, 2005, PLOS MED, V2, P1152, DOI 10.1371/journal.pmed.0020316; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647	32	154	157	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					982	985		10.1126/science.1194134	http://dx.doi.org/10.1126/science.1194134			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071671				2022-12-01	WOS:000284118000048
J	Wolfe-Simon, F; Blum, JS; Kulp, TR; Gordon, GW; Hoeft, SE; Pett-Ridge, J; Stolz, JF; Webb, SM; Weber, PK; Davies, PCW; Anbar, AD; Oremland, RS				Wolfe-Simon, Felisa; Blum, Jodi Switzer; Kulp, Thomas R.; Gordon, Gwyneth W.; Hoeft, Shelley E.; Pett-Ridge, Jennifer; Stolz, John F.; Webb, Samuel M.; Weber, Peter K.; Davies, Paul C. W.; Anbar, Ariel D.; Oremland, Ronald S.			A Bacterium That Can Grow by Using Arsenic Instead of Phosphorus	SCIENCE			English	Article							MARINE	Life is mostly composed of the elements carbon, hydrogen, nitrogen, oxygen, sulfur, and phosphorus. Although these six elements make up nucleic acids, proteins, and lipids and thus the bulk of living matter, it is theoretically possible that some other elements in the periodic table could serve the same functions. Here, we describe a bacterium, strain GFAJ-1 of the Halomonadaceae, isolated from Mono Lake, California, that is able to substitute arsenic for phosphorus to sustain its growth. Our data show evidence for arsenate in macromolecules that normally contain phosphate, most notably nucleic acids and proteins. Exchange of one of the major bio-elements may have profound evolutionary and geochemical importance.	[Wolfe-Simon, Felisa; Davies, Paul C. W.; Anbar, Ariel D.] NASA, Astrobiol Inst, Washington, DC 20546 USA; [Wolfe-Simon, Felisa; Blum, Jodi Switzer; Kulp, Thomas R.; Hoeft, Shelley E.; Oremland, Ronald S.] US Geol Survey, Menlo Pk, CA 94025 USA; [Gordon, Gwyneth W.; Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Pett-Ridge, Jennifer; Weber, Peter K.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Stolz, John F.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Webb, Samuel M.] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Davies, Paul C. W.] Arizona State Univ, BEYOND Ctr Fundamental Concepts Sci, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	National Aeronautics & Space Administration (NASA); United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Duquesne University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wolfe-Simon, F (corresponding author), NASA, Astrobiol Inst, Washington, DC 20546 USA.	felisawolfesimon@gmail.com	Weber, Peter Kilian/AAP-9517-2020; , Jennifer Pett RIdge/AAE-9934-2022; Webb, Samuel M/D-4778-2009; , Jennifer Pett RIdge/AFF-7780-2022	Weber, Peter Kilian/0000-0001-6022-6050; Webb, Samuel M/0000-0003-1188-0464; Pett-Ridge, Jennifer/0000-0002-4439-2398; Webb, Eric/0000-0003-4085-7730	DOE Office of Basic Energy Sciences, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; DOE at Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; DOE OBER [SCW1039]; NASA Exobiology; NASA; NASA Astrobiology Institute at the U.S. Geological Survey, Menlo Park, CA	DOE Office of Basic Energy Sciences, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE at Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); DOE OBER(United States Department of Energy (DOE)); NASA Exobiology(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute at the U.S. Geological Survey, Menlo Park, CA	The authors thank S. Benner, W. Hastings, I. L. ten Kate, A. Pohorille, B. Rosen, D. Schulze-Makuch, and R. Shapiro for stimulating discussions. We thank G. King, A. Oren, and L. Young for constructive criticisms of earlier drafts of this manuscript and S. Baesman, M. Dudash, and L. Miller for technical assistance. Cultures of GFAJ-1 were submitted to the American Type Culture Collection and Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) culture collections on 21 March 2011 and will be available from these sources within several months. Until then, samples of GFAJ-1 are available to the community from the Oremland lab upon completion of a materials transfer agreement, which is required by the U.S. Geological Survey for the transfer of bacterial cultures. Sequence data are deposited with GenBank (accession HQ449183). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a division of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Basic Energy Sciences, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. NanoSIMS analyses were performed under the auspices of the DOE at Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. J.P.R. and P.K.W. were supported in part by the DOE OBER Genomic Sciences program SCW1039. R.S.O. and J.F.S. were supported by NASA Exobiology. F.W.S. acknowledges support from the NASA Postdoctoral Program, NASA Astrobiology/Exobiology, and the NASA Astrobiology Institute while in residence at the U.S. Geological Survey, Menlo Park, CA. The authors declare no conflicts of interest.	BAER CD, 1981, INORG CHEM, V20, P905, DOI 10.1021/ic50217a052; BERG JM, 2007, BIOCHEMISTRY; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HOLBROOK SR, 1985, ACTA CRYSTALLOGR B, V41, P255, DOI 10.1107/S0108768185002087; Jameson G. B., 2007, BIOL INORGANIC CHEM, P354; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Lide D.R., 2010, CRC HDB CHEM PHYS, DOI DOI 10.1021/acs.est.8b00586; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; MANDELSTAM J, 1960, BACTERIOL REV, V24, P289, DOI 10.1128/MMBR.24.3.289-308.1960; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Oremland RS, 2004, FEMS MICROBIOL ECOL, V48, P15, DOI 10.1016/j.femsec.2003.12.016; Pickering IJ, 2000, PLANT PHYSIOL, V122, P1171, DOI 10.1104/pp.122.4.1171; Quillaguaman J, 2006, ENZYME MICROB TECH, V38, P148, DOI 10.1016/j.enzmictec.2005.05.013; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Smith PG, 2005, ENVIRON SCI TECHNOL, V39, P248, DOI 10.1021/es049358b; Takeuchi M, 2007, J BIOTECHNOL, V127, P434, DOI 10.1016/j.jbiotec.2006.07.018; Wolfe-Simon F, 2009, INT J ASTROBIOL, V8, P69, DOI 10.1017/S1473550408004394	18	303	312	8	417	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1163	1166		10.1126/science.1197258	http://dx.doi.org/10.1126/science.1197258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21127214	Green Submitted			2022-12-01	WOS:000291205200038
J	Miyamichi, K; Amat, F; Moussavi, F; Wang, C; Wickersham, I; Wall, NR; Taniguchi, H; Tasic, B; Huang, ZJ; He, ZG; Callaway, EM; Horowitz, MA; Luo, LQ				Miyamichi, Kazunari; Amat, Fernando; Moussavi, Farshid; Wang, Chen; Wickersham, Ian; Wall, Nicholas R.; Taniguchi, Hiroki; Tasic, Bosiljka; Huang, Z. Josh; He, Zhigang; Callaway, Edward M.; Horowitz, Mark A.; Luo, Liqun			Cortical representations of olfactory input by trans-synaptic tracing	NATURE			English	Article							PIRIFORM CORTEX; RABIES VIRUS; TOPOGRAPHIC ORGANIZATION; GENE-EXPRESSION; MOSAIC ANALYSIS; BULB GLOMERULI; DOUBLE MARKERS; PARS EXTERNA; DROSOPHILA; NUCLEUS	In the mouse, each class of olfactory receptor neurons expressing a given odorant receptor has convergent axonal projections to two specific glomeruli in the olfactory bulb, thereby creating an odour map. However, it is unclear how this map is represented in the olfactory cortex. Here we combine rabies-virus-dependent retrograde mono-trans-synaptic labelling with genetics to control the location, number and type of 'starter' cortical neurons, from which we trace their presynaptic neurons. We find that individual cortical neurons receive input from multiple mitral cells representing broadly distributed glomeruli. Different cortical areas represent the olfactory bulb input differently. For example, the cortical amygdala preferentially receives dorsal olfactory bulb input, whereas the piriform cortex samples the whole olfactory bulb without obvious bias. These differences probably reflect different functions of these cortical areas in mediating innate odour preference or associative memory. The trans-synaptic labelling method described here should be widely applicable to mapping connections throughout the mouse nervous system.	[Miyamichi, Kazunari; Tasic, Bosiljka; Luo, Liqun] Stanford Univ, Dept Biol, HHMI, Stanford, CA 94305 USA; [Amat, Fernando; Moussavi, Farshid; Horowitz, Mark A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Wang, Chen; He, Zhigang] Childrens Hosp, Dept Neurosci, Boston, MA 02115 USA; [Wickersham, Ian; Wall, Nicholas R.; Callaway, Edward M.] Univ Calif San Diego, Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Wickersham, Ian; Wall, Nicholas R.; Callaway, Edward M.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92037 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, New York, NY 11724 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Harvard University; Boston Children's Hospital; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Luo, LQ (corresponding author), Stanford Univ, Dept Biol, HHMI, Stanford, CA 94305 USA.	lluo@stanford.edu	Callaway, Edward/D-4336-2011; Miyamichi, Kazunari/AAO-3705-2021	Callaway, Edward/0000-0002-6366-5267; Huang, Z. Josh/0000-0003-0592-028X; Wall, Nicholas/0000-0003-2039-8258; Luo, Liqun/0000-0001-5467-9264	JSPS; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Stanford Transgenic Facility for help in generating transgenic mice, F. Zhang and K. Deisseroth for teaching us stereotactic injection, Y. Yoshihara and H. Zeng for reagents, C. Manalac and M. Shu for technical assistance, R. Axel, L. Buck, and L. Stryer, R. Yuste and members of the L.L. laboratory for discussion and critical reading of the manuscript. K.M. was supported by the JSPS program for Research Abroad and Human Frontier Science Program. K.M. is currently a research associate and L.L. is an investigator of the Howard Hughes Medical Institute. This work was also supported by an NIH grant.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Brunjes PC, 2005, BRAIN RES REV, V50, P305, DOI 10.1016/j.brainresrev.2005.08.005; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CONG G, 1998, P 4 IEEE WORKSH APPL, V140; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; LUSKIN MB, 1982, J COMP NEUROL, V209, P249, DOI 10.1002/cne.902090304; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; NEVELLE KR, 2004, SYNAPTIC ORG BRAIN; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SCHOENFELD TA, 1984, J COMP NEUROL, V227, P121, DOI 10.1002/cne.902270113; Schroeder W., 2010, VISUALIZATION TOOLKI, V4th ed.; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1985, J COMP NEUROL, V242, P415, DOI 10.1002/cne.902420309; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	58	343	349	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					191	196		10.1038/nature09714	http://dx.doi.org/10.1038/nature09714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21179085	Green Accepted			2022-12-01	WOS:000289469100036
J	Letessier, A; Millot, GA; Koundrioukoff, S; Lachages, AM; Vogt, N; Hansen, RS; Malfoy, B; Brison, O; Debatisse, M				Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Hansen, R. Scott; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle			Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site	NATURE			English	Article							DNA-REPLICATION; MOLECULAR-BASIS; ORIGIN CHOICE; COMMON; GENOME; FORK; CANCER; CHROMOSOMES; INSTABILITY; INDUCTION	Common fragile sites have long been identified by cytogeneticists as chromosomal regions prone to breakage upon replication stress(1). They are increasingly recognized to be preferential targets for oncogene-induced DNA damage in pre-neoplastic lesions(2) and hotspots for chromosomal rearrangements in various cancers(3). Common fragile site instability was attributed to the fact that they contain sequences prone to form secondary structures that may impair replication fork movement, possibly leading to fork collapse resulting in DNA breaks(4). Here we show, in contrast to this view, that the fragility of FRA3B-the most active common fragile site in human lymphocytes-does not rely on fork slowing or stalling but on a paucity of initiation events. Indeed, in lymphoblastoid cells, but not in fibroblasts, initiation events are excluded from a FRA3B core extending approximately 700 kilobases, which forces forks coming from flanking regions to cover long distances in order to complete replication. We also show that origins of the flanking regions fire in mid-S phase, leaving the site incompletely replicated upon fork slowing. Notably, FRA3B instability is specific to cells showing this particular initiation pattern. The fact that both origin setting(5,6) and replication timing are highly plastic(7,8) in mammalian cells explains the tissue specificity of common fragile site instability we observed. Thus, we propose that common fragile sites correspond to the latest initiation-poor regions to complete replication in a given cell type. For historical reasons, common fragile sites have been essentially mapped in lymphocytes(1). Therefore, common fragile site contribution to chromosomal rearrangements in tumours should be reassessed after mapping fragile sites in the cell type from which each tumour originates.	[Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle] Inst Curie, Ctr Rech, F-75248 Paris, France; [Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle] Univ Paris 06, F-75005 Paris, France; [Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle] CNRS, UMR 3244, F-75248 Paris, France; [Hansen, R. Scott] Univ Washington, Div Med Genet, Dept Med, Sch Med, Seattle, WA 98195 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; University of Washington; University of Washington Seattle	Debatisse, M (corresponding author), Inst Curie, Ctr Rech, 26 Rue Ulm, F-75248 Paris, France.	michelle.debatisse@curie.fr	Millot, Gael/AAO-7115-2020; Letessier, Anne/M-3431-2017	Letessier, Anne/0000-0002-1894-4072; Lachages, Anne-Marie/0000-0003-1771-1880	ARC(Association pour la recherche sur le cancer); La Ligue Nationale contre le Cancer (LNCC); INCa (Institut National du Cancer) [2009-1-PLBIO-10-IC-1]; PIC Replication, Instabilite Chromosomique et Cancer (Institut Curie)	ARC(Association pour la recherche sur le cancer)(Fondation ARC pour la Recherche sur le Cancer); La Ligue Nationale contre le Cancer (LNCC); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); PIC Replication, Instabilite Chromosomique et Cancer (Institut Curie)	We thank E. Blackburn for critical reading of the manuscript. We thank Genomic Vision for making the DNA combing technology available to us. We acknowledge the Nikon Imaging Centre at Institut Curie-CNRS. We thank C. Rouzaud for help in combing experiments. A.L. is supported by a grant from the ARC(Association pour la recherche sur le cancer). The M.D. team is supported by La Ligue Nationale contre le Cancer (LNCC) (Equipe Labellisee EL2008. LNCC/MD), INCa (Institut National du Cancer) (2009-1-PLBIO-10-IC-1) and the PIC Replication, Instabilite Chromosomique et Cancer (Institut Curie).	Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bielinsky AK, 2003, CELL CYCLE, V2, P307, DOI 10.4161/cc.2.4.435; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Dazy S, 2006, EMBO REP, V7, P806, DOI 10.1038/sj.embor.7400736; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Gregoire D, 2006, EMBO REP, V7, P812, DOI 10.1038/sj.embor.7400758; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huebner K, 2003, BRIT J CANCER, V88, P1501, DOI 10.1038/sj.bjc.6600937; Labit H, 2008, BIOTECHNIQUES, V45, P649, DOI 10.2144/000113002; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Keefe LV, 2006, CANCER LETT, V232, P37, DOI 10.1016/j.canlet.2005.07.041; Palumbo E., 2010, CHROMOSOMA; Pichiorri F, 2008, J CELL BIOCHEM, V104, P1525, DOI 10.1002/jcb.21560; R_Development_Core_Team, 2006, R LANG ENV STAT COMP; Rothstein R, 2000, GENE DEV, V14, P1; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Tsantoulis PK, 2008, ONCOGENE, V27, P3256, DOI 10.1038/sj.onc.1210989	32	303	304	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					120	U138		10.1038/nature09745	http://dx.doi.org/10.1038/nature09745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21258320				2022-12-01	WOS:000286886400046
J	Bantignies, F; Roure, V; Comet, I; Leblanc, B; Schuettengruber, B; Bonnet, J; Tixier, V; Mas, A; Cavalli, G				Bantignies, Frederic; Roure, Virginie; Comet, Itys; Leblanc, Benjamin; Schuettengruber, Bernd; Bonnet, Jerome; Tixier, Vanessa; Mas, Andre; Cavalli, Giacomo			Polycomb-Dependent Regulatory Contacts between Distant Hox Loci in Drosophila	CELL			English	Article							BITHORAX COMPLEX; NUCLEAR-ORGANIZATION; RESPONSE ELEMENTS; HOMEOTIC MUTATION; MCP ELEMENT; GENE; DOMAIN; EXPRESSION; EVOLUTION; LADYBIRD	In Drosophila melanogaster, Hox genes are organized in an anterior and a posterior cluster, called Antennapedia complex and bithorax complex, located on the same chromosome arm and separated by 10 Mb of DNA. Both clusters are repressed by Polycomb group (PcG) proteins. Here, we show that genes of the two Hox complexes can interact within nuclear PcG bodies in tissues where they are corepressed. This colocalization increases during development and depends on PcG proteins. Hox gene contacts are conserved in the distantly related Drosophila virilis species and they are part of a large gene interaction network that includes other PcG target genes. Importantly, mutations on one of the loci weaken silencing of genes in the other locus, resulting in the exacerbation of homeotic phenotypes in sensitized genetic backgrounds. Thus, the three-dimensional organization of Polycomb target genes in the cell nucleus stabilizes the maintenance of epigenetic gene silencing.	[Bantignies, Frederic; Roure, Virginie; Comet, Itys; Leblanc, Benjamin; Schuettengruber, Bernd; Bonnet, Jerome; Tixier, Vanessa; Cavalli, Giacomo] CNRS, Inst Genet Humaine, UPR 1142, F-34396 Montpellier 5, France; [Mas, Andre] Univ Montpellier 2, Inst Modelisat Math Montpellier, CNRS, UMR 5149, F-34095 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Montpellier	Bantignies, F (corresponding author), CNRS, Inst Genet Humaine, UPR 1142, 141 Rue Cardonille, F-34396 Montpellier 5, France.	frederic.bantignies@igh.cnrs.fr; giacomo.cavalli@igh.cnrs.fr	Bonnet, Jerome/AAT-5600-2020; cavalli, giacomo/Z-2754-2019; Bonnet, Jerome/D-3041-2014; Cavalli, Giacomo/A-7958-2008	Bonnet, Jerome/0000-0002-8420-9359; cavalli, giacomo/0000-0003-3709-3469; Bonnet, Jerome/0000-0002-8420-9359; Cavalli, Giacomo/0000-0003-3709-3469; Leblanc, Benjamin/0000-0002-8657-2821; Comet, Itys/0000-0001-7265-2284; Schuettengruber, Bernd/0000-0001-7338-4648	CNRS; Ministere de l'Enseignement Superieur; Association pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Fondation de la Recherche Medicale; Human Frontier Science Program Organization; European Union; European Research Council [ERC-2008-AdG No 232947]; Indo-French Centre for Promotion of Advanced Research; Ministere de l'Enseignement Superieur, ACI BCMS	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Human Frontier Science Program Organization(Human Frontier Science Program); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Indo-French Centre for Promotion of Advanced Research(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur, ACI BCMS	We would like to thank W. Gehring, F. Karch, H. Gyurkovics, J.M. Dura, and Alain Pelisson for fly lines and plasmids. We also thank T. Sexton and D. Cribbs for stimulating discussions; B. Pfeiffer and S. Celniker for sharing the D. virilis BX-C sequence before publication; Chantal Cazevieille for electron microscopy at the Centre de Ressources en Imagerie Cellulaire of Montpellier. F.B. is supported by the CNRS; V.R. and I.C. were supported by the Ministere de l'Enseignement Superieur, the Association pour la Recherche sur le Cancer, and the Agence Nationale de la Recherche. B.L. was supported by the Ministere de l'Enseignement Superieur. B.S. was supported by the Fondation de la Recherche Medicale. G.C. was supported by grants of the CNRS, the Human Frontier Science Program Organization, the European Union FP6 (Network of Excellence, The Epigenome, and STREP 3D Genome), the European Research Council (ERC-2008-AdG No 232947), by the Indo-French Centre for Promotion of Advanced Research, by the Agence Nationale de la Recherche, and by the Ministere de l'Enseignement Superieur, ACI BCMS.	Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Castelli-Gair J, 1998, INT J DEV BIOL, V42, P437; Cavalli G, 2007, CURR OPIN GENET DEV, V17, P443, DOI 10.1016/j.gde.2007.08.013; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.genet.21.1.285; Fedorova E, 2008, CHROMOSOME RES, V16, P649, DOI 10.1007/s10577-008-1218-6; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; GALLONI M, 1993, EMBO J, V12, P1087, DOI 10.1002/j.1460-2075.1993.tb05750.x; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; GYURKOVICS H, 1990, EMBO J, V9, P2579, DOI 10.1002/j.1460-2075.1990.tb07439.x; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Jagla K, 1997, DEVELOPMENT, V124, P3471; Jagla K, 1997, DEVELOPMENT, V124, P91; Jagla T, 1998, DEVELOPMENT, V125, P3699; KARCH F, 1994, NUCLEIC ACIDS RES, V22, P3138, DOI 10.1093/nar/22.15.3138; Kaufman T C, 1990, Adv Genet, V27, P309; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; KUZIORA MA, 1993, MECH DEVELOP, V42, P125, DOI 10.1016/0925-4773(93)90002-F; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lewis EB, 2003, CURR BIOL, V13, pR587, DOI 10.1016/S0960-9822(03)00520-7; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Merdes G, 2009, DEV CELL, V17, P440, DOI 10.1016/j.devcel.2009.10.001; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Miele Adriana, 2008, V464, P105; Mihaly J, 1997, DEVELOPMENT, V124, P1809; MORATA P, 1994, CANCER LETT, V81, P209, DOI 10.1016/0304-3835(94)90204-6; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Muller M, 1999, GENETICS, V153, P1333; Negre B, 2003, MOL BIOL EVOL, V20, P2042, DOI 10.1093/molbev/msg238; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; PATTATUCCI AM, 1991, GENETICS, V129, P423; PIRROTTA V, 1995, GENETICS, V141, P1439; Ranz JM, 1997, GENETICS, V145, P281; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Sexton T, 2007, SEMIN CELL DEV BIOL, V18, P691, DOI 10.1016/j.semcdb.2007.08.008; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Southworth JW, 2002, GENETICS, V161, P733; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; TALBERT PB, 1994, GENETICS, V138, P709; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049; Vazquez M, 1999, DEVELOPMENT, V126, P733; VonAllmen G, 1996, NATURE, V380, P116, DOI 10.1038/380116a0; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007	56	298	308	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					214	226		10.1016/j.cell.2010.12.026	http://dx.doi.org/10.1016/j.cell.2010.12.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241892	Bronze			2022-12-01	WOS:000286459900007
J	Kessler, JD; Valentine, DL; Redmond, MC; Du, MR; Chan, EW; Mendes, SD; Quiroz, EW; Villanueva, CJ; Shusta, SS; Werra, LM; Yvon-Lewis, SA; Weber, TC				Kessler, John D.; Valentine, David L.; Redmond, Molly C.; Du, Mengran; Chan, Eric W.; Mendes, Stephanie D.; Quiroz, Erik W.; Villanueva, Christie J.; Shusta, Stephani S.; Werra, Lindsay M.; Yvon-Lewis, Shari A.; Weber, Thomas C.			A Persistent Oxygen Anomaly Reveals the Fate of Spilled Methane in the Deep Gulf of Mexico	SCIENCE			English	Article							OXIDATION; HYDRATE; CARBON; DISSOCIATION; INPUT	Methane was the most abundant hydrocarbon released during the 2010 Deepwater Horizon oil spill in the Gulf of Mexico. Beyond relevancy to this anthropogenic event, this methane release simulates a rapid and relatively short-term natural release from hydrates into deep water. Based on methane and oxygen distributions measured at 207 stations throughout the affected region, we find that within similar to 120 days from the onset of release similar to 3.0 x 10(10) to 3.9 x 10(10) moles of oxygen were respired, primarily by methanotrophs, and left behind a residual microbial community containing methanotrophic bacteria. We suggest that a vigorous deepwater bacterial bloom respired nearly all the released methane within this time, and that by analogy, large-scale releases of methane from hydrate in the deep ocean are likely to be met by a similarly rapid methanotrophic response.	[Kessler, John D.; Du, Mengran; Chan, Eric W.; Yvon-Lewis, Shari A.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Villanueva, Christie J.; Shusta, Stephani S.; Werra, Lindsay M.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Villanueva, Christie J.; Shusta, Stephani S.; Werra, Lindsay M.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Quiroz, Erik W.] Texas A&M Univ, Geochem & Environm Res Grp, College Stn, TX 77843 USA; [Weber, Thomas C.] Univ New Hampshire, Ctr Coastal & Ocean Mapping, Durham, NH 03824 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Texas A&M University System; Texas A&M University College Station; University System Of New Hampshire; University of New Hampshire	Kessler, JD (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	jkessler@ocean.tamu.edu; valentine@geol.ucsb.edu	du, mengran/AAO-7295-2021; Kessler, John/U-6398-2017; Weber, Thomas C/H-2428-2012; Valentine, David/E-5594-2012; Yvon-Lewis, Shari/E-4108-2012	Kessler, John/0000-0003-1097-6800; Weber, Thomas C/0000-0001-8320-361X; Yvon-Lewis, Shari/0000-0003-1378-8434; du, meng ran/0000-0001-8862-5256; Redmond, Molly/0000-0003-4227-394X; Valentine, David/0000-0001-5914-9107	NSF [OCE 1042650, OCE 0849246, OCE 1042097, OCE 0961725]; U.S. Department of Energy [DE-NT0005667]; NOAA; Consolidated Safety Services, Incorporated; Direct For Education and Human Resources [0806926] Funding Source: National Science Foundation; Division Of Human Resource Development [0929836] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Consolidated Safety Services, Incorporated; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Division Of Human Resource Development(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	J.D.K. and D.L.V. contributed equally to this work. This research was supported by the NSF through grants OCE 1042650 and OCE 0849246 to J.D.K. and OCE 1042097 and OCE 0961725 to D.L.V. and by the U.S. Department of Energy (DE-NT0005667) to D.L.V. The August, September, and October expeditions were funded by NOAA through a contract with Consolidated Safety Services, Incorporated. We thank the officers and crew of the NOAA ship Pisces, as well as S. Joye, M. Heintz, C. Farwell, F. Kinnaman, K. Mouyard, T. Bryant, B. Pierce, A. Lee, R. Hansman, S. Socolofsky, L. Hu, F. Garcia Tigreros, T. Bianchi, X. Li, S. DiMarco, S. Bagby, G. Paradis, and the staff at Picarro Incorporated and Los Gatos Research Incorporated for valuable technical assistance and discussions. Sequences are available on GenBank, accession numbers HQ738556 to HQ733567, HQ433363 to HQ433432, and HQ652514 to HQ652537.	Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; Brooks J. M., 1975, THESIS TEXAS A M U C; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; DEANGELIS MA, 1993, DEEP-SEA RES PT I, V40, P1169, DOI 10.1016/0967-0637(93)90132-M; Dickens, 2001, GEOPHYS MONOGR SER, V124, P19, DOI DOI 10.1029/GM124P0019; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Judd AG, 2002, GEOFLUIDS, V2, P109, DOI 10.1046/j.1468-8123.2002.00027.x; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; Kessler JD, 2006, EARTH PLANET SC LETT, V243, P366, DOI 10.1016/j.epsl.2006.01.006; McGinnis DF, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003183; REEBURGH WS, 1991, DEEP-SEA RES, V38, pS1189; REEBURGH WS, 2003, TREATISE GEOCHEMISTR, V4, P65, DOI DOI 10.1016/B0-08-043751-6/04036-6; Rehder G, 2009, MAR CHEM, V114, P19, DOI 10.1016/j.marchem.2009.03.004; Rothman LS, 2005, J QUANT SPECTROSC RA, V96, P139, DOI 10.1016/j.jqsrt.2004.10.008; Socolofsky SA, 2005, J HYDRAUL ENG, V131, P273, DOI 10.1061/(ASCE)0733-9429(2005)131:4(273); Tavormina PL, 2008, APPL ENVIRON MICROB, V74, P3985, DOI 10.1128/AEM.00069-08; U. S. Department of Energy, DEEPW HOR RESP; U. S. Geological Survey, 2010, DEEPW HOR MC252 GULF; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Valentine DL, 2001, GEOCHIM COSMOCHIM AC, V65, P2633, DOI 10.1016/S0016-7037(01)00625-1; WARD BB, 1987, NATURE, V327, P226, DOI 10.1038/327226a0; Yvon-Lewis SA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045928	24	342	350	7	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					312	315		10.1126/science.1199697	http://dx.doi.org/10.1126/science.1199697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21212320				2022-12-01	WOS:000286636300031
J	Wan, XH; Nakatani, H; Ueno, K; Asamizuya, T; Cheng, K; Tanaka, K				Wan, Xiaohong; Nakatani, Hironori; Ueno, Kenichi; Asamizuya, Takeshi; Cheng, Kang; Tanaka, Keiji			The Neural Basis of Intuitive Best Next-Move Generation in Board Game Experts	SCIENCE			English	Article							BASAL GANGLIA; CORTICOSTRIATAL PROJECTIONS; EPISODIC MEMORY; PARIETAL CORTEX; ABACUS EXPERTS; CHESS EXPERTS; BRAIN; CONNECTIONS; ACTIVATION; AREAS	The superior capability of cognitive experts largely depends on quick automatic processes. To reveal their neural bases, we used functional magnetic resonance imaging to study brain activity of professional and amateur players in a board game named shogi. We found two activations specific to professionals: one in the precuneus of the parietal lobe during perception of board patterns, and the other in the caudate nucleus of the basal ganglia during quick generation of the best next move. Activities at these two sites covaried in relevant tasks. These results suggest that the precuneus-caudate circuit implements the automatic, yet complicated, processes of board-pattern perception and next-move generation in board game experts.	[Wan, Xiaohong; Nakatani, Hironori; Cheng, Kang; Tanaka, Keiji] RIKEN Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan; [Ueno, Kenichi; Asamizuya, Takeshi; Cheng, Kang] RIKEN Brain Sci Inst, Support Unit Funct Magnet Resonance Imaging, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Tanaka, K (corresponding author), RIKEN Brain Sci Inst, Cognit Brain Mapping Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	keiji@riken.jp	Ueno, Kenichi/A-9395-2014; Cheng, Kang/A-6448-2016; Wan, Xiaohong/B-3753-2013; Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427; Asamizuya, Takeshi/0000-0003-1004-6435	Fujitsu Laboratories; Ministry of Education, Culture, Sports, Science and Technology of Japan [19700312]	Fujitsu Laboratories; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Fujitsu Laboratories and a grant-in-aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19700312, X.W.). We thank the Japan Shogi Association for cooperation and T. Ito, K. Okuma, and T. Kawatsuma for discussion.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amidzic O, 2001, NATURE, V412, P603, DOI 10.1038/35088119; Atherton M, 2003, COGNITIVE BRAIN RES, V16, P26, DOI 10.1016/S0926-6410(02)00207-0; Berns GS, 1998, J COGNITIVE NEUROSCI, V10, P108, DOI 10.1162/089892998563815; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Campitelli G, 2007, INT J NEUROSCI, V117, P1641, DOI 10.1080/00207450601041955; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; CHARNESS N, 1981, J EXP PSYCHOL HUMAN, V7, P467, DOI 10.1037/0096-1523.7.2.467; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; de Groot A. D., 1946, DENKEN VANDENSCHAKER; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Gaser C, 2003, J NEUROSCI, V23, P9240; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Gobet F, 2004, MOVES IN MIND: THE PSYCHOLOGY OF BOARD GAMES; Gobet F, 1994, ADV COMPUTER CHESS, V7, P35; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Han S, 2010, J NEUROSCI, V30, P4767, DOI 10.1523/JNEUROSCI.3077-09.2010; Hanakawa T, 2003, NEUROIMAGE, V19, P296, DOI 10.1016/S1053-8119(03)00050-8; HOLDING DH, 1989, AM J PSYCHOL, V102, P103, DOI 10.2307/1423119; HOLDING DH, 1979, SIMULAT GAMING, V10, P207, DOI 10.1177/104687817901000205; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mishkin M., 1984, NEUROBIOLOGY LEARNIN, P65, DOI DOI 10.1523/JNEUROSCI.0840-16.2016; NICHELLI P, 1994, NATURE, V369, P191, DOI 10.1038/369191a0; ONOFRJ M, 1995, NEUROSCI LETT, V198, P169, DOI 10.1016/0304-3940(95)11985-6; Ouchi Y, 2005, COGNITIVE BRAIN RES, V23, P164, DOI 10.1016/j.cogbrainres.2004.10.004; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Saariluoma P, 2004, EUR J COGN PSYCHOL, V16, P753, DOI 10.1080/09541440340000501; SAARILUOMA P, 1992, PSYCHOL RES-PSYCH FO, V54, P17, DOI 10.1007/BF01359219; Saariluoma P., 1995, CHESS PLAYERS THINKI; SELEMON LD, 1985, J NEUROSCI, V5, P776; Tanaka S, 2002, NEUROREPORT, V13, P2187, DOI 10.1097/00001756-200212030-00005; Volke HJ, 2002, J PSYCHOPHYSIOL, V16, P23, DOI 10.1027//0269-8803.16.1.23; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; YETERIAN EH, 1995, J COMP NEUROL, V352, P436, DOI 10.1002/cne.903520309; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	42	84	85	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					341	346		10.1126/science.1194732	http://dx.doi.org/10.1126/science.1194732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712BF	21252348				2022-12-01	WOS:000286636300040
J	Hopkins, R; Rausher, MD				Hopkins, Robin; Rausher, Mark D.			Identification of two genes causing reinforcement in the Texas wildflower Phlox drummondii	NATURE			English	Article							CHARACTER DISPLACEMENT; REPRODUCTIVE ISOLATION; SPECIATION GENETICS; HYBRIDIZATION; EVOLUTION	Species formation generates biological diversity and occurs when traits evolve that prevent gene flow between populations. Discerning the number and distribution of genes underlying these traits and, in a few cases, identifying the genes involved, has greatly enhanced our understanding over the past 15 years of species formation (reviewed by Noor and Feder(1) and Wolf et al.(2)). However, this work has almost exclusively focused on traits that restrict gene flow between populations that have evolved as a by-product of genetic divergence between geographically isolated populations. By contrast, little is known about the characteristics of genes associated with reinforcement, the process by which natural selection directly favours restricted gene flow during the formation of species. Here we identify changes in two genes that appear to cause a flower colour change in Phlox drummondii, which previous work has shown contributes to reinforcement. Both changes involve cis-regulatory mutations to genes in the anthocyanin biosynthetic pathway (ABP). Because one change is recessive whereas the other is dominant, hybrid offspring produce an intermediate flower colour that is visited less by pollinators, and is presumably maladaptive. Thus genetic change selected to increase prezygotic isolation also appears to result in increased postzygotic isolation.	[Hopkins, Robin; Rausher, Mark D.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Hopkins, R (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	robin.hopkins@duke.edu; mrausher@duke.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	We thank D. Des Marais, J. Tung, S. Johnsen and T. Juenger for technical advice, D. Levin for assistance in locating natural populations, and M. Noor for comments on the manuscript. This work was supported by a National Science Foundation grant to M. D. R. and a National Science Foundation Doctoral Dissertation Research Improvement Grant to R. H. R. H. was supported in part by the National Science Foundation Graduate Research Fellowship Program.	Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; Dambroski HR, 2005, EVOLUTION, V59, P1953, DOI 10.1111/j.0014-3820.2005.tb01065.x; Des Marais DL, 2010, EVOLUTION, V64, P2044, DOI 10.1111/j.1558-5646.2010.00972.x; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; GONNET JF, 1993, J HORTIC SCI, V68, P499, DOI 10.1080/00221589.1993.11516378; Haldane J. B. S., 1924, Trans Phil Soc Cambridge U K, V23, P19; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Kelly AJ, 1998, MOL ECOL, V7, P769, DOI 10.1046/j.1365-294x.1998.00328.x; Kirkpatrick M, 2000, P ROY SOC B-BIOL SCI, V267, P1649, DOI 10.1098/rspb.2000.1191; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; LEVIN DA, 1970, EVOLUTION, V24, P367, DOI 10.1111/j.1558-5646.1970.tb01768.x; LEVIN DA, 1975, EVOLUTION, V29, P37, DOI 10.1111/j.1558-5646.1975.tb00812.x; LEVIN DA, 1967, AM J BOT, V54, P1122, DOI 10.2307/2440537; LEVIN DA, 1985, EVOLUTION, V39, P1275, DOI 10.1111/j.1558-5646.1985.tb05693.x; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Mouritzen P, 2004, BIOTECHNIQUES, V37, P492, DOI 10.2144/04373AF02; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Nosil P, 2005, EVOLUTION, V59, P705; Orr HA, 2001, GENETICS, V157, P875; Ortiz-Barrientos D, 2004, PLOS BIOL, V2, P2256, DOI 10.1371/journal.pbio.0020416; Ortiz-Barrientos D, 2009, ANN NY ACAD SCI, V1168, P156, DOI 10.1111/j.1749-6632.2009.04919.x; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Ruane LG, 2008, EVOL ECOL, V22, P229, DOI 10.1007/s10682-007-9174-8; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	34	129	131	2	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					411	+		10.1038/nature09641	http://dx.doi.org/10.1038/nature09641			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21217687				2022-12-01	WOS:000286385600055
J	Sato, T; van Es, JH; Snippert, HJ; Stange, DE; Vries, RG; van den Born, M; Barker, N; Shroyer, NF; van de Wetering, M; Clevers, H				Sato, Toshiro; van Es, Johan H.; Snippert, Hugo J.; Stange, Daniel E.; Vries, Robert G.; van den Born, Maaike; Barker, Nick; Shroyer, Noah F.; van de Wetering, Marc; Clevers, Hans			Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts	NATURE			English	Article							BETA-CATENIN; ADULT-MOUSE; EPITHELIUM; DIFFERENTIATION; GENE; EXPRESSION; CANCER; MATH1; COLON; SOX9	Homeostasis of self-renewing small intestinal crypts results from neutral competition between Lgr5 stem cells, which are small cycling cells located at crypt bottoms(1,2). Lgr5 stem cells are interspersed between terminally differentiated Paneth cells that are known to produce bactericidal products such as lysozyme and cryptdins/defensins(3). Single Lgr5-expressing stem cells can be cultured to form long-lived, self-organizing crypt-villus organoids in the absence of non-epithelial niche cells(4). Here we find a close physical association of Lgr5 stem cells with Paneth cells in mice, both in vivo and in vitro. CD24(+) Paneth cells express EGF, TGF-alpha, Wnt3 and the Notch ligand Dll4, all essential signals for stem-cell maintenance in culture. Co-culturing of sorted stem cells with Paneth cells markedly improves organoid formation. This Paneth cell requirement can be substituted by a pulse of exogenous Wnt. Genetic removal of Paneth cells in vivo results in the concomitant loss of Lgr5 stem cells. In colon crypts, CD24(+) cells residing between Lgr5 stem cells may represent the Paneth cell equivalents. We conclude that Lgr5 stem cells compete for essential niche signals provided by a specialized daughter cell, the Paneth cell.	[Sato, Toshiro; van Es, Johan H.; Snippert, Hugo J.; Stange, Daniel E.; Vries, Robert G.; van den Born, Maaike; Barker, Nick; van de Wetering, Marc; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Sato, Toshiro; van Es, Johan H.; Snippert, Hugo J.; Stange, Daniel E.; Vries, Robert G.; van den Born, Maaike; Barker, Nick; van de Wetering, Marc; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Shroyer, Noah F.] Cincinnati Childrens Hosp, Div Gastroenterol, Med Ctr, MLC 2010, Cincinnati, OH 45229 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Cincinnati Children's Hospital Medical Center	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Sato, Toshiro/J-3522-2014; Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021; Stange, Daniel E/O-1837-2015; Barker, Nick/A-5535-2011	Sato, Toshiro/0000-0001-8353-8137; Barker, Nick/0000-0003-3566-4475; Stange, Daniel E/0000-0003-4246-2230; Shroyer, Noah/0000-0002-5934-2852	NCI NIH HHS [R01 CA142826, R01 CA142826-01] Funding Source: Medline; NIDDK NIH HHS [R03 DK084167-01, R03 DK084167] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA142826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK084167] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTMANN GG, 1983, AM J ANAT, V167, P95, DOI 10.1002/aja.1001670109; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 2010, DEV BIOL, V345, P49, DOI 10.1016/j.ydbio.2010.06.021; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; POULSEN SS, 1986, HISTOCHEMISTRY, V85, P389, DOI 10.1007/BF00982668; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173	29	1604	1678	16	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					415	+		10.1038/nature09637	http://dx.doi.org/10.1038/nature09637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21113151	Green Accepted			2022-12-01	WOS:000286385600056
J	Deer, B				Deer, Brian			Secrets of the MMR scare The Lancet's two days to bury bad news	BRITISH MEDICAL JOURNAL			English	Editorial Material							STATEMENT											BARR R, 1996, PROPOSED PROTO UNPUB; CORRIGAN S, 2006, MAIL SUNDAY     0716; DEER B, IS WAKEFIELD CLUSTER; Deer B., 2006, SUNDAY TIMES 1231; DEER B, ROYAL FREE D HULL IN; DEER B, WALKERSMITH EXPLAINS; DEER B, 2004, SUNDAY TIMES    0222; Deer B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c5258; Deer B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c5347; FILIPEK PA, 1999, PEDIAT NEUROLOGY PRI; *GMC, A WAK DET SER PROF M; *GMC, J WALK DET SER PROF; *GMC, 2010, FITN PRACT PAN FIND; Hodgson H, 2004, LANCET, V363, P824, DOI 10.1016/S0140-6736(04)15711-5; Horton R, 2004, LANCET, V363, P820, DOI 10.1016/S0140-6736(04)15699-7; HORTON R, 2010, PRESS GAZETTE    MAR, P19; Horton Richard C., 2003, 2 OPINION DOCTORS DI; LAURANCE J, 2004, INDEPENDENT     0229; *LEG AID BOARD, 1996, AUTH DO CONTR WORK; MEIKLE J, 2004, GUARDIAN        0224; Murch S, 2004, LANCET, V363, P821, DOI 10.1016/S0140-6736(04)15708-5; *U COLL LOND, 2010, FREED INF REQ 10045; Wakefield A, 2004, LANCET, V363, P823, DOI 10.1016/S0140-6736(04)15710-3; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Walker-Smith J, 2004, LANCET, V363, P822, DOI 10.1016/S0140-6736(04)15709-7; [No title captured]	26	32	34	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2011	342								c7001	10.1136/bmj.c7001	http://dx.doi.org/10.1136/bmj.c7001			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OH	21245118				2022-12-01	WOS:000286600800018
J	Eikelboom, JW; Weitz, JI				Eikelboom, John W.; Weitz, Jeffrey I.			Therapeutics New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENOUS THROMBOEMBOLISM; DABIGATRAN ETEXILATE; DOUBLE-BLIND; ENOXAPARIN; RIVAROXABAN; PREVENTION; REPLACEMENT; THROMBIN					eikelbj@mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019; Eikelboom, John/AAG-6117-2019	Weitz, Jeffrey/0000-0002-1092-7550; Eikelboom, John/0000-0003-4126-1285				[Anonymous], 2010, PROD MON PRAD; [Anonymous], 2008, PROD MON XAR; Apostolakis S, 2009, PHARMACOECONOMICS, V27, P793, DOI 10.2165/11313780-000000000-00000; Eikelboom JW, 2010, CIRCULATION, V121, P1523, DOI 10.1161/CIRCULATIONAHA.109.853119; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Eriksson BI, 2009, CLIN PHARMACOKINET, V48, P1, DOI 10.2165/0003088-200948010-00001; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginsberg JS, 2009, J ARTHROPLASTY, V24, P1, DOI 10.1016/j.arth.2008.01.132; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; McCullagh L, 2009, PHARMACOECONOMICS, V27, P829, DOI 10.2165/11313800-000000000-00000; National Institute for Health and Clinical Excellence, 2010, 92 NAT I HLTH CLIN E; Trkulja V, 2010, CROAT MED J, V51, P113, DOI 10.3325/cmj.2010.51.113; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758	17	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2011	342								c7270	10.1136/bmj.c7270	http://dx.doi.org/10.1136/bmj.c7270			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711OH	21245113				2022-12-01	WOS:000286600800014
J	Rosenbaum, DM; Zhang, C; Lyons, JA; Holl, R; Aragao, D; Arlow, DH; Rasmussen, SGF; Choi, HJ; DeVree, BT; Sunahara, RK; Chae, PS; Gellman, SH; Dror, RO; Shaw, DE; Weis, WI; Caffrey, M; Gmeiner, P; Kobilka, BK				Rosenbaum, Daniel M.; Zhang, Cheng; Lyons, Joseph A.; Holl, Ralph; Aragao, David; Arlow, Daniel H.; Rasmussen, Soren G. F.; Choi, Hee-Jung; DeVree, Brian T.; Sunahara, Roger K.; Chae, Pil Seok; Gellman, Samuel H.; Dror, Ron O.; Shaw, David E.; Weis, William I.; Caffrey, Martin; Gmeiner, Peter; Kobilka, Brian K.			Structure and function of an irreversible agonist-beta(2) adrenoceptor complex	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTALLIZING MEMBRANE-PROTEINS; MOLECULAR-DYNAMICS SIMULATIONS; LIPIDIC MESOPHASES; ADRENERGIC-RECEPTOR; BINDING-SITE; FORCE-FIELDS; RHODOPSIN; ACTIVATION; AGONISTS	G-protein-coupled receptors (GPCRs) are eukaryotic integral membrane proteins that modulate biological function by initiating cellular signalling in response to chemically diverse agonists. Despite recent progress in the structural biology of GPCRs(1), the molecular basis for agonist binding and allosteric modulation of these proteins is poorly understood. Structural knowledge of agonist-bound states is essential for deciphering the mechanism of receptor activation, and for structure-guided design and optimization of ligands. However, the crystallization of agonist-bound GPCRs has been hampered by modest affinities and rapid off-rates of available agonists. Using the inactive structure of the human beta(2) adrenergic receptor (beta(2)AR) as a guide, we designed a beta(2)AR agonist that can be covalently tethered to a specific site on the receptor through a disulphide bond. The covalent beta(2)AR-agonist complex forms efficiently, and is capable of activating a heterotrimeric G protein. We crystallized a covalent agonist-bound beta(2)AR-T4L fusion protein in lipid bilayers through the use of the lipidic mesophase method(2), and determined its structure at 3.5 angstrom resolution. A comparison to the inactive structure and an antibody-stabilized active structure (companion paper(3)) shows how binding events at both the extracellular and intracellular surfaces are required to stabilize an active conformation of the receptor. The structures are in agreement with long-timescale (up to 30 mu s) molecular dynamics simulations showing that an agonist-bound active conformation spontaneously relaxes to an inactive-like conformation in the absence of a G protein or stabilizing antibody.	[Rosenbaum, Daniel M.; Zhang, Cheng; Rasmussen, Soren G. F.; Choi, Hee-Jung; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lyons, Joseph A.] Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland; [Lyons, Joseph A.; Aragao, David; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Membrane Struct & Funct Biol Grp, Dublin 2, Ireland; [Holl, Ralph; Gmeiner, Peter] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91052 Erlangan, Germany; [Arlow, Daniel H.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [DeVree, Brian T.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chae, Pil Seok; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	Stanford University; University of Limerick; Trinity College Dublin; University of Erlangen Nuremberg; D. E. Shaw Research; Stanford University; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	martin.caffrey@tcd.ie; peter.gmeiner@medchem.uni-erlangen.de; kobilka@stanford.edu	Gmeiner, Peter/N-5275-2015; Aragao, David/AAV-5514-2021; DeVree, Brian T/F-6205-2011; Sunahara, Roger/AAJ-8667-2020; Zhang, Cheng/O-4372-2015; Aragao, David/A-1695-2012; Lyons, Joseph/AAA-2528-2020; Weis, William I/G-1437-2011	Aragao, David/0000-0002-6551-4657; Zhang, Cheng/0000-0001-9042-4007; Aragao, David/0000-0002-6551-4657; Weis, William I/0000-0002-5583-6150; Gmeiner, Peter/0000-0002-4127-197X; Rasmussen, Soren/0000-0002-1853-1841; Kobilka, Brian/0000-0001-5958-3990; Lyons, Joseph/0000-0003-0218-4862; Choi, Hee-Jung/0000-0002-1167-1526; DeVree, Brian/0000-0003-0582-8125; Dror, Ron/0000-0002-6418-2793	National Institutes of Health [NS028471, GM083118, GM56169, P01 GM75913, GM75915, P50GM073210, P60DK-20572]; Mathers Foundation; Lundbeck Foundation; Science Foundation Ireland [07/IN.1/B1836]; FP7 COST Action [CM0902]; Bavaria California Technology Center; University of Michigan; Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068603, R01GM075915, P50GM073210, R01GM056169, P01GM075913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); FP7 COST Action; Bavaria California Technology Center; University of Michigan(University of Michigan System); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health Grants NS028471 and GM083118 (B. K. K.), GM56169 (W. I. W.), P01 GM75913 (S. H. G), GM75915 and P50GM073210 (M. C), and P60DK-20572 (R. K. S.), the Mathers Foundation (B. K. K and W. I. W), the Lundbeck Foundation (Junior Group Leader Fellowship, S. G. F. R.), Science Foundation Ireland (07/IN.1/B1836) and FP7 COST Action CM0902 (M. C.), the Bavaria California Technology Center (P. G.), and the University of Michigan Biomedical Sciences Scholars Program(R. K. S). We thank Stefan Lober, Harald Hubner, Albert Pan and Paul Maragakis for discussion and suggestions. We thank Foon Sun Thian for help with insect cell expression.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bowers K.J., 2006, P 2006 ACMIEEE C SUP; Buck E, 2005, P NATL ACAD SCI USA, V102, P2719, DOI 10.1073/pnas.0500016102; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen AH, 1998, CHEM PHYS LIPIDS, V95, P11, DOI 10.1016/S0009-3084(98)00060-7; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; DOHLMAN HG, 1988, BIOCHEMISTRY-US, V27, P1813, DOI 10.1021/bi00406a002; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2004, MOL PHARMACOL, V65, P1181, DOI 10.1124/mol.65.5.1181; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinelli MJ, 2002, J AM CHEM SOC, V124, P3578, DOI 10.1021/ja016031r; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; RUBENSTEIN RC, 1987, J BIOL CHEM, V262, P16655; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw D. E., 2009, P C HIGH PERF COMP N; TOTA MR, 1991, TRENDS PHARMACOL SCI, V12, P4, DOI 10.1016/0165-6147(91)90479-C; TU T, 2008, P 2008 ACM IEEE C SU; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanni S, 2010, J MOL BIOL, V397, P1339, DOI 10.1016/j.jmb.2010.01.060; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	52	625	643	1	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					236	240		10.1038/nature09665	http://dx.doi.org/10.1038/nature09665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228876	Green Accepted			2022-12-01	WOS:000286143400043
J	Bai, G; Chivatakarn, O; Bonanomi, D; Lettieri, K; Franco, L; Xia, CH; Stein, E; Ma, L; Lewcock, JW; Pfaff, SL				Bai, Ge; Chivatakarn, Onanong; Bonanomi, Dario; Lettieri, Karen; Franco, Laura; Xia, Caihong; Stein, Elke; Ma, Le; Lewcock, Joseph W.; Pfaff, Samuel L.			Presenilin-Dependent Receptor Processing Is Required for Axon Guidance	CELL			English	Article							SONIC HEDGEHOG; SLIT PROTEINS; MICE LACKING; NETRIN-1; CHEMOATTRACTANT; CHEMOREPELLENTS; ATTRACTION; MECHANISMS; OUTGROWTH; BIOLOGY	The Alzheimer's disease-linked gene presenilin is required for intramembrane proteolysis of amyloid-beta precursor protein, contributing to the pathogenesis of neurodegeneration that is characterized by loss of neuronal connections, but the role of Presenilin in establishing neuronal connections is less clear. Through a forward genetic screen in mice for recessive genes affecting motor neurons, we identified the Columbus allele, which disrupts motor axon projections from the spinal cord. We mapped this mutation to the Presenilin-1 gene. Motor neurons and commissural interneurons in Columbus mutants lacking Presenilin-1 acquire an inappropriate attraction to Netrin produced by the floor plate because of an accumulation of DCC receptor fragments within the membrane that are insensitive to Slit/Robo silencing. Our findings reveal that Presenilin-dependent DCC receptor processing coordinates the interplay between Netrin/DCC and Slit/Robo signaling. Thus, Presenilin is a key neural circuit builder that gates the spatiotemporal pattern of guidance signaling, thereby ensuring neural projections occur with high fidelity.	[Bai, Ge; Chivatakarn, Onanong; Bonanomi, Dario; Lettieri, Karen; Franco, Laura; Lewcock, Joseph W.; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Bai, Ge; Chivatakarn, Onanong; Bonanomi, Dario; Lettieri, Karen; Franco, Laura; Lewcock, Joseph W.; Pfaff, Samuel L.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Xia, Caihong; Ma, Le] Univ So Calif, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Keck Sch Med, Los Angeles, CA 90089 USA; [Stein, Elke] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of Southern California; Yale University	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu	Stein, Elke/E-8107-2013; Bai, Ge/K-2608-2014; Bonanomi, Dario/K-3450-2016; Ma, Le/A-3733-2013	Stein, Elke/0000-0001-8965-5692; Bonanomi, Dario/0000-0003-4517-1244; Ma, Le/0000-0003-2769-9416	National Institutes of Health through National Institute of Neurological Disorders and Stroke [R37NS037116]; Howard Hughes Medical Institute; NINDS [R37NS037116, P01NS031249]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037116, R01NS054172, R01NS062047, P01NS031249] Funding Source: NIH RePORTER	National Institutes of Health through National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Edward Koo for critical reading of the manuscript, Shane Andrews for assistance with imaging, and members of the Pfaff lab for advice and discussions on the experiments and manuscript. We are also grateful to Marc Tessier-Lavigne and Jie Shen for providing Netrin-1, DCC and PS1<SUP>fl/fl</SUP> mutant mice. We thank Roman Giger and Geetha Suresh for plasmids and Developmental Studies Hybridoma Bank for antibodies. These experiments were supported by National Institutes of Health Grant R37NS037116 through National Institute of Neurological Disorders and Stroke and the Howard Hughes Medical Institute. G.B., D.B., and K.L. are supported by the Howard Hughes Medical Institute. O.C. is supported by NINDS Grant R37NS037116. L.F. is supported by NINDS Grant P01NS031249. S.L.P. is a Howard Hughes Medical Institute Investigator.	Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Kandel ER., 2000, PRINCIPLES NEURAL SC, P67; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kim SK, 2005, FASEB J, V19, P157, DOI 10.1096/fj.05-4055fje; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Parent AT, 2005, J NEUROSCI, V25, P1540, DOI 10.1523/JNEUROSCI.3850-04.2005; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Patel K, 2001, DEVELOPMENT, V128, P5031; Puschel AW, 1999, MECH DEVELOP, V83, P65, DOI 10.1016/S0925-4773(99)00035-0; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	38	89	90	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					106	118		10.1016/j.cell.2010.11.053	http://dx.doi.org/10.1016/j.cell.2010.11.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215373	Green Accepted, Bronze			2022-12-01	WOS:000285993600011
J	Tonelli, M; Muntner, P; Lloyd, A; Manns, BJ; James, MT; Klarenbach, S; Quinn, RR; Wiebe, N; Hemmelgarn, BR				Tonelli, Marcello; Muntner, Paul; Lloyd, Anita; Manns, Braden J.; James, Matthew T.; Klarenbach, Scott; Quinn, Robert R.; Wiebe, Natasha; Hemmelgarn, Brenda R.		Alberta Kidney Dis Network	Using Proteinuria and Estimated Glomerular Filtration Rate to Classify Risk in Patients With Chronic Kidney Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; SERUM CREATININE; ADMINISTRATIVE DATA; GENERAL-POPULATION; PREVALENCE; MORTALITY; ALBERTA; INSUFFICIENCY; HYPERTENSION; PREDICTION	Background: The staging system for chronic kidney disease relies almost exclusively on estimated glomerular filtration rate (eGFR), although proteinuria is also associated with adverse outcomes. Objective: To validate a 5-category system for risk stratification based on the combination of eGFR and proteinuria. Design: Retrospective cohort study. Setting: A provincial laboratory registry in Alberta, Canada, and a representative sample of noninstitutionalized U.S. adults. Patients: A derivation data set of 474 521 adult outpatients, 2 independent internal validation cohorts with 51 356 and 460 623 patients, and an external validation cohort of 14 358 patients. Measurements: Glomerular filtration rate, estimated by using the Modification of Diet in Renal Disease Study equation, and proteinuria, measured by using urine albumin-to-creatinine ratio or dipstick urinalysis. Outcomes included all-cause mortality and a composite renal outcome of kidney failure or doubling of serum creatinine level. Results: Over a median follow-up of 38 months in the internal validation cohorts, higher risk categories (indicating lower eGFR or more proteinuria) were associated with a graded increase in the risk for the composite renal outcome. The projected number of U. S. adults assigned to risk categories 3 and 4 in the alternate system was 3.9 million, compared with 16.3 million assigned to stage 3 and 4 in the current staging system. The alternate system was more likely to correctly reclassify persons who did not develop the renal outcome than those who did, although some persons developed the renal outcome despite reclassification to a lower category. However, all analyses of patients reclassified to a lower category showed that substantially fewer such patients developed the renal outcome than did not. Correct reclassification by the alternate system was more likely when proteinuria was measured by using albumin-to-creatinine ratio than with dipstick testing, and also more likely for the composite renal outcome than for mortality. Limitation: The study had a short follow-up time. Conclusion: Using proteinuria in combination with eGFR may reduce unnecessary referrals for care at the cost of not referring or delaying referral for some patients who go on to develop kidney failure.	Univ Alberta, Edmonton, AB, Canada; Univ Alabama Birmingham, Birmingham, AL USA; Univ Calgary, Calgary, AB, Canada	University of Alberta; University of Alabama System; University of Alabama Birmingham; University of Calgary	Tonelli, M (corresponding author), 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2G3, Canada.		Klarenbach, Scott/E-7731-2013; Hemmelgarn, Brenda R./I-6894-2012; Tonelli, Marcello/B-3028-2009; Quinn, Robert R/E-7017-2011; Manns, Braden J/I-8942-2012; Wiebe, Natasha/V-7803-2019	Klarenbach, Scott/0000-0002-8611-1056; Tonelli, Marcello/0000-0002-0846-3187; Wiebe, Natasha/0000-0002-5613-1582	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research; Shire Biochem-KRESCENT	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Shire Biochem-KRESCENT	Primary Funding Source: Alberta Heritage Foundation for Medical Research interdisciplinary research team grant.; Grant Support: By an interdisciplinary research team grant from the Alberta Heritage Foundation for Medical Research (AHFMR), career salary awards from the AHFMR (Drs. Hemmelgarn, Tonelli, and Klarenbach), New Investigator Awards from the Canadian Institutes of Health Research (Drs. Hemmelgarn, Tonelli, and Manns), a joint initiative between Alberta Health and Wellness and the Universities of Alberta and Calgary (Drs. Hemmelgarn, Klarenbach, Manns, and Tonelli), and a Shire Biochem-KRESCENT Joint Fellowship and an AHFMR research Award (Dr. James).	Chen MLW, 2003, AM J KIDNEY DIS, V42, P623, DOI 10.1016/S0272-6386(03)00870-9; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Gansevoort RT, 2010, CURR OPIN NEPHROL HY, V19, P308, DOI 10.1097/MNH.0b013e328337bbbe; Gao S, 2007, J AM SOC NEPHROL, V18, P2953, DOI 10.1681/ASN.2007030360; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hsu C, 2000, AM J KIDNEY DIS, V36, P415, DOI 10.1053/ajkd.2000.8996; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Sin DD, 2003, CHEST, V124, P51, DOI 10.1378/chest.124.1.51; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Winearls CG, 2009, KIDNEY INT, V75, P1009, DOI 10.1038/ki.2009.49; [No title captured]; 2002, AM J KIDNEY DIS S1, V39, pS76	30	131	134	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					12	U146		10.7326/0003-4819-154-1-201101040-00003	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00003			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200034				2022-12-01	WOS:000285830900002
J	Bevilacqua, L; Doly, S; Kaprio, J; Yuan, QP; Tikkanen, R; Paunio, T; Zhou, ZF; Wedenoja, J; Maroteaux, L; Diaz, S; Belmer, A; Hodgkinson, CA; Dell'Osso, L; Suvisaari, J; Coccaro, E; Rose, RJ; Peltonen, L; Virkkunen, M; Goldman, D				Bevilacqua, Laura; Doly, Stephane; Kaprio, Jaakko; Yuan, Qiaoping; Tikkanen, Roope; Paunio, Tiina; Zhou, Zhifeng; Wedenoja, Juho; Maroteaux, Luc; Diaz, Silvina; Belmer, Arnaud; Hodgkinson, Colin A.; Dell'Osso, Liliana; Suvisaari, Jaana; Coccaro, Emil; Rose, Richard J.; Peltonen, Leena; Virkkunen, Matti; Goldman, David			A population-specific HTR2B stop codon predisposes to severe impulsivity	NATURE			English	Article							MONOAMINE-OXIDASE; MOLECULAR-GENETICS; SEROTONIN; VULNERABILITY; DOPAMINE; MUTATION; POLYMORPHISM; AGGRESSION; MECHANISMS; RECEPTORS	Impulsivity, describing action without foresight, is an important feature of several psychiatric diseases, suicidality and violent behaviour. The complex origins of impulsivity hinder identification of the genes influencing it and the diseases with which it is associated. Here we perform exon-focused sequencing of impulsive individuals in a founder population, targeting fourteen genes belonging to the serotonin and dopamine domain. A stop codon in HTR2B was identified that is common (minor allele frequency >1%) but exclusive to Finnish people. Expression of the gene in the human brain was assessed, as well as the molecular functionality of the stop codon, which was associated with psychiatric diseases marked by impulsivity in both population and family-based analyses. Knockout of Htr2b increased impulsive behaviours in mice, indicative of predictive validity. Our study shows the potential for identifying and tracing effects of rare alleles in complex behavioural phenotypes using founder populations, and indicates a role for HTR2B in impulsivity.	[Bevilacqua, Laura; Yuan, Qiaoping; Zhou, Zhifeng; Hodgkinson, Colin A.; Goldman, David] NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA; [Doly, Stephane; Maroteaux, Luc; Diaz, Silvina; Belmer, Arnaud] INSERM, UMR S 839, F-75654 Paris, France; [Doly, Stephane; Maroteaux, Luc; Diaz, Silvina; Belmer, Arnaud] Univ Paris 06, Inst du Fer Moulin, F-75654 Paris, France; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, FI-00014 Helsinki, Finland; [Kaprio, Jaakko] Inst Mol Med, FI-00014 Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Unit Child & Adolescent Psychiat, FI-00271 Helsinki, Finland; [Tikkanen, Roope; Virkkunen, Matti] Univ Helsinki, Inst Clin Med, Dept Psychiat, FI-00014 Helsinki, Finland; [Paunio, Tiina; Suvisaari, Jaana] Univ Helsinki, Dept Psychiat, Cent Hosp, FI-00014 Helsinki, Finland; [Wedenoja, Juho] Univ Helsinki, Dept Med Genet, FI-00014 Helsinki, Finland; [Wedenoja, Juho] Univ Helsinki, Inst Mol Med Finland, FI-00014 Helsinki, Finland; [Wedenoja, Juho] Natl Inst Hlth & Welf, FI-00014 Helsinki, Finland; [Dell'Osso, Liliana] Univ Pisa, Dept Psychiat, I-56100 Pisa, Italy; [Coccaro, Emil] Univ Chicago, Pritzker Sch Med, Dept Psychiat, Chicago, IL 60637 USA; [Rose, Richard J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Virkkunen, Matti] Kellokoski Psychiat Hosp, FI-04500 Kellokoski, Finland	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Pisa; University of Chicago; Indiana University System; Indiana University Bloomington	Goldman, D (corresponding author), NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA.	davidgoldman@mail.nih.gov	Wedenoja, Juho/AAX-7008-2020; Maroteaux, Luc/H-4585-2019; doly, stephane/Y-2318-2019; Belmer, Arnauld/AAE-2554-2019; Kaprio, Jaakko/A-1820-2008; Majid, Salma/AAT-2616-2020; Goldman, David/F-9772-2010	Wedenoja, Juho/0000-0002-6155-0378; Maroteaux, Luc/0000-0002-9499-8603; doly, stephane/0000-0002-3517-8605; Belmer, Arnauld/0000-0001-6640-5631; Kaprio, Jaakko/0000-0002-3716-2455; Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Yuan, Qiaoping/0000-0002-5880-8702; Suvisaari, Jaana/0000-0001-7167-0990; , Laura/0000-0002-6460-0852	National Institute on Alcohol Abuse and Alcoholism, NIH; Academy of Finland Centre of Excellence in Complex Disease Genetics; National Institute on Alcohol Abuse and Alcoholism [AA-12502, AA-09203]; Academy of Finland [100499, 205585, 118555]; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation de France; Fondation pour la Recherche Medicale; French Ministry of Research (Agence Nationale pour la Recherche); European Union; IBRO; Region Ile de France DIM STEM; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009203, R01AA012502, ZIAAA000301, R37AA012502] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Academy of Finland(Academy of Finland); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research (Agence Nationale pour la Recherche)(French National Research Agency (ANR)Ministry of Research, France); European Union(European Commission); IBRO; Region Ile de France DIM STEM(Region Ile-de-France); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study is dedicated to the memory of L.P. and M. Linnoila. We thank L. Akhtar for assistance with tissue culture, C. Marietta for assistance with measurement of receptor protein levels, V. Srivastava and G. Yamini for discussions, and P.-H. Shen for contributions to ancestry analyses. M. Eggert and L. Brown assisted with clinical ascertainment and assessment of the University of Helsinki sample. We thank M. Linnoila for his contributions to the collection of the University of Helsinki sample. E. Kempas assisted with genotyping. J.-M. Launay measured plasma testosterone levels in Htr2b<SUP>-/-</SUP> mice. We also thank A. Tuulio-Henriksson, E. Vuoksimaa, A. Happola and L. Arala. This work was supported by the Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism, NIH and the Academy of Finland Centre of Excellence in Complex Disease Genetics. The FinnTwin12 and FinnTwin16 studies were supported by the National Institute on Alcohol Abuse and Alcoholism (AA-12502 and AA-09203 to R.J.R.), and by the Academy of Finland (100499, 205585 and 118555 to J.K.). The studies on Htr2b<SUP>-/-</SUP> mice were supported by the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie, and by grants from the Fondation de France, the Fondation pour la Recherche Medicale, the French Ministry of Research (Agence Nationale pour la Recherche), and the European Union. L.M.'s team is an "Equipe Fondation pour la Recherche Medicale''. S. Diaz is supported by a fellowship from IBRO and Region Ile de France DIM STEM.	Abel L, 1998, GENET EPIDEMIOL, V15, P371, DOI 10.1002/(SICI)1098-2272(1998)15:4<371::AID-GEPI4>3.0.CO;2-5; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Blanpain C, 2003, CARDIOVASC RES, V60, P518, DOI 10.1016/j.cardiores.2003.09.015; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Cases O, 1998, J NEUROSCI, V18, P6914; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; Chiavegatto S, 2010, GENES BRAIN BEHAV, V9, P110, DOI 10.1111/j.1601-183X.2009.00544.x; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; COCCARO EF, 1993, PSYCHIAT RES, V48, P229, DOI 10.1016/0165-1781(93)90074-Q; DEJONG J, 1992, J NERV MENT DIS, V180, P543, DOI 10.1097/00005053-199209000-00001; Doly S, 2008, J NEUROSCI, V28, P2933, DOI 10.1523/JNEUROSCI.5723-07.2008; Ducci F, 2008, MOL PSYCHIATR, V13, P334, DOI 10.1038/sj.mp.4002034; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; EYSENCK SBG, 1977, BRIT J SOC CLIN PSYC, V16, P57, DOI 10.1111/j.2044-8260.1977.tb01003.x; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Gustavsson JP, 2000, ACTA PSYCHIAT SCAND, V102, P217, DOI 10.1034/j.1600-0447.2000.102003217.x; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P1438, DOI 10.1001/archpsyc.65.12.1438; Kim SJ, 2000, MOL CELL PROBE, V14, P47, DOI 10.1006/mcpr.1999.0281; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Lin ZC, 2004, PHARMACOGENETICS, V14, P805, DOI 10.1097/00008571-200412000-00003; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; Misener VL, 2004, MOL PSYCHIATR, V9, P500, DOI 10.1038/sj.mp.4001440; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Roy A, 2007, NEUROPSYCHOPHARMACOL, V32, P2046, DOI 10.1038/sj.npp.1301331; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Sjoberg RL, 2008, NEUROPSYCHOPHARMACOL, V33, P425, DOI 10.1038/sj.npp.1301417; VIRKKUNEN M, 1994, ARCH GEN PSYCHIAT, V51, P20; VIRKKUNEN M, 1993, J STUD ALCOHOL, P163, DOI 10.15288/jsas.1993.s11.163; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001	39	173	187	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1061	U460		10.1038/nature09629	http://dx.doi.org/10.1038/nature09629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179162	Green Accepted			2022-12-01	WOS:000285553800050
J	Gerstein, MB; Lu, ZJ; Van Nostrand, EL; Cheng, C; Arshinoff, BI; Liu, T; Yip, KY; Robilotto, R; Rechtsteiner, A; Ikegami, K; Alves, P; Chateigner, A; Perry, M; Morris, M; Auerbach, RK; Feng, X; Leng, J; Vielle, A; Niu, W; Rhrissorrakrai, K; Agarwal, A; Alexander, RP; Barber, G; Brdlik, CM; Brennan, J; Brouillet, JJ; Carr, A; Cheung, MS; Clawson, H; Contrino, S; Dannenberg, LO; Dernburg, AF; Desai, A; Dick, L; Dose, AC; Du, JA; Egelhofer, T; Ercan, S; Euskirchen, G; Ewing, B; Feingold, EA; Gassmann, R; Good, PJ; Green, P; Gullier, F; Gutwein, M; Guyer, MS; Habegger, L; Han, T; Henikoff, JG; Henz, SR; Hinrichs, A; Holster, H; Hyman, T; Iniguez, AL; Janette, J; Jensen, M; Kato, M; Kent, WJ; Kephart, E; Khivansara, V; Khurana, E; Kim, JK; Kolasinska-Zwierz, P; Lai, EC; Latorre, I; Leahey, A; Lewis, S; Lloyd, P; Lochovsky, L; Lowdon, RF; Lubling, Y; Lyne, R; MacCoss, M; Mackowiak, SD; Mangone, M; Mckay, S; Mecenas, D; Merrihew, G; Miller, DM; Muroyama, A; Murray, JI; Ooi, SL; Pham, H; Phippen, T; Preston, EA; Rajewsky, N; Ratsch, G; Rosenbaum, H; Rozowsky, J; Rutherford, K; Ruzanov, P; Sarov, M; Sasidharan, R; Sboner, A; Scheid, P; Segal, E; Shin, HJ; Shou, C; Slack, FJ; Slightam, C; Smith, R; Spencer, WC; Stinson, EO; Taing, S; Takasaki, T; Vafeados, D; Voronina, K; Wang, GL; Washington, NL; Whittle, CM; Wu, BJ; Yan, KK; Zeller, G; Zha, Z; Zhong, M; Zhou, XL; Ahringer, J; Strome, S; Gunsalus, KC; Micklem, G; Liu, XS; Reinke, V; Kim, SK; Hillier, LW; Henikoff, S; Piano, F; Snyder, M; Stein, L; Lieb, JD; Waterston, RH				Gerstein, Mark B.; Lu, Zhi John; Van Nostrand, Eric L.; Cheng, Chao; Arshinoff, Bradley I.; Liu, Tao; Yip, Kevin Y.; Robilotto, Rebecca; Rechtsteiner, Andreas; Ikegami, Kohta; Alves, Pedro; Chateigner, Aurelien; Perry, Marc; Morris, Mitzi; Auerbach, Raymond K.; Feng, Xin; Leng, Jing; Vielle, Anne; Niu, Wei; Rhrissorrakrai, Kahn; Agarwal, Ashish; Alexander, Roger P.; Barber, Galt; Brdlik, Cathleen M.; Brennan, Jennifer; Brouillet, Jeremy Jean; Carr, Adrian; Cheung, Ming-Sin; Clawson, Hiram; Contrino, Sergio; Dannenberg, Luke O.; Dernburg, Abby F.; Desai, Arshad; Dick, Lindsay; Dose, Andrea C.; Du, Jiang; Egelhofer, Thea; Ercan, Sevinc; Euskirchen, Ghia; Ewing, Brent; Feingold, Elise A.; Gassmann, Reto; Good, Peter J.; Green, Phil; Gullier, Francois; Gutwein, Michelle; Guyer, Mark S.; Habegger, Lukas; Han, Ting; Henikoff, Jorja G.; Henz, Stefan R.; Hinrichs, Angie; Holster, Heather; Hyman, Tony; Iniguez, A. Leo; Janette, Judith; Jensen, Morten; Kato, Masaomi; Kent, W. James; Kephart, Ellen; Khivansara, Vishal; Khurana, Ekta; Kim, John K.; Kolasinska-Zwierz, Paulina; Lai, Eric C.; Latorre, Isabel; Leahey, Amber; Lewis, Suzanna; Lloyd, Paul; Lochovsky, Lucas; Lowdon, Rebecca F.; Lubling, Yaniv; Lyne, Rachel; MacCoss, Michael; Mackowiak, Sebastian D.; Mangone, Marco; Mckay, Sheldon; Mecenas, Desirea; Merrihew, Gennifer; Miller, David M., III; Muroyama, Andrew; Murray, John I.; Ooi, Siew-Loon; Pham, Hoang; Phippen, Taryn; Preston, Elicia A.; Rajewsky, Nikolaus; Raetsch, Gunnar; Rosenbaum, Heidi; Rozowsky, Joel; Rutherford, Kim; Ruzanov, Peter; Sarov, Mihail; Sasidharan, Rajkumar; Sboner, Andrea; Scheid, Paul; Segal, Eran; Shin, Hyunjin; Shou, Chong; Slack, Frank J.; Slightam, Cindie; Smith, Richard; Spencer, William C.; Stinson, E. O.; Taing, Scott; Takasaki, Teruaki; Vafeados, Dionne; Voronina, Ksenia; Wang, Guilin; Washington, Nicole L.; Whittle, Christina M.; Wu, Beijing; Yan, Koon-Kiu; Zeller, Georg; Zha, Zheng; Zhong, Mei; Zhou, Xingliang; Ahringer, Julie; Strome, Susan; Gunsalus, Kristin C.; Micklem, Gos; Liu, X. Shirley; Reinke, Valerie; Kim, Stuart K.; Hillier, LaDeana W.; Henikoff, Steven; Piano, Fabio; Snyder, Michael; Stein, Lincoln; Lieb, Jason D.; Waterston, Robert H.		modENCODE Consortium	Integrative Analysis of the Caenorhabditis elegans Genome by the modENCODE Project	SCIENCE			English	Article							TRANSCRIPTION; REVEALS; DNA; MOTIFS; ROLES; IDENTIFICATION; ORGANIZATION; EXPRESSION; LANDSCAPE; GERMLINE	We systematically generated large-scale data sets to improve genome annotation for the nematode Caenorhabditis elegans, a key model organism. These data sets include transcriptome profiling across a developmental time course, genome-wide identification of transcription factor-binding sites, and maps of chromatin organization. From this, we created more complete and accurate gene models, including alternative splice forms and candidate noncoding RNAs. We constructed hierarchical networks of transcription factor-binding and microRNA interactions and discovered chromosomal locations bound by an unusually large number of transcription factors. Different patterns of chromatin composition and histone modification were revealed between chromosome arms and centers, with similarly prominent differences between autosomes and the X chromosome. Integrating data types, we built statistical models relating chromatin, transcription factor binding, and gene expression. Overall, our analyses ascribed putative functions to most of the conserved genome.	[Gerstein, Mark B.; Lu, Zhi John; Cheng, Chao; Yip, Kevin Y.; Robilotto, Rebecca; Alves, Pedro; Auerbach, Raymond K.; Leng, Jing; Alexander, Roger P.; Habegger, Lukas; Lochovsky, Lucas; Rozowsky, Joel; Sboner, Andrea; Shou, Chong; Yan, Koon-Kiu] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark B.; Lu, Zhi John; Cheng, Chao; Yip, Kevin Y.; Agarwal, Ashish; Alexander, Roger P.; Rozowsky, Joel; Sasidharan, Rajkumar; Sboner, Andrea; Yan, Koon-Kiu] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.; Agarwal, Ashish; Du, Jiang] Yale Univ, Dept Comp Sci, New Haven, CT 06511 USA; [Van Nostrand, Eric L.; Brdlik, Cathleen M.; Brouillet, Jeremy Jean; Kim, Stuart K.; Snyder, Michael] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Arshinoff, Bradley I.; Perry, Marc; Feng, Xin; Kephart, Ellen; Lloyd, Paul; Ruzanov, Peter; Zha, Zheng; Stein, Lincoln] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Arshinoff, Bradley I.; Stein, Lincoln] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Liu, Tao; Shin, Hyunjin; Taing, Scott; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Tao; Shin, Hyunjin; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Ikegami, Kohta; Brennan, Jennifer; Ercan, Sevinc; Jensen, Morten; Whittle, Christina M.; Zhou, Xingliang; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Ikegami, Kohta; Brennan, Jennifer; Ercan, Sevinc; Jensen, Morten; Whittle, Christina M.; Zhou, Xingliang; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Chateigner, Aurelien; Carr, Adrian; Contrino, Sergio; Gullier, Francois; Lyne, Rachel; Rutherford, Kim; Smith, Richard; Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Chateigner, Aurelien; Carr, Adrian; Contrino, Sergio; Gullier, Francois; Lyne, Rachel; Rutherford, Kim; Smith, Richard; Micklem, Gos] Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Morris, Mitzi; Rhrissorrakrai, Kahn; Gutwein, Michelle; Khurana, Ekta; Mangone, Marco; Mecenas, Desirea; Scheid, Paul; Gunsalus, Kristin C.; Piano, Fabio] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Vielle, Anne; Cheung, Ming-Sin; Kolasinska-Zwierz, Paulina; Latorre, Isabel; Ahringer, Julie] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Niu, Wei; Euskirchen, Ghia; Zhong, Mei; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06824 USA; [Niu, Wei; Janette, Judith; Wang, Guilin; Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Dannenberg, Luke O.; Holster, Heather; Iniguez, A. Leo; Rosenbaum, Heidi] Roche NimbleGen, Madison, WI 53719 USA; [Dernburg, Abby F.; Dose, Andrea C.; Pham, Hoang] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dernburg, Abby F.; Dose, Andrea C.; Pham, Hoang] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Desai, Arshad; Gassmann, Reto; Muroyama, Andrew; Voronina, Ksenia] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Ewing, Brent; Green, Phil; Leahey, Amber; MacCoss, Michael; Merrihew, Gennifer; Murray, John I.; Preston, Elicia A.; Vafeados, Dionne; Hillier, LaDeana W.; Waterston, Robert H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Feingold, Elise A.; Good, Peter J.; Guyer, Mark S.; Lowdon, Rebecca F.] NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; [Feng, Xin] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Han, Ting; Khivansara, Vishal; Kim, John K.] Univ Michigan, Inst Life Sci, Dept Human Genet, Ann Arbor, MI 48109 USA; [Henikoff, Jorja G.; Ooi, Siew-Loon; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Raetsch, Gunnar; Zeller, Georg] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Hyman, Tony; Sarov, Mihail] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Miller, David M., III; Spencer, William C.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Kato, Masaomi; Slack, Frank J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Henz, Stefan R.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Lai, Eric C.] Sloan Kettering Inst, New York, NY 10065 USA; [Lewis, Suzanna; Stinson, E. O.; Washington, Nicole L.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Lubling, Yaniv; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Mackowiak, Sebastian D.; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Div Syst Biol, D-13125 Berlin, Germany; [Mckay, Sheldon; Stein, Lincoln] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11542 USA; [Slightam, Cindie; Wu, Beijing; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Zeller, Georg] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Gunsalus, Kristin C.; Piano, Fabio] NYU, Abu Dhabi, U Arab Emirates; [Dick, Lindsay] Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10065 USA	Yale University; Yale University; Yale University; Stanford University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge; University of Cambridge; New York University; University of Cambridge; Yale University; Yale University; University of California System; University of California Santa Cruz; Roche Holding; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; Eberhard Karls University of Tubingen; Max Planck Society; Max Planck Society; Vanderbilt University; Yale University; Max Planck Society; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Weizmann Institute of Science; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Cold Spring Harbor Laboratory; Stanford University; European Molecular Biology Laboratory (EMBL); Rockefeller University	Gerstein, MB (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, Bass 432,266 Whitney Ave, New Haven, CT 06520 USA.	modencode.worm.pi@gersteinlab.org	Lai, Eric C/A-3412-2008; Khurana, Ekta/C-4933-2013; Clawson, Hiram/ABE-6101-2020; Liu, Tao/AAO-6310-2021; NUI, WEI/B-8300-2011; Hyman, Anthony A/B-3917-2017; Gassmann, Reto/M-6488-2013; Lai, Eric/AAO-1143-2021; Sboner, Andrea/C-6487-2008; Spencer, William/E-8529-2010; Segal, Eran/AAF-4855-2019; Rutherford, Kim/Y-7995-2018; Hyman, Tony/F-1923-2011; Chateigner, Aurelien/AAC-9143-2020; Yip, Kevin/AAT-4771-2020; Alexander, Roger/A-8643-2008; Hinrichs, Angie S./H-9159-2019; Zeller, Georg/M-6484-2013; Liu, Tao/G-3585-2010; Yan, Koon-Kiu/A-5940-2009; Lyne, Rachel/AAE-2189-2020; KHIVANSARA, VISHAL/P-7702-2019; Mackowiak, Sebastian D/S-3266-2017; Mangone, Marco/H-2462-2016	Liu, Tao/0000-0002-8818-8313; Hyman, Anthony A/0000-0003-3664-154X; Gassmann, Reto/0000-0002-0360-2977; Lai, Eric/0000-0002-8432-5851; Sboner, Andrea/0000-0001-6915-3070; Rutherford, Kim/0000-0001-6277-726X; Yip, Kevin/0000-0001-5516-9944; Alexander, Roger/0000-0002-2967-7395; Hinrichs, Angie S./0000-0002-1697-1130; Zeller, Georg/0000-0003-1429-7485; Liu, Tao/0000-0002-8818-8313; Lyne, Rachel/0000-0001-8050-402X; KHIVANSARA, VISHAL/0000-0003-2574-5298; Mackowiak, Sebastian D/0000-0003-1673-5389; Rajewsky, Nikolaus/0000-0002-4785-4332; Van Nostrand, Eric/0000-0002-5188-0082; Muroyama, Andrew/0000-0003-0701-212X; Clawson, Hiram/0000-0002-0480-0545; Henikoff, Steven/0000-0002-7621-8685; Rechtsteiner, Andreas/0000-0001-6031-1087; Mangone, Marco/0000-0001-7551-8793; McKay, Sheldon/0000-0002-4011-3160; Micklem, Gos/0000-0002-6883-6168; Ratsch, Gunnar/0000-0001-5486-8532; Segal, Eran/0000-0002-6859-1164; Liu, Tao/0000-0003-0446-9001; Lewis, Suzanna/0000-0002-8343-612X; Lubling, Yaniv/0000-0003-3461-9621; Latorre, Isabel/0000-0003-0638-1783; Snyder, Michael/0000-0003-0784-7987; Dernburg, Abby/0000-0001-8037-1079; contrino, sergio/0000-0003-3409-5231; Slack, Frank/0000-0001-8263-0409; Lloyd, Paul/0000-0003-3508-5553; Rozowsky, Joel/0000-0002-3565-0762; Ahringer, Julie/0000-0002-7074-4051	NHGRI of the NIH [R01GM088565]; Muscular Dystrophy Association; Pew Charitable Trusts; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); Wellcome Trust; William H. Gates III Endowed Chair of Biomedical Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088565] Funding Source: NIH RePORTER	NHGRI of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Muscular Dystrophy Association(Muscular Dystrophy Association); Pew Charitable Trusts; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); Wellcome Trust(Wellcome TrustEuropean Commission); William H. Gates III Endowed Chair of Biomedical Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work came from the NHGRI of the NIH as part of the modENCODE project, NIH (grant R01GM088565), Muscular Dystrophy Association, and the Pew Charitable Trusts (J.K.K.); the Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network) (S.D.M.); the Wellcome Trust (J.A.); the William H. Gates III Endowed Chair of Biomedical Sciences (R.H.W.); and the A. L. Williams Professorship (M.B.G.). M. Snyder has an advisory role with DNANexus, a DNA sequence storage and analysis company. Transfer of GFP-tagged fosmids requires a Materials Transfer Agreement with the Max Planck Institute of Molecular Cell Biology and Genetics. Raw microarray data are available from the Gene Expression Omnibus archive, and raw sequencing data are available from the SRA archive (accessions are in table S18). We appreciate help from S. Anthony, K. Bell, C. Davis, C. Dieterich, Y. Field, A. S. Hammonds, J. Jo, N. Kaplan, A. Manrai, B. Mathey-Prevot, R. McWhirter, S. Mohr, S. Von Stetina, J. Watson, K. Watkins, C. Xue, and Y. Zhang, and B. Carpenter. We thank C. Jan and D. Bartel for sharing data on poly(A) sites before publication, WormBase curator G. Williams for assistance in quality checking and preparing the transcriptomics data sets for publication, as well as his fellow curator P. Davis for reviewing and hand-checking the list of pseudogenes.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARNES TM, 1995, GENETICS, V141, P159; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bickel P. J., 2010, ANN APPL STAT, V0, P1; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; EDGAR LG, 1994, DEVELOPMENT, V120, P443; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; Ercan S, 2009, CURR BIOL, V19, P1777, DOI 10.1016/j.cub.2009.09.047; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Ikegami K., GENOME RES, DOI [10.1186/gb-2010-11-12-r120, DOI 10.1186/GB-2010-11-12-R120]; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jans J, 2009, GENE DEV, V23, P602, DOI 10.1101/gad.1751109; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamesch P, 2004, GENOME RES, V14, P2064, DOI 10.1101/gr.2496804; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Lu ZJ, 2011, GENOME RES, V21, P276, DOI 10.1101/gr.110189.110; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Meyer BJ., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.8.1, DOI 10.1895/WORMBOOK.1.8.1]; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Ooi SL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1090; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Riddle D. L, 1997, C ELEGANS, P47; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Stoeckius M, 2009, NAT METHODS, V6, P745, DOI [10.1038/nmeth.1370, 10.1038/NMETH.1370]; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103	76	685	691	0	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1775	1787		10.1126/science.1196914	http://dx.doi.org/10.1126/science.1196914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21177976	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000285603700031
J	Kapoor, A; Goldberg, MS; Cumberland, LK; Ratnakumar, K; Segura, MF; Emanuel, PO; Menendez, S; Vardabasso, C; LeRoy, G; Vidal, CI; Polsky, D; Osman, I; Garcia, BA; Hernando, E; Bernstein, E				Kapoor, Avnish; Goldberg, Matthew S.; Cumberland, Lara K.; Ratnakumar, Kajan; Segura, Miguel F.; Emanuel, Patrick O.; Menendez, Silvia; Vardabasso, Chiara; LeRoy, Gary; Vidal, Claudia I.; Polsky, David; Osman, Iman; Garcia, Benjamin A.; Hernando, Eva; Bernstein, Emily			The histone variant macroH2A suppresses melanoma progression through regulation of CDK8	NATURE			English	Article							INACTIVE X-CHROMOSOME; CORE HISTONE; CANCER; METASTASIS; EXPRESSION; GENE; TRANSCRIPTION; STAGE; LINES	Cancer is a disease consisting of both genetic and epigenetic changes. Although increasing evidence demonstrates that tumour progression entails chromatin-mediated changes such as DNA methylation, the role of histone variants in cancer initiation and progression currently remains unclear. Histone variants replace conventional histones within the nucleosome and confer unique biological functions to chromatin(1-3). Here we report that the histone variant macroH2A (mH2A) suppresses tumour progression of malignant melanoma. Loss of mH2A isoforms, histone variants generally associated with condensed chromatin and fine-tuning of developmental gene expression programs(1,4-6), is positively correlated with increasing malignant phenotype of melanoma cells in culture and human tissue samples. Knockdown of mH2A isoforms in melanoma cells of low malignancy results in significantly increased proliferation and migration in vitro and growth and metastasis in vivo. Restored expression of mH2A isoforms rescues these malignant phenotypes in vitro and in vivo. We demonstrate that the tumour-promoting function of mH2A loss is mediated, at least in part, through direct transcriptional upregulation of CDK8. Suppression of CDK8, a colorectal cancer oncogene(7,8), inhibits proliferation of melanoma cells, and knockdown of CDK8 in cells depleted of mH2A suppresses the proliferative advantage induced by mH2A loss. Moreover, a significant inverse correlation between mH2A and CDK8 expression levels exists in melanoma patient samples. Taken together, our results demonstrate that mH2A is a critical component of chromatin that suppresses the development of malignant melanoma, a highly intractable cutaneous neoplasm.	[Kapoor, Avnish; Goldberg, Matthew S.; Cumberland, Lara K.; Ratnakumar, Kajan; Vardabasso, Chiara; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Kapoor, Avnish; Goldberg, Matthew S.; Cumberland, Lara K.; Ratnakumar, Kajan; Emanuel, Patrick O.; Vardabasso, Chiara; Vidal, Claudia I.; Bernstein, Emily] Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA; [Emanuel, Patrick O.; Vidal, Claudia I.] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [Segura, Miguel F.; Menendez, Silvia; Polsky, David; Hernando, Eva] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Polsky, David; Osman, Iman] NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA; [Segura, Miguel F.; Menendez, Silvia; Polsky, David; Osman, Iman; Hernando, Eva] NYU, Interdisciplinary Melanoma Cooperat Grp, Langone Med Ctr, New York, NY 10016 USA; [LeRoy, Gary; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Princeton University	Bernstein, E (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA.	emily.bernstein@mssm.edu	Polsky, David/AAO-6254-2020; Grieshaber-Bouyer, Ricardo/R-7512-2016; Segura, Miguel F/J-4749-2013	Polsky, David/0000-0001-9554-5289; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Segura, Miguel F/0000-0003-0916-3618; Hernando, Eva/0000-0003-1023-0312	American Skin Association; American Society for Mass Spectrometry; New Jersey Commission on Cancer Research; National Science Foundation [CBET-0941143]; National Institutes of Health [CA109388]; Sergei S. Zlinkoff Fund for Medical Education; New York University Cancer Institute Cancer Center [5P30CA016087-27]; Marc Jacobs Campaign; NYSTEM IDEA [C024291]; Harry L. Lloyd Charitable Trust; Ellison Medical Foundation; Tisch Cancer Institute; NCI [R21CA150117]; NATIONAL CANCER INSTITUTE [R21CA150117, R21CA109388, P30CA016087] Funding Source: NIH RePORTER	American Skin Association; American Society for Mass Spectrometry; New Jersey Commission on Cancer Research; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sergei S. Zlinkoff Fund for Medical Education; New York University Cancer Institute Cancer Center; Marc Jacobs Campaign; NYSTEM IDEA; Harry L. Lloyd Charitable Trust; Ellison Medical Foundation(Lawrence Ellison Foundation); Tisch Cancer Institute; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Hannon, S. Hake and M. Wirtz for reading this manuscript; J. Doucette for statistical support; the laboratories of S. Aaronson, J. Aguirre-Ghiso, D. Burstein and M. O'Connell for discussions and advice; M. Lebwohl, S. Mercer, J. Emer and G. Singer for dermatology and pathology support. We also thank N. Mall, L. Murray, S. Malu and S. Mungamuri for technical assistance; J. Pehrson, M. Narita, A. Aplin, H. Wei, A. Ting, S. Young Kim, M. Herlyn and J. Espinosa for reagents; T. Chu (Mount Sinai School of Medicine Microarray SRF) for data analysis; Q. Yu, the New York University Interdisciplinary Melanoma Cooperative Group and Mount Sinai Biorepository Cooperative for melanoma specimens. This work was supported by an American Skin Association Medical Student Grant to M. S. G., American Society for Mass Spectrometry Award, New Jersey Commission on Cancer Research Seed Grant, and National Science Foundation CBET-0941143 to B. A. G., National Institutes of Health CA109388 and the Sergei S. Zlinkoff Fund for Medical Education to D. P., New York University Cancer Institute Cancer Center Support Grant (5P30CA016087-27) and Marc Jacobs Campaign to I.O., NYSTEM IDEA C024291 and Harry L. Lloyd Charitable Trust to E. H., and an American Skin Association Research Scholar Award, Ellison Medical Foundation New Scholar Award, Tisch Cancer Institute Developmental Funds and NCI R21CA150117 to E.B.	Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Costanzi C, 2001, J BIOL CHEM, V276, P21776, DOI 10.1074/jbc.M010919200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; QIAN F, 1994, CELL, V77, P335, DOI 10.1016/0092-8674(94)90149-X; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Thambirajah AA, 2009, BIOCHEM CELL BIOL, V87, P7, DOI 10.1139/O08-103; Yancovitz M, 2007, J MOL DIAGN, V9, P178, DOI 10.2353/jmoldx.2007.060135; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	30	284	299	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1105	U509		10.1038/nature09590	http://dx.doi.org/10.1038/nature09590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179167	Green Accepted			2022-12-01	WOS:000285553800059
J	Mozaffarian, D; Cao, HM; King, IB; Lemaitre, RN; Song, XL; Siscovick, DS; Hotamisligil, GS				Mozaffarian, Dariush; Cao, Haiming; King, Irena B.; Lemaitre, Rozenn N.; Song, Xiaoling; Siscovick, David S.; Hotamisligil, Goekhan S.			Trans-Palmitoleic Acid, Metabolic Risk Factors, and New-Onset Diabetes in U.S. Adults A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CONJUGATED LINOLEIC-ACID; DE-NOVO LIPOGENESIS; NONFATAL MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE SYNDROME; SERUM-CHOLESTEROL ESTERS; ISCHEMIC-HEART-DISEASE; C-REACTIVE PROTEIN; DAIRY FAT INTAKE; ADIPOSE-TISSUE; HIGH-CARBOHYDRATE	Background: Palmitoleic acid (cis-16:1n-7), which is produced by endogenous fat synthesis, has been linked to both beneficial and deleterious metabolic effects, potentially confounded by diverse determinants and tissue sources of endogenous production. Trans-palmitoleate (trans-16:1n-7) represents a distinctly exogenous source of 16:1n-7, unconfounded by endogenous synthesis or its determinants, that may be uniquely informative. Objective: To investigate whether circulating trans-palmitoleate is independently related to lower metabolic risk and incident type 2 diabetes. Design: Prospective cohort study from 1992 to 2006. Setting: Four U.S. communities. Patients: 3736 adults in the Cardiovascular Health Study. Measurements: Anthropometric characteristics and levels of plasma phospholipid fatty acids, blood lipids, inflammatory markers, and glucose-insulin measured at baseline in 1992 and dietary habits measured 3 years earlier. Multivariate-adjusted models were used to investigate how demographic, clinical, and lifestyle factors independently related to plasma phospholipid trans-palmitoleate; how trans-palmitoleate related to major metabolic risk factors; and how trans-palmitoleate related to new-onset diabetes (304 incident cases). Findings were validated for metabolic risk factors in an independent cohort of 327 women. Results: In multivariate analyses, whole-fat dairy consumption was most strongly associated with higher trans-palmitoleate levels. Higher trans-palmitoleate levels were associated with slightly lower adiposity and, independently, with higher high-density lipoprotein cholesterol levels (1.9% across quintiles; P = 0.040), lower triglyceride levels (-19.0%; P < 0.001), a lower total cholesterol-HDL cholesterol ratio (-4.7%; P < 0.001), lower C-reactive protein levels (-13.8%; P = 0.05), and lower insulin resistance (-16.7%, P < 0.001). Trans-palmitoleate was also associated with a substantially lower incidence of diabetes, with multivariate hazard ratios of 0.41 (95% CI, 0.27 to 0.64) and 0.38 (CI, 0.24 to 0.62) in quintiles 4 and 5 versus quintile 1 (P for trend < 0.001). Findings were independent of estimated dairy consumption or other fatty acid dairy biomarkers. Protective associations with metabolic risk factors were confirmed in the validation cohort. Limitation: Results could be affected by measurement error or residual confounding. Conclusion: Circulating trans-palmitoleate is associated with lower insulin resistance, presence of atherogenic dyslipidemia, and incident diabetes. Our findings may explain previously observed metabolic benefits of dairy consumption and support the need for detailed further experimental and clinical investigation.	[Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; NIH, Bethesda, MD 20892 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; University of New Mexico; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Cao, Haiming/P-4634-2016; Mozaffarian, Dariush/B-2276-2008		National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01-HL085710, DK064360, DK71507-04, N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079, -85086, N01-HC-15103, N01-HC-55222, U01-HL080295]; Searle Scholar Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045133, N01HC085084, N01HC075150, N01HC085086, N01HC085083, N01HC085080, N01HC035129, N01HC055222, N01HC085085, N01HC085079, N01HC015103, N01HC085081, N01HC085082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL085710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, R90DK071507, R01DK064360] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Searle Scholar Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.; By the National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (grants R01-HL085710, DK064360, and DK71507-04 and grants N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through -85086, N01-HC-15103, N01-HC-55222, and U01-HL080295 for the CHS), with additional contributions from the National Institutes of Health Office of Dietary Supplements and National Institute of Neurological Disorders and Stroke. A subset of additional fatty acid measurements was supported by a Searle Scholar Award.	Azadbakht L, 2005, AM J CLIN NUTR, V82, P523, DOI 10.1093/ajcn/82.3.523; Barazzoni R, 2003, DIABETES, V52, P1851, DOI 10.2337/diabetes.52.7.1851; Baumgard LH, 2002, J DAIRY SCI, V85, P2155, DOI 10.3168/jds.S0022-0302(02)74294-X; Beydoun MA, 2008, AM J CLIN NUTR, V87, P1914, DOI 10.1093/ajcn/87.6.1914; Brevik A, 2005, EUR J CLIN NUTR, V59, P1417, DOI 10.1038/sj.ejcn.1602256; CAMBIEN F, 1988, AM J EPIDEMIOL, V127, P75, DOI 10.1093/oxfordjournals.aje.a114793; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chardigny JM, 2008, AM J CLIN NUTR, V87, P558, DOI 10.1093/ajcn/87.3.558; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Devaraj S, 2009, CURR OPIN LIPIDOL, V20, P182, DOI 10.1097/MOL.0b013e32832ac03e; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Elwood PC, 2008, J AM COLL NUTR, V27, p723S, DOI 10.1080/07315724.2008.10719750; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gertow K, 2006, EUR J CLIN NUTR, V60, P1406, DOI 10.1038/sj.ejcn.1602471; Harvatine KJ, 2009, J NUTR, V139, P849, DOI 10.3945/jn.108.099994; Harvey-Berino J, 2005, OBES RES, V13, P1720, DOI 10.1038/oby.2005.210; Hodgson JM, 1996, ATHEROSCLEROSIS, V120, P147, DOI 10.1016/0021-9150(95)05696-3; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Hudgins LC, 2008, J NUTR BIOCHEM, V19, P237, DOI 10.1016/j.jnutbio.2007.02.013; Iggman D, 2010, DIABETOLOGIA, V53, P850, DOI 10.1007/s00125-010-1669-0; King IB, 2006, AM J CLIN NUTR, V83, P227; Kumanyika SK, 1997, AM J CLIN NUTR, V65, P1123; Kusunoki Masataka, 2007, J Med Invest, V54, P243, DOI 10.2152/jmi.54.243; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; LEPAGE G, 1986, J LIPID RES, V27, P114; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lindgarde F, 2006, AM J CLIN NUTR, V84, P1009, DOI 10.1093/ajcn/84.5.1009; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maguire LS, 2004, INT J FOOD SCI NUTR, V55, P171, DOI 10.1080/09637480410001725175; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; Micha R, 2010, AM J CLIN NUTR, V91, P883, DOI 10.3945/ajcn.2009.28877; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Motard-Belanger A, 2008, AM J CLIN NUTR, V87, P593, DOI 10.1093/ajcn/87.3.593; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2010, AM J CLIN NUTR  1013; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Okada T, 2005, AM J CLIN NUTR, V82, P747, DOI 10.1093/ajcn/82.4.747; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Petersson H, 2009, ATHEROSCLEROSIS, V203, P298, DOI 10.1016/j.atherosclerosis.2008.06.020; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Riserus U, 2004, AM J CLIN NUTR, V79, p1146S; Rosell M, 2006, AM J CLIN NUTR, V84, P1481, DOI 10.1093/ajcn/84.6.1481; ROSNER B, 1977, AM J EPIDEMIOL, V106, P306, DOI 10.1093/oxfordjournals.aje.a112466; ROSSNER S, 1989, INT J OBESITY, V13, P603; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; SALOMAA V, 1990, METABOLISM, V39, P1285, DOI 10.1016/0026-0495(90)90185-F; Sarabi M, 2001, ATHEROSCLEROSIS, V156, P349, DOI 10.1016/S0021-9150(00)00658-4; Sauma L, 2006, NUTRITION, V22, P60, DOI 10.1016/j.nut.2005.04.011; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Simon JA, 1996, HYPERTENSION, V27, P303, DOI 10.1161/01.HYP.27.2.303; SOMMERFELD M, 1983, PROG LIPID RES, V22, P221, DOI 10.1016/0163-7827(83)90010-3; Stefan N, 2010, DIABETES CARE, V33, P405, DOI [10.2337/dc09-0544, 10.2337/dc10-0002]; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Tremblay A, 2009, J AM COLL NUTR, V28, p91S, DOI 10.1080/07315724.2009.10719809; Vergnaud AC, 2008, AM J CLIN NUTR, V88, P1248, DOI 10.3945/ajcn.2007.25151; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/BF00400468; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Willett W, 2008, AM J CLIN NUTR, V87, P515, DOI 10.1093/ajcn/87.3.515; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291; Wolk A, 2001, J NUTR, V131, P828, DOI 10.1093/jn/131.3.828; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67	69	265	285	2	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					790	+		10.7326/0003-4819-153-12-201012210-00005	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173413	Green Accepted			2022-12-01	WOS:000285453700002
J	Akavia, UD; Litvin, O; Kim, J; Sanchez-Garcia, F; Kotliar, D; Causton, HC; Pochanard, P; Mozes, E; Garraway, LA; Pe'er, D				Akavia, Uri David; Litvin, Oren; Kim, Jessica; Sanchez-Garcia, Felix; Kotliar, Dylan; Causton, Helen C.; Pochanard, Panisa; Mozes, Eyal; Garraway, Levi A.; Pe'er, Dana			An Integrated Approach to Uncover Drivers of Cancer	CELL			English	Article							GENE-EXPRESSION; MELANOMA; MITF; IDENTIFICATION; TRANSFORMATION; INTERFERENCE; REGULATORS; NETWORKS; MODULES; PROTEIN	Systematic characterization of cancer genomes has revealed a staggering number of diverse aberrations that differ among individuals, such that the functional importance and physiological impact of most tumor genetic alterations remain poorly defined. We developed a computational framework that integrates chromosomal copy number and gene expression data for detecting aberrations that promote cancer progression. We demonstrate the utility of this framework using a melanoma data set. Our analysis correctly identified known drivers of melanoma and predicted multiple tumor dependencies. Two dependencies, TBC1D16 and RAB27A, confirmed empirically, suggest that abnormal regulation of protein trafficking contributes to proliferation in melanoma. Together, these results demonstrate the ability of integrative Bayesian approaches to identify candidate drivers with biological, and possibly therapeutic, importance in cancer.	[Akavia, Uri David; Litvin, Oren; Sanchez-Garcia, Felix; Kotliar, Dylan; Causton, Helen C.; Mozes, Eyal; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Akavia, Uri David; Litvin, Oren; Pe'er, Dana] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Kim, Jessica; Pochanard, Panisa; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, Jessica; Pochanard, Panisa; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Columbia University; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	dpeer@biology.columbia.edu	Lin, Jessica J/U-3020-2019; Akavia, Uri David/P-8437-2019	Causton, Helen/0000-0003-4630-6569; Pe'er, Dana/0000-0002-9259-8817	National Institutes of Health Roadmap Initiative; NIH [1-DP2-OD002414-01]; National Centers for Biomedical Computing [1U54CA121852-01A1]; Burroughs Wellcome Fund; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414] Funding Source: NIH RePORTER	National Institutes of Health Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Biomedical Computing; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors will like to thank Nir Hacohen, Antonio Iavarone, Daphne Koller, Liz Miller, Itsik Pe'er, Suzanne Pfeffer, Neal Rosen, and Olga Troyanskaya for valuable comments. This research was supported by the National Institutes of Health Roadmap Initiative, NIH Director's New Innovator Award Program through grant number 1-DP2-OD002414-01, and National Centers for Biomedical Computing Grant 1U54CA121852-01A1. D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Jordens I., 2006, CELL RES, V19, P412; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Pearl, 2000, CAUSALITY; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Sanchez-Garcia F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-189; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang L., 2009, CANCER SCI, V100, P1801; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Ying HQ, 2010, P NATL ACAD SCI USA, V107, P6912, DOI 10.1073/pnas.0914930107; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	42	349	356	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					1005	1017		10.1016/j.cell.2010.11.013	http://dx.doi.org/10.1016/j.cell.2010.11.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21129771	Green Accepted, Bronze			2022-12-01	WOS:000285182600016
J	Li, L; Jose, J; Xiang, Y; Kuhn, RJ; Rossmann, MG				Li, Long; Jose, Joyce; Xiang, Ye; Kuhn, Richard J.; Rossmann, Michael G.			Structural changes of envelope proteins during alphavirus fusion	NATURE			English	Article							SEMLIKI-FOREST-VIRUS; PH-DEPENDENT FUSION; CLASS-II VIRUS; SINDBIS VIRUS; CONFORMATIONAL-CHANGE; DYNAMIC ENVELOPE; MEMBRANE-FUSION; GLYCOPROTEIN; PRECURSOR; E3	Alphaviruses are enveloped RNA viruses that have a diameter of about 700 angstrom and can be lethal human pathogens(1). Entry of virus into host cells by endocytosis is controlled by two envelope glycoproteins, E1 and E2. The E2-E1 heterodimers form 80 trimeric spikes on the icosahedral virus surface(1,2), 60 with quasi-three-fold symmetry and 20 coincident with the icosahedral three-fold axes arranged with T 54 quasi-symmetry. The E1 glycoprotein has a hydrophobic fusion loop at one end and is responsible for membrane fusion(3,4). The E2 protein is responsible for receptor binding(5,6) and protects the fusion loop at neutral pH. The lower pH in the endosome induces the virions to undergo an irreversible conformational change in which E2 and E1 dissociate and E1 forms homotrimers, triggering fusion of the viral membrane with the endosomal membrane and then releasing the viral genome into the cytoplasm(3,4). Here we report the structure of an alphavirus spike, crystallized at low pH, representing an intermediate in the fusion process and clarifying the maturation process. The trimer of E2-E1 in the crystal structure is similar to the spikes in the neutral pH virus except that the E2 middle region is disordered, exposing the fusion loop. The amino-and carboxy-terminal domains of E2 each form immunoglobulin-like folds, consistent with the receptor attachment properties of E2.	[Li, Long; Jose, Joyce; Xiang, Ye; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mr@purdue.edu	Li, Long/F-8892-2010; Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; Xiang, Ye/0000-0003-0230-9522	NIH [P01 AI055672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank S. Sun, A. Aksyuk and T. Edwards for discussions. We are also grateful to S. Kelly for help in the preparation of the manuscript. We thank F. Rey for sharing the coordinates of Chikungunya virus E2-E1 to help interpret the Sindbis virus cryo-EM density of the E2 domain B. We would like to thank the staff at the Advanced Photon Source, Argonne National Laboratory, GM/CA sector for their help in data collection. The work was supported by NIH grant P01 AI055672 to R.J.K. and M.G.R.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DUBUISSON J, 1993, J VIROL, V67, P3363, DOI 10.1128/JVI.67.6.3363-3374.1993; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferlenghi I, 1998, J MOL BIOL, V283, P71, DOI 10.1006/jmbi.1998.2066; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GRIFFIN DE, 1995, SEMIN VIROL, V6, P249, DOI 10.1006/smvy.1995.0030; HEIDNER HW, 1994, J VIROL, V68, P2683, DOI 10.1128/JVI.68.4.2683-2692.1994; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; Lehr RV, 2000, PROTEIN EXPRES PURIF, V19, P362, DOI 10.1006/prep.2000.1258; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen KE, 1996, J VIROL, V70, P2757, DOI 10.1128/JVI.70.5.2757-2763.1996; Paredes AM, 1998, J VIROL, V72, P1534, DOI 10.1128/JVI.72.2.1534-1541.1998; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sharff AJ, 2000, ACTA CRYSTALLOGR D, V56, P785, DOI 10.1107/S090744490000370X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; STRAUSS EG, 1991, J VIROL, V65, P4654, DOI 10.1128/JVI.65.9.4654-4664.1991; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; WAHLBERG JM, 1989, J VIROL, V63, P4991, DOI 10.1128/JVI.63.12.4991-4997.1989; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; WHITE J, 1980, J CELL BIOL, V87, P264, DOI 10.1083/jcb.87.1.264; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu SR, 2008, J BIOL CHEM, V283, P26452, DOI 10.1074/jbc.M801470200; Wu SR, 2007, J BIOL CHEM, V282, P6752, DOI 10.1074/jbc.M609125200; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2005, VIROLOGY, V332, P511, DOI 10.1016/j.virol.2004.11.043; Zhang W, 2002, J VIROL, V76, P11645, DOI 10.1128/JVI.76.22.11645-11658.2002; Zhang XY, 2004, VIROLOGY, V327, P287, DOI 10.1016/j.virol.2004.06.037; ZIEMIECKI A, 1978, J MOL BIOL, V122, P259, DOI 10.1016/0022-2836(78)90189-4; ZIEMIECKI A, 1980, J GEN VIROL, V50, P111, DOI 10.1099/0022-1317-50-1-111	45	217	222	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					705	U131		10.1038/nature09546	http://dx.doi.org/10.1038/nature09546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124457	Green Accepted			2022-12-01	WOS:000284836700043
J	Seitzinger, S				Seitzinger, Sybil			A sustainable planet needs scientists to think ahead	NATURE			English	Editorial Material									Int Geosphere Biosphere Programme, Stockholm, Sweden		Seitzinger, S (corresponding author), Int Geosphere Biosphere Programme, Stockholm, Sweden.	Sybil.seitzinger@igbp.kva.se							0	4	4	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 2	2010	468	7324					601	601		10.1038/468601a	http://dx.doi.org/10.1038/468601a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	688GB	21124410	Bronze			2022-12-01	WOS:000284836700004
J	Pitman, RK				Pitman, Roger K.			A Recent VA Rules Change and the Traumatic Event Requirement in PTSD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pitman, Roger K.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Pitman, Roger K.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pitman, RK (corresponding author), MGH E, Massachusetts Gen Hosp, 120 2nd Ave, Charlestown, MA 02129 USA.	roger_pitman@hms.harvard.edu						American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890423349; DAO J, 2010, NEW YORK TIMES  1220, pA1; First M.B., 2004, DSM 4 T GUIDEBOOK; SATEL S, 2010, WALL STREET J   0717, pW3; SHINSEKI E, 2010, US TODAY        0712, pA9; US Department of Veterans Affairs, 2010, FED REGISTER, P39843; WEATHERS FA, 2009, PRACTICE GUIDELINES, P23	8	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2409	2410		10.1001/jama.2010.1739	http://dx.doi.org/10.1001/jama.2010.1739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119089				2022-12-01	WOS:000284763900024
J	Culler, SJ; Hoff, KG; Smolke, CD				Culler, Stephanie J.; Hoff, Kevin G.; Smolke, Christina D.			Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins	SCIENCE			English	Article							KAPPA-B; EXPRESSION; SELECTION; ACTIVATION; EVOLUTION; MICRORNA; APTAMER	Synthetic genetic devices that interface with native cellular pathways can be used to change natural networks to implement new forms of control and behavior. The engineering of gene networks has been limited by an inability to interface with native components. We describe a class of RNA control devices that overcome these limitations by coupling increased abundance of particular proteins to targeted gene expression events through the regulation of alternative RNA splicing. We engineered RNA devices that detect signaling through the nuclear factor kappa B and Wnt signaling pathways in human cells and rewire these pathways to produce new behaviors, thereby linking disease markers to noninvasive sensing and reprogrammed cellular fates. Our work provides a genetic platform that can build programmable sensing-actuation devices enabling autonomous control over cellular behavior.	[Culler, Stephanie J.; Hoff, Kevin G.; Smolke, Christina D.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Smolke, Christina D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California Institute of Technology; Stanford University	Smolke, CD (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 210-41, Pasadena, CA 91125 USA.	csmolke@stanford.edu	Taylor, Graham/A-4027-2012		Caltech Joseph Jacobs Institute for Molecular Engineering for Medicine; NIH; U.S. Department of Defense; Alfred P. Sloan Foundation; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091298] Funding Source: NIH RePORTER	Caltech Joseph Jacobs Institute for Molecular Engineering for Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hertel for providing the pHis-BIVT-MS2-RSp55 construct, M. Jensen for providing pCD19t-Tk-T2A-IL15op_epHIV7, L. J. Maher for providing pGAD24, and B. Stewart for laboratory assistance. This work was supported by the Caltech Joseph Jacobs Institute for Molecular Engineering for Medicine (grant to C. D. S.), the NIH (fellowship to K. G. H., grant to C. D. S.), the U.S. Department of Defense (grant to C. D. S.), the Alfred P. Sloan Foundation (fellowship to C. D. S.), and the Bill and Melinda Gates Foundation (grant to C. D. S.). The authors have filed for a patent related to this work.	Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Beltinger C, 1999, P NATL ACAD SCI USA, V96, P8699, DOI 10.1073/pnas.96.15.8699; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; CAREY J, 1983, BIOCHEMISTRY-US, V22, P4723, DOI 10.1021/bi00289a017; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chan R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj028; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Culler SJ, 2010, NUCLEIC ACIDS RES, V38, P5152, DOI 10.1093/nar/gkq248; Davidson EA, 2007, NAT CHEM BIOL, V3, P23, DOI 10.1038/nchembio846; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Hellweg CE, 2006, ANN NY ACAD SCI, V1091, P191, DOI 10.1196/annals.1378.066; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kim DS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-23; Lee HK, 2007, CANCER RES, V67, P9315, DOI 10.1158/0008-5472.CAN-07-1128; Lifang Yang, 2008, J Exp Clin Cancer Res, V27, P42, DOI 10.1186/1756-9966-27-42; Link KH, 2009, GENE THER, V16, P1189, DOI 10.1038/gt.2009.81; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mi J, 2006, NUCLEIC ACIDS RES, V34, P3577, DOI 10.1093/nar/gkl482; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Song Y, 2006, INT J GYNECOL CANCER, V16, P156, DOI 10.1111/j.1525-1438.2006.00470.x; Suess B, 2008, RNA BIOL, V5, P24, DOI 10.4161/rna.5.1.5955; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Villemaire J, 2003, J BIOL CHEM, V278, P50031, DOI 10.1074/jbc.M308897200; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011; Wurster SE, 2008, RNA, V14, P1037, DOI 10.1261/rna.878908	30	206	218	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1251	1255		10.1126/science.1192128	http://dx.doi.org/10.1126/science.1192128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109673	Green Accepted			2022-12-01	WOS:000284613700044
J	Akiyoshi, B; Sarangapani, KK; Powers, AF; Nelson, CR; Reichow, SL; Arellano-Santoyo, H; Gonen, T; Ranish, JA; Asbury, CL; Biggins, S				Akiyoshi, Bungo; Sarangapani, Krishna K.; Powers, Andrew F.; Nelson, Christian R.; Reichow, Steve L.; Arellano-Santoyo, Hugo; Gonen, Tamir; Ranish, Jeffrey A.; Asbury, Charles L.; Biggins, Sue			Tension directly stabilizes reconstituted kinetochore-microtubule attachments	NATURE			English	Article							SINGLE KINESIN MOLECULES; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC SPINDLE; PROTEIN-KINASE; CATCH BONDS; AURORA B; COMPLEX; MITOSIS; FORCE	Kinetochores are macromolecular machines that couple chromosomes to dynamic microtubule tips during cell division, thereby generating force to segregate the chromosomes(1,2). Accurate segregation depends on selective stabilization of correct 'bi-oriented' kinetochore-microtubule attachments, which come under tension as the result of opposing forces exerted by microtubules(3). Tension is thought to stabilize these bi-oriented attachments indirectly, by suppressing the destabilizing activity of a kinase, Aurora B-4,B-5. However, a complete mechanistic understanding of the role of tension requires reconstitution of kinetochore-microtubule attachments for biochemical and biophysical analyses in vitro. Here we show that native kinetochore particles retaining the majority of kinetochore proteins can be purified from budding yeast and used to reconstitute dynamic microtubule attachments. Individual kinetochore particles maintain load-bearing associations with assembling and disassembling ends of single microtubules for >30 min, providing a close match to the persistent coupling seen in vivo between budding yeast kinetochores and single microtubules(6). Moreover, tension increases the lifetimes of the reconstituted attachments directly, through a catch bond-like mechanism that does not require Aurora B7-10. On the basis of these findings, we propose that tension selectively stabilizes proper kinetochore-microtubule attachments in vivo through a combination of direct mechanical stabilization and tension-dependent phosphoregulation.	[Akiyoshi, Bungo; Nelson, Christian R.; Arellano-Santoyo, Hugo; Biggins, Sue] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Akiyoshi, Bungo; Arellano-Santoyo, Hugo] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Sarangapani, Krishna K.; Powers, Andrew F.; Arellano-Santoyo, Hugo; Asbury, Charles L.] Univ Washington, Dept Physiol Biophys, Seattle, WA 98195 USA; [Reichow, Steve L.; Gonen, Tamir] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Gonen, Tamir] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ranish, Jeffrey A.] Inst Syst Biol, Seattle, WA 98103 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB)	Biggins, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	casbury@u.washington.edu; sbiggins@fhcrc.org		Akiyoshi, Bungo/0000-0001-6010-394X; Biggins, Susan/0000-0002-4499-6319; Reichow, Steve/0000-0001-5276-7690	NSF IGERT [DGE-0504573]; NIH [T32GM07270, T32HL007312, GM078069, GM064386]; NCI Cancer Center [CA015704]; NIGMS [PM50 GM076547, R01GM79373]; Searle Scholar Award [06-L-111]; Packard Fellowship for Science and Engineering [2006-30521]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM078069, R01GM064386, R01GM079373, T32GM007270] Funding Source: NIH RePORTER	NSF IGERT(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Searle Scholar Award; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Desai for antibodies, and J. Kilmartin, G. Barnes, D. Pellman, R. Tsien and the Yeast Resource Center for strains and plasmids. We also thank M. Press for constructing the Cse4-GFP strain, M. Yuan at the ISB for help, and the Seattle Mitosis Club for comments. We are grateful to T. Davis, W. Thomas, B. Zagotta, T. Tsukiyama, J. Stumpff, F. Rieke, S. Gordon and the Biggins lab for comments on the manuscript. This work was supported by an NSF IGERT fellowship (DGE-0504573) and NIH traineeship (T32GM07270) to A.F.P., an NIH Cardiovascular Pathology traineeship (T32HL007312) to K.K.S., a Beckman Young Investigator grant to S.B., NIH grants (GM078069 and GM064386) to S.B., an NCI Cancer Center Support grant (CA015704) and an NIGMS grant (PM50 GM076547/Center for Systems Biology) to J.A.R., a Searle Scholar Award (06-L-111) to C.L.A., a Packard Fellowship for Science and Engineering (2006-30521) to C.L.A. and an NIGMS grant (R01GM79373) to C.L.A. S.B. is a Scholar of the Leukemia and Lymphoma Society and T.G. is a Howard Hughes Medical Institute Early Career Scientist.	Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Enquist-Newman M, 2001, MOL BIOL CELL, V12, P2601, DOI 10.1091/mbc.12.9.2601; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Franck AD, 2010, METHODS, V51, P242, DOI 10.1016/j.ymeth.2010.01.020; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gestaut DR, 2010, METHOD CELL BIOL, V95, P641, DOI 10.1016/S0091-679X(10)95032-2; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Kitamura E, 2007, GENE DEV, V21, P3319, DOI 10.1101/gad.449407; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; ROSE MD, 1990, METHODS YEAST GENETI; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; SIKORSKI RS, 1989, GENETICS, V122, P19; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	39	303	306	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					576	U255		10.1038/nature09594	http://dx.doi.org/10.1038/nature09594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	21107429	Green Accepted, Green Submitted			2022-12-01	WOS:000284584200045
J	Kidd, JM; Graves, T; Newman, TL; Fulton, R; Hayden, HS; Malig, M; Kallicki, J; Kaul, R; Wilson, RK; Eichler, EE				Kidd, Jeffrey M.; Graves, Tina; Newman, Tera L.; Fulton, Robert; Hayden, Hillary S.; Malig, Maika; Kallicki, Joelle; Kaul, Rajinder; Wilson, Richard K.; Eichler, Evan E.			A Human Genome Structural Variation Sequencing Resource Reveals Insights into Mutational Mechanisms	CELL			English	Article							DOUBLE-STRAND BREAKS; COPY-NUMBER; L1 RETROTRANSPOSITION; RECOMBINATION; REPEATS; IDENTIFICATION; DELETIONS; COMMON; TRANSDUCTION; POLYMORPHISM	Understanding the prevailing mutational mechanisms responsible for human genome structural variation requires uniformity in the discovery of allelic variants and precision in terms of breakpoint delineation. We develop a resource based on capillary end sequencing of 13.8 million fosmid clones from 17 human genomes and characterize the complete sequence of 1054 large structural variants corresponding to 589 deletions, 384 insertions, and 81 inversions. We analyze the 2081 breakpoint junctions and infer potential mechanism of origin. Three mechanisms account for the bulk of germline structural variation: microhomology-mediated processes involving short (2-20 bp) stretches of sequence (28%), nonallelic homologous recombination (22%), and L1 retrotransposition (19%). The high quality and long-range continuity of the sequence reveals more complex mutational mechanisms, including repeat-mediated inversions and gene conversion, that are most often missed by other methods, such as comparative genomic hybridization, single nucleotide polymorphism microarrays, and next-generation sequencing.	[Kidd, Jeffrey M.; Newman, Tera L.; Hayden, Hillary S.; Malig, Maika; Kaul, Rajinder; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Graves, Tina; Fulton, Robert; Kallicki, Joelle; Wilson, Richard K.] Washington Univ, Genome Sequencing Ctr, Sch Med, St Louis, MO 63108 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Washington University (WUSTL); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; Kidd, Jeffrey/0000-0002-9631-1465; Kaul, Rajinder/0000-0002-7895-9284	National Science Foundation; National Institutes of Health [HG004120]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG004120] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Smith and the staff at Agencourt Biosciences for library production, E. Kirkness and staff of the J. Craig Venter Institute for end-sequence data from the JVCI library, and L. Chen for computational assistance in the mapping of end-sequence data. We thank S. Girirajan, J. Moran, and C. Payen for thoughtful discussion; T. Brown for manuscript preparation assistance; and members of the University of Washington and Washington University Genome Centers for assistance with data generation. J.M.K. is supported by a National Science Foundation Graduate Research Fellowship. This work was supported by the National Institutes of Health Grant HG004120 to E.E.E., who is an investigator of the Howard Hughes Medical Institute. E.E.E is on the scientific advisory board for Pacific Biosciences. T.L.N. is an employee and founder of iGenix Inc.	Abe H, 2009, HEPATOL RES, V39, P1159, DOI 10.1111/j.1872-034X.2009.00566.x; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; An P, 2009, J INFECT DIS, V200, P1054, DOI 10.1086/605644; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Buard J, 2000, AM J HUM GENET, V67, P333, DOI 10.1086/303015; Chiaromonte F, 2002, Pac Symp Biocomput, P115; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lagerstedt K, 1997, HUM MOL GENET, V6, P627, DOI 10.1093/hmg/6.4.627; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Smit A., 1996, REPEATMASKER OPEN 3; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Szak ST, 2002, GENOME BIOL, V3; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Witherspoon DJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-410	62	187	191	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					837	847		10.1016/j.cell.2010.10.027	http://dx.doi.org/10.1016/j.cell.2010.10.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111241	Green Accepted, Bronze			2022-12-01	WOS:000284583500024
J	Ciocchi, S; Herry, C; Grenier, F; Wolff, SBE; Letzkus, JJ; Vlachos, I; Ehrlich, I; Sprengel, R; Deisseroth, K; Stadler, MB; Muller, C; Luthi, A				Ciocchi, Stephane; Herry, Cyril; Grenier, Francois; Wolff, Steffen B. E.; Letzkus, Johannes J.; Vlachos, Ioannis; Ehrlich, Ingrid; Sprengel, Rolf; Deisseroth, Karl; Stadler, Michael B.; Mueller, Christian; Luethi, Andreas			Encoding of conditioned fear in central amygdala inhibitory circuits	NATURE			English	Article							LONG-TERM POTENTIATION; CENTRAL NUCLEUS; SYNAPTIC PLASTICITY; PROJECTION NEURONS; RAT; COMPLEX; ORGANIZATION; FOREBRAIN; TRANSMISSION; MECHANISMS	The central amygdala (CEA), a nucleus predominantly composed of GABAergic inhibitory neurons, is essential for fear conditioning. How the acquisition and expression of conditioned fear are encoded within CEA inhibitory circuits is not understood. Using in vivo electrophysiological, optogenetic and pharmacological approaches in mice, we show that neuronal activity in the lateral subdivision of the central amygdala (CEl) is required for fear acquisition, whereas conditioned fear responses are driven by output neurons in the medial subdivision (CEm). Functional circuit analysis revealed that inhibitory CEA microcircuits are highly organized and that cell-type-specific plasticity of phasic and tonic activity in the CEl to CEm pathway may gate fear expression and regulate fear generalization. Our results define the functional architecture of CEA microcircuits and their role in the acquisition and regulation of conditioned fear behaviour.	[Ciocchi, Stephane; Herry, Cyril; Grenier, Francois; Wolff, Steffen B. E.; Letzkus, Johannes J.; Ehrlich, Ingrid; Stadler, Michael B.; Mueller, Christian; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Vlachos, Ioannis] Bernstein Ctr Computat Neurosci, D-79104 Freiburg, Germany; [Sprengel, Rolf] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Friedrich Miescher Institute for Biomedical Research; Max Planck Society; Stanford University	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	andreas.luthi@fmi.ch	Yan, Shuo/B-8381-2009; Herry, Cyril/AAP-9902-2020; Ehrlich, Ingrid/G-8551-2015	Herry, Cyril/0000-0003-2973-0843; Ehrlich, Ingrid/0000-0001-9078-2429; Ciocchi, Stephane/0000-0002-5701-9250; Letzkus, Johannes/0000-0001-5678-3030	Austrian Science Fund (FWF); Swiss National Science Foundation; Schering Foundation; European Commission [HEALTH-F2-2009-241498]; Indo Swiss Joint Research Programme; BMBF [01GQ0420]; Neurex Interreg-IV; Volkswagen Stiftung; Novartis Institutes for Biomedical Research; Novartis Research Foundation	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schering Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Indo Swiss Joint Research Programme; BMBF(Federal Ministry of Education & Research (BMBF)); Neurex Interreg-IV; Volkswagen Stiftung(Volkswagen); Novartis Institutes for Biomedical Research; Novartis Research Foundation	We thank all members of the Luthi laboratory for discussions and critical comments on the manuscript. This work was supported by grants from the Austrian Science Fund (FWF), the Swiss National Science Foundation, the Schering Foundation, the European Commission (Eurospin Project, Contract HEALTH-F2-2009-241498), the Indo Swiss Joint Research Programme, the BMBF (grant 01GQ0420 to BCCN Freiburg), Neurex Interreg-IV, the Volkswagen Stiftung, the Novartis Institutes for Biomedical Research, and the Novartis Research Foundation.	Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Davis M., 2000, AMYGDALA, P213; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fu Y, 2005, J NEUROPHYSIOL, V93, P3012, DOI 10.1152/jn.00871.2004; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Jolkkonen E, 2002, NEUROSCIENCE, V111, P133, DOI 10.1016/S0306-4522(01)00578-4; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; Lang EJ, 1997, J NEUROPHYSIOL, V77, P353, DOI 10.1152/jn.1997.77.1.353; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Linke R, 2000, EXP BRAIN RES, V134, P520, DOI 10.1007/s002210000475; Lopez de Armentia M, 2007, J PHYSIOL-LONDON, V581, P961, DOI 10.1113/jphysiol.2007.101822; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MILLHOUSE OE, 1986, J COMP NEUROL, V247, P246, DOI 10.1002/cne.902470209; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; PASCOE JP, 1985, BEHAV BRAIN RES, V16, P117, DOI 10.1016/0166-4328(85)90087-7; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Roberto M, 2003, P NATL ACAD SCI USA, V100, P2053, DOI 10.1073/pnas.0437926100; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Samson RD, 2005, REV NEUROSCIENCE, V16, P287; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; SUN N, 1994, J COMP NEUROL, V340, P43, DOI 10.1002/cne.903400105; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; THOMPSON RF, 1962, J COMP PHYSIOL PSYCH, V55, P279, DOI 10.1037/h0047856; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; VEENING JG, 1984, BRAIN RES, V303, P337, DOI 10.1016/0006-8993(84)91220-4; Veinante P, 2003, ANN NY ACAD SCI, V985, P552; Wickens JR, 2007, PROG BRAIN RES, V160, P313, DOI 10.1016/S0079-6123(06)60018-6; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	46	614	627	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					277	U239		10.1038/nature09559	http://dx.doi.org/10.1038/nature09559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21068837				2022-12-01	WOS:000284051000045
J	Ganten, D; Haines, A; Souhami, R				Ganten, Detlev; Haines, Andy; Souhami, Robert			Health co-benefits of policies to tackle climate change	LANCET			English	Editorial Material							STRATEGIES		[Ganten, Detlev] German Natl Acad Sci Leopoldina, D-06108 Halle, Germany; [Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Souhami, Robert] Acad Med Sci, London, England	University of London; London School of Hygiene & Tropical Medicine	Ganten, D (corresponding author), German Natl Acad Sci Leopoldina, D-06108 Halle, Germany.	detlev.ganten@charite.de		Haines, Andy/0000-0002-8053-4605				*AC MED SCI, 2009, MIT CLIM CHANG IMPR; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Gill M, 2009, LANCET, V374, P1953, DOI 10.1016/S0140-6736(09)61830-4; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; *INT MED PAN, 2010, STAT HLTH COB POL TA; Markandya A, 2009, LANCET, V374, P2006, DOI 10.1016/S0140-6736(09)61715-3; NHS Sustainable Development Unit, 2008, NHS ENGL CARB EM CAR; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Stern N., 2007, EC CLIMATE CHANGE; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	11	28	28	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2010	376	9755					1802	1804		10.1016/S0140-6736(10)62139-3	http://dx.doi.org/10.1016/S0140-6736(10)62139-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KG	21111893				2022-12-01	WOS:000285439700005
J	Basu, U; Meng, FL; Keim, C; Grinstein, V; Pefanis, E; Eccleston, J; Zhang, TT; Myers, D; Wasserman, CR; Wesemann, DR; Januszyk, K; Gregory, RI; Deng, HT; Lima, CD; Alt, FW				Basu, Uttiya; Meng, Fei-Long; Keim, Celia; Grinstein, Veronika; Pefanis, Evangelos; Eccleston, Jennifer; Zhang, Tingting; Myers, Darienne; Wasserman, Caitlyn R.; Wesemann, Duane R.; Januszyk, Kurt; Gregory, Richard I.; Deng, Haiteng; Lima, Christopher D.; Alt, Frederick W.			The RNA Exosome Targets the AID Cytidine Deaminase to Both Strands of Transcribed Duplex DNA Substrates	CELL			English	Article							CLASS SWITCH RECOMBINATION; CHROMOSOMAL R-LOOPS; PROTEIN-KINASE-A; POLYMERASE-II; SOMATIC HYPERMUTATION; MECHANISM; REGIONS; SEQUENCE; REPAIR; BREAKS	Activation-induced cytidine deaminase (AID) initiates immunoglobulin (Ig) heavy-chain (IgH) class switch recombination (CSR) and Ig variable region somatic hypermutation (SHM) in B lymphocytes by deaminating cytidines on template and nontemplate strands of transcribed DNA substrates. However, the mechanism of AID access to the template DNA strand, particularly when hybridized to a nascent RNA transcript, has been an enigma. We now implicate the RNA exosome, a cellular RNA-processing/degradation complex, in targeting AID to both DNA strands. In B lineage cells activated for CSR, the RNA exosome associates with AID, accumulates on IgH switch regions in an AID-dependent fashion, and is required for optimal CSR. Moreover, both the cellular RNA exosome complex and a recombinant RNA exosome core complex impart robust AID-and transcription-dependent DNA deamination of both strands of transcribed SHM substrates in vitro. Our findings reveal a role for noncoding RNA surveillance machinery in generating antibody diversity.	[Basu, Uttiya; Meng, Fei-Long; Eccleston, Jennifer; Zhang, Tingting; Myers, Darienne; Wasserman, Caitlyn R.; Wesemann, Duane R.; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Program Cellular & Mol Med,Dept Genet,Childrens H, Boston, MA 02115 USA; [Basu, Uttiya; Meng, Fei-Long; Eccleston, Jennifer; Zhang, Tingting; Myers, Darienne; Wasserman, Caitlyn R.; Wesemann, Duane R.; Alt, Frederick W.] Harvard Univ, Sch Med, Immune Dis Inst, Childrens Hosp Boston,Dept Genet, Boston, MA 02115 USA; [Basu, Uttiya; Keim, Celia; Grinstein, Veronika; Pefanis, Evangelos] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Deng, Haiteng] Rockefeller Univ, Prote Res Ctr, New York, NY 10065 USA; [Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Harvard Stem Cell Inst,Childrens Hosp Boston, Boston, MA 02115 USA; [Januszyk, Kurt; Lima, Christopher D.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Deng, Haiteng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Columbia University; Rockefeller University; Harvard University; Boston Children's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Tsinghua University	Basu, U (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Program Cellular & Mol Med,Dept Genet,Childrens H, 300 Longwood Ave, Boston, MA 02115 USA.	ub2121@columbia.edu; alt@enders.tch.harvard.edu		Lima, Christopher/0000-0002-9163-6092; Deng, Haiteng/0000-0001-9496-1280; Wesemann, Duane/0000-0002-6690-944X; Meng, Feilong/0000-0003-0333-6872	National Institute of Health [AI31541, GM079196]; Columbia University; Regeneron Pharmaceuticals; Cancer Biology training grant [CA09503-23]; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031541, R37AI077595, R01AI077595, U19AI031541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079196] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University; Regeneron Pharmaceuticals(Regeneron); Cancer Biology training grant; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bjoern Schwer, Jason Rodriguez, Stephen Goff, Bruce Stillman, and Tasuku Honjo for providing reagents and/or protocols. We also thank Bjoern Schwer and Cosmas Giallourakis for critically reading the manuscript. This work was supported by National Institute of Health grants AI31541 (to F. W. A.) and GM079196 (to K.J. and C. D. L.); by Trustees of Columbia University Faculty startup funds (to U. B.); and by funds from Regeneron Pharmaceuticals (in support of E. P.). F.-L. M. is a fellow of Cancer Research Institute of New York. C. K. was supported by a Cancer Biology training grant CA09503-23. K.J. is a fellow of the American Cancer Society (PF-10-236-01-RMC). U. B. is a Special Fellow of the Leukemia and Lymphoma Society of America and the recipient of a New Investigator Award from the Leukemia Research Foundation. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Anderson JR, 2006, RNA, V12, P1810, DOI 10.1261/rna.144606; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2008, MOL CELL, V32, P285, DOI 10.1016/j.molcel.2008.08.019; Besmer E, 2006, MOL CELL BIOL, V26, P4378, DOI 10.1128/MCB.02375-05; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Gomez-Gonzalez B, 2007, P NATL ACAD SCI USA, V104, P8409, DOI 10.1073/pnas.0702836104; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang FT, 2007, MOL CELL BIOL, V27, P5921, DOI 10.1128/MCB.00702-07; Huang FT, 2006, P NATL ACAD SCI USA, V103, P5030, DOI 10.1073/pnas.0506548103; Jensen TH, 2005, CELL, V121, P660, DOI 10.1016/j.cell.2005.05.018; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; LUTZKER S, 1988, MOL CELL BIOL, V8, P1849, DOI 10.1128/MCB.8.4.1849; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Oddone A, 2007, EMBO REP, V8, P63, DOI 10.1038/sj.embor.7400856; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Shen V, 2006, CELL, V127, P1093, DOI 10.1016/j.cell.2006.11.035; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yang Shu Yuan, 2007, Adv Immunol, V94, P109, DOI 10.1016/S0065-2776(06)94004-8; Yu KF, 2003, DNA REPAIR, V2, P1163, DOI 10.1016/j.dnarep.2003.08.010; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137	80	221	232	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					353	363		10.1016/j.cell.2011.01.001	http://dx.doi.org/10.1016/j.cell.2011.01.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21255825	Green Accepted, Bronze			2022-12-01	WOS:000286973100008
J	Song, MS; Carracedo, A; Salmena, L; Song, SJ; Egia, A; Malumbres, M; Pandolfi, PP				Song, Min Sup; Carracedo, Arkaitz; Salmena, Leonardo; Song, Su Jung; Egia, Ainara; Malumbres, Marcos; Pandolfi, Pier Paolo			Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner	CELL			English	Article							SMALL-MOLECULE INHIBITOR; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; GROWTH IN-VIVO; AURORA KINASES; CELLULAR SENESCENCE; MUTATIONAL SPECTRA; CHROMOSOME-10 PTEN; GENOMIC STABILITY; EXPRESSION; GENE	PTEN is a frequently mutated tumor suppressor gene that opposes the PI3K/AKT pathway through dephosphorylation of phosphoinositide-3,4,5-triphosphate. Recently, nuclear compartmentalization of PTEN was found as a key component of its tumor-suppressive activity; however its nuclear function remains poorly defined. Here we show that nuclear PTEN interacts with APC/C, promotes APC/C association with CDH1, and thereby enhances the tumor-suppressive activity of the APC-CDH1 complex. We find that nuclear exclusion but not phosphatase inactivation of PTEN impairs APC-CDH1. This nuclear function of PTEN provides a straightforward mechanistic explanation for the fail-safe cellular senescence response elicited by acute PTEN loss and the tumor-suppressive activity of catalytically inactive PTEN. Importantly, we demonstrate that PTEN mutant and PTEN null states are not synonymous as they are differentially sensitive to pharmacological inhibition of APC-CDH1 targets such as PLK1 and Aurora kinases. This finding identifies a strategy for cancer patient stratification and, thus, optimization of targeted therapies.	[Song, Min Sup; Carracedo, Arkaitz; Salmena, Leonardo; Song, Su Jung; Egia, Ainara; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA; [Malumbres, Marcos] CNIO, Cell Div & Canc Grp, Mol Oncol Programme, Madrid 28029, Spain	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Centro Nacional de Investigaciones Oncologicas (CNIO)	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Malumbres, Marcos/E-8834-2011; Carracedo, Arkaitz/F-7029-2011	Malumbres, Marcos/0000-0002-0829-6315; Carracedo, Arkaitz/0000-0001-5957-1260; Salmena, Leonardo/0000-0003-4023-658X; Pandolfi, Pier Paolo/0000-0002-5352-5295	NIH; European Molecular Biology Organization; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to former and present members of the Pandolfi lab for experimental support, advice, or discussion. We are thankful to Drs. Manuel Serrano, Pumin Zhang, Wenyi Wei, and Hongtao Yu for providing reagents. We thank Dr. John Asara for mass-spectrometric analysis. This work was supported by NIH grants to P.P.P. A.C. is supported by a Long-Term Fellowship Award from the European Molecular Biology Organization, and L.S. is supported by a Fellowship from the Canadian Institutes of Health Research.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Cairns P, 1997, CANCER RES, V57, P4997; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Georgescu MM, 2000, CANCER RES, V60, P7033; Gildea JJ, 2004, ONCOGENE, V23, P6788, DOI 10.1038/sj.onc.1207599; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Ginn-Pease ME, 2003, CANCER RES, V63, P282; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; Koul D, 2002, ONCOGENE, V21, P2357, DOI 10.1038/sj/onc/1205296; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li DM, 1997, CANCER RES, V57, P2124; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Manchado E, 2010, BIOCHEM SOC T, V38, P65, DOI 10.1042/BST0380065; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Okumura K, 2005, CELL CYCLE, V4, P540, DOI 10.4161/cc.4.4.1614; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; RUBIN SJ, 1991, J SURG ONCOL, V46, P31, DOI 10.1002/jso.2930460108; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wang CX, 2000, BLOOD, V96, P259, DOI 10.1182/blood.V96.1.259.013k36_259_263; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	56	275	300	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					187	199		10.1016/j.cell.2010.12.020	http://dx.doi.org/10.1016/j.cell.2010.12.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241890	Green Accepted, Bronze			2022-12-01	WOS:000286459900005
J	Tseng, HF; Smith, N; Harpaz, R; Bialek, SR; Sy, LS; Jacobsen, SJ				Tseng, Hung Fu; Smith, Ning; Harpaz, Rafael; Bialek, Stephanie R.; Sy, Lina S.; Jacobsen, Steven J.			Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLUENZA VACCINE; VARICELLA; EFFICACY; HOSPITALIZATIONS; EPIDEMIOLOGY; OPHTHALMICUS; MANAGEMENT; ACCURACY; CHILDREN; HISTORY	Context Approximately 1 million episodes of herpes zoster occur annually in the United States. Although prelicensure data provided evidence that herpes zoster vaccine works in a select study population under idealized circumstances, the vaccine needs to be evaluated in field conditions. Objective To evaluate risk of herpes zoster after receipt of herpes zoster vaccine among individuals in general practice settings. Design, Setting, and Participants A retrospective cohort study from January 1, 2007, through December 31, 2009, of individuals enrolled in the Kaiser Permanente Southern California health plan. Participants were immunocompetent community-dwelling adults aged 60 years or older. The 75 761 members in the vaccinated cohort were age matched (1:3) to 227 283 unvaccinated members. Main Outcome Measure Incidence of herpes zoster. Results Herpes zoster vaccine recipients were more likely to be white, women, with more outpatient visits, and fewer chronic diseases. The number of herpes zoster cases among vaccinated individuals was 828 in 130 415 person-years (6.4 per 1000 person-years; 95% confidence interval [CI], 5.9-6.8), and for unvaccinated individuals it was 4606 in 355 659 person-years (13.0 per 1000 person-years; 95% CI, 12.6-13.3). In adjusted analysis, vaccination was associated with a reduced risk of herpes zoster (hazard ratio [HR], 0.45; 95% CI, 0.42-0.48); this reduction occurred in all age strata and among individuals with chronic diseases. Risk of herpes zoster differed by vaccination status to a greater magnitude than the risk of unrelated acute medical conditions, suggesting results for herpes zoster were not due to bias. Ophthalmic herpes zoster (HR, 0.37; 95% CI, 0.23-0.61) and hospitalizations coded as herpes zoster (HR, 0.35; 95% CI, 0.24-0.51) were less likely among vaccine recipients. Conclusions Among immunocompetent community-dwelling adults aged 60 years or older, receipt of the herpes zoster vaccine was associated with a lower incidence of herpes zoster. The risk was reduced among all age strata and among individuals with chronic diseases. JAMA. 2011; 305(2): 160-166	[Tseng, Hung Fu; Smith, Ning; Sy, Lina S.; Jacobsen, Steven J.] So Calif Kaiser Permanente, Dept Res & Evaluat, Pasadena, CA USA; [Harpaz, Rafael; Bialek, Stephanie R.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Kaiser Permanente; Centers for Disease Control & Prevention - USA	Tseng, HF (corresponding author), Kaiser Permanente, So Calif Med Grp, Dept Res & Evaluat, 100 S Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	Hung-Fu.x.Tseng@kp.org	Sy, Lina/AFM-9458-2022	Sy, Lina/0000-0003-2762-9266; Jacobsen, Steven/0000-0002-8174-8533	Merck	Merck(Merck & Company)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Tseng, Smith, and Jacobsen and Ms Sy report having received research funding from Merck for other vaccine studies. Dr Jacobsen reports having served as an unpaid consultant for Merck Research Laboratories. Drs Harpaz and Bialek report no disclosures.	BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Clemens J, 1996, JAMA-J AM MED ASSOC, V275, P390, DOI 10.1001/jama.275.5.390; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Hicks LD, 2008, ARCH DERMATOL, V144, P603, DOI 10.1001/archderm.144.5.603; Hurley LP, 2010, ANN INTERN MED, V152, P555, DOI 10.7326/0003-4819-152-9-201005040-00005; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2008, CLIN INFECT DIS, V47, P754, DOI 10.1086/591132; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; Leung J, ANN INTERN IN PRESS; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Liesegang TJ, 2008, OPHTHALMOLOGY, V115, pS3, DOI 10.1016/j.ophtha.2007.10.009; Lin F, 2000, J INFECT DIS, V181, P1897, DOI 10.1086/315492; Lindley M, 2010, 44 NAT IMM C APR 19; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; Merck & Co, MERCK CO ZOSTAVAX ZO; Merck Research Laboratories, 2005, MERCK RES LAB VACC R; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Nelson JC, 2009, J CLIN EPIDEMIOL, V62, P687, DOI 10.1016/j.jclinepi.2008.06.014; Okamoto S, 2009, J INFECT DIS, V200, P1606, DOI 10.1086/644646; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Schiller JS, 2008, VACCINATION COVERAGE; Schmader K, 1998, J INFECT DIS, V178, pS67, DOI 10.1086/514254; Severson EA, 2003, ARCH OPHTHALMOL-CHIC, V121, P386, DOI 10.1001/archopht.121.3.386; Shaikh S, 2002, AM FAM PHYSICIAN, V66, P1723; Sy LS, 2010, VACCINE, V28, P5254, DOI 10.1016/j.vaccine.2010.05.061; Tate JE, 2009, PEDIATRICS, V123, P744, DOI 10.1542/peds.2008-1200; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tseng HF, 2010, PEDIATR INFECT DIS J, V29, P205, DOI 10.1097/INF.0b013e3181bc379b; Weinberg GA, 2010, J INFECT DIS, V201, P1607, DOI 10.1086/652404; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	36	151	157	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					160	166		10.1001/jama.2010.1983	http://dx.doi.org/10.1001/jama.2010.1983			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224457	Bronze			2022-12-01	WOS:000286103400021
J	Deer, B				Deer, Brian			Secrets of the MMR scare How the vaccine crisis was meant to make money	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	43	44	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2011	342								c5258	10.1136/bmj.c5258	http://dx.doi.org/10.1136/bmj.c5258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SO	21224310				2022-12-01	WOS:000286384800029
J	Kelly, B; Whiteley, A; Tallmon, D				Kelly, Brendan; Whiteley, Andrew; Tallmon, David			The Arctic melting pot	NATURE			English	Editorial Material									[Kelly, Brendan] NOAA, Natl Marine Mammal Lab, Juneau, AK 99801 USA; [Whiteley, Andrew] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Tallmon, David] Univ Alaska SE, Fac Biol & Marine Biol, Juneau, AK 99801 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Massachusetts System; University of Massachusetts Amherst; University of Alaska System; University of Alaska Southeastern	Kelly, B (corresponding author), NOAA, Natl Marine Mammal Lab, Juneau, AK 99801 USA.	brendan.kelly@noaa.gov		Whiteley, Andrew/0000-0002-8159-6381					0	74	75	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 16	2010	468	7326					891	891		10.1038/468891a	http://dx.doi.org/10.1038/468891a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164461				2022-12-01	WOS:000285344600019
J	Cohen, D; Carter, P				Cohen, Deborah; Carter, Philip			Diabetes How small changes led to big profits for insulin manufacturers	BRITISH MEDICAL JOURNAL			English	Editorial Material							PEOPLE		[Cohen, Deborah] BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						[Anonymous], 2010, CONCLUSIONS AVOCAT G; Cameron CG, 2009, CAN MED ASSOC J, V180, P400, DOI 10.1503/cmaj.081180; Cummins E, 2010, HLTH TECHNOL ASSESS, V14; Currie CJ, 2010, DIABETIC MED, V27, P938, DOI 10.1111/j.1464-5491.2010.03040.x; Diabetes Health Intelligence, 2009, PRESCR DIAB ENGL UPD; Diabetes UK, 2010, DIAB UK 2010 KEY STA; Druglibcom, INS GLARG REC CHEM B; Hauber A, 2006, DIABETOLOGIA, V49, P247, DOI 10.1007/s00125-005-0108-0; Holleman F, 2007, DIABETOLOGIA, V50, P1783, DOI 10.1007/s00125-007-0763-4; Home PD, 2010, DIABETES OBES METAB, V12, P772, DOI 10.1111/j.1463-1326.2010.01232.x; IMS Health Midas, 2009, TOP 15 GLOB THER CLA; JORGENSEN S, 1989, BRIT MED J, V299, P415, DOI 10.1136/bmj.299.6696.415; Medicines and Healthcare Products Regulatory Agency, 2004, SAN AV ASHF NURS INC; NICE, 2008, TYP 2 DIAB MAN TYP 2; Novo Nordisk, 2010, NOVO NORDISK NOVO NO; Novo Nordisk, 2010, NOV NORD A S Q4 2009; Pharmaceutical Marketing Society, NHS JOINT WORK IN AC; Presciption Medicines Code of Practice Authority, 2004, COD PRACT REV, P122; Presciption Medicines Code of Practice Authority, 2007, COMPL CAS E LILL VER; Rosenstock J, 2009, DIABETOLOGIA, V52, P1778, DOI 10.1007/s00125-009-1415-7; Sanofi-aventis, 2010, DIAB ONC IR THEM SEM; Sanofi-aventis, 2010, DIAB ROUNDT; Watermeadow Medical, 2007, ED PROGR NOM AW	23	12	12	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 15	2010	341								c7139	10.1136/bmj.c7139	http://dx.doi.org/10.1136/bmj.c7139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XJ	21159773				2022-12-01	WOS:000285552800006
J	Kim, KP; Weiner, BM; Zhang, LR; Jordan, A; Dekker, J; Kleckner, N				Kim, Keun P.; Weiner, Beth M.; Zhang, Liangran; Jordan, Amy; Dekker, Job; Kleckner, Nancy			Sister Cohesion and Structural Axis Components Mediate Homolog Bias of Meiotic Recombination	CELL			English	Article							DOUBLE-STRAND BREAK; SYNAPTONEMAL COMPLEX-FORMATION; CHROMATID COHESION; CHIASMA FORMATION; CROSSING-OVER; MEK1 KINASE; MEIOSIS; ORGANIZATION; TRANSITION; CROSSOVER	Meiotic double-strand break (DSB)-initiated recombination must occur between homologous maternal and paternal chromosomes ("homolog bias"), even though sister chromatids are present. Through physical recombination analyses, we show that sister cohesion, normally mediated by meiotic cohesin Rec8, promotes "sister bias"; that meiosis-specific axis components Red1/Mek1kinase counteract this effect, thereby satisfying an essential precondition for homolog bias; and that other components, probably recombinosome-related, directly ensure homolog partner selection. Later, Rec8 acts positively to ensure maintenance of bias. These complexities mirror opposing dictates for global sister cohesion versus local separation and differentiation of sisters at recombination sites. Our findings support DSB formation within axis-tethered recombinosomes containing both sisters and ensuing programmed sequential release of "first" and "second" DSB ends. First-end release would create a homology-searching "tentacle." Rec8 and Red1/Mek1 also independently license recombinational progression and abundantly localize to different domains. These domains could comprise complementary environments that integrate inputs from DSB repair and mitotic chromosome morphogenesis into the complete meiotic program.	[Kim, Keun P.; Weiner, Beth M.; Zhang, Liangran; Jordan, Amy; Dekker, Job; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01655 USA; [Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	Harvard University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu		zhang, liangran/0000-0002-8550-6742; Kim, Keun/0000-0002-5973-8259	National Institutes of Health [GM-044794]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kleckner laboratory members and many other colleagues for helpful comments, A. Amon for Tet repressor/operator and pREC8-MCD1 strains, and N. Hollingsworth for mek1as. Research was supported by National Institutes of Health Grant GM-044794 to N.K.	Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Callender TL, 2010, GENETICS, V185, P771, DOI 10.1534/genetics.110.117523; Cha R.S., 2000, GENE DEV, V14, P493; Covo S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001006; Diaz-Martinez LA, 2008, J CELL SCI, V121, P2107, DOI 10.1242/jcs.029132; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Joshi N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000557; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lao JP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000519; Latypov V, 2010, MOL CELL BIOL, V30, P1570, DOI 10.1128/MCB.00919-09; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Malone RE, 2004, EUKARYOT CELL, V3, P598, DOI 10.1128/EC.3.3.598-609.2004; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Niu H., 2005, MOL BIOL CELL, V16, P5804; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sanchez-Moran E., 2007, GENE DEV, V21, P2220; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Sheridan S., 2006, GENE DEV, V20, P1685; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Terentyev Y, 2010, NUCLEIC ACIDS RES, V38, P4349, DOI 10.1093/nar/gkq137; Thompson DA, 1999, GENETICS, V153, P621; Wu HY, 2010, CURR BIOL, V20, P1707, DOI 10.1016/j.cub.2010.09.016; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	48	170	171	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					924	937		10.1016/j.cell.2010.11.015	http://dx.doi.org/10.1016/j.cell.2010.11.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145459	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000285182600010
J	Newman, M				Newman, Melanie			Research Ethics The rules of retraction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												melanienewman@tbij.com						Corbyn Z., 2009, TIMES HIGHER ED 0820; *INT COMM MED J ED, CORR RETR EXPR CONC; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; LIU SV, 2005, LOGICAL BIOL, V5, P235; Martin A, 2008, J AM ACAD CHILD PSY, V47, P119, DOI 10.1097/chi.0b013e31815d6dba; *MHRA, 2008, MHRA INV GLAX SER; Nissen SE, 2010, JAMA-J AM MED ASSOC, V303, P1194, DOI 10.1001/jama.2010.333; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Sox HC, 2006, ANN INTERN MED, V144, P609, DOI 10.7326/0003-4819-144-8-200604180-00123; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008	10	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2010	341								c6985	10.1136/bmj.c6985	http://dx.doi.org/10.1136/bmj.c6985			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694YK	21138994				2022-12-01	WOS:000285337600023
J	Li, XY; Ko, HG; Chen, T; Descalzi, G; Koga, K; Wang, HS; Kim, SS; Shang, YZ; Kwak, C; Park, SW; Shim, J; Lee, K; Collingridge, GL; Kaang, BK; Zhuo, M				Li, Xiang-Yao; Ko, Hyoung-Gon; Chen, Tao; Descalzi, Giannina; Koga, Kohei; Wang, Hansen; Kim, Susan S.; Shang, Yuze; Kwak, Chuljung; Park, Soo-Won; Shim, Jaehoon; Lee, Kyungmin; Collingridge, Graham L.; Kaang, Bong-Kiun; Zhuo, Min			Alleviating Neuropathic Pain Hypersensitivity by Inhibiting PKM zeta in the Anterior Cingulate Cortex	SCIENCE			English	Article							KINASE M-ZETA; STIMULATED ADENYLYL CYCLASES; LONG-TERM POTENTIATION; IN-VIVO EXPERIENCE; SYNAPTIC-TRANSMISSION; MOLECULAR-BIOLOGY; MEMORY STORAGE; PROTEIN; MAINTENANCE; SENSITIZATION	Synaptic plasticity is a key mechanism for chronic pain. It occurs at different levels of the central nervous system, including spinal cord and cortex. Studies have mainly focused on signaling proteins that trigger these plastic changes, whereas few have addressed the maintenance of plastic changes related to chronic pain. We found that protein kinase M zeta (PKM zeta) maintains pain-induced persistent changes in the mouse anterior cingulate cortex (ACC). Peripheral nerve injury caused activation of PKM zeta in the ACC, and inhibiting PKM zeta by a selective inhibitor, zeta-pseudosubstrate inhibitory peptide (ZIP), erased synaptic potentiation. Microinjection of ZIP into the ACC blocked behavioral sensitization. These results suggest that PKM zeta in the ACC acts to maintain neuropathic pain. PKM zeta could thus be a new therapeutic target for treating chronic pain.	[Li, Xiang-Yao; Chen, Tao; Shim, Jaehoon; Collingridge, Graham L.; Kaang, Bong-Kiun; Zhuo, Min] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151747, South Korea; [Li, Xiang-Yao; Chen, Tao; Descalzi, Giannina; Koga, Kohei; Wang, Hansen; Kim, Susan S.; Shang, Yuze; Zhuo, Min] Univ Toronto, Ctr Study Pain, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Ko, Hyoung-Gon; Kwak, Chuljung; Park, Soo-Won; Shim, Jaehoon; Lee, Kyungmin; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Natl Creat Res Initiat,Ctr Nat Sci, Seoul 151747, South Korea; [Lee, Kyungmin] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu 700422, South Korea; [Collingridge, Graham L.] Univ Bristol, Sch Physiol & Pharmacol, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	Seoul National University (SNU); University of Toronto; Seoul National University (SNU); Kyungpook National University; University of Bristol	Kaang, BK (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151747, South Korea.	kaang@snu.ac.kr; min.zhuo@utoronto.ca	Li, xiang-Yao/B-7622-2011; Collingridge, Graham L/C-4605-2015; Lee, Kyungmin/ABC-5624-2020; Lee, Kyungmin/AAH-9165-2020; collingridge, graham/AAI-8362-2020; Zhuo, Min/A-2072-2008; wang, hansen/I-2510-2019	Li, xiang-Yao/0000-0002-4793-0550; Collingridge, Graham L/0000-0002-9572-5359; Lee, Kyungmin/0000-0002-5425-4212; Zhuo, Min/0000-0001-9062-3241; wang, hansen/0000-0003-4414-3372; Park, Soowon/0000-0002-3348-940X; Descalzi, Giannina/0000-0003-3734-394X; Ko, Hyoung-Gon/0000-0002-7730-6986	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health; Canada Research Chair; NeuroCanada; Canadian Institute for Health Research [CIHR66975, CIHR84256]; Ministry of Education, Science and Technology in Korea through National Research Foundation [R32-10142]; Fragile X Research Foundation of Canada; Korean Ministry of Science and Technology, Korea; BK21 fellowship, Korea; MRC (UK); Medical Research Council [G0601813] Funding Source: researchfish; MRC [G0601813] Funding Source: UKRI	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NeuroCanada; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Education, Science and Technology in Korea through National Research Foundation; Fragile X Research Foundation of Canada; Korean Ministry of Science and Technology, Korea; BK21 fellowship, Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, Canada Research Chair, NeuroCanada, and Canadian Institute for Health Research operating grants (CIHR66975 and CIHR84256) (M.Z.). M.Z., B.-K.K., and G. L. C. are also supported by the World-Class University (WCU) program of the Ministry of Education, Science and Technology in Korea through National Research Foundation (R32-10142). X.-Y.L., T. C., and H. W. are supported by postdoctoral fellowships from Fragile X Research Foundation of Canada. B.-K.K. is supported by the National Creative Research Initiative Program of the Korean Ministry of Science and Technology, Korea. H.-G. K. and C. K. are supported by a BK21 fellowship, Korea. G. L. C. receives support from the MRC (UK).	Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bliss TVP, 2006, SCIENCE, V313, P1058, DOI 10.1126/science.1132538; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelly MT, 2007, J NEUROSCI, V27, P3439, DOI 10.1523/JNEUROSCI.5612-06.2007; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Liauw J, 2005, J NEUROPHYSIOL, V94, P878, DOI 10.1152/jn.01205.2004; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Shema R, 2009, LEARN MEMORY, V16, P122, DOI 10.1101/lm.1183309; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Vadakkan KI, 2005, J PAIN, V6, P747, DOI 10.1016/j.jpain.2005.07.005; Wei F, 1999, J NEUROSCI, V19, P9346; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Wu LJ, 2005, J NEUROPHYSIOL, V94, P1805, DOI 10.1152/jn.00091.2005; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003	28	296	313	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1400	1404		10.1126/science.1191792	http://dx.doi.org/10.1126/science.1191792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127255				2022-12-01	WOS:000284902100048
J	Creton, S; Jentsch, S				Creton, Sandrine; Jentsch, Stefan			SnapShot: The SUMO System	CELL			English	Editorial Material							UBIQUITIN		[Creton, Sandrine; Jentsch, Stefan] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Creton, S (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.							Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591	6	32	35	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 24	2010	143	5					848	U329		10.1016/j.cell.2010.11.026	http://dx.doi.org/10.1016/j.cell.2010.11.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111242	Bronze			2022-12-01	WOS:000284583500025
J	Tsuchida, T; Koga, R; Horikawa, M; Tsunoda, T; Maoka, T; Matsumoto, S; Simon, JC; Fukatsu, T				Tsuchida, Tsutomu; Koga, Ryuichi; Horikawa, Mitsuyo; Tsunoda, Tetsuto; Maoka, Takashi; Matsumoto, Shogo; Simon, Jean-Christophe; Fukatsu, Takema			Symbiotic Bacterium Modifies Aphid Body Color	SCIENCE			English	Article							ACYRTHOSIPHON-PISUM; ENDOSYMBIONT; RESISTANCE; PARASITISM; INSECTS	Color variation within populations of the pea aphid influences relative susceptibility to predators and parasites. We have discovered that infection with a facultative endosymbiont of the genus Rickettsiella changes the insects' body color from red to green in natural populations. Approximately 8% of pea aphids collected in Western Europe carried the Rickettsiella infection. The infection increased amounts of blue-green polycyclic quinones, whereas it had less of an effect on yellow-red carotenoid pigments. The effect of the endosymbiont on body color is expected to influence prey-predator interactions, as well as interactions with other endosymbionts.	[Tsuchida, Tsutomu; Matsumoto, Shogo] RIKEN, Adv Sci Inst, Mol Entomol Lab, Wako, Saitama 3510198, Japan; [Koga, Ryuichi; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; [Horikawa, Mitsuyo; Tsunoda, Tetsuto] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan; [Maoka, Takashi] Res Inst Prod Dev, Kyoto 6060805, Japan; [Simon, Jean-Christophe] Univ Rennes 1, INRA, UMR 1099, BiO3P, F-35653 Le Rheu, France	RIKEN; National Institute of Advanced Industrial Science & Technology (AIST); Tokushima Bunri University; INRAE; Universite de Rennes 1	Tsuchida, T (corresponding author), RIKEN, Adv Sci Inst, Mol Entomol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-tsuchida@riken.jp; t-fukatsu@aist.go.jp	Simon, Jean-Christophe/I-2700-2014		Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan [22128007]; INRA AIP Bioresources; RIKEN; Grants-in-Aid for Scientific Research [22590032] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); INRA AIP Bioresources; RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Peccoud, Y. Outreman, S. Stoeckel, L. Mieuzet, J. Jaquiery, and W. Weisser for aphid sampling; J. Bonhomme, L. Mieuzet, and J. Makino for aphid rearing and genotyping; and X.-Y. Meng and S. Hanada for help with electron microscopy. This work was supported by the Japan-France Integrated Action Program SAKURA of the Japan Society for the Promotion of Science (to T. F. and J.-C.S.); the Grant-in-Aid for Scientific Research on Innovative Areas (22128007) of the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. F.); and funds from INRA AIP Bioresources (to J.-C.S.). T. T. was supported by a RIKEN special postdoctoral research fellowship.	BOWIE JH, 1966, NATURE, V210, P395, DOI 10.1038/210395a0; BROWN KS, 1975, CHEM SOC REV, V4, P263, DOI 10.1039/cs9750400263; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Leonard J, 2010, EVOLUTION PRIMARY SE; Libbrecht R, 2007, J INSECT BEHAV, V20, P25, DOI 10.1007/s10905-006-9055-y; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; MULLER F. P., 1962, Z. PflKrarikh., V69, P129; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; RUXTON GD, 2005, AVOIDING ATTAK EVOLU; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611	18	286	315	3	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2010	330	6007					1102	1104		10.1126/science.1195463	http://dx.doi.org/10.1126/science.1195463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097935				2022-12-01	WOS:000284374700043
J	Gaster, B; Edwards, K; Trinidad, SB; Gallagher, TH; Braddock, CH				Gaster, Barak; Edwards, Kelly; Trinidad, Susan Brown; Gallagher, Thomas H.; Braddock, Clarence H., III			Patient-Centered Discussions About Prostate Cancer Screening: A Real-World Approach	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFORMED DECISION-MAKING; AFRICAN-AMERICAN; PRIMARY-CARE; HEALTH-CARE; MEDICAL-DECISIONS; BREAST-CANCER; TIME; MEN; INTERVENTION; PREFERENCES	National guidelines recommend that primary care providers discuss the risks and benefits of prostate cancer screening with their patients but give little guidance on how to fit such a complex discussion into a busy clinic encounter. The authors propose a process-oriented approach (Ask-Tell-Ask) that promotes tailored conversations and value-based recommendations. The Ask-Tell-Ask approach includes diagnosing a patient's informational needs, providing targeted education based on those needs, and making a shared decision about testing. This time-efficient model emphasizes the provider's role as an interactive guide rather than a one-way supplier of information. Although there is no way to make these discussions simple, this streamlined strategy can help patients and providers efficiently negotiate the complex and important decision of screening for prostate cancer.	[Gaster, Barak] Univ Washington, Sch Med, Seattle, WA 98105 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	Gaster, B (corresponding author), Univ Washington, Sch Med, 4245 Roosevelt Way NE, Seattle, WA 98105 USA.	barakg@uw.edu		Trinidad, Susan Brown/0000-0002-5956-6557	CDC; National Cancer Institute through the Cancer Prevention and Control Research Network [1-U48-DP-000050]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000050] Funding Source: NIH RePORTER	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute through the Cancer Prevention and Control Research Network; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	In part by the CDC and the National Cancer Institute through the Cancer Prevention and Control Research Network, a network within the CDC's Prevention Research Centers Program (grant 1-U48-DP-000050).	Allen JD, 2009, AM J MENS HEALTH, V3, P340, DOI 10.1177/1557988308325460; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Back AL, 2005, CA-CANCER J CLIN, V55, P164, DOI 10.3322/canjclin.55.3.164; Bao YH, 2007, HEALTH SERV RES, V42, P950, DOI 10.1111/j.1475-6773.2006.00638.x; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Braddock C, 2008, J BONE JOINT SURG AM, V90A, P1830, DOI 10.2106/JBJS.G.00840; Briss P, 2004, AM J PREV MED, V26, P67, DOI 10.1016/j.amepre.2003.09.012; BRODY H, 1989, HASTINGS CENT REP, V19, P5, DOI 10.2307/3562634; Chan ECY, 2003, J COMMUN HEALTH, V28, P393, DOI 10.1023/A:1026072022853; Chan ECY, 2003, J GEN INTERN MED, V18, P350, DOI 10.1046/j.1525-1497.2003.20626.x; Cole SA, 1997, AM J MANAG C, V3, P649; Davison BJ, 2004, BJU INT, V93, P47, DOI 10.1111/j.1464-410X.2004.04553.x; Drake BF, 2010, J NATL MED ASSOC, V102, P164, DOI 10.1016/S0027-9684(15)30521-6; Dunn AS, 2001, AM J PREV MED, V20, P130, DOI 10.1016/S0749-3797(00)00288-9; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Frosch DL, 2008, ARCH INTERN MED, V168, P363, DOI 10.1001/archinternmed.2007.111; Greene GW, 1999, J AM DIET ASSOC, V99, P673, DOI 10.1016/S0002-8223(99)00164-9; Guerra CE, 2007, J GEN INTERN MED, V22, P901, DOI 10.1007/s11606-007-0142-3; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Hoffman RM, 2007, J GEN INTERN MED, V22, P1056, DOI 10.1007/s11606-007-0167-7; Hoffman RM, 2009, ARCH INTERN MED, V169, P1611, DOI 10.1001/archinternmed.2009.262; JAEN CR, 1994, J FAM PRACTICE, V38, P166; Kemp EC, 2008, J AM BOARD FAM MED, V21, P24, DOI 10.3122/jabfm.2008.01.070093; Kilbridge KL, 2009, J CLIN ONCOL, V27, P2015, DOI 10.1200/JCO.2008.17.3468; Kripalani S, 2007, AM J PREV MED, V33, P83, DOI 10.1016/j.amepre.2007.03.018; Krist AH, 2007, ANN FAM MED, V5, P112, DOI 10.1370/afm.623; Lim LS, 2008, AM J PREV MED, V34, P164, DOI 10.1016/j.amepre.2007.10.003; Linder SK, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-19; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; LUQUE JS, 2010, AM J MENS HLTH, P27953; Lyman GH, 2010, CANCER INVEST, V28, P1, DOI 10.3109/07357900903517001; McFall SL, 2009, HEALTH EDUC RES, V24, P280, DOI 10.1093/her/cyn018; Murphy AM, 2010, JAMA-J AM MED ASSOC, V303, P166, DOI 10.1001/jama.2009.1991; Myers R E, 2000, Semin Urol Oncol, V18, P172; Myers RE, 2005, J NATL MED ASSOC, V97, P1143; NEASE RF, 1995, J GEN INTERN MED, V10, P593, DOI 10.1007/BF02602742; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Ross L, 2010, J NATL MED ASSOC, V102, P228, DOI 10.1016/S0027-9684(15)30529-0; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sheridan SL, 2004, AM J PREV MED, V26, P56, DOI 10.1016/j.amepre.2003.09.011; Steginga SK, 2005, BJU INT, V96, P1209, DOI 10.1111/j.1464-410X.2005.05782.x; Talcott JA, 2003, UROLOGY, V61, P7, DOI 10.1016/S0090-4295(02)02148-9; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Vig EK, 2007, J GEN INTERN MED, V22, P1274, DOI 10.1007/s11606-007-0252-y; Volk RJ, 2007, AM J PREV MED, V33, P428, DOI 10.1016/j.amepre.2007.07.030; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Woolf SH, 2005, ANN INTERN MED, V143, P293, DOI 10.7326/0003-4819-143-4-200508160-00010; Woolf SH, 2005, AM FAM PHYSICIAN, V71, P1871; Woolf SH, 2005, PATIENT EDUC COUNS, V56, P116, DOI 10.1016/j.pec.2003.12.002; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	52	13	13	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 16	2010	153	10					661	665		10.7326/0003-4819-153-10-201011160-00010	http://dx.doi.org/10.7326/0003-4819-153-10-201011160-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680ES	21079223	Green Accepted			2022-12-01	WOS:000284215800020
J	Harel-Sharvit, L; Eldad, N; Haimovich, G; Barkai, O; Duek, L; Choder, M				Harel-Sharvit, Liat; Eldad, Naama; Haimovich, Gal; Barkai, Oren; Duek, Lea; Choder, Mordechai			RNA Polymerase II Subunits Link Transcription and mRNA Decay to Translation	CELL			English	Article							P-BODIES; SACCHAROMYCES-CEREVISIAE; DEPENDENT TRANSLATION; INITIATION-FACTORS; YEAST; PROTEIN; RPB4; COMPLEX; MUTATIONS; BINDING	Little is known about crosstalk between the eukaryotic transcription and translation machineries that operate in different cell compartments. The yeast proteins Rpb4p and Rpb7p represent one such link as they form a heterodimer that shuttles between the nucleus, where it functions in transcription, and the cytoplasm, where it functions in the major mRNA decay pathways. Here we show that the Rpb4/7 heterodimer interacts physically and functionally with components of the translation initiation factor 3 (eIF3), and is required for efficient translation initiation. Efficient translation in the cytoplasm depends on association of Rpb4/7 with RNA polymerase II (Pol II) in the nucleus, leading to a model in which Pol II remotely controls translation. Hence, like in prokaryotes, the eukaryotic translation is coupled to transcription. We propose that Rpb4/7, through its interactions at each step in the mRNA life-cycle, represents a class of factors, "mRNA coordinators," which integrate the various stages of gene expression into a system.	[Harel-Sharvit, Liat; Eldad, Naama; Haimovich, Gal; Barkai, Oren; Duek, Lea; Choder, Mordechai] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Choder, M (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel.	choder@technion.ac.il	Haimovich, Gal/H-3316-2019	Haimovich, Gal/0000-0002-3360-5108	Israel Science Foundation; Rappaport Foundation; Paamei Tikva	Israel Science Foundation(Israel Science Foundation); Rappaport Foundation; Paamei Tikva	We thank Nancy Woychik for the rpb6<SUP>Q100R</SUP> strain, David Jansma for the rpb1<SUP>C67S;</SUP> <SUP>C70S</SUP> strain, Allan Hinnebusch for anti-Nip1p and for GST fusion constructs, Tien-Hsien Chang for the DHH1-GFP plasmid and Parag Sadhale for anti-Rpb7p Abs. The help of Almog Bregman is highly appreciated. We thank Elite Levin for statistical analyses. We thank Allan Hinnebusch and Leos Valasec for critically reading the manuscript and for their advice. This work was supported by the Israel Science Foundation, by Rappaport Foundation and by Paamei Tikva.	Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; CHODER M, 1993, J BACTERIOL, V175, P6358, DOI 10.1128/JB.175.19.6358-6363.1993; Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; CHODER M, 1993, MOL CELL BIOL, V13, P6984, DOI 10.1128/MCB.13.11.6984; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Daulny A, 2008, P NATL ACAD SCI USA, V105, P19649, DOI 10.1073/pnas.0809372105; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Donaldson IM, 2000, J BIOL CHEM, V275, P13780, DOI 10.1074/jbc.275.18.13780; Eldad N, 2008, NUCLEIC ACIDS RES, V36, P6728, DOI 10.1093/nar/gkn754; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Farago M, 2003, MOL BIOL CELL, V14, P2744, DOI 10.1091/mbc.E02-11-0740; FUGE EK, 1994, J BACTERIOL, V176, P5802, DOI 10.1128/JB.176.18.5802-5813.1994; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.bi.54.070185.005333; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Paz I, 2001, J BACTERIOL, V183, P4477, DOI 10.1128/JB.183.15.4477-4483.2001; Pestova T. V., 2007, TRANSLATIONAL CONTRO, P87; Pillai B, 2003, J BIOL CHEM, V278, P3339, DOI 10.1074/jbc.M112180200; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Rosenheck S, 1998, J BACTERIOL, V180, P6187; Ruiz-Echevarria MJ, 1998, P NATL ACAD SCI USA, V95, P8721, DOI 10.1073/pnas.95.15.8721; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Sheffer A, 1999, MOL CELL BIOL, V19, P2672; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Singh SR, 2007, BIOCHEM BIOPH RES CO, V356, P266, DOI 10.1016/j.bbrc.2007.02.120; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tan Q, 2003, MOL CELL BIOL, V23, P3329, DOI 10.1128/MCB.23.9.3329-3338.2003; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; Verma-Gaur J, 2008, EUKARYOT CELL, V7, P1009, DOI 10.1128/EC.00057-08; Wyers F, 2000, MOL CELL BIOL, V20, P3538, DOI 10.1128/MCB.20.10.3538-3549.2000	59	139	141	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					552	563		10.1016/j.cell.2010.10.033	http://dx.doi.org/10.1016/j.cell.2010.10.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074047	Bronze			2022-12-01	WOS:000284149100013
J	Marchetto, MCN; Carromeu, C; Acab, A; Yu, D; Yeo, GW; Mu, YL; Chen, G; Gage, FH; Muotri, AR				Marchetto, Maria C. N.; Carromeu, Cassiano; Acab, Allan; Yu, Diana; Yeo, Gene W.; Mu, Yangling; Chen, Gong; Gage, Fred H.; Muotri, Alysson R.			A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells	CELL			English	Article							AUTISM-SPECTRUM; MOUSE MODEL; MECP2; BRAIN; DISEASE; MUTATIONS; PHENOTYPE; SYMPTOMS; GENE; PHOSPHORYLATION	Autism spectrum disorders (ASD) are complex neurodevelopmental diseases in which different combinations of genetic mutations may contribute to the phenotype. Using Rett syndrome (RTT) as an ASD genetic model, we developed a culture system using induced pluripotent stem cells (iPSCs) from RTT patients' fibroblasts. RTT patients' iPSCs are able to undergo X-inactivation and generate functional neurons. Neurons derived from RTT-iPSCs had fewer synapses, reduced spine density, smaller soma size, altered calcium signaling and electrophysiological defects when compared to controls. Our data uncovered early alterations in developing human RTT neurons. Finally, we used RTT neurons to test the effects of drugs in rescuing synaptic defects. Our data provide evidence of an unexplored developmental window, before disease onset, in RTT syndrome where potential therapies could be successfully employed. Our model recapitulates early stages of a human neurodevelopmental disease and represents a promising cellular tool for drug screening, diagnosis and personalized treatment.	[Carromeu, Cassiano; Acab, Allan; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego,Stem Cell Program, Dept Pediat,Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Marchetto, Maria C. N.; Yu, Diana; Mu, Yangling; Gage, Fred H.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Yeo, Gene W.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA; [Chen, Gong] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego,Stem Cell Program, Dept Pediat,Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	muotri@ucsd.edu	Carromeu, Cassiano/B-1487-2014; Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; Carromeu, Cassiano/0000-0002-7570-2213; Chen JNU, Gong/0000-0002-1857-3670	Emerald Foundation; National Institutes of Health [1-DP2-OD006495-01]; California Institute for Regenerative Medicine [RL1-00649-1, RC1-00115-1]; Lookout Fund; Mathers Foundation; Glenn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006495] Funding Source: NIH RePORTER	Emerald Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Lookout Fund; Mathers Foundation; Glenn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the Emerald Foundation and by the National Institutes of Health through the NIH Director's New Innovator Award Program, 1-DP2-OD006495-01. F.H.G. is supported by California Institute for Regenerative Medicine RL1-00649-1 and RC1-00115-1, The Lookout Fund and the Mathers Foundation. C.C. is a fellow from the International Rett Syndrome Foundation. M.C.N.M. is a Christopher and Danna Reeve Foundation fellow. G.C. was supported by the Glenn Foundation. We would like to thank Monica Coenraads for critical discussion; the Greenwood Genetic Center clinical diagnostic laboratory for X-inactivation analysis; Dr. Jeannie T. Lee for the Xist probe; and M.L. Gage for editorial comments.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Charman T, 2002, BRAIN DEV-JPN, V24, P281, DOI 10.1016/S0387-7604(02)00058-X; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hagberg G, 2001, BRAIN DEV-JPN, V23, pS227, DOI 10.1016/S0387-7604(01)00375-8; Hammer S, 2002, MENT RETARD DEV D R, V8, P94, DOI 10.1002/mrdd.10023; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Kellermayer R, 2006, EUR J MED GENET, V49, P445, DOI 10.1016/j.ejmg.2006.04.003; KERR AM, 1987, BRAIN DEV-JPN, V9, P487, DOI 10.1016/S0387-7604(87)80070-0; Kishi N, 2010, EXP NEUROL, V222, P51, DOI 10.1016/j.expneurol.2009.12.007; Laccone F, 2001, HUM MUTAT, V17, P183, DOI 10.1002/humu.3; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2010, HUM MOL GENET, V19, pR71, DOI 10.1093/hmg/ddq159; Mironov SL, 2009, J PHYSIOL-LONDON, V587, P2473, DOI 10.1113/jphysiol.2009.169805; Muotri AR, 2009, EPILEPSY BEHAV, V14, P81, DOI 10.1016/j.yebeh.2008.09.021; Niethammer M, 1996, J NEUROSCI, V16, P2157; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; Piven J, 1997, AM J PSYCHIAT, V154, P185; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P1; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Samaco RC, 2004, HUM MOL GENET, V13, P629, DOI 10.1093/hmg/ddh063; Santos M, 2007, GENES BRAIN BEHAV, V6, P277, DOI 10.1111/j.1601-183X.2006.00258.x; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zappella M, 2003, AM J MED GENET B, V119B, P102, DOI 10.1002/ajmg.b.10070; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	57	936	973	3	180	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					527	539		10.1016/j.cell.2010.10.016	http://dx.doi.org/10.1016/j.cell.2010.10.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074045	Green Accepted, Bronze			2022-12-01	WOS:000284149100011
J	Wilkinson, RG; Pickett, KE; De Vogli, R				Wilkinson, Richard G.; Pickett, Kate E.; De Vogli, Roberto			Essay Equality, sustainability, and quality of life	BRITISH MEDICAL JOURNAL			English	Editorial Material							ORIENTATION; VALIDATION; MORTALITY		[Wilkinson, Richard G.] Univ Nottingham, Nottingham NG7 2RD, England; [Pickett, Kate E.] Univ York, York YO10 5DD, N Yorkshire, England; [De Vogli, Roberto] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of Nottingham; University of York - UK; University of London; University College London	Wilkinson, RG (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.	Richard@RichardWilkinson.net			ESRC [ES/H033084/1] Funding Source: UKRI; Department of Health [CSA/03/07/014] Funding Source: Medline; Economic and Social Research Council [ES/H033084/1] Funding Source: researchfish; National Institute for Health Research [CSA/03/07/014] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Blanden J., 2009, CTR EC ED CEE DISCUS, V139, P673; DORLING D, 2010, COMMUNICATION   0517; Hare B., 2006, AVOIDING DANGEROUS C, P191; *INT PAN CLIM CHAN, 2007, 4 IPPC INT PAN CLIM; JOWIT J, 2008, GUARDIAN        0628; Layard R., 2005, HAPPINESS LESSONS NE; LOMBORG B, 2010, SMARTSOLUTIONS CLIMA; Moore PJ, 1996, ADDICT BEHAV, V21, P645, DOI 10.1016/0306-4603(95)00100-X; Nichols A, 2009, ENVIRON HEALTH INSIG, V3, P63; Preston SH, 2007, INT J EPIDEMIOL, V36, P484, DOI 10.1093/ije/dym075; RICHINS ML, 1992, J CONSUM RES, V19, P303, DOI 10.1086/209304; Roberts J.Timmons., 2006, CLIMATE INJUSTICE GL; Ross NA, 2005, J URBAN HEALTH, V82, P101, DOI 10.1093/jurban/jti012; Saunders S, 2000, SOC BEHAV PERSONAL, V28, P219, DOI 10.2224/sbp.2000.28.3.219; Sheldon KM, 2000, J PERS, V68, P383, DOI 10.1111/1467-6494.00101; Wilkinson R., 2010, IMPACT INCOME INEQUA; Wilkinson R., 2010, SPIRIT LEVEL WHY EQU; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041; World Economic Forum, 2002, GLOB COMP REP 2001 2	19	25	25	1	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 2	2010	341								c5816	10.1136/bmj.c5816	http://dx.doi.org/10.1136/bmj.c5816			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	678CU	21045025				2022-12-01	WOS:000284048200003
J	Blau, HM; Pomerantz, JH				Blau, Helen M.; Pomerantz, Jason H.			Re"evolutionary" Regenerative Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELL-CYCLE; INK4A/ARF; RB		[Blau, Helen M.] Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Pomerantz, Jason H.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Blau, HM (corresponding author), Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, 269 Campus Dr,CCSR 4215, Stanford, CA 94305 USA.	hblau@stanford.edu; jason.pomerantz@ucsfmedctr.org			NHLBI NIH HHS [R01 HL096113-03, U01 HL100397, U01 HL100397-03, R01 HL096113, HL100397, HL096113] Funding Source: Medline; NIAMS NIH HHS [AR059565, R43 AR059565, F32 AR051678] Funding Source: Medline; NIA NIH HHS [AG020961, AG009521, R01 AG020961, R01 AG009521, R01 AG020961-08, R01 AG009521-25, R37 AG009521] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR059565, F32AR051678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG020961, R01AG009521] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; del Arroyo AG, 2005, ADV EXP MED BIOL, V570, P227; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	10	17	19	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					87	88		10.1001/jama.2010.1938	http://dx.doi.org/10.1001/jama.2010.1938			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21177496	Green Accepted			2022-12-01	WOS:000285924100028
J	Tsai, WW; Wang, ZX; Yiu, TT; Akdemir, KC; Xia, WY; Winter, S; Tsai, CY; Shi, XB; Schwarzer, D; Plunkett, W; Aronow, B; Gozani, O; Fischle, W; Hung, MC; Patel, DJ; Barton, MC				Tsai, Wen-Wei; Wang, Zhanxin; Yiu, Teresa T.; Akdemir, Kadir C.; Xia, Weiya; Winter, Stefan; Tsai, Cheng-Yu; Shi, Xiaobing; Schwarzer, Dirk; Plunkett, William; Aronow, Bruce; Gozani, Or; Fischle, Wolfgang; Hung, Mien-Chie; Patel, Dinshaw J.; Barton, Michelle Craig			TRIM24 links a non-canonical histone signature to breast cancer	NATURE			English	Article							GENE-EXPRESSION; PHD FINGER; NUCLEAR RECEPTORS; BINDING MODULES; CHROMATIN REGULATION; COACTIVATOR HTIF1; TRANSCRIPTION; ESTROGEN; COMPLEX; ALPHA	Recognition of modified histone species by distinct structural domains within 'reader' proteins plays a critical role in the regulation of gene expression. Readers that simultaneously recognize histones with multiple marks allow transduction of complex chromatin modification patterns into specific biological outcomes. Here we report that chromatin regulator tripartite motif-containing 24 (TRIM24) functions in humans as a reader of dual histone marks by means of tandem plant homeodomain (PHD) and bromodomain (Bromo) regions. The three-dimensional structure of the PHD-Bromo region of TRIM24 revealed a single functional unit for combinatorial recognition of unmodified H3K4 (that is, histone H3 unmodified at lysine 4, H3K4me0) and acetylated H3K23 (histone H3 acetylated at lysine 23, H3K23ac) within the same histone tail. TRIM24 binds chromatin and oestrogen receptor to activate oestrogen-dependent genes associated with cellular proliferation and tumour development. Aberrant expression of TRIM24 negatively correlates with survival of breast cancer patients. The PHD-Bromo of TRIM24 provides a structural rationale for chromatin activation through a non-canonical histone signature, establishing a new route by which chromatin readers may influence cancer pathogenesis.	[Wang, Zhanxin; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Tsai, Wen-Wei; Yiu, Teresa T.; Shi, Xiaobing; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Program Genes & Dev, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Yiu, Teresa T.; Akdemir, Kadir C.; Shi, Xiaobing; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Yiu, Teresa T.; Akdemir, Kadir C.; Shi, Xiaobing; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Xia, Weiya; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Akdemir, Kadir C.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Bioinformat, Houston, TX 77030 USA; [Winter, Stefan; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Tsai, Cheng-Yu; Plunkett, William] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Schwarzer, Dirk] Leibniz Inst Mol Pharmakol FMP, Dept Chem Biol Prot Chem, D-13125 Berlin, Germany; [Aronow, Bruce] Cincinnati Childrens Hosp Med Ctr, Computat Med Ctr, Cincinnati, OH 45229 USA; [Gozani, Or] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung 404, Taiwan	Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Max Planck Society; University of Texas System; UTMD Anderson Cancer Center; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Cincinnati Children's Hospital Medical Center; Stanford University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; mbarton@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Gozani, Or P/I-6157-2013; Aronow, Bruce J/F-8438-2012; Wang, Zhanxin/A-7967-2012	Hung, Mien-Chie/0000-0003-4317-4740; Schwarzer, Dirk/0000-0002-7477-3319; Shi, Xiaobing/0000-0001-5242-8189; Gozani, Or/0000-0002-1365-4463; Tsai, Cheng-Yu/0000-0002-6351-1858; Barton, Michelle/0000-0002-4042-1374	National Institutes of Health (NIH) [GM081627, U54 RR025216, P30DK078392-01, GM079641]; George and Cynthia Mitchell Foundation; China Medical University and Hospital; MDACC; Starr Foundation; Leukemia and Lymphoma Society; Max Planck Society; NCI Cancer Center; Sowell-Huggins Foundation; EMBO; Center for Cancer Epigenetics;  [T32 HD07325]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007325] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641, P01GM081627] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George and Cynthia Mitchell Foundation; China Medical University and Hospital(China Medical University); MDACC; Starr Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Max Planck Society(Max Planck Society); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sowell-Huggins Foundation; EMBO(European Molecular Biology Organization (EMBO)); Center for Cancer Epigenetics; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Institutes of Health (NIH GM081627) and the George and Cynthia Mitchell Foundation (to M. C. B.), from NIH (U54 RR025216 and P30DK078392-01) to B. A., from NIH (GM079641) to O.G., from the Sister Institution Fund of China Medical University and Hospital and MDACC to M.-C. H., from the Starr Foundation and the Leukemia and Lymphoma Society to D.J.P., from the Max Planck Society to W. F., and from the NCI Cancer Center (Support Grant) to the UT MD Anderson Cancer Center. W.-W.T. was supported in part by the Sowell-Huggins Foundation; S. W. by a long-term EMBO fellowship; T.T.Y. by T32 HD07325; and K. C. A. by the Center for Cancer Epigenetics. We thank J. Song, D. C. Jamison, A. Dose, Z. Coban and Y. Wei for technical support and assistance. We are grateful to S. Stratton, M. Lee, M. Bedford, G. Lozano, S. Dent, A. Nardulli and members of our laboratories for advice, reagents and discussions.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Belloni E, 2005, GENE CHROMOSOME CANC, V42, P320, DOI 10.1002/gcc.20144; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Boney-Montoya J, 2010, MOL ENDOCRINOL, V24, P346, DOI 10.1210/me.2009-0429; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; ECKERT RL, 1982, J BIOL CHEM, V257, P8840; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katzenellenbogen BS, 1996, BIOL REPROD, V54, P287, DOI 10.1095/biolreprod54.2.287; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thenot S, 1997, J BIOL CHEM, V272, P12062, DOI 10.1074/jbc.272.18.12062; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	54	292	298	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					927	U320		10.1038/nature09542	http://dx.doi.org/10.1038/nature09542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21164480	Green Published, Green Accepted			2022-12-01	WOS:000285344600039
J	Watanabe, A; Choe, S; Chaptal, V; Rosenberg, JM; Wright, EM; Grabe, M; Abramson, J				Watanabe, Akira; Choe, Seungho; Chaptal, Vincent; Rosenberg, John M.; Wright, Ernest M.; Grabe, Michael; Abramson, Jeff			The mechanism of sodium and substrate release from the binding pocket of vSGLT	NATURE			English	Article							AMINO-ACID ANTIPORTER; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TRANSPORTER; COTRANSPORTER; MODEL; RESOLUTION; SOFTWARE; INSIGHTS; HOMOLOG	Membrane co-transport proteins that use a five-helix inverted repeat motif have recently emerged as one of the largest structural classes of secondary active transporters(1,2). However, despite many structural advances there is no clear evidence of how ion and substrate transport are coupled. Here we report a comprehensive study of the sodium/galactose transporter from Vibrio parahaemolyticus (vSGLT), consisting of molecular dynamics simulations, biochemical characterization and a new crystal structure of the inward-open conformation at a resolution of 2.7 angstrom. Our data show that sodium exit causes a reorientation of transmembrane helix 1 that opens an inner gate required for substrate exit, and also triggers minor rigid-body movements in two sets of transmembrane helical bundles. This cascade of events, initiated by sodium release, ensures proper timing of ion and substrate release. Once set in motion, these molecular changes weaken substrate binding to the transporter and allow galactose readily to enter the intracellular space. Additionally, we identify an allosteric pathway between the sodium-binding sites, the unwound portion of transmembrane helix 1 and the substrate-binding site that is essential in the coupling of co-transport.	[Watanabe, Akira; Chaptal, Vincent; Wright, Ernest M.; Abramson, Jeff] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Choe, Seungho; Rosenberg, John M.; Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Rosenberg, John M.; Grabe, Michael] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Abramson, J (corresponding author), Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA.	mdgrabe@pitt.edu; jabramson@mednet.ucla.edu	Choe, Seungho/B-1877-2008	Choe, Seungho/0000-0003-2291-747X; chaptal, vincent/0000-0003-2603-0294	NIH [GM078844, RGY0069, DK19567]; Human Frontier Science Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Vondriska and K. Philipson as well as members of the Abramson, Wright and Grabe labs for useful discussions and for reading the manuscript. We would also like to thank S. Faham for contributions at the early stages of this work, S. Iwata for advance release of the Mhp1 coordinates (Protein Data Bank ID, 2X79), and R. Roskies for assistance with the computations. Simulations were carried out through a TeraGrid grant at the Pittsburgh Supercomputing Center and the Texas Advanced Computing Center. This work was supported by NIH grants GM078844 (J.A.), RGY0069 (J.A.) and DK19567 (E.M.W.), and a grant from the Human Frontier Science Program (J.A.). M.G. is an Alfred P. Sloan Research Fellow.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; DeLano W.L., 2002, PYMOL MOL VIEWER; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Isaji M, 2007, CURR OPIN INVEST DR, V8, P285; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Joosten RP, 2009, ACTA CRYSTALLOGR D, V65, P176, DOI 10.1107/S0907444908037591; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Turk E, 2006, BIOCHEMISTRY-US, V45, P1470, DOI 10.1021/bi052160z; Veenstra M, 2004, BIOCHEMISTRY-US, V43, P3620, DOI 10.1021/bi0357210; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	39	147	148	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 16	2010	468	7326					988	U162		10.1038/nature09580	http://dx.doi.org/10.1038/nature09580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695BC	21131949	Green Accepted			2022-12-01	WOS:000285344600052
J	Brooks, N				Brooks, Nicholas			Is coronary artery bypass grafting the treatment of choice for diabetic patients with multivessel disease? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTION; RESTENOSIS; MELLITUS; OUTCOMES		[Brooks, Nicholas] Wythenshawe Hosp, Manchester M23 9LT, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Brooks, N (corresponding author), Wythenshawe Hosp, Manchester M23 9LT, England.	Nicholas.Brooks@uhsm.nhs.uk						Babapulle MN, 2004, LANCET, V364, P583, DOI 10.1016/S0140-6736(04)16850-5; Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057; Barsness GW, 1997, CIRCULATION, V96, P2551, DOI 10.1161/01.CIR.96.8.2551; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hong SJ, 2006, HEART, V92, P1119, DOI 10.1136/hrt.2005.075960; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Lee MS, 2010, AM J CARDIOL, V105, P1540, DOI 10.1016/j.amjcard.2010.01.009; Mathew V, 2004, CIRCULATION, V109, P476, DOI 10.1161/01.CIR.0000109693.64957.20; TIKALINOS TA, 2009, LANCET, V373, P911	11	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2010	341								c6961	10.1136/bmj.c6961	http://dx.doi.org/10.1136/bmj.c6961			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697XA	21149466				2022-12-01	WOS:000285551900007
J	Bandyopadhyay, S; Mehta, M; Kuo, D; Sung, MK; Chuang, R; Jaehnig, EJ; Bodenmiller, B; Licon, K; Copeland, W; Shales, M; Fiedler, D; Dutkowski, J; Guenole, A; van Attikum, H; Shokat, KM; Kolodner, RD; Huh, WK; Aebersold, R; Keogh, MC; Krogan, NJ; Ideker, T				Bandyopadhyay, Sourav; Mehta, Monika; Kuo, Dwight; Sung, Min-Kyung; Chuang, Ryan; Jaehnig, Eric J.; Bodenmiller, Bernd; Licon, Katherine; Copeland, Wilbert; Shales, Michael; Fiedler, Dorothea; Dutkowski, Janusz; Guenole, Aude; van Attikum, Haico; Shokat, Kevan M.; Kolodner, Richard D.; Huh, Won-Ki; Aebersold, Ruedi; Keogh, Michael-Christopher; Krogan, Nevan J.; Ideker, Trey			Rewiring of Genetic Networks in Response to DNA Damage	SCIENCE			English	Article							H2A VARIANT HTZ1; SACCHAROMYCES-CEREVISIAE; YEAST; PATHWAYS; FAMILY; MAPS; CELL	Although cellular behaviors are dynamic, the networks that govern these behaviors have been mapped primarily as static snapshots. Using an approach called differential epistasis mapping, we have discovered widespread changes in genetic interaction among yeast kinases, phosphatases, and transcription factors as the cell responds to DNA damage. Differential interactions uncover many gene functions that go undetected in static conditions. They are very effective at identifying DNA repair pathways, highlighting new damage-dependent roles for the Slt2 kinase, Pph3 phosphatase, and histone variant Htz1. The data also reveal that protein complexes are generally stable in response to perturbation, but the functional relations between these complexes are substantially reorganized. Differential networks chart a new type of genetic landscape that is invaluable for mapping cellular responses to stimuli.	[Mehta, Monika; Keogh, Michael-Christopher] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Bandyopadhyay, Sourav; Licon, Katherine; Dutkowski, Janusz; Kolodner, Richard D.; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kuo, Dwight; Chuang, Ryan; Copeland, Wilbert; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Sung, Min-Kyung; Huh, Won-Ki] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Sung, Min-Kyung; Huh, Won-Ki] Seoul Natl Univ, Inst Microbiol, Res Ctr Funct Cellul, Seoul 151742, South Korea; [Jaehnig, Eric J.; Kolodner, Richard D.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Jaehnig, Eric J.; Kolodner, Richard D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Bodenmiller, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Shales, Michael; Fiedler, Dorothea; Shokat, Kevan M.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Fiedler, Dorothea; Shokat, Kevan M.] Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Guenole, Aude; van Attikum, Haico] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands; [Kolodner, Richard D.; Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; Seoul National University (SNU); Seoul National University (SNU); Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Diego	Keogh, MC (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	michael.keogh@einstein.yu.edu; krogan@cmp.ucsf.edu; tideker@ucsd.edu	Califano, Andrea/F-7239-2012; Huh, Won-Ki/AAQ-6767-2021; jaehnig, eric/CCF-3596-2022; van Attikum, Haico/A-4596-2010	Mehta, Monika/0000-0003-3928-3733; Van Attikum, Haico/0000-0001-8590-0240; Jaehnig, Eric/0000-0001-9618-6011; Ideker, Trey/0000-0002-1708-8454	NIH [R01-ES14811, R01-GM084279]; 21C Frontier Functional Proteomics Project [FPR08A1-060]; SystemsX.ch; Swiss National Science Foundation; NCI [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448, R01GM026017, R37GM026017, R01GM084279, P50GM081879] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Collins, H. Hombauer, A. Desai, S. Gasser, X. Shen, and S. Choi for helpful discussions and strains. This work was funded by NIH grants R01-ES14811 and R01-GM084279. Additionally, W-K. H. and M-K. S. were funded by the 21C Frontier Functional Proteomics Project (FPR08A1-060), R. A. and B. B. were supported by SystemsX.ch and the Swiss National Science Foundation, and M-C. K. was supported by the NCI (P30CA013330). N.J.K. is a Keck Young Investigator Fellow and a Searle Fellow. T.I. is a David and Lucille Packard Fellow. R. D. K. is a paid consultant to On-Q-ity.	Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Begley TJ, 2002, MOL CANCER RES, V1, P103; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0165-1218(74)90185-2; Heideker J, 2007, CELL CYCLE, V6, P3058, DOI 10.4161/cc.6.24.5100; Jaimovich A, 2010, BIOINFORMATICS, V26, pi228, DOI 10.1093/bioinformatics/btq197; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948	22	332	335	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1385	1389		10.1126/science.1195618	http://dx.doi.org/10.1126/science.1195618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127252	Green Accepted			2022-12-01	WOS:000284902100044
J	Smith, FA; Boyer, AG; Brown, JH; Costa, DP; Dayan, T; Ernest, SKM; Evans, AR; Fortelius, M; Gittleman, JL; Hamilton, MJ; Harding, LE; Lintulaakso, K; Lyons, SK; McCain, C; Okie, JG; Saarinen, JJ; Sibly, RM; Stephens, PR; Theodor, J; Uhen, MD				Smith, Felisa A.; Boyer, Alison G.; Brown, James H.; Costa, Daniel P.; Dayan, Tamar; Ernest, S. K. Morgan; Evans, Alistair R.; Fortelius, Mikael; Gittleman, John L.; Hamilton, Marcus J.; Harding, Larisa E.; Lintulaakso, Kari; Lyons, S. Kathleen; McCain, Christy; Okie, Jordan G.; Saarinen, Juha J.; Sibly, Richard M.; Stephens, Patrick R.; Theodor, Jessica; Uhen, Mark D.			The Evolution of Maximum Body Size of Terrestrial Mammals	SCIENCE			English	Article							DIVERSIFICATION; VEGETATION; DINOSAURS; DYNAMICS	The extinction of dinosaurs at the Cretaceous/Paleogene (K/Pg) boundary was the seminal event that opened the door for the subsequent diversification of terrestrial mammals. Our compilation of maximum body size at the ordinal level by sub-epoch shows a near-exponential increase after the K/Pg. On each continent, the maximum size of mammals leveled off after 40 million years ago and thereafter remained approximately constant. There was remarkable congruence in the rate, trajectory, and upper limit across continents, orders, and trophic guilds, despite differences in geological and climatic history, turnover of lineages, and ecological variation. Our analysis suggests that although the primary driver for the evolution of giant mammals was diversification to fill ecological niches, environmental temperature and land area may have ultimately constrained the maximum size achieved.	[Smith, Felisa A.; Brown, James H.; Hamilton, Marcus J.; Okie, Jordan G.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Boyer, Alison G.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Dayan, Tamar] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Ernest, S. K. Morgan] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Ernest, S. K. Morgan] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Evans, Alistair R.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Fortelius, Mikael; Lintulaakso, Kari; Saarinen, Juha J.] Univ Helsinki, Dept Geosci & Geog, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Gittleman, John L.; Stephens, Patrick R.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Harding, Larisa E.] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden; [Lyons, S. Kathleen] MRC 121, Smithsonian Inst, Washington, DC 20013 USA; [McCain, Christy] Univ Colorado, CU Nat Hist Museum, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Sibly, Richard M.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Theodor, Jessica] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Uhen, Mark D.] George Mason Univ, Dept Atmospher Ocean & Earth Sci, Fairfax, VA 22030 USA	University of New Mexico; Yale University; University of California System; University of California Santa Cruz; Tel Aviv University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Monash University; University of Helsinki; University System of Georgia; University of Georgia; Umea University; Smithsonian Institution; University of Colorado System; University of Colorado Boulder; University of Reading; University of Calgary; George Mason University	Smith, FA (corresponding author), Univ New Mexico, Dept Biol, MSC03 2020, Albuquerque, NM 87131 USA.	fasmith@unm.edu	Evans, Alistair R/D-4239-2011; Ernest, Morgan/A-4355-2008; Ernest, S.K. Morgan/O-2532-2015; Smith, Felisa/ABE-6160-2021; Uhen, Mark D/AAZ-3158-2020; Opazo, Luis-Felipe/G-9586-2011; Lintulaakso, Kari/N-7775-2013; Costa, Daniel/E-2616-2013	Evans, Alistair R/0000-0002-4078-4693; Ernest, Morgan/0000-0002-6026-8530; Ernest, S.K. Morgan/0000-0002-6026-8530; Smith, Felisa/0000-0001-6262-436X; Uhen, Mark D/0000-0002-2689-0801; Lintulaakso, Kari/0000-0001-9627-8821; Theodor, Jessica/0000-0002-5159-7041; Costa, Daniel/0000-0002-0233-5782; Sibly, Richard/0000-0001-6828-3543; Lyons, S. Kathleen/0000-0001-5112-2508; Fortelius, Mikael/0000-0002-4851-783X	Integrating Macroecological Pattern and Process across Scales (IMPPS) NSF Research Coordination Network (NSF) [DEB-0541625]	Integrating Macroecological Pattern and Process across Scales (IMPPS) NSF Research Coordination Network (NSF)(National Science Foundation (NSF))	This project was supported by the Integrating Macroecological Pattern and Process across Scales (IMPPS) NSF Research Coordination Network (NSF grant DEB-0541625 to F. A. S., S. K. M. E., and S. K. L.). This is IMPPS publication no. 11.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Crompton A. W., 1980, COMP PHYSL PRIMITIVE, P1; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; GRADSTEIN F.M., 2005, GEOLOGIC TIME SCALE; GUNNELL GF, 1995, PALAEOGEOGR PALAEOCL, V115, P265, DOI 10.1016/0031-0182(94)00115-O; GUNNELL GF, 1998, EVOLUTION TERTIARY M, V1, P91; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Marquet PA, 1998, EVOL ECOL, V12, P127, DOI 10.1023/A:1006567227154; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rensch B., 1959, EVOLUTION SPECIES LE; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Smith A. G., 1994, ATLAS MESOZOIC CENOZ; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Tappan H., 1974, TOPICS MOL OXYGEN RE, P81; Trammer J, 2005, EVOLUTION, V59, P941; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN, V2nd; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	29	188	190	4	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1216	1219		10.1126/science.1194830	http://dx.doi.org/10.1126/science.1194830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21109666				2022-12-01	WOS:000284613700034
J	Pasternak, B; Hviid, A				Pasternak, Bjorn; Hviid, Anders			Use of Proton-Pump Inhibitors in Early Pregnancy and the Risk of Birth Defects.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; SAFETY; REGISTRATION; OMEPRAZOLE; MALFORMATIONS; REGISTER; COHORT	Background: Symptoms of gastroesophageal reflux are common in pregnancy, but there are limited data on the risk of birth defects associated with exposure to proton-pump inhibitors (PPIs) in early pregnancy. Methods: We conducted a cohort study to assess the association between exposure to PPIs during pregnancy and the risk of major birth defects among all infants born alive in Denmark between January 1996 and September 2008. We linked data from nationwide registries, including individual-level information on exposure to PPIs (prescriptions), birth defects, and potential confounders. Major birth defects, diagnosed within the first year of life, were categorized according to the standardized classification scheme of the European surveillance of congenital anomalies (EUROCAT). Our primary analyses assessed the use of PPIs from 4 weeks before conception through 12 weeks of gestation and from 0 through 12 weeks of gestation (first trimester). Results: Among 840,968 live births, 5082 involved exposure to PPIs between 4 weeks before conception and the end of the first trimester of pregnancy. There were 174 major birth defects in infants whose mothers had been exposed to PPIs during this period (3.4%), as compared with 21,811 in the group whose mothers had not been exposed (2.6%) (adjusted prevalence odds ratio, 1.23; 95% confidence interval [CI], 1.05 to 1.44). In analyses limited to exposure during the first trimester, there were 118 major birth defects among 3651 infants exposed to PPIs (3.2%), and the adjusted prevalence odds ratio was 1.10 (95% CI, 0.91 to 1.34). The risk of birth defects was not significantly increased in secondary analyses of exposure to individual PPIs during the first trimester or in analyses limited to the offspring of women who had filled PPI prescriptions and received enough doses to have a theoretical chance of first-trimester exposure. Conclusions: In this large cohort, exposure to PPIs during the first trimester of pregnancy was not associated with a significantly increased risk of major birth defects. (Funded by the Danish Medical Research Council and the Lundbeck Foundation.) N Engl J Med 2010;363:2114-23.	[Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Hviid, Anders/AAH-4319-2020; Hug, Balthasar L./G-1568-2010; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	Supported by the Danish Medical Research Council and the Lundbeck Foundation.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2008, PRIL; [Anonymous], 2002, DAT DANM STAT; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Dehlink E, 2009, CLIN EXP ALLERGY, V39, P246, DOI 10.1111/j.1365-2222.2008.03125.x; Diav-Citrin O, 2005, ALIMENT PHARM THER, V21, P269, DOI 10.1111/j.1365-2036.2005.02306.x; EKMAN L, 1985, SCAND J GASTROENTERO, V20, P53, DOI 10.3109/00365528509095819; Gill SK, 2009, AM J GASTROENTEROL, V104, P1541, DOI 10.1038/ajg.2009.122; Jepsen P, 2006, INT J RISK SAF MED, V18, P77; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Kallen B, 1998, BRIT J OBSTET GYNAEC, V105, P877, DOI 10.1111/j.1471-0528.1998.tb10233.x; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Lalkin A, 1998, AM J OBSTET GYNECOL, V179, P727, DOI 10.1016/S0002-9378(98)70072-9; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Matok I, 2009, ARCH DIS CHILD, V94, pe1; Matok I, 2009, NEW ENGL J MED, V360, P2528, DOI 10.1056/NEJMoa0807154; Mitchell AA, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P501; Nava-Ocampo AA, 2006, CAN FAM PHYSICIAN, V52, P853; Nielsen GL, 1999, ALIMENT PHARM THERAP, V13, P1085; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rey E, 2007, AM J GASTROENTEROL, V102, P2395, DOI 10.1111/j.1572-0241.2007.01452.x; Richter JE, 2005, ALIMENT PHARM THER, V22, P749, DOI 10.1111/j.1365-2036.2005.02654.x; Ruigomez A, 1999, AM J EPIDEMIOL, V150, P476	28	86	101	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 25	2010	363	22					2114	2123		10.1056/NEJMoa1002689	http://dx.doi.org/10.1056/NEJMoa1002689			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684XE	21105793				2022-12-01	WOS:000284587800006
J	Demontis, F; Perrimon, N				Demontis, Fabio; Perrimon, Norbert			FOXO/4E-BP Signaling in Drosophila Muscles Regulates Organism-wide Proteostasis during Aging	CELL			English	Article							FOXO TRANSCRIPTION FACTORS; EXTENDS LIFE-SPAN; PROTEIN-DEGRADATION; AUTOPHAGY; ELEGANS; DISEASE; CELLS; BODY; ACTIVATION; PATHWAYS	The progressive loss of muscle strength during aging is a common degenerative event of unclear pathogenesis. Although muscle functional decline precedes age-related changes in other tissues, its contribution to systemic aging is unknown. Here, we show that muscle aging is characterized in Drosophila by the progressive accumulation of protein aggregates that associate with impaired muscle function. The transcription factor FOXO and its target 4E-BP remove damaged proteins at least in part via the autophagy/lysosome system, whereas foxo mutants have dysfunctional proteostasis. Both FOXO and 4E-BP delay muscle functional decay and extend life span. Moreover, FOXO/4E-BP signaling in muscles decreases feeding behavior and the release of insulin from producing cells, which in turn delays the age-related accumulation of protein aggregates in other tissues. These findings reveal an organism-wide regulation of proteostasis in response to muscle aging and a key role of FOXO/4E-BP signaling in the coordination of organismal and tissue aging.	[Demontis, Fabio; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Demontis, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	fdemontis@genetics.med.harvard.edu; perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X; Demontis, Fabio/0000-0002-8698-9555	NIH [1P01CA120964-01A1]; Paul F. Glenn Labs for the Molecular Biology of Aging; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Labs for the Molecular Biology of Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Andreas Brech, Didier Contamine, Ernst Hafen, Pierre Leopold, Susan Lindquist, Ioannis Nezis, Amita Sehgal, Marc Tatar, Robert Tjian, John Tower, the DRSC/TRiP, and members of the Perrimon lab for fly stocks, reagents, and advice. We thank Maria Ericsson for assistance with electron microscopy, Christians Villalta for embryo injection, and Chris Bakal, Rami Rahal, and Jonathan Zirin for critically reading the manuscript. This work was supported by the NIH (1P01CA120964-01A1) and a Pilot Project Grant from the Paul F. Glenn Labs for the Molecular Biology of Aging. F.D. is an Ellison Medical Foundation/AFAR postdoctoral fellow. N.P. is an investigator of the Howard Hughes Medical Institute.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Garigan D, 2002, GENETICS, V161, P1101; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Needham M, 2008, NEUROMUSCULAR DISORD, V18, P6, DOI 10.1016/j.nmd.2007.11.001; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Plata-Salaman CR, 1998, NEWS PHYSIOL SCI, V13, P298; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tower J, 2009, TRENDS ENDOCRIN MET, V20, P216, DOI 10.1016/j.tem.2008.12.005; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	49	430	441	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					813	825		10.1016/j.cell.2010.10.007	http://dx.doi.org/10.1016/j.cell.2010.10.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111239	Green Accepted, Bronze			2022-12-01	WOS:000284583500022
J	Ikeda, F; Crosetto, N; Dikic, I				Ikeda, Fumiyo; Crosetto, Nicola; Dikic, Ivan			What Determines the Specificity and Outcomes of Ubiquitin Signaling?	CELL			English	Article							POLYUBIQUITIN CHAINS; STRUCTURAL BASIS; BINDING DOMAINS; RECOGNITION; PROTEASOME; DEGRADATION; ACTIVATION; PROTEINS; COMPLEX; LIGASE	Ubiquitin signals and ubiquitin-binding domains are implicated in almost every cellular process, but how is their functionality achieved in cells? We assess recent advances in monitoring the dynamics and specificity of ubiquitin networks in vivo and discuss challenges ahead.	[Ikeda, Fumiyo; Crosetto, Nicola; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Ikeda, Fumiyo; Crosetto, Nicola; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Main, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Dikic, Ivan/O-4650-2015; Ikeda, Fumiyo/AAD-3770-2020	Dikic, Ivan/0000-0001-8156-9511; Ikeda, Fumiyo/0000-0003-0407-2768				Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, PROTEOMICS, V5, P2104, DOI 10.1002/pmic.200401089; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/NCHEMBIO.426, 10.1038/nchembio.426]; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zhao SK, 2010, P NATL ACAD SCI USA, V107, P7704, DOI 10.1073/pnas.0908764107	42	125	131	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 24	2010	143	5					677	681		10.1016/j.cell.2010.10.026	http://dx.doi.org/10.1016/j.cell.2010.10.026			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	684VX	21111228	Bronze			2022-12-01	WOS:000284583500009
J	Lubitz, SA; Yin, XY; Fontes, JD; Magnani, JW; Rienstra, M; Pai, M; Villalon, ML; Vasan, RS; Pencina, MJ; Levy, D; Larson, MG; Ellinor, PT; Benjamin, EJ				Lubitz, Steven A.; Yin, Xiaoyan; Fontes, Joao D.; Magnani, Jared W.; Rienstra, Michiel; Pai, Manju; Villalon, Mark L.; Vasan, Ramachandran S.; Pencina, Michael J.; Levy, Daniel; Larson, Martin G.; Ellinor, Patrick T.; Benjamin, Emelia J.			Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; COMMON VARIANTS; AGGREGATION; HISTORY; REGRESSION; INTERVAL; ZFHX3; SCORE	Context Although the heritability of atrial fibrillation (AF) is established, the contribution of familial AF to predicting new-onset AF remains unknown. Objective To determine whether familial occurrence of AF is associated with new-onset AF beyond established risk factors. Design, Setting, and Participants The Framingham Heart Study, a prospective community-based cohort study started in 1948. Original and Offspring Cohort participants were aged at least 30 years, were free of AF at the baseline examination, and had at least 1 parent or sibling enrolled in the study. The 4421 participants in this analysis (mean age, 54 [SD, 13] years; 54% women) were followed up through December 31, 2007. Main Outcome Measures Incremental predictive value of incorporating different features of familial AF (any familial AF, premature familial AF [onset <65 years old], number of affected relatives, and youngest age of onset in a relative) into a risk model for new-onset AF. Results Across 11 971 examinations during the period 1968-2007, 440 participants developed AF. Familial AF occurred among 1185 participants (26.8%) and premature familial AF occurred among 351 participants (7.9%). Atrial fibrillation occurred more frequently among participants with familial AF than without familial AF (unadjusted absolute event rates of 5.8% and 3.1%, respectively). The association was not attenuated by adjustment for AF risk factors (multivariable-adjusted hazard ratio, 1.40; 95% confidence interval [CI], 1.13-1.74) or reported AF-related genetic variants. Among the different features of familial AF examined, premature familial AF was associated with improved discrimination beyond traditional risk factors to the greatest extent (traditional risk factors, C statistic, 0.842 [95% CI, 0.826-0.858]; premature familial AF, C statistic, 0.846 [95% CI, 0.831-0.862]; P=.004). Modest changes in integrated discrimination improvement were observed with premature familial AF (2.1%). Net reclassification improvement (assessed using 8-year risk thresholds of <5%, 5%-10%, and >10%) did not change significantly with premature familial AF (index statistic, 0.011; 95% CI, -0.021 to 0.042; P=.51), although categoryless net reclassification was improved (index statistic, 0.127; 95% CI, 0.064-0.189; P=.009). Conclusions In this cohort, familial AF was associated with an increased risk of AF that was not attenuated by adjustment for AF risk factors including genetic variants. Assessment of premature familial AF was associated with a very slight increase in predictive accuracy compared with traditional risk factors. JAMA. 2010;304(20):2263-2269 www.jama.com	[Yin, Xiaoyan; Fontes, Joao D.; Magnani, Jared W.; Vasan, Ramachandran S.; Pencina, Michael J.; Levy, Daniel; Larson, Martin G.; Benjamin, Emelia J.] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Lubitz, Steven A.; Rienstra, Michiel; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Lubitz, Steven A.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Fontes, Joao D.; Magnani, Jared W.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA; [Pai, Manju; Villalon, Mark L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Pencina, Michael J.; Larson, Martin G.] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Benjamin, Emelia J.] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Rienstra, Michiel] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA	Framingham Heart Study; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Benjamin, EJ (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,Ste 2, Framingham, MA 01702 USA.	emelia@bu.edu	Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Ramachandran, Vasan/Y-2527-2019; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Pencina, Michael/0000-0001-5798-8855; Fontes, Joao Daniel/0000-0001-5011-0855; Rienstra, Michiel/0000-0002-2581-070X; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336; Ellinor, Patrick/0000-0002-2067-0533	National Institutes of Health (NIH) [T32HL007575, 6R01-NS17950, HL092577, R01AG028321, RC1-HL01056, 1R01HL102214, DA027021, HL104156]; American Heart Association [09FTF2190028]; Netherlands Organization for Scientific Research [825.09.020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Lubitz was supported by a National Institutes of Health (NIH) training grant in the Epidemiology of Cardiovascular Disease (grant T32HL007575). Dr Magnani is supported by American Heart Association grant 09FTF2190028. Dr Rienstra is supported by a Rubicon grant from the Netherlands Organization for Scientific Research (grant 825.09.020). Dr Benjamin is supported by NIH grant 6R01-NS17950. This work was supported by grants from the NIH to Drs Benjamin and Ellinor (grant HL092577), Dr Benjamin (grants R01AG028321, RC1-HL01056, and 1R01HL102214), and Dr Ellinor (grants DA027021 and HL104156).	[Anonymous], 2008, SAS 9 2 US GUID, P4517; Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Christophersen IE, 2009, CIRC-ARRHYTHMIA ELEC, V2, P378, DOI 10.1161/CIRCEP.108.786665; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dublin S, 2010, J GEN INTERN MED, V25, P853, DOI 10.1007/s11606-010-1340-y; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Ellinor PT, 2005, HUM GENET, V118, P179, DOI 10.1007/s00439-005-0034-8; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Marcus GM, 2008, HEART RHYTHM, V5, P826, DOI 10.1016/j.hrthm.2008.02.016; Murabito JM, 2005, JAMA-J AM MED ASSOC, V294, P3117, DOI 10.1001/jama.294.24.3117; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; GAINING MORE FLEXIBI	33	207	210	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2010	304	20					2263	2269		10.1001/jama.2010.1690	http://dx.doi.org/10.1001/jama.2010.1690			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KI	21076174	Green Accepted, Bronze			2022-12-01	WOS:000284548400025
J	Jaramillo, C; Ochoa, D; Contreras, L; Pagani, M; Carvajal-Ortiz, H; Pratt, LM; Krishnan, S; Cardona, A; Romero, M; Quiroz, L; Rodriguez, G; Rueda, MJ; de la Parra, F; Moron, S; Green, W; Bayona, G; Montes, C; Quintero, O; Ramirez, R; Mora, G; Schouten, S; Bermudez, H; Navarrete, R; Parra, F; Alvaran, M; Osorno, J; Crowley, JL; Valencia, V; Vervoort, J				Jaramillo, Carlos; Ochoa, Diana; Contreras, Lineth; Pagani, Mark; Carvajal-Ortiz, Humberto; Pratt, Lisa M.; Krishnan, Srinath; Cardona, Agustin; Romero, Millerlandy; Quiroz, Luis; Rodriguez, Guillermo; Rueda, Milton J.; de la Parra, Felipe; Moron, Sara; Green, Walton; Bayona, German; Montes, Camilo; Quintero, Oscar; Ramirez, Rafael; Mora, German; Schouten, Stefan; Bermudez, Hermann; Navarrete, Rosa; Parra, Francisco; Alvaran, Mauricio; Osorno, Jose; Crowley, James L.; Valencia, Victor; Vervoort, Jeff			Effects of Rapid Global Warming at the Paleocene-Eocene Boundary on Neotropical Vegetation	SCIENCE			English	Article							THERMAL MAXIMUM; CERREJON FORMATION; CLIMATE; TEMPERATURE; DISCRIMINATION; COLOMBIA; CANOPY; FOREST; TREE; CO2	Temperatures in tropical regions are estimated to have increased by 3 degrees to 5 degrees C, compared with Late Paleocene values, during the Paleocene-Eocene Thermal Maximum (PETM, 56.3 million years ago) event. We investigated the tropical forest response to this rapid warming by evaluating the palynological record of three stratigraphic sections in eastern Colombia and western Venezuela. We observed a rapid and distinct increase in plant diversity and origination rates, with a set of new taxa, mostly angiosperms, added to the existing stock of low-diversity Paleocene flora. There is no evidence for enhanced aridity in the northern Neotropics. The tropical rainforest was able to persist under elevated temperatures and high levels of atmospheric carbon dioxide, in contrast to speculations that tropical ecosystems were severely compromised by heat stress.	[Jaramillo, Carlos; Ochoa, Diana; Contreras, Lineth; Carvajal-Ortiz, Humberto; Cardona, Agustin; Romero, Millerlandy; Quiroz, Luis; Moron, Sara; Green, Walton; Bayona, German; Montes, Camilo] Smithsonian Trop Res Inst, Balboa, Panama; [Ochoa, Diana] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA; [Contreras, Lineth; Rodriguez, Guillermo; Rueda, Milton J.; de la Parra, Felipe] Colombian Petr Inst, Bucaramanga, Colombia; [Contreras, Lineth] Goethe Univ Frankfurt, Inst Geosci, D-60438 Frankfurt, Germany; [Pagani, Mark; Krishnan, Srinath] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Carvajal-Ortiz, Humberto; Pratt, Lisa M.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Quiroz, Luis] Univ Saskatchewan, Dept Geol, Saskatoon, SK, Canada; [Rodriguez, Guillermo] Missouri Univ Sci & Technol, Dept Geol Sci & Engn, Rolla, MO 65409 USA; [Rueda, Milton J.] Paleoflora Ltd, Zapatoca, Colombia; [Moron, Sara] Univ Minnesota, Dept Geol, Minneapolis, MN 55455 USA; [Bayona, German; Montes, Camilo] Corp Geol Ares, Bogota, Colombia; [Quintero, Oscar] Petroleos Venezuela SA PDVSA Explorac, Nucleoteca Concepc, Maracaibo, Venezuela; [Mora, German] Goucher Coll, Baltimore, MD 21204 USA; [Schouten, Stefan] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Texel, Netherlands; [Bermudez, Hermann; Alvaran, Mauricio] Univ Caldas, Dept Geol Sci, Manizales, Colombia; [Parra, Francisco] Univ Toulouse 3, CU Ponsan Bellevue, F-31078 Tolulouse 04, France; [Osorno, Jose] Agencia Nacl Hidrocarburos, Bogota, Colombia; [Crowley, James L.] Boise State Univ, Dept Geosci, Boise, ID 83725 USA; [Valencia, Victor] Valencia Geoserv, Tucson, AZ 85712 USA; [Vervoort, Jeff] Washington State Univ, Sch Earth & Environm Sci, Pullman, WA 99164 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; East Tennessee State University; Goethe University Frankfurt; Yale University; Indiana University System; Indiana University Bloomington; University of Saskatchewan; University of Missouri System; Missouri University of Science & Technology; University of Minnesota System; University of Minnesota Twin Cities; PDVSA; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universidad de Caldas; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Idaho; Boise State University; Washington State University	Jaramillo, C (corresponding author), Smithsonian Trop Res Inst, Box 0843-03092, Balboa, Panama.	jaramilloc@si.edu	Pagani, Mark/B-3233-2008; Ochoa, Diana/AAV-1916-2020; Morón, Sara/AAK-5199-2021; Vervoort, Jeff/AAJ-6234-2020	Ochoa, Diana/0000-0001-6242-4202; Parra Navarrete, Francisco Javier/0000-0003-0801-9446; Polanco, Sara/0000-0002-1270-4377; Crowley, James/0000-0001-5069-0773; jaramillo, carlos/0000-0002-2616-5079; Vervoort, Jeff/0000-0002-1138-4527; Montes, Camilo/0000-0002-3553-0787; Bermudez, Hermann/0000-0003-0656-2007	Banco de la Republica; National Geographic; Smithsonian Women's Club; Instituto de Colombiano de Petroleo (ICP)-Ecopetrol SA; NSF [EAR-0628358, ATM-0902882]; Netherlands Organisation for Scientific Research; Smithsonian	Banco de la Republica; National Geographic(National Geographic Society); Smithsonian Women's Club; Instituto de Colombiano de Petroleo (ICP)-Ecopetrol SA; NSF(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Smithsonian(Smithsonian Institution)	Supported by Banco de la Republica, National Geographic, Smithsonian Women's Club, Instituto de Colombiano de Petroleo (ICP)-Ecopetrol SA, and Smithsonian, M.P. was supported by NSF EAR-0628358 and ATM-0902882. S.S. was supported by a VISI grant from Netherlands Organisation for Scientific Research. Thanks to PDVSA for access to Mar 2X and the Instituto de Patrimonio Cultural of Venezuela for allowing us to sample in Riecito Mache. Thanks to Agencia Nacional de Hidrocarburos, A. Pardo, J. Sanchez, C. Guerrero, M. Carvalho, and the Colombian Armed Forces for logistic support. Thanks to the biostratigraphic team at ICP. Patrice Brenac did preliminary palynological analysis of Gonzales. N. Atkins provided editing support. A. Mets (NIOZ) is thanked for analytical assistance. K. Winter, H. Muller-Landau, J. Wright, and S. Punyasena and three anonymous reviewers provided comments on the manuscript. Special thanks to M. I. Barreto for continuous support and sources of ideas.	BASSOW SL, 1994, ECOL APPL, V4, P593, DOI 10.2307/1941960; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Krause GH, 2010, FUNCT PLANT BIOL, V37, P890, DOI 10.1071/FP10034; Huber M, 2008, SCIENCE, V321, P353, DOI 10.1126/science.1161170; Huber M, 2009, NATURE, V457, P669, DOI 10.1038/457669a; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Jaramillo CA, 2007, PALYNOLOGY, V31, P153, DOI 10.2113/gspalynol.31.1.153; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Pagani M, 2006, SCIENCE, V314, P1556, DOI 10.1126/science.1136110; Punyasena SW, 2008, J BIOGEOGR, V35, P117, DOI 10.1111/j.1365-2699.2007.01773.x; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Royer DL, 2010, P NATL ACAD SCI USA, V107, P517, DOI 10.1073/pnas.0913188107; Schuettpelz E, 2009, P NATL ACAD SCI USA, V106, P11200, DOI 10.1073/pnas.0811136106; Scotese C. R., 2001, PALEOGEOGRAPHIC ATLA; STOSKOPF NC, 1981, UNDERSTANDING CROP P; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Westerhold T, 2009, EARTH PLANET SC LETT, V287, P412, DOI 10.1016/j.epsl.2009.08.027; Wing SL, 2009, P NATL ACAD SCI USA, V106, P18627, DOI 10.1073/pnas.0905130106; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zeebe RE, 2009, NAT GEOSCI, V2, P576, DOI 10.1038/NGEO578	27	195	200	5	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					957	961		10.1126/science.1193833	http://dx.doi.org/10.1126/science.1193833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071667				2022-12-01	WOS:000284118000041
J	Pan, BC; Xiong, Y; Steitz, TA				Pan, Baocheng; Xiong, Yong; Steitz, Thomas A.			How the CCA-Adding Enzyme Selects Adenine over Cytosine at Position 76 of tRNA	SCIENCE			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; POLYMERIZATION; TRANSLOCATION; POLYMERASE; MECHANISM; SUBSTRATE; TEMPLATE; NUCLEOTIDYLTRANSFERASE; MATURATION	CCA-adding enzymes [ATP(CTP):tRNA nucleotidyltransferases] add CCA onto the 3' end of transfer RNA (tRNA) precursors without using a nucleic acid template. Although the mechanism by which cytosine (C) is selected at position 75 of tRNA has been established, the mechanism by which adenine (A) is selected at position 76 remains elusive. Here, we report five cocrystal structures of the enzyme complexed with both a tRNA mimic and nucleoside triphosphates under catalytically active conditions. These structures suggest that adenosine 5'-monophosphate is incorporated onto the A76 position of the tRNA via a carboxylate-assisted, one-metal-ion mechanism with aspartate 110 functioning as a general base. The discrimination against incorporation of cytidine 5'-triphosphate (CTP) at position 76 arises from improper placement of the alpha phosphate of the incoming CTP, which results from the interaction of C with arginine 224 and prevents the nucleophilic attack by the 3' hydroxyl group of cytidine75.	[Pan, Baocheng; Xiong, Yong; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Steitz, Thomas A./C-6559-2009		NIH [GM57510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source beamline ID19 and at the National Synchrotron Light Source beamline X25. We also thank the staff of the Center for Structural Biology core facility at Yale University. This work was supported by NIH grant GM57510 (to T.A.S.). The coordinates and structure factors for the five structures have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank with accession numbers 3OVA, 3OV7, 3OVB, 3OUY, and 3OVS for preinsertion, initial, intermediate, product, and CTP complexes, respectively.	Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4; Balbo PB, 2007, STRUCTURE, V15, P1117, DOI 10.1016/j.str.2007.07.010; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; Cho HD, 2005, J BIOL CHEM, V280, P9555, DOI 10.1074/jbc.M412594200; Cho HDD, 2006, J BIOL CHEM, V281, P9801, DOI 10.1074/jbc.M512603200; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Steitz TA, 2007, STRUCTURE, V15, P1523, DOI 10.1016/j.str.2007.11.005; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Toh Y, 2008, EMBO J, V27, P1944, DOI 10.1038/emboj.2008.124; Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712; Tomita K, 2006, NATURE, V443, P956, DOI 10.1038/nature05204; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yue DX, 1996, RNA, V2, P895	24	24	25	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					937	940		10.1126/science.1194985	http://dx.doi.org/10.1126/science.1194985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071662	Green Accepted			2022-12-01	WOS:000284118000034
J	Victora, GD; Schwickert, TA; Fooksman, DR; Kamphorst, AO; Meyer-Hermann, M; Dustin, ML; Nussenzweig, MC				Victora, Gabriel D.; Schwickert, Tanja A.; Fooksman, David R.; Kamphorst, Alice O.; Meyer-Hermann, Michael; Dustin, Michael L.; Nussenzweig, Michel C.			Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter	CELL			English	Article							ANTI-HAPTEN ANTIBODY; HELPER T-CELLS; CENTER B-CELLS; IN-VIVO; DENDRITIC CELLS; AFFINITY MATURATION; IMMUNE-RESPONSE; SELF-TOLERANCE; PLASMA-CELL; SELECTION	The germinal center (GC) reaction produces high-affinity antibodies by random mutation and selective clonal expansion of B cells with high-affinity receptors. The mechanism by which B cells are selected remains unclear, as does the role of the two anatomically defined areas of the GC, light zone (LZ) and dark zone (DZ). We combined a transgenic photoactivatable fluorescent protein tracer with multiphoton laser-scanning microscopy and flow cytometry to examine anatomically defined LZ and DZ B cells and GC selection. We find that B cell division is restricted to the DZ, with a net vector of B cell movement from the DZ to the LZ. The decision to return to the DZ and undergo clonal expansion is controlled by T helper cells in the GC LZ, which discern between LZ B cells based on the amount of antigen captured and presented. Thus, T cell help, and not direct competition for antigen, is the limiting factor in GC selection.	[Victora, Gabriel D.; Schwickert, Tanja A.; Kamphorst, Alice O.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Victora, Gabriel D.; Fooksman, David R.; Dustin, Michael L.] NYU, Sch Med, Skirball Inst Biomol Med, Martin & Helen Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, D-38124 Braunschweig, Germany	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; New York University; Helmholtz Association; Helmholtz-Center for Infection Research	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Victora, Gabriel/C-5946-2011; Dustin, Michael/AAM-4611-2020	Schwickert, Tanja/0000-0002-3371-2376; Victora, Gabriel/0000-0001-8807-348X; Kamphorst, Alice/0000-0002-9230-9501; Dustin, Michael/0000-0003-4983-6389	NIH [R01 AI072529, P01 AI071195, CA009161-34]; NYSDOH [C023046]; EU-NEST; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072529, P01AI071195] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSDOH; EU-NEST(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank J. Lippincott-Schwartz (NIH), R. Tsien (UCSD), and B. Schaefer (USU) for the PA-GFP, tdTomato, and UbC constructs, respectively; the MSKCC Genomics Facility for performing the microarray experiments; J. Zavadil (NYU) for guidance in microarray analysis; A. North and S. Bhuvanendran (Rockefeller University Bio-Imaging Resource Center) for help with multiphoton imaging; R. Scheuerman (University of Texas Southwestern Medical Center) for ACS gene lists for GSEA analysis; and T. Cameron for helpful discussion. This work was supported in part by NIH grants R01 AI072529 (M.C.N. and M.L.D.) and P01 AI071195 (M.L.D.). Support for the Rockefeller University multiphoton microscope and cell sorter was granted by the Empire State Stem Cell Fund through NYSDOH Contract #C023046. D.R.F. was supported by NIH training grant CA009161-34. M.M.-H. was supported by the EU-NEST project MAMOCELL in FP6. M.C.N. is an HHMI Investigator.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Brink R, 2008, IMMUNOL CELL BIOL, V86, P31, DOI 10.1038/sj.icb.7100143; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Figge MT, 2008, J EXP MED, V205, P3019, DOI 10.1084/jem.20081160; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; GOIDL EA, 1968, J IMMUNOL, V100, P371; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HAN SH, 1995, J IMMUNOL, V155, P556; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hogerkorp CM, 2006, J IMMUNOL, V177, P4341, DOI 10.4049/jimmunol.177.7.4341; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; KATZ DH, 1970, J EXP MED, V132, P261, DOI 10.1084/jem.132.2.261; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Meyer-Hermann M, 2001, J THEOR BIOL, V210, P265, DOI 10.1006/jtbi.2001.2297; Meyer-Hermann M, 2009, TRENDS IMMUNOL, V30, P157, DOI 10.1016/j.it.2009.01.005; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; NUSSENZWEIG V, 1967, J EXP MED, V126, P727, DOI 10.1084/jem.126.4.727; Oprea M, 1997, J IMMUNOL, V158, P5155; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RAJEWSKY K, 1969, J EXP MED, V129, P1131, DOI 10.1084/jem.129.6.1131; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schneider M, 2005, BIOPHYS J, V89, P1346, DOI 10.1529/biophysj.104.054502; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Tarlinton DM, 2000, IMMUNOL TODAY, V21, P436, DOI 10.1016/S0167-5699(00)01687-X; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	66	765	775	0	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 12	2010	143	4					592	605		10.1016/j.cell.2010.10.032	http://dx.doi.org/10.1016/j.cell.2010.10.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074050	Bronze, Green Accepted			2022-12-01	WOS:000284149100016
J	Roberts, I; Stott, R				Roberts, Ian; Stott, Robin			Doctors and climate change	LANCET			English	Editorial Material							HEALTH		[Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk						Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; GOLDSMITH B, 2010, TORONTO SUN; Haines A, 2009, LANCET, V374, P2035, DOI 10.1016/S0140-6736(09)61667-6; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Roberts I, 2010, ENERGY GLUT POLITICS; Roberts I, 2008, BMJ-BRIT MED J, V336, P165, DOI 10.1136/bmj.39468.596262.80; Ruiz- Arregui L, 2007, SALUD PUBLICA MEX; TFWG, 2010, UN CLIM CHANG C CANC; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	9	6	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2010	376	9755					1801	1802		10.1016/S0140-6736(10)62106-X	http://dx.doi.org/10.1016/S0140-6736(10)62106-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KG	21093038	Green Accepted			2022-12-01	WOS:000285439700004
J	Mills, EJ; Rammohan, A; Awofeso, N				Mills, Edward J.; Rammohan, Anu; Awofeso, Niyi			Ageing faster with AIDS in Africa	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; COLLABORATIVE ANALYSIS; INFECTION		[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada; [Rammohan, Anu] Univ Western Australia, Sch Econ, Perth, WA 6009, Australia; [Awofeso, Niyi] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Awofeso, Niyi] Natl Open Univ Nigeria, Sch Publ Hlth, Lagos, Nigeria	University of Ottawa; University of Western Australia; University of Western Australia	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada.	edward.mills@uottawa.ca	Awofeso, Niyi/J-4705-2019	Rammohan, Anu/0000-0002-9062-4508				Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization ( WHO), 2009, 2009 AIDS EP UPD; Justice AC, 2010, INT J EPIDEMIOL, V39, P146, DOI 10.1093/ije/dyp342; Kautz T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2841; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Negin JC, 2010, B WORLD HEALTH ORGAN, V88, P1847; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; *NIH, 2010, NIH STAT NAT HIV AID; WHO, 2010, DEF OLD ELD PERS	9	29	31	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1131	1133		10.1016/S0140-6736(10)62180-0	http://dx.doi.org/10.1016/S0140-6736(10)62180-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	21126759				2022-12-01	WOS:000289539300007
J	Rabl, J; Leibundgut, M; Ataide, SF; Haag, A; Ban, N				Rabl, Julius; Leibundgut, Marc; Ataide, Sandro F.; Haag, Andrea; Ban, Nenad			Crystal Structure of the Eukaryotic 40S Ribosomal Subunit in Complex with Initiation Factor 1	SCIENCE			English	Article							PROTEIN-KINASE-C; TRANSLATION INITIATION; MESSENGER-RNA; START CODON; IN-VIVO; 70S RIBOSOME; FACTOR EIF1; RACK1; S1; YEAST	Eukaryotic ribosomes are substantially larger and more complex than their bacterial counterparts. Although their core function is conserved, bacterial and eukaryotic protein synthesis differ considerably at the level of initiation. The eukaryotic small ribosomal subunit (40S) plays a central role in this process; it binds initiation factors that facilitate scanning of messenger RNAs and initiation of protein synthesis. We have determined the crystal structure of the Tetrahymena thermophila 40S ribosomal subunit in complex with eukaryotic initiation factor 1 (eIF1) at a resolution of 3.9 angstroms. The structure reveals the fold of the entire 18S ribosomal RNA and of all ribosomal proteins of the 40S subunit, and defines the interactions with eIF1. It provides insights into the eukaryotic-specific aspects of protein synthesis, including the function of eIF1 as well as signaling and regulation mediated by the ribosomal proteins RACK1 and rpS6e.	[Rabl, Julius; Leibundgut, Marc; Ataide, Sandro F.; Haag, Andrea; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch		F Ataide, Sandro/0000-0003-1807-5708; Rabl, Julius/0000-0001-6375-852X	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR); European Research Council [250071]; European Community	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR)(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission)	All data were collected at the Swiss Light Source (SLS, Paul Scherrer Institut, Villigen). We thank C. Schulze-Briese, A. Pauluhn, R. Bingel-Erlenmeyer, M. Muller, and T. Tomizaki for their outstanding support at the SLS; B. Blattmann from the NCCR crystallization facility for screening; R. Brunisholz for help with mass spectroscopy; N. Katheder, D. Baretic, and M. Weisser for their work during the initial phase of the project; S. Arpagaus for preparation of the material; T. Maier for advice during phasing; D. Bohringer for critically reading the manuscript; all members of the Ban laboratory for suggestions and discussions; and A. Brunger for providing a prerelease version of the CNS 1.3 refinement program. Supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF, and European Research Council grant 250071 under the European Community's Seventh Framework Programme (N.B.), and the Max Roessler prize to N.B. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession codes 2xzm and 2xzn. ETH Zurich has filed a patent application to use the crystals and the coordinates of the 40S ribosomal subunit for developing compounds that can interfere with eukaryotic translation.	Alkemar G, 2006, BIOCHEMISTRY-US, V45, P8067, DOI 10.1021/bi052149z; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; CASTILHOVALAVICIUS B, 1990, GENETICS, V124, P483; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Gallina A, 2001, VIROLOGY, V283, P7, DOI 10.1006/viro.2001.0855; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Komarova AV, 2002, RNA, V8, P1137, DOI 10.1017/S1355838202029990; Korostelev A, 2007, P NATL ACAD SCI USA, V104, P16840, DOI 10.1073/pnas.0707850104; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Pachler K, 2004, FEMS YEAST RES, V5, P271, DOI 10.1016/j.femsyr.2004.07.009; PALM L, 1995, J BIOL CHEM, V270, P6000, DOI 10.1074/jbc.270.11.6000; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Reinhardt J, 2000, VET MICROBIOL, V74, P87, DOI 10.1016/S0378-1135(00)00169-3; Sang NL, 2001, J BIOL CHEM, V276, P27026, DOI 10.1074/jbc.M010346200; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Smith PR, 2000, J VIROL, V74, P3082, DOI 10.1128/JVI.74.7.3082-3092.2000; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	54	349	354	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					730	736		10.1126/science.1198308	http://dx.doi.org/10.1126/science.1198308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21205638	Green Submitted			2022-12-01	WOS:000287205700060
J	Spence, JR; Mayhew, CN; Rankin, SA; Kuhar, MF; Vallance, JE; Tolle, K; Hoskins, EE; Kalinichenko, VV; Wells, SI; Zorn, AM; Shroyer, NF; Wells, JM				Spence, Jason R.; Mayhew, Christopher N.; Rankin, Scott A.; Kuhar, Matthew F.; Vallance, Jefferson E.; Tolle, Kathryn; Hoskins, Elizabeth E.; Kalinichenko, Vladimir V.; Wells, Susanne I.; Zorn, Aaron M.; Shroyer, Noah F.; Wells, James M.			Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro	NATURE			English	Article							EFFICIENT DIFFERENTIATION; ENDOCRINE-CELLS; ENDODERM; NEUROGENIN-3; SPECIFICATION; GENERATION; CULTURE; LIVER; FATE	Studies in embryonic development have guided successful efforts to direct the differentiation of human embryonic and induced pluripotent stem cells (PSCs) into specific organ cell types in vitro(1,2). For example, human PSCs have been differentiated into monolayer cultures of liver hepatocytes and pancreatic endocrine cells(3-6) that have therapeutic efficacy in animal models of liver disease(7,8) and diabetes(9), respectively. However, the generation of complex three-dimensional organ tissues in vitro remains a major challenge for translational studies. Here we establish a robust and efficient process to direct the differentiation of human PSCs into intestinal tissue in vitro using a temporal series of growth factor manipulations to mimic embryonic intestinal development(10). This involved activin-induced definitive endoderm formation(11), FGF/Wnt-induced posterior endoderm pattering, hindgut specification and morphogenesis(12-14), and a pro-intestinal culture system(15,16) to promote intestinal growth, morphogenesis and cytodifferentiation. The resulting three-dimensional intestinal 'organoids' consisted of a polarized, columnar epithelium that was patterned into villus-like structures and crypt-like proliferative zones that expressed intestinal stem cell markers(17). The epithelium contained functional enterocytes, as well as goblet, Paneth and enteroendocrine cells. Using this culture system as a model to study human intestinal development, we identified that the combined activity of WNT3A and FGF4 is required for hindgut specification whereas FGF4 alone is sufficient to promote hindgut morphogenesis. Our data indicate that human intestinal stem cells form de novo during development. We also determined that NEUROG3, a pro-endocrine transcription factor that is mutated in enteric anendocrinosis(18), is both necessary and sufficient for human enteroendocrine cell development in vitro. PSC-derived human intestinal tissue should allow for unprecedented studies of human intestinal development and disease.	[Spence, Jason R.; Mayhew, Christopher N.; Rankin, Scott A.; Kuhar, Matthew F.; Tolle, Kathryn; Kalinichenko, Vladimir V.; Zorn, Aaron M.; Shroyer, Noah F.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Vallance, Jefferson E.; Shroyer, Noah F.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Hoskins, Elizabeth E.; Wells, Susanne I.] Cincinnati Childrens Hosp Med Ctr, Div Hematol & Oncol, Cincinnati, OH 45229 USA; [Kalinichenko, Vladimir V.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Wells, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	james.wells@cchmc.org	Mayhew, Christopher N/AGB-4929-2022	Shroyer, Noah/0000-0002-5934-2852; Mayhew, Chris/0000-0002-7408-1726; Vallance, Jefferson/0000-0001-6473-3623	Juvenile Diabetes Research Foundation [JDRF-2-2003-530]; NIH [R01GM072915, R01DK080823A1 and S1, R03 DK084167, R01 CA142826, F32 DK83202-01, T32 HD07463];  [P30 DK078392];  [U54 RR025216]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007463] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA142826] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092456, R03DK084167, K01DK091415, P30DK078392, R01DK080823, F32DK083202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072915] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the laboratory, D. Wiginton and C. Wylie for input. We also thank M. Kofron, T. Stefader and R. Lang for assistance with imaging. Vectors and antibodies were from D. Melton (Addgene no. 19410, 19413), S. Yamanaka (17217-17220), C. Baum (OCT4, KLF4, SOX4, MYC lenti), and I. Manabe (KLF5 antibody). This work was supported by the Juvenile Diabetes Research Foundation JDRF-2-2003-530 (J.M.W.) and NIH, R01GM072915 (J.M.W.); R01DK080823A1 and S1 (A.M.Z. and J.M.W.); R03 DK084167 and R01 CA142826 (N.F.S.), F32 DK83202-01 and T32 HD07463 (J.R.S.). We also acknowledge core support for viral vectors, microarrays (supported by P30 DK078392), karyotyping and the Pluripotent Stem Cell Facility (supported by U54 RR025216).	Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Groneberg DA, 2001, AM J PHYSIOL-GASTR L, V281, pG697, DOI 10.1152/ajpgi.2001.281.3.G697; Haveri H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-9; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lambert PF, 2005, METH MOLEC MED, V119, P141; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lopez-Diaz L, 2007, DEV BIOL, V309, P298, DOI 10.1016/j.ydbio.2007.07.015; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mayhew CN, 2010, CURR OPIN ORGAN TRAN, V15, P54, DOI 10.1097/MOT.0b013e3283337e1c; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Torihashi S, 2006, STEM CELLS, V24, P2618, DOI 10.1634/stemcells.2006-0148; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wells JM, 2000, DEVELOPMENT, V127, P1563; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	38	1144	1214	13	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					105	U120		10.1038/nature09691	http://dx.doi.org/10.1038/nature09691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21151107	Green Accepted			2022-12-01	WOS:000286886400043
J	Atarashi, K; Tanoue, T; Shima, T; Imaoka, A; Kuwahara, T; Momose, Y; Cheng, GH; Yamasaki, S; Saito, T; Ohba, Y; Taniguchi, T; Takeda, K; Hori, S; Ivanov, II; Umesaki, Y; Itoh, K; Honda, K				Atarashi, Koji; Tanoue, Takeshi; Shima, Tatsuichiro; Imaoka, Akemi; Kuwahara, Tomomi; Momose, Yoshika; Cheng, Genhong; Yamasaki, Sho; Saito, Takashi; Ohba, Yusuke; Taniguchi, Tadatsugu; Takeda, Kiyoshi; Hori, Shohei; Ivanov, Ivaylo I.; Umesaki, Yoshinori; Itoh, Kikuji; Honda, Kenya			Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species	SCIENCE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; INTESTINAL IMMUNE-RESPONSES; MICROBIOTA; INTERLEUKIN-10; HOMEOSTASIS; COLITIS; INFLAMMATION; SYSTEM; BETA	CD4(+) T regulatory cells (T-regs), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T-regs were most abundant in the colonic mucosa. The spore-forming component of indigenous intestinal microbiota, particularly clusters IV and XIVa of the genus Clostridium, promoted T-reg cell accumulation. Colonization of mice by a defined mix of Clostridium strains provided an environment rich in transforming growth factor-beta and affected Foxp3(+) T-reg number and function in the colon. Oral inoculation of Clostridium during the early life of conventionally reared mice resulted in resistance to colitis and systemic immunoglobulin E responses in adult mice, suggesting a new therapeutic approach to autoimmunity and allergy.	[Atarashi, Koji; Tanoue, Takeshi; Taniguchi, Tadatsugu; Honda, Kenya] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan; [Shima, Tatsuichiro; Imaoka, Akemi; Umesaki, Yoshinori] Yakult Cent Inst Microbiol Res, Tokyo 1868650, Japan; [Kuwahara, Tomomi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Bacteriol, Tokushima 7708503, Japan; [Momose, Yoshika; Itoh, Kikuji] Univ Tokyo, Dept Vet Publ Hlth, Tokyo 1138657, Japan; [Cheng, Genhong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yamasaki, Sho; Saito, Takashi] RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan; [Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido 0608638, Japan; [Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Hori, Shohei] RIKEN Res Ctr Allergy & Immunol, Res Unit Immune Homeostasis, Kanagawa 2300045, Japan; [Ivanov, Ivaylo I.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Honda, Kenya] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Yakult Honsha Company, Limited; Tokushima University; University of Tokyo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RIKEN; Hokkaido University; Osaka University; RIKEN; Columbia University; Japan Science & Technology Agency (JST)	Honda, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan.	kenya@m.u-tokyo.ac.jp	Atarashi, Koji/I-5363-2014; Ohba, Yusuke/E-7944-2011; Hori, Shohei/O-6163-2019; Honda, Kenya/N-5297-2015; Saito, Takashi/C-9684-2009	Atarashi, Koji/0000-0001-5422-0736; Hori, Shohei/0000-0001-8770-4593; Saito, Takashi/0000-0001-9495-3547; Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kato Memorial Bioscience Foundation; Mishima Kaiun Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Inoue Foundation for Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154, R01AI052359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085329] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kato Memorial Bioscience Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Inoue Foundation for Science(Inoue Foundation for Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Ueda, J. Nishimura, and H. Saiga for technical assistance, R. Eisenman for critically reading the manuscript, and A. Miyawaki for Venus. We thank the staff at the Sankyo Laboratories for gnotobiotic handling of the mice. The work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Kato Memorial Bioscience Foundation, the Mishima Kaiun Memorial Foundation, Kanae Foundation for the Promotion of Medical Science, and Inoue Foundation for Science. The authors have applied for a patent for use of bacteria belonging to the genus Clostridium or a physiologically active substance derived from these bacteria to induce proliferation or accumulation of regulatory T cells and suppress immune functions (patent application no. JP 2010-129134). Material transfer agreements are required for the use of the IL-10 Venus mice, SFB, Clostridium spp. 46 strains, Bacteroides spp. 16 strains, and Lactobacillus spp. 3 strains.	Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; D'Angelo M, 2001, J BIOL CHEM, V276, P11347, DOI 10.1074/jbc.M009725200; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; ITOH K, 1985, LAB ANIM, V19, P111, DOI 10.1258/002367785780942589; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Lyons A, 2010, CLIN EXP ALLERGY, V40, P811, DOI 10.1111/j.1365-2222.2009.03437.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Momose Y, 2009, J APPL MICROBIOL, V107, P2088, DOI 10.1111/j.1365-2672.2009.04431.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	25	2387	2573	16	442	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					337	341		10.1126/science.1198469	http://dx.doi.org/10.1126/science.1198469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21205640	Green Accepted			2022-12-01	WOS:000286636300039
J	Crimmins, SM; Dobrowski, SZ; Greenberg, JA; Abatzoglou, JT; Mynsberge, AR				Crimmins, Shawn M.; Dobrowski, Solomon Z.; Greenberg, Jonathan A.; Abatzoglou, John T.; Mynsberge, Alison R.			Changes in Climatic Water Balance Drive Downhill Shifts in Plant Species' Optimum Elevations	SCIENCE			English	Article							VEGETATION DISTRIBUTION; CALIFORNIA; 20TH-CENTURY; PHENOLOGY; MIGRATION; USA	Uphill shifts of species' distributions in response to historical warming are well documented, which leads to widespread expectations of continued uphill shifts under future warming. Conversely, downhill shifts are often considered anomalous and unrelated to climate change. By comparing the altitudinal distributions of 64 plant species between the 1930s and the present day within California, we show that climate changes have resulted in a significant downward shift in species' optimum elevations. This downhill shift is counter to what would be expected given 20th-century warming but is readily explained by species' niche tracking of regional changes in climatic water balance rather than temperature. Similar downhill shifts can be expected to occur where future climate change scenarios project increases in water availability that outpace evaporative demand.	[Crimmins, Shawn M.; Dobrowski, Solomon Z.; Mynsberge, Alison R.] Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [Greenberg, Jonathan A.] Univ Calif Davis, Ctr Spatial Technol & Remote Sensing, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Abatzoglou, John T.] Univ Idaho, Dept Geog, Coll Sci, Moscow, ID 83844 USA	University of Montana System; University of Montana; University of California System; University of California Davis; Idaho; University of Idaho	Dobrowski, SZ (corresponding author), Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA.	solomon.dobrowski@cfc.umt.edu	Crimmins, Shawn/C-6972-2012; Dobrowski, Solomon Z/Q-7132-2019; Crimmins, Shawn/M-1809-2013; Abatzoglou, John T/ABE-6134-2020; Abatzoglou, John T/C-7635-2012	Dobrowski, Solomon Z/0000-0003-2561-3850; Abatzoglou, John T/0000-0001-7599-9750; Abatzoglou, John T/0000-0001-7599-9750; Greenberg, Jonathan/0000-0001-8435-9077	NSF [BCS-0819430, BCS-0819493, EPS-0814387]; U.S. Department of Agriculture Forest Service's (USFS's) Rocky Mountain Research Station [JV11221635-201]	NSF(National Science Foundation (NSF)); U.S. Department of Agriculture Forest Service's (USFS's) Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service)	Supported by NSF (BCS-0819430 to S.Z.D. and BCS-0819493 to J.A.G.). J.T.A. was supported by NSF's Experimental Program to Stimulate Competitive Research (EPSCoR) (EPS-0814387). A.R.M. was supported by U.S. Department of Agriculture Forest Service's (USFS's) Rocky Mountain Research Station (JV11221635-201). We thank C. Daly for providing interpolated climate data; M. Kelly for Vegetation Type Mapping project data; C. Ramirez (Region 5 USFS Remote Sensing Lab) for the USFS Forest Inventory and Analysis data (plot locations were not provided to the authors); J. Thorne for compiling modern data sources; and S. Running for helpful comments on the manuscript.	Archaux F, 2004, IBIS, V146, P138, DOI 10.1111/j.1474-919X.2004.00246.x; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Doi H, 2008, AGR FOREST METEOROL, V148, P512, DOI 10.1016/j.agrformet.2007.10.002; Eckert Andrew J., 2007, Madrono, V54, P117, DOI 10.3120/0024-9637(2007)54[117:EAEEOS]2.0.CO;2; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; IPCC, 2007, 4 IPCC; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Millar CI, 2004, ARCT ANTARCT ALP RES, V36, P181, DOI 10.1657/1523-0430(2004)036[0181:ROSCIT]2.0.CO;2; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Oppel S, 2008, CONDOR, V110, P296, DOI 10.1525/cond.2008.8502; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wieslander A.E., 1935, MADRONO, V3, P140; Wieslander A. E, 1935, J FOREST, V33, P877, DOI DOI 10.1093/JOF/33.10.877; Zhang K, 2009, J HYDROL, V379, P92, DOI 10.1016/j.jhydrol.2009.09.047	24	386	399	7	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					324	327		10.1126/science.1199040	http://dx.doi.org/10.1126/science.1199040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252344				2022-12-01	WOS:000286636300035
J	Martinez, RN; Sereno, PC; Alcober, OA; Colombi, CE; Renne, PR; Montanez, IP; Currie, BS				Martinez, Ricardo N.; Sereno, Paul C.; Alcober, Oscar A.; Colombi, Carina E.; Renne, Paul R.; Montanez, Isabel P.; Currie, Brian S.			A Basal Dinosaur from the Dawn of the Dinosaur Era in Southwestern Pangaea	SCIENCE			English	Article							EARLY EVOLUTION; ORIGIN; ARGENTINA; SKELETON; SAURISCHIA	Upper Triassic rocks in northwestern Argentina preserve the most complete record of dinosaurs before their rise to dominance in the Early Jurassic. Here, we describe a previously unidentified basal theropod, reassess its contemporary Eoraptor as a basal sauropodomorph, divide the faunal record of the Ischigualasto Formation with biozones, and bracket the formation with 40Ar/39Ar ages. Some 230 million years ago in the Late Triassic (mid Carnian), the earliest dinosaurs were the dominant terrestrial carnivores and small herbivores in southwestern Pangaea. The extinction of nondinosaurian herbivores is sequential and is not linked to an increase in dinosaurian diversity, which weakens the predominant scenario for dinosaurian ascendancy as opportunistic replacement.	[Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Sereno, Paul C.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Martinez, Ricardo N.; Alcober, Oscar A.; Colombi, Carina E.] Univ Nacl San Juan, Inst Ciencias Nat, RA-5400 San Juan, Argentina; [Martinez, Ricardo N.; Alcober, Oscar A.; Colombi, Carina E.] Univ Nacl San Juan, Museo Ciencias Nat, RA-5400 San Juan, Argentina; [Colombi, Carina E.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Renne, Paul R.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Renne, Paul R.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Montanez, Isabel P.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Currie, Brian S.] Miami Univ, Dept Geol, Oxford, OH 45056 USA	University of Chicago; University of Chicago; Universidad Nacional de San Juan; Universidad Nacional de San Juan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Berkeley Geochronolgy Center; University of California System; University of California Berkeley; University of California System; University of California Davis; University System of Ohio; Miami University	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu		Montanez, Isabel/0000-0003-0492-3796; Renne, Paul/0000-0003-1769-5235; Currie, Brian/0000-0002-5759-3914	Whitten-Newman Foundation; New York Community Trust; Earthwatch Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Ann and Gordon Getty Foundation; National Geographic Society	Whitten-Newman Foundation; New York Community Trust; Earthwatch Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ann and Gordon Getty Foundation; National Geographic Society(National Geographic Society)	We thank C. Abraczinskas for final drafts of all figures, personnel of the Fossil Lab at the Univ. of Chicago for preparation of fossil material, personnel of the High-Resolution X-ray Computed Tomography Facility at The Univ. of Texas at Austin for assistance with computed tomography imaging, and S. Nesbitt and R. Irmis for examination of fossil material in their care. This work was supported by the Whitten-Newman Foundation, the Island Fund of the New York Community Trust, Earthwatch Institute, Consejo Nacional de Investigaciones Cientificas y Tecnicas, the Ann and Gordon Getty Foundation, and the National Geographic Society.	Alcober OA, 2010, ZOOKEYS, P55, DOI 10.3897/zookeys.63.550; Benton M. J., 2006, 3 JORN INT PAL DIN E, P11; BENTON MJ, 1994, IN THE SHADOW OF THE DINOSAURS, P366; BONAPARTE J F, 1982, Journal of Vertebrate Paleontology, V2, P362; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Charig A. J., 1984, ZOOL SOC LONDON S, V57, P597; Currie BS, 2009, J S AM EARTH SCI, V27, P74, DOI 10.1016/j.jsames.2008.10.004; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Langer M. C., 2007, GLOBAL TRIASSIC; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Langer MC, 2005, J S AM EARTH SCI, V19, P219, DOI 10.1016/j.jsames.2005.04.002; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Santa Luca A.P., 1980, Annals of the South African Museum, V79, P159; Sereno Paul C., 2007, Historical Biology, V19, P145, DOI 10.1080/08912960601167435; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; SERENO PC, 1992, SCIENCE, V258, P1137, DOI 10.1126/science.258.5085.1137; Tykoski R. S., 2005, THESIS U TEXAS AUSTI; Walker J. D., 2009, GSA TODAY, DOI [DOI 10.1130/2009.CTS004R2C, 10.1130/2009.CTS004R2C]	30	251	257	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					206	210		10.1126/science.1198467	http://dx.doi.org/10.1126/science.1198467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233386				2022-12-01	WOS:000286433100040
J	Helmink, BA; Tubbs, AT; Dorsett, Y; Bednarski, JJ; Walker, LM; Feng, ZH; Sharma, GG; McKinnon, PJ; Zhang, JR; Bassing, CH; Sleckman, BP				Helmink, Beth A.; Tubbs, Anthony T.; Dorsett, Yair; Bednarski, Jeffrey J.; Walker, Laura M.; Feng, Zhihui; Sharma, Girdhar G.; McKinnon, Peter J.; Zhang, Junran; Bassing, Craig H.; Sleckman, Barry P.			H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes	NATURE			English	Article							DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; GENOMIC STABILITY; HISTONE H2AX; MRN COMPLEX; MDC1; NBS1; CHROMATIN; DAMAGE; PROTEINS	DNA double-strand breaks (DSBs) are generated by the recombination activating gene (RAG) endonuclease in all developing lymphocytes as they assemble antigen receptor genes(1). DNA cleavage by RAG occurs only at the G1 phase of the cell cycle and generates two hairpin-sealed DNA (coding) ends that require nucleolytic opening before their repair by classical non-homologous end-joining (NHEJ)(1-3). Although there are several cellular nucleases that could perform this function, only the Artemis nuclease is able to do so efficiently(2,3). Here, in vivo, we show that in murine cells the histone protein H2AX prevents nucleases other than Artemis from processing hairpin-sealed coding ends; in the absence of H2AX, CtIP can efficiently promote the hairpin opening and resection of DNA ends generated by RAG cleavage. This CtIP-mediated resection is inhibited by gamma-H2AX and by MDC-1 (mediator of DNA damage checkpoint 1), which binds to gamma-H2AX in chromatin flanking DNA DSBs. Moreover, the ataxia telangiectasia mutated (ATM) kinase activates antagonistic pathways that modulate this resection. CtIP DNA end resection activity is normally limited to cells at post-replicative stages of the cell cycle, in which it is essential for homology-mediated repair(4,5). In G1-phase lymphocytes, DNA ends that are processed by CtIP are not efficiently joined by classical NHEJ and the joints that do form frequently use micro-homologies and show significant chromosomal deletions. Thus, H2AX preserves the structural integrity of broken DNA ends in G1-phase lymphocytes, thereby preventing these DNA ends from accessing repair pathways that promote genomic instability.	[Helmink, Beth A.; Tubbs, Anthony T.; Dorsett, Yair; Bednarski, Jeffrey J.; Walker, Laura M.; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Bednarski, Jeffrey J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Feng, Zhihui; Sharma, Girdhar G.; Zhang, Junran] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA; [McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Bassing, Craig H.] Univ Penn, Sch Med,Ctr Childhood Canc Res, Childrens Hosp Philadelphia,Dept Pathol & Lab Med, Abramson Family Canc Res Inst,Div Canc Pathobiol, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	sleckman@wustl.edu	Bednarski, Jeff/GLN-6651-2022	Helmink, Beth/0000-0002-8206-0351; Tubbs, Anthony/0000-0002-5605-8231	National Institutes of Health (NIH) [AI074953, AI47829, CA136470, CA125195, CA21765, NS37956, T32 HD007499]; Children's Discovery Institute; NATIONAL CANCER INSTITUTE [R01CA136470, P01CA096832, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047829, R01AI074953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956, R56NS037956] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Oltz and F. Alt for critical review of the manuscript; R. Baer for providing us with the anti-CtIP antibodies; and G. Longmore and Y. Feng for pFLRU, pHR'Delta 8.2R and pCMV-VSVg. This work is supported by National Institutes of Health (NIH) grants AI074953(B. P. S.), AI47829 (B. P. S.), CA136470 (B. P. S. and C. H. B.), CA125195 (C. H. B.), CA21765 (P.J.McK.) and NS37956 (P.J.McK.). J.J.B. is supported by a NIH Ruth L. Kirschstein National Research Service Award (T32 HD007499) and a Children's Discovery Institute Fellows Award. C. H. B. was a Pew Scholar in the Biomedical Sciences program and is a Leukemia and Lymphoma Society Scholar.	Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Hegedus E, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp539; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lu L, 2008, CELL MOTIL CYTOSKEL, V65, P281, DOI 10.1002/cm.20260; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; You ZS, 2010, TRENDS CELL BIOL, V20, P402, DOI 10.1016/j.tcb.2010.04.002	33	112	115	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					245	249		10.1038/nature09585	http://dx.doi.org/10.1038/nature09585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21160476	Green Accepted			2022-12-01	WOS:000286143400045
J	Tamsir, A; Tabor, JJ; Voigt, CA				Tamsir, Alvin; Tabor, Jeffrey J.; Voigt, Christopher A.			Robust multicellular computing using genetically encoded NOR gates and chemical 'wires'	NATURE			English	Article							SYNTHETIC GENE NETWORKS; CIRCUIT; QUORUM; LOGIC; MORPHOGENESIS; SYSTEM; CELLS; MODEL	Computation underlies the organization of cells into higher-order structures, for example during development or the spatial association of bacteria in a biofilm(1-3). Each cell performs a simple computational operation, but when combined with cell-cell communication, intricate patterns emerge. Here we study this process by combining a simple genetic circuit with quorum sensing to produce more complex computations in space. We construct a simple NOR logic gate in Escherichia coli by arranging two tandem promoters that function as inputs to drive the transcription of a repressor. The repressor inactivates a promoter that serves as the output. Individual colonies of E. coli carry the same NOR gate, but the inputs and outputs are wired to different orthogonal quorum-sensing 'sender' and 'receiver' devices(4,5). The quorum molecules form the wires between gates. By arranging the colonies in different spatial configurations, all possible two-input gates are produced, including the difficult XOR and EQUALS functions. The response is strong and robust, with 5- to >300-fold changes between the 'on' and 'off' states. This work helps elucidate the design rules by which simple logic can be harnessed to produce diverse and complex calculations by rewiring communication between cells.	[Tabor, Jeffrey J.; Voigt, Christopher A.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Tamsir, Alvin] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Voigt, CA (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	cavoigt@picasso.ucsf.edu	Tabor, Jeffrey/A-7022-2008	Tabor, Jeffrey/0000-0001-7316-0361	National Science Foundation (NSF) [0943385, CCF-0943385]; Office of Naval Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, R01GM095765] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [0943385] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank W. Mulyasasmita and K. Temme for critical discussions. This work was supported by the National Science Foundation (SynBERC, NSF#0943385 and NSF Sandpit CCF-0943385) and the Office of Naval Research.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Clancy K, 2010, CURR OPIN BIOTECH, V21, P572, DOI 10.1016/j.copbio.2010.07.005; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Ilachinski A., 2001, CELLULAR AUTOMATA DI, V1st, P1; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Katz R. H., 1994, CONT LOGIC DESIGN, P141; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Neumann J. V., 1951, GEN LOGICAL THEORY A; Niklas KJ, 2003, AM J BOT, V90, P515, DOI 10.3732/ajb.90.4.515; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; RAJU BS, 1971, INT J CONTROL, V14, P1041, DOI 10.1080/00207177108932113; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Scharle TW., 1965, NOTRE DAME J FORM L, V6, P209, DOI [10.1305/ndjfl/1093958259, DOI 10.1305/NDJFL/1093958259]; Sneppen K, 2005, J MOL BIOL, V346, P399, DOI 10.1016/j.jmb.2004.11.075; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Turing A. M., 1990, B MATH BIOL, V52, P119; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1016/S0092-8240(05)80008-4; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Wolfram S., 2002, NEW KIND SCI, P23; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	31	515	542	5	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					212	215		10.1038/nature09565	http://dx.doi.org/10.1038/nature09565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21150903	Green Accepted			2022-12-01	WOS:000286143400038
J	O'Shaughnessy, EC; Palani, S; Collins, JJ; Sarkar, CA				O'Shaughnessy, Ellen C.; Palani, Santhosh; Collins, James J.; Sarkar, Casim A.			Tunable Signal Processing in Synthetic MAP Kinase Cascades	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; SWITCH-LIKE; CELL FATE; COMPUTATIONAL DESIGN; SCAFFOLD PROTEINS; MAMMALIAN-CELLS; GENE-EXPRESSION; GLOBAL ANALYSIS; YEAST; PATHWAYS	The flexibility of MAPK cascade responses enables regulation of a vast array of cell fate decisions, but elucidating the mechanisms underlying this plasticity is difficult in endogenous signaling networks. We constructed insulated mammalian MAPK cascades in yeast to explore how intrinsic and extrinsic perturbations affect the flexibility of these synthetic signaling modules. Contrary to biphasic dependence on scaffold concentration, we observe monotonic decreases in signal strength as scaffold concentration increases. We find that augmenting the concentration of sequential kinases can enhance ultrasensitivity and lower the activation threshold. Further, integrating negative regulation and concentration variation can decouple ultrasensitivity and threshold from the strength of the response. Computational analyses show that cascading can generate ultrasensitivity and that natural cascades with different kinase concentrations are innately biased toward their distinct activation profiles. This work demonstrates that tunable signal processing is inherent to minimal MAPK modules and elucidates principles for rational design of synthetic signaling systems.	[O'Shaughnessy, Ellen C.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [O'Shaughnessy, Ellen C.; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [O'Shaughnessy, Ellen C.; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Palani, Santhosh; Sarkar, Casim A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Sarkar, Casim A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; University of Pennsylvania; University of Pennsylvania; Harvard University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu; casarkar@seas.upenn.edu			National Institutes of Health (NIH) [DP1 OD00364]; Ellison Medical Foundation; Howard Hughes Medical Institute; American Heart Association [0835132N]; University of Pennsylvania; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association(American Heart Association); University of Pennsylvania; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) through the NIH Director's Pioneer Award Program, grant number DP1 OD00364, and by the Ellison Medical Foundation and the Howard Hughes Medical Institute (to J.J.C.); and by the American Heart Association, grant number 0835132N, and startup funds from the University of Pennsylvania (to C.A.S.). We also thank Natalie Ahn, Lloyd Cantley, Gerald Fink, Steen Hansen, and David Levin for kindly providing cDNA.	Atienza JM, 2000, J BIOL CHEM, V275, P20638, DOI 10.1074/jbc.M910024199; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Chen MT, 2005, NAT BIOTECHNOL, V23, P1551, DOI 10.1038/nbt1162; Chen RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-235; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Dwyer MA, 2003, P NATL ACAD SCI USA, V100, P11255, DOI 10.1073/pnas.2032284100; Elion EA, 2001, J CELL SCI, V114, P3967; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gao XD, 2004, MOL BIOL CELL, V15, P3977, DOI 10.1091/mbc.E04-01-0079; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Grunberg R, 2010, NUCLEIC ACIDS RES, V38, P2645, DOI 10.1093/nar/gkq152; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kiel C, 2010, CELL, V140, P33, DOI 10.1016/j.cell.2009.12.028; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McMahon M, 2001, METHOD ENZYMOL, V332, P401; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Wu JJ, 2005, MOL CELL BIOL, V25, P4792, DOI 10.1128/MCB.25.11.4792-4803.2005; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200	51	116	117	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					119	131		10.1016/j.cell.2010.12.014	http://dx.doi.org/10.1016/j.cell.2010.12.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215374	Bronze, Green Accepted			2022-12-01	WOS:000285993600012
J	Albanese, A				Albanese, Alberto			Terminology for Preparations of Botulinum Neurotoxins What a Difference a Name Makes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; ACADEMY-OF-NEUROLOGY; CERVICAL DYSTONIA; THERAPEUTICS; DISORDERS; TOXIN		Univ Cattolica Sacro Cuore, Ist Neurol Carlo Besta, I-20133 Milan, Italy	Catholic University of the Sacred Heart; IRCCS Istituto Neurologico Besta	Albanese, A (corresponding author), Univ Cattolica Sacro Cuore, Ist Neurol Carlo Besta, Via G Celoria 11, I-20133 Milan, Italy.	alberto.albanese@unicatt.it	Albanese, Alberto/K-7396-2016	Albanese, Alberto/0000-0002-5864-0006				Albanese A, 2009, TOXICON, V54, P702, DOI 10.1016/j.toxicon.2009.02.003; Benecke R, 2005, NEUROLOGY, V64, P1949, DOI 10.1212/01.WNL.0000163767.99354.C3; Bentivoglio AR, 2009, NEUROTOX RES, V15, P224, DOI 10.1007/s12640-009-9023-3; Chapman MA, 2007, CLIN THER, V29, P1325, DOI 10.1016/j.clinthera.2007.07.020; Dressler D, 2006, EUR J NEUROL, V13, P11, DOI 10.1111/j.1468-1331.2006.01439.x; Naumann M, 2008, NEUROLOGY, V70, P1707, DOI 10.1212/01.wnl.0000311390.87642.d8; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Simpson DM, 2008, NEUROLOGY, V70, P1699, DOI 10.1212/01.wnl.0000311389.26145.95; *US FDA, 2010, FDA GIV UPD BOT TOX; WHO, 1997, GUID US INT NONPR NA	10	44	49	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					89	90		10.1001/jama.2010.1937	http://dx.doi.org/10.1001/jama.2010.1937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205970				2022-12-01	WOS:000285924100029
J	Ahmed, F				Ahmed, Farooq			Tales of adversity	NATURE			English	Editorial Material																			0	23	23	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S20	S20		10.1038/468S20a	http://dx.doi.org/10.1038/468S20a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179081	Bronze			2022-12-01	WOS:000285553800008
J	Waldor, MK; Hotez, PJ; Clemens, JD				Waldor, Matthew K.; Hotez, Peter J.; Clemens, John D.			A National Cholera Vaccine Stockpile - A New Humanitarian and Diplomatic Resource	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Waldor, Matthew K.] Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; [Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Hotez, Peter J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Hotez, Peter J.] Sabin Vaccine Inst, Washington, DC USA; [Clemens, John D.] Int Vaccine Inst, Seoul, South Korea	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; George Washington University; International Vaccine Institute	Waldor, MK (corresponding author), Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA.			Hotez, Peter/0000-0001-8770-1042; Waldor, Matthew/0000-0003-1843-7000	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042347, R37AI042347] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R37 AI042347, R01 AI042347] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000346; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6	5	25	25	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 9	2010	363	24					2279	2282		10.1056/NEJMp1012300	http://dx.doi.org/10.1056/NEJMp1012300			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691PA	21105832	Green Accepted			2022-12-01	WOS:000285092100002
J	Harbour, JW; Onken, MD; Roberson, EDO; Duan, SH; Cao, L; Worley, LA; Council, ML; Matatall, KA; Helms, C; Bowcock, AM				Harbour, J. William; Onken, Michael D.; Roberson, Elisha D. O.; Duan, Shenghui; Cao, Li; Worley, Lori A.; Council, M. Laurin; Matatall, Katie A.; Helms, Cynthia; Bowcock, Anne M.			Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas	SCIENCE			English	Article							UBIQUITIN HYDROLASE; BRCA1-ASSOCIATED PROTEIN-1; GNAQ; ASSOCIATION	Metastasis is a defining feature of malignant tumors and is the most common cause of cancer-related death, yet the genetics of metastasis are poorly understood. We used exome capture coupled with massively parallel sequencing to search for metastasis-related mutations in highly metastatic uveal melanomas of the eye. Inactivating somatic mutations were identified in the gene encoding BRCA1-associated protein 1 (BAP1) on chromosome 3p21.1 in 26 of 31 (84%) metastasizing tumors, including 15 mutations causing premature protein termination and 5 affecting its ubiquitin carboxyl terminal hydrolase domain. One tumor harbored a frameshift mutation that was germline in origin, thus representing a susceptibility allele. These findings implicate loss of BAP1 in uveal melanoma metastasis and suggest that the BAP1 pathway may be a valuable therapeutic target.	[Harbour, J. William; Onken, Michael D.; Worley, Lori A.; Matatall, Katie A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Roberson, Elisha D. O.; Duan, Shenghui; Cao, Li; Council, M. Laurin; Helms, Cynthia; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Harbour, J. William; Bowcock, Anne M.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Harbour, JW (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	harbour@vision.wustl.edu; bowcock@genetics.wustl.edu	Roberson, Elisha/ABC-1810-2020; Roberson, Elisha D.O./J-1747-2012; Ferris, Laura/I-7689-2012; Onken, Michael D/H-5620-2013; Harbour, J. William/B-1448-2015	Roberson, Elisha/0000-0001-5921-2399; Roberson, Elisha D.O./0000-0001-5921-2399; Onken, Michael D/0000-0003-4082-1105; Harbour, J. William/0000-0002-1104-9809; Bowcock, Anne/0000-0001-8691-9090	National Cancer Institute [R01 CA125970]; Barnes-Jewish Hospital Foundation; Kling Family Foundation; Tumori Foundation; Horncrest Foundation; Research to Prevent Blindness, Inc.; NIH [P30 EY02687c]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR007279-31A1]; Washington University; NATIONAL CANCER INSTITUTE [R01CA125970] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barnes-Jewish Hospital Foundation; Kling Family Foundation; Tumori Foundation; Horncrest Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants to J.W.H. from the National Cancer Institute (R01 CA125970), Barnes-Jewish Hospital Foundation, Kling Family Foundation, Tumori Foundation, Horncrest Foundation, and a Research to Prevent Blindness David F. Weeks Professorship, and by awards to the Department of Ophthalmology and Visual Sciences at Washington University from a Research to Prevent Blindness, Inc., unrestricted grant, and the NIH Vision Core Grant P30 EY02687c. E.D.O.R. was supported by NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases training grant AR007279-31A1. We thank J. Hoisington-Lopez from the Center for Genome Sciences (Washington University School of Medicine) for running Solexa paired end sequences and M. Lovett for comments on the manuscript. J.W.H. and Washington University may receive income based on a license of related technology by the university to Castle Biosciences, Inc.	Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Bauer J, 2009, BRIT J CANCER, V101, P813, DOI 10.1038/sj.bjc.6605226; Alonso AGD, 2007, GENETICS, V176, P2099, DOI 10.1534/genetics.107.075739; Finger PT, 2009, ARCH PATHOL LAB MED, V133, P1197, DOI 10.1043/1543-2165-133.8.1197; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Landreville S, 2008, FUTURE ONCOL, V4, P629, DOI 10.2217/14796694.4.5.629; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2006, CANCER RES, V66, P4602, DOI 10.1158/0008-5472.CAN-05-4196; Onken MD, 2010, J MOL DIAGN, V12, P461, DOI 10.2353/jmoldx.2010.090220; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Worley LA, 2007, CLIN CANCER RES, V13, P1466, DOI 10.1158/1078-0432.CCR-06-2401	21	930	959	5	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 3	2010	330	6009					1410	1413		10.1126/science.1194472	http://dx.doi.org/10.1126/science.1194472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21051595	Green Accepted			2022-12-01	WOS:000284902100051
J	Li, AA; Gong, H; Zhang, B; Wang, QD; Yan, C; Wu, JP; Liu, QA; Zeng, SQ; Luo, QM				Li, Anan; Gong, Hui; Zhang, Bin; Wang, Qingdi; Yan, Cheng; Wu, Jingpeng; Liu, Qian; Zeng, Shaoqun; Luo, Qingming			Micro-Optical Sectioning Tomography to Obtain a High-Resolution Atlas of the Mouse Brain	SCIENCE			English	Article							VISUALIZATION	The neuroanatomical architecture is considered to be the basis for understanding brain function and dysfunction. However, existing imaging tools have limitations for brainwide mapping of neural circuits at a mesoscale level. We developed a micro-optical sectioning tomography (MOST) system that can provide micrometer-scale tomography of a centimeter-sized whole mouse brain. Using MOST, we obtained a three-dimensional structural data set of a Golgi-stained whole mouse brain at the neurite level. The morphology and spatial locations of neurons and traces of neurites could be clearly distinguished. We found that neighboring Purkinje cells stick to each other.	[Li, Anan; Gong, Hui; Zhang, Bin; Wang, Qingdi; Yan, Cheng; Wu, Jingpeng; Liu, Qian; Zeng, Shaoqun; Luo, Qingming] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Luo, QM (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China.	qluo@mail.hust.edu.cn	Qian, Liu/GYU-5886-2022; liu, qian/HDM-2936-2022; Wu, Jingpeng/H-3955-2019; Liu, Qian/D-8184-2011; Wu, Jingpeng/B-5489-2019	Liu, Qian/0000-0002-8398-1021; Wu, Jingpeng/0000-0003-1604-8802; Zeng, Shaoqun/0000-0002-1802-337X; LI, Anan/0000-0002-5877-4813; Luo, Qingming/0000-0002-6725-9311	National Natural Science Foundation of China [30727002, 60025514, 30700214, 30925013]; Program for Changjiang Scholars and Innovative Research Team in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	We thank P. Wu, J. B. Wu, and L. Wu for their early work in MOST; L. Fu, T. H. Xu, and W. Zhou for helpful discussions; Z. Dong and Z. Feng for assistance in experiments; J. Zhou for the nanowire sample; and Diatome AG, Switzerland, for the diamond knife. Supported by the National Natural Science Foundation of China (grants 30727002, 60025514, 30700214, and 30925013) and the Program for Changjiang Scholars and Innovative Research Team in University.	Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Chin MH, 2007, PHYSIOL GENOMICS, V30, P313, DOI 10.1152/physiolgenomics.00287.2006; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Franklin K., 2007, MOUSE BRAIN STEREOTA; Hayworth K. J., 2006, MICROSC MICROANAL, V12, P86; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kandel E R, 2000, PRINCIPLES NEURAL SC, P19; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mayerich D, 2008, J MICROSC-OXFORD, V231, P134, DOI 10.1111/j.1365-2818.2008.02024.x; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2, 10.1007/978-0-387-45524-2_23]; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Standring S, 2004, GRAYS ANATOMY ANATOM, V39th; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Williams RW, 2000, RES PRO CEL, V30, P21; Wilt BA, 2009, ANNU REV NEUROSCI, V32, P435, DOI 10.1146/annurev.neuro.051508.135540	18	310	336	20	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1404	1408		10.1126/science.1191776	http://dx.doi.org/10.1126/science.1191776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21051596				2022-12-01	WOS:000284902100049
J	Sankaran, VG; Nathan, DG				Sankaran, Vijay G.; Nathan, David G.			Reversing the Hemoglobin Switch.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FETAL-HEMOGLOBIN; BCL11A; EXPRESSION		[Sankaran, Vijay G.] Childrens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sankaran, VG (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA.							Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	5	33	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2258	2260		10.1056/NEJMcibr1010767	http://dx.doi.org/10.1056/NEJMcibr1010767			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	21121839				2022-12-01	WOS:000284832900016
J	Voss, JE; Vaney, MC; Duquerroy, S; Vonrhein, C; Girard-Blanc, C; Crublet, E; Thompson, A; Bricogne, G; Rey, FA				Voss, James E.; Vaney, Marie-Christine; Duquerroy, Stephane; Vonrhein, Clemens; Girard-Blanc, Christine; Crublet, Elodie; Thompson, Andrew; Bricogne, Gerard; Rey, Felix A.			Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography	NATURE			English	Article							SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; CONFORMATIONAL-CHANGE; SPIKE PROTEIN; ENVELOPE; SURFACE; REPLACEMENT; E1; PH	Chikungunya virus (CHIKV) is an emerging mosquito-borne alphavirus that has caused widespread outbreaks of debilitating human disease in the past five years(1). CHIKV invasion of susceptible cells is mediated by two viral glycoproteins, E1 and E2, which carry the main antigenic determinants and form an icosahedral shell at the virion surface. Glycoprotein E2, derived from furin cleavage of the p62 precursor into E3 and E2, is responsible for receptor binding, and E1 for membrane fusion. In the context of a concerted multidisciplinary effort to understand the biology of CHIKV2, here we report the crystal structures of the precursor p62-E1 heterodimer and of the mature E3-E2-E1 glycoprotein complexes. The resulting atomic models allow the synthesis of a wealth of genetic, biochemical, immunological and electron microscopy data accumulated over the years on alphaviruses in general. This combination yields a detailed picture of the functional architecture of the 25 MDa alphavirus surface glycoprotein shell. Together with the accompanying report on the structure of the Sindbis virus E2-E1 heterodimer at acidic pH (ref. 3), this work also provides new insight into the acid-triggered conformational change on the virus particle and its inbuilt inhibition mechanism in the immature complex.	[Voss, James E.; Vaney, Marie-Christine; Duquerroy, Stephane; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France; [Voss, James E.; Vaney, Marie-Christine; Duquerroy, Stephane; Rey, Felix A.] CNRS, URA 3015, F-75724 Paris 15, France; [Duquerroy, Stephane] Univ Paris Sud, Fac Orsay, F-91405 Orsay, France; [Vonrhein, Clemens; Bricogne, Gerard] Global Phasing Ltd, Cambridge CB3 0AX, England; [Girard-Blanc, Christine; Crublet, Elodie] Inst Pasteur, Dept Biol Struct & Chim, F-75724 Paris 15, France; [Girard-Blanc, Christine; Crublet, Elodie] CNRS, URA 2185, F-75724 Paris 15, France; [Thompson, Andrew] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Global Phasing Limited; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); SOLEIL Synchrotron	Rey, FA (corresponding author), Inst Pasteur, Dept Virol, Unite Virol Struct, 25 Rue Dr Roux, F-75724 Paris 15, France.	rey@pasteur.fr	Rey, Felix/B-6497-2012	Duquerroy, Stephane/0000-0003-4386-8013; Rey, Felix/0000-0002-9953-7988	European Union Research Traning Network; French 'Agence Nationale de la Recherche'; Merck-Serono; Pediatric Dengue Vaccine Initiative; Institut Pasteur [PTR201 CHIKV]	European Union Research Traning Network; French 'Agence Nationale de la Recherche'(French National Research Agency (ANR)); Merck-Serono(Merck & Company); Pediatric Dengue Vaccine Initiative; Institut Pasteur(European Commission)	We thank the CHIKV task force at Institut Pasteur, in particular the group of F. Tangy and the staff of platform PF8 for the CHIKV complementary DNA; A. Haouz of PF6 for crystallogenesis; the staff of synchrotron beamlines PROXIMA 1 at Soleil, ID23-eh2 at the European Synchrotron Radiation Facility and PX-I at the Swiss Light Source; M. Rossmann and Y. Sun for providing the 16 angstrom cryo-EM map of CHIKV virion-like particles and for sharing the coordinates and manuscript of the low pH structure of the SINVE1-E2 heterodimer before publication; and members of the F.A.R. laboratory for help during data collection. J.E.V. was supported by a Marie Curie fellowship through the European Union Research Traning Network program "Intrapath''. This work was funded in part by the French 'Agence Nationale de la Recherche' grant DENtry in the program 'Microbiologie, Infections et Immunite', by Merck-Serono, by the Pediatric Dengue Vaccine Initiative and by the Institut Pasteur program PTR201 CHIKV to F.A.R..	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2010, BUSTER VERSION 2 9; CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FLYNN DC, 1990, J VIROL, V64, P3643, DOI 10.1128/JVI.64.8.3643-3653.1990; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; HALSTEAD SB, 2004, PEDIAT INFECT DIS, P2178; Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004; JOHNSON F, 1922, B SCH ORIENT STUDIES, V2, P417; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KIELIAN M, 1985, J CELL BIOL, V101, P2284, DOI 10.1083/jcb.101.6.2284; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LOBIGS M, 1990, J VIROL, V64, P4346, DOI 10.1128/JVI.64.9.4346-4355.1990; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993; MEYER WJ, 1992, J VIROL, V66, P3504, DOI 10.1128/JVI.66.6.3504-3513.1992; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Pierro DJ, 2008, J VIROL, V82, P2966, DOI 10.1128/JVI.02060-07; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; SALMINEN A, 1992, J CELL BIOL, V116, P349, DOI 10.1083/jcb.116.2.349; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; WAHLBERG JM, 1989, J VIROL, V63, P4991, DOI 10.1128/JVI.63.12.4991-4997.1989; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Wu SR, 2007, J BIOL CHEM, V282, P6752, DOI 10.1074/jbc.M609125200; ZIEMIECKI A, 1980, J GEN VIROL, V50, P111, DOI 10.1099/0022-1317-50-1-111	44	427	439	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					709	U137		10.1038/nature09555	http://dx.doi.org/10.1038/nature09555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124458				2022-12-01	WOS:000284836700044
J	Gorry, GA				Gorry, G. Anthony			Decisions, Decisions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tony@rice.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2010	304	21					2339	2340		10.1001/jama.2010.1748	http://dx.doi.org/10.1001/jama.2010.1748			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	687FH	21119077				2022-12-01	WOS:000284763900001
J	Scott, M; Gunderson, CW; Mateescu, EM; Zhang, ZG; Hwa, T				Scott, Matthew; Gunderson, Carl W.; Mateescu, Eduard M.; Zhang, Zhongge; Hwa, Terence			Interdependence of Cell Growth and Gene Expression: Origins and Consequences	SCIENCE			English	Article							ESCHERICHIA-COLI; PROTEIN; RIBOSOMES; BACTERIA	In bacteria, the rate of cell proliferation and the level of gene expression are intimately intertwined. Elucidating these relations is important both for understanding the physiological functions of endogenous genetic circuits and for designing robust synthetic systems. We describe a phenomenological study that reveals intrinsic constraints governing the allocation of resources toward protein synthesis and other aspects of cell growth. A theory incorporating these constraints can accurately predict how cell proliferation and gene expression affect one another, quantitatively accounting for the effect of translation-inhibiting antibiotics on gene expression and the effect of gratuitous protein expression on cell growth. The use of such empirical relations, analogous to phenomenological laws, may facilitate our understanding and manipulation of complex biological systems before underlying regulatory circuits are elucidated.	[Scott, Matthew; Mateescu, Eduard M.; Hwa, Terence] Univ Calif San Diego, Dept Phys, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Gunderson, Carl W.; Zhang, Zhongge; Hwa, Terence] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hwa, T (corresponding author), Univ Calif San Diego, Dept Phys, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA.	hwa@ucsd.edu	Hwa, Terry/GOJ-9904-2022; Hwa, Terence/J-4012-2013	Hwa, Terence/0000-0003-1837-6842	NIH [RO1GM77298]; NSF [MCB0746581, PHY0822283]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077298] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bremer, L. Csonka, P. Dennis, M. Ehrenberg, P. Geiduschek, M. Schaechter, A. Tadmor, and members of the Hwa lab for suggestions and discussions; D. Hughes for the Sm mutant strains; and P.-h. Lee and B. Willumsen for the use of unpublished data. Supported by NIH grant RO1GM77298, NSF grant MCB0746581, and the NSF-supported Center for Theoretical Biological Physics (grant PHY0822283). M. S. was supported by a Natural Sciences and Engineering Research Council of Canada fellowship.	Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257; Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; Bremer H, 1996, ESCHERICHIA COLI SAL, P1553; Chou CP, 2007, APPL MICROBIOL BIOT, V76, P521, DOI 10.1007/s00253-007-1039-0; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; FORCHHAMMER J, 1971, J MOL BIOL, V55, P563, DOI 10.1016/0022-2836(71)90337-8; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Maaloe O., 1979, BIOL REGUL DEV, V1, P487; MIKKOLA R, 1991, BIOCHIMIE, V73, P1551, DOI 10.1016/0300-9084(91)90190-C; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; VIND J, 1993, J MOL BIOL, V231, P678, DOI 10.1006/jmbi.1993.1319; Youk H, 2009, NATURE, V462, P875, DOI 10.1038/nature08653; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545	22	747	757	9	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 19	2010	330	6007					1099	1102		10.1126/science.1192588	http://dx.doi.org/10.1126/science.1192588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21097934				2022-12-01	WOS:000284374700042
J	Muotri, AR; Marchetto, MCN; Coufal, NG; Oefner, R; Yeo, G; Nakashima, K; Gage, FH				Muotri, Alysson R.; Marchetto, Maria C. N.; Coufal, Nicole G.; Oefner, Ruth; Yeo, Gene; Nakashima, Kinichi; Gage, Fred H.			L1 retrotransposition in neurons is modulated by MeCP2	NATURE			English	Article							CPG-BINDING PROTEIN-2; METHYL-CPG; STEM-CELLS; HISTONE DEACETYLASE; ADULT NEUROGENESIS; RETT-SYNDROME; TRANSCRIPTION; HIPPOCAMPUS; SEQUENCES; ELEMENTS	Long interspersed nuclear elements-1 (LINE-1 or L1s) are abundant retrotransposons that comprise approximately 20% of mammalian genomes(1-3). Active L1 retrotransposons can impact the genome in a variety of ways, creating insertions, deletions, new splice sites or gene expression fine-tuning(4-6). We have shown previously that L1 retrotransposons are capable of mobilization in neuronal progenitor cells from rodents and humans and evidence of massive L1 insertions was observed in adult brain tissues but not in other somatic tissues(7,8). In addition, L1 mobility in the adult hippocampus can be influenced by the environment(9). The neuronal specificity of somatic L1 retrotransposition in neural progenitors is partially due to the transition of a Sox2/HDAC1 repressor complex to a Wnt-mediated T-cell factor/lymphoid enhancer factor (TCF/LEF) transcriptional activator(7,10). The transcriptional switch accompanies chromatin remodelling during neuronal differentiation, allowing a transient stimulation of L1 transcription(7). The activity of L1 retrotransposons during brain development can have an impact on gene expression and neuronal function, thereby increasing brain-specific genetic mosaicism(11,12). Further understanding of the molecular mechanisms that regulate L1 expression should provide new insights into the role of L1 retrotransposition during brain development. Here we show that L1 neuronal transcription and retrotransposition in rodents are increased in the absence of methyl-CpG-binding protein 2 (MeCP2), a protein involved in global DNA methylation and human neurodevelopmental diseases. Using neuronal progenitor cells derived from human induced pluripotent stem cells and human tissues, we revealed that patients with Rett syndrome (RTT), carrying MeCP2 mutations, have increased susceptibility for L1 retrotransposition. Our data demonstrate that L1 retrotransposition can be controlled in a tissue-specific manner and that disease-related genetic mutations can influence the frequency of neuronal L1 retrotransposition. Our findings add a new level of complexity to the molecular events that can lead to neurological disorders.	[Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat,Dept Cellular & Mol Med, Rady Childrens Hosp San Diego,Stem Cell Program, La Jolla, CA 92093 USA; [Marchetto, Maria C. N.; Coufal, Nicole G.; Oefner, Ruth; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Yeo, Gene] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA; [Nakashima, Kinichi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol Neurosci, Ikoma 6300101, Japan	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Nara Institute of Science & Technology	Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat,Dept Cellular & Mol Med, Rady Childrens Hosp San Diego,Stem Cell Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.	muotri@ucsd.edu; gage@salk.edu	Coufal, Nicole/ABA-9471-2021; Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; Coufal, Nicole/0000-0001-6547-1733	National Institutes of Health [1-DP2-OD006495-01]; Emerald Foundation; Mathers Foundation; Lookout Fund; NIH/NINDS [R01MH088485]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088485] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Mathers Foundation; Lookout Fund; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.R.M. is supported by the National Institutes of Health through the NIH Director's New Innovator Award Program, 1-DP2-OD006495-01 and by the Emerald Foundation. F.H.G. is supported by the Mathers Foundation, Lookout Fund, and NIH/NINDS R01MH088485. The authors would like to thank A. Huynh, B. Aimone, K. Stecker, B. Berg and D. Sepp for help during the 3D brain model assembly, J. Moran and J. Garcia-Perez for discussion and critical review of the manuscript, M. Gage for editorial comments, and B. Moddy and G. Peng for experimental assistance.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Yu F, 2001, NUCLEIC ACIDS RES, V29, P4493, DOI 10.1093/nar/29.21.4493; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	30	438	483	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 18	2010	468	7322					443	446		10.1038/nature09544	http://dx.doi.org/10.1038/nature09544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085180	Green Accepted, Green Submitted			2022-12-01	WOS:000284313100044
J	Lind, PA; Berg, OG; Andersson, DI				Lind, Peter A.; Berg, Otto G.; Andersson, Dan I.			Mutational Robustness of Ribosomal Protein Genes	SCIENCE			English	Article							SINGLE-NUCLEOTIDE SUBSTITUTIONS; DNA-SEQUENCE DATA; DELETERIOUS MUTATIONS; BENEFICIAL MUTATIONS; MOLECULAR EVOLUTION; FITNESS; VIRUS; POPULATIONS; LANDSCAPE; SELECTION	The distribution of fitness effects (DFE) of mutations is of fundamental importance for understanding evolutionary dynamics and complex diseases and for conserving threatened species. DFEs estimated from DNA sequences have rarely been subject to direct experimental tests. We used a bacterial system in which the fitness effects of a large number of defined single mutations in two ribosomal proteins were measured with high sensitivity. The obtained DFE appears to be unimodal, where most mutations (120 out of 126) are weakly deleterious and the remaining ones are potentially neutral. The DFEs for synonymous and nonsynonymous substitutions are similar, suggesting that in some genes, strong fitness constraints are present at the level of the messenger RNA.	[Lind, Peter A.; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Berg, Otto G.] Uppsala Univ, Dept Mol Evolut, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden	Uppsala University; Uppsala University	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.	Dan.Andersson@imbim.uu.se		Andersson, Dan/0000-0001-6640-2174; Lind, Peter/0000-0003-1510-8324	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council to D. I. A. and O.G.B. We thank D. Hughes and P. B. Rainey for comments on the manuscript.	BUTCHER D, 1995, GENETICS, V141, P431; CABALLERO A, 1994, GENETICS, V138, P883; Carrasco P, 2007, J VIROL, V81, P12979, DOI 10.1128/JVI.00524-07; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Domingo-Calap P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000742; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI [10.1111/j.1558-5646.1984.tb00380.x, 10.2307/2408444]; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; Keightley PD, 2010, PHILOS T R SOC B, V365, P1187, DOI 10.1098/rstb.2009.0266; KIMURA M, 1962, GENETICS, V47, P713; Lind PA, 2010, MOL MICROBIOL, V75, P1078, DOI 10.1111/j.1365-2958.2009.07030.x; MUKAI T, 1964, GENETICS, V50, P1; Nielsen R, 2003, MOL BIOL EVOL, V20, P1231, DOI 10.1093/molbev/msg147; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Orr HA, 2003, GENETICS, V163, P1519; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Piganeau G, 2003, P NATL ACAD SCI USA, V100, P10335, DOI 10.1073/pnas.1833064100; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Trindade S, 2010, PHILOS T R SOC B, V365, P1177, DOI 10.1098/rstb.2009.0287; Wloch DM, 2001, GENETICS, V159, P441	24	76	76	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					825	827		10.1126/science.1194617	http://dx.doi.org/10.1126/science.1194617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051637				2022-12-01	WOS:000283855700044
J	Yooseph, S; Nealson, KH; Rusch, DB; McCrow, JP; Dupont, CL; Kim, M; Johnson, J; Montgomery, R; Ferriera, S; Beeson, K; Williamson, SJ; Tovchigrechko, A; Allen, AE; Zeigler, LA; Sutton, G; Eisenstadt, E; Rogers, YH; Friedman, R; Frazier, M; Venter, JC				Yooseph, Shibu; Nealson, Kenneth H.; Rusch, Douglas B.; McCrow, John P.; Dupont, Christopher L.; Kim, Maria; Johnson, Justin; Montgomery, Robert; Ferriera, Steve; Beeson, Karen; Williamson, Shannon J.; Tovchigrechko, Andrey; Allen, Andrew E.; Zeigler, Lisa A.; Sutton, Granger; Eisenstadt, Eric; Rogers, Yu-Hui; Friedman, Robert; Frazier, Marvin; Venter, J. Craig			Genomic and functional adaptation in surface ocean planktonic prokaryotes	NATURE			English	Article							PROTEIN; DIVERSITY; DATABASE; ALIGNMENT; FAMILIES; IRON	The understanding of marine microbial ecology and metabolism has been hampered by the paucity of sequenced reference genomes. To this end, we report the sequencing of 137 diverse marine isolates collected from around the world. We analysed these sequences, along with previously published marine prokaryotic genomes, in the context of marine metagenomic data, to gain insights into the ecology of the surface ocean prokaryotic picoplankton (0.1-3.0 mu m size range). The results suggest that the sequenced genomes define two microbial groups: one composed of only a few taxa that are nearly always abundant in picoplanktonic communities, and the other consisting of many microbial taxa that are rarely abundant. The genomic content of the second group suggests that these microbes are capable of slow growth and survival in energy-limited environments, and rapid growth in energy-rich environments. By contrast, the abundant and cosmopolitan picoplanktonic prokaryotes for which there is genomic representation have smaller genomes, are probably capable of only slow growth and seem to be relatively unable to sense or rapidly acclimate to energy-rich conditions. Their genomic features also lead us to propose that one method used to avoid predation by viruses and/or bacterivores is by means of slow growth and the maintenance of low biomass.	[Yooseph, Shibu; Nealson, Kenneth H.; Rusch, Douglas B.; McCrow, John P.; Dupont, Christopher L.; Kim, Maria; Johnson, Justin; Montgomery, Robert; Ferriera, Steve; Beeson, Karen; Williamson, Shannon J.; Tovchigrechko, Andrey; Allen, Andrew E.; Zeigler, Lisa A.; Sutton, Granger; Eisenstadt, Eric; Rogers, Yu-Hui; Friedman, Robert; Frazier, Marvin; Venter, J. Craig] J Craig Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute	Nealson, KH (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.	knealson@usc.edu	Allen, Andrew E/C-4896-2012	Allen, Andrew E/0000-0001-5911-6081; Yooseph, Shibu/0000-0001-5581-5002	Gordon and Betty Moore Foundation [521]; Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-FC02-02ER63453]; JCVI; US National Science Foundation [0850256]; Direct For Biological Sciences [0850256] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); JCVI; US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to acknowledge the Gordon and Betty Moore Foundation (grant award agreement #521); the Department of Energy, Office of Science, Office of Biological and Environmental Research (DE-FC02-02ER63453); and the JCVI for funding this research. A.T. and S.Y. also acknowledge support from US National Science Foundation grant 0850256. We also thank the JCVI Software Engineering team for their contribution to the analyses, L. Sheehan for help with manuscript editing, and M. Thiagarajan, L. Foster, I. Singh and M. Lewis for help with data management. Finally, we thank the many collaborators who provided strains for sequencing, including R. Amann, F. Azam, D. Bartlett, R. Belas, C. Bolch, E. Bonch-Osmolovskaya, J. Bowman, I. Brettar, T. Brinkhoff, A. Buchan, R. Case, R. Caviccholi, P. Chisholm, R. Edwards, D. Emerson, P. Falkowski, C. Francis, B. Fuchs, S. Giovannoni, J. Gonzalez, D. Green, A. Hagstrom, M. Hart, M. Haygood, R. Hill, M. Hofle, J.-C. Cho, K. Jurgens, S.-J. Kim, G. King, N. King, S. Kjelleberg, M. Klotz, M. Labrenz, E. Lilly, V. T. Marteinsson, M. A. Moran, A. Murray, J. C. Murrell, C. Pedros-Alio, J. Pinhassi, M. Polz, M. Rappe, A.-L. Reysenbach, F. Rodriguez-Valera, E. Rosenberg, N. Ruby, D. Scanlan, H. Schaefer, L. Shimkets, J. Siefert, M. Simon, T. Sokolova, E. Stabb, L. Stal, N. Tandeau de Marsac, B. Tebo, T. Thomas, C. Vetriani, I. Wagner-Dobler, B. Ward, J. Waterbury, B. Wawrik and A. Yayanos.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOND PL, 1995, APPL ENVIRON MICROB, V61, P1910, DOI 10.1128/AEM.61.5.1910-1916.1995; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Giovannoni S., 2000, P47; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Grimes DJ, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P209; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hagstrom A, 2002, APPL ENVIRON MICROB, V68, P3628, DOI 10.1128/AEM.68.7.3628-3633.2002; INGRAHAM JL, 1983, GROWTH BACTERIAL CEL, P435; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lis H, 2009, AQUAT MICROB ECOL, V56, P241, DOI 10.3354/ame01347; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McCaig AE, 1999, APPL ENVIRON MICROB, V65, P1721; Morel FMM, 2008, LIMNOL OCEANOGR, V53, P400, DOI 10.4319/lo.2008.53.1.0400; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nealson KH, 2007, ISME J, V1, P185, DOI 10.1038/ismej.2007.43; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Yooseph S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-182; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340	44	200	202	3	109	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					60	+		10.1038/nature09530	http://dx.doi.org/10.1038/nature09530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	21048761	hybrid			2022-12-01	WOS:000283786900035
J	Zhang, ZH; Pugh, BF				Zhang, Zhenhai; Pugh, B. Franklin			High-Resolution Genome-wide Mapping of the Primary Structure of Chromatin	CELL			English	Review							POSITIONS IN-VIVO; NUCLEOSOME POSITIONS; SACCHAROMYCES-CEREVISIAE; HISTONE MODIFICATIONS; DNA INTERACTIONS; GENE-EXPRESSION; STEM-CELLS; LIFE-SPAN; YEAST; IDENTIFICATION		[Zhang, Zhenhai; Pugh, B. Franklin] Penn State Univ, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu	Zhang, Zhenhai/GRX-5887-2022	Zhang, Zhenhai/0000-0002-4310-0525	NHGRI NIH HHS [R01 HG004160-05, R01 HG004160-04, R01 HG004160, HG004160] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; Fragoso G, 1997, METHODS, V11, P246, DOI 10.1006/meth.1996.0411; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GEOCKS J, 2010, GENOME BIOL, V11, P86; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Guarente L, 2000, GENE DEV, V14, P1021; Gundersen BB, 2009, NEUROPHARMACOLOGY, V57, P67, DOI 10.1016/j.neuropharm.2009.04.008; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Pardo CE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq716; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Rando OJ, 2010, METHOD ENZYMOL, V470, P105, DOI 10.1016/S0076-6879(10)70005-7; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	51	112	117	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					175	186		10.1016/j.cell.2011.01.003	http://dx.doi.org/10.1016/j.cell.2011.01.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241889	Green Accepted, Bronze			2022-12-01	WOS:000286459900004
J	Notta, F; Mullighan, CG; Wang, JCY; Poeppl, A; Doulatov, S; Phillips, LA; Ma, J; Minden, MD; Downing, JR; Dick, JE				Notta, Faiyaz; Mullighan, Charles G.; Wang, Jean C. Y.; Poeppl, Armando; Doulatov, Sergei; Phillips, Letha A.; Ma, Jing; Minden, Mark D.; Downing, James R.; Dick, John E.			Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; INTRAFEMORAL TRANSPLANTATION; PANCREATIC-CANCER; CLONAL EVOLUTION; NUMBER; GENOME; HETEROGENEITY; DELETION; ENGRAFTMENT; METASTASIS	Many tumours are composed of genetically diverse cells; however, little is known about how diversity evolves or the impact that diversity has on functional properties. Here, using xenografting and DNA copy number alteration (CNA) profiling of human BCR-ABL1 lymphoblastic leukaemia, we demonstrate that genetic diversity occurs in functionally defined leukaemia-initiating cells and that many diagnostic patient samples contain multiple genetically distinct leukaemia-initiating cell subclones. Reconstructing the subclonal genetic ancestry of several samples by CNA profiling demonstrated a branching multi-clonal evolution model of leukaemogenesis, rather than linear succession. For some patient samples, the predominant diagnostic clone repopulated xenografts, whereas in others it was outcompeted by minor subclones. Reconstitution with the predominant diagnosis clone was associated with more aggressive growth properties in xenografts, deletion of CDKN2A and CDKN2B, and a trend towards poorer patient outcome. Our findings link clonal diversity with leukaemia-initiating-cell function and underscore the importance of developing therapies that eradicate all intratumoral subclones.	[Notta, Faiyaz; Wang, Jean C. Y.; Poeppl, Armando; Doulatov, Sergei; Dick, John E.] Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada; [Notta, Faiyaz; Doulatov, Sergei; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Mullighan, Charles G.; Phillips, Letha A.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Wang, Jean C. Y.; Minden, Mark D.] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada; [Wang, Jean C. Y.; Minden, Mark D.] Univ Toronto, Dept Med, Toronto, ON M5G 2M9, Canada; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; St Jude Children's Research Hospital	Dick, JE (corresponding author), Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	Mullighan, Charles/H-3253-2011; Downing, James R./N-8102-2018	Mullighan, Charles/0000-0002-1871-1850; Dick, John/0000-0002-9527-8317; Wang, Jean/0000-0001-7543-3917	Canadian Institutes for Health Research (CIHR); Pew Charitable Trusts; Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society; Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Leukemia and Lymphoma Society; Canadian Institutes for Health Research; Canada Research Chair; American and Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Pew Charitable Trusts; Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); American and Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We would like to thank S. Minkin for statistical analysis of patient outcome, the Dick Laboratory and B. Neel for critical review of this manuscript, M. Cooper for editorial assistance, and P. A. Penttila, L. Jamieson, J. Yuan and S. Zhao for preparative flow cytometry. This work was supported by funds from Canadian Institutes for Health Research (CIHR) studentships (F.N., S.D.), the Pew Charitable Trusts (C.G.M.), The Stem Cell Network of Canadian National Centres of Excellence, the Canadian Cancer Society and the Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, the Leukemia and Lymphoma Society, the Canadian Institutes for Health Research, a Canada Research Chair, and the American and Lebanese Syrian Associated Charities of St Jude Children's Research Hospital. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Li AH, 2003, BLOOD, V102, P4520, DOI 10.1182/blood-2003-05-1455; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Pounds S, 2009, BIOINFORMATICS, V25, P315, DOI 10.1093/bioinformatics/btn624; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	34	360	374	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					362	+		10.1038/nature09733	http://dx.doi.org/10.1038/nature09733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248843				2022-12-01	WOS:000286385600044
J	Coureuil, M; Lecuyer, H; Scott, MGH; Boularan, C; Enslen, H; Soyer, M; Mikaty, G; Bourdoulous, S; Nassif, X; Marullo, S				Coureuil, Mathieu; Lecuyer, Herve; Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Soyer, Magali; Mikaty, Guillain; Bourdoulous, Sandrine; Nassif, Xavier; Marullo, Stefano			Meningococcus Hijacks a beta 2-Adrenoceptor/beta-Arrestin Pathway to Cross Brain Microvasculature Endothelium	CELL			English	Article							ARRESTIN-DEPENDENT ENDOCYTOSIS; NEISSERIA-MENINGITIDIS; TYROSINE-KINASE; BETA-ARRESTINS; IV PILI; ACTIVATION; BARRIER; ADHESION; INVASION; CELLS	Following pilus-mediated adhesion to human brain endothelial cells, meningococcus (N. meningitidis), the bacterium causing cerebrospinal meningitis, initiates signaling cascades, which eventually result in the opening of intercellular junctions, allowing meningeal colonization. The signaling receptor activated by the pathogen remained unknown. We report that N. meningitidis specifically stimulates a biased beta 2-adrenoceptor/beta-arrestin signaling pathway in endothelial cells, which ultimately traps beta-arrestin-interacting partners, such as the Src tyrosine kinase and junctional proteins, under bacterial colonies. Cytoskeletal reorganization mediated by beta-arrestinactivated Src stabilizes bacterial adhesion to endothelial cells, whereas beta-arrestin-dependent delocalization of junctional proteins results in anatomical gaps used by bacteria to penetrate into tissues. Activation of beta-adrenoceptor endocytosis with specific agonists prevents signaling events downstream of N. meningitidis adhesion and inhibits bacterial crossing of the endothelial barrier. The identification of the mechanism used for hijacking host cell signaling machineries opens perspectives for treatment and prevention of meningococcal infection.	[Coureuil, Mathieu; Lecuyer, Herve; Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Soyer, Magali; Mikaty, Guillain; Bourdoulous, Sandrine; Nassif, Xavier; Marullo, Stefano] Univ Paris 05, Fac Med, F-75006 Paris, France; [Coureuil, Mathieu; Lecuyer, Herve; Mikaty, Guillain; Nassif, Xavier] INSERM, U1002, Paris, France; [Lecuyer, Herve; Nassif, Xavier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France; [Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Bourdoulous, Sandrine; Marullo, Stefano] CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France; [Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Bourdoulous, Sandrine; Marullo, Stefano] INSERM, U1016, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Marullo, S (corresponding author), Univ Paris 05, Fac Med, F-75006 Paris, France.	stefano.marullo@inserm.fr	Scott, Mark/R-3521-2019; Coureuil, Mathieu/D-4793-2017; Enslen, Hervé/M-3400-2017; Marullo, Stefano/C-6142-2008; Enslen, Hervé/AAH-4492-2021	Coureuil, Mathieu/0000-0001-7655-9685; Enslen, Hervé/0000-0001-9741-5293; Marullo, Stefano/0000-0001-9604-9973; Enslen, Hervé/0000-0001-9741-5293; Scott, Mark G.H./0000-0002-1557-1856	Fondation pour la Recherche Medicale; AXA; Association pour la Recherche contre le Cancer [ARC-4954];  [ANR-09-BLAN-0137-03];  [ANR-07-BLAN-0072-01]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); AXA; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ; 	We thank Drs P.O. Couraud, R. Jockers, A. Benmerah, G. Bismuth, and G. Dumenil (Institut Cochin and Cardiovascular Research Center [G. D.], Paris) for reviewing the manuscript; M. Garfa-Traore, N. Goudin, and O. Duc of the Necker Institute imaging facility for their technical support; and G. Guilbaud for advice and technical assistance. M. C. was supported by fellowships of the Fondation pour la Recherche Medicale and of the AXA Research Fund. This work was supported by a collaboration study grant (ANR-09-BLAN-0137-03) to S. B., X. N., and S. M., the ANR-07-BLAN-0072-01 grant to S. M., and a grant from the Association pour la Recherche contre le Cancer (ARC-4954) to M.G.H.S.	Audet M, 2008, NAT CHEM BIOL, V4, P397, DOI 10.1038/nchembio.97; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Benmerah A, 1999, J CELL SCI, V112, P1303; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Eugene E, 2002, J CELL SCI, V115, P1231; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Lambotin M, 2005, J CELL SCI, V118, P3805, DOI 10.1242/jcs.02514; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Martin MC, 2008, EMERG INFECT DIS, V14, P1672, DOI 10.3201/eid1410.080118; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Pron B, 1997, J INFECT DIS, V176, P1285, DOI 10.1086/514124; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje	36	138	145	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1149	1160		10.1016/j.cell.2010.11.035	http://dx.doi.org/10.1016/j.cell.2010.11.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183077	Green Submitted, Bronze			2022-12-01	WOS:000285625400012
J	Famulski, JK; Trivedi, N; Howell, D; Yang, YA; Tong, YA; Gilbertson, R; Solecki, DJ				Famulski, Jakub K.; Trivedi, Niraj; Howell, Danielle; Yang, Yuan; Tong, Yiai; Gilbertson, Richard; Solecki, David J.			Siah Regulation of Pard3A Controls Neuronal Cell Adhesion During Germinal Zone Exit	SCIENCE			English	Article							ASYMMETRIC DIVISION; GRANULE CELLS; MIGRATION; NEOCORTEX; BRAIN; CENTROSOME; POLARITY; MODE	The brain's circuitry is established by directed migration and synaptogenesis of neurons during development. Although neurons mature and migrate in specific patterns, little is known about how neurons exit their germinal zone niche. We found that cerebellar granule neuron germinal zone exit is regulated by proteasomal degradation of Pard3A by the Seven in Absentia homolog (Siah) E3 ubiquitin ligase. Pard3A gain of function and Siah loss of function induce precocious radial migration. Time-lapse imaging using a probe to measure neuronal cell contact reveals that Pard3A promotes adhesive interactions needed for germinal zone exit by recruiting the epithelial tight junction adhesion molecule C to the neuronal cell surface. Our findings define a Siah-Pard3A signaling pathway that controls adhesion-dependent exit of neuronal progenitors or immature neurons from a germinal zone niche.	[Famulski, Jakub K.; Trivedi, Niraj; Howell, Danielle; Yang, Yuan; Tong, Yiai; Gilbertson, Richard; Solecki, David J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Solecki, DJ (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	david.solecki@stjude.org	Gilbertson, Richard James/ABE-1346-2021; Solecki, David/N-8080-2018	Gilbertson, Richard James/0000-0001-7539-9472; 	American Lebanese Syrian Associated Charities (ALSAC); National Cancer Institute Cancer Center; March of Dimes Basil O'Connor Starter Scholar Research Award; NATIONAL CANCER INSTITUTE [R01CA129541, P01CA096832, P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); March of Dimes Basil O'Connor Starter Scholar Research Award(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to J. Morgan, M. Dyer, M. Roussel, and N. Ayad for critically reading the manuscript; A. Sawa, S. Zakharenko, and B. Schulman for insightful discussions; S. Connell, R. Baird, and K. Kilborn (Intelligent Imaging Innovations) for timely data analysis advice and support; G. Chan for providing space for some of the revision experiments; and S. Naron for excellent editorial assistance. G. Miesenbock and Memorial Sloan-Kettering Cancer Center provided the pHluorin reporter, A. Miyawaki provided Venus, F. Polleux provided pCIG2, M. Aurrand-Lions provided anti-JAM-C antiserum, I. Dikic provided the hemagglutinin-ubiquitin (HA-Ubq) construct, and A. Sawa shared Siah reagents. Supported by American Lebanese Syrian Associated Charities (ALSAC, D.J.S.), a National Cancer Institute Cancer Center Support Grant (D.J.S.), and a March of Dimes Basil O'Connor Starter Scholar Research Award (D.J.S.).	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; FISHELL G, 1991, DEVELOPMENT, V113, P755; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2009, CANCER RES, V69, P8835, DOI 10.1158/0008-5472.CAN-09-1676; Karakuzu O, 2009, DEVELOPMENT, V136, P943, DOI 10.1242/dev.029363; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Metin C, 2008, J NEUROSCI, V28, P11746, DOI 10.1523/JNEUROSCI.3860-08.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Polleux F, 2002, DEVELOPMENT, V129, P3147; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic P, 1985, CELL CONTACT ADHESIO, P67; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	29	69	70	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1834	1838		10.1126/science.1198480	http://dx.doi.org/10.1126/science.1198480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21109632	Green Accepted			2022-12-01	WOS:000285603700044
J	Janic, A; Mendizabal, L; Llamazares, S; Rossell, D; Gonzalez, C				Janic, Ana; Mendizabal, Leire; Llamazares, Salud; Rossell, David; Gonzalez, Cayetano			Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila	SCIENCE			English	Article							TRANSCRIPTIONAL REPRESSOR; CANCER/TESTIS ANTIGENS; STEM-CELLS; COMPLEX; PROTEIN; IDENTIFICATION; MELANOGASTER; INTERACTS; DIVISION; MUTANTS	Model organisms such as the fruit fly Drosophila melanogaster can help to elucidate the molecular basis of complex diseases such as cancer. Mutations in the Drosophila gene lethal (3) malignant brain tumor cause malignant growth in the larval brain. Here we show that l(3)mbt tumors exhibited a soma-to-germline transformation through the ectopic expression of genes normally required for germline stemness, fitness, or longevity. Orthologs of some of these genes were also expressed in human somatic tumors. In addition, inactivation of any of the germline genes nanos, vasa, piwi, or aubergine suppressed l(3) mbt malignant growth. Our results demonstrate that germline traits are necessary for tumor growth in this Drosophila model and suggest that inactivation of germline genes might have tumor-suppressing effects in other species.	[Janic, Ana; Mendizabal, Leire; Llamazares, Salud; Gonzalez, Cayetano] PCB, IRB Barcelona, Cell Div Grp, Barcelona, Spain; [Rossell, David] PCB, IRB Barcelona, Bioinformat & Biostat Unit, Barcelona, Spain; [Gonzalez, Cayetano] Passeig Lluis Co 23, ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; ICREA	Gonzalez, C (corresponding author), PCB, IRB Barcelona, Cell Div Grp, C Baldiri Reixac 10-12, Barcelona, Spain.	gonzalez@irbbarcelona.org	Rossell, David/AAM-4292-2021; Gonzalez, Cayetano/K-3055-2019; Gonzalez, Cayetano/K-3933-2019; Janic, Ana/AAR-4783-2020	Rossell, David/0000-0002-7104-5789; Gonzalez, Cayetano/0000-0002-5259-3608; Janic, Ana/0000-0002-4200-2560; Llamazares, Salud/0000-0002-8771-2312	Consolider-Ingenio [CSD2006-23]; Ministerio de Ciencia e Innovacion Formacion de Personal;  [ONCASYM-037398];  [BFU2006-05813];  [BFU2009-07975];  [SGR2005];  [SRG200];  [CEN-20091016]; ICREA Funding Source: Custom	Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion Formacion de Personal; ; ; ; ; ; ; ICREA(ICREA)	We thank E. Gateff, R. Lehmann, P. Zamore, A. Spradling, F. Azorin, P. Lasko, S. Hawley, M. Siomi, T. Kai, T. Orr-Weaver, H. White-Cooper, D. McKearin, T. Schupbach, Hybridoma Bank, and Bloomington and Tubingen Drosophila Stock centers for antibodies and fly stocks; H. Auer, the IRB Functional Genomics Facility, and the European Molecular Biology Laboratory Genomics Core Facility for invaluable technical guidance; J. Januschke and members of our laboratory for discussions; and M. Llamazares for proofreading. Work in our laboratory is supported by ONCASYM-037398, BFU2006-05813, BFU2009-07975, SGR2005, SRG200, CEN-20091016, and Consolider-Ingenio CSD2006-23. A.J. is a recipient of a Ministerio de Ciencia e Innovacion Formacion de Personal Investigador fellowship. Array data sets are deposited at Gene Expression Omnibus (accession no. GSE24917).	Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bonnomet A, 2008, ONCOGENE, V27, P3692, DOI 10.1038/sj.onc.1211035; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; Jager E, 2002, CURR OPIN IMMUNOL, V14, P178, DOI 10.1016/S0952-7915(02)00318-7; Joyce EF, 2009, GENETICS, V181, P335, DOI 10.1534/genetics.108.093104; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Lee LA, 2003, GENE DEV, V17, P2979, DOI 10.1101/gad.1132603; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Old Lloyd J, 2008, Cancer Immun, V8 Suppl 1, P1; Page SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000194; Patil VS, 2010, CURR BIOL, V20, P724, DOI 10.1016/j.cub.2010.02.046; Perezgasga L, 2004, DEVELOPMENT, V131, P1691, DOI 10.1242/dev.01032; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smulders-Srinivasan TK, 2003, GENETICS, V165, P1971; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Svensson MJ, 2003, CHROMOSOMA, V112, P133, DOI 10.1007/s00412-003-0253-5; Taubert H, 2007, ONCOGENE, V26, P1098, DOI 10.1038/sj.onc.1209880; Tavosanis G, 1997, EMBO J, V16, P1809, DOI 10.1093/emboj/16.8.1809; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Tureci O, 1998, P NATL ACAD SCI USA, V95, P5211, DOI 10.1073/pnas.95.9.5211; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Yohn CB, 2003, GENETICS, V165, P1889	32	194	198	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1824	1827		10.1126/science.1195481	http://dx.doi.org/10.1126/science.1195481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205669				2022-12-01	WOS:000285603700041
J	Gallo, CM; Wang, JT; Motegi, F; Seydoux, G				Gallo, Christopher M.; Wang, Jennifer T.; Motegi, Fumio; Seydoux, Geraldine			Cytoplasmic Partitioning of P Granule Components Is Not Required to Specify the Germline in C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; ASYMMETRY; PROTEINS	Asymmetric segregation of P granules during the first four divisions of the Caenorhabditis elegans embryo is a classic example of cytoplasmic partitioning of germline determinants. It is thought that asymmetric partitioning of P granule components during mitosis is essential to distinguish germline from soma. We have identified a mutant (pptr-1) in which P granules become unstable during mitosis and P granule proteins and RNAs are distributed equally to somatic and germline blastomeres. Despite symmetric partitioning of P granule components, pptr-1 mutants segregate a germline that uniquely expresses P granules during postembryonic development. pptr-1 mutants are fertile, except at high temperatures. Hence, asymmetric partitioning of maternal P granules is not essential to specify germ cell fate. Instead, it may serve to protect the nascent germline from stress.	[Gallo, Christopher M.; Wang, Jennifer T.; Motegi, Fumio; Seydoux, Geraldine] Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Seydoux, G (corresponding author), Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Dept Mol Biol & Genet, 725 N Wolfe St,PCTB 706, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu	SEYDOUX, Geraldine/AAA-2005-2020	Wang, Jennifer/0000-0002-8506-5182; Seydoux, Geraldine/0000-0001-8257-0493	NIH [GM080042, HD007276, HD037047]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080042] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. H. Kim, S. Strome, E. Voronina, K. Kemphues, K. Bennett, and C. Eckmann for reagents and advice. We also obtained reagents from the National Bioresource Project for the Nematode (Japan), the Caenorhabditis Genetics Center, and the Developmental Studies Hybridoma Bank (USA). This work was supported by NIH grants GM080042 to C. M. G., HD007276 to J.T.W., and HD037047 to G. S. G. S. is a Howard Hughes Medical Institute investigator. Plasmids are supplied under a Materials Transfer Agreement from the Howard Hughes Medical Institute.	Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Daniels BR, 2009, J CELL BIOL, V184, P473, DOI 10.1083/jcb.200809077; Gonczy Pierre, 2005, WormBook, P1; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kawasaki L, 2004, GENETICS, V167, P645, DOI 10.1534/genetics.103.023093; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Munro E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003400; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Spike C, 2008, GENETICS, V178, P1973, DOI 10.1534/genetics.107.083469; Strome Susan, 2005, WormBook, P1, DOI 10.1895/wormbook.1.9.1; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Updike D, 2010, J ANDROL, V31, P53, DOI 10.2164/jandrol.109.008292; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	20	94	97	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1685	1689		10.1126/science.1193697	http://dx.doi.org/10.1126/science.1193697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21127218	Green Accepted			2022-12-01	WOS:000285390500069
J	Krug, U; Rollig, C; Koschmieder, A; Heinecke, A; Sauerland, MC; Schaich, M; Thiede, C; Kramer, M; Braess, J; Spiekermann, K; Haferlach, T; Haferlach, C; Koschmieder, S; Rohde, C; Serve, H; Wormann, B; Hiddemann, W; Ehninger, G; Berdel, WE; Buchner, T; Muller-Tidow, C				Krug, Utz; Roellig, Christoph; Koschmieder, Anja; Heinecke, Achim; Sauerland, Maria Cristina; Schaich, Markus; Thiede, Christian; Kramer, Michael; Braess, Jan; Spiekermann, Karsten; Haferlach, Torsten; Haferlach, Claudia; Koschmieder, Steffen; Rohde, Christian; Serve, Hubert; Woermann, Bernhard; Hiddemann, Wolfgang; Ehninger, Gerhard; Berdel, Wolfgang E.; Buechner, Thomas; Mueller-Tidow, Carsten		German Acute Myeloid Leukaemia Coo	Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes	LANCET			English	Article							MICRORNA-EXPRESSION SIGNATURES; RISK MYELODYSPLASTIC SYNDROME; STEM-CELL TRANSPLANTATION; ELDERLY-PATIENTS; INDUCTION CHEMOTHERAPY; FAVORABLE PROGNOSIS; DOSE CYTARABINE; NPM1 MUTATIONS; SURVIVAL; CANCER	Background About 50% of patients (age >= 60 years) who have acute myeloid leukaemia and are otherwise medically healthy (ie, able to undergo intensive chemotherapy) achieve a complete remission (CR) after intensive chemotherapy, but with a substantially increased risk of early death (ED) compared with younger patients. We verified the association of standard clinical and laboratory variables with CR and ED and developed a web-based application for risk assessment of intensive chemotherapy in these patients. Methods Multivariate regression analysis was used to develop risk scores with or without knowledge of the cytogenetic and molecular risk profiles for a cohort of 1406 patients (aged >= 60 years) with acute myeloid leukaemia, but otherwise medically healthy, who were treated with two courses of intensive induction chemotherapy (tioguanine, standard-dose cytarabine, and daunorubicin followed by high-dose cytarabine and mitoxantrone; or with high-dose cytarabine and mitoxantrone in the first and second induction courses) in the German Acute Myeloid Leukaemia Cooperative Group 1999 study. Risk prediction was validated in an independent cohort of 801 patients (aged >60 years) with acute myeloid leukaemia who were given two courses of cytarabine and daunorubicin in the Acute Myeloid Leukaemia 1996 study. Findings Body temperature, age, de-novo leukaemia versus leukaemia secondary to cytotoxic treatment or an antecedent haematological disease, haemoglobin, platelet count, fibrinogen, and serum concentration of lactate dehydrogenase were significantly associated with CR or ED. The probability of CR with knowledge of cytogenetic and molecular risk (score 1) was from 12% to 91%, and without knowledge (score 2) from 21% to 80%. The predicted risk of ED was from 6% to 69% for score 1 and from 7% to 63% for score 2. The predictive power of the risk scores was confirmed in the independent patient cohort (CR score 1, from 10% to 91%; CR score 2, from 16% to 80%; ED score 1, from 6% to 69%; and ED score 2, from 7% to 61%). Interpretation The scores for acute myeloid leukaemia can be used to predict the probability of CR and the risk of ED in older patients with acute myeloid leukaemia, but otherwise medically healthy, for whom intensive induction chemotherapy is planned. This information can help physicians with difficult decisions for treatment of these patients.	[Koschmieder, Anja; Koschmieder, Steffen; Rohde, Christian; Berdel, Wolfgang E.; Buechner, Thomas; Mueller-Tidow, Carsten] Univ Munster, Dept Med Haematol & Oncol A, Munster, Germany; [Roellig, Christoph; Schaich, Markus; Thiede, Christian; Kramer, Michael; Ehninger, Gerhard] Tech Univ Dresden, Dept Med 1, Dresden, Germany; [Heinecke, Achim; Sauerland, Maria Cristina] Univ Munster, Inst Biostat & Clin Res, Munster, Germany; [Braess, Jan; Spiekermann, Karsten; Hiddemann, Wolfgang] Univ Munich, Dept Internal Med 3, Munich, Germany; [Haferlach, Torsten; Haferlach, Claudia] Munich Leukaemia Lab, Munich, Germany; [Serve, Hubert] Goethe Univ Frankfurt, Dept Med, Frankfurt, Germany; [Woermann, Bernhard] Municipal Hosp, Dept Haematol & Oncol, Braunschweig, Germany	University of Munster; Technische Universitat Dresden; University of Munster; University of Munich; MLL Munich Leukemia Laboratory; Goethe University Frankfurt	Krug, U (corresponding author), Univ Hosp Munster, Dept Med A, Albert Schweitzer Str 33, D-48149 Munster, Germany.	utz.krug@ukmuenster.de	Sauerland, Maria Cristina/A-4154-2014; Müller-Tidow, Carsten CMT/B-5257-2014; Gramatzki, Martin/A-9533-2010; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232; Koschmieder, Steffen/0000-0002-1011-8171; Serve, Hubert/0000-0001-8472-5516; Thiede, Christian/0000-0003-1241-2048; Kramer, Michael/0000-0002-0251-2726	Amgen; Celgene; Bundesministerium fur Bildung und Forschung; Novartis; Bayer; Ambit; Bristol-Myers Sqibb; Mundipharma; Deutsche Forschungsgemeinschaft [Mu-1328/8-1]; Deutsche Krebshilfe; Sander-Foundation; Aicuris; Leverkusen; Deutsche Krebshilfe [70-2839-Bu4]	Amgen(Amgen); Celgene(Bristol-Myers SquibbCelgene Corporation); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Novartis(Novartis); Bayer(Bayer AG); Ambit; Bristol-Myers Sqibb; Mundipharma; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Sander-Foundation; Aicuris; Leverkusen; Deutsche Krebshilfe(Deutsche Krebshilfe)	UK has received expenses for travel, accommodation, and meetings from Amgen and Celgene. CT has received grants from Bundesministerium fur Bildung und Forschung; payment for lectures, including service on speakers' bureaus, from Novartis; payment for diagnostic services from Novartis and Ambit; and expenses for travel, accommodations, and meetings from Novartis, Bayer, and Ambit. TH has received payment for lectures including service on speakers' bureaus from Novartis, Bristol-Myers Sqibb, and Celgene; and has part ownership in Munich Leukemia Laboratory. CH has part ownership in Munich Leukemia Laboratory. SK has received grants from Novartis; and expenses for travel, accommodations, and meetings from Mundipharma, Novartis, and Bristol-Myers Sqibb. WEB has received grants from Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, and Sander-Foundation; payment for lectures, including service on speakers' bureaus, and development of educational presentations from Molecular and Targeted Therapy of Cancer; and expenses for travel, accommodations, and meetings from Amgen. CMT has received grants from Bundesministerium fur Bildung und Forschung; payment for lectures, including service on speakers' bureaus, from Novartis and Celgene; payment for manuscript preparation from Celgene; and expenses for travel, accommodations, and meetings from Celgene, Amgen, Novartis, and Bayer. GE has received payment for board membership from Rhon Klinikum; payment for consultancy from Aicuris, Leverkusen; and grants from Deutsche Forschungsgemeinschaft; payments for lectures, including service on speakers' bureaus, from Update Conference; has stock or stock options in Rhon Klinikum; and has received expenses for travel, accommodations, and meetings from Novartis. The other authors declare that they have no conflicts of interest.; This work was supported by a grant from the Deutsche Krebshilfe (70-2839-Bu4 to TB) and by a grant from the Deutsche Forschungsgemeinschaft (Mu-1328/8-1 to CMT and TB).	Anderson JE, 2002, BLOOD, V100, P3869, DOI 10.1182/blood-2001-12-0354; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; Bertz H, 2003, J CLIN ONCOL, V21, P1480, DOI 10.1200/JCO.2003.09.110; Breccia M, 2009, HEMATOL ONCOL, V27, P148, DOI 10.1002/hon.889; Buchner T, 2006, J CLIN ONCOL, V24, P2480, DOI 10.1200/JCO.2005.04.5013; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; COMINGS DE, 1973, EXP CELL RES, V77, P469, DOI 10.1016/0014-4827(73)90601-0; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Etienne A, 2007, CANCER, V109, P1376, DOI 10.1002/cncr.22537; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Giles FJ, 2007, BRIT J HAEMATOL, V136, P624, DOI 10.1111/j.1365-2141.2006.06476.x; Goldstone AH, 2002, BLOOD, V100, p88A; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Itzykson R, 2011, BLOOD, V117, P403, DOI 10.1182/blood-2010-06-289280; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1090, DOI 10.1002/cncr.21723; Kantarjian H, 2010, BLOOD, V116, P4422, DOI 10.1182/blood-2010-03-276485; Kern W, 2003, BLOOD, V101, P64, DOI 10.1182/blood-2002-02-0532; LOWENBERG B, 1989, J CLIN ONCOL, V7, P1268; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; Ohtake S, 2011, BLOOD, V117, P2358, DOI 10.1182/blood-2010-03-273243; Rollig C, 2010, BLOOD, V116, P971, DOI 10.1182/blood-2010-01-267302; Rollig C, 2009, BLOOD, V114, P139, DOI 10.1182/blood.V114.22.329.329; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Schnittger S, 2005, BLOOD, V106, p68A, DOI 10.1182/blood.V106.11.223.223; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Sekeres MA, 2009, BLOOD, V113, P28, DOI 10.1182/blood-2008-05-157065; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Walter RB, 2010, J CLIN ONCOL, V28, P1766, DOI 10.1200/JCO.2009.25.1066; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648	34	216	226	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	2010	376	9757					2000	2008		10.1016/S0140-6736(10)62105-8	http://dx.doi.org/10.1016/S0140-6736(10)62105-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	21131036				2022-12-01	WOS:000285807700029
J	Bottke, WF; Walker, RJ; Day, JMD; Nesvorny, D; Elkins-Tanton, L				Bottke, William F.; Walker, Richard J.; Day, James M. D.; Nesvorny, David; Elkins-Tanton, Linda			Stochastic Late Accretion to Earth, the Moon, and Mars	SCIENCE			English	Article							SIDEROPHILE ELEMENT SYSTEMATICS; CORE FORMATION; OSMIUM ISOTOPE; ASTEROID BELT; MANTLE; ORIGIN; DIFFERENTIATION; CONSTRAINTS; METEORITES; SILICATE	Core formation should have stripped the terrestrial, lunar, and martian mantles of highly siderophile elements (HSEs). Instead, each world has disparate, yet elevated HSE abundances. Late accretion may offer a solution, provided that >= 0.5% Earth masses of broadly chondritic planetesimals reach Earth's mantle and that similar to 10 and similar to 1200 times less mass goes to Mars and the Moon, respectively. We show that leftover planetesimal populations dominated by massive projectiles can explain these additions, with our inferred size distribution matching those derived from the inner asteroid belt, ancient martian impact basins, and planetary accretion models. The largest late terrestrial impactors, at 2500 to 3000 kilometers in diameter, potentially modified Earth's obliquity by similar to 10 degrees, whereas those for the Moon, at similar to 250 to 300 kilometers, may have delivered water to its mantle.	[Bottke, William F.; Nesvorny, David] SW Res Inst, Boulder, CO 80302 USA; [Bottke, William F.; Nesvorny, David] NASA, Lunar Sci Inst, Boulder, CO 80302 USA; [Walker, Richard J.; Day, James M. D.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Day, James M. D.] Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; [Elkins-Tanton, Linda] MIT, Cambridge, MA 02139 USA	National Aeronautics & Space Administration (NASA); University System of Maryland; University of Maryland College Park; University of California System; University of California San Diego; Scripps Institution of Oceanography; Massachusetts Institute of Technology (MIT)	Bottke, WF (corresponding author), SW Res Inst, 1050 Walnut St,Suite 400, Boulder, CO 80302 USA.	bottke@boulder.swri.edu	Elkins-Tanton, Linda/C-5508-2008; Walker, Richard/K-6869-2016; Day, James/A-5099-2010	Elkins-Tanton, Linda/0000-0003-4008-1098; Walker, Richard/0000-0003-0348-2407; Day, James/0000-0001-9520-3465	NASA's Lunar Science Institute [NNA09DB33A]; NASA [NNG04GJ49A]; Direct For Mathematical & Physical Scien [0747154] Funding Source: National Science Foundation	NASA's Lunar Science Institute; NASA(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Barr, R. Canup, R. Citron, L. Dones, H. Levison, J. Jones, H. Nekvasil, A. Morbidelli, D. Minton, S. Mojzsis, G. J. Taylor, and D. Vokouhlicky for many useful discussions and two anonymous reviewers for constructive reviews. W.F.B's and D.N.'s participation was supported by NASA's Lunar Science Institute through a grant to the Center for Lunar Origin and Evolution at the Southwest Research Institute in Boulder, Colorado. R.J.W.'s and J.M.D.D.'s work was supported by NASA's Lunar Science Institute through contract NNA09DB33A to the Center for Lunar Science and Exploration at the Lunar and Planetary Institute in Houston, Texas, and the NASA Astrobiology Program through grant NNG04GJ49A to the Goddard Center for Astrobiology in Greenbelt, Maryland.	Artemieva NA, 2008, SOLAR SYST RES+, V42, P329, DOI 10.1134/S0038094608040059; Asphaug E, 2010, CHEM ERDE-GEOCHEM, V70, P199, DOI 10.1016/j.chemer.2010.01.004; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; Bennett VC, 2002, GEOCHIM COSMOCHIM AC, V66, P2615, DOI 10.1016/S0016-7037(02)00862-1; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; BORISOV A, 1994, GEOCHIM COSMOCHIM AC, V58, P705, DOI 10.1016/0016-7037(94)90500-2; Bottke WF, 2002, ICARUS, V156, P399, DOI 10.1006/icar.2001.6788; Bottke WF, 2006, NATURE, V439, P821, DOI 10.1038/nature04536; Bottke WF, 2007, ICARUS, V190, P203, DOI 10.1016/j.icarus.2007.02.010; Brandon AD, 2000, GEOCHIM COSMOCHIM AC, V64, P4083, DOI 10.1016/S0016-7037(00)00482-8; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Chou CL, 1978, P LUNAR PLANET SCI, V9, P219; Cuzzi JN, 2010, ICARUS, V208, P518, DOI 10.1016/j.icarus.2010.03.005; Dahl TW, 2010, EARTH PLANET SC LETT, V295, P177, DOI 10.1016/j.epsl.2010.03.038; Day JMD, 2007, SCIENCE, V315, P217, DOI 10.1126/science.1133355; Day JMD, 2010, EARTH PLANET SC LETT, V289, P595, DOI 10.1016/j.epsl.2009.12.001; FARINELLA P, 1992, ICARUS, V97, P111, DOI 10.1016/0019-1035(92)90060-K; Frey HV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002449; Halliday AN, 2005, TREATISE GEOCHEM, V1, P509; HOLSAPPLE KA, 1993, ANNU REV EARTH PL SC, V21, P333, DOI 10.1146/annurev.ea.21.050193.002001; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086; JONES JH, 1986, NATURE, V323, P470, DOI 10.1038/323470a0; Jones JH, 2003, CHEM GEOL, V196, P21, DOI 10.1016/S0009-2541(02)00404-7; Levison HF, 2009, NATURE, V460, P364, DOI 10.1038/nature08094; Maier WD, 2009, NATURE, V460, P620, DOI 10.1038/nature08205; Marinova MM, 2008, NATURE, V453, P1216, DOI 10.1038/nature07070; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; Morbidelli A, 2009, ICARUS, V204, P558, DOI 10.1016/j.icarus.2009.07.011; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; Puchtel IS, 2008, GEOCHIM COSMOCHIM AC, V72, P3022, DOI 10.1016/j.gca.2008.04.006; Robert F, 2003, SPACE SCI REV, V106, P87, DOI 10.1023/A:1024629402715; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; Rubie DC, 2003, EARTH PLANET SC LETT, V205, P239, DOI 10.1016/S0012-821X(02)01044-0; Sharp ZD, 2010, SCIENCE, V329, P1050, DOI 10.1126/science.1192606; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Walker RJ, 2004, EARTH PLANET SC LETT, V224, P399, DOI 10.1016/j.epsl.2004.05.036; Ward WR, 2000, NATURE, V403, P741, DOI 10.1038/35001516; Warren PH, 2005, TREATISE GEOCHEM, V1, P559	39	157	159	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 10	2010	330	6010					1527	1530		10.1126/science.1196874	http://dx.doi.org/10.1126/science.1196874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	21148387				2022-12-01	WOS:000285153500061
J	McTighe, SM; Cowell, RA; Winters, BD; Bussey, TJ; Saksida, LM				McTighe, Stephanie M.; Cowell, Rosemary A.; Winters, Boyer D.; Bussey, Timothy J.; Saksida, Lisa M.			Paradoxical False Memory for Objects After Brain Damage	SCIENCE			English	Article							SHORT-TERM-MEMORY; RECOGNITION MEMORY; AMNESIC PATIENTS; PERIRHINAL CORTEX; ANIMAL-MODEL; RETROACTIVE INTERFERENCE; CONSOLIDATION; RETRIEVAL; LESIONS; IMPAIRMENT	Poor memory after brain damage is usually considered to be a result of information being lost or rendered inaccessible. It is assumed that such memory impairment must be due to the incorrect interpretation of previously encountered information as being novel. In object recognition memory experiments with rats, we found that memory impairment can take the opposite form: a tendency to treat novel experiences as familiar. This impairment could be rescued with the use of a visual-restriction procedure that reduces interference. Such a pattern of data can be explained in terms of a recent representational-hierarchical view of cognition.	[McTighe, Stephanie M.; Bussey, Timothy J.; Saksida, Lisa M.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [McTighe, Stephanie M.; Bussey, Timothy J.; Saksida, Lisa M.] Univ Cambridge, MRC, Cambridge CB2 3EB, England; [McTighe, Stephanie M.; Bussey, Timothy J.; Saksida, Lisa M.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Cowell, Rosemary A.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Winters, Boyer D.] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada	University of Cambridge; University of Cambridge; University of Cambridge; University of California System; University of California San Diego; University of Guelph	Saksida, LM (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	lms42@cam.ac.uk	Saksida, Lisa M/M-2753-2016; Bussey, Timothy J/M-2758-2016; Cowell, Rosemary/K-2366-2012	Saksida, Lisa M/0000-0002-8416-8171; Bussey, Timothy J/0000-0001-7518-4041; 	BBSRC; MRC at the University of Cambridge; Clinical Neuroscience Institute	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC at the University of Cambridge; Clinical Neuroscience Institute	Supported by a grant from the BBSRC (L. M. S., T.J.B., B. D. W.), and a 3-year MRC-funded Ph.D. studentship at the University of Cambridge, MRC/Wellcome Trust Behavioral and Clinical Neuroscience Institute (S.M.M.).	ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P5637, DOI 10.1073/pnas.91.12.5637; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Bartko SJ, 2010, NEUROPSYCHOLOGIA, V48, P2987, DOI 10.1016/j.neuropsychologia.2010.06.007; Bussey TJ, 2007, HIPPOCAMPUS, V17, P898, DOI 10.1002/hipo.20320; Bussey TJ, 1999, J NEUROSCI, V19, P495, DOI 10.1523/JNEUROSCI.19-01-00495.1999; Clark RE, 2010, NEUROPSYCHOLOGIA, V48, P2234, DOI 10.1016/j.neuropsychologia.2010.02.004; Cowan N, 2004, BRAIN, V127, P825, DOI 10.1093/brain/awh107; Cowell RA, 2006, J NEUROSCI, V26, P12186, DOI 10.1523/JNEUROSCI.2818-06.2006; Della Sala S, 2005, MEMORY, V13, P435, DOI 10.1080/09658210344000387; Dewar M, 2009, NEUROPSYCHOLOGY, V23, P627, DOI 10.1037/a0015568; Dewar MT, 2007, CORTEX, V43, P616, DOI 10.1016/S0010-9452(08)70492-1; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; MUMBY DG, 1994, BEHAV NEUROSCI, V108, P11, DOI 10.1037/0735-7044.108.1.11; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Saksida LM, 2010, NEUROPSYCHOLOGIA, V48, P2370, DOI 10.1016/j.neuropsychologia.2010.02.026; Saksida LM, 2009, SCIENCE, V325, P40, DOI 10.1126/science.1177156; Ungerleider L, 1982, ANAL VISUAL BEHAV, P549; WARRINGT.EK, 1970, NATURE, V228, P628, DOI 10.1038/228628a0; WARRINGTON EK, 1974, NEUROPSYCHOLOGIA, V12, P419, DOI 10.1016/0028-3932(74)90072-4; WARRINGTON EK, 1978, NEUROPSYCHOLOGIA, V16, P169, DOI 10.1016/0028-3932(78)90104-5; Winters BD, 2005, J NEUROSCI, V25, P52, DOI 10.1523/JNEUROSCI.3827-04.2005; Winters BD, 2010, NEUROPSYCHOLOGIA, V48, P2251, DOI 10.1016/j.neuropsychologia.2010.01.023; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	25	100	100	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2010	330	6009					1408	1410		10.1126/science.1194780	http://dx.doi.org/10.1126/science.1194780			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689BK	21127256				2022-12-01	WOS:000284902100050
J	Westerlund, H; Vahtera, J; Ferrie, JE; Singh-Manoux, A; Pentti, J; Melchior, M; Leineweber, C; Jokela, M; Siegrist, J; Goldberg, M; Zins, M; Kivimaki, M				Westerlund, Hugo; Vahtera, Jussi; Ferrie, Jane E.; Singh-Manoux, Archana; Pentti, Jaana; Melchior, Maria; Leineweber, Constanze; Jokela, Markus; Siegrist, Johannes; Goldberg, Marcel; Zins, Marie; Kivimaeki, Mika			Effect of retirement on major chronic conditions and fatigue: French GAZEL occupational cohort study	BRITISH MEDICAL JOURNAL			English	Article							PSYCHOSOCIAL WORK CHARACTERISTICS; MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; SLEEP DISTURBANCES; PHYSICAL HEALTH; NATIONAL-SURVEY; MORTALITY; RISK; POPULATION; TIREDNESS	Objectives To determine, using longitudinal analyses, if retirement is followed by a change in the risk of incident chronic diseases, depressive symptoms, and fatigue. Design Prospective study with repeat measures from 7 years before to 7 years after retirement. Setting Large French occupational cohort (the GAZEL study), 1989-2007. Participants 11 246 men and 2858 women. Main outcome measures Respiratory disease, diabetes, coronary heart disease and stroke, mental fatigue, and physical fatigue, measured annually by self report over the 15 year observation period; depressive symptoms measured at four time points. Results The average number of repeat measurements per participant was 12.1. Repeated measures logistic regression with generalised estimating equations showed that the cumulative prevalence of self reported respiratory disease, diabetes, and coronary heart disease and stroke increased with age, with no break in the trend around retirement. In contrast, retirement was associated with a substantial decrease in the prevalence of both mental fatigue (odds ratio for fatigue one year after versus one year before retirement 0.19, 95% confidence interval 0.18 to 0.21) and physical fatigue (0.27, 0.26 to 0.30). A major decrease was also observed in depressive symptoms (0.60, 0.53 to 0.67). The decrease in fatigue around retirement was more pronounced among people with a chronic disease before retirement. Conclusions Longitudinal modelling of repeat data showed that retirement did not change the risk of major chronic diseases but was associated with a substantial reduction in mental and physical fatigue and depressive symptoms, particularly among people with chronic diseases.	[Westerlund, Hugo; Leineweber, Constanze] Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden; [Westerlund, Hugo; Ferrie, Jane E.; Singh-Manoux, Archana; Jokela, Markus; Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Vahtera, Jussi; Pentti, Jaana; Kivimaeki, Mika] Finnish Inst Occupat Hlth, FI-00250 Helsinki, Finland; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, FI-20520 Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FI-20520 Turku, Finland; [Singh-Manoux, Archana; Melchior, Maria; Goldberg, Marcel; Zins, Marie] INSERM, U1018, F-94807 Villejuif, France; [Singh-Manoux, Archana; Melchior, Maria; Goldberg, Marcel; Zins, Marie] Univ Versailles, St Quentin En Yvelines, France; [Siegrist, Johannes] Univ Dusseldorf, Inst Med Soziol, D-40001 Dusseldorf, Germany	Stockholm University; University of London; University College London; Finnish Institute of Occupational Health; University of Turku; University of Turku; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Heinrich Heine University Dusseldorf	Westerlund, H (corresponding author), Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden.	hugo.westerlund@stress.su.se	Goldberg, Marcel/I-7834-2012; Zins, Marie/AAX-6551-2021; Singh-Manoux, Archana/F-6804-2013; Vahtera, Jussi/J-3271-2013; Kivimaki, Mika/B-3607-2012; Melchior, Maria/E-3992-2017; Westerlund, Hugo/A-3049-2012; Jokela, Markus/A-4669-2009; Ferrie, Jane/AAZ-2009-2020; Leineweber, Constanze/Z-1330-2019; Leineweber, Constanze/G-7052-2012; Siegrist, Johannes/AAL-6814-2021	Goldberg, Marcel/0000-0002-6161-5880; Singh-Manoux, Archana/0000-0002-1244-5037; Kivimaki, Mika/0000-0002-4699-5627; Westerlund, Hugo/0000-0002-8806-5698; Jokela, Markus/0000-0003-0117-0012; Leineweber, Constanze/0000-0001-8433-2405; Siegrist, Johannes/0000-0002-7530-4178	Swedish Council for Working Life and Social Research [2004-2021, 2007-1143, 2009-1758]; Academy of Finland [124271, 124322, 129262, 132944]; BUPA Foundation UK; National Institutes of Health/National Heart, Lung, and Blood Institute (NIH) [R01HL036310-20A2]; National Institute on Aging, NIH [R01AG013196, R01AG034454]; European Science Foundation; ESRC [RES-451-26-0491]; Agence nationale de la recherche (ANR); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); Academy of Finland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER; Economic and Social Research Council [RES-451-26-0491] Funding Source: researchfish	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Academy of Finland(Academy of Finland); BUPA Foundation UK; National Institutes of Health/National Heart, Lung, and Blood Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Science Foundation(European Science Foundation (ESF)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); Academy of Finland(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	HW and CL are supported by the Swedish Council for Working Life and Social Research (FAS, grants #2004-2021, #2007-1143, and #2009-1758), JV and MK are supported by the Academy of Finland (grants #124271, #124322, #129262, and #132944), MK is additionally supported by a BUPA Foundation UK specialist research grant and the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH) (R01HL036310-20A2). MK and AS-M are supported by the National Institute on Aging, NIH (R01AG013196; R01AG034454); AS-M is also supported by a EUYRI award from the European Science Foundation. This work was additionally supported by a grant from the ESRC Research Seminar Series Competition 2007/8 (RES-451-26-0491). The GAZEL Cohort Study was funded by EDF-GDF and INSERM and received grants from the "Cohortes Sante TGIR Program," Agence nationale de la recherche (ANR), and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET). The study sponsors did not contribute to the study design and had no role in the conduct of the study, data collection, data management, data analysis, or interpretation of the data, nor in the preparation, review, or approval of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) regarding the submitted work HW and CL have support from the Swedish Council for Working Life and Social Research (FAS); JV and MK have support from the Academy of Finland; MK has additional support from the BU PA Foundation, UK; MK and AS-M also have support from the National Institutes of Health (NIH), USA; AS-M has additional support from the European Science Foundation (ESF); JF and all other authors except JS have additional support from ESRC, UK; MG and MZ have additional support from the Institut de recherche en sante publique (INSERM) and Caisse centrale d'action sociale, France; and JS had support from Agence nationale de la recherche (ANR), France; (2) none of the authors have any relationships with any company or organisation that might have an interest in the submitted work in the previous 3 years; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) the authors have no non-financial interests that may be relevant to the submitted work."	Alavinia SM, 2008, INT ARCH OCC ENV HEA, V82, P39, DOI 10.1007/s00420-008-0304-6; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Avlund K, 1998, J CLIN EPIDEMIOL, V51, P323, DOI 10.1016/S0895-4356(97)00296-5; BOSSE R, 1987, PSYCHOL AGING, V2, P383, DOI 10.1037/0882-7974.2.4.383; Bultmann U, 2002, INT ARCH OCC ENV HEA, V75, P259, DOI 10.1007/s00420-001-0294-0; Butterworth P, 2006, SOC SCI MED, V62, P1179, DOI 10.1016/j.socscimed.2005.07.013; Buxton JW, 2005, SOC PSYCH PSYCH EPID, V40, P99, DOI 10.1007/s00127-005-0866-5; De Lange AH, 2009, J SLEEP RES, V18, P374, DOI 10.1111/j.1365-2869.2009.00735.x; De Raeve L, 2007, J OCCUP ENVIRON MED, V49, P890, DOI 10.1097/JOM.0b013e31811eadd3; Doyle Y, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3926; Drentea P, 2002, J AGING HEALTH, V14, P167, DOI 10.1177/089826430201400201; EKERDT DJ, 1983, AM J PUBLIC HEALTH, V73, P779, DOI 10.2105/AJPH.73.7.779; Evenson KR, 2002, AM J EPIDEMIOL, V155, P692, DOI 10.1093/aje/155.8.692; Fahlen G, 2006, INT ARCH OCC ENV HEA, V79, P371, DOI 10.1007/s00420-005-0063-6; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gall TL, 1997, J GERONTOL B-PSYCHOL, V52, pP110, DOI 10.1093/geronb/52B.3.P110; Goldberg M, 2001, AM J EPIDEMIOL, V154, P373, DOI 10.1093/aje/154.4.373; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Goldberg M, 2006, J CLIN EPIDEMIOL, V59, P1213, DOI 10.1016/j.jclinepi.2006.02.020; Goldberg P, 2001, J EPIDEMIOL COMMUN H, V55, P233, DOI 10.1136/jech.55.4.233; Gump BB, 2005, STROKE, V36, P98, DOI 10.1161/01.STR.0000149626.50127.d0; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hardy SE, 2008, J AM GERIATR SOC, V56, P1910, DOI 10.1111/j.1532-5415.2008.01957.x; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Jokela M, 2010, EPIDEMIOLOGY, V21, P284, DOI 10.1097/EDE.0b013e3181d61f53; Mein G, 2003, J EPIDEMIOL COMMUN H, V57, P46, DOI 10.1136/jech.57.1.46; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; Melchior M, 2009, AM J PUBLIC HEALTH, V99, P1417, DOI 10.2105/AJPH.2008.142273; Metzger MH, 2002, J CLIN EPIDEMIOL, V55, P48, DOI 10.1016/S0895-4356(01)00409-7; Mojon-Azzi S, 2007, SWISS MED WKLY, V137, P581; Moncrieff G, 2007, BRIT MED J, V334, P1221, DOI 10.1136/bmj.39182.615405.94; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rothman KJ., 2012, EPIDEMIOLOGY INTRO, V2nd; Vahtera J, 2009, SLEEP, V32, P1459, DOI 10.1093/sleep/32.11.1459; van Solinge H, 2007, RES AGING, V29, P225, DOI 10.1177/0164027506298223; Villamil E, 2006, PSYCHOL MED, V36, P999, DOI 10.1017/S0033291706007719; VOGEL J, 2006, HEALTHIER SOC ANAL A, P267; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1	38	149	150	0	31	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 23	2010	341								c6149	10.1136/bmj.c6149	http://dx.doi.org/10.1136/bmj.c6149			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	688DV	21098617	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000284830900010
J	Okie, S				Okie, Susan			A Flood of Opioids, a Rising Tide of Deaths	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; OVERDOSE		Georgetown Univ, Sch Med, Washington, DC 20057 USA	Georgetown University	Okie, S (corresponding author), Georgetown Univ, Sch Med, Washington, DC 20057 USA.							[Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P705; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; *SUBST AB MENT HLT, SUBST AB TREATM ADM	5	633	643	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 18	2010	363	21					1981	1985		10.1056/NEJMp1011512	http://dx.doi.org/10.1056/NEJMp1011512			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	681KC	21083382				2022-12-01	WOS:000284310000001
J	Bertero, MG; Verschueren, E; Paetzold, B; Serrrano, L				Bertero, Michela G.; Verschueren, Erik; Paetzold, Bernhard; Serrrano, Luis			ENHANCED SnapShot: Macromolecular Machines	CELL			English	Editorial Material									[Bertero, Michela G.; Verschueren, Erik; Paetzold, Bernhard; Serrrano, Luis] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Bertero, MG (corresponding author), Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain.		verschueren, erik/D-4436-2015	verschueren, erik/0000-0001-5842-6344; Bertero, Michela/0000-0002-2012-6706; Paetzold, Bernhard/0000-0003-3882-9036				Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750	3	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 12	2010	143	4							652.e1	10.1016/j.cell.2010.10.035	http://dx.doi.org/10.1016/j.cell.2010.10.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21074054	Bronze			2022-12-01	WOS:000284149100022
J	Capewell, S; Lloyd-Jones, DM				Capewell, Simon; Lloyd-Jones, Donald M.			Optimal Cardiovascular Prevention Strategies for the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEART-DISEASE MORTALITY		[Lloyd-Jones, Donald M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Lloyd-Jones, Donald M.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA; [Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Liverpool	Lloyd-Jones, DM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	dlj@northwestern.edu	Lloyd-Jones, Donald M/C-5899-2009	Lloyd-Jones, Donald/0000-0003-0847-6110	MRC [G0500920] Funding Source: UKRI; Medical Research Council [G0500920] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; National Institute for Health and Clinical Excellence, 2010, NICE PUBL HLTH GUID; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; Rose G., 1992, STRATEGY PREVENTIVE; Zatonski W, 2008, EUR J EPIDEMIOL, V23, P3, DOI 10.1007/s10654-007-9195-1	10	30	32	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2057	2058		10.1001/jama.2010.1641	http://dx.doi.org/10.1001/jama.2010.1641			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	21063015				2022-12-01	WOS:000284000600025
J	Evers, ACC; Brouwers, HAA; Hukkelhoven, CWPM; Nikkels, PGJ; Boon, J; van Egmond-Linden, A; Hillegersberg, J; Snuif, YS; Sterken-Hooisma, S; Bruinse, HW; Kwee, A				Evers, Annemieke C. C.; Brouwers, Hens A. A.; Hukkelhoven, Chantal W. P. M.; Nikkels, Peter G. J.; Boon, Janine; van Egmond-Linden, Anneke; Hillegersberg, Jacqueline; Snuif, Yvette S.; Sterken-Hooisma, Sietske; Bruinse, Hein W.; Kwee, Anneke			Perinatal mortality and severe morbidity in low and high risk term pregnancies in the Netherlands: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CARE; HEALTH; EUROPE; INDICATORS; BIRTHS; FETAL	Objective To compare incidences of perinatal mortality and severe perinatal morbidity between low risk term pregnancies supervised in primary care by a midwife and high risk pregnancies supervised in secondary care by an obstetrician. Design Prospective cohort study using aggregated data from a national perinatal register. Setting Catchment area of the neonatal intensive care unit (NICU) of the University Medical Center in Utrecht, a region in the centre of the Netherlands covering 13% of the Dutch population. Participants Pregnant women at 37 weeks' gestation or later with a singleton or twin pregnancy without congenital malformations. Main outcome measures Perinatal death (antepartum, intrapartum, and neonatal) or admission to a level 3 NICU. Results During the study period 37 735 normally formed infants were delivered at 37 weeks' gestation or later. Sixty antepartum stillbirths (1.59 (95% confidence interval 1.19 to 1.99) per 1000 babies delivered), 22 intrapartum stillbirths (0.58 (0.34 to 0.83) per 1000 babies delivered), and 210 NICU admissions (5.58 (4.83 to 6.33) per 1000 live births) occurred, of which 17 neonates died (0.45 (0.24 to 0.67) per 1000 live births). The overall perinatal death rate was 2.62 (2.11 to 3.14) per 1000 babies delivered and was significantly higher for nulliparous women compared with multiparous women (relative risk 1.65, 95% confidence interval 1.11 to 2.45). Infants of pregnant women at low risk whose labour started in primary care under the supervision of a midwife had a significant higher risk of delivery related perinatal death than did infants of pregnant women at high risk whose labour started in secondary care under the supervision of an obstetrician (relative risk 2.33, 1.12 to 4.83). NICU admission rates did not differ between pregnancies supervised by a midwife and those supervised by an obstetrician. Infants of women who were referred by a midwife to an obstetrician during labour had a 3.66 times higher risk of delivery related perinatal death than did infants of women who started labour supervised by an obstetrician (relative risk 3.66, 1.58 to 8.46) and a 2.5-fold higher risk of NICU admission (2.51, 1.87 to 3.37). Conclusions Infants of pregnant women at low risk whose labour started in primary care under the supervision of a midwife in the Netherlands had a higher risk of delivery related perinatal death and the same risk of admission to the NICU compared with infants of pregnant women at high risk whose labour started in secondary care under the supervision of an obstetrician. An important limitation of the study is that aggregated data of a large birth registry database were used and adjustment for confounders and clustering was not possible. However, the findings are unexpected and the obstetric care system of the Netherlands needs further evaluation.	[Evers, Annemieke C. C.; Bruinse, Hein W.; Kwee, Anneke] Univ Med Ctr Utrecht, Dept Obstet, NL-3584 EA Utrecht, Netherlands; [Brouwers, Hens A. A.] Univ Med Ctr Utrecht, Dept Neonatol, NL-3584 EA Utrecht, Netherlands; [Hukkelhoven, Chantal W. P. M.] Netherlands Perinatal Registry, Utrecht, Netherlands; [Nikkels, Peter G. J.] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 EA Utrecht, Netherlands; [Boon, Janine] Diakonessenhosp, Dept Obstet & Gynaecol, Utrecht, Netherlands; [van Egmond-Linden, Anneke] Zuwe Hofpoort Hosp, Dept Obstet & Gynaecol, Woerden, Netherlands; [Hillegersberg, Jacqueline] St Antonius Hosp, Dept Pediat, Nieuwegein, Netherlands; [Snuif, Yvette S.] Admiraal de Ruyter Hosp, Dept Obstet & Gynaecol, Goes, Netherlands; [Sterken-Hooisma, Sietske] Meander Med Ctr, Dept Obstet & Gynaecol, Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Diakonessenhuis; St. Antonius Hospital Utrecht; Meander Medisch Centrum	Evers, ACC (corresponding author), Univ Med Ctr Utrecht, Dept Obstet, NL-3584 EA Utrecht, Netherlands.	a.evers@umcutrecht.nl		Hukkelhoven, Chantal/0000-0002-0015-1883				Achterberg P. W., 2005, MEASURING BEST INT D; Amelink-Verburg MP, 2008, BJOG-INT J OBSTET GY, V115, P570, DOI 10.1111/j.1471-0528.2007.01580.x; Anthony S, 2009, PAEDIATR PERINAT EP, V23, P292, DOI 10.1111/j.1365-3016.2009.01044.x; Buitendijk S, 2003, EUR J OBSTET GYN R B, V111, pS66, DOI 10.1016/j.ejogrb.2003.09.007; Buitendijk S E, 2004, Ned Tijdschr Geneeskd, V148, P1855; College voor Zorgverzekeringen, 2003, VERL VAD 2003; de Jonge A, 2009, BJOG-INT J OBSTET GY, V116, P1177, DOI 10.1111/j.1471-0528.2009.02175.x; Merkus J M W M, 2008, Ned Tijdschr Geneeskd, V152, P2707; Mohangoo A D, 2008, Ned Tijdschr Geneeskd, V152, P2718; Ravelli A C J, 2008, Ned Tijdschr Geneeskd, V152, P2728; Richardus JH, 2003, BJOG-INT J OBSTET GY, V110, P97; Wildman K, 2003, EUR J OBSTET GYN R B, V111, pS53, DOI 10.1016/j.ejogrb.2003.09.006; Zeitlin J, 2009, J EPIDEMIOL COMMUN H, V63, P681, DOI 10.1136/jech.2009.087296	13	100	101	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 2	2010	341								c5639	10.1136/bmj.c5639	http://dx.doi.org/10.1136/bmj.c5639			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	678CU	21045050	hybrid			2022-12-01	WOS:000284048200001
J	Itzhaki, I; Maizels, L; Huber, I; Zwi-Dantsis, L; Caspi, O; Winterstern, A; Feldman, O; Gepstein, A; Arbel, G; Hammerman, H; Boulos, M; Gepstein, L				Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Zwi-Dantsis, Limor; Caspi, Oren; Winterstern, Aaron; Feldman, Oren; Gepstein, Amira; Arbel, Gil; Hammerman, Haim; Boulos, Monther; Gepstein, Lior			Modelling the long QT syndrome with induced pluripotent stem cells	NATURE			English	Article							CARDIOMYOCYTES; INDUCTION; RANOLAZINE; MECHANISM; MYOCYTES; BLOCK	The ability to generate patient-specific human induced pluripotent stem cells (iPSCs)(1-3) offers a new paradigm for modelling human disease and for individualizing drug testing(4). Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death(5-7). Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I-Kr. Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K-ATP-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.	[Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Zwi-Dantsis, Limor; Caspi, Oren; Winterstern, Aaron; Feldman, Oren; Gepstein, Amira; Arbel, Gil; Gepstein, Lior] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, IL-31096 Haifa, Israel; [Hammerman, Haim; Boulos, Monther; Gepstein, Lior] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Gepstein, L (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, POB9649, IL-31096 Haifa, Israel.	mdlior@techunix.technion.ac.il	Gepstein, Lior/H-9458-2012	Maizels, Leonid/0000-0001-6993-2808	Israel Science Foundation; Legacy Heritage Foundation [1225/09]; Yad Hanadiv Foundation; Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Foundation; Yad Hanadiv Foundation; Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	This study was supported in part by the Israel Science Foundation and Legacy Heritage Foundation (no. 1225/09), by the Yad Hanadiv Foundation Bruno Award, by the Lorry Lokey research fund, and by the Nancy and Stephen Grand Philanthropic Fund. We thank E. Suss-Toby and O. Shenker (from the multidisciplinary laboratory unit) and M. Tzukerman for their valuable help, A. Zamir for writing the MEA analysis software and I. Laevsky and T. Falik-Zaccai for the karyotype analysis.	Antoons G, 2010, J AM COLL CARDIOL, V55, P801, DOI 10.1016/j.jacc.2009.10.033; Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; Arbel G, 2010, METHODS MOL BIOL, V660, P85, DOI 10.1007/978-1-60761-705-1_6; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Fermini B, 2003, NAT REV DRUG DISCOV, V2, P439, DOI 10.1038/nrd1108; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Patel C, 2008, PHARMACOL THERAPEUT, V118, P138, DOI 10.1016/j.pharmthera.2008.02.001; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tenenbaum M, 2008, ISR MED ASSOC J, V10, P809; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	28	727	750	0	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					225	U113		10.1038/nature09747	http://dx.doi.org/10.1038/nature09747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21240260				2022-12-01	WOS:000288170200039
J	den Camp, RO; Streng, A; De Mita, S; Cao, QQ; Polone, E; Liu, W; Ammiraju, JSS; Kudrna, D; Wing, R; Untergasser, A; Bisseling, T; Geurts, R				den Camp, Rik Op; Streng, Arend; De Mita, Stephane; Cao, Qingqin; Polone, Elisa; Liu, Wei; Ammiraju, Jetty S. S.; Kudrna, Dave; Wing, Rod; Untergasser, Andreas; Bisseling, Ton; Geurts, Rene			LysM-Type Mycorrhizal Receptor Recruited for Rhizobium Symbiosis in Nonlegume Parasponia	SCIENCE			English	Article							MEDICAGO-TRUNCATULA; NODULATION; EVOLUTION; LEGUME; BACTERIA; KINASES; CELLS	Rhizobium-root nodule symbiosis is generally considered to be unique for legumes. However, there is one exception, and that is Parasponia. In this nonlegume, the rhizobial nodule symbiosis evolved independently and is, as in legumes, induced by rhizobium Nod factors. We used Parasponia andersonii to identify genetic constraints underlying evolution of Nod factor signaling. Part of the signaling cascade, downstream of Nod factor perception, has been recruited from the more-ancient arbuscular endomycorrhizal symbiosis. However, legume Nod factor receptors that activate this common signaling pathway are not essential for arbuscular endomycorrhizae. Here, we show that in Parasponia a single Nod factor-like receptor is indispensable for both symbiotic interactions. Therefore, we conclude that the Nod factor perception mechanism also is recruited from the widespread endomycorrhizal symbiosis.	[den Camp, Rik Op; Streng, Arend; De Mita, Stephane; Cao, Qingqin; Polone, Elisa; Liu, Wei; Untergasser, Andreas; Bisseling, Ton; Geurts, Rene] Wageningen Univ, Dept Plant Sci, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands; [Polone, Elisa] Univ Padua, Dept Agr Biotechnol, I-35020 Padua, Italy; [Liu, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Ammiraju, Jetty S. S.; Wing, Rod] Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; [Bisseling, Ton] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Wageningen University & Research; University of Padua; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Arizona; King Saud University	Bisseling, T (corresponding author), Wageningen Univ, Dept Plant Sci, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands.	ton.bisseling@wur.nl	poinssot, benoit/B-2569-2009; Op den Camp, Rik/F-4308-2011; Liu, Wei/J-6317-2013; Wing, Rod A/Z-2885-2019; Bisseling, Ton/A-2421-2013; cao, qingqin/W-5009-2019; Untergasser, Andreas/AAA-7452-2022	poinssot, benoit/0000-0001-5890-4318; Liu, Wei/0000-0003-4653-0448; Wing, Rod A/0000-0001-6633-6226; 	Dutch Science Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) [VIDI 864.06.007]	Dutch Science Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO))	We thank W. Broughton for NGR234; E. James, P. Hadobas, and T. J. Higgens for Parasponia seeds; P. van Dijk for flow cytometry; and J. Talag and W. Golser for BAC library construction. This research is funded by the Dutch Science Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) (VIDI 864.06.007).	AKKERMANS ADL, 1978, NATURE, V274, P190, DOI 10.1038/274190c0; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Cannon SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011630; Gewin V, 2010, NATURE, V466, P552, DOI 10.1038/466552a; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lohmann GV, 2010, MOL PLANT MICROBE IN, V23, P510, DOI 10.1094/MPMI-23-4-0510; Markmann K, 2009, TRENDS PLANT SCI, V14, P77, DOI 10.1016/j.tplants.2008.11.009; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Pawlowski K, 1996, PLANT CELL, V8, P1899, DOI 10.1105/tpc.8.10.1899; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Sytsma KJ, 2002, AM J BOT, V89, P1531, DOI 10.3732/ajb.89.9.1531; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; TRINICK MJ, 1973, NATURE, V244, P459, DOI 10.1038/244459a0; WEBSTER G, 1995, J EXP BOT, V46, P1131, DOI 10.1093/jxb/46.9.1131; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183; Zhu HY, 2006, GENETICS, V172, P2491, DOI 10.1534/genetics.105.051185	23	183	188	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					909	912		10.1126/science.1198181	http://dx.doi.org/10.1126/science.1198181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21205637				2022-12-01	WOS:000287455100057
J	Khomyakova, M; Bukmez, O; Thomas, LK; Erb, TJ; Berg, IA				Khomyakova, Maria; Buekmez, Oezlem; Thomas, Lorenz K.; Erb, Tobias J.; Berg, Ivan A.			A Methylaspartate Cycle in Haloarchaea	SCIENCE			English	Article							HALOPHILIC ARCHAEON; ISOCITRATE LYASE; MALATE SYNTHASE; METABOLISM; GLUTAMATE; ENZYMES	Access to novel ecological niches often requires adaptation of metabolic pathways to cope with new environments. For conversion to cellular building blocks, many substrates enter central carbon metabolism via acetyl-coenzyme A (acetyl-CoA). Until now, only two such pathways have been identified: the glyoxylate cycle and the ethylmalonyl-CoA pathway. Prokaryotes in the haloarchaea use a third pathway by which acetyl-CoA is oxidized to glyoxylate via the key intermediate methylaspartate. Glyoxylate condensation with another acetyl-CoA molecule yields malate, the final assimilation product. This cycle combines reactions that originally belonged to different metabolic processes in different groups of prokaryotes, which suggests lateral gene transfer and evolutionary tinkering of acetate assimilation. Moreover, it requires elevated intracellular glutamate concentrations, as well as coupling carbon assimilation with nitrogen metabolism.	[Khomyakova, Maria; Buekmez, Oezlem; Thomas, Lorenz K.; Erb, Tobias J.; Berg, Ivan A.] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg	Berg, IA (corresponding author), Univ Freiburg, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	ivan.berg@biologie.uni-freiburg.de	Khomyakova, Maria/E-6912-2014; Erb, Tobias/J-5214-2013; Berg, Ivan/AAZ-3917-2020	Erb, Tobias/0000-0003-3685-0894; Berg, Ivan/0000-0002-1864-4969	Deutscher Akademischer Austausch Dienst; Deutsche Forschungsgemeinschaft; Evonik-Degussa GmbH	Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evonik-Degussa GmbH	The authors thank G. Fuchs, Freiburg, for his constant support and the innumerable discussions and suggestions during this work and for his critical reading of the manuscript and N. Gad'on and C. Ebenau-Jehle, Freiburg, for growing cells and maintaining the laboratory. The work of M.K. was supported by the Deutscher Akademischer Austausch Dienst. This work was supported by the Deutsche Forschungsgemeinschaft and Evonik-Degussa GmbH.	Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Brasen C, 2001, ARCH MICROBIOL, V175, P360, DOI 10.1007/s002030100273; Buckel W., 1999, Chemistry and biochemistry of B12., P757; BUCKEL W, 1987, EUR J BIOCHEM, V164, P565, DOI 10.1111/j.1432-1033.1987.tb11164.x; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Connaris H, 1999, BIOTECHNOL BIOENG, V64, P38, DOI 10.1002/(SICI)1097-0290(19990705)64:1<38::AID-BIT4>3.0.CO;2-7; Danson MJ, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P260; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2010, J BACTERIOL, V192, P1249, DOI 10.1128/JB.01267-09; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Hezayen FF, 2000, APPL MICROBIOL BIOT, V54, P319, DOI 10.1007/s002530000394; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Johnsen U, 2009, J BIOL CHEM, V284, P27290, DOI 10.1074/jbc.M109.003814; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; LILLO JG, 1990, APPL ENVIRON MICROB, V56, P2517, DOI 10.1128/AEM.56.8.2517-2521.1990; Malki L, 2009, J BACTERIOL, V191, P5196, DOI 10.1128/JB.00297-09; OREN A, 1995, FEMS MICROBIOL LETT, V130, P91; Oren A, 2002, HALOPHILIC MICROORGA; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Serrano JA, 1998, FEBS LETT, V434, P13, DOI 10.1016/S0014-5793(98)00911-9; Serrano JA, 2001, BBA-GENE STRUCT EXPR, V1520, P154, DOI 10.1016/S0167-4781(01)00263-9; Shimizu S., 1984, MICROBIAL GROWTH C1, P113; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Zarzycki J, 2009, P NATL ACAD SCI USA, V106, P21317, DOI 10.1073/pnas.0908356106	28	70	81	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					334	337		10.1126/science.1196544	http://dx.doi.org/10.1126/science.1196544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252347				2022-12-01	WOS:000286636300038
J	Brock, DA; Douglas, TE; Queller, DC; Strassmann, JE				Brock, Debra A.; Douglas, Tracy E.; Queller, David C.; Strassmann, Joan E.			Primitive agriculture in a social amoeba	NATURE			English	Article							EVOLUTION; BACTERIA; COOPERATION; MUTUALISM	Agriculture has been a large part of the ecological success of humans(1). A handful of animals, notably the fungus-growing ants, termites and ambrosia beetles(2-4), have advanced agriculture that involves dispersal and seeding of food propagules, cultivation of the crop and sustainable harvesting(5). More primitive examples, which could be called husbandry because they involve fewer adaptations, include marine snails farming intertidal fungi(6) and damsel-fish farming algae(7). Recent work has shown that microorganisms are surprisingly like animals in having sophisticated behaviours such as cooperation, communication(8,9) and recognition(10,11), as well as many kinds of symbiosis(12-15). Here we show that the social amoeba Dictyostelium discoideum has a primitive farming symbiosis that includes dispersal and prudent harvesting of the crop. About one-third of wild-collected clones engage in husbandry of bacteria. Instead of consuming all bacteria in their patch, they stop feeding early and incorporate bacteria into their fruiting bodies. They then carry bacteria during spore dispersal and can seed a new food crop, which is a major advantage if edible bacteria are lacking at the new site. However, if they arrive at sites already containing appropriate bacteria, the costs of early feeding cessation are not compensated for, which may account for the dichotomous nature of this farming symbiosis. The striking convergent evolution between bacterial husbandry in social amoebas and fungus farming in social insects makes sense because multigenerational benefits of farming go to already established kin groups.	[Brock, Debra A.; Douglas, Tracy E.; Queller, David C.; Strassmann, Joan E.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA	Rice University	Brock, DA (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, 6100 Main St, Houston, TX 77005 USA.	dbrock@rice.edu		Strassmann, Joan/0000-0003-0638-8440	US National Science Foundation; Division Of Environmental Biology [1204352, 0816690] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Rudgers, G. Saxer Quance, L. Campbell, E. Ostrowski, O. Gilbert, A. Savage, J. Ahern, K. Crawford, S. Chamberlain, S. Read, D. Nguyen, K. Foster, H. Kaplan, D. Hatton and K. Boomsma for discussions and advice. This material is based on work supported by the US National Science Foundation.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; CLARK F. E., 1967, Soil Biology., P15; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Hata H, 2006, BIOL LETT-UK, V2, P593, DOI 10.1098/rsbl.2006.0528; HEIJNEN CE, 1993, APPL ENVIRON MICROB, V59, P743, DOI 10.1128/AEM.59.3.743-747.1993; HORN EG, 1971, ECOLOGY, V52, P475, DOI 10.2307/1937630; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Kessin RH., 2001, DICTYOSTELIUM EVOLUT; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Nadson G. A., 1899, SCRIPTA BOT HORTI U, V15, P188; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Raper K. B., 1984, DICTYOSTELIDS, P87; Raper KB, 1937, J AGRIC RES, V55, P0289; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Skupienski F. X., 1920, THESIS U PARIS; Smith BD, 1995, EMERGENCE AGR; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	32	149	152	10	182	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					393	+		10.1038/nature09668	http://dx.doi.org/10.1038/nature09668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248849				2022-12-01	WOS:000286385600051
J	Swing, K				Swing, Kelly			Day of reckoning for Ecuador's biodiversity	NATURE			English	Editorial Material									Univ San Francisco Quito, Tiputini Biodivers Stn, Quito, Ecuador		Swing, K (corresponding author), Univ San Francisco Quito, Tiputini Biodivers Stn, Quito, Ecuador.	kswing@usfq.edu.ec							0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					267	267		10.1038/469267a	http://dx.doi.org/10.1038/469267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708SW	21248795	Bronze			2022-12-01	WOS:000286385600004
J	Marcovitch, H				Marcovitch, Harvey			MMR and scientific fraud Is research safe in their hands?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MISCONDUCT					h.marcovitch@btinternet.com						Angell M., NEW YORK REV BOOKS; Deer B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7001; Dillner L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d185; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Marcovitch H, 2006, MED J AUSTRALIA, V185, P616, DOI 10.5694/j.1326-5377.2006.tb00730.x; MARCUS A, FRAUD CASE ROCKS ANE; Nylenna M, 2006, LANCET, V367, P1882, DOI 10.1016/S0140-6736(06)68821-1; PINCOCK S, SCIENTIST; Shafer SL, 2010, ANESTH ANALG, V111, P1567, DOI 10.1213/ANE.0b013e3182009a22; Steen RG, 2011, J MED ETHICS, V37, P249, DOI 10.1136/jme.2010.040923; *UK RES INT OFF, PROC INV MISC RES	11	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								d284	10.1136/bmj.d284	http://dx.doi.org/10.1136/bmj.d284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248020				2022-12-01	WOS:000286602400013
J	Olzscha, H; Schermann, SM; Woerner, AC; Pinkert, S; Hecht, MH; Tartaglia, GG; Vendruscolo, M; Hayer-Hartl, M; Hartl, FU; Vabulas, RM				Olzscha, Heidi; Schermann, Sonya M.; Woerner, Andreas C.; Pinkert, Stefan; Hecht, Michael H.; Tartaglia, Gian G.; Vendruscolo, Michele; Hayer-Hartl, Manajit; Hartl, F. Ulrich; Vabulas, R. Martin			Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions	CELL			English	Article							MOLECULAR CHAPERONES; IN-VIVO; PREDICTION; DISEASE; OLIGOMERS; TOXICITY; REGIONS; STRESS	Protein aggregation is linked with neurodegeneration and numerous other diseases by mechanisms that are not well understood. Here, we have analyzed the gain-of-function toxicity of artificial beta sheet proteins that were designed to form amyloid-like fibrils. Using quantitative proteomics, we found that the toxicity of these proteins in human cells correlates with the capacity of their aggregates to promote aberrant protein interactions and to deregulate the cytosolic stress response. The endogenous proteins that are sequestered by the aggregates share distinct physicochemical properties: They are relatively large in size and significantly enriched in predicted unstructured regions, features that are strongly linked with multifunctionality. Many of the interacting proteins occupy essential hub positions in cellular protein networks, with key roles in chromatin organization, transcription, translation, maintenance of cell architecture and protein quality control. We suggest that amyloidogenic aggregation targets a metastable subproteome, thereby causing multifactorial toxicity and, eventually, the collapse of essential cellular functions.	[Olzscha, Heidi; Schermann, Sonya M.; Woerner, Andreas C.; Pinkert, Stefan; Hayer-Hartl, Manajit; Hartl, F. Ulrich; Vabulas, R. Martin] Max Planck Inst Biochem, Dept Cellular Biochem, D-82159 Martinsried, Germany; [Hecht, Michael H.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Tartaglia, Gian G.; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Max Planck Society; Princeton University; University of Cambridge	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82159 Martinsried, Germany.	mhartl@biochem.mpg.de; uhartl@biochem.mpg.de; vabulas@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Olzscha, Heidi/AAU-1296-2020; Hayer-Hartl, Manajit/V-8078-2017; Vabulas, R. Martin/D-3506-2011; Pinkert, Stefan/A-5534-2009; Vendruscolo, Michele/F-5901-2012; Tartaglia, Gian Gaetano/K-1229-2014	Olzscha, Heidi/0000-0002-1929-1384; Hayer-Hartl, Manajit/0000-0001-8213-6742; Vendruscolo, Michele/0000-0002-3616-1610; Hecht, Michael/0000-0002-5538-9813; Tartaglia, Gian Gaetano/0000-0001-7524-6310	EU; Deutsche Forschungsgemeinschaft [SFB 596]; Ernst-Jung Foundation; Korber Foundation; Fonds der Chemischen Industrie; Elite Graduate Network of Bavaria	EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-Jung Foundation; Korber Foundation; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Elite Graduate Network of Bavaria	We thank C.G. Glabe for providing the A11 antibody and H. Wagner for plasmids HSP70-Luc and NF-kappa B-Luc. We acknowledge the help of H. Engelhardt with FTIR measurements, technical assistance by O. Mihalache and V. Marcus with electron microscopy, and R. Zenke (MPIB core facility) for confocal microscopy. Financial support from EU Framework 7 Integrated Project PROSPECTS, the Deutsche Forschungsgemeinschaft (SFB 596), the Ernst-Jung Foundation, and the Korber Foundation is acknowledged. H.O. and A.W. have a fellowship from the Fonds der Chemischen Industrie, and H.O. is supported by the Elite Graduate Network of Bavaria.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/nchembio.283, 10.1038/NCHEMBIO.283]; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Erkina TY, 2010, NUCLEIC ACIDS RES, V38, P1441, DOI 10.1093/nar/gkp1130; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim W, 2006, ACS CHEM BIOL, V1, P461, DOI 10.1021/cb600135w; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lee EK, 2006, BIOCHEM BIOPH RES CO, V344, P471, DOI 10.1016/j.bbrc.2006.03.166; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nesterov EE, 2005, ANGEW CHEM INT EDIT, V44, P5452, DOI 10.1002/anie.200500845; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pentony MM, 2010, PROTEINS, V78, P212, DOI 10.1002/prot.22504; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Shearman MS, 1999, METHOD ENZYMOL, V309, P716; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; Wei YN, 2003, PROTEIN SCI, V12, P92, DOI 10.1110/ps.0228003; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; WILLIAMS GT, 1989, MOL CELL BIOL, V9, P2574, DOI 10.1128/MCB.9.6.2574; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	43	488	494	3	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					67	78		10.1016/j.cell.2010.11.050	http://dx.doi.org/10.1016/j.cell.2010.11.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215370	Bronze, Green Submitted			2022-12-01	WOS:000285993600008
J	Stephens, PJ; Greenman, CD; Fu, BY; Yang, FT; Bignell, GR; Mudie, LJ; Pleasance, ED; Lau, KW; Beare, D; Stebbings, LA; McLaren, S; Lin, ML; McBride, DJ; Varela, I; Nik-Zainal, S; Leroy, C; Jia, MM; Menzies, A; Butler, AP; Teague, JW; Quail, MA; Burton, J; Swerdlow, H; Carter, NP; Morsberger, LA; Iacobuzio-Donahue, C; Follows, GA; Green, AR; Flanagan, AM; Stratton, MR; Futreal, PA; Campbell, PJ				Stephens, Philip J.; Greenman, Chris D.; Fu, Beiyuan; Yang, Fengtang; Bignell, Graham R.; Mudie, Laura J.; Pleasance, Erin D.; Lau, King Wai; Beare, David; Stebbings, Lucy A.; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Quail, Michael A.; Burton, John; Swerdlow, Harold; Carter, Nigel P.; Morsberger, Laura A.; Iacobuzio-Donahue, Christine; Follows, George A.; Green, Anthony R.; Flanagan, Adrienne M.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.			Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development	CELL			English	Article							CELL LUNG-CANCER; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; MUTATIONS; EVOLUTION; INSTABILITY; SIGNATURES; RESOLUTION; SEQUENCE	Cancer is driven by somatically acquired point mutations and chromosomal rearrangements, conventionally thought to accumulate gradually over time. Using next-generation sequencing, we characterize a phenomenon, which we term chromothripsis, whereby tens to hundreds of genomic rearrangements occur in a one-off cellular crisis. Rearrangements involving one or a few chromosomes crisscross back and forth across involved regions, generating frequent oscillations between two copy number states. These genomic hallmarks are highly improbable if rearrangements accumulate over time and instead imply that nearly all occur during a single cellular catastrophe. The stamp of chromothripsis can be seen in at least 2%-3% of all cancers, across many subtypes, and is present in similar to 25% of bone cancers. We find that one, or indeed more than one, cancer-causing lesion can emerge out of the genomic crisis. This phenomenon has important implications for the origins of genomic remodeling and temporal emergence of cancer.	[Stephens, Philip J.; Greenman, Chris D.; Fu, Beiyuan; Yang, Fengtang; Bignell, Graham R.; Mudie, Laura J.; Pleasance, Erin D.; Lau, King Wai; Beare, David; Stebbings, Lucy A.; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Quail, Michael A.; Burton, John; Swerdlow, Harold; Carter, Nigel P.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; [Morsberger, Laura A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; [Morsberger, Laura A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA; [Follows, George A.; Green, Anthony R.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Green, Anthony R.; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Flanagan, Adrienne M.] UCL, Inst Canc, London WC1E 6BT, England; [Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	University of Cambridge; Wellcome Trust Sanger Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; Institute of Cancer Research - UK	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England.	pc8@sanger.ac.uk	Pillay, Nischalan/F-9536-2012; Varela, Ignacio/G-1699-2016; Nik-Zainal, Serena/ABD-4437-2020; Iacobuzio-Donahue, Christine/ABF-1295-2020; Quail, michael/ABE-6131-2020; Varela, Ignacio/AAA-7680-2021; Califano, Andrea/F-7239-2012; Yang, Fan/GYU-4249-2022	Varela, Ignacio/0000-0002-0969-506X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Varela, Ignacio/0000-0002-0969-506X; Nik-Zainal, Serena/0000-0001-5054-1727; Swerdlow, Harold/0000-0002-9510-160X; Green, Anthony/0000-0002-9795-0218; Flanagan, Adrienne/0000-0002-2832-1303; Yang, Fengtang/0000-0002-3573-2354	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Chordoma Foundation; International Human Frontier Science Program Organization	Wellcome Trust(Wellcome TrustEuropean Commission); Chordoma Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z) and the Chordoma Foundation. P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. We also acknowledge support for sample banking and processing from the Cambridge and UCL/UCLH NIHR Biomedical Research Centres and Skeletal Action Cancer Trust (SCAT), especially Dr. Anthony Bench, Dr. Wendy Erber, and Miss Dina Halai. We would like to thank George Vassiliou for the neologism "chromothripsis.''	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chen JM, 2009, HUM MUTAT, V30, P1435, DOI 10.1002/humu.21088; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Geigl JB, 2006, NAT PROTOC, V1, P1172, DOI 10.1038/nprot.2006.160; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McClintock B, 1941, GENETICS, V26, P234; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104	36	1509	1546	3	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					27	40		10.1016/j.cell.2010.11.055	http://dx.doi.org/10.1016/j.cell.2010.11.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215367	Green Published, hybrid			2022-12-01	WOS:000285993600005
J	Kahn, BB; McGraw, TE				Kahn, Barbara B.; McGraw, Timothy E.			Rosiglitazone, PPAR(gamma), and Type 2 Diabetes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GAMMA; DRUGS		[Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA USA; [McGraw, Timothy E.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052852, R37DK043051] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052852, R37 DK043051, R01 DK043051] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; DeSouza C, 2009, NAT REV DRUG DISCOV, V8, P361, DOI 10.1038/nrd2872; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; McGuire DK, 2008, CIRCULATION, V117, P440, DOI 10.1161/CIRCULATIONAHA.107.704080; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512	6	49	58	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2667	2669		10.1056/NEJMcibr1012075	http://dx.doi.org/10.1056/NEJMcibr1012075			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190462	Green Accepted			2022-12-01	WOS:000285763700015
J	Ahmed, F				Ahmed, Farooq			Edible advice	NATURE			English	Editorial Material																		Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Matsuo T, 2009, OBESITY, V17, P1924, DOI 10.1038/oby.2009.199; Tripathy S, 2010, J LIPID RES, V51, P2642, DOI 10.1194/jlr.M006080; Wise Carolyn, 2009, J Diabetes Sci Technol, V3, P710	5	5	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					S10	S12		10.1038/468S10a	http://dx.doi.org/10.1038/468S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179076	Bronze			2022-12-01	WOS:000285553800004
J	Eisenstein, M				Eisenstein, Michael			More than meets the mouth	NATURE			English	Editorial Material																			0	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S18	S19		10.1038/468S18a	http://dx.doi.org/10.1038/468S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179079	Bronze			2022-12-01	WOS:000285553800007
J	James, MT; Hemmelgarn, BR; Wiebe, N; Pannu, N; Manns, BJ; Klarenbach, SW; Tonelli, M				James, Matthew T.; Hemmelgarn, Brenda R.; Wiebe, Natasha; Pannu, Neesh; Manns, Braden J.; Klarenbach, Scott W.; Tonelli, Marcello		Alberta Kidney Dis Network	Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study	LANCET			English	Article							ACUTE-RENAL-FAILURE; PERCUTANEOUS CORONARY INTERVENTION; SERUM CREATININE; DISEASE; RISK; MORTALITY; OUTCOMES; NEPHROPATHY; PREDICTION; INCREASES	Background Low values of estimated glomerular filtration rate (eGFR) predispose to acute kidney injury, and proteinuria is a marker of kidney disease. We aimed to investigate how eGFR and proteinuria jointly modified the risks of acute kidney injury and subsequent adverse clinical outcomes. Methods We did a cohort study of 920 985 adults residing in Alberta, Canada, between 2002 and 2007. Participants not needing chronic dialysis at baseline and with at least one outpatient measurement of both serum creatinine concentration and proteinuria (urine dipstick or albumin-creatinine ratio) were included. We assessed hospital admission with acute kidney injury with validated administrative codes; other outcomes were all-cause mortality and a composite renal outcome of end-stage renal disease or doubling of serum creatinine concentration. Findings During median follow-up of 35 months (range 0-59 months), 6520 (0.7%) participants were admitted with acute kidney injury. In those with eGFR 60 mL/min per 1.73 m(2) or greater, the adjusted risk of admission with this disorder was about 4 times higher in those with heavy proteinuria measured by dipstick (rate ratio 4.4 vs no proteinuria, 95% CI 3.7-5.2). The adjusted rates of admission with acute kidney injury and kidney injury needing dialysis remained high in participants with heavy dipstick proteinuria for all values of eGFR. The adjusted rates of death and the composite renal outcome were also high in participants admitted with acute kidney injury, although the rise associated with this injury was attenuated in those with low baseline eGFR and heavy proteinuria. Interpretation These findings suggest that information on proteinuria and eGFR should be used together when identifying people at risk of acute kidney injury, and that an episode of acute kidney injury provides further long-term prognostic information in addition to eGFR and proteinuria.	[James, Matthew T.; Hemmelgarn, Brenda R.; Manns, Braden J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [James, Matthew T.; Hemmelgarn, Brenda R.; Manns, Braden J.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Wiebe, Natasha; Pannu, Neesh; Klarenbach, Scott W.; Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Klarenbach, Scott W.; Tonelli, Marcello] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Alberta; University of Alberta	Tonelli, M (corresponding author), 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2G3, Canada.	mtonelli-admin@med.ualberta.ca	Klarenbach, Scott/E-7731-2013; Wiebe, Natasha/V-7803-2019; Tonelli, Marcello/B-3028-2009; Manns, Braden J/I-8942-2012; Hug, Balthasar L./G-1568-2010; Hemmelgarn, Brenda R./I-6894-2012	Klarenbach, Scott/0000-0002-8611-1056; Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187; 	Alberta Heritage Foundation for Medical Research (AHFMR); Kidney Foundation of Canada/the Canadian Institutes for Health Research (CIHR); CIHR	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Kidney Foundation of Canada/the Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This study was funded by an interdisciplinary team grant from Alberta Heritage Foundation for Medical Research (AHFMR). MTJ is supported by a KRESCENT award from the Kidney Foundation of Canada/the Canadian Institutes for Health Research (CIHR) and an AHFMR fellowship award. MT is supported by a Health Scholar and SWK and BRH by Population Health Investigator Awards from the AHFMR. MT, BJM, and BRH are supported by New Investigator Awards from the CIHR.	Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2007, AM J KIDNEY DIS, V50, P712, DOI 10.1053/j.ajkd.2007.07.018; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Ishani A, 2009, J AM SOC NEPHROL, V20, P8; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V50, P1, DOI 10.1053/j.ajkd.2007.05.008; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Sin DD, 2003, CHEST, V124, P51, DOI 10.1378/chest.124.1.51; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	219	234	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 18	2010	376	9758					2096	2103		10.1016/S0140-6736(10)61271-8	http://dx.doi.org/10.1016/S0140-6736(10)61271-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702LA	21094997				2022-12-01	WOS:000285895000027
J	Mochida, S; Maslen, SL; Skehel, M; Hunt, T				Mochida, Satoru; Maslen, Sarah L.; Skehel, Mark; Hunt, Tim			Greatwall Phosphorylates an Inhibitor of Protein Phosphatase 2A That Is Essential for Mitosis	SCIENCE			English	Article							CELL-CYCLE; ALPHA-ENDOSULFINE; XENOPUS; PHOSPHOPROTEINS; EXPRESSION; EXTRACTS; ENTRY; LOOP; EXIT	Entry into mitosis in eukaryotes requires the activity of cyclin-dependent kinase 1 (Cdk1). Cdk1 is opposed by protein phosphatases in two ways: They inhibit activation of Cdk1 by dephosphorylating the protein kinases Wee1 and Myt1 and the protein phosphatase Cdc25 (key regulators of Cdk1), and they also antagonize Cdk1's own phosphorylation of downstream targets. A particular form of protein phosphatase 2A (PP2A) containing a B55 delta subunit (PP2A-B55 delta) is the major protein phosphatase that acts on model CDK substrates in Xenopus egg extracts and has antimitotic activity. The activity of PP2A-B55 delta is high in interphase and low in mitosis, exactly opposite that of Cdk1. We report that inhibition of PP2A-B55 delta results from a small protein, known as alpha-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55 delta. This pathway represents a previously unknown element in the control of mitosis.	[Mochida, Satoru; Maslen, Sarah L.; Skehel, Mark; Hunt, Tim] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Mochida, Satoru] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8600811, Japan	Cancer Research UK; Kumamoto University	Hunt, T (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	tim.hunt@cancer.org.uk	Hunt, Tim/O-8544-2019	Hunt, Tim/0000-0001-5174-6038	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Mahbubani, J. Kirk, and L. Egbuniwe for care of frogs and other members of the laboratory for advice and reagents, especially J. Gannon for the antibody to doubly phosphorylated Thr<SUP>14</SUP>-Tyr<SUP>15</SUP> of Cdk1 (CP 3.2). S. M. was supported by a fellowship from the Japan Society for the Promotion of Science.	Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Cohen P, 2006, BIOCHEM J, V393, P1, DOI 10.1042/BJ20051545; Drummond-Barbosa D, 2004, DEV BIOL, V266, P310, DOI 10.1016/j.ydbio.2003.10.028; Dulubova I, 2001, J NEUROCHEM, V77, P229, DOI 10.1046/j.1471-4159.2001.00191.x; GIRAULT JA, 1990, J NEUROSCI, V10, P1124; Goldberg M., COMMUNICATION; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gros L, 2002, DIABETOLOGIA, V45, P703, DOI 10.1007/s00125-002-0794-9; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Morgan D.O., 2007, CELL CYCLE PRINCIPLE, P297; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Ohsumi Keita, 2006, V322, P445; Pal G, 2008, J CELL BIOL, V180, P931, DOI 10.1083/jcb.200711014; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; VIRSOLVYVERGINE A, 1992, P NATL ACAD SCI USA, V89, P6629, DOI 10.1073/pnas.89.14.6629; Von Stetina JR, 2008, DEVELOPMENT, V135, P3697, DOI 10.1242/dev.025114; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022	28	305	316	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	2010	330	6011					1670	1673		10.1126/science.1195689	http://dx.doi.org/10.1126/science.1195689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695RO	21164013				2022-12-01	WOS:000285390500065
J	deFilippi, CR; de Lemos, JA; Christenson, RH; Gottdiener, JS; Kop, WJ; Zhan, M; Seliger, SL				deFilippi, Christopher R.; de Lemos, James A.; Christenson, Robert H.; Gottdiener, John S.; Kop, Willem J.; Zhan, Min; Seliger, Stephen L.			Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREDICTION; DISEASE; RISK; VALIDATION; BIOMARKERS; COMMUNITY; EVENTS; UPDATE; MARKER; HEALTH	Context Older adults comprise the majority of new-onset heart failure (HF) diagnoses, but traditional risk-factor prediction models have limited accuracy in this population to identify those at highest risk for hospitalization or death. Objectives To determine if cardiac troponin T (cTnT) measured by a highly sensitive assay would be detectable in the majority of community-dwelling older adults, and if serial measures were associated with risk of HF hospitalization and cardiovascular death. Design, Setting, and Participants A longitudinal nationwide cohort study (Cardiovascular Health Study) of 4221 community-dwelling adults aged 65 years or older without prior HF who had cTnT measured using a highly sensitive assay at baseline (1989-1990) and repeated after 2 to 3 years (n=2918). Main Outcome Measures New-onset HF and cardiovascular death were examined through June 2008 with respect to cTnT concentrations, accounting for clinical risk predictors. Results Cardiac troponin T was detectable (>= 3.00 pg/mL) in 2794 participants (66.2%). During a median follow-up of 11.8 years, 1279 participants experienced new-onset HF and 1103 cardiovascular deaths occurred, with a greater risk of both end points associated with higher cTnT concentrations. Among those participants with the highest cTnT concentrations (>12.94 pg/mL), there was an incidence rate per 100 person-years of 6.4 (95% confidence interval [CI], 5.8-7.2; adjusted hazard ratio [aHR], 2.48; 95% CI, 2.04-3.00) for HF and an incidence rate of 4.8 (95% CI, 4.3-5.4; aHR, 2.91; 95% CI, 2.37-3.58) for cardiovascular death compared with participants with undetectable cTnT levels (incidence rate, 1.6; 95% CI, 1.4-1.8 and 1.1; 95% CI, 0.9-1.2 for HF and cardiovascular death, respectively). Among individuals with initially detectable cTnT, a subsequent increase of more than 50% (n=393, 22%) was associated with a greater risk for HF (aHR, 1.61; 95% CI, 1.32-1.97) and cardiovascular death (aHR, 1.65; 95% CI, 1.35-2.03) and a decrease of more than 50% (n=247, 14%) was associated with a lower risk for HF (aHR, 0.73; 95% CI, 0.54-0.97) and cardiovascular death (aHR, 0.71; 95% CI, 0.52-0.97) compared with participants with 50% or less change. Addition of baseline cTnT measurements to clinical risk factors was associated with only modest improvement in discrimination, with change in C statistic of 0.015 for HF and 0.013 for cardiovascular death. Conclusion In this cohort of older adults without known HF, baseline cTnT levels and changes in cTnT levels measured with a highly sensitive assay were significantly associated with incident HF and cardiovascular death. JAMA. 2010;304(22):2494-2502 www.jama.com	[deFilippi, Christopher R.; Gottdiener, John S.; Kop, Willem J.; Seliger, Stephen L.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21212 USA; [Christenson, Robert H.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21212 USA; [Zhan, Min] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21212 USA; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Southwestern Medical Center Dallas	deFilippi, CR (corresponding author), Univ Maryland, Sch Med, Dept Med, G3K63,22 S Greene St, Baltimore, MD 21212 USA.	cdefilip@medicine.umaryland.edu	de Lemos, James/ABD-6669-2021	Seliger, Stephen/0000-0002-1693-0734	Roche Diagnostics; Siemens Healthcare Diagnostics; Critical Diagnostics; BG Medicine; Biosite; Biosite/Inverness; Siemens; Siemens Medical Diagnostics and Response Biomedical; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085085, N01HC085084, N01HC085086, N01HC085083, N01HC085082, N01HC085081, N01HC015103, N01HC035129, N01HC085079, N01HC055222, N01HC075150, N01HC045133, N01HC085080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL075366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, R01AG027058, R01AG015928, R01AG020098] Funding Source: NIH RePORTER	Roche Diagnostics; Siemens Healthcare Diagnostics; Critical Diagnostics; BG Medicine; Biosite; Biosite/Inverness; Siemens(Siemens AG); Siemens Medical Diagnostics and Response Biomedical; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr deFilippi reported receiving honorarium, consulting, and grant support from Roche Diagnostics and Siemens Healthcare Diagnostics, and consulting and grant support from Critical Diagnostics and BG Medicine. Dr de Lemos reported receiving research support from Biosite and Roche Diagnostics, and consulting fees, lecture honoraria, or both from Roche Diagnostics, Biosite/Inverness, and Siemens. Dr Christenson reported receiving research funding from Siemens Medical Diagnostics and Response Biomedical. Dr Seliger reported receiving grant and consulting support from Roche Diagnostics. Drs Gottdiener, Kop, and Zahn reported no financial disclosures.; This study was supported by grants N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and U01 HL080295 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided through R01 AG-15928, R01 AG-20098, and AG-027058 from the National Institute on Aging; R01 HL-075366 from the NHLBI; and the University of Pittsburgh Claude D. Pepper Older Americans Independence Center P30-AG-024827. Additional funding was provided by Roche Diagnostics. Roche Diagnostics provided funding and laboratory reagents for the highly sensitive cardiac troponin T assay.	Clayton D., 1993, STAT MODELS EPIDEMIO; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; deFilippi CR, 2010, J AM COLL CARDIOL, V55, P441, DOI 10.1016/j.jacc.2009.07.069; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kalogeropoulos A, 2010, CIRC-HEART FAIL, V3, P495, DOI 10.1161/CIRCHEARTFAILURE.109.904300; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Rautaharju PM, 1996, HYPERTENSION, V28, P8, DOI 10.1161/01.HYP.28.1.8; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sabatine MS, 2009, EUR HEART J, V30, P162, DOI 10.1093/eurheartj/ehn504; Schellenbaum GD, 2004, AM J EPIDEMIOL, V160, P628, DOI 10.1093/aje/kwh268; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Sundstrom J, 2009, EUR HEART J, V30, P773, DOI 10.1093/eurheartj/ehp047; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Vasile VC, 2010, CLIN CHEM, V56, P1086, DOI 10.1373/clinchem.2009.140616; Wu AHB, 2009, CLIN CHEM, V55, P52, DOI 10.1373/clinchem.2008.107391; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	34	538	555	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 8	2010	304	22					2494	2502		10.1001/jama.2010.1708	http://dx.doi.org/10.1001/jama.2010.1708			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	691AS	21078811	Green Accepted, Bronze			2022-12-01	WOS:000285053300023
J	Nakada, D; Saunders, TL; Morrison, SJ				Nakada, Daisuke; Saunders, Thomas L.; Morrison, Sean J.			Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells	NATURE			English	Article							PEUTZ-JEGHERS-SYNDROME; DROSOPHILA LKB1; GENE; KINASE; DEFICIENCY; PATHWAY; MAINTENANCE; MICE; EMBRYOGENESIS; PROGENITORS	Little is known about metabolic regulation in stem cells and how this modulates tissue regeneration or tumour suppression. We studied the Lkb1 tumour suppressor and its substrate AMP-activated protein kinase (AMPK), kinases that coordinate metabolism with cell growth. Deletion of the Lkb1 (also called Stk11) gene in mice caused increased haematopoietic stem cell (HSC) division, rapid HSC depletion and pancytopenia. HSCs depended more acutely on Lkb1 for cell-cycle regulation and survival than many other haematopoietic cells. HSC depletion did not depend on mTOR activation or oxidative stress. Lkb1-deficient HSCs, but not myeloid progenitors, had reduced mitochondrial membrane potential and ATP levels. HSCs deficient for two catalytic alpha-subunits of AMPK (AMPK-deficient HSCs) showed similar changes in mitochondrial function but remained able to reconstitute irradiated mice. Lkb1-deficient HSCs, but not AMPK-deficient HSCs, exhibited defects in centrosomes and mitotic spindles in culture, and became aneuploid. Lkb1 is therefore required for HSC maintenance through AMPK-dependent and AMPK-independent mechanisms, revealing differences in metabolic and cell-cycle regulation between HSCs and some other haematopoietic progenitors.	[Nakada, Daisuke; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Nakada, Daisuke; Saunders, Thomas L.; Morrison, Sean J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Nakada, Daisuke/0000-0001-6010-7094; Saunders, Thom/0000-0003-2015-101X; Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) [CA46592]; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH)(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Howard Hughes Medical Institute. Flow cytometry was partially supported by the University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) CA46592. D.N. was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science. We thank A. Prendergast and C. Sifuentes for technical assistance; E. Hughes and the UM Transgenic Animal Model Core for help generating Lkb1<SUP>fl</SUP> mice; D. Adams and M. White for flow cytometry; E. Smith for antibody production; C. Mountford, S. Grove and R. Coolon for mouse colony management; and L. Cantley and C. Thompson for discussions.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bonaccorsi S, 2007, DEVELOPMENT, V134, P2183, DOI 10.1242/dev.02848; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cao YH, 2010, CELL RES, V20, P99, DOI 10.1038/cr.2009.141; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Pearson HB, 2008, CANCER RES, V68, P2223, DOI 10.1158/0008-5472.CAN-07-5169; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shorning BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004264; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Watts JL, 2000, DEVELOPMENT, V127, P1467; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074	45	373	386	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					653	U69		10.1038/nature09571	http://dx.doi.org/10.1038/nature09571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	21124450	Green Accepted			2022-12-01	WOS:000284836700032
J	Navarro, P; Oldfield, A; Legoupi, J; Festuccia, N; Dubois, A; Attia, M; Schoorlemmer, J; Rougeulle, C; Chambers, I; Avner, P				Navarro, Pablo; Oldfield, Andrew; Legoupi, Julie; Festuccia, Nicola; Dubois, Agnes; Attia, Mikael; Schoorlemmer, Jon; Rougeulle, Claire; Chambers, Ian; Avner, Philip			Molecular coupling of Tsix regulation and pluripotency	NATURE			English	Article							X-CHROMOSOME; TRANSCRIPTIONAL NETWORK; XIST TRANSCRIPTION; INACTIVATION; EXPRESSION; CTCF	The reprogramming of X-chromosome inactivation during the acquisition of pluripotency in vivo and in vitro(1) is accompanied by the repression of Xist(2), the trigger of X-inactivation(3), and the upregulation of its antisense counterpart Tsix(4). We have shown that key factors supporting pluripotency-Nanog, Oct4 and Sox2-bind within Xist intron 1 in undifferentiated embryonic stem cells (ESC) to repress Xist transcription(5). However, the relationship between transcription factors of the pluripotency network and Tsix regulation has remained unclear(5,6). Here we show that Tsix upregulation in embryonic stem cells depends on the recruitment of the pluripotent marker Rex1, and of the reprogramming-associated factors Klf4 and c-Myc, by the DXPas34 minisatellite associated with the Tsix promoter. Upon deletion of DXPas34, binding of the three factors is abrogated and the transcriptional machinery is no longer efficiently recruited to the Tsix promoter. Additional analyses including knockdown experiments further demonstrate that Rex1 is critically important for efficient transcription elongation of Tsix. Hence, distinct embryonic-stem-cell-specific complexes couple X-inactivation reprogramming and pluripotency, with Nanog, Oct4 and Sox2 repressing Xist to facilitate the reactivation of the inactive X, and Klf4, c-Myc and Rex1 activating Tsix to remodel Xist chromatin(7-10) and ensure random X-inactivation upon differentiation(1). The holistic pattern of Xist/Tsix regulation by pluripotent factors that we have identified suggests a general direct governance of complex epigenetic processes by the machinery dedicated to pluripotency.	[Navarro, Pablo; Oldfield, Andrew; Legoupi, Julie; Dubois, Agnes; Attia, Mikael; Rougeulle, Claire; Avner, Philip] Inst Pasteur, URA 2578, Unite Genet Mol Murine, F-75724 Paris 15, France; [Navarro, Pablo; Festuccia, Nicola; Chambers, Ian] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, Ctr Dev Stem Cell Biol,MRC, Edinburgh EH9 3JQ, Midlothian, Scotland; [Oldfield, Andrew; Rougeulle, Claire] Univ Paris Diderot, CNRS, UMR Epigenet & Destin Cellulaire 7216, F-75205 Paris 13, France; [Schoorlemmer, Jon] ARAID Fdn, Zaragoza 50013, Spain; [Schoorlemmer, Jon] Fac Vet, Inst Aragones Ciencias Salud, Dept Anat & Embriol, Zaragoza 50013, Spain	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Avner, P (corresponding author), Inst Pasteur, URA 2578, Unite Genet Mol Murine, F-75724 Paris 15, France.	pablo.navarro@ed.ac.uk; pavner@pasteur.fr	Oldfield, Andrew/ABF-1343-2021; Oldfield, Andrew J./AAP-4354-2021; Chambers, Ian/H-5416-2011; Schoorlemmer, Jon/R-6814-2019	Oldfield, Andrew/0000-0002-5401-9909; Chambers, Ian/0000-0003-2605-1597; Schoorlemmer, Jon/0000-0001-6933-0567; Rougeulle, Claire/0000-0003-3861-4940	Institut Pasteur; Royal Society; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [05-JCJC-0166-01, 07-BLAN-0047-01]; EU Epigenome Network of Excellence; INSERM; European Research Council; Wellcome Trust; EU; Medical Research Council; Medical Research Council [G0700711B] Funding Source: researchfish	Institut Pasteur(European Commission); Royal Society(Royal Society of London); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); EU Epigenome Network of Excellence; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Clerc for discussions. P.N. was initially supported by recurrent funding from the Institut Pasteur and then by the Royal Society (a Newton International Fellowship). P.A. was supported by recurrent funding from the Centre National de la Recherche Scientifique and the Institut Pasteur, contracts 05-JCJC-0166-01 and 07-BLAN-0047-01 from the Agence Nationale de la Recherche and funding from the EU Epigenome Network of Excellence. C.R. was supported by the INSERM 'Avenir' programme and by the European Research Council 'starting grant' programme. Research in I.C.'s laboratory was supported by the Wellcome Trust, by the EU Framework 7 project "EuroSyStem'' and by a Medical Research Council studentship (to N.F.).	BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Do Kim J, 2007, NUCLEIC ACIDS RES, V35, P3442, DOI 10.1093/nar/gkm235; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; Navarro P, 2010, BIOESSAYS, V32, P581, DOI 10.1002/bies.201000019; Navarro P, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-8; Navarro P, 2009, FEBS LETT, V583, P1721, DOI 10.1016/j.febslet.2009.03.043; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103	30	144	147	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					457	U287		10.1038/nature09496	http://dx.doi.org/10.1038/nature09496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21085182				2022-12-01	WOS:000284313100047
J	Geneau, R; Stuckler, D; Stachenko, S; Mckee, M; Ebrahim, S; Basu, S; Chockalingham, A; Mwatsama, M; Jamal, R; Alwan, A; Beaglehole, R				Geneau, Robert; Stuckler, David; Stachenko, Sylie; McKee, Martin; Ebrahim, Shah; Basu, Sanjay; Chockalingham, Arun; Mwatsama, Modi; Jamal, Rozmin; Alwan, Ala; Beaglehole, Robert			Chronic Diseases: Chronic Diseases and Development 1 Raising the priority of preventing chronic diseases: a political process	LANCET			English	Article							LOW-INCOME; DEVELOPING-COUNTRIES; HEALTH; TOBACCO; POLICY; TUBERCULOSIS; DETERMINANTS; GENERATION; STRATEGIES; MORTALITY	Chronic diseases especially cardiovascular diseases, diabetes cancer and chronic obstructive respiratory diseases, are neglected globally despite growing awareness of the serious burden that they cause Global and national policies have failed to stop, and in many cases have contributed to, the chronic disease pandemic Low cost and highly effective solutions for the prevention of chronic diseases are readily available the failure to respond is now a political rather than a technical issue We seek to understand this failure and to position chronic disease centrally on the global health and development agendas To identify strategies for generation of increased political priority for chronic diseases and to further the involvement of development agencies we use an adapted political process model This model has previously been used to assess the success and failure of social movements On the basis of this analysis we recommend three strategies reframe the debate to emphasise the societal determinants of disease and the inter relation between chronic disease, poverty, and development, mobilise resources through a cooperative and inclusive approach to development and by equitably distributing resources on the basis of avoidable mortality and build on emerging strategic and political opportunities such as the World Health Assembly 2008-13 Action Plan and the high level meeting of the UN General Assembly in 2011 on chronic disease Until the full set of threats which-include chronic disease-that trap poor households in cycles of debt and illness are addressed, progress towards equitable human development will remain inadequate	[Geneau, Robert] Univ Ottawa, Elizabeth Bruyere Res Inst, Ottawa, ON, Canada; [Stuckler, David] Univ Oxford, Dept Sociol, Oxford OX1 2JD, England; [Stachenko, Sylie] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2M7, Canada; [McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Ebrahim, Shah] S Asia Network Chron Dis, New Delhi, India; [Ebrahim, Shah] Publ Hlth Fdn India, New Delhi, India; [Basu, Sanjay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Basu, Sanjay] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA USA; [Chockalingham, Arun] NHLBI, Off Global Hlth, Bethesda, MD 20892 USA; [Jamal, Rozmin] Aga Khan Univ, Clin Res Unit, Karachi, Pakistan; [Alwan, Ala] WHO, CH-1211 Geneva, Switzerland; [Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand	University of Ottawa; University of Oxford; University of Alberta; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Aga Khan University; World Health Organization; University of Auckland	Geneau, R (corresponding author), Univ Ottawa, Elizabeth Bruyere Res Inst, 43 Bruyere, Ottawa, ON, Canada.		Stuckler, David/H-2261-2012; McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Stuckler, David/0000-0002-1288-8401; McKee, Martin/0000-0002-0121-9683; Geneau, Robert/0000-0001-6180-2515				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abegunde DO, 2008, SOC SCI MED, V66, P2296, DOI 10.1016/j.socscimed.2008.01.041; Abubakari AR, 2009, PUBLIC HEALTH, V123, P602, DOI 10.1016/j.puhe.2009.07.009; *AG KHAN DEV NETW, 2009, SUMM MED BRIEF INT C; Alleyne G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-15; ALWAN A, 2010, LANCET, DOI DOI 10.1016/S0140.6736(10)61853.3; Alwan A, 2009, INT HEALTH, V1, P3, DOI 10.1016/j.inhe.2009.02.003; Anderson GF, 2009, HEALTH AFFAIR, V28, P202, DOI 10.1377/hlthaff.28.1.202; [Anonymous], 2003, BRIDGING RES POLICY; [Anonymous], 2007, THEORIES POLICY PROC; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black N, 2001, BRIT MED J, V323, P275, DOI 10.1136/bmj.323.7307.275; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Costain A.N., 1992, INVITING WOMENS REBE; CSDH, 2008, COMMISSION SOCIAL DE; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Diethelm PA, 2005, LANCET, V366, P86, DOI 10.1016/S0140-6736(05)66474-4; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Ebrahim Shahul, 2007, Prev Chronic Dis, V4, pA32; ELIADAROUS HE, 2010, EXP CLIN ENDOCRINOL, V118, P220; Emmelin A, 2007, CHEST, V132, P1615, DOI 10.1378/chest.07-1398; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Fuster V, 2005, LANCET, V366, P1512, DOI 10.1016/S0140-6736(05)67610-6; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gajalakshmi V, 2009, INT J EPIDEMIOL, V38, P1018, DOI 10.1093/ije/dyp225; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Hastings G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5650; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Institute of Medicine, 2010, PROM CARD HLTH DEV W; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jones H., 2009, EQUITY DEV WHY IT IS; KINGDON JW, 1995, AGENDAS ALTERNATIVE; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lomas Jonathan, 2005, Healthc Policy, V1, P55; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Mahal A., 2010, HLTH NUTR POPUL SER; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Marx Karl, 1971, GRUNDRISSE FDN CRITI; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mbatia J, 2009, INT J ENV RES PUB HE, V6, P1991, DOI 10.3390/ijerph6071991; McAdam D., 2010, READINGS SOCIAL MOVE; McAdam Doug., 1982, POLITICAL PROCESS DE; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; Mccoy D, 2009, LANCET, V373, P1645, DOI 10.1016/S0140-6736(09)60571-7; McDaniel PA, 2009, WOMEN HEALTH, V49, P441, DOI 10.1080/03630240903238800; McKee M, 2006, BRIT MED J, V333, P871, DOI 10.1136/bmj.39003.629606.BE; McMillen IC, 2008, BASIC CLIN PHARMACOL, V102, P82, DOI 10.1111/j.1742-7843.2007.00188.x; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; *NAT HEART LUNG BL, 2009, UN NHLBI CTR EXC; *NCD ALL, NCD ALL PUTT NONC DI; NUGENT R, 2009, CHRONIC DIS POSING G; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Ong EK, 2001, AM J PUBLIC HEALTH, V91, P1749, DOI 10.2105/AJPH.91.11.1749; *OXF ALL, 2006, CHRON DIS EC PERSP; Pisani E, 2008, WISDOM WHORES; Rabinoff M, 2007, AM J PUBLIC HEALTH, V97, P1981, DOI 10.2105/AJPH.2005.078014; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Ronsmans C, 2009, FOOD NUTR BULL, V30, pS547, DOI 10.1177/15648265090304S409; SAMB B, 2010, LANCET, DOI DOI 10.1016/S0140.6736(10)61353.0; Schmidt H, 2008, LANCET, V372, P627, DOI 10.1016/S0140-6736(08)61269-6; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shiffman J, 2009, B WORLD HEALTH ORGAN, V87, P608, DOI 10.2471/BLT.08.060749; Stanciole A., 2006, ESTIMATION EC IMPACT; Stiglitz JosephE., 2010, FREEFALL AM FREE MAR; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; *TRUST W, 2010, STAT PLAN 2010 2020; *UN, UN AG LAUDS ASS RES; Walt G, 2008, HEALTH POLICY PLANN, V23, P308, DOI 10.1093/heapol/czn024; Whitehead M, 2001, LANCET, V358, P165, DOI 10.1016/S0140-6736(01)05398-3; WHO, 2008, WORLD HLTH STAT 2008; *WHO, NCDNET; *WHO, 2009, NONC DIS POV DEV AG; World Economic Forum-Global Risks Report, 2009, GLOB RISKS 2009 GLOB; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2004, TOB POV VIC CIRCL; World Health Organization, 2005, PREVENTING CHRONIC D; World Health Organization (WHO), STEPWISE APPR SURV S	87	184	185	2	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2010	376	9753					1689	1698		10.1016/S0140-6736(10)61414-6	http://dx.doi.org/10.1016/S0140-6736(10)61414-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	683DD	21074260				2022-12-01	WOS:000284451000034
J	Kessler, SA; Shimosato-Asano, H; Keinath, NF; Wuest, SE; Ingram, G; Panstruga, R; Grossniklaus, U				Kessler, Sharon A.; Shimosato-Asano, Hiroko; Keinath, Nana F.; Wuest, Samuel E.; Ingram, Gwyneth; Panstruga, Ralph; Grossniklaus, Ueli			Conserved Molecular Components for Pollen Tube Reception and Fungal Invasion	SCIENCE			English	Article							MALE-GAMETE DELIVERY; POWDERY MILDEW; ARABIDOPSIS-THALIANA; DOUBLE FERTILIZATION; SYNERGID CELL; RESISTANCE; PROTEINS; GENE; DISRUPTS; FAMILY	During sexual reproduction in flowering plants such as Arabidopsis, a tip-growing pollen tube (PT) is guided to the synergid cells of the female gametophyte, where it bursts and releases the two sperm. Here we show that PT reception and powdery mildew (PM) infection, which involves communication between a tip-growing hypha and a plant epidermal cell, share molecular components. NORTIA (NTA), a member of the MLO family originally discovered in the context of PM resistance, and FERONIA (FER), a receptor-like kinase, both control PT reception in synergids. Homozygous fer mutants also display PM resistance, revealing a new function for FER and suggesting that conserved components, such as FER and distinct MLO proteins, are involved in both PT reception and PM infection.	[Kessler, Sharon A.; Shimosato-Asano, Hiroko; Wuest, Samuel E.; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Keinath, Nana F.; Panstruga, Ralph] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Ingram, Gwyneth] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland	University of Zurich; Max Planck Society; University of Edinburgh	Grossniklaus, U (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	grossnik@botinst.uzh.ch	Kessler, Sharon A/T-4784-2017; Grossniklaus, Ueli/A-2736-2012; Grossniklaus, Ueli/E-9995-2016; Panstruga, Ralph/F-3340-2011	Kessler, Sharon A/0000-0002-7964-0451; Grossniklaus, Ueli/0000-0002-0522-8974; Panstruga, Ralph/0000-0002-3756-8957; Ingram, Gwyneth/0000-0002-1425-9545; Wuest, Samuel/0000-0003-3982-0770	University of Zurich; Max Planck Society; Human Frontiers in Science Program; Forschungskredit of the University of Zurich; International Max Planck Research School; Royal Society of London; Deutsche Forschungsgemeinschaft [SFB670]; Swiss National Science Foundation	University of Zurich; Max Planck Society(Max Planck SocietyFoundation CELLEX); Human Frontiers in Science Program(Human Frontier Science Program); Forschungskredit of the University of Zurich; International Max Planck Research School; Royal Society of London(Royal Society of London); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank A. Boisson-Dernier for providing pLat52:DsRED and for critical reading of this manuscript; S. Schauer for providing plasmids; A. Reinstadler for technical assistance with pathogen assays; and J. M. Escobar-Restrepo, H. Lindner, M. Bayer, C. Jager-Baroux, S. Pien, V. Gagliardini, and members of the Grossniklaus lab for helpful discussions. This work was supported by the University of Zurich, the Max Planck Society, fellowships of the Human Frontiers in Science Program (to S.A.K.), the Forschungskredit of the University of Zurich (to H.S.-A.), the International Max Planck Research School (to N.F.K.), the Royal Society of London (to G.I.), and grants from the Deutsche Forschungsgemeinschaft (SFB670 to R.P.) and the Swiss National Science Foundation (to U.G.).	Amano K, 1986, HOST RANGE GEOGRAPHI; AMICI JB, 1847, ANN SCI NATURELLES, P193; Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Boisson-Dernier A, 2008, CURR BIOL, V18, P63, DOI 10.1016/j.cub.2007.11.067; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Capron A, 2008, PLANT CELL, V20, P3038, DOI 10.1105/tpc.108.061713; Chen ZY, 2009, PLANT CELL, V21, P1972, DOI 10.1105/tpc.108.062653; Chen ZY, 2006, PLANT MOL BIOL, V60, P583, DOI 10.1007/s11103-005-5082-x; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Dresselhaus T, 2006, CURR OPIN PLANT BIOL, V9, P41, DOI 10.1016/j.pbi.2005.11.002; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; Higashiyama T, 2002, J PLANT RES, V115, P149, DOI 10.1007/s102650200020; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; LIVIUS T, AB URBE CONDITA LIBE; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Piffanelli P, 2002, PLANT PHYSIOL, V129, P1076, DOI 10.1104/pp.010954; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Sandaklie-Nikolova L, 2007, PLANT PHYSIOL, V144, P1753, DOI 10.1104/pp.107.098236; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051	30	286	312	6	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					968	971		10.1126/science.1195211	http://dx.doi.org/10.1126/science.1195211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071669				2022-12-01	WOS:000284118000044
J	Kuhnert, F; Mancuso, MR; Shamloo, A; Wang, HT; Choksi, V; Florek, M; Su, H; Fruttiger, M; Young, WL; Heilshorn, SC; Kuo, CJ				Kuhnert, Frank; Mancuso, Michael R.; Shamloo, Amir; Wang, Hsiao-Ting; Choksi, Vir; Florek, Mareike; Su, Hua; Fruttiger, Marcus; Young, William L.; Heilshorn, Sarah C.; Kuo, Calvin J.			Essential Regulation of CNS Angiogenesis by the Orphan G Protein-Coupled Receptor GPR124	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; ALPHA-V INTEGRINS; INACTIVATION; ENDOTHELIUM; LETHALITY; GENE; MICE; NEUROGENESIS; HEMORRHAGE	The orphan G protein-coupled receptor (GPCR) GPR124/tumor endothelial marker 5 is highly expressed in central nervous system (CNS) endothelium. Here, we show that complete null or endothelial-specific GPR124 deletion resulted in embryonic lethality from CNS-specific angiogenesis arrest in forebrain and neural tube. Conversely, GPR124 overexpression throughout all adult vascular beds produced CNS-specific hyperproliferative vascular malformations. In vivo, GPR124 functioned cell-autonomously in endothelium to regulate sprouting, migration, and developmental expression of the blood-brain barrier marker Glut1, whereas in vitro, GPR124 mediated Cdc42-dependent directional migration to forebrain-derived, vascular endothelial growth factor-independent cues. Our results demonstrate CNS-specific angiogenesis regulation by an endothelial receptor and illuminate functions of the poorly understood adhesion GPCR subfamily. Further, the functional tropism of GPR124 marks this receptor as a therapeutic target for CNS-related vascular pathologies.	[Kuhnert, Frank; Mancuso, Michael R.; Wang, Hsiao-Ting; Kuo, Calvin J.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Shamloo, Amir] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Choksi, Vir] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Florek, Mareike] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Fruttiger, Marcus] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Young, William L.] Univ Calif San Francisco, Dept Neurol Surg, Ctr Cerebrovasc Res, Dept Anesthesia & Perioperat Care,Dept Neurol, San Francisco, CA 94110 USA; [Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of London; University College London; University of California System; University of California San Francisco; Stanford University	Kuo, CJ (corresponding author), Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA.	cjkuo@stanford.edu		Fruttiger, Marcus/0000-0002-6962-5485; Kuo, Calvin/0000-0002-7427-5985; Heilshorn, Sarah/0000-0002-9801-6304; , amir/0000-0002-0131-0567	American Heart Association (AHA) [AHA09PRE2110036, 10GRNT3130004]; National Institute of General Medical Science, NIH [GM07365]; NIH [R21 NS070153, R01NS27713, P01NS44155, 1DP2 OD006477, 1R21 NS058600, 1R01NS052830, 1R01NS064517, 1R01HL074267]; U.K. Medical Research Council [G0501711]; National Academies Keck Futures Initiative; Brain Tumor Society; Goldhirsh Foundation; Stanford Center for Children's Brain Tumors; Medical Research Council [G0501711] Funding Source: researchfish; MRC [G0501711] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA095654] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058600, R21NS070153, R01NS052830, P01NS044155, R01NS027713, R01NS064517] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006477] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Institute of General Medical Science, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Academies Keck Futures Initiative; Brain Tumor Society; Goldhirsh Foundation; Stanford Center for Children's Brain Tumors; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are indebted to R. Daneman, B. Barres, C. Chartier, and the Kuo laboratory for comments; J. Yuan and J. Hampton for animal husbandry and genotyping; and A. Connolly and H. Vogel for neuropathology. F.K. was supported by an American Heart Association (AHA) Postdoctoral Fellowship and M.R.M. by AHA Predoctoral Fellowship AHA09PRE2110036 and the Stanford Medical Scientist Training Program Program (National Institute of General Medical Science, NIH, GM07365). This work was also supported by NIH R21 NS070153 and AHA 10GRNT3130004 (H.S.); NIH R01NS27713 (W.L.Y.); P01NS44155 (W.L.Y. and H.S.); U.K. Medical Research Council G0501711 (M.F.); NIH 1DP2 OD006477, 1R21 NS058600, and National Academies Keck Futures Initiative CS10 grants (S.C.H.); and NIH 1R01NS052830, 1R01NS064517, 1R01HL074267, Brain Tumor Society, Goldhirsh Foundation, and the Stanford Center for Children's Brain Tumors grants (C.J.K.). F.K., H.W., and C.J.K. have a patent pending regarding vascular applications of GPR124.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Ara T, 2005, BLOOD, V105, P3155, DOI 10.1182/blood-2004-07-2563; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fredriksson R, 2003, BIOCHEM BIOPH RES CO, V301, P725, DOI 10.1016/S0006-291X(03)00026-3; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; HERKEN R, 1989, J ANAT, V164, P85; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Mancuso Michael R., 2008, Lymphatic Research and Biology, V6, P173, DOI 10.1089/lrb.2008.1014; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; Pardridge William M, 2003, Methods Mol Med, V89, P385; Raab S, 2004, THROMB HAEMOSTASIS, V91, P595, DOI 10.1160/TH03-09-0582; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; St Croix B, 2000, SCIENCE, V289, P1197; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Vallon M, 2006, J BIOL CHEM, V281, P34179, DOI 10.1074/jbc.M605291200; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Zhu JW, 2002, DEVELOPMENT, V129, P2891	30	204	211	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					985	989		10.1126/science.1196554	http://dx.doi.org/10.1126/science.1196554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071672	Green Accepted			2022-12-01	WOS:000284118000049
J	Hughes, R				Hughes, Richard			Rational Testing Investigation of peripheral neuropathy	BRITISH MEDICAL JOURNAL			English	Editorial Material							SYMMETRIC POLYNEUROPATHY ROLE; PRACTICE PARAMETER EVALUATION; ELECTRODIAGNOSTIC MEDICINE; AMERICAN ASSOCIATION; PHYSICAL MEDICINE; NERVE BIOPSY; REHABILITATION; NEUROLOGY; ACADEMY				Hughes, R (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	rhughes11@btinternet.com						England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; Gabriel CM, 2000, J NEUROL NEUROSUR PS, V69, P442, DOI 10.1136/jnnp.69.4.442; Hughes RAC, 2004, BRAIN, V127, P1723, DOI 10.1093/brain/awh192; Hughes RAC, 2002, BRIT MED J, V324, P466, DOI 10.1136/bmj.324.7335.466; KELLY JJ, 1981, NEUROLOGY, V31, P1480, DOI 10.1212/WNL.31.11.1480; Rosenberg NR, 2001, J NEUROL NEUROSUR PS, V71, P205, DOI 10.1136/jnnp.71.2.205; Saperstein DS, 2003, ARCH NEUROL-CHICAGO, V60, P1296, DOI 10.1001/archneur.60.9.1296	8	11	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 5	2010	341								c6100	10.1136/bmj.c6100	http://dx.doi.org/10.1136/bmj.c6100			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	678DN	21056962				2022-12-01	WOS:000284052400006
J	Voorhees, RM; Schmeing, TM; Kelley, AC; Ramakrishnan, V				Voorhees, Rebecca M.; Schmeing, T. Martin; Kelley, Ann C.; Ramakrishnan, V.			The Mechanism for Activation of GTP Hydrolysis on the Ribosome	SCIENCE			English	Article							ELONGATION-FACTOR TU; AMINOACYL-TRANSFER-RNA; TRANSITION-STATE ANALOG; CENTER-DOT-GDP; EF-TU; CRYSTAL-STRUCTURE; BINDING DOMAIN; COMPLEX; PROTEIN; CONFORMATION	Protein synthesis requires several guanosine triphosphatase (GTPase) factors, including elongation factor Tu (EF-Tu), which delivers aminoacyl-transfer RNAs (tRNAs) to the ribosome. To understand how the ribosome triggers GTP hydrolysis in translational GTPases, we have determined the crystal structure of EF-Tu and aminoacyl-tRNA bound to the ribosome with a GTP analog, to 3.2 angstrom resolution. EF-Tu is in its active conformation, the switch I loop is ordered, and the catalytic histidine is coordinating the nucleophilic water in position for inline attack on the gamma-phosphate of GTP. This activated conformation is due to a critical and conserved interaction of the histidine with A2662 of the sarcin-ricin loop of the 23S ribosomal RNA. The structure suggests a universal mechanism for GTPase activation and hydrolysis in translational GTPases on the ribosome.	[Voorhees, Rebecca M.; Schmeing, T. Martin; Kelley, Ann C.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	martin.schmeing@mcgill.ca; ramak@mrc-lmb.cam.ac.uk		Ramakrishnan, V/0000-0002-4699-2194; VOORHEES, REBECCA/0000-0003-1640-2293	Medical Research Council UK; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Gates-Cambridge scholarship; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Gates-Cambridge scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Green for reagents and D. de Sanctis at the European Synchrotron Radiation Facility for facilitating data collection. This work was supported by the Medical Research Council UK, the Wellcome Trust, the Agouron Institute, and the Louis-Jeantet Foundation. R. M. V. is supported by a Gates-Cambridge scholarship, and T. M. S. by the Human Frontier Science Program and Emmanuel College. V. R. is on the Scientific Advisory Board and holds stock options in Rib-X pharmaceuticals. Transfer of Thermus thermophilis ribosome strain T. th. HB8-MRC-MSAW1 requires a Materials Transfer Agreement with the MRC. Coordinates and structure factors have been deposited at the Protein Data Bank with accession codes 2xqd and 2xqe.	BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BILGIN N, 1994, J MOL BIOL, V235, P813, DOI 10.1006/jmbi.1994.1041; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; ECCLESTON JF, 1982, J BIOL CHEM, V257, P5046; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; HOLMBERG L, 1994, BIOCHEMISTRY-US, V33, P15159, DOI 10.1021/bi00254a027; JACQUET E, 1988, EMBO J, V7, P2861, DOI 10.1002/j.1460-2075.1988.tb03142.x; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Knudsen C, 2001, J BIOL CHEM, V276, P22183, DOI 10.1074/jbc.M102186200; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; MESTERS JR, 1994, J MOL BIOL, V242, P644, DOI 10.1006/jmbi.1994.1614; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; RAMBELLI F, 1989, BIOCHEM J, V259, P307, DOI 10.1042/bj2590307; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengupta J, 2008, J MOL BIOL, V382, P179, DOI 10.1016/j.jmb.2008.07.004; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Wieden HJ, 2001, J MOL EVOL, V52, P129, DOI 10.1007/s002390010141	33	268	273	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					835	838		10.1126/science.1194460	http://dx.doi.org/10.1126/science.1194460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	21051640	Green Accepted			2022-12-01	WOS:000283855700047
J	Lamont, T; Cousins, D; Rosario, C				Lamont, Tara; Cousins, David; Rosario, Catherine			Safety Alerts Safer treatment doses for low molecular weight heparins: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK		[Lamont, Tara; Cousins, David; Rosario, Catherine] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						Baglin T, 2006, BRIT J HAEMATOL, V133, P19, DOI 10.1111/j.1365-2141.2005.05953.x; *BMJ GROUP, 2010, BRIT NAT FORM; *DEP HLTH EST FAC, 2010, EFA 2010 001 MED PAT; EDITH AN, 2009, ANN PHARMACOTHER, V43, P1064; Hendershot KM, 2006, J AM COLL SURGEONS, V203, P887, DOI 10.1016/j.jamcollsurg.2006.08.018; Hilmer SN, 2007, INTERN MED J, V37, P647, DOI 10.1111/j.1445-5994.2007.01457.x; LaPointe NMA, 2007, ARCH INTERN MED, V167, P1539, DOI 10.1001/archinte.167.14.1539; Lin BW, 2009, AM J EMERG MED, V27, P1060, DOI 10.1016/j.ajem.2008.08.018; MARCIL A, 2004, CAN J HOSP PHARM, P220; MCARTNEY R, 2009, IJPP S17, V17, pB38; National Institute for Health and Clinical Excellence, 2010, VEN THROMB RED RISK; *NHS PRESCR SERV, PRESCR DAT ENGL 2008	12	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 2	2010	341								c5884	10.1136/bmj.c5884	http://dx.doi.org/10.1136/bmj.c5884			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	678CU	21045026				2022-12-01	WOS:000284048200022
J	Schmidt, O; Harbauer, AB; Rao, S; Eyrich, B; Zahedi, RP; Stojanovski, D; Schonfisch, B; Guiard, B; Sickmann, A; Pfanner, N; Meisinger, C				Schmidt, Oliver; Harbauer, Angelika B.; Rao, Sanjana; Eyrich, Beate; Zahedi, Rene P.; Stojanovski, Diana; Schoenfisch, Birgit; Guiard, Bernard; Sickmann, Albert; Pfanner, Nikolaus; Meisinger, Chris			Regulation of Mitochondrial Protein Import by Cytosolic Kinases	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION SITES; RECEPTOR TOM70; COMPLEX-I; PREPROTEINS; BINDING; CK2; IDENTIFICATION; TRANSLOCATION; EVOLUTION	Mitochondria import a large number of nuclear-encoded proteins via membrane-bound transport machineries; however, little is known about regulation of the preprotein translocases. We report that the main protein entry gate of mitochondria, the translocase of the outer membrane (TOM complex), is phosphorylated by cytosolic kinases-in particular, casein kinase 2 (CK2) and protein kinase A (PKA). CK2 promotes biogenesis of the TOM complex by phosphorylation of two key components, the receptor Tom22 and the import protein Mim1, which in turn are required for import of further Tom proteins. Inactivation of CK2 decreases the levels of the TOM complex and thus mitochondrial protein import. PKA phosphorylates Tom70 under nonrespiring conditions, thereby inhibiting its receptor activity and the import of mitochondrial metabolite carriers. We conclude that cytosolic kinases exert stimulatory and inhibitory effects on biogenesis and function of the TOM complex and thus regulate protein import into mitochondria.	[Schmidt, Oliver; Harbauer, Angelika B.; Rao, Sanjana; Stojanovski, Diana; Schoenfisch, Birgit; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Schmidt, Oliver; Harbauer, Angelika B.; Schoenfisch, Birgit; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Schmidt, Oliver; Harbauer, Angelika B.; Rao, Sanjana] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Rao, Sanjana] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Eyrich, Beate; Zahedi, Rene P.; Sickmann, Albert] Leibniz Inst Analyt Wissensch ISAS eV, D-44139 Dortmund, Germany; [Stojanovski, Diana] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [Sickmann, Albert] Ruhr Univ Bochum, Med Proteom Ctr, D-44801 Bochum, Germany; [Meisinger, Chris] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); La Trobe University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ruhr University Bochum; University of Bern	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de; chris.meisinger@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Sickmann, Albert/A-1010-2011; Zahedi, René/A-9148-2012; Meisinger, Chris/J-1110-2014	Sickmann, Albert/0000-0002-2388-5265; Zahedi, René/0000-0002-4960-5460; Meisinger, Chris/0000-0002-8326-3548; Harbauer, Angelika/0000-0002-4568-9003; Schmidt, Oliver/0000-0002-7921-4663; Stojanovski, Diana/0000-0002-0199-3222	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments; Bundesministerium fur Bildung und Forschung (Dynamo); Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, Sonderforschungsbereich [746]; Gottfried Wilhelm Leibniz Program; Landesforschungspreis Baden-Wurttemberg	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Dynamo)(Federal Ministry of Education & Research (BMBF)); Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, Sonderforschungsbereich(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; Landesforschungspreis Baden-Wurttemberg	We thank Drs. C.V. Glover, A.P. Bidwai, K.M. Dombek, and C. Mann for strains and antisera; Drs. N. Wiedemann, K. Wagner, T. Becker, N. Gebert, M. Bohnert, M. Gebert, and D. Stroud for discussion; and C. Prinz for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School), Bundesministerium fur Bildung und Forschung (Dynamo), Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, Sonderforschungsbereich 746, Gottfried Wilhelm Leibniz Program, and Landesforschungspreis Baden-Wurttemberg. This paper is dedicated to Klaus Paal (1955-2009), who is deeply missed.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Brix J, 2000, J MOL BIOL, V303, P479, DOI 10.1006/jmbi.2000.4120; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; De Rasmo D, 2008, CELL SIGNAL, V20, P989, DOI 10.1016/j.cellsig.2008.01.017; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Onorato TM, 2005, J BIOL CHEM, V280, P19527, DOI 10.1074/jbc.M410422200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Tripodi F, 2010, BIOCHEM BIOPH RES CO, V398, P44, DOI 10.1016/j.bbrc.2010.06.028; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	30	177	177	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					227	239		10.1016/j.cell.2010.12.015	http://dx.doi.org/10.1016/j.cell.2010.12.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21215441	Bronze			2022-12-01	WOS:000286459900008
J	Haldane, AG; May, RM				Haldane, Andrew G.; May, Robert M.			Systemic risk in banking ecosystems	NATURE			English	Article							NETWORK STRUCTURE; COMPLEX-SYSTEMS; ECOLOGY; MODEL	In the run-up to the recent financial crisis, an increasingly elaborate set of financial instruments emerged, intended to optimize returns to individual institutions with seemingly minimal risk. Essentially no attention was given to their possible effects on the stability of the system as a whole. Drawing analogies with the dynamics of ecological food webs and with networks within which infectious diseases spread, we explore the interplay between complexity and stability in deliberately simplified models of financial networks. We suggest some policy lessons that can be drawn from such models, with the explicit aim of minimizing systemic risk.	[May, Robert M.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England; [Haldane, Andrew G.] Bank England, London EC2R 8AH, England	University of Oxford; Bank of England	May, RM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	robert.may@zoo.ox.ac.uk						Alessandri P., 2009, BANKING ON THE STATE; ANDERSON R M, 1991; Arrow KJ, 1954, ECONOMETRICA, V22, P265, DOI 10.2307/1907353; Avellaneda M, 2003, QUANT FINANC, V3, P417, DOI 10.1088/1469-7688/3/6/301; Bank of England, 2009, ROL MACR POL DISC PA; Barabesi A.-L., 2002, LINKED NEW SCI NETWO; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Battiston A., 2009, LIAISONS DANGEREUSES; Brock W. A., 2008, J EC DYNAM CONT, V33, P1912; Buffet W. E., 2002, 15 BERKSH HATH INC, P15; Caccioli F, 2009, EUR PHYS J B, V71, P467, DOI 10.1140/epjb/e2009-00316-y; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Elton C. S, 1958, ECOLOGY INVASIONS AN; Farmer JD, 2002, IND CORP CHANGE, V11, P895, DOI 10.1093/icc/11.5.895; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; Haldane A, 2009, RETHINKING FINANCIAL; Haldane A. G., 2010, 100 BILLION QUESTION; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jones C, 2010, CENT BANKING, V21, P69; Kyriakopoulos F, 2009, EUR PHYS J B, V71, P523, DOI 10.1140/epjb/e2009-00255-7; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; May R.M., 1973, STABILITY COMPLEXITY; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; May RM, 2010, J R SOC INTERFACE, V7, P823, DOI 10.1098/rsif.2009.0359; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Osler CL, 2006, INT J FINANC ECON, V11, P55, DOI 10.1002/ijfe.288; Pascuale M., 2006, ECOLOGICAL NETWORKS; Pliska S.R., 1997, INTRO MATH FINANCE D; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Sircar R., 1998, APPL MATH FINANC, V5, P45, DOI [10.1080/135048698334727, DOI 10.1080/135048698334727]; Stiglitz J., J GLOBAL DE IN PRESS; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Sugihara G, 2009, NATURE, V458, P979, DOI 10.1038/458979a; Turner P., 2009, DEBATE FINANCIAL SYS	40	697	714	20	386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330								10.1038/nature09659	http://dx.doi.org/10.1038/nature09659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248842	Green Submitted			2022-12-01	WOS:000286385600042
J	Joynt, KE; Orav, EJ; Jha, AK				Joynt, Karen E.; Orav, E. John; Jha, Ashish K.			The Association Between Hospital Volume and Processes, Outcomes, and Costs of Care for Congestive Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; PERCUTANEOUS CORONARY INTERVENTIONS; REGIONAL-VARIATIONS; MORTALITY; EXPERIENCE	Background: Congestive heart failure (CHF) is common and costly, and outcomes remain suboptimal despite pharmacologic and technical advances. Objective: To examine whether hospitals with more experience in caring for patients with CHF provide better, more efficient care. Design: Retrospective cohort study. Setting: 4095 hospitals in the United States. Patients: Medicare fee-for-service patients with a primary discharge diagnosis of CHF. Measurements: Hospital Quality Alliance CHF process measures; 30-day, risk-adjusted mortality rates; 30-day, risk-adjusted readmission rates; and costs per discharge. National Medicare claims data from 2006 to 2007 were used to examine the relationship between hospital case volume and quality, outcomes, and costs for patients with CHF. Results: Hospitals in the low-volume group had lower performance on the process measures (80.2%) than did medium-volume (87.0%) or high-volume (89.1%) hospitals (P < 0.001). In the low-volume group, being admitted to a hospital with a higher case volume was associated with lower mortality, lower readmission, and higher costs. Similar, though smaller, relationships were found between case volume and both mortality and costs in the medium- and high-volume hospital groups. Limitations: Analysis was limited to Medicare patients 65 years or older. Risk adjustment was performed by using administrative data. Conclusion: Experience with managing CHF, as measured by an institution's volume, is associated with higher quality of care and better outcomes for patients but a higher cost. Understanding which practices employed by high-volume institutions account for these advantages can help improve quality of care and clinical outcomes for all patients with CHF. Primary Funding Source: American Heart Association. Ann Intern Med. 2011;154:94-102.	[Joynt, Karen E.] Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA; Vet Affairs Boston Hlth Care Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health	Joynt, KE (corresponding author), Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			American Heart Association [10CRP3780037]; National Institutes of Health [T32HL007604-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By an American Heart Association Clinical Research Program grant (10CRP3780037). Dr. Joynt was supported by a National Institutes of Health Training Grant (T32HL007604-24) held by Brigham and Women's Hospital Division of Cardiovascular Medicine.	Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Cunningham WE, 1999, AM J MED, V107, P137, DOI 10.1016/S0002-9343(99)00195-3; Desai MM, 2009, 2009 MEASURES MAINTE; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATIONAHA.104.528455; Hannan EL, 2003, CIRCULATION, V108, P795, DOI 10.1161/01.CIR.0000084551.52010.3B; Ho V, 2008, MED CARE, V46, P718, DOI 10.1097/MLR.0b013e3181653d6b; Jha AK, 2006, HEALTH AFFAIR, V25, P844, DOI 10.1377/hlthaff.25.3.844; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Jollis JG, 1997, CIRCULATION, V95, P2485, DOI 10.1161/01.CIR.95.11.2485; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Lindenauer PK, 2006, ANN INTERN MED, V144, P262, DOI 10.7326/0003-4819-144-4-200602210-00008; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; LUFT HS, 1987, HEALTH SERV RES, V22, P157; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; Mechanic R, 1998, JAMA-J AM MED ASSOC, V280, P1015, DOI 10.1001/jama.280.11.1015; Medicare Payment Advisory Commission, 2009, DAT BOOK HEALTHC SPE; Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; Swisher SG, 2000, J THORAC CARDIOV SUR, V119, P1126, DOI 10.1067/mtc.2000.105644; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; US Department of Health and Human Services, 2010, HOSP COMP; Ward MM, 2002, J RHEUMATOL, V29, P1198; Wu CT, 2004, CIRCULATION, V110, P784, DOI 10.1161/01.CIR.0000138744.13516.B5; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566	39	124	125	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2					94	+		10.7326/0003-4819-154-2-201101180-00008	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-00008			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706MW	21242366	Green Accepted			2022-12-01	WOS:000286223500003
J	Lyall, J; Irvine, RM; Sherman, A; McKinley, TJ; Nunez, A; Purdie, A; Outtrim, L; Brown, IH; Rolleston-Smith, G; Sang, H; Tiley, L				Lyall, Jon; Irvine, Richard M.; Sherman, Adrian; McKinley, Trevelyan J.; Nunez, Alejandro; Purdie, Auriol; Outtrim, Linzy; Brown, Ian H.; Rolleston-Smith, Genevieve; Sang, Helen; Tiley, Laurence			Suppression of Avian Influenza Transmission in Genetically Modified Chickens	SCIENCE			English	Article							VIRUS; TRANSCRIPTION; POLYMERASE; SYSTEM; RNAS; H5N1	Infection of chickens with avian influenza virus poses a global threat to both poultry production and human health that is not adequately controlled by vaccination or by biosecurity measures. A novel alternative strategy is to develop chickens that are genetically resistant to infection. We generated transgenic chickens expressing a short-hairpin RNA designed to function as a decoy that inhibits and blocks influenza virus polymerase and hence interferes with virus propagation. Susceptibility to primary challenge with highly pathogenic avian influenza virus and onward transmission dynamics were determined. Although the transgenic birds succumbed to the initial experimental challenge, onward transmission to both transgenic and nontransgenic birds was prevented.	[Lyall, Jon; McKinley, Trevelyan J.; Tiley, Laurence] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Irvine, Richard M.; Nunez, Alejandro; Outtrim, Linzy; Brown, Ian H.] Vet Lab Agcy, Addlestone KT15 3NB, Surrey, England; [Sherman, Adrian; Purdie, Auriol; Rolleston-Smith, Genevieve; Sang, Helen] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9PS, Midlothian, Scotland; [Sherman, Adrian; Purdie, Auriol; Rolleston-Smith, Genevieve; Sang, Helen] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9PS, Midlothian, Scotland	University of Cambridge; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Tiley, L (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	Lst21@cam.ac.uk	Castel, Alejandro Núñez/C-2560-2011; Brown, Ian H/E-1119-2011; Irvine, Richard M/E-2556-2011	Irvine, Richard M/0000-0002-1584-4076; Nunez, Alejandro/0000-0001-5926-7541; Purdie, Auriol/0000-0003-1941-6658	Biotechnology and Biological Sciences Research Council [BB/G00479X/1, BBS/B/00239, BBS/B/00301]; Cambridge Infectious Diseases Consortium Department for Environment, Food and Rural Affairs-Higher Education Funding Council for England [VT0105]; Cobb-Vantress Ltd.; Medical Research Council [G0300009] Funding Source: researchfish; BBSRC [BB/G00479X/1] Funding Source: UKRI; MRC [G0300009] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Infectious Diseases Consortium Department for Environment, Food and Rural Affairs-Higher Education Funding Council for England; Cobb-Vantress Ltd.; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Lillico, F. Song, and H. Gilhooley for advice on laboratory methods and technical support; R. Mitchell, F. Thomson, and M. Hutchison for assistance in production and breeding of transgenic birds; S. Essen and W. Cox for assistance with the in vivo challenge studies at the Veterinary Laboratories Agency, Weybridge; P. Digard and W. Barclay for providing the component plasmids of the minireplicon assays; and Cobb-Vantress Ltd. for supporting part of this work. This work was supported by the Biotechnology and Biological Sciences Research Council (grants BB/G00479X/1, BBS/B/00239, and BBS/B/00301) and by the Cambridge Infectious Diseases Consortium Department for Environment, Food and Rural Affairs-Higher Education Funding Council for England (grant VT0105). Crown Copyright 2010.	Biswas SK, 1996, J VIROL, V70, P6716, DOI 10.1128/JVI.70.10.6716-6722.1996; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; Chen JZ, 2008, J INFECT DIS, V197, pS25, DOI 10.1086/524987; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Howard W, 2007, AVIAN DIS, V51, P393, DOI 10.1637/7645-050906R1.1; Hunter CV, 2005, TRENDS MOL MED, V11, P293, DOI 10.1016/j.molmed.2005.04.001; Luo GX, 1997, J GEN VIROL, V78, P2329, DOI 10.1099/0022-1317-78-9-2329; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Swayne DE, 2001, AVIAN DIS, V45, P355, DOI 10.2307/1592975; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Umbach JL, 2010, MBIO, V1, DOI 10.1128/mBio.00204-10; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; WEBSTER RG, 1995, AM J RESP CRIT CARE, V152, pS25, DOI 10.1164/ajrccm/152.4_Pt_2.S25	14	126	136	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					223	226		10.1126/science.1198020	http://dx.doi.org/10.1126/science.1198020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233391				2022-12-01	WOS:000286433100045
J	Silk, AW; McTigue, KM				Silk, Ann Willman; McTigue, Kathleen M.			Reexamining the Physical Examination for Obese Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BODY-MASS INDEX; BREAST-CANCER; DIAGNOSIS; STAGE		[Silk, Ann Willman] Univ Pittsburgh, Sch Med, UPMC Montefiore Hosp, Internal Med Residency Program, Pittsburgh, PA 15213 USA; [McTigue, Kathleen M.] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Silk, AW (corresponding author), Univ Pittsburgh, Sch Med, UPMC Montefiore Hosp, Internal Med Residency Program, N-713,200 Lothrop St, Pittsburgh, PA 15213 USA.	awsilk@gmail.com	Silk, Ann/J-6752-2017	Silk, Ann/0000-0003-3877-3984				Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Chagpar AB, 2007, AM SURGEON, V73, P555; Cooke M, 2010, NEW ENGL J MED, V362, P1253, DOI 10.1056/NEJMp0911502; Ferrante JM, 2007, AM J PREV MED, V32, P525, DOI 10.1016/j.amepre.2007.02.004; Ferrante JM, 2010, OBESITY, V18, P1153, DOI 10.1038/oby.2009.481; Fink HA, 2000, ARCH INTERN MED, V160, P833, DOI 10.1001/archinte.160.6.833; Hahn KME, 2007, AM J EPIDEMIOL, V166, P1035, DOI 10.1093/aje/kwm177; National Center for Health Statistics, 2017, HLTH US 2016 CHARTB; National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; WILLIAMS JW, 1992, JAMA-J AM MED ASSOC, V267, P2645, DOI 10.1001/jama.267.19.2645	10	31	32	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					193	194		10.1001/jama.2010.1950	http://dx.doi.org/10.1001/jama.2010.1950			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21191004				2022-12-01	WOS:000286103400026
J	Decramer, M; Sibille, Y				Decramer, Marc; Sibille, Yves			European conference on chronic respiratory disease	LANCET			English	Editorial Material							PULMONARY REHABILITATION; COPD; CHILDHOOD; IMPACT		[Decramer, Marc] Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium; [Sibille, Yves] Univ Louvain, Louvain, Belgium	KU Leuven	Decramer, M (corresponding author), Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium.	marc.decramer@uzleuven.be						Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Brooks D, 2007, CAN RESPIR J, V14, P87, DOI 10.1155/2007/951498; Bush A, 2008, COPD, V5, P53, DOI 10.1080/15412550701815965; Casas A, 2006, EUR RESPIR J, V28, P123, DOI 10.1183/09031936.06.00063205; Chronic Disease Alliance, UN PREV APPR; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; *EUR COMM, 2009, SURV TOB AN REP; Gibson J, 2013, EUROPEAN LUNG WHITE BOOK: RESPIRATORY HEALTH AND DISEASE IN EUROPE, P16; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Laurent GJ, 2004, THORAX, V59, P1010, DOI 10.1136/thx.2004.024182; Li YF, 2005, CHEST, V127, P1232, DOI 10.1378/chest.127.4.1232; Munthe-Kaas MC, 2010, J ALLERGY CLIN IMMUN, V125, P1361, DOI 10.1016/j.jaci.2010.02.010; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; The Forum of International Respiratory Societies (FIRS), YEAR LUNG; Troosters T, 2005, AM J RESP CRIT CARE, V172, P19, DOI 10.1164/rccm.200408-1109SO; WHO, 2008, WORLD HLTH STAT	18	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					104	106		10.1016/S0140-6736(10)62239-8	http://dx.doi.org/10.1016/S0140-6736(10)62239-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21168909				2022-12-01	WOS:000286292800007
J	Bao, YH; Shen, XT				Bao, Yunhe; Shen, Xuetong			SnapShot: Chromatin Remodeling: INO80 and SWR1	CELL			English	Editorial Material							COMPLEXES; TRANSCRIPTION; REPAIR		[Bao, Yunhe; Shen, Xuetong] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Bao, YH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA.			Shen, Xuetong/0000-0002-4267-5298	NIGMS NIH HHS [R01 GM093104] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093104] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altaf M, 2009, BIOCHEM CELL BIOL, V87, P35, DOI 10.1139/O08-140; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Lu PYT, 2009, BIOCHEM CELL BIOL, V87, P799, DOI 10.1139/O09-062; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001	9	36	38	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					158	U165		10.1016/j.cell.2010.12.024	http://dx.doi.org/10.1016/j.cell.2010.12.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215376	Green Accepted, Bronze			2022-12-01	WOS:000285993600015
J	Alexandrou, MA; Oliveira, C; Maillard, M; McGill, RAR; Newton, J; Creer, S; Taylor, MI				Alexandrou, Markos A.; Oliveira, Claudio; Maillard, Marjorie; McGill, Rona A. R.; Newton, Jason; Creer, Simon; Taylor, Martin I.			Competition and phylogeny determine community structure in Mullerian co-mimics	NATURE			English	Article							POSITIVE INTERACTIONS; STABLE-ISOTOPES; DNA CONTENT; FISH; CONSPICUOUSNESS; FACILITATION; EVOLUTION	Until recently, the study of negative and antagonistic interactions (for example, competition and predation) has dominated our understanding of community structure, maintenance and assembly(1). Nevertheless, a recent theoretical model suggests that positive interactions (for example, mutualisms) may counterbalance competition, facilitating long-term coexistence even among ecologically undifferentiated species(2). Mullerian mimics are mutualists that share the costs of predator education(3) and are therefore ideally suited for the investigation of positive and negative interactions in community dynamics. The sole empirical test of this model in a Mullerian mimetic community supports the prediction that positive interactions outweigh the negative effects of spatial overlap(4) (without quantifying resource acquisition). Understanding the role of trophic niche partitioning in facilitating the evolution and stability of Mullerian mimetic communities is now of critical importance, but has yet to be formally investigated. Here we show that resource partitioning and phylogeny determine community structure and outweigh the positive effects of Mullerian mimicry in a species-rich group of neotropical catfishes. From multiple, independent reproductively isolated allopatric communities displaying convergently evolved colour patterns, 92% consist of species that do not compete for resources. Significant differences in phylogenetically conserved traits (snout morphology and body size) were consistently linked to trait-specific resource acquisition. Thus, we report the first evidence, to our knowledge, that competition for trophic resources and phylogeny are pivotal factors in the stable evolution of Mullerian mimicry rings. More generally, our work demonstrates that competition for resources is likely to have a dominant role in the structuring of communities that are simultaneously subject to the effects of both positive and negative interactions.	[Alexandrou, Markos A.; Maillard, Marjorie; Creer, Simon; Taylor, Martin I.] Bangor Univ, Coll Nat Sci, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab,Environm Ctr Wales, Bangor LL57 2UW, Gwynedd, Wales; [Oliveira, Claudio] Univ Estadual Paulista, Inst Biociencias, Dept Morfol, BR-18618970 Botucatu, SP, Brazil; [McGill, Rona A. R.; Newton, Jason] Scottish Univ Environm Res Ctr, NERC Life Sci Mass Spectrometry Facil, E Kilbride G75 0QF, Lanark, Scotland	Bangor University; Universidade Estadual Paulista; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Taylor, MI (corresponding author), Bangor Univ, Coll Nat Sci, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab,Environm Ctr Wales, Bangor LL57 2UW, Gwynedd, Wales.	m.taylor@bangor.ac.uk	Alexandrou, Markos/E-1509-2012; McGill, Rona/F-1793-2010; Taylor, Martin I/B-4298-2013; Oliveira, Claudio/D-7713-2012; Newton, Jason/A-9536-2009	McGill, Rona/0000-0003-0400-7288; Oliveira, Claudio/0000-0002-7010-8880; Newton, Jason/0000-0001-7594-3693	NERC [NE/C001168/1, NE/F007205/1]; UNESP, Brazil; Natural Environment Research Council [NE/C001168/2] Funding Source: researchfish; NERC [lsmsf010002] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UNESP, Brazil; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by NERC small grant (NE/C001168/1), NERC Mass Spectrometry access grant (NE/F007205/1) awarded to M.I.T., and a NERC PhD studentship (NE/F007205/1) awarded to M.A.A. Research was also supported by UNESP, Brazil. We would like to thank the staff and students of UNESP, Botucatu, Brazil for facilities and research support during fieldwork including P. Venere for helping to collect samples in the Rio Araguaia, and M. Britto for identifying samples. We would also like to thank B. Emerson and G. Ruxton for their suggestions and critical evaluation of the manuscript. We thank J. Montoya-Burgos, M. Sabaj Perez, I. Fuller, H.-G. Evers, M. Walters and K. Mathiesen for providing tissue samples and photographs, and A. Orchard for photographing preserved specimens.	Axenrot T. E., 2003, ICHTHYOL EXPLOR FRES, V14, P249; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Drummond A, 2009, GENEIOUS V4 7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elias M, 2008, PLOS BIOL, V6, P2642, DOI 10.1371/journal.pbio.0060300; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Fuller IA, 2005, IDENTIFYING CORYDORA; Genner MJ, 1999, ECOL LETT, V2, P185; Greven H., 2006, VERHANDLUNGEN GESELL, V5, P65; Gross K, 2008, ECOL LETT, V11, P929, DOI 10.1111/j.1461-0248.2008.01204.x; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kiehl Ernst, 2006, Verhandlungen der Gesellschaft fuer Ichthyologie (GfI) e V, V5, P111; Kovach W. L, 1999, MVSP MULTIVARIATE ST; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Luz-Agostinho KDG, 2008, HYDROBIOLOGIA, V607, P187, DOI 10.1007/s10750-008-9390-4; MAY RM, 1981, AM ZOOL, V21, P903; Merilaita S, 2007, J THEOR BIOL, V245, P268, DOI 10.1016/j.jtbi.2006.10.022; Mualler F., 1878, ZOOL ANZ, V1, P54; Nelson J.S., 2006, FISHES WORLD; NIJSSEN H, 1970, Beaufortia, V18, P1; OLIVEIRA C, 1992, J FISH BIOL, V40, P419, DOI 10.1111/j.1095-8649.1992.tb02587.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWER ME, 1984, ECOLOGY, V65, P523, DOI 10.2307/1941414; RAMBAUT A, 2004, TRACER V1 4; Rowland HM, 2007, NATURE, V448, P64, DOI 10.1038/nature05899; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Ruxton G. D., 2004, AVOIDING ATTACK; Sands D. D., 1994, BEHAV EVOLUTIONARY E; Stachowicz JJ, 2001, BIOSCIENCE, V51, P235, DOI 10.1641/0006-3568(2001)051[0235:MFATSO]2.0.CO;2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Wright JJ, 2011, EVOLUTION, V65, P395, DOI 10.1111/j.1558-5646.2010.01149.x; Wright JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-282; Wuster W, 2004, P ROY SOC B-BIOL SCI, V271, P2495, DOI 10.1098/rspb.2004.2894	42	94	101	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					84	U97		10.1038/nature09660	http://dx.doi.org/10.1038/nature09660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209663				2022-12-01	WOS:000285921600036
J	Jarosz, DF; Lindquist, S				Jarosz, Daniel F.; Lindquist, Susan			Hsp90 and Environmental Stress Transform the Adaptive Value of Natural Genetic Variation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MORPHOLOGICAL EVOLUTION; PHENOTYPIC VARIATION; DRUG-RESISTANCE; CHAPERONE; PROTEIN; CAPACITOR; YEAST; ACTS	How can species remain unaltered for long periods yet also undergo rapid diversification? By linking genetic variation to phenotypic variation via environmental stress, the Hsp90 protein-folding reservoir might promote both stasis and change. However, the nature and adaptive value of Hsp90-contingent traits remain uncertain. In ecologically and genetically diverse yeasts, we find such traits to be both common and frequently adaptive. Most are based on preexisting variation, with causative polymorphisms occurring in coding and regulatory sequences alike. A common temperature stress alters phenotypes similarly. Both selective inhibition of Hsp90 and temperature stress increase correlations between genotype and phenotype. This system broadly determines the adaptive value of standing genetic variation and, in so doing, has influenced the evolution of current genomes.	[Jarosz, Daniel F.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu		Jarosz, Daniel/0000-0003-3497-5888	Broad Institute; Harold and Leila Y. Mathers Foundation; HHMI	Broad Institute; Harold and Leila Y. Mathers Foundation; HHMI(Howard Hughes Medical Institute)	We are grateful to L. Kruglyak, E. Perlstein, L. Cowen, S. Schreiber, A. Regev, I. Barassa, E. Louis, S. Dietzmann, and F. Dietrich for materials, discussion, and help. S.L. is a Howard Hughes Medical Institute (HHMI) investigator, and D.F.J. is an HHMI fellow of the Damon Runyon Cancer Research Foundation (DRG-1964-08). This work was supported by grants from the Broad Institute, the G. Harold and Leila Y. Mathers Foundation, and HHMI.	BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Hikkel I, 2003, J BIOL CHEM, V278, P11427, DOI 10.1074/jbc.M208549200; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ramanathan Arvind, 2007, J Biol, V6, P3, DOI 10.1186/jbiol56; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; VITOLS E, 1970, BIOCHEM BIOPH RES CO, V41, P71, DOI 10.1016/0006-291X(70)90470-5; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324	27	236	241	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1820	1824		10.1126/science.1195487	http://dx.doi.org/10.1126/science.1195487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205668	Green Accepted, Green Submitted			2022-12-01	WOS:000285603700040
J	Katz, KA				Katz, Kenneth A.			Health Hazards of "Don't Ask, Don't Tell"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Katz, Kenneth A.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Katz, Kenneth A.] Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego	Katz, KA (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.							Gates G., 2010, LESBIAN GAY BISEXUAL; Nagel Frederick, 2010, Virtual Mentor, V12, P663, DOI 10.1001/virtualmentor.2010.12.8.pfor1-1008; *OFF SECR DEF, SUMM CHANG REV DONT; OREILLY KB, 2009, AM MED NEWS     1123; Smith DM, 2008, J HOMOSEXUAL, V54, P277, DOI 10.1080/00918360801982173	5	14	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 16	2010	363	25					2380	2381		10.1056/NEJMp1012496	http://dx.doi.org/10.1056/NEJMp1012496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	694ZK	21121826				2022-12-01	WOS:000285340200002
J	Wenk, MR				Wenk, Markus R.			Lipidomics: New Tools and Applications	CELL			English	Article							RAMAN SCATTERING MICROSCOPY; MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; CRYSTAL-STRUCTURE; LIPIDS; PHOSPHOLIPIDS; IDENTIFICATION; MEDIATORS; CHEMISTRY; CELLS	Once viewed simply as a reservoir for carbon storage, lipids are no longer cast as bystanders in the drama of biological systems. The emerging field of lipidomics is driven by technology, most notably mass spectrometry, but also by complementary approaches for the detection and characterization of lipids and their biosynthetic enzymes in living cells. The development of these integrated tools promises to greatly advance our understanding of the diverse biological roles of lipids.	[Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117456, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Ctr Life Sci CeLS, Singapore 117456, Singapore; [Wenk, Markus R.] Univ Basel, CH-4003 Basel, Switzerland	National University of Singapore; National University of Singapore; University of Basel	Wenk, MR (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, 28 Med Dr, Singapore 117456, Singapore.	markus_wenk@nuhs.edu.sg	Wenk, Markus Rene/D-1441-2014					Alving CR, 2006, J LIPOSOME RES, V16, P157, DOI 10.1080/08982100600848553; Andreyev AY, 2010, MOL CELL PROTEOMICS, V9, P388, DOI 10.1074/mcp.M900432-MCP200; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Baker CJO, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S5; Becker JS, 2009, CHEM SOC REV, V38, P1969, DOI 10.1039/b618635c; Berry KAZ, 2010, EUR J MASS SPECTROM, V16, P463, DOI 10.1255/ejms.1083; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Deigner HP, 2008, CURR OPIN LIPIDOL, V19, P289, DOI 10.1097/MOL.0b013e3282fe1d0e; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ernst AM, 2010, FEBS LETT, V584, P1713, DOI 10.1016/j.febslet.2009.12.060; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2007, METHOD ENZYMOL, V432, P247, DOI 10.1016/S0076-6879(07)32011-9; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Gubbens J, 2010, MOL BIOSYST, V6, P1751, DOI 10.1039/c003064n; Hakomori S, 1997, CHEM BIOL, V4, P97, DOI 10.1016/S1074-5521(97)90253-2; Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; KIM HY, 1994, ANAL CHEM, V66, P3977, DOI 10.1021/ac00094a020; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Marshall AG, 2008, P NATL ACAD SCI USA, V105, P18090, DOI 10.1073/pnas.0805069105; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Martin DDO, 2008, FASEB J, V22, P797, DOI 10.1096/fj.07-9198com; Milne SB, 2010, NAT CHEM BIOL, V6, P205, DOI 10.1038/NCHEMBIO.311; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Miskovic L, 2010, TRENDS BIOTECHNOL, V28, P391, DOI 10.1016/j.tibtech.2010.05.003; Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Postle AD, 2009, J CHROMATOGR B, V877, P2716, DOI 10.1016/j.jchromb.2009.03.046; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ridenour WB, 2010, ANAL CHEM, V82, P1881, DOI 10.1021/ac9026115; Rinaldi S, 2010, PROG LIPID RES, V49, P87, DOI 10.1016/j.plipres.2009.09.001; Serhan CN, 2009, J THROMB HAEMOST, V7, P44, DOI 10.1111/j.1538-7836.2009.03396.x; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; SWARTZ GM, 1988, P NATL ACAD SCI USA, V85, P1902, DOI 10.1073/pnas.85.6.1902; SYED SA, 1992, LANCET, V339, P496, DOI 10.1016/0140-6736(92)91106-I; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Thomas MC, 2009, METHODS MOL BIOL, V579, P413, DOI 10.1007/978-1-60761-322-0_21; Tully SE, 2010, J AM CHEM SOC, V132, P3264, DOI 10.1021/ja1000505; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Volkmer A, 2005, J PHYS D APPL PHYS, V38, pR59, DOI 10.1088/0022-3727/38/5/R01; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wheelock CE, 2009, METHODS MOL BIOL, V580, P339, DOI 10.1007/978-1-60761-325-1_19; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yang K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001368; Yang PY, 2010, J AM CHEM SOC, V132, P656, DOI 10.1021/ja907716f; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/nchembio.405, 10.1038/NCHEMBIO.405]	65	412	419	6	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 10	2010	143	6					888	895		10.1016/j.cell.2010.11.033	http://dx.doi.org/10.1016/j.cell.2010.11.033			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	692VB	21145456	Green Accepted, Bronze			2022-12-01	WOS:000285182600007
J	Tozan, Y; Klein, EY; Darley, S; Panicker, R; Laxminarayan, R; Breman, JG				Tozan, Yesim; Klein, Eili Y.; Darley, Sarah; Panicker, Rajashree; Laxminarayan, Ramanan; Breman, Joel G.			Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis	LANCET			English	Article							FALCIPARUM-MALARIA; CHILDREN; PRIORITIES; TANZANIA; HEALTH	Background Severely ill patients with malaria with vomiting, prostration, and altered consciousness cannot be treated orally and need injections. In rural areas, access to health facilities that provide parenteral antimalarial treatment is poor. Safe and effective treatment of most severe malaria cases is delayed or not achieved. Rectal artesunate interrupts disease progression by rapidly reducing parasite density, but should be followed by further antimalarial treatment. We estimated the cost-effectiveness of community-based prereferral artesunate treatment of children suspected to have severe malaria in areas with poor access to formal health care. Methods We assessed the cost-effectiveness (in international dollars) of the intervention from the provider perspective. We studied a cohort of 1000 newborn babies until 5 years of age. The analysis assessed how the cost-effectiveness results changed with low (25%), moderate (50%), high (75%), and full (100%) referral compliance and intervention uptake. Findings At low intervention uptake and referral compliance (25%), the intervention was estimated to avert 19 disability-adjusted life-years (DALYs; 95% CI 16-21) and to cost I$1173 (95% CI 1050-1297) per DALY averted. Under the full uptake and compliance scenario (100%), the intervention could avert 967 DALYs (884-1050) at a cost of I$77 (73-81) per DALY averted. Interpretation Prereferral artesunate treatment is a cost-effective, life-saving intervention, which can substantially improve the management of severe childhood malaria in rural African settings in which programmes for community health workers are in place.	[Tozan, Yesim] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA 02118 USA; [Klein, Eili Y.; Darley, Sarah; Panicker, Rajashree; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Klein, Eili Y.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Tozan, Yesim; Breman, Joel G.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Boston University; Princeton University; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Tozan, Y (corresponding author), Boston Univ, Sch Publ Hlth, Dept Int Hlth, 801 Massachusetts Ave, Boston, MA 02118 USA.	tozan@bu.edu	Klein, Eili/C-3745-2012; Laxminarayan, Ramanan/ABD-5050-2021	Klein, Eili/0000-0002-1304-5289	Disease Control Priorities Project; Fogarty International Center; US National Institutes of Health; Boston University	Disease Control Priorities Project; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University	Funding The Disease Control Priorities Project; Fogarty International Center; US National Institutes of Health; and the Peter Paul Career Development Professorship, Boston University.	[Anonymous], 11 NIH FOG INT CTR; [Anonymous], 2005, METHODS EC EVALUATIO; [Anonymous], 2010, WHO GUID TREATM MAL; Ayeiko P, 2009, COST EFFECT RESOUR A, V7, P3, DOI DOI 10.1186/1478-7547-7-3; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; Font Fidel, 2002, BMC Int Health Hum Rights, V2, P4, DOI 10.1186/1472-698X-2-4; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Idro R, 2006, ANN TROP MED PARASIT, V100, P95, DOI 10.1179/136485906X91459; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mills A., 2000, EC ANAL MALARIA CONT; Montanari RM, 2001, B WORLD HEALTH ORGAN, V79, P648; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Najera JA, 1996, WHOCTDMAL9610; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Onwujekwe O, 2007, ACTA TROP, V101, P95, DOI 10.1016/j.actatropica.2006.07.013; Roca-Feltrer A, 2008, TROP MED INT HEALTH, V13, P771, DOI 10.1111/j.1365-3156.2008.02076.x; Roll Back Malaria, 2007, ROLL BACK MAL; Simba DO, 2009, TROP MED INT HEALTH, V14, P775, DOI 10.1111/j.1365-3156.2009.02299.x; TEKLEHAIMANOT A, 2005, COMING GRIPS MALARIA; U.S. Department of State Bureau of Democracy, 2010, 2009 HUM RIGHTS REP; Warsame M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000149; *WHO, 2009, WORLD MAL REP; World Bank, 1993, WORLD DEV REP INV HL; World Health Organization (WHO), 2005, METH ASS US EST COST	30	25	26	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 4	2010	376	9756					1910	1915		10.1016/S0140-6736(10)61460-2	http://dx.doi.org/10.1016/S0140-6736(10)61460-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KH	21122910				2022-12-01	WOS:000285439800032
J	Lock, K; Smith, RD; Dangour, AD; Brown, MK; Pigatto, G; Hawkes, C; Fisberg, RM; Chalabi, Z				Lock, Karen; Smith, Richard D.; Dangour, Alan D.; Brown, Marcus Keogh; Pigatto, Gessuir; Hawkes, Corinna; Fisberg, Regina Mara; Chalabi, Zaid			Chronic Diseases: Chronic Diseases and Development 2 Health, agricultural, and economic effects of adoption of healthy diet recommendations	LANCET			English	Article							CORONARY-HEART-DISEASE; GLOBAL BURDEN; CONSUMPTION; RISK; TIME; FAT	Transition to diets that are high in saturated fat and sugar has caused a global public health concern as the pattern of food consumption is a mayor modifiable risk factor for chronic non-communicable diseases Although agri food systems are intimately associated with this transition, agriculture and health sectors are largely disconnected in their priorities policy, and analysis with neither side considering the complex inter relation between agri trade patterns of food consumption health, and development We show the importance of connection of these perspectives through estimation of the effect of adopting a healthy diet on population health, agricultural production trade the economy and livelihoods, with a computable general equilibrium approach On the basis of case studies from the UK and Brazil we suggest that benefits of a healthy diet policy will vary substantially between different populations, not only because of population dietary intake but also because of agricultural production trade and other economic factors	[Smith, Richard D.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England; [Lock, Karen; Smith, Richard D.; Dangour, Alan D.; Brown, Marcus Keogh; Chalabi, Zaid] Leverhulme Ctr Integrat Res Agr & Hlth, London, England; [Pigatto, Gessuir] Univ Estadual Paulista, Tupa, Brazil; [Hawkes, Corinna; Fisberg, Regina Mara] Univ Sao Paulo, Fac Publ Hlth, Sao Paulo, Brazil	University of London; London School of Hygiene & Tropical Medicine; Universidade Estadual Paulista; Universidade de Sao Paulo	Smith, RD (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, 15-17 Tavistock Pl, London WC1H 9SH, England.		Fisberg, Regina Mara/Q-6494-2019; Fisberg, Regina M/C-4069-2012; Pigatto, Gessuir GP/F-9053-2012	Fisberg, Regina Mara/0000-0002-4490-9035; Fisberg, Regina M/0000-0002-4490-9035; Pigatto, Gessuir GP/0000-0002-5240-2381; Smith, Richard/0000-0003-3837-6559; Dangour, Alan/0000-0001-6908-1273; Keogh-Brown, Marcus/0000-0002-7556-0016				*ABEF, 2008, REL AN 2008 2009; *ABIPECS, 2008, REL AB 2008; Allender S., 2008, CORONARY HEART DIS S; BATES B, 2010, NATL DIET NUTR SURVE; Beutels P, 2008, HEALTH ECON, V17, P1317, DOI 10.1002/hec.1339; Castro Michelle Alessandra de, 2009, Rev. Saúde Pública, V43, P991, DOI 10.1590/S0034-89102009005000084; *CENTR INT AG, 2009, WORLD FACTB GDP COMP; Curioni C, 2009, REV PANAM SALUD PUBL, V25, P9, DOI 10.1590/S1020-49892009000100002; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; DEJESUS C, 2007, CADEIA CARNE FRANGO, P191; DENKE MA, 1991, AM J CLIN NUTR, V54, P1036, DOI 10.1093/ajcn/54.6.1036; Ezzati M., 2004, COMP QUANTIFICATION; *FAO, 2008, LIV LONG SHAD ENV IS; FAO, 2008, STAT FOOD INS WORLD; *FAO STAT DIV, 2009, SUMM WORLD FOOD AGR; Fisberg RM, 2006, J AM DIET ASSOC, V106, P2067, DOI 10.1016/j.jada.2006.09.010; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; GENEAU R, 2010, LANCET, DOI DOI 10.1016/S0140.6736(10)61414-6; Hawkes C, 2010, TRADE FOOD DIET HLTH; Hawkes C, 2007, FOOD NUTR BULL, V28, pS312, DOI 10.1177/15648265070282S210; Hawkes C, 2006, B WORLD HEALTH ORGAN, V84, P984, DOI 10.2471/BLT.05.025650; *HLTH SAF EX, EST DAYS FULL DAY EQ; *HLTH SAF EX, EST INC RAT SELF REP; *HM GOV, 2008, FOOD MATT STRAT 21 C; Horridge M, 2008, EXERCISES CONTRIBUTI; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; *IBGE, 2001, EST PESQ INF DEM SOC; *ILO, 2010, EC ACT POP 1950 2010; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Lock K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2403; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Moura EC, 2009, REV PANAM SALUD PUBL, V26, P17, DOI 10.1590/S1020-49892009000700003; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; *NAT, BRAZ LAB STATS; *OFF NAT STAT, 2010, LAB MARK STAT STAT B; *OFF NAT STAT, LAB FORC SURV 2005; Pattanayak SK, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.2096; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; SCARF H, 1967, SIAM J APPL MATH, V15, P1328, DOI 10.1137/0115116; SCARF HE, 1967, 10 EC STUDIES TRADIT; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Smith RD, 2006, APPL HEALTH ECON HEA, V5, P55, DOI 10.2165/00148365-200605010-00007; Smith RD, 2010, J PUBLIC HEALTH-UK, V32, P2, DOI 10.1093/pubmed/fdp122; Smith RD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4571; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; Srinivasan CS, 2006, FOOD POLICY, V31, P53, DOI 10.1016/j.foodpol.2005.08.002; Stamler J, 2010, AM J CLIN NUTR, V91, P497, DOI 10.3945/ajcn.2010.29216; TARINO PWS, 2010, AM J CLIN NUTR, V91, P502; *UN FAO, FAOSTAT FOOD CONS DA; *WCRF, 2007, FOOD NUTR PHYS ACT P, pCH10; WHO, 2008, WORLD HLTH STAT 2008; *WHO FAO, 2003, TECHN REP SER WHO FA, V916; *WHO FAO, 2008, COD AL AN FOOD PROD; World Health Organization, 2009, GLOB HLTH RISKS MORT; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; YACH D, 2004, GLOB STRAT DIET PHYS; Ye CY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-62	61	78	79	2	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 13	2010	376	9753					1699	1709		10.1016/S0140-6736(10)61352-9	http://dx.doi.org/10.1016/S0140-6736(10)61352-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	683DD	21074259				2022-12-01	WOS:000284451000035
J	Arrenberg, AB; Stainier, DYR; Baier, H; Huisken, J				Arrenberg, Aristides B.; Stainier, Didier Y. R.; Baier, Herwig; Huisken, Jan			Optogenetic Control of Cardiac Function	SCIENCE			English	Article							CONDUCTION SYSTEM; ZEBRAFISH; CHANNELRHODOPSIN-2; DISSECTION; BEHAVIOR	The cardiac pacemaker controls the rhythmicity of heart contractions and can be substituted by a battery-operated device as a last resort. We created a genetically encoded, optically controlled pacemaker by expressing halorhodopsin and channelrhodopsin in zebrafish cardiomyocytes. Using patterned illumination in a selective plane illumination microscope, we located the pacemaker and simulated tachycardia, bradycardia, atrioventricular blocks, and cardiac arrest. The pacemaker converges to the sinoatrial region during development and comprises fewer than a dozen cells by the time the heart loops. Perturbation of the activity of these cells was entirely reversible, demonstrating the resilience of the endogenous pacemaker. Our studies combine optogenetics and light-sheet microscopy to reveal the emergence of organ function during development.	[Stainier, Didier Y. R.; Huisken, Jan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Stainier, Didier Y. R.; Huisken, Jan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Arrenberg, Aristides B.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 95158 USA; [Arrenberg, Aristides B.] Univ Freiburg, Inst Biol 1, D-79104 Freiburg, Germany; [Huisken, Jan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Freiburg; Max Planck Society	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	didier.stainier@ucsf.edu	Huisken, Jan/B-2472-2009	Huisken, Jan/0000-0001-7250-3756; Arrenberg, Aristides/0000-0001-8262-7381; Stainier, Didier/0000-0002-0382-0026	NIH [HL54737, R01 NS053358]; Packard Foundation; Sandler Opportunity Award; Byers Award for Basic Science; NIH Nanomedicine Development Center; Human Frontier Science Program (HFSP); Boehringer Ingelheim Fonds (B.I.F.); Krevans fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); Sandler Opportunity Award; Byers Award for Basic Science; NIH Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Boehringer Ingelheim Fonds (B.I.F.)(Boehringer Ingelheim); Krevans fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Mikawa, R. Shaw, and A. Mussigbrodt for feedback and comments on the manuscript. Supported by NIH grant HL54737 (D.Y.R.S.), the Packard Foundation (D.Y.R.S.), NIH grant R01 NS053358 (H.B.), a Sandler Opportunity Award, the Byers Award for Basic Science (H.B.), and the NIH Nanomedicine Development Center "Optical Control of Biological Functions" (H.B.). J.H. was supported by a Human Frontier Science Program (HFSP) cross-disciplinary fellowship. A.B.A. was supported by a Boehringer Ingelheim Fonds (B.I.F.) and a Krevans fellowship. The optogenetic idea, transgenic lines, and original observation originated in H.B.'s lab; follow-up experiments were carried out in D.Y.R.S.'s lab as an equal collaboration between A.B.A. and J.H. All authors worked on the manuscript, which was drafted by A.B.A. and J.H.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Baier H, 2009, CURR OPIN NEUROBIOL, V19, P553, DOI 10.1016/j.conb.2009.08.001; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Jenkins MW, 2010, NAT PHOTONICS, V4, P623, DOI 10.1038/NPHOTON.2010.166; Jongbloed MRM, 2008, THESCIENTIFICWORLDJO, V8, P239, DOI 10.1100/tsw.2008.40; KAMINO K, 1981, NATURE, V290, P595, DOI 10.1038/290595a0; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mikawa T, 2007, SEMIN CELL DEV BIOL, V18, P90, DOI 10.1016/j.semcdb.2006.12.008; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nygren A, 1998, CIRC RES, V82, P63; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; SCHERF D., 1927, ZEIT SCHR GES EXP MED, V57, P188, DOI 10.1007/BF02610224; Scherz PJ, 2008, DEVELOPMENT, V135, P1179, DOI 10.1242/dev.010694; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Sedmera D, 2003, AM J PHYSIOL-HEART C, V284, pH1152, DOI 10.1152/ajpheart.00870.2002; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; WILDERS R, 2007, C P IEEE ENG MED BIO, P152; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	28	313	324	5	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					971	974		10.1126/science.1195929	http://dx.doi.org/10.1126/science.1195929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	21071670				2022-12-01	WOS:000284118000045
J	Han, DW; Tapia, N; Joo, JY; Greber, B; Arauzo-Bravo, MJ; Bernemann, C; Ko, K; Wu, GM; Stehling, M; Do, JT; Scholer, HR				Han, Dong Wook; Tapia, Natalia; Joo, Jin Young; Greber, Boris; Arauzo-Bravo, Marcos J.; Bernemann, Christof; Ko, Kinarm; Wu, Guangming; Stehling, Martin; Do, Jeong Tae; Schoeler, Hans R.			Epiblast Stem Cell Subpopulations Represent Mouse Embryos of Distinct Pregastrulation Stages	CELL			English	Article							CLONAL ANALYSIS; GROUND-STATE; PLURIPOTENCY; EXPRESSION; NANOG; LINES; CYCLE; MICE	Embryonic stem cells (ESCs) comprise at least two populations of cells with divergent states of pluripotency. Here, we show that epiblast stem cells (EpiSCs) also comprise two distinct cell populations that can be distinguished by the expression of a specific Oct4-GFP marker. These two subpopulations, Oct4-GFP positive and negative EpiSCs, are capable of converting into each other in vitro. Oct4-GFP positive and negative EpiSCs are distinct from ESCs with respect to global gene expression pattern, epigenetic profile, and Oct4 enhancer utilization. Oct4-GFP negative cells share features with cells of the late mouse epiblast and cannot form chimeras. However, Oct4-GFP positive EpiSCs, which only represent a minor EpiSC fraction, resemble cells of the early epiblast and can readily contribute to chimeras. Our findings suggest that the rare ability of EpiSCs to contribute to chimeras is due to the presence of the minor EpiSC fraction representing the early epiblast.	[Han, Dong Wook; Tapia, Natalia; Joo, Jin Young; Greber, Boris; Arauzo-Bravo, Marcos J.; Bernemann, Christof; Wu, Guangming; Stehling, Martin; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Ko, Kinarm] Konkuk Univ, Inst Biomed Sci & Technol, Ctr Stem Cell Res, Seoul 143701, South Korea; [Ko, Kinarm] Konkuk Univ, Sch Med, Dept Neurosci, Seoul 143701, South Korea; [Do, Jeong Tae] CHA Univ, CHA Stem Cell Inst, Lab Stem Cell & Dev Biol, Seoul 135081, South Korea; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Konkuk University; Konkuk University; Konkuk University Medical Center; Pochon Cha University; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	, HS/AAB-4434-2019; Marcos, Arauzo-Bravo/A-1706-2011; Han, Dong Wook/D-6041-2011; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Wu, Guangming/0000-0003-1923-7609; Tapia, Natalia/0000-0003-0226-1952; Greber, Boris/0000-0002-9404-7293; Do, Jeong Tae/0000-0001-6721-1441	Federal Ministry of Education and Research (BMBF) initiative [01GN0539]	Federal Ministry of Education and Research (BMBF) initiative(Federal Ministry of Education & Research (BMBF))	We are indebted to all members of the Scholer laboratory for fruitful discussions on the results. We are especially grateful to Dr. Paul Tesar for providing the T9 EpiSC line. We are also grateful to Goran Key, Inge Sobek-Klocke, Martina Sinn, and David Obridge for technical assistance and Areti Malapetsas for editing the manuscript. This work was supported by the Federal Ministry of Education and Research (BMBF) initiative "Cell-Based Regenerative Medicine" (Grant 01GN0539).	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P349; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lovell-Badge R, 2007, NAT BIOTECHNOL, V25, P1114, DOI 10.1038/nbt1007-1114; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	25	166	172	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					617	627		10.1016/j.cell.2010.10.015	http://dx.doi.org/10.1016/j.cell.2010.10.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21056461	Bronze			2022-12-01	WOS:000284149100018
J	Clarkson, AN; Huang, BS; MacIsaac, SE; Mody, I; Carmichael, ST				Clarkson, Andrew N.; Huang, Ben S.; MacIsaac, Sarah E.; Mody, Istvan; Carmichael, S. Thomas			Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke	NATURE			English	Article							RECEPTOR SUBUNITS; ALPHA-5 SUBUNIT; PLASTICITY; BRAIN; MECHANISMS; RATS; MICE; REORGANIZATION; CONDUCTANCES; ACTIVATION	Stroke is a leading cause of disability, but no pharmacological therapy is currently available for promoting recovery. The brain region adjacent to stroke damage-the peri-infarct zone-is critical for rehabilitation, as it shows heightened neuroplasticity, allowing sensorimotor functions to re-map from damaged areas(1-3). Thus, understanding the neuronal properties constraining this plasticity is important for the development of new treatments. Here we show that after a stroke in mice, tonic neuronal inhibition is increased in the peri-infarct zone. This increased tonic inhibition is mediated by extrasynaptic GABA(A) receptors and is caused by an impairment in GABA (gamma-aminobutyric acid) transporter (GAT-3/GAT-4) function. To counteract the heightened inhibition, we administered in vivo a benzodiazepine inverse agonist specific for alpha 5-subunit-containing extrasynaptic GABA(A) receptors at a delay after stroke. This treatment produced an early and sustained recovery of motor function. Genetically lowering the number of alpha 5- or delta-subunit-containing GABA(A) receptors responsible for tonic inhibition also proved beneficial for recovery after stroke, consistent with the therapeutic potential of diminishing extrasynaptic GABA(A) receptor function. Together, our results identify new pharmacological targets and provide the rationale for a novel strategy to promote recovery after stroke and possibly other brain injuries.	[Clarkson, Andrew N.; Huang, Ben S.; MacIsaac, Sarah E.; Mody, Istvan; Carmichael, S. Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Huang, Ben S.; Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA; [Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Carmichael, ST (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 635 Charles Young Dr S, Los Angeles, CA 90095 USA.	scarmichael@mednet.ucla.edu	Huang, Ben S./AAH-8370-2019	Huang, Ben S./0000-0003-2838-6315; Carmichael, S Thomas/0000-0002-1169-9203; Clarkson, Andrew/0000-0003-3804-3834	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Larry L. Hillblom Foundation; Coelho Endowment; National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS30549]; American Heart Association; New Zealand Neurological Foundation; Health Research Council of New Zealand; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R01NS030549] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Larry L. Hillblom Foundation; Coelho Endowment; National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); New Zealand Neurological Foundation; Health Research Council of New Zealand(Health Research Council of New Zealand); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I.M., A.N.C. and S.T.C. were supported by The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. S.T.C. was supported by the Larry L. Hillblom Foundation, I. M. was supported by the Coelho Endowment and National Institutes of Health/National Institute of Neurological Disorders and Stroke grant NS30549. This manuscript was completed partially during tenure of an American Heart Association Postdoctoral Fellowship, a Repatriation Fellowship from the New Zealand Neurological Foundation and the Sir Charles Hercus Fellowship from the Health Research Council of New Zealand (A.N.C.). We thank E. O. Mann, J. Chu, J. J. Overman, J. Zhong and R. M. Lazaro for discussion and assistance.	Alonso-Alonso Miguel, 2007, Cerebrovasc Dis, V24 Suppl 1, P157, DOI 10.1159/000107392; Atack JR, 2006, NEUROPHARMACOLOGY, V51, P1023, DOI 10.1016/j.neuropharm.2006.04.018; BARLOW R, 1990, TRENDS PHARMACOL SCI, V11, P404, DOI 10.1016/0165-6147(90)90146-Y; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Collinson N, 2002, J NEUROSCI, V22, P5572; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Di Lazzaro V, 2010, CEREB CORTEX, V20, P1523, DOI 10.1093/cercor/bhp216; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Dobkin BH, 2008, NAT CLIN PRACT NEURO, V4, P76, DOI 10.1038/ncpneuro0709; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, pE288, DOI 10.1161/STROKEAHA.109.551820; Foeller E, 2005, J NEUROPHYSIOL, V94, P4387, DOI 10.1152/jn.00553.2005; Frahm C, 2004, J COMP NEUROL, V478, P176, DOI 10.1002/cne.20282; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Keros S, 2005, J NEUROPHYSIOL, V94, P2073, DOI 10.1152/jn.00520.2005; Kharlamov EA, 2008, BRAIN RES, V1210, P29, DOI 10.1016/j.brainres.2008.02.070; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Moore CS, 2008, J NEUROIMMUNOL, V203, P79, DOI 10.1016/j.jneuroim.2008.06.030; Neumann-Haefelin T, 1998, NEUROSCIENCE, V87, P871, DOI 10.1016/S0306-4522(98)00124-9; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Que M, 1999, NEUROSCIENCE, V93, P1233, DOI 10.1016/S0306-4522(99)00197-9; Redecker C, 2000, J NEUROSCI, V20, P5045; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Tanaka Y, 2008, J NEUROSCI METH, V171, P118, DOI 10.1016/j.jneumeth.2008.02.021; Verheugen JAH, 1999, J NEUROSCI, V19, P2546; Walker Matthew C., 2008, V44, P29, DOI 10.1007/400_2007_030; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029	38	573	591	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					305	U193		10.1038/nature09511	http://dx.doi.org/10.1038/nature09511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	21048709	Green Submitted, Green Accepted			2022-12-01	WOS:000284051000051
J	Levi, M; Levy, JH; Andersen, HF; Truloff, D				Levi, Marcel; Levy, Jerrold H.; Andersen, Henning Friis; Truloff, David			Safety of Recombinant Activated Factor VII in Randomized Clinical Trials.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COAGULATION-FACTOR-VII; DOUBLE-BLIND; INTRACEREBRAL HEMORRHAGE; RISK-FACTORS; EFFICACY; CIRRHOSIS; THERAPY; SURGERY; PHARMACOKINETICS; TRANSFUSION	Background: The use of recombinant activated factor VII (rFVIIa) on an off-label basis to treat life-threatening bleeding has been associated with a perceived increased risk of thromboembolic complications. However, data from placebo-controlled trials are needed to properly assess the thromboembolic risk. To address this issue, we evaluated the rate of thromboembolic events in all published randomized, placebo-controlled trials of rFVIIa used on an off-label basis. Methods: We analyzed data from 35 randomized clinical trials (26 studies involving patients and 9 studies involving healthy volunteers) to determine the frequency of thromboembolic events. The data were pooled with the use of random-effects models to calculate the odds ratios and 95% confidence intervals. Results: Among 4468 subjects (4119 patients and 349 healthy volunteers), 498 had thromboembolic events (11.1%). Rates of arterial thromboembolic events among all 4468 subjects were higher among those who received rFVIIa than among those who received placebo (5.5% vs. 3.2%, P=0.003). Rates of venous thromboembolic events were similar among subjects who received rFVIIa and those who received placebo (5.3% vs. 5.7%). Among subjects who received rFVIIa, 2.9% had coronary arterial thromboembolic events, as compared with 1.1% of those who received placebo (P=0.002). Rates of arterial thromboembolic events were highest among subjects older than 65 years of age, as compared with those who were 65 years of age or younger (9.0% vs. 3.8%, P=0.003); the rates were especially high among subjects 75 years of age or older, as compared with those who were younger than 75 years of age (10.8% vs. 4.1%, P=0.02). Conclusions: In a large and comprehensive cohort of persons in placebo-controlled trials of rFVIIa, treatment with high doses of rFVIIa on an off-label basis significantly increased the risk of arterial but not venous thromboembolic events, especially among the elderly. (Funded by Novo Nordisk.) N Engl J Med 2010;363:1791-800.	[Levi, Marcel] Univ Amsterdam, Acad Med Ctr, Dept Med F4, NL-1105 AZ Amsterdam, Netherlands; [Levy, Jerrold H.] Emory Univ, Sch Med, Atlanta, GA USA; [Andersen, Henning Friis; Truloff, David] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark	University of Amsterdam; Academic Medical Center Amsterdam; Emory University; Novo Nordisk	Levi, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med F4, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.m.levi@amc.uva.nl	Levi, Marcel/AAZ-8559-2020		Novo Nordisk	Novo Nordisk(Novo Nordisk)	Supported by Novo Nordisk.	Abbott RD, 2003, J CLIN EPIDEMIOL, V56, P479, DOI 10.1016/S0895-4356(02)00611-X; Abshire T, 2008, SEMIN HEMATOL, V45, pS3, DOI 10.1053/j.seminhematol.2008.03.006; Aledort LM, 2004, J THROMB HAEMOST, V2, P1700, DOI 10.1111/j.1538-7836.2004.00944.x; Bijsterveld NR, 2004, BRIT J HAEMATOL, V124, P653, DOI 10.1111/j.1365-2141.2003.04811.x; Bijsterveld NR, 2002, CIRCULATION, V106, P2550, DOI 10.1161/01.CIR.0000038501.87442.02; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Bosch J, 2004, GASTROENTEROLOGY, V127, P1123, DOI 10.1053/j.gastro.2004.07.015; Bosch J, 2008, HEPATOLOGY, V47, P1604, DOI 10.1002/hep.22216; CARRENO V, 2001, 18 C INT SOC THROMB, pP2612; Chuansumrit A, 2005, BLOOD COAGUL FIBRIN, V16, P549, DOI 10.1097/01.mbc.0000186837.78432.2f; Diprose P, 2005, BRIT J ANAESTH, V95, P596, DOI 10.1093/bja/aei244; Ekert H, 2006, BLOOD COAGUL FIBRIN, V17, P389, DOI 10.1097/01.mbc.0000233369.03358.c1; Erhardtsen E, 1998, BLOOD COAGUL FIBRIN, V9, P741, DOI 10.1097/00001721-199811000-00003; Fridberg MJ, 2005, BLOOD COAGUL FIBRIN, V16, P259, DOI 10.1097/01.mbc.0000169218.15926.34; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; Friederich PW, 2003, LANCET, V361, P1138; Friederich PW, 2001, CIRCULATION, V103, P2555; Gill R, 2009, CIRCULATION, V120, P21, DOI 10.1161/CIRCULATIONAHA.108.834275; Hedner U, 2008, THROMB HAEMOSTASIS, V100, P557, DOI 10.1160/TH08-07-0434; Hedner U, 2006, SEMIN THROMB HEMOST, V32, P77, DOI 10.1055/s-2006-939557; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Levi M, 2005, CRIT CARE MED, V33, P883, DOI 10.1097/01.CCM.0000159087.85970.38; Levy JH, 2006, TRANSFUSION, V46, P919, DOI 10.1111/j.1537-2995.2006.00824.x; Lodge JPA, 2005, LIVER TRANSPLANT, V11, P973, DOI 10.1002/lt.20470; Lodge JPA, 2005, ANESTHESIOLOGY, V102, P269, DOI 10.1097/00000542-200502000-00006; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mayer SA, 2006, NEUROCRIT CARE, V4, P206, DOI 10.1385/NCC:4:3:206; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; Pihusch M, 2005, J THROMB HAEMOST, V3, P1935, DOI 10.1111/j.1538-7836.2005.01523.x; Planinsic RM, 2005, LIVER TRANSPLANT, V11, P895, DOI 10.1002/lt.20458; Raobaikady R, 2005, BRIT J ANAESTH, V94, P586, DOI 10.1093/bja/aei102; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; Sachs B, 2007, SPINE, V32, P2285, DOI 10.1097/BRS.0b013e3181557d45; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Shao YF, 2006, AM J SURG, V191, P245, DOI 10.1016/j.amjsurg.2005.10.019; Villar A, 2004, HAEMOPHILIA, V10, P352, DOI 10.1111/j.1365-2516.2004.00925.x; Wolzt M, 2004, THROMB HAEMOSTASIS, V91, P1090, DOI 10.1160/TH03-09-0605	41	445	466	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 4	2010	363	19					1791	1800		10.1056/NEJMoa1006221	http://dx.doi.org/10.1056/NEJMoa1006221			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674YK	21047223				2022-12-01	WOS:000283787800004
